<SEC-DOCUMENT>0000899923-21-000021.txt : 20210316
<SEC-HEADER>0000899923-21-000021.hdr.sgml : 20210316
<ACCEPTANCE-DATETIME>20210316142440
ACCESSION NUMBER:		0000899923-21-000021
CONFORMED SUBMISSION TYPE:	10-KT
PUBLIC DOCUMENT COUNT:		131
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210316
DATE AS OF CHANGE:		20210316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-KT
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		21745133

	BUSINESS ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
		BUSINESS PHONE:		801-584-3600

	MAIL ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-KT
<SEQUENCE>1
<FILENAME>mygn-20201231.htm
<DESCRIPTION>10-KT
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:efa3350f-b8a9-4fda-9dc1-67977795f671,g:9ff9af07-fed3-4eeb-865c-11c477b6a054,d:c01b255bce00439ba9380fc219eb70e1--><html xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:mygn="http://www.myriad.com/20201231" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mygn-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl8zLTEtMS0xLTE1MDI2_1eaef4a7-f5b1-4623-b6c1-06b9d67e5791">10-KT</ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl80LTEtMS0xLTA_87a6349a-9b8a-4954-94dd-fbd6d3c4607d">false</ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl82LTEtMS0xLTA_fa5668cb-f72c-435c-95d4-efb06548bb2e">2020</ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl83LTEtMS0xLTA_19693f97-7014-415f-bbbb-48e3743bf4c5">FY</ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl8xOC0xLTEtMS0w_fa5f3cb7-ac37-4d29-b48b-2d01217cd98e">0000899923</ix:nonNumeric><ix:nonNumeric contextRef="i3c7e7c0e30134c1f85ddb2bb2b412b35_D20200701-20201231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYxNA_1b34527f-c366-49c7-adfd-f87850ee8bcc">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i2b6d0590314f493197793e32e6438ba4_D20200701-20201231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc2NA_20a77949-7d3f-4d64-b771-723fbeeb3bce">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i550af371f2b04deca040bcd59c119038_I20201231" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE4MA_d8822eb6-7013-498c-93f5-ea1a56cc78c9">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mygn-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i12f58929baf0442f9477c970c47bf549_I20210309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3713c16ca67a4a2c92019768c7306642_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69f08e4358544efba7545f11fac65d70_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic729b712df4f4a8ead8475fab8f0790d_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib871150772b344349cbdf35a395d8267_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7633cb8e372444994b1efa8de166955_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie935c63c1ef24d07993e26cd5a18d415_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c097ed969db458690ef357352106593_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fbf604a73ce4ed6bb5884b4cb199fac_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib094ccbcf5d544e9803960dda6b5c3f0_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97a926ad86c54867989a14b026bd3593_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i81b96726504343d28522421de58c84e0_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i043df983c75d4d9790fca62e5627f01e_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i605b2c9f9a9b44f3bbf09333a54305b7_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b39f6952cb488a9feeaf585599ff97_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ea8f3abcd243cc8055858b4e824489_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c0e698144e42648f61bbf6031c1c5c_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7794eda7c67461e96370052bfb99427_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a575b7c8ca744ed8ee5d39d3377da1f_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec0b2aaccecb48f5b7031f656787f005_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a96e8e1248b4ab6be94a21fba042643_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44d866f0781417d83a00587086cfc79_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i947239044e8241b8b52a22ece554dedc_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171870dd15d143e2bd07f52254307cce_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99f729f126dc44f9b8d4c81d5418ce8f_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d35e18907a547819b6deae0efc98b7a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95fef7707d9841e09fdeefb682e39bfb_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55d0ee12bc344eeeb30b549901738171_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c71239012bf47869827c00bc3e89106_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i312cecad66074aa4a77f2187852e77ab_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie27fadcacb1f46029eb6fd3895d61378_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6b952dfa944ca698bd7b95b7b9c665_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52119e935ff9454ca95aa15f28434db7_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eefa8a416fd4ec6972a8e54adb82cbc_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie824f0b48e99445ebdbd34568b4a740c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b2496737dd9420db74ac84923507079_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic821396f205a43a1b2be38d8d4ea121d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdbb159f7b6a41a28bf0f80b2e7f99a6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i941e632acb5a4786968dffa4c42b7c43_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cad8a5377bb4f6583cdde4abd9bf533_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5d5fb59c6a349e99c8e0851e720a933_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d1a7c06a6ad43389dd94e306a8d5f31_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i778d038d06274b8a8f9c85edc661fbd2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a7c360decc543eb8824c43a173dc0d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78ee580b5334e728f7c6add95026777_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee94c647141649b6bb2fb3d6b3b18e85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i8f96d09d51df44fbad84bb579131bdab_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10cba38383e5458b892db6d39c7d18c8_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide4c77d70ac54992b13f6f397ae45339_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0deff0d97a2e4113ac45f71cc4c1aee6_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c7e7c0e30134c1f85ddb2bb2b412b35_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff673b26c96b445a959922f9e0f6766d_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b6d0590314f493197793e32e6438ba4_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63bb7805ca1545da94822eeccb9d2208_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea7c3564b9c44c23a5c4dfb365017793_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i875db6ff7af64f6c9b97fad10e61b5fd_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbb4994d91de4c549d6dae2b213aebe6_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8669478b996c461297c9b935fda6b141_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida7c7b6ac227491f92c17991812e3869_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f622f3ae0ff49d8b617b9d61d2c97ad_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3b0cd7d81bb4bb89cd9aa952ab8bd0f_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id09b5abba4b34fb68e4eb34834cba9f1_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52e307d2445b40d8aa07d3ec14ba2be0_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ec76ab3fed647e58dde13a62d7ab5cb_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1612014e0c7849f8bd70b02fabac071a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e77a5395ef4cd98c05a28cd36491b6_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib82a8ffe32674a43a4391daf728784cd_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26f87eb2c79e4687904b9c3be92b905d_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbdba8e49ff540fe876fbb36882f6f5d_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if506fdf6e01e48fabc4c32668075bd86_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2772ca9aefb2473c9f3ff73415e8016b_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e90e77c40c74a8d9ce1811c7fec3667_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8154ac2d56b4a3ebdb3fb57f831633a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69345f3695f9481ca79acaab212b8bc8_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i333fb6ad9b6b43ac9e8439a13405ff71_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i520c7e479d204ea1ab81cbebaa679338_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i139ff307433f4c42ba54d26e15f894d9_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a2be4df4b147d6aad9dab664baae09_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b2dabb0c3074d16846d868ece0861f2_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49a6759c9c7f46b5bea7b177dbc8de41_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92ef11da463d4f049fdb71cb91e6e4ac_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed4976cdda34693bc7a2223ae7a47d8_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdde0ae552b34e9394dd2670d0615284_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bd823528cb5452e9aa3bd695577208b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6fd54ea912347b6bbee02a245eae55c_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51af285dcaea45c8a830624ee2362d76_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04423ea583664800b488265dcd960706_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">mygn:PerformanceObligationEstimatedTransactionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i034631d7d5ef4b7c8d6d34aca4620ab5_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabcdc79361b245d5916d394962a748d5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05d1b3e5218742268c6886435321836a_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2974f743032d446b86850b246d3a169c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd8402868f614fb2b5d8521dad255a8b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1a64b6a9eaf445c8e78ea7644ec0770_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i013cb277d59546beb41c64814afb77eb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8283a90bb7fd45f88844263b5bcf523d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e5b571f465447868a30d8b17e73e370_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i807cd346a0754d6dba10fa435ce3ad0b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic00c784d2aed485bbb379ba0192e5f8e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdb4f19b39fa4edcb9b9756b242e799d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3637c2bf3c6e4176a82ad149102c6280_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i828a886282af459f9e614c44191e6917_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ebf87daee4405886567face5312f8a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ae088f58f74d08ab0ee5cc22457e63_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>mygn:security</xbrli:measure></xbrli:unit><xbrli:context id="ia8a8fb4d167d466eb4a4cce37a8e2b4e_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i931f10a967bd4961a4edc7f16b906bfd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i896a61f417824c539c7a8aaecb838a3c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a9f5109771b480db9fd53efad3cf0a0_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83200f7a7cb74ffb8132d4a54cb8fe09_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c8d3889def46bf8964906a008e20a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib838376273ee40509009d40b54ad4e6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d419b15db0344df99a90536add6f225_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f6fd7e6971b43b1972bf113b61ed7ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488a249f7b4a42e39a29a4875e046abc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a6d1096e6b24d2691f8c3c10e1db359_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f8f4f7fa0654056a7679cd94f503372_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bd6bdb2356e42e79e270f09478ee175_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i239bdbcee2ee46d7816c4aa9f59360cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e81c739fd94f7aa9cd55bdaa5d052f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f0be353e5f417cbe7b3331221c88de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4dcb16a16b64061ab91c4bb405d02f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85bf9bccc1f74000bc926d84844d459f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic516541272e1460189dd7d9460be5e00_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7c5d5ea4d24bd5bc15c709de8583c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75d72cd70f074af99ccef915b106a5c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a837ac64224a79a96732a4ab5ce550_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84dba07dc1964a8eaaa12c3e6bf3ac13_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a4dcb3d42434870ab26e0dc5985c286_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i386c2dd77d7b42f1b542c00daa2a0722_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb92da4147d4f0aa235d0cbea519f7e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c3dd37fd2174277a0fe47e35a4fcb5a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1476418622484fd6b123b4bcc1a2cd75_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie82bd2619aee4c15a6f7979e3f556c90_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id29e6e511f214306bdfcc76ff6f3baac_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd61fd98056c4fe8828fa4f7907744d5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i825805b3de504095bdb13927c6069785_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3089884931004023a798595ad2485260_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2426bfb819934ac9a2b31c1f162f3528_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf88e0e27ffa4a739ee3847915ee542a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b0a8ffc8cf1459d84e87db58725f2de_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc4eeb4c0edb43d59cd752375d0ffdc5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c10b20b0e9404abc88a8f6d54ce6bb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibff6a96abc6e47a3a7673fe45b09702d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea094ed8a36e482dad6d4d4ce8912c5e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i418f1c63d800430dbdfe171f2e5fdb7b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171eeb2ca4ff40c8aa59454fe0649995_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae043b92111d49dea53104af438cae87_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43dfaf6a69a9448dbeaad8511ca6599f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i727b4cea45e840c595ed4071c0efc30f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bbcb194e016455ca224904b253aff7e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i627dc77dc581425492e6a2efc7a71b6a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1779215bab2443df9518c0d760bd4097_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb619380c1df42aca737476da470cd1b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f28be2e5f414109aa6edba56d928690_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29fb3e347dc345cfba47e9db7ea6e116_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28101a6be104f06a27d6e814b1c6d6c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d425a4039143e3bb5d1b13ef3c1d5f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5905013aeeb4f2cb39823bb0b2d36dd_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3993179bb8cd412da2e86291f6b169ba_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6271e87a89724d4d97a244263fb2044b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004fd5a8f7654961a111888fd81ed882_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5590cd4c08ee46cc806334b73e196d71_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e485d31ad9f497993d65a0f26c27664_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6992e3c7faab476d8c03869ab63ff121_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i148159c157ef42c8a13aff97edbcbef2_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8191d090ea2745db981907ddafd93a9d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa2f364539a64eaaa92b3b40cb82a18d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i979b5982652c43468a70262328a06272_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23f0bb6109514d5090ecfde3255f9f3d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15149e8fedda4395b8646b2382f7a984_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5746fc0bcf194215abbb27e272d355fa_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa550eed64f4c2ea0f18c17f0902c9f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb748777a421482d8700ebe22fb9d4ee_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c60fa1e6044f6e8667dcbf536b76df_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i575f18ab83bc40979444ed5ab8404853_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mygn:ClinicAssetGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91ea1f91d8664913a4764506bfd207e4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87ab67a6dd04168b8b70d5bdbae26ca_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0452133252384a1cbc2014d4918a6cae_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6930cef02e60442f932a3ba59be2846f_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cbd1c604d9240fb9eab710d8047bbcb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf79e13bdaa84cbcb926eceecb0225f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib992d3be9ee24862b803ebce955a4939_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe1dff6ed82241299a6565c84a2b4ad3_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7293118ad87849e1979a9a4529ece677_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bd030e591724771a7ef00c6278cee2c_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife885bcb6b0042d8879fb750f6ac752c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mygn:MyriadAutoimmuneReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a2fa48f3c343368a8e72ee16163874_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mygn:ClinicReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08cb205cf6ff477cbb17f7110077d7cd_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:DevelopedTechnologyAndDatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdf71da88168472ba6c7919001d183a6_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:DevelopedTechnologyAndDatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i358e9cbf8de8453c97ef831209748f8b_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90d7ec9fb1de477e8189293731c018d6_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia52ebc6a5c564a3ba28fffe021227a85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82e7ad1d54745bf9f3e53cb046e5adb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83a65cbe1f3b4d65b6f51bc3d1b557ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i063c58e973c84e0c90eb3b292cd80d2f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ceb8d39a9034275a4786f69cadfae9d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05db2823ea2e4f1983fc881d4d120ee6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0836938b4b5749e7b04cda79f7d778d7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5eb1e7015b84a099b7eec0436d24272_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide312d0b744845ed9d38a50c79ac314f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3927b5f25dab43d8bba22d95423cf7a5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i368a22ba17754f239a339d70f874d4e4_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i777e19d7ca9f43749f30b1d52f56cb12_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f6ff2934a84433bafc32b6df84630bf_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8168706f12149b6b5546e5eb8c2880d_I20161223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8db25c9c8c1a4f0d9143e0fa38d1b8c0_I20200501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb698caa638b42d1979314bc3a5847bd_D20200401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id495302512264408b7c35e7b17c70ddd_D20200401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia62ae255eb174dda98733a496df5ac02_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a3ba1b79114c77afaf02ff36fa05be_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if227e7110e014058a767b9bd13ef0d3e_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82d2b9e5a08048bf9897aa33a87b7756_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1482ec3ab648658454bf97344b72e8_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ac03d04962f4c50ba2419ea9529b2bd_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fa5fc13241a4e07b520ff640cb97a2c_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica5c0cd9bacd45798f5d92217ef8280f_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plan"><xbrli:measure>mygn:plan</xbrli:measure></xbrli:unit><xbrli:context id="i0012a57e73a64c94a8b83d10ea8ca5ba_I20160630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6f9ba489d8849db94d404a44fac34d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifee3f7598bd244628200eb7c1522a119_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mygn:OptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib74ba2f47ec14d41bf4fd7f946d4e02f_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">mygn:NonEmployeeDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mygn:OptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd2633e1f6014c3f8b71c92e1326ca6e_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">mygn:OptionsGrantedAfterDecemberFiveTwentyTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56adf440338546748219fa30995a4533_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">mygn:OptionsGrantedPriorToDecemberFiveTwentyTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib34f688522b74b03a5e5fc2174018149_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7cae64d7814598b02a93c49e574096_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i7db90b2bd66041aca744d0be2fd86e66_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc558508c633449db6077544b82b507d_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29183a8749ff4b8b950a784fb91f41f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4d8a6bd4ff54f7fb304b7cde55db513_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if914d6dc8c544ca9bf117a7b245ae056_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b2ee9bf2f354a29b8a1b740bfdc485c_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea4af06edff047ee8cd215ccaf7dd5a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ba05d7b0e05418d9b5864d5649ff8a3_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8e685bf03924016a2c1ce3f87d79686_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05899c67f3004572be84cd6af2e63fe0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13ddbf93c05491fb76d747f160a6ad5_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38be9b78e6e342588bbc14159dd49ce3_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ab2a24695d64791be56bebc9b0cb5c2_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43833f7c5d3b4c9c95d487f7e63e9156_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bfbbfa5a61e4bc6aa5bdeaa03ce3091_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id248408952024238bf703d63749f4e7a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1127c488310e4180956064bbc8092648_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02292b2ac40d46f0810c4f1a5b7d76a1_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c834bbd0ecb46ad9e21a66915c89bee_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7909094154b445eb24949027733ca0d_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69beccee306244899e7edc744b9830e8_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i684fee383d8541d38b5854aeea927eef_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccae9b334463460489fb7e7e124291af_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d841afaaabb47038d152a7cc4778e70_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i670c9600a2a343be93044b942108970a_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie295001ae44145ad9a4d6b31fb6ba297_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31d63dfe2df342b8b82f3e732ee0282e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d855b4fd3e14b829f9b52d5ab9a2dec_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied19858901194f0fb47bb12a54ee79e3_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ad05ffee6ab407185af3f3ebf0e736f_I20121205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5e8d6c3e7334a0db7f88d66dc52bdb9_D20121205-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-12-05</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaf36f83f64d4f13b41bbd03dd9248e5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fac106fccce4731bad8f044406b0d14_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04912f8e67024702bb6f1c7d9d8715ea_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib296c9d50bcd48e081759995543ac418_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7682eeb892144ef397fcb8d2b3f3b075_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i339e09f971f1423ca61ec703598013f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifef84203e8cf4c45a050df8ee892e0ab_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e4dd2b1c99b42c4830a26066e6f5d03_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff189668e46b4b2d99f01b54ece5899e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a77486cbfda4985a95b5409f5114d75_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8dee92637b14ad4b0ddc3ee7a893148_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28b353bd32614ef98f4d1b7b28197946_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i801b880fffca41b7981a7975da3eba9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:OtherStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e435f848ff041c69b87c98ccab2b8f2_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:OtherStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f20a97b70f8439284f983b91fd4a5ce_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:OtherStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7066ecd804994d66ab4a3853aa09f501_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:OtherStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc0e279dbee74c3b96393ff366a521d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i442e0a95c01243a3836a2900086d9a01_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3a8545dd5b34bafb56de3bd607512ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8308537e63d24a72a6fcf5c902e127e2_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i373106c9787844db8567a937ae2715a1_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7667d8c3c8a9406ab36ea5da42680f55_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2893df02bcc84b2e95bf0c21a4687f83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3484e0b911345c28f8748b196210eb4_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65319c42541d4efc8d864e8dcfdd14e9_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if348e8b1625f477a94c7cf316377a0f5_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d7ca3e4ae2740b884faeec8053514ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5b6e713bd16480f900779c66826595d_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i994ec55512434040bf3680a9030ee7ce_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c5f75363cf466e8c5c30864649562a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i394783302fb644de93bf6aa850b4dc82_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92918a0809ac433d8348fe4fa4338b6b_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5864baf1324e4e15b61aadc049035ef1_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa2c73215b4412381289f30cd0a1630_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2263ff4bbd034dac9cc9bc7dbeb427ea_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbfaa476fbe246298adb7720d942ac91_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77fc28b9a23e4dfcaa3fbc650b50adbb_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30273d0d5378455ba4f0bb60b947d31e_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f0397e662d04de99568a428f4703477_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d38d53cfdc4cd0afb30d1604caabf9_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9d4db6aa0484fc0a5e43e4cfb14bc3a_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c324220132439d95ca49aab6989a29_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:FederalMinistryOfFinanceGermanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e4548adbe5b4e3d9fb80fd7b51ed7cb_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:FederalMinistryOfFinanceGermanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i259c8637e98a44e8aec3d5243fde0562_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf91bb0e041742dfbd75694127229a2f_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i550af371f2b04deca040bcd59c119038_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2066eada724e118523d0b6f7522a9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mygn:segment</xbrli:measure></xbrli:unit><xbrli:context id="i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91ef0e4a089942639d68319973aeaa47_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic71c74fc3d084045809129a196e2f974_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i664dad294d884038be88785f325b2bf5_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i476843d04c844d4e95a7e5e176903dcb_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4659bde391c4d01852f685ef94ad2be_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89e55ec2aeb84ba29ad2e15182881349_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ef3b53c398c432a93dbdbb67ae409c1_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i428a5fa0807f4da086f039c34215397a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0db858d5901a46708854a964d2b950ba_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied74c9d465394d488f630f4d4876d14a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4a637b79289401cacaeae110a5223e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b939605911461db48890438cae974c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea3f9a2649e348faaacb48e8cc8e8902_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2a0de5212d9437b9c547a36e207b87f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e876378b87406f8adbbf8ce2e6cddd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i395a6bf2ed5a4516a97cb9dfd143feb1_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950b875f77734623b789ea990425b829_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a1f560877784761aecb5fecd5cc3ec6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb7f24f854d147699f0cbec384e49317_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71f9622e189741ed9e209051bad9c565_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i095006ddbfd24e619e8e422986256785_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9be740ad7044f4882e0d2a5c0a6dc86_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaed4be03cd544752819f842c6fdf12ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d28bb175fb446de9c4a1a2ff2e5f146_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8619e2e18714ee0808436fe3942e76f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8622695f21e2408d87455391982da0ec_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e62f9190914161943bf5ea28f91cef_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc2b51c7302d434a8cc407ad3c95cc0e_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4d9c21becba4a2e82b923527a2ec975_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a0fa951cb5a4ec2b189987010cc8a1c_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib714b0e057fc4f5e8fb0c1045086c48f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe81c4efa2445fdb62fa8055200c3d2_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b03b59516e541509ec6f0854b5b2266_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mygn:ClinicAssetGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-28</xbrli:startDate><xbrli:endDate>2020-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a834facdc34dff87795122a884aa47_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4404c2e49c864be6b8c89615b7c19e72_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01ca278c54bd4c979932880e1cf44d22_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib375fb1450054a4aad0facea3d6370ce_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i989c0ce93f6e4f0fad3b86a4df6adedf_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5274fcc1e4cf4cddb09da83ac2cbc368_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e14cc8f30fb41298c08929c2d88cda2_I20210222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4d51abe6c704a11849ba0fee98381b0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7379beb581ae4463a448487c90805d3e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8d38cab5c564bc9b20105859dec05a3_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i417fd6436fa34961ad7783ba3007e98d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie222e257470d49d4b5328c8b76c753c1_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280a6b01f275425d87a80ea2b0b0a40e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacfe0fce6e9744d5958f4fc65b2cceb5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7da9afb8114544a681d59d52fbda4b5f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia66a2e9352774e61bb66d72a0ec6ba0a_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa76971edb2f495597ee3f81808bc71c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieea11b6adbeb41c5bcf4dadb78975fbb_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5aa650d52994396ad41ee3b0e5b738c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f36b0ed57f4719bdab785d76fd50ae_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c8bb11b2e0d4568a0ef8208b3edb143_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d1e7b850654e99931da975936ee358_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30498117f20e422cbecf6623972988bf_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41ddfab48a7c49588075c9ec7dc244bc_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:GoodwillAndIntangibleAssetImpairmentChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66fa6edac2d94c43bca8e78ac4dac0ea_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eec8d2bdc5c4301bfe722e319ae93cc_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c5f6f6847984744b8727e6b2748075b_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6d258bc15d9449697c4b3d79d8b436b_D20180701-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ad87c73a1144a68bba850b4fd323dcf_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib895d88eeb224f0886c00fd6c2b4b139_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313a22005bec4e29ad90ba1925c6405a_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25884080c80b406690ede2277d9da6dd_D20180701-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea7896145214af8aee0379692eb0499_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf7a7e67e93c4b6c84e303b4742aafc0_D20190701-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c63d45d0a049b1b11b7c5d73024451_D20190701-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic01b255bce00439ba9380fc219eb70e1_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6Nzg5MGZmMmNhMWFiNGY5MWIzNGZlNjE2NTJlYTM4ZmQvdGFibGVyYW5nZTo3ODkwZmYyY2ExYWI0ZjkxYjM0ZmU2MTY1MmVhMzhmZF8wLTAtMS0xLTA_13ff8dc0-4b0a-41fe-b155-57d6b4c64c15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6ZWQ4Yzk5YWE0ZDliNGI0MTlkMDMyYzJlNjEwMDg0MDMvdGFibGVyYW5nZTplZDhjOTlhYTRkOWI0YjQxOWQwMzJjMmU2MTAwODQwM18wLTAtMS0xLTA_f93d2a5c-9cf1-4eb5-b2f7-d63c367fc5a9">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodStartDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDE4_3ab0e08d-0caf-4bdd-b5f4-e309a2511e72">July&#160;1, 2020</ix:nonNumeric> to <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDIy_dfb0fcae-f257-448d-9aad-2e3c0b725faa"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDIy_43c1f6b1-c18f-4e8f-a75a-d9b9511274a0">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number:&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDk2_88839caf-1155-4279-af24-d9140971e5b0">0-26642</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDI3_b5704273-28e1-4eda-9ba1-3bf6b48aa7e5">MYRIAD GENETICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDI4_b07776e6-9cec-4b90-8c59-e61086f159c6">Delaware</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of incorporation or organization)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDI5_eec19089-1b07-4841-964a-1a6dd18370a6">320 Wakara Way</ix:nonNumeric>, <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDMw_99beaa2e-58b0-431f-ba8a-1e3fcd60630a">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDMx_f945fffa-be5f-4c2a-9ec1-ce751a47c6ef">UT</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDMy_9c3e12ed-2539-4aee-a6ab-431f37184c16">87-0494517</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Identification No.)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDM1_d42d7366-8153-4d13-8f18-ccbc25e08126">84108</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDYy_999580d7-f967-4579-ad00-f2f3309a4d90">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDcx_ee81c29e-b69c-4f4c-9469-3b91babb8ba3">584-3600</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6MjcwMDAxM2FmNTlmNDdiYWIwMjI5MTU4ZmI1YjdkY2QvdGFibGVyYW5nZToyNzAwMDEzYWY1OWY0N2JhYjAyMjkxNThmYjViN2RjZF8xLTAtMS0xLTA_b8e90b49-72cb-4ac7-8e19-4b87c35140a6">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6MjcwMDAxM2FmNTlmNDdiYWIwMjI5MTU4ZmI1YjdkY2QvdGFibGVyYW5nZToyNzAwMDEzYWY1OWY0N2JhYjAyMjkxNThmYjViN2RjZF8xLTItMS0xLTA_e7f969d6-e62f-46eb-96ca-6bb388763aa0">MYGN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6MjcwMDAxM2FmNTlmNDdiYWIwMjI5MTU4ZmI1YjdkY2QvdGFibGVyYW5nZToyNzAwMDEzYWY1OWY0N2JhYjAyMjkxNThmYjViN2RjZF8xLTQtMS0xLTA_d1c475c9-f5e7-44c0-8a1f-e864ae1b0be4">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Exchange Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________________________________</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDc5_2175b49b-22ec-4e2c-a484-caabc82262e9">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDc4_fbab5973-63f0-408b-8aac-689aa228b5b3">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDgw_84258246-020b-43bd-97a2-585413537ac1">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDgx_1f790045-2218-4bb4-9b77-02f536290341">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;&#160;See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:20.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.731%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6YzI0ZTBhYWEzNTZhNGM3NmJiYjc5ODk5ZDkyOGMxNDgvdGFibGVyYW5nZTpjMjRlMGFhYTM1NmE0Yzc2YmJiNzk4OTlkOTI4YzE0OF8wLTAtMS0xLTA_cee6c2ac-689f-42bc-9eb4-cbd2a0509c10">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6YzI0ZTBhYWEzNTZhNGM3NmJiYjc5ODk5ZDkyOGMxNDgvdGFibGVyYW5nZTpjMjRlMGFhYTM1NmE0Yzc2YmJiNzk4OTlkOTI4YzE0OF8xLTQtMS0xLTA_a531895e-668d-441e-b6e3-4c0c41c138d3">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6YzI0ZTBhYWEzNTZhNGM3NmJiYjc5ODk5ZDkyOGMxNDgvdGFibGVyYW5nZTpjMjRlMGFhYTM1NmE0Yzc2YmJiNzk4OTlkOTI4YzE0OF8yLTEtMS0xLTA_8a4c673d-a848-494c-8935-30e71cafec51">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. &#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDEx_c9047b46-ddb2-4aab-9f8f-d91ef0db8279">&#9746;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF8zNjUx_2017a06d-f7d6-4212-8e66-ecf9d78b5a69">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the registrant's common stock held by non-affiliates of the registrant (without admitting that any person whose shares are not included in such calculation is an affiliate), computed by reference to the price at which the common stock was last sold on June 30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDgz_77df50a7-5015-4f1d-b4b1-e8ce69e100e4">847,193,483</ix:nonFraction>.&#160;&#160;</span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March&#160;9, 2021 the registrant had <ix:nonFraction unitRef="shares" contextRef="i12f58929baf0442f9477c970c47bf549_I20210309" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF8zMTky_39c1814c-6c94-469b-b9fe-53472cfa9e23">76,297,150</ix:nonFraction> shares of common stock outstanding.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:2pt;text-align:justify"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF8zNjQx_0b6f3d72-57a6-4c1e-85c6-3bb2d7ce4b43" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following documents (or parts thereof) are incorporated by reference into the following parts of this Form 10-K:&#160;&#160;Certain information required in Part III of this Transition Report on Form 10-K is incorporated from the Registrant's Proxy Statement, to be filed no later than 120 days following </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, for the Annual Meeting of Stockholders to be held on June 3, 2021.</span></ix:nonNumeric></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_13">PART I</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_19">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_19">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_22">Item 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_22">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_25">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_25">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_28">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_28">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_31">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_31">44</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_34">PART II</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_37">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_37">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_37">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_40">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_40">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_40">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_43">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_43">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_43">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_67">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_67">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_67">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_70">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_70">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_70">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_181">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_181">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_181">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_184">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_184">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_184">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_187">Item 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_187">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_187">106</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_190">PART III</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_193">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_193">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_193">107</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_196">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_196">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_196">107</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_199">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_199">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_199">107</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_202">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_202">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_202">107</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_205">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_205">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_205">107</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_208">PART IV</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_211">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_211">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_211">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_214">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_214">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_214">111</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_217">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic01b255bce00439ba9380fc219eb70e1_217">112</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company&#8217;s future prospects and make informed investment decisions. This Transition Report on Form 10&#8209;K contains such &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Words such as &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seek,&#8221; &#8220;could,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; &#8220;will,&#8221; &#8220;strategy&#8221; and &#8220;goal&#8221; and words and terms of similar substance used in connection with any discussion of future operating or financial performance, identify forward-looking statements. All forward-looking statements are management&#8217;s present expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">uncertainties associated with COVID-19, including its possible effects on our operations and the demand for our products and services; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to our ability to efficiently and flexibly manage our business amid uncertainties associated with COVID-19; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the risk that sales and profit margins of our existing molecular diagnostic tests and pharmaceutical and clinical services may decline or that we may not be able to operate our business on a profitable basis; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to our ability to generate sufficient revenue from our existing product portfolio or in launching and commercializing new tests; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to changes in governmental or private insurers&#8217; coverage and reimbursement levels for our tests or our ability to obtain reimbursement for our new tests at comparable levels to our existing tests; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to increased competition and the development of new competing tests and services; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the risk that we may be unable to develop or achieve commercial success for additional molecular diagnostic tests and pharmaceutical and clinical services in a timely manner, or at all; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the risk that we may not successfully develop new markets for our molecular diagnostic tests and pharmaceutical and clinical services, including our ability to successfully generate revenue outside the United States; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the risk that licenses to the technology underlying our molecular diagnostic tests and pharmaceutical and clinical services tests and any future tests are terminated or cannot be maintained on satisfactory terms; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to delays or other problems with operating our laboratory testing facilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to public concern over genetic testing in general or our tests in particular;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of the healthcare system or healthcare payment systems; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to our ability to obtain new corporate collaborations or licenses and acquire new technologies or businesses on satisfactory terms, if at all; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we license or acquire; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to our projections about the potential market opportunity for our products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the risk that we or our licensors may be unable to protect or that third parties will infringe the proprietary technologies underlying our tests; the risk of patent-infringement claims or challenges to the validity of our patents; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to changes in intellectual property laws covering our molecular diagnostic tests and pharmaceutical and clinical services, or patents or enforcement, in the United States and foreign countries; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks of new, changing and competitive technologies and regulations in the United States and internationally;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the risk that we may be unable to comply with financial operating covenants under our credit or lending agreements:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the risk that we will be unable to pay, when due, amounts due under our credit or lending agreements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks related to the material weakness identified in our internal control over financial reporting, including the impact thereof and our remediation plan; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">other factors discussed under the heading &#8220;Risk Factors&#8221; contained in Item 1A of this Transition Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of these assumptions, risks and uncertainties, the results and events discussed in the forward-looking statements contained in this Transition Report or in any document incorporated by reference might not occur. Stockholders are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this Transition Report. We are not under any obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements in this Transition Report attributable to us or to any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;We,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Myriad&#8221; and the &#8220;Company&#8221; as used in this Transition Report on Form 10&#8209;K refer to Myriad Genetics, Inc., a Delaware corporation, and its subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Myriad,&#8221; BRACAnalysis, BRACAnalysis CDx, BART, COLARIS, COLARIS AP, MELARIS, myPath, myPlan, myChoice, myRisk, Myriad myRisk, PANEXIA, PREZEON, Prolaris, myChoice CDx, Vectra, Vectraview, TruCulture, DiscoveryMAP, RodentMap, GeneSight, and EndoPredict are registered trademarks or trademarks of Myriad.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_16"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;BUSINESS</span></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transition Period</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 9, 2020, our Board of Directors approved a change in our fiscal year end from the last day of June to a calendar fiscal year ending on the last day of December of each year, effective January 1, 2021. In this Transition Report, references to &#8220;fiscal year&#8221; refer to years ending June 30. References in this report to the &#8220;transition period&#8221; refer to the six-month period ended December&#160;31, 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics and are one of the largest specialty molecular diagnostic laboratories in the world. Since our founding in 1992, we have performed tests for approximately five million patients. Through our proprietary technologies, we believe we are positioned to identify important disease genes, the proteins they produce, and the biological pathways in which they are involved to better understand the genetic basis of human disease. We believe that identifying these biomarkers (DNA, RNA and proteins) will enable us to develop novel molecular diagnostic tests that can provide important information to solve unmet medical needs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Mission</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leader in genetic testing and precision medicine, Myriad Genetics advances the health and well-being of our patients and empowers our patients and healthcare providers with life-changing genetic insights. We apply the power of precision medicine to reveal answers that help better diagnose, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where our genetic expertise can contribute to better health outcomes and lower costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Updates</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We made the following recent announcements of publications, collaborations and coverage decisions: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Announced that Myriad recently signed a contract with the majority of the affiliated health plans of Anthem Blue Cross Blue Shield, which returns all Myriad products to in-network status. The new contract will aid in providing easier access to testing for patients and providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Announced a strategic collaboration with Illumina, Inc. to create a kit-based version of the myChoice&#174; companion diagnostic (CDx) test for select international markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Received Japanese reimbursement for the Myriad myChoice&#174; Diagnostic System, which helps determine if women with ovarian cancer will benefit from the PARP inhibitor, Zejula&#174; (niraparib).</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Announced that technological enhancements to Myriad's Foresight&#174; carrier screen test increased the detection rate for alpha thalassemia inherited blood conditions from 90% to &gt;99% in high-risk ethnicities such as Hispanic patients where the risk of alpha thalassemia can be 200 times greater than the risk of cystic fibrosis. These changes reduced the risk of a false negative by 10 times and improved the accuracy of the Foresight test for ethnic minority populations. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The scientific journal Genetics in Medicine published a study demonstrating that Myriad&#8217;s proprietary AMPLIFY&#174; technology increases the accuracy of the Prequel prenatal screen for five common microdeletions by an average of 9 times.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Received new local coverage determination for the Prolaris&#174; prostate cancer test from two administrative contractors for the Centers for Medicare &amp; Medicaid Services. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Received acceptance for a new study publication in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Prostate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> demonstrating high accuracy for Prolaris in predicting metastases and disease specific mortality in men following a radical prostatectomy and announced that a new study in Clinical Genitourinary Cancer demonstrated that the Prolaris test can accurately predict which patients will benefit from multi-modality therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">Shared new data at the American College of Rheumatology annual meeting further demonstrating that Vectra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> testing and three additional biomarkers, combined with traditional risk factors, can predict the risk of cardiovascular events in patients with rheumatoid arthritis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">Presented a new study highlighting how riskScore, a proprietary tool used to evaluate a woman&#8217;s risk of developing breast cancer, can accurately provide breast cancer risk information in the form of a personalized assessment model for women carrying a pathogenic variant in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ATM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">Announced that the German Federal Joint Committee (G-BA) has successfully completed the method evaluation assessment for the EndoPredict</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> breast cancer prognostic test. The positive decision means that EndoPredict can be made available to all patients with statutory health insurance in Germany as a benefit of the statutory health insurance scheme.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Announced a new publication in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Psychiatry Research</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that demonstrated that the GeneSight combinatorial test was superior to single gene testing using the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines. In a sub-analysis utilizing the GUIDED study data, only the GeneSight combinatorial approach was able to accurately predict variations in outcomes for patients with depression and statistically significantly predicted remission, response, and symptom improvement. Also announced a meta-analysis of 1,556 patients based upon four prospective controlled clinical trials that was published in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacogenomics</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The meta-analysis demonstrated statistically significant improvements in remission, response and symptom improvement. We are actively in discussions with commercial payers based upon these positive data sets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Announced that we are exploring strategic alternatives for the Myriad RBM, Myriad Dermatology, and Myriad Autoimmune business units.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business Strategy</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personalized genetic data, digital, and virtual consumer trends are converging to change traditional models of care. Significant growth opportunities exist to help patient populations with pressing healthcare needs through innovative solutions and services. We look to capitalize on those trends by focusing on the following strategic priorities: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Put patients and customers first by improving the experience through new digital tools;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Build new commercial capabilities;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Elevate core products to full potential; and  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Create new avenues for growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To execute on these priorities, we are first focused on the near term opportunities, including prioritizing product innovation, research and technology initiatives, and defining and deploying a customer-centric technology-enabled commercial model. We believe that by reorganizing around these strategic priorities, we will be able to reduce complexity and cost, improve our financial performance, build a more effective and cost-efficient sales model, and enhance our reimbursement and revenue cycle capabilities. With a foundation of financial, commercial, operational and technological strength, we will accelerate growth as we invest in innovation, research and partnerships, develop capabilities to support our sales team with new digital tools and add more direct-to-consumer engagement, and build commercial capabilities to support new products and potential mergers and acquisitions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Molecular Diagnostic Testing</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our molecular diagnostic tests are designed to analyze genes and their expression levels and corresponding proteins to assess an individual&#8217;s risk for developing disease later in life; accurately diagnose disease; determine a patient&#8217;s likelihood of either responding to a particular drug or disease recurrence; and assess a patient&#8217;s risk of disease progression. Provided with this valuable information, physicians may more effectively manage their patients' healthcare. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">myRisk&#8482; Hereditary Cancer:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">DNA sequencing test for assessing the risks for hereditary cancers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our myRisk Hereditary Cancer test is designed to determine a patient&#8217;s hereditary cancer risk for breast, ovarian, colorectal, endometrial, melanoma, pancreatic, prostate, and gastric cancers. The test analyzes 35 separate genes to look for deleterious mutations that put a patient at a substantially higher risk than the general population for developing one or more of these cancers. All 35 genes in the panel are well documented in clinical literature for the role they play in hereditary cancer and have been shown to have actionable clinical interventions for the patient to facilitate earlier cancer detection, lower disease risk or reduce risk of cancer recurrence. The myRisk Genetic Test Result and myRisk Management Tool</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> summarize medical society guidelines for managing a patient with a genetic mutation in view of their personal and family history of cancer. myRisk Hereditary Cancer testing identifies more mutation carriers than our BRACAnalysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> and COLARIS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> tests combined.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRACAnalysis CDx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DNA sequencing test to help determine the appropriate therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of the test are used as an aid to identify patents who are eligible for treatment with U.S. Food and Drug Administration approved PARP inhibitors. This is an in vitro diagnostic device intended for the qualitative detection and classification of variants in the protein coding regions and intron/exon boundaries of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BRCA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BRCA2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> genes using genomic DNA obtained from whole blood specimens collected in EDTA.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MyChoice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> CDx: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the most comprehensive tumor test that determines homologous recombination (HRD) status in patients with ovarian cancer.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This FDA-approved test helps provide information on the magnitude of benefit for PARP inhibitor therapy. HRD status is determined using two independent methods: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BRCA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BRCA2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> status that encompasses sequence variants and large rearrangements, and Genomic Instability Status (GIS) encompassing loss of heterozygosity, telomeric allelic imbalance and large-scale state transitions across the entire genome. The combination of these methods is a more comprehensive way to measure HRD status, versus either one alone.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prolaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RNA expression tumor analysis for assessing the aggressiveness of prostate cancer.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Prolaris test is a gene expression assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that may warrant aggressive intervention such as a radical prostatectomy or radiation therapy. The Prolaris test was developed to improve physicians&#8217; ability to predict disease outcome and thereby to optimize patient treatment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EndoPredict</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RNA expression test for assessing the aggressiveness of breast cancer.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The EndoPredict test is a next-generation RNA expression test used to determine which women with breast cancer may benefit from chemotherapy. EndoPredict predicts the likelihood of metastases to help guide treatment decisions for chemotherapy and extended endocrine therapy. EndoPredict has been shown to accurately predict risk of distant recurrence in Her 2-, ER+, node negative and node positive breast cancer patients with no confusing intermediate results in 13 published clinical studies with more than 2,200 patients and is CE marked.</span></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Foresight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The test screens for "carrier status" of up to 175 serious and clinically actionable conditions. The test has been shown to have a detection rate of 99% across all ethnicities. Studies have shown that with prior knowledge of recessive genetic conditions, 76% of patients took preventive actions such as in-vitro fertilization with pre-implantation genetic testing to reduce the risk of having an affected offspring.</span></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prequel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The test uses whole genome sequencing to test for trisomies and monosomies in all 23 chromosomal pairs including the sex chromosomes, along with microdeletions associated with common genetic diseases. Prequel has a low test failure rate at less than 1 in 1,000 patients and has been validated in multiple clinical studies to be highly accurate.</span></div><div style="margin-top:15pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GeneSight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, and other psychiatric conditions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeneSight&#174; is for use by health-care professionals seeking patient-specific information on gene-drug interactions when contemplating an alteration in neuropsychiatric medication for patients diagnosed with major depressive disorder (MDD) who are suffering with refractory moderate to very severe depression after at least one prior neuropsychiatric medication failure. Because genes influence the way a person&#8217;s body responds to specific medications, the medications may work differently for each person. Using DNA gathered with a simple cheek swab, GeneSight analyzes a patient&#8217;s genes and provides individualized information to help healthcare providers select medications that better match the patient&#8217;s genes. Multiple clinical studies have shown that when clinicians used GeneSight to help guide treatment decisions, patients were more likely to respond compared to standard of care.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sales and Marketing</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our tests through our own direct sales force and marketing efforts in the United States, France, Germany and Japan, and service additional global accounts through indirect sales channels. Our United States sales force is comprised of approximately 900 individuals across five separate sales channels. We continue to evaluate our sales and marketing channels including increased digital marketing, direct to patient marketing, enhanced virtual sales tools, and inside sales teams to drive efficiency in our model. We intend to elevate our existing products to their full potential by increasing awareness, access, and differentiation of our products, while we reinforce clinical utility data, and maximize cross-selling and synergies across our portfolio.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to continue to use our proprietary DNA sequencing, RNA expression and protein analysis technologies, including our supporting bioinformatics and robotic technologies, in an effort to efficiently discover important biomarkers and to understand their role in human disease.&#160;Based on these biomarkers, we plan to develop highly accurate, informative tests that may help physicians better manage their patients&#8217; healthcare. We believe that our technologies provide us with a significant competitive advantage and the potential for numerous product opportunities. For the transition period ended December&#160;31, 2020, and fiscal years ended June&#160;30, 2020, 2019 and 2018, we incurred research and development expense of $35.8 million, $77.2 million, $85.9 million and $70.8 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry and Competition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patients, providers, payors and health systems are looking to apply the power of molecular diagnostics and precision medicine to achieve improved clinical outcomes and lower cost. Key industry trends include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Accelerating shifts in consumer engagement, early detection, home-based care models, telemedicine and virtual care; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption in the way outpatient care is delivered in the wake of the COVID-19 pandemic, coupled with broadened awareness of the vital role of diagnostic testing; </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expanding access to genetic insights, particularly among underserved populations with increased focus on disparities in healthcare outcomes and access for challenged communities; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Growth in personalized medicine </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the interest in new partnership models to advance companion diagnostics and serve patients with specific treatments based on their own genetic makeup and biology.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These market trends create new opportunities to position Myriad Genetics, and our products and services, for growth and commercial success through enhanced customer service levels and a stronger alignment of our value proposition with physicians and payors. Our record of innovation will be leveraged not only in research and development and technology, but also in go-to-market approaches and other applications so we can adapt quickly to customer preferences and market dynamics.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Oncology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In oncology, we offer genetic testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs. Our major competitors in the oncology market include Invitae, Ambry Genetics, Quest Diagnostics, LabCorp, Exact Sciences, Foundation Medicine, and other commercial and academic laboratories.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the key opportunities and potential catalysts are our international expansion of companion diagnostics and market expansion through new clinical guidelines. We recently signed an agreement with Illumina to offer a myChoice CDx kit as part of their Trusight oncology offering. This kit will be targeted to international markets and will increase global access to our myChoice CDx solution. The agreement combines Illumina's expertise in next-generation sequencing with Myriad's proprietary myChoice CDx assay technology to advance comprehensive genetic profiling of tumor samples and drive improved outcomes in oncology.  This collaboration reflects our focus on partnering with high-caliber healthcare leaders to bring innovative solutions to the oncology market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently offer our FDA-approved BRACAnalysis CDx test as a companion diagnostic for the prediction of response to a class of drugs called PARP inhibitors. Currently, we are the only laboratory with an FDA-approved germline test for this indication and have received approvals from the FDA in ovarian cancer, metastatic breast cancer, pancreatic cancer, and advanced prostate cancer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we received FDA approval for the myChoice CDx&#174; test for use as a companion diagnostic by healthcare professionals to identify advanced ovarian cancer patients with positive homologous recombination deficiency status, who are eligible or may become eligible, for treatment with Lynparza (olaparib) in combination with bevacizumab. We also have started to receive myChoice CDx samples from Japan following regulatory approval of myChoice CDX to be used as a companion diagnostic for olaparib in fall 2020. With BRACAnalysis CDx, we also received regulatory approval in Japan for new indications in pancreatic and prostate cancer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Women&#8217;s Health </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the women&#8217;s health market, we serve women assessing their genetic predisposition to cancer, offer prenatal tests for the assessment of fetal chromosomal disorders, and screen prospective parents for recessive genetic conditions that can be passed on to their offspring. We compete with multiple companies including large national reference laboratories, specialty laboratories, academic/university laboratories, and kit-based products with our myRisk, riskScore, Foresight, and Prequel tests. Some of our major competitors include Invitae, Natera, Ambry Genetics, Quest Diagnostics, LabCorp, Progenity, and Sema4. We compete mainly based on our test breadth and accuracy, commercial scale in the prenatal market, and the quality of our customer service and informatics tools.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We see opportunities to improve our economics and improve the customer experience on these products. We are focused on the reimbursement for carrier screening and finding streamlined patient payment models. We are also developing new global riskScore capabilities to expand access to genetic insights for more ethnic groups and providing new channels for customers to access our products. These include a new online myRisk portal to engage with patients and physicians, patient cost estimators across our product lines, and AI-based tools for interacting with patients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The launch of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">new AMPLIFY&#8482; technology in 2020 further increases the accuracy of the Prequel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">test, enabling </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">more women to receive highly accurate test results and avoid invasive procedures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">regardless of body mass index (BMI), race, or ethnicity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Mental Health </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In mental health, we help physicians understand how genetic alterations impact patient response to antidepressants and other drugs. Our GeneSight Psychotropic test meets a significant unmet clinical need and is the leading product to help physicians anticipate patient response to psychotropic drugs, the selection of which has historically been done through trial and error based approaches. The test is clinically proven to improve response rates in patients. Our major competitors in this market include Genomind, AltheaDx, and numerous other commercial and academic laboratories. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key drivers for this market include primary care expansion, commercial payer reimbursement, and telehealth partnerships. We are broadening access to GeneSight among front-line providers of mental health treatment, including primary care physicians and nurse practitioners who treat the majority of depression and anxiety patients, through the expansion of sales and digital marketing capabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Across the core specialties of our business &#8211; women&#8217;s health, oncology, and mental health &#8211; we have numerous opportunities to elevate our products. We have a respected portfolio and internationally recognized scientific know-how. Our long-standing record of innovation will be leveraged not only in research and development and technology, but also in go-to-market strategies and other applications so we can advance our mission of improving lives while adapting quickly to customer preferences and market dynamics.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically experienced seasonality in our testing business. The quarter ending December 31 is generally strong as we see an increase in volumes from patients who have met their annual insurance deductible. Conversely, in the quarter ending March 31 we see a decrease in volumes due to the annual reset of patient deductibles. Additionally, the volume of testing is negatively impacted by the summer season, which is generally reflected in the quarter ended June 30. Due to the global pandemic, we cannot predict if seasonality will follow the same pattern as in prior years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad is dedicated to being a trusted advisor to transform patient lives through pioneering molecular diagnostics. We believe the success of our business will depend, in part, on our ability to attract and retain qualified personnel. To ensure that Myriad can attract, retain and motivate the exceptional people needed to carry out our mission, we maintain competitive compensation and benefits programs designed to help our employees balance their work and personal lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have approximately 2,700 full-time equivalent employees. Most of our employees are engaged directly in research, development, production, sales and marketing activities.&#160;Our employees are not covered by a collective bargaining agreement, and we consider our relations with our employees to be good.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oversight and Management. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly conduct surveys to seek feedback from our employees on a variety of topics, including but not limited to, employee engagement, strengths, focus areas and culture drivers. The results are reviewed by the Board and senior leadership, who analyze areas of progress or deterioration and prioritize actions and activities in response to this feedback to drive meaningful improvements in employee engagement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Benefits Program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our compensation program is designed to attract and reward talented individuals who possess the skills necessary to support our business objectives, assist in the achievement of our strategic goals and create long-term value for our stockholders. We provide employees with competitive cash compensation programs and stock ownership opportunities. In addition to cash and equity compensation, we also offer benefits such as medical, dental and vision healthcare coverage, insurance and disability coverage, 401(k) investment plans with company matching, tax advantaged savings accounts, paid time off and leaves of absence, employee assistance programs, community outreach programs, training and development opportunities and wellness programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a united team, these values have allowed us to rise to the occasion of this pandemic, together. During the pandemic, we have aligned with CDC guidelines to protect our employees, and in addition to all employees wearing masks and adhering to social distancing guidelines, we also perform contact tracing when an exposure occurs. We recently began offering COVID-19 test kits to employees who may have come into contact with someone exposed to COVID-19 as an additional benefit to our employees and in order to limit disruption to our business operations. There is power in caring, team, diversity, equality and belonging.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Career Development and Training</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We offer several career development and training opportunities to our employees, including an extensive curriculum of company-sponsored technical, business and leadership courses, on-the-job training and a support network to all new employees, tuition reimbursement for approved external training and educational pursuits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity and Inclusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe in equality and in the power of diversity and inclusion. We are striving to make Myriad a place where all employees have a sense of belonging. We recently implemented a diversity, equity and inclusion council that is committed to ensuring that everyone at Myriad has equal opportunities to participate in programs aimed to foster diversity and inclusion. Our focus for diversity is on seeking diverse candidate slates and interview panels for select roles at the leadership level, which is where we have the greatest opportunity to expand. Our focus for inclusion is on embedding inclusion practices into key programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad also sponsors the Women&#8217;s Leadership Forum, which is a Company initiative that mentors, fosters, encourages and inspires women in all stages of their career by providing access to role models, peer groups, and other valuable resources to help women pursue their career ambitions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents and Proprietary Rights</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own or have license rights to various issued patents and patent applications in the United States and foreign countries. These patents and patent applications relate to a variety of subject matter, including diagnostic biomarkers, gene expression signatures, assays, assay reagents, informatics and data analytics, methods for determining genetic predisposition, methods for disease diagnosis, methods for determining disease progression, methods for determining disease treatment, and general molecular diagnostic techniques. For some of the patent assets, we hold rights through exclusive or non-exclusive license agreements. Material patent assets relating to our tests that generate material revenue are described in the following table:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Test</span></td><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Patent Assets</span></td><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Expiration</span></td><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Claims</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Vectra</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We own or hold an exclusive license to one or more issued U.S. patents and pending patent applications in the U.S. and other jurisdictions relating to Vectra&#174; testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The issued U.S. patent has a term expected to expire in 2031 and these U.S. applications, if issued as patents and depending on term adjustments or terminal disclaimers if applicable, are expected to have similar expiration timeframes.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These patents and applications contain multiple claims including but not limited to claims relating to biomarkers, kits, systems and methods for measuring and monitoring inflammatory disease activity.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Prolaris</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We own or hold an exclusive license to one or more issued patents and pending patent applications in the U.S. and other jurisdictions relating to Prolaris&#174; testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These issued U.S. patents have terms expected to begin expiring in 2032 and these applications, if issued as patents and depending on term adjustments or terminal disclaimers if applicable, are expected to have similar expiration timeframes.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These patents and applications contain multiple claims including but not limited to claims relating to biomarkers, kits, systems and methods for detecting, diagnosing, prognosing and selecting therapy for prostate cancer.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">EndoPredict</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We own or hold an exclusive license to one or more issued patents and pending patent applications in the U.S., Europe and other jurisdictions relating to EndoPredict&#174; testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These issued patents have terms expected to begin expiring in 2031 and these applications, if issued as patents and depending on term adjustments or terminal disclaimers if applicable, are expected to have similar expiration timeframes.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These patents and applications contain multiple claims including but not limited to claims relating to biomarkers, kits, systems and methods for prognosing and selecting therapy for breast cancer.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">myChoice CDx</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We own or hold an exclusive license to one or more issued patents and pending patent applications in the U.S. and other jurisdictions relating to myChoice&#174; CDx testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These issued patents have terms expected to expire in 2032 and these applications, if issued as patents and depending on term adjustments or terminal disclaimers if applicable, are expected to have similar expiration timeframes.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These patents contain multiple claims including but not limited to claims relating to biomarkers, kits, systems and methods for detecting homologous recombination deficiency and selecting therapy based on such detection.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">GeneSight</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We own or hold an exclusive license to one or more issued patents and pending patent applications in the U.S. and other jurisdictions relating to GeneSight&#174; testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These issued patents have terms expected to begin expiring in 2024 and these applications, if issued as patents and depending on term adjustments or terminal disclaimers if applicable, are expected to have similar expiration timeframes.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These patents contain multiple claims including but not limited to claims relating to biomarkers, kits, systems and methods for detecting single nucleotide polymorphisms and selecting and/or optimizing therapy based on such detection.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Foresight</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We own or hold an exclusive license to one or more issued patents and pending patent applications in the U.S. and other jurisdictions that relate to laboratory and informatic methods used to enhance Foresight&#174; testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These issued patents have terms expected to begin expiring in 2032 and these applications, if issued as patents and depending on term adjustments or terminal disclaimers if applicable, are expected to have similar expiration timeframes.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These patents contain multiple claims including but not limited to claims relating to systems and methods for detecting genetic sequences.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Prequel</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We own or hold a license to one or more issued patents and pending patent applications in the U.S. and other jurisdictions that relate to laboratory and informatic methods used to enhance Prequel&#8482; testing.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These issued patents have terms expected to begin expiring in 2022 and these applications, if issued as patents and depending on term adjustments or terminal disclaimers if applicable, are expected to have similar expiration timeframes.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">These patents contain multiple claims including but not limited to claims relating to systems and methods for detecting genetic sequences.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to seek patent protection in the United States and major foreign jurisdictions for these and other inventions which we believe are patentable and where we believe our interests would be best served by seeking patent protection. However, any patents issued to us or our licensors may not afford meaningful protection for our products or technology or may be subsequently circumvented, invalidated or narrowed or found unenforceable. Any patent applications which we have filed, or will file, or to which we have licensed or will license rights may not issue, and patents that do issue may not contain commercially valuable claims. In addition, others may obtain patents having claims which cover aspects of our tests or processes which are necessary for or useful to the development, use or performance of our diagnostic products. Should any other group obtain patent protection with respect to our discoveries, our commercialization of our molecular diagnostic tests could be limited or prohibited.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Others may offer clinical diagnostic genomic laboratory testing services which may infringe patents we control. We may seek to negotiate a license to use our patent rights or decide to seek enforcement of our patent rights through litigation. Patent litigation is expensive, the outcome is often uncertain and we may not be able to enforce our patent rights against others.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tests and processes may also conflict with patents which have been or may be granted to competitors, academic institutions or others. In addition, third parties could bring legal actions against us seeking to invalidate our owned or licensed patents, claiming damages, or seeking to enjoin clinical testing, development and marketing of our tests or processes. If any of these actions are successful, in addition to any potential liability for damages, we could lose patent coverage for our tests, be required to cease the infringing activity or obtain a license in order to continue to develop or market the relevant test or process. We may not prevail in any such action, and any license required under any such patent may not be made available on acceptable terms, if at all. Our failure to maintain patent protection for our tests and processes or to obtain a license to any technology that we may require to commercialize our tests and technologies could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely upon unpatented proprietary technology, and in the future may determine in some cases that our interests would be better served by protecting certain technologies as trade secrets or through confidentiality agreements rather than patents or licenses. These include some of our genomic, proteomic, RNA expression, mutation analysis, robotic and bioinformatic technologies which may be used in discovering and characterizing new biomarkers and ultimately used in the development or analysis of molecular diagnostic tests. We also maintain a database of gene mutations and their status as either harmful or benign for some of our tests. To further protect our trade secrets and other proprietary information, we require that our employees and consultants enter into confidentiality and invention assignment agreements. However, those confidentiality and invention assignment agreements may not provide us with adequate protection. We may not be able to protect our rights to such unpatented proprietary technology and others may independently develop substantially equivalent technologies. If we are unable to obtain strong proprietary rights to our processes or tests, competitors may be able to market competing processes and tests.</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to license agreements which give us the rights to use certain technologies in the research, development, testing processes, and commercialization of our molecular diagnostic tests and pharmaceutical and clinical services.  We may not be able to continue to license these technologies on commercially reasonable terms, if at all.  Additionally, patents underlying our license agreements may not afford meaningful protection for our technology or tests or may be subsequently circumvented, invalidated or narrowed, or found unenforceable. Our failure to maintain rights to this technology could have a material adverse effect on our business. We have licenses with the following entities:</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.539%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Entity</span></td><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Subject</span></td><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Royalties</span></td><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Expiration</span></td><td colspan="3" style="background-color:#c6d9f1;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%;text-decoration:underline">Termination</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Mayo Foundation for Medical Education and Research (&#8220;Mayo&#8221;)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Exclusive world-wide license to certain rights of Mayo in intellectual property relating to our GeneSight testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We pay Mayo a royalty based on net sales of our GeneSight test.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">License expires upon expiration of the last to expire patent right covered by the Mayo agreement, which presently is not anticipated to expire until 2024.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Mayo has the right to terminate the agreement for the uncured breach of any material term of the agreement.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Oklahoma Medical Research Foundation (&#8220;OMRF&#8221;)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Exclusive world-wide right to certain intellectual property rights of OMRF in intellectual property relating to our Vectra testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We pay OMRF a royalty based on net sales of our Vectra test.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">License agreement ends on expiration of the last to expire patent right covered by the license agreement, which presently is not anticipated to expire until 2031.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">OMRF has the right to terminate the license agreement for the uncured breach of any material term of the license agreement.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">University of Texas M.D. Anderson Cancer Center (&#8220;UTMDACC&#8221;)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Exclusive world-wide right to certain rights of UTMDACC in intellectual property relating to our myChoice&#174; HRD testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We will pay UTMDACC a royalty based on net sales of our myChoice&#174; HRD test.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">License agreement ends on expiration of the last to expire patent right covered by the license agreement, which presently is not anticipated to expire until 2032.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">UTMDACC has the right to terminate the license agreement for the uncured breach of any material term of the license agreement.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Children&#8217;s Medical Center in Boston (&#8220;CMCC&#8221;)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Exclusive world-wide right to certain rights of CMCC in intellectual property relating to our myChoice&#174; HRD testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We expect to pay CMCC a royalty based on net sales of our myChoice&#174; HRD test.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">License agreement ends on expiration of the last to expire patent right covered by the license agreement, which presently is not anticipated to expire until 2032.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">CMCC has the right to terminate the license agreement for the uncured breach of any material term of the license agreement.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Institut Curie and INSERM (&#8220;INSERM&#8221;)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Exclusive world-wide right to certain rights of INSERM in intellectual property relating to our myChoice&#174; HRD testing.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We expect to pay INSERM a royalty based on net sales of our myChoice&#174; HRD test.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">License agreement ends on expiration of the last to expire patent right covered by the license agreement, which presently is not anticipated to expire until 2032.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">INSERM has the right to terminate the license agreement for the uncured breach of any material term of the license agreement.</span></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Illumina, Inc. (&#8220;Illumina&#8221;)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Non-exclusive license to certain rights held by or licensed to Illumina to intellectual property relating to non-invasive prenatal screening and the Prequel test.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We pay Illumina a royalty based on the volume of Prequel testing administered by us.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">License runs for the term of the Illumina agreement and, in any event, expires upon expiration of the last to expire patent right covered by the Illumina agreement.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Illumina has the right to terminate the agreement for the uncured breach of any material term of the agreement.</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Regulation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are regulated by federal, state and foreign governmental authorities.  Failure to comply with the applicable laws and regulations can subject us to repayment of amounts previously paid to us, significant civil and criminal penalties, loss of licensure, certification, or accreditation, or exclusion from state and federal health care programs.  The significant areas of regulation are summarized below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Clinical Laboratory Improvement Amendments of 1988 and State Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our clinical laboratories must hold certain federal, state and local licenses, certifications, and permits to conduct our business.  Laboratories in the United States that perform testing on human specimens for the purpose of providing information for the diagnosis, prevention, or treatment of disease are subject to the Clinical Laboratory Improvement Amendments of 1988 (&#8220;CLIA&#8221;).  CLIA requires such laboratories to be certified by the federal government and mandates compliance with various operational, personnel, facilities administration, quality and proficiency testing requirements intended to ensure that testing services are accurate, reliable and timely.  CLIA certification also is a prerequisite to be eligible to bill state and federal health care programs, as well as many private insurers, for laboratory testing services. Our laboratories in Salt Lake City, Utah; Austin, Texas; Mason, Ohio; and South San Francisco, California are CLIA certified to perform high complexity tests.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, CLIA requires each of our certified laboratories to enroll in an approved proficiency testing program if performing testing in any category for which proficiency testing is required.  Each of our laboratories periodically tests specimens received from an outside proficiency testing organization and then submits the results back to that organization for evaluation.  If one of our laboratories fails to achieve a passing score on a proficiency test, then it may lose its right to perform testing.  Further, failure to comply with other proficiency testing regulations, such as the prohibition on referral of a proficiency testing specimen to another laboratory for analysis, can result in revocation of the laboratory&#8217;s CLIA certification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of CLIA certification, each of our laboratories is subject to survey and inspection every other year, in addition to being subject to additional random inspections.  The biennial survey is conducted by the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), a CMS agent (typically a state agency), or a CMS-approved accreditation organization.  Because our laboratories are accredited by the College of American Pathologists (&#8220;CAP&#8221;), which is a CMS-approved accreditation organization, they are typically subject to CAP inspections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our laboratories are licensed by the appropriate state agencies in the states in which they operate, if such licensure is required.  In addition, our laboratories hold state licenses or permits, as applicable, from various states, including, but not limited to, California, New York, Pennsylvania, Rhode Island and Maryland, to the extent that they accept specimens from one or more of these states, each of which requires out-of-state laboratories to obtain licensure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a laboratory is out of compliance with state laws or regulations governing licensed laboratories or with CLIA, penalties may include suspension, limitation or revocation of the license or CLIA certificate, assessment of financial penalties or fines, or imprisonment.  Loss of a laboratory&#8217;s CLIA certificate or state license may also result in the inability to receive payments from state and federal health care programs as well as private third party payors.  We believe that we are in material compliance with CLIA and all applicable licensing laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Food and Drug Administration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, in vitro diagnostic (&#8220;IVD&#8221;) products are subject to regulation by the FDA as medical devices to the extent that they are intended for use in the diagnosis, treatment, mitigation or prevention of disease or other conditions. They are subject to premarket review and post-market controls that will differ depending on how the FDA classifies a specific IVD. For certain types of tests known as laboratory developed tests (&#8220;LDTs&#8221;)&#8212;which are in vitro diagnostic tests that are designed, manufactured and used within a single laboratory&#8212;FDA regulation is less clear than for IVDs. Historically FDA has exercised enforcement discretion for LDTs, which means that FDA generally has not enforced premarket review and other applicable FDA requirements. However, as LDTs have increased in complexity, the FDA has taken a risk-based approach to their regulation. Congress has also signaled interest in clarifying the regulatory landscape for LDTs. In 2020, the Verifying Accurate, Leading-edge IVCT Development (&#8220;VALID&#8221;) Act was introduced in both chambers of Congress. If enacted, clinical laboratories that develop and offer LDTs and traditional IVD medical device manufacturers would be subjected to the same regulatory oversight. The VALID Act defines both LDTs and IVDs as in vitro clinical tests (&#8220;IVCT&#8221;) and would establish a new regulatory framework under the Food, Drug and Cosmetic Act (&#8220;FDCA&#8221;) for the review and oversight of IVCTs. The proposed regulatory framework adopts various concepts from the FDCA, utilizing a risk-based approach that aims to ensure that all marketed IVCTs have a reasonable assurance of both analytical and clinical validity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Vitro Diagnostics</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information that must be submitted to the FDA in order to obtain clearance or approval to market a new IVD varies depending on how the device is classified by the FDA. Medical devices are classified into one of three classes on the basis of the controls deemed by the FDA to be necessary to reasonably ensure their safety and effectiveness. Class I devices are subject to general controls, including labeling, and adherence to the FDA&#8217;s quality system regulations, which are device-specific good manufacturing practices. Class II devices are subject to premarket notification, general controls and sometimes special controls, including performance standards and post-market surveillance. Class III devices are subject to most of the previously identified requirements as well as to premarket approval. All Class I devices are exempt from premarket review; most Class II devices require 510(k) clearance, and all Class III devices must receive premarket approval before they can be sold in the United States. The payment of a fee, that is typically adjusted annually, to the FDA is usually required when a 510(k) notice or premarket approval application is submitted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">510(k) Premarket Notification</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A 510(k) notification requires the sponsor to demonstrate that an IVD is substantially equivalent to another marketed device, termed a &#8220;predicate device&#8221;, that is legally marketed in the United States and for which a premarket approval application (&#8220;PMA&#8221;) was not required. A device is substantially equivalent to a predicate device if it has the same intended use and technological characteristics as the predicate; or has the same intended use but different technological characteristics, where the information submitted to the FDA does not raise new questions of safety and effectiveness and demonstrates that the device is at least as safe and effective as the legally marketed device.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most 510(k)s do not require clinical data for clearance, but a minority will. Requests for additional data, including clinical data, will increase the time necessary to review the notice. If the FDA believes that the IVD is not substantially equivalent to a predicate device, it will issue a &#8220;Not Substantially Equivalent&#8221; letter and designate the device as a Class III device, which will require the submission and approval of a PMA before the new device may be marketed. Under certain circumstances, the sponsor may request the FDA to make a risk-based determination of the new device and reclassify the new device as a Class I or Class II device. The FDA continues to reevaluate the 510(k) pathway and process and the de novo process, and has taken what it describes as a risk-based approach to develop innovative regulatory policy to propose a more &#8220;contemporary&#8221; approach. We cannot predict what if any changes will occur or how they will affect our current or future products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premarket Approval</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PMA process is more complex, costly and time consuming than the 510(k) process. A PMA must be supported by more detailed and comprehensive scientific evidence, including clinical data, to demonstrate the safety and efficacy of the IVD for its intended purpose. If the device is determined to present a &#8220;significant risk,&#8221; the sponsor may not begin a clinical trial until it submits an investigational device exemption (&#8220;IDE&#8221;) to the FDA and obtains approval to begin the trial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the PMA is submitted, the FDA has 45 days to make a threshold determination that the PMA is sufficiently complete to permit a substantive review. If the PMA is complete, the FDA will file the PMA. The FDA is subject to a performance goal review time for a PMA that is 180 days from the date of filing, although in practice this review time is longer. Questions from the FDA, requests for additional data including additional clinical data and referrals to advisory committees may delay the process considerably. The total process may take several years and there is no guarantee that the PMA will ever be approved. Even if approved, the FDA may limit the indications for which the device may be marketed. Any changes to an approved medical device may require a supplemental PMA to be submitted and approved before the changed medical device may be marketed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any products sold by us pursuant to FDA clearances or approvals will be subject to pervasive and continuing regulation by the FDA, including record keeping requirements, reporting of adverse experiences with the use of the device and restrictions on the advertising and promotion of our products. Device manufacturers are required to register their establishments and list their devices with the FDA and are subject to periodic inspections by the FDA and certain state agencies. Noncompliance with applicable FDA requirements can result in, among other things, warning letters, fines, injunctions, civil penalties, recalls or seizures of products, total or partial suspension of production, refusal of the FDA to grant 510(k) clearance or PMA approval for new devices, withdrawal of 510(k) clearances and/or PMA approvals, civil penalties and criminal prosecution. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulation of Companion Diagnostic Devices</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If a sponsor or the FDA believes that a diagnostic test is essential for the safe and effective use of a corresponding therapeutic product, the sponsor of the therapeutic product will typically work with a collaborator to develop an IVD companion diagnostic device. IVDs are regulated by the FDA as medical devices, and FDA issued a final guidance document in 2014, entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In Vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Companion Diagnostic Devices&#8221; that is intended to assist companies developing in vitro companion diagnostic devices and companies developing therapeutic products that depend on the use of a specific in vitro companion diagnostic for the safe and effective use of the product. In the guidance, the FDA defined an IVD companion diagnostic device as a device that provides information that is essential for the safe and effective use of a corresponding therapeutic product. The FDA also noted that in some cases, if evidence is sufficient to conclude that the IVD companion diagnostic device is appropriate for use with a class of therapeutic products, the intended use/indications for use should name the therapeutic class, rather than each specific product within the class. In April 2020, FDA published a final guidance entitled, &#8220;Developing and Labeling In Vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeutic Products&#8221; that expands on the idea of a class of therapeutic products introduced in the 2014 guidance.  The new guidance describes considerations for the development and labeling of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> companion diagnostic devices to support the indicated uses of multiple drug or biological oncology products, when appropriate.  The FDA expects that the therapeutic sponsor will address the need for an approved or cleared IVD companion diagnostic device in its therapeutic product development plan and that, in most cases, the therapeutic product and its corresponding IVD companion diagnostic will be developed contemporaneously. To that end, the FDA issued draft guidance on July 15, 2016 entitled &#8220;Principles for Codevelopment of an In Vitro Companion Diagnostic Device with a Therapeutic Product&#8221; to serve as a practical guide to assist therapeutic product sponsors and IVD sponsors in developing a therapeutic product and an accompanying IVD companion diagnostic.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA indicated that it will apply a risk-based approach to determine the regulatory pathway for IVD companion diagnostic devices, as it does with all medical devices. This means that the regulatory pathway will depend on the level of risk to patients, based on the intended use of the IVD companion diagnostic device and the controls necessary to provide a reasonable assurance of safety and effectiveness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the companion diagnostic test will be used to make critical treatment decisions such as patient selection, treatment assignment, or treatment arm, it will likely be considered a significant risk device for which a clinical trial will be required. The sponsor of the IVD companion diagnostic device will be required to comply with the FDA&#8217;s IDE requirements that apply to clinical trials of significant risk devices. If the diagnostic test and the therapeutic drug are studied together to support their respective approvals, the clinical trial must meet both the IDE and IND requirements. We expect that any IVD companion diagnostic device developed for use with drug products will utilize the PMA pathway and that a clinical trial performed under an IDE will have to be completed before the PMA may be submitted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing companion diagnostic tests for use with drug products in development by pharmaceutical companies, such as our collaborations with pharmaceutical companies on PARP inhibitors for the treatment of ovarian, breast and other cancers.  The FDA has also introduced the concept of a complementary diagnostic that it defines as a test that is not required but which provides significant information about the use of a drug.  A complementary test can help guide treatment strategy and identify which patients are likely to derive the greatest benefit from therapy, and if approved by the FDA information regarding the IVD will be included in the therapeutic product labeling. Although the FDA has not yet issued any written guidance regarding complementary diagnostics, it has already approved some complementary diagnostics, including a supplementary premarket approval for BRACAnalysis CDx and myChoice CDx as complementary diagnostic tests in ovarian cancer patients associated with enhanced progression-free survival (PFS) when used with the PARP inhibitor Zejula&#8482; (niraparib).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2014, we first obtained premarket approval for BRAC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CDx, which is used as a companion diagnostic test to identify ovarian cancer patients who may benefit from AstraZeneca&#8217;s PARP inhibitor Lynparza&#8482; (olaparib). Since then, other indications for BRAC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CDx in ovarian, breast, prostate and pancreatic cancer have received supplemental PMA approval as a companion diagnostic for Lynparza. The myChoice CDx test has also received approvals as a companion diagnostic test. The premarket approval process is a complex, costly and time consuming procedure.  Approvals must be supported by valid scientific evidence, submitted as part of a PMA, which typically requires extensive data, including quality technical, preclinical, clinical and manufacturing data to demonstrate to the FDA&#8217;s satisfaction the safety and effectiveness of the companion diagnostic. We are currently collaborating with several pharmaceutical companies, including AstraZeneca, Merck, Pfizer, GSK, AbbVie, and others for additional indications and geographical commercialization opportunities for BRACAnalysis CDx and myChoice CDx, to evaluate the use of several of our tests as companion diagnostics with other drugs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a medical device is placed on the market, numerous regulatory requirements apply. These include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">compliance with the FDA&#8217;s Quality System Regulation (&#8220;QSR&#8221;), which requires manufacturers to follow stringent design, testing, control, documentation, record maintenance, including maintenance of complaint and related investigation files, and other quality assurance controls during the manufacturing process;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">labeling regulations, which prohibit the promotion of products for uncleared, or unapproved uses, or &#8220;off-label&#8221; uses, and impose other restrictions on labeling; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">medical device reporting obligations, which require that manufacturers investigate and report to the FDA adverse events, including deaths, or serious injuries that may have been or were caused by a medical device and malfunctions in the device that would likely cause or contribute to a death or serious injury if it were to recur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include sanctions, including but not limited to, warning letters; fines, injunctions, and civil penalties; recall or seizure of the device; operating restrictions, partial suspension or total shutdown of production; refusal to grant 510(k) clearance or approval of PMAs of new devices; withdrawal of clearance or approval; and civil or criminal prosecution.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Products intended for use in in vitro diagnostic applications require regulatory approvals in many other countries and geographic areas, some of which also provide for approval of companion diagnostics. For example, in the European Union, in vitro diagnostic medical devices have been regulated under the European Union Directive 98/79/EC (the &#8220;Directive&#8221;), since 2003, and all products and kits used for in vitro diagnostic applications must be compliant with the Directive.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IVDs have not been subject to pre-market authorization under the Directive, but instead they had to comply with essential requirements based on conformity with harmonized standards. The majority of IVDs have been self-certified by manufacturers which can place a CE mark on most products to show that they meet the conformity assessment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">EU Member States must ensure that IVDs are only placed on the market if they conform to the requirements, and must ensure the free movement of such devices in the internal market. Member States will designate independent organizations, or Notified Bodies, that ensure that a conformity assessment is carried out for devices. These Notified Bodies may carry out inspections of certain manufacturers, and manufacturers must report any incident causing death to, or damaging the health of, a patient to the competent authorities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Directive will be replaced by the In Vitro Diagnostic Device Regulation (IVDR) European Union (EU) 2017/746 that was published in May 2017, and given a 5-year transition period until its implementation on May 27, 2022. Unlike the Directive that specifies certain results that must be achieved by each Member State and permits each Member State to decide how to transpose the Directive into national law, the IVDR has binding legal force throughout every Member State and it will become effective on a set date in all the Member States. The major goals of the IVDR are to standardize diagnostic procedures within the EU, increase reliability of diagnostic analysis and enhance patient safety. Under the IVDR, as enacted by the European Commission (EC), in vitro diagnostics will be subject to additional legal regulatory requirements after it comes into full effect.  Among other things, the IVDR introduces a new risk classification system and requirements for conformity assessments. Products already certified by a Notified Body may remain on the market until May 25, 2024 under some conditions including fulfillment of specific requirements in the IVDR, but ultimately most products will have to be approved.  Compliance with the IVDR may be expensive and time-consuming.  Manufacturers will need to provide more data to demonstrate that a device performs safely and effectively.  As noted above, the vast majority of IVDs under the Directive are self-certified, so many device manufacturers have not previously been subject to the Notified Body audits that will occur under the IVDR and will have to revise their Quality Management System (QMS) and Technical Documentation which will be reviewed.  There will also be a greater emphasis on post-market surveillance and submission of post-market performance follow-up reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">UK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK's withdrawal from the EU will have major ramifications for IVD manufacturers, that will, among other things, have to follow new procedures that will apply in the UK including appointment of UK Responsible Persons rather than relying on European Authorized Representatives to manage their compliance efforts in the UK.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Medicine and Healthcare Products Regulatory Agency (MHRA) issued new guidance on how the country will regulate IVDs after January 1, 2021, According to MHRA, IVDs in the future will require certification in the UK, which is defined as England, Scotland, and Wales, while companies will still be able to sell tests in Northern Ireland under existing EU IVD regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in the guidance, MHRA will continue to recognize CE marks until June 30, 2023.  Companies wishing to place IVDs on the UK market will require registration with MHRA after January 1, 2021, but will still be able to sell CE-IVD marked products for the next two-and-a-half years. After July 1, 2023, companies selling in the UK will have to obtain a new marking called a UK Conformity Assessed mark, or UKCA. This mark will not be automatically recognized in EU countries, meaning that companies that wish to sell in the UK and the EU will have to seek both a UKCA and CE-IVD mark in the future. We anticipate that more information about the new UK requirements will become available in the near future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Japan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IVDs are regulated in Japan by the Pharmaceutical and Medical Devices Agency, or PMDA, and are assigned to one of three classes depending on the perceived level of risk. Those in the least risky class may be registered and marketed after filing a pre-market submission, while those in the middle class are subject to pre-market certification by a registered certification body.  The riskiest IVDs must be approved. Submissions may be made only by marketing authorization holders, which must satisfy specific requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant revisions to Japanese regulations of medical devices, IVDs and other healthcare products are on-going, with phased implementations of new and updated requirements planned through 2022.  The first round of changes to Japan&#8217;s Pharmaceuticals and Medical Devices Act took effect September 1, 2020, and additional revisions will come into force in August 2021 and December 2022. Some of those changes will affect IVDs, including the ability to qualify for fast track designation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Regulatory Requirements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our laboratories are subject to federal, state and local regulations relating to the handling and disposal of regulated medical waste, hazardous waste and biohazardous waste, including chemical, biological agents and compounds, blood and bone marrow samples and other human tissue. Typically, we use outside vendors who are contractually obligated to comply with applicable laws and regulations to dispose of such waste. These vendors are licensed or otherwise qualified to handle and dispose of such waste.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">HIPAA and other privacy laws</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), which applies to health plans, healthcare clearing houses, and healthcare providers that conduct certain healthcare transactions electronically (&#8220;Covered Entities&#8221;) contains provisions that address the privacy of health data, the security of health data, the standardization of identifying numbers used in the healthcare system and the standardization of certain healthcare transactions. The privacy regulations protect health information by limiting its use and release, giving patients the right to access their medical records and limiting most disclosures of health information to the minimum amount necessary to accomplish an intended purpose. The HIPAA security standards require the adoption of administrative, physical, and technical safeguards and the adoption of written security policies and procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 17, 2009, Congress enacted the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;), which expanded and strengthened HIPAA, created new targets for enforcement, imposed new penalties for noncompliance and established new breach notification requirements for Covered Entities. Under HITECH&#8217;s breach notification requirements, Covered Entities must report breaches of protected health information that has not been encrypted or otherwise secured in accordance with guidance from the Secretary of the U.S. Department of Health and Human Services (the &#8220;Secretary&#8221;). Required breach notices must be made as soon as is reasonably practicable, but no later than 60 days following discovery of the breach. Reports must be made to affected individuals and to the Secretary and, in some cases depending on the size of the breach, they must be reported through local and national media. Breach reports can lead to investigation, enforcement, civil monetary penalties and civil litigation, including class action lawsuits and enforcement by state.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently subject to the HIPAA regulations and maintain an active compliance program that is designed to identify security incidents and other issues in a timely fashion and enable us to remediate, mitigate harm or report if required by law. However, even if we make required reports and remediate on a timely basis, we may still be subject to penalties for the underlying breach.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the federal privacy and security regulations, there are a number of state laws regarding the privacy and security of health information and personal data that are applicable to our clinical laboratories.  Many states have also implemented genetic testing and privacy laws imposing specific patient consent requirements and protecting test results by strictly limiting the disclosure of those results. State requirements are particularly stringent regarding predictive genetic tests, due to the risk of genetic discrimination against healthy patients identified through testing as being at a high risk for disease. We believe that we have taken the steps required of us to comply with health information privacy and security statutes and regulations, including genetic testing and genetic information privacy laws in all jurisdictions, both state and federal. However, these laws constantly change, and we may not be able to maintain compliance in all jurisdictions where we do business. Failure to maintain compliance, or changes in state or federal laws regarding privacy or security could result in civil and/or criminal penalties, significant reputational damage and could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Data Protection Regulation (&#8220;GDPR&#8221;), which applies to all EU member states from May 25, 2018, also applies to some of our operations. The GDPR is discussed in more detail elsewhere in this report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws and regulations related to the protection of the environment, the health and safety of employees and the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials. For example, the U.S. Occupational Safety and Health Administration (&#8220;OSHA&#8221;) has established extensive requirements relating specifically to workplace safety for healthcare employers in the U.S. This includes requirements to develop and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including preventing or minimizing any exposure through needle stick injuries. For purposes of transportation, some biological materials and laboratory supplies are classified as hazardous materials and are subject to regulation by one or more of the following agencies: the U.S. Department of Transportation, the U.S. Public Health Service, the United States Postal Service, the Office of Foreign Assets Control, and the International Air Transport Association. We generally use third-party vendors to dispose of regulated medical waste, hazardous waste and radioactive materials and contractually require them to comply with applicable laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Transparency Laws and Regulations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A federal law known as the Physician Payments Sunshine Act (the &#8220;Sunshine Act&#8221;) requires medical device manufacturers to track and report to the federal government certain payments and other transfers of value made to covered recipients, which is defined as physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse-midwives who are not bona fide employees of the manufacturer, as well as teaching hospitals, and ownership or investment interests held by physicians and their immediate family members. Manufacturers must report data for the previous calendar year by the 90th day of the then-current calendar year. CMS then publishes the data on a publicly available website no later than June 30th. There are also state &#8220;sunshine&#8221; laws that require manufacturers to provide reports to state governments on pricing and marketing information. Several states have enacted legislation requiring medical device manufacturers to, among other things, establish marketing compliance programs, file periodic reports with the state, make periodic public disclosures on sales and marketing activities, and such laws may also prohibit or limit certain other sales and marketing practices. These laws may adversely affect our sales, marketing, and other activities by imposing administrative and compliance burdens on us. If we fail to track and report if and the extent required by these laws or to otherwise comply with these laws, we could be subject to the penalty provisions of the pertinent state and federal authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Reimbursement and Billing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursement and billing for diagnostic services is highly complex. Laboratories must bill various payors, such as private third-party payors, including managed care organizations (&#8220;MCO&#8221;), and state and federal health care programs, such as Medicare and Medicaid, and each may have different billing requirements. Additionally, the audit requirements we must meet to ensure compliance with applicable laws and regulations, as well as our internal compliance policies and procedures, add further complexity to the billing process. Other factors that complicate billing include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">variability in coverage and information requirements among various payors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">patient financial assistance programs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">missing, incomplete or inaccurate billing information provided by ordering physicians;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">billings to payors with whom we do not have contracts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">disputes with payors as to which party is responsible for payment; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">disputes with payors as to the appropriate level of reimbursement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the reimbursement arrangement and applicable law, the party that reimburses us for our services may be:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a third party who provides coverage to the patient, such as an insurance company or MCO;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a state or federal healthcare program; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the patient.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presently, approximately 65% of our revenue comes from private third-party payors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Federal and State Fraud and Abuse Laws</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A variety of state and federal laws prohibit fraud and abuse involving state and federal healthcare programs, such as Medicare and Medicaid.  These laws are interpreted broadly and enforced aggressively by various state and federal agencies, including CMS, the Department of Justice, the Office of Inspector General for the Department of Health and Human Services (&#8220;OIG&#8221;), and various state agencies.  In addition, the Medicare and Medicaid programs increasingly use a variety of contractors to review claims data and to identify improper payments as well as fraud and abuse.  Any overpayments must be repaid within 60 days of identification unless a favorable decision is obtained on appeal.  In some cases, these overpayments can be used as the basis for an extrapolation, by which the error rate is applied to a larger set of claims, and which can result in even higher repayments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Anti-Kickback Laws</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting, receiving or providing remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual, or the furnishing, arranging for or recommending of an item or service that is reimbursable, in whole or in part, by a federal health care program. &#8220;Remuneration&#8221; is broadly interpreted by some agencies to include anything of monetary value, such as, for example, cash payments, gifts or gift certificates, discounts, or the furnishing of services, supplies or equipment. The Anti-Kickback Statute can be interpreted broadly to prohibit many arrangements and practices that are lawful in businesses outside of the health care industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recognizing the potential breadth of interpretation of the Anti-Kickback Statute and the fact that it may technically prohibit many innocuous or beneficial arrangements within the health care industry, the OIG has issued a series of regulations, or safe harbors intended to protect such arrangements. Compliance with all requirements of a safe harbor immunizes the parties to the business arrangement from prosecution under the Anti-Kickback Statute. The failure of a business arrangement to fit within a safe harbor does not necessarily mean that the arrangement is illegal or that the OIG will pursue prosecution. Still, in the absence of an applicable safe harbor, a violation of the Anti-Kickback Statute may occur even if only one purpose of an arrangement is to induce referrals. The penalties for violating the Anti-Kickback Statute can be severe. These sanctions include criminal and civil penalties, imprisonment and possible exclusion from federal health care programs. Many states have adopted laws similar to the Anti-Kickback Statute, and some apply to items and services reimbursable by any payor, including private third-party payors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in October 2018, the Eliminating Kickbacks in Recovery Act of 2018 (&#8220;EKRA&#8221;), was enacted as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the &#8220;SUPPORT Act&#8221;). EKRA is an all-payor anti-kickback law that makes it a criminal offense to pay any remuneration to induce referrals to, or in exchange for, patients using the services of a recovery home, a substance use clinical treatment facility, or laboratory. Although it appears that EKRA was intended to reach patient brokering and similar arrangements to induce patronage of substance use recovery and treatment, the language in EKRA is broadly written. Further, certain of EKRA&#8217;s exceptions, such as the exception applicable to relationships with employees that effectively prohibits volume-based incentive compensation, are inconsistent with the Anti-Kickback Statute regulations, which permit payment of employee incentive compensation, a practice that is common in the industry. Significantly, EKRA permits the U.S. Department of Justice to issue regulations clarifying EKRA&#8217;s exceptions or adding additional exceptions, but such regulations have not yet been issued. Laboratory industry stakeholders are reportedly seeking clarification regarding EKRA&#8217;s scope and/or amendments to its language. Because EKRA is a new law, there is no agency guidance or court precedent to indicate how and to what extent it will be applied and enforced.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Physician Self-Referral Bans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal ban on physician self-referrals, commonly known as the Stark Law, prohibits, subject to certain exceptions, physician referrals of Medicare patients to an entity providing certain designated health services, which include laboratory services, if the physician or an immediate family member of the physician has any financial relationship with the entity. Several Stark Law exceptions are relevant to arrangements involving clinical laboratories, including but not limited to: (1) fair market value compensation for the provision of items or services; (2) payments by physicians to a laboratory for clinical laboratory services; (3) certain space and equipment rental arrangements that satisfy certain requirements; and (4) personal services arrangements. Penalties for violating the Stark Law include the return of funds received for all prohibited referrals, fines, civil monetary penalties and possible exclusion from federal health care programs. In addition to the Stark Law, many states have their own self-referral bans, which may extend to all self-referrals, regardless of the payor.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">State and Federal Prohibitions on False Claims</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal False Claims Act imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment to the federal government. Under the False Claims Act, a person acts knowingly if he or she has actual knowledge of the information or acts in deliberate ignorance or in reckless disregard of the truth or falsity of the information. Specific intent to defraud is not required. The qui tam provisions of the False Claims Act allow a private individual to bring an action on behalf of the federal government and to share in any amounts paid by the defendant to the government in connection with the action.  Penalties include payment of up to three times the actual damages sustained by the government, plus civil penalties of between $5,500 and $11,000 for each false claim, as well as possible exclusion from federal health care programs. However, the civil penalty amounts are adjusted annually for inflation. For civil penalties assessed after June 19, 2020, whose associated violations occurred after November 2, 2015, the civil penalty amount ranges between $11,665 and $23,331 per claim. In addition, various states have enacted similar laws modeled after the False Claims Act that apply to items and services reimbursed under Medicaid and other state health care programs, and, in several states, such laws apply to claims submitted to any payor. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Civil Monetary Penalties Law</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Civil Monetary Penalties Law (the &#8220;CMP Law&#8221;), prohibits, among other things, (1) the offering or transfer of remuneration to a Medicare or state health care program beneficiary if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program, unless an exception applies; (2) employing or contracting with an individual or entity that the provider knows or should know is excluded from participation in a federal health care program; (3) billing for services requested by an unlicensed physician or an excluded provider; and (4) billing for medically unnecessary services. The penalties for violating the CMP Law include exclusion, substantial fines, and payment of up to three times the amount billed, depending on the nature of the offense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">International regulations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market, directly or through distributors, some of our tests outside of the United States and are subject to foreign regulatory requirements governing laboratory licensure, human clinical testing, use of tissue, privacy and data security, and marketing approval for our tests. These requirements vary by jurisdiction, differ from those in the United States and may require us to implement additional compliance measures or perform additional pre-clinical or clinical testing. For example, the In Vitro Diagnostic Medical Devices (2017/746/EU) (&#8220;IVDR&#8221;) will replace the existing In Vitro Diagnostic Medical Devices Directive (98/79/EC) (&#8220;IVDD&#8221;) in the European Union (&#8220;EU&#8221;). The IVDR was published in May 2017, marking the start of a five-year period of transition from the IVDD. During the transitional period the IVDR will come into force gradually, starting with the provisions related to the designation of Notified Bodies and the ability of manufacturers to apply for new certificates under the IVDR. The transitional period will end on May 26, 2022, the &#8220;Date of Application&#8221; of the Regulation. From that point the IVDR will apply fully. The EU has also implemented the GDPR, which requires us to meet new and more stringent requirements regarding the handling of personal data about European Union residents. In many countries outside of the United States, coverage, pricing and reimbursement approvals are also required. We are also required to maintain accurate information on and control over sales and distributors&#8217; activities that may fall within the purview of the Foreign Corrupt Practices Act, its books and records provisions and its anti-bribery provisions.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a Delaware corporation with our principal executive offices located at 320 Wakara Way, Salt Lake City, Utah 84108. Our telephone number is (801) 584-3600 and our website address is www.myriad.com. We make available free of charge through the Investor Relations section of our website our Corporate Code of Conduct and Ethics, our Audit Committee and other committee charters and our other corporate governance policies, as well as our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission. The Securities and Exchange Commission maintains an internet site (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http://www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the Securities and Exchange Commission. We include our website address in this Transition Report on Form 10-K only as an inactive textual reference and do not intend it to be an active link to our website.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors Summary</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the principal risks that could adversely affect our business, operations, and financial results: </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Our Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our financial condition and results of operations could be further adversely affected by the ongoing coronavirus outbreak.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to generate sufficient revenue from our existing tests or develop new tests to be profitable.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to maintain revenue growth or operate our business on a profitable basis.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we do not continue to generate sufficient revenue from sales of our molecular diagnostic tests and are unable to secure additional funding, we may have to reduce our operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to debt covenants that impose operating and financial restrictions on us and if we are not able to comply with them, it could have a material adverse impact on our operations and liquidity.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our current operating plan changes and we find that our existing capital resources will not meet our needs, we may find it necessary to raise additional funding, which may not be available.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may acquire technologies, assets or other businesses that could cause us to incur significant expense and expose us to a number of unanticipated operational and financial risks, which could adversely affect our financial condition, results of operations and business prospects. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we were successfully sued for product liability, we could face substantial liabilities that exceed our resources.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are dependent on our information technology and telecommunications systems, and any failure of these systems could harm our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches, loss of data and other disruptions could compromise sensitive information related to our business, prevent us from accessing critical information or expose us to liability, which could adversely affect our business and our reputation.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be adversely impacted if we are unable to successfully implement new systems or unable to adapt systems to our change in fiscal year-end.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have identified a material weakness in our internal control over accounting for intercompany transactions, foreign currency exchanges and foreign currency translation related to our international subsidiaries and such weakness led to a conclusion that our internal control over financial reporting and disclosure controls and procedures were not effective as of December 31, 2020. Our ability to remediate the material weakness, our discovery of additional weaknesses, and our inability to achieve and maintain effective disclosure controls and procedures and internal control over financial reporting, could adversely affect our results of operations, our stock price and investor confidence in our company.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business involves environmental risks that may result in liability for us.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in health care policy could increase our costs, decrease our revenues and impact sales of and reimbursement for our tests. </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face risks associated with currency exchange rate fluctuations, which could adversely affect our operating results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Commercialization of Our Tests, Our Services and Test Candidates</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our pharmaceutical testing services customers may reduce the amount of testing they conduct through us.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our molecular diagnostic and companion diagnostic tests in development may never achieve significant commercial market acceptance.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we do not compete effectively with scientific and commercial competitors, we may not be able to successfully commercialize our tests.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our international business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign governments may impose reimbursement standards, which may adversely affect our future profitability.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International data protection laws and regulations may restrict our activities and increase our costs.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on a single laboratory facility to process each of our molecular diagnostic tests in the United States and Europe a single laboratory facility to perform our pharmaceutical and clinical services. Failure to maintain the operations of these laboratories in compliance with applicable regulations would seriously harm our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend on a limited number of third parties for some of our supplies of equipment and reagents. If these supplies become unavailable, then we may not be able to successfully perform our research or operate our business on a timely basis or at all.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our current research collaborators or scientific advisors terminate their relationships with us or develop relationships with a competitor, our ability to discover genes, proteins, and biomarkers, and to validate and commercialize molecular diagnostic and companion diagnostic tests could be adversely affected.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to retain our key personnel and hire, train and retain qualified employees and consultants, we may not be able to successfully continue our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not able to protect our proprietary technology, others could compete against us more directly, which would harm our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we were sued for patent infringement by third parties, we might incur significant costs and delays in test introduction.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to adequately prevent disclosure of trade secrets, proprietary databases, and other proprietary information.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with our obligations under license or technology agreements with third parties, we could lose license rights that are critical to our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to claims that we or our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with the complex federal, state, local and foreign laws and regulations that apply to our business, we could suffer severe consequences that could materially and adversely affect our operating results and financial condition.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA regulation of our industry generally or our tests specifically could be disruptive to our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to comply with laws and regulations related to submission of claims for our services could result in significant monetary damages and penalties and exclusion from the Medicare and Medicaid programs and corresponding foreign reimbursement programs.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are currently subject to government investigation(s), the unfavorable outcome of which may have a material adverse effect on our financial condition, results of operations and cash flows. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business could be harmed by the loss, suspension, or other restriction on a license, certification, or accreditation, or by the imposition of a fine or penalties, under CLIA, its implementing regulations, or other state, federal and foreign laws and regulations affecting licensure or certification, or by future changes in these laws or regulations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the way that the FDA regulates tests performed by laboratories like ours could result in delay or additional expense in offering our tests and tests that we may develop in the future.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Companion and complementary diagnostic tests require FDA approval and we may not be able to secure such approval in a timely manner or at all.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the government and third-party payors fail to provide coverage and adequate payment for our tests and future tests, if any, our revenue and prospects for profitability will be harmed. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business could be adversely impacted by our failure or the failure of physicians to comply with any new ICD Code Set.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our stock price is highly volatile, and our stock may lose all or a significant part of its value.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Anti-takeover provisions of Delaware law, provisions in our charter and bylaws and re-adoption of our stockholders&#8217; rights plan, or poison pill, could make a third-party acquisition of us difficult.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Our Strategy</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial condition and results of operations could be further adversely affected by the ongoing coronavirus outbreak.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any outbreak of contagious diseases, such as COVID-19, or other adverse public health developments, could have a material and adverse effect on our business operations. For example, government public health officials may place additional restrictions to curb the spread of COVID-19, further limiting patients' access to our services, which may impede our progress in returning to profitability. Such adverse effects could include diversion or prioritization of healthcare resources away from the conduct of genetic testing, disruptions or restrictions on the ability of laboratories to process our tests, and delays or difficulties in patients accessing our tests, including those resulting from an inability to travel as a result of quarantines or other restrictions resulting from COVID-19.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As COVID-19 continues to affect individuals and businesses around the globe, we will likely experience disruptions that could severely impact our business, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased volume of testing as a result of disruptions to healthcare providers and limitations on the ability of providers to administer tests;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions or restrictions on the ability of our, our collaborators&#8217;, or our suppliers&#8217; personnel to travel, and could result in temporary closures of our facilities or the facilities of our collaborators or suppliers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations on employee resources that would otherwise be focused on the development of our products, processing our diagnostic tests, and the conduct of our clinical trials, including because of sickness of employees or their families or requirements imposed on employees to avoid contact with large groups of people; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations in employee resources or forced furlough of government employees.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the continued spread of COVID-19 globally could adversely affect our manufacturing and supply chain. Parts of our direct and indirect supply chain are located overseas and both international and domestic components may be subject to disruption as a result of COVID-19 and ongoing responses to it. Additionally, our results of operations could be adversely affected to the extent that COVID-19 or any other public health emergency harms our business or the economy in general either domestically or in any other region in which we do business. The extent to which COVID-19 affects our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information that may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others, which could have an adverse effect on our business and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to generate sufficient revenue from our existing tests or develop new tests to be profitable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our future success is dependent upon our ability to successfully market our existing molecular diagnostic tests to additional patients within the United States, to expand into new markets within and outside the United States, and to develop and commercialize new molecular diagnostic and companion diagnostic tests. However, we may not be able to generate sufficient revenue from our existing tests and in launching and commercializing our new tests. The demand for our existing molecular diagnostic tests may decrease or may not continue to increase at historical rates due to sales of new tests that may replace our existing product portfolio, or for other reasons. For example, because most of our molecular diagnostic tests are only utilized once per patient, we will need to sell our services through physicians to new patients or develop new molecular diagnostic tests in order to continue to generate revenue. Our pipeline of new molecular diagnostic and companion diagnostic test candidates is in various stages of development and may take several more years to develop and must undergo extensive clinical validation. We may be unable to discover or develop any additional molecular diagnostic or companion diagnostic tests through the utilization of our technologies or technologies we license or acquire from others. Even if we develop tests or services for commercial use, we may not be able to develop tests or services that:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">meet applicable regulatory standards, in a timely manner or at all;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully compete with other technologies and tests;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">avoid infringing the proprietary rights of others;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">are adequately reimbursed by third-party payors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">can be performed at commercial levels or at reasonable cost; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">can be successfully marketed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must generate significant revenue to maintain profitability. Even if we succeed in marketing our existing molecular diagnostic tests to physicians for use in new patients and in developing and commercializing any additional molecular diagnostic tests and companion diagnostic tests, we may not be able to generate sufficient revenue and we may not be profitable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to maintain revenue growth or operate our business on a profitable basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to generate revenue growth or maintain existing revenue levels. Historically, our molecular diagnostic business has operated profitably providing a cash contribution to our funding and operational needs. We may not, however, be able to operate our molecular diagnostic business on a profitable basis in the future. Potential events or factors that may have a significant impact on our ability to sustain revenue growth and obtain profitability for our molecular diagnostic business include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased costs of reagents and other consumables required for molecular diagnostic testing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased personnel and facility costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to hire competent, trained staff, including laboratory directors required to review and approve all reports we issue in our molecular diagnostic business, and sales personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to obtain necessary equipment or reagents to perform molecular diagnostic testing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to increase production capacity as demand increases;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to expand into new markets within or outside the United States;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the efforts of third-party payors to limit or decrease the amounts that they are willing to pay for our tests, recoup amounts already paid, or institute burdensome administrative requirements for reimbursement, such as prior authorization requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased licensing or royalty costs, and our ability to maintain and enforce the intellectual property rights underlying our tests and services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in intellectual propriety law applicable to our patents or enforcement in the United States and foreign countries;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential obsolescence of our tests;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to increase commercial acceptance of our molecular diagnostic tests;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased competition and loss of market share;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased regulatory requirements; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">material litigation costs and judgments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not continue to generate sufficient revenue from sales of our molecular diagnostic tests and are unable to secure additional funding, we may have to reduce our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we anticipate that our existing cash, cash equivalents and marketable securities and expected net cash to be generated from sales of our molecular diagnostic tests and pharmaceutical and clinical services will be sufficient to fund our current operations for the foreseeable future, changes could occur that would consume available capital resources more quickly than we currently expect and we may need or want to raise additional financing. On December 23, 2016, we entered into a senior  secured revolving credit facility as borrower, with the lenders from time to time party thereto, which was amended on July 31, 2018, May 1, 2020 and February 22, 2021 (the "Amended Facility"). If we are unable to secure additional funding, we may be unable to repay our Amended Facility when it becomes due, or in the event of a debt covenant default, and be required to reduce research and development projects, limit sales and marketing activities, scale back our expansion efforts within or outside the United States, reduce headcount or potentially even discontinue operations. Our future capital requirements will depend on many factors that are currently unknown to us, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, progress, results and cost of development, clinical testing and pre-market studies of any new molecular diagnostic tests that we may discover or acquire;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the progress, results, and costs to develop additional molecular diagnostic tests;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our current issued patents, and defending intellectual property-related claims;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enter into collaborations, licensing or other arrangements favorable to us;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of acquiring technologies or businesses, and our ability to successfully integrate and achieve the expected benefits of our business development activities and acquisitions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the progress, cost and results of our international efforts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of expanding our sales and marketing functions and commercial operation facilities in the United States and in new markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing and outcome of any litigation against us; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs to satisfy our current and future obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to debt covenants that impose operating and financial restrictions on us and if we are not able to comply with them, it could have a material adverse impact on our operations and liquidity.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covenants in the Amended Facility impose operating and financial restrictions on us. These restrictions may prohibit or place limitations on, among other things, our ability to incur additional indebtedness, create certain types of liens, and complete mergers, consolidations, or change in control transactions. Under the Amended Facility, a change in control of the Company, which means that a stockholder or a group of stockholders is or becomes the beneficial owner, directly or indirectly, of more than 35% of the total voting power of the voting stock of the Company, would require mandatory prepayment of the outstanding debt. The Amended Facility may also prohibit or place limitations on our ability to sell assets, pay dividends or provide other distributions to stockholders. These restrictions could also limit our ability to take advantage of business opportunities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must maintain specified leverage and interest ratios measured as of the end of each applicable quarter as financial covenants in the Amended Facility. The Amended Facility, through Amendment No. 2 entered into on May 1, 2020 and Amendment No. 3 entered into on February 22, 2021, modified compliance with the leverage covenant and the interest coverage ratio covenant, which were waived through March 31, 2022, and added a minimum liquidity covenant. If we are unable to improve our results of operations, it is possible that we could be in violation of certain financial covenants contained in the Amended Facility in the future. If we are unable to comply with the covenants and ratio in the Amended Facility, we may be in default under the agreement. A default would result in an increase in the rate of interest and limits on our ability to incur certain additional indebtedness and it could potentially cause the loan repayment to be accelerated, any of which could have a material adverse impact on our operations and liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our current operating plan changes and we find that our existing capital resources will not meet our needs, we may find it necessary to raise additional funding, which may not be available.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our existing capital resources and expected net cash to be generated from sales of our molecular diagnostic tests will enable us to maintain our currently planned operations for the foreseeable future. However, we base this expectation on our current operating plan, which may change. We have incurred, and will continue to incur, significant costs in the discovery, development and marketing of current and prospective molecular diagnostic and companion diagnostic tests. Our ongoing efforts to develop tests and expand our business, which may be through internally developed products, in-licensing and mergers and acquisitions, will require substantial cash resources. If, due to changes in our current operating plan, adequate funds are not available, we may be required to raise additional funds. Sources of potential additional capital resources may include, but are not limited to, public or private equity financings, expanding or supplementing our Amended Facility, or selling convertible or non-convertible debt securities. This additional funding, if necessary, may not be available to us on reasonable terms, or at all.  If we issue shares of stock or other securities to acquire new companies or technologies, the ownership interests of our existing stockholders may be significantly diluted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of our potential long-term capital requirements, we may access the public or private equity or debt markets whenever conditions are favorable, even if we do not have an immediate need for additional capital at that time. Under Securities and Exchange Commission rules, we currently qualify as a well-known seasoned issuer, or WKSI, and can at any time file a registration statement registering securities to be sold to the public which would become effective upon filing.  If additional funds are raised by issuing equity securities, existing stockholders may suffer significant dilution. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring debt, making capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies or tests or grant licenses on terms that are not favorable to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire technologies, assets or other businesses that could cause us to incur significant expense and expose us to a number of unanticipated operational and financial risks, which could adversely affect our financial condition, results of operations and business prospects. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to organic growth, we intend to continue to pursue growth through the acquisition of technology, assets or other businesses that may enable us to enhance our technologies and capabilities, expand our geographic market, add experienced management personnel and increase our test offerings. For example, in July 2018, we acquired Counsyl, Inc. and believe the acquisition allowed for greater entry into the high-growth reproductive testing market, with the ability to become a leader in women&#8217;s health genetic testing.  However, these acquisitions may not achieve profitability or generate a positive return on our investment. Additionally, we may be unable to implement our growth strategy if we cannot identify suitable acquisition candidates, reach agreement on potential acquisitions on acceptable terms, successfully integrate personnel or assets that we acquire or for other reasons. Additionally, we may experience increased expenses, distraction of our management, personnel and customer uncertainty. Our acquisition efforts may involve certain risks, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may have difficulty integrating operations and systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">key personnel and customers of the acquired company may terminate their relationships with the acquired company as a result of the acquisition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be successful in launching new molecular diagnostic tests or companion diagnostic tests, or if those tests are launched, they may not prove successful in the marketplace;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may experience additional financial and accounting challenges and complexities in areas such as tax planning and financial reporting;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may assume or be held liable for risks and liabilities, including for legal, compliance, recoupment, and environmental-related costs and liabilities, as a result of our acquisitions, some of which we may not discover during our due diligence;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may incur significant additional operating expenses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may experience possible inconsistencies in the standards, controls, procedures, policies and compensation structures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may encounter risks and limitations on our ability to consolidate corporate and administrative infrastructures of the two companies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ongoing business may be disrupted or receive insufficient management attention; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to realize synergies, the cost savings or other financial and operational benefits we anticipated, or such synergies, savings or benefits may take longer than we expected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of negotiating acquisitions and integrating acquired tests, services, technologies, personnel or businesses might result in operating difficulties and expenditures and might require significant management attention that would otherwise be available for ongoing development of our business, whether or not any such transaction is ever consummated. Moreover, we might never realize the anticipated benefits of any acquisition such as increase in our scale, diversification, cash flows and operational efficiency and meaningful accretion to our diluted earnings per share. Future acquisitions could result in the use of our available cash and marketable securities, potentially dilutive issuances of equity securities, the need to incur additional debt, contingent liabilities, or impairment expenses related to goodwill, and impairment or amortization expenses related to other intangible assets, which could harm our financial condition. In addition, if we are unable to integrate any acquired businesses, tests or technologies effectively, our business, financial condition and results of operations may be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the other hand, we may seek to divest assets, including but not limited to large capital equipment, diagnostic tests, intellectual property, business units, or corporate affiliates. For example, the Company announced in the last quarter, its intention to seek strategic alternatives for its Myriad RBM, myPath Melanoma, and Vectra businesses. The price we are able to command for such assets may not be high and, in some cases, may be lower than the amount we invested in or paid for such assets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we were successfully sued for product liability, we could face substantial liabilities that exceed our resources.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to potential liability risks inherent in the testing, marketing and processing of molecular diagnostic products, including possible misdiagnoses. Although we are insured against such risks in amounts that we believe to be commercially reasonable, our present professional and product liability insurance may be inadequate. A successful product liability claim in excess of our insurance coverage could have a material adverse effect on our business. Any successful product liability claim may prevent us from obtaining adequate product liability insurance in the future on commercially desirable or reasonable terms. An inability to obtain sufficient insurance coverage at an acceptable cost or otherwise to protect against potential product liability claims could prevent or inhibit the commercialization of our products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on our information technology and telecommunications systems, and any failure of these systems could harm our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on information technology ("IT") and telecommunications systems for significant aspects of our business. These IT and telecommunications systems support a variety of functions, including sample processing, tracking, quality control, customer service and support, billing, research and development activities, and various general and administrative activities. Failures or significant downtime of our IT or telecommunications systems could prevent us from processing samples, providing test results to physicians, billing payors, addressing patient or physician inquiries, conducting research and development activities and conducting general and administrative elements of our business. Any disruption or loss of IT or telecommunications systems on which critical aspects of our operations depend could have an adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches, loss of data and other disruptions, including from cyberattacks, could compromise sensitive information related to our business, prevent us from accessing critical information or expose us to liability, which could adversely affect our business and our reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, including legally protected patient health information, credit card information, personally identifiable information about our employees, intellectual property, and proprietary business information. We manage and maintain our applications and data utilizing on-site, remote, or cloud-based systems. These applications and data encompass a wide variety of business-critical information including research and development information, commercial information and business and financial information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The secure processing, storage, maintenance and transmission of this critical information is vital to our operations and business strategy, and we devote significant resources to protecting such information. Although we take measures to protect sensitive information from unauthorized access or disclosure, our information technology and infrastructure may be vulnerable to attacks by hackers, or viruses, malware, including ransomware, breaches or interruptions due to employee error, malfeasance or other disruptions, or lapses in compliance with privacy and security mandates. Any such malicious cyberattack, virus, breach or interruption could compromise our networks and the information stored there could be accessed by unauthorized parties, publicly disclosed, held for ransom, lost or stolen. We have measures in place that are designed to prevent, and if necessary, to detect and respond to such cybersecurity incidents and breaches of privacy and security mandates. While we have experienced unauthorized accesses to our information technology systems and infrastructure in the past, which may occur again in the future, our security measures have been able to detect, respond to and prevent any material adverse effect to our information systems and business operations from such breaches. However, in the future, any such access, disclosure or other loss of information could result in legal claims or proceedings, liability under laws that protect the privacy of personal information, such as HIPAA, government enforcement actions and civil or even criminal penalties. Unauthorized access, loss or dissemination could also disrupt our operations, including our ability to process samples, provide test results, bill payors or patients, provide customer support services, conduct research and development activities, process and prepare company financial information, and manage various general and administrative aspects of our business, and may damage our reputation, any of which could adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State privacy and data security laws are becoming more stringent.  For example, California recently adopted the California Consumer Privacy Act of 2018 (&#8220;CCPA&#8221;), which was effective in January 2020.  The CCPA establishes a new privacy framework for covered businesses by creating an expanded definition of personal information, establishing new data privacy rights for consumers in the State of California, imposing special rules on the collection of consumer data from minors, and creating a new and potentially severe statutory damages framework for violations of the CCPA and for businesses that fail to implement reasonable security procedures and practices to prevent data breaches.  In addition to the CCPA, other states are introducing similar legislation which will impact compliance obligations and increase complexity and cost of compliance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2016, the European Union (&#8220;EU&#8221;) formally adopted the GDPR, which applies to all EU member states from May 25, 2018. The GDPR introduced stringent new data protection requirements for business activities in the European Union and substantial fines for breaches of the EU data protection rules. The GDPR has increased our responsibility and liability in relation to personal data that we process, and we may be required to put in place additional procedures to ensure compliance with the new EU data protection rules. The GDPR is a complex law with still evolving regulatory guidance, including with respect to how the GDPR should be applied in the context of clinical studies or other transactions from which we may gain access to personal data. Furthermore, many of the countries within the European Union are still in the process of drafting supplementary data protection legislation in key fields where the GDPR allows for national variation, including the fields of clinical study and other health-related information. These national variations may raise our costs of compliance and result in greater potential legal risks.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely impacted if we are unable to successfully implement new systems or unable to adapt systems to our change in fiscal year-end.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IT systems are an important part of our business operations. We are in the midst of a multi-year transformation project to achieve better analytics and process efficiencies through the use of Oracle Fusion Cloud Services System (&#8220;Oracle Fusion&#8221;). This project is expected to improve the efficiency and effectiveness of certain financial and business transaction processes and the underlying systems environment. During the quarter ended September 30, 2020, we completed the implementation of certain modules used in the financial statement close process and management reporting. Additional integrations are expected to take place over the next year. An implementation of this nature is a major undertaking from a financial, management and personnel perspective. The implementation of Oracle Fusion may prove to be more difficult, costly, or time consuming than expected, and there can be no assurance that this system will be beneficial to the extent anticipated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we changed our fiscal year end from a fiscal year ending on the last day of June of each year to a calendar fiscal year ending on the last day of December each year, effective January 1, 2021, which will require certain modifications to our systems used for accounting and management reporting. If the systems are not appropriately configured for the change in fiscal year-end it could have a material adverse effect on our results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have identified a material weakness in our internal control over accounting for intercompany transactions, foreign currency exchanges and foreign currency translation related to our international subsidiaries and such weakness led to a conclusion that our internal control over financial reporting and disclosure controls and procedures were not effective as of December 31, 2020. Our ability to remediate the material weakness, our discovery of additional weaknesses, and our inability to achieve and maintain effective disclosure controls and procedures and internal control over financial reporting, could adversely affect our results of operations, our stock price and investor confidence in our company.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 404 of the Sarbanes-Oxley Act of 2002 requires that companies evaluate and report on the effectiveness of their internal control over financial reporting. In addition, we engaged our independent registered public accounting firm to report on its evaluation of those controls. As disclosed in more detail under Item 9A, &#8220;Controls and Procedures&#8221; below, we have identified a material weakness as of December 31, 2020 in our internal control over accounting for intercompany transactions, foreign currency exchanges and foreign currency translation related to our international subsidiaries. Due to the material weakness in our internal control over financial reporting, we have also concluded our disclosure controls and procedures were not effective as of December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to have effective internal control over financial reporting and disclosure controls and procedures could impair our ability to produce accurate financial statements on a timely basis and could lead to a restatement of our financial statements. For example, the identified material weakness resulted in immaterial corrections to intercompany accounts, as well as foreign currency exchange and translation gains and losses, in our consolidated financial statements for the transition period ended December 31, 2020 and caused a difference between the financial statements we reported in the press release we issued on February 23, 2021 and furnished to the SEC with our Current Report on Form 8-K on the same date and reported in this transition report. Management, however, has concluded that the material weakness did not result in any misstatements that are material to our consolidated financial statements for any of the periods presented. If, as a result of the ineffectiveness of our internal control over financial reporting and disclosure controls and procedures, we cannot provide reliable financial statements, our business decision processes may be adversely affected, our business and results of operations could be harmed, investors could lose confidence in our reported financial information and our ability to obtain additional financing, or additional financing on favorable terms, could be adversely affected. In addition, failure to maintain effective internal control over financial reporting could result in investigations or sanctions by regulatory authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management has taken immediate action to begin remediating the material weaknesses, however, certain remedial actions have not started or have only recently been undertaken, and while we expect to continue to implement our remediation plans throughout the fiscal year ended December 31, 2021, we cannot be certain as to when remediation will be fully completed. Additional details regarding the initial remediation efforts are disclosed in more detail under Item 9A, &#8220;Controls and Procedures&#8221; below. In addition, we may in the future identify additional internal control deficiencies that could rise to the level of a material weakness or uncover other errors in financial reporting. During the course of our evaluation, we may identify areas requiring improvement and may be required to design additional enhanced processes and controls to address issues identified through this review. In addition, there can be no assurance that such remediation efforts will be successful, that our internal control over financial reporting will be effective as a result of these efforts or that any such future deficiencies identified may not be material weaknesses that would be required to be reported in future periods. In addition, we cannot assure you that our independent registered public accounting firm will be able to attest that such internal controls are effective when they are required to do so.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to remediate the material weakness and maintain effective disclosure controls and procedures or internal control over financial reporting, we may not be able to rely on the integrity of our financial results, which could result in inaccurate or late reporting of our financial results, as well as delays or the inability to meet our reporting obligations or to comply with SEC rules and regulations. Any of these could result in delisting actions by the Nasdaq Stock Market, investigation and sanctions by regulatory authorities, stockholder investigations and lawsuits, and could adversely affect our business and the trading price of our common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business involves environmental risks that may result in liability for us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our research and development activities, we are subject to federal, state and local laws, rules, regulations and policies governing the use, generation, manufacture, storage, air emission, effluent discharge, handling and disposal of certain materials, biological specimens, chemicals and wastes. Although we believe that we have complied with the applicable laws, regulations and policies in all material respects and have not been required to correct any material noncompliance, we may be required to incur significant costs to comply with environmental and health and safety regulations in the future. Although we believe that our safety procedures for handling and disposing of controlled materials comply with the standards prescribed by state and federal regulations, accidental contamination or injury from these materials may occur. In the event of such an occurrence, we could be held liable for any damages that result and any such liability could exceed our resources.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in health care policy could increase our costs, decrease our revenues and impact sales of and reimbursement for our tests. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, collectively called the ACA, became law.  This law substantially changed the way health care is financed by both government and private third-party payors and continues to significantly impact our business and operations in ways we cannot currently predict. Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA. Both Congress and former President Trump expressed their intention to repeal or repeal and replace the ACA, and as a result, certain sections of the ACA have not been fully implemented or were effectively repealed. On November 10, 2020, the U.S. Supreme Court upheld the ACA in a 6-3 ruling. Additionally, the new U.S. presidential administration, led by President Biden, are active proponents of the ACA. The uncertainty around the future of the ACA, and in particular the impact to reimbursement levels and the number of insured individuals, may lead to delay in the purchasing decisions of our customers, which may in turn negatively impact our product sales. Further, if reimbursement levels are inadequate, our business and results of operations could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the ACA, there will continue to be proposals by legislators at both the federal and state levels, regulators and private third-party payors to reduce costs while expanding individual healthcare benefits. Certain of these changes could impose additional limitations on the prices we will be able to charge for our tests or the amounts of reimbursement available for our tests from governmental agencies or private third-party payors.  Any future changes to legal or regulatory requirements or new cost containment initiatives could have a materially adverse effect on our business, financial condition, results of operation, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks associated with currency exchange rate fluctuations, which could adversely affect our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive a portion of our revenues and pay a portion of our expenses in currencies other than the United States dollar, such as the Euro, the Swiss franc, the British pound, the Australian dollar, the Japanese yen, and the Canadian dollar. As a result, we are at risk for exchange rate fluctuations between such foreign currencies and the United States dollar, which could affect the results of our operations. If the U.S. dollar strengthens against foreign currencies, the translation of these foreign currency denominated transactions will result in decreased revenues and operating expenses. We may not be able to offset adverse foreign currency impact with increased revenues. We do not currently utilize hedging strategies to mitigate foreign currency risk and even if we were to implement hedging strategies to mitigate foreign currency risk, these strategies might not eliminate our exposure to foreign exchange rate fluctuations and would involve costs and risks of their own, such as ongoing management time and expertise, external costs to implement the strategies and potential accounting implications.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Commercialization of Our Tests, Our Services and Test Candidates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our pharmaceutical testing services customers may reduce the amount of testing they conduct through us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there is a change in the regulatory environment or intellectual property law, or our pharmaceutical testing services customers consolidate, our customers may divert resources from testing, resulting in a reduced demand for our laboratory testing services. Alternatively, customers may decide to perform their own laboratory testing services in-house.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our molecular diagnostic and companion diagnostic tests in development may never achieve significant commercial market acceptance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not succeed in achieving significant commercial market acceptance of our diagnostic test and clinical service offerings that we have launched in recent years or are currently developing. Our ability to successfully develop and commercialize our current molecular diagnostic and companion diagnostic tests, as well as any future molecular diagnostic and companion diagnostic tests that we may develop, will depend on several factors, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to convince the medical community of the clinical utility of our tests and their potential advantages over existing tests;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to collaborate with biotechnology and pharmaceutical companies to develop and commercialize companion diagnostic tests for their therapeutic drugs and drug candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the agreement by third-party payors to reimburse our tests, the scope and extent of which will affect patients&#8217; willingness or ability to pay for our tests and will likely heavily influence physicians&#8217; decisions to recommend our tests; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the willingness of physicians to utilize our tests, which can be difficult to interpret. This difficulty is caused by the ability of our tests to predict only as to a probability, not certainty, that a tested individual will develop, have the disease, benefit from a particular therapy or has an aggressive form of the disease that the test is intended to predict.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These factors present obstacles to commercial acceptance of our tests, which we would have to spend substantial time and money to overcome, if we can do so at all. Our inability to successfully do so would harm our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not compete effectively with scientific and commercial competitors, we may not be able to successfully commercialize our tests.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The clinical laboratory and genetics testing fields are intense and highly competitive. Tests that are developed are characterized by rapid technological change. Our competitors in the United States and abroad are numerous and include, among others, major diagnostic companies, reference laboratories, molecular diagnostic firms, universities and other research institutions. Some of our potential competitors have considerably greater financial, technical, marketing and other resources than we do, which may allow these competitors to discover important genes and determine their function before we do. We could be adversely affected if we do not discover genes, proteins or biomarkers and characterize their function, develop molecular diagnostic and pharmaceutical and clinical services based on these discoveries, obtain required regulatory and other approvals and launch these tests and their related services before our competitors. We also expect to encounter significant competition with respect to any molecular diagnostic and companion diagnostic tests that we may develop or commercialize. Those companies that bring to market new molecular diagnostic and companion tests before we do may achieve a significant competitive advantage in marketing and commercializing their tests. We may not be able to develop additional molecular diagnostic tests successfully and we or our licensors may not obtain or enforce patents covering these tests that provide protection against our competitors. Moreover, our competitors may succeed in developing molecular diagnostic and companion diagnostic tests that circumvent our technologies or tests. Furthermore, our competitors may succeed in developing technologies or tests that are more effective or less costly than those developed by us or that would render our technologies or tests less competitive or obsolete. We expect competition to intensify in the fields in which we are involved as technical advances in these fields occur and become more widely known and changes in intellectual property laws generate challenges to our intellectual property position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our international business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we operate in international markets. Though we recently narrowed our international operations, we have established active sales operations in Germany, France, and Japan; production operations in Germany; and international headquarters in Switzerland. We may establish additional operations or acquire additional properties outside the United States in order to advance our international sales doing business internationally involves a number of risks, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure by us to obtain regulatory approvals or adequate reimbursement for the use of our tests in various countries;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ineffective marketing campaigns leading to failure in establishing a viable, profitable, and sustainable presence in our international markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in staffing and managing foreign operations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">managing multiple payor reimbursement and self-pay systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">logistics and regulations associated with shipping patient samples, including infrastructure conditions and transportation delays;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limits in our ability to penetrate international markets if we are not able to process tests locally;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financial risks, such as longer payment cycles, difficulty collecting accounts receivable and exposure to foreign currency exchange rate fluctuations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political and economic instability, including wars, terrorism, and political unrest, outbreak of disease, boycotts, curtailment of trade and other business restrictions; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple, conflicting and changing laws and regulations such as tax laws, export and import restrictions, employment laws, data and privacy laws such as the EU GDPR, regulatory requirements and other governmental approvals, permits and licenses; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory and compliance risks that relate to maintaining accurate information and control over sales and distributors&#8217; activities that may fall within the purview of the U.S. Foreign Corrupt Practice Act, UK Bribery Act, anti-boycott laws and other anti-corruption laws.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these factors could significantly harm our international operations and, consequently, our revenues and results of operations. In addition, any failure to comply with applicable legal and regulatory obligations could impact us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments, and restrictions on certain business activities. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our distribution and sales activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations could be affected by changes in laws, trade regulations, labor and employment regulations, and procedures and actions affecting approval, production, pricing, reimbursement and marketing of tests, as well as by inter-governmental disputes. Any of these changes could adversely affect our business. Our success internationally will depend, in part, on our ability to develop and implement policies and strategies that are effective in anticipating and managing these and other risks in the countries in which we do business. Failure to manage these and other risks may have a material adverse effect on our operations in any particular country and on our business as a whole.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign governments may impose reimbursement standards, which may adversely affect our future profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our tests in foreign jurisdictions and as such may be subject to rules and regulations in those jurisdictions relating to our testing. In some foreign countries, the reimbursement of diagnostic tests is subject to governmental control. In these countries, reimbursement negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a test candidate. If reimbursement of our future tests is unavailable or limited in scope or amount, or if reimbursement rates are set at unsatisfactory levels, we may be unable to achieve or sustain profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International data protection laws and regulations may restrict our activities and increase our costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International data protection laws and regulations may affect our collection, use, storage, and transfer of information obtained outside of the United States. In particular, GDPR requires us to meet new and more stringent requirements regarding the handling of personal data about European Union residents. Failure to meet GDPR requirements could result in penalties of up to 4% of our worldwide revenue. The GDPR is a complex law and the regulatory guidance is still evolving. Furthermore, many of the countries within the European Union are still in the process of drafting supplementary data protection legislation in key fields where the GDPR allows for national variation, including the fields of clinical study and other health-related information. These variations in European data protection laws may raise our costs of compliance and result in greater legal risks. Failure to comply with data protection laws and regulations could result in government enforcement actions, which may involve civil and criminal penalties, private litigation and/or adverse publicity and could negatively affect our operating results and business. Claims that we have violated individuals&#8217; privacy rights or breached our contractual obligations, even if we are not found liable, could be expensive and time-consuming to defend and could result in adverse publicity that could harm our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on a single laboratory facility to process each of our molecular diagnostic tests in the United States and Europe and a single laboratory facility to perform our pharmaceutical and clinical services. Failure to maintain the operations of these laboratories in compliance with applicable regulations would seriously harm our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a CLIA-certified facility in Salt Lake City, Utah to perform most of our molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California to perform our Foresight and Prequel tests; a single laboratory facility in Cologne, Germany to perform and produce our EndoPredict test kits; a CLIA-certified laboratory in Mason, Ohio to perform our GeneSight test; and a CLIA-certified laboratory facility in Austin, Texas to perform our pharmaceutical and clinical testing services. These facilities and certain pieces of laboratory equipment would be difficult to replace and may require significant replacement lead-time. In the event any of our clinical testing facilities were to lose its CLIA certification or other required certifications or licenses or were affected by a pandemic or man-made or natural disaster, we would be unable to continue our molecular diagnostic and pharmaceutical and clinical services business at current levels to meet customer demands for a significant period of time. Although we maintain insurance on these facilities, including business interruption insurance, it may not be adequate to protect us from all potential losses if these facilities were damaged or destroyed. In addition, any interruption in our molecular diagnostic or pharmaceutical and clinical services business would result in a loss of goodwill, including damage to our reputation. If our molecular diagnostic or pharmaceutical and clinical services business were interrupted, it would seriously harm our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on a limited number of third parties for some of our supplies of equipment and reagents. If these supplies become unavailable or are disrupted, including as a result of COVID-19 and responses to it, then we may not be able to successfully perform our research or operate our business on a timely basis or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely on a small number of suppliers to provide our gene sequencing equipment, content enrichment equipment, multiplex protein analysis equipment, robots, and specialty reagents and laboratory supplies required in connection with our testing and research. We believe that currently there are limited alternative suppliers of these equipment, robots, and reagents. The equipment, robots, or the reagents may not remain available in commercial quantities at acceptable costs. If we are unable to obtain when needed additional or alternative equipment, robots, or an adequate supply of reagents or other ingredients at commercially reasonable rates, our ability to continue to identify genes and perform molecular diagnostic testing and pharmaceutical and clinical services would be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have experienced and may continue to experience a shortage of certain laboratory supplies and equipment, and we may experience a suspension of services from other laboratories or third parties as a result of COVID&#8209;19 and ongoing responses to it. Political, administrative, legislative, legal or regulatory actions in response to COVID&#8209;19, including the possible use of the Defense Production Act in the United States to compel manufacturers to prioritize other products or customers over us, could create additional supply shortages, disruptions or other uncertainties affecting our research and business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our current research collaborators or scientific advisors terminate their relationships with us or develop relationships with a competitor, our ability to discover genes, proteins, and biomarkers, and to validate and commercialize molecular diagnostic and companion diagnostic tests could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relationships with research collaborators at academic and other institutions who conduct research at our request. These research collaborators are not our employees. As a result, we have limited control over their activities and, except as otherwise required by our collaboration agreements, can expect only limited amounts of their time to be dedicated to our activities. Our ability to discover genes, proteins, and biomarkers involved in human disease and validate and commercialize molecular diagnostic and companion diagnostic tests will depend in part on the continuation of these collaborations. If any of these collaborations are terminated, we may not be able to enter into other acceptable collaborations. In addition, our existing collaborations may not be successful.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research collaborators and scientific advisors may have relationships with other commercial entities, some of which could compete with us. Our research collaborators and scientific advisors sign agreements which provide for the confidentiality of our proprietary information. We may not, however, be able to maintain the confidentiality of our technology and other confidential information related to all collaborations. The dissemination of our confidential information could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to retain our key personnel and hire, train and retain qualified employees and consultants, we may not be able to successfully continue our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the specialized scientific nature of our business, we are highly dependent upon our ability to attract and retain qualified management, scientific and technical personnel. We are currently recruiting additional qualified management, scientific and technical personnel. Competition for such personnel is intense. Loss of the services of or failure to recruit additional key management, scientific and technical personnel would adversely affect our research and development programs and molecular diagnostic and pharmaceutical and clinical services business and may have a material adverse effect on our business as a whole.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our agreements with our employees generally provide for employment that can be terminated by either party without cause at any time, subject to specified notice requirements. Further, the non-competition provision to which each employee is subject expires for certain key employees on the applicable date of termination of employment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to protect our proprietary technology, others could compete against us more directly, which would harm our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, our patent portfolio included issued patents owned or licensed by us and numerous patent applications in the United States and other countries with claims protecting our intellectual property rights. Our commercial success will depend, in part, on our ability to obtain additional patents and licenses and protect our existing patent position, both in the United States and in other countries, for compositions, processes, methods and other inventions that we believe are patentable. Our ability to preserve our trade secrets, proprietary data bases and other intellectual property is also important to our long-term success. If our intellectual property is not adequately protected, competitors may be able to use our technologies and erode or negate any competitive advantage we may have, which could harm our business and ability to maintain profitability. Patents may also issue to third parties which could interfere with our ability to bring our molecular diagnostic tests to market. The laws of some foreign countries do not protect our proprietary rights to the same extent as U.S. laws, and we may encounter significant problems in protecting our proprietary rights in these countries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent positions of diagnostic companies, including our patent position, are generally highly uncertain and involve complex legal and factual questions, and, therefore, any patents issued to us may be challenged, deemed unenforceable, invalidated or circumvented. We will be able to protect our proprietary rights from unauthorized use by third parties only to the extent that our proprietary technologies and any future tests are covered by valid and enforceable patents or are effectively maintained as trade secrets. Our patent applications may never issue as patents, and the claims of any issued patents may not afford meaningful protection for our technology or tests. In addition, any patents issued to us or our licensors may be challenged, and subsequently narrowed, invalidated or circumvented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where necessary, we may initiate litigation to enforce our patent or other intellectual property rights. Any such litigation may require us to spend a substantial amount of time and money and could distract management from our day-to-day operations. Moreover, there is no assurance that we will be successful in any such litigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The degree of future protection for our proprietary rights is uncertain, and we cannot ensure that:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or our licensors were the first to make the inventions covered by each of our patent applications;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or our licensors were the first to file patent applications for these inventions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others will not independently develop similar or alternative technologies or duplicate any of our technologies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any of our or our licensors&#8217; patent applications will result in issued patents;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any of our or our licensors&#8217; patents will be valid or enforceable;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any patents issued to us or our licensors and collaborators will provide a basis for commercially viable tests, will provide us with any competitive advantages or will not be challenged by third parties;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we will develop additional proprietary technologies or tests that are patentable;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents of others will not have an adverse effect on our business; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our patents or patents that we license from others will survive legal challenges and remain valid and enforceable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a third party files a patent application with claims to subject matter we have invented, the United States Patent and Trademark Office (&#8220;USPTO&#8221;) may declare interference between competing patent applications. If an interference is declared, we may not prevail in the interference. If the other party prevails in the interference, we may be precluded from commercializing services or tests based on the invention or may be required to seek a license. A license may not be available to us on commercially acceptable terms, if at all. For example, in January 2020 the Patent Trial and Appeal Board (the &#8220;PTAB&#8221;) of the USPTO declared patent Interference No. 106,122 between U.S. Patent No. 9,200,324 controlled by Myriad (under the license agreement with OMRF) relating to the Vectra test and U.S. Application No. 15/363,991 owned by Meso Scale Technologies, LLC. On February 24, 2021 the PTAB issued a decision and judgment denying Meso Scale's motion for a finding of priority and inventorship in their favor and refusing Meso Scale's claims in U.S. Application No. 15/363,991. The PTAB's judgment may be appealed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely upon unpatented proprietary technologies and databases. Although we require employees, consultants and collaborators to sign confidentiality agreements, we may not be able to adequately protect our rights in such unpatented proprietary technologies and databases, which could have a material adverse effect on our business. For example, others may independently develop substantially equivalent proprietary information or techniques or otherwise gain access to our proprietary technologies or disclose our technologies to our competitors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we were sued for patent infringement by third parties, we might incur significant costs and delays in test introduction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tests may also conflict with patents that have been or may be granted to others. Our industry includes many organizations that have or are seeking to discern biomarkers and develop genomic, proteomic and other technologies. To the extent any patents are issued or have been issued to those organizations, the risk increases that the sale of our molecular diagnostic and companion diagnostic tests currently being marketed or under development may give rise to claims of patent infringement. Others may have filed and in the future are likely to file patent applications covering biomarkers that are similar or identical to our tests. Any of these patent applications may have priority over our patent applications and these entities or persons could bring legal proceedings against us seeking damages or seeking to enjoin us from testing or marketing our tests. Patent litigation is costly, and even if we prevail, the cost of such litigation could have a material adverse effect on us. If the other parties in any such actions are successful, in addition to any liability for damages, we could be required to cease the infringing activity or obtain a license. Any license required may not be available to us on commercially acceptable terms, if at all. Our failure to obtain a license to any technology that we may require to commercialize our tests could have a material adverse effect on our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that there may be significant litigation in the industry regarding patent and other intellectual property rights. If we become involved in this litigation, it could consume a substantial portion of our managerial and financial resources.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to adequately prevent disclosure of trade secrets, proprietary databases, and other proprietary information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on trade secrets to protect our proprietary technologies and databases, especially where we do not believe patent protection is appropriate or obtainable. However, trade secrets are difficult to protect. We rely in part on confidentiality agreements with our employees, consultants, outside scientific collaborators, sponsored researchers and others to protect our trade secrets and other proprietary information. These agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy if unauthorized disclosure of confidential information occurs. In addition, others may independently discover our trade secrets and proprietary information. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive position.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with our obligations under license or technology agreements with third parties, we could lose license rights that are critical to our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We license intellectual property that is important to our business, including licenses underlying the technology in our molecular diagnostic and pharmaceutical and clinical services, and in the future, we may enter into additional agreements that provide us with licenses to valuable intellectual property or technology. These licenses impose various royalty payments, milestones, and other obligations on us. If we fail to comply with any of these obligations, the licensor may have the right to terminate the license. Termination by the licensor would cause us to lose valuable rights, and could prevent us from distributing our current tests, or inhibit our ability to commercialize future test candidates. Our business would suffer if any current or future licenses terminate, if the licensors fail to abide by the terms of the license, if the licensors fail to prevent infringement by third parties, if the licensed patents or other rights are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that we or our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is commonplace in our industry, we employ individuals who were previously employed at other biotechnology or pharmaceutical companies, including our potential competitors. Although no claims against us are currently pending, we may be subject to claims that these employees have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with the complex federal, state, local and foreign laws and regulations that apply to our business, we could suffer severe consequences that could materially and adversely affect our operating results and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject to extensive federal, state, local and foreign laws and regulations, all of which are subject to change.  These laws and regulations currently include, among other things:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CLIA, which requires that laboratories obtain certification from the federal government, and state licensure laws;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA laws and regulations that apply to medical devices such as our in vitro diagnostics;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, which imposes comprehensive federal standards with respect to the privacy and security of protected health information and requirements for the use of certain standardized electronic transactions; amendments to HIPAA under HITECH, which strengthened and expanded HIPAA privacy and security compliance requirements, increased penalties for violators, extended enforcement authority to state attorneys general and imposed requirements for breach notification;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws regulating genetic testing and protecting the privacy of genetic test results, as well as state laws protecting the privacy and security of health information and personal data and mandating reporting of breaches to affected individuals and state regulators;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute, which prohibits knowingly and willfully offering, paying, soliciting, receiving, or providing remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual, or the furnishing, arranging for, or recommending of an item or service that is reimbursable, in whole or in part, by a federal health care program;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal False Claims Act, which imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment to the federal government;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Civil Monetary Penalties Law, which prohibits, among other things, the offering or transfer of remuneration to a Medicare or state health care program beneficiary if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program, unless an exception applies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other federal and state fraud and abuse laws, such as anti-kickback laws, prohibitions on self-referral, and false claims acts, which may extend to services reimbursable by any third-party payor, including private insurers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Physician Payments Sunshine Act, which requires medical device manufactures to track and report to the federal government certain payments and other transfers of value made to physicians and teaching hospitals and ownership or investment interests held by physicians and their immediate family members;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Section 216 of the federal Protecting Access to Medicare Act of 2014 (&#8220;PAMA&#8221;), which requires the Centers for Medicare &amp; Medicaid Services to set Medicare rates for clinical laboratory testing based on private payor data reported by applicable laboratories;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws that impose reporting and other compliance-related requirements; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">similar foreign laws and regulations that apply to us in the countries in which we operate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a clinical laboratory, our business practices may face heightened scrutiny from government enforcement agencies such as the Department of Justice, the OIG, and CMS. The OIG has issued fraud alerts in recent years that identify certain arrangements between clinical laboratories and referring physicians as implicating the Anti-Kickback Statute. The OIG has stated that it is particularly concerned about these types of arrangements because the choice of laboratory, as well as the decision to order laboratory tests, typically are made or strongly influenced by the physician, with little or no input from the patient. Moreover, the provision of payments or other items of value by a clinical laboratory to a referral source could be prohibited under the federal self-referral prohibition, commonly known as the Stark Law or the Physician Self-Referral Law, unless the arrangement meets all criteria of an applicable exception. The government has actively enforced these laws against clinical laboratories in recent years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations are complex and are subject to interpretation by the courts and by government agencies. Our failure to comply could lead to civil or criminal penalties, exclusion from participation in state and federal health care programs, or prohibitions or restrictions on our laboratories&#8217; ability to provide or receive payment for our services. We believe that we are in material compliance with all statutory and regulatory requirements, but there is a risk that one or more government agencies could take a contrary position, or that a private party could file suit under the qui tam provisions of the federal False Claims Act or a similar state law. Such occurrences, regardless of their outcome, could damage our reputation and adversely affect important business relationships with third parties, including managed care organizations, and other private third-party payors.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth of our business and our expansion outside of the United States may increase the potential of violating similar foreign laws or our internal policies and procedures. The risk of us being found in violation of these or other laws and regulations is further increased by the fact that many have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action brought against us for violation of these or other laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. Any of the foregoing consequences could seriously harm our business and our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA regulation of our industry generally or our tests specifically could be disruptive to our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described further below, the FDA has long claimed authority to regulate laboratory-developed tests but has exercised its &#8220;enforcement discretion&#8221; to limit enforcement of in vitro diagnostic regulatory requirements on this category of products. More recently, the FDA has appeared to increase its attention to the marketing of pharmacogenetic tests. For example, in late 2018, the FDA issued a safety communication regarding &#8220;genetic tests that claim results can be used to help physicians identify which antidepressant medication would have increased effectiveness or side effects compared to other antidepressant medications.&#8221; This safety communication explained that the FDA had reached out to several firms marketing such pharmacogenetic tests where the FDA believed the relationship between genetic variations and a medication&#8217;s effects had not been established, including a warning letter to Inova Genomics Laboratory.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2019, we provided the FDA with clinical evidence and other information to support our GeneSight Psychotropic test. Later that year, the FDA requested changes to the GeneSight test offering. Although we disagreed that changes to the test were required, we submitted a proposal regarding the reporting of GeneSight test results to healthcare providers that we believed addressed the FDA&#8217;s principal concerns. We believe this approach should not affect the benefits that we believe are provided by the GeneSight test.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since submitting our proposal to the FDA, we have continued to engage with our trade association in their efforts to defend the offering of pharmacogenomic tests as LDTs and to monitor broader developments across the stakeholder community. In response to public letters from the national laboratory trade association and patient groups, on February 20, 2020, the FDA announced a new &#8220;collaboration between FDA&#8217;s Center for Devices and Radiological Health and Center for Drug Evaluation and Research intended to provide the agency&#8217;s view of the state of the current science in pharmacogenetics.&#8221; Although the announcement again asserted that some of these test offerings may be potentially dangerous, the agency also acknowledged that pharmacogenetic testing &#8220;offers promise for informing the selection or dosing of some medications for certain individuals.&#8221; In conjunction with the announcement, the FDA also released an updated &#8220;Table of Pharmacogenetic Associations,&#8221;which lists gene-drug interactions that the agency believes are supported by FDA-approved drug labeling and/or &#8220;sufficient scientific evidence based on published literature.&#8221; Based on our discussions with the agency over the past year and these recent developments, we have not implemented our earlier proposal or any other changes to the GeneSight Psychotropic test. While we see these developments in 2020 as signaling a positive shift in the FDA&#8217;s approach to regulating pharmacogenetic tests, we cannot predict with certainty the outcome of this matter or its timing, or whether the ultimate form of the GeneSight Psychotropic test offering will have an adverse effect on our revenues from the test.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with laws and regulations related to submission of claims for our services could result in significant monetary damages and penalties and exclusion from the Medicare and Medicaid programs and corresponding foreign reimbursement programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws and regulations governing the submission of claims for payment for our services, such as those relating to: coverage of our services under Medicare, Medicaid and other state, federal and foreign health care programs; the amounts that we may bill for our services; and the party to which we must submit claims. Our failure to comply with applicable laws and regulations could result in our inability to receive payment for our services or in attempts by state and federal healthcare programs, such as Medicare and Medicaid, to recover payments already made. Submission of claims in violation of these laws and regulations can result in recoupment of payments already received, substantial civil monetary penalties, and exclusion from state and federal health care programs, and can subject us to liability under the federal False Claims Act and similar laws. The failure to report and return an overpayment to the Medicare or Medicaid program within 60 days of identifying its existence can give rise to liability under the False Claims Act. Further, a government agency could attempt to hold us liable for causing the improper submission of claims by another entity for services that we performed if we were found to have knowingly participated in the arrangement at issue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are currently subject to government investigation(s), the unfavorable outcome of which may have a material adverse effect on our financial condition, results of operations and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, our wholly-owned subsidiary, Crescendo Bioscience, Inc. (&#8220;CBI&#8221;), received a subpoena from the Office of Inspector General of the Department of Health and Human Services requesting that CBI produce documents relating to entities that received payment from CBI for the collection and processing of blood specimens for testing, including a named unrelated company, healthcare providers and other third party entities.  The Office of Inspector General subsequently requested additional documentation in December 2017.  CBI provided to the Office of Inspector General the documents requested.  On January 30, 2020, the United States District Court for the Northern District of California unsealed a qui tam complaint, filed on April 16, 2016 against CBI, alleging violations of the Federal and California False Claims Acts and the California Insurance Fraud Prevention Act.  On January 22, 2020, after a multi-year investigation into CBI&#8217;s and the Company&#8217;s alleged conduct, the United States declined to intervene.  On January 27, 2020, the State of California likewise filed its notice of declination. The Company was not aware of the complaint until after it was unsealed. On April 16, 2020, CBI filed a motion to dismiss the action with prejudice. On May 23, 2020, the court denied that motion. The Company intends to continue to vigorously defend against this action. We are unable to predict what action, if any, might be taken in the future by the Office of Inspector General or any other regulatory authority as a result of the matters related to this investigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above case may divert management resources and/or cause us to incur substantial costs, and any unfavorable outcome may have a material adverse effect on our financial condition, results or operations and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be harmed by the loss, suspension, or other restriction on a license, certification, or accreditation, or by the imposition of a fine or penalties, under CLIA, its implementing regulations, or other state, federal and foreign laws and regulations affecting licensure or certification, or by future changes in these laws or regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The diagnostic testing industry is subject to extensive laws and regulations, many of which have not been interpreted by the courts. CLIA requires virtually all laboratories to be certified by the federal government and mandates compliance with various operational, personnel, facilities administration, quality and proficiency testing requirements intended to ensure that testing services are accurate, reliable and timely. CLIA certification is also a prerequisite to be eligible to bill state and federal health care programs, as well as many private third-party payors, for laboratory testing services. As a condition of CLIA certification, each of our laboratories is subject to survey and inspection every other year, in addition to being subject to additional random inspections. The biennial survey is conducted by CMS; a CMS agent (typically a state agency); or, if the laboratory holds a CLIA certificate of accreditation, a CMS-approved accreditation organization. Sanctions for failure to comply with CLIA requirements, including proficiency testing violations, may include suspension, revocation, or limitation of a laboratory&#8217;s CLIA certificate, which is necessary to conduct business, as well as the imposition of significant fines or criminal penalties. In addition, we are subject to regulation under state laws and regulations governing laboratory licensure. Some states have enacted state licensure laws that are more stringent than CLIA. We are also subject to laws and regulations governing our reference laboratory in Germany. Changes in state or foreign licensure laws that affect our ability to offer and provide diagnostic services across state or foreign country lines could materially and adversely affect our business. In addition, state and foreign requirements for laboratory certification may be costly or difficult to meet and could affect our ability to receive specimens from certain states or foreign countries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any sanction imposed under CLIA, its implementing regulations, or state or foreign laws or regulations governing licensure, or our failure to renew a CLIA certificate, a state or foreign license, or accreditation, could have a material adverse effect on our business. If the CLIA certificate of any one of our laboratories is revoked, CMS could seek revocation of the CLIA certificates of our other laboratories based on their common ownership or operation, even though they are separately certified.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the way that the FDA regulates tests performed by laboratories like ours could result in delay or additional expense in offering our tests and tests that we may develop in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the FDA has exercised enforcement discretion with respect to most LDTs and has generally not required laboratories that furnish LDTs to comply with the agency&#8217;s requirements for medical devices (e.g., establishment registration, device listing, quality systems regulations, premarket clearance or premarket approval, and post-market controls). In recent years, however, the FDA publicly announced its intention to regulate certain LDTs and issued two draft guidance documents that set forth a proposed phased-in risk-based regulatory framework that would apply varying levels of FDA oversight to LDTs. However, these guidance documents were not finalized, and the framework was abandoned and replaced by an informal discussion paper reflecting some of the feedback that FDA had received on LDT regulation. The FDA acknowledged that the January 2017 discussion paper does not represent the formal position of the FDA and is not enforceable. Nevertheless, the FDA wanted to share its synthesis of the feedback that it had received in the hope that it might advance public discussion on future LDT oversight. Notwithstanding the discussion paper, the FDA continues to exercise enforcement discretion and may attempt to regulate certain LDTs on a case-by-case basis at any time, which could result in delay or additional expense in offering our tests and tests that we may develop in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to potential enforcement priority changes from the FDA, in December 2018, members of Congress released a discussion draft of a legislation to regulate in vitro clinical tests including LDTs under a shared FDA/CMS framework, and provided opportunities for stakeholders to comment on the proposed legislation. On March 5, 2020, U.S. Representatives Diana DeGette (D-CO) and Dr. Larry Bucshon (R-IN) formally introduced the legislation, called the Verifying Accurate, Leading-edge IVCT Development (VALID) Act. An identical version of the bill was also introduced in the Senate and is sponsored by U.S. Senators Michael Bennet (D-CO) and Richard Burr (R-NC), demonstrating both bicameral and bipartisan support for the effort to overhaul how diagnostic tests are regulated. The VALID Act would codify into law the term &#8220;in vitro clinical test&#8221; (IVCT) to create a new medical product category separate from medical devices that includes products currently regulated as in vitro diagnostics (IVDs) as well as LDTs.  The framework would give the FDA the authority to ensure IVCTs are both analytically and clinically valid.  CMS would retain the authority to ensure the quality of operations within laboratories.  All LDTs on the market prior to enactment of the legislation would be grandfathered and not subject to the new regulation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is unclear whether the VALID Act will be passed by Congress in its current form or signed into law by the President. Until the FDA finalizes its regulatory position regarding LDTs, or the VALID Act or other legislation is passed reforming the federal government&#8217;s regulation of LDTs, it is unknown how the FDA may attempt to regulate our tests in the future and what testing and data may be required to support any required clearance or approval of our tests by the agency. If the VALID Act is implemented as drafted it could have an adverse material impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Companion and complementary diagnostic tests require FDA approval and we may not be able to secure such approval in a timely manner or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our companion and complementary diagnostic products, marketing, sales and development activities and manufacturing processes are subject to extensive and rigorous regulation by the FDA pursuant to the Federal Food, Drug, and Cosmetic Act (FDCA), by comparable agencies in foreign countries, and by other regulatory agencies and governing bodies. Under the FDCA, companion diagnostics must receive FDA clearance or approval before they can be commercially marketed in the U.S. The process of obtaining marketing approval or clearance from the FDA or by comparable agencies in foreign countries for new products could:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">take a significant period of time;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require the expenditure of substantial resources;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">involve rigorous pre-clinical testing, as well as increased post-market surveillance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require changes to products; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">result in limitations on the indicated uses of products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have successfully achieved FDA approval for some tests (e.g., our BRAC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CDx and myChoice CDx tests), we cannot predict whether or when we will be able to obtain FDA approval for other companion diagnostics that we are developing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the government and third-party payors fail to provide coverage and adequate payment for our existing and future tests, if any, our revenue and prospects for profitability will be harmed. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In both domestic and foreign markets, sales of our molecular diagnostic tests or any future diagnostic tests will depend in large part, upon the availability of reimbursement from third-party payors. Such third-party payors include state and federal health care programs such as Medicare, managed care providers, private health insurers and other organizations. These third-party payors are increasingly attempting to contain healthcare costs by demanding price discounts or rebates and limiting both coverage regarding which diagnostic tests they will pay for and the amounts that they will pay for existing and new molecular diagnostic tests. We have recently experienced price reductions from CMS for some of our products, including for our GeneSight&#174; psychotropic test subsequent to the July 2020 release of the final pharmacogenomics LCD, and we may experience future price reductions from CMS, managed care organizations, and other third-party payors. The fact that a diagnostic test has been approved for reimbursement in the past, for any particular indication or in any particular jurisdiction, does not guarantee that such a diagnostic test will remain approved for reimbursement, that the reimbursement amount approved for such test will not be reduced in the future, or that similar or additional diagnostic tests will be approved in the future. Moreover, there can be no assurance that any new tests we have launched or may launch will be reimbursed at rates that are comparable to the rates that we historically obtained for our existing product portfolio. As a result, third-party payors may not cover or provide adequate payment for our current or future molecular diagnostic tests to enable us to maintain past levels of revenue or profitability with respect to such tests. Further, third-party reimbursement might not be available to enable us to maintain price levels sufficient to realize an appropriate return on investment in product development. In addition, under PAMA, Medicare reimbursement for any given diagnostic test is based on the weighted-median of the payments made by private payors for such test, rendering private payor payment levels even more significant. As a result, future Medicare payments may fluctuate more often and become subject to the willingness of private payors to recognize the value of diagnostic tests generally and any given test individually. </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, Congress passed the Coronavirus Aid, Relief, and Economic Security Act, which included a provision that delays the next PAMA reporting period for clinical laboratory tests that are not advanced diagnostic tests to January 1, 2022 through March 31, 2022. In addition, the next round of rate cuts will not be implemented until 2022, with tests receiving cuts of up to 15 percent a year from 2022 through 2024. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any declines in average selling prices of our products due to pricing pressures may have an adverse impact on our business, results of operations and financial condition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and foreign governments continue to propose and pass legislation designed to reduce the cost of health care.  For example, in some foreign markets, the government controls the pricing of many health care products. We expect that there will continue to be federal and state proposals to implement governmental controls or impose health care requirements. In addition, the Medicare program and increasing emphasis on managed care in the United States will continue to put pressure on product pricing. Cost control initiatives could decrease the price that we would receive for any tests in the future, which would limit our revenue and profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be adversely impacted by our failure or the failure of physicians to comply with any new ICD Code Set.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS periodically adopts new coding set for diagnoses, commonly known as ICD code sets. Compliance with ICD is required for all claims with dates of service on or after the effective dates specified when such code sets are adopted. We believe we have fully implemented the current ICD-10-CM code set and expect to be able to implement any future code set, however, our failure to implement and apply this or any new code set could adversely impact our business. In addition, if physicians fail to provide appropriate codes for desired tests, we may not be reimbursed for tests we perform.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is highly volatile, and our stock may lose all or a significant part of its value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market prices for securities of molecular diagnostic companies have been volatile. This volatility has significantly affected the market prices for these securities for reasons frequently unrelated to the operating performance of the specific companies. These broad market fluctuations may adversely affect the market price of our common stock. The market price for our common stock has fluctuated significantly since public trading commenced in October 1995, and it is likely that the market price will continue to fluctuate in the future. In the two years ended December 31, 2020, our stock price has ranged from $9.24 per share to $48.40 per share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the stock market in general has experienced extreme price and volume fluctuations. Events or factors that may have a significant impact on our business and on the market price of our common stock include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">major market events, such as the market&#8217;s reaction to the COVID-19 pandemic generally and its specific impact on the Company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of any of our recently launched tests and any new test candidates to achieve commercial success;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to sustain revenue growth or margins in our molecular diagnostic business;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure of healthcare payment systems and changes in governmental or private insurer reimbursement levels for our molecular diagnostic tests;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">introduction of new commercial tests or technological innovations by competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">termination of the licenses underlying our molecular diagnostic and pharmaceutical and clinical services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or other problems with operating our laboratory facilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of any of our research and development programs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in intellectual property laws or enforcement of our patents in the United States and foreign countries;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning patents or other proprietary rights involving us directly or otherwise affecting the industry as a whole;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">missing or changing the financial guidance we provide;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in estimates or recommendations by securities analysts relating to our common stock or the securities of our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the government regulatory approval process for our existing and new tests;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to meet estimates or recommendations by securities analysts that cover our common stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public concern over our approved tests and any test candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government and regulatory investigations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future sales or anticipated sales of our common stock by us or our stockholders;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of any repurchases of our common stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general market conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seasonal slowness in sales, particularly in the quarters ending September 30 and March 31, the effects of which may be difficult to understand during periods of growth;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general perception of public health, the DNA industry and our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic, healthcare and diagnostic trends, disasters or crises and other external factors; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">period-to-period fluctuations in our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and other external factors may cause the market price and demand for our common stock to fluctuate substantially, which may limit or prevent investors from readily selling their shares of common stock and may otherwise negatively affect the liquidity of our common stock. In addition, securities class action litigation such as the current stockholder suit pending against the Company discussed below may affect the market price and demand for our common stock. If any of our other stockholders brought another lawsuit against us, we could incur substantial costs defending the lawsuit regardless of the outcome. Such a lawsuit could also divert the time and attention of our management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions of Delaware law, provisions in our charter and bylaws and re-adoption of our stockholders&#8217; rights plan, or poison pill, could make a third-party acquisition of us difficult.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we are a Delaware corporation, the anti-takeover provisions of Delaware law could make it more difficult for a third party to acquire control of us, even if the change in control would be beneficial to stockholders. We are subject to the provisions of Section 203 of the General Corporation Law of Delaware, which prohibits us from engaging in certain business combinations, unless the business combination is approved in a prescribed manner. In addition, our restated certificate of incorporation and restated bylaws also contain certain provisions that may make a third-party acquisition of us difficult, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a classified board of directors, with three classes of directors each serving a staggered three-year term;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the board of directors to issue preferred stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a 70% super-majority stockholder vote to amend our bylaws and certain provisions of our certificate of incorporation; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability of our stockholders to call a special meeting or act by written consent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, we implemented a stockholders&#8217; rights plan, also called a poison pill, which could make it uneconomical for a third party to acquire the Company on a hostile basis. Although the plan expired in July 2011, our Board of Directors could adopt a new plan at any time. The provisions in a stockholders&#8217; rights plan, as well as Section 203, may discourage certain types of transactions in which our stockholders might otherwise receive a premium for their shares over the then-current market price, and may limit the ability of our stockholders to approve transactions that they think may be in their best interests.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_22"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;PROPERTIES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters and facilities are located in Salt Lake City, Utah. We currently lease a total of approximately 335,000 square feet of building space in Salt Lake City dedicated to research and development, administration and our laboratory that has received federal certification under CLIA. Activities related to our oncology, urology, autoimmune, dermatology and women&#8217;s health molecular diagnostic business are performed at this location.&#160;&#160;The leases on our existing Salt Lake City facilities have terms of five to fifteen years, expiring from 2022 through 2027, and provide for renewal options for up to ten additional years. In addition, in December 2018 we entered into a lease agreement for a building, which is currently under construction and will contain approximately 125,000 square feet of additional office space upon completion. We anticipate completion of the building during the first half of calendar year 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease approximately 93,000 square feet in South San Francisco, California under two leases that expire in April 2025 and September 2025.&#160;&#160;This space is dedicated to administration, research and development and the CLIA-certified laboratory for our women&#8217;s health business.&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we lease approximately 36,000 square feet in Austin, Texas under a lease that expires in June 2025. This space is dedicated to administration, research and development and the CLIA-certified laboratory used for pharmaceutical and clinical services, which are performed at this location.&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease 2 spaces in Mason, Ohio, the leases for which will expire in December 2021 and August 2024 respectively, and one in Toronto, Ontario, Canada, which is month to month, with a total square footage for the 3 lease spaces of approximately 35,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain leases for several small office locations, such as our manufacturing facility located in Cologne, Germany. These spaces are generally used for the administration of our international operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing facilities and equipment are well maintained and in good working condition. We believe our current facilities and those planned will provide adequate capacity for at least the next two years. We continue to make investments in capital equipment as needed to meet the anticipated demand for our molecular diagnostic tests and our pharmaceutical and clinical services.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_28"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Qui Tam Lawsuit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, our wholly-owned subsidiary, Crescendo Bioscience, Inc. (&#8220;CBI&#8221;), received a subpoena from the Office of Inspector General of the Department of Health and Human Services requesting that CBI produce documents relating to entities that received payment from CBI for the collection and processing of blood specimens for testing, including a named unrelated company, healthcare providers and other third party entities. The Office of Inspector General subsequently requested additional documentation in December 2017. CBI provided to the Office of Inspector General the documents requested. On January 30, 2020, the United States District Court for the Northern District of California unsealed a qui tam complaint, filed on April 16, 2016 against CBI and the Company, alleging violations of the Federal and California False Claims Acts and the California Insurance Fraud Prevention Act.&#160;&#160;On January 22, 2020, after a multi-year investigation into CBI&#8217;s and the Company&#8217;s alleged conduct, the United States declined to intervene. On January 27, 2020, the State of California likewise filed its notice of declination. The Company was not aware of the complaint until after it was unsealed. On May 23, 2020, the court denied CBI and the Company&#8217;s motion to dismiss. The Company intends to continue to vigorously defend against this action. Due to the nature of this matter and inherent uncertainties, it is not possible to provide an evaluation of the likelihood of an unfavorable outcome or an estimate of the amount or range of potential loss, if any.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purported Securities Class Action</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2019, a purported class action complaint was filed in the United States District Court for the District of Utah, against the Company, its former President and Chief Executive Officer, Mark C. Capone, and its Interim President and Chief Executive Officer, Executive Vice President and Chief Financial Officer, R. Bryan Riggsbee (&#8220;Defendants&#8221;). On February 21, 2020, the plaintiff filed an amended class action complaint, which added the Company&#8217;s Executive Vice President of Clinical Development, Bryan M. Dechairo, as an additional Defendant. This action, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In re Myriad Genetics, Inc. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (No. 2:19-cv-00707-DBB), is premised upon allegations that the Defendants made false and misleading statements regarding our business, operations, and acquisitions.&#160;&#160;The lead plaintiff seeks the payment of damages allegedly sustained by it and the purported class by reason of the allegations set forth in the amended complaint, plus interest, and legal and other costs and fees.&#160;&#160;The Company intends to vigorously defend against this action.&#160;Due to the nature of this matter and inherent uncertainties, it is not possible to provide an evaluation of the likelihood of an unfavorable outcome or an estimate of the amount or range of potential loss, if any.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2018, Assurex Health, Inc. was served with an Amended Complaint which had been filed in the Circuit Court of Cook County, Illinois, County Department, Law Division, Civil Action No. 2018 L 004972, by Pipe Trades Services MN Welfare Plan ("Pipe Trades"), as a qui tam relator, on behalf of the State of Illinois, Pipe Trades, and all others similarly situated, purportedly arising from Assurex's alleged violations of the Illinois Insurance Claims Fraud Prevention Act and other causes of action. Pipe Trades seeks certification of a putative class, certification as the purported class representative, and the payment of treble damages allegedly sustained by Pipe Trades and the purported class by reason of the allegations set forth in the amended complaint, plus statutory damages and penalties, plus interest, and legal and other costs and fees. The State of Illinois and Cook County, Illinois, have declined to intervene in the matter. On February 19, 2021, the court granted Assurex's motion to dismiss the complaint, without prejudice and with leave for Pipe Trades to file an amended complaint, for failure to state a claim on which relief can be granted. If Pipe Trades files an amended complaint, we intend to continue to vigorously defend against this action. Due to the nature of this matter and inherent uncertainties, it is not possible to provide an evaluation of the likelihood of an unfavorable outcome or an estimate of the amount or range of potential loss, if any.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as set forth above, we are not a party to any legal proceedings that we believe will have a material impact on our business, financial position or results of operations.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_31"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_37"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on The Nasdaq Global Select Market under the symbol "MYGN."&#160;&#160;</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February 24, 2021, there were approximately 105 stockholders of record of our common stock and, according to our estimates, approximately 35,186 beneficial owners of our common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unregistered Sales of Securities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ard of Directors has previously authorized us to repurchase up to $200.0 million of our outstanding common stock, of which $110.7 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is still available to repurchase as of December&#160;31, 2020. We are authorized to complete the repurchase through open market transactions or through an accelerated share repurchase program, in each case to be executed at management&#8217;s discretion based on business and market conditions, stock price, trading restrictions, acquisition activity and other factors. The repurchase program may be suspended or discontinued at any time without prior notice.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No stock repurchases were made under our stock repurchase program during the transition period ended December&#160;31, 2020.</span></div><div style="margin-top:18pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph set forth below compares the annual percentage change in our cumulative total stockholder return on our common stock during a period commencing on December 31, 2015 and ending on December&#160;31, 2020 (as measured by dividing (A) the difference between our share price at the end and the beginning of the measurement period; by (B) our share price at the beginning of the measurement period) with the cumulative total return of The Nasdaq Stock Market, Inc. and the Nasdaq Health Care Providers Stock Index during such period.&#160;&#160;We have not paid any cash dividends on our common stock, and we do not include cash dividends in the representation of our performance.&#160;&#160;The price of a share of common stock is based upon the closing price per share as quoted on The Nasdaq Global Select Market on the last trading day of the year shown.&#160;&#160;The graph lines merely connect year-end values and do not reflect fluctuations between those dates.&#160;&#160;The comparison assumes $100 was invested on December 31, 2015 in our common stock and in each of the foregoing indices.&#160;&#160;The comparisons shown in the graph below are based upon historical data. We caution that the stock price performance shown in the graph below is not necessarily indicative of, nor is it intended to forecast, the potential future performance of our common stock.</span></div><div style="margin-top:6pt;text-align:center"><img src="mygn-20201231_g1.jpg" alt="mygn-20201231_g1.jpg" style="height:362px;margin-bottom:5pt;vertical-align:text-bottom;width:568px"/></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Myriad Genetics, Inc.</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.62</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.59</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.35</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.09</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;45.81 </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NASDAQ Stock Index (U.S.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.50</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.86</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.51</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;257.38 </span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NASDAQ Health Care Providers Stocks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.09</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.79</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.59</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.54</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;158.03 </span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note:&#160;&#160;Information used on the graph was obtained from the CRSP Total Return Indexes, a source believed to be reliable, but we are not responsible for any errors or omission in such information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance graph shall not be deemed to be incorporated by reference by means of any general statement incorporating by reference this Form 10-K into any filing under the Securities Act of 1933, as amended or the Securities Exchange Act of 1934, as amended, except to the extent that we specifically incorporate such information by reference, and shall not otherwise be deemed filed under such acts.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_40"></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;SELECTED CONSOLIDATED FINANCIAL DATA</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our selected consolidated financial data and has been derived from our audited consolidated financial statements. Consolidated balance sheets as of the transition period ended December 31, 2020, and the fiscal years ended June 30, 2020 and 2019, as well as consolidated statements of operations for the transition period ended December 31, 2020 and for the fiscal years ended June 30, 2020, 2019 and 2018 and the reports thereon are included elsewhere in this Transition Report on Form 10-K.&#160;&#160;The information below should be read in conjunction with our audited consolidated financial statements (and notes thereon) and "Management's Discussion and Analysis of Financial Condition and Results of Operations," included in Item 7.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted Accounting Standards Update No. 2014-09, &#8220;Revenue from Contracts with Customers (Topic 606)&#8221; using the full retrospective transition method and recast results from 2018 and 2017 including interim periods therein. Results from periods prior to 2017 have not been recast for the adoption of this standard. During the transition period ended December 31, 2020, we identified certain errors that originated in prior periods that we determined to be immaterial and were corrected in the current period. See additional details in Note 1.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017 (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016 (a)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and marketable investment securities</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">211.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">199.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">230.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">225.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,418.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,404.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,562.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,175.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,207.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">867.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncurrent operating lease liabilities (b)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">233.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">918.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,088.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">966.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">767.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">739.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:17.03pt">We acquired Counsyl, Inc., Assurex Health, Inc., and Sividon Diagnostics GmbH in fiscal years ended June 30, 2019, 2017 and 2016, respectively. As such, the results of each year may not be comparable. See additional details within notes to previously issued financial statements.</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Results for the transition period ended December&#160;31, 2020 and for the fiscal year ended June 30, 2020 are presented under ASU 2016-02, Leases. Prior period amounts were not adjusted and continue to be reported under previous lease accounting guidance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.&#160;&#160;&#160;&#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with Part II, ITEM 6 of this Report and the audited Consolidated Financial Statements and accompanying notes thereto included elsewhere in this Report. Unless otherwise noted, all of the financial information in this Report is consolidated financial information for the Company.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_46"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics and are one of the largest specialty molecular diagnostic laboratories in the world. Since our founding in 1992, we have performed tests for approximately five million patients. Through our proprietary technologies, we believe we are positioned to identify important disease genes, the proteins they produce, and the biological pathways in which they are involved to better understand the genetic basis of human disease. We believe that identifying these biomarkers will enable us to develop novel molecular diagnostic tests that can provide important information to solve unmet medical needs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated revenues consist primarily of sales of molecular diagnostic tests and pharmaceutical and clinical services through our wholly-owned subsidiaries.&#160;&#160;During the transition period ended December&#160;31, 2020, we reported total revenues of $299.8 million, net loss attributable to Myriad Genetics, Inc. stockholders of $53.1 million and basic and diluted loss per share of $0.71.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 15 &#8220;Segment and Related Information&#8221; in the notes to our Consolidated Financial Statements for information regarding our operating segments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry and Competition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patients, providers, payors and health systems are looking to apply the power of molecular diagnostics and precision medicine to achieve improved clinical outcomes and lower cost. Key industry trends include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Accelerating shifts in consumer engagement, early detection, home-based care models, telemedicine and virtual care; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption in the way outpatient care is delivered in the wake of the COVID-19 pandemic, coupled with broadened awareness of the vital role of diagnostic testing; </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expanding access to genetic insights, particularly among underserved populations with increased focus on disparities in healthcare outcomes and access for challenged communities; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Growth in personalized medicine </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the interest in new partnership models to advance companion diagnostics and serve patients with specific treatments based on their own genetic makeup and biology.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These market trends create new opportunities to position Myriad Genetics, and our products and services, for growth and commercial success through enhanced customer service levels and a stronger alignment of our value proposition with physicians and payors. Our record of innovation will be leveraged not only in research and development and technology, but also in go-to-market approaches and other applications so we can adapt quickly to customer preferences and market dynamics.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically experienced seasonality in our testing business. The quarter ending December 31 is generally strong as we see an increase in volumes from patients who have met their annual insurance deductible. Conversely, in the quarter ending March 31 we see a decrease in volumes due to the annual reset of patient deductibles. Additionally, the volume of testing is negatively impacted by the summer season, which is generally reflected in the quarter ended June 30. Due to the global pandemic, we cannot predict if seasonality will follow the same pattern as in prior years.</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Consolidated Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Molecular Diagnostic Testing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our molecular diagnostic tests are designed to analyze genes and their expression levels to assess an individual&#8217;s risk for developing disease later in life, accurately diagnose disease, determine a patient&#8217;s likelihood of responding to a particular drug, or disease recurrence, and assess a patient&#8217;s risk of disease progression. Provided with this valuable information, physicians may more effectively manage their patients&#8217; healthcare. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmaceutical and Clinical Service</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through Myriad RBM, we provide biomarker discovery, pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries utilizing our multiplexed immunoassay technology. Our technology enables us to efficiently screen large sets of well-characterized clinical samples from both diseased and non-diseased populations against our extensive menu of biomarkers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs and Expenses</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel-related costs for each category of Costs and Expenses includes salaries, bonuses, employee benefits costs, employer payroll taxes, and stock-based compensation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Molecular Diagnostic Testing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of molecular diagnostic testing consists primarily of costs related to lab supplies, overhead costs, and personnel-related costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Pharmaceutical and Clinical Service.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of pharmaceutical and clinical service consists primarily of costs related to lab supplies and personnel-related costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include costs incurred in formulating, improving, validating and creating alternative or modified processes related to and expanding the use of our current molecular diagnostic test offerings and costs incurred for the discovery, development and validation of our pipeline of molecular diagnostic and companion diagnostic candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in the Fair Value of Contingent Consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Change in the fair value of contingent consideration includes changes in the timing and amount of expected cash payments associated with the contingent consideration related to the Sividon acquisition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative expenses include costs associated with managing and growing our businesses domestically and internationally. Selling, general and administrative expenses consist primarily of salaries, commissions and related personnel costs for sales, marketing, customer service, billing and collection, legal, finance and accounting, information technology, human resources, and allocated facilities expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) includes interest income earned on our cash and cash equivalents holdings in short-term interest-bearing accounts; interest expense associated with our debt and amortization of deferred financing costs and original issue discount costs; and foreign currency gains and losses, realized gain or loss on marketable securities, and other nonrecurring income and expenses.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_49"></div><div style="margin-top:18pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Six Months Ended December 31, 2020 and 2019 </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019<br/>(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular diagnostic revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hereditary Cancer Testing</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GeneSight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vectra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myChoice CDx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prolaris</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EndoPredict</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total molecular diagnostic revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical and clinical service revenue</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue for the six months ended December 31, 2020 continued to be impacted by factors related to the COVID-19 pandemic, including patients experiencing obstacles to accessing healthcare professionals and deferring elective medical care, which resulted in a decrease in testing volumes compared to the prior year in the majority of the Company's products. In addition, the average expected reimbursement per test decreased due to a variety of facto</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rs such as negotiating new contracts with payors and the impact of estimating future refunds across the Company's products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hereditary cancer testing revenues for the six months ended December 31, 2020 decreased $62.9 million compared to the six months ended December 31, 2019 due primarily to an approximate 17% decrease in volumes and an approximate 14% decrease in average reimbursement per test. GeneSight revenues for the six months ended December 31, 2020 declined $15.4 million compared to the six months ended December 31, 2019 due primarily to an approximate 23% decrease in volumes and an approximate 14% decrease in average reimbursement per test. Prenatal revenues for the six months ended December 31, 2020 declined $2.3 million compared to the six months ended December 31, 2019 due primarily to a decrease in average reimbursement per test of approximately 15%. Vectra revenues for the six months ended December 31, 2020 declined $3.4 million compared to the six months ended December 31, 2019 primarily due to a decrease in the average reimbursement per test of approximately 13%. These declines were partially offset by an increase in myChoice CDx revenues of $7.3 million due to increased volumes from the test being offered in new markets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical and clinical service revenue for the six months ended December 31, 2020 declined $8.1 million compared to the six months ended December 31, 2019, primarily due to the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Privatklinik Dr. Robert Schindlbeck GmbH &amp; Co. KG ("</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Clinic") in February 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing as a % of revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services as a % of revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of molecular diagnostic testing as a percentage of revenue</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased from 23.3% to 29.5% during the six months ended December 31, 2020 compared to the six months ended December 31, 2019.&#160;&#160;The increase was primarily driven by the decline in revenue from lower test volumes during the current period, attributable to the continued impact of COVID-19 as lower revenues were generated to cover fixed costs of performing the tests. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of pharmaceutical and clinical services as a percentage of revenue decreased from 60.4% to 43.6% during the six months ended December 31, 2020 compared to the six months ended December 31, 2019 primarily due to the sale of the Clinic in February 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense as a % of total revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">Research and development expense for the six months ended December 31, 2020 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">decreased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">compared to the six months ended December 31, 2019 primarily due to decreased personnel expenses due to a decline in headcount and technology related expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in the Fair Value of Contingent Consideration</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in the fair value of contingent consideration</span></div></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in the fair value of contingent consideration as a % of total revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">The fair value of contingent consideration for the six months ended December 31, 2020 increased compared to the six months ended December 31, 2019 due to changes in the timing of expected cash payments associated with the contingent consideration related to the Sividon acquisition as a result of revised revenue forecasts.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></div></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense as a % of total revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">Selling, general and administrative expense decreased for the six months ended December 31, 2020 compared to the six months ended December 31, 2019 primarily due to the Company implementing cost saving measures due to the decline in testing volumes as a result of the impacts of COVID-19 and due to a decline in expense from the sale of the Clinic in February 2020. The cost savings measures implemented by the Company have been partially offset by increased legal and professional service expenses related to our leadership transition and restructuring in the current period. Selling, general and administrative expense as a percentage of total revenue increased for the six months ended December 31, 2020 compared to the six months ended December 31, 2019 primarily due to decreases in revenue outpacing the cost savings measures implemented in the current period.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">Other expense increased for the six months ended December 31, 2020 compared to the six months ended December 31, 2019 due to foreign exchange losses and due to decreased interest income. </span></div><div style="margin-top:18pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax rate is the product of a U.S. federal effective rate of 21% and a blended state income tax rate of approximately 3.5%. Certain significant or unusual items are separately recognized during the period in which they occur and can be a source of variability in the effective tax rates from period to period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit for the six months ended December 31, 2020 was $41.0 million, and our effective tax rate was 43.6%. The increase in the effective tax rate for the current period compared to the six months ended December 31, 2019 is due primarily to carrying back net operating losses under the provisions of the CARES Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fiscal Years Ended June 30, 2020, 2019 and 2018</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenue</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Molecular diagnostic revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hereditary Cancer Testing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GeneSight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vectra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">myChoice CDx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prolaris</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EndoPredict</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total molecular diagnostic revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">586.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">789.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">690.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(202.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical and clinical service revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(212.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues for fiscal year 2020 were significantly impacted by COVID-19 during the third and fourth quarter, as testing volumes declined across the majority of products. The decrease in revenue during fiscal year 2020 was primarily driven by a decrease of $132.3 million in Hereditary cancer testing primarily due an approximate 8% decrease in volumes and an approximate 21% decrease in reimbursement per test, a decrease of $38.5 million in GeneSight revenue due to an approximate 39% decrease in volumes partially offset by an approximate 9% increase in reimbursement per test, a decrease of $28.2 million in Prenatal revenue due to an approximate 30% decrease in reimbursement per test, a $9.2 million decrease in Vectra revenue due to an approximate 18% decrease in volumes, and a $10.0 million decrease in Pharmaceutical and clinical service revenue primarily as a result of selling the Clinic in February 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the increase in revenue was primarily due to the inclusion of $104.9 million in Prenatal revenue due to the acquisition of Counsyl, an increase of $8.4 million in Pharmaceutical and clinical service revenue due to increased volumes, an increase of $8.3 million in Hereditary cancer testing due to increased volumes, a $4.0 million increase in Prolaris revenue due to increased volumes and reimbursement, and a $1.6 million increase in EndoPredict revenue due to increased volumes. The increases were partially offset by decreases of $12.3 million in GeneSight revenue due to reduced reimbursement, and a $6.9 million decrease in Vectra revenue due to lower volumes.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of Sales</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing as a % of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services as a % of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cost of molecular diagnostic testing as a percentage of revenue increased from 21.3% to 26.8% during fiscal year 2020 compared to fiscal year 2019. The increase was primarily driven by the decline in revenue from lower test volumes during the period, attributable to the impact of COVID-19 primarily during the fourth quarter as lower revenues were generated to cover fixed costs, and due to reduction of reimbursement related to Hereditary cancer testing and Prenatal. Cost of pharmaceutical and clinical services decreased $4.2 million during fiscal year 2020 compared to fiscal year 2019 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">primarily due to the sale of the Clinic in February 2020 </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of molecular diagnostic testing as a percentage of revenue decreased slightly from 21.5% to 21.3% during fiscal year 2019 compared to fiscal year 2018. The decrease was primarily driven by the implementation of efficiency programs in our DNA, RNA, and protein-based laboratories. These decreases were partially offset by lower gross margins associated with the Counsyl business and reduction of reimbursement related to Hereditary cancer testing and GeneSight.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Research and Development Expense</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense as a % of total revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In fiscal year 2020, research and development expense decreased compared to the fiscal year 2019 primarily due to synergies recognized as part of the integration of the Counsyl business partially offset by an additional month of Counsyl business expenses included in the current year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2019, research and development expense increased compared to fiscal year 2018 primarily driven by $17.3 million in costs related to the inclusion of Counsyl. This increase was partially offset by a reduction in costs related to internal development of existing products.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in the Fair Value of Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.2)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration as a % of total revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In fiscal year 2020, the decrease in the change in fair value of contingent consideration compared to fiscal year 2019 is due to changes in timing of expected cash payments associated with the contingent consideration related to the Sividon acquisition as a result of revised revenue forecasts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2019, the increase in the change in fair value of contingent consideration compared to the prior year is primarily due to an increase in the fair value of contingent consideration related to the Sividon acquisition as well as the one-time benefit received in the prior year resulting from not having to pay the clinical trial milestone associated with the GUIDED study</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Selling, General and Administrative Expense</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.4)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense as a % of total revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2020, the decrease in selling, general, and administrative expense compared to the prior year is primarily due to the Company implementing cost saving measures during the fourth quarter due to the decline in testing volumes as a result of the impacts of COVID-19 and a reduction in costs related to synergies recognized relating to the integration of the Counsyl business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2019, the increase in selling, general, and administrative expense compared to the prior year is primarily due to $55.0 million in costs related to the inclusion of Counsyl, $22.1 million of Counsyl amortization of intangible assets, $20.8 million in costs related to the acquisition and integration of Counsyl, $9.1 million related to the settlement of the complaint filed by a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relator, and additional spend related to improving our IT infrastructure.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Goodwill and Intangible Asset Impairment Charges</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In fiscal year 2020, goodwill and intangible asset impairment charges increased compared to the same period in the prior year due to the Company recognizing goodwill impairment charges related to the Myriad Autoimmune and Clinic reporting units and charges related to the abandonment of an in-process research and development intangible asset in the current year. There were no impairments recognized in the prior fiscal years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Income (Expense)</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In fiscal year 2020, the increase in other income (expense) compared to fiscal year 2019 is primarily driven by the receipt of stimulus funds from the CARES Act in the amount of $14.6 million, the gain recognized on the sale of the Clinic, income from a state grant, and a decrease in interest expense.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2019, the increase in other expense compared to the prior year was primarily driven by an increase in interest expense related to the debt incurred to fund the acquisition of Counsyl. This was partially offset by increased interest income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Tax Expense</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14107.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our tax rate is the product of a U.S. federal effective rate of 21% and a blended state income tax rate of approximately 3.5%. Certain significant or unusual items are separately recognized during the period in which they occur and can be a source of variability in the effective tax rates from period to period.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit for the fiscal year ended June 30, 2020 is $23.7 million for an effective tax benefit rate of 10.6%. The change in the effective rate as compared to the prior year is due to the prior year being near break-even, resulting in a very large effective rate. Differences related to the recognition of the tax effect of equity compensation expense from the disqualification of incentive stock options, asset impairment, uncertain tax benefits and changes in valuation allowance also impacted the current and prior year effective tax rates.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit for the fiscal year ended June 30, 2019 is $4.4 million for an effective tax rate of (14,107.7%). The decrease in the effective rate as compared to the prior year is due to a $32.0 million one-time Tax Act benefit in the prior year, disregarded election of foreign entities, amended filing and method changes, and statute lapse of uncertain tax positions. Differences related to the recognition of the tax effect of equity compensation expense from the disqualification of incentive stock options also impacted the current and prior year effective tax rate.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_52"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are our cash, cash equivalents and marketable investment securities, our cash flows from operations and amounts available under our Amended Facility. Additionally, we recently announced that we are exploring strategic alternatives for our Myriad RBM, Myriad Dermatology, and Myriad Autoimmune business units. If we choose to sell these or other assets, the proceeds will also provide additional liquidity. Our capital deployment strategy focuses on use of resources in the key areas of research and development, infrastructure, debt repayment, acquisitions, and the repurchase of our common stock. We believe that investing organically through research and development or acquisitively to support business strategy provides the best return on invested capita</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">l.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing capital resources and the cash to be generated from future sales, taking into consideration the potential further impacts of COVID-19 on our operations, will be sufficient to meet our projected operating requirements and repay the outstanding Amended Facility, which matures on July 31, 2023 and which has no scheduled principal payments prior to that date.  Our available capital resources, however, may be consumed more rapidly than currently expected, and we may need or want to raise additional financing. We may not be able to secure such financing in a timely manner or on favorable terms, if at all. We are subject to financial covenants as part of our outstanding Amended Facility. It is possible that we could be in violation of certain financial covenants contained in the Amended Facility in the future. We may seek waivers or amendments from our lenders in order to avoid a future potential covenant violation, in addition to taking other potential actions. For example, on February 22, 2021, we amended our credit facility to waive compliance with the leverage ratio covenant and the interest coverage ratio covenant through the quarter ended March 31, 2022 and to also lower the minimum liquidity covenant through the same period. If we were unable to comply with the covenants in the future, that could result in an increase in the rate of interest and limits on our ability to incur certain additional indebtedness and could potentially cause the loan repayment to be accelerated. Without additional funds, we may be forced to delay, scale back or eliminate some of our sales and marketing efforts, research and development activities, or other operations and potentially delay development of our diagnostic tests in an effort to provide sufficient funds to continue our operations. If any of these events occurs, our ability to achieve our development and commercialization goals could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility restricts the Company from borrowing under the revolving credit facility if unrestricted cash and cash equivalents exceed $150.0 million, unless such borrowings are in connection with acquisitions. The Amended Facility also includes an immediate reduction in the commitment to $300.0 million and further reduction to $250.0 million by September 30, 2021, and includes terms for further reductions, or mandatory prepayments of revolving loans, in the event of certain asset sales, which could limit our borrowing capacity, or reduce liquidity, in future periods. The Amended Facility allows the Company to keep the net cash proceeds of material asset sales received above certain dollar thresholds without corresponding mandatory prepayments or commitment reductions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the COVID-19 pandemic and resulting global disruptions have caused significant volatility in financial markets. This disruption may affect asset valuations resulting in impairment charges, may contribute to potential defaults in our accounts receivable, and affect the availability of lease and financing credit as well as other segments of the credit markets. However, due to the continuing evolving global situation, it is not possible to predict whether unanticipated consequences of the pandemic are reasonably likely to materially affect our liquidity and capital resources in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had approximately $21.4 million of non-cancelable contractual purchase obligations with varying terms over the next four years, with most purchase obligations due within the next 12 months.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the balances of cash, cash equivalents and marketable investment securities:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended <br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investment securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and marketable investment securities</span></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.8&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.3&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the transition period ended December 31, 2020, the decrease in cash, cash equivalents and marketable investment securities was primarily driven by the Company using $73.7 million in cash for operating activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2020, the increase in cash, cash equivalents and marketable investment securities was primarily driven by $60.7 million in cash provided by operating activities and $21.3 million from the sale of a subsidiary.&#160;&#160;These increases were partially offset by $8.6 million in payments towards our Amended Facility.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2019, the decrease in cash, cash equivalents and marketable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> investment securities was driven by $286.4 million in cash used in investing activities primarily related to $278.5 million of cash used in the acquisition of Counsyl. This decrease was partially offset by an increase in cash of $182.3 million related to financing activities primarily related to a $225.0 million net increase in proceeds from the Amended Facility and an increase in cash provided by operating activities of $83.7 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the condensed cash flow statement:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31, (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of foreign exchange rates on cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash and cash equivalents classified as <br/>     held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at the beginning of the<br/>     period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Operating Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the transition period ended December 31, 2020, the primary driver of the decrease in cash flows from operating activities was a decline in revenues of $81.6 million primarily due to factors related to the COVID-19 impact on volumes and a decline in the average expected reimbursement per test. Our Hereditary Cancer products were impacted the most from these factors with a decrease </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $62.9 million in revenues for the six months ended December 31, 2020 compared to the six months ended December 31, 2019. Revenue from Hereditary Cancer products declined primarily due to an approximate 17% decrease in volumes and an approximate 14% decrease in average reimbursement per test. Decreases in cash flows from operations was also due to an increase in trade receivables in the transition period due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delays</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in receipt of reimbursements compared to the prior period. The decrease in cash flows from operations was partially offset by cost reductions due to lower volumes and cost saving initiatives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2020, the primary driver of the decrease in cash flows from operating activities was the $104.4 million decrease in net income (loss), excluding the impact of the impairment of goodwill and intangible assets, and a decrease in the non-cash adjustment related to deferred income taxes of $74.4 million compared to 2019. These changes were partially offset by a $152.2 million net change in assets and liabilities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2019, the primary driver of the decrease in cash flows from operating activities was the $107.5 million decrease in net income excluding contingent consideration and a $45.6 million change in assets and liabilities.&#160;&#160;These were partially offset by a $142.1 million increase related to non-cash charges.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Investing Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the transition period ended December 31, 2020, the increase in cash flows from investing activities was primarily driven by the use of proceeds from the maturities of marketable investment securities to fund operations compared to reinvesting such proceeds in purchases of marketable securities in prior years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2020, the increase in cash flows from investing activities was primarily driven by the $278.5 million of cash used for the purchase of Counsyl in the prior fiscal year as well as $21.3 million in proceeds from the sale of a subsidiary in the current fiscal year.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2019, the decrease in cash flows from investing activities was primarily driven by the $278.5 million of cash used for the purchase of Counsyl.&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Financing Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the transition period ended December 31, 2020, the decrease in cash flows from financing activities was driven primarily by repayments of the Amended Facility completed in the prior period compared to no repayments in the current period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2020, the decrease in cash flows from financing activities was driven primarily by the prior year&#8217;s net proceeds from the Amended Facility of $225.0 million, offset by the prior year&#8217;s $50.0 million reduction in cash used for share repurchases, compared to the current year repayment of the Amended Facility of $8.6 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2019, the increase in cash flows from financing activities was driven primarily by a $225.0 million increase in net proceeds from the Amended Facility and the prior year&#8217;s $42.4 million payment of contingent consideration related to the Assurex acquisition. These were partially offset by a $50.0 million reduction in cash used for share repurchase and $28.2 million decrease in proceeds from common stock issued under share-based compensation plans.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effects of Inflation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that inflation has had a material impact on our business, revenues, or operating results during the periods presented.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_58"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market, Industry and Other Data</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Transition Report on Form 10-K contains estimates, projections and other information concerning our industry, our business and relevant molecular diagnostics markets, including data regarding the estimated size of relevant molecular diagnostic markets, patient populations, and the perceptions and preferences of patients and physicians regarding certain therapies, as well as data regarding market research and estimates. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources that we believe to be reliable. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_61"></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting policies are those policies which are both important to the portrayal of a company&#8217;s financial condition and results and require management&#8217;s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Our critical accounting policies are as follows:</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">revenue recognition;</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">goodwill; and</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">income taxes.</span></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;Revenue is recognized when, or as, performance obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to a customer. We exclude sales, use, value-added, and other taxes we collect on behalf of third parties from revenue. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services to a customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue by performing molecular diagnostic testing and pharmaceutical and clinical services and perform our obligation under a contract with a customer by processing those diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated transaction price. We have determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes. We have the right to bill our customers upon the completion of performance obligations and thus does not record contract assets.&#160;Occasionally customers make payments prior to our performance of our contractual obligations.&#160;When this occurs, we record a contract liability as deferred revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgments are required in determining the transaction price and satisfying performance obligations under the revenue standard. In determining the transaction price, we estimate the expected amount of consideration as revenue. We apply this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled.&#160;&#160;An estimate of transaction price does not include any estimated amount of variable consideration that is constrained. We consider all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. To determine our estimated transaction price, we apply the expected value method for sales where we have a large number of contracts with similar characteristics. We then consider the probability of the variable consideration for each possible scenario. We have significant experience with historical discount patterns and use this experience to estimate transaction prices. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimate of revenue is affected by assumptions in payor mix and in payor behavior such as changes in payor collections, current customer contractual requirements, and experience with ultimate collection from third-party payors. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in accrued liabilities in the consolidated balance sheets in anticipation of request for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill.&#160;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test goodwill for impairment on an annual basis and in the interim by reporting unit if events and circumstances indicate that goodwill may be impaired.&#160;&#160;The events and circumstances that are considered include business climate and market conditions, legal factors, operating performance indicators and competition. Impairment of goodwill is evaluated on a qualitative basis before calculating the fair value of the reporting unit. If the qualitative assessment suggests that impairment is more likely than not, a quantitative impairment analysis is performed.&#160;&#160;The quantitative analysis involves comparison of the fair value of a reporting unit with its carrying amount.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of a reporting unit requires judgment in estimating future cash flows, discount rates, residual growth rates and other factors. In making these judgments, we evaluate the financial health of our business, including such factors as industry performance, market saturation and opportunity, changes in technology and operating cash flows.&#160;Changes in our forecasts or decreases in the value of our common stock could cause book value of reporting units to exceed their fair values.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. If an event occurs that would cause a revision to the estimates and assumptions used in analyzing the value of the goodwill, the revision could result in a non-cash impairment charge that could have a material impact on the financial results.</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have recorded goodwill of $329.2 million on our Consolidated Balance Sheet. Of this goodwill, $272.3 million is related to our molecular diagnostic segment for Myriad Autoimmune, Myriad Mental Health (formerly known as Myriad Neuroscience), Myriad International, and Myriad Women's Health reporting units and $56.9 million for the Myriad RBM reporting unit related to our other segment (see Note 15 for segment descriptions). We qualitatively evaluated the Myriad RBM reporting unit for impairment noting no indicators of impairment. For the remaining four reporting units, quantitative impairment analyses were completed to evaluate for impairment. We measured the fair value of Myriad Autoimmune, Myriad Mental Health (formerly known as Myriad Neuroscience), Myriad International, and Myriad Women's Health reporting units utilizing the market approach and also utilizing the discounted cash flow method under the income approach. The income approach considered management's business plans and projections as the basis for expected cash flow for the next thirteen to fifteen years and a 2% long-term growth rate, and profitability as the significant estimate used in the analysis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average discount rate and fair value of each reporting unit in excess of its carrying valuing using the assumptions above are as follows: </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"></td><td style="width:40.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Fair Value in Excess of Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Myriad Mental Health</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Myriad Autoimmune</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Myriad International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Myriad Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;Our income tax provision is based on income before taxes and is computed using the liability method in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740 &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using tax rates projected to be in effect for the year in which the differences are expected to reverse.&#160;&#160;Significant estimates are required in determining our provision for income taxes.&#160;&#160;Some of these estimates are based on interpretations of existing tax laws or regulations, or the expected results from any future tax examinations.&#160;&#160;Various internal and external factors may have favorable or unfavorable effects on our future provision for income taxes.&#160;&#160;Those factors include, but are not limited to, changes in tax laws, regulations and/or rates, the results of any future tax examinations, changing interpretations of existing tax laws or regulations, changes in estimates of prior years&#8217; items, past levels of research and development spending, acquisitions, changes in our corporate structure, and changes in overall levels of income before taxes all of which may result in periodic revisions to our provision for income taxes.&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing our provision for income taxes, including our effective tax rate and analysis of potential uncertain tax positions, if any, requires significant judgment and expertise in federal and state income tax laws, regulations and strategies, including the determination of deferred tax assets and liabilities and any estimated valuation allowance we deem necessary to offset deferred tax assets.&#160;&#160;If we do not maintain taxable income from operations in future periods, we may increase the valuation allowance for our deferred tax assets and record material adjustments to our income tax expense.&#160;&#160;Our judgment and tax strategies are subject to audit by various taxing authorities.&#160;&#160;While we believe we have provided adequately for our uncertain income tax positions in our consolidated financial statements, adverse determination by these taxing authorities could have a material adverse effect on our consolidated financial condition, results of operations or cash flows.&#160;Interest and penalties on income tax items are included as a component of overall income tax expense.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_64"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Note 1 to the Consolidated Financial Statements included in Item 8 of this Report for a description of recent accounting pronouncements.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_67"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an investment portfolio in accordance with our written investment policy. The primary objectives of our investment policy are to preserve principal, maintain proper liquidity to meet operating needs and maximize yields. Our investment policy specifies credit quality standards for our investments and limits the amount of credit exposure to any single issue, issuer or type of investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments consist of debt securities of various types and maturities of five years or less, with an average maturity of two years. These securities are classified as available-for-sale. Available-for-sale securities are recorded on the balance sheet at fair market value with unrealized gains or losses reported as part of Accumulated Other Comprehensive Income (Loss). Realized gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. A decline in the market value of any available-for-sale security below cost that is deemed other-than-temporary results in a charge to earnings and establishes a new cost basis for the security.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our investment policy guidelines are intended to ensure the preservation of principal, market conditions can result in high levels of uncertainty.&#160;Our ability to trade or redeem the marketable investment securities in which we invest, including certain corporate bonds, may become difficult.&#160;Valuation and pricing of these securities can also become variable and subject to uncertainty.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had $0.8 million in unrealized gains in our investment portfolio.&#160;&#160;For the transition period ended December&#160;31, 2020 we have experienced fluctuations in our portfolio value primarily from our investments in corporate bonds. If interest rates rise, the market value of our investments may decline, which could result in a realized loss if we are forced to sell an investment before its scheduled maturity. A hypothetical increase in interest rates by 25 basis points would have resulted in an increase in the fair value of our net investment position of approximately $0.3 million as of December&#160;31, 2020 and 2019, respectively. We do not utilize derivative financial instruments to manage our interest rate risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain a long-term debt balance that has exposure to market risk for changes in interest rates. Our long-term debt balance is carried at amortized cost and fluctuations in interest rates do not impact our consolidated financial statements. However, the fair value of our debt will generally fluctuate with movements of interest rates, including in periods of declining rates of interest. If interest rates rise, we would incur additional interest expense related to the long-term debt balance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be exposed to fluctuations in foreign currencies with regard to certain agreements with service providers. Depending on the strengthening or weakening of the United States dollar, realized and unrealized currency fluctuations could be significant.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_70">Index to Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_73">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_76">Consolidated Balance Sheets as of December 31, 2020, June 30, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_82">Consolidated Statements of Operations for the Transition Period ended December 31, 2020 and for the Years</a></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_82">En</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_82">ded June 30, 2020, 2019, and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_85">Consolidated Statements of Comprehensive Income (Loss) for the Transition Period ended December 31, 2020</a></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_85">&#160;and for the Years Ended June 30, 2020, 2019, and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_88">Consolidated Statements of Stockholders' Equity for the Transition Period Ended December 31, 2020 and for</a></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_88">&#160;the Years Ended June 30, 2020, 2019, and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_91">Consolidated Statements of Cash Flows for the Transition Period ended December 31, 2020 and for the Years</a></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_91">Ended June 30, 2020, 2019, and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_94">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Myriad Genetics, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Myriad Genetics, Inc. and subsidiaries (the Company) as of December&#160;31, 2020, June&#160;30, 2020 and June 30, 2019, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity and cash flows for the six month period ended December&#160;31, 2020 and each of the three years in the period ended June&#160;30, 2020, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2020, June&#160;30, 2020 and 2019, and the results of its operations and its cash flows for the six month period ended December&#160;31, 2020 and each of the three years in the period ended June&#160;30, 2020, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December&#160;31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated March&#160;16, 2021 expressed an adverse opinion thereon.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.572%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 84.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Impairment evaluation of goodwill</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company&#8217;s goodwill balance w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $329.2 million. A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s discussed in Note 5 of the financial statements, goodwill is tested for impairment at least annually or more frequently if indicators of impairment require the performance of an interim impairment assessment. Auditing management&#8217;s impairment tests was complex and highly judgmental due to the significant estimation required in determining the fair value of the reporting units containing goodwill. Specifically, the fair value estimates of the reporting units were sensitive to significant assumptions including the estimation of expected cash flows, discount rates, and residual growth rates. The fair value estimates of the reporting units are affected by such factors as industry performance, market saturation and opportunity, changes in technology and operating cash flows.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.572%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s goodwill impairment review processes. For example, we tested controls over the quantitative impairment analyses of goodwill, including the valuation models and underlying assumptions used to develop such estimates.<br/><br/>To test the estimated fair value of the Company&#8217;s reporting units, we performed audit procedures that included, among others, evaluating the Company&#8217;s valuation methodology used, evaluating the prospective financial information utilized in the valuations, and involving our valuation specialists to assist in testing certain significant assumptions described above, such as residual growth rates and discount rates including company risk premiums. We assessed the historical accuracy of management&#8217;s estimates and performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting units that would result from changes in the assumptions.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 84.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Measurement of molecular diagnostic testing revenue</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six month transition period ended December&#160;31, 2020, the Company&#8217;s molecular diagnostic testing revenue was $279.6 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 of the consolidated financial statements, molecular diagnostic testing revenue is recognized when the performance obligation is complete. Auditing the measurement of the Company&#8217;s molecular diagnostic testing revenue was complex and judgmental due to the significant estimation required in estimating the amount that will be collected for each test. In particular, the estimate of revenue is affected by assumptions related to payors such as changes in payor mix, payor collections, current customer contractual requirements, and experience with ultimate collection from third-party payors.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding and evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s revenue recognition process. As part of our testing, we considered controls over management&#8217;s review of the significant assumptions above and inputs used in calculating the estimated amount that would be collected for each test and tested management&#8217;s controls to compare actual payments received to previously forecasted activity. We also tested controls used by management to compare the current and historical data used in making the estimates for completeness and accuracy.<br/><br/>Our audit procedures over the Company&#8217;s molecular diagnostic testing revenue included, among others, assessing valuation methodologies and models and testing the significant assumptions above and the underlying data used by the Company in its analysis. We agreed transactions selected for testing back to the actual customer contract terms. We compared the significant assumptions above and inputs used by management to changes in the Company&#8217;s contracted rates, third-party payor collection trends, and other relevant factors. We assessed the historical accuracy of the cash collections used in the Company&#8217;s revenue models and assessed the completeness of adjustments to estimates of future cash collections as a result of significant contract amendments, changes in collection trends and changes in payor behavior.</span></td></tr></table></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2006.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salt Lake City, UT</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;16, 2021</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNC0xLTEtMS00NTE_82806cc2-ec2f-4f5d-aadc-ed1f51150d37">117.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNC0xLTEtMS0w_d0accf03-e865-4827-b44b-b3733227a990">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNC0zLTEtMS0w_a0b569c4-b36c-4677-8f6a-58e7c0da9839">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNS0xLTEtMS00NTg_25d0b315-1b7b-4ac9-90d2-735d16f36a0c">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNS0xLTEtMS0w_ce3d9fb7-6b92-401b-8bca-036fac940b59">54.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNS0zLTEtMS0w_85ad8686-45b8-4685-9241-0c8b6e3634c2">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNi0xLTEtMS00NTg_1fa9271c-9c94-4c2d-af4e-4c70adc9db93">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNi0xLTEtMS0w_7fa2d6b3-1c4f-452b-8149-6e84a62d2279">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNi0zLTEtMS0w_c6e071fe-1ac7-4a0e-8216-680478b08539">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNy0xLTEtMS00NTg_617dca9e-ea91-4234-91aa-e9998bba013c">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNy0xLTEtMS0w_1f0a6c56-cf84-4ce5-9cb0-e854e97a46bc">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNy0zLTEtMS0w_f888edca-e3b5-475f-8e71-176195816b18">31.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOC0xLTEtMS00NTg_e5fe176b-193c-4909-bb3b-9d4ff8077222">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOC0xLTEtMS0w_08a991f3-605f-49ac-8d9b-6831b2fe7600">68.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOC0zLTEtMS0w_0fd95373-b759-44b4-9d8a-983f3f070f90">133.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOS0xLTEtMS00NTg_a595272d-523c-44ec-a8d1-12dca66f3a12">108.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOS0xLTEtMS0w_958fc6a5-7a1f-41a2-bdda-61aa098bc9c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOS0zLTEtMS0w_96c9cf80-4c82-4c50-b27f-494ec9c60dfd">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTAtMS0xLTEtNDU4_70fe4634-ef5e-4290-811d-e980f4c9a0d8">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTAtMS0xLTEtMA_764293be-2e0c-474a-a21f-09cc28c5d181">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTAtMy0xLTEtMA_5f8de33f-9727-4f56-9415-24273b225c1f">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTEtMS0xLTEtNDU4_0c271e88-b2a0-42bd-9718-a1c8ad58787b">389.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTEtMS0xLTEtMA_cb1b24fe-00d8-4ed8-920a-2defc0c41aef">331.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTEtMy0xLTEtMA_0742d040-0671-4d56-8a61-6d2922086a37">348.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTItMS0xLTEtNDU4_f2731463-d1e1-4e70-8c35-63165412dc6f">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTItMS0xLTEtMA_a860c509-321f-40f0-9525-218653b66e41">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTItMy0xLTEtMA_dbf9c03c-a5c9-4cd0-a6f2-fd7c80585723">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTMtMS0xLTEtNDU4_b7de98e6-c2f6-49fd-8e3c-8cad9a7eb8ff">59.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTMtMS0xLTEtMA_2ba7be32-9975-45bc-9c40-5e951e872a31">66.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTMtMy0xLTEtMA_1ad5d25f-78b9-4f25-bac4-ad1b1229d81c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term marketable investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTQtMS0xLTEtNDU4_629aa629-3a39-4a16-8a1d-14d071d7d6f1">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTQtMS0xLTEtMA_a81fab52-820d-4c6e-9e99-7002f0345bb4">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTQtMy0xLTEtMA_fd8e538b-8a67-4c9d-aab4-244d9b35c892">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTUtMS0xLTEtNDU4_3d779f76-996a-42ae-8984-e86c2f831640">576.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTUtMS0xLTEtMA_2e6053a1-0694-426e-b9ae-8ca84fa68772">605.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTUtMy0xLTEtMA_a7c8fa5b-5e71-49fb-af04-03cb7b88f7c3">684.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTYtMS0xLTEtNDU4_cdfcacc8-83c8-47e3-b6d8-db2d6f2fe495">329.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTYtMS0xLTEtMA_961fce50-955d-4450-a1b3-17945f516408">327.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTYtMy0xLTEtMA_5bb59b11-4576-45aa-9797-f2752aecef22">417.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMS0xLTEtNjUyNQ_8c9d2309-3146-4ee6-925b-6a478af476dd">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMy0xLTEtMTM3ODE_c29b03f6-e861-4619-89e5-917f72df6ff8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctNS0xLTEtMTM3ODM_596dabd9-d621-4bcc-920c-af35df2dc1cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMS0xLTEtNDU4_45aaf753-0407-45ae-b36f-2182e618db18">1,418.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMS0xLTEtMA_3d2185af-0428-469f-8d8b-3e8298886573">1,404.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMy0xLTEtMA_a622e912-cfd0-4031-ad1a-27061d920b5a">1,562.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjAtMS0xLTEtNDYx_d869e4f1-429d-4b4b-99f7-7ce90a9ee730">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjAtMS0xLTEtMA_af9036c0-2dca-4f52-a083-31d633aad762">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjAtMy0xLTEtMA_3e8348a2-400a-4005-b9db-86667a7e9426">33.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjEtMS0xLTEtNDYx_06d863fd-5b8b-470a-9985-df342486af48">79.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjEtMS0xLTEtMA_f6e5bb7c-3844-48d8-8267-24d6e3ddeb31">79.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjEtMy0xLTEtMA_bcb036d3-282c-4dc3-a29d-b5d24d3f45a5">82.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjItMS0xLTEtNDYx_f3c63817-8903-4e50-a790-44c7ecad9632">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjItMS0xLTEtMA_ef9413e5-4934-4076-b2ba-3fcb6f73afe5">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjItMy0xLTEtMA_f109adca-adcf-424e-bb5b-b721a4fc84c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjQtMS0xLTEtNDYx_dbe86c00-a0a7-48ad-9b0e-ad6dfdfeabd7">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjQtMS0xLTEtMA_6b1e608b-652a-41a4-8734-6f4419fffa02">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjQtMy0xLTEtMA_8c21bd67-45ec-49ad-86cd-9052bc398a3f">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjUtMS0xLTEtNDYx_a4f21a8b-9f78-4857-9deb-695b8c985758">145.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjUtMS0xLTEtMA_b62a4688-07af-407d-a3a0-7b45ea17942f">147.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjUtMy0xLTEtMA_d9f9af01-3957-4038-8d3f-318dbfdb5e5a">117.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:UnrecognizedTaxBenefitsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjYtMS0xLTEtNDYx_6fc1cf00-7b0d-4b4f-8a37-2a9732a49beb">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="mygn:UnrecognizedTaxBenefitsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjYtMS0xLTEtMA_07d661f8-0487-4805-9325-ad398b94cabf">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="mygn:UnrecognizedTaxBenefitsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjYtMy0xLTEtMA_b2e740b2-8b74-4e95-a526-6dcaecf09399">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMS0xLTEtNjUzMw_cbe9b0a8-9aa4-4b95-a9fd-32e0456be8a3">71.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMy0xLTEtNjUzNQ_fc5b3ea0-2317-4d66-bff1-763b62d4a3f9">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtNS0xLTEtNjUzNQ_5b613a54-d81c-4e9e-a7a1-5ed6e5d9cf34">82.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjktMS0xLTEtNjU0Ng_d7e1f17a-b45e-4805-acc5-fd26cfb6db2c">224.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjktMy0xLTEtNjU0Ng_2cbb3e69-d1d6-433f-8867-d33c08893a93">224.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjktNS0xLTEtNjU0Ng_bb7e952f-bfea-45f6-9e05-2fbc8fe5dd78">233.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjctMS0xLTEtNDYx_88a16120-0225-41c2-8a09-2262a0bf5221">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjctMS0xLTEtMA_9f4f3426-5210-4c3b-918a-6ed29e1d0f78">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjctMy0xLTEtMA_e5fc352a-3135-4cb6-8516-9d2bd23cbefd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMS0xLTEtNDYx_918de255-87b6-4761-8dd6-a206a079204d">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMS0xLTEtMA_0cac4840-e9ba-4a24-ba07-9e0a02a5e9d9">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMy0xLTEtMA_e7e645d1-be85-4fa2-806d-362ca02e8c53">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzItMS0xLTEtNDYx_983f567d-088c-47c2-b5ce-4e85be1b6d5e">537.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzItMS0xLTEtMA_5d84e696-0c26-42f0-b78b-1c44e60ac59a">486.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzItMy0xLTEtMA_749aa494-5e7d-4648-b156-6f03d1bf5e03">473.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzItMS0xLTEtMTM4MjI_b8ca94ce-2fe2-4eda-946a-73b92df2ed24"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzMtMS0xLTEtMA_99d24724-27d5-49bb-bab2-587317e8b14f"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzMtMy0xLTEtMA_70ebdc58-01dd-435d-a3c7-f7934374c00a"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, <ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzQtMC0xLTEtMTM4NTgvdGV4dHJlZ2lvbjpiOWU4NTQyMDUxY2Q0Nzk4YTI0ZjNiNGRhMjE5MzViMF8xMTU0NDg3MjA5MTc3NQ_0610e208-c473-472b-835a-264e41603b12">75.4</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzQtMC0xLTEtMTM4NTgvdGV4dHJlZ2lvbjpiOWU4NTQyMDUxY2Q0Nzk4YTI0ZjNiNGRhMjE5MzViMF8xMTU0NDg3MjA5MTc4Mg_3862fcdc-a755-480c-82c0-364fd56cd4bf">74.7</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzQtMC0xLTEtMTM4NTgvdGV4dHJlZ2lvbjpiOWU4NTQyMDUxY2Q0Nzk4YTI0ZjNiNGRhMjE5MzViMF8xMTU0NDg3MjA5MTc4OQ_f2abb5c6-a4b0-402d-965d-14116cdd9f98">73.5</ix:nonFraction> shares outstanding at December 31, 2020, June 30, 2020 and 2019, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzUtMS0xLTEtNDY0_4410fbd4-2485-4897-a626-6ac2b38dbf7b">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzUtMS0xLTEtMA_ee3c8c98-715a-4e8f-b509-a64a6f68d6e2">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzUtMy0xLTEtMA_3d36845f-f2d3-46ed-b46d-9593786e94a1">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzYtMS0xLTEtNDY0_c65c1e13-d08f-484a-88fe-ee08fa5f150d">1,109.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzYtMS0xLTEtMA_16b6f3f6-e314-4bf4-ac34-ff560b48eace">1,096.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzYtMy0xLTEtMA_81684969-2036-4dec-91a8-0cbb2902fb90">1,068.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzctMS0xLTEtNDY0_b8a47ef5-6e2d-46c8-bb6f-caaefeb0e286">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzctMS0xLTEtMA_811b2ecb-0be1-488d-b7bc-94ba955b12e6">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzctMy0xLTEtMA_5b9685f6-7ed4-41d6-b070-b31f523f5af7">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzgtMS0xLTEtNDY0_f29b987a-5b29-4ebb-a379-509f73dc88a1">227.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzgtMS0xLTEtMA_c93cece8-f751-4c33-aa33-b05fa50b1ecc">173.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzgtMy0xLTEtMA_22b2c75d-3628-4195-b765-96d843b84714">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Myriad Genetics, Inc. stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzktMS0xLTEtNDY0_49e9d6d0-1337-4500-82fc-e22614281dd9">881.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzktMS0xLTEtMA_e0d10d81-3ee9-48a5-a19a-258a03d10f78">918.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzktMy0xLTEtMA_5ac9ddfa-2c62-4512-bd3d-3a61ae90c744">1,088.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDAtMS0xLTEtNDY0_38ec5440-afea-4916-9c24-4463bc5aca3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDAtMS0xLTEtMA_2ff68495-9184-45b3-80fc-b1d52f482604">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDAtMy0xLTEtMA_1d741d7c-81b8-4076-82af-7e1a65ef6b84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDEtMS0xLTEtNDY0_aaf9e735-66cd-4b01-a98e-5caee14b118c">881.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDEtMS0xLTEtMA_6bd5ec2f-49ba-4693-9451-1fbe03b480bf">918.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDEtMy0xLTEtMA_056f3560-71f5-42af-a66e-f59968b7c26b">1,088.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDItMS0xLTEtNDY0_7e29eb48-963c-4da3-9367-7c8664a6d631">1,418.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDItMS0xLTEtMA_d6187821-a7b4-459c-bd79-b8b8146ba360">1,404.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDItMy0xLTEtMA_b22e0a7a-762b-496b-b873-b4d3ee59bdaa">1,562.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six-month Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic729b712df4f4a8ead8475fab8f0790d_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMi0xLTEtMS00NzA_de7bf453-e2a9-48d9-a5ef-08f714a4eb09">279.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib871150772b344349cbdf35a395d8267_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMi0xLTEtMS0w_03bd5541-cf22-4f89-8032-04d513f06980">586.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7633cb8e372444994b1efa8de166955_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMi0zLTEtMS0w_ecf49399-3122-4a80-8dce-b2e1030d684b">789.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie935c63c1ef24d07993e26cd5a18d415_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMi01LTEtMS0w_ef13812a-1d5d-4f15-8d3f-2babcc607a8c">690.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c097ed969db458690ef357352106593_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMy0xLTEtMS00NzA_ec10df1b-03a4-4536-85d8-23438d6b6a90">20.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fbf604a73ce4ed6bb5884b4cb199fac_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMy0xLTEtMS0w_45949589-8c25-4e69-bee1-bdcb4a937b1f">51.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib094ccbcf5d544e9803960dda6b5c3f0_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMy0zLTEtMS0w_9ffcd166-f75b-4d43-a0cb-a2ac303cead7">61.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97a926ad86c54867989a14b026bd3593_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMy01LTEtMS0w_4bf2191b-b890-4f62-89fb-4600e7c11007">53.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNC0xLTEtMS00NzA_91405895-8bd8-43d6-9e90-363107ef992f">299.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNC0xLTEtMS0w_eac71abe-9d3c-43e3-8bf2-5f523fa7eeab">638.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNC0zLTEtMS0w_c9e9cc3a-d8a1-41a9-ac2c-0bf76e75fd77">851.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNC01LTEtMS0w_5a30a794-6b92-4743-b702-1be8eeaee585">743.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic729b712df4f4a8ead8475fab8f0790d_D20200701-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNi0xLTEtMS00NzA_6232e853-52fb-4ffe-9adb-7ea978050b2c">82.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib871150772b344349cbdf35a395d8267_D20190701-20200630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNi0xLTEtMS0w_3d495606-fb9a-4751-adaf-c698c46b594f">157.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7633cb8e372444994b1efa8de166955_D20180701-20190630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNi0zLTEtMS0w_a29f3516-1950-4f5a-bfdb-c8fa5273f8c4">168.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie935c63c1ef24d07993e26cd5a18d415_D20170701-20180630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNi01LTEtMS0w_2eac113e-fa53-4fca-b58c-fc35507ff38a">148.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c097ed969db458690ef357352106593_D20200701-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNy0xLTEtMS00NzA_c0d1872b-8358-4f5f-a48d-38e48e02e23d">8.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fbf604a73ce4ed6bb5884b4cb199fac_D20190701-20200630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNy0xLTEtMS0w_17061b9e-cffb-472b-b3c4-836b1c454a14">28.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib094ccbcf5d544e9803960dda6b5c3f0_D20180701-20190630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNy0zLTEtMS0w_5f5e5230-4315-42f9-bc0c-0e561c17c568">32.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97a926ad86c54867989a14b026bd3593_D20170701-20180630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNy01LTEtMS0w_411d7944-db8f-424f-bb6e-c03600f8b9d9">28.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOC0xLTEtMS00NzA_55b2d686-4f41-48b4-8bfd-0c943dcfc843">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOC0xLTEtMS0w_20a4fcbd-bce7-410b-8a29-7d1215a67c7e">77.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOC0zLTEtMS0w_36eb0dbd-88c5-47c2-bafe-f6c081db780e">85.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOC01LTEtMS0w_454306e0-c34b-45fe-9531-90af160d9e5c">70.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOS0xLTEtMS00NzA_6ec19f30-d1de-40fd-8b78-53cd3f07c76c">3.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOS0xLTEtMS0w_ddca314d-34c2-415f-a029-ab303d2bd367">2.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOS0zLTEtMS0w_e6f31ee7-8aa9-4281-b2b1-c650a2fb67fc">1.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOS01LTEtMS0w_a3afb4d7-9d39-44bc-8dbc-81693c8928e5">61.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTAtMS0xLTEtNDcw_644a5a47-b82d-49b2-841b-07172a5b9d62">256.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTAtMS0xLTEtMA_edf0b0d6-abdd-4c7c-966d-1434bdee21b6">510.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTAtMy0xLTEtMA_7f6fe8b3-6028-4cba-a15d-c6367e4a1535">555.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTAtNS0xLTEtMA_51160e05-3356-497d-966c-0a9fb1633897">435.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTEtMS0xLTEtNDcw_a38380c7-1ad8-48bc-9fad-1ce4354935b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTEtMS0xLTEtMA_7e3f6c79-d90c-46ef-8692-378e2c4fb84f">99.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTEtMy0xLTEtMA_19216d18-00a1-4c89-a087-7bed619c25e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTEtNS0xLTEtMA_5c1baf72-979e-463b-8554-3d524e404470">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTItMS0xLTEtNDcw_53a0c75d-8851-4f50-adb2-6b7415ee7729">387.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTItMS0xLTEtMA_a10d27d2-d7ea-43a5-b27e-94835d48c269">870.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTItMy0xLTEtMA_d2ad95f6-e618-4b37-853f-870ff254bd3c">843.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTItNS0xLTEtMA_64f6be2d-fee4-465f-8d51-b9588141e28e">621.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTMtMS0xLTEtNDcw_2c91112b-e3b7-4e6a-bb2a-97fdba02e640">87.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTMtMS0xLTEtMA_3413e2b8-f48c-4bae-b63f-5b367438b543">231.7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTMtMy0xLTEtMA_e1d54998-8286-4fe8-ad4c-17261a782798">7.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTMtNS0xLTEtMA_210ae50d-263e-4af8-bf7c-b0fd586ddb43">121.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTUtMS0xLTEtNDcw_ab701e64-8229-4857-8dbc-432d3ece12c8">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTUtMS0xLTEtMA_2d096475-b45d-4ccb-bbfe-1bd53908c19d">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTUtMy0xLTEtMA_d96a9546-b919-4247-b745-1b9e6f6d123f">3.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTUtNS0xLTEtMA_9f1ed3fe-c091-4037-b8a2-085a7ea194e5">1.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTYtMS0xLTEtNDcw_70c68a94-86e0-4d96-8e54-5671a0e2da95">5.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTYtMS0xLTEtMA_0c1ab714-8672-45de-af1c-6b4bf6da7d9b">10.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTYtMy0xLTEtMA_4092fa35-f6db-4f8b-8c11-75ccd97b402e">12.0</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTYtNS0xLTEtMA_73fefd3d-274b-4b66-b006-439b5f650172">3.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTctMS0xLTEtNDcw_c7bc5990-88e4-42ee-bcdc-d0a1a62a3f29">1.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTctMS0xLTEtMA_da792416-9391-4ccf-b7c6-3e8cf9f6cf12">16.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTctMy0xLTEtMA_10ae1b9e-642c-40ef-ae63-ce0db7a47df8">1.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTctNS0xLTEtMA_b44d11cb-e64a-4fd1-8889-7d3d1dde6cd2">0.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTgtMS0xLTEtNDcw_127091df-0c8a-4c56-9500-eff0f3815567">6.3</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTgtMS0xLTEtMA_1e6d0741-04a2-47de-8a91-9eeb3bf4de63">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTgtMy0xLTEtMA_59de58d2-d929-4499-bfbd-4b07c8028232">7.6</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTgtNS0xLTEtMA_709ce939-98e8-4262-8d78-4783b7fefe6a">1.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTktMS0xLTEtNDcw_4af422f5-115a-48e8-b1f4-f1a210785932">94.1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTktMS0xLTEtMA_4749fa4f-eee8-4883-8c5d-fa432f599e3c">223.3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTktMy0xLTEtMA_d8b2c152-6bd1-4bbc-8fd1-4a4dff31219a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTktNS0xLTEtMA_59117d2d-2842-47a1-8cc9-da4d007ee6d3">120.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjAtMS0xLTEtNDcw_cb9addcc-29b0-4383-97e0-592d5a968476">41.0</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjAtMS0xLTEtMA_101259f5-e7d9-4a8b-b2b7-17ab5912247b">23.7</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjAtMy0xLTEtMA_8b633266-859e-4eac-8da2-4cd3063670b8">4.4</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjAtNS0xLTEtMA_5d0770f9-6aa3-41a1-9b27-0c3a1ac63bac">13.0</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjEtMS0xLTEtNDcw_48b108f2-dbba-4400-8371-d49998219f25">53.1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjEtMS0xLTEtMA_2d2eba85-a9b6-45df-b0f5-622203394b1b">199.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjEtMy0xLTEtMA_48f56ee9-360a-4a7a-9a5a-bc23c9669200">4.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjEtNS0xLTEtMA_92c434ee-6b1a-47de-996a-d8b69ee471fe">133.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjItMS0xLTEtNDcw_7356454e-5d26-47db-a95e-1c0224c9b6cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjItMS0xLTEtMA_64dad20b-29d1-4c8e-8e01-cf7d5934e845">0.1</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjItMy0xLTEtMA_6eb091eb-2a28-4f4b-8d0c-b6b7b13c2bf4">0.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjItNS0xLTEtMA_194933f1-ef66-427d-8bcb-94d7a79439f9">0.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjMtMS0xLTEtNDcw_e7b7a1bb-2261-4a92-b0ef-7b1db5d0af6e">53.1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjMtMS0xLTEtMA_3c5cad38-a8aa-449b-a00f-03fafbf07745">199.5</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjMtMy0xLTEtMA_2b24f951-e63e-427d-85dd-c9acea00e9fb">4.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjMtNS0xLTEtMA_bced6939-3cc5-4571-a017-dc6c41fa690f">133.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjUtMS0xLTEtNDcw_00874f3f-1319-45c8-b8dc-17a061428b97">0.71</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjUtMS0xLTEtMA_7eabf2ac-cb3d-4c7d-baf0-7c7590a8e8d9">2.69</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjUtMy0xLTEtMA_2852a520-22a0-48c1-9be3-dd1bd87a9f98">0.06</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjUtNS0xLTEtMA_7a22d9dd-10e9-4792-87dc-2199b81e4fb7">1.92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjYtMS0xLTEtNDcw_150bcdb9-8acb-42bf-abcb-491e860e7992">0.71</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjYtMS0xLTEtMA_5a24affc-2134-42fd-bc91-d48d70b11df4">2.69</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjYtMy0xLTEtMA_516f9f97-3248-497e-a984-2da1d338bfe2">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjYtNS0xLTEtMA_4df18f68-b15c-411a-a4f1-1b044fc9274d">1.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjgtMS0xLTEtNDcw_13de22d6-f65c-43bd-952e-b0feee3c769b">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjgtMS0xLTEtMA_3fb318e8-78fc-4ece-bf81-d5981f4295f0">74.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjgtMy0xLTEtMA_85664eda-33f3-4548-adf2-07881da1dec2">73.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjgtNS0xLTEtMA_32ee4e6a-2416-4c20-8d3b-e64daa065a2f">69.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjktMS0xLTEtNDcw_def52eaf-f742-4543-be5f-f894db362a27">75.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjktMS0xLTEtMA_601887ee-fa46-4d28-ba94-77033398cb62">74.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjktMy0xLTEtMA_078f96a7-e3ac-4a01-994c-922319f7c214">76.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjktNS0xLTEtMA_752c54d3-28e6-4c9d-9b99-3f4889460cb9">72.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Comprehensive Income (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six-month Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMi0xLTEtMS04MjU_6bd2fd6b-428e-4e32-b742-0338670f808f">53.1</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMi0xLTEtMS0w_5500a566-8ad7-4cf0-beb8-963a67d46640">199.5</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMi0zLTEtMS0w_dab10188-4695-4707-ba8d-4065308612ea">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMi01LTEtMS0w_d8c78805-6721-4626-8e83-e36914653f56">133.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on available-for-sale securities, net of tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMy0xLTEtMS04MjU_79e06ed1-0be6-42d1-87e3-cd891eac4019">0.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMy0xLTEtMS0w_026aefc5-3948-4953-8d75-392cc41ca606">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMy0zLTEtMS0w_04d32e5f-0f37-4bd7-864f-fb9686179669">1.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMy01LTEtMS0w_c7cb84fe-fd76-4a04-8d5b-b968e09f17b6">0.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in pension liability</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNC0xLTEtMS04MjU_47fdcbe7-87cf-4f37-aacc-e0a782b4293d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNC0xLTEtMS0w_9b2004e0-92b1-4d6d-9558-efe0d77dc213">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNC0zLTEtMS0w_577a5976-2d12-4ad0-9d41-62131abb93af">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNC01LTEtMS0w_cebc3b21-3c44-4db5-b477-540a8049afd9">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in foreign currency translation adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNS0xLTEtMS04MjU_88d93e9c-a854-466c-ab95-ff579ac23c0a">3.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNS0xLTEtMS0w_4a548c0f-7562-4e54-80f0-8470e04b2cfc">0.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNS0zLTEtMS0w_d23f0f14-e1e2-4bd5-887d-1a0da1cee384">3.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNS01LTEtMS0w_21af94d5-b13c-4bdd-ae57-6be513d1d218">1.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNi0xLTEtMS04MjU_f08138c9-240e-4fc5-a7a3-f7cfee67ceb5">50.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNi0xLTEtMS0w_6aa30cf1-8361-4e26-98ad-630dfb7022d8">199.4</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNi0zLTEtMS0w_2f1b299b-12e7-4edb-b93f-75fe7cefb061">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNi01LTEtMS0w_f0819750-2050-4939-bffa-5e76d890f84e">134.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>earnings<br/>(accumulated<br/>deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Myriad<br/>Genetics, Inc.<br/>Stockholders&#8217;<br/>equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCES AT JUNE 30, 2017</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81b96726504343d28522421de58c84e0_I20170630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS0xLTEtMS0w_c263a17c-3eb2-4a00-8c2f-ff4d1b2eadc3">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043df983c75d4d9790fca62e5627f01e_I20170630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS0zLTEtMS0w_985e8b01-b04b-4249-932a-ad927861a6c8">851.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i605b2c9f9a9b44f3bbf09333a54305b7_I20170630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS01LTEtMS0w_9b17f9fd-8640-4461-951e-8c0cbe044b34">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6b39f6952cb488a9feeaf585599ff97_I20170630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS03LTEtMS0w_28d3566f-7896-4760-a37c-5eeab8fda062">79.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS05LTEtMS0w_98538446-5538-43fa-a64d-8781d7aa9055">767.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c0e698144e42648f61bbf6031c1c5c_D20170701-20180630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMi0zLTEtMS0w_43fc76d2-3925-46e8-8722-fa2633d282f5">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMi05LTEtMS0w_ebb8ab2c-3723-4ef9-9778-d0ac5f2cae0a">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payment expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c0e698144e42648f61bbf6031c1c5c_D20170701-20180630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMy0zLTEtMS0w_6458aa3c-0bf4-4ad2-9439-c9870570e1b5">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMy05LTEtMS0w_45e13403-a90f-420b-b4bc-06ff7ec606c7">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7794eda7c67461e96370052bfb99427_D20170701-20180630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNC03LTEtMS0w_a5ada811-b2b5-4602-8d69-a484d4e2a827">133.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNC05LTEtMS0w_9eea3c7e-4f4b-4920-91f1-79578375f027">133.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a575b7c8ca744ed8ee5d39d3377da1f_D20170701-20180630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNS01LTEtMS0w_e3c737a6-e82a-4093-8e4c-8984abb92d2e">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNS05LTEtMS0w_79594662-185f-4fbf-b92a-fd39c9003b05">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCES AT JUNE 30, 2018</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec0b2aaccecb48f5b7031f656787f005_I20180630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi0xLTEtMS0w_0311ca07-6d03-4768-aa09-821ac58d4984">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a96e8e1248b4ab6be94a21fba042643_I20180630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi0zLTEtMS0w_e2fd9ff0-a291-498f-a105-ca56664ed6b0">915.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia44d866f0781417d83a00587086cfc79_I20180630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi01LTEtMS0w_6a05ffbb-5225-4ea6-b70b-35ce20bfe2f9">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i947239044e8241b8b52a22ece554dedc_I20180630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi03LTEtMS0w_5ae2a8d7-9938-4a09-993c-88bf891bf2f8">54.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi05LTEtMS0w_7ffcb355-0c62-4af3-bd74-89c25af6e066">966.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f729f126dc44f9b8d4c81d5418ce8f_D20180701-20190630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNy0zLTEtMS0w_cb8dc2d9-8aba-49c7-81e8-61a41802ecf5">136.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNy05LTEtMS0w_b84b7674-0128-4b64-a718-10ec8f2c947e">136.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payment expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f729f126dc44f9b8d4c81d5418ce8f_D20180701-20190630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOC0zLTEtMS0w_df68af7c-ee6c-4c56-b809-8c365cb569ae">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOC05LTEtMS0w_0e0488cf-491f-4345-9209-1840ae588cec">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99f729f126dc44f9b8d4c81d5418ce8f_D20180701-20190630" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOS0zLTEtMS0w_d9bc9cd9-cd69-44fa-93c3-424bb3d08f09">16.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d35e18907a547819b6deae0efc98b7a_D20180701-20190630" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOS03LTEtMS0w_4d3e1e69-8bd8-409c-b736-5ee86de25625">33.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOS05LTEtMS0w_c2e4eef2-d7e2-4813-85d7-a9e01763e8fc">50.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d35e18907a547819b6deae0efc98b7a_D20180701-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTAtNy0xLTEtMA_1a1ebe19-0447-48d8-81ac-cf9248701c2f">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTAtOS0xLTEtMA_f7a6d40d-d2a5-4fc0-8a30-658e339270fe">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95fef7707d9841e09fdeefb682e39bfb_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTEtNS0xLTEtMA_46c9a553-ff50-44f1-af09-2ac1420ecf2a">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTEtOS0xLTEtMA_a500fa0c-8107-495d-adc5-97a306c3cb6f">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCES AT JUNE 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d0ee12bc344eeeb30b549901738171_I20190630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItMS0xLTEtMA_f49e349a-e642-451c-b701-327cbb9f112f">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c71239012bf47869827c00bc3e89106_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItMy0xLTEtMA_5df1fc88-a812-4935-a765-1269127e52ad">1,068.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i312cecad66074aa4a77f2187852e77ab_I20190630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItNS0xLTEtMA_4243ba59-64f7-43f0-a16e-c461de3e1040">5.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie27fadcacb1f46029eb6fd3895d61378_I20190630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItNy0xLTEtMA_dee6ea16-164e-489e-89eb-6c0276b21e55">25.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItOS0xLTEtMA_6e910192-10c7-4fec-b00f-84d71483a671">1,088.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under share-based compensation plans, net shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6b952dfa944ca698bd7b95b7b9c665_D20190701-20200630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTMtMy0xLTEtMA_80f42d35-24af-417e-b051-caaf7f5bd770">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTMtOS0xLTEtMA_d10bc2f2-b325-4f16-9bd6-3db703031262">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payment expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6b952dfa944ca698bd7b95b7b9c665_D20190701-20200630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTQtMy0xLTEtMA_dba2fdee-94f6-4209-a5bd-b7b9a02f2e36">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTQtOS0xLTEtMA_d195355e-cf5f-4e64-9d49-903723f3a57a">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52119e935ff9454ca95aa15f28434db7_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTUtNy0xLTEtMA_18803d18-7d4e-4275-ae9f-b94c25f5f57d">199.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTUtOS0xLTEtMA_3ba10a65-c5cd-41ab-83b8-102fedfdc8c7">199.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification out of accumulated other comprehensive loss upon the deconsolidation of a subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eefa8a416fd4ec6972a8e54adb82cbc_D20190701-20200630" decimals="-5" name="mygn:ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTYtNS0xLTEtMA_599f3f7c-ff56-4872-935a-9b3407540169">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTYtOS0xLTEtMA_c48345c2-7f43-474c-99c6-65fc6835e14f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eefa8a416fd4ec6972a8e54adb82cbc_D20190701-20200630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTctNS0xLTEtMA_d128ef9d-946c-4ee7-9631-00e4ed5ba168">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTctOS0xLTEtMA_5fc7f69e-69c6-4493-979d-4c4b36738c41">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCES AT JUNE 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie824f0b48e99445ebdbd34568b4a740c_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtMS0xLTEtMA_73ccd451-ca6b-44ee-ab96-31e04ef9d3db">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2496737dd9420db74ac84923507079_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtMy0xLTEtMA_c1c28a12-182a-4d66-b86b-fdf2c1fdd64e">1,096.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic821396f205a43a1b2be38d8d4ea121d_I20200630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtNS0xLTEtMA_04013163-42bd-4fbd-b0aa-77ea37231229">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdbb159f7b6a41a28bf0f80b2e7f99a6_I20200630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtNy0xLTEtMA_b77411ec-7d84-4aed-808e-8d6bb0c9e324">173.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtOS0xLTEtMA_ce70fb43-efe5-4f12-9821-f97d3c3452f6">918.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under share-based compensation plans, net shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i941e632acb5a4786968dffa4c42b7c43_D20200701-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTktMS0xLTEtODM4_6677f13c-a7b6-4ab8-bce5-ac2636753604">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cad8a5377bb4f6583cdde4abd9bf533_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTktMy0xLTEtODM4_b37ff3b9-0ad2-4f9e-bede-e99c24e2c8b1">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTktOS0xLTEtODM4_e6b18de8-ad27-41a2-9f5e-a2eff508fe8b">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payment expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cad8a5377bb4f6583cdde4abd9bf533_D20200701-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjAtMy0xLTEtODM4_143da3da-422a-4f09-9ebc-b6684b6b13d8">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjAtOS0xLTEtODM4_804fa0bd-acd2-4f90-9575-ebaf4f6e35db">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5d5fb59c6a349e99c8e0851e720a933_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjEtNy0xLTEtODM4_9e959d55-c308-4930-b4a1-799739f0792e">53.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjEtOS0xLTEtODM4_0aa9a56e-7385-494e-84f6-76ace610b68f">53.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d1a7c06a6ad43389dd94e306a8d5f31_D20200701-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjMtNS0xLTEtODM4_4466a461-928d-45f2-88f7-e0ffe80fbf4a">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjMtOS0xLTEtODM4_17f077ca-d8c9-46fe-b6d0-10b1e9df81ee">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCES AT DECEMBER 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778d038d06274b8a8f9c85edc661fbd2_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtMS0xLTEtODM4_a47dccda-6546-4f02-a8e5-41491733da9d">0.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a7c360decc543eb8824c43a173dc0d4_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtMy0xLTEtODM4_e6118745-1df9-4236-8dbb-4e1d00eeab05">1,109.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib78ee580b5334e728f7c6add95026777_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtNS0xLTEtODM4_a516c1a3-006d-4a0f-88f3-10a1782283b2">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee94c647141649b6bb2fb3d6b3b18e85_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtNy0xLTEtODM4_49a40cc6-4486-46fb-a20d-ab2bb965b795">227.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtOS0xLTEtODM4_f63b877f-2649-4ed0-8c35-d3b4485e3da8">881.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six-month Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMy0xLTEtMS04NDg_91a17c7a-41d4-4ff4-b0f8-f27962dad61e">53.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMy0xLTEtMS0w_738e5267-a7c6-4db6-b8ce-ad33d11a6e56">199.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMy0zLTEtMS0w_4c33e582-c72b-48b6-a3a2-29edfda643aa">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMy01LTEtMS0w_a8c88a73-5370-4b6c-9c99-205abae9f724">133.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNS0xLTEtMS04NDg_bde15296-e4ad-4d46-bcfb-18847115e167">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNS0xLTEtMS0w_3e82f0b9-b61f-48d6-89bf-fd24c90e46a2">72.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNS0zLTEtMS0w_86a3d91b-86ca-4ebc-a480-a382f440da13">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNS01LTEtMS0w_efbfdadb-9cc2-4a16-86ef-555bb8ae8690">54.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="mygn:NonCashInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNi0xLTEtMS04NDg_54e97ac9-17e1-4ac6-84af-3f6550be3a0a">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:NonCashInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNi0xLTEtMS0w_80c6a065-3532-467f-baba-24b21a45e0c6">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:NonCashInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNi0zLTEtMS0w_2c047532-591b-4677-9020-d1e584cacb26">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="mygn:NonCashInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNi01LTEtMS0w_ef4b5077-7581-4936-ad85-01883b5256a5">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0xLTEtMS0xMTAxNQ_21f90f58-af5f-4435-99a3-21de29375ece">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0zLTEtMS0xMTAxOQ_09e802be-8b13-4b01-8063-17638804b760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy01LTEtMS0xMTAxOQ_a371afff-7452-401d-a9b2-e1daba05e861">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy03LTEtMS0xMTAxOQ_7746eca6-42dd-4d58-9191-0b51b235f323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on deconsolidation of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0xLTEtMS04NDg_7f5e87b7-1844-4f28-953f-5342cddadcba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0xLTEtMS0w_6de34450-4d5f-4596-85c9-d9346a8b7554">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0zLTEtMS0w_1af62ebc-0067-4f49-bf1f-ed7b2c5497de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy01LTEtMS0w_2c5215fc-37b0-4f65-b2a1-05890b5734c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash impact of foreign currency transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0xLTEtMS0xNzEyMQ_2ae15e60-b280-49ae-bb9a-686643cc3167">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0zLTEtMS0xNzEyNQ_9b9df7a6-b842-4d9c-bb18-c8cb2297bb1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS01LTEtMS0xNzEyNQ_b1a12800-d4c4-41a3-9c3c-df3909da6f19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS03LTEtMS0xNzEyNQ_0eca048e-4c7a-43b8-8408-7eb32d14ae7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on disposition of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOC0xLTEtMS04NDg_52c577aa-4fe7-4721-99f4-3bafdb36b4a4">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOC0xLTEtMS0w_59733ed2-5fb4-44f3-bcc2-0bd39ea03a0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOC0zLTEtMS0w_a777df78-48c5-4f49-a42c-d5d6396588b5">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOC01LTEtMS0w_ec37ed03-641f-4951-9201-e4201ce2e0cd">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0xLTEtMS04NDg_6b5fa639-4f3a-4e81-a1d9-706b6ccd25b2">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0xLTEtMS0w_0913eac9-bf83-4869-8f65-bc9b80ce9f25">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0zLTEtMS0w_a93c6f94-038e-4265-8475-d6da24ae9527">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS01LTEtMS0w_ba97a418-84c2-4a98-bca4-c9e9f2e55a12">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTAtMS0xLTEtODQ4_d46cb5c7-d270-4b56-9ec1-f7be6121813f">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTAtMS0xLTEtMA_419b0bc0-b59d-4c1e-823e-081249be4635">55.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTAtMy0xLTEtMA_2ab25d2c-dff5-47cd-b5b6-33e7d3e429f0">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTAtNS0xLTEtMA_83f0ad49-5101-4de6-8570-d19185fc1482">23.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="mygn:IncreaseDecreaseInUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTEtMS0xLTEtODQ4_4fe5137c-b025-429e-9e94-a12e59b0c066">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="mygn:IncreaseDecreaseInUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTEtMS0xLTEtMA_f28f98e7-9568-476d-a148-c1e0b44158dd">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:IncreaseDecreaseInUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTEtMy0xLTEtMA_05a36842-3efd-4111-b445-c3cc1ff24b12">5.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="mygn:IncreaseDecreaseInUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTEtNS0xLTEtMA_14b1732b-8f37-46d1-aa8b-5687e93167a7">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of goodwill and intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTItMS0xLTEtODQ4_6f4911be-17a7-4ca5-b025-3751a38e7cef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTItMS0xLTEtMA_3759705b-c445-422f-92e6-d0e53d6d57fc">99.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTItMy0xLTEtMA_e0c6e469-df50-4cd3-aa5b-73ed3f50df77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTItNS0xLTEtMA_dde22ed0-c368-4331-b128-32204974fea7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="mygn:ChangeInFairValueOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTMtMS0xLTEtODQ4_25500577-ab02-4f64-9edb-7649389fba1e">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:ChangeInFairValueOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTMtMS0xLTEtMA_ea90f90b-146e-4a07-9147-d3bbc36c40d9">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="mygn:ChangeInFairValueOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTMtMy0xLTEtMA_a4ccc98c-dc32-42a8-bb91-b9e925a25f1a">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="mygn:ChangeInFairValueOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTMtNS0xLTEtMA_00379a76-7b4c-4c19-87ed-8ea8dec92715">60.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTQtMS0xLTEtODQ4_7165f43b-1613-4fa6-8c6a-fdd030a33883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTQtMS0xLTEtMA_40e377e9-aa31-43c2-b898-19fed192ea81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTQtMy0xLTEtMA_d36b53b3-c939-4eb0-a163-26a1d336924b">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTQtNS0xLTEtMA_13c1dff0-9205-46ea-84b3-8ae28e730b82">22.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTYtMS0xLTEtODQ4_2456e304-c2b4-4ce4-84ef-dd8a7918524f">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTYtMS0xLTEtMA_5fc755df-4388-4a8b-badc-a6b12a454409">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTYtMy0xLTEtMA_79582c26-d2af-42df-8c49-f8fd876d5a2d">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTYtNS0xLTEtMA_1fa177e3-d7e1-452f-b99e-866ec720fb11">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTctMS0xLTEtODQ4_ed05f354-f751-4a69-b8af-deccf913f522">21.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTctMS0xLTEtMA_dffe4152-b478-4fe9-a5fc-3e523e5db14c">64.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTctMy0xLTEtMA_5da9bcff-bbf1-40ac-86a4-5d59c6a808c2">18.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTctNS0xLTEtMA_744ff44c-00fc-4cfd-8415-0000f77b507c">9.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTgtMS0xLTEtODQ4_c6bf4cd3-bb7f-4e8d-a618-67ed079e5d20">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTgtMS0xLTEtMA_283dbb75-7fef-4d83-978b-eac933e21702">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTgtMy0xLTEtMA_d0159121-d6d9-4994-8c2c-2c55d3162c64">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTgtNS0xLTEtMA_d2d45a5b-0576-43aa-ba1f-b1dcfc98b227">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTktMS0xLTEtODQ4_ccf67d85-c0f3-4feb-93fc-90e3e62680a1">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTktMS0xLTEtMA_54e60e3e-e955-4033-979b-595439f8ebc3">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTktMy0xLTEtMA_dedddd42-4d54-4f22-9aeb-31fbaa5c90b1">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTktNS0xLTEtMA_10bc1455-c230-4cb9-b89b-9ee7eaddf30b">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjAtMS0xLTEtODQ4_87e62dc0-2e4a-4ac1-9c2f-3b00da0d87b0">108.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjAtMS0xLTEtMA_fafd9ddb-f2c3-479e-9749-285b7cb5faed">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjAtMy0xLTEtMA_fd928ac6-eb0e-4036-a138-a9365b1bf8cb">25.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjAtNS0xLTEtMA_6407c798-e575-4b2e-8978-ccfd5fdb4a38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMS0xLTEtMTc1OTc_bae00f7d-1e4e-4e70-99d0-ab26caa7f5a1">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMy0xLTEtMTc2MTE_d9c69a99-926e-4ea0-a9e2-887a6fecf0b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtNS0xLTEtMTc2MTE_d25e148c-b24b-4644-8a61-721324fcfe63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtNy0xLTEtMTc2MTE_fae1d275-080d-4d5b-bd04-254a43bf10fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjEtMS0xLTEtODQ4_1c30bf8b-1856-4b60-982f-15a7a26e4271">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjEtMS0xLTEtMA_1e0b05b1-5bfc-4cbe-b8d6-dd444886bcbf">10.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjEtMy0xLTEtMA_6d3611fe-3333-4d4d-a565-137588e6dea7">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjEtNS0xLTEtMA_f71804c3-3303-404d-8b6c-854142bff0d7">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjItMS0xLTEtODQ4_54c5e2e1-86b5-479e-a227-b114b1d60750">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjItMS0xLTEtMA_c2158a41-a48e-4e4f-95d1-c281987a9644">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjItMy0xLTEtMA_d0fc0e22-da02-428a-9d77-ec00abd71fd1">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjItNS0xLTEtMA_68a07de5-051a-41fa-adb5-b4b7b16b5dd6">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMS0xLTEtODQ4_892860bb-2280-4abc-aa7d-16dc1c9a2b03">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMS0xLTEtMA_b75be70b-5a32-4b3d-ab4d-a8a77e2711c2">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMy0xLTEtMA_fe9c4aab-c99a-4675-abde-61bc5c627274">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtNS0xLTEtMA_7eedd170-6fde-4446-be23-815239e8bc20">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjQtMS0xLTEtODQ4_3d2de5d0-2dc6-4aac-a485-10323470571f">73.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjQtMS0xLTEtMA_a5b63b76-a8c3-48e1-bbf1-c2a16cfe4f19">60.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjQtMy0xLTEtMA_af42e10b-5df4-4077-b5b6-228f676e38c1">83.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjQtNS0xLTEtMA_a0ecc5b5-8c22-4595-9827-1c2a6c0b721b">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjYtMS0xLTEtODQ4_1c33b42d-21e7-4c23-9cc2-5bd59b273113">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjYtMS0xLTEtMA_c7a348fe-b94c-4d7b-a3ca-92ddf17d3b9f">10.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjYtMy0xLTEtMA_143ca60c-c2b2-44b6-b7a0-2d0d87e459af">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjYtNS0xLTEtMA_be4dbd58-2943-4989-93ae-63d3d8afc776">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjctMS0xLTEtODQ4_5870dc39-3994-4204-b777-6ed26ee403c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjctMS0xLTEtMA_e3ef4f0e-a3cf-4fed-b1e9-b0da520728c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjctMy0xLTEtMA_832471aa-7727-45ef-9625-fc545e09c731">278.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjctNS0xLTEtMA_65070c5e-ce80-4bf1-a259-5ab39d31896b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjgtMS0xLTEtODQ4_9807b5c4-bfae-4491-956c-8ec154004bc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjgtMS0xLTEtMA_05d10ed7-e7db-4c09-958b-a0dca29c948c">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjgtMy0xLTEtMA_245da604-4993-4893-a131-57bd01048a52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjgtNS0xLTEtMA_ed940953-07d5-436a-b895-b16e92bdcd04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjktMS0xLTEtODQ4_98ad3239-b662-4a7f-8e32-d8a6a3500fea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjktMS0xLTEtMA_a295e421-b42a-4872-a225-420afead1f5f">60.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjktMy0xLTEtMA_48dec1ea-03d2-446b-94ea-6c22f3f4cab6">78.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjktNS0xLTEtMA_ab3bad36-982a-45c1-9a73-83fb9f270e83">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturities and sales of marketable investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzAtMS0xLTEtODQ4_f522d4fe-02c2-49be-bc42-32ca9d81d8c3">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzAtMS0xLTEtMA_951a9d75-de20-4b91-a84b-59e64c10e73c">69.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzAtMy0xLTEtMA_d6fe74e8-d0fe-4e49-bdab-dddd2d48377f">79.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzAtNS0xLTEtMA_ffc95ab7-1de5-479d-b468-70f87cef7c3b">77.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzEtMS0xLTEtODQ4_73a39173-e5d8-489f-b16c-f50db467c3ab">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzEtMS0xLTEtMA_c295c482-b197-4a15-8285-61a5286e7599">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzEtMy0xLTEtMA_1790f4a8-7458-44eb-846a-385496bc3ac2">286.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzEtNS0xLTEtMA_6067b0f7-4147-4fd7-b967-3a218bcb1b1b">11.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from common stock issued under share-based compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzMtMS0xLTEtODQ4_3218e6e1-5964-4498-bd41-38bf2730452f">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzMtMS0xLTEtMA_25c7f0cf-0386-48a5-a901-3fe4a5c1d731">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzMtMy0xLTEtMA_42da0da9-24e1-48e2-8fa0-5229747fd422">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzMtNS0xLTEtMA_dc3d8cab-1d51-49df-9ee1-46e492521f2c">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of tax withheld for common stock issued under share-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMS0xLTEtMTgwMTk_94a7c0a2-7018-4c92-b08d-9e18bbf39cfb">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMy0xLTEtMTgwMjM_54524939-a5b4-4906-8680-0a8d02c8a09a">9.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctNS0xLTEtMTgwMjM_4f1cb3c8-9acc-48ae-afcc-a218f1d212ab">14.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctNy0xLTEtMTgwMjM_f9424879-2a1f-455f-a495-0288df0f5683">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzQtMS0xLTEtODQ4_43a3c0f4-7183-4057-8371-ed5dfae796ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzQtMS0xLTEtMA_52dce659-34a6-471d-97b4-44f32f494bf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzQtMy0xLTEtMA_a6377507-81e5-4631-88ba-1f14dbe3ea3f">340.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzQtNS0xLTEtMA_99a60b58-f334-4b1e-9873-b37407bd9246">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzUtMS0xLTEtODQ4_24f3e3ac-af1d-4b30-bda2-404a840b4e0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzUtMS0xLTEtMA_61d776b6-40fa-4d12-a3d1-d82121ed6849">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzUtMy0xLTEtMA_42c777c2-8e91-473a-b679-7ea43023684a">115.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzUtNS0xLTEtMA_78a269ec-849f-40db-ab64-e62b0d1c2b65">143.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of contingent consideration recognized at acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzYtMS0xLTEtODQ4_7bb42fee-c13f-45f2-ba5c-f80d856ee3af">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzYtMS0xLTEtMA_0e278af4-da7b-403e-8b6d-4d12e11a575f">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzYtMy0xLTEtMA_0b9347d8-e0f9-49dc-a8cc-3df1086a3db3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzYtNS0xLTEtMA_45eb867e-b74e-491c-9922-3a3776753bdd">42.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fees associated with refinancing of revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMS0xLTEtODQ4_4ec4b6f7-77fc-464c-b66f-b7990ad42805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMS0xLTEtMA_a4741ba6-e436-4f7b-af03-762fc2e78dae">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMy0xLTEtMA_52fc7a22-e8d9-41b7-978c-86ea0d33d3f5">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctNS0xLTEtMA_09af0616-87b1-4635-9879-08342c214a31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzgtMS0xLTEtODQ4_c1de13af-55b6-4236-80dc-c75b936ed80b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzgtMS0xLTEtMA_d859bab2-0a6e-4fb2-be9a-26b57af7e454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzgtMy0xLTEtMA_ac04deab-ebf6-4231-b570-42b1def56df1">50.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzgtNS0xLTEtMA_2fe26f51-295d-4baf-88e9-42790c22c951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzktMS0xLTEtODQ4_3746bd74-9e34-422b-a791-fa071d32fdfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzktMS0xLTEtMA_48a1fe85-d337-412e-8ecc-ca2d2728b4a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzktMy0xLTEtMA_5fe3749d-72e8-44f8-b144-0e6deadb67d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzktNS0xLTEtMA_21d473c3-2f0a-4cd0-9768-c0ca06ac3214">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDAtMS0xLTEtODQ4_0a0ae9aa-5f70-4370-906e-7fcc845b83a3">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDAtMS0xLTEtMA_c6385ce4-bd2a-4d9d-be16-bb52fcf2f814">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDAtMy0xLTEtMA_db9b7f98-64ac-4d69-9f95-19ef06f3a6c8">182.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDAtNS0xLTEtMA_1fd050d6-2503-47c5-bf0a-a92a46684281">95.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDEtMS0xLTEtODQ4_d7b8c39d-7319-477e-98bb-cedbe2b9cb5e">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDEtMS0xLTEtMA_64435ad5-0bd2-4cbe-8a51-79c6c5196962">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDEtMy0xLTEtMA_b4f15911-c0ea-49c5-95bc-629d89d19e65">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDEtNS0xLTEtMA_bf741566-00eb-4977-9a48-58644baf15be">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDItMS0xLTEtODQ4_085b4292-f722-4702-8c46-2d8ec8e6a9a3">46.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDItMS0xLTEtMA_23a7cb3d-f2cb-437f-86db-2c2de08a9769">70.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDItMy0xLTEtMA_4087ad8b-6444-44ac-841c-aadaf480ded6">17.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDItNS0xLTEtMA_d7abed7f-0c1b-48b9-901e-3487098cd9b6">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDMtMS0xLTEtODQ4_3352802e-24cd-4cb6-a312-babf1a457600">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDMtMS0xLTEtMA_8ef596e6-e701-403b-b332-8d3f7ddb4509">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDMtMy0xLTEtMA_4ea69b27-14f9-47a2-b4fa-479a642934fa">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDMtNS0xLTEtMA_b970cbfa-bc3f-4c68-b67f-7dc66f4a630e">102.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDQtMS0xLTEtODQ4_5ea34c4f-3b57-45ff-bdff-419553c38c46">117.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDQtMS0xLTEtMA_aed2a8d0-f1c3-4fbc-b0c5-65c5390bf190">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDQtMy0xLTEtMA_e3802c6a-bb6a-4334-8af3-b3c25f675a44">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDQtNS0xLTEtMA_4f90816e-7695-433c-a7d3-1c9c0a40525d">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_97"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODc_7b43ea17-6938-4c2b-8b00-15d5e654667a" continuedAt="ifdc84a0a1ab241109b3c29ae2f96abc7" escape="true">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="ifdc84a0a1ab241109b3c29ae2f96abc7" continuedAt="ief3cac38966e4e7887332798f0ff081d"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODM_dc365155-bad3-4d7d-abf1-0e8a40c38ccf" continuedAt="id0aa71b9b8db4ffabdd20c548b6d5945" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Financial Statement Presentation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad Genetics, Inc. and subsidiaries (collectively, the&#160;"Company" or "Myriad") is a leading personalized precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics. The Company employs a number of proprietary technologies, including DNA, RNA and protein analysis, that help it to understand the genetic basis of human disease and the role that genes and their related proteins may play in the onset and progression of disease. The Company uses this information to guide the development of molecular diagnostic and companion diagnostic tests that are designed to assess an individual&#8217;s risk for developing disease later in life (predictive medicine), identify a patient&#8217;s likelihood of responding to drug therapy and guide a patient&#8217;s dosing to ensure optimal treatment (personalized medicine), or assess a patient&#8217;s risk of disease progression and disease recurrence (prognostic medicine).&#160;&#160;The Company generates revenue by performing molecular diagnostic tests as well as by providing pharmaceutical and clinical services to the pharmaceutical and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.&#160;The Company&#8217;s corporate headquarters are located in Salt Lake City, Utah.  </span></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id0aa71b9b8db4ffabdd20c548b6d5945">The accompanying consolidated financial statements have been prepared by the Company in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.&#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with U.S. GAAP.</ix:continuation>&#160;&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the transition period ended December&#160;31, 2020, the Company identified errors related to its accounting for its international su</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bsidiaries and its determination of fair value of contingent consideration related to an acquisition that occurred</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in May 2016. These errors were not material to any previously reported period. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management analyzed the potential impact of these errors in accordance with the SEC Staff Accounting Bulletin No. 108, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and concluded that the correction of the errors are not material to the transition period ended December 31, 2020.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODA_29aa800b-f4b8-42a6-95c8-32fe3ab3c67c" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires Company management to make estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include revenue recognition estimates for the average expected reimbursement per test, valuation allowances for deferred income tax assets, certain accrued liabilities, share-based compensation, and impairment analysis of goodwill and intangible assets. Actual results could differ from those estimates.</span></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full impact of the COVID-19 outbreak continues to evolve and its future impacts remain uncertain and unpredictable. Management is actively monitoring the impact of the global situation on the Company&#8217;s financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for future periods.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="ief3cac38966e4e7887332798f0ff081d" continuedAt="ie3237c9e21414e309f4990b3ed50aa85"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODg_531b3276-6386-4653-917c-b9b476556df5" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Substantially all of the Company&#8217;s account receivable are with companies in the healthcare industry, U.S. and state governmental agencies, and individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments. The Company only has one payor, Medicare, that represents greater than 10% of its revenues. Revenues received from Medicare are included within the Diagnostics reporting segment and represented approximately <ix:nonFraction unitRef="number" contextRef="i8f96d09d51df44fbad84bb579131bdab_D20200701-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTM3NDM4OTU0MDgyODU_7af2f639-4b5a-4512-959a-94a0c352cbe9">16</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i10cba38383e5458b892db6d39c7d18c8_D20190701-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNDM0NQ_63d1241d-f4d0-432e-be0b-c74109352ab0">15</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ide4c77d70ac54992b13f6f397ae45339_D20180701-20190630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNDM0OQ_603702be-8dd5-48fb-9104-9b4612d7c568">14</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i0deff0d97a2e4113ac45f71cc4c1aee6_D20170701-20180630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNDM1Ng_3a840041-966c-461d-9961-fd2b7191791d">17</ix:nonFraction>% of total revenue for the six-month transition period ended December&#160;31, 2020 (the "Transition Period") and the fiscal years ended June&#160;30, 2020, 2019 and 2018, respectively. Concentrations of credit risk are mitigated due to the number of the Company&#8217;s customers as well as their dispersion across many geographic regions. No customer accounted for&#160;more than 10%&#160;of accounts receivable at&#160;December&#160;31, 2020, June&#160;30, 2020 or June 30, 2019.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTY_6724cfb4-bfd2-4453-9483-6dcd73c7bc69" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Investment Securities</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its marketable investment securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders&#8217; equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The Company&#8217;s cash equivalents consist of short-term, highly liquid investments that are readily convertible to known amounts of cash.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A decline in the market value of any available-for-sale security below cost that is deemed other than temporary results in a charge to earnings and establishes a new cost basis for the security. Losses are charged against Other income when a decline in fair value is determined to be other than temporary. The Company reviews several factors to determine whether a loss is other than temporary. These factors include but are not limited to: (i) the extent to which the fair value is less than cost and the cause for the fair value decline, (ii) the financial condition and near term prospects of the issuer, (iii) the length of time a security is in an unrealized loss position and (iv) the Company&#8217;s ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. There were <ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNjE3Ng_037e399f-7b4d-43f6-8a5e-63cf7d024a87"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNjE3Ng_d036d2d6-8e98-4fbc-a1b3-3e9396abad6c"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNjE3Ng_d7f29f20-ab68-4357-b5b6-f4170ccd5f8e"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNjE3Ng_e4886a1f-a857-472f-99c5-3a11f57803df">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> other-than-temporary impairments recognized during the transition period ended December&#160;31, 2020 or during the fiscal years ended June&#160;30, 2020, 2019 and 2018.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTc_2cf50233-e6b6-42c8-86c2-5c6740f5255f" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of supplies such as reagents, plates and testing kits, which are consumed when providing test results, and therefore the Company does not maintain finished goods inventory. Inventories are stated at the lower of cost or market and costs are determined on a first-in, first-out basis.&#160;&#160;In order to assess the ultimate realization of inventories, the Company is required to make judgments as to future demand requirements compared to current or committed inventory levels.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its inventories for excess quantities and obsolescence.&#160;&#160;Inventories that are considered excess or obsolete are expensed.&#160;&#160;The valuation of inventories requires the use of estimates as to the amounts of current inventories that will be sold. These estimates are dependent on management&#8217;s assessment of current and expected orders from the Company&#8217;s customers.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTg_5ab07118-f44c-4d0f-86af-e3329be267cf" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Accounts Receivable</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable represents amounts billed to customers for revenue recognized related to molecular diagnostic tests and pharmaceutical and clinical services. The Company does not have any off-balance-sheet credit exposure related to its customers and does not require collateral.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODk_4e06202c-c392-49fb-a358-4a9015a5a94d" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method based on the lesser of estimated useful lives of the related assets or lease terms. Equipment items have depreciable lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYxNA_1b34527f-c366-49c7-adfd-f87850ee8bcc">five</span> to <ix:nonNumeric contextRef="iff673b26c96b445a959922f9e0f6766d_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYyMA_9afd3128-3054-4d45-829a-c37fb1b87048">seven years</ix:nonNumeric>. Leasehold improvements are depreciated over the shorter of the estimated useful lives or the associated lease terms, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc2NA_20a77949-7d3f-4d64-b771-723fbeeb3bce">one</span> to <ix:nonNumeric contextRef="i63bb7805ca1545da94822eeccb9d2208_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc3MA_03b7e6f4-e5b6-40ae-b5f6-fbfaa01ddbe0">seven years</ix:nonNumeric>. Repairs and maintenance costs are charged to expense as incurred.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="ie3237c9e21414e309f4990b3ed50aa85" continuedAt="i877c1e62078647d69eb63292ee43dd4c"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTk_721e47a8-e803-4410-8285-f96f51291313" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible and other long-lived assets are comprised of acquired licenses, technology and intellectual property and purchased in-process research and development. Acquired intangible assets are recorded at fair value and amortized over the shorter of the contractual life or the estimated useful life. The estimated useful life of acquired in-process research and development was also evaluated in conjunction with the annual impairment analysis of intangible assets. The classification of the Company&#8217;s acquired in-process research and development as an indefinite lived asset was deemed appropriate as the related research and development was not yet complete nor had it been abandoned. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain implementation costs incurred in a cloud computing arrangement to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. Implementation costs incurred in cloud computing arrangement are capitalized as part of Other assets in the Consolidated Balance Sheets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually reviews and monitors long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODQ_4732049b-f4b9-45cd-a5eb-610743ad27b6" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment by reporting unit on an annual basis as of October 1 and in the interim if events and circumstances indicate that goodwill may be impaired. Prior to the change in the Company's fiscal year from the last day of June to a calendar fiscal year end, goodwill was tested for impairment on an annual basis as of April 1 and in the interim if events and circumstances indicated that goodwill may be impaired. The voluntary change is preferable under the circumstances as it provides the Company with additional time to complete its annual goodwill impairment testing in advance of its year-end reporting and results in better alignment with the Company&#8217;s strategic planning and forecasting process given the Company's change in fiscal year end. The events and circumstances that are considered include business climate and market conditions, legal factors, operating performance indicators and competition.&#160;&#160;Impairment of goodwill is first assessed using a qualitative approach.&#160;&#160;If the qualitative assessment suggests that impairment is more likely than not, a quantitative analysis is performed.&#160;&#160;The quantitative analysis involves a comparison of the fair value of the reporting unit with its carrying amount.&#160;If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.&#160;&#160;If an event occurs that would cause a revision to the estimates and assumptions used in analyzing the value of the goodwill, the revision could result in a non-cash impairment charge that could have a material impact on the financial results.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTA_6b4a1e4f-1539-47f3-9c10-ac77753e8e55" continuedAt="i67e6e8ab292e4e3ebe4eacd1326fb214" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad generates revenue by performing molecular diagnostic testing and pharmaceutical services. The Company previously provided clinical services until selling Privatklinik Dr. Robert Schindlbeck GmbH &amp; Co. KG (the "Clinic") in February 2020. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated transaction price. The Company has determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i877c1e62078647d69eb63292ee43dd4c" continuedAt="if4f7539890d147f585b377559f0cebc5"><ix:continuation id="i67e6e8ab292e4e3ebe4eacd1326fb214" continuedAt="ib1d329c8f05c4b93a5121b3d8f652ef5"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTE1NDQ4NzIxNTAwOTE_99da09e6-137e-4a96-8281-f7ac4ce3aca9" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s revenue by type for the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, 2019, and 2018:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic revenues:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hereditary Cancer Testing</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea7c3564b9c44c23a5c4dfb365017793_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMy0xLTEtMS0xODAzNg_e7b1d5c9-93f2-42a8-acfd-f0d7787fea70">159.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875db6ff7af64f6c9b97fad10e61b5fd_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMy0zLTEtMS0xODAzNg_04fdd9ec-04a0-4c07-a92c-ba2fae8805a5">347.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbb4994d91de4c549d6dae2b213aebe6_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMy01LTEtMS0xODAzNg_706e7aad-d42f-454c-bc81-fa0231ae9229">479.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8669478b996c461297c9b935fda6b141_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMy03LTEtMS0xODAzNg_ae98f580-bf09-4540-b58f-e8a707abeebc">471.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GeneSight</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7c7b6ac227491f92c17991812e3869_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNC0xLTEtMS0xODAzNg_c19ea81e-7d3e-429b-a98f-71f78afce4be">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f622f3ae0ff49d8b617b9d61d2c97ad_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNC0zLTEtMS0xODAzNg_321e2452-4b89-4836-9cd1-9a5825f41a4f">74.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b0cd7d81bb4bb89cd9aa952ab8bd0f_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNC01LTEtMS0xODAzNg_76169d26-caf0-4f96-93b7-969daac6ffbf">112.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09b5abba4b34fb68e4eb34834cba9f1_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNC03LTEtMS0xODAzNg_978abc6a-71a7-450a-ac88-42941998a4a1">124.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e307d2445b40d8aa07d3ec14ba2be0_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNS0xLTEtMS0xODAzNg_bf2b1441-914b-45f6-9e0a-7c5c5aec6724">37.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec76ab3fed647e58dde13a62d7ab5cb_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNS0zLTEtMS0xODAzNg_c81565bb-af69-4f8e-aa69-8b25ab7bca1e">76.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1612014e0c7849f8bd70b02fabac071a_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNS01LTEtMS0xODAzNg_0527f079-49e0-43fd-afdb-0b734632bbdf">104.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e77a5395ef4cd98c05a28cd36491b6_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNS03LTEtMS0xODAzNg_3df99c97-5fe1-4f3e-b874-f14b9a17890f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vectra</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82a8ffe32674a43a4391daf728784cd_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNi0xLTEtMS0xODAzNg_2c4d289a-8468-4b4b-8678-a047a695288a">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26f87eb2c79e4687904b9c3be92b905d_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNi0zLTEtMS0xODAzNg_83426908-e272-4e55-9b39-9e282c6a5c44">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdba8e49ff540fe876fbb36882f6f5d_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNi01LTEtMS0xODAzNg_59ffeac9-efe9-49e3-bb57-eff1c5716234">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if506fdf6e01e48fabc4c32668075bd86_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNi03LTEtMS0xODAzNg_dd0412c3-0d04-4ad9-a4c7-5147ead3e18c">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myChoice CDx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2772ca9aefb2473c9f3ff73415e8016b_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNy0xLTEtMS0xODAzNg_0af00423-b086-4d2b-9656-757bb1f41ae9">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e90e77c40c74a8d9ce1811c7fec3667_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNy0zLTEtMS0xODAzNg_eb8c6c82-30a2-4003-a9c7-0837ded52c97">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8154ac2d56b4a3ebdb3fb57f831633a_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNy01LTEtMS0xODAzNg_db12d194-5338-432b-9dc5-41d2233e5d84">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69345f3695f9481ca79acaab212b8bc8_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNy03LTEtMS0xODAzNg_e9839855-c327-4420-8259-3cefa8ecc063">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prolaris</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i333fb6ad9b6b43ac9e8439a13405ff71_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOC0xLTEtMS0xODAzNg_0ce48caf-95c8-40b5-a2b7-2b7254a9b51c">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i520c7e479d204ea1ab81cbebaa679338_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOC0zLTEtMS0xODAzNg_a26ef33b-8f10-4b80-91f2-d1af32223af0">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i139ff307433f4c42ba54d26e15f894d9_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOC01LTEtMS0xODAzNg_33b0e8bc-ed9b-494d-8085-7ea810f0a231">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a2be4df4b147d6aad9dab664baae09_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOC03LTEtMS0xODAzNg_f238172d-3a89-441e-9488-e441675f396a">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EndoPredict</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b2dabb0c3074d16846d868ece0861f2_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOS0xLTEtMS0xODAzNg_92a76351-00cc-445e-8cc1-4d3cbb127b24">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49a6759c9c7f46b5bea7b177dbc8de41_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOS0zLTEtMS0xODAzNg_d6b4e548-3908-44cc-bfd7-1768f89d5882">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ef11da463d4f049fdb71cb91e6e4ac_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOS01LTEtMS0xODAzNg_2847b898-8689-4f76-9672-388900fa65eb">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed4976cdda34693bc7a2223ae7a47d8_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOS03LTEtMS0xODAzNg_8cc66664-ea99-4c66-b1e5-6a875a6428b3">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdde0ae552b34e9394dd2670d0615284_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTAtMS0xLTEtMTgwMzY_1bbd1af4-9257-4b99-9df9-97f0c2b7f031">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd823528cb5452e9aa3bd695577208b_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTAtMy0xLTEtMTgwMzY_a2bbdd28-f0fd-4ffa-9020-709a9560eb70">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fd54ea912347b6bbee02a245eae55c_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTAtNS0xLTEtMTgwMzY_04113804-96e4-4090-9030-537968e14a9f">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af285dcaea45c8a830624ee2362d76_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTAtNy0xLTEtMTgwMzY_56dae5cb-b9e6-40c5-b4e8-212317e81100">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total molecular diagnostic revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic729b712df4f4a8ead8475fab8f0790d_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTEtMS0xLTEtMTgwMzY_2039ced0-b62c-4f37-816c-86b5ff01f080">279.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib871150772b344349cbdf35a395d8267_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTEtMy0xLTEtMTgwMzY_1f33b426-ab8a-417b-9be6-09538389a0b3">586.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7633cb8e372444994b1efa8de166955_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTEtNS0xLTEtMTgwMzY_23aed0a6-1ebf-45dd-93e7-f45526cf7b18">789.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie935c63c1ef24d07993e26cd5a18d415_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTEtNy0xLTEtMTgwMzY_5ff768df-bd52-41c3-b802-d32dfd74052b">690.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical service revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c097ed969db458690ef357352106593_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTItMS0xLTEtMTgwMzY_534182ca-f5a3-4581-bd4a-534a6fbea9a5">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fbf604a73ce4ed6bb5884b4cb199fac_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTItMy0xLTEtMTgwMzY_0d3b1a3d-ab84-46b3-9b0d-b5dd3e50de7d">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib094ccbcf5d544e9803960dda6b5c3f0_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTItNS0xLTEtMTgwMzY_90e4bf5c-2d06-4467-bc7d-8f55ef59a2c2">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97a926ad86c54867989a14b026bd3593_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTItNy0xLTEtMTgwMzY_d6a82e1a-9521-437a-9523-e4b860c3a2c4">53.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTMtMS0xLTEtMTgwMzY_d2714997-beef-43ba-bf22-b4addc0af5fd">299.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTMtMy0xLTEtMTgwMzY_37712a28-9b85-47f5-b03e-5f99bf2d4fa6">638.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTMtNS0xLTEtMTgwMzY_1cd4fdca-e8a3-4bd9-87a6-21e9be877a0a">851.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTMtNy0xLTEtMTgwMzY_6ecbca7e-37dd-4e5d-8a92-f10f54f92b7f">743.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC Topic 606, Revenue from Contracts with Customers (&#8220;Topic 606&#8221;), an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company performs its obligation under a contract with a customer by processing diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. The Company has the right to bill its customers upon the completion of performance obligations and thus does not record contract assets.&#160;Occasionally customers make payments prior to the Company's performance of its contractual obligations.&#160;When this occurs, the Company records a contract liability as deferred revenue. During the fiscal year ended June 30, 2020, the Company received approximately $<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="mygn:CARESActOf2020MedicarePaymentAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTE1ODQ_685f1bfb-b736-4307-8fc2-005f9ab9e9a1">29.7</ix:nonFraction> million in advance Medicare payments as part of the CARES Act, which was enacted on March 27, 2020 to provide relief from the economic impacts of COVID-19. Repayment of the advanced Medicare payments begins April 2021. The advance Medicare payments are included in prepayments of deferred revenue for the fiscal year ended June 30, 2020 and in the beginning and ending balance of deferred revenue for the transition period ended December 31, 2020. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc3MDA_4d4aa3bd-e702-413a-a633-616a56864a1b" continuedAt="i52ff5fc53b66433198fd2e6c00570406" escape="true">A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt"><ix:continuation id="i52ff5fc53b66433198fd2e6c00570406"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:60.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMi0xLTEtMS04ODc_74ef5a5b-feca-449e-ae70-87f01f011730">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMi0xLTEtMS0w_066a45f7-53c0-4d33-815a-b4c9572cc571">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMi0zLTEtMS0w_6f81c4a9-6283-4f60-8c5d-77e7cedc51fc">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMy0xLTEtMS04ODc_9b154929-8ba0-4dcc-b4ab-a5b04d2a0305">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMy0xLTEtMS0w_e858c6e2-d225-41ef-be2a-39a5a57ef90f">7.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMy0zLTEtMS0w_a8d7ee83-2cf9-43cf-bbfc-bed382832c6a">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="mygn:ContractWithCustomerLiabilityPrepayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNC0xLTEtMS04OTI_a64ad7a5-3cc9-483a-b09a-2d52b8a7186a">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:ContractWithCustomerLiabilityPrepayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNC0xLTEtMS0w_3310b7e1-15ed-4cc8-a4e4-a6c50cfc4cd5">37.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:ContractWithCustomerLiabilityPrepayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNC0zLTEtMS0w_6b498700-8bb5-44e4-b26c-3e154c362ae7">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNS0xLTEtMS04OTI_c36113d1-5392-4393-a764-d25cc9ad010b">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNS0xLTEtMS0w_fdb21b39-9d8a-4b5d-98e1-7c84920f49e7">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNS0zLTEtMS0w_9b2ffb90-c1c1-4f78-9134-143b72b6cdc7">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 606, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#8217;s right to payment is in an amount that directly corresponds with the value of Company&#8217;s performance to date. However, periodically, the Company enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations. As of December&#160;31, 2020, the aggregate amount of the transaction price of such contracts that is allocated to the remaining performance obligations is $<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTI0OTc_66b8905a-14ca-4dc1-b0b8-a120e466188c">11.2</ix:nonFraction> million.</span></div></ix:continuation></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="if4f7539890d147f585b377559f0cebc5" continuedAt="i6c59c2d86d4b431487cc0631a5e2b550"><ix:continuation id="ib1d329c8f05c4b93a5121b3d8f652ef5"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the transaction price, Myriad includes an estimate of the expected amount of consideration as revenue. The Company applies this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled. An estimate of transaction price does not include any estimated amount of variable consideration that are constrained. In addition, the Company considers all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. In determining the expected value, the Company considers the probability of the variable consideration for each possible scenario. The Company also has significant experience with historical discount patterns and uses this experience to estimate transaction prices. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimate of revenue is affected by assumptions in payor behavior such as changes in payor mix, payor collections, current customer contractual requirements, and experience with collections from third-party payors. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in Accrued liabilities in the Consolidated Balance Sheets in anticipation of request for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the Consolidated Statements of Operations and Comprehensive Income (Loss). </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash collections for certain diagnostic tests delivered may differ from rates originally estimated, primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third party payors. As a result of this new information, the Company updates its estimate of the amounts to be recognized for previously delivered tests. During the transition period ended December 31, 2020, and fiscal year ended June 30, 2019 and 2018, the impact to revenue and earnings (loss) per share, for tests in which the performance obligation of delivering the test results was met in the prior period was immaterial. During the fiscal year ended June 30, 2020, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTQzNjk_00631f0d-d98b-4322-9c2e-c44702322e84">9.9</ix:nonFraction> million decrease in revenue, which resulted in a $(<ix:nonFraction unitRef="usdPerShare" contextRef="i04423ea583664800b488265dcd960706_D20190701-20200630" decimals="2" sign="-" name="mygn:IncreaseDecreaseInEarningsLossPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTQ1MDA_f45bc95b-594d-4d65-b4ec-17df145d17f8">0.10</ix:nonFraction>) impact to earnings (loss) per share for tests in which the performance obligation of delivering the tests results was met in prior periods. The changes were primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third-party payors. In addition, during the fiscal year ended June 30, 2020, the Company identified an error related to prior periods for Medicare claims and has reduced revenue and recorded an accrued liability for a total of $<ix:nonFraction unitRef="usd" contextRef="i034631d7d5ef4b7c8d6d34aca4620ab5_D20190701-20200630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTUxMjE_33c95b39-fe28-495a-8cda-8877e9c21f32"><ix:nonFraction unitRef="usd" contextRef="iabcdc79361b245d5916d394962a748d5_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTUxMjE_97351117-722d-45e1-ac4f-da6d1f8809f7">4.7</ix:nonFraction></ix:nonFraction> million that will be refunded to Medicare. The impact of correcting the error during that period and the impact to all prior periods was concluded to be immaterial. The correction of the error in the fiscal year ended June 30, 2020 resulted in an impact to earnings (loss) per share for the fiscal year ended June 30, 2020 of $(<ix:nonFraction unitRef="usdPerShare" contextRef="i05d1b3e5218742268c6886435321836a_D20190701-20200630" decimals="2" sign="-" name="mygn:IncreaseDecreaseInEarningsLossPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTU0MDI_196a6289-3557-4a36-a8b4-7fbc32d0224c">0.05</ix:nonFraction>).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 606, the Company has elected to exclude from the measurement of transaction price, all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer for e.g. sales tax, value added tax etc.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to apply the practical expedient related to costs to obtain or fulfill a contract since the amortization period for such costs will be one year or less. Accordingly, <ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CapitalizedContractCostGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTU2MTA_5b40ebb9-9386-42f5-b848-585a7a458d37">no</ix:nonFraction> costs incurred to obtain or fulfill a contract have been capitalized. The Company has also elected to apply the practical expedient for not adjusting revenue recognized for the effects of the time value of money. This practical expedient has been elected because the Company collects very little cash from customers under payment terms and vast majority of payments terms have a payback period of less than one year.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODE_68cd7372-7588-4f9f-b47f-98966eb03cd9" escape="true"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based payment expense</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the fair value compensation cost relating to share-based payment transactions in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718, Compensation &#8211; Stock Compensation. Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#8217;s requisite service period, which is generally the vesting period. The fair value of restricted stock units (RSUs) is based on the number of shares granted and the quoted price of the Company&#8217;s common stock on the grant date. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. The fair value of shares issued under the Employee Stock Purchase Plan is calculated using the Black-Scholes option-pricing model, based on assumptions including the risk-free interest rate, expected life, expected dividend yield and expected volatility. The average risk-free interest rate is determined using the U.S. Treasury rate. We determine the expected life based on offering period of the Employee Stock Purchase Plan. The expected volatility is determined using the weighted average of daily historical volatility of our stock price.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i6c59c2d86d4b431487cc0631a5e2b550" continuedAt="i41a534e9843c4c2f9498c21ee1297c85"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="mygn:OtherIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTE_53cc66e0-96f0-439b-a219-657256ed4050" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stimulus or grant payments that it receives that do not need to be paid back as other income. During the fiscal year ended June 30, 2020, the Company received approximately $<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="mygn:CARESActOf2020ProviderReliefFundAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTczODM_af61b1bf-e496-4286-a287-fa35ca32f34e">14.6</ix:nonFraction> million from the Provider Relief Fund under the CARES Act to reimburse the Company for health care related expenses or lost revenues that are attributable to COVID-19, which was recognized as a component of Other income in the Consolidated Statements of Operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTQ_41ebea64-51e2-4a04-9837-86e83161f537" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes income taxes under the asset and liability method. This approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes, including the effective tax rate and analysis of potential tax exposure items, if any, requires significant judgment and expertise in federal and state income tax laws, regulations and strategies, including the determination of deferred tax assets and liabilities and any estimated valuation allowances deemed necessary to recognize deferred tax assets at an amount that is more likely than not to be realized. The Company&#8217;s filings, including the positions taken therein, are subject to audit by various taxing authorities. While the Company believes it has provided adequately for its income tax liabilities in the consolidated financial statements, adverse determinations by these taxing authorities could have a material adverse effect on the consolidated financial condition, results of operations or cash flows.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODI_5806897d-2de2-4453-bd69-e0260e2f0ae7" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding.&#160;&#160;Diluted earnings per share is computed based on the weighted-average number of shares of common stock, including the dilutive effect of common stock equivalents, outstanding.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTI_a63d37ed-0d20-4e4e-b6a3-ca1e031bde99" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 16.75pt;text-indent:31.5pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding used to compute <br/>    basic EPS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfMy0xLTEtMS05NjA_d4f59644-2faf-4b50-b16c-5fd30646cd7d">75.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfMy0xLTEtMS0w_8a75366e-59ae-4410-9c0c-150e1c971de3">74.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfMy0zLTEtMS0w_e6e82918-763b-4044-b3c7-2b55e12af540">73.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfMy01LTEtMS0w_122d69d1-e09b-4d73-9a03-ba8a7d07c8f1">69.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive stock options</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNC0xLTEtMS05NjA_3834eeb5-4e53-459d-91a4-82749ee87f95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNC0xLTEtMS0w_edac5da7-e634-4ff8-9a3e-3060f3b3a7c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNC0zLTEtMS0w_10fc7802-ce60-4fc9-82ba-abf85647cc49">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNC01LTEtMS0w_7337f2cf-cac1-469c-83f2-a606b92c3d2a">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding and dilutive <br/>   securities used to compute diluted EPS</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNS0xLTEtMS05NjA_e6710d15-239d-4ec7-8deb-2c8ce5752db9">75.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNS0xLTEtMS0w_e6986756-459a-4732-aed3-f12ec66e8ad5">74.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNS0zLTEtMS0w_08f23e2d-e64f-40bb-bac3-59698b4ec8e7">76.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNS01LTEtMS0w_2e5d3b56-8bec-4fdd-9d42-5c34013a1d75">72.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain outstanding options and RSUs were excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODU_d364724a-7a7c-401a-93b1-7342bd340877" continuedAt="ib691d672a08c4b82bc8424482b8e9403" escape="true">These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:</ix:nonNumeric></span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><ix:continuation id="ib691d672a08c4b82bc8424482b8e9403"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-dilutive options and RSUs excluded from EPS computation</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmQ3ZWYwNGU0YTk3ZjRhYTc4NWJkN2VkM2IwODZlYzZkL3RhYmxlcmFuZ2U6ZDdlZjA0ZTRhOTdmNGFhNzg1YmQ3ZWQzYjA4NmVjNmRfMi0xLTEtMS05NjU_6a4bbdad-c330-44da-b414-c7f991e7f5f9">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmQ3ZWYwNGU0YTk3ZjRhYTc4NWJkN2VkM2IwODZlYzZkL3RhYmxlcmFuZ2U6ZDdlZjA0ZTRhOTdmNGFhNzg1YmQ3ZWQzYjA4NmVjNmRfMi0xLTEtMS0w_6da6b7fb-1c4b-483e-b760-1a1474b13f1c">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmQ3ZWYwNGU0YTk3ZjRhYTc4NWJkN2VkM2IwODZlYzZkL3RhYmxlcmFuZ2U6ZDdlZjA0ZTRhOTdmNGFhNzg1YmQ3ZWQzYjA4NmVjNmRfMi0zLTEtMS0w_5b90d289-9d34-4877-a600-a25b402780a3">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmQ3ZWYwNGU0YTk3ZjRhYTc4NWJkN2VkM2IwODZlYzZkL3RhYmxlcmFuZ2U6ZDdlZjA0ZTRhOTdmNGFhNzg1YmQ3ZWQzYjA4NmVjNmRfMi01LTEtMS0w_7dfa6520-7ce5-4729-9261-9b1521754673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i41a534e9843c4c2f9498c21ee1297c85"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTU_ba2b31ba-b9b4-4bca-90dc-c645b7e7463b" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of the Company&#8217;s international subsidiaries is the local currency. For those subsidiaries, expenses denominated in the functional currency are translated into U.S. dollars using average exchange rates in effect during the period and assets and liabilities are translated using period-end exchange rates. The foreign currency translation adjustments are included in Accumulated other comprehensive income (loss) as a separate component of Stockholders&#8217; equity.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODY_f6255955-0eac-44a5-b48c-d0f2d4447afb" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the cumulative translation adjustments included in Accumulated other comprehensive income (loss) (in millions):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:86.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance June 30, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmY3MmZjM2Y4NWYxNzRlMWY5Y2I5MjBmNjJjMWNjNTY3L3RhYmxlcmFuZ2U6ZjcyZmMzZjg1ZjE3NGUxZjljYjkyMGY2MmMxY2M1NjdfMy0xLTEtMS0w_33732dea-12c7-4eb0-aa80-9290ad0c3324">6.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmY3MmZjM2Y4NWYxNzRlMWY5Y2I5MjBmNjJjMWNjNTY3L3RhYmxlcmFuZ2U6ZjcyZmMzZjg1ZjE3NGUxZjljYjkyMGY2MmMxY2M1NjdfNC0xLTEtMS05ODA_a62496aa-0f87-4fa9-9d2e-7568d7c09dbe">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="mygn:OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmY3MmZjM2Y4NWYxNzRlMWY5Y2I5MjBmNjJjMWNjNTY3L3RhYmxlcmFuZ2U6ZjcyZmMzZjg1ZjE3NGUxZjljYjkyMGY2MmMxY2M1NjdfMi0xLTEtMS0xNzk2OA_9608b4ee-485b-4373-a297-3bd3fe0e05ad">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmY3MmZjM2Y4NWYxNzRlMWY5Y2I5MjBmNjJjMWNjNTY3L3RhYmxlcmFuZ2U6ZjcyZmMzZjg1ZjE3NGUxZjljYjkyMGY2MmMxY2M1NjdfNi0xLTEtMS05ODA_eb70262f-1c39-4881-b9e4-2bb5fa6e1085">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTE1NDQ4NzIxNTAwOTM_08daa358-4ccf-4b58-9b0f-f35a8d1b4336" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders' equity, cash flows from operations, or net loss for the period.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTM_0a9131c2-bbd7-4217-88bd-71e3762c18bf" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Effective in Future Years and Not Yet Adopted</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for public companies with fiscal years beginning after December 15, 2020, with early adoption permitted. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Recently Adopted Standards</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326) (&#8220;ASU 2016-13&#8221;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.  </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, Intangibles &#8211; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU 2018-15&#8221;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of Other assets in the Consolidated Balance Sheets.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzYxNA_deaeb740-de07-4cd8-a5f3-a30e2fbf752c" continuedAt="i2da829dc282f4cd4b1ecaf7570abbd2e" escape="true">MARKETABLE INVESTMENT SECURITIES</ix:nonNumeric></span></div><ix:continuation id="i2da829dc282f4cd4b1ecaf7570abbd2e" continuedAt="i146cf40b753245dabd2b8a69526df368"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzYxNQ_0cc01332-db3a-4d8f-a11c-b2762b5858b4" continuedAt="iaa916be068954561aadf89833a4202dd" escape="true"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value debt securities classified as available-for-sale securities by major security type and class of security at December&#160;31, 2020, June&#160;30, 2020 and June 30, 2019 were as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:48.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzMtMS0xLTEtNDU1MQ_24dfd956-e0d9-4dd6-a02b-f6c8012bfdb5">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzMtNy0xLTEtNDU1MQ_44f36d90-c886-4ede-9783-701559bd48a1">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2974f743032d446b86850b246d3a169c_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzQtMS0xLTEtNDU1MQ_f6b9f40b-1fca-4817-818f-9e9cb5bc240f">69.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2974f743032d446b86850b246d3a169c_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzQtNy0xLTEtNDU1MQ_74012bfd-97ab-4dec-95af-fa49f99fcac9">69.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzUtMS0xLTEtNDU1MQ_aed3dd4b-471d-4c7f-a500-9a72defb564e">117.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzUtNy0xLTEtNDU1MQ_d2eb19af-e332-4374-8caa-f651bfd7bf4a">117.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzctMS0xLTEtNDU1MQ_b3a09d0c-ae1a-4d1a-a1bb-1d921aa3abb4">28.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzctMy0xLTEtNDU1MQ_b0395eba-72de-47f2-8499-4f203d495a69">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzctNS0xLTEtNDU1MQ_14757e5f-b889-498e-9a35-ecabf8d828d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzctNy0xLTEtNDU1MQ_7736a7e6-5d41-407f-a322-b52b992f8093">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzgtMS0xLTEtNDU1MQ_4d95e932-284a-46d2-981f-e610858f14e3">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzgtMy0xLTEtNDU1MQ_a65484ed-3aba-4627-8292-64da24b46a77">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzgtNS0xLTEtNDU1MQ_3d1ad79a-d542-466d-a9e2-a2008a978ae1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzgtNy0xLTEtNDU1MQ_f62f9b61-8534-4a90-8beb-c85b5a3ae53a">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzktMS0xLTEtNDU1MQ_72a493ac-0303-48de-93ee-b8f84676ca78">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzktMy0xLTEtNDU1MQ_c47fe23a-a45a-45d7-a977-74beb7e6f6b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzktNS0xLTEtNDU1MQ_97e4d733-a129-49f1-98c9-7d801228dbed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzktNy0xLTEtNDU1MQ_df22a483-847c-4966-9db6-684ffb28f8b3">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzEwLTEtMS0xLTQ1NTE_90dfa2cd-b58c-45a5-9aca-44c0fa16af4d">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzEwLTMtMS0xLTQ1NTE_2c8a3247-afb0-4983-904b-d481ac454f36">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzEwLTUtMS0xLTQ1NTE_b1ecafc7-94c5-4355-9e7d-196680ab46d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzEwLTctMS0xLTQ1NTE_f9d07daa-3999-4df5-8557-97ae425a1736">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:InvestmentsAndCashAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzExLTEtMS0xLTQ1NTE_9a876f05-e01d-484d-a9b1-55b4cd37d122">170.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzExLTMtMS0xLTQ1NTE_7fd646ec-e090-4c22-b0cf-ead210e67909">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzExLTUtMS0xLTQ1NTE_1e1014c3-7383-4d63-9f1c-9df088f78493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:InvestmentsAndCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzExLTctMS0xLTQ1NTE_5b07ef0f-7757-45d0-93c1-54d7e6ceddcf">171.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:47.676%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a64b6a9eaf445c8e78ea7644ec0770_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzMtMS0xLTEtMA_ff90288b-ce95-4a99-b75b-c6fe5a7d4a61">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a64b6a9eaf445c8e78ea7644ec0770_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzMtNy0xLTEtMA_d1ba2367-de92-49f9-88d8-6da2c3f09aae">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013cb277d59546beb41c64814afb77eb_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzQtMS0xLTEtMA_da43f144-87a9-4888-9a78-2756486b00a7">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013cb277d59546beb41c64814afb77eb_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzQtNy0xLTEtMA_8d2f892e-6b77-4152-8b05-ea1845b513cb">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzUtMS0xLTEtMA_e7b5de75-ee05-4bb9-b65a-33a5501820c2">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzUtNy0xLTEtMA_a56ac17e-28b0-40d8-b467-d5ef54c18f7d">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzctMS0xLTEtMA_084e63d9-e8de-48d5-b608-8efae2f72807">50.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzctMy0xLTEtMA_12e1b722-0286-4ccc-9dbe-e7fa8da6f70e">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzctNS0xLTEtMA_29479800-55ce-4327-a770-b120c157d45f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzctNy0xLTEtMA_1eeb24de-918f-4733-972c-22510ed9b4ee">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzgtMS0xLTEtMA_d492e263-71c7-43d8-9657-b918aeafdd78">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzgtMy0xLTEtMA_e6216e47-64a2-4f00-a3f8-585f004f1d3f">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzgtNS0xLTEtMA_a963cdcb-bae8-457e-a529-9b3f448b83e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzgtNy0xLTEtMA_8347d8db-a8f3-428b-bc2f-368140f343a5">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzktMS0xLTEtMA_9268a977-7905-4e07-9312-2121fa17abe0">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzktMy0xLTEtMA_2bca4bb5-1a5a-4ede-9f02-e8b02f0f6b88">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzktNS0xLTEtMA_3047ca14-ab5c-40f9-aec0-7abf20ee3b6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzktNy0xLTEtMA_9b681ec6-aa04-4420-ba4e-9f2ee35dea25">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzEwLTEtMS0xLTA_a9cf1b99-f770-4040-98dc-5f945eb5a0ca">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzEwLTMtMS0xLTA_691b04ff-9c3e-4c89-b893-abb2e8dcbf47">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzEwLTUtMS0xLTA_1fee252d-c137-4abb-b0ad-7ddbe0ffdde2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzEwLTctMS0xLTA_f45d8ea0-8cf1-4d9a-a7dc-477e806de992">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="mygn:InvestmentsAndCashAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzExLTEtMS0xLTA_2518d249-4292-4ad1-aeb6-dc5e6a665024">253.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzExLTMtMS0xLTA_510f40f0-acf0-478c-9b2e-709adb93ff22">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzExLTUtMS0xLTA_9d85284f-930c-4fcb-b5f6-1cc378b743dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:InvestmentsAndCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzExLTctMS0xLTA_f6d1ebcd-7620-4a8c-9208-b6d03e536cfa">254.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i146cf40b753245dabd2b8a69526df368"><div style="padding-left:36pt;text-align:justify"><ix:continuation id="iaa916be068954561aadf89833a4202dd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"></td><td style="width:47.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb4f19b39fa4edcb9b9756b242e799d_I20190630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzMtMS0xLTEtMA_a39d8c6b-fa23-4f94-849c-bfce4c0ff215">68.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb4f19b39fa4edcb9b9756b242e799d_I20190630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzMtNy0xLTEtMA_52fb6731-7d44-43d5-91f0-eb12e1f25fe1">68.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3637c2bf3c6e4176a82ad149102c6280_I20190630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzQtMS0xLTEtMA_7a6c25ce-7291-48ec-b843-3c80ddce237a">24.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3637c2bf3c6e4176a82ad149102c6280_I20190630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzQtNy0xLTEtMA_babbf3d8-ef34-4420-80a3-1055adfb42c6">24.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzUtMS0xLTEtMA_892d7218-651c-482e-baf6-e6b7d6d54319">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzUtNy0xLTEtMA_b34aea59-18a5-4008-b36b-96fc3f217b80">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzctMS0xLTEtMA_755f2715-b23b-4ec6-8414-cd3871b39583">64.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzctMy0xLTEtMA_cacc8ebe-f420-46ac-beda-464dbb7fc64d">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzctNS0xLTEtMA_a84cf949-ae1a-42ab-8d9e-56b5b1d0e8b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzctNy0xLTEtMA_7d0b8929-1e08-4679-b496-67b6515fbc7b">64.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828a886282af459f9e614c44191e6917_I20190630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzgtMS0xLTEtMA_04e80755-f57d-4c43-b980-c35bbf14288e">15.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828a886282af459f9e614c44191e6917_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzgtMy0xLTEtMA_24fa6ecb-9f43-48a2-a632-868765c21cad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828a886282af459f9e614c44191e6917_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzgtNS0xLTEtMA_afaf223f-4cf8-4f22-a9df-94d65cfe5c19">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828a886282af459f9e614c44191e6917_I20190630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzgtNy0xLTEtMA_6bde0c9b-4186-4a54-aabf-2ca7bb6535b1">15.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ebf87daee4405886567face5312f8a_I20190630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzktMS0xLTEtMA_b1cc9302-f2a2-4d38-9385-e1544f05359f">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ebf87daee4405886567face5312f8a_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzktMy0xLTEtMA_cd3cf339-f984-4767-8d96-635efad1f9cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ebf87daee4405886567face5312f8a_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzktNS0xLTEtMA_54ac87ab-8cc2-4a57-8eb4-a2832c2b2d58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ebf87daee4405886567face5312f8a_I20190630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzktNy0xLTEtMA_88c3ca4e-4817-4c77-99a2-638048b6e33e">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzEwLTEtMS0xLTA_96875349-9374-4817-b866-1766a15d07c6">9.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzEwLTMtMS0xLTA_59834c90-4f9b-4009-821c-5c5a2b2c4e3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzEwLTUtMS0xLTA_f316dd28-c88b-453f-baf2-a9d878f63001">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzEwLTctMS0xLTA_077442ae-9b61-4b16-a6f1-f96a382863a8">9.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="mygn:InvestmentsAndCashAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzExLTEtMS0xLTA_18c80420-0bf0-4b75-81fc-f85aac0123ae">191.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzExLTMtMS0xLTA_9b705beb-2625-4fbe-841e-aa4609f09109">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzExLTUtMS0xLTA_05aee9e7-045d-42e1-815e-40840e4a4a78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:InvestmentsAndCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzExLTctMS0xLTA_2134a779-b755-41a3-8913-6d246c11e89a">191.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzYxNg_230d6efc-8545-46be-9287-9592f419577e" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and maturities of debt securities classified as available-for-sale are as follows at December&#160;31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"></td><td style="width:73.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzEtMS0xLTEtMA_a8079e53-6b6e-4284-bea3-2b8b679a5ce2">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzEtMy0xLTEtMA_512a9564-c1a4-434f-94ed-856a9ec30502">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2974f743032d446b86850b246d3a169c_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzItMS0xLTEtMA_c38f6a9a-7463-46ea-8884-a8936f0b0f7b">69.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2974f743032d446b86850b246d3a169c_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzItMy0xLTEtMA_b4119d53-a587-49d2-89e5-380d757e6a36">69.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzQtMS0xLTEtMA_b4f3ee57-bfa1-49be-af45-3febc46558bb">33.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzQtMy0xLTEtMA_50054e55-49c7-49b9-b13a-a4c475260df8">33.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzUtMS0xLTEtMA_59f81e6e-82ff-435a-acc8-1630a3ffaee7">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzUtMy0xLTEtMA_23ce707d-2c94-406c-8a53-936c9ce9c6bf">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzYtMS0xLTEtMA_99f2fcaf-f806-4059-8f31-513235c042c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzYtMy0xLTEtMA_d8a7e614-dfa3-45b6-851f-1c3564e5ff92">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:InvestmentsAndCashAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzctMS0xLTEtMA_b4a6bc70-fd25-473f-8d5b-2084a3d55bed">170.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:InvestmentsAndCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzctMy0xLTEtMA_029092e6-ce0f-4350-948a-1902431a40e0">171.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="security" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzQwNg_849b04eb-d7eb-4c49-b0d4-04a7749b0ac4"><ix:nonFraction unitRef="security" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzQwNg_d7910e78-e065-4b36-8ddb-a138f82ec8f7"><ix:nonFraction unitRef="security" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzQwNg_f3b08a04-9051-4b09-b090-8a06d1723224">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> debt securities classified as available-for-sale in a gross unrealized loss position as of December&#160;31, 2020, June&#160;30, 2020 or June 30, 2019.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information relating to fair value of marketable investment securities can be found in Note 3.</span></div></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_109"></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzQ0ODE_99baa2a6-352c-4e20-a386-19359659edec" continuedAt="i25fccef0bafe4d02bba452c9a784d68f" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i25fccef0bafe4d02bba452c9a784d68f" continuedAt="ibab3dfc4df934349901b927aa8298801"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s financial instruments reflects the amounts that the Company estimates to receive in connection with the sale of an asset or paid in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1&#8212;quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2&#8212; observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&#160;&#160;Some of the Company&#8217;s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#8212;unobservable inputs.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="ibab3dfc4df934349901b927aa8298801" continuedAt="i5243f56e489b481187699b5112d8f9da"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s financial instruments are valued using quoted prices in active markets or based on other observable inputs.&#160;&#160;For Level 2 securities, the Company uses a third-party pricing service which provides documentation on an ongoing basis that includes, among other things, pricing information with respect to reference data, methodology, inputs summarized by asset class, pricing application and corroborative information.&#160;&#160;For Level 3 contingent consideration, the Company reassesses the fair value of expected contingent consideration and the corresponding liability each reporting period using the Monte Carlo Method, which is consistent with the initial measurement of the expected earn out liability.&#160;&#160;This fair value measurement is considered a Level 3 measurement because the Company estimates projections during the earn out period of approximately <ix:nonNumeric contextRef="ia8a8fb4d167d466eb4a4cce37a8e2b4e_D20200701-20201231" format="ixt-sec:duryear" name="mygn:BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzEzNzQzODk1MzUzMTEz_6a11cdf6-f04c-4996-8b72-0bc0c5fc9da9">14.5</ix:nonNumeric> years utilizing various potential pay-out scenarios.&#160;&#160;Probabilities were applied to each potential scenario and the resulting values were discounted using a rate that considers weighted average cost of capital as well as a specific risk premium associated with the riskiness of the earn out itself, the related projections, and the overall business.&#160;&#160;The contingent consideration liabilities are classified as a component of long-term and short-term contingent consideration in the Company&#8217;s Consolidated Balance Sheets.&#160;Changes to the contingent consideration liabilities are reflected in Change in the fair value of contingent consideration in our Consolidated Statements of Operations. Changes to the unobservable inputs could have a material impact on the Company&#8217;s financial statements.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term debt, which we consider a Level 3 measurement, is estimated using discounted cash flow analyses, based on the Company&#8217;s current estimated incremental borrowing rates for similar borrowing arrangements.&#160;&#160;The fair value of long-term debt is estimated to be $<ix:nonFraction unitRef="usd" contextRef="i931f10a967bd4961a4edc7f16b906bfd_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzM4NDgyOTA3MDE5NzI_a0883e33-e0b6-4afb-b8c3-25e414676e9b">225.8</ix:nonFraction> million at December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i896a61f417824c539c7a8aaecb838a3c_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzMxNjQ_a9474f12-fd9b-4e41-9b20-861a5d57344f">225.5</ix:nonFraction> million at June&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i4a9f5109771b480db9fd53efad3cf0a0_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzMxNzc_e9eb4fa5-36b1-4642-b189-2c2f2c75633d">192.7</ix:nonFraction> million at June&#160;30, 2019.&#160;&#160;</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzQ0ODI_810ae423-094f-4277-a238-24c19bbac540" continuedAt="i095b89baedf5428f8136ebe05c6362c2" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the fair value of the Company&#8217;s financial assets and liabilities that are re-measured on a regular basis:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"><tr><td style="width:1.0%"></td><td style="width:48.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83200f7a7cb74ffb8132d4a54cb8fe09_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzItMS0xLTEtMTEwNQ_799cc883-4f5e-452e-a343-3c5beaffcafd">69.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c8d3889def46bf8964906a008e20a0_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzItMy0xLTEtMTEwNQ_975ea36c-c6a1-4e90-8060-5535e17021c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib838376273ee40509009d40b54ad4e6c_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzItNS0xLTEtMTEwNQ_040c69c8-9de7-40f7-8871-8b45660b9454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d419b15db0344df99a90536add6f225_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzItNy0xLTEtMTEwNQ_1c53f5fe-4e5e-46f8-b078-6683e9ddeef2">69.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6fd7e6971b43b1972bf113b61ed7ac_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzMtMS0xLTEtMTEwNQ_12a95124-ec24-44f9-818b-543b94392f04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488a249f7b4a42e39a29a4875e046abc_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzMtMy0xLTEtMTEwNQ_f97e7f9b-4741-48c3-84b7-a2d5aa608ce7">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a6d1096e6b24d2691f8c3c10e1db359_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzMtNS0xLTEtMTEwNQ_755ba968-58be-49e5-bb06-e0bc48b92567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzMtNy0xLTEtMTEwNQ_04d3fc2c-7a55-4d96-bf73-c628baed61c7">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8f4f7fa0654056a7679cd94f503372_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzQtMS0xLTEtMTEwNQ_53049d26-5c84-48ad-b982-0033d266a5d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd6bdb2356e42e79e270f09478ee175_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzQtMy0xLTEtMTEwNQ_2cc0801d-e47a-417b-8fcb-b1f2ca933e87">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i239bdbcee2ee46d7816c4aa9f59360cf_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzQtNS0xLTEtMTEwNQ_b0c519ef-ae5d-41f0-b47d-3d1076169e4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzQtNy0xLTEtMTEwNQ_0bf347e1-73c7-4789-b791-ddedf37bf58f">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e81c739fd94f7aa9cd55bdaa5d052f_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzUtMS0xLTEtMTEwNQ_2874a37b-d9f2-418e-b8fa-6a2b0309b5cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f0be353e5f417cbe7b3331221c88de_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzUtMy0xLTEtMTEwNQ_913068f1-eb17-47cc-a2a1-f14b22e2607b">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4dcb16a16b64061ab91c4bb405d02f4_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzUtNS0xLTEtMTEwNQ_f5752a05-04a4-44c8-ab98-7be39577c294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzUtNy0xLTEtMTEwNQ_4250943c-ae54-4a41-8a25-f8c402eb54e4">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bf9bccc1f74000bc926d84844d459f_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzYtMS0xLTEtMTEwNQ_a6023bfc-dcab-4eb6-a85e-664fd3f99c3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic516541272e1460189dd7d9460be5e00_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzYtMy0xLTEtMTEwNQ_aaa3ada0-1749-404c-98e2-bb9c1ee99e23">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7c5d5ea4d24bd5bc15c709de8583c8_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzYtNS0xLTEtMTEwNQ_7d63c13e-6c93-48ae-8cc5-a5233991bee4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzYtNy0xLTEtMTEwNQ_9f2762c4-323e-44a8-b656-18432ba5b78b">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d72cd70f074af99ccef915b106a5c7_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzctMS0xLTEtMTEwNQ_b5e0efab-575e-4f37-b8bf-8a046d383783">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a837ac64224a79a96732a4ab5ce550_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzctMy0xLTEtMTEwNQ_b544ceb6-d9c6-4c5a-9952-4e6dbde70a3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84dba07dc1964a8eaaa12c3e6bf3ac13_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzctNS0xLTEtMTEwNQ_d441c17e-68cc-4332-9f41-5a8c8461c23c">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a4dcb3d42434870ab26e0dc5985c286_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzctNy0xLTEtMTEwNQ_f904d792-ed5d-4d7e-88c3-bd37eb17cf14">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386c2dd77d7b42f1b542c00daa2a0722_I20201231" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzgtMS0xLTEtMTEwNQ_cdbef9b4-d0e1-4e36-a67f-6ca820ca7df4">69.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb92da4147d4f0aa235d0cbea519f7e_I20201231" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzgtMy0xLTEtMTEwNQ_4c41e346-c007-42c5-b6a6-7d3e1e8f115a">54.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i931f10a967bd4961a4edc7f16b906bfd_I20201231" decimals="-5" sign="-" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzgtNS0xLTEtMTEwNQ_d59e6db8-5a9e-4919-b8aa-fc149fdc3e53">10.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzgtNy0xLTEtMTEwNQ_0ba36485-b9e3-4404-a0bf-8384f6926695">112.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"><tr><td style="width:1.0%"></td><td style="width:48.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c3dd37fd2174277a0fe47e35a4fcb5a_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzItMS0xLTEtMA_478fd9f9-d7d5-47b1-b3f9-999cc5b69d2f">30.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1476418622484fd6b123b4bcc1a2cd75_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzItMy0xLTEtMA_31356195-dade-4855-89ed-7dfa24b370c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie82bd2619aee4c15a6f7979e3f556c90_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzItNS0xLTEtMA_e0c9568a-cf5a-4028-bde0-aa2a068dfede">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id29e6e511f214306bdfcc76ff6f3baac_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzItNy0xLTEtMA_a8d09fe2-6be4-49fd-b1b1-b0874c9dc32a">30.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd61fd98056c4fe8828fa4f7907744d5_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzMtMS0xLTEtMA_9286f4fd-02d1-4e63-beae-ab1ddefcd75d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825805b3de504095bdb13927c6069785_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzMtMy0xLTEtMA_d9b27d1b-7626-4fce-8274-f2462417c4d9">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3089884931004023a798595ad2485260_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzMtNS0xLTEtMA_aaec0972-086d-44c7-9351-1ebd9ae2fea8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzMtNy0xLTEtMA_fe8c030b-90be-44ce-b9b9-5b1563df6f6a">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2426bfb819934ac9a2b31c1f162f3528_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzQtMS0xLTEtMA_cc6234f2-7528-410b-897d-6eb0c0d561b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf88e0e27ffa4a739ee3847915ee542a_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzQtMy0xLTEtMA_c9befd19-1e49-4195-b0bc-86c7ca3678e6">18.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b0a8ffc8cf1459d84e87db58725f2de_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzQtNS0xLTEtMA_31f4c2fc-cf79-4335-89ec-c4a3ae4aea97">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzQtNy0xLTEtMA_e58e54a9-8a77-4462-beb0-e71857d52609">18.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc4eeb4c0edb43d59cd752375d0ffdc5_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzUtMS0xLTEtMA_b6d319f2-0e59-4781-a4b3-4d92a002daec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c10b20b0e9404abc88a8f6d54ce6bb_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzUtMy0xLTEtMA_76a97060-58d7-49c3-a488-00e04986f26d">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff6a96abc6e47a3a7673fe45b09702d_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzUtNS0xLTEtMA_1d5797b7-821a-4d1a-8556-056e4d67dff9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzUtNy0xLTEtMA_94a0abfb-d7e7-41a4-b8ae-ef0c4aca4799">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea094ed8a36e482dad6d4d4ce8912c5e_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzYtMS0xLTEtMA_42659877-a6e6-428d-b4d6-1fc84c23dca6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i418f1c63d800430dbdfe171f2e5fdb7b_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzYtMy0xLTEtMA_4faa3ce3-5478-4e8d-85f1-dc26b9509bae">16.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171eeb2ca4ff40c8aa59454fe0649995_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzYtNS0xLTEtMA_5c0ae356-dfa7-4dd7-ba23-5dc67f99a7b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzYtNy0xLTEtMA_4e9e9595-6219-4f34-9250-9fed0154b4f6">16.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae043b92111d49dea53104af438cae87_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzctMS0xLTEtMA_fae57ba6-d6fc-4dc3-8cd2-2f8c8c7f2baf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43dfaf6a69a9448dbeaad8511ca6599f_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzctMy0xLTEtMA_86454153-b8b8-438c-a018-d6493f803c35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i727b4cea45e840c595ed4071c0efc30f_I20200630" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzctNS0xLTEtMA_5f8ed9db-bd62-4efb-8886-216bdac9c836">6.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bbcb194e016455ca224904b253aff7e_I20200630" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzctNy0xLTEtMA_462d8152-11bf-449a-8062-09b4c94378f1">6.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i627dc77dc581425492e6a2efc7a71b6a_I20200630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzgtMS0xLTEtMA_a13174eb-b9d6-46cf-b24b-453b99c61a53">30.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1779215bab2443df9518c0d760bd4097_I20200630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzgtMy0xLTEtMA_c6a36c2d-73af-4802-a63a-f3d541fd0650">91.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i896a61f417824c539c7a8aaecb838a3c_I20200630" decimals="-5" sign="-" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzgtNS0xLTEtMA_ed0946f2-7853-49a4-a187-4a3ef4d90436">6.8</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzgtNy0xLTEtMA_03548655-965b-4498-9ef6-aa8ac88fed75">115.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i5243f56e489b481187699b5112d8f9da"><ix:continuation id="i095b89baedf5428f8136ebe05c6362c2"><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:47.676%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb619380c1df42aca737476da470cd1b_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzItMS0xLTEtMA_a0e076fe-6c9b-4873-a070-ece77e4e17af">17.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f28be2e5f414109aa6edba56d928690_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzItMy0xLTEtMA_69331be7-c1c7-4a6c-a8b0-71d0f9aa53ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29fb3e347dc345cfba47e9db7ea6e116_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzItNS0xLTEtMA_ade5efb9-e37c-48f7-8360-9f68f78879d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28101a6be104f06a27d6e814b1c6d6c_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzItNy0xLTEtMA_73581cdd-b922-4324-915b-4459ca03f4db">17.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d425a4039143e3bb5d1b13ef3c1d5f_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzMtMS0xLTEtMA_01b32532-2e3a-41af-9f81-c0e5f4892dcc">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5905013aeeb4f2cb39823bb0b2d36dd_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzMtMy0xLTEtMA_9f0b1142-927c-4a1b-b33b-58af56890016">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3993179bb8cd412da2e86291f6b169ba_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzMtNS0xLTEtMA_ca33b6ce-595b-4d1a-aada-21ac52cea6b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzMtNy0xLTEtMA_26a653a2-6141-4f9a-80a2-fcd0b98e9724">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6271e87a89724d4d97a244263fb2044b_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzQtMS0xLTEtMA_8123f3ca-2bb4-44c9-980b-22f604d15fbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i004fd5a8f7654961a111888fd81ed882_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzQtMy0xLTEtMA_83896819-5bf4-4273-8f20-50ae3653f0d1">15.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5590cd4c08ee46cc806334b73e196d71_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzQtNS0xLTEtMA_ad7eb2d6-5cc5-4489-a2cd-d3ca27e33821">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828a886282af459f9e614c44191e6917_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzQtNy0xLTEtMA_ec7dcc9b-4f32-4f3a-957b-eea3cec0ccd6">15.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e485d31ad9f497993d65a0f26c27664_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzUtMS0xLTEtMA_067e4220-ddc6-4ecb-a64a-eeb0bcf9fde4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6992e3c7faab476d8c03869ab63ff121_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzUtMy0xLTEtMA_a20e2125-833b-4be6-9e0d-ab9f353a55ac">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148159c157ef42c8a13aff97edbcbef2_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzUtNS0xLTEtMA_73fa02b4-3bbb-435c-80f7-18c1189aa733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ebf87daee4405886567face5312f8a_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzUtNy0xLTEtMA_b1ae81d4-ae99-4e19-8804-ae1b317bde64">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8191d090ea2745db981907ddafd93a9d_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzYtMS0xLTEtMA_813ebf70-cd09-4335-b2d4-77bf95e41f43">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa2f364539a64eaaa92b3b40cb82a18d_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzYtMy0xLTEtMA_fc24605e-d7d1-4283-ad91-114c3ddad50c">9.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979b5982652c43468a70262328a06272_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzYtNS0xLTEtMA_9a2614ba-3933-49f6-b264-8a9bfc38107e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzYtNy0xLTEtMA_3fb96368-e4c2-4c10-aff8-36358d8def62">9.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23f0bb6109514d5090ecfde3255f9f3d_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzctMS0xLTEtMA_6c33f77d-a252-450f-8990-2889815162a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15149e8fedda4395b8646b2382f7a984_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzctMy0xLTEtMA_977d5b5b-2cac-47cc-a3e8-ed736660efd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5746fc0bcf194215abbb27e272d355fa_I20190630" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzctNS0xLTEtMA_7756a708-9f2b-425b-8fbf-0c1cd9b564ad">13.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfa550eed64f4c2ea0f18c17f0902c9f_I20190630" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzctNy0xLTEtMA_f65eef00-080c-46d1-9ae4-b365655719dd">13.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb748777a421482d8700ebe22fb9d4ee_I20190630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzgtMS0xLTEtMA_b9f1c09f-793d-4b09-960e-57b68f7cd0d2">19.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c60fa1e6044f6e8667dcbf536b76df_I20190630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzgtMy0xLTEtMA_cb6a911d-bb27-4998-bc18-40faf228425e">98.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9f5109771b480db9fd53efad3cf0a0_I20190630" decimals="-5" sign="-" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzgtNS0xLTEtMA_3432ca5c-c247-434b-9116-0f847af6e5c2">13.8</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzgtNy0xLTEtMA_6f308ad0-8784-4201-b4c5-ea20e8ab5e21">104.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.03pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzQ0ODM_fd7d2f6a-432e-4334-bd6c-5e602af0e4ed" escape="true"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the change in the fair value of the contingent consideration during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"></td><td style="width:61.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount at beginning of period</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzEtMS0xLTEtMA_ee0fa568-6ec1-4bdb-948a-7393ea364664">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzEtMy0xLTEtMTY3OTU_d472062a-1757-4b04-b1d2-777a9cbdf713">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzEtNS0xLTEtMTY3OTU_331e8db1-9c95-424d-b084-dabf273c7f41">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzItMS0xLTEtMA_851af1b2-e148-423f-a2d2-eb89bc393070">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzItMy0xLTEtMTY3OTU_a2024fe9-ebcf-415b-b891-b7e7abe1073c">3.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzItNS0xLTEtMTY3OTU_90386ec9-491b-4842-bd29-15a57b21192d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in the statement of operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzMtMS0xLTEtMA_657510ba-2fd4-4487-9b75-dafbf4f03cb3">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzMtMy0xLTEtMTY3OTU_37a8ad16-c74f-440a-a5a1-47d663df3852">2.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzMtNS0xLTEtMTY3OTU_34e9a32e-3a5b-4171-80b6-496c3d581e0c">1.1</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments recognized in other comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzQtMS0xLTEtMA_a89b0e6d-5575-469f-8ea5-3fc33042d36e">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzQtMy0xLTEtMTY3OTU_1ff33086-7cf2-4f73-9d9f-684f61be9b65">0.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzQtNS0xLTEtMTY3OTU_8f812037-9416-46ba-b517-dd07c5dd421f">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount at end of period</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzUtMS0xLTEtMA_e112c6e2-4733-4f10-8696-da65c7ee3609">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzUtMy0xLTEtMTY3OTU_d9ad7daa-c2d3-44c9-81ee-de8a3bce95fe">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzUtNS0xLTEtMTY3OTU_b788d7d1-d7e8-4584-9ddc-2e89f3dc0899">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ic01b255bce00439ba9380fc219eb70e1_115"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90ZXh0cmVnaW9uOjNmZWJhMWYwNTMyYzRhZjQ4MWYzMDVkN2JlMjA4ZjI5XzI4MQ_c8c32384-0c81-47eb-8237-7e85b24a8490" continuedAt="id611b9d051c440feb115f127e77b1334" escape="true">PROPERTY, PLANT AND EQUIPMENT, NET</ix:nonNumeric></span></div><ix:continuation id="id611b9d051c440feb115f127e77b1334"><div style="padding-left:36pt"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90ZXh0cmVnaW9uOjNmZWJhMWYwNTMyYzRhZjQ4MWYzMDVkN2JlMjA4ZjI5XzI4Mg_c78f5083-7de3-4961-8e16-1f5711cb1e1a" continuedAt="i107a347e6b2e47f38b9db475601e4376" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:60.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzItMS0xLTEtMTEyMg_10dd8c31-e1e8-4027-9296-029ccbe07954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzItMS0xLTEtMA_edcb2e1d-2d29-4189-8722-39bdf35080d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzItMy0xLTEtMA_a9f5507a-fcf8-48eb-b657-76cfd889b5d3">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzMtMS0xLTEtMTEyMg_780f1f2b-c38d-41f7-b045-3af9001e0f08">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzMtMS0xLTEtMA_897f4813-67d4-4c89-8a3d-714497795146">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzMtMy0xLTEtMA_d421e69f-f4b8-4bbc-b290-3438a03e8e44">18.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzQtMS0xLTEtMTEyMg_40e852b3-e17e-43b6-8243-ce84774d19a2">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzQtMS0xLTEtMA_2cc27a9e-1b6c-441f-a268-e995d869e6f7">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzQtMy0xLTEtMA_a801aca3-0da6-4fc1-b394-44b70fb8e658">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzUtMS0xLTEtMTEyMg_2643a9df-992b-4416-94c5-05e45e32cd08">117.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzUtMS0xLTEtMA_f325d55e-77da-4e19-a5b0-842cf6e0205b">112.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzUtMy0xLTEtMA_4459063f-5ae9-456e-b198-cb9d5f8a9951">117.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzYtMS0xLTEtMTEyMg_fd41999a-a00c-4392-a1b8-c8b7c67b0543">153.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzYtMS0xLTEtMA_b3465f09-d27b-4c17-b6d5-3efc429a2fc8">143.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzYtMy0xLTEtMA_bf112d83-efd5-42b9-ba45-2007b191f37c">169.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzctMS0xLTEtMTEyMg_8464b334-950f-48b2-9c1f-8906af006689">112.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzctMS0xLTEtMA_2830199b-ced1-44df-b587-b23f8f869336">106.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzctMy0xLTEtMA_c3e5fe60-c5c6-4fec-a68c-e298609dd312">111.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzgtMS0xLTEtMTEyMg_d0cd9243-6f60-4f33-97bb-3cb4772a468d">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzgtMS0xLTEtMA_f4c0afff-e8cf-45e7-af98-41086c6d5a71">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzgtMy0xLTEtMA_aef7b52e-e8c2-4f9e-a11a-0c64a51eec08">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June 30, 2020, the Company sold the Clinic resulting in the deconsolidation of $<ix:nonFraction unitRef="usd" contextRef="i575f18ab83bc40979444ed5ab8404853_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentDisposals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90ZXh0cmVnaW9uOjNmZWJhMWYwNTMyYzRhZjQ4MWYzMDVkN2JlMjA4ZjI5XzE1NQ_2adffd66-d2f3-4b1b-8dfc-60174df99b9d">19.5</ix:nonFraction> million of the balance of property, plant and equipment. See Note 16 for additional information regarding the sale of the Clinic.</span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i107a347e6b2e47f38b9db475601e4376"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"></td><td style="width:47.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTpkNzQzYzY5ZDllZjc0NWZjOTQ4MGZlODFiMDJjOWNmNi90YWJsZXJhbmdlOmQ3NDNjNjlkOWVmNzQ1ZmM5NDgwZmU4MWIwMmM5Y2Y2XzItMS0xLTEtMTEyNw_f20c91d2-830f-46d3-b8d8-02bd2fc1ac17">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTpkNzQzYzY5ZDllZjc0NWZjOTQ4MGZlODFiMDJjOWNmNi90YWJsZXJhbmdlOmQ3NDNjNjlkOWVmNzQ1ZmM5NDgwZmU4MWIwMmM5Y2Y2XzItMS0xLTEtMA_16ac899b-f403-4fe8-a281-b4f0f37bda99">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTpkNzQzYzY5ZDllZjc0NWZjOTQ4MGZlODFiMDJjOWNmNi90YWJsZXJhbmdlOmQ3NDNjNjlkOWVmNzQ1ZmM5NDgwZmU4MWIwMmM5Y2Y2XzItMy0xLTEtMA_2c9fd57b-0dc2-4465-bcfb-8264e396eb14">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTpkNzQzYzY5ZDllZjc0NWZjOTQ4MGZlODFiMDJjOWNmNi90YWJsZXJhbmdlOmQ3NDNjNjlkOWVmNzQ1ZmM5NDgwZmU4MWIwMmM5Y2Y2XzItNS0xLTEtMA_120ab044-de3d-43a0-8a5f-f43b53d5dcff">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_118"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5ODY_257b765a-3c4e-42f5-97fc-da7fdb6c5e54" continuedAt="i11aeb2064e4343d08ffed7bed58bbd61" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i11aeb2064e4343d08ffed7bed58bbd61" continuedAt="ifa1e0cb66d9d46779182645f0e8b0684"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5ODc_952abbbc-a1f6-492c-bcd0-274ed141912d" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the transition period ended December&#160;31, 2020 are as follows: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:39.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ea1f91d8664913a4764506bfd207e4_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzMtMS0xLTEtNDkyNw_0dbea68b-ae7c-4aa3-8957-9aedb555d01f">270.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87ab67a6dd04168b8b70d5bdbae26ca_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzMtMy0xLTEtNDkyNA_4ee1d5e2-44e1-44d6-b83a-a661218475ea">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzMtNS0xLTEtNDkzMg_2a5fc10c-b25b-47a4-b314-464a38a0fa76">327.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0452133252384a1cbc2014d4918a6cae_D20200701-20201231" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzgtMS0xLTEtNDkyNw_693dde0a-43d0-46d2-8440-85c078d78f21">1.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6930cef02e60442f932a3ba59be2846f_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzgtMy0xLTEtNDkyNA_0b0322f0-0055-4ed6-92ed-615d57238a3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzgtNS0xLTEtNDkzMg_a3a76eea-b751-49a1-9f16-ebcf4d7149f5">1.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cbd1c604d9240fb9eab710d8047bbcb_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzktMS0xLTEtNDkyNw_81cd041e-40cb-4a92-8210-b8cde5711066">272.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf79e13bdaa84cbcb926eceecb0225f7_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzktMy0xLTEtNDkyNA_70915183-ab43-4cf4-8c11-8d8404837592">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzktNS0xLTEtNDkzMg_5c16ff9d-1649-4c7d-9ae8-41ef39ae58ca">329.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the fiscal years ended June 30, 2020 and 2019 are as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.877%"><tr><td style="width:1.0%"></td><td style="width:26.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib992d3be9ee24862b803ebce955a4939_I20190630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtMS0xLTEtMA_3175743c-1e7a-4ec8-aef0-b82df43d10bb">351.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe1dff6ed82241299a6565c84a2b4ad3_I20180630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtMy0xLTEtMA_5f25244f-7eac-492c-b3af-3fbb9dc0e942">252.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7293118ad87849e1979a9a4529ece677_I20190630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtNS0xLTEtMA_9998d421-b687-4f5d-ad99-2dafe0c5220b">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd030e591724771a7ef00c6278cee2c_I20180630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtNy0xLTEtMA_21518030-7817-4b35-9d36-9a28eb61b3bc">65.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtOS0xLTEtMA_a58c7aa5-7ab6-4b66-b3d3-ccf4e52f1cc8">417.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtMTEtMS0xLTA_e05b4647-0b5b-4564-a738-f50aef1368ea">318.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (see note 17)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtMS0xLTEtMA_22eecd1c-61e3-4275-bdfb-77cf862dff29">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtMy0xLTEtMA_69d2b4c6-bbb7-401d-bed3-f3176f55446e">94.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtNS0xLTEtMA_e9cc05dd-4cf8-4a69-b7b9-f1b1a1e33c7c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtNy0xLTEtMA_3aac09d2-ef9a-4fd3-920d-40017e018097">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtOS0xLTEtMA_e7bd5c53-f7ad-4614-b27c-c801caed2403">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtMTEtMS0xLTA_2f059d4b-65aa-4d1a-b964-9e81561ce012">94.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to acquisitions (see note 17)</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtMS0xLTEtMA_ff6e3814-b04f-4541-b58e-fceae92dea7d">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtMy0xLTEtMA_8722466f-c38e-491d-967d-85a9eb052cb4">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtNS0xLTEtMA_e2c9cfc5-52b9-4d24-a7d6-2e833be34128">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtNy0xLTEtMA_3d177d83-fe3e-4d2a-859f-048806cce03b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtOS0xLTEtMA_c924c411-9bbc-4577-b209-0beeb8426c31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtMTEtMS0xLTA_832e7208-4cc8-4519-976a-c31a2d1c462a">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill deconsolidated on sale of Clinic</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtMS0xLTEtMA_0eaac89b-1e79-470a-a750-3da949d697fe">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtMy0xLTEtMA_6c1d15db-b564-4d4b-afe6-e77cad8f5530">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630" decimals="-5" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtNS0xLTEtMA_fd3ec656-a62d-4d7f-8aa4-612edf905ea5">7.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtNy0xLTEtMA_86d28d1a-49d4-479e-a64f-34df6b6f483b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtOS0xLTEtMA_3169ca22-e81f-4a6c-8f31-59f84f707a41">7.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtMTEtMS0xLTA_a85d583c-3789-498c-8684-bbebc3baeb85">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctMS0xLTEtMA_c5399f2b-e0b0-4fb7-994d-4ad718031404">80.7</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctMy0xLTEtMA_3cb553cc-ecc9-46fb-b1d1-b835b61cc427">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctNS0xLTEtMA_08896b71-d85a-4b5f-b791-bdaa69e63bc8">1.3</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctNy0xLTEtMA_f4caf69f-661a-4535-8fc6-c530b3e8115c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctOS0xLTEtMA_5555fe2b-856f-46e0-a886-b849f2721bb8">82.0</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctMTEtMS0xLTA_1ed56975-ebc5-4ffe-afd3-b5db0fab8dd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtMS0xLTEtMA_97dc1d1e-c0bf-4f70-bce3-7142b409b0e0">0.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtMy0xLTEtMA_7bfd5f48-6d07-4f85-a495-4bbbfbcb254c">0.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtNS0xLTEtMA_2c45ee0b-7939-421b-be51-4859da6da241">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtNy0xLTEtMA_49cf46d1-3612-4670-bdbe-eb61684fe53b">0.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtOS0xLTEtMA_ad76ce31-3aa9-42c5-8d02-cbecd3a3348d">0.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtMTEtMS0xLTA_c43c7fec-be9c-4992-803a-b09661726f5e">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ea1f91d8664913a4764506bfd207e4_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktMS0xLTEtMA_f1e295f8-8219-4311-bf17-b15bfd883009">270.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib992d3be9ee24862b803ebce955a4939_I20190630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktMy0xLTEtMA_e6ca2597-f680-4b4e-b18f-5c634432c7bf">351.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87ab67a6dd04168b8b70d5bdbae26ca_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktNS0xLTEtMA_6e865128-b523-4a6c-823b-7b68ee9e58ac">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7293118ad87849e1979a9a4529ece677_I20190630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktNy0xLTEtMA_feffc1bf-af98-4c8a-a5df-2278f52b1bbf">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktOS0xLTEtMA_4c8f6a3c-e0de-4b2b-bcf8-0e9992ddd6a7">327.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktMTEtMS0xLTA_15376602-ca29-4f0c-979e-a454d7dabd8e">417.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company assessed goodwill for impairment in accordance with the appropriate guidance (see Note 1) and determined <ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzk2NjI_94580da1-4764-4c2f-9fd3-9d62d2bc63b0">no</ix:nonFraction>ne of its reporting units were impaired during the transition period ended December 31, 2020. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fiscal year ended June 30, 2020, as a result of the effect of COVID-19 on expected future cash flows and a corresponding decline in market capitalization and enterprise value, the Company performed an interim quantitative impairment review of goodwill for the Myriad Mental Health, Myriad Autoimmune and Myriad International reporting units as of March 31, 2020. Based on this analysis, the Company recognized a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ife885bcb6b0042d8879fb750f6ac752c_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MTI_ea7cd84d-567e-4404-bc5f-a1203a161ec9">80.7</ix:nonFraction> million related to the goodwill from the Myriad Autoimmune reporting unit. The Myriad Autoimmune reporting unit is part of the Company&#8217;s diagnostic segment. The goodwill impairment charge is reflected in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fiscal year ended June 30, 2020, the Company also recognized a $<ix:nonFraction unitRef="usd" contextRef="i45a2fa48f3c343368a8e72ee16163874_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MjI_394f0271-65aa-4ed2-ba3a-81488db4dd79">1.3</ix:nonFraction> million impairment charge for goodwill allocated to the Clinic asset group that is included in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations. The Clinic asset group was part of the Company&#8217;s other segment.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, developed technology, a laboratory database, trademarks, and customer relationships as well as a non-amortizable intangible asset of in-process research and development.&#160;&#160;The Company&#8217;s developed technology and database acquired have estimated remaining useful lives between <ix:nonNumeric contextRef="i08cb205cf6ff477cbb17f7110077d7cd_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzM0MTA_cb769f15-d908-4908-b29d-67f392df8275">1</ix:nonNumeric> and <ix:nonNumeric contextRef="ibdf71da88168472ba6c7919001d183a6_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzM0MTc_5b5f8654-d466-477a-89c2-62063a5589f7">16</ix:nonNumeric> years, trademarks acquired have an estimated remaining useful life of approximately <ix:nonNumeric contextRef="i358e9cbf8de8453c97ef831209748f8b_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzM0OTg_7d902729-9ccf-4e55-ab37-5079a707cceb">eight years</ix:nonNumeric> and customer relationships have an estimated remaining useful life of approximately <ix:nonNumeric contextRef="i90d7ec9fb1de477e8189293731c018d6_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzM1ODU_e2ba1dd6-ea45-4435-b96b-0825df212558">one year</ix:nonNumeric>.&#160;The estimated useful life of acquired in-process research and development was also evaluated in conjunction with the annual impairment analysis of intangible assets.&#160;&#160;The classification of the acquired in-process research and development as an indefinite lived asset was deemed appropriate as the related research and development was not yet complete nor had it been abandoned. During the fiscal year ended June 30, 2020, the Company decided to abandon the development of one of its in-process research and development intangible assets, and as a result the Company recognized a charge of $<ix:nonFraction unitRef="usd" contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2NDA_aab163d7-6f8c-48bd-a836-4f74798de459">17.7</ix:nonFraction> million, which is reflected in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations. The abandoned in-process research and development intangible asset was reported as part of the Company&#8217;s diagnostic segment. The Company concluded there was <ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ0NDc_08dd0988-da9d-4891-b6fb-867adb03a894"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ0NDc_4b3960b4-b70a-4164-966d-9078a0f2ca83"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ0NDc_68e4e54d-a277-4687-a856-3e194980f4bd"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ0NDc_8c55e84e-ff30-4ada-8e92-41b89390f280">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of long-lived assets for the transition period ended December&#160;31, 2020 or for the fiscal years ended June&#160;30, 2020, 2019 and 2018.</span></div></ix:continuation><div style="margin-top:3pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="ifa1e0cb66d9d46779182645f0e8b0684" continuedAt="if9e0abdb38a8421a876b47e0d2f8ae76"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MDk_74592303-6aea-45f4-8a29-77fe2e70cffe" escape="true"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MDk_cb13d986-fe57-42d6-8dd1-b33a51ec6090" escape="true"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the amounts reported as intangible assets (in millions):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"></td><td style="width:61.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52ebc6a5c564a3ba28fffe021227a85_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzEtMi0xLTEtNDU4MQ_f24916ce-381f-4d23-a206-94ac732be820">818.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia52ebc6a5c564a3ba28fffe021227a85_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzEtNC0xLTEtNDU4MQ_db116998-7d69-462e-99a8-ca46d465b043">248.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52ebc6a5c564a3ba28fffe021227a85_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzEtNi0xLTEtNDU4MQ_f9ea2f7f-661c-46f3-a6d8-c56d5f96d4a4">570.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82e7ad1d54745bf9f3e53cb046e5adb_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzItMi0xLTEtNDU4MQ_eaefa53d-3f49-4d18-9a12-3af9ee604902">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib82e7ad1d54745bf9f3e53cb046e5adb_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzItNC0xLTEtNDU4MQ_bc7bd050-4ab3-4aa6-b676-1170a716ee83">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82e7ad1d54745bf9f3e53cb046e5adb_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzItNi0xLTEtNDU4MQ_2197d4bc-2259-4635-9b00-9eac360668c0">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83a65cbe1f3b4d65b6f51bc3d1b557ab_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzMtMi0xLTEtNDU4MQ_63e4a099-9f63-414f-bf86-e1588279434a">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83a65cbe1f3b4d65b6f51bc3d1b557ab_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzMtNC0xLTEtNDU4MQ_f88989c0-50a0-43f9-a6a4-2f199ebc37e2">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83a65cbe1f3b4d65b6f51bc3d1b557ab_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzMtNi0xLTEtNDU4MQ_a05dd424-c5fe-40ef-a643-1fc950e93bb6">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzQtMi0xLTEtNDU4MQ_2a650ac7-5231-46ed-81fa-b45f6bbbc6b5">825.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzQtNC0xLTEtNDU4MQ_2584d2f1-debe-431e-8266-ae69661d42e3">254.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzQtNi0xLTEtNDU4MQ_459e7bf5-cda2-4911-b2cf-47f4c2fb8da1">571.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063c58e973c84e0c90eb3b292cd80d2f_I20201231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzUtMi0xLTEtNDU4MQ_17d1eca0-77ff-40a0-a022-d4e8df8a19e2">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063c58e973c84e0c90eb3b292cd80d2f_I20201231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzUtNi0xLTEtNDU4MQ_427fc00b-7e97-463a-9557-0e9b3392dee8">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzYtMi0xLTEtNDU4MQ_36915001-0113-40ac-8ba5-5a0f9206e541">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzYtNi0xLTEtNDU4MQ_893882d7-9ced-4049-b411-012ad7cc9497">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzctMi0xLTEtNDU4MQ_603772fe-7ff5-4060-851d-fd16306da912">830.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzctNC0xLTEtNDU4MQ_b2258a2d-ca89-408c-b54d-90a5320827ba">254.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzctNi0xLTEtNDU4MQ_b006beb8-45fc-424c-ad7f-ec7ee7c47c40">576.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"></td><td style="width:60.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At June 30, 2020:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ceb8d39a9034275a4786f69cadfae9d_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzEtMS0xLTEtMA_e21af39a-2388-45c7-aa50-49287b5ac2c7">815.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ceb8d39a9034275a4786f69cadfae9d_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzEtMy0xLTEtMA_d073e869-79f0-44b3-b019-b1dff7746e71">217.1</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ceb8d39a9034275a4786f69cadfae9d_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzEtNS0xLTEtMA_803c0713-af2c-4c1d-acba-6f0b33bc4902">598.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05db2823ea2e4f1983fc881d4d120ee6_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzItMS0xLTEtMA_f0ae0807-f2f2-496c-8a76-a3631d05c4a0">4.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05db2823ea2e4f1983fc881d4d120ee6_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzItMy0xLTEtMA_23946dee-0ed7-455e-b5e5-8dfab8ba690f">4.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05db2823ea2e4f1983fc881d4d120ee6_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzItNS0xLTEtMA_fe3285a9-7ae0-4812-9516-335ba616aa52">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0836938b4b5749e7b04cda79f7d778d7_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzMtMS0xLTEtMA_9b2320bb-7124-44bc-ab3a-3e6392d100ae">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0836938b4b5749e7b04cda79f7d778d7_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzMtMy0xLTEtMA_cadd7ad8-daa9-4e5b-a8ba-549d9785dc53">1.4</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0836938b4b5749e7b04cda79f7d778d7_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzMtNS0xLTEtMA_910b189b-da07-4f71-8df4-60b16f943531">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzQtMS0xLTEtMA_122c6388-eb89-4c23-83b2-e508943f49f2">823.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzQtMy0xLTEtMA_c483c5fb-57e7-4874-b78a-f580265e74b9">222.7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzQtNS0xLTEtMA_50492a56-de23-463e-8b4a-2548c5a54858">600.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5eb1e7015b84a099b7eec0436d24272_I20200630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzUtMS0xLTEtMA_9d2bae3a-fb03-4136-9c62-64ed310b107d">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5eb1e7015b84a099b7eec0436d24272_I20200630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzUtNS0xLTEtMA_b9a29889-4cf7-4c05-bfda-7b0587af05fb">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzYtMS0xLTEtMA_340ae605-2897-4adc-ae4a-48749af2bde7">4.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzYtNS0xLTEtMA_813640a7-0829-4301-a4a5-b9e8081d7821">4.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzctMS0xLTEtMA_6458790b-e00f-4465-bafc-0506d5381eee">828.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzctMy0xLTEtMA_18179219-8f7f-4db9-9e94-9a0b9f7d75b1">222.7</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzctNS0xLTEtMA_8276e5c4-ef16-4bf5-a384-e3e0d14173d5">605.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"></td><td style="width:60.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At June 30, 2019:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide312d0b744845ed9d38a50c79ac314f_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzEtMS0xLTEtMA_1799906f-3f4d-4b9b-ae83-23a4547217e0">815.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide312d0b744845ed9d38a50c79ac314f_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzEtMy0xLTEtMA_6a3d4d47-4256-4049-a18d-8b67512a553e">156.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide312d0b744845ed9d38a50c79ac314f_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzEtNS0xLTEtMA_a9e08188-75ea-4d24-a1f1-1696cd838033">659.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3927b5f25dab43d8bba22d95423cf7a5_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzItMS0xLTEtMA_4a6ada40-6a0d-4056-bebd-679f577f2e39">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3927b5f25dab43d8bba22d95423cf7a5_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzItMy0xLTEtMA_6f7155f3-50ee-4d93-ba1f-898b0be796d3">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3927b5f25dab43d8bba22d95423cf7a5_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzItNS0xLTEtMA_46c0816e-367d-4981-b553-377ac0b29a23">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368a22ba17754f239a339d70f874d4e4_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzMtMS0xLTEtMA_a594b331-c2c7-42c9-a748-ac863d940086">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i368a22ba17754f239a339d70f874d4e4_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzMtMy0xLTEtMA_5aef62e4-75b2-43c9-ab0b-75b0055c3b55">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368a22ba17754f239a339d70f874d4e4_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzMtNS0xLTEtMA_6ce361ec-1d18-462c-afd9-34c3af066d2e">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzQtMS0xLTEtMA_54f74765-6938-4c5f-92ff-5ead5206e09e">823.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzQtMy0xLTEtMA_10a76a17-089d-4bfc-aec0-77c826417cb3">161.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzQtNS0xLTEtMA_a0e08672-ba6a-452a-b2d7-4418aaa5bb6c">661.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i777e19d7ca9f43749f30b1d52f56cb12_I20190630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzUtMS0xLTEtMA_4cfb12dd-60c4-4616-b934-56f56632cc68">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i777e19d7ca9f43749f30b1d52f56cb12_I20190630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzUtNS0xLTEtMA_5dd2462c-c3df-47f6-919e-417ab3afc5a6">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzYtMS0xLTEtMA_6511086e-ea39-4b5d-aa83-2218af8b8299">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzYtNS0xLTEtMA_e8c68eca-c310-4f49-a5e7-661d879c2e74">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzctMS0xLTEtMA_44044700-40bf-4983-91a5-959f7cb3bb7b">846.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzctMy0xLTEtMA_285a7dae-84b5-4c9b-8565-0ed7ac4badc3">161.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzctNS0xLTEtMA_e96a9d62-f677-4568-93fd-089200bf7d33">684.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 the weighted average remaining amortization period for purchased licenses and technologies, trademarks, and customer relationships is approximately <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ3NDY_3aebd2f7-864d-480f-935e-b5c34a467852">11</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5ODk_d8b5030f-5e98-433b-bb91-a55c4038ca0f" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization during the respective periods for these intangible assets as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"></td><td style="width:33.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmNDVmZjZkNDRmZDU0ZmUwODBhMTRmMzllZmMzOTUwYS90YWJsZXJhbmdlOmY0NWZmNmQ0NGZkNTRmZTA4MGExNGYzOWVmYzM5NTBhXzItMS0xLTEtMjcyNw_4030becb-8aec-4dc5-9d6c-eaf36a7f37ad">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmNDVmZjZkNDRmZDU0ZmUwODBhMTRmMzllZmMzOTUwYS90YWJsZXJhbmdlOmY0NWZmNmQ0NGZkNTRmZTA4MGExNGYzOWVmYzM5NTBhXzItMS0xLTEtMA_aebf9f1a-4c0d-4484-acd9-3239e28e85c2">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmNDVmZjZkNDRmZDU0ZmUwODBhMTRmMzllZmMzOTUwYS90YWJsZXJhbmdlOmY0NWZmNmQ0NGZkNTRmZTA4MGExNGYzOWVmYzM5NTBhXzItMy0xLTEtMA_74937ac2-c028-469e-8ed4-b019a8a0c262">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmNDVmZjZkNDRmZDU0ZmUwODBhMTRmMzllZmMzOTUwYS90YWJsZXJhbmdlOmY0NWZmNmQ0NGZkNTRmZTA4MGExNGYzOWVmYzM5NTBhXzItNy0xLTEtMTY5MDg_c8efc72e-93bc-4169-8a4e-83303b416278">37.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="if9e0abdb38a8421a876b47e0d2f8ae76"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MTA_96e1e506-420e-4e81-8d65-3ffe4eea0972" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense of intangible assets as of December 31, 2020 is estimated to be as follows (in millions):</span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.264%"><tr><td style="width:1.0%"></td><td style="width:66.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzEtMS0xLTEtMTA4NDg_04336cd6-b845-45ef-9b87-0a094828ec7e">58.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzItMS0xLTEtMTA4NDg_b88f3170-e2b3-4bf9-9c58-018064591e8f">52.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzMtMS0xLTEtMTA4NDg_4289fcd1-d9ff-4770-bfc3-b4f8d59467c7">52.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzQtMS0xLTEtMTA4NDg_fb88e6d4-ce69-450d-a21b-d5d44e5d82ae">52.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzUtMS0xLTEtMTA4NDg_ac5aad5e-5a1c-4430-a8c6-7f39e03285dd">52.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzYtMS0xLTEtMTI2MDM_cc780516-9323-4310-9e4d-e82fd59dceed">302.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzctMS0xLTEtMTMyOTg_bf2d4371-3be8-406e-bfff-855b0e5db867">571.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_124"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90ZXh0cmVnaW9uOjM1ZDIxMmI2MjI0NzQ0ZGU5NDkzNDhkOTlkMWI2N2QyXzI5_634171d2-c08d-41aa-9003-db04acf4c6ab" continuedAt="i71366ae2af0546eab4885c682eb9134f" escape="true">ACCRUED LIABILITIES</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i71366ae2af0546eab4885c682eb9134f"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90ZXh0cmVnaW9uOjM1ZDIxMmI2MjI0NzQ0ZGU5NDkzNDhkOTlkMWI2N2QyXzMw_60ee53d7-4708-4306-b289-62a3086f8e9c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:60.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzItMS0xLTEtMTEzNg_d280d3cd-323c-441a-974e-28a85ef63994">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzItMS0xLTEtMA_73146740-fc09-4897-a64f-49c21df8d100">47.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzItMy0xLTEtMA_b48dd134-80d9-4ac8-bd92-2a4bd5645b67">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzMtMS0xLTEtMTEzNg_a0a8daa6-e9ce-447d-8650-7993bf5983c4">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzMtMS0xLTEtMA_21efd1c0-c0b8-445c-892d-9812fb1b408c">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzMtMy0xLTEtMA_dfb6d8b8-4b00-4ed8-a266-7fc97596594e">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qui tam settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzQtMS0xLTEtMTEzNg_70c6414c-b52e-42b4-9edb-77e71526ce49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzQtMS0xLTEtMA_2e2c8d6d-8c22-426b-a49e-0975044b9ff2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzQtMy0xLTEtMA_e23ceee1-a33b-477c-a81e-26dde53a3cf1">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoupments payable and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:RecoupmentsPayableAndReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMS0xLTEtOTY4NA_2cc8f4b7-4f61-48d9-8644-cdeb2172f700">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="mygn:RecoupmentsPayableAndReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMy0xLTEtMTMzODU_7742bb81-40ea-4fda-ab00-79dc10e083be">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="mygn:RecoupmentsPayableAndReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtNS0xLTEtMTMzODc_6717f90e-1b36-43fb-af6a-168cc81acfe8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMS0xLTEtMTIxODg_e36c53fd-51c8-486a-b129-8c9e35c2caf4">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMy0xLTEtMTIxOTA_c1021357-4f2b-4318-88cb-039527a04dcc">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtNS0xLTEtMTIxOTA_5f7c9cd5-da95-439a-8a00-566210db8f24">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMS0xLTEtMTEzNg_72bbef5a-3c55-415b-942d-5eabcc331386">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMS0xLTEtMA_c38412d9-75a5-4414-ae99-ab575e9ce89b">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMy0xLTEtMA_ccd264bb-ec74-40b2-a164-83459d64b505">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMS0xLTEtMTEzNg_709893bb-d9a6-4dca-ac27-28646753c54a">79.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMS0xLTEtMA_3a99bd92-ce1f-4ef4-97ad-ca9f719f1105">79.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMy0xLTEtMA_76e59050-b38f-4f2e-92e8-7cde6a7589f7">82.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="ic01b255bce00439ba9380fc219eb70e1_127"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQxOTc_b341e602-fac0-42aa-b3e2-a5c08892b9da" continuedAt="ide31f5b87f7847109e79b9e610882e31" escape="true">LONG-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="ide31f5b87f7847109e79b9e610882e31" continuedAt="id6a28e0c464e42a5b6059f1137d3a299"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2016, the Company entered into a senior secured revolving credit facility (the &#8220;Facility&#8221;) as borrower, with the lenders from time to time party thereto. On July 31, 2018, the Company entered into Amendment No. 1 to the Facility (the &#8220;Amended Facility&#8221;), which effected an &#8220;amend and extend&#8221; transaction with respect to the Facility by which the maturity date thereof was extended to <ix:nonNumeric contextRef="i0f6ff2934a84433bafc32b6df84630bf_D20180731-20180731" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQyMg_48e84557-50ea-4e57-96df-5fd93e1bad2d">July 31, 2023</ix:nonNumeric> and the maximum aggregate principal commitment was increased from $<ix:nonFraction unitRef="usd" contextRef="ic8168706f12149b6b5546e5eb8c2880d_I20161223" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQ5MQ_f67f38ff-753f-4735-a49b-e0f898d537db">300.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQ5Nw_28464775-251a-47ec-9273-d9a2f1f04fe9">350.0</ix:nonFraction> million.&#160;&#160;On May 1, 2020, the Company entered into Amendment No. 2 to the Amended Facility, which waived the Company&#8217;s compliance with certain covenants and modified the interest rate and other terms during the Amendment Period from March 31, 2020 through June 30, 2021 (&#8220;Amendment Period&#8221;). Both amendments were accounted for as modifications pursuant to guidance in ASC 470-50. &#160;&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended Facility, the Company borrowed revolving loans in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4Xzk4MQ_b5cae528-3dcd-44f7-b939-aedec0a8098d">300.0</ix:nonFraction> million with $<ix:nonFraction unitRef="usd" contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4Xzk4OQ_eef2d804-7456-4e86-9afb-a8f1222955c3">1.8</ix:nonFraction> million in upfront fees and $<ix:nonFraction unitRef="usd" contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzEwMTI_fc948d52-b8e7-4014-8c18-04c2d8a19948">0.3</ix:nonFraction> million debt issuance costs recorded as a debt discount to be amortized over the term of the Amended Facility. The Company incurred an additional $<ix:nonFraction unitRef="usd" contextRef="i8db25c9c8c1a4f0d9143e0fa38d1b8c0_I20200501" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzExNTM_1e40d8a2-0ba8-4593-848e-950395306373">1.0</ix:nonFraction> million in upfront fees as a result of Amendment No. 2, which was also recorded as a debt discount that will be amortized over the term of the Amended Facility. There are <ix:nonFraction unitRef="usd" contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzEzNzI_7ff3562b-4421-4da8-83bf-8c4820d5859d">no</ix:nonFraction> scheduled principal payments of the Amended Facility prior to its maturity date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proceeds of the Amended Facility were used to: (i) refinance in full the obligations under the Facility, (ii) finance the acquisition of Counsyl (See Note 17), (iii) pay fees, commissions, transactions costs and expenses incurred in connection with the foregoing, and (iv) for working capital and other general corporate purposes.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility contains customary loan terms, interest rates, representations and warranties, affirmative and negative covenants, in each case, subject to customary limitations, exceptions and exclusions. The Amended Facility also contains certain customary events of default. Amendment No. 2 modified the Amended Facility to increase the interest rate to be fixed at a spread of LIBOR plus <ix:nonFraction unitRef="number" contextRef="ieb698caa638b42d1979314bc3a5847bd_D20200401-20210630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzIxODc_eab1e86b-707b-40b4-ae99-fe66cad5bdf3">350</ix:nonFraction> basis points on drawn balances and the undrawn fee was increased to <ix:nonFraction unitRef="number" contextRef="id495302512264408b7c35e7b17c70ddd_D20200401-20210630" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzIyNTg_eb545321-f9bd-429c-8010-293f12f0ac6a">50</ix:nonFraction> basis points during the Amendment Period, at which point they return to the existing pricing of <ix:nonFraction unitRef="number" contextRef="ia62ae255eb174dda98733a496df5ac02_D20210701-20210701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzIzNTc_611d5277-2d76-485c-a79a-0d5c673b9a8a">200</ix:nonFraction> basis points on drawn balances and an undrawn fee ranging from <ix:nonFraction unitRef="number" contextRef="id0a3ba1b79114c77afaf02ff36fa05be_D20210701-20210701" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzI0MjM_765f79ff-f242-4abd-abcf-6dd2be3319f1">25</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="if227e7110e014058a767b9bd13ef0d3e_D20210701-20210701" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzI0Mjk_08db68af-9988-431f-981f-0b9747bff076">45</ix:nonFraction> basis points based on the Company&#8217;s leverage ratio. The LIBOR floor was also increased to <ix:nonFraction unitRef="number" contextRef="id495302512264408b7c35e7b17c70ddd_D20200401-20210630" decimals="INF" name="mygn:DebtInstrumentLIBORFloorPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzI1MjI_4fc6b5e6-6a6f-4860-867c-069f3addfe73">1.0</ix:nonFraction>% during the Amendment Period. The interest rate as of December&#160;31, 2020 was <ix:nonFraction unitRef="number" contextRef="i82d2b9e5a08048bf9897aa33a87b7756_I20201231" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzM4NDgyOTA3MDE2NTI_a12f5c77-e19b-47f4-bbf7-affc85693723">4.5</ix:nonFraction>%.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="id6a28e0c464e42a5b6059f1137d3a299"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covenants in the Amended Facility impose operating and financial restrictions on the Company. These restrictions may prohibit or place limitations on, among other things, the Company&#8217;s ability to incur additional indebtedness, create certain types of liens or complete mergers or consolidations, and/or change in control transactions. The Amended Facility may also prohibit or place limitations on the Company&#8217;s ability to sell assets, pay dividends or provide other distributions to stockholders. The Company must maintain specified leverage and interest ratios measured as of the end of each quarter as a financial covenant in the Amended Facility. Amendment No. 2 modified the Amended Facility&#8217;s compliance with the leverage ratio covenant and the interest coverage ratio covenant, which were waived through March 31, 2021. A minimum liquidity covenant was added for the period beginning May 2020 until March 2021, and a minimum EBITDA covenant was added for the quarters ending December 31, 2020 and March 31, 2021. Amendment No. 2 also revised certain negative covenants of the Amended Facility during the Amendment Period. As of December&#160;31, 2020, the Company was not in compliance with the minimum EBITDA covenant related to the Amended Facility. The Company is in compliance with all debt covenants as of the date the consolidated financial statements are available for issuance. As discussed in Note 18, on February 22, 2021 the Company entered into Amendment No. 3 to the Amended Facility which removed the minimum EBITDA covenant and also amended other covenant terms. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the transition period ended December 31, 2020, the Company did <ix:nonFraction unitRef="usd" contextRef="i6f1482ec3ab648658454bf97344b72e8_D20200701-20201231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:RepaymentsOfLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQ5NDc4MDIzMzAyMDY_3738fd06-56ec-48fe-9117-fe62e3338bef">no</ix:nonFraction>t make any principal repayments. During the fiscal years ended June&#160;30, 2020, 2019 and 2018 the Company made $<ix:nonFraction unitRef="usd" contextRef="i0ac03d04962f4c50ba2419ea9529b2bd_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzM4Mjk_ed87a911-6614-4d3a-bba4-6c1c45f26d2c">8.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7fa5fc13241a4e07b520ff640cb97a2c_D20180701-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzM4MzM_1e0f4d97-b7ee-4768-8d35-2789a32b32f6">115.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica5c0cd9bacd45798f5d92217ef8280f_D20170701-20180630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzM4NDA_5283fbb0-a5f0-4aa5-a129-449777b44550">143.0</ix:nonFraction> million in principal repayments, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility is secured by a first-lien security interest in substantially all of the assets of Myriad and certain of its domestic subsidiaries and each such domestic subsidiary of Myriad has guaranteed the repayment of the Amended Facility. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQxOTk_faab02f7-5ab0-4b41-8b1b-05e32b2780df" continuedAt="id97d0f0ee3e64f1e9b4b950317e0fa2d" escape="true">Amounts outstanding under the Amended Facility were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="id97d0f0ee3e64f1e9b4b950317e0fa2d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:60.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzItMS0xLTEtMTE1Mw_bd44f87f-b60d-4ee2-b53b-f4d9332eb876">226.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzItMS0xLTEtMA_ad3bc0cb-0927-427a-aa4e-9160125b4ff3">226.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzItMy0xLTEtMA_3b909bdd-2f82-4cba-9cd8-f9aca74ecbab">235.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzMtMS0xLTEtMTE1Mw_bd007194-54c3-4fd9-9363-90aa4fd61157">1.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzMtMS0xLTEtMA_68beac4d-b198-4c53-8c75-eba715994067">2.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzMtMy0xLTEtMA_c23073da-260b-419d-86a5-dc5a0a1a6bf5">1.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzQtMS0xLTEtMTE1Mw_1705e08b-7926-4ae7-b641-59d95434099a">224.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzQtMS0xLTEtMA_ac2b8872-5cb7-4c41-902e-24b8f72338ce">224.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzQtMy0xLTEtMA_65b08b7d-57b7-4bb8-9fbd-2a06a5f91716">233.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="ic01b255bce00439ba9380fc219eb70e1_133"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzc5MQ_c7c31256-12fd-4f7b-9d98-a639df28fbf2" continuedAt="i3b70f707a47349b1a085ff71a770da2d" escape="true">OTHER LONG-TERM LIABILITIES</ix:nonNumeric></span></div><ix:continuation id="i3b70f707a47349b1a085ff71a770da2d"><div style="margin-top:5pt;padding-left:36pt"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzc5Mg_53590a0e-789c-4c53-bd4f-db5a860ca235" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"></td><td style="width:60.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.116%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzItMS0xLTEtMTE1Nw_66549eb2-b4b9-43ea-918e-cad72fc1254a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzItMS0xLTEtMA_ee1ce4cd-01e0-4b10-8fb6-ce8e3382d868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzItMy0xLTEtMA_189369aa-8b1e-4aef-b486-272b81180978">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMS0xLTEtNzA2OA_03066269-c2f3-4647-8a18-6e14d7deb984">7.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMy0xLTEtNzA2OA_e5fb3762-70a2-49c0-9f71-907842f21b6d">3.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtNS0xLTEtNzA2OA_47ac4142-c6c9-4c1d-a994-406447d42019">10.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMS0xLTEtMTE1Nw_6b93b7f0-8bc6-4cdb-b93d-115c6da0899e">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMS0xLTEtMA_e22a476d-4dde-41b7-8e56-992e4b398b64">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMy0xLTEtMA_b633544d-8b5a-4382-b233-2996b5f02c5c">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzQtMS0xLTEtMTE1Nw_9ce19e5c-e5d7-4252-a0d2-b3c59fa2eb64">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzQtMS0xLTEtMA_0d03ceb5-4a1d-43a6-a3c7-f367449cc706">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzQtMy0xLTEtMA_3395061c-df72-4f1d-a6eb-147eec3426d8">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s balance of other long-term liabilities for the transition period ended December&#160;31, 2020 consists of Company&#8217;s portion of social security taxes that have been deferred under the CARES Act that do not have to be deposited until December 2022. The Company previously held <ix:nonFraction unitRef="plan" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="INF" format="ixt-sec:numwordsen" name="mygn:NumberOfDefinedBenefitPensionPlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzMwNA_c88d00c4-c92a-4687-abbe-f9f75ec3d824">two</ix:nonFraction> non-contributory defined benefit pension plans for its current and former Clinic employees. The Company has closed participation in the plans to exclude those employees hired after 2002. As of June&#160;30, 2019 the fair value of the plan assets were approximately $<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzU1Ng_6c0306be-4cdc-4d27-a7da-753a0787e102">0.1</ix:nonFraction> million&#160;resulting in a net pension liability of $<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzU5OQ_d48d3a52-9986-4a82-973f-b5fa9a4e6810">6.8</ix:nonFraction> million. The Company sold the Clinic in February 2020 and as a result the net pension liability was removed upon deconsolidation. See Note 16 for further discussion regarding the sale of the Clinic.</span></div></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_136"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE2NDk_0d1358ca-2c65-488f-82e7-46373bc2ecb2" continuedAt="iaaf08ae25f124a84abbfba842eea8dfd" escape="true">PREFERRED AND COMMON STOCKHOLDERS' EQUITY</ix:nonNumeric></span></div><ix:continuation id="iaaf08ae25f124a84abbfba842eea8dfd"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2Xzkx_a90ebf18-2041-46f0-b648-bb0096087589">5.0</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzEzMQ_3a29bcb5-0a52-493f-901d-9fa570725121">0.01</ix:nonFraction> per share.&#160;There were <ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE1Nw_2725a9b2-a287-4e15-8a03-545554590b87"><ix:nonFraction unitRef="shares" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE1Nw_31ead9a0-56b9-4004-910d-a79b0000c1a1"><ix:nonFraction unitRef="shares" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE1Nw_6fe3e2ac-820e-4fad-ae27-d262caac5af2"><ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE1Nw_e65d8b91-7b1d-4fd5-be6a-cc77ce0eb2c3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> preferred shares outstanding at December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzI0OA_d554d046-21d9-466a-9e83-6174535198e3">150.0</ix:nonFraction> million shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzI4NQ_fde23bed-01c1-447b-a73d-879715850ddf">0.01</ix:nonFraction> per share. There were <ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzQ5NDc4MDIzMjczNzQ_32649eff-fb73-4540-bff7-c9f7398337e8"><ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzQ5NDc4MDIzMjczNzQ_946acc59-7a87-4bd9-8a92-5323e8cf0d94">75.4</ix:nonFraction></ix:nonFraction>&#160;million, <ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMxMA_10c9f50c-0c47-4d7e-9e74-cff8d2c7c780"><ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMxMA_31155553-f250-486f-81b2-d4f453336286">74.7</ix:nonFraction></ix:nonFraction>&#160;million, <ix:nonFraction unitRef="shares" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMxNA_7c7ebc7f-c119-4748-8e20-218acf667a92"><ix:nonFraction unitRef="shares" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMxNA_8c29bbe5-c9a2-4b17-9902-90e6d7466fe6">73.5</ix:nonFraction></ix:nonFraction>&#160;million, and <ix:nonFraction unitRef="shares" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMyMg_8c6beaa7-3465-4ba3-a809-4c241fedf76a"><ix:nonFraction unitRef="shares" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMyMg_dfa4e853-ceff-4369-8ecb-8bb2ee32869b">70.6</ix:nonFraction></ix:nonFraction>&#160;million shares issued and outstanding at December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 respectively.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE2NTA_748f5a34-009f-4537-ba62-3345c7ce0ad6" escape="true"><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common shares issued and outstanding</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"></td><td style="width:48.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning common stock issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMS0xLTEtNzA4OA_08e638fe-a3ff-4a0d-a70c-f65d8172d75e"><ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMS0xLTEtNzA4OA_98ec168a-9d09-43a4-816d-ad5c171af3e0">74.7</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMS0xLTEtMA_1809de55-b444-45b9-8602-a15de260e8ad"><ix:nonFraction unitRef="shares" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMS0xLTEtMA_a6230d77-1986-462c-94dd-c3a53ca92cb8">73.5</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMy0xLTEtMA_068a6fe6-1e28-4e77-a422-468a8316db68"><ix:nonFraction unitRef="shares" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMy0xLTEtMA_1b954b01-606f-400d-80a8-2e7e5ac515c3">70.6</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItNS0xLTEtMA_2008537a-08d3-48c0-93f3-f2ecb6cb4cb7"><ix:nonFraction unitRef="shares" contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItNS0xLTEtMA_29ba6f84-9724-4c2f-a6f4-d46cbf9045d5">68.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued upon exercise of options and employee stock plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzMtMS0xLTEtNzA4OA_9be17de2-3380-4414-8b12-1956a1e089ce">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzMtMS0xLTEtMA_18a52988-fd93-4677-bc62-9ada5fb39ef3">1.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzMtMy0xLTEtMA_ccf76194-13a7-44fa-a37c-5d48b23d79c4">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzMtNS0xLTEtMA_84eccd77-6254-42fd-97cd-714dc756b9da">2.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzQtMS0xLTEtNzA4OA_38238a0e-f0db-43fe-81ea-ed3741966083">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzQtMS0xLTEtMA_d4d64e86-52a0-42b2-b969-2ca366ef83bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzQtMy0xLTEtMA_2741b9a4-36ff-420f-90e7-efc84d0e5c2c">1.6</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzQtNS0xLTEtMA_24b12071-e1af-4cfb-8a32-61a9805f823d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending common stock issued and outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMS0xLTEtNzA4OA_26d6551f-c230-4895-9bc2-5ec96e6515d8"><ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMS0xLTEtNzA4OA_d3ace5f5-2336-41f5-98f4-148bda6b2fab">75.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMS0xLTEtMA_342cb66b-47a9-42ba-8d5f-0ce935f81f0e"><ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMS0xLTEtMA_9f1ba7cc-9964-44fb-9d96-7d41bcdc63d9">74.7</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMy0xLTEtMA_1fab5138-91f2-432c-a159-0aee3001d0f6"><ix:nonFraction unitRef="shares" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMy0xLTEtMA_5181a096-9e7b-4dba-8bce-b26d0e8092a5">73.5</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtNS0xLTEtMA_10cabd18-a2f5-4956-b916-d5aec80c8686"><ix:nonFraction unitRef="shares" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtNS0xLTEtMA_4204e516-c13f-42ba-ba33-0d6c5749a5fb">70.6</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Company&#8217;s Board of Directors authorized a share repurchase program of $<ix:nonFraction unitRef="usd" contextRef="i0012a57e73a64c94a8b83d10ea8ca5ba_I20160630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzUzOA_9b795993-8868-4e22-8056-af59acb80425">200.0</ix:nonFraction> million of the Company&#8217;s outstanding common stock. The Company may repurchase its common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company&#8217;s management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.&#160;&#160;As of December&#160;31, 2020, the Company has $<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzEwMDE_de660504-5d9d-42cc-8b47-0d4d47172f31">110.7</ix:nonFraction> million remaining on its current share repurchase authorization.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the par value method of accounting for its stock repurchases.&#160;&#160;As a result of the stock repurchases, the Company reduced common stock and additional paid-in capital and recorded charges to Retained earnings (accumulated deficit).&#160;&#160;During the fiscal year ended June 30, 2019 the Company used $<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzEzNzQzODk1MzQ5NDg2_8711e21d-bbeb-4e40-9828-08c84adf9a08">50.0</ix:nonFraction> million to repurchase shares of the Company&#8217;s stock as part of an accelerated share repurchase. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="mygn:ScheduleOfCommonStockRepurchasedTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE2NTE_de92ab7c-207f-4e3b-a74e-548d497d2c8d" continuedAt="i3ee515318e8e4dff862cb63f687c7edc" escape="true">The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to Retained earnings (accumulated deficit) for the repurchases for periods ended December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i3ee515318e8e4dff862cb63f687c7edc"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"></td><td style="width:48.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased and retired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzItMS0xLTEtMTk5MA_ee87c2e9-c2a1-4238-bfc0-be67e89b11e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzItMS0xLTEtMA_42646509-a3bc-4d96-aadd-65171651caec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzItMy0xLTEtMA_d2756e93-5462-4046-8ce9-1e5ac97abc9d">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzItNS0xLTEtMA_901eca94-4a20-4dc7-992e-b6e2592361cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock and additional paid-in-capital reductions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzMtMS0xLTEtMTk5MA_cbb3e340-e9b0-47f4-9bd5-bdd397bfb599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzMtMS0xLTEtMA_5f6ee7bb-b865-49e4-bc88-821527b09c7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzMtMy0xLTEtMA_2a3993e1-3216-41c8-a325-4ead834bba85">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzMtNS0xLTEtMA_7f7a1dd4-0a63-42a0-8322-d5c6fd7cf974">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to retained earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzQtMS0xLTEtMTk5MA_69c530fe-b20a-4434-bc2a-9346b2e9ef2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzQtMS0xLTEtMA_c4924c30-d06b-4f06-a35c-f3136a67b566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzQtMy0xLTEtMA_f50f5ac0-4e0a-4ca2-b69a-dea0aecb4f1c">33.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzQtNS0xLTEtMA_14ddd86a-e453-4197-93b9-5fa898389d00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="ic01b255bce00439ba9380fc219eb70e1_142"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjY_3437a626-4fec-41ed-843b-302050898c49" continuedAt="i7791b8af569f41bb9f753d5e04111b55" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7791b8af569f41bb9f753d5e04111b55" continuedAt="i3bd8ed536e0842c19f70a7ef18d109dd">On November 30, 2017, the Company&#8217;s stockholders approved the adoption of the 2017 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2017 Plan&#8221;).&#160;&#160;The 2017 Plan allows the Company, under the direction of the Compensation Committee of the Board of Directors, to make grants of restricted and unrestricted stock awards to employees, consultants and directors.&#160;&#160;The 2017 Plan allows for issuance of up to <ix:nonFraction unitRef="shares" contextRef="ie6f9ba489d8849db94d404a44fac34d1_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQ0MA_5af6d533-45b5-4ff2-a4ee-f8eca4838842">4.6</ix:nonFraction> million shares of common stock.&#160;&#160;In addition, as of December&#160;31, 2020, the Company may grant additional shares of common stock under the 2017 Plan with up to <ix:nonFraction unitRef="shares" contextRef="ifee3f7598bd244628200eb7c1522a119_D20200701-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzYyMw_02cd48c3-18f8-458b-ae7b-1f3d7c1e94e3">4.0</ix:nonFraction> million options and restricted stock units outstanding under its 2010 Employee, Director and Consultant Equity Incentive Plan, as amended, that expire or are cancelled without delivery of shares of common stock. If an RSU awarded under the 2017 Plan is cancelled or forfeited without the issuance of shares of common stock, the unissued or reacquired shares, which were subject to the RSU, shall again be available for issuance pursuant to the 2017 Plan. </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i3bd8ed536e0842c19f70a7ef18d109dd" continuedAt="i24fea119115e423daaeffa68d6495a98"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares, terms, and vesting periods are determined by the Company&#8217;s Board of Directors or a committee thereof on an award-by-award basis. RSUs granted to employees generally vest ratably over <ix:nonNumeric contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQzOTgwNDY1MTc5NzM_d9c330ac-779a-4d40-a7ce-205ffdec5d2a">four years</ix:nonNumeric> from the month of the anniversary date in which the RSUs are granted. Options and RSUs granted to our non-employee directors vest in full upon completion of <ix:nonNumeric contextRef="ib74ba2f47ec14d41bf4fd7f946d4e02f_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzExNTQ0ODcyMTAyNTM0_57fcc02e-7d0d-4ae0-9a89-ff4413fb2d46">one year</ix:nonNumeric> of service on the anniversary following the date of the grant. Options generally vest ratably over service periods of <ix:nonNumeric contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzExNTQ0ODcyMTAyNTU4_f92ed507-1f5a-4152-81aa-fb6b6b973817">four years</ix:nonNumeric>. Options granted after December 5, 2012 expire <ix:nonNumeric contextRef="idd2633e1f6014c3f8b71c92e1326ca6e_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQzOTgwNDY1MTgwMjc_3a1b9485-f6d6-40fb-ae86-52099e3927c6">eight years</ix:nonNumeric> from the date of grant, and options granted prior to that date generally expire <ix:nonNumeric contextRef="i56adf440338546748219fa30995a4533_D20200701-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQzOTgwNDY1MTgwNDA_01fa1684-1fbe-4788-80c7-34ee64365fe0">ten years</ix:nonNumeric> from the date of grant. In September 2014, the Company began generally issuing RSUs in lieu of stock options.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of RSUs awarded to certain executive officers that ultimately vest may be increased or reduced based on certain additional performance and market conditions. The performance and market conditions associated with awards granted during the transition period ended December 31, 2020 include vesting that is based <ix:nonFraction unitRef="number" contextRef="ib34f688522b74b03a5e5fc2174018149_D20200701-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE0MjkzNjUxMTcyMjg5_01653195-af6d-44f4-b2ce-6a106e8fe9f6">50</ix:nonFraction>% on achieving certain levels of earnings per share targets, and <ix:nonFraction unitRef="number" contextRef="i7d7cae64d7814598b02a93c49e574096_D20200701-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE0MjkzNjUxMTcyNDE5_65a5d1f3-70d6-4ae4-9054-6f1cf97c91d8">50</ix:nonFraction>% based on achieving certain performance targets compared to the performance of the Nasdaq Healthcare Provider Index. The Company estimates the likelihood of achievement of performance conditions at the end of each period. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the transition period ended December 31, 2020, the Company granted stock-based awards to the Company's President and Chief Executive Officer as an inducement material to his commencement of employment and entry into an employment agreement with the Company. The awards that were granted consist of time-based RSUs as well as RSUs that have the same performance conditions as other executives discussed in the preceding paragraph. The awards also consist of time-based stock options as well as stock options with market-based vesting conditions based on achievement of certain levels of Myriad's stock price for a period of <ix:nonFraction unitRef="d" contextRef="i7db90b2bd66041aca744d0be2fd86e66_D20200701-20201231" decimals="INF" name="mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQ5NDc4MDIzMzkxNDU_f90d3fe1-b2cc-4dc8-90a3-1022fa2664be">20</ix:nonFraction> consecutive days. The inducement awards were made in accordance with Nasdaq Stock Market rules and were not made under the Company's existing equity plans. The inducement awards are included in the tables presented. </span></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjc_107f8b9b-242a-49f8-b561-98556261b976" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the Company's equity plans, including the Company's inducement awards, is as follows for the transition period ended December&#160;31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"></td><td style="width:73.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(number of shares in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzEtMS0xLTEtMA_becc89e0-8f43-4fb8-9f1f-0de0281824a6">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzEtMy0xLTEtMA_4bb0f2f8-48c4-4434-a776-c8c2cff7c170">24.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzItMS0xLTEtMA_cc1b46f0-c265-47de-8ddd-40c726dede6a">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzItMy0xLTEtMA_b01dc8ad-fc65-451b-9e4d-ce9fa6cfb267">13.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzQtMS0xLTEtMA_9a215876-8ee7-4228-af58-69415c115100">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzQtMy0xLTEtMA_5ca9ddc5-44ae-449e-b915-075d11864531">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options canceled or expired</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzUtMS0xLTEtMA_a70699a9-baa7-4e28-8c65-bedeb3dac1b6">0.3</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzUtMy0xLTEtMA_7631d4b1-cbee-4c41-9ecf-29d8db23e6ef">19.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at end of period</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzYtMS0xLTEtMA_127b6214-bf6b-44b8-8994-9b68c8816062">5.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzYtMy0xLTEtMA_eb838e12-f461-4e08-949d-55041549d251">23.24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at end of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzctMS0xLTEtMA_a0fcedae-6025-4ede-a43f-09896899c0b5">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzctMy0xLTEtMA_889e8500-6521-4f52-b420-4ade9c37687b">24.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzgtMS0xLTEtMA_53202144-093b-4465-976a-469b675d4a57">5.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzgtMy0xLTEtMA_7849ba13-634f-4740-af7a-d2ea979e6375">23.24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options granted is estimated on the grant date using the Black-Scholes option-pricing model except for options with a market condition, which are valued using a Monte Carlo Simulation. The fair value of the stock options is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQ5NDc4MDIzMzU4NzY_7fe36ee2-684f-40b3-8177-cacb78115d5d" continuedAt="ie2a56baf3b3643bfb3bb4ea472f45197" escape="true">During the transition period ended December 31, 2020, the valuation assumptions used for stock options were as follows:</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><ix:continuation id="ie2a56baf3b3643bfb3bb4ea472f45197"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.826%"><tr><td style="width:1.0%"></td><td style="width:80.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzItMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo0NzRiZTBhZTUzZDc0OTE5ODNiZTNjZGY2Njg5MjhlM180OTQ3ODAyMzI1MDEx_445436c8-4b16-44c2-ba00-76e4e7576881">0.3</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzItMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo0NzRiZTBhZTUzZDc0OTE5ODNiZTNjZGY2Njg5MjhlM180OTQ3ODAyMzI1MDE4_7d6359b3-6798-4ed0-87f5-57da21e27908">0.5</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzMtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo3YzRkMTZmM2FmZGQ0M2E4OTUzNmM5YTZmZGE5ZDU4Nl80OTQ3ODAyMzI0OTk4_0b79a531-6943-43f1-8b7b-ccf1ed05c2eb">&#8212;</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzQtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjpkZjVhMjEwM2EzMWU0MTVlOGM0NDZlYmFkNGJkNGEyOF80OTQ3ODAyMzI1MDA0_47631752-8210-4a71-a9b5-9b2d0c9c7ea7">4.75</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derived service period (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" format="ixt-sec:duryear" name="mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzUtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo5ZDBiYmFhMjk3OWE0OWEwYmQwNjE2ZTMzY2ZjMzUwZl80OTQ3ODAyMzI1MDA0_91917690-8ede-44de-b34d-7e4474f21762">1</ix:nonNumeric> - <ix:nonNumeric contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" format="ixt-sec:duryear" name="mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzUtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo5ZDBiYmFhMjk3OWE0OWEwYmQwNjE2ZTMzY2ZjMzUwZl80OTQ3ODAyMzI1MDEw_4d8d8180-1303-4fb3-8e65-7bf8fc2cb647">2.6</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzYtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjpjNWI4Yzg0NjllOGQ0MWI4YTlhMjVhYTQ4MmI5NDMwOV80OTQ3ODAyMzI1MDA4_a51ad6d2-4cd3-4df4-bb38-24b2a9c2e8e7">73</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzYtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjpjNWI4Yzg0NjllOGQ0MWI4YTlhMjVhYTQ4MmI5NDMwOV80OTQ3ODAyMzI1MDE0_d6248ac5-57f6-4bb4-a4fe-b5dd8c7b7a25">77</ix:nonFraction>%</span></div></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i24fea119115e423daaeffa68d6495a98" continuedAt="ica8b0d4621a74637851f5ae55969ec3b"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE2MDQ_366516d9-74f0-4450-8f43-a4e281ae6bf2"><ix:nonFraction unitRef="shares" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE2MDQ_7f803449-094f-4028-a0e8-cb90d3620f5a"><ix:nonFraction unitRef="shares" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE2MDQ_c928c1bb-b175-4020-bc76-fa2a43c69dda">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> options granted during the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjI_ccb386a9-19e4-44bb-a3ec-8dce669fda89" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at December&#160;31, 2020 (number of shares in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:59.909%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options outstanding and exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of<br/>exercise<br/>prices</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number outstanding at December 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual<br/>life (years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc558508c633449db6077544b82b507d_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItMC0xLTEtNjE4NC90ZXh0cmVnaW9uOmNiNWYxZmVjZTBlYzQzY2RhZGExNzRiZDEzYjYzNDJmXzQ5NDc4MDIzMjUwMzQ_bea36062-25a1-49c2-8eff-08536b104181">13.38</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="ifc558508c633449db6077544b82b507d_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItMC0xLTEtNjE4NC90ZXh0cmVnaW9uOmNiNWYxZmVjZTBlYzQzY2RhZGExNzRiZDEzYjYzNDJmXzQ5NDc4MDIzMjUwNDI_817eaa97-8c6d-41f3-a306-8f1795b664ab">19.47</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29183a8749ff4b8b950a784fb91f41f1_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItMi0xLTEtMA_ff9cdea1-0d75-44ea-9c21-b70a31e9b242">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifc558508c633449db6077544b82b507d_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItNC0xLTEtMA_4704b00e-50db-48f0-a5fa-7ac5c62fdd55">2.92</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29183a8749ff4b8b950a784fb91f41f1_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItNi0xLTEtMA_61d302ef-f95e-44dd-8249-d284fb5df73a">19.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4d8a6bd4ff54f7fb304b7cde55db513_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjU2NWY1YmEzMjY2MTQwMTliYTkzNzI0NTY4OWE4YTU5XzQ5NDc4MDIzMjUwMjQ_3739ba4f-34eb-4eea-9bf4-c2d40592c4a7">21.29</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="ie4d8a6bd4ff54f7fb304b7cde55db513_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjU2NWY1YmEzMjY2MTQwMTliYTkzNzI0NTY4OWE4YTU5XzQ5NDc4MDIzMjUwMzI_ad378644-f102-4285-ad57-390c2c9dd163">25.39</ix:nonFraction></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if914d6dc8c544ca9bf117a7b245ae056_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtMi0xLTEtMA_635f27cb-4e49-4fd8-9126-a6660957e7e8">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie4d8a6bd4ff54f7fb304b7cde55db513_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtNC0xLTEtMA_18a8beb8-691b-460a-9e16-60ff83146972">0.98</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if914d6dc8c544ca9bf117a7b245ae056_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtNi0xLTEtMA_ccd588ea-228a-4ab3-938d-e51b33c07123">23.97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4b2ee9bf2f354a29b8a1b740bfdc485c_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjVmYmRlMmYzM2ZhZDQxN2U4ZmUzZmU1MjM1ZjUwNTljXzQ5NDc4MDIzMjUwMTQ_f419f019-875b-41fe-b099-126e3474f034">26.49</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i4b2ee9bf2f354a29b8a1b740bfdc485c_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjVmYmRlMmYzM2ZhZDQxN2U4ZmUzZmU1MjM1ZjUwNTljXzQ5NDc4MDIzMjUwMjI_d36b9d06-cc3e-4613-9c58-470b028e6c77">26.49</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea4af06edff047ee8cd215ccaf7dd5a2_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtMi0xLTEtMA_8f3dac2b-05be-49e4-8cc6-91256d141ed4">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4b2ee9bf2f354a29b8a1b740bfdc485c_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtNC0xLTEtMA_7a8b11cc-96e9-4517-bc7f-af9c1b332a5a">0.70</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iea4af06edff047ee8cd215ccaf7dd5a2_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtNi0xLTEtMA_4ddcdc0f-294a-449a-b821-40e7c1e4a83d">26.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4ba05d7b0e05418d9b5864d5649ff8a3_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjNkZWJmNWNmMzcxOTQxZTZhN2JhMTdmMWQzMDY5NjA5XzQ5NDc4MDIzMjUwMTQ_c2236a6d-7253-4a58-92e3-356e31909890">27.07</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i4ba05d7b0e05418d9b5864d5649ff8a3_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjNkZWJmNWNmMzcxOTQxZTZhN2JhMTdmMWQzMDY5NjA5XzQ5NDc4MDIzMjUwMjI_87830394-070a-4298-826d-77d77892f863">36.55</ix:nonFraction></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8e685bf03924016a2c1ce3f87d79686_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtMi0xLTEtMA_c9306071-0dfc-48f9-b61c-53c09f8338b5">1.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4ba05d7b0e05418d9b5864d5649ff8a3_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtNC0xLTEtMA_21e41533-9a82-41b4-a9f7-0e4db50895d3">1.69</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8e685bf03924016a2c1ce3f87d79686_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtNi0xLTEtMA_f460e111-b71f-40b8-b58f-171b23deab7d">27.18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzYtMi0xLTEtMA_00bd8d23-8f69-49b0-939b-db8b29790241">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzYtNC0xLTEtMA_03df647f-f748-4caa-95ac-2d1e2dbb7f45">1.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzYtNi0xLTEtMA_246151a6-c6f3-4ab1-b663-1d7035af1c8e">24.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 there was $<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE0MjkzNjUxMTcxODU4_9c20c990-45aa-43b2-a74b-7035180d5561">4.6</ix:nonFraction> million of unrecognized share-based compensation expense related to the inducement stock options that will be recognized over a weighted-average period of <ix:nonNumeric contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQ5NDc4MDIzMzU5NDk_44a62999-aa7c-4fb9-9eff-26aa42b013de">2.5</ix:nonNumeric> years. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjg_ac87e662-824d-407d-aef6-f6432d05a6de" escape="true"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the RSU activity under the Company's equity plans, including the Company's inducement awards and RSU awards with performance metrics, is as follows for the transition period ended December 31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:73.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(number of shares in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05899c67f3004572be84cd6af2e63fe0_I20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzItMS0xLTEtMA_ca751f6e-3b08-472e-9fe0-49ec3cf985b6">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05899c67f3004572be84cd6af2e63fe0_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzItMy0xLTEtMA_419c94c4-d74b-4b08-9049-e4ccff6efc05">32.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzMtMS0xLTEtMA_f0e8e3fd-ea26-4c90-912f-0010f5a89100">2.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzMtMy0xLTEtMA_6de6a903-e723-49d2-a9fe-78ba33f454ac">13.69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzUtMS0xLTEtMA_47cb4561-b763-4f6c-9126-0b64b14d7493">0.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzUtMy0xLTEtMA_b0a536e0-f906-4552-829c-83913c2996bf">32.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs canceled</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzYtMS0xLTEtMA_393fbda3-8103-4d2b-88c4-b8b7b7bfa56d">0.3</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzYtMy0xLTEtMA_6f19c6e9-b499-4da6-9258-8b4bfc6ee224">31.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs outstanding at end of period</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzctMS0xLTEtMA_040de222-70b4-4dbb-9f3e-8efb2062c469">3.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzctMy0xLTEtMA_9f807336-22b0-4748-bb4c-1935d7a7753b">20.56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant-date fair value of restricted stock units grants during the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 was $<ix:nonFraction unitRef="usdPerShare" contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQzOTgwNDY1MTk1NTg_6de6a903-e723-49d2-a9fe-78ba33f454ac">13.69</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="if13ddbf93c05491fb76d747f160a6ad5_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIwMDM_b7e989dc-b0a6-4852-b522-dc3eed45d972">27.96</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i38be9b78e6e342588bbc14159dd49ce3_D20180701-20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIwMDc_74551937-3ec6-4d0f-b341-77789ff5db4b">46.62</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i0ab2a24695d64791be56bebc9b0cb5c2_D20170701-20180630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIwMTQ_be7a5232-30b3-4351-9ef4-9a6bead4d42c">32.67</ix:nonFraction>, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units that vested during the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 was $<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzI3NDg3NzkwNzkzMzE_06b14256-023f-4f8d-a090-d0d3691950bb">29.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="if13ddbf93c05491fb76d747f160a6ad5_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIxMTc_b71483b4-bd0d-46ca-b3d5-5af6b95eea67">32.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i38be9b78e6e342588bbc14159dd49ce3_D20180701-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIxMjE_448ce040-adb4-4dcf-8047-d75476ca7822">27.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0ab2a24695d64791be56bebc9b0cb5c2_D20170701-20180630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIxMjg_5a930ce0-7fdc-428b-ae9d-67ce0c5848b6">20.4</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIxNjY_7002effa-b0aa-41fd-8182-22f2d488c79b">54.3</ix:nonFraction> million of total unrecognized share-based compensation expense related to RSUs that will be recognized over a weighted-average period of <ix:nonNumeric contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIyOTk_37dc0086-4fae-4999-9a34-10c662a81151">2.7</ix:nonNumeric> years. We expect all unvested awards to vest and recognize forfeitures as they occur.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="ica8b0d4621a74637851f5ae55969ec3b" continuedAt="if4beb69ac2b24d9c9d9c583039158544"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjM_1aed0b69-1f31-4e98-b65f-e9bc86f60705" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense recognized and included in the Consolidated Statements of Operations were as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43833f7c5d3b4c9c95d487f7e63e9156_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzItMS0xLTEtMjA4Mw_0dddd856-4b5c-440f-8974-49c79ddcd695">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bfbbfa5a61e4bc6aa5bdeaa03ce3091_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzItMS0xLTEtMA_bcd5e041-e504-4610-9592-60c4f010c6cb">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id248408952024238bf703d63749f4e7a_D20180701-20190630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzItMy0xLTEtMA_271d9596-cd73-4015-b3d1-2462344d7459">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1127c488310e4180956064bbc8092648_D20170701-20180630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzItNS0xLTEtMA_fb6e9667-6c53-477d-9d0b-26c0b0f8b94b">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02292b2ac40d46f0810c4f1a5b7d76a1_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzMtMS0xLTEtMjA4Mw_8732576a-9f51-4021-b06a-048c36201d0e">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c834bbd0ecb46ad9e21a66915c89bee_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzMtMS0xLTEtMA_41dfeaea-de4d-42a2-b741-17c7b9b98aaf">0.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7909094154b445eb24949027733ca0d_D20180701-20190630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzMtMy0xLTEtMA_4f622852-42e5-4493-b71e-32e42f68fc04">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69beccee306244899e7edc744b9830e8_D20170701-20180630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzMtNS0xLTEtMA_6f10ca92-9d28-4df6-a711-552c60e60b6e">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684fee383d8541d38b5854aeea927eef_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzQtMS0xLTEtMjA4Mw_c677ba38-cb2d-4cc9-961a-69b8766838e7">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccae9b334463460489fb7e7e124291af_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzQtMS0xLTEtMA_2fc149ee-526e-466d-a3cc-bcb87d6eb8cf">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d841afaaabb47038d152a7cc4778e70_D20180701-20190630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzQtMy0xLTEtMA_f9e8f806-7626-407d-a561-8a257b21ffa7">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670c9600a2a343be93044b942108970a_D20170701-20180630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzQtNS0xLTEtMA_9a7b0182-e755-4a4d-adcb-4276673eaae1">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie295001ae44145ad9a4d6b31fb6ba297_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzUtMS0xLTEtMjA4Mw_30178049-034e-4f3b-bf7d-6eda91e9b209">11.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31d63dfe2df342b8b82f3e732ee0282e_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzUtMS0xLTEtMA_f77db6ca-b0fd-4b9e-9346-f582a87282c4">18.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d855b4fd3e14b829f9b52d5ab9a2dec_D20180701-20190630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzUtMy0xLTEtMA_a6baf21f-bb97-4160-9e7b-075e872777b2">27.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied19858901194f0fb47bb12a54ee79e3_D20170701-20180630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzUtNS0xLTEtMA_dc08a109-33e5-4895-a059-161776c6a283">21.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzYtMS0xLTEtMjA4Mw_95c2b7da-c97e-4a23-9d46-bd97a601a425">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzYtMS0xLTEtMA_5792726e-88f5-4b68-9240-02f62a90099e">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzYtMy0xLTEtMA_eb53bc0c-49c7-4671-be18-cbe5557f7700">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzYtNS0xLTEtMA_1a0aee61-18f7-4309-a815-f0c9725d27f0">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjQ_79c2ecba-7eef-49f2-ad16-548087742a56" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has unrecognized share-based compensation cost related to share-based compensation granted under its current plans.&#160;&#160;The estimated unrecognized share-based compensation cost and related weighted average recognition period, aggregate intrinsic value of options outstanding, aggregate intrinsic value of options that are fully vested and aggregate intrinsic value of RSUs vested and expected to vest is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:86.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of<br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized share-based compensation cost</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZToyOTk3OWQ2ZDc2NWM0MGExYTc5MDZmYjE2NjBhMzFlMS90YWJsZXJhbmdlOjI5OTc5ZDZkNzY1YzQwYTFhNzkwNmZiMTY2MGEzMWUxXzEtMS0xLTEtMA_7b979a3c-d015-4a3d-a083-daa8dfaa553a">54.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of options outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZToyOTk3OWQ2ZDc2NWM0MGExYTc5MDZmYjE2NjBhMzFlMS90YWJsZXJhbmdlOjI5OTc5ZDZkNzY1YzQwYTFhNzkwNmZiMTY2MGEzMWUxXzItMS0xLTEtMA_47302fe9-3a38-4682-860f-d1b5455459f3">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of options fully vested</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZToyOTk3OWQ2ZDc2NWM0MGExYTc5MDZmYjE2NjBhMzFlMS90YWJsZXJhbmdlOjI5OTc5ZDZkNzY1YzQwYTFhNzkwNmZiMTY2MGEzMWUxXzMtMS0xLTEtMA_58a82f03-1467-4230-97cd-d673daf093f8">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of RSUs outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZToyOTk3OWQ2ZDc2NWM0MGExYTc5MDZmYjE2NjBhMzFlMS90YWJsZXJhbmdlOjI5OTc5ZDZkNzY1YzQwYTFhNzkwNmZiMTY2MGEzMWUxXzQtMS0xLTEtMA_193bdb0e-4854-402e-b1e8-a0f85f9153f0">63.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjk_97a09767-ec44-4a79-afb3-06f5f86cdae3" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised was as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of options exercised</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo0YzhmMmVlZWZlNWI0Y2FlYTQzZDFjNzk2OTM5MGJjNy90YWJsZXJhbmdlOjRjOGYyZWVlZmU1YjRjYWVhNDNkMWM3OTY5MzkwYmM3XzItMS0xLTEtMjA5Mw_e64d69f3-2167-4cbe-9441-97cee3744f53">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo0YzhmMmVlZWZlNWI0Y2FlYTQzZDFjNzk2OTM5MGJjNy90YWJsZXJhbmdlOjRjOGYyZWVlZmU1YjRjYWVhNDNkMWM3OTY5MzkwYmM3XzItMS0xLTEtMA_8928d54f-31d3-4d92-be75-c31fc1f5aab7">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo0YzhmMmVlZWZlNWI0Y2FlYTQzZDFjNzk2OTM5MGJjNy90YWJsZXJhbmdlOjRjOGYyZWVlZmU1YjRjYWVhNDNkMWM3OTY5MzkwYmM3XzItMy0xLTEtMA_6738f130-19fe-409f-a8d3-733568d01544">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo0YzhmMmVlZWZlNWI0Y2FlYTQzZDFjNzk2OTM5MGJjNy90YWJsZXJhbmdlOjRjOGYyZWVlZmU1YjRjYWVhNDNkMWM3OTY5MzkwYmM3XzItNS0xLTEtMA_a0bafe99-cf7a-438a-86b1-0724cf60efbe">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2012, following stockholder approval, the Company adopted the 2012 Employee Stock Purchase Plan (the &#8220;2012 Purchase Plan&#8221;), under which <ix:nonFraction unitRef="shares" contextRef="i2ad05ffee6ab407185af3f3ebf0e736f_I20121205" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzMyMjg_055bdd6f-74b9-472e-9f90-76b7a75a04b7">2.0</ix:nonFraction> million shares of common stock have been authorized. Shares are issued under the 2012 Purchase Plan twice yearly at the end of each offering period. At December&#160;31, 2020, a total of <ix:nonFraction unitRef="shares" contextRef="if5e8d6c3e7334a0db7f88d66dc52bdb9_D20121205-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzMzOTA_2c5eb148-0e7c-4f8b-a68a-4a033de5a9a8">1.8</ix:nonFraction> million shares of common stock had been purchased under the 2012 Plan. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMzA_110e4995-a8cd-4d91-9e10-71072e1ea1cd" continuedAt="i566935c88c0f4c4f8870b5daf531859c" escape="true">Shares purchased under and compensation expense associated with the 2012 Plan for the years reported are as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i566935c88c0f4c4f8870b5daf531859c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under the plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzItMS0xLTEtMjEwNA_188a0fac-5ba7-4441-9c60-3aea3939331a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzItMS0xLTEtMA_a9fdcd83-d92d-474d-ac07-db8cca323178">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzItMy0xLTEtMA_e7929305-0913-42cc-9024-a0e8e7158c29">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzItNS0xLTEtMA_cccb10b8-0d5b-43a4-8854-dc1473c1e264">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan compensation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzMtMS0xLTEtMjEwNA_9a73cbae-49ae-4b24-ba36-b40deef63a13">0.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzMtMS0xLTEtMA_66b777ed-6c86-4290-a157-3b2922caa74c">1.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzMtMy0xLTEtMA_de2e80ae-e02e-4673-a8ad-a3a3675b7725">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzMtNS0xLTEtMA_74ef13cd-99b1-4103-af03-ef5eb9838ea5">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From June 1, 2017 through May 31, 2018 there was an amendment to the 2012 Purchase Plan implemented such that the plan was non-compensatory.&#160;&#160;As of December&#160;31, 2020, there is $<ix:nonFraction unitRef="usd" contextRef="ieaf36f83f64d4f13b41bbd03dd9248e5_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzM3MzY_fc08c755-dde6-48f8-960d-dbd4d5ee35df">0.5</ix:nonFraction> million unrecognized share-based compensation expense related to the 2012 Purchase Plan.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="if4beb69ac2b24d9c9d9c583039158544"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjU_8c781ad0-f6db-42e3-a8fd-c0845cfb997d" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of shares issued under the Plan that was in effect for each period reported was calculated using the Black&#8209;Scholes option-pricing model using the following weighted-average assumptions:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:47.676%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzEtMS0xLTEtMjExNg_7d994fe1-6362-4d06-b844-06e9fc5f64b8">0.2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzEtMS0xLTEtMA_9c6e87b7-e958-40ef-bae2-14eebf624eeb">1.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzEtMy0xLTEtMA_90b261f0-5460-4179-a70c-6ac07630327c">2.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzEtNS0xLTEtMA_cdeda71f-d994-437e-be8b-70271a5553af">2.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzItMS0xLTEtMjExNg_42963fe8-b865-46a2-bd47-bf86e73ebc1a">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzItMS0xLTEtMA_56d6e810-b7c1-49ab-b863-690bff3ea7db">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzItMy0xLTEtMA_caa0d8c0-e10d-4bea-8f4b-ecac0b7d9fa7">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzItNS0xLTEtMA_abd88dab-9493-4404-bd75-c46e74e2d155">&#8212;</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzMtMS0xLTEtMjExNg_936bf362-9799-4915-b5f8-f5f39e4bec01">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzMtMS0xLTEtMA_d8cea9ff-b62f-4e74-a616-f6c27375e98c">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzMtMy0xLTEtMA_34fa5206-61e8-489f-b76c-ba7d270644b1">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzMtNS0xLTEtMA_14211879-1197-4260-82a2-cc822bc3c18a">0.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzQtMS0xLTEtMjExNg_c70a2b37-4601-4e9b-9b87-6d7cec6c2549">94</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzQtMS0xLTEtMA_330dd556-316d-4f3e-94b8-6cbb050a1a6a">99</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzQtMy0xLTEtMA_e5823e07-6344-45fd-a087-b7768f415989">55</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzQtNS0xLTEtMA_569cd378-4f7c-492f-9283-8b937d0681cb">45</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_148"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxODg_7c00daee-73f7-4e47-8210-cc13613bdd0a" continuedAt="i4d7cdf8b4f0e4e038baa2dabc3785f20" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i4d7cdf8b4f0e4e038baa2dabc3785f20" continuedAt="i36ca79830d794aa5b652a2b4ceb0cff0"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxODk_b725591a-f06b-4b95-aa6b-d95809dc7eb4" escape="true"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit consists of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzMtMS0xLTEtMTMwMzI_4e8b956c-4591-4990-a2cd-be9950c31d7a">75.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzMtMS0xLTEtMA_5ec77349-9b26-4520-93c9-3727d99299c5">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzMtMy0xLTEtMA_bff58095-5f42-427a-a5ae-2b19306f1693">24.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzMtNS0xLTEtMA_af259b8b-8207-47ad-b7d9-ef8b8c551537">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzQtMS0xLTEtMTMwMzI_5fae198f-c33f-4693-89bd-319817d998e2">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzQtMS0xLTEtMA_a707595c-ec71-4237-9b63-6fa8c925d08e">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzQtMy0xLTEtMA_2bbdf08b-cfa2-4a31-8bbe-4ecd7ef973cd">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzQtNS0xLTEtMA_4eb39390-25f7-4fa4-b089-1232c6cbc695">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzUtMS0xLTEtMTMwMzI_ef1a2a09-92ab-4edc-85bb-95a010bb8eac">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzUtMS0xLTEtMA_2e9ae9c3-f827-4691-8a71-6ec5e4554b44">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzUtMy0xLTEtMA_39b8bbe3-a60f-4df5-bb32-110b08f49437">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzUtNS0xLTEtMA_89a971ed-9498-45cc-b4d0-84785ea04f33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzYtMS0xLTEtMTMwMzI_a08516fd-baca-4800-b8a0-c17926e7f46b">76.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzYtMS0xLTEtMA_1858c20d-638d-41f4-8f01-6389d0c95526">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzYtMy0xLTEtMA_9ee1f9cf-d4b6-4bd0-b43e-da30ae3212c6">24.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzYtNS0xLTEtMA_207c668c-3468-4a62-8230-e298ef13d541">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzgtMS0xLTEtMTMwMzI_56b4adae-81b3-41e9-8f25-a1bd13888710">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzgtMS0xLTEtMA_087f93d8-c029-4efc-81f0-58b9c9378d18">51.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzgtMy0xLTEtMA_83f4cd3c-e865-46a0-bf76-d58b7665107c">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzgtNS0xLTEtMA_bdca5750-d601-4e3b-902e-4ef6e9b084c2">22.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzktMS0xLTEtMTMwMzI_170378c7-bcdb-4dbd-813d-c7a7e0e786ab">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzktMS0xLTEtMA_64078293-5086-4804-8726-3621512f73b5">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzktMy0xLTEtMA_271efd72-085d-47e4-beae-61aafc9af0dd">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzktNS0xLTEtMA_c53340e4-7e49-4306-b57e-0436ba448691">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEwLTEtMS0xLTEzMDMy_4a89fdee-0474-4730-9d21-cb569319a0c7">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEwLTEtMS0xLTA_f1f2102c-27e4-4ba2-aa87-3c80fe4567fa">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEwLTMtMS0xLTA_55f7aaeb-d0d1-4149-8606-1b67b65a29d6">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEwLTUtMS0xLTA_e275a326-5b8a-4238-9f8d-a20e37f85372">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzExLTEtMS0xLTEzMDMy_50b2a8fc-141c-4fb0-a966-994ceaf7b657">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzExLTEtMS0xLTA_0dc68a3d-a073-424b-a049-3e57569d4faa">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzExLTMtMS0xLTA_d8904f9c-1561-4856-b75a-a68f032d1430">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzExLTUtMS0xLTA_efd3baca-24be-4857-a1f5-6c94fe7065d0">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEyLTEtMS0xLTEzMDMy_bc287499-7b43-43ef-943e-ea4925485334">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEyLTEtMS0xLTA_8ef9ecb2-ec29-4bf4-a815-dfc2b2333145">55.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEyLTMtMS0xLTA_bc9e650b-5645-47a2-a57d-2ab18329b1ab">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEyLTUtMS0xLTA_c286d76a-ac92-4747-94d4-f1d16213c6c3">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEzLTEtMS0xLTEzMDMy_2cce8398-3712-475d-9ce8-b790354c7ba5">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEzLTEtMS0xLTA_2150359c-4b9b-4b51-bab6-a15b5fcce93f">23.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEzLTMtMS0xLTA_b89ac5bc-ec00-4b7a-9538-954857e6a4a3">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEzLTUtMS0xLTA_1e65d060-683d-4ae6-bf0d-dabaf4ae24b9">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTA_711c732e-4df7-4d19-b55b-475493b288e7" escape="true"><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes consists of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"></td><td style="width:47.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzItMS0xLTEtMTMwNjc_a5955165-3dc8-4bfe-8428-a7495fa439a3">101.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzItMS0xLTEtMA_24d28621-c06b-41f2-9483-9859f290a527">240.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzItMy0xLTEtMA_c236de27-600d-4633-ad25-adb8d3a1a1ae">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzItNS0xLTEtMA_06b4a563-3444-4d48-b1b7-9789a6238531">122.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzMtMS0xLTEtMTMwNjc_4a13d3af-f142-4cd6-a9d8-0975584408e6">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzMtMS0xLTEtMA_151c2ee6-4d5b-44d8-8bc4-5c393291427c">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzMtMy0xLTEtMA_c390c60c-e64c-43f4-9e2d-4a9c4471ec16">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzMtNS0xLTEtMA_2ab519f2-621f-42b9-978c-b736e0599a6c">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzQtMS0xLTEtMTMwNjc_c4c715d7-7079-4609-a2c0-4d648d719c2f">94.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzQtMS0xLTEtMA_3bb7f386-d61c-41d6-98b5-b1246fe08471">223.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzQtMy0xLTEtMA_5f621e0b-391a-4339-9027-a73c97a67f12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzQtNS0xLTEtMA_3c76eb99-ad4b-4342-9405-a708200ffe59">120.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i36ca79830d794aa5b652a2b4ceb0cff0" continuedAt="i5266d094e7784a3eb5355a245b4ea9ac"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTE_370d2ac3-6755-407e-b590-c38ba116982b" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between income taxes at the statutory federal income tax rate and income taxes reported in the consolidated statements of operations were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.369%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.369%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.880%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax expense at the statutory rate</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMS0xLTEtMTMwNzI_aabcb449-73c2-4db5-ac3d-09100739e38e">19.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMy0xLTEtMTMwNzI_8ffb307b-3032-4d82-8b62-9741fad28f2e">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMS0xLTEtMA_f0d936da-ee0d-4f82-95ca-f2b16cdaba25">46.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMy0xLTEtMA_875ef5f8-e9d7-45f9-b1c0-c853dae58eb8">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItNS0xLTEtMA_988bb2d7-5911-4d52-8fea-5f3978ff2ea4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItNy0xLTEtMA_4aa690e1-b634-456d-ada6-e2ecfa862475">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItOS0xLTEtMA_df684c6e-7081-4d57-9ebf-1c657d61c942">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMTEtMS0xLTA_ca04cee2-168a-48b8-97b3-e43a23a9218a">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMS0xLTEtMTMwNzI_e44d2e9c-c4ed-40ea-94e8-38645844a84c">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMy0xLTEtMTMwNzI_31c24354-20ca-4405-b7eb-0ad3be826309">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMS0xLTEtMA_60884b48-7464-4b26-bff1-99ecade2def2">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMy0xLTEtMA_555f9d1a-9266-4387-8fb3-c732cebff3d3">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtNS0xLTEtMA_3f613db5-e54d-44f7-9684-87d6eb6ca3d7">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtNy0xLTEtMA_dafc0a3a-29db-4b45-9488-91c8f3c76c40">6,422.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtOS0xLTEtMA_b5412288-a6af-4ab5-ab31-740f0fb99378">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMTEtMS0xLTA_5977a1fa-ebdf-4736-8866-3a729a222559">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development credits, net of the federal tax on state credits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMS0xLTEtMTMwNzI_4664fdbf-240b-4517-8e35-ccdcfb0791bf">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMy0xLTEtMTMwNzI_ab9e913b-525b-468c-bf8c-59358ec0395f">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMS0xLTEtMA_3d5744e0-8775-4aa3-96b5-3cc04fc0bbfa">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMy0xLTEtMA_325a1bf1-35cd-465e-80fd-609ff9d3bdbf">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtNS0xLTEtMA_dbab0cf9-4e2f-4a4e-b790-637568452041">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtNy0xLTEtMA_138bfad3-d1bb-44b5-891d-d219d4793faf">11,880.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtOS0xLTEtMA_7ce1590e-7538-45de-a76a-dd64d60f8fd4">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMTEtMS0xLTA_4e153b76-51c3-40d4-b892-9ace52731f0c">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMS0xLTEtMTMwNzI_a6a315f3-9399-4e55-9e47-7d3896e5e6a9">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMy0xLTEtMTMwNzI_78405f0a-9d55-4275-a211-b5d9358c74ba">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMS0xLTEtMA_2cf0e126-3b7b-4f1e-b1f1-3655b5751ef7">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMy0xLTEtMA_88d2df4e-9f8b-49f2-98e1-b7aa9e01aad7">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtNS0xLTEtMA_781dd286-1daf-403c-adaf-6db4c65fc8fc">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtNy0xLTEtMA_40ea69c1-ef7f-44eb-ad43-20e1e925daa8">9,312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtOS0xLTEtMA_7514793f-b217-4b53-b0e2-32f87270c509">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMTEtMS0xLTA_66c93a9a-8847-4522-af24-41ca1b8297de">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertain tax benefits statute expired, net of federal benefit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="mygn:IncomeTaxReconciliationStatuteExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMS0xLTEtMTMwNzI_5b20628e-a11c-48aa-afbb-034288cd12f9">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" name="mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMy0xLTEtMTMwNzI_784cdacc-69c0-4f12-865c-4a6016cb50a2">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="mygn:IncomeTaxReconciliationStatuteExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMS0xLTEtMA_18f746a9-3444-4d57-a4af-1604f97115c0">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" name="mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMy0xLTEtMA_8a928c2d-2410-45c3-ad6a-76306ac91e93">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="mygn:IncomeTaxReconciliationStatuteExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtNS0xLTEtMA_d4ee5c0c-f395-4818-ac3b-9d5c6d2f4437">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" sign="-" format="ixt:numdotdecimal" name="mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtNy0xLTEtMA_8691750d-37d7-425e-aa8b-bdcbb143d563">22,798.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationStatuteExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtOS0xLTEtMA_9881070d-b6b3-4bc4-9a65-99602e91cedf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMTEtMS0xLTA_1a3e7447-c31c-418c-b214-4fea36dc7d41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incentive stock option and employee stock purchase plan expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMS0xLTEtMTMwNzI_e9a3a24f-16b2-4ef1-9d43-e241b6055150">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMy0xLTEtMTMwNzI_ed9d82b1-a147-49b9-8a73-e3a9f32683ef">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMS0xLTEtMA_86b027d9-1f03-45d6-87ad-87775c0c2628">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMy0xLTEtMA_6bde3868-2012-476f-8639-1ac2908fd033">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctNS0xLTEtMA_048f1722-e9c8-4029-9357-248a51a52b4b">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctNy0xLTEtMA_9c4d18ab-5130-4f13-97db-3374d75ba827">9,954.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctOS0xLTEtMA_70057864-0522-4ffb-a370-cbe54b3e1a68">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMTEtMS0xLTA_b8c0f04e-71ee-4538-84c1-86b68786d5ba">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMS0xLTEtMTMwNzI_3b0a59e2-9e01-4c47-b6ac-0f4826f865f6">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMy0xLTEtMTMwNzI_765a4a58-4b7f-4589-a440-fcee9b65bc11">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMS0xLTEtMA_2a8dd46d-b0ed-4cd5-ae4b-f3c12c5b82a9">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMy0xLTEtMA_7deafc65-0ab6-46d7-9375-981035483981">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtNS0xLTEtMA_2e1eef22-b0ad-4bc1-b0f2-e85b2fb2266e">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtNy0xLTEtMA_33a911b2-6341-4d46-9ab7-f9914b485580">2,568.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtOS0xLTEtMA_2086a009-b6ae-4fb5-a5fb-6f612ad71da9">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMTEtMS0xLTA_d1151461-6bd7-4b0f-bdf2-3e915a9457fa">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMS0xLTEtMTMwNzI_b9e32666-c149-40ca-af2f-57447b7e5a08">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMy0xLTEtMTMwNzI_d5f532b6-9142-4717-9069-dbcb9b08269d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMS0xLTEtMA_d8c1d968-ad68-44b2-9475-e1c54f3c7124">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMy0xLTEtMA_4772d642-bc4b-4585-a65e-24d45c23bade">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktNS0xLTEtMA_f9f1f6c3-d3b1-4a9b-ac86-64187b2d2d47">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktNy0xLTEtMA_6917971f-53d0-4167-ac7b-29e88911e947">642.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktOS0xLTEtMA_5e0aa7ac-f6fc-427f-a05b-dd37d31f33fc">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMTEtMS0xLTA_4730a525-1862-48d9-a11b-336ac210190b">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Cut and Jobs Act impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTEtMS0xLTEzMDcy_50096c14-9821-4b1b-b0ca-9543c8fd0131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTMtMS0xLTEzMDcy_cad28829-7e2a-4968-93dc-d43478e3052e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTEtMS0xLTA_7251e896-db71-4ce8-a870-57868bf44044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTMtMS0xLTA_07b4675e-99f7-4033-96af-76dcdee4fe5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTUtMS0xLTA_174343ee-0997-478e-b009-f69caea48877">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTctMS0xLTA_a6555dd4-fcee-4434-98c6-0360fe2185c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTktMS0xLTA_71a956ca-3467-4852-b8d4-c26d87e4519c">32.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" sign="-" name="mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTExLTEtMS0w_331bb5a6-6222-44b7-891b-11f4d6d0f3d5">26.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CARES Act</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="mygn:IncomeTaxReconciliationCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTEtMS0xLTEzMDg0_9338ee76-ef33-4f10-aa63-b80e2095a6a2">20.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="INF" name="mygn:EffectiveIncomeTaxRateReconciliationCARESAct" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTMtMS0xLTEzMDg0_c2752c10-d7ee-41ce-8581-29afd350c324">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value adjustments related to acquisition contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTEtMS0xLTEzMDcy_bf7c61b1-9a56-49d4-b28a-d01cb19a1d8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTMtMS0xLTEzMDcy_3cafd5ec-1153-45c2-ab7c-6d6cf1a3825e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTEtMS0xLTA_ad507f03-7657-4cff-b704-371ff42eb8ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTMtMS0xLTA_ee17a399-d98d-4123-869e-ff8ee82d0b48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTUtMS0xLTA_f6b1adf8-4b23-476d-9595-30d854302fb9">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" sign="-" format="ixt:numdotdecimal" name="mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTctMS0xLTA_1ca7c303-eace-4112-8d30-241b7bcebd00">2,568.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTktMS0xLTA_b1b27251-f4d1-4fcf-9fca-c7a005d7df21">17.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" name="mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTExLTEtMS0w_66cb1155-67aa-47a1-879d-093c4b791412">14.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible contingent purchase price and transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTEtMS0xLTEzMDcy_e82e629e-0f08-4529-bcf8-13321167618d">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" sign="-" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTMtMS0xLTEzMDcy_98ca87c5-d715-4af1-b995-c606a44e15b1">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTEtMS0xLTA_750c5b1e-8da6-4a0f-a6ab-bfe9dae1b8ab">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTMtMS0xLTA_4c6d2348-d50b-4fbe-a93d-a26fa552acaf">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTUtMS0xLTA_458d5dc8-7d8a-4617-8f22-fa90dda18bc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTctMS0xLTA_63a2f15e-1ffb-4677-b869-c558fae54ee2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTktMS0xLTA_0b8ff0e0-b35a-4f83-a060-0ee586b59b95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTExLTEtMS0w_35a44379-f0ad-486d-9cc0-db4e64fbf3b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTEtMS0xLTEzMDcy_7e073e0f-0ce8-4b1e-9b53-c532c7996ff7">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTMtMS0xLTEzMDcy_1cdbec03-ec8d-431d-bf95-95d15082eab8">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTEtMS0xLTA_f853a98e-f92e-40f7-97ab-de57f2186bad">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTMtMS0xLTA_160419b8-8f7d-4f55-ab3e-08c66e6ed3ea">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTUtMS0xLTA_3e7f37b7-e145-45ea-ad3a-4cca69ade49a">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTctMS0xLTA_8efd5acd-2192-430e-a919-d682ac05b5b7">4,174.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTktMS0xLTA_e5d7687c-41d7-4638-a456-5651e509c7cf">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTExLTEtMS0w_15aa7b79-c980-46c9-aa02-6f5bb8ae1de9">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTEtMS0xLTEzMDcy_0b8d9291-53ee-45d2-a319-6236a3178328">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" sign="-" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTMtMS0xLTEzMDcy_b7883d75-3384-447c-9799-82919d464221">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTEtMS0xLTA_886e7689-7c44-43d1-980e-f7a48b75392b">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTMtMS0xLTA_7a6473d2-a701-4219-847f-6d5a3701ee65">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTUtMS0xLTA_7984a768-1c59-401f-9d26-46b30e879adf">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:numdotdecimal" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTctMS0xLTA_6c1b4ff4-2ad4-4301-b91e-d55f98a49698">1,926.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTktMS0xLTA_5632e327-dc6a-416d-acdf-3e5ee9b95f9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTExLTEtMS0w_6c1db60f-70c5-4633-88eb-1e0b8cea52cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTEtMS0xLTEzMDcy_140ee4b3-9164-40ff-bb91-9c151d4ba352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTMtMS0xLTEzMDcy_13802005-25ec-4bd6-881c-1e2610dcb5c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:IncomeTaxReconciliationAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTEtMS0xLTA_a249f2b0-5dee-4b91-b474-3020700d98e2">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTMtMS0xLTA_7e93ca42-9e44-4d62-b2b6-c6e03328a0d7">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTUtMS0xLTA_3be502e4-c9f0-4e05-a6de-ef78ba595e77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTctMS0xLTA_37b44401-5dd8-4eab-96de-20fb3527d64f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTktMS0xLTA_b73118fa-babd-4321-bf89-93302d9c9b82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTExLTEtMS0w_f04fc8e0-c5e8-4299-8d3e-7e87e75e2432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired tax attributes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationExpiredTaxAttributes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTEtMS0xLTEzMDcy_229fd187-8048-480e-80c7-9de0c08ad6b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTMtMS0xLTEzMDcy_8776db27-e129-453a-91e9-3fe758668dd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:IncomeTaxReconciliationExpiredTaxAttributes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTEtMS0xLTA_7cc044d5-96f3-46b4-8376-345e74b39ae6">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTMtMS0xLTA_42e960de-f9bf-4e2b-8681-add970550221">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationExpiredTaxAttributes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTUtMS0xLTA_02430885-7be7-4324-8ac5-685626f5d5d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTctMS0xLTA_3f0dedad-0909-4e6c-84e9-38d6f1e5df42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationExpiredTaxAttributes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTktMS0xLTA_c964ad6a-1b9e-4873-b932-788ccb6afbd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTExLTEtMS0w_a920058c-fa93-40a9-b366-777ed076c59b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTEtMS0xLTEzMDcy_d86af89e-f0c8-473d-8b24-a8b328934363">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTMtMS0xLTEzMDcy_b9f219ea-e095-4307-9620-2b8785a3ee79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTEtMS0xLTA_b8f69cdd-e508-4474-ba34-537607ca2dab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTMtMS0xLTA_ae152a68-ca45-470a-bb41-6c3e77133c39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTUtMS0xLTA_866e54bf-7542-4f0b-9689-b52ec7d0a210">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:numdotdecimal" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTctMS0xLTA_569395f0-ee02-4e88-9801-2bdea5445b46">6,101.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTktMS0xLTA_62c29674-2270-46b5-a884-138783ad0016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTExLTEtMS0w_2e6ad592-0953-4195-9b4c-e1670402c16d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign disregarded election</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationForeignDisregardedElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTEtMS0xLTEzMDcy_d1d6881f-e914-4e92-b5a9-17034ba68d12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTMtMS0xLTEzMDcy_5bdc5c3e-cdf2-47e6-bfff-ca565927766d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationForeignDisregardedElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTEtMS0xLTA_08bf0988-c7d2-4162-8856-5bf9fe399474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTMtMS0xLTA_5429d412-c1f5-42de-85c8-6da2d1948078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:IncomeTaxReconciliationForeignDisregardedElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTUtMS0xLTA_f6957824-ee1d-48e3-9a44-e2299cdaf038">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" format="ixt:numdotdecimal" name="mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTctMS0xLTA_cb319e86-c24b-4282-a69d-2751003fb2bb">20,550.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationForeignDisregardedElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTktMS0xLTA_eece378c-6d40-4d7a-96a8-7371eab80279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTExLTEtMS0w_fcf2ee0e-262c-43fe-8b85-f30e6dbf0652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in revenue recognition/method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTEtMS0xLTEzMDcy_0d7447af-6c99-4cca-81b4-5df5c4669741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTMtMS0xLTEzMDcy_98d68c36-f12f-4b68-913d-76255a4447bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTEtMS0xLTA_c9f4d1c4-5e27-4497-b423-af67d4856760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTMtMS0xLTA_781cd7f3-6695-427a-9b45-0588f85f3abf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTUtMS0xLTA_3c7e8f15-2f5a-4223-a840-5104189435bc">7.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" sign="-" format="ixt:numdotdecimal" name="mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTctMS0xLTA_6e8b7ca4-104d-4e79-bc43-098600c234b7">23,440.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTktMS0xLTA_190e1af9-42ab-44ba-aff2-9a3dc49e94be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" format="ixt:zerodash" name="mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTExLTEtMS0w_c77bcf40-a63c-42ad-b1e2-e14cbbdf8a1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTEtMS0xLTEzMDcy_d0569b1b-8231-4a5b-81aa-0ca77427992f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTMtMS0xLTEzMDcy_809563b4-b59f-4542-bbd5-ea78609c5b4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTEtMS0xLTA_e883e99b-d0f9-4944-8538-3df99f891ed7">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTMtMS0xLTA_7dc0af9d-fd3d-4e37-aa83-b0e7bc0f66d1">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTUtMS0xLTA_6f2d2317-5dcc-4cdf-92e5-6f57bf414874">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTctMS0xLTA_c5f9dca3-a625-4125-9f6d-6504b1ff6963">963.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTktMS0xLTA_86720468-573e-4a0b-9beb-d2a597638f2e">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTExLTEtMS0w_f05bd095-e569-41ef-927b-269f1462bbc2">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTEtMS0xLTEzMDcy_844dbcf5-7c64-4af6-87da-cbde68f8e242">41.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTMtMS0xLTEzMDcy_c5fef8b3-3127-4ec2-bdbf-d5521a5a0721">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTEtMS0xLTA_ed147d71-a829-4bb5-940f-eedf672798ec">23.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTMtMS0xLTA_49265315-5dd8-4fbe-87d9-abb2c06e8b38">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTUtMS0xLTA_a88da3a2-2ab9-4bea-839c-c54ecb1fe97b">4.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTctMS0xLTA_93df5ebf-0b72-4abd-a105-5110c4d5ae28">14,107.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTktMS0xLTA_446989dc-ebb0-4b59-b0e4-10ce2c9d82b9">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTExLTEtMS0w_de15826f-d2c5-4a5e-b68b-9965650f1ccc">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i5266d094e7784a3eb5355a245b4ea9ac" continuedAt="ia2da40079692454292a842bb1156279c"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTI_09592f96-b6ec-439e-a5c8-4f0bdbed139f" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of the Company&#8217;s deferred tax assets and liabilities were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:60.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzMtMS0xLTEtMTMxMDA_5b314890-3233-4f60-95cc-966f9941db39">72.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzMtMS0xLTEtMA_7ae51247-3597-4cc0-96bb-7468b42b2e70">73.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzMtMy0xLTEtMA_59afa89f-fed7-4b3e-9c46-78f623993554">85.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzQtMS0xLTEtMTMxMDA_970e5be8-3043-4f18-bfa1-001f63ae78a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzQtMS0xLTEtMA_b6bb5455-12ad-4f5a-86ef-6edf295bac20">37.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzQtMy0xLTEtMA_637a7453-7ca2-4b57-b9bd-2355f9ff226b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzUtMS0xLTEtMTMxMDA_db6e8a41-a8d2-4f8d-8adf-8616997559f0">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzUtMS0xLTEtMA_d89a41f9-445a-4d9e-b89e-0958da1a186a">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzUtMy0xLTEtMA_8e7b21e1-8fed-49b2-8316-ebcee34267e0">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AR allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzYtMS0xLTEtMTMxMDA_e5c4ef3d-c096-4e06-b877-1f5dce305a99">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzYtMS0xLTEtMA_6c2b49c0-1b00-4892-addd-6401fb1a860a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzYtMy0xLTEtMA_a8b0db7f-753a-4d17-920e-eddb52f7113c">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzctMS0xLTEtMTMxMDA_78bf221b-4b54-4039-a0d2-a36fa7e7583e">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzctMS0xLTEtMA_1dcdaf3a-6c68-4bd4-ae75-1d9bf9577534">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzctMy0xLTEtMA_1b9b1e12-9eee-40a0-a5ed-7e7bb7124a60">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzgtMS0xLTEtMTMxMDA_05f498c2-29c6-4e2e-a095-493ebe96e525">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzgtMS0xLTEtMA_759b3817-41f1-4c56-a3ed-151237af1efe">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzgtMy0xLTEtMA_16d4b816-f829-4045-b705-29e39ca86ceb">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:DeferredTaxAssetsLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzktMS0xLTEtMTMxMDA_87a7005f-9da6-47bb-ae62-3614583c9a52">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="mygn:DeferredTaxAssetsLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzktMS0xLTEtMA_96243c1d-d1f9-4acc-9860-fe6cecafde12">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="mygn:DeferredTaxAssetsLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzktMy0xLTEtMA_36c1d8a8-b676-4917-9a2d-b341cb500476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain state tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:DeferredTaxAssetsUncertainStateTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEwLTEtMS0xLTEzMTAw_f164f65e-bd8a-41b2-9e44-8d3059daed9e">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="mygn:DeferredTaxAssetsUncertainStateTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEwLTEtMS0xLTA_30ff9fbd-f09d-4284-8581-6a279ec6c9a6">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="mygn:DeferredTaxAssetsUncertainStateTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEwLTMtMS0xLTA_0102e23c-e17c-4bac-9140-f88566d03214">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzExLTEtMS0xLTEzMTAw_263660d3-9f2d-40e3-8c10-9cd15614b203">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzExLTEtMS0xLTA_833aca77-e5f1-4015-85d0-ed7713b6d20a">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzExLTMtMS0xLTA_774325c8-db7b-4ed4-a36b-c1d8b9805fdf">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEyLTEtMS0xLTEzMTAw_378a4c14-8651-49ed-a114-c46174b77e15">145.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEyLTEtMS0xLTA_095fadae-4e40-46dc-8f1f-17684be13b6f">181.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEyLTMtMS0xLTA_c223d058-bcc4-4030-8247-d8cea7919a1d">141.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEzLTEtMS0xLTEzMTAw_d9e36876-04c1-44be-9944-adaf0fb47057">42.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEzLTEtMS0xLTA_854386df-3e5e-45a3-ad2d-844c8d4f645d">42.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEzLTMtMS0xLTA_988880d1-f651-4811-9f1a-5922f1c435dd">38.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE0LTEtMS0xLTEzMTAw_141f8432-b912-4533-8cac-0447759dfb4f">103.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE0LTEtMS0xLTA_946e1280-4021-4ccb-92dd-a4538a5a460e">139.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE0LTMtMS0xLTA_1a319969-f354-4892-9509-47bf8eda8ac4">103.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE2LTEtMS0xLTEzMTAw_9bab2b18-7f85-4dbc-80c1-27f227951e00">144.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE2LTEtMS0xLTA_27e2c502-27d9-4aa9-9c98-758e8da4e9db">150.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE2LTMtMS0xLTA_607d85a2-81aa-472b-8d80-7781a741857a">175.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="mygn:DeferredTaxLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE3LTEtMS0xLTEzMTAw_1a2a10c4-6c4c-4f06-b1fc-7ca202dd25da">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="mygn:DeferredTaxLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE3LTEtMS0xLTA_1be97e8e-1235-4bc0-ae16-c5c077814393">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:zerodash" name="mygn:DeferredTaxLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE3LTMtMS0xLTA_264457c5-3d27-4ced-94e1-a77c7d0a0d78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE4LTEtMS0xLTEzMTAw_25b2c965-d1a8-4618-9872-2d59d1c112c3">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE4LTEtMS0xLTA_37dedaf5-8dd2-45aa-bd0f-97db71a9cf05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE4LTMtMS0xLTA_9f0a30e2-2fde-46ab-8350-db44805f56e0">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE5LTEtMS0xLTEzMTAw_62624d54-e1b3-407b-a3d4-5af0673db266">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE5LTEtMS0xLTA_33605f2d-c326-4e64-b7c9-f4e1f195dfe1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE5LTMtMS0xLTA_e34ff1a1-58d5-42c8-ad18-8c7e792f620e">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIwLTEtMS0xLTEzMTAw_1a73f978-619e-4a05-9fee-eae95bea2a6e">174.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIwLTEtMS0xLTA_6e6061d9-62f6-48b8-aba9-45d29d6a7b1c">166.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIwLTMtMS0xLTA_c192d62b-3292-45f0-ae50-cba6a0673b1c">185.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIxLTEtMS0xLTEzMTAw_f806ce1b-9bc5-4459-bb3e-cf0eafceef0c">71.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIxLTEtMS0xLTA_87da0dfd-001d-4f0d-9ed1-2ed171c3afbe">26.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIxLTMtMS0xLTA_acdfdd60-3774-44a1-b6aa-2b96e2009248">82.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;) was enacted in response to COVID-19 pandemic. The CARES Act made various tax law changes, including among other things (i) increased the limitation under IRC Section 163(j) for 2019 and 2020 to permit additional expensing of interest (ii), enacted technical corrections so that qualified improvement property can be immediately expensed under IRC Section 168(k) and net operating losses arising in fiscal tax years beginning before January 1, 2018 and ending after December 31, 2017 can be carried back two years and carried forward twenty years without a taxable income limitation as opposed to carried forward indefinitely, and (iii) made modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years. As a result of the provision provided under the CARES Act, the Company was able to carry-back federal net operating losses to previous periods, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="mygn:IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzQ1OTM_5f58db1a-713b-4da7-81a0-3749a6709f05">20.7</ix:nonFraction> million tax benefit in the transition period ended December 31, 2020.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;) was enacted. The Tax Act makes broad and complex changes to the U.S. tax code that are affecting our fiscal year ending June 30, 2018, and all following fiscal years. The Company&#8217;s final analysis of the impact of the Tax Cuts and Jobs Act resulted in a net income tax benefit during the fiscal year ended June 30, 2018 of approximately $<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzQ2MDM_07611589-5844-41ce-87d0-a43943765334">32.0</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="2" name="mygn:TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzEzNzQzODk1MzYwNDM1_a0852b90-3fff-480e-ba70-aaf060fd1053">0.44</ix:nonFraction> earnings per share increase).&#160;&#160;This amount primarily consisted of a net benefit for the corporate rate reduction due to the revaluing of net deferred tax liabilities as a result of the reduction in the federal corporate tax rates.&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the provisions of the Tax Act affecting foreign earnings had no material effect or were not applicable to the Company&#8217;s fiscal years ended June 30, 2018, 2019, 2020, or to the transition period ended December 31, 2020. This was primarily due to the Company's election made during the fiscal year ended June 30, 2019 to treat its foreign subsidiaries as disregarded entities.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="ia2da40079692454292a842bb1156279c" continuedAt="ic50415c5f5ee4d8990b4d43debbd474a"><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of the economic impact of COVID-19, the Company has incurred a cumulative three-year loss. Pursuant to Accounting Standards Codification Topic 740, the negative evidence of a cumulative loss may be difficult to overcome. However, the Company will have significant future taxable income resulting from the reversal of taxable temporary differences. Primarily due to the availability of such expected future taxable income, the Company concluded that it is more likely than not that the benefits of the majority of its deferred income tax assets will be realized. However, for certain deferred tax assets a valuation allowance has been established, primarily due to limitations imposed by I.R.C. Section 382 and certain jurisdictional limitations. For the transition period ended December 31, 2020, the Company's valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzgyMDE_3ecc8a2e-e3a6-4fe5-81d6-33cd5e41daa2">0.3</ix:nonFraction> million. For the fiscal years ended June 30, 2020, 2019 and 2018, the Company&#8217;s valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzgxODQ_24859f09-7ffd-42db-9a2d-64771c1e5899">3.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:numdotdecimal" name="mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzUyOTU_3f1a1a6c-7614-46cd-895a-6b3693fd10e4">1.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:numdotdecimal" name="mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzgxOTU_0fd4c078-717f-429e-9d8e-8c7580b1bcd5">0.6</ix:nonFraction> million,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">respectively. The Company will continue to evaluate the impact that the COVID-19 pandemic may have on its results of operations and its ability to realize its deferred tax assets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired Counsyl, Inc. on July 31, 2018 (see Note 17).&#160;&#160;As part of the purchase accounting for the acquisition, a net deferred tax liability of approximately $<ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzU2NDk_b534c300-e227-4418-a57b-da00190d522c">67.6</ix:nonFraction> million was recorded, consisting primarily of intangible assets for which the book basis exceeds the tax basis. A corresponding deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzU3OTQ_bb46d680-c05a-48c1-b234-d055ac12606f">60.7</ix:nonFraction> million was recorded, consisting primarily of net operating loss and research credit carryforwards.&#160;</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTM_77ce3bb6-c2d1-40a1-9113-8f56f929e948" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company had the following net operating loss and research credit carryforwards (tax effected), with their respective expiration periods. Certain carryforwards are subject to the limitations of Section 382 and 383 of the Internal Revenue Code as indicated (in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.735%"><tr><td style="width:1.0%"></td><td style="width:52.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.959%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.194%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforwards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subject to<br/>sections 382, 383</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expires<br/>beginning in year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Through</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal net operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fac106fccce4731bad8f044406b0d14_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzEtMi0xLTEtMA_d231af2d-8846-41a2-826d-772a128d7a49">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i04912f8e67024702bb6f1c7d9d8715ea_D20200701-20201231" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzEtNC0xLTEtMA_54c9cb27-6bf4-47ee-9fc4-b4d6c80bb44a">Yes</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib296c9d50bcd48e081759995543ac418_D20200701-20201231" name="mygn:OperatingLossCarryforwardsExpirationYear" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzEtNi0xLTEtMA_6c95cfc2-626d-4dfd-af69-a51c933e073f">2031</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7682eeb892144ef397fcb8d2b3f3b075_D20200701-20201231" name="mygn:OperatingLossCarryforwardsExpirationYear" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzEtOC0xLTEtMA_ceaa30a7-a0a8-4ea2-9fa3-4d12315ab03f">2038</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah net operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339e09f971f1423ca61ec703598013f6_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzItMi0xLTEtMA_98d0a09a-7943-4e6e-bb77-c82014c1ed8e">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifef84203e8cf4c45a050df8ee892e0ab_D20200701-20201231" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzItNC0xLTEtMA_923aed90-86b6-4434-8e53-60bad3caf32f">No</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e4dd2b1c99b42c4830a26066e6f5d03_D20200701-20201231" name="mygn:OperatingLossCarryforwardsExpirationYear" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzItNi0xLTEtMA_ede39314-8ebe-44eb-b0f5-8c58ab200692">2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California net operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff189668e46b4b2d99f01b54ece5899e_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzMtMi0xLTEtMA_29c62e4b-4b31-4f5d-a82b-e086c641918b">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8a77486cbfda4985a95b5409f5114d75_D20200701-20201231" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzMtNC0xLTEtMA_7a16f895-859a-4e1e-a088-daf5c3edfb1e">No</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8dee92637b14ad4b0ddc3ee7a893148_D20200701-20201231" name="mygn:OperatingLossCarryforwardsExpirationYear" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzMtNi0xLTEtMA_0747b1f2-4908-4fe5-940e-671424e15ce4">2027</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28b353bd32614ef98f4d1b7b28197946_D20200701-20201231" name="mygn:OperatingLossCarryforwardsExpirationYear" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzMtOC0xLTEtMA_569c0b1d-93fe-4529-a40d-6fbd7de061d2">2042</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other state net operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i801b880fffca41b7981a7975da3eba9d_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzQtMi0xLTEtMA_d923c40f-d36a-4a0b-ac3a-02783824861a">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8e435f848ff041c69b87c98ccab2b8f2_D20200701-20201231" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzQtNC0xLTEtMA_5d02ef94-e2e3-497e-bc8f-620f5e8a2fad">Yes</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f20a97b70f8439284f983b91fd4a5ce_D20200701-20201231" name="mygn:OperatingLossCarryforwardsExpirationYear" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzQtNi0xLTEtMA_275e1ada-37a9-4d2f-989a-e1144dbeca52">2027</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7066ecd804994d66ab4a3853aa09f501_D20200701-20201231" name="mygn:OperatingLossCarryforwardsExpirationYear" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzQtOC0xLTEtMA_56557d0d-caa2-41e8-a396-a370d311a6ac">2040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign net operating losses (various jurisdictions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc0e279dbee74c3b96393ff366a521d0_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzUtMi0xLTEtMA_1860d389-725a-45b6-9d34-cf98ef8b0ebf">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i442e0a95c01243a3836a2900086d9a01_D20200701-20201231" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzUtNC0xLTEtMA_5e0e70db-9bd4-4e4a-85d8-f120d07649a2">No</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a8545dd5b34bafb56de3bd607512ca_I20201231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzYtMi0xLTEtMA_37bc6e7c-c89a-46b2-ab9d-eb90a968023d">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8308537e63d24a72a6fcf5c902e127e2_D20200701-20201231" name="us-gaap:TaxCreditCarryforwardLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzYtNC0xLTEtMA_79053bea-119b-4813-850f-20eb085b38b3">Yes</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i373106c9787844db8567a937ae2715a1_D20200701-20201231" name="mygn:TaxCreditCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzYtNi0xLTEtMA_e95a8b61-cb60-42ef-864e-e05211ff2696">2027</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7667d8c3c8a9406ab36ea5da42680f55_D20200701-20201231" name="mygn:TaxCreditCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzYtOC0xLTEtMA_e96ba247-33d1-4a5c-a2b4-664f85f6ef1b">2040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah research credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2893df02bcc84b2e95bf0c21a4687f83_I20201231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzctMi0xLTEtMA_d20548e1-9713-4a1b-9418-06babc1135b0">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3484e0b911345c28f8748b196210eb4_D20200701-20201231" name="us-gaap:TaxCreditCarryforwardLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzctNC0xLTEtMA_0ac34673-7b5f-4e69-8834-a1d998be34c0">No</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65319c42541d4efc8d864e8dcfdd14e9_D20200701-20201231" name="mygn:TaxCreditCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzctNi0xLTEtMA_778be554-f40b-495e-9301-713bf63a6d61">2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if348e8b1625f477a94c7cf316377a0f5_D20200701-20201231" name="mygn:TaxCreditCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzctOC0xLTEtMA_d6de4dc6-c9d5-4fff-bedc-d3fd759f4e6a">2034</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d7ca3e4ae2740b884faeec8053514ab_I20201231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzgtMi0xLTEtMA_4b13f59f-17a7-456d-9660-b83a799a577f">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib5b6e713bd16480f900779c66826595d_D20200701-20201231" name="us-gaap:TaxCreditCarryforwardLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzgtNC0xLTEtMA_f2cc0ff3-8b0b-43da-99b0-368335097f16">No</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i994ec55512434040bf3680a9030ee7ce_D20200701-20201231" name="mygn:TaxCreditCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzgtNi0xLTEtMA_62df6148-9f5b-498a-a253-9b101a74ae2c">2027</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas research credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c5f75363cf466e8c5c30864649562a_I20200630" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzktMi0xLTEtMTczMjE_0842c7b1-2447-46b6-b122-6b956dfe4a83">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i394783302fb644de93bf6aa850b4dc82_D20200701-20201231" name="us-gaap:TaxCreditCarryforwardLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzktNC0xLTEtMTc2NjU_96f8b21b-2671-4db3-b101-29c4b247847b">No</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i92918a0809ac433d8348fe4fa4338b6b_D20200701-20201231" name="mygn:TaxCreditCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzktNi0xLTEtMTc2NTk_566453da-b14c-4f0c-a629-26450909fc55">2039</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5864baf1324e4e15b61aadc049035ef1_D20200701-20201231" name="mygn:TaxCreditCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzktOC0xLTEtMTc2NjE_ee4977e0-8aa1-4494-989d-5b7eafc67a81">2040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consistent with the indefinite reversal criteria of ASC 740-30-25-17, the Company intends to continue to invest undistributed earnings of its foreign subsidiaries indefinitely. However, due to the cumulative losses that have been incurred to date in such foreign operations, the changes of the Tax Act and the aforementioned election to treat its foreign subsidiaries as disregarded entities, no deferred taxes related to the Company&#8217;s foreign operations have been recorded. For those foreign entities for which an election has been made to be treated as disregarded for U.S. tax purposes, the appropriate U.S. jurisdiction deferred tax assets and liabilities have been recorded.&#160;</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="ic50415c5f5ee4d8990b4d43debbd474a"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement criteria as set forth in ASC 740. As of December&#160;31, 2020 and June 30, 2020, the Company had net unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mygn:UnrecognizedTaxBenefitsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzEzNzQzODk1MzYwNDI3_4630607d-6569-4876-a19c-ad2ba3af3318">30.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:numdotdecimal" name="mygn:UnrecognizedTaxBenefitsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzgyNDU_3e277a0d-e80d-47af-90c9-ad93c3dce76c">23.5</ix:nonFraction>&#160;million, respectively. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTQ_3d3a4889-290d-4f12-a916-9d1fdf57b610" continuedAt="iaa7dcb462d354668942e6f8f4bc599f9" escape="true">The Company&#8217;s gross unrecognized tax benefits as of the transition period ended December&#160;31, 2020 and the fiscal years ended June 30, 2020, 2019 and 2018, and the changes in those balances are as follows:&#160;</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="iaa7dcb462d354668942e6f8f4bc599f9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:50.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.155%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at the beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzItMS0xLTEtMTMwOTI_17f140d1-7cf9-47a9-880f-5993cc34b6d5">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzItMS0xLTEtMA_14285091-00a2-40ee-8eed-7934cb1f595c">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzItMy0xLTEtMA_6b560538-f128-409c-b64a-9e773df324ba">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzItNS0xLTEtMA_34514ab5-a003-4134-b022-d2aa1ec16242">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzMtMS0xLTEtMTMwOTI_0dabbe2f-d9cf-4fb7-9cbc-6ac58f187a2d">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzMtMS0xLTEtMA_d84020c9-c5ed-4a19-8fbb-2f1030417921">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzMtMy0xLTEtMA_e4aa4338-7ac5-4058-91fe-251afbd6ef31">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzMtNS0xLTEtMA_e8252e7d-05a0-41ad-8d02-324c392d1cc6">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzQtMS0xLTEtMTMwOTI_4f9e1fb6-9546-4c3d-b82d-e9a32391f363">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzQtMS0xLTEtMA_abb5e0ca-f5de-4d32-bc8f-c2a771fc4a33">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzQtMy0xLTEtMA_bcc87e42-d418-434a-82de-409c598c0727">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzQtNS0xLTEtMA_a4bfe6e6-9960-4b18-9aaf-9175ef274f9b">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzUtMS0xLTEtMTMwOTI_06d60476-067f-4f60-a5b8-a072b7a97e61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzUtMS0xLTEtMA_12d6faf9-23c4-4e45-b316-cfb13eae36f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzUtMy0xLTEtMA_f5cbd36f-390c-482d-a905-f1d2dd7e999b">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzUtNS0xLTEtMA_c76ed6ed-acec-4fc1-8b62-55405af3d06d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzYtMS0xLTEtMTMwOTI_669e0f2f-69f5-4148-9b05-7cb9f5089b29">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzYtMS0xLTEtMA_b1f8feb4-2bc0-4831-842a-be9ed8ea9550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzYtMy0xLTEtMA_d6ddb80d-522c-4a31-a9ea-a5cc41c3300e">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzYtNS0xLTEtMA_00b01d9c-95ec-4c98-b66a-72846fb840be">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzctMS0xLTEtMTMwOTI_b8c23879-9a73-46c0-af6f-43b7b6d7b835">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzctMS0xLTEtMA_b92237a0-7489-4042-8603-814050ba6d08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzctMy0xLTEtMA_f931fb85-d9e0-4c25-9825-59468ac29b9a">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzctNS0xLTEtMA_949ee59a-0878-43eb-8111-54b71e5147a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - statute lapse</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzgtMS0xLTEtMTMwOTI_d870ed7a-900d-4989-8308-48d3b324acbc">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzgtMS0xLTEtMA_aeaa45af-08e0-440d-ba51-d0d8f5a29225">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzgtMy0xLTEtMA_af89acc2-0b2f-420f-9115-e4bd5695c8c1">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzgtNS0xLTEtMA_25545818-c37e-469f-9b83-2a522e10f2bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzktMS0xLTEtMTMwOTI_ec9d7aee-1ffe-4d7b-b609-0a35106a5f31">37.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzktMS0xLTEtMA_87c754c4-3a56-4ee1-b047-22d41de52887">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzktMy0xLTEtMA_413bff5a-d1a4-447b-b400-4607280df46e">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzktNS0xLTEtMA_60d05e08-6c17-4f4d-ad6f-3f038c4da578">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and penalties in year-end balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzEwLTEtMS0xLTEzMDky_9d4b761f-46e7-44f0-b120-3ef4a3d462d1">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzEwLTEtMS0xLTA_e93a22f9-4cbe-4458-9918-99adf25d76f5">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzEwLTMtMS0xLTA_2d335413-87a9-4c37-a4d2-d00d8e3e3959">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171870dd15d143e2bd07f52254307cce_I20180630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzEwLTUtMS0xLTA_d0233542-9b1b-4cf6-ba53-7c5e047c13be">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties related to uncertain tax positions are included as a component of income tax expense and all other interest and penalties are included as a component of other income (expense).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S. federal, foreign and state income tax returns in jurisdictions with various statutes of limitations and is subject to examination for the open tax years in the U.S. federal and state jurisdictions of <ix:nonNumeric contextRef="i3aa2c73215b4412381289f30cd0a1630_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc1ODg_fc785791-2682-4648-841c-1682f11716b3">2015</ix:nonNumeric> through <ix:nonNumeric contextRef="i2263ff4bbd034dac9cc9bc7dbeb427ea_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc1OTk_fc234502-5b95-4919-803c-0c0d1e3177c0">2020</ix:nonNumeric> and in the foreign jurisdictions of <ix:nonNumeric contextRef="idbfaa476fbe246298adb7720d942ac91_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc2Mzg_6ee7c2c4-a71d-4d7c-8520-485e49f77207">2013</ix:nonNumeric> through <ix:nonNumeric contextRef="i77fc28b9a23e4dfcaa3fbc650b50adbb_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc2NDk_84e82490-1208-42c6-a251-6ce8eef09f69">2020</ix:nonNumeric>. The Company is currently under audit by the State of New Jersey for the fiscal years June 30, <ix:nonNumeric contextRef="i30273d0d5378455ba4f0bb60b947d31e_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc3NDc_4bd2f2f2-7b41-4a10-bad7-15e5e0941379">2013</ix:nonNumeric> through <ix:nonNumeric contextRef="i0f0397e662d04de99568a428f4703477_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc3NTg_829a415a-4170-4a18-a996-b6af6c06f245">2017</ix:nonNumeric>; the city of New York for the fiscal years June 30, <ix:nonNumeric contextRef="if0d38d53cfdc4cd0afb30d1604caabf9_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc4MTM_039b5f97-d292-462a-906e-1c54b52fa957">2016</ix:nonNumeric> through <ix:nonNumeric contextRef="ia9d4db6aa0484fc0a5e43e4cfb14bc3a_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc4MjQ_b2389f6b-f735-4917-92c9-7b3b9e2f3ff6">2018</ix:nonNumeric>; Germany for the fiscal years June 30, <ix:nonNumeric contextRef="i90c324220132439d95ca49aab6989a29_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc4NjY_3a334fb2-b053-40d4-bd3c-7fc6975df6e4">2013</ix:nonNumeric> through <ix:nonNumeric contextRef="i2e4548adbe5b4e3d9fb80fd7b51ed7cb_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc4Nzc_f96c5dfe-7a55-4117-9aae-9f320e37a9a2">2015</ix:nonNumeric>; and Switzerland for the fiscal years June 30, <ix:nonNumeric contextRef="i259c8637e98a44e8aec3d5243fde0562_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc5Mjc_e11b1e96-f235-4caa-805e-60b5b080e1fb">2015</ix:nonNumeric> through <ix:nonNumeric contextRef="icf91bb0e041742dfbd75694127229a2f_D20200701-20201231" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc5Mzg_cce15bdc-29b4-4b62-b1a7-62442bd7cf5b">2016</ix:nonNumeric>.&#160;&#160;Annual tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued.</span></div></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_154"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTQvZnJhZzphY2NjMTczNzAwNGQ0YzUxYWM2MWFmYzA1MGI3OThmYS90ZXh0cmVnaW9uOmFjY2MxNzM3MDA0ZDRjNTFhYzYxYWZjMDUwYjc5OGZhXzQyNg_3ef143f3-5e83-4f9c-b073-c4c157cfe4c7" continuedAt="ic145fb65505d43fea8daf06321a94faa" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="ic145fb65505d43fea8daf06321a94faa"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. As of December&#160;31, 2020, management of the Company believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company&#8217;s consolidated financial position, operating results, or cash flows.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company received recoupment requests from third-party payors for alleged overpayments. The Company disagrees with the contentions of the pending requests or has recorded an estimated reserve for the alleged overpayments.</span></div></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_157"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzIwMzY_c3c7a4d0-3426-46c2-abc0-99f1f7fec75e" continuedAt="ie47504c5b8fd4173a45104a45795d39c" escape="true">LEASES</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie47504c5b8fd4173a45104a45795d39c" continuedAt="if34cf7cc876044edade43541b44922c7">The Company leases certain office spaces and research and development laboratory facilities, vehicles, and office equipment with remaining lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE4MA_d8822eb6-7013-498c-93f5-ea1a56cc78c9">one</span> to <ix:nonNumeric contextRef="ied2066eada724e118523d0b6f7522a9d_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE4Ng_b8a16137-e1e8-48dd-b4f6-7daca1dd0481">seven years</ix:nonNumeric>. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options which allows the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These optional periods have not been considered in the determination of the right-of-use-assets or lease liabilities associated with these leases as the Company did not consider it reasonably certain it would exercise the options.</ix:continuation></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="if34cf7cc876044edade43541b44922c7"><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 1, 2019, the Company adopted ASU 2016-02 under the modified retrospective approach by initially applying ASU 2016-02 at the adoption date, rather than at the beginning of the earliest comparative period presented. Results for the fiscal year ended June 30, 2020 are presented under ASU 2016-02. Prior period amounts were not adjusted and continue to be reported under previous lease accounting guidance. As part of the adoption, the Company elected the package of practical expedients to avoid reassessing prior conclusions about lease identification, lease classification and initial direct costs. The Company also elected the practical expedient allowing the use of hindsight in determining the lease term and assessing impairment of right-of-use assets based on all facts and circumstances through the effective date of the new standard. The Company has elected the recognition exemption for short-term leases for all leases that qualify. Under this exemption, the Company will not recognize right-of-use assets or lease liabilities for those leases that qualify as a short-term lease (leases with lease terms of 12 months or less), which includes not recognizing right-of-use assets or lease liabilities for existing short-term leases in transition. The Company also has elected the practical expedient to avoid separating lease and non-lease components for any of its leases within its existing classes of assets.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company performed evaluations of its contracts and determined each of its identified leases are operating leases. For the transition period ended December&#160;31, 2020, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQzOTgwNDY1MTMxNDU_fb3b6f0a-4f56-40ec-8cfe-2224ccdc7c4d">9.9</ix:nonFraction> million in lease costs which are included in operating expenses in the consolidated statement of operations in relation to these operating leases. Of such lease costs, $<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQzOTgwNDY1MTMyMDU_507f3b23-0d68-4253-8bc1-aaac9cc5d8fe">1.8</ix:nonFraction> million was variable lease expense and $<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQzOTgwNDY1MTMyMDE_2eadb85b-1283-4d17-9910-b361c5ff823d">0.1</ix:nonFraction> million was short-term lease expense, neither of which were included in the measurement of the Company's operating right of use assets and lease liabilities. The variable rent expense is comprised primarily of the Company's proportionate share of operating expenses, property taxes, and insurance and is classified as lease expense due to the Company's election to not separate lease and non-lease components. For the fiscal year ended June 30, 2020, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQ5NDc4MDIzMzM1MDU_6b674eaf-b3b5-40c3-8932-35d1a2d0f459">18.4</ix:nonFraction> million in lease costs, of which $<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQ5NDc4MDIzMzM1MTU_61e355d7-d9c7-4ffc-9f2f-8ceace6ccc28">2.6</ix:nonFraction> million was variable lease expense and $<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQ5NDc4MDIzMzM1MjQ_d274c289-9861-4350-92c4-bdeebe821a31">0.2</ix:nonFraction> million was short-term lease expense. Prior to the adoption of the lease guidance in ASU 2016-02, the Company's total rent expense for the fiscal years ended June&#160;30, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzI3NDg3NzkwNzI4MzY_4c6ed4c1-c264-444a-bb31-fa6338f85ffd">19.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzI3NDg3NzkwNzI4NDQ_5a1ed69b-4a8d-425e-812f-f0a65d712d82">15.5</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzIwMzc_51173480-4819-47b4-b9e0-38c016381289" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of the Company&#8217;s operating lease liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:86.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year ending:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzEtMS0xLTEtMA_daa39921-52cb-47f6-9bb6-7c8185471fd4">15.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzItMS0xLTEtMA_7a1e3b4e-b327-43b0-9708-1b24ab1d6447">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzMtMS0xLTEtMA_4e73b865-3b97-493f-a0d3-c507881a22e0">13.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzQtMS0xLTEtMA_16df180b-1d7b-4b41-bdeb-577ce38dc1ab">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzUtMS0xLTEtMA_1543423c-150e-4955-a9f8-396c62933e77">7.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzYtMS0xLTEtMA_87fd9904-39cd-4872-9d21-cb16136b2d30">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzctMS0xLTEtMA_afb45b46-53bf-4dac-97d4-a6082531b893">70.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts representing interest</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzgtMS0xLTEtMA_f75e1c6e-9c0c-404e-b28d-369df2d68a28">6.4</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzktMS0xLTEtMA_0e726e92-15ac-4452-87ca-d8b8a81aefc8">64.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current maturities of operating lease liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzEwLTEtMS0xLTA_706c88a4-1768-4323-a07a-4909654650e3">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzExLTEtMS0xLTA_36585d2d-53b4-4daf-a1ef-22a059035901">50.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the weighted average remaining lease term is <ix:nonNumeric contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE1OTc_eef38d79-7a51-4cb9-953b-2f79d3710bf6">4.9</ix:nonNumeric> years and the weighted average discount rate used to determine the operating lease liability was <ix:nonFraction unitRef="number" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE2OTE_e5822a4e-13f9-4afa-9e3b-95e0d2ce8df6">3.87</ix:nonFraction>%. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the implicit rate in the Company's leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of future lease payments. When calculating the Company&#8217;s incremental borrowing rates, the Company gives consideration to its credit risk, term of the lease, total lease payments and adjust for the impacts of collateral, as necessary. The lease term used may reflect any option to extend or terminate the lease when it is reasonably certain the Company will exercise such options. Lease expenses for the Company's operating leases are recognized on a straight-line basis over the lease term.</span></div></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_160"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90ZXh0cmVnaW9uOjRlNWM3NmY0NzZmZTQ5MjBiMGMyZDg0MzAxZWRiZWYwXzY0OA_f03172c2-93ac-465c-a20c-7d11cc817402" continuedAt="i4ff3e1d187594bde9e51326207738c81" escape="true">EMPLOYEE DEFERRED SAVINGS PLAN</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4ff3e1d187594bde9e51326207738c81" continuedAt="i401800c68e0047d58eac2b633e88180f">The Company has a deferred savings plan which qualifies under Section&#160;401(k) of the Internal Revenue Code. Substantially all of the Company&#8217;s U.S. employees are covered by the plan. The Company makes matching contributions of <ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90ZXh0cmVnaW9uOjRlNWM3NmY0NzZmZTQ5MjBiMGMyZDg0MzAxZWRiZWYwXzI2Ng_0dbe92dc-cf5c-4c78-81b0-f699b7fe9080">50</ix:nonFraction>% of each employee&#8217;s contribution with the employer&#8217;s contribution not to exceed <ix:nonFraction unitRef="number" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90ZXh0cmVnaW9uOjRlNWM3NmY0NzZmZTQ5MjBiMGMyZDg0MzAxZWRiZWYwXzM0OA_fdd35363-b757-4c96-88fb-c30956c14b61">4</ix:nonFraction>% of the employee&#8217;s compensation. </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i401800c68e0047d58eac2b633e88180f"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:DefinedContributionPlanDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90ZXh0cmVnaW9uOjRlNWM3NmY0NzZmZTQ5MjBiMGMyZDg0MzAxZWRiZWYwXzY0OQ_89255d5b-879e-44ad-b580-00417e291521" escape="true"><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s recorded contributions to the plan are as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred savings plan contributions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90YWJsZToyZjk3ZDgzMDhiZDI0ZWUzOGM3YTZhNTM4MThhYWM1Mi90YWJsZXJhbmdlOjJmOTdkODMwOGJkMjRlZTM4YzdhNmE1MzgxOGFhYzUyXzItMS0xLTEtNzM1Mw_93b2aa6f-d164-406f-95b4-1c4375c9b3be">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90YWJsZToyZjk3ZDgzMDhiZDI0ZWUzOGM3YTZhNTM4MThhYWM1Mi90YWJsZXJhbmdlOjJmOTdkODMwOGJkMjRlZTM4YzdhNmE1MzgxOGFhYzUyXzItMS0xLTEtMA_05763a3f-9533-45c1-a1e9-cd2959f2c8ac">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90YWJsZToyZjk3ZDgzMDhiZDI0ZWUzOGM3YTZhNTM4MThhYWM1Mi90YWJsZXJhbmdlOjJmOTdkODMwOGJkMjRlZTM4YzdhNmE1MzgxOGFhYzUyXzItMy0xLTEtMA_40d8b0b7-c658-4998-ac24-eafefbb42b82">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90YWJsZToyZjk3ZDgzMDhiZDI0ZWUzOGM3YTZhNTM4MThhYWM1Mi90YWJsZXJhbmdlOjJmOTdkODMwOGJkMjRlZTM4YzdhNmE1MzgxOGFhYzUyXzItNS0xLTEtMA_f524e896-ccbf-488b-bbdd-f4c1e5f97100">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ic01b255bce00439ba9380fc219eb70e1_163"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzE1NTg_04e48a26-9427-445c-b0a8-01443e1221cb" continuedAt="ice7be9e855d642b48e2ce6610d0cd90c" escape="true">SEGMENT AND RELATED INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ice7be9e855d642b48e2ce6610d0cd90c" continuedAt="i1f602e8048e1416d83017981502176ec"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business is aligned with how the chief operating decision maker ("CODM") reviews performance and makes decisions in managing the Company. The Company&#8217;s operating segments have been aggregated into <ix:nonFraction unitRef="segment" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzk2_0e5c4e7e-b4b3-4eb4-8c2b-03d37d90ad31">two</ix:nonFraction> reportable segments: (i)&#160;diagnostics and (ii) other. The diagnostics segment primarily provides testing and collaborative development of testing that is designed to assess an individual&#8217;s risk for developing disease later in life, identify a patient&#8217;s likelihood of responding to drug therapy and guide a patient&#8217;s dosing to ensure optimal treatment, or assess a patient&#8217;s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. <ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzE1NTk_29fc3a73-ce42-4d14-be46-48b4ace006b9" continuedAt="i04884f82839b48bc8daac8a024812ee8" escape="true">The CODM evaluates segment performance based on operating income (loss).</ix:nonNumeric></span></div><ix:continuation id="i04884f82839b48bc8daac8a024812ee8"><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"></td><td style="width:60.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.116%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition Period Ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItMS0xLTEtMjI2OA_e6ca919a-6c10-4a04-a040-f7332485b225">271.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ef0e4a089942639d68319973aeaa47_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItMy0xLTEtMjI2OA_2107138f-7710-4ee3-aea3-c7da895134e2">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItNS0xLTEtMjI2OA_85064ab2-a001-458d-9767-d3bba5bebd01">299.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtMS0xLTEtMjI2OA_7c794ce1-37d1-43fd-bf9e-83f6a12d5c26">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ef0e4a089942639d68319973aeaa47_D20200701-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtMy0xLTEtMjI2OA_b72cd2f4-c065-4cda-bcb2-4f8894cd01a1">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtNS0xLTEtMjI2OA_5937ab9b-3ed2-41a5-91b9-ba9057306f25">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtMS0xLTEtMjI2OA_8682b372-72bf-4fd7-9a09-1cc0c711a0ec">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91ef0e4a089942639d68319973aeaa47_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtMy0xLTEtMjI2OA_a044a926-1f22-4aed-bc19-87ae98b3e8c2">86.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtNS0xLTEtMjI2OA_6a226f7e-94bd-4d71-bc46-9263b85e887e">87.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71c74fc3d084045809129a196e2f974_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItMS0xLTEtMA_046be84a-e774-4d94-aae7-8af8a1cae507">593.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664dad294d884038be88785f325b2bf5_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItMy0xLTEtMA_48196bc3-26ea-4572-a909-84fb9b263dd8">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItNS0xLTEtMA_e9f76914-ac17-44d6-aeec-cc8ab475c60a">638.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71c74fc3d084045809129a196e2f974_D20190701-20200630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtMS0xLTEtMA_c3bec33c-b67c-4573-bab4-cf7ea63bb499">68.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664dad294d884038be88785f325b2bf5_D20190701-20200630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtMy0xLTEtMA_1d2eee26-ad51-4e3a-9753-8945e81f76f4">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtNS0xLTEtMA_5749d009-a027-46b5-aff6-a77e123ac26a">72.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic71c74fc3d084045809129a196e2f974_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtMS0xLTEtMA_28d07fe4-eb8c-4694-83e7-a948b10e2e67">82.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i664dad294d884038be88785f325b2bf5_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtMy0xLTEtMA_3a6a58c0-c886-4462-b626-31eca5ce3039">149.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtNS0xLTEtMA_ec341062-3230-4f89-993f-74a5da94350e">231.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476843d04c844d4e95a7e5e176903dcb_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzYtMS0xLTEtMA_7dcddc97-a68d-4fa1-b1f3-8a14bcc6358f">789.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4659bde391c4d01852f685ef94ad2be_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzYtMy0xLTEtMA_2f05e46e-3c17-444d-b9ad-7b54730cbef7">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzYtNS0xLTEtMA_361ccedd-dc73-4b9d-95f0-1031aed48894">851.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476843d04c844d4e95a7e5e176903dcb_D20180701-20190630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzctMS0xLTEtMA_76d04670-b9ee-473f-ba92-ececa32a13a5">67.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4659bde391c4d01852f685ef94ad2be_D20180701-20190630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzctMy0xLTEtMA_e6156eb9-e54f-4ea1-8d1a-bdd3b8f4a5d9">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzctNS0xLTEtMA_2a6b5b85-b94f-416b-9bf2-650e7669ec6f">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476843d04c844d4e95a7e5e176903dcb_D20180701-20190630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzgtMS0xLTEtMA_0f144ac9-025a-4860-aeeb-d003cfc4fc4e">133.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4659bde391c4d01852f685ef94ad2be_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzgtMy0xLTEtMA_6cc155dc-72df-445a-a311-2b55b82374af">125.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzgtNS0xLTEtMA_f5aa414c-c4c0-4322-8ff3-1e3a10b5ec3f">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2018:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e55ec2aeb84ba29ad2e15182881349_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEwLTEtMS0xLTA_2238eb8f-75f8-4525-96d7-8d6dc445272f">690.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef3b53c398c432a93dbdbb67ae409c1_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEwLTMtMS0xLTA_a04919e5-970c-43e8-96b9-48e1b8d74306">53.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEwLTUtMS0xLTA_563de34d-f93a-40a6-b4fe-9774c47f1682">743.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e55ec2aeb84ba29ad2e15182881349_D20170701-20180630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzExLTEtMS0xLTA_3b33c8ff-69f3-4b84-9873-85f8ecc99d96">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef3b53c398c432a93dbdbb67ae409c1_D20170701-20180630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzExLTMtMS0xLTA_f5ed7e25-b404-4d1c-872a-fd703826ad31">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzExLTUtMS0xLTA_0c102253-8d45-4669-9f05-d6f0671799aa">54.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e55ec2aeb84ba29ad2e15182881349_D20170701-20180630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEyLTEtMS0xLTA_86cdca65-7d2f-472e-8f2b-a30a00a3ce0d">142.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ef3b53c398c432a93dbdbb67ae409c1_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEyLTMtMS0xLTA_8a9f36dd-7c22-4e9c-956a-1ee116ed87ef">20.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEyLTUtMS0xLTA_ac9a4b9f-5f0b-48f5-aead-6c61cba8e152">121.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"></td><td style="width:58.136%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income (loss) for reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzItMS0xLTEtMjI5Nw_2c91112b-e3b7-4e6a-bb2a-97fdba02e640">87.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzItMS0xLTEtMA_f1566870-04bc-4230-b121-f826609aa6e5">231.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzItMy0xLTEtMA_995b893d-7323-4272-8a49-03b05fe44a21">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzItNS0xLTEtMA_6d837289-53aa-457f-98b4-f187e070463e">121.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzQtMS0xLTEtMjI5Nw_ab701e64-8229-4857-8dbc-432d3ece12c8">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzQtMS0xLTEtMA_652a21e7-c1e4-44ed-9baa-ed35e9010638">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzQtMy0xLTEtMA_89d6602d-be61-4b4c-89c4-efb199e8bcfd">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzQtNS0xLTEtMA_4cb585cd-3896-44a1-bfa8-b562e6617167">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzUtMS0xLTEtMjI5Nw_70c68a94-86e0-4d96-8e54-5671a0e2da95">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzUtMS0xLTEtMA_861008c7-4ecc-42f5-8f5e-7747ffc7be98">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzUtMy0xLTEtMA_32022b89-132e-4532-b78f-6a4ab0fbf8b6">12.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzUtNS0xLTEtMA_2b858d36-3722-4b86-8acb-7547f7204ef8">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzYtMS0xLTEtMjI5Nw_c7bc5990-88e4-42ee-bcdc-d0a1a62a3f29">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzYtMS0xLTEtMA_49702c44-03e6-4049-ad4d-23907ee0a2bf">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzYtMy0xLTEtMA_2bc742e4-ab7f-4e24-aa29-487d3181ec92">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzYtNS0xLTEtMA_20d7dd77-e288-45b0-b7bb-8d554a835b48">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzctMS0xLTEtMjI5Nw_bdf5cdab-55ae-4142-8624-e43eb0fb7aa8">94.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzctMS0xLTEtMA_b5987645-86a7-4be1-b9af-abb3757842ee">223.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzctMy0xLTEtMA_740287a3-99c5-42b5-b4f1-1259248e1c49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzctNS0xLTEtMA_c9845146-08dd-409d-945c-b932c539a847">120.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzgtMS0xLTEtMjI5Nw_12d2b8ef-eb11-4b48-86b5-22ed62c1035b">41.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzgtMS0xLTEtMA_1ab17132-3d8d-4158-ae86-9640569cb491">23.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzgtMy0xLTEtMA_3e254934-cae8-4ab6-abe4-f0adeb978dd0">4.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzgtNS0xLTEtMA_e4f89d86-b27c-465d-a05d-8d1392228890">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzktMS0xLTEtMjI5Nw_5c67998b-2e91-41aa-ae83-4975e49a4f3f">53.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzktMS0xLTEtMA_a40815c8-0eae-4740-8707-5afa4cc88380">199.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzktMy0xLTEtMA_81a4168d-8167-4441-9e74-fec9705eddf3">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzktNS0xLTEtMA_95ab07bd-e806-4de8-a940-202cc3f90893">133.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzEwLTEtMS0xLTIyOTc_9bfa9219-d7e9-422d-93c2-e6aa48e798a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzEwLTEtMS0xLTA_9e920750-6feb-4e8a-92ad-65eb0ac7030a">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzEwLTMtMS0xLTA_b956fdc3-7833-4f11-9344-ce15d6caae46">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzEwLTUtMS0xLTA_39700de1-8fb6-4e0c-bb68-7693f1638d70">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc stockholders</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzExLTEtMS0xLTIyOTc_5988b40f-ed51-43df-82ca-d6c5b9fb357b">53.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzExLTEtMS0xLTA_a232686a-4849-4904-82e0-a967407f459a">199.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzExLTMtMS0xLTA_cb43b66f-02dc-4879-89ff-3dbc1cbba6b6">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzExLTUtMS0xLTA_45489bd2-c458-4753-9c54-234ddfc2b39e">133.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i1f602e8048e1416d83017981502176ec"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="mygn:ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzE1NTU_03d19bae-1493-457e-bc13-e8aa97afb3e2" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a comparison of balance sheet assets by operating segment:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"></td><td style="width:61.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net equipment, leasehold improvements and property:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i428a5fa0807f4da086f039c34215397a_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzMtMS0xLTEtMjMxNg_c29b0c0c-292c-4bf2-b5ef-0ea58421f7c6">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db858d5901a46708854a964d2b950ba_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzMtMS0xLTEtMA_91af6653-1ca7-40b3-be27-33f4e7038566">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied74c9d465394d488f630f4d4876d14a_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzMtMy0xLTEtMA_8db0003d-7992-401e-b5d8-56364d53824e">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a637b79289401cacaeae110a5223e9_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzQtMS0xLTEtMjMxNg_89bae49c-238e-42cf-9712-5482b4b871ec">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b939605911461db48890438cae974c_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzQtMS0xLTEtMA_3f8ee62d-25a2-4cb7-a7d1-5907db1e90bd">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3f9a2649e348faaacb48e8cc8e8902_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzQtMy0xLTEtMA_205c4711-7ad2-43db-86c1-8a7fef2460de">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a0de5212d9437b9c547a36e207b87f_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzUtMS0xLTEtMjMxNg_ec371e78-a2e6-4faa-ae92-7387d9cf75b1">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e876378b87406f8adbbf8ce2e6cddd_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzUtMS0xLTEtMA_f6152ef5-5e7c-4aa3-b1a2-591b152c612c">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i395a6bf2ed5a4516a97cb9dfd143feb1_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzUtMy0xLTEtMA_0cdd64d1-e6d3-4481-88d6-8a315c8c4ac7">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total assets less cash, cash equivalents, and marketable investment securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i428a5fa0807f4da086f039c34215397a_I20201231" decimals="-5" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzctMS0xLTEtMjMxNg_3ff39786-6368-4700-bd6a-f325d46eaf5d">994.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db858d5901a46708854a964d2b950ba_I20200630" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzctMS0xLTEtMA_d8d2d286-7d97-4d71-851c-74c6d0d76a4f">1,002.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied74c9d465394d488f630f4d4876d14a_I20190630" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzctMy0xLTEtMA_d71b7b76-2125-4ae7-a863-7ae86eb8f852">1,215.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a637b79289401cacaeae110a5223e9_I20201231" decimals="-5" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzgtMS0xLTEtMjMxNg_fb4f4cb4-3b5f-4c84-bab3-fd08d2db3f35">253.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b939605911461db48890438cae974c_I20200630" decimals="-5" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzgtMS0xLTEtMA_c5c5d99d-84de-44f1-a12d-29acaa5cce03">147.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3f9a2649e348faaacb48e8cc8e8902_I20190630" decimals="-5" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzgtMy0xLTEtMA_ba4806a2-7ecf-4591-80c6-1616d935b6b6">155.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a0de5212d9437b9c547a36e207b87f_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzktMS0xLTEtMjMxNg_662962e2-5e45-43ec-a20b-c8be7fd46bbd">1,247.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e876378b87406f8adbbf8ce2e6cddd_I20200630" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzktMS0xLTEtMA_48facf7f-7942-4e6f-a721-43c4230ca67c">1,149.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i395a6bf2ed5a4516a97cb9dfd143feb1_I20190630" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzktMy0xLTEtMA_881a7b24-522f-4d1b-8940-2870c8539544">1,370.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzE1NTY_10fe58cb-3708-449e-a7a1-dbd5b930c643" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles assets by geographical region to total assets:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"></td><td style="width:60.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net equipment, leasehold improvements and property:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950b875f77734623b789ea990425b829_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzMtMS0xLTEtMjMzMg_a0df78e4-8744-4d7a-a280-e93c6ad8e42c">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a1f560877784761aecb5fecd5cc3ec6_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzMtMS0xLTEtMA_2f339d2e-3521-4bf5-84cd-bf402c14aec6">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb7f24f854d147699f0cbec384e49317_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzMtMy0xLTEtMA_ddb95dea-7a32-400e-99b1-d81155661b76">36.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71f9622e189741ed9e209051bad9c565_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzQtMS0xLTEtMjMzMg_48bdae4d-e4aa-44e6-872f-81ef42ad1a8a">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095006ddbfd24e619e8e422986256785_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzQtMS0xLTEtMA_d43287f7-eb5a-4780-afec-ac33216ffd01">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9be740ad7044f4882e0d2a5c0a6dc86_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzQtMy0xLTEtMA_78ed2a8a-d02b-4c26-9089-36da6642b191">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed4be03cd544752819f842c6fdf12ae_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzUtMS0xLTEtMjMzMg_e9afccff-9822-4d8b-8f0c-1d7b18179908">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d28bb175fb446de9c4a1a2ff2e5f146_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzUtMS0xLTEtMA_15cd95c2-ace2-4a67-b0f9-d9c33eb0f8fb">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8619e2e18714ee0808436fe3942e76f_I20190630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzUtMy0xLTEtMA_321939ee-bc39-40d3-9f2f-bd8c04c5b75e">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950b875f77734623b789ea990425b829_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzctMS0xLTEtMjMzMg_f3c801f4-e5bd-485f-9143-8228bc716bb8">1,190.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a1f560877784761aecb5fecd5cc3ec6_I20200630" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzctMS0xLTEtMA_3362fb1a-fa32-4506-98a5-62874de3361f">1,097.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb7f24f854d147699f0cbec384e49317_I20190630" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzctMy0xLTEtMA_6dd44542-cbe5-4627-bdf4-e21daaff5ec7">1,265.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71f9622e189741ed9e209051bad9c565_I20201231" decimals="-5" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzgtMS0xLTEtMjMzMg_82d28950-b3a1-46ae-b054-fc6d6537c2da">56.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095006ddbfd24e619e8e422986256785_I20200630" decimals="-5" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzgtMS0xLTEtMA_ca78e965-bd14-4c78-a1f1-071fdd289f25">52.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9be740ad7044f4882e0d2a5c0a6dc86_I20190630" decimals="-5" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzgtMy0xLTEtMA_37cf708f-53a0-4ffe-a3cf-ba11fed06e1f">105.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets by segment and geographical region</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed4be03cd544752819f842c6fdf12ae_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzktMS0xLTEtMjMzMg_6fdb6c64-def8-4e46-b38c-527ac0ea8c9a">1,247.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d28bb175fb446de9c4a1a2ff2e5f146_I20200630" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzktMS0xLTEtMA_28c8a78b-82af-4b95-9436-8db6a0a41682">1,149.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8619e2e18714ee0808436fe3942e76f_I20190630" decimals="-5" format="ixt:numdotdecimal" name="mygn:AssetsLessCashCashEquivalentsAndInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzktMy0xLTEtMA_5f08533e-fe94-47f1-adbc-6f8c6c6162b3">1,370.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and marketable investment <br/>     securities (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzEwLTEtMS0xLTEzNDMx_e8827dcd-e8a3-4341-a7f6-4e0e15b77c6e">171.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzEwLTMtMS0xLTEzNDMx_f28c7263-c34a-41b9-a836-ac0a43a7872e">254.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzEwLTUtMS0xLTEzNDMx_8c28702c-505c-483e-9e1f-7b1acef497a3">191.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzExLTEtMS0xLTEzNDMx_987ba71c-9789-4d49-9ef4-c0824950cb4d">1,418.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzExLTMtMS0xLTEzNDMx_3e80aa4b-a7b9-4fab-94bb-771405dd2114">1,404.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f08e4358544efba7545f11fac65d70_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzExLTUtMS0xLTEzNDMx_f0836ed7-723e-4ad9-aa72-944a9e937e5f">1,562.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzQ5NDc4MDIzMjkzNzc_945ef728-1f2b-4d12-8297-33b2d142a428" escape="true"><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles revenue by geographical region to total revenue:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"></td><td style="width:48.212%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8622695f21e2408d87455391982da0ec_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzItMS0xLTEtMTY3MTg_268e6bac-ac08-4a0d-bf94-39d44fe92070">275.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e62f9190914161943bf5ea28f91cef_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzItMy0xLTEtMTY3MTg_44e32efe-36d1-47d9-bc47-b8e6d7a0a4ce">596.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc2b51c7302d434a8cc407ad3c95cc0e_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzItNS0xLTEtMTY3MTg_e481a4a6-a27e-4348-9274-28042322991d">805.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4d9c21becba4a2e82b923527a2ec975_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzItNy0xLTEtMTY3MTg_315b5aee-18e6-4f64-a3e8-a233d23eab2c">700.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0fa951cb5a4ec2b189987010cc8a1c_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzMtMS0xLTEtMTY3MTg_82925dd9-782e-42ad-b55a-cd7d2ca94f5c">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib714b0e057fc4f5e8fb0c1045086c48f_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzMtMy0xLTEtMTY3MTg_bfb8740b-53cd-48bd-9fd4-658793d0f84f">42.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe81c4efa2445fdb62fa8055200c3d2_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzMtNS0xLTEtMTY3MTg_d49129df-cf93-4e4f-91b5-b641af6094b5">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b03b59516e541509ec6f0854b5b2266_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzMtNy0xLTEtMTY3MTg_fec544b7-26b4-46c2-9d60-2572a95e18cb">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzQtMS0xLTEtMTY3MTg_f33c1ec9-734f-46bb-acba-aa39930320f5">299.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzQtMy0xLTEtMTY3MTg_f5db733e-a2eb-4997-bdc3-a1b868a16103">638.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzQtNS0xLTEtMTY3MTg_785365da-eb5c-4ba2-a2e6-3b4329aaa9dd">851.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzQtNy0xLTEtMTY3MTg_9527b7e8-a48b-4628-95e2-607e991116ab">743.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic01b255bce00439ba9380fc219eb70e1_166"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjYvZnJhZzo0MjEzNjNkOTNmMDY0MjBiYjcxZmUwOTAyZDc4MmE0OS90ZXh0cmVnaW9uOjQyMTM2M2Q5M2YwNjQyMGJiNzFmZTA5MDJkNzgyYTQ5XzcxMQ_25bddd92-0a95-4607-91ca-4902795de7af" continuedAt="i993bc979974e4bc4a71f01e1f9f4b12b" escape="true">SALE OF SUBSIDIARY</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i993bc979974e4bc4a71f01e1f9f4b12b">On February 28, 2020, the Company closed the sale of the Clinic with Landkreis Starnberg. As a result of the sale, the Clinic was deconsolidated from the Company&#8217;s consolidated financial statements in accordance with ASC 810. The Company recorded a pre-tax net gain of $<ix:nonFraction unitRef="usd" contextRef="idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjYvZnJhZzo0MjEzNjNkOTNmMDY0MjBiYjcxZmUwOTAyZDc4MmE0OS90ZXh0cmVnaW9uOjQyMTM2M2Q5M2YwNjQyMGJiNzFmZTA5MDJkNzgyYTQ5XzI5Nw_19ddc634-60d3-47a4-8302-e66c52c41020">1.0</ix:nonFraction> million on the sale, which was recorded in other income in the Company&#8217;s Consolidated Statements of Operations during the fiscal year ended June 30, 2020. The gain recorded consists of a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228" decimals="-5" format="ixt:numdotdecimal" name="mygn:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjYvZnJhZzo0MjEzNjNkOTNmMDY0MjBiYjcxZmUwOTAyZDc4MmE0OS90ZXh0cmVnaW9uOjQyMTM2M2Q5M2YwNjQyMGJiNzFmZTA5MDJkNzgyYTQ5XzQ1MA_8654d8a7-9cfb-4884-bb5c-95f3240a9ff2">1.2</ix:nonFraction> million associated with the settlement of the Clinic pension, offset by a loss of $<ix:nonFraction unitRef="usd" contextRef="idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228" decimals="-5" sign="-" format="ixt:numdotdecimal" name="mygn:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjYvZnJhZzo0MjEzNjNkOTNmMDY0MjBiYjcxZmUwOTAyZDc4MmE0OS90ZXh0cmVnaW9uOjQyMTM2M2Q5M2YwNjQyMGJiNzFmZTA5MDJkNzgyYTQ5XzUyNw_8f60cabf-bbfa-4bf2-84cc-2aded0e4db81">0.2</ix:nonFraction> million due to the difference between the purchase price and net assets as well as the effects of foreign currency. The Clinic was previously reported as part of the Company&#8217;s other segment.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU1MjU_e98e594a-e295-4005-ba8b-616b6c69a476" continuedAt="ic5cc2544820d4ba2a4331056fda6aead" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><ix:continuation id="ic5cc2544820d4ba2a4331056fda6aead" continuedAt="i8c497d608b1f437ab1a6de90b846be7b"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counsyl</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2018, the Company completed the acquisition of Counsyl, Inc. (&#8220;Counsyl&#8221;), a leading provider of genetic testing and DNA analysis services, pursuant to the Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), dated May 25, 2018.&#160;&#160;Pursuant to the terms of the Merger Agreement, Myriad Merger Sub, Inc., a newly created wholly-owned subsidiary of the Company, was merged with and into Counsyl, with Counsyl continuing as the surviving corporation and a wholly-owned subsidiary of Myriad.&#160;&#160;The Company believes the acquisition allows for further entry into the high-growth reproductive testing market, with the ability to become a leader in women&#8217;s health genetic testing.&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired Counsyl for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzc2OQ_5a530daa-dd64-42f8-810e-255d4f8643a9">405.9</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzc4Nw_7aea4440-685d-46b0-8987-f44d0fcad92e">278.5</ix:nonFraction> million in cash, financed in part by the Amendment No. 1 to the Facility (see Note 7) and <ix:nonFraction unitRef="shares" contextRef="i4404c2e49c864be6b8c89615b7c19e72_D20180731-20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzg3MQ_9d5f90ae-6121-4d0d-b69d-8285fd231055">3.0</ix:nonFraction> million shares of common stock issued, valued at $<ix:nonFraction unitRef="usd" contextRef="i01ca278c54bd4c979932880e1cf44d22_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzkxNQ_81d51c53-7dfd-4826-a311-987cac20f2fa">127.4</ix:nonFraction> million.&#160;&#160;The shares were issued and valued as of July&#160;31, 2018 at a per share market closing price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i01ca278c54bd4c979932880e1cf44d22_I20180731" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzEwMTM_93bd62ae-ffa1-4de9-b19f-5aa118edae3e">42.53</ix:nonFraction>.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the cash consideration, $<ix:nonFraction unitRef="usd" contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EscrowDepositDisbursementsRelatedToPropertyAcquisition1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzEwNDQ_67d6b5f1-6c31-4e65-97bb-51f367b63c12">5.0</ix:nonFraction> million was deposited into an escrow account to fund any post-closing adjustments payable to Myriad based upon differences between the estimated working capital and the actual working capital of Counsyl at closing.&#160;&#160;The working capital was finalized during the fiscal year ended June 30, 2019 as described below.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration transferred was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the acquisition date. Management estimated the fair value of tangible and intangible assets and liabilities in accordance with the applicable accounting guidance for business combinations and utilized the services of third-party valuation consultants. The significant assumptions used in the model to estimate the value of the intangible assets included projected cash flows, discount rates, net working capital and long-term growth rate. The initial allocation of the consideration transferred is based on a preliminary valuation and is subject to adjustments. Balances subject to adjustment primarily include the valuations of acquired assets (tangible and intangible), liabilities assumed, as well as tax-related matters. During the measurement period, the Company may record adjustments to the provisional amounts recognized. During the fiscal year ended June 30, 2019, $<ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzIzMjc_7c09c91d-e2c2-43c4-8c15-4baf70e57ae8">1.1</ix:nonFraction> million of this escrow was returned to Myriad as a result of a working capital adjustment which reduced the total consideration and goodwill.&#160;&#160;There was also a reduction in the intangible assets of $<ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzI1MjA_6155c475-1213-45a3-9c1e-b40fb7b08c80">2.9</ix:nonFraction> million due to updated assumptions related to contributory asset charges associated with the related acquired asset, a $<ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzI2MzQ_a46ab755-a629-43f7-962f-916e7deeaaa0">1.9</ix:nonFraction> million decrease in the deferred tax liability, and a $<ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzI2ODM_5ac7b4c2-5c81-4687-89e6-2ff68f28fddd">0.7</ix:nonFraction> million reduction to equipment due to updated valuations. The offset for the intangible asset, deferred tax liability and equipment changes was a $<ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzI4MjQ_def697f5-bc49-43d7-b4f1-015235179b0d">4.4</ix:nonFraction> million increase in goodwill. The allocation of the consideration transferred was finalized within the measurement period.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzQ5NDc4MDIzMzEyNzA_dd78cddf-e122-4e23-818a-1af6fc75ecc1" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the estimated fair value of total consideration transferred:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:86.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzEtMS0xLTEtMA_fa41d59f-18fd-4727-80d2-f23960dd7192">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzItMS0xLTEtMA_9cb580bd-9280-4eaa-b0a5-f3ac1d66568c">290.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzMtMS0xLTEtMA_83cd02ee-ffbc-43e6-82f2-151e716c1fce">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzQtMS0xLTEtMA_7a257318-8555-4d34-843e-a675c254b4a0">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzUtMS0xLTEtMA_07541075-b649-4354-9bda-94272a14dc55">99.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzYtMS0xLTEtMA_ef01ee29-4b1d-489b-b403-ff4aaec66d94">19.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzctMS0xLTEtMA_44d5f521-2b4c-4b3f-bf04-b09d2e3cc717">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzgtMS0xLTEtMA_856c5299-8fa3-469b-8491-cb19ffa8f3f6">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value purchase price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzktMS0xLTEtMA_6f979417-722e-4ab2-8b2a-f46ccb05fddb">421.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731" decimals="-5" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzEwLTEtMS0xLTA_12efa770-c7ac-4840-8298-f62686f50c10">15.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzExLTEtMS0xLTA_8a43927d-1bdf-47f0-af5d-ce116d56f0d6">405.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Identifiable Intangible Assets</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired intangible assets that consisted of developed screening processes, which had an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="ib375fb1450054a4aad0facea3d6370ce_D20180731-20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzMxMDA_d9d16dde-d95c-4055-9c88-379bbd1006f3">290.0</ix:nonFraction> million. The fair values of these developed screening processes and related useful lives were determined using a probability-weighted income approach that discounts expected future cash flows to present value. The estimated net cash flows were discounted using a discount rate of <ix:nonFraction unitRef="number" contextRef="ib375fb1450054a4aad0facea3d6370ce_D20180731-20180731" decimals="INF" name="mygn:AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzMzNzU_e676614b-8473-4c10-8128-e26f0af4b9da">12.5</ix:nonFraction>%, which is based on the estimated internal rate of return for the acquisition and represents the rate that market participants might use to value the intangible assets. The Company will amortize the intangible assets on a straight-line basis over their estimated useful lives of <ix:nonNumeric contextRef="ib375fb1450054a4aad0facea3d6370ce_D20180731-20180731" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzM2NTY_bf9adb4b-60bf-48b2-936b-cd5d24b1dde7">12</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i8c497d608b1f437ab1a6de90b846be7b"><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill represents the excess of consideration transferred over the fair value of assets acquired and liabilities assumed and is attributable to the benefits expected from combining the Company&#8217;s expertise with Counsyl&#8217;s technology, customer insights, and ability to effectively integrate genetic screening into clinical practice with OBGYNs.&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:BusinessCombinationSegmentAllocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU1Mjc_600f771d-d3bc-4fa8-ba10-d0a87ef5d88b" continuedAt="i4f4073770ffd4646bda6678066f35d71" escape="true">Changes in goodwill since the initial purchase are shown below:</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i4f4073770ffd4646bda6678066f35d71"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"></td><td style="width:86.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance September 30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i989c0ce93f6e4f0fad3b86a4df6adedf_I20180930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzEtMS0xLTEtMA_81ea6891-bfd3-46ae-9d66-81fad894dd48">94.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment to equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231" decimals="-5" name="mygn:GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzItMS0xLTEtMA_5f380889-bbd9-43cb-9b98-e80f4247df05">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231" decimals="-5" name="mygn:GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzMtMS0xLTEtMA_7d4dc888-fd98-412f-9c88-99df9e126697">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231" decimals="-5" sign="-" name="mygn:GoodwillIncreaseDecreaseWorkingCapitalAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzQtMS0xLTEtMA_ccb4ed6a-32e1-4270-a7f0-d9ef549c64e4">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231" decimals="-5" name="mygn:GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzUtMS0xLTEtMA_c4de2e44-b8f4-4998-b38f-fac43bbde752">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5274fcc1e4cf4cddb09da83ac2cbc368_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzYtMS0xLTEtMA_20b6a907-f13d-492f-a7be-49a6c74b29f7">99.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This goodwill is not deductible for income tax purposes.</span></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma Information (Unaudited)</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro-forma results presented below include the effects of the Counsyl acquisition as if it had been consummated as of July 1, 2017, with adjustments to give effect to pro forma events that are directly attributable to the acquisition, which includes adjustments related to the amortization of acquired intangible assets, interest income and expense, and depreciation.</span></div><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU1MjQ_1210f57a-fad2-4181-b103-63bc4a0d285b" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results do not reflect any operating efficiency or potential cost savings that may result from the consolidation of Counsyl with the Company. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operation of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations and are not necessarily indicative of results that might have been achieved had the acquisition been consummated as of July 1, 2017.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"></td><td style="width:73.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzItMS0xLTEtMA_6e63c123-770c-4c48-977f-b7cfbeb4c2d4">861.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzItMy0xLTEtMA_094c6359-afec-4b63-83df-9920d82abbba">881.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzMtMS0xLTEtMA_11ca367f-f6d3-4765-8e2e-9a3e2b990bfa">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzMtMy0xLTEtMA_e9ee4734-e611-4b11-898f-dbe59e631656">74.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzQtMS0xLTEtMA_d456b20c-01b0-4fb0-b3fc-1faed1721dd4">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzQtMy0xLTEtMA_6e4361f3-5605-4250-995b-8bb7819b6577">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzUtMS0xLTEtMA_d4643e12-2c4e-4cf8-9dd7-ccebdc74f676">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzUtMy0xLTEtMA_430f1a32-1bea-413f-8728-8b7e28ac75d6">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzYtMS0xLTEtMA_7d1d861d-68ff-44c4-b9aa-e20fbc132c67">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzYtMy0xLTEtMA_630817a4-e1eb-46d6-8376-78b86abb0f20">0.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To complete the purchase transaction, the Company incurred approximately $<ix:nonFraction unitRef="usd" contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzUyNjk_7f09e9b8-6af4-4aae-b459-cba801108cea">6.8</ix:nonFraction> million of acquisition costs, which are recorded as selling, general and administrative expenses in the period incurred. For the fiscal year ended June 30, 2019, Counsyl contributed revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU0NDU_a5f5f5b7-4fa4-49e3-b9b7-22c2da29c27a">104.9</ix:nonFraction> million.&#160;For the fiscal year ended June 30, 2019, operating expenses related to Counsyl were approximately $<ix:nonFraction unitRef="usd" contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU1MjI_58caa4cf-da61-4f4d-8914-b15eb0425af5">67.6</ix:nonFraction> million.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_1896"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODk2L2ZyYWc6MTkwNTYxNmYzNGU4NDAyZWI2YTU5YjM0OTJkNTlmYzQvdGV4dHJlZ2lvbjoxOTA1NjE2ZjM0ZTg0MDJlYjZhNTliMzQ5MmQ1OWZjNF80OTQ3ODAyMzMxNzc2_6acda383-40bd-47c2-a5c2-370c870689af" continuedAt="ia8f0bee897d3439cb0d8491b562326b2" escape="true">SUBSEQUENT EVENT</ix:nonNumeric></span></div><ix:continuation id="ia8f0bee897d3439cb0d8491b562326b2" continuedAt="i9375034939cb446ba877fb13370680e3"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, the Company entered into Amendment No. 3 to the Amended Facility discussed in Note 7, which modified the Amended Facility as follows:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Extends the Modification Period established pursuant to Amendment No. 2 for an additional year, through June 30, 2022, and revises certain negative covenants in connection therewith.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricts the Company from borrowing under the revolving credit facility if unrestricted cash and cash equivalents exceed $<ix:nonFraction unitRef="usd" contextRef="i4e14cc8f30fb41298c08929c2d88cda2_I20210222" decimals="INF" format="ixt:numdotdecimal" name="mygn:DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODk2L2ZyYWc6MTkwNTYxNmYzNGU4NDAyZWI2YTU5YjM0OTJkNTlmYzQvdGV4dHJlZ2lvbjoxOTA1NjE2ZjM0ZTg0MDJlYjZhNTliMzQ5MmQ1OWZjNF80OTQ3ODAyMzMxNzQ0_0a8a8e3f-15eb-4705-a6bd-a5b7ba082956">150.0</ix:nonFraction> million, unless such borrowings are in connection with acquisitions.</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Reduces the revolving commitments to $<ix:nonFraction unitRef="usd" contextRef="i4e14cc8f30fb41298c08929c2d88cda2_I20210222" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODk2L2ZyYWc6MTkwNTYxNmYzNGU4NDAyZWI2YTU5YjM0OTJkNTlmYzQvdGV4dHJlZ2lvbjoxOTA1NjE2ZjM0ZTg0MDJlYjZhNTliMzQ5MmQ1OWZjNF80OTQ3ODAyMzMxNzU1_2d62e58e-b2cc-4831-82d1-5f02f462a406">300.0</ix:nonFraction> million, with a further reduction to $<ix:nonFraction unitRef="usd" contextRef="if4d51abe6c704a11849ba0fee98381b0_I20210930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODk2L2ZyYWc6MTkwNTYxNmYzNGU4NDAyZWI2YTU5YjM0OTJkNTlmYzQvdGV4dHJlZ2lvbjoxOTA1NjE2ZjM0ZTg0MDJlYjZhNTliMzQ5MmQ1OWZjNF80OTQ3ODAyMzMxNzY2_d647f394-6eda-43b2-918a-877ab9dc157c">250.0</ix:nonFraction> million by September 30, 2021. Provides for further reductions to the revolving commitments, or mandatory prepayments of outstanding revolving loans, in the event of certain asset sales.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Waives compliance with the leverage ratio and the interest coverage ratio covenants through the quarter ended March 31, 2022 and also lowers the minimum liquidity covenant applicable through such quarter.</span></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Removes the minimum EBITDA covenant added pursuant to Amendment No. 2.</span></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Permits the Company to change its fiscal year end to December 31.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:108pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9375034939cb446ba877fb13370680e3" continuedAt="i16627497c6554c1ea6bec7ea5d6f3e63">&#9702;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"><ix:continuation id="i16627497c6554c1ea6bec7ea5d6f3e63">Permits the Company to keep the net cash proceeds of material asset sales received above certain dollar thresholds without corresponding mandatory prepayments or commitment reductions.</ix:continuation>   </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90ZXh0cmVnaW9uOmMyMDVmNGRlMzM1NTQ0ZWU4M2UzZmU2YzM5MjI3MjU3XzQ1_c79335b4-c6b3-4f5c-8af3-5c6aef108ce3" continuedAt="i6c4269be767445c1bc68e5ab7433ac2c" escape="true">SUPPLEMENTAL CASH FLOW INFORMATION</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i6c4269be767445c1bc68e5ab7433ac2c"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90ZXh0cmVnaW9uOmMyMDVmNGRlMzM1NTQ0ZWU4M2UzZmU2YzM5MjI3MjU3XzQ2_df0f27db-cf3e-4696-a388-a598a9e04209" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzItMS0xLTEtMjM1Mg_2492ec00-c212-4efa-9085-3db609beb6cb">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzItMS0xLTEtMA_57e953d7-3d2b-422e-9503-359ee565bc33">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzItMy0xLTEtMA_1334bbde-2cc2-4c02-ac63-aaf027355512">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzItNS0xLTEtMA_0076e5b9-6214-4b34-84e3-f690cfc0023c">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzMtMS0xLTEtMjM1Mg_0fb5eb09-1f1b-4280-a7f8-31bbd5ed521e">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzMtMS0xLTEtMA_cc88459f-0530-421c-ac1c-913684beeaed">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzMtMy0xLTEtMA_ecfcb44f-1fc8-4d89-b4eb-800bf2ef0360">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzMtNS0xLTEtMA_6bdae661-cb06-4864-8ae6-f1707335226e">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment on marketable investment securities recorded to stockholders' equity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" decimals="-5" sign="-" name="mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzUtMS0xLTEtMjM1Mg_70c4dd6f-44aa-453f-9fb9-40f42aafaa54">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzUtMS0xLTEtMA_b10d3ebf-5856-427e-b0e3-600f9a36e3bc">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630" decimals="-5" name="mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzUtMy0xLTEtMA_cdcd9575-1464-4a44-9f87-32a27c3e9b9f">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630" decimals="-5" sign="-" name="mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzUtNS0xLTEtMA_035621f0-9fd4-4a0a-bfa7-a124904ef69e">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment of operation lease right-of-use assets and lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7379beb581ae4463a448487c90805d3e_D20190701-20200630" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzctMS0xLTEtMA_1706e283-733b-45ad-a0d3-99ddde90d11c">74.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7379beb581ae4463a448487c90805d3e_D20190701-20200630" decimals="-5" name="mygn:OperatingLeaseLiabilityEstablished" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzgtMS0xLTEtMA_3e4199d2-0a9b-4fd1-b1b0-6989457d56bf">78.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzktMS0xLTEtMA_6374732f-e8d9-4a79-af77-e63204b4a566">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="ic01b255bce00439ba9380fc219eb70e1_178"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90ZXh0cmVnaW9uOjYzNTBiYjc1ZjJkYzQ2MTY4NTIyZTViNThjMTE1NTQzXzQ1Ng_42936a25-963e-496a-ae64-c9b8de56dd92" continuedAt="ifbd908c478da492f93d0c42854d3eaea" escape="true">SUPPLEMENTARY QUARTERLY FINANCIAL DATA (UNAUDITED)</ix:nonNumeric></span></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><ix:continuation id="ifbd908c478da492f93d0c42854d3eaea" continuedAt="i6ca5e8759353407e990477deb7188880"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90ZXh0cmVnaW9uOjYzNTBiYjc1ZjJkYzQ2MTY4NTIyZTViNThjMTE1NTQzXzQ1Nw_0ed13c6a-367e-463a-ae30-d3dd6468006a" continuedAt="i809f7da1445d4c79bffc17a7f3e848fe" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8d38cab5c564bc9b20105859dec05a3_D20201001-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzItMS0xLTEtNzQyOQ_22a6294a-f844-4b96-a8a2-6a27ea76424d">143.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i417fd6436fa34961ad7783ba3007e98d_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzItMy0xLTEtMTM3NTQ_bd18e51f-05f0-4e3b-8e59-4655d8f887e9">135.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie222e257470d49d4b5328c8b76c753c1_D20201001-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzMtMS0xLTEtNzQzMg_404f1696-0f66-4038-8cd6-ea5f71c1718c">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280a6b01f275425d87a80ea2b0b0a40e_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzMtMy0xLTEtMTM3NTQ_b0e121e1-4d88-49d9-a16c-354d1f9562fb">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzQtMS0xLTEtNzQzMg_a1e504a2-1a81-46b6-8bec-b150f90875aa">154.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzQtMy0xLTEtMTM3NTQ_64690a3e-76e0-4621-a861-cb4039fdb381">145.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8d38cab5c564bc9b20105859dec05a3_D20201001-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzYtMS0xLTEtNzQzMg_f8287689-ac12-4716-8cab-ae3c6dd66cc1">42.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i417fd6436fa34961ad7783ba3007e98d_D20200701-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzYtMy0xLTEtMTM3NTQ_08f70c92-f9db-46b3-8e13-afb8684e4257">39.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie222e257470d49d4b5328c8b76c753c1_D20201001-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzctMS0xLTEtNzQzMg_a6c79dd3-4207-4bf3-844e-a90940bb5f64">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280a6b01f275425d87a80ea2b0b0a40e_D20200701-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzctMy0xLTEtMTM3NTQ_9f3f5229-6864-45d1-a2c6-7e0a287c8e98">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzgtMS0xLTEtNzQzMg_619e8324-ad8b-47ea-9206-19c012a6cb0b">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzgtMy0xLTEtMTM3NTQ_323a5c95-9c52-49c7-8b69-9570eb799da8">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzktMS0xLTEtNzQzMg_7a5856a1-361b-4f1d-a2ce-b3e864286c69">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzktMy0xLTEtMTM3NTQ_23571489-5e39-4ab5-bbd1-2a2b26c41d67">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzEwLTEtMS0xLTc0MzI_9dc7c084-3b50-4c2d-8fe9-e3bfaeebd069">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzEwLTMtMS0xLTEzNzU0_cf01bcfc-d2b9-4f3b-b0d2-2adfaa63e229">124.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzExLTEtMS0xLTc0MzI_2ad2b8f1-69df-4acb-a1ba-c6bf59b6cd25">202.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzExLTMtMS0xLTEzNzU0_e79e7d12-1760-4500-bee1-0559b04c0569">184.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzEyLTEtMS0xLTc0MzI_09331529-6537-48c2-8082-95373ad2c146">48.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzEyLTMtMS0xLTEzNzU2_432626c9-3725-4ee5-b124-dbb78f908a52">39.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE0LTEtMS0xLTc0MzI_5251aec1-69c5-450e-9ce5-bf27d1db651c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE0LTMtMS0xLTEzNzU0_0e317772-2cee-4c01-ad07-0b1ebb679628">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE1LTEtMS0xLTc0MzI_664177d4-538c-4f28-92e5-7adaf83f3308">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE1LTMtMS0xLTEzNzU0_17c9eea1-5999-471b-8301-914b966a2008">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE2LTEtMS0xLTc0MzI_1066acee-6923-4410-8bb9-3ba5b70ad873">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE2LTMtMS0xLTEzNzU0_dde9c46c-f0bf-4d76-a19e-e0274feaf58a">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total other expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE3LTEtMS0xLTc0MzI_3ff7ba9a-f494-4413-afbb-f25b447c6ea2">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE3LTMtMS0xLTEzNzU0_bc8d1536-76c0-45bf-9fe1-2782d7ab4d6d">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE4LTEtMS0xLTc0MzI_2c80466d-1126-4c38-8fc3-9eabe1fabdce">50.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE4LTMtMS0xLTEzNzU0_cdb490d9-29ea-47c9-846a-9388a209f99f">43.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE5LTEtMS0xLTc0MzI_72df2099-b7df-4770-8e30-8155fdcc9cd1">12.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE5LTMtMS0xLTEzNzU0_e1655fad-93ee-4be8-9241-90e2007ce8e6">28.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIwLTEtMS0xLTc0MzI_294cd040-1095-4cc0-96da-d5b9b8673f59">37.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIwLTMtMS0xLTEzNzU0_8cc3f180-16b1-4b0c-b0f0-ae162a14a06d">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net loss attributable to non-controlling interest  </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIxLTEtMS0xLTc0MzI_a273e35d-da06-45d9-9f2a-120a5d8cbd73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIxLTMtMS0xLTEzNzU0_181b470d-3708-4e8e-b939-99852ad4488b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Myriad Genetics Inc. stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIyLTEtMS0xLTc0MzI_ca4dba33-315b-4327-8830-30d424f3c19f">37.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIyLTMtMS0xLTEzNzU0_9a039426-4592-486b-94d8-8b7f981208b8">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI0LTEtMS0xLTc0MzU_980cc111-2ad1-4704-acc0-1f64d6b86da4">0.50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI0LTMtMS0xLTEzNzU0_b22ddd54-e189-4a4c-9fd9-c04f662393be">0.20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI1LTEtMS0xLTc0MzU_0f7bab43-f3d0-497d-9bae-bc565cc86189">0.50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI1LTMtMS0xLTEzNzU0_392df9dd-40b0-4ea1-8a03-939f04230020">0.20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI3LTEtMS0xLTc0MzU_547e1bac-7925-4e6b-81bd-3e957dca0a7b">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI3LTMtMS0xLTEzNzU0_88be0a78-7348-4c68-8a07-24e4897639f4">74.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI4LTEtMS0xLTc0MzU_684a71fc-d805-4f60-9bf2-41db3f025174">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI4LTMtMS0xLTEzNzU0_6a5f08fe-bf19-4f2f-9a44-7838fcfb377a">74.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><ix:continuation id="i6ca5e8759353407e990477deb7188880" continuedAt="id3b9ebb560c745c5ad000cc0fb09c99a"><ix:continuation id="i809f7da1445d4c79bffc17a7f3e848fe" continuedAt="ib1d3e7edb8ec4a0f8fe681d3852a8612"><div style="margin-top:5pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019 (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfe0fce6e9744d5958f4fc65b2cceb5_D20200401-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzItMS0xLTEtMA_e0b66769-eca7-4523-9134-bd9aafd9ff06">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da9afb8114544a681d59d52fbda4b5f_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzItMy0xLTEtMA_0db7d9a7-7c55-45ae-9dda-c6bb701ed7d5">150.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66a2e9352774e61bb66d72a0ec6ba0a_D20191001-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzItNS0xLTEtMA_b81cdf0c-aea8-4351-b367-5f3b1f624cd8">181.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76971edb2f495597ee3f81808bc71c_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzItNy0xLTEtMA_148b09e9-2441-4be6-84f5-e9e86c8659ec">172.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea11b6adbeb41c5bcf4dadb78975fbb_D20200401-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzMtMS0xLTEtMA_ae323c28-dd65-4e59-bf1d-20c05a65221c">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5aa650d52994396ad41ee3b0e5b738c_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzMtMy0xLTEtMA_eb7fb0ec-94f0-4e4e-b11a-d8e2532105bc">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f36b0ed57f4719bdab785d76fd50ae_D20191001-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzMtNS0xLTEtMA_5dc2a86f-353a-476f-a041-59a28a8275fe">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8bb11b2e0d4568a0ef8208b3edb143_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzMtNy0xLTEtMA_7bc1380d-03cc-4390-bd21-512cdfea37e6">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzQtMS0xLTEtMA_cd8d4247-26bf-408f-a26b-22b9063ccb54">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzQtMy0xLTEtMA_2ffd6464-9197-481c-a13b-0147c4a4016a">164.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzQtNS0xLTEtMA_9e754361-eb3b-4c09-b700-23baa219584c">195.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzQtNy0xLTEtMA_54374154-fc63-4845-9737-5d14fc528696">186.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfe0fce6e9744d5958f4fc65b2cceb5_D20200401-20200630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzYtMS0xLTEtMA_03616ce2-1739-47bd-a733-5579f796e07e">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da9afb8114544a681d59d52fbda4b5f_D20200101-20200331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzYtMy0xLTEtMA_bd970787-4f69-4c62-be0a-baf110f9fb76">43.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66a2e9352774e61bb66d72a0ec6ba0a_D20191001-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzYtNS0xLTEtMA_a5461fb9-0136-4f88-b464-b673c55ef758">41.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76971edb2f495597ee3f81808bc71c_D20190701-20190930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzYtNy0xLTEtMA_25a862d1-4030-4a2c-a314-3fd8b48a9a71">41.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea11b6adbeb41c5bcf4dadb78975fbb_D20200401-20200630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzctMS0xLTEtMA_ebad950c-5326-4cb6-8a67-92dda98a6364">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5aa650d52994396ad41ee3b0e5b738c_D20200101-20200331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzctMy0xLTEtMA_afea7f60-4564-4f0c-a6ff-68b5138244fe">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f36b0ed57f4719bdab785d76fd50ae_D20191001-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzctNS0xLTEtMA_a51dc5d0-54fd-46aa-bd4f-264b9059ba23">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8bb11b2e0d4568a0ef8208b3edb143_D20190701-20190930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzctNy0xLTEtMA_39a05158-6db9-4a1c-963f-bb046c42f6b8">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzgtMS0xLTEtMA_6c9c9be0-c962-4115-af22-b4b113b9648c">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzgtMy0xLTEtMA_af8b8452-3370-46d4-bbea-15bcffcef7f8">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzgtNS0xLTEtMA_6d66cfae-5a36-43c5-8803-022d1f870d17">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzgtNy0xLTEtMA_b7c750e4-b0c4-487e-8b6b-c3073358666b">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzktMS0xLTEtMA_ad3aac24-00a0-48ba-a993-57dc911dba5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzktMy0xLTEtMA_46eb4057-eb05-4129-b469-67f21aa41dc5">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzktNS0xLTEtMA_f4446157-1002-40a6-aac4-23bf7b768d89">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzktNy0xLTEtMA_1f30c09e-e880-47f3-baa4-5abe252ba433">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEwLTEtMS0xLTA_49f80181-2be9-4b7f-819a-1ee00bfcf305">107.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEwLTMtMS0xLTA_b33fc04c-2ea0-4b22-879d-4032ac18be3d">132.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEwLTUtMS0xLTA_d01d875a-5289-4953-abbe-d1fc3c4fa341">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEwLTctMS0xLTA_fc1faf7d-0001-47b1-a95d-1114af942b32">135.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzExLTEtMS0xLTA_85ca9f7e-c337-47d7-b660-d1accc039385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzExLTMtMS0xLTA_3218d5ae-a29d-4d47-b4ae-61fa1f83024e">98.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzExLTUtMS0xLTA_e511278e-1303-4e97-81a3-8b1325ccb585">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzExLTctMS0xLTA_acd95aa7-a487-4e74-83c8-01aafc4a23c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEyLTEtMS0xLTA_2da88fc1-e44a-42a1-9471-39757198b586">161.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEyLTMtMS0xLTA_e044d903-bad1-4b25-af75-f99e09a8f51a">297.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEyLTUtMS0xLTA_e9b6d2fa-4682-445f-8b84-2d3e15f865a1">203.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEyLTctMS0xLTA_0bd81eea-8bfb-4e11-9a29-7c537d6f91fd">207.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEzLTEtMS0xLTA_77e2d9f1-68b7-4abc-9dd4-ee8c315598a7">68.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEzLTMtMS0xLTA_21a772b0-0b08-4cb3-bd8e-22211b9a824e">133.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEzLTUtMS0xLTA_b0a3e120-e43d-4be7-ad5e-92e87db32151">8.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEzLTctMS0xLTA_87035aa1-f52a-415a-8ce4-b6c5d87ee918">20.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE1LTEtMS0xLTA_0fbf0f05-5693-4abb-90b6-e1e5b8c79537">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE1LTMtMS0xLTA_e5eb2aa6-373a-457a-9b25-b9be6a31e9e5">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE1LTUtMS0xLTA_b797417b-7be4-4104-b1f6-d319e9398313">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE1LTctMS0xLTA_e95b744e-5627-4c46-8df6-b93bc3059381">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE2LTEtMS0xLTA_a9d54f50-e39e-4912-a9a6-983f7af0cb10">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE2LTMtMS0xLTA_df6e634b-507b-4516-832e-0580d8e2ad24">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE2LTUtMS0xLTA_4389c99e-d10f-4a26-b2b9-a973d6e3eac6">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE2LTctMS0xLTA_ad3348d6-fc65-494c-b7e2-ed2f484cc9a4">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE3LTEtMS0xLTA_e47913ac-d1a5-43b2-af2c-cd835d233d36">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE3LTMtMS0xLTA_7ac03e62-2d01-482e-a2d4-ca291a043211">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE3LTUtMS0xLTA_1756ca20-3da8-4b2c-affd-4d779fec704e">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE3LTctMS0xLTA_a913b78c-0638-4c2d-8f7c-2535a5f4e336">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE4LTEtMS0xLTA_97707762-89c8-4344-a1d7-6150d9c69a7e">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE4LTMtMS0xLTA_31a7986b-b9b2-4167-b821-c89898fe5cb3">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE4LTUtMS0xLTA_0b0c8c3d-169a-4a99-81a5-9fc67aa35035">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE4LTctMS0xLTA_2595d0b2-bb5d-422f-913a-1588c9587379">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE5LTEtMS0xLTA_763a6ec4-a5e0-4f6d-b01e-b10fcaf774eb">58.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE5LTMtMS0xLTA_19897e03-04f2-416f-af94-2cbf1472448e">131.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE5LTUtMS0xLTA_bf9c1536-d909-47fa-a64a-4228ba526aa9">11.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE5LTctMS0xLTA_4c6c63e4-9489-4ab8-8e4c-36610b138546">22.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIwLTEtMS0xLTA_efed0357-cdeb-40db-92cd-97b631dc8d15">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIwLTMtMS0xLTA_537acc45-55f6-4dbb-aa15-3c73b0c7215b">15.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIwLTUtMS0xLTA_3fdbf09a-47ec-4f06-ac0e-09ec70d82ebb">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIwLTctMS0xLTA_f5d9ef0a-0f50-478d-980b-39ae2c51fe19">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIxLTEtMS0xLTA_7dd2dded-4d76-4c5c-85d3-2d21ac73bd4d">55.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIxLTMtMS0xLTA_89de2281-df5a-4e47-a4f5-e9a4af358f52">115.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIxLTUtMS0xLTA_ee4776d3-5c1c-4dc9-a453-4a37a89011d6">8.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIxLTctMS0xLTA_baa4647e-0388-4bbe-ba57-6f172a4db6b4">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIyLTEtMS0xLTA_964a3558-e0b7-4008-9496-fb622837695a">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIyLTMtMS0xLTA_ff53b4c5-25d4-4698-b10b-a1cfab9a3e4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIyLTUtMS0xLTA_9ae5f2c9-2fed-4978-bc0b-2f583de81632">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIyLTctMS0xLTA_d670b17e-c380-44f0-88d6-13fa8a2f3eb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics Inc. stockholders</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIzLTEtMS0xLTA_c6cd3e0d-85b9-47db-af47-9bb1bccbd107">55.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIzLTMtMS0xLTA_4bf3f6b6-5fd3-4761-8042-dc00a442043e">115.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIzLTUtMS0xLTA_2d238bc9-5216-4dbc-b66d-62fe23f87930">8.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIzLTctMS0xLTA_35878a0a-deba-4cbb-8892-819d795e5935">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI1LTEtMS0xLTA_5cead4d7-9d50-4425-8db8-130324b2494d">0.74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI1LTMtMS0xLTA_38027f76-0ba5-4915-8b8a-087970f1afa3">1.55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI1LTUtMS0xLTA_96e323ec-4d9d-447c-aa9d-296b0a768888">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI1LTctMS0xLTA_c630c3f6-7ea3-4ad5-a5b5-ee4e6c65838f">0.28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI2LTEtMS0xLTA_ac2e2898-af0c-4784-bac1-9acfdfdea793">0.74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI2LTMtMS0xLTA_61c622ec-537e-40e7-a0d2-2083dc14b9d4">1.55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI2LTUtMS0xLTA_6f4b4ae1-4400-428b-9cad-3c742ae6fa37">0.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI2LTctMS0xLTA_5bf2da16-305c-4fb6-9e31-5cb1de79cda9">0.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI4LTEtMS0xLTA_97a317d7-aa18-4454-b74c-8da8778e8770">74.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI4LTMtMS0xLTA_ce6240ae-a3d5-4b27-82ae-343537d9a4ef">74.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI4LTUtMS0xLTA_423c665e-0012-4331-869f-c3775e96b134">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI4LTctMS0xLTA_186c8466-5288-4d28-b1c3-e124eb726152">73.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI5LTEtMS0xLTA_f570475e-7d54-4919-9c48-2f50073081ad">74.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI5LTMtMS0xLTA_5270c7cd-324f-4841-9918-0b06d2323c17">74.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI5LTUtMS0xLTA_86392c20-ecd0-4e8d-b9ec-488aaba7fcd7">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI5LTctMS0xLTA_3a8052a9-183f-4a5a-97c1-775fa12472bc">73.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) An immaterial prior period goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i30498117f20e422cbecf6623972988bf_D20191001-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90ZXh0cmVnaW9uOjYzNTBiYjc1ZjJkYzQ2MTY4NTIyZTViNThjMTE1NTQzXzEyMA_33b0cf38-d576-4c6e-8bfa-c8f30f3d479f"><ix:nonFraction unitRef="usd" contextRef="i41ddfab48a7c49588075c9ec7dc244bc_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90ZXh0cmVnaW9uOjYzNTBiYjc1ZjJkYzQ2MTY4NTIyZTViNThjMTE1NTQzXzEyMA_c5548548-683a-4baa-907c-3d985e75139d">1.3</ix:nonFraction></ix:nonFraction> million was previously classified as part of selling, general and administrative expense in the condensed consolidated statements of operations was reclassified to conform to the current period presentation and is included as part of the goodwill and intangible asset impairment charges financial statement line item in the current period.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:5pt"><ix:continuation id="id3b9ebb560c745c5ad000cc0fb09c99a"><ix:continuation id="ib1d3e7edb8ec4a0f8fe681d3852a8612"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fa6edac2d94c43bca8e78ac4dac0ea_D20190401-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzItMS0xLTEtMA_fda03b82-1eab-497f-b2b2-1efc92ecbe72">196.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eec8d2bdc5c4301bfe722e319ae93cc_D20190101-20190331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzItMy0xLTEtMA_1808642a-8750-49fe-8056-6aae9a4a9622">200.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5f6f6847984744b8727e6b2748075b_D20181001-20181231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzItNS0xLTEtMA_99da8508-a1c2-4389-90ab-e5a4e4967b18">203.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d258bc15d9449697c4b3d79d8b436b_D20180701-20180930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzItNy0xLTEtMA_8049dc75-ab3f-42b9-ac8b-0f34bd457478">189.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad87c73a1144a68bba850b4fd323dcf_D20190401-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzMtMS0xLTEtMA_c31be0d9-1ed5-4c60-8582-7cdc725a2fff">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib895d88eeb224f0886c00fd6c2b4b139_D20190101-20190331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzMtMy0xLTEtMA_9f0a1a77-fa5d-4384-ac3b-ec58b5af05db">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313a22005bec4e29ad90ba1925c6405a_D20181001-20181231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzMtNS0xLTEtMA_0924783b-bda9-4165-b47a-3c5230fa7b40">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25884080c80b406690ede2277d9da6dd_D20180701-20180930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzMtNy0xLTEtMA_8f81fe7e-ee8e-4d5e-976c-b1db6e778db5">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzQtMS0xLTEtMA_4a2e9c95-ae1f-4182-b532-7d440d7fa7d2">215.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzQtMy0xLTEtMA_7a2ebe33-ccab-4f7b-897c-97b284391300">216.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzQtNS0xLTEtMA_f653597e-25db-4a59-bf8f-9cd9ec2b4503">216.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzQtNy0xLTEtMA_e909ba34-4cd1-4376-a3f9-d923edc18fb3">202.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fa6edac2d94c43bca8e78ac4dac0ea_D20190401-20190630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzYtMS0xLTEtMA_fe9f3bbf-a4c1-4c44-9d05-0965def99c44">41.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eec8d2bdc5c4301bfe722e319ae93cc_D20190101-20190331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzYtMy0xLTEtMA_3ae76708-7c99-461e-aa73-6e0082dc4e1a">40.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5f6f6847984744b8727e6b2748075b_D20181001-20181231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzYtNS0xLTEtMA_09fe0a76-9810-4be0-b9f9-51217a26f7b8">44.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d258bc15d9449697c4b3d79d8b436b_D20180701-20180930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzYtNy0xLTEtMA_7e0ae924-82a1-49ce-9de7-3fa8c16d7f56">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad87c73a1144a68bba850b4fd323dcf_D20190401-20190630" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzctMS0xLTEtMA_d77124c7-77c5-48a9-9f8c-f1d2378dc780">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib895d88eeb224f0886c00fd6c2b4b139_D20190101-20190331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzctMy0xLTEtMA_d5429d49-30d3-4f95-a1df-ebc02dacceb8">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313a22005bec4e29ad90ba1925c6405a_D20181001-20181231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzctNS0xLTEtMA_984fde47-8be4-47a9-a8c8-c4e3eda9d3c1">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25884080c80b406690ede2277d9da6dd_D20180701-20180930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzctNy0xLTEtMA_e00bad34-0eb9-4ca5-985c-ea7268bd4a54">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzgtMS0xLTEtMA_b1bc7fd8-0a0b-406f-a191-6da598b7e9d3">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzgtMy0xLTEtMA_0a3aecbb-047b-4c87-9893-5b5fa01dc41a">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzgtNS0xLTEtMA_2657c9f0-3a30-4eac-9c51-864e3e0940af">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzgtNy0xLTEtMA_4f65332c-217f-43e3-af30-6c9d78d0e173">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzktMS0xLTEtMA_ff5ba8db-75c2-40fe-8594-486722705fd5">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzktMy0xLTEtMA_c20a5f04-1ab0-4472-b293-c35bb4cda640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzktNS0xLTEtMA_9a1f7faa-e856-40ab-9311-0767b6cf17b3">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzktNy0xLTEtMA_b9eb6909-70e0-46fd-baa2-bfc80f144773">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEwLTEtMS0xLTA_288292e9-5f1f-4593-a106-6d6a1430ada8">149.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEwLTMtMS0xLTA_da330202-4e6a-4b2e-87f5-8daa88c7bca1">140.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEwLTUtMS0xLTA_c1636cb8-490d-4def-9b42-c5373451f9a6">135.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEwLTctMS0xLTA_cca526f5-45f0-427d-b5b2-808426c4dc5e">129.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzExLTEtMS0xLTA_e224e3d7-c2dd-4a5a-968e-c1cfac763458">221.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzExLTMtMS0xLTA_3eefbff6-6a86-4f7c-9935-0d6f98793d5b">210.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzExLTUtMS0xLTA_21efe404-d1c2-4e01-8e36-bee8a17709d1">210.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzExLTctMS0xLTA_d21b07dd-e12f-43f3-b455-fd546fb2562a">201.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEyLTEtMS0xLTA_03c09ef3-971d-46af-a63f-e126fab2c26e">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEyLTMtMS0xLTA_262df015-282c-49e8-a779-ef223ace3436">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEyLTUtMS0xLTA_750b61f0-0fe0-4650-a8f3-1beffbb46c85">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEyLTctMS0xLTA_7e0c150d-15f0-4265-84b8-b322f1d3ad84">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE0LTEtMS0xLTA_b7387a30-5e96-4877-b6f1-ac348363eda1">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE0LTMtMS0xLTA_ca3c038f-16e5-4ee3-b5dc-d90ad8a66183">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE0LTUtMS0xLTA_49c9370b-1db0-4c60-8c3f-09a3ff3233ed">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE0LTctMS0xLTA_e4093792-7791-4299-a6dd-849ac814d239">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE1LTEtMS0xLTA_daf0c261-b0c2-4203-9d3b-adaff5bff4c1">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE1LTMtMS0xLTA_65d064a7-ad3e-4132-8438-1bcbbe8e869c">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE1LTUtMS0xLTA_208a94cb-5e44-4789-a2d7-cd642a6b69d6">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE1LTctMS0xLTA_73585b50-dede-4779-b585-af44f57147e6">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE2LTEtMS0xLTA_1dcff1ad-dfa3-42a6-ad83-e20c4a417608">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE2LTMtMS0xLTA_db352b18-2c92-4125-a26d-d591a65289dd">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE2LTUtMS0xLTA_d3929487-5b6c-4a72-b2f7-86125a3d20bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE2LTctMS0xLTA_f55e3450-8774-4355-9450-88e5828fa181">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE3LTEtMS0xLTA_86c5955b-1560-4eee-86ed-36fc2526d0c0">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE3LTMtMS0xLTA_dcfa4fb5-87a1-4306-a83a-06f67105b835">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE3LTUtMS0xLTA_57727710-7898-4a84-9bdb-5e224e950841">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE3LTctMS0xLTA_ccac5536-9ac1-47e9-95f8-87cdb1f7a544">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE4LTEtMS0xLTA_c29ac134-6dfb-44c4-b50e-a9c5738fce5f">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE4LTMtMS0xLTA_49cbb4c5-5777-464a-b670-ba8f287061e7">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE4LTUtMS0xLTA_7061c058-3aef-47e8-97d8-97f6e49f008f">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE4LTctMS0xLTA_fb109422-5c00-43ff-9833-02f4ea441e7b">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE5LTEtMS0xLTA_69a81761-0ff7-4f60-a60f-e223c0286e09">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE5LTMtMS0xLTA_f2373e73-c495-47a1-a1e5-ac610a59ea92">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE5LTUtMS0xLTA_127224c6-60da-4138-b073-29f03ea11508">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE5LTctMS0xLTA_40c5c838-4d43-43fa-b4f6-050125425ac1">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIwLTEtMS0xLTA_583606d4-c036-42a8-ba42-f315db2383ef">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIwLTMtMS0xLTA_e2056291-d1f3-41bf-937d-ec6edbf49823">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIwLTUtMS0xLTA_cb27cbaf-d71d-4ccf-ba7c-c8c7a8a04b8a">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIwLTctMS0xLTA_84c60044-d12c-4426-a8f5-623309ca8662">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIxLTEtMS0xLTA_8019939f-7bfd-4fed-aa15-16737ee82b46">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIxLTMtMS0xLTA_5e02c4ee-ed34-42f6-a9ce-1ae5ff26dedf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIxLTUtMS0xLTA_fa3fb76e-388b-4fa0-814c-d913e420790e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIxLTctMS0xLTA_4398a648-ad4b-4c65-9c74-7221898d917f">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIyLTEtMS0xLTA_f8b524ee-2ced-42ca-aaa8-d02ada54832d">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIyLTMtMS0xLTA_2a81693e-adcb-479f-b4e9-d7d6a215a28a">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIyLTUtMS0xLTA_f874b9c7-970b-4730-bc32-f113bc4e7744">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIyLTctMS0xLTA_5be54446-22b0-4c6e-83bb-efb30e89cb98">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI0LTEtMS0xLTA_7de46ad4-14e5-4d77-af22-976ae267b590">0.06</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI0LTMtMS0xLTA_b9b0d33d-c4c9-4e7b-97de-d849e0a02835">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI0LTUtMS0xLTA_ff261d11-45a7-442b-977e-e10e302fee2a">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI0LTctMS0xLTA_30a4590a-0ce8-4131-b30a-7000fd5d01d5">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI1LTEtMS0xLTA_4f594f9c-1fb3-4cc1-9a85-bec73cc7f5a5">0.06</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI1LTMtMS0xLTA_6000e246-da87-48e2-95be-c92e2d2358ca">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI1LTUtMS0xLTA_b8a7d699-cb6a-443b-9452-efbf36bfe732">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI1LTctMS0xLTA_942d351b-45e9-46e0-aa2b-c2f24729fb89">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI3LTEtMS0xLTA_bd25eb1e-01b4-43e6-890b-e98e01c5bda7">73.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI3LTMtMS0xLTA_9fc6f074-93f6-4764-926e-79d5ba2beaf5">73.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI3LTUtMS0xLTA_7c5ab684-430a-47f3-9248-4d47166ece0c">74.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI3LTctMS0xLTA_691ee690-e3e7-4c91-9df7-dfcd2bfb627f">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI4LTEtMS0xLTA_ab79fc28-db89-4d1f-a95b-1b674fd2c2f6">74.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI4LTMtMS0xLTA_c3841755-5300-4e0d-97b4-2988877552c6">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI4LTUtMS0xLTA_148539d9-aa66-4b11-95ea-3089b0e3540e">76.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI4LTctMS0xLTA_41dd3a68-3688-430c-a3ca-2dd549a33fb7">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:5pt"><span><br/></span></div><div id="ic01b255bce00439ba9380fc219eb70e1_1887"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="mygn:TransitionPeriodComparativeDataTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGV4dHJlZ2lvbjozMjY2Mzg1OWI3OGI0NzY1OGMyNDNjNGU3YzVjNzM1Ml80OTQ3ODAyMzI1MDU0_5faa3671-25ed-4797-a13a-c58c64f865da" continuedAt="i5205b7bb92a044e089ae4e05d84f659a" escape="true">TRANSITION PERIOD COMPARATIVE DATA (UNAUDITED)</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-top:5pt"><ix:continuation id="i5205b7bb92a044e089ae4e05d84f659a"><ix:nonNumeric contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231" name="mygn:ScheduleOfTransitionPeriodComparativeDataTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGV4dHJlZ2lvbjozMjY2Mzg1OWI3OGI0NzY1OGMyNDNjNGU3YzVjNzM1Ml80OTQ3ODAyMzI1MDU1_5960b5ec-27f2-4632-a3eb-5a87140837f1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six-month Period Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf7a7e67e93c4b6c84e303b4742aafc0_D20190701-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yLTEtMS0xLTEyODY3_205ccda0-010e-47e6-9ae5-e06400d45059">353.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90c63d45d0a049b1b11b7c5d73024451_D20190701-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8zLTEtMS0xLTEyODY3_75b9b154-3003-4da9-ab74-67fef21c2980">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF80LTEtMS0xLTEyODY3_a18f5fc0-6ee6-4e7e-a85a-2d892155a8c1">381.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf7a7e67e93c4b6c84e303b4742aafc0_D20190701-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF82LTEtMS0xLTEyODY3_942a05c0-7b1e-4af5-8b6a-41a721c38db7">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90c63d45d0a049b1b11b7c5d73024451_D20190701-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF83LTEtMS0xLTEyODY3_2747dc09-85b2-4c81-a265-eed955aa7b47">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF84LTEtMS0xLTEyODY3_c66567db-ad58-4a8a-9560-57897650c3de">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF85LTEtMS0xLTEyODY3_b50ea286-a0ee-4aaa-89bc-d39c396e5cc6">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xMC0xLTEtMS0xMjg2Nw_ada9a03b-340d-4ffc-9e6f-4c609a9d3e28">269.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xMS0xLTEtMS0xNjQxOQ_8e0ea5a0-d785-47f3-b6a4-97534ce4aa0f">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xMS0xLTEtMS0xMjg2Nw_76b667b3-33c8-4231-ac6a-4e7693db3de5">411.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xMi0xLTEtMS0xMjg2Nw_f9024618-6f51-4fdc-a047-44107bd855c3">29.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xNC0xLTEtMS0xMjg2Nw_93ccac21-8d48-4c89-9ecf-e2949baea562">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xNS0xLTEtMS0xMjg2Nw_b1307736-68e2-45f6-a012-c77f055e77da">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xNi0xLTEtMS0xMjg2Nw_0e2fd9ce-03b9-4954-93de-e987ec6c842e">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xNy0xLTEtMS0xMjg2Nw_e37a48a3-ac9b-4265-ab01-abf1054bcf07">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xOC0xLTEtMS0xMjg2Nw_11139e5a-1b70-4217-b66f-b1bac2809384">33.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xOS0xLTEtMS0xMjg2Nw_d877a273-505a-46b2-aced-7258f59c0ac1">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yMC0xLTEtMS0xMjg2Nw_adc043ec-56b1-45b4-af2c-ea319cc563ec">28.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yMS0xLTEtMS0xMjg2Nw_d7d34e47-eb3e-40f5-8777-db1a01d9836f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Myriad Genetics Inc. stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yMi0xLTEtMS0xMjg2Nw_3efb6c6d-7d20-4be7-8d87-689b84d64213">28.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yNC0xLTEtMS0xMjg2Nw_4419ca1e-1929-4154-8864-c134edb9bbeb">0.39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yNS0xLTEtMS0xMjg2Nw_ebaa269f-2f39-4e8a-87da-37c0a0973c67">0.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yNy0xLTEtMS0xNTAzNg_6bf11add-765b-4ba8-8b4b-49602d2124e4">74.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yOC0xLTEtMS0xNTAzNg_3b938e2f-2a72-4d8f-9655-57def119e2aa">74.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_184"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (Disclosure Controls) within the meaning of Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Our Disclosure Controls are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act, such as this Transition Report on Form 10-K, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms. Our Disclosure Controls are also designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our Disclosure Controls, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily applied its judgment in evaluating and implementing possible controls and procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this Transition Report on Form 10-K, we evaluated the effectiveness of the design and operation of our Disclosure Controls, which was done under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. Based on the evaluation of our Disclosure Controls, our Chief Executive Officer and Chief Financial Officer has concluded that, as of December&#160;31, 2020, our Disclosure Controls were not effective due to a material weakness in the Company's internal control over financial reporting as disclosed below.</span></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a&#8209;15(f) and 15d&#8209;15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the preparation of our consolidated financial statements as of and for the transition period ended December 31, 2020, we identified a material weakness in controls over the accounting for intercompany transactions, foreign currency exchanges and foreign currency translation related to our international subsidiaries. Specifically, as part of our financial statement close process, certain of our control activities were not sufficiently designed or operating effectively to ensure all of our policies were in compliance with generally accepted accounting principles, consistent in their application, retained in appropriate documentation and communicated to relevant parties. As a result of the material weakness, we recorded certain immaterial corrections to intercompany accounts, as well as foreign currency exchange and translation gains and losses, in our consolidated financial statements for the transition period ended December 31, 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies may deteriorate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of our internal control over financial reporting as of December&#160;31, 2020, has been audited by Ernst &amp; Young LLP, an independent registered public accounting firm, as stated in their report included elsewhere herein.</span></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. Plans to Remediate Material Weakness</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have begun the process of, and we are focused on, designing and implementing effective internal controls measures to improve our internal control over financial reporting and remediate the material weakness identified above. Our efforts include the following actions:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We are designing and implementing application controls in our financial systems to improve the reliability of our process and reporting.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We are designing and implementing additional review procedures within our accounting and finance department to provide more robust and comprehensive internal controls over financial reporting that address the risks of material misstatement related to the accounting for intercompany transactions, foreign currency exchanges and foreign currency translation within our business processes.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While these actions and planned actions are subject to ongoing management evaluation and will require validation and testing of the design and operating effectiveness of internal controls over a sustained period of financial reporting cycles, we are committed to the continuous improvement of our internal control over financial reporting and will continue to diligently review our internal control over financial reporting for that purpose.</span></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  Change in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is in the midst of a multi-year transformation project to achieve better analytics and process efficiencies through the use of Oracle Fusion Cloud Services System. During the transition period ended December 31, 2020, the Company completed the implementation of certain modules used in the financial statement close process and management reporting. Additional phases will continue to be implemented over the coming year. Emphasis will continue to be placed on the maintenance of effective internal controls and assessment of the design and operating effectiveness of key control activities throughout development and deployment of each phase.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as described above, there were no changes in our internal control over financial reporting that occurred during the quarter or transition period ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Myriad Genetics, Inc.&#160;&#160;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Myriad Genetics, Inc. and subsidiaries&#8217; internal control over financial reporting as of December&#160;31, 2020, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria).  In our opinion, because of the effect of the material weakness described below on the achievement of the objectives of the control criteria, Myriad Genetics, Inc. and subsidiaries (the Company) has not maintained effective internal control over financial reporting as of December 31, 2020, based on the COSO criteria.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weakness has been identified and included in management&#8217;s assessment. Management identified a material weakness in controls over the accounting for intercompany transactions, foreign currency exchanges and foreign currency translation related to its international subsidiaries.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of Myriad Genetics, Inc. and subsidiaries as of December&#160;31, 2020, June&#160;30, 2020 and 2019, and the related consolidated statements of operations, comprehensive income, stockholders&#8217; equity and cash flows for the transition period ended December&#160;31, 2020 and each of the three years in the period ended June&#160;30, 2020, and the related notes and our report dated March&#160;16, 2021 expressed an unqualified opinion thereon.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salt Lake City, UT</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;16, 2021</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_187"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_193"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this item is incorporated by reference from the discussion responsive thereto under the captions &#8220;Management and Corporate Governance,&#8221; &#8220;Delinquent Section 16(a) Reports&#8221; and &#8220;Corporate Code of Conduct and Ethics&#8221; in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be held on June 3, 2021.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_196"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this item is incorporated by reference from the discussion responsive thereto under the captions &#8220;Executive Compensation,&#8221; &#8220;Management and Corporate Governance &#8211; Committees of the Board of Directors and Meetings &#8211; Compensation Committee Interlocks and Insider Participation,&#8221; &#8220;Compensation Committee Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and &#8220;Management and Corporate Governance &#8211; Board&#8217;s Role in the Oversight of Risk Management&#8221; in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be held on June 3, 2021.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_199"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this item is incorporated by reference from the discussion responsive thereto under the captions &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Executive Compensation - Equity Compensation Plan Information&#8221; in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be held on June 3, 2021.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_202"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this item is incorporated by reference from the discussion responsive thereto under the caption &#8220;Certain Relationships and Related Person Transactions&#8221; and &#8220;Management and Corporate Governance &#8211; Director Independence&#8221; in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be held </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on June 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 2021.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_205"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this item is incorporated by reference from the discussion responsive thereto in the proposal entitled &#8220;Selection of Independent Registered Public Accounting Firm&#8221; in our Proxy Statement for the 2021 Annual Meeting of the Stockholders to be held on June 3, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_208"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_211"></div><div style="-sec-extract:summary;margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.&#160;&#160;&#160;&#160;EXHIBITS, FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The following documents are included as part of this Transition Report on Form 10-K.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;Financial Statements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Index to Consolidated Financial Statements&#8221; at Item 8 to this Transition Report on Form 10-K.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Financial Statement Schedules</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statement schedules have not been included because they are not applicable, or the information is included in financial statements or notes thereto.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.    Exhibits</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:9.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed with this<br/>Report</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference herein<br/>from Form or<br/>Schedule</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SEC File/<br/>Registration<br/>Number</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000119312511223211/dex31.htm">Restated Certificate of Incorporation, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K<br/>(Exhibit 3.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/15/2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000119312520269801/d102302dex31.htm">Restated By-Laws</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>(Exhibit 3.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000899923/000119312511223211/dex41.htm">Specimen common stock certificate</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K<br/>(Exhibit 4.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/15/2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mygn-20201231xexx42.htm">Description of Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Agreements</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/0000927016-96-001627.txt">Lease Agreement, dated October 12, 1995, between the Registrant and Boyer Research Park Associates V, by its general partner, the Boyer Company</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/8/1996</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000899923/000119312516576683/d173578dex101.htm">Amendment to Phase I Lease Agreement, dated February 3, 2016, between the Registrant and HCPI/UTAH</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000899923/000119312516576683/d173578dex101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000899923/000119312516576683/d173578dex101.htm">II, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/4/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/0000927356-98-001556.txt">Lease Agreement-Research Park Building Phase II, dated March 6, 1998, between the Registrant and Research Park Associated VI, by its general partner, the Boyer Company, L.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K<br/>(Exhibit 10.44)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/24/1998</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312516576683/d173578dex102.htm">Amendment to Phase II Lease Agreement, dated February 3, 2016, between Myriad Genetics, Inc. and HCPI/UTAH II, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/4/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000092735601500159/dex101.txt">Lease Agreement, dated March 31, 2001, between the Registrant and Boyer Research Park Associates VI, by its general partner, The Boyer Company, L.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/15/2001</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312516576683/d173578dex103.htm">Amendment to Phase III Lease Agreement, dated February 3, 2016, between Myriad Genetics, Inc. and HCPI/UTAH II, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/4/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312505137356/dex991.htm">Lease Agreement, effective as of May 31, 2005, dated June 29, 2005, between the Registrant and Boyer Research Park Associates VIII, by its general partner, The Boyer Company, L.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>(Exhibit 99.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/5/2005</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312505137356/dex992.htm">Letter of Understanding regarding Lease, dated June 29, 2005, between the Registrant and Boyer Research Park Associates VIII, by its general partner, The Boyer Company, L.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>(Exhibit 99.2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/5/2005</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:9.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed with this<br/>Report</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference herein<br/>from Form or<br/>Schedule</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SEC File/<br/>Registration<br/>Number</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312516576683/d173578dex104.htm">Amendment to Phase IV Lease Agreement, dated February&#160;16, 2007, between Myriad Genetics, Inc. and Boyer Research Park Associates VIII, L.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/4/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312508186392/dex1032.htm">Lease Agreement, dated March 11, 2008, between the Registrant and Boyer Research Park Associates IX, by its general partner, The Boyer Company, L.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K<br/>(Exhibit 10.32)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/28/2008</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312510107257/dex104.htm">Amendment to Lease Agreement, dated February 12, 2010 between the Registrant and Boyer Research Park Associates IX, L.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/5/2010</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000156459019031849/mygn-ex106_159.htm">Lease Agreement, dated January 31, 2019 between the Registrant and Boyer Research Park Associates X, L.C., by its Manager, The Boyer Company, L.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K(Exhibit 10.6)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/13/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreements with Executive Officers and Directors</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000156459020003770/mygn-ex101_304.htm">Form of Executive Retention Agreement, as amended+@</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/7/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mygn-20201231xexx108.htm">Non-Employee Director Compensation Policy+</a></span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312509181226/dex1034.htm">Form of director and executive officer indemnification agreement+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K<br/>(Exhibit 10.34)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/25/2009</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000089992320000006/exhibit1012017employee.htm">Form of Severance and Change in Control Agreement+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K (Exhibit 10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000162828020016036/exhibit101-diazemploym.htm">Executive Employment Agreement between the Registrant and Paul J. Diaz dated July 24, 2020+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000162828020016036/exhibit102-diazpsuagre.htm">Performance-Based Restricted Stock Unit Agreement between Registrant and Paul J. Diaz dated October 8, 2020+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000162828020016036/exhibit103-diazrsuagre.htm">Restricted Stock Unit Agreement between the Registrant and Paul J. Diaz dated August 13, 2020+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000162828020016036/exhibit104-diazperform.htm">Performance-Based Non-Qualified Stock Option Agreement between the Registrant and Paul J. Diaz dated August 13, 2020+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000162828020016036/exhibit105-diaztimexba.htm">Non-Qualified Stock Option Agreement between the Registrant and Paul J. Diaz dated August 13, 2020+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.5)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000162828020016036/exhibit106-diazformofs.htm">Form of Separation and Release Agreement between the Registrant and Paul J. Diaz+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.6)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity Compensation Plans</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000119312516783506/d308192dex101.htm">2010 Employee, Director and Consultant Equity Incentive Plan, as amended+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>(Exhibit 10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/2/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:9.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed with this<br/>Report</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference herein<br/>from Form or<br/>Schedule</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SEC File/<br/>Registration<br/>Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000119312511019910/dex103.htm">Form of Stock Option Agreement under the 2010 Equity Incentive Plan+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000119312511019910/dex104.htm">Form of Director Stock Option Agreement under the 2010 Equity Incentive Plan+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000119312514397661/d802835dex101.htm">Form of Restricted Stock Unit Agreement for Executive Officers under the 2010 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000119312514397661/d802835dex101.htm">Equity Incentive </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000119312514397661/d802835dex101.htm">Plan+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit<br/>10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/5/2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000089992320000006/exhibit1012017employee.htm">2017 Employee, Director and Consultant Equity Incentive Plan, as amended+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>(Exhibit 10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/7/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000156459020040011/mygn-ex1011_355.htm">Form of Restricted Stock Unit Agreement</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000156459020040011/mygn-ex1011_355.htm"> unde</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000156459020040011/mygn-ex1011_355.htm">r the 2017 Equity Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000156459020040011/mygn-ex1011_355.htm">+</a></span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K<br/>(Exhibit 10.11)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/13/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312512494792/d444902dex102.htm">2012 Employee Stock Purchase Plan+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>(Exhibit 10.2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/7/2012</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000156459017024444/mygn-ex102_44.htm">2013 Executive Incentive Plan, as amended+</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>(Exhibit 10.2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Agreement</span></td></tr><tr style="height:6pt"><td colspan="33" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000089992321000007/mygn-x1231earningsreleasex.htm">Amendment No. 3, dated February 22, 2021, to the Credit Agreement, dated December 23, 2016, among the Company, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent, as amended July 31, 2018 and May 1, 2020.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>(Exhibit 10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/23/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Merger Agreements</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/899923/000119312516756511/d253869dex101.htm">Agreement and Plan of Merger among the Registrant, Myriad Merger Sub, Inc., Assurex Health, Inc. and Fortis Advisors LLC, dated as of August 3, 2016</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>(Exhibit 10.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/2/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr style="height:6pt"><td colspan="33" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000899923/000156459018022312/mygn-ex1018_113.htm">Agreement and Plan of Merger among the Registrant, Cinnamon Merger Sub, Inc., a wholly owned subsidiary of Myriad, Inc., Counsyl, Inc, and Fortis Advisors, dated as of May 25, 2018.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K (Exhibit 10.18)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td></tr><tr style="height:6pt"><td colspan="33" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/899923/000156459020040011/mygn-ex211_8.htm">List of Subsidiaries of the Registrant</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K (Exhibit 21.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/13/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-26642</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mygn-20201231xexx231.htm">Consent of Independent Registered Public Accounting Firm (Ernst &amp; Young LLP)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mygn-20201231xexx311.htm">Certification of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mygn-20201231xexx311.htm">Chief Executive</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mygn-20201231xexx311.htm"> Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mygn-20201231xexx312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:9.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed with this<br/>Report</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference herein<br/>from Form or<br/>Schedule</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SEC File/<br/>Registration<br/>Number</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mygn-20201231xexx32.htm">Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from Myriad Genetics, Inc.&#8217;s Transition Report on Form 10-K for the transition period ended December 31, 2020, formatted in XBRL (Xtensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii)&#160;Consolidated Statements of Comprehensive Income, (iii) Consolidated Statements of Stockholders&#8217; Equity, (iv)&#160; Consolidated Statements of Cash Flows, and (v)&#160;Notes to Consolidated Financial Statements. Inline XBRL Instance Document &#8211; Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(+)&#160;&#160;&#160;&#160;Management contract or compensatory plan arrangement.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(@)&#160;&#160;&#160;&#160;The agreements with all executives are identical except for the executive who is a party to the agreement and the date of execution, which are listed at the end of the exhibit.</span></div><div id="ic01b255bce00439ba9380fc219eb70e1_214"></div><div style="margin-top:18pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;FORM 10-K SUMMARY</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><div id="ic01b255bce00439ba9380fc219eb70e1_217"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">Con</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic01b255bce00439ba9380fc219eb70e1_7">tents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March&#160;16, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MYRIAD GENETICS, INC.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Paul J. Diaz</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Paul J. Diaz</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated below and on the dates indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signatures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Paul J. Diaz</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Paul J. Diaz</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ R. Bryan Riggsbee</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R. Bryan Riggsbee</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ S. Louise Phanstiel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S. Louise Phanstiel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Heiner Dreismann</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heiner Dreismann, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Rashmi Kumar</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rashmi Kumar</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dennis Langer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dennis Langer, M.D., J.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Lee N. Newcomer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lee N. Newcomer, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Colleen F. Reitan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Colleen F. Reitan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel M. Skovronsky</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Daniel M. Skovronsky, M.D., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel K. Spiegelman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Daniel K. Spiegelman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>mygn-20201231xexx42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i56bd4cf5e4d6455692a9fa3416c1cb7c_32"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;padding-right:72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Myriad Genetics, Inc. (the &#8220;Company&#8221; or &#8220;we&#8221;) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended&#58; our common stock, par value $0.01 per share.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">DESCRIPTION OF COMMON STOCK</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following description of our common stock is a summary and does not purport to be complete. You should refer to our Restated Certificate of Incorporation, as amended (&#8220;restated certificate of incorporation&#8221;) and our Restated By-laws (&#8220;restated bylaws&#8221;), both of which are incorporated by reference as exhibits to the Company&#8217;s Transition Report on Form 10&#8209;K of which this exhibit is a part. The summary below is also qualified by provisions of the Delaware General Corporation Law.</font></div><div style="text-indent:10.1pt"><font><br></font></div><div style="text-indent:10.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Authorized Capital Stock</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under our restated certificate of incorporation our authorized capital stock consists of 150,000,000 shares of common stock, $0.01 par value per share, and 5,000,000 shares of preferred stock, $0.01 par value per share, of which 600,000 shares have been designated Series A Junior Participating Preferred Stock. We designated the Series A Junior Participating Preferred Stock in connection with a stockholders&#8217; rights plan that has expired. Accordingly, we have no present intention to issue any shares of Series A Junior Participating Preferred Stock.</font></div><div style="text-indent:10.1pt"><font><br></font></div><div style="text-indent:10.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">General</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Holders of our common stock are entitled to one vote for each share of common stock held of record for the election of directors and on all matters submitted to a vote of stockholders. Holders of our common stock are entitled to receive dividends ratably, if any, as may be declared by our board of directors out of legally available funds, subject to any preferential dividend rights of any preferred stock then outstanding. Upon our dissolution, liquidation or winding up, holders of our common stock are entitled to share ratably in our net assets legally available after the payment of all of our debts and other liabilities, subject to the preferential rights of any preferred stock then outstanding. Holders of our common stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we have designated and may issue in the future or that we may designate and issue in the future. Except as described under &#8220;Certain Provisions of Delaware Law and of the Company&#8217;s Certificate of Incorporation and Bylaws&#8221; below, a majority vote of the holders of our common stock is generally required to take action under our restated certificate of incorporation and restated bylaws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Transfer Agent and Registrar</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The transfer agent and registrar for our common stock is American Stock Transfer &#38; Trust Company, LLC, with offices at 6201 15th Avenue, Brooklyn, New York 11219.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Stock Exchange Listing</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our common stock is listed for quotation on The Nasdaq Global Select Market under the symbol &#8220;MYGN.&#8221;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTAIN PROVISIONS OF DELAWARE LAW AND OF THE COMPANY&#8217;S CERTIFICATE OF INCORPORATION AND BYLAWS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Anti-Takeover Provisions</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provisions of Delaware law and of our restated certificate of incorporation and restated bylaws discussed below could discourage or make it more difficult to accomplish a proxy contest or other change in our management or the acquisition of control by a holder of a substantial amount of our voting stock. It is possible that these provisions could make it more difficult to accomplish, or could deter, transactions that stockholders may otherwise consider to be in their best interests or the best interests of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Delaware Law</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to Section 203 of the Delaware General Corporation Law. Subject to certain exceptions, Section 203 prevents a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with any &#8220;interested stockholder&#8221; for a three-year period following the time that such stockholder becomes an interested stockholder, unless the interested stockholder attained such status with the approval of our board of directors or unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes, among other things, a merger or consolidation involving us and the &#8220;interested stockholder&#8221; and the sale of more than 10% of our assets. In general, an &#8220;interested stockholder&#8221; is any entity or person beneficially owning 15% or more of our outstanding voting stock and any entity or person affiliated with or controlling or controlled by such entity or person.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Restated Certificate of Incorporation and Restated Bylaws</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our board of directors is divided into three classes. Each year our stockholders elect the members of one of the three classes to a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">term of office to expire at the third succeeding annual meeting of stockholders after their election. All directors elected to our classified board of directors serve until the election and qualification of their respective successors or their earlier resignation or removal. Only the board of directors is authorized to create new directorships and to fill such positions so created and is permitted to specify the class to which any such new position is assigned. The person filling such position would serve for the term applicable to that class. Only the board of directors (or its remaining members, even if less than a quorum) is empowered to fill vacancies on the board of directors occurring for any reason for the remainder of the term of the class of directors in which the vacancy occurred. Members of the board of directors may only be removed for cause. These provisions are likely to increase the time required for stockholders to change the composition of the board of directors. For example, in general, at least two annual meetings would be necessary for stockholders to effect a change in a majority of the members of the board of directors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our restated bylaws provide that, for nominations to the board of directors or for other business to be properly brought by a stockholder before a meeting of stockholders, the stockholder must first have given timely notice of the proposal in writing to our Secretary. For an annual meeting, a stockholder&#8217;s notice generally must be delivered not less than 60 days nor more than 90 days prior to the anniversary of the previous year&#8217;s annual meeting. For a special meeting, the notice must generally be delivered by not less than 60 days nor more than 90 days prior to the special meeting or ten days following the day on which public announcement of the meeting is first made. Detailed requirements as to the form of the notice and information required in the notice are specified in our restated bylaws. If it is determined that business was not properly brought before a meeting in accordance with the provisions of our restated bylaws, such business will not be conducted at the meeting.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Special meetings of the stockholders may be called only by the chair of our board of directors, the chief executive officer or president with the approval of the executive committee of the board of directors, or by the entire board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors, whether or not there exists any vacancy in previously authorized directorships.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our restated certificate of incorporation does not permit our stockholders to act by written consent. As a result, any action to be effected by our stockholders must be effected at a duly called annual or special meeting of the stockholders.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Delaware General Corporation Law provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation&#8217;s certificate of incorporation or bylaws, unless the corporation&#8217;s certificate of incorporation or bylaws, as the case may be, requires a greater percentage. Our restated certificate of incorporation requires the affirmative vote of the holders of at least 70% of our outstanding voting stock to amend or repeal any of the provisions discussed above in this section entitled &#8220;Anti&#8209;Takeover Provisions &#8212; Restated Certificate of Incorporation and Restated Bylaws.&#8221; This 70% stockholder vote would be in addition to any separate class vote that might in the future be required pursuant to the terms of any preferred stock that might then be outstanding. A 70% vote will also be required for any amendment to, or repeal of, our restated bylaws by the stockholders. Our restated bylaws may be amended or repealed by a simple majority vote of the board of directors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our board of directors is authorized, without action by our stockholders, to designate and issue shares of our preferred stock in one or more series and to designate the rights, preferences and privileges of the shares of each series and any of its qualifications, limitations or restrictions. The existence of authorized but unissued shares of preferred stock enables our board of directors to render more difficult or to discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>3
<FILENAME>mygn-20201231xexx108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i38c5e3dddabf41c5ba88f243fd90376f_32"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NON-EMPLOYEE DIRECTOR COMPENSATION POLICY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(Effective&#58; Fiscal Year 2021)</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The following is a description of the standard compensation arrangements under which the non-employee directors of Myriad Genetics, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">our</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">we</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) are compensated for their service as directors of the Company, including as members of the various committees of our Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:60.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Annual Retainer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (all members)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$60,000</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:60.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Chair of the Board</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$120,000 additional retainer</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:60.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Committee Chair Compensation</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Audit and Finance Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$28,000 additional retainer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Compensation and Human Capital Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$20,000 additional retainer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Nominating and Governance Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$15,000 additional retainer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Research and Product Innovation Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$28,000 additional retainer</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:60.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Committee Member Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Audit and Finance Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$13,500 additional retainer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Compensation and Human Capital Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$10,000 additional retainer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Nominating and Governance Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$7,500 additional retainer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Research and Product Innovation Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$13,500 additional retainer</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">            (1) Other than each Committee Chair</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Attendance</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Non-employee directors do not receive any fees (other than the retainers outlined above) for attending Board or committee meetings. However, directors are reimbursed for any out-of-pocket costs and expenses incurred in attending Board and committee meetings.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Equity Awards </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Under our 2017 Employee, Director and Consultant Equity Incentive Plan (as amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">2017 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), non-employee directors may receive an award of equity in the Company. As recommended and determined by our Compensation and Human Capital Committee, and approved by our Board, on the date of each annual meeting of stockholders, we may grant to each non-employee director equity awards under the 2017 Plan. In addition, depending on the proximity to our annual meeting of stockholders, we may grant equity awards under the 2017 Plan to each new non-employee director upon his or her initial appointment to the Board&#59; provided, however, that it is our policy that directors should generally not receive more than one equity award per year. The number of shares of restricted stock, restricted stock units and&#47;or other equity awards granted will be determined by dividing $350,000 by the NASDAQ closing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">trading price of our common stock on the date of the applicable annual meeting of stockholders or the date that such new non-employee director is appointed to the Board, as applicable. Restricted stock, restricted stock units and other equity awards granted to our non-employee directors may vest, in the discretion of the Board and&#47;or Compensation and Human Capital Committee, (1) in the case of awards granted on the date of our annual meeting of stockholders, upon the earlier of (i) one year of service on the Board following the date of grant or (ii) the date of the next annual meeting of stockholders following such grant and (2) in the case of awards granted on the date that a new non-employee director is appointed to the Board, on the date that is one year following the date of such grant. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Options granted to our non-employee directors under the 2010 Employee, Director and Consultant Equity Incentive Plan (as amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">2010 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) are exercisable after the termination of the director&#8217;s service on the Board for the remaining term of the applicable option to the extent such option was exercisable on the date of such termination. All options or restricted stock units granted to our non-employee directors will become fully exercisable or vested upon a change of control of Myriad or upon their death as provided for under the forms of award agreement for directors under our 2010 Plan or 2017 Plan, as applicable.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>mygn-20201231xexx231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i36a683c0dc344773b07bae23baaa5957_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">We consent to the incorporation by reference in the following Registration Statements of Myriad Genetics, Inc.&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statement on Form S-8 (File No. 333-245718) pertaining to the Myriad Genetics, Inc. Non-Qualified Stock Option Agreement, Performance-Based Non-Qualified Stock Option Agreement, Restricted Stock Unit Agreement, and Performance-Based Restricted Stock Unit Agreement,</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statement on Form S-3 (File No. 333-226492) pertaining to the Myriad Genetics, Inc. shelf registration for the sale of common stock,</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statement on Form S-8 (File No. 333-222913, File No. 333-229574, File No. 333-236324) pertaining to the Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan,</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statement on Form S-8 (File No. 333-185325) pertaining to the Myriad Genetics, Inc. 2012 Employee Stock Purchase Plan,</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statements on Form S-8 (File No.&#8217;s 333-171994, 333-179281, 333-185325, 333-193767, 333-209354 and 333-215959) pertaining to the Myriad Genetics, Inc. 2010 Employee, Director and Consultant Equity Incentive Plan, as amended, and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statements on Form S-8 (File No.&#8217;s 333-115409, 333-120398, 333-131653, 333-140830, 333-150792, 333-157130 and 333-164670) pertaining to the Myriad Genetics, Inc. 2003 Employee, Director and Consultant Stock Option Plan, as amended&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">of our reports dated March&#160;16, 2021, with respect to the consolidated financial statements of Myriad Genetics, Inc. and the effectiveness of internal control over financial reporting of Myriad Genetics, Inc. included in this Transition Report (Form 10-K) of Myriad Genetics, Inc. for the six-month period ended December 31, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Salt Lake City, UT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March&#160;16, 2021</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>mygn-20201231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ifaa4a694cef3403f862da5bd39738818_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY SECTION 302 CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Paul J. Diaz, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this transition report on Form 10-K of Myriad Genetics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 16, 2021</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Paul J. Diaz</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paul J. Diaz</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>mygn-20201231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6d5d9e1962d540cd9c6c3ee175766ec0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY SECTION 302 CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, R. Bryan Riggsbee, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this transition report on Form 10-K of Myriad Genetics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 16, 2021</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; R. Bryan Riggsbee</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bryan Riggsbee</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>mygn-20201231xexx32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i690275d425ed49a18c4da17c66271032_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Transition Report on Form 10-K for the transition period ended December 31, 2020 (the &#8220;Form 10-K&#8221;) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 16, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 16, 2021</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Paul J. Diaz</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; R. Bryan Riggsbee</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paul J. Diaz</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bryan Riggsbee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>mygn-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efa3350f-b8a9-4fda-9dc1-67977795f671,g:9ff9af07-fed3-4eeb-865c-11c477b6a054-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mygn="http://www.myriad.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.myriad.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.myriad.com/role/Cover">
        <link:definition>000010001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.myriad.com/role/ConsolidatedBalanceSheets">
        <link:definition>100010002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.myriad.com/role/ConsolidatedStatementsofOperations">
        <link:definition>100030004 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>100040005 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>100050006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.myriad.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100060007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPolicies" roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Organization and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>240044001 - Disclosure - Organization and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails" roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails">
        <link:definition>240054002 - Disclosure - Organization and Summary of Significant Accounting Policies - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails" roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails">
        <link:definition>240064003 - Disclosure - Organization and Summary of Significant Accounting Policies - Reconciliation of Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails" roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails">
        <link:definition>240074004 - Disclosure - Organization and Summary of Significant Accounting Policies - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails" roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails">
        <link:definition>240084005 - Disclosure - Organization and Summary of Significant Accounting Policies - Foreign Currency Cumulative Translation Adjustments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecurities" roleURI="http://www.myriad.com/role/MarketableInvestmentSecurities">
        <link:definition>210091002 - Disclosure - Marketable Investment Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecuritiesTables" roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables">
        <link:definition>230103002 - Disclosure - Marketable Investment Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails">
        <link:definition>240114006 - Disclosure - Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails">
        <link:definition>240124007 - Disclosure - Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecuritiesNarrativeDetails" roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails">
        <link:definition>240134008 - Disclosure - Marketable Investment Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.myriad.com/role/FairValueMeasurements">
        <link:definition>210141003 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.myriad.com/role/FairValueMeasurementsTables">
        <link:definition>230153003 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>240164009 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" roleURI="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails">
        <link:definition>240174010 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" roleURI="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails">
        <link:definition>240184011 - Disclosure - Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNet" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNet">
        <link:definition>210191004 - Disclosure - Property, Plant and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetTables" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables">
        <link:definition>230203004 - Disclosure - Property, Plant and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetBalancesDetails" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails">
        <link:definition>240214012 - Disclosure - Property, Plant and Equipment, Net - Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetNarrativeDetails" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails">
        <link:definition>240224013 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetDepreciationExpenseDetails" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails">
        <link:definition>240234014 - Disclosure - Property, Plant and Equipment, Net - Depreciation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssets">
        <link:definition>210241005 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>230253005 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails">
        <link:definition>240264015 - Disclosure - Goodwill and Intangible Assets - Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>240274016 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangibleAssetsDetails" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails">
        <link:definition>240284017 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangibleAssetsDetails_1" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails_1">
        <link:definition>240284017 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails">
        <link:definition>240294018 - Disclosure - Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails">
        <link:definition>240304019 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilities" roleURI="http://www.myriad.com/role/AccruedLiabilities">
        <link:definition>210311006 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.myriad.com/role/AccruedLiabilitiesTables">
        <link:definition>230323006 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.myriad.com/role/AccruedLiabilitiesDetails">
        <link:definition>240334020 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.myriad.com/role/LongTermDebt">
        <link:definition>210341007 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.myriad.com/role/LongTermDebtTables">
        <link:definition>230353007 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.myriad.com/role/LongTermDebtNarrativeDetails">
        <link:definition>240364021 - Disclosure - Long Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongTermDebtDetails" roleURI="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails">
        <link:definition>240374022 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLongTermLiabilities" roleURI="http://www.myriad.com/role/OtherLongTermLiabilities">
        <link:definition>210381008 - Disclosure - Other Long-Term Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLongTermLiabilitiesTables" roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesTables">
        <link:definition>230393008 - Disclosure - Other Long-Term Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLongTermLiabilitiesSummaryDetails" roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails">
        <link:definition>240404023 - Disclosure - Other Long-Term Liabilities - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLongTermLiabilitiesNarrativeDetails" roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails">
        <link:definition>240414024 - Disclosure - Other Long-Term Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquity" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquity">
        <link:definition>210421009 - Disclosure - Preferred and Common Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityTables" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables">
        <link:definition>230433009 - Disclosure - Preferred and Common Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityNarrativeDetails" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails">
        <link:definition>240444025 - Disclosure - Preferred and Common Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails">
        <link:definition>240454026 - Disclosure - Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityStockRepurchasesDetails" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails">
        <link:definition>240464027 - Disclosure - Preferred and Common Stockholders' Equity - Stock Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.myriad.com/role/ShareBasedCompensation">
        <link:definition>210471010 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.myriad.com/role/ShareBasedCompensationTables">
        <link:definition>230483010 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>240494028 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionsActivityDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails">
        <link:definition>240504029 - Disclosure - Share-Based Compensation - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationValuationAssumptionsforStockOptionsDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails">
        <link:definition>240514030 - Disclosure - Share-Based Compensation - Valuation Assumptions for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionsOutstandingDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails">
        <link:definition>240524031 - Disclosure - Share-Based Compensation - Stock Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedStockUnitsActivityDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails">
        <link:definition>240534032 - Disclosure - Share-Based Compensation - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationShareBasedCompensationExpenseDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails">
        <link:definition>240544033 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails">
        <link:definition>240554034 - Disclosure - Share-Based Compensation - Unrecognized Share-Based Compensation Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails">
        <link:definition>240564035 - Disclosure - Share-Based Compensation - Intrinsic Value of Options Exercised (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails">
        <link:definition>240574036 - Disclosure - Share-Based Compensation - Shares Purchased and Compensation Expenses for ESPP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationValuationAssumptionsforESPPDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails">
        <link:definition>240584037 - Disclosure - Share-Based Compensation - Valuation Assumptions for ESPP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.myriad.com/role/IncomeTaxes">
        <link:definition>210591011 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.myriad.com/role/IncomeTaxesTables">
        <link:definition>230603011 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxBenefitDetails" roleURI="http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails">
        <link:definition>240614038 - Disclosure - Income Taxes - Income Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" roleURI="http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails">
        <link:definition>240624039 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails" roleURI="http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails">
        <link:definition>240634040 - Disclosure - Income Taxes - Statutory Federal Income Tax Rate and Income Taxes Reported (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240644041 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.myriad.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240654042 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails" roleURI="http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails">
        <link:definition>240664043 - Disclosure - Income Taxes - Net Operating Loss and Research Credit Carryforwards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>240674044 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.myriad.com/role/CommitmentsandContingencies">
        <link:definition>210681012 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.myriad.com/role/Leases">
        <link:definition>210691013 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.myriad.com/role/LeasesTables">
        <link:definition>230703012 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.myriad.com/role/LeasesNarrativeDetails">
        <link:definition>240714045 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>240724046 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>240724046 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeDeferredSavingsPlan" roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlan">
        <link:definition>210731014 - Disclosure - Employee Deferred Savings Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeDeferredSavingsPlanTables" roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables">
        <link:definition>230743013 - Disclosure - Employee Deferred Savings Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeDeferredSavingsPlanNarrativeDetails" roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails">
        <link:definition>240754047 - Disclosure - Employee Deferred Savings Plan - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeDeferredSavingsPlanContributionstoPlanDetails" roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails">
        <link:definition>240764048 - Disclosure - Employee Deferred Savings Plan - Contributions to Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformation" roleURI="http://www.myriad.com/role/SegmentandRelatedInformation">
        <link:definition>210771015 - Disclosure - Segment and Related Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationTables" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTables">
        <link:definition>230783014 - Disclosure - Segment and Related Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationNarrativeDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails">
        <link:definition>240794049 - Disclosure - Segment and Related Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationSegmentOperatingIncomeLossDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails">
        <link:definition>240804050 - Disclosure - Segment and Related Information - Segment Operating Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails">
        <link:definition>240814051 - Disclosure - Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails">
        <link:definition>240824052 - Disclosure - Segment and Related Information - Balance Sheet Assets By Operating Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationAssetsbyGeographicalRegionDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails">
        <link:definition>240834053 - Disclosure - Segment and Related Information - Assets by Geographical Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationRevenuebyGeographicalRegionDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails">
        <link:definition>240844054 - Disclosure - Segment and Related Information - Revenue by Geographical Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofSubsidiary" roleURI="http://www.myriad.com/role/SaleofSubsidiary">
        <link:definition>210851016 - Disclosure - Sale of Subsidiary</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofSubsidiaryDetails" roleURI="http://www.myriad.com/role/SaleofSubsidiaryDetails">
        <link:definition>240864055 - Disclosure - Sale of Subsidiary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitions" roleURI="http://www.myriad.com/role/BusinessAcquisitions">
        <link:definition>210871017 - Disclosure - Business Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsTables" roleURI="http://www.myriad.com/role/BusinessAcquisitionsTables">
        <link:definition>230883015 - Disclosure - Business Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsNarrativeDetails" roleURI="http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails">
        <link:definition>240894056 - Disclosure - Business Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsTotalConsiderationTransferredDetails" roleURI="http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails">
        <link:definition>240904057 - Disclosure - Business Acquisitions - Total Consideration Transferred (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsChangestoGoodwillBalanceDetails" roleURI="http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails">
        <link:definition>240914058 - Disclosure - Business Acquisitions - Changes to Goodwill Balance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsProFormaResultsDetails" roleURI="http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails">
        <link:definition>240924059 - Disclosure - Business Acquisitions - Pro Forma Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://www.myriad.com/role/SubsequentEvent">
        <link:definition>210931018 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventDetails" roleURI="http://www.myriad.com/role/SubsequentEventDetails">
        <link:definition>240944060 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformation" roleURI="http://www.myriad.com/role/SupplementalCashFlowInformation">
        <link:definition>210951019 - Disclosure - Supplemental Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationTables" roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationTables">
        <link:definition>230963016 - Disclosure - Supplemental Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationDetails" roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationDetails">
        <link:definition>240974061 - Disclosure - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementaryQuarterlyFinancialDataUnaudited" roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited">
        <link:definition>210981020 - Disclosure - Supplementary Quarterly Financial Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementaryQuarterlyFinancialDataUnauditedTables" roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables">
        <link:definition>230993017 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails" roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails">
        <link:definition>241004062 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) - Quarterly Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails" roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails">
        <link:definition>241014063 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TransitionPeriodComparativeDataUnaudited" roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited">
        <link:definition>211021021 - Disclosure - Transition Period Comparative Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TransitionPeriodComparativeDataUnauditedTables" roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables">
        <link:definition>231033018 - Disclosure - Transition Period Comparative Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TransitionPeriodComparativeDataUnauditedDetails" roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails">
        <link:definition>241044064 - Disclosure - Transition Period Comparative Data (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" abstract="true" name="OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" abstract="false" name="ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mygn_RangeFourMember" abstract="true" name="RangeFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" abstract="true" name="InProcessResearchAndDevelopmentWithIndefiniteLivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ClinicReportingUnitMember" abstract="true" name="ClinicReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_MolecularDiagnosticVectraTestingMember" abstract="true" name="MolecularDiagnosticVectraTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_MolecularDiagnosticTestingMember" abstract="true" name="MolecularDiagnosticTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" abstract="false" name="IncreaseDecreaseInUnrecognizedTaxBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_MolecularDiagnosticProlarisTestingMember" abstract="true" name="MolecularDiagnosticProlarisTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_PerformanceObligationEstimatedTransactionPriceMember" abstract="true" name="PerformanceObligationEstimatedTransactionPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod" abstract="false" name="IncomeTaxReconciliationChangesInRevenueRecognitionMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_ClinicAssetGroupMember" abstract="true" name="ClinicAssetGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_TransitionPeriodFinancialInformationTable" abstract="true" name="TransitionPeriodFinancialInformationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" abstract="false" name="IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_IncreaseDecreaseInEarningsLossPerShare" abstract="false" name="IncreaseDecreaseInEarningsLossPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" abstract="false" name="DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" abstract="false" name="DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_OptionsAndRestrictedStockUnitsMember" abstract="true" name="OptionsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_DeferredTaxLeaseLiability" abstract="false" name="DeferredTaxLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_DevelopedTechnologyAndDatabaseMember" abstract="true" name="DevelopedTechnologyAndDatabaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_PharmaceuticalAndClinicalServicesMember" abstract="true" name="PharmaceuticalAndClinicalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" abstract="false" name="PrepaidExpenseExcludingPrepaidTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_TransitionPeriodFinancialInformationLineItems" abstract="true" name="TransitionPeriodFinancialInformationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mygn_TaxCreditCarryforwardsExpirationDate" abstract="false" name="TaxCreditCarryforwardsExpirationDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:gYearItemType"/>
  <xs:element id="mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_AmendmentToCreditAgreementMember" abstract="true" name="AmendmentToCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_AssetsLessCashCashEquivalentsAndInvestments" abstract="false" name="AssetsLessCashCashEquivalentsAndInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_CARESActOf2020MedicarePaymentAmount" abstract="false" name="CARESActOf2020MedicarePaymentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement" abstract="false" name="IncomeTaxReconciliationNonDeductibleLegalSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_RangeTwoMember" abstract="true" name="RangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod" abstract="false" name="ValuationAllowanceIncreaseDecreaseDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases" abstract="false" name="AmountChargedToRetainedEarningsAsResultOfStockRepurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_NonEmployeeDirectorMember" abstract="true" name="NonEmployeeDirectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" abstract="false" name="TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment" abstract="false" name="GoodwillIncreaseDecreaseWorkingCapitalAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IntangibleAssetsLineItems" abstract="true" name="IntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment" abstract="false" name="EffectiveIncomeTaxRateReconciliationAssetImpairment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_GoodwillAndIntangibleAssetsTable" abstract="true" name="GoodwillAndIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mygn_MolecularDiagnosticMyChoiceCDxMember" abstract="true" name="MolecularDiagnosticMyChoiceCDxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" abstract="false" name="GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_MolecularDiagnosticPrenatalTestingMember" abstract="true" name="MolecularDiagnosticPrenatalTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationStatuteExpiration" abstract="false" name="IncomeTaxReconciliationStatuteExpiration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" abstract="false" name="EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_OperatingLeaseLiabilityEstablished" abstract="false" name="OperatingLeaseLiabilityEstablished" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" abstract="false" name="FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_ChangeInFairValueOfContingentConsideration" abstract="false" name="ChangeInFairValueOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" abstract="false" name="IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mygn_GoodwillAndIntangibleAssetsLineItems" abstract="true" name="GoodwillAndIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" abstract="false" name="ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact" abstract="false" name="IncomeTaxReconciliationTaxCutAndJobsActImpact" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_OperatingLossCarryforwardsExpirationYear" abstract="false" name="OperatingLossCarryforwardsExpirationYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:gYearItemType"/>
  <xs:element id="mygn_NumberOfDefinedBenefitPensionPlans" abstract="false" name="NumberOfDefinedBenefitPensionPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mygn_TransitionPeriodComparativeDataTextBlock" abstract="false" name="TransitionPeriodComparativeDataTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" abstract="false" name="DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationExpiredTaxAttributes" abstract="false" name="IncomeTaxReconciliationExpiredTaxAttributes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" abstract="false" name="ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_CounsylIncMember" abstract="true" name="CounsylIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_DiagnosticMember" abstract="true" name="DiagnosticMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_DeferredTaxAssetsLeaseRightOfUseAsset" abstract="false" name="DeferredTaxAssetsLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationCARESAct" abstract="false" name="EffectiveIncomeTaxRateReconciliationCARESAct" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_DebtInstrumentLIBORFloorPercentage" abstract="false" name="DebtInstrumentLIBORFloorPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_MolecularDiagnosticOtherTestingMember" abstract="true" name="MolecularDiagnosticOtherTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_MolecularDiagnosticGenesightTestingMember" abstract="true" name="MolecularDiagnosticGenesightTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_EmployeeStockPurchasePlanTwentyTwelveMember" abstract="true" name="EmployeeStockPurchasePlanTwentyTwelveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock" abstract="false" name="ScheduleOfCommonStockRepurchasedTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mygn_MolecularDiagnosticEndoPredictTestingMember" abstract="true" name="MolecularDiagnosticEndoPredictTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" abstract="true" name="OptionsGrantedAfterDecemberFiveTwentyTwelveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_PurchasedLicensesAndTechnologiesMember" abstract="true" name="PurchasedLicensesAndTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationForeignDisregardedElection" abstract="false" name="IncomeTaxReconciliationForeignDisregardedElection" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" abstract="false" name="IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" abstract="false" name="GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_NonCashInterestExpense" abstract="false" name="NonCashInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_RangeOneMember" abstract="true" name="RangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ScheduleOfIntangibleAssetsTable" abstract="true" name="ScheduleOfIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mygn_CostOfMolecularDiagnosticTestingMember" abstract="true" name="CostOfMolecularDiagnosticTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mygn_MolecularDiagnosticHereditaryCancerTestingMember" abstract="true" name="MolecularDiagnosticHereditaryCancerTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_GoodwillAndIntangibleAssetImpairmentChargesMember" abstract="true" name="GoodwillAndIntangibleAssetImpairmentChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" abstract="false" name="IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" abstract="false" name="AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_CostOfPharmaceuticalAndClinicalServicesMember" abstract="true" name="CostOfPharmaceuticalAndClinicalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember" abstract="true" name="TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" abstract="false" name="EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_RangeThreeMember" abstract="true" name="RangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_CARESActOf2020ProviderReliefFundAmount" abstract="false" name="CARESActOf2020ProviderReliefFundAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_MyriadAutoimmuneReportingUnitMember" abstract="true" name="MyriadAutoimmuneReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases" abstract="false" name="AmountOfReductionInCommonStockAsResultOfStockRepurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" abstract="false" name="IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" abstract="true" name="TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ContractWithCustomerLiabilityPrepayments" abstract="false" name="ContractWithCustomerLiabilityPrepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_OtherIncomePolicyPolicyTextBlock" abstract="false" name="OtherIncomePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mygn_UnrecognizedTaxBenefitsNet" abstract="false" name="UnrecognizedTaxBenefitsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock" abstract="false" name="ScheduleOfTransitionPeriodComparativeDataTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" abstract="false" name="GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations" abstract="false" name="EffectiveIncomeTaxRateReconciliationStatuteExpirations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_RecoupmentsPayableAndReserveCurrent" abstract="false" name="RecoupmentsPayableAndReserveCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_OtherStateMember" abstract="true" name="OtherStateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_InvestmentsAndCashAmortizedCost" abstract="false" name="InvestmentsAndCashAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_DeferredTaxAssetsUncertainStateTaxPositions" abstract="false" name="DeferredTaxAssetsUncertainStateTaxPositions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" abstract="false" name="StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationAssetImpairment" abstract="false" name="IncomeTaxReconciliationAssetImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncomeTaxReconciliationCARESAct" abstract="false" name="IncomeTaxReconciliationCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>mygn-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efa3350f-b8a9-4fda-9dc1-67977795f671,g:9ff9af07-fed3-4eeb-865c-11c477b6a054-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.myriad.com/role/Cover" xlink:type="simple" xlink:href="mygn-20201231.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_33fd7d81-12f4-4f6f-b58f-e51aa33b3b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_46c55ca7-fa28-4053-96e4-d175ff5a147e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_33fd7d81-12f4-4f6f-b58f-e51aa33b3b5a" xlink:to="loc_us-gaap_StockholdersEquity_46c55ca7-fa28-4053-96e4-d175ff5a147e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_36e75f8f-7cc4-4ac1-9c6b-0e9b057d7b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_33fd7d81-12f4-4f6f-b58f-e51aa33b3b5a" xlink:to="loc_us-gaap_MinorityInterest_36e75f8f-7cc4-4ac1-9c6b-0e9b057d7b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_897a5ef9-43c2-4ccc-86ec-f0ad25ae8467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d3971814-5ed0-428d-9b61-223f571d51f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_897a5ef9-43c2-4ccc-86ec-f0ad25ae8467" xlink:to="loc_us-gaap_AccountsPayableCurrent_d3971814-5ed0-428d-9b61-223f571d51f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e757b53e-85a9-4755-9d40-7d6bd0685c11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_897a5ef9-43c2-4ccc-86ec-f0ad25ae8467" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e757b53e-85a9-4755-9d40-7d6bd0685c11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4e72b7ef-1ff3-4c0f-ae5e-ba6ea30baa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_897a5ef9-43c2-4ccc-86ec-f0ad25ae8467" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4e72b7ef-1ff3-4c0f-ae5e-ba6ea30baa71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1a06ddce-9a8d-4a55-99ec-fc456f4b80b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_897a5ef9-43c2-4ccc-86ec-f0ad25ae8467" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1a06ddce-9a8d-4a55-99ec-fc456f4b80b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a5bebaaa-1bcf-46c9-a3fa-f7b6b9d3d7b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fef0c031-5e22-455d-8e9c-a16b7ee2e23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5bebaaa-1bcf-46c9-a3fa-f7b6b9d3d7b2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fef0c031-5e22-455d-8e9c-a16b7ee2e23b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_6bdb1277-9891-4481-9262-f2d760ea9472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5bebaaa-1bcf-46c9-a3fa-f7b6b9d3d7b2" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_6bdb1277-9891-4481-9262-f2d760ea9472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_107057ea-0427-432e-a9a1-f81ce73505cb" xlink:href="mygn-20201231.xsd#mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5bebaaa-1bcf-46c9-a3fa-f7b6b9d3d7b2" xlink:to="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_107057ea-0427-432e-a9a1-f81ce73505cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_143d575e-8fc0-4b3a-a2ce-79c0c4da6ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5bebaaa-1bcf-46c9-a3fa-f7b6b9d3d7b2" xlink:to="loc_us-gaap_InventoryNet_143d575e-8fc0-4b3a-a2ce-79c0c4da6ff8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4c5bb610-91f3-48bf-8652-871573dcd4f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5bebaaa-1bcf-46c9-a3fa-f7b6b9d3d7b2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4c5bb610-91f3-48bf-8652-871573dcd4f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_314dbc48-c483-4a24-a43c-b48ff25d99dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5bebaaa-1bcf-46c9-a3fa-f7b6b9d3d7b2" xlink:to="loc_us-gaap_PrepaidTaxes_314dbc48-c483-4a24-a43c-b48ff25d99dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_dfd6465d-495e-402e-b28c-438c4119d3b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5bebaaa-1bcf-46c9-a3fa-f7b6b9d3d7b2" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_dfd6465d-495e-402e-b28c-438c4119d3b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1be1135f-edae-45a0-b06a-6cd517326180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3f444d48-373a-43bc-b861-d91cba2de7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1be1135f-edae-45a0-b06a-6cd517326180" xlink:to="loc_us-gaap_CommonStockValue_3f444d48-373a-43bc-b861-d91cba2de7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b793a979-2681-4837-bf43-950eb2826d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1be1135f-edae-45a0-b06a-6cd517326180" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b793a979-2681-4837-bf43-950eb2826d26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_94f258dc-a257-4b52-be3c-a4b184bf1b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1be1135f-edae-45a0-b06a-6cd517326180" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_94f258dc-a257-4b52-be3c-a4b184bf1b53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9bb637c8-704e-457d-bb13-7a8b1ea0fe89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1be1135f-edae-45a0-b06a-6cd517326180" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9bb637c8-704e-457d-bb13-7a8b1ea0fe89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2b7e4c99-d826-4148-9528-5c83beeb14f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_58c81c4c-8956-48b3-a217-244bcfa35a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2b7e4c99-d826-4148-9528-5c83beeb14f6" xlink:to="loc_us-gaap_LiabilitiesCurrent_58c81c4c-8956-48b3-a217-244bcfa35a55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_UnrecognizedTaxBenefitsNet_67480dda-ba0f-42f9-8fc4-863bed12f9ce" xlink:href="mygn-20201231.xsd#mygn_UnrecognizedTaxBenefitsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2b7e4c99-d826-4148-9528-5c83beeb14f6" xlink:to="loc_mygn_UnrecognizedTaxBenefitsNet_67480dda-ba0f-42f9-8fc4-863bed12f9ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a4e29c81-76d5-4bcf-be65-a91968a4b8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2b7e4c99-d826-4148-9528-5c83beeb14f6" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a4e29c81-76d5-4bcf-be65-a91968a4b8a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2a7c1d48-f61f-4f6e-b101-bec58031105f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2b7e4c99-d826-4148-9528-5c83beeb14f6" xlink:to="loc_us-gaap_LongTermDebt_2a7c1d48-f61f-4f6e-b101-bec58031105f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_12ffbfba-4b30-4464-a71e-0bb64ed75b30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2b7e4c99-d826-4148-9528-5c83beeb14f6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_12ffbfba-4b30-4464-a71e-0bb64ed75b30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_81ea526a-9cef-48ac-9b37-2dadd7d2037f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2b7e4c99-d826-4148-9528-5c83beeb14f6" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_81ea526a-9cef-48ac-9b37-2dadd7d2037f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_30bd3c0b-1476-4c57-b391-5119f3eb34f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f5f346af-c11a-4264-a9c7-6e8dcb6e9325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_30bd3c0b-1476-4c57-b391-5119f3eb34f7" xlink:to="loc_us-gaap_Liabilities_f5f346af-c11a-4264-a9c7-6e8dcb6e9325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8bda1bd1-e2be-423d-938c-69b7bc7d6630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_30bd3c0b-1476-4c57-b391-5119f3eb34f7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8bda1bd1-e2be-423d-938c-69b7bc7d6630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_15586529-f9a8-4a7a-8861-655a427d3053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_30bd3c0b-1476-4c57-b391-5119f3eb34f7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_15586529-f9a8-4a7a-8861-655a427d3053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3503272b-e1ce-4aa9-9d78-a627170531c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8c50230e-a3d6-415c-91fa-1ec61062581b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3503272b-e1ce-4aa9-9d78-a627170531c7" xlink:to="loc_us-gaap_AssetsCurrent_8c50230e-a3d6-415c-91fa-1ec61062581b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_74754f14-3b0f-49fa-a93a-85afda23febb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3503272b-e1ce-4aa9-9d78-a627170531c7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_74754f14-3b0f-49fa-a93a-85afda23febb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_89136c4f-126b-4bf8-a156-beeebfe3c4cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3503272b-e1ce-4aa9-9d78-a627170531c7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_89136c4f-126b-4bf8-a156-beeebfe3c4cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_0c8db4a7-dc3b-48d6-ae8f-d48a735a0a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3503272b-e1ce-4aa9-9d78-a627170531c7" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_0c8db4a7-dc3b-48d6-ae8f-d48a735a0a30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f40475db-aee7-49d9-9761-fe51c88292b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3503272b-e1ce-4aa9-9d78-a627170531c7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f40475db-aee7-49d9-9761-fe51c88292b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dfd47971-3ce8-4693-9ba2-2f3d40b198e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3503272b-e1ce-4aa9-9d78-a627170531c7" xlink:to="loc_us-gaap_Goodwill_dfd47971-3ce8-4693-9ba2-2f3d40b198e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_399adf87-8c21-42a1-bc97-35424eb0c7d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3503272b-e1ce-4aa9-9d78-a627170531c7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_399adf87-8c21-42a1-bc97-35424eb0c7d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6502873e-7261-4e91-8d42-e52b50abadb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_23c73725-afb2-4d06-aacb-442a90723431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6502873e-7261-4e91-8d42-e52b50abadb4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_23c73725-afb2-4d06-aacb-442a90723431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b455574a-6d3b-4abc-ba94-87ab2f2c9614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6502873e-7261-4e91-8d42-e52b50abadb4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b455574a-6d3b-4abc-ba94-87ab2f2c9614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b22548bc-d0fb-4b64-a964-adf47138555c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6502873e-7261-4e91-8d42-e52b50abadb4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b22548bc-d0fb-4b64-a964-adf47138555c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_59031747-bb4f-4f6e-b266-4a57f91d4d24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6502873e-7261-4e91-8d42-e52b50abadb4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_59031747-bb4f-4f6e-b266-4a57f91d4d24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_3516ec78-0e27-40cb-9407-0803d189019c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6502873e-7261-4e91-8d42-e52b50abadb4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_3516ec78-0e27-40cb-9407-0803d189019c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e6719431-a58b-4a51-a3ee-8ec8dbe75acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_4ed8d26d-0261-4fcf-8a14-b7189d046695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e6719431-a58b-4a51-a3ee-8ec8dbe75acf" xlink:to="loc_us-gaap_InvestmentIncomeInterest_4ed8d26d-0261-4fcf-8a14-b7189d046695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_11ddedc1-4127-4cde-99f8-baf5c7025221" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e6719431-a58b-4a51-a3ee-8ec8dbe75acf" xlink:to="loc_us-gaap_InterestExpense_11ddedc1-4127-4cde-99f8-baf5c7025221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_df5847a7-9a48-4865-bc60-711763ff17a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e6719431-a58b-4a51-a3ee-8ec8dbe75acf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_df5847a7-9a48-4865-bc60-711763ff17a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_63d2cbb9-a112-4fc9-ab5f-fe5b1b73d0ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c11ae242-3251-4c08-9f4d-fbcd4c551c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63d2cbb9-a112-4fc9-ab5f-fe5b1b73d0ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c11ae242-3251-4c08-9f4d-fbcd4c551c20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_43032dff-518b-48df-b3e0-6d3e491a8e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63d2cbb9-a112-4fc9-ab5f-fe5b1b73d0ff" xlink:to="loc_us-gaap_CostsAndExpenses_43032dff-518b-48df-b3e0-6d3e491a8e63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_73ac662c-4084-4e48-a791-ffc16cc86d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6c069549-d2da-4c4f-a5f6-6db996a74db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_73ac662c-4084-4e48-a791-ffc16cc86d1c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6c069549-d2da-4c4f-a5f6-6db996a74db5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_28942a37-7a59-4391-af28-cb54ad43828f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_73ac662c-4084-4e48-a791-ffc16cc86d1c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_28942a37-7a59-4391-af28-cb54ad43828f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_26e6c296-d23d-43b6-8f2c-20b69f422c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_31b95098-e5fb-4665-9c3a-5d60091bef3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_26e6c296-d23d-43b6-8f2c-20b69f422c15" xlink:to="loc_us-gaap_ProfitLoss_31b95098-e5fb-4665-9c3a-5d60091bef3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_64908c78-6dfb-4f16-b546-eeee4143dd51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_26e6c296-d23d-43b6-8f2c-20b69f422c15" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_64908c78-6dfb-4f16-b546-eeee4143dd51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d0a8bea9-c062-40df-8e94-163d76cf1532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c802355d-b940-444c-81ba-d78160d23a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d0a8bea9-c062-40df-8e94-163d76cf1532" xlink:to="loc_us-gaap_OperatingIncomeLoss_c802355d-b940-444c-81ba-d78160d23a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4297e4df-aee3-4faa-b4d3-8fd76f834c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d0a8bea9-c062-40df-8e94-163d76cf1532" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4297e4df-aee3-4faa-b4d3-8fd76f834c27" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_74884f7d-7212-4bfa-b0e5-10f1014a1004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8ea9640f-b1b1-4c80-b6ea-3e94518f884d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_74884f7d-7212-4bfa-b0e5-10f1014a1004" xlink:to="loc_us-gaap_NetIncomeLoss_8ea9640f-b1b1-4c80-b6ea-3e94518f884d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_a64dd16a-997b-47e8-a4a0-823289f9c40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_74884f7d-7212-4bfa-b0e5-10f1014a1004" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_a64dd16a-997b-47e8-a4a0-823289f9c40d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_9e49f296-59c8-4233-8993-d268969d77ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_74884f7d-7212-4bfa-b0e5-10f1014a1004" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_9e49f296-59c8-4233-8993-d268969d77ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f89cb76c-81cb-47a3-81b4-c12e13f48c50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_74884f7d-7212-4bfa-b0e5-10f1014a1004" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f89cb76c-81cb-47a3-81b4-c12e13f48c50" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_726ad9e4-6d0e-4009-8387-bf260a2d1a12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6441849a-6b8f-4a1b-8e9d-01d80b31d708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_726ad9e4-6d0e-4009-8387-bf260a2d1a12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6441849a-6b8f-4a1b-8e9d-01d80b31d708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_42debc21-4027-4b20-a018-ed6a5a6ecf24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_726ad9e4-6d0e-4009-8387-bf260a2d1a12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_42debc21-4027-4b20-a018-ed6a5a6ecf24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4eb110ed-d005-458d-b868-0deec4e0be46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_726ad9e4-6d0e-4009-8387-bf260a2d1a12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4eb110ed-d005-458d-b868-0deec4e0be46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d8a5718e-fc19-45e1-86f6-de1aa674fa5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_726ad9e4-6d0e-4009-8387-bf260a2d1a12" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d8a5718e-fc19-45e1-86f6-de1aa674fa5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f920a36f-acab-485b-939e-9c6049aa00ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_a972e90e-f8ff-4356-b33d-302661633d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f920a36f-acab-485b-939e-9c6049aa00ca" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_a972e90e-f8ff-4356-b33d-302661633d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_83317136-6325-4780-922d-4be8c8b2e0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f920a36f-acab-485b-939e-9c6049aa00ca" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_83317136-6325-4780-922d-4be8c8b2e0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_c8a5c5ab-5f72-4bfe-ba6d-ded883867251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f920a36f-acab-485b-939e-9c6049aa00ca" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_c8a5c5ab-5f72-4bfe-ba6d-ded883867251" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_bbf8af26-f3d6-432a-9509-ba18b4847853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f920a36f-acab-485b-939e-9c6049aa00ca" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_bbf8af26-f3d6-432a-9509-ba18b4847853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_c545873d-2621-4940-b444-8ebfe9d12637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f920a36f-acab-485b-939e-9c6049aa00ca" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_c545873d-2621-4940-b444-8ebfe9d12637" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c9f44235-dfb0-415d-bb79-d4f6accb4082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c9f44235-dfb0-415d-bb79-d4f6accb4082" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bd3c4550-3226-40db-9fa6-8c3d055cf1d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bd3c4550-3226-40db-9fa6-8c3d055cf1d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_e9c741e7-2429-4d70-ace1-3b7be3c0de89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_e9c741e7-2429-4d70-ace1-3b7be3c0de89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_26413a31-f80c-435f-82a4-786697a1dab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_26413a31-f80c-435f-82a4-786697a1dab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9f9effe8-e4db-4fdd-a0bf-364ab648eafe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9f9effe8-e4db-4fdd-a0bf-364ab648eafe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_8b5f735f-1dd5-4b88-8ad4-c597fafd29c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_8b5f735f-1dd5-4b88-8ad4-c597fafd29c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_729addcd-511b-4d2e-bda5-1e55202e3220" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_729addcd-511b-4d2e-bda5-1e55202e3220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_6f167401-d573-4cc0-844e-1e28231be926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fcd3202-eb69-4f99-9718-e146632ddea6" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_6f167401-d573-4cc0-844e-1e28231be926" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0b9d54ef-7208-4de1-8d72-012e0b5a1a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_NetIncomeLoss_0b9d54ef-7208-4de1-8d72-012e0b5a1a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_09f739c3-ca7e-4c3d-9202-6f4c333dc5b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_DepreciationAndAmortization_09f739c3-ca7e-4c3d-9202-6f4c333dc5b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonCashInterestExpense_5a2a65a0-5628-4c24-91c5-b85f7f0a9902" xlink:href="mygn-20201231.xsd#mygn_NonCashInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_mygn_NonCashInterestExpense_5a2a65a0-5628-4c24-91c5-b85f7f0a9902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_39d8ed7a-848b-4e4b-a7b7-89d90397c6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_39d8ed7a-848b-4e4b-a7b7-89d90397c6b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_b8f09408-5f49-4e48-b277-f0c654772175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_b8f09408-5f49-4e48-b277-f0c654772175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7a1b566d-bfc3-4f7b-a7ff-4d87ff70f965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7a1b566d-bfc3-4f7b-a7ff-4d87ff70f965" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_00bf44a6-4921-456e-9ec5-afe9db8b15e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_00bf44a6-4921-456e-9ec5-afe9db8b15e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ae3de439-b3a3-4920-8872-bcace01ab65c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_ShareBasedCompensation_ae3de439-b3a3-4920-8872-bcace01ab65c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_af1b1610-f7e9-483b-935f-de744c5785d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_af1b1610-f7e9-483b-935f-de744c5785d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_e2d6fb78-afed-4571-b6e7-5c26663d1970" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInUnrecognizedTaxBenefits"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_e2d6fb78-afed-4571-b6e7-5c26663d1970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_fa34a569-e823-47f7-94f5-ef6885b3e7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_fa34a569-e823-47f7-94f5-ef6885b3e7b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ChangeInFairValueOfContingentConsideration_e7b34449-fd18-4b21-a61d-73c03a998800" xlink:href="mygn-20201231.xsd#mygn_ChangeInFairValueOfContingentConsideration"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_mygn_ChangeInFairValueOfContingentConsideration_e7b34449-fd18-4b21-a61d-73c03a998800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_af20d1bd-8216-4376-a3b7-55b46ad89723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_af20d1bd-8216-4376-a3b7-55b46ad89723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_f2a24a21-16fa-485d-aa06-ab2db86906a4" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_f2a24a21-16fa-485d-aa06-ab2db86906a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a083bcba-615e-45ca-8452-247bfa801e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a083bcba-615e-45ca-8452-247bfa801e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_fba58fcc-79fe-4f99-8a04-746a55f1019e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_fba58fcc-79fe-4f99-8a04-746a55f1019e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_726c49de-a188-46c4-90c9-cf521db42a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_726c49de-a188-46c4-90c9-cf521db42a9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_dc7998cb-953a-4b66-9b0f-7c54c7442303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_dc7998cb-953a-4b66-9b0f-7c54c7442303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e68cb7e1-79f0-46e3-a06e-df3a450659be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e68cb7e1-79f0-46e3-a06e-df3a450659be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3f46d039-7b6a-43ad-bb38-0255c6366a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3f46d039-7b6a-43ad-bb38-0255c6366a64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7401a000-cfa7-4792-a2c8-19d88f450050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7401a000-cfa7-4792-a2c8-19d88f450050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5e1b860c-d284-4bec-9e64-7ad5ae57461b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0eeecb2a-8e5b-44ef-aa9a-e4a0db2a17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5e1b860c-d284-4bec-9e64-7ad5ae57461b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_62c7b615-87f4-454b-a67b-24e94294fab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c780f5b-d21e-44b5-b73a-70155b20c2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_62c7b615-87f4-454b-a67b-24e94294fab4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c780f5b-d21e-44b5-b73a-70155b20c2c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a9bb11c6-d675-4805-8503-09a0ef2b8d40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_62c7b615-87f4-454b-a67b-24e94294fab4" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a9bb11c6-d675-4805-8503-09a0ef2b8d40" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecurities"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_97cf8bb6-ef28-49b6-a411-7e59b38d07bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_10c29868-3945-4299-abfc-20f2d8811b77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_97cf8bb6-ef28-49b6-a411-7e59b38d07bf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_10c29868-3945-4299-abfc-20f2d8811b77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_07f29111-90d8-40dc-ad15-3abb0b05152a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_97cf8bb6-ef28-49b6-a411-7e59b38d07bf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_07f29111-90d8-40dc-ad15-3abb0b05152a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6eba083b-8d22-4ba1-acfa-aa60defcfd0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_97cf8bb6-ef28-49b6-a411-7e59b38d07bf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6eba083b-8d22-4ba1-acfa-aa60defcfd0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_a4ad8178-b2fd-4b89-88cd-656ab5d20123" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_4043e5f2-dad3-4d52-ac80-ff5e85726d01" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_a4ad8178-b2fd-4b89-88cd-656ab5d20123" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_4043e5f2-dad3-4d52-ac80-ff5e85726d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_32724342-ec12-4688-8fc7-f321a762e1ea" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_a4ad8178-b2fd-4b89-88cd-656ab5d20123" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_32724342-ec12-4688-8fc7-f321a762e1ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_8da8375c-e015-4577-9748-a9a769e55e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_a4ad8178-b2fd-4b89-88cd-656ab5d20123" xlink:to="loc_us-gaap_InvestmentsAndCash_8da8375c-e015-4577-9748-a9a769e55e6c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_70f5efd9-d6b3-4111-b0eb-8fae961e881c" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a326fb68-6f3b-46f9-9dc1-58cae1cae876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_70f5efd9-d6b3-4111-b0eb-8fae961e881c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a326fb68-6f3b-46f9-9dc1-58cae1cae876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_88d08ac8-8a24-41b3-a040-826d3b3df158" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_70f5efd9-d6b3-4111-b0eb-8fae961e881c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_88d08ac8-8a24-41b3-a040-826d3b3df158" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_8315930b-201f-4673-821d-39d409ea9c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_70f5efd9-d6b3-4111-b0eb-8fae961e881c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_8315930b-201f-4673-821d-39d409ea9c74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_47a07076-9ed9-4da3-8b3c-953d910baa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_70f5efd9-d6b3-4111-b0eb-8fae961e881c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_47a07076-9ed9-4da3-8b3c-953d910baa71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_04acd8dd-99e1-405a-a2d0-5f5aa23d7c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a9fc3cd5-73e8-4bc5-b286-b942dc02d747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsAndCash_04acd8dd-99e1-405a-a2d0-5f5aa23d7c91" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a9fc3cd5-73e8-4bc5-b286-b942dc02d747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a38229ac-e46a-4ff7-917d-9400f26bc57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsAndCash_04acd8dd-99e1-405a-a2d0-5f5aa23d7c91" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a38229ac-e46a-4ff7-917d-9400f26bc57a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_835d212a-ec65-4580-8562-322ebfdea585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsAndCash_04acd8dd-99e1-405a-a2d0-5f5aa23d7c91" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_835d212a-ec65-4580-8562-322ebfdea585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_994e2019-d5ac-4d3d-add1-a226a6357338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsAndCash_04acd8dd-99e1-405a-a2d0-5f5aa23d7c91" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_994e2019-d5ac-4d3d-add1-a226a6357338" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_6e27aed1-b3cf-41a3-8292-196995df05c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e5fdd064-c978-4962-a123-b9f2f7cbcc7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_6e27aed1-b3cf-41a3-8292-196995df05c9" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e5fdd064-c978-4962-a123-b9f2f7cbcc7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_7b550c26-f258-4c7a-9e22-7a6ba1df2959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_6e27aed1-b3cf-41a3-8292-196995df05c9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_7b550c26-f258-4c7a-9e22-7a6ba1df2959" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNet"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a7a14d20-143f-46bd-9966-8d6ad887fb21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_03686bae-160a-4b33-98df-72223badbcb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a7a14d20-143f-46bd-9966-8d6ad887fb21" xlink:to="loc_us-gaap_Land_03686bae-160a-4b33-98df-72223badbcb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_10a46d70-f495-44f7-8207-0b047e8c50ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a7a14d20-143f-46bd-9966-8d6ad887fb21" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_10a46d70-f495-44f7-8207-0b047e8c50ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_1d0c0ffc-67fa-42a2-869d-1ffea61429ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a7a14d20-143f-46bd-9966-8d6ad887fb21" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_1d0c0ffc-67fa-42a2-869d-1ffea61429ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_efb9d207-714d-46be-b1ea-ba377041427b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a7a14d20-143f-46bd-9966-8d6ad887fb21" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_efb9d207-714d-46be-b1ea-ba377041427b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_78441dba-20cd-47e6-92cb-cf548906eccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_770eee0a-0281-4516-a4e3-0ea7794c17fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_78441dba-20cd-47e6-92cb-cf548906eccc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_770eee0a-0281-4516-a4e3-0ea7794c17fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c641bee5-795d-4eec-b832-312accbe323f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_78441dba-20cd-47e6-92cb-cf548906eccc" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c641bee5-795d-4eec-b832-312accbe323f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetDepreciationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b683b6fc-061b-4819-b3b3-ea31234a19ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7fa05856-312b-46f9-bb70-c3ec97e3233c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b683b6fc-061b-4819-b3b3-ea31234a19ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7fa05856-312b-46f9-bb70-c3ec97e3233c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_31f059c5-89ed-4e24-aa8a-ac92357bb99d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b683b6fc-061b-4819-b3b3-ea31234a19ff" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_31f059c5-89ed-4e24-aa8a-ac92357bb99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_dcff50fa-1f34-47cf-afc4-ca9ebef7d790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95f3056d-ea2c-45d0-b61c-e091243ebe83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_dcff50fa-1f34-47cf-afc4-ca9ebef7d790" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95f3056d-ea2c-45d0-b61c-e091243ebe83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8ac08b60-2c90-48cd-9f9e-df41ca403ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_dcff50fa-1f34-47cf-afc4-ca9ebef7d790" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8ac08b60-2c90-48cd-9f9e-df41ca403ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_22c0452b-9609-4792-b7a0-a33b2b9fee10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_01d463fb-81c5-41a2-861f-718ca68b1df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_22c0452b-9609-4792-b7a0-a33b2b9fee10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_01d463fb-81c5-41a2-861f-718ca68b1df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c8a51079-16e9-412c-8551-d78cd62da128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_22c0452b-9609-4792-b7a0-a33b2b9fee10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c8a51079-16e9-412c-8551-d78cd62da128" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6b54b13e-cc6e-444f-965f-6f19da714ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d7b55f1c-bc4d-45e7-baee-91ace1a7cc5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6b54b13e-cc6e-444f-965f-6f19da714ca9" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d7b55f1c-bc4d-45e7-baee-91ace1a7cc5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a70f2746-0e54-4cba-a4a6-ffcc9fde11ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6b54b13e-cc6e-444f-965f-6f19da714ca9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a70f2746-0e54-4cba-a4a6-ffcc9fde11ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1543ba96-9813-4fe6-8db6-a9da26826cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2caf10ab-7db2-49b4-878f-c36a9f563b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1543ba96-9813-4fe6-8db6-a9da26826cb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2caf10ab-7db2-49b4-878f-c36a9f563b8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dda267f3-f4c9-4aef-8031-db375cabafda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1543ba96-9813-4fe6-8db6-a9da26826cb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dda267f3-f4c9-4aef-8031-db375cabafda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_635c0b56-93c6-4dfb-b3cd-924797615663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1543ba96-9813-4fe6-8db6-a9da26826cb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_635c0b56-93c6-4dfb-b3cd-924797615663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8609d462-108d-45e8-b61a-6fdda454b371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1543ba96-9813-4fe6-8db6-a9da26826cb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8609d462-108d-45e8-b61a-6fdda454b371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_33c2ef27-25d0-4301-9abc-ba737cc7d7ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1543ba96-9813-4fe6-8db6-a9da26826cb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_33c2ef27-25d0-4301-9abc-ba737cc7d7ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8129fcca-4067-4e33-abb0-42b50ff4427d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1543ba96-9813-4fe6-8db6-a9da26826cb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8129fcca-4067-4e33-abb0-42b50ff4427d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilities"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/AccruedLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f536a5ac-61fa-4c11-84e7-1132cc52e639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_320c0d62-58ff-43db-b30a-99c82a1c81e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f536a5ac-61fa-4c11-84e7-1132cc52e639" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_320c0d62-58ff-43db-b30a-99c82a1c81e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_fec7eda4-946f-46b3-bd26-112f41764192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f536a5ac-61fa-4c11-84e7-1132cc52e639" xlink:to="loc_us-gaap_TaxesPayableCurrent_fec7eda4-946f-46b3-bd26-112f41764192" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_e541e427-9cfe-47d4-b521-891c18b783ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f536a5ac-61fa-4c11-84e7-1132cc52e639" xlink:to="loc_us-gaap_LitigationReserveCurrent_e541e427-9cfe-47d4-b521-891c18b783ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RecoupmentsPayableAndReserveCurrent_0a99893c-4998-45dc-8e6b-ffef1d2cb3ac" xlink:href="mygn-20201231.xsd#mygn_RecoupmentsPayableAndReserveCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f536a5ac-61fa-4c11-84e7-1132cc52e639" xlink:to="loc_mygn_RecoupmentsPayableAndReserveCurrent_0a99893c-4998-45dc-8e6b-ffef1d2cb3ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ba0d4174-47c8-4c7b-8c6f-757b34ce9678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f536a5ac-61fa-4c11-84e7-1132cc52e639" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ba0d4174-47c8-4c7b-8c6f-757b34ce9678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_53450ec5-eb8e-4531-9424-6f6a194efd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f536a5ac-61fa-4c11-84e7-1132cc52e639" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_53450ec5-eb8e-4531-9424-6f6a194efd00" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebt" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebt"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LongTermDebt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LongTermDebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9c717ad3-1eb8-4dcd-8a2c-afb210cf4365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8ed736b2-d451-4780-acf9-46856c6f08a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_9c717ad3-1eb8-4dcd-8a2c-afb210cf4365" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8ed736b2-d451-4780-acf9-46856c6f08a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_6dfcf96b-874a-4396-ae50-5a58b7849a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_9c717ad3-1eb8-4dcd-8a2c-afb210cf4365" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_6dfcf96b-874a-4396-ae50-5a58b7849a97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilities"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5bc21d54-9e64-4c5a-b97e-50a650c27ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_5b091873-8e08-4029-b6d3-2c3abcac42ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_5bc21d54-9e64-4c5a-b97e-50a650c27ef5" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_5b091873-8e08-4029-b6d3-2c3abcac42ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5c057c75-bc96-4d1f-8f43-b426cfb1a146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_5bc21d54-9e64-4c5a-b97e-50a650c27ef5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5c057c75-bc96-4d1f-8f43-b426cfb1a146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_adbfa2c0-b054-405a-90ef-bc0f08a2781a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_5bc21d54-9e64-4c5a-b97e-50a650c27ef5" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_adbfa2c0-b054-405a-90ef-bc0f08a2781a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityStockRepurchasesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationStockOptionsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationStockOptionsOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationValuationAssumptionsforESPPDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesIncomeTaxBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_26ae3c8a-4335-490d-9a59-5e225cb134ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_7ddf01c9-367d-40ce-a457-7c2fa468cc74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_26ae3c8a-4335-490d-9a59-5e225cb134ea" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_7ddf01c9-367d-40ce-a457-7c2fa468cc74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9002d59a-b00c-4620-8c74-2193590b4e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_26ae3c8a-4335-490d-9a59-5e225cb134ea" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9002d59a-b00c-4620-8c74-2193590b4e6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2e5c6fe1-2201-40b0-b480-297f144f2b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_26ae3c8a-4335-490d-9a59-5e225cb134ea" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2e5c6fe1-2201-40b0-b480-297f144f2b4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f1b63486-aede-4d1c-a65d-87b0213f4c2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_663c5d79-39ae-4c39-b77d-d277aa80a8b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_f1b63486-aede-4d1c-a65d-87b0213f4c2b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_663c5d79-39ae-4c39-b77d-d277aa80a8b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8ac51239-5207-4e41-8769-f50df1544470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_f1b63486-aede-4d1c-a65d-87b0213f4c2b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8ac51239-5207-4e41-8769-f50df1544470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cfe2eb69-576f-4ffd-a996-2e3e19962532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4265802a-5c63-4035-8099-71837c680c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cfe2eb69-576f-4ffd-a996-2e3e19962532" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4265802a-5c63-4035-8099-71837c680c78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4d9723bc-45fe-4cf1-893a-3a4f71fd9688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cfe2eb69-576f-4ffd-a996-2e3e19962532" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4d9723bc-45fe-4cf1-893a-3a4f71fd9688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_72462d48-d858-4a94-ad7a-2cd51928c8ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cfe2eb69-576f-4ffd-a996-2e3e19962532" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_72462d48-d858-4a94-ad7a-2cd51928c8ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_06c803b3-0ea6-48e1-bd41-16acd765bc10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cfe2eb69-576f-4ffd-a996-2e3e19962532" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_06c803b3-0ea6-48e1-bd41-16acd765bc10" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2ab34357-4633-48be-a4bc-ca1424b78385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e676275f-3b3a-454f-bf2a-9a54991a43f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2ab34357-4633-48be-a4bc-ca1424b78385" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e676275f-3b3a-454f-bf2a-9a54991a43f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_28eca7f4-1a5a-4362-9145-5e71c530648e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2ab34357-4633-48be-a4bc-ca1424b78385" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_28eca7f4-1a5a-4362-9145-5e71c530648e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3ca51a62-3eef-4594-adeb-57e73f9785b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3ca51a62-3eef-4594-adeb-57e73f9785b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_5b423864-410a-4fb0-8a9b-0d7d8abec57f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_5b423864-410a-4fb0-8a9b-0d7d8abec57f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_b05ec611-6065-4b12-bf06-9d74ccb48ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_b05ec611-6065-4b12-bf06-9d74ccb48ba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_2cce2581-7aa5-479b-80c6-9b4be49f385f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_2cce2581-7aa5-479b-80c6-9b4be49f385f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationStatuteExpiration_90d32829-4e94-46b7-b165-27d84237ca95" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationStatuteExpiration"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationStatuteExpiration_90d32829-4e94-46b7-b165-27d84237ca95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_abbb52e9-96d6-47e2-a86a-847cdcbe7df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_abbb52e9-96d6-47e2-a86a-847cdcbe7df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_026530b6-79a6-444e-b83b-67eabcd4a3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_026530b6-79a6-444e-b83b-67eabcd4a3f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0e61aa10-9db7-40e6-8e9c-71c9a0a1ab95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0e61aa10-9db7-40e6-8e9c-71c9a0a1ab95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact_b68ab9d9-71be-489e-9c2b-f787aaf988d4" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact_b68ab9d9-71be-489e-9c2b-f787aaf988d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationCARESAct_f0e76bee-6d0d-4f84-9759-d7ec401d67a3" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationCARESAct"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationCARESAct_f0e76bee-6d0d-4f84-9759-d7ec401d67a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_0f13aad1-ff7b-40d1-bab2-e02a4054fd9c" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_0f13aad1-ff7b-40d1-bab2-e02a4054fd9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_70b5a493-b715-4bad-bf1b-ffa7484cf6f3" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_70b5a493-b715-4bad-bf1b-ffa7484cf6f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_60b15cfb-aef0-4662-ab60-27bb8ca9a6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_60b15cfb-aef0-4662-ab60-27bb8ca9a6da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation_bc4ed982-7c0e-40ff-992b-28de5e18f1c3" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation_bc4ed982-7c0e-40ff-992b-28de5e18f1c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationAssetImpairment_f28a2aac-72ba-4461-b7b7-ca74d34e732a" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationAssetImpairment"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationAssetImpairment_f28a2aac-72ba-4461-b7b7-ca74d34e732a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationExpiredTaxAttributes_10ddad3c-719f-45aa-9295-7ea8b3e0b3f7" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationExpiredTaxAttributes"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationExpiredTaxAttributes_10ddad3c-719f-45aa-9295-7ea8b3e0b3f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement_dc0af7ad-8c04-4427-a4b0-b412cacaec77" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement_dc0af7ad-8c04-4427-a4b0-b412cacaec77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationForeignDisregardedElection_9f701c67-8dac-47fa-ad5f-8dcff5240c14" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationForeignDisregardedElection"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationForeignDisregardedElection_9f701c67-8dac-47fa-ad5f-8dcff5240c14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod_ba095580-0ff9-4998-94cb-f6fd94804c8d" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod_ba095580-0ff9-4998-94cb-f6fd94804c8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6c0507e1-1f2d-423f-90b2-9296d68cd5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a4bf0532-2b78-4d49-b843-7a070f114772" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6c0507e1-1f2d-423f-90b2-9296d68cd5b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5b655e02-251c-476e-b8af-5092ff290959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5b655e02-251c-476e-b8af-5092ff290959" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9383a131-12d1-4e2c-88d1-5014aa548d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9383a131-12d1-4e2c-88d1-5014aa548d65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_afcd5201-d7c1-4d07-bbdb-ba7975196926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_afcd5201-d7c1-4d07-bbdb-ba7975196926" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_6031017b-bb7b-4047-aa0d-e5ebf01f30ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_6031017b-bb7b-4047-aa0d-e5ebf01f30ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations_0537b177-4548-460a-8ce0-3943ba44ac7e" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations_0537b177-4548-460a-8ce0-3943ba44ac7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_3e6f4ed2-1e04-4377-a552-fec8822de349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_3e6f4ed2-1e04-4377-a552-fec8822de349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_78bae701-e40c-4fb2-8e09-8a9062557613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_78bae701-e40c-4fb2-8e09-8a9062557613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2a7db41f-689d-46a8-9d68-def6dd76a67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2a7db41f-689d-46a8-9d68-def6dd76a67b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact_2248cc91-9c6a-4189-9453-f177f2779034" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact_2248cc91-9c6a-4189-9453-f177f2779034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationCARESAct_743e9f75-3b99-4dae-a1cc-9db60e709941" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationCARESAct"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationCARESAct_743e9f75-3b99-4dae-a1cc-9db60e709941" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_e0bd8b82-d79c-45f1-a84c-f0197f511431" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_e0bd8b82-d79c-45f1-a84c-f0197f511431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_323eeaa6-b513-4130-bfd7-f2827a443db5" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_323eeaa6-b513-4130-bfd7-f2827a443db5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_b63998bc-403a-4ee4-8e06-35d86c204d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_b63998bc-403a-4ee4-8e06-35d86c204d0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation_b6803111-cb60-475d-93e6-8702d395b763" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation_b6803111-cb60-475d-93e6-8702d395b763" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment_94ea6e84-9aab-4b5f-ad92-7114a02147c9" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment_94ea6e84-9aab-4b5f-ad92-7114a02147c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes_56c3c423-f190-4228-9049-ab78e5cc91f4" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes_56c3c423-f190-4228-9049-ab78e5cc91f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements_a18247df-6824-477f-98e0-29e157ac7990" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements_a18247df-6824-477f-98e0-29e157ac7990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection_b8a6fa63-080d-446c-8221-6d4265e96e79" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection_b8a6fa63-080d-446c-8221-6d4265e96e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod_4c5bbf86-fc8d-4441-812b-33ff0a5dcff5" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod_4c5bbf86-fc8d-4441-812b-33ff0a5dcff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4d1fb9b1-ae43-46a7-90af-1f56d560f26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_aa340542-4126-4060-a59c-d864fe9bbeba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4d1fb9b1-ae43-46a7-90af-1f56d560f26b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_8e353616-75e4-45d2-b3ef-b63088e07727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_15972b7a-6228-456c-af1a-6d5701142292" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8e353616-75e4-45d2-b3ef-b63088e07727" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_15972b7a-6228-456c-af1a-6d5701142292" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_19732bb0-9668-4d4c-b785-bef588e28b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8e353616-75e4-45d2-b3ef-b63088e07727" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_19732bb0-9668-4d4c-b785-bef588e28b78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e447c7cf-f293-425c-91f9-3128f7eb910e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_6b13f0a3-41e9-4f95-b03d-cc325b4eaef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e447c7cf-f293-425c-91f9-3128f7eb910e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_6b13f0a3-41e9-4f95-b03d-cc325b4eaef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxLeaseLiability_2fec98ac-ccf6-4e36-a0ef-271e5ca565b7" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e447c7cf-f293-425c-91f9-3128f7eb910e" xlink:to="loc_mygn_DeferredTaxLeaseLiability_2fec98ac-ccf6-4e36-a0ef-271e5ca565b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d62a8e41-0eaf-4429-953c-5e59a89e4e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e447c7cf-f293-425c-91f9-3128f7eb910e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d62a8e41-0eaf-4429-953c-5e59a89e4e7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_758ce157-b70a-4a29-b386-cc3b9e215b97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e447c7cf-f293-425c-91f9-3128f7eb910e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_758ce157-b70a-4a29-b386-cc3b9e215b97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_0fc24e55-a3e2-4af3-9684-31f070b9b586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_92eb3a6b-cbb0-443e-99d8-e62cc504f95a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_0fc24e55-a3e2-4af3-9684-31f070b9b586" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_92eb3a6b-cbb0-443e-99d8-e62cc504f95a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_b5c5afe5-3ce3-42b7-8495-799083212b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_0fc24e55-a3e2-4af3-9684-31f070b9b586" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_b5c5afe5-3ce3-42b7-8495-799083212b27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7317e786-5495-4120-a562-09c60955a945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7317e786-5495-4120-a562-09c60955a945" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_c22d019e-3329-4ad0-a864-5a7c5e426126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_c22d019e-3329-4ad0-a864-5a7c5e426126" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_a68e9da7-7419-4c88-b874-b445851a8f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_a68e9da7-7419-4c88-b874-b445851a8f99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_6ec6154d-a209-430c-90ac-29a5833c0bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_6ec6154d-a209-430c-90ac-29a5833c0bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_139a3411-fda7-4758-9065-e0c8683a3b51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_139a3411-fda7-4758-9065-e0c8683a3b51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_401f6d29-a5b6-4854-9b31-da1c5c810540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_401f6d29-a5b6-4854-9b31-da1c5c810540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxAssetsLeaseRightOfUseAsset_8eb2621f-5129-4ba4-b5d5-380289525eb4" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxAssetsLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_mygn_DeferredTaxAssetsLeaseRightOfUseAsset_8eb2621f-5129-4ba4-b5d5-380289525eb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxAssetsUncertainStateTaxPositions_7747e5ec-8c8e-498c-8e69-a9a8daa7f6c3" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxAssetsUncertainStateTaxPositions"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_mygn_DeferredTaxAssetsUncertainStateTaxPositions_7747e5ec-8c8e-498c-8e69-a9a8daa7f6c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_df5da150-8e57-451b-af81-1979682d93dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c16b7fd7-a4ac-461a-8970-8628636af20a" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_df5da150-8e57-451b-af81-1979682d93dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mygn-20201231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/Leases" xlink:type="simple" xlink:href="mygn-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_365ba719-99f4-4b3a-9a01-4260ffb0ca7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9e36d698-4b25-4320-b4bc-f1c7399d8a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_365ba719-99f4-4b3a-9a01-4260ffb0ca7c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9e36d698-4b25-4320-b4bc-f1c7399d8a51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7ba63d65-d09a-4c22-b3d9-7857eee5f2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_365ba719-99f4-4b3a-9a01-4260ffb0ca7c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7ba63d65-d09a-4c22-b3d9-7857eee5f2c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_99ffdbd3-437a-4884-bb33-34e545128efa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_54ad53af-101f-462a-8d51-c775d09a96b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_99ffdbd3-437a-4884-bb33-34e545128efa" xlink:to="loc_us-gaap_OperatingLeaseLiability_54ad53af-101f-462a-8d51-c775d09a96b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_28ab825a-2c4e-4986-a612-d37130881fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_99ffdbd3-437a-4884-bb33-34e545128efa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_28ab825a-2c4e-4986-a612-d37130881fd8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b4663b-aa37-4a36-b5d5-705c4e7575ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_01c8dc47-0393-4aeb-8191-e70bb92617db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b4663b-aa37-4a36-b5d5-705c4e7575ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_01c8dc47-0393-4aeb-8191-e70bb92617db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6aaf3b99-d07a-44ef-af41-41a8f5adc00d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b4663b-aa37-4a36-b5d5-705c4e7575ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6aaf3b99-d07a-44ef-af41-41a8f5adc00d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a8549e80-624b-4b10-8251-38b39b59a2b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b4663b-aa37-4a36-b5d5-705c4e7575ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a8549e80-624b-4b10-8251-38b39b59a2b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ff62cb30-8b5e-4f00-a1cd-1d82b5c22636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b4663b-aa37-4a36-b5d5-705c4e7575ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ff62cb30-8b5e-4f00-a1cd-1d82b5c22636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7408251f-bc5e-44fb-9d7f-065b1546567b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b4663b-aa37-4a36-b5d5-705c4e7575ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7408251f-bc5e-44fb-9d7f-065b1546567b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f0e29bcf-174b-4b93-8a95-6061f638a32c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b4663b-aa37-4a36-b5d5-705c4e7575ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f0e29bcf-174b-4b93-8a95-6061f638a32c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlan" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlan"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlan" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanContributionstoPlanDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformation"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb4f6d2f-241c-4eac-9074-7171194b03d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_58b691db-1eb9-4ed6-8d00-2c943ae4b311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb4f6d2f-241c-4eac-9074-7171194b03d9" xlink:to="loc_us-gaap_OperatingIncomeLoss_58b691db-1eb9-4ed6-8d00-2c943ae4b311" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6c14fb9b-43ad-4546-9e43-e34cd145e51c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb4f6d2f-241c-4eac-9074-7171194b03d9" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6c14fb9b-43ad-4546-9e43-e34cd145e51c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6808f6b7-5188-480b-92c9-51a7f80747f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb4f6d2f-241c-4eac-9074-7171194b03d9" xlink:to="loc_us-gaap_InterestExpense_6808f6b7-5188-480b-92c9-51a7f80747f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d21adcf4-1106-4314-8df3-c2c14d568b80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb4f6d2f-241c-4eac-9074-7171194b03d9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d21adcf4-1106-4314-8df3-c2c14d568b80" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationAssetsbyGeographicalRegionDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationRevenuebyGeographicalRegionDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SaleofSubsidiary" xlink:type="simple" xlink:href="mygn-20201231.xsd#SaleofSubsidiary"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SaleofSubsidiary" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SaleofSubsidiaryDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SaleofSubsidiaryDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SaleofSubsidiaryDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitions" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitions"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitions" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsTotalConsiderationTransferredDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_4e3d52c7-c177-40ed-8a9c-852cfa2b7468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_4e3d52c7-c177-40ed-8a9c-852cfa2b7468" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7b25f7b9-cdc5-401f-8af6-83cc548dc2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7b25f7b9-cdc5-401f-8af6-83cc548dc2cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_5adc3abd-4fc9-4565-a333-eb93c76ad94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_5adc3abd-4fc9-4565-a333-eb93c76ad94d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_58ff1136-4020-4a14-8656-7e20bb0f219d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_58ff1136-4020-4a14-8656-7e20bb0f219d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eb1aa0d9-c8db-452d-a820-018e8e377abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:to="loc_us-gaap_Goodwill_eb1aa0d9-c8db-452d-a820-018e8e377abe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_22bcf7c7-18c0-408e-b68d-919d2d83726f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_22bcf7c7-18c0-408e-b68d-919d2d83726f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4e1d0758-1157-4f0a-a14e-bc127d000fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4e1d0758-1157-4f0a-a14e-bc127d000fe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f1a91d13-b010-4833-bda0-c23d7774e19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0e56d089-d8c0-4519-ae52-33ab2e510dcf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f1a91d13-b010-4833-bda0-c23d7774e19a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsChangestoGoodwillBalanceDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsProFormaResultsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEvent" xlink:type="simple" xlink:href="mygn-20201231.xsd#SubsequentEvent"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SubsequentEvent" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SubsequentEventDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SubsequentEventDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformation"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformationTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnaudited"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnaudited"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnauditedTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnauditedDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>mygn-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efa3350f-b8a9-4fda-9dc1-67977795f671,g:9ff9af07-fed3-4eeb-865c-11c477b6a054-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.myriad.com/role/Cover" xlink:type="simple" xlink:href="mygn-20201231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/Cover" xlink:type="extended" id="i973dac5a5f5c41c6a2137374aceb36af_Cover"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i70e938f590da4715ad43aca7b2025483_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i1f6f19e7f9284f29b1a37981de286a9b_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i6f55cd98c14749dc8c061df9b7ab47f3_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_79319d9a-cab6-4244-b37b-50eab34c9c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_79319d9a-cab6-4244-b37b-50eab34c9c09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_df590817-3c06-41be-9a4d-05b0546f0209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_df590817-3c06-41be-9a4d-05b0546f0209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c7c198d3-8325-468f-8b44-c210dc70916c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c7c198d3-8325-468f-8b44-c210dc70916c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8b378ebf-638d-4a1b-aa74-6e9235f53d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8b378ebf-638d-4a1b-aa74-6e9235f53d4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_817a4702-bb82-4c9c-bb8f-c7ee3a4154da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_817a4702-bb82-4c9c-bb8f-c7ee3a4154da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d3861041-bf63-4794-949d-ce4b25d0dff1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d3861041-bf63-4794-949d-ce4b25d0dff1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_59b6f985-1e8d-4465-a204-54742c879908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_CostsAndExpenses_59b6f985-1e8d-4465-a204-54742c879908" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bed4810f-719c-4675-a7d8-9944313a1e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_OperatingIncomeLoss_bed4810f-719c-4675-a7d8-9944313a1e39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_78db6040-647a-4da0-990a-033fe3341f32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:to="loc_us-gaap_InvestmentIncomeInterest_78db6040-647a-4da0-990a-033fe3341f32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e8e900c1-3a41-4450-b3ec-0b531fc52893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:to="loc_us-gaap_InterestExpense_e8e900c1-3a41-4450-b3ec-0b531fc52893" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e8d85a6a-7367-43e5-bc60-0e45d50f82c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e8d85a6a-7367-43e5-bc60-0e45d50f82c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_915ad46e-e25f-4733-9457-8ebfc07ec933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_915ad46e-e25f-4733-9457-8ebfc07ec933" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ba6c8669-4060-466a-8ef0-1a6c6a33ad31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ba6c8669-4060-466a-8ef0-1a6c6a33ad31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5202b682-5113-40d6-816b-d139433c1855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5202b682-5113-40d6-816b-d139433c1855" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_19742106-af61-4ace-a9bc-c10418117dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_ProfitLoss_19742106-af61-4ace-a9bc-c10418117dd8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4112a0d-3510-4544-9d07-96821981969f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4112a0d-3510-4544-9d07-96821981969f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e1ffe90a-bdf1-483f-bb07-a69d4bfc3e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_NetIncomeLoss_e1ffe90a-bdf1-483f-bb07-a69d4bfc3e3b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd1b00b7-086b-47ac-938d-0494c52b8adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd1b00b7-086b-47ac-938d-0494c52b8adb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_97724b64-bbd0-440e-a514-b574e1bdc397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd1b00b7-086b-47ac-938d-0494c52b8adb" xlink:to="loc_us-gaap_EarningsPerShareBasic_97724b64-bbd0-440e-a514-b574e1bdc397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c508bbf5-006d-4d83-b295-b13e47778700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd1b00b7-086b-47ac-938d-0494c52b8adb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c508bbf5-006d-4d83-b295-b13e47778700" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d606cc00-7830-4732-be14-d7e25abc7d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d606cc00-7830-4732-be14-d7e25abc7d53" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7681551c-48b6-43ca-9639-430f5574e69c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d606cc00-7830-4732-be14-d7e25abc7d53" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7681551c-48b6-43ca-9639-430f5574e69c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af51f7d8-20ac-4e58-99d4-4ac16bc726a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d606cc00-7830-4732-be14-d7e25abc7d53" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af51f7d8-20ac-4e58-99d4-4ac16bc726a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2bb1a5c8-fb3c-4ed3-b8d4-a2bf49524b17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_StatementTable_2bb1a5c8-fb3c-4ed3-b8d4-a2bf49524b17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_56826c73-7cf7-4790-97c8-423ccea74ec6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2bb1a5c8-fb3c-4ed3-b8d4-a2bf49524b17" xlink:to="loc_srt_ProductOrServiceAxis_56826c73-7cf7-4790-97c8-423ccea74ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_56826c73-7cf7-4790-97c8-423ccea74ec6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_56826c73-7cf7-4790-97c8-423ccea74ec6" xlink:to="loc_srt_ProductsAndServicesDomain_56826c73-7cf7-4790-97c8-423ccea74ec6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3640236d-efd9-4695-834f-1e986f5038d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_56826c73-7cf7-4790-97c8-423ccea74ec6" xlink:to="loc_srt_ProductsAndServicesDomain_3640236d-efd9-4695-834f-1e986f5038d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_74bec684-75ab-41c7-ab0f-c0bb19771764" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3640236d-efd9-4695-834f-1e986f5038d4" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_74bec684-75ab-41c7-ab0f-c0bb19771764" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_0b5e6c57-9396-4680-932b-749508655571" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3640236d-efd9-4695-834f-1e986f5038d4" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_0b5e6c57-9396-4680-932b-749508655571" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="ifb7e01366dcd4df5ae90677ec3f6f0fe_ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="if906b2f20bb248549a9f461bc66eb6e1_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3be0949c-fd72-4117-bcd7-76b1cb32bff9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3be0949c-fd72-4117-bcd7-76b1cb32bff9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c2a8e23c-d053-4392-96f5-13a71e0fa68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c2a8e23c-d053-4392-96f5-13a71e0fa68a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f3be882c-ae16-4296-8d92-d1a78b43e61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f3be882c-ae16-4296-8d92-d1a78b43e61d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5820c395-0df3-45ee-9ad0-785e148cb12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5820c395-0df3-45ee-9ad0-785e148cb12a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_565b4326-1f58-42db-9c32-bb41305a9567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_NetIncomeLoss_565b4326-1f58-42db-9c32-bb41305a9567" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary_5e4e820f-4632-40d7-a46f-c51372f828e4" xlink:href="mygn-20201231.xsd#mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary_5e4e820f-4632-40d7-a46f-c51372f828e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_33a3f704-1c57-42c2-ae77-9352eecdb557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_33a3f704-1c57-42c2-ae77-9352eecdb557" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a0683ad8-b839-4bcb-bf1b-08519f2a9f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cd8a8503-c1e7-4312-93da-cd8134c4b891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_StatementTable_cd8a8503-c1e7-4312-93da-cd8134c4b891" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cd8a8503-c1e7-4312-93da-cd8134c4b891" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba" xlink:to="loc_us-gaap_EquityComponentDomain_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba" xlink:to="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ae72cf57-c744-4a53-8879-177174bad59f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:to="loc_us-gaap_CommonStockMember_ae72cf57-c744-4a53-8879-177174bad59f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f1449102-1a9c-4428-b77e-a974861fd038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f1449102-1a9c-4428-b77e-a974861fd038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_499156cb-d439-4949-9200-b9cd36bb53a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_499156cb-d439-4949-9200-b9cd36bb53a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c62aba39-351b-4ffd-bd1e-6f1815e4815a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:to="loc_us-gaap_RetainedEarningsMember_c62aba39-351b-4ffd-bd1e-6f1815e4815a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i57d7cb62e90245ebbffb8079208a158a_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="extended" id="i8cdbb2e64fef434c91ffdb72a49d268b_OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="ia38c7ecd94bb4faebae0254803750041_OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="ia431f66781cb4d74aeebb1b54ecaec1f_OrganizationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i4d572b738590464298db946319087718_OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:href="mygn-20201231.xsd#mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_896593ea-e5aa-4ef3-b546-b137a8a36dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_896593ea-e5aa-4ef3-b546-b137a8a36dbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_6ec6659a-eec1-4edf-9f4f-28784a10fea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_6ec6659a-eec1-4edf-9f4f-28784a10fea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_39ad28bf-b1af-4b57-a68c-d7bfcc239610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_39ad28bf-b1af-4b57-a68c-d7bfcc239610" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CARESActOf2020MedicarePaymentAmount_87949f5e-5cfe-46cc-8b96-5520d52772ad" xlink:href="mygn-20201231.xsd#mygn_CARESActOf2020MedicarePaymentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_mygn_CARESActOf2020MedicarePaymentAmount_87949f5e-5cfe-46cc-8b96-5520d52772ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_af8ff11d-da0d-4247-b8c4-8463f9370730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_af8ff11d-da0d-4247-b8c4-8463f9370730" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_a9a40aac-7abd-4570-8f38-8a198876de62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_a9a40aac-7abd-4570-8f38-8a198876de62" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInEarningsLossPerShare_9e6f155b-b37b-4697-85f8-72e8ba439b35" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInEarningsLossPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_mygn_IncreaseDecreaseInEarningsLossPerShare_9e6f155b-b37b-4697-85f8-72e8ba439b35" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c38d47cb-87a9-4e33-a566-fad5e52df999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c38d47cb-87a9-4e33-a566-fad5e52df999" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d35e065-ef15-4249-ab2a-3448bb718889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d35e065-ef15-4249-ab2a-3448bb718889" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross_5f274855-f45a-4812-ac65-bc152f7de07a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_CapitalizedContractCostGross_5f274855-f45a-4812-ac65-bc152f7de07a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CARESActOf2020ProviderReliefFundAmount_2184d4e8-3280-446e-9d8d-705a36069fbf" xlink:href="mygn-20201231.xsd#mygn_CARESActOf2020ProviderReliefFundAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_mygn_CARESActOf2020ProviderReliefFundAmount_2184d4e8-3280-446e-9d8d-705a36069fbf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:href="mygn-20201231.xsd#mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_32e46da9-38fc-47cf-b81b-38e2cd875ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_32e46da9-38fc-47cf-b81b-38e2cd875ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_32e46da9-38fc-47cf-b81b-38e2cd875ac3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_32e46da9-38fc-47cf-b81b-38e2cd875ac3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_32e46da9-38fc-47cf-b81b-38e2cd875ac3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_336e3044-379d-438b-9e01-ef33019ac018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_32e46da9-38fc-47cf-b81b-38e2cd875ac3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_336e3044-379d-438b-9e01-ef33019ac018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractsConcentrationRiskMember_23a6d1a4-caa8-4473-bb59-47d8e0317acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GovernmentContractsConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_336e3044-379d-438b-9e01-ef33019ac018" xlink:to="loc_us-gaap_GovernmentContractsConcentrationRiskMember_23a6d1a4-caa8-4473-bb59-47d8e0317acb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9aadc3e1-3019-41af-857f-fec00e84f851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9aadc3e1-3019-41af-857f-fec00e84f851" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9aadc3e1-3019-41af-857f-fec00e84f851_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9aadc3e1-3019-41af-857f-fec00e84f851" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9aadc3e1-3019-41af-857f-fec00e84f851_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5e2b749-ac5f-4daa-ac33-fad022fbcae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9aadc3e1-3019-41af-857f-fec00e84f851" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5e2b749-ac5f-4daa-ac33-fad022fbcae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_9fc94468-9494-40d3-97a0-d633ee8e45c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5e2b749-ac5f-4daa-ac33-fad022fbcae5" xlink:to="loc_us-gaap_SalesRevenueNetMember_9fc94468-9494-40d3-97a0-d633ee8e45c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd17313e-1a1f-48ae-915e-5999cbe83bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd17313e-1a1f-48ae-915e-5999cbe83bbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_e058b4b8-a02b-4727-8f5f-647bd8a8448b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd17313e-1a1f-48ae-915e-5999cbe83bbb" xlink:to="loc_us-gaap_EquipmentMember_e058b4b8-a02b-4727-8f5f-647bd8a8448b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_16bd6a6d-c69c-4c75-a81c-cb40f9a6e3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd17313e-1a1f-48ae-915e-5999cbe83bbb" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_16bd6a6d-c69c-4c75-a81c-cb40f9a6e3f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a728ee6b-a791-4ee4-b0cd-430e5e45e25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a728ee6b-a791-4ee4-b0cd-430e5e45e25c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_a728ee6b-a791-4ee4-b0cd-430e5e45e25c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a728ee6b-a791-4ee4-b0cd-430e5e45e25c" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_a728ee6b-a791-4ee4-b0cd-430e5e45e25c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_b954ce68-6e82-471b-bc5b-e88c3a160e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a728ee6b-a791-4ee4-b0cd-430e5e45e25c" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_b954ce68-6e82-471b-bc5b-e88c3a160e23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PerformanceObligationEstimatedTransactionPriceMember_62a14760-8c10-455c-8f04-00ae578db09c" xlink:href="mygn-20201231.xsd#mygn_PerformanceObligationEstimatedTransactionPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_b954ce68-6e82-471b-bc5b-e88c3a160e23" xlink:to="loc_mygn_PerformanceObligationEstimatedTransactionPriceMember_62a14760-8c10-455c-8f04-00ae578db09c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_8c752fc5-c2b9-4850-adbe-5b0f52da76bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_srt_RestatementAxis_8c752fc5-c2b9-4850-adbe-5b0f52da76bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_8c752fc5-c2b9-4850-adbe-5b0f52da76bb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_8c752fc5-c2b9-4850-adbe-5b0f52da76bb" xlink:to="loc_srt_RestatementDomain_8c752fc5-c2b9-4850-adbe-5b0f52da76bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0d843c14-6159-431d-b128-c0c4bffbc2de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_8c752fc5-c2b9-4850-adbe-5b0f52da76bb" xlink:to="loc_srt_RestatementDomain_0d843c14-6159-431d-b128-c0c4bffbc2de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_c56f69c3-afb7-45c2-9362-8211007fa2d2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_0d843c14-6159-431d-b128-c0c4bffbc2de" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_c56f69c3-afb7-45c2-9362-8211007fa2d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a09e0283-34b3-4b72-82df-f8b3133b4957" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_srt_RangeAxis_a09e0283-34b3-4b72-82df-f8b3133b4957" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a09e0283-34b3-4b72-82df-f8b3133b4957_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a09e0283-34b3-4b72-82df-f8b3133b4957" xlink:to="loc_srt_RangeMember_a09e0283-34b3-4b72-82df-f8b3133b4957_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c50fc93f-0b34-45fb-8010-053e5dd6a392" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a09e0283-34b3-4b72-82df-f8b3133b4957" xlink:to="loc_srt_RangeMember_c50fc93f-0b34-45fb-8010-053e5dd6a392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_45f70eec-42ec-45bd-91d9-46771a68914b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c50fc93f-0b34-45fb-8010-053e5dd6a392" xlink:to="loc_srt_MinimumMember_45f70eec-42ec-45bd-91d9-46771a68914b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6e1cf1d1-a5ef-4f91-926c-e51c9a0b06a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c50fc93f-0b34-45fb-8010-053e5dd6a392" xlink:to="loc_srt_MaximumMember_6e1cf1d1-a5ef-4f91-926c-e51c9a0b06a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0ab99d79-7d68-47be-85ef-4d2bd2e0e153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0ab99d79-7d68-47be-85ef-4d2bd2e0e153" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0ab99d79-7d68-47be-85ef-4d2bd2e0e153_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0ab99d79-7d68-47be-85ef-4d2bd2e0e153" xlink:to="loc_us-gaap_SegmentDomain_0ab99d79-7d68-47be-85ef-4d2bd2e0e153_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6fd003f-3553-4b4d-bafa-f714dca74ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0ab99d79-7d68-47be-85ef-4d2bd2e0e153" xlink:to="loc_us-gaap_SegmentDomain_b6fd003f-3553-4b4d-bafa-f714dca74ce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_73484f27-e9a5-4ead-a4ab-80ae7d21f747" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b6fd003f-3553-4b4d-bafa-f714dca74ce3" xlink:to="loc_mygn_DiagnosticMember_73484f27-e9a5-4ead-a4ab-80ae7d21f747" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails" xlink:type="extended" id="i11384ae9e5e24268a688b49f396997aa_OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2103a2e5-bbcf-4c70-ae42-e244a15d2b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d4df8e8-445e-42ea-9787-c69ca2ad7341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2103a2e5-bbcf-4c70-ae42-e244a15d2b91" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d4df8e8-445e-42ea-9787-c69ca2ad7341" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bfd34280-cb00-4545-851c-eb1356187d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2103a2e5-bbcf-4c70-ae42-e244a15d2b91" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bfd34280-cb00-4545-851c-eb1356187d6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bfd34280-cb00-4545-851c-eb1356187d6c" xlink:to="loc_srt_ProductOrServiceAxis_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67" xlink:to="loc_srt_ProductsAndServicesDomain_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b192e3db-b24f-451c-9b17-11b3473758dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67" xlink:to="loc_srt_ProductsAndServicesDomain_b192e3db-b24f-451c-9b17-11b3473758dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b192e3db-b24f-451c-9b17-11b3473758dc" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember_152aab34-1343-41eb-ad44-7a345734491e" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticHereditaryCancerTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember_152aab34-1343-41eb-ad44-7a345734491e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticGenesightTestingMember_ae1096b1-9099-4d48-89e5-e089d285b945" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticGenesightTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticGenesightTestingMember_ae1096b1-9099-4d48-89e5-e089d285b945" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticPrenatalTestingMember_187ad384-839f-4a01-9534-838047445ef6" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticPrenatalTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticPrenatalTestingMember_187ad384-839f-4a01-9534-838047445ef6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticVectraTestingMember_171b10a6-6613-4cdc-accd-3186904cfe0a" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticVectraTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticVectraTestingMember_171b10a6-6613-4cdc-accd-3186904cfe0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticMyChoiceCDxMember_f7f6d7f2-f75c-4a44-9126-6ac334be1b32" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticMyChoiceCDxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticMyChoiceCDxMember_f7f6d7f2-f75c-4a44-9126-6ac334be1b32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticProlarisTestingMember_0d026f96-2129-4989-b3b2-8d8b7184d2c9" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticProlarisTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticProlarisTestingMember_0d026f96-2129-4989-b3b2-8d8b7184d2c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticEndoPredictTestingMember_1665b5c9-b8c4-4a80-8340-b054a776014b" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticEndoPredictTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticEndoPredictTestingMember_1665b5c9-b8c4-4a80-8340-b054a776014b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticOtherTestingMember_b92e92e6-d4d6-41d0-bb17-10c8c5cbb857" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticOtherTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticOtherTestingMember_b92e92e6-d4d6-41d0-bb17-10c8c5cbb857" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_4676ab84-500f-4752-a146-7e74f028dcc0" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b192e3db-b24f-451c-9b17-11b3473758dc" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_4676ab84-500f-4752-a146-7e74f028dcc0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails" xlink:type="extended" id="i0ee876b1f14749c9b56593d2935c39e7_OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended" id="ifaaadd46452e4634966cac3d477faf03_OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails" xlink:type="extended" id="ia80b48a5b6a24d248087d048036a4375_OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecurities"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="extended" id="i82eeadef8887465eaef12a24775f7d9c_MarketableInvestmentSecurities"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="extended" id="id81e12e3cf06421c9c12cd51de198598_MarketableInvestmentSecuritiesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="extended" id="i976859025bbd430c94ddf86b7a2656ee_MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_e9836743-7270-47a1-9bee-af35e6e8a13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_e9836743-7270-47a1-9bee-af35e6e8a13e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8673244c-7243-4162-b6e9-481c715ef109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_e9836743-7270-47a1-9bee-af35e6e8a13e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8673244c-7243-4162-b6e9-481c715ef109" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_352c1b29-095d-4a0e-a8ec-2f43ed3ac758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_e9836743-7270-47a1-9bee-af35e6e8a13e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_352c1b29-095d-4a0e-a8ec-2f43ed3ac758" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_75c1836b-8742-4738-b1aa-560a17d78e96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_75c1836b-8742-4738-b1aa-560a17d78e96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_df03a4b9-f507-4572-afa5-899661165f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_df03a4b9-f507-4572-afa5-899661165f34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_139816ae-72fd-4c38-a85e-9e4bb2aba0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_139816ae-72fd-4c38-a85e-9e4bb2aba0b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3e38d0aa-0263-44b7-8d52-206a5de5c42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3e38d0aa-0263-44b7-8d52-206a5de5c42a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCashAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:to="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_a6dc6395-272b-4452-a9c7-9fc02fb90d95" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:to="loc_mygn_InvestmentsAndCashAmortizedCost_a6dc6395-272b-4452-a9c7-9fc02fb90d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_234b1177-45c2-43b9-afa7-e8780b41bc2d" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_234b1177-45c2-43b9-afa7-e8780b41bc2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_19750f32-3cfe-4d53-9256-b72ed1e4a8d9" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_19750f32-3cfe-4d53-9256-b72ed1e4a8d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_0c1c2a90-442d-463a-b6e6-58552740392b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:to="loc_us-gaap_InvestmentsAndCash_0c1c2a90-442d-463a-b6e6-58552740392b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_00a62dfe-0cb4-4534-b475-c62f47916564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:to="loc_us-gaap_InvestmentTypeAxis_00a62dfe-0cb4-4534-b475-c62f47916564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_00a62dfe-0cb4-4534-b475-c62f47916564_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_00a62dfe-0cb4-4534-b475-c62f47916564" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_00a62dfe-0cb4-4534-b475-c62f47916564_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_00a62dfe-0cb4-4534-b475-c62f47916564" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_21e6493c-e3b0-41f4-971d-5e767bbde17c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_21e6493c-e3b0-41f4-971d-5e767bbde17c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_1a7c2a0a-8770-4043-a833-ba8c29b706eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:to="loc_us-gaap_MunicipalBondsMember_1a7c2a0a-8770-4043-a833-ba8c29b706eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_26649ad5-7407-4f72-b5e3-58fe255e727b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_26649ad5-7407-4f72-b5e3-58fe255e727b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fd87c50a-e1bb-4eac-ab23-2ea8a060fbb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fd87c50a-e1bb-4eac-ab23-2ea8a060fbb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_e121fe9d-77df-4daf-ac0c-efc191936763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_e121fe9d-77df-4daf-ac0c-efc191936763" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e121fe9d-77df-4daf-ac0c-efc191936763_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_e121fe9d-77df-4daf-ac0c-efc191936763" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e121fe9d-77df-4daf-ac0c-efc191936763_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2394f80-6810-45dc-9d79-6bc959f865b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_e121fe9d-77df-4daf-ac0c-efc191936763" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2394f80-6810-45dc-9d79-6bc959f865b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_35bcbace-feeb-4135-9447-d8a7b547123e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2394f80-6810-45dc-9d79-6bc959f865b7" xlink:to="loc_us-gaap_CashMember_35bcbace-feeb-4135-9447-d8a7b547123e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_783bd6f9-22d4-4bfa-8144-c1c98d05402a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2394f80-6810-45dc-9d79-6bc959f865b7" xlink:to="loc_us-gaap_CashEquivalentsMember_783bd6f9-22d4-4bfa-8144-c1c98d05402a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="extended" id="ifd570ead9cf74ac2b99d77406593d727_MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ea5b4228-f403-474c-b211-b349c56f5adf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ea5b4228-f403-474c-b211-b349c56f5adf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8884d751-73d1-4c95-a143-e23e13ecbe91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8884d751-73d1-4c95-a143-e23e13ecbe91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5a767299-816a-4cc6-b3ae-619a81edc3c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5a767299-816a-4cc6-b3ae-619a81edc3c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_78b81e38-3169-4d63-93b5-4153e14e0782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_78b81e38-3169-4d63-93b5-4153e14e0782" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c030b011-4937-426b-a104-801aff7c3b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c030b011-4937-426b-a104-801aff7c3b53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_5132ed1f-2934-409b-a211-552c8c52ef47" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_mygn_InvestmentsAndCashAmortizedCost_5132ed1f-2934-409b-a211-552c8c52ef47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ea5b4228-f403-474c-b211-b349c56f5adf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1f7a0772-5c72-462a-9ed8-f0e90e0615f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1f7a0772-5c72-462a-9ed8-f0e90e0615f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_b3725033-db2b-484b-9e33-cbbe56baf438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_b3725033-db2b-484b-9e33-cbbe56baf438" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_4b623b53-9a70-4738-bdd5-f79f0a713841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_4b623b53-9a70-4738-bdd5-f79f0a713841" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_78bc4d3b-744e-4c56-a217-a9a3a87927ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_78bc4d3b-744e-4c56-a217-a9a3a87927ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_99354ebe-8eb5-41b6-ad1a-3a31fc630b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_InvestmentsAndCash_99354ebe-8eb5-41b6-ad1a-3a31fc630b73" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_fe9e3122-fa07-4dc7-8d27-714180f620d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ea5b4228-f403-474c-b211-b349c56f5adf" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_fe9e3122-fa07-4dc7-8d27-714180f620d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_fe9e3122-fa07-4dc7-8d27-714180f620d3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5c406756-e8f5-4e93-9f21-db773fa6d9c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5c406756-e8f5-4e93-9f21-db773fa6d9c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_b9edac2b-95a5-4dfb-8fff-129b234a6ff1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5c406756-e8f5-4e93-9f21-db773fa6d9c5" xlink:to="loc_us-gaap_CashMember_b9edac2b-95a5-4dfb-8fff-129b234a6ff1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_c5030e5c-3135-4f9f-a7bb-512637dc8be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5c406756-e8f5-4e93-9f21-db773fa6d9c5" xlink:to="loc_us-gaap_CashEquivalentsMember_c5030e5c-3135-4f9f-a7bb-512637dc8be4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails" xlink:type="extended" id="i2eae8cffbc49473cac8d5b4ed1fd38d0_MarketableInvestmentSecuritiesNarrativeDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurements" xlink:type="extended" id="ibee8e1d3e7f7404fb9087bee7e2ee68e_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i3f3614e6c0e7473bbdc608d6a046770b_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i59bb8e0521524ab7854ed20130c29750_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3e871dea-48df-43e2-a4b8-978a93c7eb6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_50f8625d-ffb1-45f4-b635-e23ddf13f43a" xlink:href="mygn-20201231.xsd#mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3e871dea-48df-43e2-a4b8-978a93c7eb6a" xlink:to="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_50f8625d-ffb1-45f4-b635-e23ddf13f43a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_cf8eea77-4215-4f4c-95bf-45fdaeb4517f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3e871dea-48df-43e2-a4b8-978a93c7eb6a" xlink:to="loc_us-gaap_LongTermDebtFairValue_cf8eea77-4215-4f4c-95bf-45fdaeb4517f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3e871dea-48df-43e2-a4b8-978a93c7eb6a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb742a79-8e23-4807-bc40-8965e34bb187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb742a79-8e23-4807-bc40-8965e34bb187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb742a79-8e23-4807-bc40-8965e34bb187_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb742a79-8e23-4807-bc40-8965e34bb187" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb742a79-8e23-4807-bc40-8965e34bb187_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32a3a9c2-ccc1-4dd1-8998-0fe7850eac34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb742a79-8e23-4807-bc40-8965e34bb187" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32a3a9c2-ccc1-4dd1-8998-0fe7850eac34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3404115d-5336-4f55-858d-709d28ace939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32a3a9c2-ccc1-4dd1-8998-0fe7850eac34" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3404115d-5336-4f55-858d-709d28ace939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_d9fb39d6-6273-4562-b5ce-d59e4c001feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_d9fb39d6-6273-4562-b5ce-d59e4c001feb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_d9fb39d6-6273-4562-b5ce-d59e4c001feb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_d9fb39d6-6273-4562-b5ce-d59e4c001feb" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_d9fb39d6-6273-4562-b5ce-d59e4c001feb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_eed84904-f1ef-48f4-b9bd-edb0a0f95e72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_d9fb39d6-6273-4562-b5ce-d59e4c001feb" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_eed84904-f1ef-48f4-b9bd-edb0a0f95e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_6929b907-904a-4d4a-9b3f-4a081ad75ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_eed84904-f1ef-48f4-b9bd-edb0a0f95e72" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_6929b907-904a-4d4a-9b3f-4a081ad75ac5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="extended" id="idf7b0ff2c4104e2bb552fbcf9db42eb8_FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c01a61c6-da3a-4dfc-8b03-1cb763766f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c01a61c6-da3a-4dfc-8b03-1cb763766f4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1236a67b-013c-4b75-9ac3-02038326bc36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1236a67b-013c-4b75-9ac3-02038326bc36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_ff0729d9-c512-472f-bc36-005453c3c64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:to="loc_us-gaap_FairValueNetAssetLiability_ff0729d9-c512-472f-bc36-005453c3c64c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_81b7a87a-7136-4ccc-905a-22ff2c220e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_81b7a87a-7136-4ccc-905a-22ff2c220e46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81b7a87a-7136-4ccc-905a-22ff2c220e46_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_81b7a87a-7136-4ccc-905a-22ff2c220e46" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81b7a87a-7136-4ccc-905a-22ff2c220e46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_81b7a87a-7136-4ccc-905a-22ff2c220e46" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3b2682b9-104f-435d-a857-612c0ffb6234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3b2682b9-104f-435d-a857-612c0ffb6234" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d7520b9e-3b78-4644-a43d-48e59b01beda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d7520b9e-3b78-4644-a43d-48e59b01beda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c17a5f77-21e3-4b12-b6fb-cc8c91cc52c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c17a5f77-21e3-4b12-b6fb-cc8c91cc52c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_626df666-01da-47e2-bd31-30d6600ea239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_626df666-01da-47e2-bd31-30d6600ea239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContingentConsiderationMember_2c8c9e92-f4ee-4f2c-bad2-c4283898cf45" xlink:href="mygn-20201231.xsd#mygn_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_626df666-01da-47e2-bd31-30d6600ea239" xlink:to="loc_mygn_ContingentConsiderationMember_2c8c9e92-f4ee-4f2c-bad2-c4283898cf45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_5d40f0bb-8ec2-4aab-94b5-3417bee993aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:to="loc_us-gaap_InvestmentTypeAxis_5d40f0bb-8ec2-4aab-94b5-3417bee993aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_5d40f0bb-8ec2-4aab-94b5-3417bee993aa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_5d40f0bb-8ec2-4aab-94b5-3417bee993aa" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_5d40f0bb-8ec2-4aab-94b5-3417bee993aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_5d40f0bb-8ec2-4aab-94b5-3417bee993aa" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a9942c05-18b8-4df3-b985-7ead90e81378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a9942c05-18b8-4df3-b985-7ead90e81378" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_eb44687b-9489-450e-b7f0-cef5fdee20f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_eb44687b-9489-450e-b7f0-cef5fdee20f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_ace1b407-37d0-444b-a4f7-9296be8a9e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_MunicipalBondsMember_ace1b407-37d0-444b-a4f7-9296be8a9e1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_d0338ef1-02e2-4ae6-b1ed-ffd24bf65d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_d0338ef1-02e2-4ae6-b1ed-ffd24bf65d12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0172f305-dd45-4424-8549-f44d421e0384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0172f305-dd45-4424-8549-f44d421e0384" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="extended" id="i969e6a59d87a4a3c905169b8e749315f_FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNet"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="extended" id="i49f90ae39cf5425db4e06aafd11d843f_PropertyPlantandEquipmentNet"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended" id="i0d061a5088b54910aee347a2f563cf26_PropertyPlantandEquipmentNetTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="extended" id="i55fafb06cdca4c5989e413e4e9263cbc_PropertyPlantandEquipmentNetBalancesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="extended" id="ica79863e44ec4c6c9aa1c5a958ad4720_PropertyPlantandEquipmentNetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c8a7621d-2099-4d6d-89d6-5c0d23e9363c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_602f1937-101f-48e4-bb0f-49d4c7166027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c8a7621d-2099-4d6d-89d6-5c0d23e9363c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_602f1937-101f-48e4-bb0f-49d4c7166027" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6add2543-ce85-450f-8d07-015e0f14c225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c8a7621d-2099-4d6d-89d6-5c0d23e9363c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6add2543-ce85-450f-8d07-015e0f14c225" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d51fc070-b31c-4d26-b013-4f3dc3ef705a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6add2543-ce85-450f-8d07-015e0f14c225" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d51fc070-b31c-4d26-b013-4f3dc3ef705a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d51fc070-b31c-4d26-b013-4f3dc3ef705a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d51fc070-b31c-4d26-b013-4f3dc3ef705a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d51fc070-b31c-4d26-b013-4f3dc3ef705a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3eb8de9d-383d-4e11-bae0-ce68fc090d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d51fc070-b31c-4d26-b013-4f3dc3ef705a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3eb8de9d-383d-4e11-bae0-ce68fc090d0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ClinicAssetGroupMember_5972815e-23c8-408f-ac13-8409e41c82c2" xlink:href="mygn-20201231.xsd#mygn_ClinicAssetGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3eb8de9d-383d-4e11-bae0-ce68fc090d0e" xlink:to="loc_mygn_ClinicAssetGroupMember_5972815e-23c8-408f-ac13-8409e41c82c2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetDepreciationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="extended" id="i95f792d6be9d4c0881e9fd2abe059849_PropertyPlantandEquipmentNetDepreciationExpenseDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="extended" id="iec914383f8384702811aa032359188b4_GoodwillandIntangibleAssets"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended" id="i8f48e7bdf7da4748a88bf9842c5fa0a6_GoodwillandIntangibleAssetsTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="extended" id="i1b18800a83fc4ac6bdcf2bfb6967dfe2_GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2a406ff9-11b1-44e0-8332-d5813faf309e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2a406ff9-11b1-44e0-8332-d5813faf309e" xlink:to="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6e2c566b-6b27-4ef5-801e-2a339fc42aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_Goodwill_6e2c566b-6b27-4ef5-801e-2a339fc42aa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4a0b788c-0ac0-4cc5-8a8a-c1335fd76722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4a0b788c-0ac0-4cc5-8a8a-c1335fd76722" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f65d91ed-9675-43c6-bbd4-c4a01c95f693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f65d91ed-9675-43c6-bbd4-c4a01c95f693" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_5c2d07c6-d72f-42b2-bf24-8d774324ee53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_5c2d07c6-d72f-42b2-bf24-8d774324ee53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ddcc909b-3b1e-421b-ae33-ffc6e392932c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ddcc909b-3b1e-421b-ae33-ffc6e392932c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_fae04037-d32e-4a22-8fad-875d50fd7302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_fae04037-d32e-4a22-8fad-875d50fd7302" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26bc9e77-b168-4b64-9c82-d8bca1395ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5ffbac0f-766d-453c-b302-9c339a1b48f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_2a406ff9-11b1-44e0-8332-d5813faf309e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5ffbac0f-766d-453c-b302-9c339a1b48f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5ffbac0f-766d-453c-b302-9c339a1b48f3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30" xlink:to="loc_us-gaap_SegmentDomain_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_94f94115-d653-46f6-a20a-de86d8c90d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30" xlink:to="loc_us-gaap_SegmentDomain_94f94115-d653-46f6-a20a-de86d8c90d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_226c7bd4-e791-4511-9862-adde733ce68f" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94f94115-d653-46f6-a20a-de86d8c90d9b" xlink:to="loc_mygn_DiagnosticMember_226c7bd4-e791-4511-9862-adde733ce68f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_1636d20e-f834-4bff-bc2e-0235bbf42d62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94f94115-d653-46f6-a20a-de86d8c90d9b" xlink:to="loc_us-gaap_AllOtherSegmentsMember_1636d20e-f834-4bff-bc2e-0235bbf42d62" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i07dc946b10914ee6b8a061963ccd7acf_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ef4fa00e-5fbf-44b8-b785-6e3dca656b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ef4fa00e-5fbf-44b8-b785-6e3dca656b03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7e39b8a9-0e02-4a81-929b-250014af9c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7e39b8a9-0e02-4a81-929b-250014af9c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7eae3aa3-f1ab-419a-9300-ee13fb9eeef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7eae3aa3-f1ab-419a-9300-ee13fb9eeef3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a92d8e36-da10-48e7-a2a0-4e3901852c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a92d8e36-da10-48e7-a2a0-4e3901852c37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_81e17a3d-a970-4a5b-83a1-60f841cc8c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_81e17a3d-a970-4a5b-83a1-60f841cc8c40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_32b04a7d-9425-495c-9328-45c3e96ce34a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_32b04a7d-9425-495c-9328-45c3e96ce34a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_32b04a7d-9425-495c-9328-45c3e96ce34a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_32b04a7d-9425-495c-9328-45c3e96ce34a" xlink:to="loc_us-gaap_SegmentDomain_32b04a7d-9425-495c-9328-45c3e96ce34a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f9ffe1a-1a43-4dd5-a69c-2ebb12ccf54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_32b04a7d-9425-495c-9328-45c3e96ce34a" xlink:to="loc_us-gaap_SegmentDomain_9f9ffe1a-1a43-4dd5-a69c-2ebb12ccf54a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_bc8e6f49-6730-46fb-a9d9-7a283f4682e9" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9f9ffe1a-1a43-4dd5-a69c-2ebb12ccf54a" xlink:to="loc_mygn_DiagnosticMember_bc8e6f49-6730-46fb-a9d9-7a283f4682e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_3ae9f4b4-2a35-4367-b1d2-8383b6d35ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9f9ffe1a-1a43-4dd5-a69c-2ebb12ccf54a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_3ae9f4b4-2a35-4367-b1d2-8383b6d35ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_61bebbe0-b78d-4730-a737-3af7a2a3dc7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_us-gaap_ReportingUnitAxis_61bebbe0-b78d-4730-a737-3af7a2a3dc7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_61bebbe0-b78d-4730-a737-3af7a2a3dc7a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_61bebbe0-b78d-4730-a737-3af7a2a3dc7a" xlink:to="loc_us-gaap_ReportingUnitDomain_61bebbe0-b78d-4730-a737-3af7a2a3dc7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_57539e62-c4d1-4727-bf59-cfce6b4ec758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_61bebbe0-b78d-4730-a737-3af7a2a3dc7a" xlink:to="loc_us-gaap_ReportingUnitDomain_57539e62-c4d1-4727-bf59-cfce6b4ec758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MyriadAutoimmuneReportingUnitMember_661d18ab-906e-42c6-b312-62480dc32035" xlink:href="mygn-20201231.xsd#mygn_MyriadAutoimmuneReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_57539e62-c4d1-4727-bf59-cfce6b4ec758" xlink:to="loc_mygn_MyriadAutoimmuneReportingUnitMember_661d18ab-906e-42c6-b312-62480dc32035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ClinicReportingUnitMember_cf798ddc-be47-4128-a682-933a24de7bce" xlink:href="mygn-20201231.xsd#mygn_ClinicReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_57539e62-c4d1-4727-bf59-cfce6b4ec758" xlink:to="loc_mygn_ClinicReportingUnitMember_cf798ddc-be47-4128-a682-933a24de7bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ba46a4-47f1-4843-9a18-9c9bac25e36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ba46a4-47f1-4843-9a18-9c9bac25e36b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ba46a4-47f1-4843-9a18-9c9bac25e36b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ba46a4-47f1-4843-9a18-9c9bac25e36b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ba46a4-47f1-4843-9a18-9c9bac25e36b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ba46a4-47f1-4843-9a18-9c9bac25e36b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DevelopedTechnologyAndDatabaseMember_2a40cca8-9d7c-4455-9078-5834d9142812" xlink:href="mygn-20201231.xsd#mygn_DevelopedTechnologyAndDatabaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:to="loc_mygn_DevelopedTechnologyAndDatabaseMember_2a40cca8-9d7c-4455-9078-5834d9142812" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_33de9ab2-4dcc-47ea-86df-c94175836fb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:to="loc_us-gaap_TrademarksMember_33de9ab2-4dcc-47ea-86df-c94175836fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d9747d2f-1d8d-48ad-83db-02bd2622a1df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d9747d2f-1d8d-48ad-83db-02bd2622a1df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PurchasedLicensesAndTechnologiesMember_5bdf255a-bd25-4116-830a-b0c4f47f25f2" xlink:href="mygn-20201231.xsd#mygn_PurchasedLicensesAndTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:to="loc_mygn_PurchasedLicensesAndTechnologiesMember_5bdf255a-bd25-4116-830a-b0c4f47f25f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2f6adf12-4030-4844-bb04-09632bb75b7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_srt_RangeAxis_2f6adf12-4030-4844-bb04-09632bb75b7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2f6adf12-4030-4844-bb04-09632bb75b7b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2f6adf12-4030-4844-bb04-09632bb75b7b" xlink:to="loc_srt_RangeMember_2f6adf12-4030-4844-bb04-09632bb75b7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9a21d076-91d9-4cde-97cf-7d220ef6ec9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2f6adf12-4030-4844-bb04-09632bb75b7b" xlink:to="loc_srt_RangeMember_9a21d076-91d9-4cde-97cf-7d220ef6ec9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_57c281e6-31bf-4302-9580-9a95b505f7d8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9a21d076-91d9-4cde-97cf-7d220ef6ec9f" xlink:to="loc_srt_MinimumMember_57c281e6-31bf-4302-9580-9a95b505f7d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d2459008-7203-49b7-bf4f-fed9909f3576" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9a21d076-91d9-4cde-97cf-7d220ef6ec9f" xlink:to="loc_srt_MaximumMember_d2459008-7203-49b7-bf4f-fed9909f3576" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended" id="i4e498d2baa304623bc53a77eebd27974_GoodwillandIntangibleAssetsIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:href="mygn-20201231.xsd#mygn_IntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f21828b-0f51-4f63-b9bd-4b3639c4e451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f21828b-0f51-4f63-b9bd-4b3639c4e451" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc1c5789-e845-452b-867a-fa9781aee447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc1c5789-e845-452b-867a-fa9781aee447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d95bb506-a29c-490f-bbee-54e4f3b7e949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d95bb506-a29c-490f-bbee-54e4f3b7e949" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_6a80bf31-40e0-47a8-b531-e825f12e7380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_6a80bf31-40e0-47a8-b531-e825f12e7380" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ea4986de-14e1-4c75-8b3e-fd024f9791bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ea4986de-14e1-4c75-8b3e-fd024f9791bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0919e68b-c3b2-47cf-b04c-276be0fadad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0919e68b-c3b2-47cf-b04c-276be0fadad1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_195747b2-640a-4893-9388-8b499b185609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_195747b2-640a-4893-9388-8b499b185609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_91d66107-906c-4f42-9400-838fab33c637" xlink:href="mygn-20201231.xsd#mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_195747b2-640a-4893-9388-8b499b185609" xlink:to="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_91d66107-906c-4f42-9400-838fab33c637" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PurchasedLicensesAndTechnologiesMember_19e6fc8b-ff78-4b6b-b597-02b8a6c3e479" xlink:href="mygn-20201231.xsd#mygn_PurchasedLicensesAndTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:to="loc_mygn_PurchasedLicensesAndTechnologiesMember_19e6fc8b-ff78-4b6b-b597-02b8a6c3e479" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_70bee276-0f27-44d7-96fd-a29e0288392c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:to="loc_us-gaap_CustomerRelationshipsMember_70bee276-0f27-44d7-96fd-a29e0288392c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c5b3992e-8407-4a48-8a15-f525bda363b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:to="loc_us-gaap_TrademarksMember_c5b3992e-8407-4a48-8a15-f525bda363b1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="extended" id="i2d45bd877bd24836a2548dee82770e1e_GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended" id="ic71506fa511d4eae86a533858b812c02_GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilities"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/AccruedLiabilities" xlink:type="extended" id="iecbddb529693471bab589d24e70d94ac_AccruedLiabilities"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="extended" id="i5da60d7aed24493d82da5100ce25eb16_AccruedLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="extended" id="id13f6372ba60412ebb7408f5dc7268ab_AccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebt" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebt"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LongTermDebt" xlink:type="extended" id="i29a3120e66ec4c0884318678743917dc_LongTermDebt"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LongTermDebtTables" xlink:type="extended" id="i432412affabd410e9087954e4dc0fec4_LongTermDebtTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i2565c21ef4464a8aad5159f2c64c9e1e_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_6f8ff035-5379-4997-9a0b-f0f2e2f598d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_6f8ff035-5379-4997-9a0b-f0f2e2f598d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eb7e2700-ac2c-4aaa-b03e-05491b6d3414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eb7e2700-ac2c-4aaa-b03e-05491b6d3414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1cebf537-973a-43a6-9ac7-f29a77921091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1cebf537-973a-43a6-9ac7-f29a77921091" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_1211d911-5606-4ba7-99ec-e468a1b55327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_1211d911-5606-4ba7-99ec-e468a1b55327" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_60638d10-4f9c-441d-9001-ad02a40bc283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_60638d10-4f9c-441d-9001-ad02a40bc283" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_11fe1f3f-185e-4e1e-8167-46c7a85d4d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_11fe1f3f-185e-4e1e-8167-46c7a85d4d64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0b3625f6-0acd-4d45-b18c-516cde72ff9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0b3625f6-0acd-4d45-b18c-516cde72ff9d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b4d125da-c6a3-45b8-a490-0cc2643f4d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b4d125da-c6a3-45b8-a490-0cc2643f4d0d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtInstrumentLIBORFloorPercentage_8521545f-f403-4479-8859-2817a46d1011" xlink:href="mygn-20201231.xsd#mygn_DebtInstrumentLIBORFloorPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_mygn_DebtInstrumentLIBORFloorPercentage_8521545f-f403-4479-8859-2817a46d1011" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_b50d658f-7c6b-4e15-b36c-28695ddf12b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_b50d658f-7c6b-4e15-b36c-28695ddf12b7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_8766063d-a8bb-47f3-a4c4-d95f9e629556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_8766063d-a8bb-47f3-a4c4-d95f9e629556" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_19acff98-8875-4dc0-a922-7fbe8413f63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_us-gaap_CreditFacilityAxis_19acff98-8875-4dc0-a922-7fbe8413f63d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_19acff98-8875-4dc0-a922-7fbe8413f63d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_19acff98-8875-4dc0-a922-7fbe8413f63d" xlink:to="loc_us-gaap_CreditFacilityDomain_19acff98-8875-4dc0-a922-7fbe8413f63d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e2f636a7-32f0-450f-8850-0edf97fba03a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_19acff98-8875-4dc0-a922-7fbe8413f63d" xlink:to="loc_us-gaap_CreditFacilityDomain_e2f636a7-32f0-450f-8850-0edf97fba03a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_69bd7314-754c-4a43-8194-260a53c01eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e2f636a7-32f0-450f-8850-0edf97fba03a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_69bd7314-754c-4a43-8194-260a53c01eb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ac148244-b928-42c7-bb4f-69dcdc8f468a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_us-gaap_DebtInstrumentAxis_ac148244-b928-42c7-bb4f-69dcdc8f468a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ac148244-b928-42c7-bb4f-69dcdc8f468a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ac148244-b928-42c7-bb4f-69dcdc8f468a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ac148244-b928-42c7-bb4f-69dcdc8f468a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dda2a9ec-de72-4794-a5c4-c015301bdb62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ac148244-b928-42c7-bb4f-69dcdc8f468a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dda2a9ec-de72-4794-a5c4-c015301bdb62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmendmentToCreditAgreementMember_e81680fc-f8cd-45a3-a9e9-73fe670d5ead" xlink:href="mygn-20201231.xsd#mygn_AmendmentToCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dda2a9ec-de72-4794-a5c4-c015301bdb62" xlink:to="loc_mygn_AmendmentToCreditAgreementMember_e81680fc-f8cd-45a3-a9e9-73fe670d5ead" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d6cdd874-7f87-421b-a387-fb650bed8315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_us-gaap_VariableRateAxis_d6cdd874-7f87-421b-a387-fb650bed8315" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d6cdd874-7f87-421b-a387-fb650bed8315_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d6cdd874-7f87-421b-a387-fb650bed8315" xlink:to="loc_us-gaap_VariableRateDomain_d6cdd874-7f87-421b-a387-fb650bed8315_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9eeeabe4-8d8c-4911-82b1-0d0224f17c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d6cdd874-7f87-421b-a387-fb650bed8315" xlink:to="loc_us-gaap_VariableRateDomain_9eeeabe4-8d8c-4911-82b1-0d0224f17c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_bef90d4e-6a09-40a5-9521-82d57b7457af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9eeeabe4-8d8c-4911-82b1-0d0224f17c62" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_bef90d4e-6a09-40a5-9521-82d57b7457af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f7686939-3385-4aed-b3cc-ef25517999df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_srt_StatementScenarioAxis_f7686939-3385-4aed-b3cc-ef25517999df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f7686939-3385-4aed-b3cc-ef25517999df_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f7686939-3385-4aed-b3cc-ef25517999df" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f7686939-3385-4aed-b3cc-ef25517999df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1ec32032-8ee1-42a4-94ed-6ecdc358bf2b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f7686939-3385-4aed-b3cc-ef25517999df" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1ec32032-8ee1-42a4-94ed-6ecdc358bf2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_5e5696bc-9fec-4667-9459-03d840bc5b62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1ec32032-8ee1-42a4-94ed-6ecdc358bf2b" xlink:to="loc_srt_ScenarioForecastMember_5e5696bc-9fec-4667-9459-03d840bc5b62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_86332c97-43cf-406e-8461-4d4279ee3df9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_srt_RangeAxis_86332c97-43cf-406e-8461-4d4279ee3df9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_86332c97-43cf-406e-8461-4d4279ee3df9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_86332c97-43cf-406e-8461-4d4279ee3df9" xlink:to="loc_srt_RangeMember_86332c97-43cf-406e-8461-4d4279ee3df9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0f848813-821d-47b3-b5d1-e5cd62d4f1ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_86332c97-43cf-406e-8461-4d4279ee3df9" xlink:to="loc_srt_RangeMember_0f848813-821d-47b3-b5d1-e5cd62d4f1ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ee3bd5b9-91fa-4e13-b789-eed714c44aec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0f848813-821d-47b3-b5d1-e5cd62d4f1ad" xlink:to="loc_srt_MinimumMember_ee3bd5b9-91fa-4e13-b789-eed714c44aec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_21260c1a-0a2b-46fa-8528-776cf67be868" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0f848813-821d-47b3-b5d1-e5cd62d4f1ad" xlink:to="loc_srt_MaximumMember_21260c1a-0a2b-46fa-8528-776cf67be868" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended" id="ie54b980e179e4f6bac4c64f980d4c9f2_LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilities"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="extended" id="i552f3dad57c743bb893a9b98f3af3edf_OtherLongTermLiabilities"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="extended" id="i0d716d96490b4d37a5b8bad4f3ae9fcd_OtherLongTermLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails" xlink:type="extended" id="i4a6cb79510114c25a28f892315c40813_OtherLongTermLiabilitiesSummaryDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails" xlink:type="extended" id="i752f1f815b0d440eb7df01a4da43706f_OtherLongTermLiabilitiesNarrativeDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="extended" id="i08e77cf00cb54844b24290de6e98a989_PreferredandCommonStockholdersEquity"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="extended" id="ied800d46806c4f9a875bad875da23fcd_PreferredandCommonStockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="extended" id="i2c86ad025b034df79cf3dfc3565c9a8e_PreferredandCommonStockholdersEquityNarrativeDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="extended" id="i69486cfa0a7b482589568a6bf7f63379_PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityStockRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails" xlink:type="extended" id="ibadd4837c0a04985b80d6576d42408a0_PreferredandCommonStockholdersEquityStockRepurchasesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="extended" id="i69695a5375944b5e993990db755a8d99_ShareBasedCompensation"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="extended" id="i7f286f6193c84d96a158ca910bca5309_ShareBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="if7a506a9c3e543faa1ba919e588fdeff_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7fba7030-de19-498f-93e6-4b074784c514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7fba7030-de19-498f-93e6-4b074784c514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7b457102-e1eb-4941-a0a6-5a737310e56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7b457102-e1eb-4941-a0a6-5a737310e56e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4a3ccfce-445c-463f-8dd9-38071c5e5cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4a3ccfce-445c-463f-8dd9-38071c5e5cfb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3c3ba0bb-f781-4d55-ac7f-f80ce92d45e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3c3ba0bb-f781-4d55-ac7f-f80ce92d45e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b47803f6-b9c3-41a2-ad4d-f37b5ec195d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b47803f6-b9c3-41a2-ad4d-f37b5ec195d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice_f4abe7d1-e98d-4114-a613-63edaacbc9ef" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice_f4abe7d1-e98d-4114-a613-63edaacbc9ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_133c4b24-db4f-4575-94ef-2a083a97c64f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_133c4b24-db4f-4575-94ef-2a083a97c64f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_6230deb2-7d0d-4d0e-85c8-f50eba679b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_6230deb2-7d0d-4d0e-85c8-f50eba679b64" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8a8844f1-3693-4c4c-9798-145fe5d52072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8a8844f1-3693-4c4c-9798-145fe5d52072" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_45edb994-f3e8-4c1a-bc72-c7f30ea56cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_45edb994-f3e8-4c1a-bc72-c7f30ea56cb7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4b2fdc8b-b0cd-4674-b90a-88fb1792d466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4b2fdc8b-b0cd-4674-b90a-88fb1792d466" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_72378bef-f845-42e0-b95e-189eae81ca28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_72378bef-f845-42e0-b95e-189eae81ca28" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_03e6c175-6cb5-4391-bd2e-a29af99f6d73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_03e6c175-6cb5-4391-bd2e-a29af99f6d73" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5199a881-efde-49e1-948b-9c53748dcb49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_PlanNameAxis_5199a881-efde-49e1-948b-9c53748dcb49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5199a881-efde-49e1-948b-9c53748dcb49_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5199a881-efde-49e1-948b-9c53748dcb49" xlink:to="loc_us-gaap_PlanNameDomain_5199a881-efde-49e1-948b-9c53748dcb49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5199a881-efde-49e1-948b-9c53748dcb49" xlink:to="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember_bb3c0f61-65c0-4a87-be1d-65213d0b0524" xlink:href="mygn-20201231.xsd#mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:to="loc_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember_bb3c0f61-65c0-4a87-be1d-65213d0b0524" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_e9656570-cc1e-4fb0-88c2-dc18d11d9bbc" xlink:href="mygn-20201231.xsd#mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:to="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_e9656570-cc1e-4fb0-88c2-dc18d11d9bbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_f466537d-2498-44bd-8fa2-00e0153f044e" xlink:href="mygn-20201231.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:to="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_f466537d-2498-44bd-8fa2-00e0153f044e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6ba90a69-61a2-429d-8184-356f76061e69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_AwardTypeAxis_6ba90a69-61a2-429d-8184-356f76061e69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ba90a69-61a2-429d-8184-356f76061e69_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6ba90a69-61a2-429d-8184-356f76061e69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ba90a69-61a2-429d-8184-356f76061e69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2aa6a13e-1543-422c-b6b6-e2d70768e2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6ba90a69-61a2-429d-8184-356f76061e69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2aa6a13e-1543-422c-b6b6-e2d70768e2cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsAndRestrictedStockUnitsMember_60e94dc5-cfa4-4419-94bc-64d8ebb25b95" xlink:href="mygn-20201231.xsd#mygn_OptionsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2aa6a13e-1543-422c-b6b6-e2d70768e2cf" xlink:to="loc_mygn_OptionsAndRestrictedStockUnitsMember_60e94dc5-cfa4-4419-94bc-64d8ebb25b95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_63756b8c-76c6-42c8-96cc-0b0b3db4cd8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OptionsAndRestrictedStockUnitsMember_60e94dc5-cfa4-4419-94bc-64d8ebb25b95" xlink:to="loc_us-gaap_EmployeeStockOptionMember_63756b8c-76c6-42c8-96cc-0b0b3db4cd8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a19e2560-46ff-4147-9e96-6c473d8c931c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_OptionsAndRestrictedStockUnitsMember_60e94dc5-cfa4-4419-94bc-64d8ebb25b95" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a19e2560-46ff-4147-9e96-6c473d8c931c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_8996b2a1-7940-40d9-a565-27ef95141324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2aa6a13e-1543-422c-b6b6-e2d70768e2cf" xlink:to="loc_us-gaap_PerformanceSharesMember_8996b2a1-7940-40d9-a565-27ef95141324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_4ed2639c-ea77-431c-a4c4-2c92a2e928bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_AwardDateAxis_4ed2639c-ea77-431c-a4c4-2c92a2e928bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_4ed2639c-ea77-431c-a4c4-2c92a2e928bb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_4ed2639c-ea77-431c-a4c4-2c92a2e928bb" xlink:to="loc_us-gaap_AwardDateDomain_4ed2639c-ea77-431c-a4c4-2c92a2e928bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_cd3ca425-8150-43e6-b658-7aefe11c489b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_4ed2639c-ea77-431c-a4c4-2c92a2e928bb" xlink:to="loc_us-gaap_AwardDateDomain_cd3ca425-8150-43e6-b658-7aefe11c489b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_7f39793d-5210-4036-976c-a76599746bf2" xlink:href="mygn-20201231.xsd#mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_cd3ca425-8150-43e6-b658-7aefe11c489b" xlink:to="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_7f39793d-5210-4036-976c-a76599746bf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_c3d0920e-08f3-42f7-b499-53c4c9613890" xlink:href="mygn-20201231.xsd#mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_cd3ca425-8150-43e6-b658-7aefe11c489b" xlink:to="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_c3d0920e-08f3-42f7-b499-53c4c9613890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_90e893b2-2389-4017-af93-e7ad1dae915b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_srt_TitleOfIndividualAxis_90e893b2-2389-4017-af93-e7ad1dae915b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_90e893b2-2389-4017-af93-e7ad1dae915b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_90e893b2-2389-4017-af93-e7ad1dae915b" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_90e893b2-2389-4017-af93-e7ad1dae915b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7db8fa66-47a4-4579-83c6-74fb0d572edc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_90e893b2-2389-4017-af93-e7ad1dae915b" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7db8fa66-47a4-4579-83c6-74fb0d572edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonEmployeeDirectorMember_768449db-0306-40c7-b7c1-c6274df85f7b" xlink:href="mygn-20201231.xsd#mygn_NonEmployeeDirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7db8fa66-47a4-4579-83c6-74fb0d572edc" xlink:to="loc_mygn_NonEmployeeDirectorMember_768449db-0306-40c7-b7c1-c6274df85f7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_1a4c34e2-27c0-48cd-98c5-e406c2d35b38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7db8fa66-47a4-4579-83c6-74fb0d572edc" xlink:to="loc_srt_ChiefExecutiveOfficerMember_1a4c34e2-27c0-48cd-98c5-e406c2d35b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_3bdba423-865b-4663-8601-246ff4086003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_VestingAxis_3bdba423-865b-4663-8601-246ff4086003" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_3bdba423-865b-4663-8601-246ff4086003_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_3bdba423-865b-4663-8601-246ff4086003" xlink:to="loc_us-gaap_VestingDomain_3bdba423-865b-4663-8601-246ff4086003_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ed12d752-a2da-474c-946b-909a19bee7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_3bdba423-865b-4663-8601-246ff4086003" xlink:to="loc_us-gaap_VestingDomain_ed12d752-a2da-474c-946b-909a19bee7c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_e956bfff-704a-47c7-9b86-41f79161b736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_ed12d752-a2da-474c-946b-909a19bee7c2" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_e956bfff-704a-47c7-9b86-41f79161b736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_25fa44fb-50f4-41e1-ba83-cb2a20582086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_ed12d752-a2da-474c-946b-909a19bee7c2" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_25fa44fb-50f4-41e1-ba83-cb2a20582086" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails" xlink:type="extended" id="id0e54f1dfa504fa29b4e5b61a9dcdc7d_ShareBasedCompensationStockOptionsActivityDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails" xlink:type="extended" id="idcde5681849e436e813c6140ddb89c8d_ShareBasedCompensationValuationAssumptionsforStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51bfcab1-d0ae-4250-a9ab-5bd1fe2d4685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51bfcab1-d0ae-4250-a9ab-5bd1fe2d4685" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f7d00387-2d12-4242-add1-0ba4af99ec13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f7d00387-2d12-4242-add1-0ba4af99ec13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_9731db43-353a-448a-ab74-3b8f43d9b5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_9731db43-353a-448a-ab74-3b8f43d9b5e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_596d9191-48ea-4868-95c8-062d3fa1d49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_596d9191-48ea-4868-95c8-062d3fa1d49c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_addeb37f-e5ea-462b-9d60-0082df0bbb55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_addeb37f-e5ea-462b-9d60-0082df0bbb55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum_eb56e3ec-f519-4527-a9a4-1537e70669c2" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum_eb56e3ec-f519-4527-a9a4-1537e70669c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum_f4ce738e-868d-4967-814f-b2afb7d26318" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum_f4ce738e-868d-4967-814f-b2afb7d26318" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_ad983c07-ea81-4161-9c8e-250444dcd6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_ad983c07-ea81-4161-9c8e-250444dcd6a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f7fb9609-d7ce-4eb9-a6f3-2de10a9a8a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f7fb9609-d7ce-4eb9-a6f3-2de10a9a8a94" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_141b6ea8-501b-4ba3-8920-b2c6eddfaec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51bfcab1-d0ae-4250-a9ab-5bd1fe2d4685" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_141b6ea8-501b-4ba3-8920-b2c6eddfaec3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b833c2a6-1aeb-4c6e-a671-e6236535d5bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_141b6ea8-501b-4ba3-8920-b2c6eddfaec3" xlink:to="loc_us-gaap_AwardTypeAxis_b833c2a6-1aeb-4c6e-a671-e6236535d5bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b833c2a6-1aeb-4c6e-a671-e6236535d5bd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b833c2a6-1aeb-4c6e-a671-e6236535d5bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b833c2a6-1aeb-4c6e-a671-e6236535d5bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf37be84-1f17-4443-808c-fc83fedd4462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b833c2a6-1aeb-4c6e-a671-e6236535d5bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf37be84-1f17-4443-808c-fc83fedd4462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bb6d2261-7fcd-41af-98ce-f1cf1140d22e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf37be84-1f17-4443-808c-fc83fedd4462" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bb6d2261-7fcd-41af-98ce-f1cf1140d22e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationStockOptionsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails" xlink:type="extended" id="i72f3dd4f311a47dd961270fe8d7583aa_ShareBasedCompensationStockOptionsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c8cadd17-f8b5-4878-8ecc-0a78af4ef2e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c8cadd17-f8b5-4878-8ecc-0a78af4ef2e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a0c9bd01-f411-43d8-bc9a-631801fd2e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a0c9bd01-f411-43d8-bc9a-631801fd2e9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_516bb92a-3b3a-46ce-9eef-2cc8a074e6f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_516bb92a-3b3a-46ce-9eef-2cc8a074e6f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_db10a6b0-9fbd-4f20-8a86-317bd8b435dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_db10a6b0-9fbd-4f20-8a86-317bd8b435dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_885995cf-f514-445b-8f1b-981d82beb26f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_885995cf-f514-445b-8f1b-981d82beb26f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_dfaf7fa3-8c46-4da0-9448-6ec27ea03afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_dfaf7fa3-8c46-4da0-9448-6ec27ea03afc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_adc86254-d7d7-4f1f-bd7f-8e112b184e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_dfaf7fa3-8c46-4da0-9448-6ec27ea03afc" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_adc86254-d7d7-4f1f-bd7f-8e112b184e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_adc86254-d7d7-4f1f-bd7f-8e112b184e61_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_adc86254-d7d7-4f1f-bd7f-8e112b184e61" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_adc86254-d7d7-4f1f-bd7f-8e112b184e61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_adc86254-d7d7-4f1f-bd7f-8e112b184e61" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeOneMember_500847bf-25e9-467f-b3d4-4462795baef8" xlink:href="mygn-20201231.xsd#mygn_RangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:to="loc_mygn_RangeOneMember_500847bf-25e9-467f-b3d4-4462795baef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeTwoMember_de7f3294-18fb-4aeb-815e-2f9d8a64a4ad" xlink:href="mygn-20201231.xsd#mygn_RangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:to="loc_mygn_RangeTwoMember_de7f3294-18fb-4aeb-815e-2f9d8a64a4ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeThreeMember_4b79ea21-ef5e-4c1d-8244-abfc04bdd53d" xlink:href="mygn-20201231.xsd#mygn_RangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:to="loc_mygn_RangeThreeMember_4b79ea21-ef5e-4c1d-8244-abfc04bdd53d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeFourMember_cbf27f58-6b73-45f8-a263-d095089434e1" xlink:href="mygn-20201231.xsd#mygn_RangeFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:to="loc_mygn_RangeFourMember_cbf27f58-6b73-45f8-a263-d095089434e1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended" id="i80851e3fff71491ea5d3d4c7f48d6218_ShareBasedCompensationRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70deade6-4432-464d-9214-a517a92b9eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70deade6-4432-464d-9214-a517a92b9eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_88c8a821-a21d-4f79-982f-1fd0f6f77186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_88c8a821-a21d-4f79-982f-1fd0f6f77186" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34f268c3-9536-431e-9748-2d0212a15587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34f268c3-9536-431e-9748-2d0212a15587" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_504b94a8-dbcf-4cc0-9f10-6b0c95da02ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_504b94a8-dbcf-4cc0-9f10-6b0c95da02ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1cdb87cc-5375-4395-89ae-939fadfb7cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1cdb87cc-5375-4395-89ae-939fadfb7cfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a92ae2be-e820-47bd-9292-150de6c07ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70deade6-4432-464d-9214-a517a92b9eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_024613b8-8d9d-4517-8dc4-7bffc010adb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_024613b8-8d9d-4517-8dc4-7bffc010adb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_630bda48-d0bb-4303-a1b2-98e4d8f2f703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_630bda48-d0bb-4303-a1b2-98e4d8f2f703" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e5405284-3539-4d6f-8a9d-48ffaeffe6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e5405284-3539-4d6f-8a9d-48ffaeffe6bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d568c918-b381-4e2b-b521-db50045db88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d568c918-b381-4e2b-b521-db50045db88c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_76b59746-1cfc-4080-ac6b-7bb76ac8679e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_542b1b78-2188-4872-ba4c-ede59f9ffa20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70deade6-4432-464d-9214-a517a92b9eb4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_542b1b78-2188-4872-ba4c-ede59f9ffa20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_75c4e113-66e1-47d6-870a-c1eefdbd6890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_542b1b78-2188-4872-ba4c-ede59f9ffa20" xlink:to="loc_us-gaap_AwardTypeAxis_75c4e113-66e1-47d6-870a-c1eefdbd6890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75c4e113-66e1-47d6-870a-c1eefdbd6890_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_75c4e113-66e1-47d6-870a-c1eefdbd6890" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75c4e113-66e1-47d6-870a-c1eefdbd6890_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abf7eb51-3ba7-4ba9-a4cf-cc9bf56d72ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_75c4e113-66e1-47d6-870a-c1eefdbd6890" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abf7eb51-3ba7-4ba9-a4cf-cc9bf56d72ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5cfc9199-663b-4eb9-bd5b-ed96e6288ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abf7eb51-3ba7-4ba9-a4cf-cc9bf56d72ff" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5cfc9199-663b-4eb9-bd5b-ed96e6288ba4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended" id="i746593c2d54d47b698b93c1035a7fc97_ShareBasedCompensationShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_531c0417-e77c-4074-abc3-7bcdf28f3c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7d01b6f4-c8eb-40e7-8d9c-ce390660620a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_531c0417-e77c-4074-abc3-7bcdf28f3c45" xlink:to="loc_us-gaap_ShareBasedCompensation_7d01b6f4-c8eb-40e7-8d9c-ce390660620a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_29e31768-7e92-4a0a-a1d7-09fc7f6673e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_531c0417-e77c-4074-abc3-7bcdf28f3c45" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_29e31768-7e92-4a0a-a1d7-09fc7f6673e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_68e83d20-dc07-4d7c-a5c8-36ede6f2631c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_29e31768-7e92-4a0a-a1d7-09fc7f6673e4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_68e83d20-dc07-4d7c-a5c8-36ede6f2631c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_68e83d20-dc07-4d7c-a5c8-36ede6f2631c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_68e83d20-dc07-4d7c-a5c8-36ede6f2631c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_68e83d20-dc07-4d7c-a5c8-36ede6f2631c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_68e83d20-dc07-4d7c-a5c8-36ede6f2631c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfMolecularDiagnosticTestingMember_011000ae-9ef7-4c49-8bea-ceea13ee2b3d" xlink:href="mygn-20201231.xsd#mygn_CostOfMolecularDiagnosticTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:to="loc_mygn_CostOfMolecularDiagnosticTestingMember_011000ae-9ef7-4c49-8bea-ceea13ee2b3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember_85dc41c0-c18e-48a8-9fa7-43a0ceca68d0" xlink:href="mygn-20201231.xsd#mygn_CostOfPharmaceuticalAndClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:to="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember_85dc41c0-c18e-48a8-9fa7-43a0ceca68d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2391501d-864f-4df1-9463-a667ab25b162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2391501d-864f-4df1-9463-a667ab25b162" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d2b5effc-0b82-4cd3-8783-cbe99a637aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d2b5effc-0b82-4cd3-8783-cbe99a637aba" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails" xlink:type="extended" id="i66e74aa086d94e73aa9846b5ab2e0940_ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_342a7e55-c8f4-4f05-9361-37008190bad2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_342a7e55-c8f4-4f05-9361-37008190bad2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5d303bc1-59e6-4088-80f5-8d4cb52568d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5d303bc1-59e6-4088-80f5-8d4cb52568d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_05193dc8-da26-4fb4-96c9-74428436c599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_05193dc8-da26-4fb4-96c9-74428436c599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_ba190904-9fec-4b61-adaa-bdd0d180a5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_ba190904-9fec-4b61-adaa-bdd0d180a5e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e905d3a-bb39-4dab-8674-f0b30382fe3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e905d3a-bb39-4dab-8674-f0b30382fe3f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e905d3a-bb39-4dab-8674-f0b30382fe3f" xlink:to="loc_us-gaap_AwardTypeAxis_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf556339-7773-46f7-8c40-b3effddd6823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf556339-7773-46f7-8c40-b3effddd6823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ebf6e8a8-da2d-4fbc-a418-a663672fc923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf556339-7773-46f7-8c40-b3effddd6823" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ebf6e8a8-da2d-4fbc-a418-a663672fc923" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails" xlink:type="extended" id="i2617db2ed0f74203a96c95c08e1bc434_ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails" xlink:type="extended" id="ieb203a7167b24e129d775e8527f475c5_ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e868023-7c8c-4e56-9d59-e3dfcc4d0670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_9a24d1fa-c233-4b94-9869-53e4579c0ea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e868023-7c8c-4e56-9d59-e3dfcc4d0670" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_9a24d1fa-c233-4b94-9869-53e4579c0ea9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_844b87c2-c4fd-4f3a-9130-defc04ec305d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e868023-7c8c-4e56-9d59-e3dfcc4d0670" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_844b87c2-c4fd-4f3a-9130-defc04ec305d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06bb8575-8863-4894-b211-b9e5cb62b1f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e868023-7c8c-4e56-9d59-e3dfcc4d0670" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06bb8575-8863-4894-b211-b9e5cb62b1f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06bb8575-8863-4894-b211-b9e5cb62b1f6" xlink:to="loc_us-gaap_PlanNameAxis_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd" xlink:to="loc_us-gaap_PlanNameDomain_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1ad9d8d1-8c51-487a-8f0e-09ecc6995bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd" xlink:to="loc_us-gaap_PlanNameDomain_1ad9d8d1-8c51-487a-8f0e-09ecc6995bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_e76c2bac-897a-43b6-9641-690aaf1fc4fc" xlink:href="mygn-20201231.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1ad9d8d1-8c51-487a-8f0e-09ecc6995bcd" xlink:to="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_e76c2bac-897a-43b6-9641-690aaf1fc4fc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationValuationAssumptionsforESPPDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails" xlink:type="extended" id="i350bb1d218f44e278d754d10e58c58ec_ShareBasedCompensationValuationAssumptionsforESPPDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5561b7bf-25fa-4a54-a7df-f63badfc4c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5561b7bf-25fa-4a54-a7df-f63badfc4c63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7da2193d-b9e3-4d73-8467-507e57467997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7da2193d-b9e3-4d73-8467-507e57467997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e767558a-d35a-4367-91e2-dc5561d317b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e767558a-d35a-4367-91e2-dc5561d317b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_45469a17-d007-4485-84b7-ec1bfea76d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_45469a17-d007-4485-84b7-ec1bfea76d0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c0e91932-26b4-4f1a-8603-6a81f60c94c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c0e91932-26b4-4f1a-8603-6a81f60c94c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71768e4c-9ee1-4e44-9160-568e03dabe45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5561b7bf-25fa-4a54-a7df-f63badfc4c63" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71768e4c-9ee1-4e44-9160-568e03dabe45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_876499f1-47f6-4dfc-8a08-62d7c1d75917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71768e4c-9ee1-4e44-9160-568e03dabe45" xlink:to="loc_us-gaap_PlanNameAxis_876499f1-47f6-4dfc-8a08-62d7c1d75917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_876499f1-47f6-4dfc-8a08-62d7c1d75917_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_876499f1-47f6-4dfc-8a08-62d7c1d75917" xlink:to="loc_us-gaap_PlanNameDomain_876499f1-47f6-4dfc-8a08-62d7c1d75917_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2b5a82ec-e30a-40ca-a529-cc6ee093a780" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_876499f1-47f6-4dfc-8a08-62d7c1d75917" xlink:to="loc_us-gaap_PlanNameDomain_2b5a82ec-e30a-40ca-a529-cc6ee093a780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_c0df1444-c270-4ff0-a120-41a7695bdfbd" xlink:href="mygn-20201231.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_2b5a82ec-e30a-40ca-a529-cc6ee093a780" xlink:to="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_c0df1444-c270-4ff0-a120-41a7695bdfbd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxes" xlink:type="extended" id="id5be077e5f4d4e91bc05f794ae655594_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesTables" xlink:type="extended" id="i983c1510aa6843feb148c98c7b5d8917_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesIncomeTaxBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails" xlink:type="extended" id="ibd25b964346a45b49317084b36510034_IncomeTaxesIncomeTaxBenefitDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended" id="i72a4239185ac4ee080869227463fc3b6_IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails" xlink:type="extended" id="i4ca39541ab49466b8bf0257fcabe2d10_IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i97556a92592c4b2796e55d4f1717c7d6_IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i273cf90cd4af4bf3a0f5a1e0e84b9622_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct_c1cad114-737b-46f8-9ab7-73114ef840c4" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct_c1cad114-737b-46f8-9ab7-73114ef840c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_788e59c9-d03c-43ee-8e84-7cd0a7b93248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_788e59c9-d03c-43ee-8e84-7cd0a7b93248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare_f133cd6f-abc2-4e5d-8a72-6169dbe9009d" xlink:href="mygn-20201231.xsd#mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare_f133cd6f-abc2-4e5d-8a72-6169dbe9009d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod_a03a5180-50cf-4ad2-be58-15a3bb9fc982" xlink:href="mygn-20201231.xsd#mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod_a03a5180-50cf-4ad2-be58-15a3bb9fc982" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_8924c80a-9f96-49c7-9788-d2200eadc696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_8924c80a-9f96-49c7-9788-d2200eadc696" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1c7c5fee-4e0e-4c62-b406-9695793d5f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1c7c5fee-4e0e-4c62-b406-9695793d5f01" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_UnrecognizedTaxBenefitsNet_81e2ad12-7d45-4814-8da7-de3eb826bfb0" xlink:href="mygn-20201231.xsd#mygn_UnrecognizedTaxBenefitsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_mygn_UnrecognizedTaxBenefitsNet_81e2ad12-7d45-4814-8da7-de3eb826bfb0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_3d82ee44-2b5f-4d73-bd16-0d0cc7127df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_3d82ee44-2b5f-4d73-bd16-0d0cc7127df8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c6115097-a066-417a-823d-b8cd13bd2f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c6115097-a066-417a-823d-b8cd13bd2f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6115097-a066-417a-823d-b8cd13bd2f94_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c6115097-a066-417a-823d-b8cd13bd2f94" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6115097-a066-417a-823d-b8cd13bd2f94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe811682-9665-44c5-968a-c1363edf0270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c6115097-a066-417a-823d-b8cd13bd2f94" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe811682-9665-44c5-968a-c1363edf0270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_087a894f-04ef-4027-9886-84c382000aac" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe811682-9665-44c5-968a-c1363edf0270" xlink:to="loc_mygn_CounsylIncMember_087a894f-04ef-4027-9886-84c382000aac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e1b97662-1ebc-495d-89ea-1f2957e85fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e1b97662-1ebc-495d-89ea-1f2957e85fb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e1b97662-1ebc-495d-89ea-1f2957e85fb2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e1b97662-1ebc-495d-89ea-1f2957e85fb2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e1b97662-1ebc-495d-89ea-1f2957e85fb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e1b97662-1ebc-495d-89ea-1f2957e85fb2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_be349e83-f7ef-48c7-b09c-7c3ec8395fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:to="loc_us-gaap_DomesticCountryMember_be349e83-f7ef-48c7-b09c-7c3ec8395fe0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_9578f917-6988-47d3-a541-865e59bb8d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:to="loc_us-gaap_ForeignCountryMember_9578f917-6988-47d3-a541-865e59bb8d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d839bcf2-7405-4dee-b84a-c13a32f62c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d839bcf2-7405-4dee-b84a-c13a32f62c0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_863d17fe-6bb5-411b-a996-8d913e4d53f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_863d17fe-6bb5-411b-a996-8d913e4d53f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_863d17fe-6bb5-411b-a996-8d913e4d53f4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_863d17fe-6bb5-411b-a996-8d913e4d53f4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_863d17fe-6bb5-411b-a996-8d913e4d53f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_863d17fe-6bb5-411b-a996-8d913e4d53f4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember_7a108d16-cb67-4770-91cc-530cc9c7320c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:to="loc_us-gaap_NewJerseyDivisionOfTaxationMember_7a108d16-cb67-4770-91cc-530cc9c7320c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_4336b756-0b66-4c5e-885f-a9657dab768a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:to="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_4336b756-0b66-4c5e-885f-a9657dab768a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalMinistryOfFinanceGermanyMember_4d25f8a3-5213-4e3a-89d4-c670f4b0f502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalMinistryOfFinanceGermanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:to="loc_us-gaap_FederalMinistryOfFinanceGermanyMember_4d25f8a3-5213-4e3a-89d4-c670f4b0f502" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_166be2b8-de33-45ca-8627-291a10e5ded5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_166be2b8-de33-45ca-8627-291a10e5ded5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_c8a5c71c-23e9-47a9-9654-caf770cfc324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_TaxPeriodAxis_c8a5c71c-23e9-47a9-9654-caf770cfc324" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_c8a5c71c-23e9-47a9-9654-caf770cfc324_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_c8a5c71c-23e9-47a9-9654-caf770cfc324" xlink:to="loc_us-gaap_TaxPeriodDomain_c8a5c71c-23e9-47a9-9654-caf770cfc324_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_0aa8a861-fce1-4e6f-9d60-8d50896b914f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_c8a5c71c-23e9-47a9-9654-caf770cfc324" xlink:to="loc_us-gaap_TaxPeriodDomain_0aa8a861-fce1-4e6f-9d60-8d50896b914f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember_c10bb0c6-af1d-444c-af1a-e80844543fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_0aa8a861-fce1-4e6f-9d60-8d50896b914f" xlink:to="loc_us-gaap_EarliestTaxYearMember_c10bb0c6-af1d-444c-af1a-e80844543fe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_82fce63f-b6fe-49ac-bc49-624b9d85cb52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_0aa8a861-fce1-4e6f-9d60-8d50896b914f" xlink:to="loc_us-gaap_LatestTaxYearMember_82fce63f-b6fe-49ac-bc49-624b9d85cb52" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails" xlink:type="extended" id="ie43c5428fb3d497ca31f21357d5f7db4_IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_f1349a81-69dd-46db-9025-a19c25027e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_OperatingLossCarryforwards_f1349a81-69dd-46db-9025-a19c25027e25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_9e273480-a2e9-4efd-a857-4ccca8fd594e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_9e273480-a2e9-4efd-a857-4ccca8fd594e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_f7f150d3-ee5e-4d87-8e4b-cec88741244a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_f7f150d3-ee5e-4d87-8e4b-cec88741244a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse_d6ef7423-f54b-49f7-8fb3-14ec918a0e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse_d6ef7423-f54b-49f7-8fb3-14ec918a0e42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLossCarryforwardsExpirationYear_67e83fa0-9e79-4d54-8020-f7d98a368a16" xlink:href="mygn-20201231.xsd#mygn_OperatingLossCarryforwardsExpirationYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_mygn_OperatingLossCarryforwardsExpirationYear_67e83fa0-9e79-4d54-8020-f7d98a368a16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TaxCreditCarryforwardsExpirationDate_a01addea-9505-47ef-9d98-157817899313" xlink:href="mygn-20201231.xsd#mygn_TaxCreditCarryforwardsExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_mygn_TaxCreditCarryforwardsExpirationDate_a01addea-9505-47ef-9d98-157817899313" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1b3f277e-07f0-416d-b95e-e9753657d1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1b3f277e-07f0-416d-b95e-e9753657d1fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1b3f277e-07f0-416d-b95e-e9753657d1fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1b3f277e-07f0-416d-b95e-e9753657d1fc" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1b3f277e-07f0-416d-b95e-e9753657d1fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1b3f277e-07f0-416d-b95e-e9753657d1fc" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_d8fcf006-764a-4431-b62f-ca306fda27ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:to="loc_us-gaap_DomesticCountryMember_d8fcf006-764a-4431-b62f-ca306fda27ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_5b5fe7e0-9b0d-4695-9402-080df127df6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_5b5fe7e0-9b0d-4695-9402-080df127df6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_918a98b8-3340-442b-b3e1-6b5abd79576b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:to="loc_us-gaap_ForeignCountryMember_918a98b8-3340-442b-b3e1-6b5abd79576b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_82c3a23b-64a9-46d6-83a7-c5aaa08b8265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_82c3a23b-64a9-46d6-83a7-c5aaa08b8265" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_82c3a23b-64a9-46d6-83a7-c5aaa08b8265_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_82c3a23b-64a9-46d6-83a7-c5aaa08b8265" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_82c3a23b-64a9-46d6-83a7-c5aaa08b8265_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_82c3a23b-64a9-46d6-83a7-c5aaa08b8265" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_deaa5742-46e9-406d-a340-c7b47ed7e1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_deaa5742-46e9-406d-a340-c7b47ed7e1f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_UT_2ab28b3a-2c4c-4326-9e11-202144890c14" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_UT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_stpr_UT_2ab28b3a-2c4c-4326-9e11-202144890c14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_566403da-f6e5-48f9-85b6-f129640ba754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_566403da-f6e5-48f9-85b6-f129640ba754" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_401152df-1aad-40e2-ae6e-0fe5f2026b41" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_stpr_TX_401152df-1aad-40e2-ae6e-0fe5f2026b41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OtherStateMember_6a9ecff2-d5e1-4ce9-a783-98ea28bc19e5" xlink:href="mygn-20201231.xsd#mygn_OtherStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_mygn_OtherStateMember_6a9ecff2-d5e1-4ce9-a783-98ea28bc19e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_930b010b-82bd-4778-8008-c4bd8b215996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_930b010b-82bd-4778-8008-c4bd8b215996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_293d3245-027a-4bbe-b44d-80ab06025d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_930b010b-82bd-4778-8008-c4bd8b215996" xlink:to="loc_us-gaap_ResearchMember_293d3245-027a-4bbe-b44d-80ab06025d0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_srt_RangeAxis_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43" xlink:to="loc_srt_RangeMember_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e474ef7-606a-47aa-8004-91dded1835a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43" xlink:to="loc_srt_RangeMember_6e474ef7-606a-47aa-8004-91dded1835a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_242e531b-1f0b-4807-b64f-97557de521c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e474ef7-606a-47aa-8004-91dded1835a8" xlink:to="loc_srt_MinimumMember_242e531b-1f0b-4807-b64f-97557de521c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d71569e8-cbcb-48f0-b4dc-0698d187f27b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e474ef7-606a-47aa-8004-91dded1835a8" xlink:to="loc_srt_MaximumMember_d71569e8-cbcb-48f0-b4dc-0698d187f27b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="i936f877e5cf6414c89682147608e7665_IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mygn-20201231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="extended" id="i7f957659614b441ab9149b1a517fc206_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.myriad.com/role/Leases" xlink:type="simple" xlink:href="mygn-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/Leases" xlink:type="extended" id="id37c3f1d0bcf49c2b4c90cdc1c5d8f39_Leases"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LeasesTables" xlink:type="extended" id="i4ce570a2e7704d73aa01213e9a6420d4_LeasesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LeasesNarrativeDetails" xlink:type="extended" id="ie3a26a3ba0224eac95e4cd2de6fde112_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e76b761c-12c9-4f73-b2e9-426759f02225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e76b761c-12c9-4f73-b2e9-426759f02225" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9643319d-37e5-4b44-ad08-164947142de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_LeaseCost_9643319d-37e5-4b44-ad08-164947142de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_fcaabf55-079f-4900-9e24-e49fe67a56e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_VariableLeaseCost_fcaabf55-079f-4900-9e24-e49fe67a56e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_4d1a54e9-3402-4431-8596-9f1779a6c006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_ShortTermLeaseCost_4d1a54e9-3402-4431-8596-9f1779a6c006" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_3ffd1162-5ddb-426c-8b11-b1f7fcaabbf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_3ffd1162-5ddb-426c-8b11-b1f7fcaabbf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_df68fe99-02e9-4952-b231-164f325a1572" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_df68fe99-02e9-4952-b231-164f325a1572" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_eb77f23e-c603-4883-818b-70f135feb955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_eb77f23e-c603-4883-818b-70f135feb955" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_75908d5e-8edd-4603-86d4-3cb4f077603b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_75908d5e-8edd-4603-86d4-3cb4f077603b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b6f445e8-1620-42ab-a377-f28854d43230" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_75908d5e-8edd-4603-86d4-3cb4f077603b" xlink:to="loc_srt_RangeAxis_b6f445e8-1620-42ab-a377-f28854d43230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6f445e8-1620-42ab-a377-f28854d43230_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b6f445e8-1620-42ab-a377-f28854d43230" xlink:to="loc_srt_RangeMember_b6f445e8-1620-42ab-a377-f28854d43230_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b7da022c-c934-4f9a-805f-6ab792bbc047" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b6f445e8-1620-42ab-a377-f28854d43230" xlink:to="loc_srt_RangeMember_b7da022c-c934-4f9a-805f-6ab792bbc047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d63cd72c-f3e1-46e1-85f0-b2365ba96f5e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b7da022c-c934-4f9a-805f-6ab792bbc047" xlink:to="loc_srt_MinimumMember_d63cd72c-f3e1-46e1-85f0-b2365ba96f5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5447f079-1113-4d8f-b6bc-e16b1aebb370" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b7da022c-c934-4f9a-805f-6ab792bbc047" xlink:to="loc_srt_MaximumMember_5447f079-1113-4d8f-b6bc-e16b1aebb370" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended" id="i744dabb4a0394ccba7b117a9e0120a30_LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlan" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlan"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlan" xlink:type="extended" id="i3e3e9c1a89d040eab068ab12b3a686bd_EmployeeDeferredSavingsPlan"/>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables" xlink:type="extended" id="ic51a4936327f45f2882bb2a89f5889c8_EmployeeDeferredSavingsPlanTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails" xlink:type="extended" id="i3638c67e73444a12b9b3f8764e32f5d2_EmployeeDeferredSavingsPlanNarrativeDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanContributionstoPlanDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails" xlink:type="extended" id="i925e7299cc2f450eafc9f33416824653_EmployeeDeferredSavingsPlanContributionstoPlanDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformation"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="extended" id="i7c7654af99c444aeb27af59232a89b93_SegmentandRelatedInformation"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="extended" id="i99061a84e01e4d5589c72289fcb2ba8a_SegmentandRelatedInformationTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="extended" id="ib6d12c5dab9d46f79938e340f25386af_SegmentandRelatedInformationNarrativeDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails" xlink:type="extended" id="i8b734dba565e4c779856a9e35ff57933_SegmentandRelatedInformationSegmentOperatingIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea171b00-0c9d-4e0b-bcf3-16821790e393" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea171b00-0c9d-4e0b-bcf3-16821790e393" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_50ed9327-0c44-4019-b7a3-74c84e340ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:to="loc_us-gaap_DepreciationAndAmortization_50ed9327-0c44-4019-b7a3-74c84e340ffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_841d5948-aa8d-4b8d-9ba0-e6c8eb405ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:to="loc_us-gaap_OperatingIncomeLoss_841d5948-aa8d-4b8d-9ba0-e6c8eb405ae6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0e74ef88-0a78-4d1b-87fa-d65d2729da1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:to="loc_srt_ConsolidationItemsAxis_0e74ef88-0a78-4d1b-87fa-d65d2729da1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0e74ef88-0a78-4d1b-87fa-d65d2729da1b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0e74ef88-0a78-4d1b-87fa-d65d2729da1b" xlink:to="loc_srt_ConsolidationItemsDomain_0e74ef88-0a78-4d1b-87fa-d65d2729da1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_385a61e7-8950-4ae1-8c80-105f60ce61ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0e74ef88-0a78-4d1b-87fa-d65d2729da1b" xlink:to="loc_srt_ConsolidationItemsDomain_385a61e7-8950-4ae1-8c80-105f60ce61ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ca8c66aa-998d-4b57-af25-b0ea5dc6e0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_385a61e7-8950-4ae1-8c80-105f60ce61ac" xlink:to="loc_us-gaap_OperatingSegmentsMember_ca8c66aa-998d-4b57-af25-b0ea5dc6e0a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_da7f5ed8-b422-4032-86dc-53d9fc933c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_da7f5ed8-b422-4032-86dc-53d9fc933c4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_da7f5ed8-b422-4032-86dc-53d9fc933c4d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_da7f5ed8-b422-4032-86dc-53d9fc933c4d" xlink:to="loc_us-gaap_SegmentDomain_da7f5ed8-b422-4032-86dc-53d9fc933c4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a0b56454-e611-4770-8d5e-464dfb835a1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_da7f5ed8-b422-4032-86dc-53d9fc933c4d" xlink:to="loc_us-gaap_SegmentDomain_a0b56454-e611-4770-8d5e-464dfb835a1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_9ca8d979-a038-4c67-8b76-030e698bf763" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a0b56454-e611-4770-8d5e-464dfb835a1f" xlink:to="loc_mygn_DiagnosticMember_9ca8d979-a038-4c67-8b76-030e698bf763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_2bfbe66e-1ec1-4c32-8b54-b325040e5cf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a0b56454-e611-4770-8d5e-464dfb835a1f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_2bfbe66e-1ec1-4c32-8b54-b325040e5cf0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="extended" id="iff27d1b2422b49969edb92e99eaeacdd_SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails" xlink:type="extended" id="i80e87ac0e45e41bd9566e20419cace1a_SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d90c8016-0a53-4a39-b2f0-ad89a7ccd835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6b69fe38-896f-4cb3-8bdb-6f57c15862c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d90c8016-0a53-4a39-b2f0-ad89a7ccd835" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6b69fe38-896f-4cb3-8bdb-6f57c15862c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments_98117f0a-c40b-43fb-8a58-1594a3d94ece" xlink:href="mygn-20201231.xsd#mygn_AssetsLessCashCashEquivalentsAndInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d90c8016-0a53-4a39-b2f0-ad89a7ccd835" xlink:to="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments_98117f0a-c40b-43fb-8a58-1594a3d94ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d90c8016-0a53-4a39-b2f0-ad89a7ccd835" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:to="loc_srt_ConsolidationItemsAxis_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9" xlink:to="loc_srt_ConsolidationItemsDomain_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b37b2b52-4a3e-4c3d-a489-b57a9d28993f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9" xlink:to="loc_srt_ConsolidationItemsDomain_b37b2b52-4a3e-4c3d-a489-b57a9d28993f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_44d3d561-4c7c-4df3-9640-7abe0a561e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b37b2b52-4a3e-4c3d-a489-b57a9d28993f" xlink:to="loc_us-gaap_OperatingSegmentsMember_44d3d561-4c7c-4df3-9640-7abe0a561e54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83f976c3-1bd3-41a3-a84f-ae96a7ceb392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83f976c3-1bd3-41a3-a84f-ae96a7ceb392" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83f976c3-1bd3-41a3-a84f-ae96a7ceb392_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83f976c3-1bd3-41a3-a84f-ae96a7ceb392" xlink:to="loc_us-gaap_SegmentDomain_83f976c3-1bd3-41a3-a84f-ae96a7ceb392_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2681276c-4af0-43de-ac0b-534a54a9e659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83f976c3-1bd3-41a3-a84f-ae96a7ceb392" xlink:to="loc_us-gaap_SegmentDomain_2681276c-4af0-43de-ac0b-534a54a9e659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_b790ba11-d541-40c6-9da5-a2d44bb727b9" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2681276c-4af0-43de-ac0b-534a54a9e659" xlink:to="loc_mygn_DiagnosticMember_b790ba11-d541-40c6-9da5-a2d44bb727b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_e70b861e-e379-451b-9afc-b3d286dea784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2681276c-4af0-43de-ac0b-534a54a9e659" xlink:to="loc_us-gaap_AllOtherSegmentsMember_e70b861e-e379-451b-9afc-b3d286dea784" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationAssetsbyGeographicalRegionDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails" xlink:type="extended" id="i2ae380c6027f4750b014da46f025bacd_SegmentandRelatedInformationAssetsbyGeographicalRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fbd36235-5dc9-4a65-9515-04f282b93d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fbd36235-5dc9-4a65-9515-04f282b93d4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments_eb9dcdda-f42f-4886-b2ea-12c095f4766d" xlink:href="mygn-20201231.xsd#mygn_AssetsLessCashCashEquivalentsAndInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments_eb9dcdda-f42f-4886-b2ea-12c095f4766d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f5425fb4-1d7c-4328-920e-c32402d3b7cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f5425fb4-1d7c-4328-920e-c32402d3b7cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2cbe7a4c-1bed-4470-a3b8-6cdc77f4c2e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_us-gaap_Assets_2cbe7a4c-1bed-4470-a3b8-6cdc77f4c2e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3dd00fbe-165b-49ab-a6af-792f12e13677" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:to="loc_srt_ConsolidationItemsAxis_3dd00fbe-165b-49ab-a6af-792f12e13677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3dd00fbe-165b-49ab-a6af-792f12e13677_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3dd00fbe-165b-49ab-a6af-792f12e13677" xlink:to="loc_srt_ConsolidationItemsDomain_3dd00fbe-165b-49ab-a6af-792f12e13677_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a8713db4-027e-4128-8415-df3bfd36406d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3dd00fbe-165b-49ab-a6af-792f12e13677" xlink:to="loc_srt_ConsolidationItemsDomain_a8713db4-027e-4128-8415-df3bfd36406d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember_71a35f6a-a51c-437f-a32e-b4413ff21f2b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a8713db4-027e-4128-8415-df3bfd36406d" xlink:to="loc_srt_ReportableGeographicalComponentsMember_71a35f6a-a51c-437f-a32e-b4413ff21f2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d8506cc0-92a0-4370-9baa-80e10db15eb0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:to="loc_srt_StatementGeographicalAxis_d8506cc0-92a0-4370-9baa-80e10db15eb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d8506cc0-92a0-4370-9baa-80e10db15eb0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d8506cc0-92a0-4370-9baa-80e10db15eb0" xlink:to="loc_srt_SegmentGeographicalDomain_d8506cc0-92a0-4370-9baa-80e10db15eb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f2e84cb9-fc2b-40fb-94e8-77e3990c1a4c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d8506cc0-92a0-4370-9baa-80e10db15eb0" xlink:to="loc_srt_SegmentGeographicalDomain_f2e84cb9-fc2b-40fb-94e8-77e3990c1a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7f351ab8-2e16-4b0e-a7f2-2635800da4aa" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f2e84cb9-fc2b-40fb-94e8-77e3990c1a4c" xlink:to="loc_country_US_7f351ab8-2e16-4b0e-a7f2-2635800da4aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_1159c011-47d5-436e-b3bc-d69d509c4bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f2e84cb9-fc2b-40fb-94e8-77e3990c1a4c" xlink:to="loc_us-gaap_NonUsMember_1159c011-47d5-436e-b3bc-d69d509c4bc9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationRevenuebyGeographicalRegionDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails" xlink:type="extended" id="iec7cc0acfefc4d4280075e525fbfd600_SegmentandRelatedInformationRevenuebyGeographicalRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1aa14d9d-9f8b-42a6-92e1-60cd47cb4f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_684f534f-209a-4c45-a6de-b58784453519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1aa14d9d-9f8b-42a6-92e1-60cd47cb4f93" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_684f534f-209a-4c45-a6de-b58784453519" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8be86047-0e36-47b7-bf34-a5ebadbba999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1aa14d9d-9f8b-42a6-92e1-60cd47cb4f93" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8be86047-0e36-47b7-bf34-a5ebadbba999" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8be86047-0e36-47b7-bf34-a5ebadbba999" xlink:to="loc_srt_StatementGeographicalAxis_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1" xlink:to="loc_srt_SegmentGeographicalDomain_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4593bfa3-493e-4e75-b213-790a944de4a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1" xlink:to="loc_srt_SegmentGeographicalDomain_4593bfa3-493e-4e75-b213-790a944de4a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ca1963d4-5059-4370-86be-0da3c2a115f7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4593bfa3-493e-4e75-b213-790a944de4a3" xlink:to="loc_country_US_ca1963d4-5059-4370-86be-0da3c2a115f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_699ee70d-10db-435e-b6f6-9ccf95317dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4593bfa3-493e-4e75-b213-790a944de4a3" xlink:to="loc_us-gaap_NonUsMember_699ee70d-10db-435e-b6f6-9ccf95317dc7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SaleofSubsidiary" xlink:type="simple" xlink:href="mygn-20201231.xsd#SaleofSubsidiary"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SaleofSubsidiary" xlink:type="extended" id="ifeeac074ba8e44e9a76ab5bce0a8beba_SaleofSubsidiary"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SaleofSubsidiaryDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SaleofSubsidiaryDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SaleofSubsidiaryDetails" xlink:type="extended" id="i147d0e1ef70c4ec28aac88f77e2cf820_SaleofSubsidiaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_904a2a40-6157-436d-86cd-afa5515fa66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_904a2a40-6157-436d-86cd-afa5515fa66f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension_8036ee9e-eec4-4846-a3d8-4b09dd16ba8e" xlink:href="mygn-20201231.xsd#mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:to="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension_8036ee9e-eec4-4846-a3d8-4b09dd16ba8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect_f1939946-514b-474d-ae7c-aaece897ba9c" xlink:href="mygn-20201231.xsd#mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:to="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect_f1939946-514b-474d-ae7c-aaece897ba9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f22fbb58-002c-4480-9966-2eb0beea887b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f22fbb58-002c-4480-9966-2eb0beea887b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_910ef082-b9f4-4b0f-9ca7-294932c32615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f22fbb58-002c-4480-9966-2eb0beea887b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_910ef082-b9f4-4b0f-9ca7-294932c32615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_910ef082-b9f4-4b0f-9ca7-294932c32615_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_910ef082-b9f4-4b0f-9ca7-294932c32615" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_910ef082-b9f4-4b0f-9ca7-294932c32615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0fb6db34-0b89-4569-836c-beb8bf67f3c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_910ef082-b9f4-4b0f-9ca7-294932c32615" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0fb6db34-0b89-4569-836c-beb8bf67f3c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ClinicAssetGroupMember_d5b4dce6-235c-4c4c-ad54-96a9a40a0821" xlink:href="mygn-20201231.xsd#mygn_ClinicAssetGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0fb6db34-0b89-4569-836c-beb8bf67f3c2" xlink:to="loc_mygn_ClinicAssetGroupMember_d5b4dce6-235c-4c4c-ad54-96a9a40a0821" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitions" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitions"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/BusinessAcquisitions" xlink:type="extended" id="i1b50af5f4d0944e28d0350635d03f00c_BusinessAcquisitions"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsTables" xlink:type="extended" id="i33d608e3c122499f9c213d3563635e3e_BusinessAcquisitionsTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails" xlink:type="extended" id="ic0cccb79c34d4ece87473289dce209a3_BusinessAcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_882a4e86-67d7-46d5-bdb2-06458edf87b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_882a4e86-67d7-46d5-bdb2-06458edf87b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_612d6391-44d2-4458-94f3-4d0c0017525e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_612d6391-44d2-4458-94f3-4d0c0017525e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_725cdd3d-44be-4076-8850-28a26eccd97a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_725cdd3d-44be-4076-8850-28a26eccd97a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_24ba933a-7958-420c-a99c-9f8a320ab91a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_24ba933a-7958-420c-a99c-9f8a320ab91a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_77580489-14db-414b-980e-f9844af8e65c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_77580489-14db-414b-980e-f9844af8e65c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1_5ccc54f5-f80c-4823-afa6-8957ee4a0f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1_5ccc54f5-f80c-4823-afa6-8957ee4a0f24" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_f58a6666-defb-4b31-a284-e0bc0e00e477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_f58a6666-defb-4b31-a284-e0bc0e00e477" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_74de38c3-5b44-40e7-8b84-1c5dfcb0a355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_74de38c3-5b44-40e7-8b84-1c5dfcb0a355" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_fbe3d9da-6f40-4f73-a358-cc3db65ff42d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_fbe3d9da-6f40-4f73-a358-cc3db65ff42d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_798054e6-d96c-4aa0-95ca-683b1b607cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_798054e6-d96c-4aa0-95ca-683b1b607cc1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_59ec94dc-63da-4185-afe1-d443a53be5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_59ec94dc-63da-4185-afe1-d443a53be5f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_3b96e18b-ee82-499f-afbb-9ef0c9817db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_3b96e18b-ee82-499f-afbb-9ef0c9817db3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent_983572b0-33a3-4202-9207-c23c50225c71" xlink:href="mygn-20201231.xsd#mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent_983572b0-33a3-4202-9207-c23c50225c71" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c0041ab8-1f59-4c50-802c-efbcd4e87e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c0041ab8-1f59-4c50-802c-efbcd4e87e3f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_227df039-780d-4548-b5f3-40adc7fca200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_227df039-780d-4548-b5f3-40adc7fca200" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_b9b7939b-68b2-4bf1-a150-26deba15bbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_b9b7939b-68b2-4bf1-a150-26deba15bbc7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_241325a9-abb8-4e76-a4bb-89384ae71596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_OperatingExpenses_241325a9-abb8-4e76-a4bb-89384ae71596" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_963e4150-0baa-4fe9-8291-ce145f98ac34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_963e4150-0baa-4fe9-8291-ce145f98ac34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963e4150-0baa-4fe9-8291-ce145f98ac34_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_963e4150-0baa-4fe9-8291-ce145f98ac34" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963e4150-0baa-4fe9-8291-ce145f98ac34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_313b7829-bcb6-46ef-a145-5938782903b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_963e4150-0baa-4fe9-8291-ce145f98ac34" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_313b7829-bcb6-46ef-a145-5938782903b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_26d1ab44-79c1-432c-849d-51e21016b0b0" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_313b7829-bcb6-46ef-a145-5938782903b8" xlink:to="loc_mygn_CounsylIncMember_26d1ab44-79c1-432c-849d-51e21016b0b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6" xlink:to="loc_us-gaap_ClassOfStockDomain_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4da4d7de-3095-4bd9-b204-e4e8dd931d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6" xlink:to="loc_us-gaap_ClassOfStockDomain_4da4d7de-3095-4bd9-b204-e4e8dd931d4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_b17cb24f-947f-490d-aa8a-8a196d17597d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4da4d7de-3095-4bd9-b204-e4e8dd931d4d" xlink:to="loc_us-gaap_CommonClassAMember_b17cb24f-947f-490d-aa8a-8a196d17597d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59f36706-07db-48f3-8244-c0ea2defc5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59f36706-07db-48f3-8244-c0ea2defc5fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59f36706-07db-48f3-8244-c0ea2defc5fe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59f36706-07db-48f3-8244-c0ea2defc5fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59f36706-07db-48f3-8244-c0ea2defc5fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e2d3d647-2830-4796-94aa-413a98556a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59f36706-07db-48f3-8244-c0ea2defc5fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e2d3d647-2830-4796-94aa-413a98556a31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_30872c91-c1da-48ff-89fb-92040d68087c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e2d3d647-2830-4796-94aa-413a98556a31" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_30872c91-c1da-48ff-89fb-92040d68087c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsTotalConsiderationTransferredDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails" xlink:type="extended" id="i81d1f37e6a4c40069bf8828ba302d3b3_BusinessAcquisitionsTotalConsiderationTransferredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_aebf786a-fd8a-41cb-9348-4e213e28606d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_aebf786a-fd8a-41cb-9348-4e213e28606d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b1ce42a1-6086-47a5-8d0c-fc20103b6ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b1ce42a1-6086-47a5-8d0c-fc20103b6ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c6e08f7a-1d4c-4437-8b76-561bd98ee94a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c6e08f7a-1d4c-4437-8b76-561bd98ee94a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_908eff77-f85f-4858-ac5e-b79367ba9143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_908eff77-f85f-4858-ac5e-b79367ba9143" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6477a3c4-9f50-4bb7-be4c-0bea0b87c6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_Goodwill_6477a3c4-9f50-4bb7-be4c-0bea0b87c6ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_30c5e684-d8cf-4284-8220-fa004f118c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_30c5e684-d8cf-4284-8220-fa004f118c34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_210b7705-9cbd-4fff-b2c9-af1f40ab1da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_210b7705-9cbd-4fff-b2c9-af1f40ab1da1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ff12f2a6-9d06-4576-aeda-84450d29043e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ff12f2a6-9d06-4576-aeda-84450d29043e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0516af91-2de1-4b13-975f-1713fdf4e88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0516af91-2de1-4b13-975f-1713fdf4e88d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_b0ce3346-fb86-4b93-aeb8-09838479435f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_b0ce3346-fb86-4b93-aeb8-09838479435f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_27c066db-6d66-4c93-bb31-9d11d5ec8db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_27c066db-6d66-4c93-bb31-9d11d5ec8db4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_62143bf7-7099-45b0-992d-b4b0ce953175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_62143bf7-7099-45b0-992d-b4b0ce953175" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_62143bf7-7099-45b0-992d-b4b0ce953175" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_651d7201-d0ad-4382-839e-f47aa9a0c7b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_651d7201-d0ad-4382-839e-f47aa9a0c7b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_35cbbd1b-8b25-42b4-b1eb-ccc6e91d3b47" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_651d7201-d0ad-4382-839e-f47aa9a0c7b3" xlink:to="loc_mygn_CounsylIncMember_35cbbd1b-8b25-42b4-b1eb-ccc6e91d3b47" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsChangestoGoodwillBalanceDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails" xlink:type="extended" id="ia9f8db1dfcd143d2a8aebcab55556054_BusinessAcquisitionsChangestoGoodwillBalanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f31cf9ea-6b3f-4639-916b-8d87cbe443c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f31cf9ea-6b3f-4639-916b-8d87cbe443c3" xlink:to="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5c25d7d7-29ad-47f2-8dc4-0db3ece3c62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_us-gaap_Goodwill_5c25d7d7-29ad-47f2-8dc4-0db3ece3c62b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment_10f54e53-bb67-4582-9f4e-33a694037682" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment_10f54e53-bb67-4582-9f4e-33a694037682" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment_15ead665-4249-4dcb-8ff9-2949e1385ab3" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment_15ead665-4249-4dcb-8ff9-2949e1385ab3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment_ae7a05a6-f953-45dd-b5a5-89767bb1daa3" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment_ae7a05a6-f953-45dd-b5a5-89767bb1daa3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment_e8670d38-73d8-42d2-adc6-5606cb0b8f18" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment_e8670d38-73d8-42d2-adc6-5606cb0b8f18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f13985f1-541b-48a0-a491-cddca1cada66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c446519c-f32b-4385-8292-15f3099b7121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_f31cf9ea-6b3f-4639-916b-8d87cbe443c3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c446519c-f32b-4385-8292-15f3099b7121" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c446519c-f32b-4385-8292-15f3099b7121" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9afb707b-a411-4797-be39-b375110bd474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9afb707b-a411-4797-be39-b375110bd474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_48494d12-d6f4-4abc-a433-1ebd62ced585" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9afb707b-a411-4797-be39-b375110bd474" xlink:to="loc_mygn_CounsylIncMember_48494d12-d6f4-4abc-a433-1ebd62ced585" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsProFormaResultsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails" xlink:type="extended" id="i4c5e179797b04cb8a1c2371727025f19_BusinessAcquisitionsProFormaResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fd65dd85-c56a-4a88-b159-df6f5359d0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fd65dd85-c56a-4a88-b159-df6f5359d0ac" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_61018608-b3db-4dcb-94f8-f13cd3660554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_61018608-b3db-4dcb-94f8-f13cd3660554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_9b801fa4-3f5d-46bb-84f2-cf92d9a8bd15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_9b801fa4-3f5d-46bb-84f2-cf92d9a8bd15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4f9eba22-53d6-45ef-b7d1-e852ab51483b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4f9eba22-53d6-45ef-b7d1-e852ab51483b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_f8fb24e4-2ac0-4c9d-a682-eba167dd6297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_f8fb24e4-2ac0-4c9d-a682-eba167dd6297" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_bd2c00cb-f1f0-488a-a7d9-0d270e87b7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_bd2c00cb-f1f0-488a-a7d9-0d270e87b7fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0703f802-6e87-4703-8a6b-060e0e65493d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fd65dd85-c56a-4a88-b159-df6f5359d0ac" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0703f802-6e87-4703-8a6b-060e0e65493d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ff213eb0-2439-48ea-932e-8f8983f3670f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0703f802-6e87-4703-8a6b-060e0e65493d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ff213eb0-2439-48ea-932e-8f8983f3670f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff213eb0-2439-48ea-932e-8f8983f3670f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ff213eb0-2439-48ea-932e-8f8983f3670f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff213eb0-2439-48ea-932e-8f8983f3670f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a3696feb-d831-4ee1-88dc-fbc4e3f9dc51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ff213eb0-2439-48ea-932e-8f8983f3670f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a3696feb-d831-4ee1-88dc-fbc4e3f9dc51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_b310324e-b57d-41a3-9ed2-21f65075fb13" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a3696feb-d831-4ee1-88dc-fbc4e3f9dc51" xlink:to="loc_mygn_CounsylIncMember_b310324e-b57d-41a3-9ed2-21f65075fb13" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEvent" xlink:type="simple" xlink:href="mygn-20201231.xsd#SubsequentEvent"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SubsequentEvent" xlink:type="extended" id="i07d42d005298486dae23b16fc94c31ce_SubsequentEvent"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SubsequentEventDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SubsequentEventDetails" xlink:type="extended" id="i45b636ef8858479091d8377585f69d38_SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8f7e0c65-8e15-472c-961b-d0a84a72ccfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum_10a9c37e-0678-4f8c-93b1-3ecc799a8700" xlink:href="mygn-20201231.xsd#mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8f7e0c65-8e15-472c-961b-d0a84a72ccfd" xlink:to="loc_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum_10a9c37e-0678-4f8c-93b1-3ecc799a8700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_aa735290-13ae-4b88-bdc5-35e472e4982d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8f7e0c65-8e15-472c-961b-d0a84a72ccfd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_aa735290-13ae-4b88-bdc5-35e472e4982d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_8f7e0c65-8e15-472c-961b-d0a84a72ccfd" xlink:to="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7afcf928-9b3a-45d1-affd-dc840f308951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_us-gaap_CreditFacilityAxis_7afcf928-9b3a-45d1-affd-dc840f308951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7afcf928-9b3a-45d1-affd-dc840f308951_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7afcf928-9b3a-45d1-affd-dc840f308951" xlink:to="loc_us-gaap_CreditFacilityDomain_7afcf928-9b3a-45d1-affd-dc840f308951_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c721267f-88ef-44e9-9b53-e11d7140155b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7afcf928-9b3a-45d1-affd-dc840f308951" xlink:to="loc_us-gaap_CreditFacilityDomain_c721267f-88ef-44e9-9b53-e11d7140155b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e8a72cce-001c-43bc-a195-d8579c5e954c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c721267f-88ef-44e9-9b53-e11d7140155b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e8a72cce-001c-43bc-a195-d8579c5e954c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_us-gaap_DebtInstrumentAxis_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c5f6a554-74c1-422b-9200-c34f917a76f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c5f6a554-74c1-422b-9200-c34f917a76f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmendmentToCreditAgreementMember_9b572712-340b-41cc-8fdb-657a22e36355" xlink:href="mygn-20201231.xsd#mygn_AmendmentToCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c5f6a554-74c1-422b-9200-c34f917a76f7" xlink:to="loc_mygn_AmendmentToCreditAgreementMember_9b572712-340b-41cc-8fdb-657a22e36355" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f9103bbd-8383-4250-b86e-2f22bf330642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f9103bbd-8383-4250-b86e-2f22bf330642" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f9103bbd-8383-4250-b86e-2f22bf330642_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f9103bbd-8383-4250-b86e-2f22bf330642" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f9103bbd-8383-4250-b86e-2f22bf330642_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5e3cd3ca-3675-49da-b862-2828b6697585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f9103bbd-8383-4250-b86e-2f22bf330642" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5e3cd3ca-3675-49da-b862-2828b6697585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_99e62366-ddda-48ca-8e04-8bce616f66a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5e3cd3ca-3675-49da-b862-2828b6697585" xlink:to="loc_us-gaap_SubsequentEventMember_99e62366-ddda-48ca-8e04-8bce616f66a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_srt_StatementScenarioAxis_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cf895492-ed7f-4dbd-b3e6-0fea9ce64f3f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cf895492-ed7f-4dbd-b3e6-0fea9ce64f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_f0bc1ebb-32d9-4303-99d8-12b6367f674f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_cf895492-ed7f-4dbd-b3e6-0fea9ce64f3f" xlink:to="loc_srt_ScenarioForecastMember_f0bc1ebb-32d9-4303-99d8-12b6367f674f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformation"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="extended" id="iac0bb88c6c4c4b90abd20f7f1a823b7d_SupplementalCashFlowInformation"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformationTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="extended" id="if384b7729058417cad863f0fce0ed63b_SupplementalCashFlowInformationTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended" id="i253abb12ce3b4dc6ad85f01ef23729f4_SupplementalCashFlowInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c36ac18-5cf7-44b4-b5c5-8e73b4d8a2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c36ac18-5cf7-44b4-b5c5-8e73b4d8a2bb" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5b8fe47d-6060-40c6-8135-64b72e3866de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5b8fe47d-6060-40c6-8135-64b72e3866de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLeaseLiabilityEstablished_2a07fd9e-8f3f-4766-b5a4-8dc00bdd47a4" xlink:href="mygn-20201231.xsd#mygn_OperatingLeaseLiabilityEstablished"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:to="loc_mygn_OperatingLeaseLiabilityEstablished_2a07fd9e-8f3f-4766-b5a4-8dc00bdd47a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_67552679-a140-4161-a0e7-6b8762433de8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_67552679-a140-4161-a0e7-6b8762433de8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ec0c87b5-64f1-42b3-abf0-c9fac05fa607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c36ac18-5cf7-44b4-b5c5-8e73b4d8a2bb" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ec0c87b5-64f1-42b3-abf0-c9fac05fa607" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cbda8780-d334-4d77-91c6-623586c436f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ec0c87b5-64f1-42b3-abf0-c9fac05fa607" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cbda8780-d334-4d77-91c6-623586c436f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_cbda8780-d334-4d77-91c6-623586c436f0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cbda8780-d334-4d77-91c6-623586c436f0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_cbda8780-d334-4d77-91c6-623586c436f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_e271ab4d-8ea7-4fb6-9828-a1001933b1de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cbda8780-d334-4d77-91c6-623586c436f0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_e271ab4d-8ea7-4fb6-9828-a1001933b1de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_6d311bb0-65e6-4a45-b05f-ed758a7779ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_e271ab4d-8ea7-4fb6-9828-a1001933b1de" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_6d311bb0-65e6-4a45-b05f-ed758a7779ad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnaudited"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited" xlink:type="extended" id="i85cad8bd83ec4aadad0053354dad7219_SupplementaryQuarterlyFinancialDataUnaudited"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables" xlink:type="extended" id="i696ea8ba0c1b4df1bdeb67c7fe81c6ff_SupplementaryQuarterlyFinancialDataUnauditedTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails" xlink:type="extended" id="i979bf9f04b784aaca58206bba8444926_SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d6e4db7-4aa7-4a6c-9d2e-d622f945ff13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d6e4db7-4aa7-4a6c-9d2e-d622f945ff13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a08dad5a-9681-4d60-a2db-1436836fc01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a08dad5a-9681-4d60-a2db-1436836fc01d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0175ab49-f00d-4bc3-a59f-c18460c7fe9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0175ab49-f00d-4bc3-a59f-c18460c7fe9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_93793807-a02f-43ca-85e3-5610f044cdbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_93793807-a02f-43ca-85e3-5610f044cdbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eb342847-31cb-467e-b103-d32c5fc72697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eb342847-31cb-467e-b103-d32c5fc72697" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b1463164-47d0-4f51-b886-80bb1b8b4f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b1463164-47d0-4f51-b886-80bb1b8b4f29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_c3280566-865c-4f06-a2d1-363ff112cda1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_CostsAndExpenses_c3280566-865c-4f06-a2d1-363ff112cda1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b7882291-bab8-4325-b1e1-333708b48596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_OperatingIncomeLoss_b7882291-bab8-4325-b1e1-333708b48596" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_dd0baafc-eaac-46b2-8896-24fcb2c7b61f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:to="loc_us-gaap_InvestmentIncomeInterest_dd0baafc-eaac-46b2-8896-24fcb2c7b61f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_31000d64-94c9-4634-b06f-d35c8b4e4abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:to="loc_us-gaap_InterestExpense_31000d64-94c9-4634-b06f-d35c8b4e4abe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bf3e573c-238a-490f-98b1-d7ab8d4a4c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bf3e573c-238a-490f-98b1-d7ab8d4a4c61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cd46d9cf-3adb-49b5-be94-142583a7d91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cd46d9cf-3adb-49b5-be94-142583a7d91b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1888b324-dc4b-496e-b354-43ccbcfcb63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1888b324-dc4b-496e-b354-43ccbcfcb63a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d3ce94b4-fd88-4faf-a423-e9bcf6da33cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d3ce94b4-fd88-4faf-a423-e9bcf6da33cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9b0965f6-3a9f-43a0-a0b2-4e34997ace9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_ProfitLoss_9b0965f6-3a9f-43a0-a0b2-4e34997ace9c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efe09464-7d5f-4c4b-9e80-bdbf57a74d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efe09464-7d5f-4c4b-9e80-bdbf57a74d13" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2b435570-d2a3-4c57-9290-3249ea35b5e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_NetIncomeLoss_2b435570-d2a3-4c57-9290-3249ea35b5e4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a006d4b9-275c-4b87-b484-c65ffd0cf0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a006d4b9-275c-4b87-b484-c65ffd0cf0b7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_652fd041-c189-492a-9b41-f003dd7f0dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a006d4b9-275c-4b87-b484-c65ffd0cf0b7" xlink:to="loc_us-gaap_EarningsPerShareBasic_652fd041-c189-492a-9b41-f003dd7f0dbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_729322e1-9a52-460b-9a3f-a033ee90cd13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a006d4b9-275c-4b87-b484-c65ffd0cf0b7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_729322e1-9a52-460b-9a3f-a033ee90cd13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cca5e8f7-87ff-4566-88f0-fe98d55f77ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cca5e8f7-87ff-4566-88f0-fe98d55f77ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_035504ca-f567-45d3-b045-465ac039bee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cca5e8f7-87ff-4566-88f0-fe98d55f77ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_035504ca-f567-45d3-b045-465ac039bee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_949ae761-c9a5-4d34-9cad-f4447ebbaac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cca5e8f7-87ff-4566-88f0-fe98d55f77ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_949ae761-c9a5-4d34-9cad-f4447ebbaac3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f6a66828-ec59-424b-bef8-aeb8ae2c92b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_StatementTable_f6a66828-ec59-424b-bef8-aeb8ae2c92b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f6a66828-ec59-424b-bef8-aeb8ae2c92b2" xlink:to="loc_srt_ProductOrServiceAxis_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0" xlink:to="loc_srt_ProductsAndServicesDomain_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_68acb295-3f38-40c6-8783-efde68b1036c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0" xlink:to="loc_srt_ProductsAndServicesDomain_68acb295-3f38-40c6-8783-efde68b1036c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_9850656d-ff81-4d6c-85a5-e42b85aaa5c9" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_68acb295-3f38-40c6-8783-efde68b1036c" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_9850656d-ff81-4d6c-85a5-e42b85aaa5c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_e8d53a00-ae7c-4564-90a3-5c2ad718529a" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_68acb295-3f38-40c6-8783-efde68b1036c" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_e8d53a00-ae7c-4564-90a3-5c2ad718529a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails" xlink:type="extended" id="ia91677b03ead44f085652245d4372b9a_SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_92d6766c-bf1f-4268-b00f-9e83470a99ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_97ce8972-753c-43ec-8878-a0855e651f9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationLineItems_92d6766c-bf1f-4268-b00f-9e83470a99ce" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_97ce8972-753c-43ec-8878-a0855e651f9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationLineItems_92d6766c-bf1f-4268-b00f-9e83470a99ce" xlink:to="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_b5c38832-abce-45c2-902d-6e1ef606d44c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:to="loc_srt_RestatementAxis_b5c38832-abce-45c2-902d-6e1ef606d44c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_b5c38832-abce-45c2-902d-6e1ef606d44c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_b5c38832-abce-45c2-902d-6e1ef606d44c" xlink:to="loc_srt_RestatementDomain_b5c38832-abce-45c2-902d-6e1ef606d44c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_2f399a65-8b84-489f-b0c2-e7a09bd61ded" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_b5c38832-abce-45c2-902d-6e1ef606d44c" xlink:to="loc_srt_RestatementDomain_2f399a65-8b84-489f-b0c2-e7a09bd61ded" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_3c358dbc-2172-4e23-a278-81d7f653b373" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_2f399a65-8b84-489f-b0c2-e7a09bd61ded" xlink:to="loc_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_3c358dbc-2172-4e23-a278-81d7f653b373" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f170ca23-0a63-4100-b9f2-60312b917511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f170ca23-0a63-4100-b9f2-60312b917511" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f170ca23-0a63-4100-b9f2-60312b917511_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f170ca23-0a63-4100-b9f2-60312b917511" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f170ca23-0a63-4100-b9f2-60312b917511_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8a5d4494-5e0b-42e1-93e6-e23f02097d11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f170ca23-0a63-4100-b9f2-60312b917511" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8a5d4494-5e0b-42e1-93e6-e23f02097d11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3e956223-d7e7-4b82-89d3-62639208814f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8a5d4494-5e0b-42e1-93e6-e23f02097d11" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3e956223-d7e7-4b82-89d3-62639208814f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember_de94878d-10c5-4a6d-a986-26533bc5a7eb" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetImpairmentChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8a5d4494-5e0b-42e1-93e6-e23f02097d11" xlink:to="loc_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember_de94878d-10c5-4a6d-a986-26533bc5a7eb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnaudited"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited" xlink:type="extended" id="i4a354c2a95f14b48a3ee67f162019c19_TransitionPeriodComparativeDataUnaudited"/>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnauditedTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables" xlink:type="extended" id="i5ffe906e338d4e82b65b50203b2ce75b_TransitionPeriodComparativeDataUnauditedTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnauditedDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails" xlink:type="extended" id="i5ec451519f134b54965b87c84c9c4e37_TransitionPeriodComparativeDataUnauditedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:href="mygn-20201231.xsd#mygn_TransitionPeriodFinancialInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f6883ca-b081-4034-ac8b-8088dc8f71d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f6883ca-b081-4034-ac8b-8088dc8f71d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_92ba05ff-1c8b-436a-997c-8f56cdb6846e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_92ba05ff-1c8b-436a-997c-8f56cdb6846e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f2b5c618-742b-4511-b3a7-e77818e27eab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f2b5c618-742b-4511-b3a7-e77818e27eab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b0962161-cf3f-4194-9b22-b92503452f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b0962161-cf3f-4194-9b22-b92503452f20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c6fc638b-0463-4fb5-9b73-5820f24f2984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c6fc638b-0463-4fb5-9b73-5820f24f2984" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_3f119f73-321f-40f5-b5d3-046a9c07992e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_3f119f73-321f-40f5-b5d3-046a9c07992e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_41d00bd8-8b96-4cab-894b-168657069e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_CostsAndExpenses_41d00bd8-8b96-4cab-894b-168657069e14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f06a4e30-1e59-4958-aa8d-e1671a41b256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_OperatingIncomeLoss_f06a4e30-1e59-4958-aa8d-e1671a41b256" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_4cfb6708-e344-40db-9e7c-e18ab9fa6dd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:to="loc_us-gaap_InvestmentIncomeInterest_4cfb6708-e344-40db-9e7c-e18ab9fa6dd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_673c8265-4e0b-43ed-a7a9-95bce3e1eb39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:to="loc_us-gaap_InterestExpense_673c8265-4e0b-43ed-a7a9-95bce3e1eb39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_30db024b-9523-49f7-9726-2d35f47a3ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_30db024b-9523-49f7-9726-2d35f47a3ca6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_8a693e82-0ed8-4403-969e-16524a3683af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_8a693e82-0ed8-4403-969e-16524a3683af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32707960-d0d5-4a3c-ac4c-6a7df0abd53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32707960-d0d5-4a3c-ac4c-6a7df0abd53f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ae35bb72-0b42-45e0-8bc4-93877fea8aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ae35bb72-0b42-45e0-8bc4-93877fea8aa6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3a733a8e-0e89-4f22-8a30-0da9f7e96bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_ProfitLoss_3a733a8e-0e89-4f22-8a30-0da9f7e96bf0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ee005ec1-d9d5-4257-ac83-91f669470fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ee005ec1-d9d5-4257-ac83-91f669470fea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9e53a91c-5d42-48e3-ad5c-39f55145ea93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_NetIncomeLoss_9e53a91c-5d42-48e3-ad5c-39f55145ea93" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_23754fd1-ce4a-42f9-a100-ae46272d68be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_23754fd1-ce4a-42f9-a100-ae46272d68be" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_430c4ec1-53f1-44c1-b7a4-fae75be008f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_23754fd1-ce4a-42f9-a100-ae46272d68be" xlink:to="loc_us-gaap_EarningsPerShareBasic_430c4ec1-53f1-44c1-b7a4-fae75be008f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3e8b7330-62ff-418c-b813-34212109be68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_23754fd1-ce4a-42f9-a100-ae46272d68be" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3e8b7330-62ff-418c-b813-34212109be68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cfe00214-535f-4b35-bf3b-1577c8df012f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cfe00214-535f-4b35-bf3b-1577c8df012f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd8733c3-b9b7-4e39-bdef-d8c8245625df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cfe00214-535f-4b35-bf3b-1577c8df012f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd8733c3-b9b7-4e39-bdef-d8c8245625df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88b5039b-4217-45d6-9096-0e6ee42b156b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cfe00214-535f-4b35-bf3b-1577c8df012f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88b5039b-4217-45d6-9096-0e6ee42b156b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TransitionPeriodFinancialInformationTable_1661b798-c644-41df-8250-df19da7a1ffe" xlink:href="mygn-20201231.xsd#mygn_TransitionPeriodFinancialInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_mygn_TransitionPeriodFinancialInformationTable_1661b798-c644-41df-8250-df19da7a1ffe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_25b90b05-1d86-4514-8887-694206b28a6e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_TransitionPeriodFinancialInformationTable_1661b798-c644-41df-8250-df19da7a1ffe" xlink:to="loc_srt_ProductOrServiceAxis_25b90b05-1d86-4514-8887-694206b28a6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_25b90b05-1d86-4514-8887-694206b28a6e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_25b90b05-1d86-4514-8887-694206b28a6e" xlink:to="loc_srt_ProductsAndServicesDomain_25b90b05-1d86-4514-8887-694206b28a6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5cc02d37-5a93-4bce-a780-20bf5f632be9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_25b90b05-1d86-4514-8887-694206b28a6e" xlink:to="loc_srt_ProductsAndServicesDomain_5cc02d37-5a93-4bce-a780-20bf5f632be9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_6440a712-76d0-4042-85b5-99d05c21e475" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cc02d37-5a93-4bce-a780-20bf5f632be9" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_6440a712-76d0-4042-85b5-99d05c21e475" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_e0d4a0d4-05c7-473f-b320-f0fd56f2e80c" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cc02d37-5a93-4bce-a780-20bf5f632be9" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_e0d4a0d4-05c7-473f-b320-f0fd56f2e80c" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>mygn-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efa3350f-b8a9-4fda-9dc1-67977795f671,g:9ff9af07-fed3-4eeb-865c-11c477b6a054-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32df9739-adf6-4925-a141-364ae3d682d1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d4390d71-fe8d-47cb-bd35-a33656f11ce2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_8b0f7bc4-8db9-4335-a80a-e1580e2ad4dd_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2f4ca44b-e934-4854-b5ac-2c8206b876cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_bd300722-b944-4da0-9d85-f1e611d6c9b1_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b4ae6597-8ccf-4d2c-bccc-5e4c8e113ca3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_03eaa567-6a07-4c61-9922-305e6097a7a7_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_fdaf6373-f2c7-4122-91b4-736a2af9e3c2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Investment Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OtherIncomePolicyPolicyTextBlock_cd72be59-f933-4e0d-a693-18b8fa317da8_terseLabel_en-US" xlink:label="lab_mygn_OtherIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:label id="lab_mygn_OtherIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_mygn_OtherIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Policy [Policy Text Block]</link:label>
    <link:label id="lab_mygn_OtherIncomePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_mygn_OtherIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income policy text block.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OtherIncomePolicyPolicyTextBlock" xlink:href="mygn-20201231.xsd#mygn_OtherIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OtherIncomePolicyPolicyTextBlock" xlink:to="lab_mygn_OtherIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_78844d67-4ff7-4fdf-8142-95331fb31157_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss subject to sections 382,383</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Limitations on Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_ae38d72b-33b0-47b8-aa7d-20a7b73f9694_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares available for future grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_3fd57608-2695-47c7-8830-76840d1c85e4_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_eb6eb09a-2508-4eee-98c0-379a50c1b1dd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period increase to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_81fe0099-f2e2-4fe2-a3e0-bfb4f3d1d09e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities and sales of marketable investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_82255549-26d1-4f7c-81c1-dc5075529785_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_37e7ea47-3ff7-4bcb-8a4a-97e224c30922_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5a6749cb-e873-496e-910c-5a35241cf043_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49a36cbf-3cc2-4d06-8d9a-7c1913cce13e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9be361ea-6f67-4065-9847-03376464e7e6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_bb719a29-3f31-41c5-9730-190659087d2d_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Deferred Savings Plan</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalMinistryOfFinanceGermanyMember_371ce730-4b1d-4d03-aaec-b07cdc73abe2_terseLabel_en-US" xlink:label="lab_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany</link:label>
    <link:label id="lab_us-gaap_FederalMinistryOfFinanceGermanyMember_label_en-US" xlink:label="lab_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Ministry of Finance, Germany [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalMinistryOfFinanceGermanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:to="lab_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b1d6872f-a5db-41be-beca-157ee5e8a9d6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_3de7cb2d-d316-440a-adee-b15041a99617_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_05a00772-eb6d-40ce-b580-cc4c4c348169_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Assets by Geographical Region</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ad37ff85-cf11-4b7b-a454-be35e98cb752_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_ee8b603d-d49d-490f-88b8-f667fe8e8202_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_7afbd0a2-ae3f-4c4e-abd3-38ec3fe08ffb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share, diluted</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_21da2b8c-454d-4dd4-aa8d-cefa08049125_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d87d0b45-fb4f-41dc-9a45-d74d7fcb4c67_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding, beginning (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c0a41e2b-6d61-42f4-b006-5e753d38e41c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding, ending (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_c0f7b587-ddb0-49ac-8ce8-fa8806e1dfc4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember_6c9c1a5c-ae0d-460f-b15d-6d7cd032aa0d_terseLabel_en-US" xlink:label="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of pharmaceutical and clinical services</link:label>
    <link:label id="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember_label_en-US" xlink:label="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Pharmaceutical And Clinical Services [Member]</link:label>
    <link:label id="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember_documentation_en-US" xlink:label="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primary financial statement caption in which the reported facts about the cost of pharmaceutical and clinical services expense have been included.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:href="mygn-20201231.xsd#mygn_CostOfPharmaceuticalAndClinicalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:to="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3588d556-ebe8-44c8-829e-862bf952c1af_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1b385574-9445-47fe-9a09-4ce486f5cdf4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_68250e7d-b604-4a42-97b8-5302215eb36c_terseLabel_en-US" xlink:label="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York</link:label>
    <link:label id="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_label_en-US" xlink:label="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York State Division of Taxation and Finance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:to="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cce53dea-bbee-4522-af0e-ae9bdce47137_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_83983472-73d6-484e-aa7e-4e59aff0e86e_negatedLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c819a0ff-61dd-4aa0-aa49-926673a7af7b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d869859b-f89a-4de8-9fb7-4bbd3e5a3f0c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_ca9a3c7b-5daf-411c-a769-188ffcc63228_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_66db9464-ca62-48a1-a02c-c811f2c65c6b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0a36e5f8-f1bd-4690-9c57-956d1f325743_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_000de31b-c0d6-4761-ada3-522323d0533c_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets, estimated useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5eb565ef-a82a-4f46-8f59-bfde24080e76_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_36304501-29a7-4f96-bef9-8a10aca9c874_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a323df57-a643-4ef8-add2-8e8373114d71_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_46fe669f-34d9-4525-aa51-e2f83c34b6d7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e7b58158-15a3-4d69-aafb-5c151845bc07_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d5a88502-6168-4e70-8ca8-6e069f8bde2e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6229c568-2de8-4ba2-9a17-e39ca10b6a14_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_804e631b-25be-4a74-95d3-45dcbfd3b729_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research credit</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OperatingLeaseLiabilityEstablished_f9a00d7f-16e3-49af-8031-f2123c523d1a_negatedLabel_en-US" xlink:label="lab_mygn_OperatingLeaseLiabilityEstablished" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_mygn_OperatingLeaseLiabilityEstablished_label_en-US" xlink:label="lab_mygn_OperatingLeaseLiabilityEstablished" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability Established</link:label>
    <link:label id="lab_mygn_OperatingLeaseLiabilityEstablished_documentation_en-US" xlink:label="lab_mygn_OperatingLeaseLiabilityEstablished" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability Established</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLeaseLiabilityEstablished" xlink:href="mygn-20201231.xsd#mygn_OperatingLeaseLiabilityEstablished"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OperatingLeaseLiabilityEstablished" xlink:to="lab_mygn_OperatingLeaseLiabilityEstablished" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_9f6da161-0bc4-45db-aabd-1fa743bd2a2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3fbe9a9f-9dec-4a1e-84f5-dfdd31bd7854_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses related to acquired entity</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_008ead80-50bd-40e2-a86c-70b5e03b0b09_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticGenesightTestingMember_be960bb3-f439-4911-8c88-69077326b37f_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticGenesightTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - GeneSight</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticGenesightTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticGenesightTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Genesight Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticGenesightTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticGenesightTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic GeneSight testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticGenesightTestingMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticGenesightTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticGenesightTestingMember" xlink:to="lab_mygn_MolecularDiagnosticGenesightTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4046c3e1-74f6-491f-af5c-7e135b845455_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ee778100-0d27-4474-ae59-d75cf14c3731_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3f8005ff-1776-4146-a1c9-c13a76590027_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled or expired (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_470bcc48-3500-48e9-8f0d-0fbe4ca10012_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable investment securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_df77f347-e912-4a4f-9e4d-63686db6a20f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of restricted stock units vested during period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_662ec79e-43cc-48b3-b6dd-ea9993fafd24_terseLabel_en-US" xlink:label="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted after December 5, 2012</link:label>
    <link:label id="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_label_en-US" xlink:label="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Granted After December Five Twenty Twelve [Member]</link:label>
    <link:label id="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_documentation_en-US" xlink:label="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted after December 5, 2012.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:href="mygn-20201231.xsd#mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:to="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97127ff8-ec25-4619-baa1-07c7a52db530_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_bfb8884c-483f-41ea-bace-724a9b238294_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_b73650c8-3bc9-4357-a909-1a7a8cda9831_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases - acquisitions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_da79a43f-57c4-4d7a-8802-d020772f4d08_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_9ccf8fb4-d86e-4acd-9c4d-0019eb5cd491_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_db915663-6595-4e2f-99b0-23c8a6933786_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due after five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_4c31af47-7406-4407-8161-14d0059aca15_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d5d3116b-d835-4ffb-b839-10b5b9e3b164_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Potential Dilutive Common Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_d2ba2844-7e60-4afc-a308-0262f98300c1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_4cf9395d-01df-47ae-b205-41dfd403a100_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_36e9b08f-9d18-4d63-b402-3ad349ad30a9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_56e2c5b1-e7e2-4547-b3a7-1a80a7d14c11_negatedLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments related to acquisition contingent consideration</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Fair Value Adjustments Related To Acquisition Contingent Consideration</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation fair value adjustments related to acquisition contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_9a131b91-68e3-481c-8d64-bf4d39646821_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a2302186-fcf4-439b-98bd-0df13fa5a85b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_c32fd411-a739-450b-8e52-d93dbba5cc9b_terseLabel_en-US" xlink:label="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</link:label>
    <link:label id="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_label_en-US" xlink:label="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</link:label>
    <link:label id="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_documentation_en-US" xlink:label="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:href="mygn-20201231.xsd#mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_2976e991-9fc8-4799-809b-410bcb583fff_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_05f26de5-02dc-43cb-83d6-9fd87a1aa5e9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_8a7020d7-6e4c-49e6-a9e1-c96a8a36eef2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_faeb16df-c649-4cfd-bada-5b2ba4737541_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Investment Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d233f7e4-ae9f-46dd-af7f-dee9c9ca3e43_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ca6d3356-2986-40d1-a5f1-2d479f2254ec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f31e1e3a-4de9-41fe-b706-cae525e4b116_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_d995af08-94d3-4a6d-b566-30be96b92323_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive stock option and employee stock purchase plan expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_69255995-5fe8-4e32-a80e-46a241f089d5_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_2717f7d0-d25c-45fa-bba1-6c80a4973d4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5eb14a3c-3fd3-48a0-a8e9-5269d6536bad_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_9fbbde81-91be-4e39-9ba8-22312b8e41f7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and penalties in year-end balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_318788c9-46a3-4321-addd-6533bf6ef670_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d825fd8d-bc18-4463-bec6-78ebc59e9caf_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_8a727a3d-79b9-4aea-bfbc-db279d56b9ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, value of shares issued</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_eab76f2f-9c92-4914-a2f4-3a636b66b9f2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line of Credit Arrangements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:to="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_e3058101-cd11-4c98-a759-bbb878e8cb91_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan compensation expense</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_321907f8-824b-451a-bf08-bc4ded0ee165_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_a7068ce1-e4f2-4740-8ccf-2ecb465b40a8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for Medicare refund</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_76bee60b-70fb-478e-9e69-91afcc708d79_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_71a8c2f2-501e-419d-acee-ef9c9bf67220_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shares Purchased and Compensation Expenses for ESPP</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_CostOfMolecularDiagnosticTestingMember_b6f6995e-4b47-45fd-a1b9-94e11e3e1db8_terseLabel_en-US" xlink:label="lab_mygn_CostOfMolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of molecular diagnostic testing</link:label>
    <link:label id="lab_mygn_CostOfMolecularDiagnosticTestingMember_label_en-US" xlink:label="lab_mygn_CostOfMolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Molecular Diagnostic Testing [Member]</link:label>
    <link:label id="lab_mygn_CostOfMolecularDiagnosticTestingMember_documentation_en-US" xlink:label="lab_mygn_CostOfMolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primary financial statement caption in which the reported facts about the cost of molecular diagnostic testing expense have been included.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfMolecularDiagnosticTestingMember" xlink:href="mygn-20201231.xsd#mygn_CostOfMolecularDiagnosticTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_CostOfMolecularDiagnosticTestingMember" xlink:to="lab_mygn_CostOfMolecularDiagnosticTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_6fcccc52-ce2b-4fbb-9aed-a20c49008ece_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_a7997576-1058-4ee5-9094-43226274b3a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under the Plan</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_09b9b119-1ee6-4fb3-a69c-c68d5c37dae0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense related to stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2eec806b-a0af-41c7-a4c7-1f00818763e7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive stock options</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4639c7a0-e3cb-4d08-8e3b-86991693f1d6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ebf1a1e0-d69e-4f2e-95f9-b371bfb9fdc7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a368245c-1e8c-47f3-ab54-c680e80e238d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits, net of the federal tax on state credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_16be8182-8093-43a4-8fd1-e3d2ea276313_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_bf4fbd44-9b99-49f2-99aa-b9e22ad242de_verboseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local jurisdictions</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_0b1df5b2-f595-422e-bdde-db3f3220c280_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3969209f-fc87-4742-94e7-c4337f8488e6_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_f190a0fe-e436-4360-9e41-511738417e66_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_5aa36167-a64b-4e78-ae06-bb8a1af1a5bf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4d4d2350-45a4-48da-a1a6-f70074b8885e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_32d13b4f-43e4-4afc-9e01-39573b04d6db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_1eadc457-c40b-4c08-b589-1a18ef84d378_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cea0d722-55cb-4b16-84b5-f51f8ef1f9b1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, Estimated fair value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e00449c7-998f-4bb7-958e-d63ffa4625b3_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases_8a5158e9-fe09-48ee-8d31-f31e876373e1_terseLabel_en-US" xlink:label="lab_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges to retained earnings</link:label>
    <link:label id="lab_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases_label_en-US" xlink:label="lab_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Charged To Retained Earnings As Result Of Stock Repurchases</link:label>
    <link:label id="lab_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases_documentation_en-US" xlink:label="lab_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount charged to retained earnings as a result of stock repurchases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases" xlink:href="mygn-20201231.xsd#mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases" xlink:to="lab_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b83cd5cc-3afb-46d2-a511-1f710eb00b36_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_25ea5d2f-788f-4f8d-9505-224448e4e287_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a35612bc-8f52-4714-a409-8b3d0c1b4c28_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets impairment charge</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_66c771eb-8487-400c-9979-fa1c134e29ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_34b66e21-3db2-42cc-9e6d-d8ca36be27b7_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent_f5e96640-b04f-4791-ae83-7097951daa5a_terseLabel_en-US" xlink:label="lab_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets, valuation assumptions discount rate</link:label>
    <link:label id="lab_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent_label_en-US" xlink:label="lab_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Valuation Assumptions, Net Cash Flow Discount Rate, Percent</link:label>
    <link:label id="lab_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent_documentation_en-US" xlink:label="lab_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Valuation Assumptions, Net Cash Flow Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" xlink:href="mygn-20201231.xsd#mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" xlink:to="lab_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94afb54a-3666-43f2-9fc1-ab196431a032_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding, beginning (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d83fcc64-814b-4a4e-8c2d-2acfde93d576_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding, ending (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_f0297fb4-2930-4d5e-bfce-e57ededdbed4_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6fb45838-c06c-4400-b43b-038d1109dee4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_f0227fd8-47e9-49db-9d00-2aef2a0618c0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c53fad9c-994f-450f-b6e8-c1e656bc39af_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_0807cc99-0edf-4686-ab8c-be88c51ffd97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Common Shares Issued and Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_822668cf-ece4-4e81-ba8b-5ef5b36ac6bc_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum_999a40b1-40e2-4731-9c6d-075562f293d4_terseLabel_en-US" xlink:label="lab_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum unrestricted cash required for borrowing</link:label>
    <link:label id="lab_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum_label_en-US" xlink:label="lab_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Unrestricted Cash Required For Borrowing, Minimum</link:label>
    <link:label id="lab_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum_documentation_en-US" xlink:label="lab_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Unrestricted Cash Required For Borrowing, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" xlink:href="mygn-20201231.xsd#mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" xlink:to="lab_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_f64163a9-3070-462c-b2f6-990e2868f4cd_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_22f32b56-9691-403a-8b56-b675290698d1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_22d62d98-44fa-40ec-9c18-efcdaf395974_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_21b407dc-0e80-4f87-b7fc-1b0d5547e991_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b75a9b6e-67f0-4cae-98a3-52398efc00ba_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_61af092e-ac02-4ff6-a522-e265a410883d_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aafe57c1-bad2-4396-a52e-c63be7e93e14_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_139a3a8e-9be6-4261-8145-50f65f007452_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TransitionPeriodFinancialInformationLineItems_6dc49422-2f8a-4318-bbb0-c18975633b3a_terseLabel_en-US" xlink:label="lab_mygn_TransitionPeriodFinancialInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Financial Information [Line Items]</link:label>
    <link:label id="lab_mygn_TransitionPeriodFinancialInformationLineItems_label_en-US" xlink:label="lab_mygn_TransitionPeriodFinancialInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Financial Information [Line Items]</link:label>
    <link:label id="lab_mygn_TransitionPeriodFinancialInformationLineItems_documentation_en-US" xlink:label="lab_mygn_TransitionPeriodFinancialInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TransitionPeriodFinancialInformationLineItems" xlink:href="mygn-20201231.xsd#mygn_TransitionPeriodFinancialInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems" xlink:to="lab_mygn_TransitionPeriodFinancialInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_bfb15233-85bb-4048-9c12-cbb0fa2af955_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6416e48d-d7e2-435b-ac19-15c564cd15b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs, Number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OperatingLossCarryforwardsExpirationYear_ffb0e86e-d726-47b2-a43b-941600d92e51_terseLabel_en-US" xlink:label="lab_mygn_OperatingLossCarryforwardsExpirationYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss, expiration in year</link:label>
    <link:label id="lab_mygn_OperatingLossCarryforwardsExpirationYear_label_en-US" xlink:label="lab_mygn_OperatingLossCarryforwardsExpirationYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards Expiration Year</link:label>
    <link:label id="lab_mygn_OperatingLossCarryforwardsExpirationYear_documentation_en-US" xlink:label="lab_mygn_OperatingLossCarryforwardsExpirationYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Expiration Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLossCarryforwardsExpirationYear" xlink:href="mygn-20201231.xsd#mygn_OperatingLossCarryforwardsExpirationYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OperatingLossCarryforwardsExpirationYear" xlink:to="lab_mygn_OperatingLossCarryforwardsExpirationYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e60a5c04-3291-4d15-9408-01917d25fbd0_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_f5896ea6-961d-4111-8227-bd5aaf396d6e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_a12f4bc9-5da0-40cd-b5d1-a89a0e273a72_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input, expected term</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetsTable_be2c4b55-9b04-4ec3-904e-b03c18b0f4a0_terseLabel_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Intangible Assets [Table]</link:label>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetsTable_label_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Intangible Assets [Table]</link:label>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetsTable_documentation_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetsTable" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable" xlink:to="lab_mygn_GoodwillAndIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DeferredTaxLeaseLiability_ef203536-dc38-41c8-bd30-623eda61d651_terseLabel_en-US" xlink:label="lab_mygn_DeferredTaxLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_mygn_DeferredTaxLeaseLiability_label_en-US" xlink:label="lab_mygn_DeferredTaxLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Lease Liability</link:label>
    <link:label id="lab_mygn_DeferredTaxLeaseLiability_documentation_en-US" xlink:label="lab_mygn_DeferredTaxLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax lease liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxLeaseLiability" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DeferredTaxLeaseLiability" xlink:to="lab_mygn_DeferredTaxLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9e4c64d1-0ce8-4094-8cf2-2d28fc7a0193_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a8e31625-dc9f-4437-906e-c70cd2ed92c3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning common stock outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c65dc44b-ce88-4719-9e47-2bb878585d16_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending common stock outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_f8d5630c-e9ef-44d6-9978-0faec5f5305f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_739803df-f5f4-4a88-a216-79589b5715d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_78185cbf-8a6f-4979-9c25-27a1238df54b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_058f53ec-567a-483c-87a2-4c326b3014df_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_e85ace65-d4de-400f-8902-13d408ecc48e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7986de74-dfeb-47b0-a5d4-d10125e8ac9b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsMember_ed82273d-7070-4d49-b133-3beb64cef3a6_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsMember" xlink:to="lab_us-gaap_CashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationYearUnderExamination_acaee367-0e0f-4f74-bbd0-45cbd03af19d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax year being audited in income tax examination</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationYearUnderExamination_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Year under Examination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:to="lab_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_16f1c17d-e621-4596-a524-33b49bc50f1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in revenue due to changes in estimated transaction price due to contractual adjustments</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:to="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4752b463-eb1a-4742-a111-136a6afd698d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8c0e83ec-7d5d-4097-91ba-b5cbfee63ad6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_514fb6af-4e1e-4e6b-b10b-6fa39fbad814_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_5466b12d-4b34-46fe-900c-fda26d877641_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_628b67d9-91f8-428f-bd74-9b79cf499db8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_80506ef3-29b6-4880-b68a-5b9335d153ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_5c6d3ef9-5733-463f-8d69-715f8d5934f5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Revenue by Geographic Region</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_fee17621-1bec-40e0-90df-89a570222604_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4d5dba98-8e09-40dc-b346-888ffc112c26_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_cc581c80-bb6a-405d-be88-ab0a5c52f967_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Revenue and Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum_ab811451-0f25-4fec-9478-69a19f52d139_terseLabel_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derived service period, minimum (in years)</link:label>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum_label_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Minimum</link:label>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum_documentation_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" xlink:to="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember_5b9f1818-5613-40fb-ac60-20c09f9b463b_terseLabel_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible asset impairment charges</link:label>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember_label_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Intangible Asset Impairment Charges [Member]</link:label>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember_documentation_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Intangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetImpairmentChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember" xlink:to="lab_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_6acfac63-eb43-49ff-85d2-83fa5378aaca_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_58798f4a-3e34-40ab-8d52-c0a27894d551_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c359f6f-b96c-4b7f-bd18-43b3e278868b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_e7cc5b9c-3144-4da3-a677-426c60bb6edb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ba6107f9-a2e4-43a1-ba23-6d288deb4128_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fab29867-cf3f-4ee6-bf01-931f45f30b39_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_964de40d-3912-47a9-ade8-207a2a8b4643_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_ceebe31e-25ae-4b9a-bd01-c85e38f38733_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_d13fbb5e-7f63-41e1-92ab-c52a1c1c4702_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_0f45e2ed-7f6f-46e2-a1ff-65ff77c5a657_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AR allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_8c727352-0b99-4e4c-8d08-f4120f63822e_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_12d2c5cf-eaaf-4c02-aacf-fd67eaaf49fc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_2000f7e0-1607-4496-bad6-f98f1391b163_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_338d422d-1e2a-4745-8de8-52c95a19984b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationAssetImpairment_8391279d-3d00-47b8-9d77-bfcb08836e2b_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationAssetImpairment_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Asset Impairment</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationAssetImpairment_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation asset impairment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationAssetImpairment" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationAssetImpairment" xlink:to="lab_mygn_IncomeTaxReconciliationAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_a17458f8-7bd0-4fd1-a9d5-d8843c371b4a_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_d96ddc3a-6e1d-48f6-a512-a3588b7f07a1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_5cd38223-6258-4859-b660-5128db975477_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_566922da-1b40-40fc-9698-3a788bd4c73d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of tax withheld for common stock issued under share-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_d90c440f-9458-47a1-9280-7400ee4f530d_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_ea1820fb-264e-4b9e-9bdb-f58ac33ce6af_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplementary Quarterly Financial Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_NonEmployeeDirectorMember_211124f6-ab8b-475b-aa6d-08b8d103faaf_terseLabel_en-US" xlink:label="lab_mygn_NonEmployeeDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-employee director</link:label>
    <link:label id="lab_mygn_NonEmployeeDirectorMember_label_en-US" xlink:label="lab_mygn_NonEmployeeDirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Employee Director [Member]</link:label>
    <link:label id="lab_mygn_NonEmployeeDirectorMember_documentation_en-US" xlink:label="lab_mygn_NonEmployeeDirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non employee director.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonEmployeeDirectorMember" xlink:href="mygn-20201231.xsd#mygn_NonEmployeeDirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_NonEmployeeDirectorMember" xlink:to="lab_mygn_NonEmployeeDirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_1c26797d-a470-4351-845e-1dd4c100aa17_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_140635bb-c403-4ef7-8463-15fdf4d431fc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1_e847836c-7885-41d7-a663-e3d6e5d89ba6_terseLabel_en-US" xlink:label="lab_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of cash consideration deposited in escrow account</link:label>
    <link:label id="lab_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1_label_en-US" xlink:label="lab_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposit Disbursements Related to Property Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:to="lab_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_b805e05e-128a-45b7-a6f6-a8977e0cdcd1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_70cb53ea-da36-498a-aaae-3cccb5585d5f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_098c363c-9272-4e58-8b2b-33958b9fc145_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_30f52e82-765b-428c-ba10-c563faed302e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1009f8e3-5a6e-400e-a088-6928cbbb8e0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fd39b0e5-5888-4a42-827b-4973b998c7cf_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_PurchasedLicensesAndTechnologiesMember_465c7b28-2e54-4536-ad49-80f43f9c1045_terseLabel_en-US" xlink:label="lab_mygn_PurchasedLicensesAndTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased licenses and technologies</link:label>
    <link:label id="lab_mygn_PurchasedLicensesAndTechnologiesMember_label_en-US" xlink:label="lab_mygn_PurchasedLicensesAndTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Licenses And Technologies [Member]</link:label>
    <link:label id="lab_mygn_PurchasedLicensesAndTechnologiesMember_documentation_en-US" xlink:label="lab_mygn_PurchasedLicensesAndTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased licenses and technologies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PurchasedLicensesAndTechnologiesMember" xlink:href="mygn-20201231.xsd#mygn_PurchasedLicensesAndTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_PurchasedLicensesAndTechnologiesMember" xlink:to="lab_mygn_PurchasedLicensesAndTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6acff146-824a-41fe-a7d9-106321cd72ed_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_01a2cef4-cceb-4ac8-a1ad-c9877fe7096e_terseLabel_en-US" xlink:label="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Plan</link:label>
    <link:label id="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_label_en-US" xlink:label="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Ten Employee Director And Consultant Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand ten employee director and consultant equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:href="mygn-20201231.xsd#mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:to="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_afc6a936-7344-4732-b465-757b7519ce69_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_bb8e5b5b-7972-4b5d-86fa-27d312df163d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect_d55ff00a-ed4c-4d3e-8930-5727efbcf31a_negatedTerseLabel_en-US" xlink:label="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss to adjust net assets to purchase price and effects of foreign currency</link:label>
    <link:label id="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect_label_en-US" xlink:label="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Writedown And Foreign Currency Effect</link:label>
    <link:label id="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect_documentation_en-US" xlink:label="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Writedown And Foreign Currency Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" xlink:href="mygn-20201231.xsd#mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" xlink:to="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2f9ffd5a-91a4-4eca-ae4f-3d4a776fe01a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c2649e8a-27fb-427a-bd02-0c3d92348522_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs canceled (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1cf4bc26-1fe5-40b0-a198-4ed42be9b8b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Assumptions for Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_bc291583-bb05-480a-9906-51940af9a5de_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company matching contribution as percentage of employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_0c7e185d-7c98-412d-bef0-7be3626976e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_645d56a1-ab8a-45c2-bbc8-97c776bb071c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_186313b4-c445-4da2-8224-8125c4e71a3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of intangible assets related to updated assumptions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_a464e738-9a17-4e38-a0ad-ffbe6df93b8f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contributions to the Plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_0fe2f3ec-21e5-49d5-b1d4-681121614d32_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Other Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_ff77dcdc-2e8c-41a5-95e7-cb2557012bc4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_252ccab9-1363-43b1-a3f6-815023355e83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue contributed by acquired entity</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:to="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_03d7bf9e-285e-4758-ba38-6f426b69f848_verboseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_73a55912-3f3b-4c74-87e6-8ee41d61d2ea_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_df9f4afe-6a0d-4569-9369-e168426c9f0b_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a749bc4e-13a0-4af8-a1f3-d15e0d7cbc94_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_ba6b227c-5c1b-4ff1-848a-c236676c56a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5d478532-23d1-49f2-a0e5-a1e78e8c9f44_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_0c4e3839-0685-4547-9649-aa25000236fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock_d6b51081-d750-47c9-8e09-e708a4977d74_terseLabel_en-US" xlink:label="lab_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comparison of Balance Sheet Assets by Operating Segment</link:label>
    <link:label id="lab_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock_label_en-US" xlink:label="lab_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Comparison Of Balance Sheet Assets By Operating Segment Table [Table Text Block]</link:label>
    <link:label id="lab_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock_documentation_en-US" xlink:label="lab_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Comparison Of Balance Sheet Assets By Operating Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" xlink:to="lab_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_353e839c-31f5-4fb7-adb2-c51384a5c9a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_050a8875-6ffc-4a6b-bba2-6642559e4b1a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ede09faa-25af-426e-a30b-02e596e22c2f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes_fa800b61-b599-4e84-a29a-c28671747a75_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired tax attributes</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Expired Tax Attributes</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation expired tax attributes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax_f531e7f7-0af1-4677-a1be-777904fc754b_terseLabel_en-US" xlink:label="lab_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax_label_en-US" xlink:label="lab_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency, Other Adjustment, Net of Tax</link:label>
    <link:label id="lab_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax_documentation_en-US" xlink:label="lab_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency, Other Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" xlink:href="mygn-20201231.xsd#mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" xlink:to="lab_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_9c2c1aba-3086-4bae-8a41-881b1f2b8402_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1087ba93-b39e-46ac-84d9-f835c313f6be_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_fa7afe25-f919-4035-bece-5102e6178cd1_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposition of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_98617d17-0f81-43d6-8211-55900194fd7d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Gross unrealized holding losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_d964829c-c246-4a5e-a214-f95d485b6379_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_e0fbef42-014b-47af-addd-e83897c9b9b1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued vacation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_c264dad6-a3fb-4551-95a1-cb19610262fa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_65090b96-ce92-40cc-9305-e8598c4caea5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3fb6c086-f29f-45a2-aee8-a5a3b7d1a8b3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_57cf103f-04a1-431d-bd45-24587cfdd714_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_94a92bbb-56aa-44fd-a083-820a851b2c32_terseLabel_en-US" xlink:label="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_label_en-US" xlink:label="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense Excluding Prepaid Taxes Current</link:label>
    <link:label id="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_documentation_en-US" xlink:label="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expense excluding prepaid taxes current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:href="mygn-20201231.xsd#mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:to="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_dc74d050-ed1c-4bf6-9f32-55c180812a78_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_1f4f06cc-e014-4185-b1af-534e4fd50d18_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_3ba86020-0b20-4758-95b3-cf84b6a2cea5_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_0b35d795-5b83-4e59-b2db-88a7e714fd3c_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_140f1eac-2df1-4d66-8c79-d226644c1456_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5f61ea31-0cb2-481e-bec1-5f48676e7aaf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_f291496d-268f-4431-8d8e-c8f553a78c42_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7cd03f44-8203-4c2b-994d-f92c63403c74_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_108c29f2-ae53-4b0b-948e-29e38a223488_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9aef32ee-e47c-44af-9cf9-db4a0319ffb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_01e626e1-0081-497e-ac8e-b9366c746e88_terseLabel_en-US" xlink:label="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_label_en-US" xlink:label="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development With Indefinite Lives [Member]</link:label>
    <link:label id="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_documentation_en-US" xlink:label="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development with indefinite lives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:href="mygn-20201231.xsd#mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:to="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticOtherTestingMember_2fe56782-1b08-4924-8fa9-6d130228a91e_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticOtherTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Other</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticOtherTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticOtherTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Other Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticOtherTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticOtherTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic other testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticOtherTestingMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticOtherTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticOtherTestingMember" xlink:to="lab_mygn_MolecularDiagnosticOtherTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_f3bb1919-239a-403d-81b5-a2796ad0758f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_30db6b12-7ef8-415a-a7c6-7caaf5ef1119_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_2a587865-cd1e-4c2a-a767-cb0871f5a7a0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c5ed3620-cab6-4156-970e-3432d32d4b67_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Subsidiary</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_a7c76717-ab9e-49f2-9d8d-fe695ec4f671_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qui tam settlement</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_b841ffb8-249d-4393-854e-1b2d7afb05a7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_2fef368e-1f94-48d2-9b12-cae6e00311cd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue - beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_bd2c0f78-05d4-47d1-8813-9cd470309a34_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue - ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4125cfe8-ee9b-4a46-8687-616c57b81a39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IntangibleAssetsLineItems_28d33903-adec-4cef-8757-d047b2022ad6_terseLabel_en-US" xlink:label="lab_mygn_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Line Items]</link:label>
    <link:label id="lab_mygn_IntangibleAssetsLineItems_label_en-US" xlink:label="lab_mygn_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Line Items]</link:label>
    <link:label id="lab_mygn_IntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_mygn_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IntangibleAssetsLineItems" xlink:href="mygn-20201231.xsd#mygn_IntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IntangibleAssetsLineItems" xlink:to="lab_mygn_IntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_98dea0f5-ac79-4ac2-95da-5e2196e6521c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Amortization Expense of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d5ccf218-80bf-4661-a33f-68bafa77a7a6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (weighted average shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_65b8783f-66f2-4f9a-9b60-0d674da401e5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding and dilutive securities used to compute diluted EPS</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_1c409d8f-2599-47bd-b479-078c0c35cf95_terseLabel_en-US" xlink:label="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Purchase Plan</link:label>
    <link:label id="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_label_en-US" xlink:label="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Twenty Twelve [Member]</link:label>
    <link:label id="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_documentation_en-US" xlink:label="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Twenty Twelve [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:href="mygn-20201231.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:to="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_ec68d9f9-cba1-4d51-aad7-62567cb97184_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Financial Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_975a3a7c-ccd8-4986-9dfb-9b50fc6efb3e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs canceled (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_929195ab-6191-42a4-88d4-d1184e3dd261_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5f000453-644f-43ce-9f7e-bedfefd7147d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment_c73dd7d5-d4c7-4eec-bce4-5764de8fd104_terseLabel_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible adjustment</link:label>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment_label_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Increase (Decrease), Intangible Assets Adjustment</link:label>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment_documentation_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, intangible adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" xlink:to="lab_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_11c8f29f-9da6-4201-88a0-2c1faacc3ef5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodStartDate_04199153-95ef-42e1-ad50-d1d2e76974a5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodStartDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period Start Date</link:label>
    <link:label id="lab_dei_DocumentPeriodStartDate_label_en-US" xlink:label="lab_dei_DocumentPeriodStartDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period Start Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodStartDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodStartDate" xlink:to="lab_dei_DocumentPeriodStartDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_InvestmentsAndCashAmortizedCost_7e11d385-e165-49f8-8ded-208a8b5f52b6_totalLabel_en-US" xlink:label="lab_mygn_InvestmentsAndCashAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Amortized cost</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAmortizedCost_label_en-US" xlink:label="lab_mygn_InvestmentsAndCashAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Amortized Cost</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAmortizedCost_documentation_en-US" xlink:label="lab_mygn_InvestmentsAndCashAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost" xlink:to="lab_mygn_InvestmentsAndCashAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e739a543-1712-4868-be59-ad36549aaa52_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at the beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d93fa140-6029-4efa-a172-687767a85e99_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_52e3ed28-b23b-4b8d-9b29-5e3f1826d676_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases_4c03bbf0-ed8d-450f-9b18-03eaecfea78f_terseLabel_en-US" xlink:label="lab_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock and additional paid-in-capital reductions</link:label>
    <link:label id="lab_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases_label_en-US" xlink:label="lab_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Reduction In Common Stock As Result Of Stock Repurchases</link:label>
    <link:label id="lab_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases_documentation_en-US" xlink:label="lab_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of reduction in common stock as a result of stock repurchases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases" xlink:href="mygn-20201231.xsd#mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases" xlink:to="lab_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_90827991-d253-4d0f-bf83-adaa13bd414b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, 75.4, 74.7 and 73.5 shares outstanding at December 31, 2020, June 30, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_678c3e94-d795-4e96-9f13-99ce11077cf3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_RangeFourMember_df12a9c4-4663-437b-b670-b3eb3fd0ef2f_terseLabel_en-US" xlink:label="lab_mygn_RangeFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$ 27.07 - 36.55</link:label>
    <link:label id="lab_mygn_RangeFourMember_label_en-US" xlink:label="lab_mygn_RangeFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Four [Member]</link:label>
    <link:label id="lab_mygn_RangeFourMember_documentation_en-US" xlink:label="lab_mygn_RangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeFourMember" xlink:href="mygn-20201231.xsd#mygn_RangeFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_RangeFourMember" xlink:to="lab_mygn_RangeFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6649b955-16af-496a-8c3c-d274e70ea494_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_166fc80a-ab0b-4753-9bca-0ab6975cb24d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_9ed0e0a3-bba1-47fa-9b68-4ee9e61e53fb_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross decreases - settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b8b4d0ce-28ef-439e-9fe6-6a27edd462a1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_aff82b96-7f8b-4997-8289-952d2eb4d9cb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in the statement of operations</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_44cc032f-d50c-422d-932d-b9769f3576eb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_3bd65ed6-52fc-4292-9618-294e334e9dc9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_ff0437f7-e5a9-424c-aa32-49ae6493a516_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_65b83962-57ff-4b80-a2c2-7f957ebca4c5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, per share market closing price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f74a8f91-295c-431b-95b5-e7ba673fb4b1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting weight (percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock_6acf0f84-e2d3-4507-8699-eca720998bed_terseLabel_en-US" xlink:label="lab_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Repurchases</link:label>
    <link:label id="lab_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock_label_en-US" xlink:label="lab_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Common Stock Repurchased Table [Table Text Block]</link:label>
    <link:label id="lab_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock_documentation_en-US" xlink:label="lab_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of common stock repurchased table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock" xlink:to="lab_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_56de1774-9598-4395-bc0f-739a84dd4d74_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_763cd6da-89d0-45e4-91ee-0adc2cf88597_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning common stock issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5b62df9a-d00c-46cd-992b-c96c98783919_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending common stock issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e1ff0f07-d1be-48aa-b996-ae2c5e3e698d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ebd606d1-32f2-4666-9c20-0fc8db16d8c5_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, Amortized cost</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1482cc35-8613-4d43-bd46-c6fda11c1878_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewJerseyDivisionOfTaxationMember_5afd3672-10dd-41b5-8c8c-5db86fa8b179_terseLabel_en-US" xlink:label="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey</link:label>
    <link:label id="lab_us-gaap_NewJerseyDivisionOfTaxationMember_label_en-US" xlink:label="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey Division of Taxation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:to="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3cda0d36-98a5-4d5b-886c-4f7cd723989b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_ebc1c742-38a6-41c4-8bed-dc5e0689328b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_ad1610d9-f407-4283-8821-bfb085d3a8ea_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_c5ad1a6b-cab7-4275-97cf-757377e84bed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e8da4cd8-eae6-4ba7-9f3d-6e267658c560_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Myriad Genetics, Inc. stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_7ad0b025-93c5-4922-9c8b-a4aada7a98c1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0a286e24-fe73-4819-9e39-da35d5dc8554_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_bffebefa-77a4-4db6-aea2-56cb738d3114_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2a31b313-6c9a-4c3c-9dab-bbe982abb54b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, shares issued</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MyriadAutoimmuneReportingUnitMember_379d5e72-8159-41cc-bb39-6e0adbd46262_terseLabel_en-US" xlink:label="lab_mygn_MyriadAutoimmuneReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myriad Autoimmune reporting unit</link:label>
    <link:label id="lab_mygn_MyriadAutoimmuneReportingUnitMember_label_en-US" xlink:label="lab_mygn_MyriadAutoimmuneReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myriad Autoimmune Reporting Unit [Member]</link:label>
    <link:label id="lab_mygn_MyriadAutoimmuneReportingUnitMember_documentation_en-US" xlink:label="lab_mygn_MyriadAutoimmuneReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myriad Autoimmune Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MyriadAutoimmuneReportingUnitMember" xlink:href="mygn-20201231.xsd#mygn_MyriadAutoimmuneReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MyriadAutoimmuneReportingUnitMember" xlink:to="lab_mygn_MyriadAutoimmuneReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e1ccdf3e-4f9b-4833-8709-1bc67a746481_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_169e6c07-881a-4d92-8f71-8df6696a262c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_191998dc-86a8-44fb-8398-7ff40f6f7ee9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_4ef7dc07-1e35-4fa8-bdb8-3ddd256f4323_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_PharmaceuticalAndClinicalServicesMember_5bd10308-ebb3-4833-91ae-4791d64ed0e3_terseLabel_en-US" xlink:label="lab_mygn_PharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and clinical services</link:label>
    <link:label id="lab_mygn_PharmaceuticalAndClinicalServicesMember_label_en-US" xlink:label="lab_mygn_PharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical And Clinical Services [Member]</link:label>
    <link:label id="lab_mygn_PharmaceuticalAndClinicalServicesMember_documentation_en-US" xlink:label="lab_mygn_PharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and clinical services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_PharmaceuticalAndClinicalServicesMember" xlink:to="lab_mygn_PharmaceuticalAndClinicalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f7851e2a-26a2-4817-b956-dccbf4655747_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DeferredTaxAssetsLeaseRightOfUseAsset_0aefe0b4-5c3e-4618-a6bd-7691325cdad1_terseLabel_en-US" xlink:label="lab_mygn_DeferredTaxAssetsLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease right-of-use asset</link:label>
    <link:label id="lab_mygn_DeferredTaxAssetsLeaseRightOfUseAsset_label_en-US" xlink:label="lab_mygn_DeferredTaxAssetsLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Lease Right Of Use Asset</link:label>
    <link:label id="lab_mygn_DeferredTaxAssetsLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_mygn_DeferredTaxAssetsLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets lease right-of-use asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxAssetsLeaseRightOfUseAsset" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxAssetsLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DeferredTaxAssetsLeaseRightOfUseAsset" xlink:to="lab_mygn_DeferredTaxAssetsLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_8a033565-1dd4-4132-a640-26797d8e22cf_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_NonCashInterestExpense_736a7e90-b704-43fe-b424-0dd068ab7a17_terseLabel_en-US" xlink:label="lab_mygn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_mygn_NonCashInterestExpense_label_en-US" xlink:label="lab_mygn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Interest Expense</link:label>
    <link:label id="lab_mygn_NonCashInterestExpense_documentation_en-US" xlink:label="lab_mygn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash interest expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonCashInterestExpense" xlink:href="mygn-20201231.xsd#mygn_NonCashInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_NonCashInterestExpense" xlink:to="lab_mygn_NonCashInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_d7d0988b-38cf-4e82-94d4-3ac01f696346_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in pension liability</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_c5401a59-5736-422d-a1aa-912bebac8be7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease expense</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_b48a6fa9-7c05-4bc9-94ff-bb1226f16967_verboseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period translation adjustments</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ReportableGeographicalComponentsMember_53526790-6ed3-45db-abcc-5b13090d5870_terseLabel_en-US" xlink:label="lab_srt_ReportableGeographicalComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable geographical components</link:label>
    <link:label id="lab_srt_ReportableGeographicalComponentsMember_label_en-US" xlink:label="lab_srt_ReportableGeographicalComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Geographical Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ReportableGeographicalComponentsMember" xlink:to="lab_srt_ReportableGeographicalComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_546eb242-55ae-4600-94ee-19fe8c1b6071_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment_f4906b16-3fa9-4b64-8d61-9d7af1697f17_terseLabel_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred tax liability</link:label>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment_label_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Increase (Decrease), Deferred Tax Liabilities Adjustment</link:label>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment_documentation_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill adjustment to deferred tax liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" xlink:to="lab_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_b6050dc7-ce04-44f1-893f-c3ed35ac7ebe_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation_a41c8f3f-70f8-49b5-877e-8fb847fde5a5_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible officer compensation</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Non Deductible Officer Compensation</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation non-deductible officer compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_5bf4a0ea-5db8-4605-b354-8e1bba0abfcf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_29892d0b-a2b9-42d4-a1d6-7c367916ce31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6e5a819a-a79f-4311-80f2-47aa0bca56bd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticMyChoiceCDxMember_cf26406c-9a9f-4a44-abb1-f07fa830f5d0_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - myChoice CDx</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticMyChoiceCDxMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic MyChoice CDx [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticMyChoiceCDxMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic MyChoice CDx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticMyChoiceCDxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:to="lab_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_f00a1d37-fb4c-4df2-bead-7cc4b43e3a11_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OptionsAndRestrictedStockUnitsMember_8636013c-f3f2-4157-ac0d-c0cdccaafa6b_terseLabel_en-US" xlink:label="lab_mygn_OptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options and RSUs</link:label>
    <link:label id="lab_mygn_OptionsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_mygn_OptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_mygn_OptionsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_mygn_OptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options and Restricted Stock Units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsAndRestrictedStockUnitsMember" xlink:href="mygn-20201231.xsd#mygn_OptionsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OptionsAndRestrictedStockUnitsMember" xlink:to="lab_mygn_OptionsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_fe59dbd8-a11a-41d3-8161-c19680de105f_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0bb2df86-a1e8-4149-bf85-c838f55fa453_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ea02e335-2c82-4849-84b9-74160fbe763c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_c553800d-02a2-4a98-a30e-0d5ece746643_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_4aecd510-0f47-4f1b-baa7-cc43e1c1f404_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3cd8b30a-1da7-4629-abad-666e78314540_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations_b84daa70-538f-499d-af2b-02dd59cabc2b_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax benefits statute expired, net of federal benefit</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Statute Expirations</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Statute Expirations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_51d8a559-d50b-4f50-9122-71d4da0a5456_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f88d9db7-2f93-4d65-b007-524cdf0d2446_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_0449b939-dbd2-4349-a753-2c5314a0dfde_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_f3e65184-2407-46b2-85a6-377053c101af_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8276d033-e942-44e8-a865-fb5245efe1f0_verboseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_ffec918f-7fb8-4e0b-a834-45e36a3aa368_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_f5e9d9fd-3b65-4be5-91c9-289a17c85ed6_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pension liability</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity_c251fb2c-845b-4321-8d8c-ecc51a7a8ec1_terseLabel_en-US" xlink:label="lab_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustment on marketable investment securities recorded to stockholders' equity</link:label>
    <link:label id="lab_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity_label_en-US" xlink:label="lab_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment On Marketable Investment Securities Recorded To Stockholders Equity</link:label>
    <link:label id="lab_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity_documentation_en-US" xlink:label="lab_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustment on marketable investment securities recorded to stockholders equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" xlink:href="mygn-20201231.xsd#mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" xlink:to="lab_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_4def4fde-68bc-4593-94f6-11a45e7af0fc_terseLabel_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_label_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Federal Tax Administration (FTA) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:to="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_85196352-7adf-4033-a49b-1de67cec3f9c_terseLabel_en-US" xlink:label="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</link:label>
    <link:label id="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_label_en-US" xlink:label="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</link:label>
    <link:label id="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_documentation_en-US" xlink:label="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:href="mygn-20201231.xsd#mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="lab_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DebtInstrumentLIBORFloorPercentage_f2088a1b-4068-4aa1-9164-9fc878b3cd99_terseLabel_en-US" xlink:label="lab_mygn_DebtInstrumentLIBORFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR floor (percent)</link:label>
    <link:label id="lab_mygn_DebtInstrumentLIBORFloorPercentage_label_en-US" xlink:label="lab_mygn_DebtInstrumentLIBORFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, LIBOR Floor, Percentage</link:label>
    <link:label id="lab_mygn_DebtInstrumentLIBORFloorPercentage_documentation_en-US" xlink:label="lab_mygn_DebtInstrumentLIBORFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, LIBOR Floor, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtInstrumentLIBORFloorPercentage" xlink:href="mygn-20201231.xsd#mygn_DebtInstrumentLIBORFloorPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DebtInstrumentLIBORFloorPercentage" xlink:to="lab_mygn_DebtInstrumentLIBORFloorPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_79fb141c-ddef-41be-ad14-ba26659a85ec_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ecab5ab2-6dae-47eb-9f2d-40f339f1633e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5f544ba8-4b52-4555-bb10-343a5394e876_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_5ed76d54-fca1-4beb-af3b-fe0692434f6b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6c933e63-ab87-4d4a-b1d6-eff346ad3a99_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_c6498d68-1c68-4d65-9a1b-ea9d5bd56231_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_4bcb73e6-2b85-40d5-a747-e3d8755ed8fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible meals and entertainment</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember_54119f39-5468-45d5-a6c3-1772d1aa1796_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Hereditary Cancer Testing</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Hereditary Cancer Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic hereditary cancer testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticHereditaryCancerTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:to="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ClinicAssetGroupMember_46b6f293-bc08-48f5-9f69-230b27dd7ca1_verboseLabel_en-US" xlink:label="lab_mygn_ClinicAssetGroupMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinic</link:label>
    <link:label id="lab_mygn_ClinicAssetGroupMember_d60f670d-a907-4039-b49d-46b88eb59ad9_terseLabel_en-US" xlink:label="lab_mygn_ClinicAssetGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinic asset group</link:label>
    <link:label id="lab_mygn_ClinicAssetGroupMember_label_en-US" xlink:label="lab_mygn_ClinicAssetGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinic Asset Group [Member]</link:label>
    <link:label id="lab_mygn_ClinicAssetGroupMember_documentation_en-US" xlink:label="lab_mygn_ClinicAssetGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinic asset group.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ClinicAssetGroupMember" xlink:href="mygn-20201231.xsd#mygn_ClinicAssetGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ClinicAssetGroupMember" xlink:to="lab_mygn_ClinicAssetGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_c8eade19-acf9-4486-bf88-fdb878fa0393_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_b3e5ff0a-fd11-4a9d-b9d8-00212d5521eb_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_af839f9a-09d8-4426-964a-c4efcaddd349_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_ed329daa-cc2e-4200-bdea-f102fc716008_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal bonds</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_5efb072c-3ae3-48ec-a686-6b43aede9ca1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_2f09fd13-5ea8-4fbc-a951-c249ed2de7de_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_ccd8b16d-5d40-419f-bc4a-ab3b4ff48dad_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_453d1869-0717-4354-a352-a13330beb4f6_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b9b5e3d5-9e60-4330-a0e2-d0940a64055c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_5511bd9e-7a57-45c4-8ca8-7c8c04c10488_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_01789689-85ee-4668-9d16-a20cfdc9cb34_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationForeignDisregardedElection_5df65525-ea96-4845-9997-3e4b133e2c89_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationForeignDisregardedElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign disregarded election</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationForeignDisregardedElection_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationForeignDisregardedElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Foreign Disregarded Election</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationForeignDisregardedElection_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationForeignDisregardedElection" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation foreign disregarded election.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationForeignDisregardedElection" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationForeignDisregardedElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationForeignDisregardedElection" xlink:to="lab_mygn_IncomeTaxReconciliationForeignDisregardedElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_155d4b26-5ed5-4942-aa30-09ae5e225200_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_e9cf83aa-724e-4f4e-975d-4df8201e34b4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_8ffd0d1d-20a4-4a35-acf5-6c74db6975c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale, in unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e55adde7-6697-456f-bade-5a63e563da0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_b2dd2fde-d009-4a55-a61d-8a6e3808ebf3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of escrow as result of working capital adjustment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_676a5db8-7164-40d1-bb2c-67d8528aac29_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d35ce91c-c195-4da9-aa76-e3dc60b251f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_16ae042d-252e-435a-bbca-1fcdd0125a57_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_62ccc5d0-fcc8-4b26-95bd-1c28d86e50c4_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_RangeTwoMember_8ffd24fb-d6cd-4305-8ff9-fcbddfdf9346_terseLabel_en-US" xlink:label="lab_mygn_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$ 21.29 - 25.39</link:label>
    <link:label id="lab_mygn_RangeTwoMember_label_en-US" xlink:label="lab_mygn_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:label id="lab_mygn_RangeTwoMember_documentation_en-US" xlink:label="lab_mygn_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeTwoMember" xlink:href="mygn-20201231.xsd#mygn_RangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_RangeTwoMember" xlink:to="lab_mygn_RangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_393507d4-dcc6-45bd-bb74-8aaaff56fb0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bffd8ee-31dc-462c-b5af-dbd5f78ebe36_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_acb813b0-0ffe-4327-99bc-b2fd9d6e4f4a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1291fa6d-f0e2-47e2-a341-77b9c1a216aa_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_ed53e6da-68ef-4174-8074-dc957fd0eb2e_terseLabel_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California</link:label>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_label_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0522f306-df9a-444d-9b9a-9f836afb109d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_eafd6bab-17f4-49a1-9e7e-771a05022530_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_28ec76d3-3036-47c8-9dcd-e31e622d8155_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred savings plan contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_RangeThreeMember_164f55dc-c60d-424f-891a-880607bbbcc8_terseLabel_en-US" xlink:label="lab_mygn_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$ 26.49 - 26.49</link:label>
    <link:label id="lab_mygn_RangeThreeMember_label_en-US" xlink:label="lab_mygn_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Three [Member]</link:label>
    <link:label id="lab_mygn_RangeThreeMember_documentation_en-US" xlink:label="lab_mygn_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeThreeMember" xlink:href="mygn-20201231.xsd#mygn_RangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_RangeThreeMember" xlink:to="lab_mygn_RangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1ed57626-5a6a-462c-923c-b70e37fb57db_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_3b63e52c-d8ae-442b-8e54-d963866de2f5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_fdcf8f68-fe8f-4c70-b7b0-28ee39f072f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_20300251-140d-4a61-9318-398c580433b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_cfbead91-e859-4d73-9ddb-1d52e875ce31_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5f0dbc67-9ad0-418b-ae2b-39317cefb26d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_42ab37e4-683b-4a02-b687-ea067184dffc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_2852bd65-4746-400c-9b16-b257e70a2a43_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_fb1fe33f-e2d1-4b58-ae44-abf0ef3640d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_6f9f54ef-4377-46aa-b413-c7a2b653fc82_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b4dcdbda-f6fa-4d98-92d3-9d720b42c398_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisposals_668b47c0-fff7-4442-99bb-d2d0b88f2fd7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment sold and deconsolidated</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisposals_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Disposals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4bb9a203-174c-421d-9da9-191f31286497_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_29a31fc7-3a80-437a-958d-7040eecfbc40_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-amortizable</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_1d76788d-ba31-4caf-9a63-2a284cb1b9a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_05cefaeb-63bd-435c-8e8b-2dd07b9c879c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ScheduleOfIntangibleAssetsTable_3d1ea499-5844-435d-91b0-1b188766cace_terseLabel_en-US" xlink:label="lab_mygn_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets [Table]</link:label>
    <link:label id="lab_mygn_ScheduleOfIntangibleAssetsTable_label_en-US" xlink:label="lab_mygn_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets [Table]</link:label>
    <link:label id="lab_mygn_ScheduleOfIntangibleAssetsTable_documentation_en-US" xlink:label="lab_mygn_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfIntangibleAssetsTable" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable" xlink:to="lab_mygn_ScheduleOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dc167963-a1c3-4c0c-8b75-607d448f334b_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4952b737-6225-41a6-bdc8-6dfe14b190d9_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_438db7c4-e5ec-43da-9e1e-547013d97dc2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_960dd405-4628-4652-8bea-a4dec80cefe8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_7fa48cf0-586f-4e36-8f3b-6115750f98d3_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_label_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment Summary [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:to="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e75c1626-f68c-46d5-a563-796b034cdda3_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b9b623f-9273-4144-acf8-7baef42a0061_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd7c5d18-4da5-4084-8df6-5ae1f16ee1e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationTable_96e2f553-2199-456f-adc1-069d3015ca7a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationTable" xlink:to="lab_us-gaap_ReclassificationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_5abb809f-e167-40ea-bee8-dac64b07e65f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_25428168-d3a2-4a25-910d-a60425830772_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final tax benefit of Tax Act</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_NumberOfDefinedBenefitPensionPlans_68b0ef33-e725-465f-9c04-594a02f9b165_terseLabel_en-US" xlink:label="lab_mygn_NumberOfDefinedBenefitPensionPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of defined benefit pension plans</link:label>
    <link:label id="lab_mygn_NumberOfDefinedBenefitPensionPlans_label_en-US" xlink:label="lab_mygn_NumberOfDefinedBenefitPensionPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Defined Benefit Pension Plans</link:label>
    <link:label id="lab_mygn_NumberOfDefinedBenefitPensionPlans_documentation_en-US" xlink:label="lab_mygn_NumberOfDefinedBenefitPensionPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of defined benefit pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NumberOfDefinedBenefitPensionPlans" xlink:href="mygn-20201231.xsd#mygn_NumberOfDefinedBenefitPensionPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_NumberOfDefinedBenefitPensionPlans" xlink:to="lab_mygn_NumberOfDefinedBenefitPensionPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_799cc3f0-fd01-4d54-aa64-099355d39dbc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary_da4f5b38-b821-40d5-b3c6-eb7a8b409982_terseLabel_en-US" xlink:label="lab_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of accumulated other comprehensive loss upon the deconsolidation of a subsidiary</link:label>
    <link:label id="lab_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary_label_en-US" xlink:label="lab_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification From Accumulated Other Comprehensive Loss, Deconsolidation Of Subsidiary</link:label>
    <link:label id="lab_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary_documentation_en-US" xlink:label="lab_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification From Accumulated Other Comprehensive Loss, Deconsolidation Of Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" xlink:href="mygn-20201231.xsd#mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" xlink:to="lab_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment_bd96a2ac-19b4-41ab-b51e-d50c0af31d1d_terseLabel_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital adjustment</link:label>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment_label_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Increase (Decrease), Working Capital Adjustment</link:label>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment_documentation_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Increase (Decrease), Working Capital Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment" xlink:to="lab_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_3955d43a-9def-4467-9c4a-be1b1cf62dd7_totalLabel_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_label_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetAssetLiability" xlink:to="lab_us-gaap_FairValueNetAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ae5776d0-fedc-4937-8c52-4d0ecdc46f3d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from common stock issued under share-based compensation plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_ee5b607e-6a49-4b9c-b38b-6bc5392c733a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_4fe4dc52-2558-41d8-9086-17c2965ab638_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Segment Allocation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:to="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_3b4e7c5f-04d1-4af9-9e2a-5106ade19358_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_669e1c15-3f71-4441-8949-692b6bcd01c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_877dac1e-38bd-49e4-a3a2-1f1710168669_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_0d78cf15-4c51-4ca4-88f8-18939902ad89_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_5b5bda51-164c-4041-a4a7-17e1939160d7_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d99afddd-ffdc-4f82-bed2-369b227fa371_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationCARESAct_813f88f2-2062-4a22-951f-900cf90638f7_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationCARESAct_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation CARES Act</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationCARESAct_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationCARESAct" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationCARESAct" xlink:to="lab_mygn_IncomeTaxReconciliationCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_978232c7-cf07-401a-8805-dfa1d15c472e_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_8f2d9f52-1d21-4a79-a602-be893f5e2a17_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b7cace67-40b2-4fc1-b1b8-19cd24aef7b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_b2f92486-8473-422a-acd2-843fa796d21d_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_e8ceb296-b52d-4058-82bd-62aa5b18062a_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TransitionPeriodFinancialInformationTable_05c8455f-9181-48bf-9e0b-483f14407bd3_terseLabel_en-US" xlink:label="lab_mygn_TransitionPeriodFinancialInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Financial Information [Table]</link:label>
    <link:label id="lab_mygn_TransitionPeriodFinancialInformationTable_label_en-US" xlink:label="lab_mygn_TransitionPeriodFinancialInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Financial Information [Table]</link:label>
    <link:label id="lab_mygn_TransitionPeriodFinancialInformationTable_documentation_en-US" xlink:label="lab_mygn_TransitionPeriodFinancialInformationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TransitionPeriodFinancialInformationTable" xlink:href="mygn-20201231.xsd#mygn_TransitionPeriodFinancialInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TransitionPeriodFinancialInformationTable" xlink:to="lab_mygn_TransitionPeriodFinancialInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LatestTaxYearMember_17d15b2a-ec9a-443e-bc89-4a82e38623c8_terseLabel_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latest tax years</link:label>
    <link:label id="lab_us-gaap_LatestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LatestTaxYearMember" xlink:to="lab_us-gaap_LatestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_623bbe4b-b8cf-4191-bd0f-a958c10cf680_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4a22cd4e-65de-48dd-99dd-8b73b15fc564_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_348a4935-7ac9-49d5-9eea-d86c43752095_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cumulative Translation Adjustments Included in Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_bcbe6362-41d1-470c-be3e-84fb01804da5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0a5e9057-443f-4d4e-8c3c-4dbb9fb1683c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_8302e4e8-4c4d-4fc6-b4e2-04c860e0ce2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_ef29fbc7-17b0-49e1-8b1a-cb799d11a4b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_39ceb59c-e4c7-491a-9221-7ecacf01e64c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_32292ff2-c368-4186-81c0-6e844d792468_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_fd6a5b3c-3f4a-4644-affc-e0e8eb1cc6ad_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net, total</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e612f8ec-8b02-4155-9238-fe1db380f582_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_cc433caf-0624-454d-ad9a-82aa7592980e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TaxCreditCarryforwardsExpirationDate_5180e228-6697-4e78-98a7-f3faff8b7965_terseLabel_en-US" xlink:label="lab_mygn_TaxCreditCarryforwardsExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research credit, expiration in year</link:label>
    <link:label id="lab_mygn_TaxCreditCarryforwardsExpirationDate_label_en-US" xlink:label="lab_mygn_TaxCreditCarryforwardsExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforwards Expiration Date</link:label>
    <link:label id="lab_mygn_TaxCreditCarryforwardsExpirationDate_documentation_en-US" xlink:label="lab_mygn_TaxCreditCarryforwardsExpirationDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforwards Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TaxCreditCarryforwardsExpirationDate" xlink:href="mygn-20201231.xsd#mygn_TaxCreditCarryforwardsExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TaxCreditCarryforwardsExpirationDate" xlink:to="lab_mygn_TaxCreditCarryforwardsExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_7a6d1847-8072-44c5-9af8-1da499075876_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Deferred Revenue Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_520fb7bf-02e4-4165-a1ad-c9231952dc4d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db0ed99f-0aec-492d-bf7d-250ec76bf943_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DevelopedTechnologyAndDatabaseMember_832bd997-a57c-4a8c-a25a-6a58f5629c41_terseLabel_en-US" xlink:label="lab_mygn_DevelopedTechnologyAndDatabaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology and database</link:label>
    <link:label id="lab_mygn_DevelopedTechnologyAndDatabaseMember_label_en-US" xlink:label="lab_mygn_DevelopedTechnologyAndDatabaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology And Database [Member]</link:label>
    <link:label id="lab_mygn_DevelopedTechnologyAndDatabaseMember_documentation_en-US" xlink:label="lab_mygn_DevelopedTechnologyAndDatabaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology and database.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DevelopedTechnologyAndDatabaseMember" xlink:href="mygn-20201231.xsd#mygn_DevelopedTechnologyAndDatabaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DevelopedTechnologyAndDatabaseMember" xlink:to="lab_mygn_DevelopedTechnologyAndDatabaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_0da054c1-76d5-403f-ae55-702d4015238b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_5352c745-cb48-46c3-98fe-cf0acbf36934_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company matching contribution, maximum as percentage of employee compensation</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_5d538d97-36cd-450e-9cc3-3411c0dead57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance based on Nasdaq Healthcare Provider Index</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_5aee4222-69de-4fe6-bc56-c8eddeb759a5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_324ba844-6d7c-4bc7-9ee3-8fd01e3516e9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Company stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77712138-334e-42f1-a369-d6b828f732f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service period for award vesting (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7fa5ed9f-f892-40af-bd90-d663296ac9aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_aa08134e-15ac-4c1d-8f81-02a0df5af853_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment_d3d4d51b-4a80-43e0-b151-1da9442059c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments prior to maturity date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Annual Principal Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_519a2cab-7d48-4189-a2e7-15d76e3ab807_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9cdbe096-c2c7-4edd-9572-e05f03df76a2_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_f907717b-560e-46a8-bab2-e5efd73ea3a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal income tax expense at the statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_debac9c7-2b81-4e87-bddd-a72c3266746d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_f3044298-09f9-4124-bca6-339015b0780a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum_96d002b1-d039-4f0a-add2-c17893b9ee95_terseLabel_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derived service period, maximum (in years)</link:label>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum_label_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Maximum</link:label>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum_documentation_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" xlink:to="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_5c7fdca2-bc52-4c13-94cc-831a38e7f699_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_91fdae32-ebda-45da-9603-5b90c05f9047_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_ceec4e83-b2b0-48ed-91b0-bd7b8d38a1c3_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayment</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b0e87d45-3223-4572-923d-5baee39a0d37_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_98332ae3-0652-4e4b-87d0-ae5602e8637a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_5f139c9e-7720-4c60-8143-383ba70bf7dd_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarliestTaxYearMember_28017ea1-66c5-476b-b820-193c47cef930_terseLabel_en-US" xlink:label="lab_us-gaap_EarliestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earliest tax year</link:label>
    <link:label id="lab_us-gaap_EarliestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_EarliestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarliestTaxYearMember" xlink:to="lab_us-gaap_EarliestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_8c2ce728-ff40-4c31-9915-74524bd56af1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationStatuteExpiration_18ae0f77-bbec-45bd-a876-4ae9aca4e1b4_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationStatuteExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax benefits statute expired, net of federal benefit</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationStatuteExpiration_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationStatuteExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Statute Expiration</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationStatuteExpiration_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationStatuteExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation statute expiration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationStatuteExpiration" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationStatuteExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationStatuteExpiration" xlink:to="lab_mygn_IncomeTaxReconciliationStatuteExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_f714c8f7-f0df-4fc6-a7d5-26157c87e870_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_4ff40a94-e37c-45e8-8153-3b077de3f71a_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_9d48c4fb-f419-476d-a6f7-be23756d2e3a_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal agency issues</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ae437849-513e-436b-94d5-b686e6c574f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_04304fe0-cb9c-4048-871f-76fd7d600804_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_7e56d62b-e809-48d5-94ab-a7b8aa1d711d_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_872308e1-6190-41a0-ae21-47162275d766_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_eea2b907-453b-4ed4-8644-b869bd95b898_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled or expired (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1746d15d-9c53-4ff0-8264-2a622c4cd3b8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cf846877-1f39-499d-b392-ac3a8d81f222_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_PerformanceObligationEstimatedTransactionPriceMember_a81b6548-7d17-4825-9e38-15e40539ec49_terseLabel_en-US" xlink:label="lab_mygn_PerformanceObligationEstimatedTransactionPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation estimate</link:label>
    <link:label id="lab_mygn_PerformanceObligationEstimatedTransactionPriceMember_label_en-US" xlink:label="lab_mygn_PerformanceObligationEstimatedTransactionPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Obligation Estimated Transaction Price [Member]</link:label>
    <link:label id="lab_mygn_PerformanceObligationEstimatedTransactionPriceMember_documentation_en-US" xlink:label="lab_mygn_PerformanceObligationEstimatedTransactionPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Obligation Estimated Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PerformanceObligationEstimatedTransactionPriceMember" xlink:href="mygn-20201231.xsd#mygn_PerformanceObligationEstimatedTransactionPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_PerformanceObligationEstimatedTransactionPriceMember" xlink:to="lab_mygn_PerformanceObligationEstimatedTransactionPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_5e3e963f-2ba1-4778-abdd-deed19f89cf3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_568478b6-1c97-40cf-863a-61fe4232a3e3_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod_6f3992be-5319-4be0-b7b4-46e6d7b29d33_terseLabel_en-US" xlink:label="lab_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod_label_en-US" xlink:label="lab_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Increase (Decrease) During Period</link:label>
    <link:label id="lab_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod_documentation_en-US" xlink:label="lab_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Increase (Decrease) During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod" xlink:href="mygn-20201231.xsd#mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod" xlink:to="lab_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e195b967-d71e-4b66-a430-a41012641d79_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_62767b20-042e-4892-87cf-14d42808641f_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_de576a05-e464-45d8-bde9-2f38d95c7a98_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd810509-68a5-45d3-880a-d64ce19b9fec_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_0103c0f8-a619-48b1-8daa-82c7a904585e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_CARESActOf2020ProviderReliefFundAmount_80698c7b-3494-49b9-98c9-e61c848e7ac1_terseLabel_en-US" xlink:label="lab_mygn_CARESActOf2020ProviderReliefFundAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider fund relief under CARES Act</link:label>
    <link:label id="lab_mygn_CARESActOf2020ProviderReliefFundAmount_label_en-US" xlink:label="lab_mygn_CARESActOf2020ProviderReliefFundAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C A R E S Act Of2020 Provider Relief Fund Amount</link:label>
    <link:label id="lab_mygn_CARESActOf2020ProviderReliefFundAmount_documentation_en-US" xlink:label="lab_mygn_CARESActOf2020ProviderReliefFundAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act of 2020 Provider Relief Fund amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CARESActOf2020ProviderReliefFundAmount" xlink:href="mygn-20201231.xsd#mygn_CARESActOf2020ProviderReliefFundAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_CARESActOf2020ProviderReliefFundAmount" xlink:to="lab_mygn_CARESActOf2020ProviderReliefFundAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_78d9a9f3-b740-4fa3-9363-d0343bda2cca_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3d7fb154-8bdc-48d0-a498-5bf890ab5a97_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_6bf7f9ee-f8c7-456d-a533-4afb96255b85_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0cdd895d-8679-43e7-bea7-64ee37ac448c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f6a4d607-c665-4e49-a066-407da6fcd263_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_3e25356a-8f32-4251-9d96-9c8f9e2d1672_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0da56215-6f58-4117-a601-9986b7182db7_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0b1823f0-5746-4705-8cef-568a547c6808_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare_8ec91ebb-1a90-4438-90e3-bf91d130fd55_terseLabel_en-US" xlink:label="lab_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share impact of Tax Act</link:label>
    <link:label id="lab_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare_label_en-US" xlink:label="lab_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts And Jobs Act, Change In Tax Rate, Increase (Decrease) In Earnings Per Share</link:label>
    <link:label id="lab_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare_documentation_en-US" xlink:label="lab_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts And Jobs Act, Change In Tax Rate, Increase (Decrease) In Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" xlink:href="mygn-20201231.xsd#mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" xlink:to="lab_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_2619f66e-0930-45c1-a02e-cb4caf21a0ff_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_fe5371b1-bd4e-4d9e-8c5c-34333fe856c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationCARESAct_014da79e-77bd-40e6-b444-1564a41b98f4_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationCARESAct_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation CARES Act</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationCARESAct_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationCARESAct" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationCARESAct" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_RangeOneMember_04fbf17b-2774-4107-aaaf-be9775207c3e_terseLabel_en-US" xlink:label="lab_mygn_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$ 13.38 - 19.47</link:label>
    <link:label id="lab_mygn_RangeOneMember_label_en-US" xlink:label="lab_mygn_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:label id="lab_mygn_RangeOneMember_documentation_en-US" xlink:label="lab_mygn_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeOneMember" xlink:href="mygn-20201231.xsd#mygn_RangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_RangeOneMember" xlink:to="lab_mygn_RangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f44daf3d-23e8-401d-bdd5-5aefa465ed16_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5083a84f-315a-49c3-a3bb-e4a9e3b61b82_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_AmendmentToCreditAgreementMember_39cac770-1cb6-4d69-afbb-3de82c956c48_terseLabel_en-US" xlink:label="lab_mygn_AmendmentToCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended facility</link:label>
    <link:label id="lab_mygn_AmendmentToCreditAgreementMember_label_en-US" xlink:label="lab_mygn_AmendmentToCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment To Credit Agreement [Member]</link:label>
    <link:label id="lab_mygn_AmendmentToCreditAgreementMember_documentation_en-US" xlink:label="lab_mygn_AmendmentToCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment to Credit Agreement [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmendmentToCreditAgreementMember" xlink:href="mygn-20201231.xsd#mygn_AmendmentToCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_AmendmentToCreditAgreementMember" xlink:to="lab_mygn_AmendmentToCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2fcc44c3-0c58-4fa0-96d5-5df5ad72af9b_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8bee8f9c-db75-4bf0-b4fc-292372ebb604_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_f0eeda19-3d83-4686-ab53-c4cc652c89a7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_UT_72e3f6c4-c984-40b1-b1b0-9c4033471a22_terseLabel_en-US" xlink:label="lab_stpr_UT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utah</link:label>
    <link:label id="lab_stpr_UT_label_en-US" xlink:label="lab_stpr_UT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UTAH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_UT" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_UT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_UT" xlink:to="lab_stpr_UT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_d2cd82ca-593f-4eb7-9388-1f56fef748f8_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_c0ce7143-ede7-4952-ba2d-d6c1a60241ca_terseLabel_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Gross unrealized holding gains</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_e19a64e2-501f-4a82-a365-df034d469c1d_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation_79dbf7eb-f901-4016-bbdb-67d5e4a270b8_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible officer compensation</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Nondeductible Expense Officers Compensation</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation nondeductible expense officers compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" xlink:to="lab_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cc377ec6-4532-41ac-8489-7939b6282fa9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_c0b96816-c9ba-4348-b91d-3f60fad84550_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7d0e5bdb-d24d-4641-9e7b-71362167faef_verboseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0b99d2e1-6968-499f-9dec-0358eb1c8337_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_32a368d8-3b70-4957-ada3-27d9cf6b8589_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amortizable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_d5c65eeb-188e-4517-9396-ba0f0472f5ea_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_58864093-d6df-4892-9bac-8e3d93e497b8_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_e9be4de6-7c8c-4f90-ade6-f46f275929e2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ed9a1108-f798-4366-8f6a-6bdbf046528d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f45748af-d045-4a98-b0b2-69505f47916d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements_cbc1c201-8893-43d0-af2b-b00dfd86482e_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible legal settlement</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Non Deductible Legal Settlements</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation non deductible legal settlements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a7a15e9a-b093-4055-ac29-9cb113d8b21e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Gross unrealized holding gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_dcf913e9-13a6-45d6-8bfa-9ac2407db564_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticProlarisTestingMember_0c8ad4b6-d1fc-4d7f-aea3-e2ad8c5ce00b_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticProlarisTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Prolaris</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticProlarisTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticProlarisTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Prolaris Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticProlarisTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticProlarisTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic Prolaris testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticProlarisTestingMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticProlarisTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticProlarisTestingMember" xlink:to="lab_mygn_MolecularDiagnosticProlarisTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLimitationsOnUse_c3b9d4b7-6411-4f99-a7ac-4af276028075_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research credit subject to sections 382,383</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLimitationsOnUse_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Limitations on Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:to="lab_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_3ad52465-c54e-4e16-bbd8-986cb4d41271_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2da7838e-6858-4eca-ab92-42dd29f689e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_cd71bf9b-a7ac-4e78-b458-313657fa44bf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life (years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_3e2ced91-2116-4699-b923-43f1aa33e0ee_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_62f8df62-6192-4304-b65d-fd29cf63b9c8_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_5fbe16fc-464b-45aa-ae45-efd99b32ffb3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_e351f096-967d-4385-9f2e-2f053662a4fc_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_5e8d7023-b2b2-4b9b-a5f8-aca76579d789_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_97077f31-3319-4e4c-82ce-92ff284841da_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Tax Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_164ee10d-92a4-4681-bf51-1f668ee3c37c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f9c22533-3328-44e3-b223-d4e693dc9496_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Related Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_c7d53c2b-665a-4ee1-8244-24ba7fa12760_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable investment securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_2cd73014-8b35-417f-a471-d703512b6d1e_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_16e4d364-3eba-42db-90bf-491977906577_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_f57d910c-5c77-4f19-9622-45a4e086a302_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b489f281-c5fd-4b2f-83e7-564baee4b343_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, net, amortizable</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationLineItems_939b7818-d21f-4bfd-8499-8b26f13e8004_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationLineItems" xlink:to="lab_us-gaap_ReclassificationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_70b0bf3a-671f-495d-9855-f7ba6ad7a22b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_e25c0234-bf99-4a02-aaae-2db493218cec_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_2d238785-df23-493d-8d7d-0fb655293fe5_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">President and Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized_7f794021-4b87-4526-a625-0f85f587e30f_negatedLabel_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized_label_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Including New Contract, Revenue Recognized</link:label>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized_documentation_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Including New Contract, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" xlink:href="mygn-20201231.xsd#mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" xlink:to="lab_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_be44d944-9052-424c-9d29-4c67655245df_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_6cb3312b-d0f7-4133-a0c9-9944a30f9af9_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3817745e-c27b-4d07-9059-c6d37df002f2_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_d4a14e78-6a51-4dff-abec-bee58c26c604_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research credit</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_80073a4f-bbae-4e90-a502-9535d6c9209f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Benefit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_4735ccbe-b8f7-46bf-b053-fb4390f099d2_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice_2061ffd3-128f-4821-a813-ff3534854db4_terseLabel_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price consecutive days threshold for award vesting condition</link:label>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice_label_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Metric, Threshold Consecutive Days, Stock Price</link:label>
    <link:label id="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice_documentation_en-US" xlink:label="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Metric, Threshold Consecutive Days, Stock Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" xlink:to="lab_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_fdc46bba-1b19-470b-b950-1110841d90cd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d9e320a4-3f42-4c07-b517-f54aa1dec8d0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense, weighted-average period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_6ae25b47-d3d8-4461-8291-c196af1c301f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_c94ada0e-8025-4a7f-bb7d-a8c79bdc3f2b_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ClinicReportingUnitMember_d4881d65-a233-411f-910c-496e2c7ec3ed_terseLabel_en-US" xlink:label="lab_mygn_ClinicReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinic reporting unit</link:label>
    <link:label id="lab_mygn_ClinicReportingUnitMember_label_en-US" xlink:label="lab_mygn_ClinicReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinic Reporting Unit [Member]</link:label>
    <link:label id="lab_mygn_ClinicReportingUnitMember_documentation_en-US" xlink:label="lab_mygn_ClinicReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinic Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ClinicReportingUnitMember" xlink:href="mygn-20201231.xsd#mygn_ClinicReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ClinicReportingUnitMember" xlink:to="lab_mygn_ClinicReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock_c14f02dd-f917-491b-8f07-49deac990fce_terseLabel_en-US" xlink:label="lab_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transition Period Comparative Data</link:label>
    <link:label id="lab_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock_label_en-US" xlink:label="lab_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Transition Period Comparative Data [Table Text Block]</link:label>
    <link:label id="lab_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock_documentation_en-US" xlink:label="lab_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Transition Period Comparative Data</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock" xlink:to="lab_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DeferredTaxAssetsUncertainStateTaxPositions_926685c2-913d-4754-ae9f-f2e8bca203d9_terseLabel_en-US" xlink:label="lab_mygn_DeferredTaxAssetsUncertainStateTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain state tax positions</link:label>
    <link:label id="lab_mygn_DeferredTaxAssetsUncertainStateTaxPositions_label_en-US" xlink:label="lab_mygn_DeferredTaxAssetsUncertainStateTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Uncertain State Tax Positions</link:label>
    <link:label id="lab_mygn_DeferredTaxAssetsUncertainStateTaxPositions_documentation_en-US" xlink:label="lab_mygn_DeferredTaxAssetsUncertainStateTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Uncertain State Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxAssetsUncertainStateTaxPositions" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxAssetsUncertainStateTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DeferredTaxAssetsUncertainStateTaxPositions" xlink:to="lab_mygn_DeferredTaxAssetsUncertainStateTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f09b6091-93c3-40e0-9427-f65e58235592_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_adbc7ccb-58e0-478d-9cfb-ee88fb23a213_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_1c7f84e9-e398-47c1-846c-dac8e0626e70_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Operating Loss and Research Credit Carryforwards (Tax Effected)</link:label>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_a18b4b20-c2ef-4af8-a66c-a0d637afa8f6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of RSUs outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_4de3342c-15b3-45e7-9e44-7478555b7614_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_c5698df2-d06d-47f5-8449-9ac6918169e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Total Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_c4d14676-f23e-4dda-a73c-4476dfce63f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Quarterly Financial Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_0a42a069-b992-455d-9d6f-171d08f1d8b6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_CounsylIncMember_ef4cbdcb-6e7c-49af-8208-e8fdcc27b2e3_terseLabel_en-US" xlink:label="lab_mygn_CounsylIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counsyl Inc</link:label>
    <link:label id="lab_mygn_CounsylIncMember_label_en-US" xlink:label="lab_mygn_CounsylIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counsyl Inc [Member]</link:label>
    <link:label id="lab_mygn_CounsylIncMember_documentation_en-US" xlink:label="lab_mygn_CounsylIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counsyl Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_CounsylIncMember" xlink:to="lab_mygn_CounsylIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_51b2ac3b-d9c9-4aff-93c7-ca29bd5dfe26_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible contingent purchase price and transaction costs</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Non Deductible Contingent Purchase Price And Transaction Costs</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation non deductible contingent purchase price and transaction costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:to="lab_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_007e38e3-f6e7-4f95-8923-78d51c61c891_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_8ca680c6-68ad-410a-9adb-6c84fc367b84_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_f0618e8e-c756-4b6d-84af-4ebeb4be77ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f888ca75-253f-439f-afb1-3e0f8d254203_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection_8f2be02a-3d30-4636-aba1-44f07ec5769d_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign disregarded election</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Foreign Disregarded Election</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation foreign disregarded election.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_924b6db0-0255-48df-9d21-db70989cf35c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_c4d2b05e-1386-4ea9-8eab-c15c226e048c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments_de8c78ea-5376-43d8-b43c-2063adb6b7fb_terseLabel_en-US" xlink:label="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets less cash, cash equivalents, and marketable investment securities</link:label>
    <link:label id="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments_ce9e11ec-3008-4ae1-8c4c-d7e8de0045bd_verboseLabel_en-US" xlink:label="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets by segment and geographical region</link:label>
    <link:label id="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments_label_en-US" xlink:label="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Less Cash, Cash Equivalents, And Investments</link:label>
    <link:label id="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments_documentation_en-US" xlink:label="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Less Cash, Cash Equivalents, And Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments" xlink:href="mygn-20201231.xsd#mygn_AssetsLessCashCashEquivalentsAndInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments" xlink:to="lab_mygn_AssetsLessCashCashEquivalentsAndInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_31496363-8c92-4b4b-afbe-357cbead1535_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_08cd7c80-ff3f-418f-a07c-04f0e02be753_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension_aa42cfd2-8b13-4acf-acac-1078ff51f263_terseLabel_en-US" xlink:label="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain related to pension settlement</link:label>
    <link:label id="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension_label_en-US" xlink:label="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Settlement Of Pension</link:label>
    <link:label id="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension_documentation_en-US" xlink:label="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Settlement Of Pension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" xlink:href="mygn-20201231.xsd#mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" xlink:to="lab_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_f81107cf-3bb5-4e14-8244-3ffb70a540a4_verboseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal and state jurisdictions</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_4cf861e2-9d07-44ec-bf75-fed99f8ac62b_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_93af30dd-f29b-4d2c-a411-3461d3b89fa2_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_643f35ee-f1f8-4267-9e9d-18f1cf7a0af4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod_b6e7dd6a-1eb5-4d10-ad92-f1770d5beb6b_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in revenue recognition/method</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Changes In Revenue Recognition Method</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation changes in revenue recognition method.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod" xlink:to="lab_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_a6f481c6-5c8a-4afc-835b-a75afb8d8b84_negatedLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments related to acquisition contingent consideration</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Fair Value Adjustments Related To Acquisition Contingent Consideration</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation fair value adjustments related to acquisition contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:to="lab_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_ee55ec1b-f72b-4655-9677-5f7444627ac6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ae3eab9a-d5cd-4352-9393-7ea4bc0b9dc1_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets Held-for-use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticEndoPredictTestingMember_52865dd5-8464-438c-b77c-5a212d67c924_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - EndoPredict</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticEndoPredictTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Endo Predict Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticEndoPredictTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic EndoPredict testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticEndoPredictTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:to="lab_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_CARESActOf2020MedicarePaymentAmount_c86d61b1-ed91-436c-9cdf-c70385b0a548_terseLabel_en-US" xlink:label="lab_mygn_CARESActOf2020MedicarePaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare payments to provide relief from economic impacts of COVID-19</link:label>
    <link:label id="lab_mygn_CARESActOf2020MedicarePaymentAmount_label_en-US" xlink:label="lab_mygn_CARESActOf2020MedicarePaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Of 2020 Medicare Payment Amount</link:label>
    <link:label id="lab_mygn_CARESActOf2020MedicarePaymentAmount_documentation_en-US" xlink:label="lab_mygn_CARESActOf2020MedicarePaymentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act of 2020 medicare payment amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CARESActOf2020MedicarePaymentAmount" xlink:href="mygn-20201231.xsd#mygn_CARESActOf2020MedicarePaymentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_CARESActOf2020MedicarePaymentAmount" xlink:to="lab_mygn_CARESActOf2020MedicarePaymentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_5d527fdf-718a-47c9-80d1-c63d480f93ec_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_517fdd4d-7452-4ab1-855f-d23c671b954b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtRestructuringCosts_614c0b1a-ba9c-4352-a630-b4ea11ec0e43_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees associated with refinancing of revolving credit facility</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:to="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_26f67b52-d276-44bf-bf1c-a1be9e8a9607_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_f267ad27-8e72-44e7-98cb-bc2fb8bb70c6_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits, net of the federal tax on state credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_68481cc7-6779-4ec5-ac91-4a0714b3216c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_0a3a7c62-5e02-4f20-be1b-d2550a0546cb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_584f985e-f11e-4de6-b81b-8eee725092e0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive stock option and employee stock purchase plan expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cf5416b7-60e7-4e25-9a9f-8bd9f279956f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining repurchase authorization</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TransitionPeriodComparativeDataTextBlock_1e085621-8c00-453b-b1b6-d191e011cb09_terseLabel_en-US" xlink:label="lab_mygn_TransitionPeriodComparativeDataTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Comparative Data (Unaudited)</link:label>
    <link:label id="lab_mygn_TransitionPeriodComparativeDataTextBlock_label_en-US" xlink:label="lab_mygn_TransitionPeriodComparativeDataTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Comparative Data [Text Block]</link:label>
    <link:label id="lab_mygn_TransitionPeriodComparativeDataTextBlock_documentation_en-US" xlink:label="lab_mygn_TransitionPeriodComparativeDataTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Period Comparative Data</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TransitionPeriodComparativeDataTextBlock" xlink:href="mygn-20201231.xsd#mygn_TransitionPeriodComparativeDataTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TransitionPeriodComparativeDataTextBlock" xlink:to="lab_mygn_TransitionPeriodComparativeDataTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_f1249d59-a91c-4787-8f48-262f144a70e9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9dbb3564-5418-461c-997c-4629724a1984_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_f5ac24c7-1b43-41c1-ac3f-6eb19fc566e8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_5f622e65-49cd-4fff-a76a-886153cb9f81_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_aedb1643-ad9e-4be5-a6dc-030f43a61cb8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Differences Between Statutory Federal Income Tax Rate and Income Taxes Reported</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticPrenatalTestingMember_872e9b25-e49c-4e1c-af45-13b84be80858_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Prenatal</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticPrenatalTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Prenatal Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticPrenatalTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic Prenatal testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticPrenatalTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:to="lab_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_374b0893-ab8c-4a13-ace4-f7b74220ec27_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_b3f4fe8a-59ca-4c25-83a6-fbd8a2097e9d_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Establishment of operation lease right-of-use assets and lease liabilities</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_eca0cc99-df6a-46fa-b49b-21d7caefccdc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intrinsic Value of Options Exercised</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_02657c64-5cec-4159-9585-c62557767d54_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_26557ea6-b4ec-4ee2-a40e-3d23696b46db_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8cf642f9-f43c-4ce6-98d0-2b79371355ca_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_a0c1667b-b934-4eb8-a300-5e8c8833e456_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_df4369d9-a33e-403a-9c20-aad182294ee9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Type</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_8b419256-18d1-4a87-a0fa-6992822119b3_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_aa4db327-8ed9-438e-95b4-ea02d7e54678_negatedLabel_en-US" xlink:label="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Prepaid Expense Excluding Increase Decrease In Prepaid Taxes</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_documentation_en-US" xlink:label="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in prepaid expense excluding increase decrease in prepaid taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:to="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_6028f113-51a5-41a3-bd0e-0342c9385b18_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a2a9cf96-ea50-45de-be5d-693a0b3863ec_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_40bf23b7-675f-485f-b8df-98b055778e33_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_648a344d-b111-4f08-b75c-5a2e2821967e_negatedLabel_en-US" xlink:label="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_label_en-US" xlink:label="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Unrecognized Tax Benefits</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_documentation_en-US" xlink:label="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in unrecognized tax benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInUnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:to="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_7bc39657-e27d-4aff-9751-0a1ed8ef602f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_980db0c5-5d6a-4f51-8d33-d974daa2b9f1_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_bc6be59c-3bb9-49c8-8cfc-78a42f17c8a1_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_6e876327-f39a-4328-b89d-bd8ce229dfc3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_752ed9e9-4d25-492e-a70b-59be7f075130_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased and retired</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_6e680c0d-8667-4853-aef0-4bca23564d37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a41f7b89-5a43-494c-aac9-f67d3f98ac32_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_dd676299-0f9c-4cba-8bbc-ee58d607b723_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_c51154f7-3e8e-4517-b964-1ee29e209b2a_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6f914e96-dc23-49fa-8b07-eaf8ac669c30_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_e0b2e7a2-a631-4686-9eb3-fad51aaff011_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_dae10f9b-8393-42b5-b400-173ddb080415_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_ba52dcfa-a5d4-4e47-91b3-9784a379387c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_574cb1b9-04e0-48a5-927c-f5a71cacc19b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_0080392a-73e5-48cd-b444-4a1a79eaa887_terseLabel_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Gross unrealized holding gains</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_f85d3793-4889-4321-994a-61dcc375ae6c_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationExpiredTaxAttributes_2c52d904-73c8-4c1b-89d8-bfcab17a2a5b_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationExpiredTaxAttributes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired tax attributes</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationExpiredTaxAttributes_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationExpiredTaxAttributes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Expired Tax Attributes</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationExpiredTaxAttributes_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationExpiredTaxAttributes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation expired tax attributes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationExpiredTaxAttributes" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationExpiredTaxAttributes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationExpiredTaxAttributes" xlink:to="lab_mygn_IncomeTaxReconciliationExpiredTaxAttributes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_78b1523c-dd8f-4cd5-a810-6925d0bf7f63_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e88713fb-2f3a-4b7b-b051-88c40a22d11a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a865a851-427c-478c-8c25-0d1469d72c32_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_e17b3ad7-7fa7-414e-a61a-8dbaea031463_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_715345e3-a709-416a-8487-20124cba899c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_5c5b8bf1-1e42-4038-8678-4297df4ea07c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_6758352c-af37-4c3d-8597-9f7d46e2f63d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ff9af7cb-32c1-43bb-8212-d691de460da4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_761a55da-5429-4e7e-a116-a160549f28c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct_dc9e45c6-5783-4506-9a43-a3d3e45a46e2_negatedTerseLabel_en-US" xlink:label="lab_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit related to operating loss carryback, CARES Act</link:label>
    <link:label id="lab_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct_label_en-US" xlink:label="lab_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Operating Loss Carryback, CARES Act</link:label>
    <link:label id="lab_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct_documentation_en-US" xlink:label="lab_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Operating Loss Carryback, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" xlink:to="lab_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_2b517289-8a9b-475e-b706-6dadc15ec01f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ab8a2cc-e980-49d7-9e46-b283aa502cb7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4eeb41c0-bf18-4cec-a893-9ec5931ec508_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_753ded61-eb0d-4536-a70a-8ca6dd6c2cc8_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAndCash_07b008b5-4462-4007-b1da-7c8dccd2d2cd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Estimated fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndCash_09e633f6-c283-4f59-979b-effc67f96d6a_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Estimated fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndCash_label_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAndCash" xlink:to="lab_us-gaap_InvestmentsAndCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3036e535-f57b-4977-97b3-2420bd04d671_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0481ac6d-f05f-4300-8eb5-9297ac7a9103_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f6277ac3-4298-4359-94bf-a78d13f37a94_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred and Common Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_595fc213-435e-4ac1-b21e-86aa9d3df91b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_108dce56-4645-4145-8b0e-c4658ce001f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact_30994e90-93ea-44c5-8c56-4410d0cf05b5_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cut and Jobs Act impact</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Tax Cut And Jobs Act Impact</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation tax cut and jobs act impact.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_91b9afdf-99e6-46fe-86c1-6fe3e38d9c81_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_848bb403-3fde-41fb-913f-6a6da489112c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncreaseDecreaseInEarningsLossPerShare_c4e45a35-6a9f-4b5d-88d0-1ef422fcd8e6_terseLabel_en-US" xlink:label="lab_mygn_IncreaseDecreaseInEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in earnings (loss) per share (dollars per share)</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInEarningsLossPerShare_label_en-US" xlink:label="lab_mygn_IncreaseDecreaseInEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Earnings Loss Per Share</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInEarningsLossPerShare_documentation_en-US" xlink:label="lab_mygn_IncreaseDecreaseInEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in earnings (loss) per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInEarningsLossPerShare" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInEarningsLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncreaseDecreaseInEarningsLossPerShare" xlink:to="lab_mygn_IncreaseDecreaseInEarningsLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_9efadfe7-49fd-483f-a813-3e8dc526d63e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_9846c882-dc89-454d-9912-5212256c4e1e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DiagnosticMember_df76af97-6ecf-4cb9-9f18-fcdd1ff0ddef_terseLabel_en-US" xlink:label="lab_mygn_DiagnosticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic</link:label>
    <link:label id="lab_mygn_DiagnosticMember_label_en-US" xlink:label="lab_mygn_DiagnosticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic [Member]</link:label>
    <link:label id="lab_mygn_DiagnosticMember_documentation_en-US" xlink:label="lab_mygn_DiagnosticMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DiagnosticMember" xlink:to="lab_mygn_DiagnosticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0493f567-5f56-46c6-ac8c-f67df24c73b4_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, total</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_cae41aa7-ff13-45cf-84df-a5d2bf442863_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f5a114cf-6feb-4344-b9f4-20d4ed864882_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in the fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_641ae265-6452-4b1c-93b3-2cec3c856138_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Share-Based Compensation Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_bf7e5801-1594-47c7-b8e7-5a5cd2c84c9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_93d9bef2-e056-40cc-af80-18178a8a3427_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_2d339aa4-6aa3-4b9a-8ebc-5d24854439a0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ChangeInFairValueOfContingentConsideration_83cf7d76-c54c-4f6b-8b24-f91bb537d118_terseLabel_en-US" xlink:label="lab_mygn_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_mygn_ChangeInFairValueOfContingentConsideration_label_en-US" xlink:label="lab_mygn_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value Of Contingent Consideration</link:label>
    <link:label id="lab_mygn_ChangeInFairValueOfContingentConsideration_documentation_en-US" xlink:label="lab_mygn_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ChangeInFairValueOfContingentConsideration" xlink:href="mygn-20201231.xsd#mygn_ChangeInFairValueOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ChangeInFairValueOfContingentConsideration" xlink:to="lab_mygn_ChangeInFairValueOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_d325f0ce-cdb1-4974-bcbd-8dbab01de1eb_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_c516783f-d637-4fe8-a3ec-b3a5d283f44d_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3a2837bc-d2c4-462d-8a80-89f3e855567d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c2bb63b3-232f-4692-bf61-a252349acf7f_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityPrepayments_24151032-c62c-4756-8499-1cbc4289b514_terseLabel_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityPrepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments</link:label>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityPrepayments_label_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityPrepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Prepayments</link:label>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityPrepayments_documentation_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityPrepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability, prepayments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContractWithCustomerLiabilityPrepayments" xlink:href="mygn-20201231.xsd#mygn_ContractWithCustomerLiabilityPrepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ContractWithCustomerLiabilityPrepayments" xlink:to="lab_mygn_ContractWithCustomerLiabilityPrepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_9efe3d4c-e24d-4ee1-9464-d6d4094dcb06_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3fb24144-5623-45e1-8a4b-51506d0c00cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary impairments</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_433ca84c-a5b1-4dbb-aa03-09eb1b2a5f5e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_98fadef6-f226-47a4-adba-8f513cdbac72_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_02eb44c0-457f-485b-bf80-8e3494d607d5_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticVectraTestingMember_ad76d8a9-870d-486c-9dc8-37a47190b29a_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticVectraTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Vectra</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticVectraTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticVectraTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Vectra Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticVectraTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticVectraTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic Vectra testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticVectraTestingMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticVectraTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticVectraTestingMember" xlink:to="lab_mygn_MolecularDiagnosticVectraTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_68a86e4f-7651-4b88-ace6-c0b76582c54d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment_500f1a57-9780-4e56-b069-0b9d4639871d_terseLabel_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustment to equipment</link:label>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment_label_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Increase (Decrease), Fair Value Adjustment, Equipment</link:label>
    <link:label id="lab_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment_documentation_en-US" xlink:label="lab_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Increase (Decrease), Fair Value Adjustment, Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" xlink:to="lab_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_1d922804-442f-4dc1-a197-8ad89abf5112_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share, basic</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_36e9ad17-db6b-429d-9ec6-d6e2e856f312_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_1974d3af-fd82-43be-b2ae-5b43a93165ca_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_3ceacc2f-dacb-406a-84c0-9f9fed92fda1_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_b2a7e081-56fc-4821-b56b-223ab8dac7cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Assumptions for ESPP</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_76b9599b-3c71-4ad8-85c4-70845bd76cf6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_9800f8b6-1ecc-4bda-b6fa-c3c22d98f406_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_88ad8c6c-f40a-4a8e-85b7-a5de20a38f17_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostGross_ebfa2cfd-1962-4f82-b6c6-b8472ecdd1e2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized costs incurred to obtain or fulfill contract</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostGross" xlink:to="lab_us-gaap_CapitalizedContractCostGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_fbaad1cd-7337-4a5f-a5c8-aea65de210d9_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_255f79d9-58af-47d9-ada1-debf58f42f6b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_3e86dee2-a947-4806-a112-d7078863bd26_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due after five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_a29c41ec-e8be-464c-9a21-6d65d0f05e8f_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_9e193151-8e8c-4547-bba1-2bc3aa9e700b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_fac8368d-d5f5-4dc0-9f36-358567eaa68d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6bedb21a-776e-4230-9506-34734fe66b48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_0dacb669-ba44-4cd2-ad98-6591ba014781_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_77ca96e0-c376-4789-a2f5-a95626d81011_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_06cbc887-d221-4257-84b9-c05ef838f684_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_75e331cb-d2f4-4081-8208-b00006522fb0_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember_e463217a-221d-4aa0-b588-28a2c90a954e_terseLabel_en-US" xlink:label="lab_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Plan</link:label>
    <link:label id="lab_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember_label_en-US" xlink:label="lab_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Employee Director And Consultant Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand seventeen employee director and consultant equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:href="mygn-20201231.xsd#mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:to="lab_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f17a604a-1073-483f-97ae-a16841a13b9d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_89638aa1-a150-49f5-866f-49047cee96d3_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_eb5fc742-5794-46cd-87aa-2a723ee25f66_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_79009fac-607e-409c-bbba-e42d9d3d3580_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from non-controlling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ContingentConsiderationMember_2591c89b-51fa-478a-8e1d-5dbb818a646f_terseLabel_en-US" xlink:label="lab_mygn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_mygn_ContingentConsiderationMember_label_en-US" xlink:label="lab_mygn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_mygn_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_mygn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContingentConsiderationMember" xlink:href="mygn-20201231.xsd#mygn_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ContingentConsiderationMember" xlink:to="lab_mygn_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_bcb7998c-21ec-4772-ab7c-baf5bd54d2c0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_48e601ab-bbae-4b48-9f0c-d811c0a1f3f9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ce667302-eac7-4bca-93f5-4d0ad2d624a7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_8ab019f4-2b75-4780-a1b8-f3e280658990_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_02863cdd-6e74-43c9-911a-2d23b227a269_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_2eb50e31-18bf-4916-b87c-65b9b557e490_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_883d2d25-b899-41d7-b6aa-c2a15f749243_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a5f6b6ad-b0e6-46f5-a843-1ad76e352d4e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_bae8eba1-8f4c-439c-acab-fe14f954e0bc_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_ad31b4bf-1537-4bab-907f-dcd67892e108_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible contingent purchase price and transaction costs</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Non Deductible Contingent Purchase Price And Transaction Costs</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation non deductible contingent purchase price and transaction costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4a2481e5-d8bc-47fb-99db-74c37ca427d3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7fcbec94-15e9-45fb-94a6-cac85334d0b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs granted (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract_4bc971f8-061f-4749-b24e-842033963deb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3c8754c7-ea7e-43d5-aa2a-921ca4e8493e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_cb4ee015-af42-4143-ad0d-78ac3b6ec631_negatedLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on deconsolidation of subsidiary</link:label>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_label_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Gain (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeconsolidationGainOrLossAmount" xlink:to="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_a2a9e517-847e-427c-b1f3-ebd88e8b098f_terseLabel_en-US" xlink:label="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period for earn out liability</link:label>
    <link:label id="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_label_en-US" xlink:label="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input, Term</link:label>
    <link:label id="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_documentation_en-US" xlink:label="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:href="mygn-20201231.xsd#mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:to="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a64871c9-b59c-4121-bab9-639c1320cea8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal of Subsidiary [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_04311215-ebb5-4cbb-b226-ce813e7e1cd5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_af3b1cb5-f48d-4e8c-80fa-88cf3f43029b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_c921ef9c-ab10-4031-8ac7-2363fd15c897_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_31c2b56c-bc96-4b3b-bd2b-7ec764fad460_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense (prior to adoption of ASU 2016-02)</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_26835876-b2a4-49a4-a22b-0a615d38f5e3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_5fa5db4f-e0a1-45ec-b9d6-1355c1598477_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e19b2429-ba3b-43fb-a4b3-b7fdec9a5301_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ec5c5fe4-b4c3-4ead-af83-cfe4e198eab3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2540c752-f3ba-479e-b9b3-c5f404037c9e_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross decreases - statute lapse</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1594050c-0222-4d16-bbb1-30f100658863_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_fb72b5a0-c748-4b30-9973-91ec5ded8ee0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fc6eb8f4-b57c-498d-a15c-189cfa7059d8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive options and RSUs excluded from EPS computation</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_499e9837-3cb7-44d8-9524-713d26a8138d_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e1bb37ec-a930-45b7-bd95-b4fb9bca3e8f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases - prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_eb0b3f7f-521c-47b9-8c5d-c7c3dca0322c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases - current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_61f36a65-11b2-474a-94cb-c831677cd789_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_9c60d3e8-59d4-46f9-9a1f-0911bc4f2267_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_b353b4c4-7315-4b68-8dc8-188d3a83aa42_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and marketable investment securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_4eaf194d-1eaf-4c0e-8f0b-2eaaa29e1cdc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under the plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ea658ae4-c18b-47e8-b950-aedc184a6d8e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2bb85692-455c-46fd-bbb5-94d23e6306ab_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1ac91c8c-7d86-468e-badd-89bca7be0fd4_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net equipment, leasehold improvements and property</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_72665328-9969-48a0-b34b-31e204627a00_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_255d523e-d64c-476c-af6f-6c60a1dd6304_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bad38c52-cca8-4aac-a46c-ba06c6085164_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_b09d8bbb-f8d5-40fd-8786-45f458bfd5a1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_1c4f949f-ceed-4799-99ed-98668f812cc4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3c0c9603-e5a2-45da-849a-e397e2115441_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b7fdad95-f4b2-45dd-8983-96b3827a04a6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_96837da2-cedf-4821-ba94-9f30027ed406_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_d301ddc5-a779-412e-9683-94b23e8efb0f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_93197f77-85ba-4a20-a305-45884174c001_verboseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetsLineItems_9958663d-a1d0-4c0b-8864-25e15485746c_terseLabel_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Intangible Assets [Line Items]</link:label>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetsLineItems_label_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Intangible Assets [Line Items]</link:label>
    <link:label id="lab_mygn_GoodwillAndIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_mygn_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetsLineItems" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems" xlink:to="lab_mygn_GoodwillAndIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_RecoupmentsPayableAndReserveCurrent_0830b83b-84c6-4090-88ee-feea196e51fe_terseLabel_en-US" xlink:label="lab_mygn_RecoupmentsPayableAndReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recoupments payable and reserves</link:label>
    <link:label id="lab_mygn_RecoupmentsPayableAndReserveCurrent_label_en-US" xlink:label="lab_mygn_RecoupmentsPayableAndReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recoupments Payable And Reserve, Current</link:label>
    <link:label id="lab_mygn_RecoupmentsPayableAndReserveCurrent_documentation_en-US" xlink:label="lab_mygn_RecoupmentsPayableAndReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recoupments Payable And Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RecoupmentsPayableAndReserveCurrent" xlink:href="mygn-20201231.xsd#mygn_RecoupmentsPayableAndReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_RecoupmentsPayableAndReserveCurrent" xlink:to="lab_mygn_RecoupmentsPayableAndReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_19e2d0ec-bff8-44fd-b8b0-42a5164f316b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of equipment related to updated assumptions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact_a59696d4-e2f3-4b44-87e3-a98d0a22522c_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cut and Jobs Act impact</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Tax Cut And Jobs Act Impact</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation tax cut and jobs act impact.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact" xlink:to="lab_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6ff00951-1b17-49b9-aab3-02d79fa836b4_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_b5b9a94a-8838-4a4d-9dc8-a00371ca3a3e_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed screening processes</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f7895d5b-0ac4-4819-9375-06ebac4fd23d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_a411beaa-e144-4c86-ab47-fc603b7eca18_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_877b8ff2-22a6-45e8-a48a-1340b5b4e1dd_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill and intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAndCashAbstract_b6364f27-997b-475e-9d34-9afd75ef1ce3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total:</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndCashAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAndCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCashAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract" xlink:to="lab_us-gaap_InvestmentsAndCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_69a02772-c640-47dc-a94c-75130660238d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentContractsConcentrationRiskMember_2bf907c2-46cb-4530-927a-b8a930b47bda_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_us-gaap_GovernmentContractsConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Contracts Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GovernmentContractsConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:to="lab_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_9e8f7814-0b14-47ba-87ba-2263a224cf4b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bd623465-8bfa-4810-9adf-7f3c36d2cce0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_7e7d01a6-f181-4deb-9c86-b6ae9805a888_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_a9825061-789d-4324-95b2-b83d740c8f17_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_f891f213-ea40-415c-9ea8-3afc8f6b5fee_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_7fa68e1a-e518-474e-893d-02f1e14e4623_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_6e89659f-a62f-439d-a13d-01fa437b7642_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_13bccbd7-802a-4cc4-a4f0-efbf60f232e3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_197d2421-67dc-4589-9882-cdbf4f2827fb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, amortizable</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_1077f20d-881a-4462-a3b9-c6f401b57d52_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6259ca05-e615-42a5-b84b-27f4e187cb03_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_f27a3e30-1c80-4c34-84d1-5c7f228cc7b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options fully vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement_056e133e-9890-4d6b-8bce-1fa9ef2100e3_terseLabel_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible legal settlement</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement_label_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Non Deductible Legal Settlement</link:label>
    <link:label id="lab_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement_documentation_en-US" xlink:label="lab_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation non-deductible legal settlement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement" xlink:to="lab_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_31a653e4-8f2b-4587-bde3-93963c789fe3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4e6e6de9-44fd-4882-8177-7cfa0a481a40_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_72ba1182-760b-4455-9174-bd3504a1409f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Financial Statement Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_d23f25bb-6445-4457-afda-331162aea268_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f88633af-ba96-4c2f-a185-fc8ea16866ce_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (weighted average shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7d981325-a796-4b0d-9abf-0b169b26c8d4_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding used to compute basic EPS</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_eeb5c531-f84e-4aec-b26e-ce65b7397bf9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible meals and entertainment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5dab79a1-84da-4cc4-8cf0-bc5fbc4111c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c404ad0b-6420-451c-b882-619787b7486e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_UnrecognizedTaxBenefitsNet_826f9893-bd76-4676-b4c0-01cdfd5efdc7_terseLabel_en-US" xlink:label="lab_mygn_UnrecognizedTaxBenefitsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_mygn_UnrecognizedTaxBenefitsNet_fe1d4ee0-96c3-40f3-8d7c-c16b2f0e04a4_verboseLabel_en-US" xlink:label="lab_mygn_UnrecognizedTaxBenefitsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized tax benefits</link:label>
    <link:label id="lab_mygn_UnrecognizedTaxBenefitsNet_label_en-US" xlink:label="lab_mygn_UnrecognizedTaxBenefitsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Net</link:label>
    <link:label id="lab_mygn_UnrecognizedTaxBenefitsNet_documentation_en-US" xlink:label="lab_mygn_UnrecognizedTaxBenefitsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_UnrecognizedTaxBenefitsNet" xlink:href="mygn-20201231.xsd#mygn_UnrecognizedTaxBenefitsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_UnrecognizedTaxBenefitsNet" xlink:to="lab_mygn_UnrecognizedTaxBenefitsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_4670b485-c1d3-4465-afe4-181019d7e1d5_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_74286955-96d0-4aa9-a3ec-9b581e9fb068_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f175a376-214b-4bf7-95f3-5c53280f4bbc_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_635bdb1f-10c7-4d57-987e-b0608b0b5df6_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Reclassification, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_3ca32bb0-4d97-4843-a572-0f3d1691da9c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7c0ac501-d443-4287-89c3-e074aea8f41e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of foreign currency transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_a110de56-dad4-448e-ace1-0b953f7e24bd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_10c5d2db-1f89-4efb-ba37-680a58d22dc5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_96be1bcf-9958-49bd-a1af-344fdbe18a2d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_77436f1b-dcdd-4779-8c25-1e30e0410843_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment_fd311d1b-968c-4066-82b5-1d1b38bea83c_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Asset Impairment</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation asset impairment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87f6630d-1c26-4390-9999-ddf10043c30e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_07099521-f5e8-4c94-9908-29cdc9053229_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_653aef77-5342-4de7-8849-f0f8fdd53405_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_f748f8d2-c291-4c78-a395-5d6c9ee2ad06_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_68d93d05-4b1c-4f9b-b5a2-083464cf6db6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_30eaecaa-8f47-4a4a-831f-23560daef5ea_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_db8f093a-4fcb-478d-aac5-e8f5f552d1c3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment on business acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_27036378-5cbe-47b9-83b3-7b7deef0008a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pro Forma Results</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_9d2e92ed-9d69-4493-b098-a1bf0af2dc6f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recorded Amortization Expense for Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_25f56e65-224f-4da9-9c7e-7cdd9f2232a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement levels based on EPS targets</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_490575bd-661a-4883-ba8d-e33a36b6bcda_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_ade83b99-5130-4ad7-b61e-0f5e53541d8f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_69d3845c-8dcb-4c14-a9c5-8ff4778ddcda_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Fair Value of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_f932d1b9-b812-4b30-8620-fbeafda1c526_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_d53c3539-3aa0-47b8-b157-4909e4dd1de9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-amortizable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c5e5e993-2997-4d07-ab33-76babb5c89e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_14c99afd-a159-4da5-b818-621542ae2fc2_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount of loan</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_c25a2e7d-0d10-4b20-89b5-f363b4fcffbe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_58ee3246-69cc-454f-ad2a-3efe84901b70_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross decreases - prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_d3961d5b-85ec-42f7-b7ea-197f238ae074_terseLabel_en-US" xlink:label="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted prior to December 5, 2012</link:label>
    <link:label id="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_label_en-US" xlink:label="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Granted Prior To December Five Twenty Twelve [Member]</link:label>
    <link:label id="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_documentation_en-US" xlink:label="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted prior to December 5, 2012.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:href="mygn-20201231.xsd#mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:to="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fd8942c9-d691-4e56-959a-a0bedc28043b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate principal commitment</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_d11f019c-e7ee-4888-8619-7779ffe51681_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d6812d19-f915-45c4-b5fa-d88a65707807_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_88fa9780-f2ae-4e6a-8557-a68c097fab02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs, Weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_b2770d7f-e36f-4fe2-a363-8a658dada41c_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immaterial prior period Medicare claims</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_1f47e38c-f979-421b-98aa-c3811509bf68_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_99f85d48-3ab4-4ffc-a8f3-cf565499e351_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ed5dfa3a-900b-4dda-92ad-023e92356986_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_e561b560-9c3d-43ff-804b-4899925106c7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_7c890d61-79c8-479d-9e2c-722e53cd32c4_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deconsolidated on sale of Clinic</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d38354e1-c567-4ba1-846e-b491576ef8b7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration recognized at acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OtherStateMember_c47f25cc-a819-482c-92ad-afdafcfea56f_terseLabel_en-US" xlink:label="lab_mygn_OtherStateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mygn_OtherStateMember_label_en-US" xlink:label="lab_mygn_OtherStateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other State [Member]</link:label>
    <link:label id="lab_mygn_OtherStateMember_documentation_en-US" xlink:label="lab_mygn_OtherStateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other State.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OtherStateMember" xlink:href="mygn-20201231.xsd#mygn_OtherStateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OtherStateMember" xlink:to="lab_mygn_OtherStateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_853d3aa2-402a-438e-b8cd-c876ef6352d5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f753f5a1-df67-4c52-ac60-9e478719ce73_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_8061a736-01da-47fb-9311-42794acefe2c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_d53ca660-ae71-4745-bdf5-dd5ac19a6fc5_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds and notes</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_9e8b0140-02aa-4f70-8492-3cfa1133d528_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0ca08f4d-c542-4b30-b1b2-236879d28b87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_52010fa1-e02a-4cf5-9a89-88ed423ea856_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_988de185-a6d4-4d10-9f08-0d2f400bc3b3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_f1cbc90d-0f46-4013-a79c-eb4b32e74f57_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undrawn fee (percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_4ee9c6fe-ea69-43c1-8cb6-89910339d503_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_0e0bb8a7-eb51-4654-834a-fc33c0336c07_terseLabel_en-US" xlink:label="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued upon exercise of options and employee stock plans</link:label>
    <link:label id="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans</link:label>
    <link:label id="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_documentation_en-US" xlink:label="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:href="mygn-20201231.xsd#mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:to="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod_9f097c34-dd98-4131-9676-c517a7045b10_terseLabel_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in revenue recognition/method</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod_label_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Changes In Revenue Recognition Method</link:label>
    <link:label id="lab_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod_documentation_en-US" xlink:label="lab_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, changes in revenue recognition/method.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" xlink:to="lab_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_01169cd5-47c9-4f22-a8d2-1fb0726f0011_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_14150b16-4035-4767-9ded-8cb8fef1f9d8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal income tax expense at the statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0ce539a4-9977-4e3b-9552-3f0e9baafbdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_9c52bac3-4705-4ded-a73a-b67e276c9174_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_39eeeea4-2145-413d-8110-21bdc9457ac0_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_e82d6ac8-3057-44b1-8f68-049f7233144c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticTestingMember_b508b731-0295-4a77-80be-542931f9703f_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic testing</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticTestingMember" xlink:to="lab_mygn_MolecularDiagnosticTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_35562592-2764-4ffc-b18c-b85bf2f373b7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>mygn-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efa3350f-b8a9-4fda-9dc1-67977795f671,g:9ff9af07-fed3-4eeb-865c-11c477b6a054-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.myriad.com/role/Cover" xlink:type="simple" xlink:href="mygn-20201231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0f9b8280-486c-4483-9a3f-e4ec8e18cbad" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_DocumentType_0f9b8280-486c-4483-9a3f-e4ec8e18cbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_50c1ceea-f479-457c-a19c-c5295141aef6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_DocumentAnnualReport_50c1ceea-f479-457c-a19c-c5295141aef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_7aa46be4-209e-4898-8b9f-058c25a31c38" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_DocumentTransitionReport_7aa46be4-209e-4898-8b9f-058c25a31c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodStartDate_af290352-f76a-42cb-9c58-23d8474656b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_DocumentPeriodStartDate_af290352-f76a-42cb-9c58-23d8474656b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9427f83c-9d32-4d26-a771-0e8b0b00260a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_DocumentPeriodEndDate_9427f83c-9d32-4d26-a771-0e8b0b00260a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_46cb49d9-15f5-4deb-b464-87fb5bce8bf2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_CurrentFiscalYearEndDate_46cb49d9-15f5-4deb-b464-87fb5bce8bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_697e55c0-5c3e-4ff2-bd1f-76c087aa8361" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityFileNumber_697e55c0-5c3e-4ff2-bd1f-76c087aa8361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a6baefca-d427-4053-b2c9-5611380ec2ae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityRegistrantName_a6baefca-d427-4053-b2c9-5611380ec2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_20ff42c8-89eb-45f7-aa0b-bb687ca46379" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityCentralIndexKey_20ff42c8-89eb-45f7-aa0b-bb687ca46379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_46352e5a-7dbd-4e5b-a1fd-eb45dbaa63a5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_DocumentFiscalYearFocus_46352e5a-7dbd-4e5b-a1fd-eb45dbaa63a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_43d0879d-bafa-46c6-9e5f-e19c6c48ed08" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_43d0879d-bafa-46c6-9e5f-e19c6c48ed08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_35ac7420-2664-4fbd-a67f-7b7474e40fa6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_AmendmentFlag_35ac7420-2664-4fbd-a67f-7b7474e40fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_78da79e3-0439-49f7-8ffd-2794d5106fc1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_78da79e3-0439-49f7-8ffd-2794d5106fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4f60d486-5483-4ca2-8e88-3fe2f8770070" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityTaxIdentificationNumber_4f60d486-5483-4ca2-8e88-3fe2f8770070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5fc0d6d4-2c60-4cd0-87fa-c7cf9f31d689" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityAddressAddressLine1_5fc0d6d4-2c60-4cd0-87fa-c7cf9f31d689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e2270b94-bbaf-4990-90ef-fc438738954e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityAddressCityOrTown_e2270b94-bbaf-4990-90ef-fc438738954e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ce4b59e9-3b95-4ae4-81e5-ced03dc18b77" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityAddressStateOrProvince_ce4b59e9-3b95-4ae4-81e5-ced03dc18b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bed4fd49-168c-400a-a1a8-2a2f9f368f88" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityAddressPostalZipCode_bed4fd49-168c-400a-a1a8-2a2f9f368f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_26ce9dac-e15e-4440-8ce7-fda4938b426e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_CityAreaCode_26ce9dac-e15e-4440-8ce7-fda4938b426e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e8eccc59-7be4-4779-ba84-b22fcede889f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_LocalPhoneNumber_e8eccc59-7be4-4779-ba84-b22fcede889f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2051a15c-fe55-42e2-a91c-868d3b0ec290" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_Security12bTitle_2051a15c-fe55-42e2-a91c-868d3b0ec290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5ccba8de-3196-42d8-a8fe-20605e8af463" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_TradingSymbol_5ccba8de-3196-42d8-a8fe-20605e8af463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_06125983-5ea4-4958-bd65-3ab06c08f836" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_SecurityExchangeName_06125983-5ea4-4958-bd65-3ab06c08f836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_f7339e87-bc01-4af7-a775-89babd621d47" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_f7339e87-bc01-4af7-a775-89babd621d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_3e46320d-00dc-4ded-8464-cccbe4bd7445" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityVoluntaryFilers_3e46320d-00dc-4ded-8464-cccbe4bd7445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_17f6cedb-fe97-4a51-9f25-2cb736e19484" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityCurrentReportingStatus_17f6cedb-fe97-4a51-9f25-2cb736e19484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c0d09cc9-4f99-427b-b638-da74870e0612" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityInteractiveDataCurrent_c0d09cc9-4f99-427b-b638-da74870e0612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b259df9b-7dc0-464c-ae5c-f0b9e4cd2bdb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityFilerCategory_b259df9b-7dc0-464c-ae5c-f0b9e4cd2bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_60c2ad71-f488-49a7-b302-d05b6a22f32c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntitySmallBusiness_60c2ad71-f488-49a7-b302-d05b6a22f32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4f445610-9f92-4de0-b7c8-e447b1968017" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityEmergingGrowthCompany_4f445610-9f92-4de0-b7c8-e447b1968017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_9a54d9d0-7920-44ec-aa48-43f6c3e8b3b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_IcfrAuditorAttestationFlag_9a54d9d0-7920-44ec-aa48-43f6c3e8b3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_87e89558-0827-4829-8f0a-a6e83e07271a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityShellCompany_87e89558-0827-4829-8f0a-a6e83e07271a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_f898d5ae-8992-4534-b660-46a083bcb45a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityPublicFloat_f898d5ae-8992-4534-b660-46a083bcb45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6ab9980b-7451-4ca0-8f06-c59ec7693ab2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6ab9980b-7451-4ca0-8f06-c59ec7693ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_c78104e9-428f-40d7-bafc-bed02a8b0dee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7074c620-6b3a-4898-917e-ea4a1662880b" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_c78104e9-428f-40d7-bafc-bed02a8b0dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4d059719-94f2-4cf7-b456-7584b3153301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4d059719-94f2-4cf7-b456-7584b3153301" xlink:to="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c314547d-a9d2-41f4-8b70-81a0059f35cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c314547d-a9d2-41f4-8b70-81a0059f35cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_52c0de4d-8d76-446a-bf54-9f62d81f4597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_52c0de4d-8d76-446a-bf54-9f62d81f4597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_fcd25d83-8772-4e06-97c3-d6af146658dd" xlink:href="mygn-20201231.xsd#mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:to="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_fcd25d83-8772-4e06-97c3-d6af146658dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e2f8078a-8600-4ce4-8e71-98780ada41b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:to="loc_us-gaap_InventoryNet_e2f8078a-8600-4ce4-8e71-98780ada41b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1de267cf-c62e-41ce-894f-5b48352c5de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1de267cf-c62e-41ce-894f-5b48352c5de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_9bb6585f-830b-404d-a797-672080dc484d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:to="loc_us-gaap_PrepaidTaxes_9bb6585f-830b-404d-a797-672080dc484d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_d674acff-676b-421e-b88c-debc0430e97d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_d674acff-676b-421e-b88c-debc0430e97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_edcce0ed-c8eb-4f0e-8981-c607a17368c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f2a3e462-4cb9-4783-9c6c-868e853ccb5d" xlink:to="loc_us-gaap_AssetsCurrent_edcce0ed-c8eb-4f0e-8981-c607a17368c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_53c9644c-7acb-4ef4-b080-33dcb2f0c4fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_53c9644c-7acb-4ef4-b080-33dcb2f0c4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cfb34b8a-4d00-4698-823c-78009b5008ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cfb34b8a-4d00-4698-823c-78009b5008ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_21d4fb0b-df4d-480b-9157-1c0048cfd392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_21d4fb0b-df4d-480b-9157-1c0048cfd392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2b58ab95-229b-47e5-92a0-60299ceef733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2b58ab95-229b-47e5-92a0-60299ceef733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_35717c65-8531-4931-8431-e8473a2276b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:to="loc_us-gaap_Goodwill_35717c65-8531-4931-8431-e8473a2276b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ddb938bf-3a8a-4c05-bfb6-ef3d9e249168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ddb938bf-3a8a-4c05-bfb6-ef3d9e249168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3f7e973d-cca5-4a8d-8ea8-2f4f152fdcd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0792ce51-9d1e-4985-9800-5fa89c3511ab" xlink:to="loc_us-gaap_Assets_3f7e973d-cca5-4a8d-8ea8-2f4f152fdcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4d059719-94f2-4cf7-b456-7584b3153301" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_56c4e9e2-e39e-48e7-a1a4-31a84f1bb9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_56c4e9e2-e39e-48e7-a1a4-31a84f1bb9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_617e06a0-373b-470d-90ff-5f85cc928a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56c4e9e2-e39e-48e7-a1a4-31a84f1bb9bb" xlink:to="loc_us-gaap_AccountsPayableCurrent_617e06a0-373b-470d-90ff-5f85cc928a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5bd1d5c7-2766-4d25-a6e7-392c422f5831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56c4e9e2-e39e-48e7-a1a4-31a84f1bb9bb" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5bd1d5c7-2766-4d25-a6e7-392c422f5831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a1d49865-16b8-44e7-a416-79944c33e0b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56c4e9e2-e39e-48e7-a1a4-31a84f1bb9bb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a1d49865-16b8-44e7-a416-79944c33e0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4015b656-2332-4e40-9d3f-3eeb05f7d6fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56c4e9e2-e39e-48e7-a1a4-31a84f1bb9bb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4015b656-2332-4e40-9d3f-3eeb05f7d6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d54ffadd-4676-4f2d-a818-ae5ed5994e49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56c4e9e2-e39e-48e7-a1a4-31a84f1bb9bb" xlink:to="loc_us-gaap_LiabilitiesCurrent_d54ffadd-4676-4f2d-a818-ae5ed5994e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_UnrecognizedTaxBenefitsNet_f53fc70c-dd9e-4e76-8908-77ca862907e9" xlink:href="mygn-20201231.xsd#mygn_UnrecognizedTaxBenefitsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_mygn_UnrecognizedTaxBenefitsNet_f53fc70c-dd9e-4e76-8908-77ca862907e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9cd2d6c7-132f-447c-8fc4-91d191e922c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9cd2d6c7-132f-447c-8fc4-91d191e922c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_84ca73c6-8cbe-4215-9136-ae720900283f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_LongTermDebt_84ca73c6-8cbe-4215-9136-ae720900283f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_79e9c47e-2b44-4fad-96b2-a816fa194bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_79e9c47e-2b44-4fad-96b2-a816fa194bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_87b3d2e6-e65c-4141-a6b2-01cca4ca9f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_87b3d2e6-e65c-4141-a6b2-01cca4ca9f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_355cdfb9-49d6-445b-90e6-747e2cc13e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_Liabilities_355cdfb9-49d6-445b-90e6-747e2cc13e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_be2c25bd-a9f2-453c-9bf7-8550cb4e5cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_CommitmentsAndContingencies_be2c25bd-a9f2-453c-9bf7-8550cb4e5cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_68413262-ccc1-4932-8169-f8d0d98bfc9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:to="loc_us-gaap_CommonStockValue_68413262-ccc1-4932-8169-f8d0d98bfc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_dd028642-0f82-45b7-9d33-2f9ba9da0fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_dd028642-0f82-45b7-9d33-2f9ba9da0fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e050e58c-6424-4f26-a54c-63b3ffa589b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e050e58c-6424-4f26-a54c-63b3ffa589b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bf8eb8c6-4341-4484-80b9-6605f34c588d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bf8eb8c6-4341-4484-80b9-6605f34c588d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_652dd740-7830-4673-8b40-947561f5decf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:to="loc_us-gaap_StockholdersEquity_652dd740-7830-4673-8b40-947561f5decf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a7613ba8-f905-4370-bfed-120e218d81a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:to="loc_us-gaap_MinorityInterest_a7613ba8-f905-4370-bfed-120e218d81a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_281165ea-4f80-4996-8550-da1ac08c315a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a12e56e-1d7c-4bfe-a89b-bc2176947741" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_281165ea-4f80-4996-8550-da1ac08c315a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bc57dc69-6315-44ee-8d27-c5e21065a763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_599306e8-a5ec-481d-ba2b-d1c4cf2d9b52" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bc57dc69-6315-44ee-8d27-c5e21065a763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_85595a05-4565-424b-a413-63e6454fb67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f867d192-4364-4b8f-9d6b-971ecb278461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_85595a05-4565-424b-a413-63e6454fb67a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f867d192-4364-4b8f-9d6b-971ecb278461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c4358dd9-8a07-4226-ad65-d02cfecb614b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2bb1a5c8-fb3c-4ed3-b8d4-a2bf49524b17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4358dd9-8a07-4226-ad65-d02cfecb614b" xlink:to="loc_us-gaap_StatementTable_2bb1a5c8-fb3c-4ed3-b8d4-a2bf49524b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_56826c73-7cf7-4790-97c8-423ccea74ec6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2bb1a5c8-fb3c-4ed3-b8d4-a2bf49524b17" xlink:to="loc_srt_ProductOrServiceAxis_56826c73-7cf7-4790-97c8-423ccea74ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3640236d-efd9-4695-834f-1e986f5038d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_56826c73-7cf7-4790-97c8-423ccea74ec6" xlink:to="loc_srt_ProductsAndServicesDomain_3640236d-efd9-4695-834f-1e986f5038d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_74bec684-75ab-41c7-ab0f-c0bb19771764" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3640236d-efd9-4695-834f-1e986f5038d4" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_74bec684-75ab-41c7-ab0f-c0bb19771764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_0b5e6c57-9396-4680-932b-749508655571" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3640236d-efd9-4695-834f-1e986f5038d4" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_0b5e6c57-9396-4680-932b-749508655571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2bb1a5c8-fb3c-4ed3-b8d4-a2bf49524b17" xlink:to="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_79319d9a-cab6-4244-b37b-50eab34c9c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_79319d9a-cab6-4244-b37b-50eab34c9c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_df590817-3c06-41be-9a4d-05b0546f0209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_df590817-3c06-41be-9a4d-05b0546f0209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c7c198d3-8325-468f-8b44-c210dc70916c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c7c198d3-8325-468f-8b44-c210dc70916c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8b378ebf-638d-4a1b-aa74-6e9235f53d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8b378ebf-638d-4a1b-aa74-6e9235f53d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_817a4702-bb82-4c9c-bb8f-c7ee3a4154da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_817a4702-bb82-4c9c-bb8f-c7ee3a4154da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d3861041-bf63-4794-949d-ce4b25d0dff1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d3861041-bf63-4794-949d-ce4b25d0dff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_59b6f985-1e8d-4465-a204-54742c879908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c8721509-d36a-4069-8c5a-7ab2cb0dab7b" xlink:to="loc_us-gaap_CostsAndExpenses_59b6f985-1e8d-4465-a204-54742c879908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bed4810f-719c-4675-a7d8-9944313a1e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_OperatingIncomeLoss_bed4810f-719c-4675-a7d8-9944313a1e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_78db6040-647a-4da0-990a-033fe3341f32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:to="loc_us-gaap_InvestmentIncomeInterest_78db6040-647a-4da0-990a-033fe3341f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e8e900c1-3a41-4450-b3ec-0b531fc52893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:to="loc_us-gaap_InterestExpense_e8e900c1-3a41-4450-b3ec-0b531fc52893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e8d85a6a-7367-43e5-bc60-0e45d50f82c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e8d85a6a-7367-43e5-bc60-0e45d50f82c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_915ad46e-e25f-4733-9457-8ebfc07ec933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_58eb4bfb-569e-469a-9344-052e62ea1a16" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_915ad46e-e25f-4733-9457-8ebfc07ec933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ba6c8669-4060-466a-8ef0-1a6c6a33ad31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ba6c8669-4060-466a-8ef0-1a6c6a33ad31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5202b682-5113-40d6-816b-d139433c1855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5202b682-5113-40d6-816b-d139433c1855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_19742106-af61-4ace-a9bc-c10418117dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_ProfitLoss_19742106-af61-4ace-a9bc-c10418117dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4112a0d-3510-4544-9d07-96821981969f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4112a0d-3510-4544-9d07-96821981969f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e1ffe90a-bdf1-483f-bb07-a69d4bfc3e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_NetIncomeLoss_e1ffe90a-bdf1-483f-bb07-a69d4bfc3e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd1b00b7-086b-47ac-938d-0494c52b8adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd1b00b7-086b-47ac-938d-0494c52b8adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_97724b64-bbd0-440e-a514-b574e1bdc397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd1b00b7-086b-47ac-938d-0494c52b8adb" xlink:to="loc_us-gaap_EarningsPerShareBasic_97724b64-bbd0-440e-a514-b574e1bdc397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c508bbf5-006d-4d83-b295-b13e47778700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cd1b00b7-086b-47ac-938d-0494c52b8adb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c508bbf5-006d-4d83-b295-b13e47778700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d606cc00-7830-4732-be14-d7e25abc7d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa0cea4e-d9b2-40f9-9cf2-3a769d9dd9c8" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d606cc00-7830-4732-be14-d7e25abc7d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7681551c-48b6-43ca-9639-430f5574e69c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d606cc00-7830-4732-be14-d7e25abc7d53" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7681551c-48b6-43ca-9639-430f5574e69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af51f7d8-20ac-4e58-99d4-4ac16bc726a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d606cc00-7830-4732-be14-d7e25abc7d53" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af51f7d8-20ac-4e58-99d4-4ac16bc726a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5dcdc2-db6b-4dc0-ae4b-22ed2ff1353f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1964d1de-fea7-4469-b9cc-f37d8eb89626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5dcdc2-db6b-4dc0-ae4b-22ed2ff1353f" xlink:to="loc_us-gaap_NetIncomeLoss_1964d1de-fea7-4469-b9cc-f37d8eb89626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_027a1d24-5ff3-461e-a01f-11f8d10ab4cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5dcdc2-db6b-4dc0-ae4b-22ed2ff1353f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_027a1d24-5ff3-461e-a01f-11f8d10ab4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_ed6d215d-d68f-47d1-9307-96fb029db5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5dcdc2-db6b-4dc0-ae4b-22ed2ff1353f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_ed6d215d-d68f-47d1-9307-96fb029db5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c933ba4-6774-4c4a-a231-2584a56fac59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5dcdc2-db6b-4dc0-ae4b-22ed2ff1353f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c933ba4-6774-4c4a-a231-2584a56fac59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7d9cda38-37c3-4617-b3ec-a16589aa5e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5dcdc2-db6b-4dc0-ae4b-22ed2ff1353f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7d9cda38-37c3-4617-b3ec-a16589aa5e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2a83e873-0cdf-452c-8f61-588bb9bc9a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cd8a8503-c1e7-4312-93da-cd8134c4b891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2a83e873-0cdf-452c-8f61-588bb9bc9a0b" xlink:to="loc_us-gaap_StatementTable_cd8a8503-c1e7-4312-93da-cd8134c4b891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cd8a8503-c1e7-4312-93da-cd8134c4b891" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b4724a77-6cd9-4d69-aa6b-ec67e57e04ba" xlink:to="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ae72cf57-c744-4a53-8879-177174bad59f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:to="loc_us-gaap_CommonStockMember_ae72cf57-c744-4a53-8879-177174bad59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f1449102-1a9c-4428-b77e-a974861fd038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f1449102-1a9c-4428-b77e-a974861fd038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_499156cb-d439-4949-9200-b9cd36bb53a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_499156cb-d439-4949-9200-b9cd36bb53a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c62aba39-351b-4ffd-bd1e-6f1815e4815a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ec6f849a-4e1b-483b-996a-e767f290a617" xlink:to="loc_us-gaap_RetainedEarningsMember_c62aba39-351b-4ffd-bd1e-6f1815e4815a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cd8a8503-c1e7-4312-93da-cd8134c4b891" xlink:to="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3be0949c-fd72-4117-bcd7-76b1cb32bff9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3be0949c-fd72-4117-bcd7-76b1cb32bff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c2a8e23c-d053-4392-96f5-13a71e0fa68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c2a8e23c-d053-4392-96f5-13a71e0fa68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f3be882c-ae16-4296-8d92-d1a78b43e61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f3be882c-ae16-4296-8d92-d1a78b43e61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5820c395-0df3-45ee-9ad0-785e148cb12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5820c395-0df3-45ee-9ad0-785e148cb12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_565b4326-1f58-42db-9c32-bb41305a9567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_NetIncomeLoss_565b4326-1f58-42db-9c32-bb41305a9567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary_5e4e820f-4632-40d7-a46f-c51372f828e4" xlink:href="mygn-20201231.xsd#mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary_5e4e820f-4632-40d7-a46f-c51372f828e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_33a3f704-1c57-42c2-ae77-9352eecdb557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_33a3f704-1c57-42c2-ae77-9352eecdb557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a0683ad8-b839-4bcb-bf1b-08519f2a9f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_175d56e7-3212-47b8-91ca-1d143526454d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a0683ad8-b839-4bcb-bf1b-08519f2a9f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mygn-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_e7b1deba-0733-4b45-9389-e27536c4b0d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_99e8d5bb-fce8-4d3c-92f8-8f49a1d1cd50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e7b1deba-0733-4b45-9389-e27536c4b0d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_99e8d5bb-fce8-4d3c-92f8-8f49a1d1cd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a899b33c-444a-44a2-9e10-400bc63fbbdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_99e8d5bb-fce8-4d3c-92f8-8f49a1d1cd50" xlink:to="loc_us-gaap_NetIncomeLoss_a899b33c-444a-44a2-9e10-400bc63fbbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_99e8d5bb-fce8-4d3c-92f8-8f49a1d1cd50" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_7718065c-164c-4eb8-ac86-d1b4ce6c421c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_DepreciationAndAmortization_7718065c-164c-4eb8-ac86-d1b4ce6c421c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonCashInterestExpense_43a84d44-9171-410d-a18c-a338911013c6" xlink:href="mygn-20201231.xsd#mygn_NonCashInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_mygn_NonCashInterestExpense_43a84d44-9171-410d-a18c-a338911013c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3059768b-d632-440f-a95b-63637ad785a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3059768b-d632-440f-a95b-63637ad785a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_bbb88fd4-5d19-4871-9f6a-93fd3faccc0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_bbb88fd4-5d19-4871-9f6a-93fd3faccc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d77932f7-fd83-4150-bc36-f4a6705d1319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d77932f7-fd83-4150-bc36-f4a6705d1319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_449ce74f-0906-4af7-a59a-bc94e7bfe2d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_449ce74f-0906-4af7-a59a-bc94e7bfe2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ddf54d7b-d36a-4dcf-95e5-469d66dafbf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_ShareBasedCompensation_ddf54d7b-d36a-4dcf-95e5-469d66dafbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5a985314-8509-4d2f-a560-6c2ac3ead03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5a985314-8509-4d2f-a560-6c2ac3ead03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_e4be5eb3-66c2-41b2-953b-1e97e9282629" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInUnrecognizedTaxBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_e4be5eb3-66c2-41b2-953b-1e97e9282629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_c7ec343a-f7d7-46f5-b260-cb218859c141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_c7ec343a-f7d7-46f5-b260-cb218859c141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ChangeInFairValueOfContingentConsideration_321d7fe0-d608-4b41-bd78-5439414419ae" xlink:href="mygn-20201231.xsd#mygn_ChangeInFairValueOfContingentConsideration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_mygn_ChangeInFairValueOfContingentConsideration_321d7fe0-d608-4b41-bd78-5439414419ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_be78c9bf-bc4f-45ae-8bd7-265e4ba95696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_be78c9bf-bc4f-45ae-8bd7-265e4ba95696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_144e37fa-c23f-4ce9-9cfb-1caf59f29765" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_b7d2131b-077d-444c-8132-6e20f5c36d46" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_b7d2131b-077d-444c-8132-6e20f5c36d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c404d892-be8d-4ca8-8b0e-80d2bffb6c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c404d892-be8d-4ca8-8b0e-80d2bffb6c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_9b5e5aa7-ba22-47b4-88b9-abb7acbbd654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_9b5e5aa7-ba22-47b4-88b9-abb7acbbd654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5a946935-fc6e-4cb7-8c46-4a1870d47cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5a946935-fc6e-4cb7-8c46-4a1870d47cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_82cbcdf4-9cf9-48b4-8acb-ca4676453b44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_82cbcdf4-9cf9-48b4-8acb-ca4676453b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_d334d336-b823-4180-a987-5760ae045f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_d334d336-b823-4180-a987-5760ae045f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1885dd73-28f9-4927-8c92-45e1290b4588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1885dd73-28f9-4927-8c92-45e1290b4588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2f082b35-c37d-40c9-9779-d0ba6e3c096b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2f082b35-c37d-40c9-9779-d0ba6e3c096b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0f7cf528-8ea9-4e7e-b6f2-e85ec3813337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f6644530-1aa0-4232-9a83-e3fe1663fde9" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0f7cf528-8ea9-4e7e-b6f2-e85ec3813337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5da51268-553c-4ec9-ad08-8543267b9781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_99e8d5bb-fce8-4d3c-92f8-8f49a1d1cd50" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5da51268-553c-4ec9-ad08-8543267b9781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f85efe1-6599-4260-9f1c-7e0015f4cfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e7b1deba-0733-4b45-9389-e27536c4b0d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f85efe1-6599-4260-9f1c-7e0015f4cfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_21091c09-ac78-4861-acf0-7156fb3ff286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f85efe1-6599-4260-9f1c-7e0015f4cfb1" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_21091c09-ac78-4861-acf0-7156fb3ff286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4349bc79-b34b-41da-a692-ef66d89732a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f85efe1-6599-4260-9f1c-7e0015f4cfb1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4349bc79-b34b-41da-a692-ef66d89732a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_3c27a9c1-1290-40ca-a099-de4bd644100c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f85efe1-6599-4260-9f1c-7e0015f4cfb1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_3c27a9c1-1290-40ca-a099-de4bd644100c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_4f410559-0cfc-4c5a-b541-b3224c560cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f85efe1-6599-4260-9f1c-7e0015f4cfb1" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_4f410559-0cfc-4c5a-b541-b3224c560cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_42ec58d7-b4f3-49dc-ab63-21b074012649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f85efe1-6599-4260-9f1c-7e0015f4cfb1" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_42ec58d7-b4f3-49dc-ab63-21b074012649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_236f8a7f-1cce-4d59-b6a7-b0479372384c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f85efe1-6599-4260-9f1c-7e0015f4cfb1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_236f8a7f-1cce-4d59-b6a7-b0479372384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e7b1deba-0733-4b45-9389-e27536c4b0d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_93b77fa3-7025-467e-a074-3fc329ec30b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_93b77fa3-7025-467e-a074-3fc329ec30b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_886f74e4-3c2e-4909-a977-c584bfe69b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_886f74e4-3c2e-4909-a977-c584bfe69b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_eb443e94-033b-47be-9ad5-6cab145944ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_eb443e94-033b-47be-9ad5-6cab145944ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_7ca46b17-f4b8-4a59-94e7-5a261f2c2cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_7ca46b17-f4b8-4a59-94e7-5a261f2c2cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_2d6d76fd-cb4e-48b0-883c-641ebcd97763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_2d6d76fd-cb4e-48b0-883c-641ebcd97763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_2c78602b-74f9-41cf-9db8-55a2d40b5d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_2c78602b-74f9-41cf-9db8-55a2d40b5d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_baccd65e-9c94-4ca0-a8ad-b23505d9df72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_baccd65e-9c94-4ca0-a8ad-b23505d9df72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_42cb9bf8-3d71-4081-bcaa-b7e05ec15208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_42cb9bf8-3d71-4081-bcaa-b7e05ec15208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_623ee7be-2882-4572-a1c9-cddb86688a72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da7b9d57-7bd4-4a40-ae26-2b82ca437092" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_623ee7be-2882-4572-a1c9-cddb86688a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_570cca91-fb55-4fed-b9dd-afbb9fceee68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e7b1deba-0733-4b45-9389-e27536c4b0d4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_570cca91-fb55-4fed-b9dd-afbb9fceee68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1c634fe8-4612-4488-a476-2729ccbe4b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e7b1deba-0733-4b45-9389-e27536c4b0d4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1c634fe8-4612-4488-a476-2729ccbe4b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5704f870-c808-4d1a-bd9e-e57610cbacd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e7b1deba-0733-4b45-9389-e27536c4b0d4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5704f870-c808-4d1a-bd9e-e57610cbacd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05cc719-eb91-49e4-b9ac-77512d80195c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e7b1deba-0733-4b45-9389-e27536c4b0d4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05cc719-eb91-49e4-b9ac-77512d80195c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c23c57d0-60a8-44f1-8d28-6c3c583a707d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_380a18f3-1f99-4deb-ac00-3c728c335996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c23c57d0-60a8-44f1-8d28-6c3c583a707d" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_380a18f3-1f99-4deb-ac00-3c728c335996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_07dc8b0d-8ec1-41ea-837f-8aeeafd61f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_07dc8b0d-8ec1-41ea-837f-8aeeafd61f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c8fcbe5b-3c44-4650-bbb8-3536fa3693c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_UseOfEstimates_c8fcbe5b-3c44-4650-bbb8-3536fa3693c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_06ddea54-e642-4d6a-a56d-bd0a1b0cc22f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_06ddea54-e642-4d6a-a56d-bd0a1b0cc22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_0d24469e-3f72-43f5-abad-099408dd63d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_0d24469e-3f72-43f5-abad-099408dd63d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_1d3618c0-ed89-4e39-be94-a1acceb70981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_1d3618c0-ed89-4e39-be94-a1acceb70981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_88fe3b88-7cc0-45a4-acfd-4f14a7345670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_88fe3b88-7cc0-45a4-acfd-4f14a7345670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3cb8d87a-feb1-47c4-bb40-3041f0b9d7ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3cb8d87a-feb1-47c4-bb40-3041f0b9d7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_12f4ec5d-c972-405b-8dfb-da1e19d3a2f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_12f4ec5d-c972-405b-8dfb-da1e19d3a2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_da9f1e80-fc29-4d9e-bc0a-d1d0264f5e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_da9f1e80-fc29-4d9e-bc0a-d1d0264f5e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_c6bdf965-faa3-47ff-9ea3-073436e54932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_c6bdf965-faa3-47ff-9ea3-073436e54932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4abea16c-95cd-41d5-b24b-0454e3161311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4abea16c-95cd-41d5-b24b-0454e3161311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OtherIncomePolicyPolicyTextBlock_021bc0c1-7b65-4ec5-ab5c-155b9c41fa2f" xlink:href="mygn-20201231.xsd#mygn_OtherIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_mygn_OtherIncomePolicyPolicyTextBlock_021bc0c1-7b65-4ec5-ab5c-155b9c41fa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_56322976-f7d5-439c-8c75-303a6b8590b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_56322976-f7d5-439c-8c75-303a6b8590b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_5875c0f5-324d-4c65-8496-2568150aa443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_5875c0f5-324d-4c65-8496-2568150aa443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_20178315-2005-4bde-9b69-2cdf0d3c17d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_20178315-2005-4bde-9b69-2cdf0d3c17d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_78feca4c-4756-4fc8-8f9f-4c2c29b5a8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_78feca4c-4756-4fc8-8f9f-4c2c29b5a8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b626ff86-dfc8-40b4-a281-059c4f91f79d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db2937b3-33c2-456c-9d4c-b085efca735a" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b626ff86-dfc8-40b4-a281-059c4f91f79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_85094812-d013-42cf-9274-d4629372328b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1807f927-2a79-4f15-8cf1-ea3731fa4bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_85094812-d013-42cf-9274-d4629372328b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1807f927-2a79-4f15-8cf1-ea3731fa4bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_78766583-33b5-4d11-8a0c-086cf0b8a1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_85094812-d013-42cf-9274-d4629372328b" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_78766583-33b5-4d11-8a0c-086cf0b8a1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_75e77813-2f60-4503-b3e3-fb6d529df6a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_85094812-d013-42cf-9274-d4629372328b" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_75e77813-2f60-4503-b3e3-fb6d529df6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_70661d19-6b93-4392-acac-435064e9226e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_85094812-d013-42cf-9274-d4629372328b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_70661d19-6b93-4392-acac-435064e9226e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4b660aa4-ea3c-437c-bdfa-ed61c19d9683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_85094812-d013-42cf-9274-d4629372328b" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4b660aa4-ea3c-437c-bdfa-ed61c19d9683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d12998dd-e829-4fb3-a633-31012e8da305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:href="mygn-20201231.xsd#mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12998dd-e829-4fb3-a633-31012e8da305" xlink:to="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_32e46da9-38fc-47cf-b81b-38e2cd875ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_32e46da9-38fc-47cf-b81b-38e2cd875ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_336e3044-379d-438b-9e01-ef33019ac018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_32e46da9-38fc-47cf-b81b-38e2cd875ac3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_336e3044-379d-438b-9e01-ef33019ac018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractsConcentrationRiskMember_23a6d1a4-caa8-4473-bb59-47d8e0317acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GovernmentContractsConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_336e3044-379d-438b-9e01-ef33019ac018" xlink:to="loc_us-gaap_GovernmentContractsConcentrationRiskMember_23a6d1a4-caa8-4473-bb59-47d8e0317acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9aadc3e1-3019-41af-857f-fec00e84f851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9aadc3e1-3019-41af-857f-fec00e84f851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5e2b749-ac5f-4daa-ac33-fad022fbcae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9aadc3e1-3019-41af-857f-fec00e84f851" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5e2b749-ac5f-4daa-ac33-fad022fbcae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_9fc94468-9494-40d3-97a0-d633ee8e45c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5e2b749-ac5f-4daa-ac33-fad022fbcae5" xlink:to="loc_us-gaap_SalesRevenueNetMember_9fc94468-9494-40d3-97a0-d633ee8e45c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd17313e-1a1f-48ae-915e-5999cbe83bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7861ee6d-5197-4dc9-aa65-6e475e6d0ed9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd17313e-1a1f-48ae-915e-5999cbe83bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_e058b4b8-a02b-4727-8f5f-647bd8a8448b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd17313e-1a1f-48ae-915e-5999cbe83bbb" xlink:to="loc_us-gaap_EquipmentMember_e058b4b8-a02b-4727-8f5f-647bd8a8448b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_16bd6a6d-c69c-4c75-a81c-cb40f9a6e3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd17313e-1a1f-48ae-915e-5999cbe83bbb" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_16bd6a6d-c69c-4c75-a81c-cb40f9a6e3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a728ee6b-a791-4ee4-b0cd-430e5e45e25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a728ee6b-a791-4ee4-b0cd-430e5e45e25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_b954ce68-6e82-471b-bc5b-e88c3a160e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a728ee6b-a791-4ee4-b0cd-430e5e45e25c" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_b954ce68-6e82-471b-bc5b-e88c3a160e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PerformanceObligationEstimatedTransactionPriceMember_62a14760-8c10-455c-8f04-00ae578db09c" xlink:href="mygn-20201231.xsd#mygn_PerformanceObligationEstimatedTransactionPriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_b954ce68-6e82-471b-bc5b-e88c3a160e23" xlink:to="loc_mygn_PerformanceObligationEstimatedTransactionPriceMember_62a14760-8c10-455c-8f04-00ae578db09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_8c752fc5-c2b9-4850-adbe-5b0f52da76bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_srt_RestatementAxis_8c752fc5-c2b9-4850-adbe-5b0f52da76bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0d843c14-6159-431d-b128-c0c4bffbc2de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_8c752fc5-c2b9-4850-adbe-5b0f52da76bb" xlink:to="loc_srt_RestatementDomain_0d843c14-6159-431d-b128-c0c4bffbc2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_c56f69c3-afb7-45c2-9362-8211007fa2d2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_0d843c14-6159-431d-b128-c0c4bffbc2de" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_c56f69c3-afb7-45c2-9362-8211007fa2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a09e0283-34b3-4b72-82df-f8b3133b4957" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_srt_RangeAxis_a09e0283-34b3-4b72-82df-f8b3133b4957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c50fc93f-0b34-45fb-8010-053e5dd6a392" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a09e0283-34b3-4b72-82df-f8b3133b4957" xlink:to="loc_srt_RangeMember_c50fc93f-0b34-45fb-8010-053e5dd6a392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_45f70eec-42ec-45bd-91d9-46771a68914b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c50fc93f-0b34-45fb-8010-053e5dd6a392" xlink:to="loc_srt_MinimumMember_45f70eec-42ec-45bd-91d9-46771a68914b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6e1cf1d1-a5ef-4f91-926c-e51c9a0b06a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c50fc93f-0b34-45fb-8010-053e5dd6a392" xlink:to="loc_srt_MaximumMember_6e1cf1d1-a5ef-4f91-926c-e51c9a0b06a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0ab99d79-7d68-47be-85ef-4d2bd2e0e153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0ab99d79-7d68-47be-85ef-4d2bd2e0e153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6fd003f-3553-4b4d-bafa-f714dca74ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0ab99d79-7d68-47be-85ef-4d2bd2e0e153" xlink:to="loc_us-gaap_SegmentDomain_b6fd003f-3553-4b4d-bafa-f714dca74ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_73484f27-e9a5-4ead-a4ab-80ae7d21f747" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b6fd003f-3553-4b4d-bafa-f714dca74ce3" xlink:to="loc_mygn_DiagnosticMember_73484f27-e9a5-4ead-a4ab-80ae7d21f747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:href="mygn-20201231.xsd#mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_93fb02c5-7353-4645-8a98-d1eb0533758c" xlink:to="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_896593ea-e5aa-4ef3-b546-b137a8a36dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_896593ea-e5aa-4ef3-b546-b137a8a36dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_6ec6659a-eec1-4edf-9f4f-28784a10fea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_6ec6659a-eec1-4edf-9f4f-28784a10fea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_39ad28bf-b1af-4b57-a68c-d7bfcc239610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_39ad28bf-b1af-4b57-a68c-d7bfcc239610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CARESActOf2020MedicarePaymentAmount_87949f5e-5cfe-46cc-8b96-5520d52772ad" xlink:href="mygn-20201231.xsd#mygn_CARESActOf2020MedicarePaymentAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_mygn_CARESActOf2020MedicarePaymentAmount_87949f5e-5cfe-46cc-8b96-5520d52772ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_af8ff11d-da0d-4247-b8c4-8463f9370730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_af8ff11d-da0d-4247-b8c4-8463f9370730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_a9a40aac-7abd-4570-8f38-8a198876de62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_a9a40aac-7abd-4570-8f38-8a198876de62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInEarningsLossPerShare_9e6f155b-b37b-4697-85f8-72e8ba439b35" xlink:href="mygn-20201231.xsd#mygn_IncreaseDecreaseInEarningsLossPerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_mygn_IncreaseDecreaseInEarningsLossPerShare_9e6f155b-b37b-4697-85f8-72e8ba439b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c38d47cb-87a9-4e33-a566-fad5e52df999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c38d47cb-87a9-4e33-a566-fad5e52df999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d35e065-ef15-4249-ab2a-3448bb718889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d35e065-ef15-4249-ab2a-3448bb718889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross_5f274855-f45a-4812-ac65-bc152f7de07a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_us-gaap_CapitalizedContractCostGross_5f274855-f45a-4812-ac65-bc152f7de07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CARESActOf2020ProviderReliefFundAmount_2184d4e8-3280-446e-9d8d-705a36069fbf" xlink:href="mygn-20201231.xsd#mygn_CARESActOf2020ProviderReliefFundAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_a8f706f4-594e-4f8a-8214-f9844b921899" xlink:to="loc_mygn_CARESActOf2020ProviderReliefFundAmount_2184d4e8-3280-446e-9d8d-705a36069fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_74403c12-99e1-4eac-a2a0-bc5a6b7595f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bfd34280-cb00-4545-851c-eb1356187d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74403c12-99e1-4eac-a2a0-bc5a6b7595f1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bfd34280-cb00-4545-851c-eb1356187d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bfd34280-cb00-4545-851c-eb1356187d6c" xlink:to="loc_srt_ProductOrServiceAxis_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b192e3db-b24f-451c-9b17-11b3473758dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bbd5d91a-4fc7-46fd-9b1a-fb6b3b94bb67" xlink:to="loc_srt_ProductsAndServicesDomain_b192e3db-b24f-451c-9b17-11b3473758dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b192e3db-b24f-451c-9b17-11b3473758dc" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember_152aab34-1343-41eb-ad44-7a345734491e" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticHereditaryCancerTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember_152aab34-1343-41eb-ad44-7a345734491e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticGenesightTestingMember_ae1096b1-9099-4d48-89e5-e089d285b945" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticGenesightTestingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticGenesightTestingMember_ae1096b1-9099-4d48-89e5-e089d285b945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticPrenatalTestingMember_187ad384-839f-4a01-9534-838047445ef6" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticPrenatalTestingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticPrenatalTestingMember_187ad384-839f-4a01-9534-838047445ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticVectraTestingMember_171b10a6-6613-4cdc-accd-3186904cfe0a" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticVectraTestingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticVectraTestingMember_171b10a6-6613-4cdc-accd-3186904cfe0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticMyChoiceCDxMember_f7f6d7f2-f75c-4a44-9126-6ac334be1b32" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticMyChoiceCDxMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticMyChoiceCDxMember_f7f6d7f2-f75c-4a44-9126-6ac334be1b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticProlarisTestingMember_0d026f96-2129-4989-b3b2-8d8b7184d2c9" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticProlarisTestingMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticProlarisTestingMember_0d026f96-2129-4989-b3b2-8d8b7184d2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticEndoPredictTestingMember_1665b5c9-b8c4-4a80-8340-b054a776014b" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticEndoPredictTestingMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticEndoPredictTestingMember_1665b5c9-b8c4-4a80-8340-b054a776014b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticOtherTestingMember_b92e92e6-d4d6-41d0-bb17-10c8c5cbb857" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticOtherTestingMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_MolecularDiagnosticTestingMember_11bf0911-128e-4552-a3a2-82531ca48b7b" xlink:to="loc_mygn_MolecularDiagnosticOtherTestingMember_b92e92e6-d4d6-41d0-bb17-10c8c5cbb857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_4676ab84-500f-4752-a146-7e74f028dcc0" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b192e3db-b24f-451c-9b17-11b3473758dc" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_4676ab84-500f-4752-a146-7e74f028dcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2103a2e5-bbcf-4c70-ae42-e244a15d2b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bfd34280-cb00-4545-851c-eb1356187d6c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_2103a2e5-bbcf-4c70-ae42-e244a15d2b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d4df8e8-445e-42ea-9787-c69ca2ad7341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2103a2e5-bbcf-4c70-ae42-e244a15d2b91" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d4df8e8-445e-42ea-9787-c69ca2ad7341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8cc290d0-c6a4-43eb-ad41-1f7545f1ff56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5d687230-ac1c-47f4-97ee-496b7a4f89ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8cc290d0-c6a4-43eb-ad41-1f7545f1ff56" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5d687230-ac1c-47f4-97ee-496b7a4f89ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8878ef26-6806-48d5-b455-d368d4f3fd4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5d687230-ac1c-47f4-97ee-496b7a4f89ad" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8878ef26-6806-48d5-b455-d368d4f3fd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized_6804134a-c817-49c2-af9a-622b19164f02" xlink:href="mygn-20201231.xsd#mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5d687230-ac1c-47f4-97ee-496b7a4f89ad" xlink:to="loc_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized_6804134a-c817-49c2-af9a-622b19164f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContractWithCustomerLiabilityPrepayments_74585a9c-18b0-45f1-8be0-30307df74e00" xlink:href="mygn-20201231.xsd#mygn_ContractWithCustomerLiabilityPrepayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5d687230-ac1c-47f4-97ee-496b7a4f89ad" xlink:to="loc_mygn_ContractWithCustomerLiabilityPrepayments_74585a9c-18b0-45f1-8be0-30307df74e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c52009b9-ff76-4fd8-97ca-67a15821b744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5d687230-ac1c-47f4-97ee-496b7a4f89ad" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c52009b9-ff76-4fd8-97ca-67a15821b744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2c4ab55e-d628-4da9-a096-d8abe3e47c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_074354e6-8459-4719-99e3-84e7bd0dd347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c4ab55e-d628-4da9-a096-d8abe3e47c44" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_074354e6-8459-4719-99e3-84e7bd0dd347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8e4b3ba3-debd-4d5a-b7fc-b85a52914e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c4ab55e-d628-4da9-a096-d8abe3e47c44" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8e4b3ba3-debd-4d5a-b7fc-b85a52914e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_93f039a7-f292-4e60-b9b5-6de4301c6027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c4ab55e-d628-4da9-a096-d8abe3e47c44" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_93f039a7-f292-4e60-b9b5-6de4301c6027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fd49a06a-a9cb-42c2-aef5-0ff812309cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c4ab55e-d628-4da9-a096-d8abe3e47c44" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fd49a06a-a9cb-42c2-aef5-0ff812309cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e790bc6a-0361-4e67-a064-15433f8acf33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_ecce0bca-055c-40bd-b6b5-8fce966f79c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e790bc6a-0361-4e67-a064-15433f8acf33" xlink:to="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_ecce0bca-055c-40bd-b6b5-8fce966f79c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_75a40af5-d9f0-42c9-a88b-292aca3b3c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_ecce0bca-055c-40bd-b6b5-8fce966f79c7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_75a40af5-d9f0-42c9-a88b-292aca3b3c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_fe284fc6-10a7-4fe4-9010-2bf592424162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_ecce0bca-055c-40bd-b6b5-8fce966f79c7" xlink:to="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_fe284fc6-10a7-4fe4-9010-2bf592424162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax_89a3180f-ee6f-401b-8706-068c3b36832d" xlink:href="mygn-20201231.xsd#mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_ecce0bca-055c-40bd-b6b5-8fce966f79c7" xlink:to="loc_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax_89a3180f-ee6f-401b-8706-068c3b36832d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_355ad315-754f-492f-84c4-6ad0f8a9395f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_ecce0bca-055c-40bd-b6b5-8fce966f79c7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_355ad315-754f-492f-84c4-6ad0f8a9395f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecurities"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e5a786f9-201c-43c7-9447-b489d25517a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_6d312782-6d98-4013-9028-6ca2dd301835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e5a786f9-201c-43c7-9447-b489d25517a2" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_6d312782-6d98-4013-9028-6ca2dd301835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_04006159-95c2-4d43-a5c3-e9d7e0ee318e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_019deab4-ec34-4800-be42-3c92adc648c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_04006159-95c2-4d43-a5c3-e9d7e0ee318e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_019deab4-ec34-4800-be42-3c92adc648c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_91ab6584-99bd-4d6e-acb9-1cebe3d7562e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_04006159-95c2-4d43-a5c3-e9d7e0ee318e" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_91ab6584-99bd-4d6e-acb9-1cebe3d7562e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fce0f5a3-4610-42cb-a7b5-f7414fb02e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fce0f5a3-4610-42cb-a7b5-f7414fb02e10" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_00a62dfe-0cb4-4534-b475-c62f47916564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:to="loc_us-gaap_InvestmentTypeAxis_00a62dfe-0cb4-4534-b475-c62f47916564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_00a62dfe-0cb4-4534-b475-c62f47916564" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_21e6493c-e3b0-41f4-971d-5e767bbde17c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_21e6493c-e3b0-41f4-971d-5e767bbde17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_1a7c2a0a-8770-4043-a833-ba8c29b706eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:to="loc_us-gaap_MunicipalBondsMember_1a7c2a0a-8770-4043-a833-ba8c29b706eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_26649ad5-7407-4f72-b5e3-58fe255e727b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_26649ad5-7407-4f72-b5e3-58fe255e727b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fd87c50a-e1bb-4eac-ab23-2ea8a060fbb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_26639972-304b-425c-94c3-fab9a3b0cdc0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fd87c50a-e1bb-4eac-ab23-2ea8a060fbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_e121fe9d-77df-4daf-ac0c-efc191936763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_e121fe9d-77df-4daf-ac0c-efc191936763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2394f80-6810-45dc-9d79-6bc959f865b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_e121fe9d-77df-4daf-ac0c-efc191936763" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2394f80-6810-45dc-9d79-6bc959f865b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_35bcbace-feeb-4135-9447-d8a7b547123e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2394f80-6810-45dc-9d79-6bc959f865b7" xlink:to="loc_us-gaap_CashMember_35bcbace-feeb-4135-9447-d8a7b547123e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_783bd6f9-22d4-4bfa-8144-c1c98d05402a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2394f80-6810-45dc-9d79-6bc959f865b7" xlink:to="loc_us-gaap_CashEquivalentsMember_783bd6f9-22d4-4bfa-8144-c1c98d05402a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2531eda8-f744-43ed-9798-03a1b7e5cf03" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_e9836743-7270-47a1-9bee-af35e6e8a13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_e9836743-7270-47a1-9bee-af35e6e8a13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8673244c-7243-4162-b6e9-481c715ef109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_e9836743-7270-47a1-9bee-af35e6e8a13e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8673244c-7243-4162-b6e9-481c715ef109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_352c1b29-095d-4a0e-a8ec-2f43ed3ac758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_e9836743-7270-47a1-9bee-af35e6e8a13e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_352c1b29-095d-4a0e-a8ec-2f43ed3ac758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_75c1836b-8742-4738-b1aa-560a17d78e96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_75c1836b-8742-4738-b1aa-560a17d78e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_df03a4b9-f507-4572-afa5-899661165f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_df03a4b9-f507-4572-afa5-899661165f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_139816ae-72fd-4c38-a85e-9e4bb2aba0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_139816ae-72fd-4c38-a85e-9e4bb2aba0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3e38d0aa-0263-44b7-8d52-206a5de5c42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_25dffde0-4361-43d4-9860-97ffd8b439f3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3e38d0aa-0263-44b7-8d52-206a5de5c42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCashAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f876961e-d53d-459d-a405-ee73f54a530a" xlink:to="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_a6dc6395-272b-4452-a9c7-9fc02fb90d95" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:to="loc_mygn_InvestmentsAndCashAmortizedCost_a6dc6395-272b-4452-a9c7-9fc02fb90d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_234b1177-45c2-43b9-afa7-e8780b41bc2d" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_234b1177-45c2-43b9-afa7-e8780b41bc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_19750f32-3cfe-4d53-9256-b72ed1e4a8d9" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_19750f32-3cfe-4d53-9256-b72ed1e4a8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_0c1c2a90-442d-463a-b6e6-58552740392b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_34bb2197-1fe4-47e4-8e6d-2aee747dd331" xlink:to="loc_us-gaap_InvestmentsAndCash_0c1c2a90-442d-463a-b6e6-58552740392b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9ed9b369-3bbf-4be9-b939-b33edba48faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_fe9e3122-fa07-4dc7-8d27-714180f620d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9ed9b369-3bbf-4be9-b939-b33edba48faf" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_fe9e3122-fa07-4dc7-8d27-714180f620d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_fe9e3122-fa07-4dc7-8d27-714180f620d3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5c406756-e8f5-4e93-9f21-db773fa6d9c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fe24ddf1-2209-4a44-a406-1a76c4bfdc6f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5c406756-e8f5-4e93-9f21-db773fa6d9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_b9edac2b-95a5-4dfb-8fff-129b234a6ff1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5c406756-e8f5-4e93-9f21-db773fa6d9c5" xlink:to="loc_us-gaap_CashMember_b9edac2b-95a5-4dfb-8fff-129b234a6ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_c5030e5c-3135-4f9f-a7bb-512637dc8be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5c406756-e8f5-4e93-9f21-db773fa6d9c5" xlink:to="loc_us-gaap_CashEquivalentsMember_c5030e5c-3135-4f9f-a7bb-512637dc8be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ea5b4228-f403-474c-b211-b349c56f5adf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_fe9e3122-fa07-4dc7-8d27-714180f620d3" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ea5b4228-f403-474c-b211-b349c56f5adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ea5b4228-f403-474c-b211-b349c56f5adf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8884d751-73d1-4c95-a143-e23e13ecbe91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8884d751-73d1-4c95-a143-e23e13ecbe91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5a767299-816a-4cc6-b3ae-619a81edc3c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5a767299-816a-4cc6-b3ae-619a81edc3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_78b81e38-3169-4d63-93b5-4153e14e0782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_78b81e38-3169-4d63-93b5-4153e14e0782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c030b011-4937-426b-a104-801aff7c3b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c030b011-4937-426b-a104-801aff7c3b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_5132ed1f-2934-409b-a211-552c8c52ef47" xlink:href="mygn-20201231.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8531289c-532f-4c50-ad24-0ab81661b845" xlink:to="loc_mygn_InvestmentsAndCashAmortizedCost_5132ed1f-2934-409b-a211-552c8c52ef47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ea5b4228-f403-474c-b211-b349c56f5adf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1f7a0772-5c72-462a-9ed8-f0e90e0615f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1f7a0772-5c72-462a-9ed8-f0e90e0615f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_b3725033-db2b-484b-9e33-cbbe56baf438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_b3725033-db2b-484b-9e33-cbbe56baf438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_4b623b53-9a70-4738-bdd5-f79f0a713841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_4b623b53-9a70-4738-bdd5-f79f0a713841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_78bc4d3b-744e-4c56-a217-a9a3a87927ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_78bc4d3b-744e-4c56-a217-a9a3a87927ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_99354ebe-8eb5-41b6-ad1a-3a31fc630b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_93c15f21-94c3-4508-a3ce-fa18ac582dac" xlink:to="loc_us-gaap_InvestmentsAndCash_99354ebe-8eb5-41b6-ad1a-3a31fc630b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#MarketableInvestmentSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_03238c2b-c5c9-4543-bdc1-6f904c3cb323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_86e58ade-e7e6-4b59-a64b-6b6c44312559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_03238c2b-c5c9-4543-bdc1-6f904c3cb323" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_86e58ade-e7e6-4b59-a64b-6b6c44312559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bc940e7d-ecda-4b79-9f04-50200df1056d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_bbe67870-9642-4868-9702-925677d18214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bc940e7d-ecda-4b79-9f04-50200df1056d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_bbe67870-9642-4868-9702-925677d18214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ca1b5749-ec4f-449b-b0e9-677cd1bb1884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_cc6a76fc-e387-4957-8b60-ae5c66eb064b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ca1b5749-ec4f-449b-b0e9-677cd1bb1884" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_cc6a76fc-e387-4957-8b60-ae5c66eb064b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6698e4ac-0c5b-4e45-8d58-48bc075292f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ca1b5749-ec4f-449b-b0e9-677cd1bb1884" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6698e4ac-0c5b-4e45-8d58-48bc075292f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e4ec85a9-0313-4540-9074-12985802e208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e4ec85a9-0313-4540-9074-12985802e208" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb742a79-8e23-4807-bc40-8965e34bb187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb742a79-8e23-4807-bc40-8965e34bb187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32a3a9c2-ccc1-4dd1-8998-0fe7850eac34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb742a79-8e23-4807-bc40-8965e34bb187" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32a3a9c2-ccc1-4dd1-8998-0fe7850eac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3404115d-5336-4f55-858d-709d28ace939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32a3a9c2-ccc1-4dd1-8998-0fe7850eac34" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3404115d-5336-4f55-858d-709d28ace939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_d9fb39d6-6273-4562-b5ce-d59e4c001feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_d9fb39d6-6273-4562-b5ce-d59e4c001feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_eed84904-f1ef-48f4-b9bd-edb0a0f95e72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_d9fb39d6-6273-4562-b5ce-d59e4c001feb" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_eed84904-f1ef-48f4-b9bd-edb0a0f95e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_6929b907-904a-4d4a-9b3f-4a081ad75ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_eed84904-f1ef-48f4-b9bd-edb0a0f95e72" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_6929b907-904a-4d4a-9b3f-4a081ad75ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3e871dea-48df-43e2-a4b8-978a93c7eb6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cdb21544-86f6-4f52-90e1-1205621b5a39" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3e871dea-48df-43e2-a4b8-978a93c7eb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_50f8625d-ffb1-45f4-b635-e23ddf13f43a" xlink:href="mygn-20201231.xsd#mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3e871dea-48df-43e2-a4b8-978a93c7eb6a" xlink:to="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_50f8625d-ffb1-45f4-b635-e23ddf13f43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_cf8eea77-4215-4f4c-95bf-45fdaeb4517f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3e871dea-48df-43e2-a4b8-978a93c7eb6a" xlink:to="loc_us-gaap_LongTermDebtFairValue_cf8eea77-4215-4f4c-95bf-45fdaeb4517f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_26bc1f48-a166-4c7d-8df2-196d6cbed8e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_26bc1f48-a166-4c7d-8df2-196d6cbed8e4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_81b7a87a-7136-4ccc-905a-22ff2c220e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_81b7a87a-7136-4ccc-905a-22ff2c220e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_81b7a87a-7136-4ccc-905a-22ff2c220e46" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3b2682b9-104f-435d-a857-612c0ffb6234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3b2682b9-104f-435d-a857-612c0ffb6234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d7520b9e-3b78-4644-a43d-48e59b01beda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d7520b9e-3b78-4644-a43d-48e59b01beda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c17a5f77-21e3-4b12-b6fb-cc8c91cc52c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3f5dd4c5-d2e7-4fae-9588-dd8d0f78b850" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c17a5f77-21e3-4b12-b6fb-cc8c91cc52c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_626df666-01da-47e2-bd31-30d6600ea239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ee8f1945-0c00-48e3-a771-d3b6d37fb3d3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_626df666-01da-47e2-bd31-30d6600ea239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContingentConsiderationMember_2c8c9e92-f4ee-4f2c-bad2-c4283898cf45" xlink:href="mygn-20201231.xsd#mygn_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_626df666-01da-47e2-bd31-30d6600ea239" xlink:to="loc_mygn_ContingentConsiderationMember_2c8c9e92-f4ee-4f2c-bad2-c4283898cf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_5d40f0bb-8ec2-4aab-94b5-3417bee993aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:to="loc_us-gaap_InvestmentTypeAxis_5d40f0bb-8ec2-4aab-94b5-3417bee993aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_5d40f0bb-8ec2-4aab-94b5-3417bee993aa" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a9942c05-18b8-4df3-b985-7ead90e81378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a9942c05-18b8-4df3-b985-7ead90e81378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_eb44687b-9489-450e-b7f0-cef5fdee20f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_eb44687b-9489-450e-b7f0-cef5fdee20f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_ace1b407-37d0-444b-a4f7-9296be8a9e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_MunicipalBondsMember_ace1b407-37d0-444b-a4f7-9296be8a9e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_d0338ef1-02e2-4ae6-b1ed-ffd24bf65d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_d0338ef1-02e2-4ae6-b1ed-ffd24bf65d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0172f305-dd45-4424-8549-f44d421e0384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8351a846-d845-4afe-92d4-0b51621152cd" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0172f305-dd45-4424-8549-f44d421e0384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f61ee0f4-8618-4a37-9e82-dc2f4282d203" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c01a61c6-da3a-4dfc-8b03-1cb763766f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c01a61c6-da3a-4dfc-8b03-1cb763766f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1236a67b-013c-4b75-9ac3-02038326bc36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1236a67b-013c-4b75-9ac3-02038326bc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_ff0729d9-c512-472f-bc36-005453c3c64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be8d94ad-0d49-40d2-9b04-41e5d9996175" xlink:to="loc_us-gaap_FairValueNetAssetLiability_ff0729d9-c512-472f-bc36-005453c3c64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_092ddea1-8c95-4a5a-9ccb-524d0c2becf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6dbc3314-d0da-4063-bf34-32368927bb6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_092ddea1-8c95-4a5a-9ccb-524d0c2becf8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6dbc3314-d0da-4063-bf34-32368927bb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e899e51d-a969-4cb8-b2a1-22672259d7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6dbc3314-d0da-4063-bf34-32368927bb6c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e899e51d-a969-4cb8-b2a1-22672259d7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_c685f793-4a47-410f-bb8b-0517ab9dada7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6dbc3314-d0da-4063-bf34-32368927bb6c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_c685f793-4a47-410f-bb8b-0517ab9dada7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_47d3b286-c50c-468d-9cbb-1ee529ab50da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6dbc3314-d0da-4063-bf34-32368927bb6c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_47d3b286-c50c-468d-9cbb-1ee529ab50da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_5d12a8af-adf6-4711-a918-885b987986e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6dbc3314-d0da-4063-bf34-32368927bb6c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_5d12a8af-adf6-4711-a918-885b987986e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4f5b75db-ea51-4393-a2e2-9cc226514e83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6dbc3314-d0da-4063-bf34-32368927bb6c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4f5b75db-ea51-4393-a2e2-9cc226514e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1bfb6e3b-c888-4f07-ad76-a8d3da4e5892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_e656d39b-2e5f-4722-86cb-bc3cafc2d31e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1bfb6e3b-c888-4f07-ad76-a8d3da4e5892" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_e656d39b-2e5f-4722-86cb-bc3cafc2d31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_efdc25cb-0dee-41b7-99fd-92562db64ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_082abb8d-f64a-4be4-ac01-c593b3842aed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_efdc25cb-0dee-41b7-99fd-92562db64ea5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_082abb8d-f64a-4be4-ac01-c593b3842aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5601312-5707-42ce-9727-804cf3aad156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e7ec7c21-9aa4-4e09-bf44-8390795aec99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5601312-5707-42ce-9727-804cf3aad156" xlink:to="loc_us-gaap_Land_e7ec7c21-9aa4-4e09-bf44-8390795aec99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_2a3b39ee-64e1-406a-9bd8-e2c78138c9f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5601312-5707-42ce-9727-804cf3aad156" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_2a3b39ee-64e1-406a-9bd8-e2c78138c9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_42fc6f9a-8299-4fcb-b347-72acdd79ceb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5601312-5707-42ce-9727-804cf3aad156" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_42fc6f9a-8299-4fcb-b347-72acdd79ceb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_5b0f4cb4-6713-4f0a-95cf-491cd23d8a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5601312-5707-42ce-9727-804cf3aad156" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_5b0f4cb4-6713-4f0a-95cf-491cd23d8a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9302c315-d40c-4b56-b63d-c560df1c50b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5601312-5707-42ce-9727-804cf3aad156" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9302c315-d40c-4b56-b63d-c560df1c50b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b6ad3657-051e-406a-ab5f-6326dd3b570c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5601312-5707-42ce-9727-804cf3aad156" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b6ad3657-051e-406a-ab5f-6326dd3b570c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_180739ff-6ca1-4875-9f68-86d6584968e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5601312-5707-42ce-9727-804cf3aad156" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_180739ff-6ca1-4875-9f68-86d6584968e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b9edbdc8-1c7f-434b-b552-1e35610e5c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6add2543-ce85-450f-8d07-015e0f14c225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b9edbdc8-1c7f-434b-b552-1e35610e5c33" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6add2543-ce85-450f-8d07-015e0f14c225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d51fc070-b31c-4d26-b013-4f3dc3ef705a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6add2543-ce85-450f-8d07-015e0f14c225" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d51fc070-b31c-4d26-b013-4f3dc3ef705a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3eb8de9d-383d-4e11-bae0-ce68fc090d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d51fc070-b31c-4d26-b013-4f3dc3ef705a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3eb8de9d-383d-4e11-bae0-ce68fc090d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ClinicAssetGroupMember_5972815e-23c8-408f-ac13-8409e41c82c2" xlink:href="mygn-20201231.xsd#mygn_ClinicAssetGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3eb8de9d-383d-4e11-bae0-ce68fc090d0e" xlink:to="loc_mygn_ClinicAssetGroupMember_5972815e-23c8-408f-ac13-8409e41c82c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c8a7621d-2099-4d6d-89d6-5c0d23e9363c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6add2543-ce85-450f-8d07-015e0f14c225" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c8a7621d-2099-4d6d-89d6-5c0d23e9363c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_602f1937-101f-48e4-bb0f-49d4c7166027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c8a7621d-2099-4d6d-89d6-5c0d23e9363c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_602f1937-101f-48e4-bb0f-49d4c7166027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PropertyPlantandEquipmentNetDepreciationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_59967430-3493-4204-b6e2-ae3035a87546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7d87ed58-c614-46f9-bdbe-89762177143d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_59967430-3493-4204-b6e2-ae3035a87546" xlink:to="loc_us-gaap_Depreciation_7d87ed58-c614-46f9-bdbe-89762177143d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ec7dbba7-cb06-4566-942a-f36e3a27e313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2b638a80-48c9-4710-9184-0bbf039504aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ec7dbba7-cb06-4566-942a-f36e3a27e313" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2b638a80-48c9-4710-9184-0bbf039504aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c195f734-d340-4123-808a-7267486b4238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_60054be3-7795-4a6a-9609-eeaf951a8f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c195f734-d340-4123-808a-7267486b4238" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_60054be3-7795-4a6a-9609-eeaf951a8f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_edcf39f9-975d-4569-b965-187c347d248c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c195f734-d340-4123-808a-7267486b4238" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_edcf39f9-975d-4569-b965-187c347d248c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_8e9ebb98-5481-4079-bf63-e600c43e9469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c195f734-d340-4123-808a-7267486b4238" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_8e9ebb98-5481-4079-bf63-e600c43e9469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_c9886c81-2178-4efe-a0cf-ae0e3c467ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c195f734-d340-4123-808a-7267486b4238" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_c9886c81-2178-4efe-a0cf-ae0e3c467ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c3369f60-301c-4512-8ba5-7747a29ee23e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c195f734-d340-4123-808a-7267486b4238" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c3369f60-301c-4512-8ba5-7747a29ee23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0d305908-f046-4567-b923-c0a38a3d0c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5ffbac0f-766d-453c-b302-9c339a1b48f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0d305908-f046-4567-b923-c0a38a3d0c64" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5ffbac0f-766d-453c-b302-9c339a1b48f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5ffbac0f-766d-453c-b302-9c339a1b48f3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_94f94115-d653-46f6-a20a-de86d8c90d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5edbfea9-3b4d-4033-bd7e-6ef23ced6d30" xlink:to="loc_us-gaap_SegmentDomain_94f94115-d653-46f6-a20a-de86d8c90d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_226c7bd4-e791-4511-9862-adde733ce68f" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94f94115-d653-46f6-a20a-de86d8c90d9b" xlink:to="loc_mygn_DiagnosticMember_226c7bd4-e791-4511-9862-adde733ce68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_1636d20e-f834-4bff-bc2e-0235bbf42d62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94f94115-d653-46f6-a20a-de86d8c90d9b" xlink:to="loc_us-gaap_AllOtherSegmentsMember_1636d20e-f834-4bff-bc2e-0235bbf42d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2a406ff9-11b1-44e0-8332-d5813faf309e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5ffbac0f-766d-453c-b302-9c339a1b48f3" xlink:to="loc_us-gaap_GoodwillLineItems_2a406ff9-11b1-44e0-8332-d5813faf309e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2a406ff9-11b1-44e0-8332-d5813faf309e" xlink:to="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6e2c566b-6b27-4ef5-801e-2a339fc42aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_Goodwill_6e2c566b-6b27-4ef5-801e-2a339fc42aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4a0b788c-0ac0-4cc5-8a8a-c1335fd76722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4a0b788c-0ac0-4cc5-8a8a-c1335fd76722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f65d91ed-9675-43c6-bbd4-c4a01c95f693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f65d91ed-9675-43c6-bbd4-c4a01c95f693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_5c2d07c6-d72f-42b2-bf24-8d774324ee53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_5c2d07c6-d72f-42b2-bf24-8d774324ee53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ddcc909b-3b1e-421b-ae33-ffc6e392932c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ddcc909b-3b1e-421b-ae33-ffc6e392932c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_fae04037-d32e-4a22-8fad-875d50fd7302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_fae04037-d32e-4a22-8fad-875d50fd7302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26bc9e77-b168-4b64-9c82-d8bca1395ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3374a81e-4cf8-4973-bdd5-7e4228d29db7" xlink:to="loc_us-gaap_Goodwill_26bc9e77-b168-4b64-9c82-d8bca1395ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f495ac0-972e-47bd-9f26-029f0aa87b11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f495ac0-972e-47bd-9f26-029f0aa87b11" xlink:to="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_32b04a7d-9425-495c-9328-45c3e96ce34a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_32b04a7d-9425-495c-9328-45c3e96ce34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f9ffe1a-1a43-4dd5-a69c-2ebb12ccf54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_32b04a7d-9425-495c-9328-45c3e96ce34a" xlink:to="loc_us-gaap_SegmentDomain_9f9ffe1a-1a43-4dd5-a69c-2ebb12ccf54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_bc8e6f49-6730-46fb-a9d9-7a283f4682e9" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9f9ffe1a-1a43-4dd5-a69c-2ebb12ccf54a" xlink:to="loc_mygn_DiagnosticMember_bc8e6f49-6730-46fb-a9d9-7a283f4682e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_3ae9f4b4-2a35-4367-b1d2-8383b6d35ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9f9ffe1a-1a43-4dd5-a69c-2ebb12ccf54a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_3ae9f4b4-2a35-4367-b1d2-8383b6d35ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_61bebbe0-b78d-4730-a737-3af7a2a3dc7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_us-gaap_ReportingUnitAxis_61bebbe0-b78d-4730-a737-3af7a2a3dc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_57539e62-c4d1-4727-bf59-cfce6b4ec758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_61bebbe0-b78d-4730-a737-3af7a2a3dc7a" xlink:to="loc_us-gaap_ReportingUnitDomain_57539e62-c4d1-4727-bf59-cfce6b4ec758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MyriadAutoimmuneReportingUnitMember_661d18ab-906e-42c6-b312-62480dc32035" xlink:href="mygn-20201231.xsd#mygn_MyriadAutoimmuneReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_57539e62-c4d1-4727-bf59-cfce6b4ec758" xlink:to="loc_mygn_MyriadAutoimmuneReportingUnitMember_661d18ab-906e-42c6-b312-62480dc32035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ClinicReportingUnitMember_cf798ddc-be47-4128-a682-933a24de7bce" xlink:href="mygn-20201231.xsd#mygn_ClinicReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_57539e62-c4d1-4727-bf59-cfce6b4ec758" xlink:to="loc_mygn_ClinicReportingUnitMember_cf798ddc-be47-4128-a682-933a24de7bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ba46a4-47f1-4843-9a18-9c9bac25e36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ba46a4-47f1-4843-9a18-9c9bac25e36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ba46a4-47f1-4843-9a18-9c9bac25e36b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DevelopedTechnologyAndDatabaseMember_2a40cca8-9d7c-4455-9078-5834d9142812" xlink:href="mygn-20201231.xsd#mygn_DevelopedTechnologyAndDatabaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:to="loc_mygn_DevelopedTechnologyAndDatabaseMember_2a40cca8-9d7c-4455-9078-5834d9142812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_33de9ab2-4dcc-47ea-86df-c94175836fb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:to="loc_us-gaap_TrademarksMember_33de9ab2-4dcc-47ea-86df-c94175836fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d9747d2f-1d8d-48ad-83db-02bd2622a1df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d9747d2f-1d8d-48ad-83db-02bd2622a1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PurchasedLicensesAndTechnologiesMember_5bdf255a-bd25-4116-830a-b0c4f47f25f2" xlink:href="mygn-20201231.xsd#mygn_PurchasedLicensesAndTechnologiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_94c575e2-305c-46a7-b273-97564c38ca44" xlink:to="loc_mygn_PurchasedLicensesAndTechnologiesMember_5bdf255a-bd25-4116-830a-b0c4f47f25f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2f6adf12-4030-4844-bb04-09632bb75b7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_srt_RangeAxis_2f6adf12-4030-4844-bb04-09632bb75b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9a21d076-91d9-4cde-97cf-7d220ef6ec9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2f6adf12-4030-4844-bb04-09632bb75b7b" xlink:to="loc_srt_RangeMember_9a21d076-91d9-4cde-97cf-7d220ef6ec9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_57c281e6-31bf-4302-9580-9a95b505f7d8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9a21d076-91d9-4cde-97cf-7d220ef6ec9f" xlink:to="loc_srt_MinimumMember_57c281e6-31bf-4302-9580-9a95b505f7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d2459008-7203-49b7-bf4f-fed9909f3576" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9a21d076-91d9-4cde-97cf-7d220ef6ec9f" xlink:to="loc_srt_MaximumMember_d2459008-7203-49b7-bf4f-fed9909f3576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsTable_23df56c9-ad92-4d29-b9ff-556d353d9e21" xlink:to="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ef4fa00e-5fbf-44b8-b785-6e3dca656b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ef4fa00e-5fbf-44b8-b785-6e3dca656b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7e39b8a9-0e02-4a81-929b-250014af9c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7e39b8a9-0e02-4a81-929b-250014af9c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7eae3aa3-f1ab-419a-9300-ee13fb9eeef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7eae3aa3-f1ab-419a-9300-ee13fb9eeef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a92d8e36-da10-48e7-a2a0-4e3901852c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a92d8e36-da10-48e7-a2a0-4e3901852c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_81e17a3d-a970-4a5b-83a1-60f841cc8c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_GoodwillAndIntangibleAssetsLineItems_8cb89592-64e1-4306-b12c-d7af16eaeb6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_81e17a3d-a970-4a5b-83a1-60f841cc8c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6fb34cce-29fa-4b35-aabd-8982c71e2847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6fb34cce-29fa-4b35-aabd-8982c71e2847" xlink:to="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_195747b2-640a-4893-9388-8b499b185609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a821fbd-5c3c-4e85-8c80-a26018bd8d1e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_195747b2-640a-4893-9388-8b499b185609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_91d66107-906c-4f42-9400-838fab33c637" xlink:href="mygn-20201231.xsd#mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_195747b2-640a-4893-9388-8b499b185609" xlink:to="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_91d66107-906c-4f42-9400-838fab33c637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1fa550d1-479b-4aa1-9fe2-f6b4e2a3e94e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PurchasedLicensesAndTechnologiesMember_19e6fc8b-ff78-4b6b-b597-02b8a6c3e479" xlink:href="mygn-20201231.xsd#mygn_PurchasedLicensesAndTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:to="loc_mygn_PurchasedLicensesAndTechnologiesMember_19e6fc8b-ff78-4b6b-b597-02b8a6c3e479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_70bee276-0f27-44d7-96fd-a29e0288392c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:to="loc_us-gaap_CustomerRelationshipsMember_70bee276-0f27-44d7-96fd-a29e0288392c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c5b3992e-8407-4a48-8a15-f525bda363b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6234003-f982-47cd-b6a7-4fd779db28bf" xlink:to="loc_us-gaap_TrademarksMember_c5b3992e-8407-4a48-8a15-f525bda363b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:href="mygn-20201231.xsd#mygn_IntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_1f59867f-eb25-433e-8fbf-64de85db1f8a" xlink:to="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f21828b-0f51-4f63-b9bd-4b3639c4e451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f21828b-0f51-4f63-b9bd-4b3639c4e451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc1c5789-e845-452b-867a-fa9781aee447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc1c5789-e845-452b-867a-fa9781aee447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d95bb506-a29c-490f-bbee-54e4f3b7e949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d95bb506-a29c-490f-bbee-54e4f3b7e949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_6a80bf31-40e0-47a8-b531-e825f12e7380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_6a80bf31-40e0-47a8-b531-e825f12e7380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ea4986de-14e1-4c75-8b3e-fd024f9791bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ea4986de-14e1-4c75-8b3e-fd024f9791bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0919e68b-c3b2-47cf-b04c-276be0fadad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_6eb724a5-0b1e-4dcd-a823-de7c7ca3c07b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0919e68b-c3b2-47cf-b04c-276be0fadad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f1a2ccc7-d123-4ba1-817d-75af98fb2984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4912bc38-fe04-4153-a768-e2a91476b9a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f1a2ccc7-d123-4ba1-817d-75af98fb2984" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4912bc38-fe04-4153-a768-e2a91476b9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c162efb7-cc5a-491c-9513-68556757d9e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c162efb7-cc5a-491c-9513-68556757d9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f2bdb2f3-9b4b-41c5-a702-9738e7badbb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f2bdb2f3-9b4b-41c5-a702-9738e7badbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c5cb438c-04b0-4cfe-bb53-8580faedcc53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c5cb438c-04b0-4cfe-bb53-8580faedcc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_20ca68f4-4e4e-4250-9b25-bc715c4b842e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_20ca68f4-4e4e-4250-9b25-bc715c4b842e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e0e61fb0-867e-41ec-b583-c04f8a6da465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e0e61fb0-867e-41ec-b583-c04f8a6da465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_157426cb-2315-4cc9-add5-17977d6fd647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_157426cb-2315-4cc9-add5-17977d6fd647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_36b598f6-52fa-42e9-a0ad-a742bc037102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_36b598f6-52fa-42e9-a0ad-a742bc037102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3cd1d58e-96b8-43f8-ac69-6a987bfe513a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cef78ed2-a637-45ee-8478-e5db806119de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3cd1d58e-96b8-43f8-ac69-6a987bfe513a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_9ae4264b-9528-47a2-b261-93afa191c24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_e5e84279-2003-497e-8dd9-8e7eec558c56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_9ae4264b-9528-47a2-b261-93afa191c24b" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_e5e84279-2003-497e-8dd9-8e7eec558c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e501d855-6ff9-44e7-afc7-d74fd993872a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_db587733-8961-486b-a4b6-2685c95df9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e501d855-6ff9-44e7-afc7-d74fd993872a" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_db587733-8961-486b-a4b6-2685c95df9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_f87a5e1b-78b3-459f-9b3c-65f020a93b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a927d22a-49e8-44f2-987e-a26b56ac76b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f87a5e1b-78b3-459f-9b3c-65f020a93b96" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a927d22a-49e8-44f2-987e-a26b56ac76b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_a5142d8e-a7d2-4621-93f1-76e95e75322d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f87a5e1b-78b3-459f-9b3c-65f020a93b96" xlink:to="loc_us-gaap_TaxesPayableCurrent_a5142d8e-a7d2-4621-93f1-76e95e75322d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_41af2e4e-ae5c-4f2d-a6fb-e0cb3afcd81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f87a5e1b-78b3-459f-9b3c-65f020a93b96" xlink:to="loc_us-gaap_LitigationReserveCurrent_41af2e4e-ae5c-4f2d-a6fb-e0cb3afcd81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RecoupmentsPayableAndReserveCurrent_0c60674f-2740-4211-8bd3-784937b4ba12" xlink:href="mygn-20201231.xsd#mygn_RecoupmentsPayableAndReserveCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f87a5e1b-78b3-459f-9b3c-65f020a93b96" xlink:to="loc_mygn_RecoupmentsPayableAndReserveCurrent_0c60674f-2740-4211-8bd3-784937b4ba12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_c07ecb67-4acc-4939-9d3f-539bb49ab734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f87a5e1b-78b3-459f-9b3c-65f020a93b96" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_c07ecb67-4acc-4939-9d3f-539bb49ab734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_15f6335d-0238-4a3c-9e77-81720ba9527d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f87a5e1b-78b3-459f-9b3c-65f020a93b96" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_15f6335d-0238-4a3c-9e77-81720ba9527d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a40a55a3-1783-43a4-93d9-e5706c59a013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f87a5e1b-78b3-459f-9b3c-65f020a93b96" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a40a55a3-1783-43a4-93d9-e5706c59a013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebt" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e283312e-e84a-403f-a46e-8bfad18b739b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_bec481c0-ad5c-4c24-8dc6-84200c210c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e283312e-e84a-403f-a46e-8bfad18b739b" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_bec481c0-ad5c-4c24-8dc6-84200c210c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dfd91c6d-555f-4887-87a1-63f025cbb2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_417e6977-5f1b-4dc8-ac33-6a38f4077182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dfd91c6d-555f-4887-87a1-63f025cbb2a3" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_417e6977-5f1b-4dc8-ac33-6a38f4077182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8c46647b-20bf-4ee0-9b2f-2406389713e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8c46647b-20bf-4ee0-9b2f-2406389713e9" xlink:to="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_19acff98-8875-4dc0-a922-7fbe8413f63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_us-gaap_CreditFacilityAxis_19acff98-8875-4dc0-a922-7fbe8413f63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e2f636a7-32f0-450f-8850-0edf97fba03a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_19acff98-8875-4dc0-a922-7fbe8413f63d" xlink:to="loc_us-gaap_CreditFacilityDomain_e2f636a7-32f0-450f-8850-0edf97fba03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_69bd7314-754c-4a43-8194-260a53c01eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e2f636a7-32f0-450f-8850-0edf97fba03a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_69bd7314-754c-4a43-8194-260a53c01eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ac148244-b928-42c7-bb4f-69dcdc8f468a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_us-gaap_DebtInstrumentAxis_ac148244-b928-42c7-bb4f-69dcdc8f468a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dda2a9ec-de72-4794-a5c4-c015301bdb62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ac148244-b928-42c7-bb4f-69dcdc8f468a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dda2a9ec-de72-4794-a5c4-c015301bdb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmendmentToCreditAgreementMember_e81680fc-f8cd-45a3-a9e9-73fe670d5ead" xlink:href="mygn-20201231.xsd#mygn_AmendmentToCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dda2a9ec-de72-4794-a5c4-c015301bdb62" xlink:to="loc_mygn_AmendmentToCreditAgreementMember_e81680fc-f8cd-45a3-a9e9-73fe670d5ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d6cdd874-7f87-421b-a387-fb650bed8315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_us-gaap_VariableRateAxis_d6cdd874-7f87-421b-a387-fb650bed8315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9eeeabe4-8d8c-4911-82b1-0d0224f17c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d6cdd874-7f87-421b-a387-fb650bed8315" xlink:to="loc_us-gaap_VariableRateDomain_9eeeabe4-8d8c-4911-82b1-0d0224f17c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_bef90d4e-6a09-40a5-9521-82d57b7457af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9eeeabe4-8d8c-4911-82b1-0d0224f17c62" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_bef90d4e-6a09-40a5-9521-82d57b7457af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f7686939-3385-4aed-b3cc-ef25517999df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_srt_StatementScenarioAxis_f7686939-3385-4aed-b3cc-ef25517999df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1ec32032-8ee1-42a4-94ed-6ecdc358bf2b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f7686939-3385-4aed-b3cc-ef25517999df" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1ec32032-8ee1-42a4-94ed-6ecdc358bf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_5e5696bc-9fec-4667-9459-03d840bc5b62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1ec32032-8ee1-42a4-94ed-6ecdc358bf2b" xlink:to="loc_srt_ScenarioForecastMember_5e5696bc-9fec-4667-9459-03d840bc5b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_86332c97-43cf-406e-8461-4d4279ee3df9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_srt_RangeAxis_86332c97-43cf-406e-8461-4d4279ee3df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0f848813-821d-47b3-b5d1-e5cd62d4f1ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_86332c97-43cf-406e-8461-4d4279ee3df9" xlink:to="loc_srt_RangeMember_0f848813-821d-47b3-b5d1-e5cd62d4f1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ee3bd5b9-91fa-4e13-b789-eed714c44aec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0f848813-821d-47b3-b5d1-e5cd62d4f1ad" xlink:to="loc_srt_MinimumMember_ee3bd5b9-91fa-4e13-b789-eed714c44aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_21260c1a-0a2b-46fa-8528-776cf67be868" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0f848813-821d-47b3-b5d1-e5cd62d4f1ad" xlink:to="loc_srt_MaximumMember_21260c1a-0a2b-46fa-8528-776cf67be868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26302d02-4ec2-4400-8599-eb7fd3c88d51" xlink:to="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_6f8ff035-5379-4997-9a0b-f0f2e2f598d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_6f8ff035-5379-4997-9a0b-f0f2e2f598d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eb7e2700-ac2c-4aaa-b03e-05491b6d3414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eb7e2700-ac2c-4aaa-b03e-05491b6d3414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1cebf537-973a-43a6-9ac7-f29a77921091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1cebf537-973a-43a6-9ac7-f29a77921091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_1211d911-5606-4ba7-99ec-e468a1b55327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_1211d911-5606-4ba7-99ec-e468a1b55327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_60638d10-4f9c-441d-9001-ad02a40bc283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_60638d10-4f9c-441d-9001-ad02a40bc283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_11fe1f3f-185e-4e1e-8167-46c7a85d4d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_11fe1f3f-185e-4e1e-8167-46c7a85d4d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0b3625f6-0acd-4d45-b18c-516cde72ff9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0b3625f6-0acd-4d45-b18c-516cde72ff9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b4d125da-c6a3-45b8-a490-0cc2643f4d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b4d125da-c6a3-45b8-a490-0cc2643f4d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtInstrumentLIBORFloorPercentage_8521545f-f403-4479-8859-2817a46d1011" xlink:href="mygn-20201231.xsd#mygn_DebtInstrumentLIBORFloorPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_mygn_DebtInstrumentLIBORFloorPercentage_8521545f-f403-4479-8859-2817a46d1011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_b50d658f-7c6b-4e15-b36c-28695ddf12b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_b50d658f-7c6b-4e15-b36c-28695ddf12b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_8766063d-a8bb-47f3-a4c4-d95f9e629556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779eb5ce-45bd-487e-9d02-b1785cb378cc" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_8766063d-a8bb-47f3-a4c4-d95f9e629556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b352554b-e256-4a5a-b9bb-72c103120981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_f6e3f6b3-d1d8-4d70-8111-99bf6c9d9ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b352554b-e256-4a5a-b9bb-72c103120981" xlink:to="loc_us-gaap_LongTermDebtAbstract_f6e3f6b3-d1d8-4d70-8111-99bf6c9d9ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9d13714e-00ef-4671-ac8f-18bfa9d6871e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_f6e3f6b3-d1d8-4d70-8111-99bf6c9d9ec4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_9d13714e-00ef-4671-ac8f-18bfa9d6871e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_3aba10b8-4b97-482d-bfed-8017ef191ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_f6e3f6b3-d1d8-4d70-8111-99bf6c9d9ec4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_3aba10b8-4b97-482d-bfed-8017ef191ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d0aed646-196a-4d2c-9fb3-174a368f98f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_f6e3f6b3-d1d8-4d70-8111-99bf6c9d9ec4" xlink:to="loc_us-gaap_LongTermDebt_d0aed646-196a-4d2c-9fb3-174a368f98f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilities"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_3341260e-4c9b-47e1-87ac-38bae54a8659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_39551114-fac7-4c97-b0d8-aeaee1211498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_3341260e-4c9b-47e1-87ac-38bae54a8659" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_39551114-fac7-4c97-b0d8-aeaee1211498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_f09f0d38-3de0-4e09-afed-7ee89e2627f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_a5deebeb-e323-4110-a598-b8abbdc7b145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_f09f0d38-3de0-4e09-afed-7ee89e2627f8" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_a5deebeb-e323-4110-a598-b8abbdc7b145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_239c5ffa-5348-49d7-beb2-a96ad2b68f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_ce629eb4-c3da-4905-97e7-3dac4e611006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_239c5ffa-5348-49d7-beb2-a96ad2b68f9c" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_ce629eb4-c3da-4905-97e7-3dac4e611006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_474ce494-9f96-40b0-a0b9-d2eda4b9efbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_239c5ffa-5348-49d7-beb2-a96ad2b68f9c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_474ce494-9f96-40b0-a0b9-d2eda4b9efbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_48a76cd2-5566-4775-bf1b-e9098512f90d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_239c5ffa-5348-49d7-beb2-a96ad2b68f9c" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_48a76cd2-5566-4775-bf1b-e9098512f90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2029d598-a074-4bda-b994-9c3b9a12e2f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_239c5ffa-5348-49d7-beb2-a96ad2b68f9c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2029d598-a074-4bda-b994-9c3b9a12e2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#OtherLongTermLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_beaca990-53c4-42a0-ae1e-9d7264eec002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NumberOfDefinedBenefitPensionPlans_ac751bc9-8e43-4c98-843b-99f8a67a3a08" xlink:href="mygn-20201231.xsd#mygn_NumberOfDefinedBenefitPensionPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_beaca990-53c4-42a0-ae1e-9d7264eec002" xlink:to="loc_mygn_NumberOfDefinedBenefitPensionPlans_ac751bc9-8e43-4c98-843b-99f8a67a3a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1328dc29-274e-4dea-b69b-f4a9affdf85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_beaca990-53c4-42a0-ae1e-9d7264eec002" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1328dc29-274e-4dea-b69b-f4a9affdf85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_e3d051f3-1c9e-446a-88a7-125f2d27189f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_beaca990-53c4-42a0-ae1e-9d7264eec002" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_e3d051f3-1c9e-446a-88a7-125f2d27189f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7ed52d69-7856-4969-ab4c-9b0dc7897eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ca8abfd5-2e13-456b-b9a0-9a9005e447da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7ed52d69-7856-4969-ab4c-9b0dc7897eb1" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ca8abfd5-2e13-456b-b9a0-9a9005e447da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b404706a-adcd-47b4-be45-1deb72e3c29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_7a4ff4f9-52a4-4975-8888-b089b25161e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b404706a-adcd-47b4-be45-1deb72e3c29f" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_7a4ff4f9-52a4-4975-8888-b089b25161e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock_8b497b51-c2de-4023-a2f4-462a2d1482d0" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b404706a-adcd-47b4-be45-1deb72e3c29f" xlink:to="loc_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock_8b497b51-c2de-4023-a2f4-462a2d1482d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f72ef352-a593-473c-906f-4ff072c7a98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f72ef352-a593-473c-906f-4ff072c7a98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6c07c6c7-2673-461e-a413-d790fa092d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6c07c6c7-2673-461e-a413-d790fa092d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_b15f7524-9ae4-461d-befc-8fbe43f46a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_b15f7524-9ae4-461d-befc-8fbe43f46a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_807a0e0d-bcc0-40c4-a355-6e6f9af09c4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_807a0e0d-bcc0-40c4-a355-6e6f9af09c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c5ca2bb3-1ddf-4383-802a-02d537c53841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c5ca2bb3-1ddf-4383-802a-02d537c53841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_011f47d1-e2fa-4000-a0aa-14a4f1780b60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_CommonStockSharesIssued_011f47d1-e2fa-4000-a0aa-14a4f1780b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ed6b3ac4-aaa9-4e8e-9e70-3c9d47f0f4fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ed6b3ac4-aaa9-4e8e-9e70-3c9d47f0f4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_97f54e05-ca5f-49e8-8e57-d86bb8b8671f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_97f54e05-ca5f-49e8-8e57-d86bb8b8671f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a81510f8-8aa0-4b95-9364-61cb854dc677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a81510f8-8aa0-4b95-9364-61cb854dc677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6f0416cc-9130-4a21-af40-f236193228e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99e6b03f-1253-4ff6-81d2-a6565006a04c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6f0416cc-9130-4a21-af40-f236193228e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_35e1d032-2966-4312-8b97-a09a4f2bdef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3eb1757f-b7f3-421c-b1ad-c2a5a88a48cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_35e1d032-2966-4312-8b97-a09a4f2bdef0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3eb1757f-b7f3-421c-b1ad-c2a5a88a48cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ea14c091-ed4e-46b1-9318-7524e546c51b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3eb1757f-b7f3-421c-b1ad-c2a5a88a48cf" xlink:to="loc_us-gaap_CommonStockSharesIssued_ea14c091-ed4e-46b1-9318-7524e546c51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a66b7177-82b4-4666-bc23-038c092b55cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3eb1757f-b7f3-421c-b1ad-c2a5a88a48cf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a66b7177-82b4-4666-bc23-038c092b55cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_e96fe2f0-3301-463f-a4cc-89d3f948c16f" xlink:href="mygn-20201231.xsd#mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3eb1757f-b7f3-421c-b1ad-c2a5a88a48cf" xlink:to="loc_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_e96fe2f0-3301-463f-a4cc-89d3f948c16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3c754098-6036-40b0-a27c-6119088afd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3eb1757f-b7f3-421c-b1ad-c2a5a88a48cf" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3c754098-6036-40b0-a27c-6119088afd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4851aec4-1454-4c8e-ba13-62b4863acf37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3eb1757f-b7f3-421c-b1ad-c2a5a88a48cf" xlink:to="loc_us-gaap_CommonStockSharesIssued_4851aec4-1454-4c8e-ba13-62b4863acf37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0f9d3085-0a58-4da1-a7e3-4f51ec8583bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3eb1757f-b7f3-421c-b1ad-c2a5a88a48cf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0f9d3085-0a58-4da1-a7e3-4f51ec8583bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#PreferredandCommonStockholdersEquityStockRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0ea4b07a-815f-4509-bb22-72bf03f81237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_762c7cb0-3adf-49a1-b4ea-da4b72c3eb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ea4b07a-815f-4509-bb22-72bf03f81237" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_762c7cb0-3adf-49a1-b4ea-da4b72c3eb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases_c32948a9-c267-4998-8477-2a19aea34605" xlink:href="mygn-20201231.xsd#mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ea4b07a-815f-4509-bb22-72bf03f81237" xlink:to="loc_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases_c32948a9-c267-4998-8477-2a19aea34605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases_b16b44c2-314d-4ca9-8511-d1896d5b755e" xlink:href="mygn-20201231.xsd#mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ea4b07a-815f-4509-bb22-72bf03f81237" xlink:to="loc_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases_b16b44c2-314d-4ca9-8511-d1896d5b755e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d61d9029-c279-427a-bb88-59d1ca644d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_326a8ad2-8adf-4e21-b7dd-1cfc9907647e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d61d9029-c279-427a-bb88-59d1ca644d6e" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_326a8ad2-8adf-4e21-b7dd-1cfc9907647e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_640f45bc-a116-4ad6-9b15-363ce04d4c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_640f45bc-a116-4ad6-9b15-363ce04d4c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6a604a58-d821-431f-b680-7430ada61420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6a604a58-d821-431f-b680-7430ada61420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_067f3a85-35a8-4596-8519-50b877ea82bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_067f3a85-35a8-4596-8519-50b877ea82bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_ccce002a-b719-4edf-b058-c4e0401d2620" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_ccce002a-b719-4edf-b058-c4e0401d2620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_fe57b6fd-be66-46c3-8e70-0345da964a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_fe57b6fd-be66-46c3-8e70-0345da964a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_eae5cbcb-7555-4748-bd5b-5cbae48055f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_eae5cbcb-7555-4748-bd5b-5cbae48055f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_b1d4c60c-69e1-4d34-a760-37a960222699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_b1d4c60c-69e1-4d34-a760-37a960222699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_19b16941-61b4-44d9-9d92-d44b6b03302e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_19b16941-61b4-44d9-9d92-d44b6b03302e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_a4003d94-cc68-4413-b640-4d937e02cc02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12022c57-803b-4581-bdee-b009a27b8fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_a4003d94-cc68-4413-b640-4d937e02cc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c466e63a-f681-4ffb-97d7-42afc51d7dbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c466e63a-f681-4ffb-97d7-42afc51d7dbd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5199a881-efde-49e1-948b-9c53748dcb49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_PlanNameAxis_5199a881-efde-49e1-948b-9c53748dcb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5199a881-efde-49e1-948b-9c53748dcb49" xlink:to="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember_bb3c0f61-65c0-4a87-be1d-65213d0b0524" xlink:href="mygn-20201231.xsd#mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:to="loc_mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember_bb3c0f61-65c0-4a87-be1d-65213d0b0524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_e9656570-cc1e-4fb0-88c2-dc18d11d9bbc" xlink:href="mygn-20201231.xsd#mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:to="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_e9656570-cc1e-4fb0-88c2-dc18d11d9bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_f466537d-2498-44bd-8fa2-00e0153f044e" xlink:href="mygn-20201231.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6ad8e751-cc08-4c62-8afd-07d47e0c3905" xlink:to="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_f466537d-2498-44bd-8fa2-00e0153f044e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6ba90a69-61a2-429d-8184-356f76061e69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_AwardTypeAxis_6ba90a69-61a2-429d-8184-356f76061e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2aa6a13e-1543-422c-b6b6-e2d70768e2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6ba90a69-61a2-429d-8184-356f76061e69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2aa6a13e-1543-422c-b6b6-e2d70768e2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsAndRestrictedStockUnitsMember_60e94dc5-cfa4-4419-94bc-64d8ebb25b95" xlink:href="mygn-20201231.xsd#mygn_OptionsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2aa6a13e-1543-422c-b6b6-e2d70768e2cf" xlink:to="loc_mygn_OptionsAndRestrictedStockUnitsMember_60e94dc5-cfa4-4419-94bc-64d8ebb25b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_63756b8c-76c6-42c8-96cc-0b0b3db4cd8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OptionsAndRestrictedStockUnitsMember_60e94dc5-cfa4-4419-94bc-64d8ebb25b95" xlink:to="loc_us-gaap_EmployeeStockOptionMember_63756b8c-76c6-42c8-96cc-0b0b3db4cd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a19e2560-46ff-4147-9e96-6c473d8c931c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_OptionsAndRestrictedStockUnitsMember_60e94dc5-cfa4-4419-94bc-64d8ebb25b95" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a19e2560-46ff-4147-9e96-6c473d8c931c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_8996b2a1-7940-40d9-a565-27ef95141324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2aa6a13e-1543-422c-b6b6-e2d70768e2cf" xlink:to="loc_us-gaap_PerformanceSharesMember_8996b2a1-7940-40d9-a565-27ef95141324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_4ed2639c-ea77-431c-a4c4-2c92a2e928bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_AwardDateAxis_4ed2639c-ea77-431c-a4c4-2c92a2e928bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_cd3ca425-8150-43e6-b658-7aefe11c489b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_4ed2639c-ea77-431c-a4c4-2c92a2e928bb" xlink:to="loc_us-gaap_AwardDateDomain_cd3ca425-8150-43e6-b658-7aefe11c489b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_7f39793d-5210-4036-976c-a76599746bf2" xlink:href="mygn-20201231.xsd#mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_cd3ca425-8150-43e6-b658-7aefe11c489b" xlink:to="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_7f39793d-5210-4036-976c-a76599746bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_c3d0920e-08f3-42f7-b499-53c4c9613890" xlink:href="mygn-20201231.xsd#mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_cd3ca425-8150-43e6-b658-7aefe11c489b" xlink:to="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_c3d0920e-08f3-42f7-b499-53c4c9613890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_90e893b2-2389-4017-af93-e7ad1dae915b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_srt_TitleOfIndividualAxis_90e893b2-2389-4017-af93-e7ad1dae915b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7db8fa66-47a4-4579-83c6-74fb0d572edc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_90e893b2-2389-4017-af93-e7ad1dae915b" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7db8fa66-47a4-4579-83c6-74fb0d572edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonEmployeeDirectorMember_768449db-0306-40c7-b7c1-c6274df85f7b" xlink:href="mygn-20201231.xsd#mygn_NonEmployeeDirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7db8fa66-47a4-4579-83c6-74fb0d572edc" xlink:to="loc_mygn_NonEmployeeDirectorMember_768449db-0306-40c7-b7c1-c6274df85f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_1a4c34e2-27c0-48cd-98c5-e406c2d35b38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7db8fa66-47a4-4579-83c6-74fb0d572edc" xlink:to="loc_srt_ChiefExecutiveOfficerMember_1a4c34e2-27c0-48cd-98c5-e406c2d35b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_3bdba423-865b-4663-8601-246ff4086003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_VestingAxis_3bdba423-865b-4663-8601-246ff4086003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ed12d752-a2da-474c-946b-909a19bee7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_3bdba423-865b-4663-8601-246ff4086003" xlink:to="loc_us-gaap_VestingDomain_ed12d752-a2da-474c-946b-909a19bee7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_e956bfff-704a-47c7-9b86-41f79161b736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_ed12d752-a2da-474c-946b-909a19bee7c2" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_e956bfff-704a-47c7-9b86-41f79161b736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_25fa44fb-50f4-41e1-ba83-cb2a20582086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_ed12d752-a2da-474c-946b-909a19bee7c2" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_25fa44fb-50f4-41e1-ba83-cb2a20582086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f8a2bc2-d206-401f-832c-90cc1a2e09e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7fba7030-de19-498f-93e6-4b074784c514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7fba7030-de19-498f-93e6-4b074784c514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7b457102-e1eb-4941-a0a6-5a737310e56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7b457102-e1eb-4941-a0a6-5a737310e56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4a3ccfce-445c-463f-8dd9-38071c5e5cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4a3ccfce-445c-463f-8dd9-38071c5e5cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3c3ba0bb-f781-4d55-ac7f-f80ce92d45e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3c3ba0bb-f781-4d55-ac7f-f80ce92d45e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b47803f6-b9c3-41a2-ad4d-f37b5ec195d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b47803f6-b9c3-41a2-ad4d-f37b5ec195d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice_f4abe7d1-e98d-4114-a613-63edaacbc9ef" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice_f4abe7d1-e98d-4114-a613-63edaacbc9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_133c4b24-db4f-4575-94ef-2a083a97c64f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_133c4b24-db4f-4575-94ef-2a083a97c64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_6230deb2-7d0d-4d0e-85c8-f50eba679b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_6230deb2-7d0d-4d0e-85c8-f50eba679b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8a8844f1-3693-4c4c-9798-145fe5d52072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8a8844f1-3693-4c4c-9798-145fe5d52072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_45edb994-f3e8-4c1a-bc72-c7f30ea56cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_45edb994-f3e8-4c1a-bc72-c7f30ea56cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4b2fdc8b-b0cd-4674-b90a-88fb1792d466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4b2fdc8b-b0cd-4674-b90a-88fb1792d466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_72378bef-f845-42e0-b95e-189eae81ca28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_72378bef-f845-42e0-b95e-189eae81ca28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_03e6c175-6cb5-4391-bd2e-a29af99f6d73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0cc05efa-12eb-4337-9e85-9e7018cf6924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_03e6c175-6cb5-4391-bd2e-a29af99f6d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2340a040-3186-4555-afbb-02a470756faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77e47b34-cc8e-4a8c-897d-b1f1eb55e80d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2340a040-3186-4555-afbb-02a470756faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77e47b34-cc8e-4a8c-897d-b1f1eb55e80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5ac75ba-9792-45b7-9b79-c87607495b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77e47b34-cc8e-4a8c-897d-b1f1eb55e80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5ac75ba-9792-45b7-9b79-c87607495b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_086c94c6-48a8-422e-b75d-78fc95b0ee48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77e47b34-cc8e-4a8c-897d-b1f1eb55e80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_086c94c6-48a8-422e-b75d-78fc95b0ee48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fb23a74c-7a78-4895-bdbd-04e33fed29b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77e47b34-cc8e-4a8c-897d-b1f1eb55e80d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fb23a74c-7a78-4895-bdbd-04e33fed29b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_71ff1f59-f729-4ae8-81d6-ebe35d6c0616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77e47b34-cc8e-4a8c-897d-b1f1eb55e80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_71ff1f59-f729-4ae8-81d6-ebe35d6c0616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0b018c68-9661-4c29-86a4-642c4179af09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77e47b34-cc8e-4a8c-897d-b1f1eb55e80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0b018c68-9661-4c29-86a4-642c4179af09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_29f203e9-e1ff-4914-951b-ec0f42c9e490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2340a040-3186-4555-afbb-02a470756faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_29f203e9-e1ff-4914-951b-ec0f42c9e490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_499b3fcb-7525-4392-be59-abff600dde1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2340a040-3186-4555-afbb-02a470756faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_499b3fcb-7525-4392-be59-abff600dde1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5841cf66-bea7-485e-9da4-8d7c7d3c503d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2340a040-3186-4555-afbb-02a470756faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5841cf66-bea7-485e-9da4-8d7c7d3c503d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ceb8462c-cf7e-480f-886c-bb65e42ec136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5841cf66-bea7-485e-9da4-8d7c7d3c503d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ceb8462c-cf7e-480f-886c-bb65e42ec136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1af70c01-ea4a-4989-a22b-1ecb55365971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5841cf66-bea7-485e-9da4-8d7c7d3c503d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1af70c01-ea4a-4989-a22b-1ecb55365971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_52891560-db15-4c7d-86cf-9fbe74385f7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5841cf66-bea7-485e-9da4-8d7c7d3c503d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_52891560-db15-4c7d-86cf-9fbe74385f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ba3f9874-c531-439a-8b75-5f05d62378de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5841cf66-bea7-485e-9da4-8d7c7d3c503d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ba3f9874-c531-439a-8b75-5f05d62378de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd85a663-5528-4491-a7c9-e3749c5a585b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5841cf66-bea7-485e-9da4-8d7c7d3c503d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd85a663-5528-4491-a7c9-e3749c5a585b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_41a727a2-16ba-4b00-a9a9-fdbb064e3fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2340a040-3186-4555-afbb-02a470756faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_41a727a2-16ba-4b00-a9a9-fdbb064e3fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2094dc27-bb52-4268-b428-9c8827780610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2340a040-3186-4555-afbb-02a470756faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2094dc27-bb52-4268-b428-9c8827780610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a723abf-b41b-41d1-a26f-b34314b034b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_141b6ea8-501b-4ba3-8920-b2c6eddfaec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a723abf-b41b-41d1-a26f-b34314b034b3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_141b6ea8-501b-4ba3-8920-b2c6eddfaec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b833c2a6-1aeb-4c6e-a671-e6236535d5bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_141b6ea8-501b-4ba3-8920-b2c6eddfaec3" xlink:to="loc_us-gaap_AwardTypeAxis_b833c2a6-1aeb-4c6e-a671-e6236535d5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf37be84-1f17-4443-808c-fc83fedd4462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b833c2a6-1aeb-4c6e-a671-e6236535d5bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf37be84-1f17-4443-808c-fc83fedd4462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bb6d2261-7fcd-41af-98ce-f1cf1140d22e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf37be84-1f17-4443-808c-fc83fedd4462" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bb6d2261-7fcd-41af-98ce-f1cf1140d22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51bfcab1-d0ae-4250-a9ab-5bd1fe2d4685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_141b6ea8-501b-4ba3-8920-b2c6eddfaec3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51bfcab1-d0ae-4250-a9ab-5bd1fe2d4685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51bfcab1-d0ae-4250-a9ab-5bd1fe2d4685" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f7d00387-2d12-4242-add1-0ba4af99ec13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f7d00387-2d12-4242-add1-0ba4af99ec13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_9731db43-353a-448a-ab74-3b8f43d9b5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_9731db43-353a-448a-ab74-3b8f43d9b5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_596d9191-48ea-4868-95c8-062d3fa1d49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_596d9191-48ea-4868-95c8-062d3fa1d49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_addeb37f-e5ea-462b-9d60-0082df0bbb55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_addeb37f-e5ea-462b-9d60-0082df0bbb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum_eb56e3ec-f519-4527-a9a4-1537e70669c2" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum_eb56e3ec-f519-4527-a9a4-1537e70669c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum_f4ce738e-868d-4967-814f-b2afb7d26318" xlink:href="mygn-20201231.xsd#mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum_f4ce738e-868d-4967-814f-b2afb7d26318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_ad983c07-ea81-4161-9c8e-250444dcd6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_ad983c07-ea81-4161-9c8e-250444dcd6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f7fb9609-d7ce-4eb9-a6f3-2de10a9a8a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_f31788e2-0913-41a6-8bc2-df4c82f9019e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f7fb9609-d7ce-4eb9-a6f3-2de10a9a8a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationStockOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dcd81f58-b31c-4018-92c5-d7a9aa74ba44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_dfaf7fa3-8c46-4da0-9448-6ec27ea03afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dcd81f58-b31c-4018-92c5-d7a9aa74ba44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_dfaf7fa3-8c46-4da0-9448-6ec27ea03afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_adc86254-d7d7-4f1f-bd7f-8e112b184e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_dfaf7fa3-8c46-4da0-9448-6ec27ea03afc" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_adc86254-d7d7-4f1f-bd7f-8e112b184e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_adc86254-d7d7-4f1f-bd7f-8e112b184e61" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeOneMember_500847bf-25e9-467f-b3d4-4462795baef8" xlink:href="mygn-20201231.xsd#mygn_RangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:to="loc_mygn_RangeOneMember_500847bf-25e9-467f-b3d4-4462795baef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeTwoMember_de7f3294-18fb-4aeb-815e-2f9d8a64a4ad" xlink:href="mygn-20201231.xsd#mygn_RangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:to="loc_mygn_RangeTwoMember_de7f3294-18fb-4aeb-815e-2f9d8a64a4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeThreeMember_4b79ea21-ef5e-4c1d-8244-abfc04bdd53d" xlink:href="mygn-20201231.xsd#mygn_RangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:to="loc_mygn_RangeThreeMember_4b79ea21-ef5e-4c1d-8244-abfc04bdd53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_RangeFourMember_cbf27f58-6b73-45f8-a263-d095089434e1" xlink:href="mygn-20201231.xsd#mygn_RangeFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_bc59e5ec-ec05-4e60-a9b2-168fbe2f224e" xlink:to="loc_mygn_RangeFourMember_cbf27f58-6b73-45f8-a263-d095089434e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_dfaf7fa3-8c46-4da0-9448-6ec27ea03afc" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c8cadd17-f8b5-4878-8ecc-0a78af4ef2e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c8cadd17-f8b5-4878-8ecc-0a78af4ef2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a0c9bd01-f411-43d8-bc9a-631801fd2e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a0c9bd01-f411-43d8-bc9a-631801fd2e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_516bb92a-3b3a-46ce-9eef-2cc8a074e6f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_516bb92a-3b3a-46ce-9eef-2cc8a074e6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_db10a6b0-9fbd-4f20-8a86-317bd8b435dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_db10a6b0-9fbd-4f20-8a86-317bd8b435dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_885995cf-f514-445b-8f1b-981d82beb26f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_441a1847-5dfe-4bd6-a716-917022ebc052" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_885995cf-f514-445b-8f1b-981d82beb26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40a92a9a-659f-4ac3-87a4-aea0f9fd71cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_542b1b78-2188-4872-ba4c-ede59f9ffa20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40a92a9a-659f-4ac3-87a4-aea0f9fd71cd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_542b1b78-2188-4872-ba4c-ede59f9ffa20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_75c4e113-66e1-47d6-870a-c1eefdbd6890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_542b1b78-2188-4872-ba4c-ede59f9ffa20" xlink:to="loc_us-gaap_AwardTypeAxis_75c4e113-66e1-47d6-870a-c1eefdbd6890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abf7eb51-3ba7-4ba9-a4cf-cc9bf56d72ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_75c4e113-66e1-47d6-870a-c1eefdbd6890" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abf7eb51-3ba7-4ba9-a4cf-cc9bf56d72ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5cfc9199-663b-4eb9-bd5b-ed96e6288ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abf7eb51-3ba7-4ba9-a4cf-cc9bf56d72ff" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5cfc9199-663b-4eb9-bd5b-ed96e6288ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70deade6-4432-464d-9214-a517a92b9eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_542b1b78-2188-4872-ba4c-ede59f9ffa20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70deade6-4432-464d-9214-a517a92b9eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70deade6-4432-464d-9214-a517a92b9eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_88c8a821-a21d-4f79-982f-1fd0f6f77186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_88c8a821-a21d-4f79-982f-1fd0f6f77186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34f268c3-9536-431e-9748-2d0212a15587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34f268c3-9536-431e-9748-2d0212a15587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_504b94a8-dbcf-4cc0-9f10-6b0c95da02ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_504b94a8-dbcf-4cc0-9f10-6b0c95da02ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1cdb87cc-5375-4395-89ae-939fadfb7cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1cdb87cc-5375-4395-89ae-939fadfb7cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a92ae2be-e820-47bd-9292-150de6c07ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04cdc1a6-2710-4a64-aa91-02e04425e941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a92ae2be-e820-47bd-9292-150de6c07ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_70deade6-4432-464d-9214-a517a92b9eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_024613b8-8d9d-4517-8dc4-7bffc010adb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_024613b8-8d9d-4517-8dc4-7bffc010adb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_630bda48-d0bb-4303-a1b2-98e4d8f2f703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_630bda48-d0bb-4303-a1b2-98e4d8f2f703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e5405284-3539-4d6f-8a9d-48ffaeffe6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e5405284-3539-4d6f-8a9d-48ffaeffe6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d568c918-b381-4e2b-b521-db50045db88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d568c918-b381-4e2b-b521-db50045db88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_76b59746-1cfc-4080-ac6b-7bb76ac8679e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77f46117-35dd-4953-ad78-1528c3bcae3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_76b59746-1cfc-4080-ac6b-7bb76ac8679e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b9cdd44-9197-4463-bdc5-e1a5163c3383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_29e31768-7e92-4a0a-a1d7-09fc7f6673e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b9cdd44-9197-4463-bdc5-e1a5163c3383" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_29e31768-7e92-4a0a-a1d7-09fc7f6673e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_68e83d20-dc07-4d7c-a5c8-36ede6f2631c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_29e31768-7e92-4a0a-a1d7-09fc7f6673e4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_68e83d20-dc07-4d7c-a5c8-36ede6f2631c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_68e83d20-dc07-4d7c-a5c8-36ede6f2631c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfMolecularDiagnosticTestingMember_011000ae-9ef7-4c49-8bea-ceea13ee2b3d" xlink:href="mygn-20201231.xsd#mygn_CostOfMolecularDiagnosticTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:to="loc_mygn_CostOfMolecularDiagnosticTestingMember_011000ae-9ef7-4c49-8bea-ceea13ee2b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember_85dc41c0-c18e-48a8-9fa7-43a0ceca68d0" xlink:href="mygn-20201231.xsd#mygn_CostOfPharmaceuticalAndClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:to="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember_85dc41c0-c18e-48a8-9fa7-43a0ceca68d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2391501d-864f-4df1-9463-a667ab25b162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2391501d-864f-4df1-9463-a667ab25b162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d2b5effc-0b82-4cd3-8783-cbe99a637aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e416c50c-dbe6-4018-893e-ec170ad76eff" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d2b5effc-0b82-4cd3-8783-cbe99a637aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_531c0417-e77c-4074-abc3-7bcdf28f3c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_29e31768-7e92-4a0a-a1d7-09fc7f6673e4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_531c0417-e77c-4074-abc3-7bcdf28f3c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7d01b6f4-c8eb-40e7-8d9c-ce390660620a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_531c0417-e77c-4074-abc3-7bcdf28f3c45" xlink:to="loc_us-gaap_ShareBasedCompensation_7d01b6f4-c8eb-40e7-8d9c-ce390660620a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dab40646-fc16-4389-8a71-a805ee15b89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e905d3a-bb39-4dab-8674-f0b30382fe3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dab40646-fc16-4389-8a71-a805ee15b89a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e905d3a-bb39-4dab-8674-f0b30382fe3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e905d3a-bb39-4dab-8674-f0b30382fe3f" xlink:to="loc_us-gaap_AwardTypeAxis_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf556339-7773-46f7-8c40-b3effddd6823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ac042b36-9a4e-4e4e-b3f1-e23ea0fb680e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf556339-7773-46f7-8c40-b3effddd6823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ebf6e8a8-da2d-4fbc-a418-a663672fc923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf556339-7773-46f7-8c40-b3effddd6823" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ebf6e8a8-da2d-4fbc-a418-a663672fc923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e905d3a-bb39-4dab-8674-f0b30382fe3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_342a7e55-c8f4-4f05-9361-37008190bad2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_342a7e55-c8f4-4f05-9361-37008190bad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5d303bc1-59e6-4088-80f5-8d4cb52568d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5d303bc1-59e6-4088-80f5-8d4cb52568d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_05193dc8-da26-4fb4-96c9-74428436c599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_05193dc8-da26-4fb4-96c9-74428436c599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_ba190904-9fec-4b61-adaa-bdd0d180a5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8018d5-81cb-4791-8cbf-909f4fbe747e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_ba190904-9fec-4b61-adaa-bdd0d180a5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11b7a010-bac0-4433-a337-18c2bdea2993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_7c1470cb-9283-4870-a426-5d2ee84d2504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11b7a010-bac0-4433-a337-18c2bdea2993" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_7c1470cb-9283-4870-a426-5d2ee84d2504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7121f05-07d9-498f-befa-8d895e1a0536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06bb8575-8863-4894-b211-b9e5cb62b1f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7121f05-07d9-498f-befa-8d895e1a0536" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06bb8575-8863-4894-b211-b9e5cb62b1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06bb8575-8863-4894-b211-b9e5cb62b1f6" xlink:to="loc_us-gaap_PlanNameAxis_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1ad9d8d1-8c51-487a-8f0e-09ecc6995bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4e1ce8ca-6fa2-44aa-9390-e1a905192fbd" xlink:to="loc_us-gaap_PlanNameDomain_1ad9d8d1-8c51-487a-8f0e-09ecc6995bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_e76c2bac-897a-43b6-9641-690aaf1fc4fc" xlink:href="mygn-20201231.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1ad9d8d1-8c51-487a-8f0e-09ecc6995bcd" xlink:to="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_e76c2bac-897a-43b6-9641-690aaf1fc4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e868023-7c8c-4e56-9d59-e3dfcc4d0670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06bb8575-8863-4894-b211-b9e5cb62b1f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e868023-7c8c-4e56-9d59-e3dfcc4d0670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_9a24d1fa-c233-4b94-9869-53e4579c0ea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e868023-7c8c-4e56-9d59-e3dfcc4d0670" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_9a24d1fa-c233-4b94-9869-53e4579c0ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_844b87c2-c4fd-4f3a-9130-defc04ec305d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e868023-7c8c-4e56-9d59-e3dfcc4d0670" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_844b87c2-c4fd-4f3a-9130-defc04ec305d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#ShareBasedCompensationValuationAssumptionsforESPPDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6971af19-504f-4a1a-81e2-921ba617bde9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71768e4c-9ee1-4e44-9160-568e03dabe45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6971af19-504f-4a1a-81e2-921ba617bde9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71768e4c-9ee1-4e44-9160-568e03dabe45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_876499f1-47f6-4dfc-8a08-62d7c1d75917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71768e4c-9ee1-4e44-9160-568e03dabe45" xlink:to="loc_us-gaap_PlanNameAxis_876499f1-47f6-4dfc-8a08-62d7c1d75917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2b5a82ec-e30a-40ca-a529-cc6ee093a780" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_876499f1-47f6-4dfc-8a08-62d7c1d75917" xlink:to="loc_us-gaap_PlanNameDomain_2b5a82ec-e30a-40ca-a529-cc6ee093a780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_c0df1444-c270-4ff0-a120-41a7695bdfbd" xlink:href="mygn-20201231.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_2b5a82ec-e30a-40ca-a529-cc6ee093a780" xlink:to="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_c0df1444-c270-4ff0-a120-41a7695bdfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5561b7bf-25fa-4a54-a7df-f63badfc4c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71768e4c-9ee1-4e44-9160-568e03dabe45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5561b7bf-25fa-4a54-a7df-f63badfc4c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5561b7bf-25fa-4a54-a7df-f63badfc4c63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7da2193d-b9e3-4d73-8467-507e57467997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7da2193d-b9e3-4d73-8467-507e57467997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e767558a-d35a-4367-91e2-dc5561d317b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e767558a-d35a-4367-91e2-dc5561d317b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_45469a17-d007-4485-84b7-ec1bfea76d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_45469a17-d007-4485-84b7-ec1bfea76d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c0e91932-26b4-4f1a-8603-6a81f60c94c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1a1600c3-a7b8-41d4-8921-897d33f51f9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c0e91932-26b4-4f1a-8603-6a81f60c94c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_13d774c7-2603-40c2-b471-9ac749df4e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ba79e2e3-d5bf-4309-8274-83d8e36caec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_13d774c7-2603-40c2-b471-9ac749df4e5a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ba79e2e3-d5bf-4309-8274-83d8e36caec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_33bea7e4-df68-4862-bee6-87364f8383e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d201460b-8cc2-455b-804c-49269bc09419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33bea7e4-df68-4862-bee6-87364f8383e7" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d201460b-8cc2-455b-804c-49269bc09419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_4ba3f639-d8c7-41b7-8ea5-cf6a30c04970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33bea7e4-df68-4862-bee6-87364f8383e7" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_4ba3f639-d8c7-41b7-8ea5-cf6a30c04970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9f7c7b14-2310-496c-830f-3df482c5f206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33bea7e4-df68-4862-bee6-87364f8383e7" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9f7c7b14-2310-496c-830f-3df482c5f206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a5ae2f9b-0470-4cef-aefa-93fc2a799288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33bea7e4-df68-4862-bee6-87364f8383e7" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a5ae2f9b-0470-4cef-aefa-93fc2a799288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_f6bcf5a7-75d4-4b95-8abd-62541f7c2bce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33bea7e4-df68-4862-bee6-87364f8383e7" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_f6bcf5a7-75d4-4b95-8abd-62541f7c2bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_486e56d6-c0de-49b4-88e6-cda7ea9fba19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33bea7e4-df68-4862-bee6-87364f8383e7" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_486e56d6-c0de-49b4-88e6-cda7ea9fba19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesIncomeTaxBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f6508b42-622c-4ceb-8cd0-c12170d8ba87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b069c71b-5eed-4418-b7b5-ec5035c1ea0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f6508b42-622c-4ceb-8cd0-c12170d8ba87" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b069c71b-5eed-4418-b7b5-ec5035c1ea0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_83385591-b5ed-4039-b817-b2709273a9b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b069c71b-5eed-4418-b7b5-ec5035c1ea0d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_83385591-b5ed-4039-b817-b2709273a9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_89e383fc-b25e-45ed-a89e-3920b4331c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b069c71b-5eed-4418-b7b5-ec5035c1ea0d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_89e383fc-b25e-45ed-a89e-3920b4331c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_da41055f-f2df-4bb8-b6d2-c1004c860de9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b069c71b-5eed-4418-b7b5-ec5035c1ea0d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_da41055f-f2df-4bb8-b6d2-c1004c860de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4f4c2d23-1c9f-433f-8b7b-05784052f11f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b069c71b-5eed-4418-b7b5-ec5035c1ea0d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4f4c2d23-1c9f-433f-8b7b-05784052f11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bce5b782-0d0f-45ac-aa40-c2b000e04513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f6508b42-622c-4ceb-8cd0-c12170d8ba87" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bce5b782-0d0f-45ac-aa40-c2b000e04513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_dd677d9d-632c-4ad8-ae47-6ce00b4d2896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bce5b782-0d0f-45ac-aa40-c2b000e04513" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_dd677d9d-632c-4ad8-ae47-6ce00b4d2896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d8a28bc6-c5e9-49bf-9ed5-c1d483778397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bce5b782-0d0f-45ac-aa40-c2b000e04513" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d8a28bc6-c5e9-49bf-9ed5-c1d483778397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c4d94731-2981-45bc-80d3-653761c1d15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bce5b782-0d0f-45ac-aa40-c2b000e04513" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c4d94731-2981-45bc-80d3-653761c1d15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_280b6c43-32db-4b82-9950-3bd256cceb56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bce5b782-0d0f-45ac-aa40-c2b000e04513" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_280b6c43-32db-4b82-9950-3bd256cceb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_837b3f47-e3e8-4469-9321-5c3f3769f29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bce5b782-0d0f-45ac-aa40-c2b000e04513" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_837b3f47-e3e8-4469-9321-5c3f3769f29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c84a0fb6-1f73-4ac3-9410-657703784f8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f6508b42-622c-4ceb-8cd0-c12170d8ba87" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c84a0fb6-1f73-4ac3-9410-657703784f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1712ee57-3e1d-4525-812a-c6ff56c2b7a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_d0d5f3a8-a927-4b35-a5c2-c62ec2ee2e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1712ee57-3e1d-4525-812a-c6ff56c2b7a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_d0d5f3a8-a927-4b35-a5c2-c62ec2ee2e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ce1ed6b8-85e9-4244-868b-7d8b7b29d78c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_d0d5f3a8-a927-4b35-a5c2-c62ec2ee2e37" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ce1ed6b8-85e9-4244-868b-7d8b7b29d78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8cfe4295-5839-48e2-890f-1463c39b608a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_d0d5f3a8-a927-4b35-a5c2-c62ec2ee2e37" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8cfe4295-5839-48e2-890f-1463c39b608a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a65aeab1-a147-4f8a-a28e-909f82f59b60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_d0d5f3a8-a927-4b35-a5c2-c62ec2ee2e37" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a65aeab1-a147-4f8a-a28e-909f82f59b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d82fd1b8-c4b4-4217-9955-b79157ee8638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d82fd1b8-c4b4-4217-9955-b79157ee8638" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_f58f1fd5-3b72-4177-b42c-6fa4a3f4763d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_f58f1fd5-3b72-4177-b42c-6fa4a3f4763d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_4502bc93-4869-4da6-b92c-e5e00ae50e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_4502bc93-4869-4da6-b92c-e5e00ae50e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_cd574a9f-b5dc-490e-b05c-61be6eaa4fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_cd574a9f-b5dc-490e-b05c-61be6eaa4fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_5685901a-8bb5-42ea-9d19-71233f95a4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_5685901a-8bb5-42ea-9d19-71233f95a4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationStatuteExpiration_78d0498c-3d70-4388-9443-303dae356efe" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationStatuteExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationStatuteExpiration_78d0498c-3d70-4388-9443-303dae356efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_b6f0ce36-8f6c-4214-919b-e70572be7f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_b6f0ce36-8f6c-4214-919b-e70572be7f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0647f3b6-8c0e-4237-8bb8-48be615d9a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0647f3b6-8c0e-4237-8bb8-48be615d9a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ca4c4a09-8573-427e-bc1a-6f3f7bb0c166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ca4c4a09-8573-427e-bc1a-6f3f7bb0c166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact_624d33f0-b91c-4565-9668-260fcc0968a8" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact_624d33f0-b91c-4565-9668-260fcc0968a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationCARESAct_73e131e4-30e8-43cd-a97c-23638490b1e5" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationCARESAct"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationCARESAct_73e131e4-30e8-43cd-a97c-23638490b1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_d393709e-b2bd-4407-b686-d391d75142a4" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_d393709e-b2bd-4407-b686-d391d75142a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_0e5949bf-33da-48c1-a89f-1aeeed49c4fb" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_0e5949bf-33da-48c1-a89f-1aeeed49c4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_ac9eafa9-4931-40f9-8e34-1d6b1c230217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_ac9eafa9-4931-40f9-8e34-1d6b1c230217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation_f37f649b-8381-4049-8da1-976cc378af1a" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation_f37f649b-8381-4049-8da1-976cc378af1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationAssetImpairment_d5ed1cd5-5593-429c-b148-96203e98fa86" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationAssetImpairment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationAssetImpairment_d5ed1cd5-5593-429c-b148-96203e98fa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationExpiredTaxAttributes_0f5e005b-4104-4191-af45-d8bcf3555738" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationExpiredTaxAttributes"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationExpiredTaxAttributes_0f5e005b-4104-4191-af45-d8bcf3555738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement_a711ae73-de2a-4d3e-b614-fae143bd83fc" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement_a711ae73-de2a-4d3e-b614-fae143bd83fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationForeignDisregardedElection_e3aefb75-5e08-4ee2-9192-29d8675c0d5d" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationForeignDisregardedElection"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationForeignDisregardedElection_e3aefb75-5e08-4ee2-9192-29d8675c0d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod_cc29be58-7c4b-49a9-817d-aaf1cdcccb02" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod_cc29be58-7c4b-49a9-817d-aaf1cdcccb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f6a47405-e685-4f1e-aed5-cb5296f1a81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f6a47405-e685-4f1e-aed5-cb5296f1a81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f6714faf-1bf0-4587-9e1f-678609b697b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_2c7a590f-71a7-43b6-b47c-211e33fe9564" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f6714faf-1bf0-4587-9e1f-678609b697b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d82fd1b8-c4b4-4217-9955-b79157ee8638" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cc24d427-7454-4b9d-8f32-bd57a5eda0dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cc24d427-7454-4b9d-8f32-bd57a5eda0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_89bc1878-7c05-4ef7-9ac4-198aa7c2147b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_89bc1878-7c05-4ef7-9ac4-198aa7c2147b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_680a0dcf-7e23-4bb7-9630-d80624b7a6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_680a0dcf-7e23-4bb7-9630-d80624b7a6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_c93f9676-1121-489b-8b05-b19f54cc18ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_c93f9676-1121-489b-8b05-b19f54cc18ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations_4dce1c42-d664-47de-8e03-84a38aa7e530" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations_4dce1c42-d664-47de-8e03-84a38aa7e530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_07774813-2e2b-482b-87f8-42812ef042e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_07774813-2e2b-482b-87f8-42812ef042e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_35665348-807d-422a-bfb5-938abe3004f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_35665348-807d-422a-bfb5-938abe3004f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_9fc521d6-90a7-4215-8950-a208067f2b80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_9fc521d6-90a7-4215-8950-a208067f2b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact_e6ea22b0-7143-4021-aa42-a28343aae0d4" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact_e6ea22b0-7143-4021-aa42-a28343aae0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationCARESAct_c8a4b53b-2971-4799-9aab-662ab970fec5" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationCARESAct"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationCARESAct_c8a4b53b-2971-4799-9aab-662ab970fec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_09ada62b-e6d3-41cd-ab94-7070d82d11f1" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration_09ada62b-e6d3-41cd-ab94-7070d82d11f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_69c357be-2ed9-44b1-850d-8c55b58a9083" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts_69c357be-2ed9-44b1-850d-8c55b58a9083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_765d911f-e91e-4f31-a20f-aebdddbcd817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_765d911f-e91e-4f31-a20f-aebdddbcd817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation_1a9b9b9a-3b40-482c-b2ea-4b9e40095c53" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation_1a9b9b9a-3b40-482c-b2ea-4b9e40095c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment_7e44104f-bc1c-4b5d-a9cc-2282589f99bd" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment_7e44104f-bc1c-4b5d-a9cc-2282589f99bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes_e82f158d-67ff-42f5-941d-7bfabfa5108d" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes_e82f158d-67ff-42f5-941d-7bfabfa5108d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements_e5514957-0e58-4d55-9fb5-f6ff223c01ca" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements_e5514957-0e58-4d55-9fb5-f6ff223c01ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection_a31d82b9-39d7-4302-9fd9-f976f1e94b58" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection_a31d82b9-39d7-4302-9fd9-f976f1e94b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod_7476a684-9f9e-4fdd-b0bb-8e21a90cc062" xlink:href="mygn-20201231.xsd#mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod_7476a684-9f9e-4fdd-b0bb-8e21a90cc062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_37a2210b-6973-41a6-ba73-65fb4af8f51e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_37a2210b-6973-41a6-ba73-65fb4af8f51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5e1f8482-f4f2-48d2-a345-c37b4de9f762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bfc05a45-1f50-47a5-88d3-9c46b047af7e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5e1f8482-f4f2-48d2-a345-c37b4de9f762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b263f8b6-c7c1-465e-a784-b79cf6881bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b263f8b6-c7c1-465e-a784-b79cf6881bd3" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a35a2f09-0b7e-459e-a118-f58dabe77b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a35a2f09-0b7e-459e-a118-f58dabe77b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_6e8301e6-3df9-4e41-a777-55501ba0c4be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_6e8301e6-3df9-4e41-a777-55501ba0c4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_b09e6a0e-6bd2-4fac-add8-dfbdf898321b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_b09e6a0e-6bd2-4fac-add8-dfbdf898321b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f5830230-734b-40bb-a840-973127920d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f5830230-734b-40bb-a840-973127920d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_19001ce7-1221-4279-8562-e78fd63a3217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_19001ce7-1221-4279-8562-e78fd63a3217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_8d917e39-0405-4797-b927-ba8bd6e0043f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_8d917e39-0405-4797-b927-ba8bd6e0043f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxAssetsLeaseRightOfUseAsset_b68e71a1-d6d5-41bd-8dbf-8f233d148137" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxAssetsLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_mygn_DeferredTaxAssetsLeaseRightOfUseAsset_b68e71a1-d6d5-41bd-8dbf-8f233d148137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxAssetsUncertainStateTaxPositions_5a16ac63-8364-4559-8640-5d59d21d6837" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxAssetsUncertainStateTaxPositions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_mygn_DeferredTaxAssetsUncertainStateTaxPositions_5a16ac63-8364-4559-8640-5d59d21d6837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_35ed8219-a19a-4928-93b8-2b255524e5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_35ed8219-a19a-4928-93b8-2b255524e5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d390aeef-ad18-49d1-86d9-d93fac5a69a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d390aeef-ad18-49d1-86d9-d93fac5a69a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f3604c79-1e30-4977-af9d-11f613b9c2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f3604c79-1e30-4977-af9d-11f613b9c2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_5399cee7-52d6-4850-add4-fb25d2265d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c12da1d9-b2d7-4590-86ab-d86cba84fd17" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_5399cee7-52d6-4850-add4-fb25d2265d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a6093f3a-79e1-4c78-a9d1-15497beea510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b263f8b6-c7c1-465e-a784-b79cf6881bd3" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a6093f3a-79e1-4c78-a9d1-15497beea510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_8180fdfa-e893-4a9a-b30a-bd94d6be2e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a6093f3a-79e1-4c78-a9d1-15497beea510" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_8180fdfa-e893-4a9a-b30a-bd94d6be2e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DeferredTaxLeaseLiability_4eb107d2-0652-4f07-a5d3-b5ae21dffb64" xlink:href="mygn-20201231.xsd#mygn_DeferredTaxLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a6093f3a-79e1-4c78-a9d1-15497beea510" xlink:to="loc_mygn_DeferredTaxLeaseLiability_4eb107d2-0652-4f07-a5d3-b5ae21dffb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_12ce1fcb-49e1-44ef-ac64-a74ad8d14c80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a6093f3a-79e1-4c78-a9d1-15497beea510" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_12ce1fcb-49e1-44ef-ac64-a74ad8d14c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_18448004-4142-487f-8496-e2d639479021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a6093f3a-79e1-4c78-a9d1-15497beea510" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_18448004-4142-487f-8496-e2d639479021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a9c4499c-f72c-49d0-8ce3-258e20b0da7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a6093f3a-79e1-4c78-a9d1-15497beea510" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a9c4499c-f72c-49d0-8ce3-258e20b0da7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_bf31ad15-3be6-4d4b-93bd-26c8d42724b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a6093f3a-79e1-4c78-a9d1-15497beea510" xlink:to="loc_us-gaap_DeferredTaxLiabilities_bf31ad15-3be6-4d4b-93bd-26c8d42724b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e3305cda-3d41-447a-80ca-776d23d39009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3305cda-3d41-447a-80ca-776d23d39009" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c6115097-a066-417a-823d-b8cd13bd2f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c6115097-a066-417a-823d-b8cd13bd2f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe811682-9665-44c5-968a-c1363edf0270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c6115097-a066-417a-823d-b8cd13bd2f94" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe811682-9665-44c5-968a-c1363edf0270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_087a894f-04ef-4027-9886-84c382000aac" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe811682-9665-44c5-968a-c1363edf0270" xlink:to="loc_mygn_CounsylIncMember_087a894f-04ef-4027-9886-84c382000aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e1b97662-1ebc-495d-89ea-1f2957e85fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e1b97662-1ebc-495d-89ea-1f2957e85fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e1b97662-1ebc-495d-89ea-1f2957e85fb2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_be349e83-f7ef-48c7-b09c-7c3ec8395fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:to="loc_us-gaap_DomesticCountryMember_be349e83-f7ef-48c7-b09c-7c3ec8395fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_9578f917-6988-47d3-a541-865e59bb8d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:to="loc_us-gaap_ForeignCountryMember_9578f917-6988-47d3-a541-865e59bb8d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d839bcf2-7405-4dee-b84a-c13a32f62c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5f0c9d8d-e6dc-402c-b654-adaefed2cdf6" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d839bcf2-7405-4dee-b84a-c13a32f62c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_863d17fe-6bb5-411b-a996-8d913e4d53f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_863d17fe-6bb5-411b-a996-8d913e4d53f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_863d17fe-6bb5-411b-a996-8d913e4d53f4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember_7a108d16-cb67-4770-91cc-530cc9c7320c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:to="loc_us-gaap_NewJerseyDivisionOfTaxationMember_7a108d16-cb67-4770-91cc-530cc9c7320c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_4336b756-0b66-4c5e-885f-a9657dab768a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:to="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_4336b756-0b66-4c5e-885f-a9657dab768a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalMinistryOfFinanceGermanyMember_4d25f8a3-5213-4e3a-89d4-c670f4b0f502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalMinistryOfFinanceGermanyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:to="loc_us-gaap_FederalMinistryOfFinanceGermanyMember_4d25f8a3-5213-4e3a-89d4-c670f4b0f502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_166be2b8-de33-45ca-8627-291a10e5ded5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_4514c5b3-b1df-4e77-8dba-290e3e7fb87a" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_166be2b8-de33-45ca-8627-291a10e5ded5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_c8a5c71c-23e9-47a9-9654-caf770cfc324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_TaxPeriodAxis_c8a5c71c-23e9-47a9-9654-caf770cfc324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_0aa8a861-fce1-4e6f-9d60-8d50896b914f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_c8a5c71c-23e9-47a9-9654-caf770cfc324" xlink:to="loc_us-gaap_TaxPeriodDomain_0aa8a861-fce1-4e6f-9d60-8d50896b914f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember_c10bb0c6-af1d-444c-af1a-e80844543fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_0aa8a861-fce1-4e6f-9d60-8d50896b914f" xlink:to="loc_us-gaap_EarliestTaxYearMember_c10bb0c6-af1d-444c-af1a-e80844543fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_82fce63f-b6fe-49ac-bc49-624b9d85cb52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_0aa8a861-fce1-4e6f-9d60-8d50896b914f" xlink:to="loc_us-gaap_LatestTaxYearMember_82fce63f-b6fe-49ac-bc49-624b9d85cb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5768a31f-8812-448b-a2aa-2a51ae163fd6" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct_c1cad114-737b-46f8-9ab7-73114ef840c4" xlink:href="mygn-20201231.xsd#mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct_c1cad114-737b-46f8-9ab7-73114ef840c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_788e59c9-d03c-43ee-8e84-7cd0a7b93248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_788e59c9-d03c-43ee-8e84-7cd0a7b93248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare_f133cd6f-abc2-4e5d-8a72-6169dbe9009d" xlink:href="mygn-20201231.xsd#mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare_f133cd6f-abc2-4e5d-8a72-6169dbe9009d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod_a03a5180-50cf-4ad2-be58-15a3bb9fc982" xlink:href="mygn-20201231.xsd#mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod_a03a5180-50cf-4ad2-be58-15a3bb9fc982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_8924c80a-9f96-49c7-9788-d2200eadc696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_8924c80a-9f96-49c7-9788-d2200eadc696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1c7c5fee-4e0e-4c62-b406-9695793d5f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1c7c5fee-4e0e-4c62-b406-9695793d5f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_UnrecognizedTaxBenefitsNet_81e2ad12-7d45-4814-8da7-de3eb826bfb0" xlink:href="mygn-20201231.xsd#mygn_UnrecognizedTaxBenefitsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_mygn_UnrecognizedTaxBenefitsNet_81e2ad12-7d45-4814-8da7-de3eb826bfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_3d82ee44-2b5f-4d73-bd16-0d0cc7127df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6439ec91-2f68-4ccd-9741-c06e9c5257da" xlink:to="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_3d82ee44-2b5f-4d73-bd16-0d0cc7127df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e32719c9-5741-47c8-9005-acc917e5ba41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e32719c9-5741-47c8-9005-acc917e5ba41" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1b3f277e-07f0-416d-b95e-e9753657d1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1b3f277e-07f0-416d-b95e-e9753657d1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1b3f277e-07f0-416d-b95e-e9753657d1fc" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_d8fcf006-764a-4431-b62f-ca306fda27ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:to="loc_us-gaap_DomesticCountryMember_d8fcf006-764a-4431-b62f-ca306fda27ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_5b5fe7e0-9b0d-4695-9402-080df127df6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_5b5fe7e0-9b0d-4695-9402-080df127df6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_918a98b8-3340-442b-b3e1-6b5abd79576b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8c62f84b-1a35-4c8a-8b2d-6f07f77100fd" xlink:to="loc_us-gaap_ForeignCountryMember_918a98b8-3340-442b-b3e1-6b5abd79576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_82c3a23b-64a9-46d6-83a7-c5aaa08b8265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_82c3a23b-64a9-46d6-83a7-c5aaa08b8265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_82c3a23b-64a9-46d6-83a7-c5aaa08b8265" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_deaa5742-46e9-406d-a340-c7b47ed7e1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_deaa5742-46e9-406d-a340-c7b47ed7e1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_UT_2ab28b3a-2c4c-4326-9e11-202144890c14" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_UT"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_stpr_UT_2ab28b3a-2c4c-4326-9e11-202144890c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_566403da-f6e5-48f9-85b6-f129640ba754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_566403da-f6e5-48f9-85b6-f129640ba754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_401152df-1aad-40e2-ae6e-0fe5f2026b41" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_stpr_TX_401152df-1aad-40e2-ae6e-0fe5f2026b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OtherStateMember_6a9ecff2-d5e1-4ce9-a783-98ea28bc19e5" xlink:href="mygn-20201231.xsd#mygn_OtherStateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_a32356d7-5f3b-4f4e-9692-6b7f54cf2215" xlink:to="loc_mygn_OtherStateMember_6a9ecff2-d5e1-4ce9-a783-98ea28bc19e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_930b010b-82bd-4778-8008-c4bd8b215996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6aa1c30c-b4d3-4e31-84f3-3489bdb5d5a5" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_930b010b-82bd-4778-8008-c4bd8b215996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_293d3245-027a-4bbe-b44d-80ab06025d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_930b010b-82bd-4778-8008-c4bd8b215996" xlink:to="loc_us-gaap_ResearchMember_293d3245-027a-4bbe-b44d-80ab06025d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_srt_RangeAxis_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e474ef7-606a-47aa-8004-91dded1835a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6c02c0ca-5b87-4551-8ce1-8f5eeac22d43" xlink:to="loc_srt_RangeMember_6e474ef7-606a-47aa-8004-91dded1835a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_242e531b-1f0b-4807-b64f-97557de521c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e474ef7-606a-47aa-8004-91dded1835a8" xlink:to="loc_srt_MinimumMember_242e531b-1f0b-4807-b64f-97557de521c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d71569e8-cbcb-48f0-b4dc-0698d187f27b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e474ef7-606a-47aa-8004-91dded1835a8" xlink:to="loc_srt_MaximumMember_d71569e8-cbcb-48f0-b4dc-0698d187f27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_ced74841-25a7-403b-9fa6-0d2b02e6d402" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_f1349a81-69dd-46db-9025-a19c25027e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_OperatingLossCarryforwards_f1349a81-69dd-46db-9025-a19c25027e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_9e273480-a2e9-4efd-a857-4ccca8fd594e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_9e273480-a2e9-4efd-a857-4ccca8fd594e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_f7f150d3-ee5e-4d87-8e4b-cec88741244a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_f7f150d3-ee5e-4d87-8e4b-cec88741244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse_d6ef7423-f54b-49f7-8fb3-14ec918a0e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse_d6ef7423-f54b-49f7-8fb3-14ec918a0e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLossCarryforwardsExpirationYear_67e83fa0-9e79-4d54-8020-f7d98a368a16" xlink:href="mygn-20201231.xsd#mygn_OperatingLossCarryforwardsExpirationYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_mygn_OperatingLossCarryforwardsExpirationYear_67e83fa0-9e79-4d54-8020-f7d98a368a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TaxCreditCarryforwardsExpirationDate_a01addea-9505-47ef-9d98-157817899313" xlink:href="mygn-20201231.xsd#mygn_TaxCreditCarryforwardsExpirationDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_6eb11c7f-4f9a-4274-934d-01f2bc3abe87" xlink:to="loc_mygn_TaxCreditCarryforwardsExpirationDate_a01addea-9505-47ef-9d98-157817899313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fe6c52bd-396c-434c-9c81-8a8faebcc2d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fe6c52bd-396c-434c-9c81-8a8faebcc2d3" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8240d6ed-5dfe-4f0f-b0ab-58c756adc2f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8240d6ed-5dfe-4f0f-b0ab-58c756adc2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_fb7ee4ba-a247-4882-9817-62238408f7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_fb7ee4ba-a247-4882-9817-62238408f7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_8abd89cd-5cc3-420c-b664-b59fdeba7ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_8abd89cd-5cc3-420c-b664-b59fdeba7ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_031bde11-ea3e-4e07-9b80-3af361882837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_031bde11-ea3e-4e07-9b80-3af361882837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_b1685279-09b8-4e9a-abca-279a1f5369e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_b1685279-09b8-4e9a-abca-279a1f5369e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_0beeeabe-8e1a-4c31-ac0e-86a5830509a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_0beeeabe-8e1a-4c31-ac0e-86a5830509a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_4c6e0807-23e4-4ca4-ba51-c30a0639d5fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_4c6e0807-23e4-4ca4-ba51-c30a0639d5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7022042b-7518-4d24-a9ab-7e82b0ac44c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a50a245b-456d-4a23-b970-2fc1d0d2fa7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7022042b-7518-4d24-a9ab-7e82b0ac44c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_f57055d6-1c0f-4772-b03c-c232df2e0912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fe6c52bd-396c-434c-9c81-8a8faebcc2d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_f57055d6-1c0f-4772-b03c-c232df2e0912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mygn-20201231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1880bdc1-2653-4c54-83bb-003ce2eefbbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_29eed980-b7fd-446e-9ce1-98c733612026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1880bdc1-2653-4c54-83bb-003ce2eefbbb" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_29eed980-b7fd-446e-9ce1-98c733612026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/Leases" xlink:type="simple" xlink:href="mygn-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5eca5b60-9cb7-4447-8499-c398ae4af756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1e257059-42ce-47e5-b7eb-fb38a14f021f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5eca5b60-9cb7-4447-8499-c398ae4af756" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1e257059-42ce-47e5-b7eb-fb38a14f021f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_62ba9e5d-398d-4c8a-8c70-f897da54fb81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7dec07a9-f979-40f2-870b-72bdb36e52c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_62ba9e5d-398d-4c8a-8c70-f897da54fb81" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7dec07a9-f979-40f2-870b-72bdb36e52c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7ad8a134-4a03-4b70-8c1a-7243debaddc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_75908d5e-8edd-4603-86d4-3cb4f077603b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7ad8a134-4a03-4b70-8c1a-7243debaddc4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_75908d5e-8edd-4603-86d4-3cb4f077603b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b6f445e8-1620-42ab-a377-f28854d43230" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_75908d5e-8edd-4603-86d4-3cb4f077603b" xlink:to="loc_srt_RangeAxis_b6f445e8-1620-42ab-a377-f28854d43230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b7da022c-c934-4f9a-805f-6ab792bbc047" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b6f445e8-1620-42ab-a377-f28854d43230" xlink:to="loc_srt_RangeMember_b7da022c-c934-4f9a-805f-6ab792bbc047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d63cd72c-f3e1-46e1-85f0-b2365ba96f5e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b7da022c-c934-4f9a-805f-6ab792bbc047" xlink:to="loc_srt_MinimumMember_d63cd72c-f3e1-46e1-85f0-b2365ba96f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5447f079-1113-4d8f-b6bc-e16b1aebb370" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b7da022c-c934-4f9a-805f-6ab792bbc047" xlink:to="loc_srt_MaximumMember_5447f079-1113-4d8f-b6bc-e16b1aebb370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_75908d5e-8edd-4603-86d4-3cb4f077603b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e76b761c-12c9-4f73-b2e9-426759f02225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e76b761c-12c9-4f73-b2e9-426759f02225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9643319d-37e5-4b44-ad08-164947142de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_LeaseCost_9643319d-37e5-4b44-ad08-164947142de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_fcaabf55-079f-4900-9e24-e49fe67a56e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_VariableLeaseCost_fcaabf55-079f-4900-9e24-e49fe67a56e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_4d1a54e9-3402-4431-8596-9f1779a6c006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_ShortTermLeaseCost_4d1a54e9-3402-4431-8596-9f1779a6c006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_3ffd1162-5ddb-426c-8b11-b1f7fcaabbf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_3ffd1162-5ddb-426c-8b11-b1f7fcaabbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_df68fe99-02e9-4952-b231-164f325a1572" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_df68fe99-02e9-4952-b231-164f325a1572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_eb77f23e-c603-4883-818b-70f135feb955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce5729d8-d916-43c1-b0d7-43d096d18e24" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_eb77f23e-c603-4883-818b-70f135feb955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a8b6e3b4-3f95-4a4b-af4c-a3ad35529a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a8b6e3b4-3f95-4a4b-af4c-a3ad35529a86" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_914e122e-7e0c-4b42-ae71-4cd05d9075e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_914e122e-7e0c-4b42-ae71-4cd05d9075e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8c1a1299-2f5f-42f9-86ea-79590b270357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8c1a1299-2f5f-42f9-86ea-79590b270357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d57df4ec-fbe0-4994-bc12-c852996c5cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d57df4ec-fbe0-4994-bc12-c852996c5cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6f5eba4e-75e7-4789-9501-ec0dfe6771ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6f5eba4e-75e7-4789-9501-ec0dfe6771ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4ae57fca-f9ad-4fa7-ba74-3f01deadc4fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4ae57fca-f9ad-4fa7-ba74-3f01deadc4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c73fc3fa-9aef-4e1c-80b1-8993a6098e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c73fc3fa-9aef-4e1c-80b1-8993a6098e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b67ab1d-73f2-4418-961f-f86b1c0a7595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b67ab1d-73f2-4418-961f-f86b1c0a7595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f81f50c9-7a9b-4a6b-9eef-33fa0c03be54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f81f50c9-7a9b-4a6b-9eef-33fa0c03be54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d80bdd19-99d2-4831-88a9-0324c0d956b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_OperatingLeaseLiability_d80bdd19-99d2-4831-88a9-0324c0d956b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_793add8f-788f-4a81-b9c1-5cbdd1f1967b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_793add8f-788f-4a81-b9c1-5cbdd1f1967b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_aa28ff48-9141-4187-9e2a-1297476bf00d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6d5676af-a242-47f4-9995-b0c78fb51a67" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_aa28ff48-9141-4187-9e2a-1297476bf00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="mygn-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlan" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlan"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4f17cc1e-89aa-489c-b3bb-1b64f56fcb60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_570373b8-eaa1-44cb-85aa-f8c6502b8383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4f17cc1e-89aa-489c-b3bb-1b64f56fcb60" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_570373b8-eaa1-44cb-85aa-f8c6502b8383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3593fcde-5228-45b6-b9ce-bddc0dadb3af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_57d1c22d-d82c-4379-a4b4-6b51d26c3690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3593fcde-5228-45b6-b9ce-bddc0dadb3af" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_57d1c22d-d82c-4379-a4b4-6b51d26c3690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f97d4d6c-b38a-47a9-9426-da0959667828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_3cc0b8ee-75f5-4012-98f3-4b97082dc3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f97d4d6c-b38a-47a9-9426-da0959667828" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_3cc0b8ee-75f5-4012-98f3-4b97082dc3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1b66e1cb-fce1-425e-ae32-2c2856dbb51a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f97d4d6c-b38a-47a9-9426-da0959667828" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1b66e1cb-fce1-425e-ae32-2c2856dbb51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#EmployeeDeferredSavingsPlanContributionstoPlanDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8fae4692-7824-45ca-a570-f9aabfe7d3e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_23e4af69-affe-4896-bfb0-fc0317e88150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8fae4692-7824-45ca-a570-f9aabfe7d3e4" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_23e4af69-affe-4896-bfb0-fc0317e88150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformation"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f9bfbb2e-f33c-4ebc-8b64-1dba6d1a1b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_788a2a74-86be-4384-8472-c546d8a847fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f9bfbb2e-f33c-4ebc-8b64-1dba6d1a1b5a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_788a2a74-86be-4384-8472-c546d8a847fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3c0a74e3-f9af-4438-9180-e672e8337b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_745eda35-e3b5-4047-92d8-5c1793df8382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3c0a74e3-f9af-4438-9180-e672e8337b7d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_745eda35-e3b5-4047-92d8-5c1793df8382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock_fc14eb36-7e95-448b-b92d-68c3f27de1df" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3c0a74e3-f9af-4438-9180-e672e8337b7d" xlink:to="loc_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock_fc14eb36-7e95-448b-b92d-68c3f27de1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_593df4ef-e3fd-4fca-8925-8717a0263449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3c0a74e3-f9af-4438-9180-e672e8337b7d" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_593df4ef-e3fd-4fca-8925-8717a0263449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_860a5c59-36b1-4387-ac70-5dcd3d5abb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3c0a74e3-f9af-4438-9180-e672e8337b7d" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_860a5c59-36b1-4387-ac70-5dcd3d5abb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_498b7afa-1c2a-47ea-a383-d1ddeb957da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b7d5534d-f6e2-49e4-abfa-3d1e73e93788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_498b7afa-1c2a-47ea-a383-d1ddeb957da3" xlink:to="loc_us-gaap_NumberOfReportableSegments_b7d5534d-f6e2-49e4-abfa-3d1e73e93788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8a8d3d47-e6e9-4b0b-b348-1493536fa65b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8a8d3d47-e6e9-4b0b-b348-1493536fa65b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0e74ef88-0a78-4d1b-87fa-d65d2729da1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:to="loc_srt_ConsolidationItemsAxis_0e74ef88-0a78-4d1b-87fa-d65d2729da1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_385a61e7-8950-4ae1-8c80-105f60ce61ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0e74ef88-0a78-4d1b-87fa-d65d2729da1b" xlink:to="loc_srt_ConsolidationItemsDomain_385a61e7-8950-4ae1-8c80-105f60ce61ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ca8c66aa-998d-4b57-af25-b0ea5dc6e0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_385a61e7-8950-4ae1-8c80-105f60ce61ac" xlink:to="loc_us-gaap_OperatingSegmentsMember_ca8c66aa-998d-4b57-af25-b0ea5dc6e0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_da7f5ed8-b422-4032-86dc-53d9fc933c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_da7f5ed8-b422-4032-86dc-53d9fc933c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a0b56454-e611-4770-8d5e-464dfb835a1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_da7f5ed8-b422-4032-86dc-53d9fc933c4d" xlink:to="loc_us-gaap_SegmentDomain_a0b56454-e611-4770-8d5e-464dfb835a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_9ca8d979-a038-4c67-8b76-030e698bf763" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a0b56454-e611-4770-8d5e-464dfb835a1f" xlink:to="loc_mygn_DiagnosticMember_9ca8d979-a038-4c67-8b76-030e698bf763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_2bfbe66e-1ec1-4c32-8b54-b325040e5cf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a0b56454-e611-4770-8d5e-464dfb835a1f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_2bfbe66e-1ec1-4c32-8b54-b325040e5cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8cd943a7-5e19-4655-ae13-37718d302a4c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea171b00-0c9d-4e0b-bcf3-16821790e393" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea171b00-0c9d-4e0b-bcf3-16821790e393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_50ed9327-0c44-4019-b7a3-74c84e340ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:to="loc_us-gaap_DepreciationAndAmortization_50ed9327-0c44-4019-b7a3-74c84e340ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_841d5948-aa8d-4b8d-9ba0-e6c8eb405ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bdba0061-f544-4f12-afcc-16936bdf1d32" xlink:to="loc_us-gaap_OperatingIncomeLoss_841d5948-aa8d-4b8d-9ba0-e6c8eb405ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e1a3a8a9-234e-4d36-9e73-36a13149f38b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_OperatingIncomeLoss_e1a3a8a9-234e-4d36-9e73-36a13149f38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_78125ab1-db67-4997-b46e-711ace23262a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_InvestmentIncomeInterest_78125ab1-db67-4997-b46e-711ace23262a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_393f9dfd-da7c-4fec-a5dc-b0dde47e8369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_InterestExpense_393f9dfd-da7c-4fec-a5dc-b0dde47e8369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eb29cec4-5cfa-4d92-813d-ee3c8e446aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eb29cec4-5cfa-4d92-813d-ee3c8e446aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b94fee6-57fb-4909-9eed-aca1e4481e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b94fee6-57fb-4909-9eed-aca1e4481e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2de9ed6c-eecd-48d2-b25d-fa15f2ac619b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2de9ed6c-eecd-48d2-b25d-fa15f2ac619b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e73d3b12-e19f-46ba-8831-725cecb2bbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_ProfitLoss_e73d3b12-e19f-46ba-8831-725cecb2bbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a2bac548-690b-43b8-b906-2fa5124e9127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a2bac548-690b-43b8-b906-2fa5124e9127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_766bd7f1-3d82-4159-bc1a-081aba96a438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f54d0bd8-1a32-414f-be07-93b3bd8ed3b9" xlink:to="loc_us-gaap_NetIncomeLoss_766bd7f1-3d82-4159-bc1a-081aba96a438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ced30306-4c12-480d-b49c-5ee6e3b5b42c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ced30306-4c12-480d-b49c-5ee6e3b5b42c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:to="loc_srt_ConsolidationItemsAxis_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b37b2b52-4a3e-4c3d-a489-b57a9d28993f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0ca3b18f-fdb5-4488-a14f-29a8d0aadad9" xlink:to="loc_srt_ConsolidationItemsDomain_b37b2b52-4a3e-4c3d-a489-b57a9d28993f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_44d3d561-4c7c-4df3-9640-7abe0a561e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b37b2b52-4a3e-4c3d-a489-b57a9d28993f" xlink:to="loc_us-gaap_OperatingSegmentsMember_44d3d561-4c7c-4df3-9640-7abe0a561e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83f976c3-1bd3-41a3-a84f-ae96a7ceb392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83f976c3-1bd3-41a3-a84f-ae96a7ceb392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2681276c-4af0-43de-ac0b-534a54a9e659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83f976c3-1bd3-41a3-a84f-ae96a7ceb392" xlink:to="loc_us-gaap_SegmentDomain_2681276c-4af0-43de-ac0b-534a54a9e659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticMember_b790ba11-d541-40c6-9da5-a2d44bb727b9" xlink:href="mygn-20201231.xsd#mygn_DiagnosticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2681276c-4af0-43de-ac0b-534a54a9e659" xlink:to="loc_mygn_DiagnosticMember_b790ba11-d541-40c6-9da5-a2d44bb727b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_e70b861e-e379-451b-9afc-b3d286dea784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2681276c-4af0-43de-ac0b-534a54a9e659" xlink:to="loc_us-gaap_AllOtherSegmentsMember_e70b861e-e379-451b-9afc-b3d286dea784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d90c8016-0a53-4a39-b2f0-ad89a7ccd835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe230d2-ed61-4a0e-a459-2672f8deefef" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d90c8016-0a53-4a39-b2f0-ad89a7ccd835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6b69fe38-896f-4cb3-8bdb-6f57c15862c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d90c8016-0a53-4a39-b2f0-ad89a7ccd835" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6b69fe38-896f-4cb3-8bdb-6f57c15862c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments_98117f0a-c40b-43fb-8a58-1594a3d94ece" xlink:href="mygn-20201231.xsd#mygn_AssetsLessCashCashEquivalentsAndInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d90c8016-0a53-4a39-b2f0-ad89a7ccd835" xlink:to="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments_98117f0a-c40b-43fb-8a58-1594a3d94ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationAssetsbyGeographicalRegionDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_25901b06-b5b0-45a0-ba47-166793e553f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_25901b06-b5b0-45a0-ba47-166793e553f5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3dd00fbe-165b-49ab-a6af-792f12e13677" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:to="loc_srt_ConsolidationItemsAxis_3dd00fbe-165b-49ab-a6af-792f12e13677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a8713db4-027e-4128-8415-df3bfd36406d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3dd00fbe-165b-49ab-a6af-792f12e13677" xlink:to="loc_srt_ConsolidationItemsDomain_a8713db4-027e-4128-8415-df3bfd36406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember_71a35f6a-a51c-437f-a32e-b4413ff21f2b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a8713db4-027e-4128-8415-df3bfd36406d" xlink:to="loc_srt_ReportableGeographicalComponentsMember_71a35f6a-a51c-437f-a32e-b4413ff21f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d8506cc0-92a0-4370-9baa-80e10db15eb0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:to="loc_srt_StatementGeographicalAxis_d8506cc0-92a0-4370-9baa-80e10db15eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f2e84cb9-fc2b-40fb-94e8-77e3990c1a4c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d8506cc0-92a0-4370-9baa-80e10db15eb0" xlink:to="loc_srt_SegmentGeographicalDomain_f2e84cb9-fc2b-40fb-94e8-77e3990c1a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7f351ab8-2e16-4b0e-a7f2-2635800da4aa" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f2e84cb9-fc2b-40fb-94e8-77e3990c1a4c" xlink:to="loc_country_US_7f351ab8-2e16-4b0e-a7f2-2635800da4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_1159c011-47d5-436e-b3bc-d69d509c4bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f2e84cb9-fc2b-40fb-94e8-77e3990c1a4c" xlink:to="loc_us-gaap_NonUsMember_1159c011-47d5-436e-b3bc-d69d509c4bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74497a6b-a34b-40e1-9655-31991676cbbe" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fbd36235-5dc9-4a65-9515-04f282b93d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fbd36235-5dc9-4a65-9515-04f282b93d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments_eb9dcdda-f42f-4886-b2ea-12c095f4766d" xlink:href="mygn-20201231.xsd#mygn_AssetsLessCashCashEquivalentsAndInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_mygn_AssetsLessCashCashEquivalentsAndInvestments_eb9dcdda-f42f-4886-b2ea-12c095f4766d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f5425fb4-1d7c-4328-920e-c32402d3b7cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f5425fb4-1d7c-4328-920e-c32402d3b7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2cbe7a4c-1bed-4470-a3b8-6cdc77f4c2e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363e5fcd-8ded-4ade-93aa-1f8d8694461d" xlink:to="loc_us-gaap_Assets_2cbe7a4c-1bed-4470-a3b8-6cdc77f4c2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SegmentandRelatedInformationRevenuebyGeographicalRegionDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0a2bb35e-602b-4522-a731-eb058951232a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8be86047-0e36-47b7-bf34-a5ebadbba999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0a2bb35e-602b-4522-a731-eb058951232a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8be86047-0e36-47b7-bf34-a5ebadbba999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8be86047-0e36-47b7-bf34-a5ebadbba999" xlink:to="loc_srt_StatementGeographicalAxis_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4593bfa3-493e-4e75-b213-790a944de4a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c4211b76-6a71-49ac-8cf5-2eea51a4f9c1" xlink:to="loc_srt_SegmentGeographicalDomain_4593bfa3-493e-4e75-b213-790a944de4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ca1963d4-5059-4370-86be-0da3c2a115f7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4593bfa3-493e-4e75-b213-790a944de4a3" xlink:to="loc_country_US_ca1963d4-5059-4370-86be-0da3c2a115f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_699ee70d-10db-435e-b6f6-9ccf95317dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4593bfa3-493e-4e75-b213-790a944de4a3" xlink:to="loc_us-gaap_NonUsMember_699ee70d-10db-435e-b6f6-9ccf95317dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1aa14d9d-9f8b-42a6-92e1-60cd47cb4f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8be86047-0e36-47b7-bf34-a5ebadbba999" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1aa14d9d-9f8b-42a6-92e1-60cd47cb4f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_684f534f-209a-4c45-a6de-b58784453519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1aa14d9d-9f8b-42a6-92e1-60cd47cb4f93" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_684f534f-209a-4c45-a6de-b58784453519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SaleofSubsidiary" xlink:type="simple" xlink:href="mygn-20201231.xsd#SaleofSubsidiary"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SaleofSubsidiary" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_695e588e-83d1-4b77-abc8-1d438f1147c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_f27420cd-7f36-4808-a9a7-499cd0325837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_695e588e-83d1-4b77-abc8-1d438f1147c3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_f27420cd-7f36-4808-a9a7-499cd0325837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SaleofSubsidiaryDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SaleofSubsidiaryDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SaleofSubsidiaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_efe96ed9-b452-4f9f-ab66-02193979c422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f22fbb58-002c-4480-9966-2eb0beea887b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_efe96ed9-b452-4f9f-ab66-02193979c422" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f22fbb58-002c-4480-9966-2eb0beea887b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_910ef082-b9f4-4b0f-9ca7-294932c32615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f22fbb58-002c-4480-9966-2eb0beea887b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_910ef082-b9f4-4b0f-9ca7-294932c32615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0fb6db34-0b89-4569-836c-beb8bf67f3c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_910ef082-b9f4-4b0f-9ca7-294932c32615" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0fb6db34-0b89-4569-836c-beb8bf67f3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ClinicAssetGroupMember_d5b4dce6-235c-4c4c-ad54-96a9a40a0821" xlink:href="mygn-20201231.xsd#mygn_ClinicAssetGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0fb6db34-0b89-4569-836c-beb8bf67f3c2" xlink:to="loc_mygn_ClinicAssetGroupMember_d5b4dce6-235c-4c4c-ad54-96a9a40a0821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f22fbb58-002c-4480-9966-2eb0beea887b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_904a2a40-6157-436d-86cd-afa5515fa66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_904a2a40-6157-436d-86cd-afa5515fa66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension_8036ee9e-eec4-4846-a3d8-4b09dd16ba8e" xlink:href="mygn-20201231.xsd#mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:to="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension_8036ee9e-eec4-4846-a3d8-4b09dd16ba8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect_f1939946-514b-474d-ae7c-aaece897ba9c" xlink:href="mygn-20201231.xsd#mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5fdb0567-1287-4f29-b2ad-add41987b4c2" xlink:to="loc_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect_f1939946-514b-474d-ae7c-aaece897ba9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitions" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitions"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7bb1bc6b-c393-4a6a-bcb5-b06e3a5c5fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b13b9e16-37ee-47b1-a04a-4898cee8854a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7bb1bc6b-c393-4a6a-bcb5-b06e3a5c5fdc" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b13b9e16-37ee-47b1-a04a-4898cee8854a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d148382a-fc27-4dc7-a8b5-5136172b505b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_e705c636-ada3-47ae-aca5-d84aeb158712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d148382a-fc27-4dc7-a8b5-5136172b505b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_e705c636-ada3-47ae-aca5-d84aeb158712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_01756036-728d-4841-a3b6-31fe2d6b1018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d148382a-fc27-4dc7-a8b5-5136172b505b" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_01756036-728d-4841-a3b6-31fe2d6b1018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_916271ae-1ae2-41de-aaf1-bf754dcee12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d148382a-fc27-4dc7-a8b5-5136172b505b" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_916271ae-1ae2-41de-aaf1-bf754dcee12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c9622745-fb1e-43da-86b3-d294bfc8abe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c9622745-fb1e-43da-86b3-d294bfc8abe9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_963e4150-0baa-4fe9-8291-ce145f98ac34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_963e4150-0baa-4fe9-8291-ce145f98ac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_313b7829-bcb6-46ef-a145-5938782903b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_963e4150-0baa-4fe9-8291-ce145f98ac34" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_313b7829-bcb6-46ef-a145-5938782903b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_26d1ab44-79c1-432c-849d-51e21016b0b0" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_313b7829-bcb6-46ef-a145-5938782903b8" xlink:to="loc_mygn_CounsylIncMember_26d1ab44-79c1-432c-849d-51e21016b0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4da4d7de-3095-4bd9-b204-e4e8dd931d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4b49c6d3-7893-49f4-a2d4-20fa0bc034c6" xlink:to="loc_us-gaap_ClassOfStockDomain_4da4d7de-3095-4bd9-b204-e4e8dd931d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_b17cb24f-947f-490d-aa8a-8a196d17597d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4da4d7de-3095-4bd9-b204-e4e8dd931d4d" xlink:to="loc_us-gaap_CommonClassAMember_b17cb24f-947f-490d-aa8a-8a196d17597d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59f36706-07db-48f3-8244-c0ea2defc5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59f36706-07db-48f3-8244-c0ea2defc5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e2d3d647-2830-4796-94aa-413a98556a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59f36706-07db-48f3-8244-c0ea2defc5fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e2d3d647-2830-4796-94aa-413a98556a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_30872c91-c1da-48ff-89fb-92040d68087c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e2d3d647-2830-4796-94aa-413a98556a31" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_30872c91-c1da-48ff-89fb-92040d68087c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6fc8e51-afd1-46b8-94d9-59a4eebf36f4" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_882a4e86-67d7-46d5-bdb2-06458edf87b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_882a4e86-67d7-46d5-bdb2-06458edf87b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_612d6391-44d2-4458-94f3-4d0c0017525e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_612d6391-44d2-4458-94f3-4d0c0017525e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_725cdd3d-44be-4076-8850-28a26eccd97a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_725cdd3d-44be-4076-8850-28a26eccd97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_24ba933a-7958-420c-a99c-9f8a320ab91a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_24ba933a-7958-420c-a99c-9f8a320ab91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_77580489-14db-414b-980e-f9844af8e65c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_77580489-14db-414b-980e-f9844af8e65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1_5ccc54f5-f80c-4823-afa6-8957ee4a0f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1_5ccc54f5-f80c-4823-afa6-8957ee4a0f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_f58a6666-defb-4b31-a284-e0bc0e00e477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_f58a6666-defb-4b31-a284-e0bc0e00e477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_74de38c3-5b44-40e7-8b84-1c5dfcb0a355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_74de38c3-5b44-40e7-8b84-1c5dfcb0a355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_fbe3d9da-6f40-4f73-a358-cc3db65ff42d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_fbe3d9da-6f40-4f73-a358-cc3db65ff42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_798054e6-d96c-4aa0-95ca-683b1b607cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_798054e6-d96c-4aa0-95ca-683b1b607cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_59ec94dc-63da-4185-afe1-d443a53be5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_59ec94dc-63da-4185-afe1-d443a53be5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_3b96e18b-ee82-499f-afbb-9ef0c9817db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_3b96e18b-ee82-499f-afbb-9ef0c9817db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent_983572b0-33a3-4202-9207-c23c50225c71" xlink:href="mygn-20201231.xsd#mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent_983572b0-33a3-4202-9207-c23c50225c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c0041ab8-1f59-4c50-802c-efbcd4e87e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c0041ab8-1f59-4c50-802c-efbcd4e87e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_227df039-780d-4548-b5f3-40adc7fca200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_227df039-780d-4548-b5f3-40adc7fca200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_b9b7939b-68b2-4bf1-a150-26deba15bbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_b9b7939b-68b2-4bf1-a150-26deba15bbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_241325a9-abb8-4e76-a4bb-89384ae71596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f1b688e5-8a88-46b2-89fe-103ae2f51f55" xlink:to="loc_us-gaap_OperatingExpenses_241325a9-abb8-4e76-a4bb-89384ae71596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsTotalConsiderationTransferredDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_33ee729d-4f07-45be-8867-26766b615c35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_62143bf7-7099-45b0-992d-b4b0ce953175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_33ee729d-4f07-45be-8867-26766b615c35" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_62143bf7-7099-45b0-992d-b4b0ce953175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_62143bf7-7099-45b0-992d-b4b0ce953175" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_651d7201-d0ad-4382-839e-f47aa9a0c7b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7d034b6-6aa3-45a2-ba81-7dd69ed243ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_651d7201-d0ad-4382-839e-f47aa9a0c7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_35cbbd1b-8b25-42b4-b1eb-ccc6e91d3b47" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_651d7201-d0ad-4382-839e-f47aa9a0c7b3" xlink:to="loc_mygn_CounsylIncMember_35cbbd1b-8b25-42b4-b1eb-ccc6e91d3b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_62143bf7-7099-45b0-992d-b4b0ce953175" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_aebf786a-fd8a-41cb-9348-4e213e28606d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_aebf786a-fd8a-41cb-9348-4e213e28606d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b1ce42a1-6086-47a5-8d0c-fc20103b6ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b1ce42a1-6086-47a5-8d0c-fc20103b6ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c6e08f7a-1d4c-4437-8b76-561bd98ee94a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c6e08f7a-1d4c-4437-8b76-561bd98ee94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_908eff77-f85f-4858-ac5e-b79367ba9143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_908eff77-f85f-4858-ac5e-b79367ba9143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6477a3c4-9f50-4bb7-be4c-0bea0b87c6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_Goodwill_6477a3c4-9f50-4bb7-be4c-0bea0b87c6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_30c5e684-d8cf-4284-8220-fa004f118c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_30c5e684-d8cf-4284-8220-fa004f118c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_210b7705-9cbd-4fff-b2c9-af1f40ab1da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_210b7705-9cbd-4fff-b2c9-af1f40ab1da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ff12f2a6-9d06-4576-aeda-84450d29043e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ff12f2a6-9d06-4576-aeda-84450d29043e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0516af91-2de1-4b13-975f-1713fdf4e88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0516af91-2de1-4b13-975f-1713fdf4e88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_b0ce3346-fb86-4b93-aeb8-09838479435f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_b0ce3346-fb86-4b93-aeb8-09838479435f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_27c066db-6d66-4c93-bb31-9d11d5ec8db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c299874-0b2e-40a2-9a4f-362c6ccbf5a8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_27c066db-6d66-4c93-bb31-9d11d5ec8db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsChangestoGoodwillBalanceDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_60ddedd8-9b67-4606-80bb-deddb65927ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c446519c-f32b-4385-8292-15f3099b7121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_60ddedd8-9b67-4606-80bb-deddb65927ea" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c446519c-f32b-4385-8292-15f3099b7121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c446519c-f32b-4385-8292-15f3099b7121" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9afb707b-a411-4797-be39-b375110bd474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_10abbe7a-8d20-4dfa-a4f8-607deb9f7b44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9afb707b-a411-4797-be39-b375110bd474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_48494d12-d6f4-4abc-a433-1ebd62ced585" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9afb707b-a411-4797-be39-b375110bd474" xlink:to="loc_mygn_CounsylIncMember_48494d12-d6f4-4abc-a433-1ebd62ced585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f31cf9ea-6b3f-4639-916b-8d87cbe443c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c446519c-f32b-4385-8292-15f3099b7121" xlink:to="loc_us-gaap_GoodwillLineItems_f31cf9ea-6b3f-4639-916b-8d87cbe443c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f31cf9ea-6b3f-4639-916b-8d87cbe443c3" xlink:to="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5c25d7d7-29ad-47f2-8dc4-0db3ece3c62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_us-gaap_Goodwill_5c25d7d7-29ad-47f2-8dc4-0db3ece3c62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment_10f54e53-bb67-4582-9f4e-33a694037682" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment_10f54e53-bb67-4582-9f4e-33a694037682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment_15ead665-4249-4dcb-8ff9-2949e1385ab3" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment_15ead665-4249-4dcb-8ff9-2949e1385ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment_ae7a05a6-f953-45dd-b5a5-89767bb1daa3" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment_ae7a05a6-f953-45dd-b5a5-89767bb1daa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment_e8670d38-73d8-42d2-adc6-5606cb0b8f18" xlink:href="mygn-20201231.xsd#mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment_e8670d38-73d8-42d2-adc6-5606cb0b8f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f13985f1-541b-48a0-a491-cddca1cada66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_222788ed-f61b-4d24-ac3a-874d035d57a9" xlink:to="loc_us-gaap_Goodwill_f13985f1-541b-48a0-a491-cddca1cada66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#BusinessAcquisitionsProFormaResultsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_21e80974-7867-4772-bb69-4c057d471c32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0703f802-6e87-4703-8a6b-060e0e65493d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_21e80974-7867-4772-bb69-4c057d471c32" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0703f802-6e87-4703-8a6b-060e0e65493d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ff213eb0-2439-48ea-932e-8f8983f3670f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0703f802-6e87-4703-8a6b-060e0e65493d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ff213eb0-2439-48ea-932e-8f8983f3670f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a3696feb-d831-4ee1-88dc-fbc4e3f9dc51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ff213eb0-2439-48ea-932e-8f8983f3670f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a3696feb-d831-4ee1-88dc-fbc4e3f9dc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CounsylIncMember_b310324e-b57d-41a3-9ed2-21f65075fb13" xlink:href="mygn-20201231.xsd#mygn_CounsylIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a3696feb-d831-4ee1-88dc-fbc4e3f9dc51" xlink:to="loc_mygn_CounsylIncMember_b310324e-b57d-41a3-9ed2-21f65075fb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fd65dd85-c56a-4a88-b159-df6f5359d0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0703f802-6e87-4703-8a6b-060e0e65493d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_fd65dd85-c56a-4a88-b159-df6f5359d0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fd65dd85-c56a-4a88-b159-df6f5359d0ac" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_61018608-b3db-4dcb-94f8-f13cd3660554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_61018608-b3db-4dcb-94f8-f13cd3660554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_9b801fa4-3f5d-46bb-84f2-cf92d9a8bd15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_9b801fa4-3f5d-46bb-84f2-cf92d9a8bd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4f9eba22-53d6-45ef-b7d1-e852ab51483b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4f9eba22-53d6-45ef-b7d1-e852ab51483b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_f8fb24e4-2ac0-4c9d-a682-eba167dd6297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_f8fb24e4-2ac0-4c9d-a682-eba167dd6297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_bd2c00cb-f1f0-488a-a7d9-0d270e87b7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_dc7af8d8-b36f-4df1-be42-285bd183cddf" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_bd2c00cb-f1f0-488a-a7d9-0d270e87b7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEvent" xlink:type="simple" xlink:href="mygn-20201231.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0628ad4c-7c9e-465f-8ba5-7cdb7349c2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_7201d70a-7332-4e1c-bbb5-c6ced38b0b41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0628ad4c-7c9e-465f-8ba5-7cdb7349c2a4" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_7201d70a-7332-4e1c-bbb5-c6ced38b0b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SubsequentEventDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SubsequentEventDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1519e8c2-1da6-4294-906a-61a55db249da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1519e8c2-1da6-4294-906a-61a55db249da" xlink:to="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7afcf928-9b3a-45d1-affd-dc840f308951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_us-gaap_CreditFacilityAxis_7afcf928-9b3a-45d1-affd-dc840f308951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c721267f-88ef-44e9-9b53-e11d7140155b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7afcf928-9b3a-45d1-affd-dc840f308951" xlink:to="loc_us-gaap_CreditFacilityDomain_c721267f-88ef-44e9-9b53-e11d7140155b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e8a72cce-001c-43bc-a195-d8579c5e954c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c721267f-88ef-44e9-9b53-e11d7140155b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e8a72cce-001c-43bc-a195-d8579c5e954c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_us-gaap_DebtInstrumentAxis_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c5f6a554-74c1-422b-9200-c34f917a76f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0bc8edb0-606a-458d-9f7b-1f60d9fe0c5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c5f6a554-74c1-422b-9200-c34f917a76f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmendmentToCreditAgreementMember_9b572712-340b-41cc-8fdb-657a22e36355" xlink:href="mygn-20201231.xsd#mygn_AmendmentToCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c5f6a554-74c1-422b-9200-c34f917a76f7" xlink:to="loc_mygn_AmendmentToCreditAgreementMember_9b572712-340b-41cc-8fdb-657a22e36355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f9103bbd-8383-4250-b86e-2f22bf330642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f9103bbd-8383-4250-b86e-2f22bf330642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5e3cd3ca-3675-49da-b862-2828b6697585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f9103bbd-8383-4250-b86e-2f22bf330642" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5e3cd3ca-3675-49da-b862-2828b6697585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_99e62366-ddda-48ca-8e04-8bce616f66a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5e3cd3ca-3675-49da-b862-2828b6697585" xlink:to="loc_us-gaap_SubsequentEventMember_99e62366-ddda-48ca-8e04-8bce616f66a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_srt_StatementScenarioAxis_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cf895492-ed7f-4dbd-b3e6-0fea9ce64f3f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_bd010a1c-ca54-4ed3-a488-7298c5fd9fa2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cf895492-ed7f-4dbd-b3e6-0fea9ce64f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_f0bc1ebb-32d9-4303-99d8-12b6367f674f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_cf895492-ed7f-4dbd-b3e6-0fea9ce64f3f" xlink:to="loc_srt_ScenarioForecastMember_f0bc1ebb-32d9-4303-99d8-12b6367f674f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8f7e0c65-8e15-472c-961b-d0a84a72ccfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_01ab9d26-f76e-4747-9a6d-17c13a73ada5" xlink:to="loc_us-gaap_SubsequentEventLineItems_8f7e0c65-8e15-472c-961b-d0a84a72ccfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum_10a9c37e-0678-4f8c-93b1-3ecc799a8700" xlink:href="mygn-20201231.xsd#mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8f7e0c65-8e15-472c-961b-d0a84a72ccfd" xlink:to="loc_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum_10a9c37e-0678-4f8c-93b1-3ecc799a8700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_aa735290-13ae-4b88-bdc5-35e472e4982d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8f7e0c65-8e15-472c-961b-d0a84a72ccfd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_aa735290-13ae-4b88-bdc5-35e472e4982d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_849a8995-2ef0-436e-8eb4-0c8deade9a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_1d30eabd-900a-4292-b2b1-669fe8c7d3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_849a8995-2ef0-436e-8eb4-0c8deade9a3c" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_1d30eabd-900a-4292-b2b1-669fe8c7d3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_b194f5d1-01bc-4086-8276-7137e62f6752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_a3e913fd-f852-41eb-aad4-c7461489b814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_b194f5d1-01bc-4086-8276-7137e62f6752" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_a3e913fd-f852-41eb-aad4-c7461489b814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_9610461c-dba7-4eaa-9db3-17e9b27f42de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_547c3966-3034-466f-84ca-84740e284836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9610461c-dba7-4eaa-9db3-17e9b27f42de" xlink:to="loc_us-gaap_IncomeTaxesPaid_547c3966-3034-466f-84ca-84740e284836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_05f1a754-52ce-42aa-964a-cf2b540d2b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9610461c-dba7-4eaa-9db3-17e9b27f42de" xlink:to="loc_us-gaap_InterestPaidNet_05f1a754-52ce-42aa-964a-cf2b540d2b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ea1c04f9-bd0c-4572-b000-261247da1a29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9610461c-dba7-4eaa-9db3-17e9b27f42de" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ea1c04f9-bd0c-4572-b000-261247da1a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity_61e5f830-af69-440c-88c4-63aaac669cb8" xlink:href="mygn-20201231.xsd#mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ea1c04f9-bd0c-4572-b000-261247da1a29" xlink:to="loc_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity_61e5f830-af69-440c-88c4-63aaac669cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ec0c87b5-64f1-42b3-abf0-c9fac05fa607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9610461c-dba7-4eaa-9db3-17e9b27f42de" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ec0c87b5-64f1-42b3-abf0-c9fac05fa607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cbda8780-d334-4d77-91c6-623586c436f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ec0c87b5-64f1-42b3-abf0-c9fac05fa607" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cbda8780-d334-4d77-91c6-623586c436f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_e271ab4d-8ea7-4fb6-9828-a1001933b1de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cbda8780-d334-4d77-91c6-623586c436f0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_e271ab4d-8ea7-4fb6-9828-a1001933b1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_6d311bb0-65e6-4a45-b05f-ed758a7779ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_e271ab4d-8ea7-4fb6-9828-a1001933b1de" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_6d311bb0-65e6-4a45-b05f-ed758a7779ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c36ac18-5cf7-44b4-b5c5-8e73b4d8a2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ec0c87b5-64f1-42b3-abf0-c9fac05fa607" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c36ac18-5cf7-44b4-b5c5-8e73b4d8a2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c36ac18-5cf7-44b4-b5c5-8e73b4d8a2bb" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5b8fe47d-6060-40c6-8135-64b72e3866de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5b8fe47d-6060-40c6-8135-64b72e3866de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLeaseLiabilityEstablished_2a07fd9e-8f3f-4766-b5a4-8dc00bdd47a4" xlink:href="mygn-20201231.xsd#mygn_OperatingLeaseLiabilityEstablished"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:to="loc_mygn_OperatingLeaseLiabilityEstablished_2a07fd9e-8f3f-4766-b5a4-8dc00bdd47a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_67552679-a140-4161-a0e7-6b8762433de8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_56bb29f1-1447-4450-8b4e-82ad01af899b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_67552679-a140-4161-a0e7-6b8762433de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnaudited"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_17d79fa3-7a12-4419-a82f-f2377b0c6be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_d972ec6c-4e10-43cc-b0b2-cc577c0b4f8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_17d79fa3-7a12-4419-a82f-f2377b0c6be9" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_d972ec6c-4e10-43cc-b0b2-cc577c0b4f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_2d10d507-bcff-407f-b7aa-77ebaebae370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1640c1fc-0faa-4778-922d-038194d525de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_2d10d507-bcff-407f-b7aa-77ebaebae370" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1640c1fc-0faa-4778-922d-038194d525de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_4fd6e3f2-9194-4953-b3b8-f2b68fee9a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f6a66828-ec59-424b-bef8-aeb8ae2c92b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_4fd6e3f2-9194-4953-b3b8-f2b68fee9a58" xlink:to="loc_us-gaap_StatementTable_f6a66828-ec59-424b-bef8-aeb8ae2c92b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f6a66828-ec59-424b-bef8-aeb8ae2c92b2" xlink:to="loc_srt_ProductOrServiceAxis_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_68acb295-3f38-40c6-8783-efde68b1036c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_aaf8f0d1-45ee-417b-80fb-06e5a21e66c0" xlink:to="loc_srt_ProductsAndServicesDomain_68acb295-3f38-40c6-8783-efde68b1036c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_9850656d-ff81-4d6c-85a5-e42b85aaa5c9" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_68acb295-3f38-40c6-8783-efde68b1036c" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_9850656d-ff81-4d6c-85a5-e42b85aaa5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_e8d53a00-ae7c-4564-90a3-5c2ad718529a" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_68acb295-3f38-40c6-8783-efde68b1036c" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_e8d53a00-ae7c-4564-90a3-5c2ad718529a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f6a66828-ec59-424b-bef8-aeb8ae2c92b2" xlink:to="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d6e4db7-4aa7-4a6c-9d2e-d622f945ff13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d6e4db7-4aa7-4a6c-9d2e-d622f945ff13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a08dad5a-9681-4d60-a2db-1436836fc01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a08dad5a-9681-4d60-a2db-1436836fc01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0175ab49-f00d-4bc3-a59f-c18460c7fe9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0175ab49-f00d-4bc3-a59f-c18460c7fe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_93793807-a02f-43ca-85e3-5610f044cdbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_93793807-a02f-43ca-85e3-5610f044cdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eb342847-31cb-467e-b103-d32c5fc72697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eb342847-31cb-467e-b103-d32c5fc72697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b1463164-47d0-4f51-b886-80bb1b8b4f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b1463164-47d0-4f51-b886-80bb1b8b4f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_c3280566-865c-4f06-a2d1-363ff112cda1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_CostsAndExpenses_c3280566-865c-4f06-a2d1-363ff112cda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b7882291-bab8-4325-b1e1-333708b48596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e051777c-3314-4d23-832a-a81890649bcb" xlink:to="loc_us-gaap_OperatingIncomeLoss_b7882291-bab8-4325-b1e1-333708b48596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_dd0baafc-eaac-46b2-8896-24fcb2c7b61f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:to="loc_us-gaap_InvestmentIncomeInterest_dd0baafc-eaac-46b2-8896-24fcb2c7b61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_31000d64-94c9-4634-b06f-d35c8b4e4abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:to="loc_us-gaap_InterestExpense_31000d64-94c9-4634-b06f-d35c8b4e4abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bf3e573c-238a-490f-98b1-d7ab8d4a4c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bf3e573c-238a-490f-98b1-d7ab8d4a4c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cd46d9cf-3adb-49b5-be94-142583a7d91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bda2a1d0-5a58-4881-9a5f-d2c90cb2609b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cd46d9cf-3adb-49b5-be94-142583a7d91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1888b324-dc4b-496e-b354-43ccbcfcb63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1888b324-dc4b-496e-b354-43ccbcfcb63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d3ce94b4-fd88-4faf-a423-e9bcf6da33cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d3ce94b4-fd88-4faf-a423-e9bcf6da33cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9b0965f6-3a9f-43a0-a0b2-4e34997ace9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_ProfitLoss_9b0965f6-3a9f-43a0-a0b2-4e34997ace9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efe09464-7d5f-4c4b-9e80-bdbf57a74d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efe09464-7d5f-4c4b-9e80-bdbf57a74d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2b435570-d2a3-4c57-9290-3249ea35b5e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_NetIncomeLoss_2b435570-d2a3-4c57-9290-3249ea35b5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a006d4b9-275c-4b87-b484-c65ffd0cf0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a006d4b9-275c-4b87-b484-c65ffd0cf0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_652fd041-c189-492a-9b41-f003dd7f0dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a006d4b9-275c-4b87-b484-c65ffd0cf0b7" xlink:to="loc_us-gaap_EarningsPerShareBasic_652fd041-c189-492a-9b41-f003dd7f0dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_729322e1-9a52-460b-9a3f-a033ee90cd13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a006d4b9-275c-4b87-b484-c65ffd0cf0b7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_729322e1-9a52-460b-9a3f-a033ee90cd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cca5e8f7-87ff-4566-88f0-fe98d55f77ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fdd283-a774-4735-a222-2eb55881378c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cca5e8f7-87ff-4566-88f0-fe98d55f77ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_035504ca-f567-45d3-b045-465ac039bee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cca5e8f7-87ff-4566-88f0-fe98d55f77ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_035504ca-f567-45d3-b045-465ac039bee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_949ae761-c9a5-4d34-9cad-f4447ebbaac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cca5e8f7-87ff-4566-88f0-fe98d55f77ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_949ae761-c9a5-4d34-9cad-f4447ebbaac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_6c8e1d4a-ca63-4a36-8e82-22549214b57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_6c8e1d4a-ca63-4a36-8e82-22549214b57a" xlink:to="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_b5c38832-abce-45c2-902d-6e1ef606d44c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:to="loc_srt_RestatementAxis_b5c38832-abce-45c2-902d-6e1ef606d44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_2f399a65-8b84-489f-b0c2-e7a09bd61ded" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_b5c38832-abce-45c2-902d-6e1ef606d44c" xlink:to="loc_srt_RestatementDomain_2f399a65-8b84-489f-b0c2-e7a09bd61ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_3c358dbc-2172-4e23-a278-81d7f653b373" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_2f399a65-8b84-489f-b0c2-e7a09bd61ded" xlink:to="loc_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_3c358dbc-2172-4e23-a278-81d7f653b373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f170ca23-0a63-4100-b9f2-60312b917511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f170ca23-0a63-4100-b9f2-60312b917511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8a5d4494-5e0b-42e1-93e6-e23f02097d11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f170ca23-0a63-4100-b9f2-60312b917511" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8a5d4494-5e0b-42e1-93e6-e23f02097d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3e956223-d7e7-4b82-89d3-62639208814f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8a5d4494-5e0b-42e1-93e6-e23f02097d11" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3e956223-d7e7-4b82-89d3-62639208814f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember_de94878d-10c5-4a6d-a986-26533bc5a7eb" xlink:href="mygn-20201231.xsd#mygn_GoodwillAndIntangibleAssetImpairmentChargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8a5d4494-5e0b-42e1-93e6-e23f02097d11" xlink:to="loc_mygn_GoodwillAndIntangibleAssetImpairmentChargesMember_de94878d-10c5-4a6d-a986-26533bc5a7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_92d6766c-bf1f-4268-b00f-9e83470a99ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_8d002482-717e-4148-afdd-1c61a4a1d511" xlink:to="loc_us-gaap_ReclassificationLineItems_92d6766c-bf1f-4268-b00f-9e83470a99ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_97ce8972-753c-43ec-8878-a0855e651f9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationLineItems_92d6766c-bf1f-4268-b00f-9e83470a99ce" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_97ce8972-753c-43ec-8878-a0855e651f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnaudited"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4a6a201f-102c-4183-ace3-88a1529605d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TransitionPeriodComparativeDataTextBlock_b1079bea-cd8d-42f0-bafa-61c3626204f9" xlink:href="mygn-20201231.xsd#mygn_TransitionPeriodComparativeDataTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4a6a201f-102c-4183-ace3-88a1529605d6" xlink:to="loc_mygn_TransitionPeriodComparativeDataTextBlock_b1079bea-cd8d-42f0-bafa-61c3626204f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_66938f43-81c6-4edf-a46e-6c387ef274b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock_61d0111d-2b4c-463e-be56-db212b2e1ca6" xlink:href="mygn-20201231.xsd#mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_66938f43-81c6-4edf-a46e-6c387ef274b7" xlink:to="loc_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock_61d0111d-2b4c-463e-be56-db212b2e1ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails" xlink:type="simple" xlink:href="mygn-20201231.xsd#TransitionPeriodComparativeDataUnauditedDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2bf06454-d6b6-4d2b-8323-dd03c2765c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TransitionPeriodFinancialInformationTable_1661b798-c644-41df-8250-df19da7a1ffe" xlink:href="mygn-20201231.xsd#mygn_TransitionPeriodFinancialInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2bf06454-d6b6-4d2b-8323-dd03c2765c2c" xlink:to="loc_mygn_TransitionPeriodFinancialInformationTable_1661b798-c644-41df-8250-df19da7a1ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_25b90b05-1d86-4514-8887-694206b28a6e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationTable_1661b798-c644-41df-8250-df19da7a1ffe" xlink:to="loc_srt_ProductOrServiceAxis_25b90b05-1d86-4514-8887-694206b28a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5cc02d37-5a93-4bce-a780-20bf5f632be9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_25b90b05-1d86-4514-8887-694206b28a6e" xlink:to="loc_srt_ProductsAndServicesDomain_5cc02d37-5a93-4bce-a780-20bf5f632be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_6440a712-76d0-4042-85b5-99d05c21e475" xlink:href="mygn-20201231.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cc02d37-5a93-4bce-a780-20bf5f632be9" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_6440a712-76d0-4042-85b5-99d05c21e475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_e0d4a0d4-05c7-473f-b320-f0fd56f2e80c" xlink:href="mygn-20201231.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cc02d37-5a93-4bce-a780-20bf5f632be9" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_e0d4a0d4-05c7-473f-b320-f0fd56f2e80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:href="mygn-20201231.xsd#mygn_TransitionPeriodFinancialInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationTable_1661b798-c644-41df-8250-df19da7a1ffe" xlink:to="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f6883ca-b081-4034-ac8b-8088dc8f71d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f6883ca-b081-4034-ac8b-8088dc8f71d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_92ba05ff-1c8b-436a-997c-8f56cdb6846e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_92ba05ff-1c8b-436a-997c-8f56cdb6846e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f2b5c618-742b-4511-b3a7-e77818e27eab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f2b5c618-742b-4511-b3a7-e77818e27eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b0962161-cf3f-4194-9b22-b92503452f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b0962161-cf3f-4194-9b22-b92503452f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c6fc638b-0463-4fb5-9b73-5820f24f2984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c6fc638b-0463-4fb5-9b73-5820f24f2984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_3f119f73-321f-40f5-b5d3-046a9c07992e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_3f119f73-321f-40f5-b5d3-046a9c07992e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_41d00bd8-8b96-4cab-894b-168657069e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_c58f1021-3938-4420-8d66-a45af50873a6" xlink:to="loc_us-gaap_CostsAndExpenses_41d00bd8-8b96-4cab-894b-168657069e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f06a4e30-1e59-4958-aa8d-e1671a41b256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_OperatingIncomeLoss_f06a4e30-1e59-4958-aa8d-e1671a41b256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_4cfb6708-e344-40db-9e7c-e18ab9fa6dd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:to="loc_us-gaap_InvestmentIncomeInterest_4cfb6708-e344-40db-9e7c-e18ab9fa6dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_673c8265-4e0b-43ed-a7a9-95bce3e1eb39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:to="loc_us-gaap_InterestExpense_673c8265-4e0b-43ed-a7a9-95bce3e1eb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_30db024b-9523-49f7-9726-2d35f47a3ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_30db024b-9523-49f7-9726-2d35f47a3ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_8a693e82-0ed8-4403-969e-16524a3683af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c03c99ad-479c-4360-8668-6dd1f5c902db" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_8a693e82-0ed8-4403-969e-16524a3683af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32707960-d0d5-4a3c-ac4c-6a7df0abd53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32707960-d0d5-4a3c-ac4c-6a7df0abd53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ae35bb72-0b42-45e0-8bc4-93877fea8aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ae35bb72-0b42-45e0-8bc4-93877fea8aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3a733a8e-0e89-4f22-8a30-0da9f7e96bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_ProfitLoss_3a733a8e-0e89-4f22-8a30-0da9f7e96bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ee005ec1-d9d5-4257-ac83-91f669470fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ee005ec1-d9d5-4257-ac83-91f669470fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9e53a91c-5d42-48e3-ad5c-39f55145ea93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_NetIncomeLoss_9e53a91c-5d42-48e3-ad5c-39f55145ea93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_23754fd1-ce4a-42f9-a100-ae46272d68be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_23754fd1-ce4a-42f9-a100-ae46272d68be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_430c4ec1-53f1-44c1-b7a4-fae75be008f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_23754fd1-ce4a-42f9-a100-ae46272d68be" xlink:to="loc_us-gaap_EarningsPerShareBasic_430c4ec1-53f1-44c1-b7a4-fae75be008f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3e8b7330-62ff-418c-b813-34212109be68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_23754fd1-ce4a-42f9-a100-ae46272d68be" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3e8b7330-62ff-418c-b813-34212109be68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cfe00214-535f-4b35-bf3b-1577c8df012f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_TransitionPeriodFinancialInformationLineItems_efb83adf-60a7-4069-a614-0a8a35f36a24" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cfe00214-535f-4b35-bf3b-1577c8df012f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd8733c3-b9b7-4e39-bdef-d8c8245625df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cfe00214-535f-4b35-bf3b-1577c8df012f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd8733c3-b9b7-4e39-bdef-d8c8245625df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88b5039b-4217-45d6-9096-0e6ee42b156b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_cfe00214-535f-4b35-bf3b-1577c8df012f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88b5039b-4217-45d6-9096-0e6ee42b156b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>mygn-20201231_g1.jpg
<TEXT>
begin 644 mygn-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 Z17AI9@  34T *@    @  U$0  $
M   ! 0   %$1  0    !     %$2  0    !          #_VP!#  (! 0(!
M 0(" @(" @(" P4# P,# P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,
M# P,!PD.#PT,#@L,# S_VP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" %J
M C@# 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+
M_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$(
M(T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W
M^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"
M! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 5
M8G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F
M9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W
MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!
M  (1 Q$ /P#]V?"7A+2KOPKIDLNF:?)+):1.[O;(S.2@))..2:T/^$*T?_H$
MZ9_X"I_A1X*_Y$W2?^O*'_T 5R7[2(\4+\/E?PG-XMCOX[@-(OAJ#2I-1D38
MW"G4F%LJ!MI;Y6<@84 G(F4N57*C&[L=;_PA6C_] G3/_ 5/\*/^$*T?_H$Z
M9_X"I_A7RY!\?_'7BGP--XKM/&RK%X(T30+R[M+'284LO$L]PV;WSA<P_:(5
M95*(L9A:-LLP;A%Z_P"#'Q/\8:O\0_!^KZIXFN-2T?X@S:U!_8;V5K':Z-]E
MD8V[02)&L[$1Q,LGG22!VDW*(PH2M)1M+E?G^'^?3\;&:DFKKR_'_+9_A<]T
M_P"$*T?_ *!.F?\ @*G^%'_"%:/_ - G3/\ P%3_  KYX\??&[QEX5\2ZQXQ
MB\13MH>B^,&\,CPO]CMA97%N+3_7-/Y1N1/Y["3<)!'L4)Y9.7/3?LU^,?%W
M_"=:=I_B3Q7=>*X?%'@^U\3+]HL+6U&EW#2;988/(C0F!A*FU93)(OE<R/NX
MFE^\5X^7XQYU_P"2J_X;Z%5'R.TOZM+D?W2=OQ6FI[#_ ,(5H_\ T"=,_P#
M5/\ "C_A"M'_ .@3IG_@*G^%:=5-0UJ'3)561+QF89'E6LLP_-%('TH K_\
M"%:/_P! G3/_  %3_"C_ (0K1_\ H$Z9_P" J?X4?\);:_\ /'4__!;<?_$4
M?\);:_\ /'4__!;<?_$4 '_"%:/_ - G3/\ P%3_  H_X0K1_P#H$Z9_X"I_
MA1_PEMK_ ,\=3_\ !;<?_$4?\);:_P#/'4__  6W'_Q% !_PA6C_ /0)TS_P
M%3_"C_A"M'_Z!.F?^ J?X4?\);:_\\=3_P#!;<?_ !%'_"6VO_/'4_\ P6W'
M_P 10 ?\(5H__0)TS_P%3_"C_A"M'_Z!.F?^ J?X4?\ "6VO_/'4_P#P6W'_
M ,11_P );:_\\=3_ /!;<?\ Q% !_P (5H__ $"=,_\  5/\*/\ A"M'_P"@
M3IG_ ("I_A1_PEMK_P \=3_\%MQ_\11_PEMK_P \=3_\%MQ_\10 ?\(5H_\
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M_P#$4?\ "6VO_/'4_P#P6W'_ ,10 ?\ "%:/_P! G3/_  %3_"C_ (0K1_\
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MTS_P%3_"C_A"M'_Z!.F?^ J?X4?\);:_\\=3_P#!;<?_ !%'_"6VO_/'4_\
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M6F:?'+':2NCI;(K(0A((.."**T/&O_(FZM_UY3?^@&B@ \%?\B;I/_7E#_Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH S/&O_(FZM_UY3?^@&BCQK_R)NK?]>4W_H!HH /!7_(FZ3_UY0_^@"M.
MLSP5_P B;I/_ %Y0_P#H K3H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,SQK_R)NK?]>4W_H!HH\:_\B;JW_7E-_Z
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M=%9G]@W7_0:U/_OBW_\ C5']@W7_ $&M3_[XM_\ XU0!IT5F?V#=?]!K4_\
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M#=?]!K4_^^+?_P"-4?V#=?\ 0:U/_OBW_P#C5 &G169_8-U_T&M3_P"^+?\
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M[!NO^@UJ?_?%O_\ &J/[!NO^@UJ?_?%O_P#&JHDTZ*S/[!NO^@UJ?_?%O_\
M&JOVD+6]NJ/-)<,O620*&;Z[0!^0H H>-?\ D3=6_P"O*;_T T4>-?\ D3=6
M_P"O*;_T T4 '@K_ )$W2?\ KRA_] %:=9G@K_D3=)_Z\H?_ $ 5IT %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M94)'K@FK=% S,_X371_^@MIG_@4G^-'_  FNC_\ 06TS_P "D_QK3HH S/\
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M (%)_C1_PFNC_P#06TS_ ,"D_P :TZ* ,S_A-='_ .@MIG_@4G^-'_":Z/\
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M (%)_C1_PFNC_P#06TS_ ,"D_P :TZ* ,S_A-='_ .@MIG_@4G^-'_":Z/\
M]!;3/_ I/\:TZ* ,S_A-='_Z"VF?^!2?XT?\)KH__06TS_P*3_&M.B@#,_X3
M71_^@MIG_@4G^-'_  FNC_\ 06TS_P "D_QK3HH S/\ A-='_P"@MIG_ (%)
M_C5^TO(;^W6:"6.:%^5>-@RM]"*DHH S/&O_ ")NK?\ 7E-_Z :*/&O_ ")N
MK?\ 7E-_Z :* #P5_P B;I/_ %Y0_P#H K3K,\%?\B;I/_7E#_Z *TZ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTZ* ,S[+K/\ S_Z9_P" #_\ QZC[+K/_ #_Z9_X /_\ 'JTZ* ,S[+K/_/\
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MB#])Q_S..ID.9P^/#U%ZPDOT.K^RZS_S_P"F?^ #_P#QZC[+K/\ S_Z9_P"
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M3HK0S,S[+K/_ #_Z9_X /_\ 'J/LNL_\_P#IG_@ _P#\>K3HH S/LNL_\_\
MIG_@ _\ \>H^RZS_ ,_^F?\ @ __ ,>K3HH S/LNL_\ /_IG_@ __P >H^RZ
MS_S_ .F?^ #_ /QZM.N6^(WQK\*_":V\SQ!K=EI[8W+ 6WSN/]F-<N?J!B@#
M6^RZS_S_ .F?^ #_ /QZF3IJUK"TDNI:3''&"S.UBZJH'<GSJ\)O?VS?$GQ3
MNY+'X8>";[5.=G]I7Z[8(S[@$*/4;I!_NTR#]D3QI\8ITNOB=XVNIK<D/_9>
MF$+$G<<X$8(]D8G^]WH V_B5^VMX>\ R-:V>N6/B34L[$MM,T]Y5+= #)YVS
MKQ\I8^U<[9^*?CM\?( MC86/P_TB;_EYG1H[AU/H&W/]"JK_ +U>R_#7X ^$
M/A'$O]AZ'9VMPHP;IU\VY;U_>-EN?0$#VKL: /GSPE^P'I=AJ_\ :?B+6I/%
MVI.0SOJ,,C1LWJ0)@S?\"8@^E>RZ)X7N_#6G1V>G-H5A:1<)#;Z6T4:_15E
MK>HH S/LNL_\_P#IG_@ _P#\>H^RZS_S_P"F?^ #_P#QZM.B@#,^RZS_ ,_^
MF?\ @ __ ,>H^RZS_P _^F?^ #__ !ZM.B@#,^RZS_S_ .F?^ #_ /QZK]HL
MR6ZB=XY)OXFC0HI^@)./S-244 9GC7_D3=6_Z\IO_0#11XU_Y$W5O^O*;_T
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MN[?RQ^2D"LF[_8(^$=['M?P;:J,Y_=WES&?S60&O8**Y)\/Y7/X\-3?K"/\
MD=E/B/-H?!BJB])R7ZGAEY_P3B^$=S(63P[=6X(QMCU.Y('O\SDUE7?_  3
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M*-Y&VQQX,CL55 I>, .7W'9L<'%7=D>A45X3\8_V@_&'A/QAX@FT1/#2^'/
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MG169_P )KH__ $%M,_\  I/\:/\ A-='_P"@MIG_ (%)_C0!IT5F?\)KH_\
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M_@1 3_QZLSPU_P $^?AWH;J]Y!JVM29RQO+PJ&/TB"?K^.:]$\+_  )\&>#
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MQK'\1]+4RC*^;:W4('&>2\0V_0X]*YI\/YI'XL-4_P# )?Y&T<TP;VJQ_P#
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MS[+K/_/_ *9_X /_ /'J/LNL_P#/_IG_ ( /_P#'J -.BLS[+K/_ #_Z9_X
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MTDOAE\^C\G\F?:E%94,6K7$2R1ZEI4D<@#*RV+D,#T(/G4[[+K/_ #_Z9_X
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MX7.O"Y?A\/K3CKU;U;]6]33HK,^RZS_S_P"F?^ #_P#QZC[+K/\ S_Z9_P"
M#_\ QZO*.TTZ*S/LNL_\_P#IG_@ _P#\>H^RZS_S_P"F?^ #_P#QZ@#3HK,^
MRZS_ ,_^F?\ @ __ ,>H^RZS_P _^F?^ #__ !Z@#3HK,^RZS_S_ .F?^ #_
M /QZC[+K/_/_ *9_X /_ /'J -.BLS[+K/\ S_Z9_P" #_\ QZC[+K/_ #_Z
M9_X /_\ 'J -.BLS[+K/_/\ Z9_X /\ _'J/LNL_\_\ IG_@ _\ \>H TZ*S
M/LNL_P#/_IG_ ( /_P#'J/LNL_\ /_IG_@ __P >H TZ*S/LNL_\_P#IG_@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M *!.F?\ @*G^% &G169_PA6C_P#0)TS_ ,!4_P */^$*T?\ Z!.F?^ J?X4
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MZ=#I&G6]I;1K#;VL:PQ(.B(H  'T %342M?38F-[+FW"O.OB3\1O$WA#XV>
M=)M;;0_^$8\3WDUA=RRM+)?M*MG=7 V*-L<:K]G3YB9"_FL-L>P,_HM>??%'
MX"S?$[XA>&?$'_":^+-!_P"$5N/M=II^G1Z<;668I+$[R&>TEE)>*9XR%D4
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M6K:7\3-:\<:+\0/%TNOWUFL$6G:@--?3'\N+$<!;["UQ# T@$CK#(N79FQG
MI1=EJM;M_*RLOO3]$[[[-J^B[6^=WK^*?G:STN<_XI^-WC >%_&'B71=0MH-
M)M_$3Z1IAD\*WWB+RH+6,Q3R"UL"D\A>\25-[2".-(PW?!TM"^/7B_5]0^#=
MQ):^$%T7X@0*FIO9WCWT@NCIUS=,MO)&?)$*- H$FZ7S!(0 FP,_26?[/LVD
M?"3PSX8T?QEXI\+W'AV-%.IZ2;5KB^;8PE,J7,$T+^8[&0DQ[@V"".<Y=]^R
M19I<>!5TCQEXR\/Z=\/0C:;I]F;":&:01RQ/+,]Q:RS.\D4TB-B0#YMP"O\
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M@GBA$#2LX(F+3Q$)MQB1><L 1:Z+S_!7?X:@]-^U_DW;\T>B45SOBCXP>$O
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M ;&=I]#4,_QJ\/Z;XA\26&I7D>CQ^%5M&O;V_ECM[0?:0?* D9NI(V_,!RP
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M-F;!*84MD9J2:;3Z;_.Z_1DW6C[_ .2?Y-/YGK%%>,:U^VE8Z#>:M)<>!?B
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MJE@0:U&_:$\ K/H$/_";>$3-XL02:'&-8M]^LJ3@&V&_,P)(&8\\FDY)*_\
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M*>X21=A&71&"CD$D!BHYKVJBJ<FVI/=-/YIW_/\ RVL*UG?^OZ_X?=MOY_\
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M -2LH_DE_P"#:O\ \F?6?Z]9S_/#_P %4O\ Y ^8?^&%/B)_T<!XT_[YN?\
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M\X1)*=Q!<K\E5&VB?G?[WR_\'RMK>Y.O*FM]/SU_#S[Z*RO[!1114E!1110
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M9_Z"VI_^!3_XT ?0M%?/7_":ZS_T%M3_ / I_P#&C_A-=9_Z"VI_^!3_ .-
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M ,"G_P :/^$UUG_H+:G_ .!3_P"- 'T+17SU_P )KK/_ $%M3_\  I_\:/\
MA-=9_P"@MJ?_ (%/_C0!]"T5\]?\)KK/_06U/_P*?_&C_A-=9_Z"VI_^!3_X
MT ?0M%?/7_":ZS_T%M3_ / I_P#&C_A-=9_Z"VI_^!3_ .- 'N7C7_D3=6_Z
D\IO_ $ T5X9)XNU:ZC:.35-0DCD&UT:Y<JP/!!&>0:* /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>mygn-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mygn="http://www.myriad.com/20201231"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mygn-20201231.xsd" xlink:type="simple"/>
    <context id="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i12f58929baf0442f9477c970c47bf549_I20210309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2021-03-09</instant>
        </period>
    </context>
    <context id="i3713c16ca67a4a2c92019768c7306642_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69f08e4358544efba7545f11fac65d70_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic729b712df4f4a8ead8475fab8f0790d_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib871150772b344349cbdf35a395d8267_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic7633cb8e372444994b1efa8de166955_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie935c63c1ef24d07993e26cd5a18d415_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i2c097ed969db458690ef357352106593_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4fbf604a73ce4ed6bb5884b4cb199fac_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib094ccbcf5d544e9803960dda6b5c3f0_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i97a926ad86c54867989a14b026bd3593_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i81b96726504343d28522421de58c84e0_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="i043df983c75d4d9790fca62e5627f01e_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="i605b2c9f9a9b44f3bbf09333a54305b7_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="ib6b39f6952cb488a9feeaf585599ff97_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="i28ea8f3abcd243cc8055858b4e824489_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="i29c0e698144e42648f61bbf6031c1c5c_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="ic7794eda7c67461e96370052bfb99427_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i6a575b7c8ca744ed8ee5d39d3377da1f_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="iec0b2aaccecb48f5b7031f656787f005_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i5a96e8e1248b4ab6be94a21fba042643_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="ia44d866f0781417d83a00587086cfc79_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i947239044e8241b8b52a22ece554dedc_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i171870dd15d143e2bd07f52254307cce_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i99f729f126dc44f9b8d4c81d5418ce8f_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0d35e18907a547819b6deae0efc98b7a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i95fef7707d9841e09fdeefb682e39bfb_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i55d0ee12bc344eeeb30b549901738171_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i2c71239012bf47869827c00bc3e89106_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i312cecad66074aa4a77f2187852e77ab_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie27fadcacb1f46029eb6fd3895d61378_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ibb6b952dfa944ca698bd7b95b7b9c665_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i52119e935ff9454ca95aa15f28434db7_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3eefa8a416fd4ec6972a8e54adb82cbc_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie824f0b48e99445ebdbd34568b4a740c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9b2496737dd9420db74ac84923507079_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic821396f205a43a1b2be38d8d4ea121d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifdbb159f7b6a41a28bf0f80b2e7f99a6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i941e632acb5a4786968dffa4c42b7c43_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1cad8a5377bb4f6583cdde4abd9bf533_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id5d5fb59c6a349e99c8e0851e720a933_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d1a7c06a6ad43389dd94e306a8d5f31_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i778d038d06274b8a8f9c85edc661fbd2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a7c360decc543eb8824c43a173dc0d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib78ee580b5334e728f7c6add95026777_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee94c647141649b6bb2fb3d6b3b18e85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f96d09d51df44fbad84bb579131bdab_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i10cba38383e5458b892db6d39c7d18c8_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ide4c77d70ac54992b13f6f397ae45339_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0deff0d97a2e4113ac45f71cc4c1aee6_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i3c7e7c0e30134c1f85ddb2bb2b412b35_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff673b26c96b445a959922f9e0f6766d_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2b6d0590314f493197793e32e6438ba4_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63bb7805ca1545da94822eeccb9d2208_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea7c3564b9c44c23a5c4dfb365017793_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i875db6ff7af64f6c9b97fad10e61b5fd_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idbb4994d91de4c549d6dae2b213aebe6_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8669478b996c461297c9b935fda6b141_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="ida7c7b6ac227491f92c17991812e3869_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f622f3ae0ff49d8b617b9d61d2c97ad_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id3b0cd7d81bb4bb89cd9aa952ab8bd0f_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id09b5abba4b34fb68e4eb34834cba9f1_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i52e307d2445b40d8aa07d3ec14ba2be0_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ec76ab3fed647e58dde13a62d7ab5cb_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1612014e0c7849f8bd70b02fabac071a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i63e77a5395ef4cd98c05a28cd36491b6_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="ib82a8ffe32674a43a4391daf728784cd_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i26f87eb2c79e4687904b9c3be92b905d_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifbdba8e49ff540fe876fbb36882f6f5d_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if506fdf6e01e48fabc4c32668075bd86_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i2772ca9aefb2473c9f3ff73415e8016b_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e90e77c40c74a8d9ce1811c7fec3667_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib8154ac2d56b4a3ebdb3fb57f831633a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i69345f3695f9481ca79acaab212b8bc8_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i333fb6ad9b6b43ac9e8439a13405ff71_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i520c7e479d204ea1ab81cbebaa679338_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i139ff307433f4c42ba54d26e15f894d9_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib4a2be4df4b147d6aad9dab664baae09_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i5b2dabb0c3074d16846d868ece0861f2_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49a6759c9c7f46b5bea7b177dbc8de41_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i92ef11da463d4f049fdb71cb91e6e4ac_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1ed4976cdda34693bc7a2223ae7a47d8_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="ifdde0ae552b34e9394dd2670d0615284_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1bd823528cb5452e9aa3bd695577208b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie6fd54ea912347b6bbee02a245eae55c_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i51af285dcaea45c8a830624ee2362d76_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i04423ea583664800b488265dcd960706_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">mygn:PerformanceObligationEstimatedTransactionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i034631d7d5ef4b7c8d6d34aca4620ab5_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iabcdc79361b245d5916d394962a748d5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i05d1b3e5218742268c6886435321836a_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2974f743032d446b86850b246d3a169c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd8402868f614fb2b5d8521dad255a8b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1a64b6a9eaf445c8e78ea7644ec0770_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i013cb277d59546beb41c64814afb77eb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8283a90bb7fd45f88844263b5bcf523d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0e5b571f465447868a30d8b17e73e370_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i807cd346a0754d6dba10fa435ce3ad0b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic00c784d2aed485bbb379ba0192e5f8e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibdb4f19b39fa4edcb9b9756b242e799d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3637c2bf3c6e4176a82ad149102c6280_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i828a886282af459f9e614c44191e6917_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i91ebf87daee4405886567face5312f8a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i22ae088f58f74d08ab0ee5cc22457e63_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ia8a8fb4d167d466eb4a4cce37a8e2b4e_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i931f10a967bd4961a4edc7f16b906bfd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i896a61f417824c539c7a8aaecb838a3c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4a9f5109771b480db9fd53efad3cf0a0_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i83200f7a7cb74ffb8132d4a54cb8fe09_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1c8d3889def46bf8964906a008e20a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib838376273ee40509009d40b54ad4e6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d419b15db0344df99a90536add6f225_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f6fd7e6971b43b1972bf113b61ed7ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i488a249f7b4a42e39a29a4875e046abc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9a6d1096e6b24d2691f8c3c10e1db359_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f8f4f7fa0654056a7679cd94f503372_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bd6bdb2356e42e79e270f09478ee175_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i239bdbcee2ee46d7816c4aa9f59360cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67e81c739fd94f7aa9cd55bdaa5d052f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45f0be353e5f417cbe7b3331221c88de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4dcb16a16b64061ab91c4bb405d02f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85bf9bccc1f74000bc926d84844d459f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic516541272e1460189dd7d9460be5e00_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a7c5d5ea4d24bd5bc15c709de8583c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75d72cd70f074af99ccef915b106a5c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32a837ac64224a79a96732a4ab5ce550_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84dba07dc1964a8eaaa12c3e6bf3ac13_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9a4dcb3d42434870ab26e0dc5985c286_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i386c2dd77d7b42f1b542c00daa2a0722_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ideb92da4147d4f0aa235d0cbea519f7e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c3dd37fd2174277a0fe47e35a4fcb5a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1476418622484fd6b123b4bcc1a2cd75_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie82bd2619aee4c15a6f7979e3f556c90_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id29e6e511f214306bdfcc76ff6f3baac_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibd61fd98056c4fe8828fa4f7907744d5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i825805b3de504095bdb13927c6069785_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3089884931004023a798595ad2485260_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2426bfb819934ac9a2b31c1f162f3528_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idf88e0e27ffa4a739ee3847915ee542a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4b0a8ffc8cf1459d84e87db58725f2de_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibc4eeb4c0edb43d59cd752375d0ffdc5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i35c10b20b0e9404abc88a8f6d54ce6bb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibff6a96abc6e47a3a7673fe45b09702d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iea094ed8a36e482dad6d4d4ce8912c5e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i418f1c63d800430dbdfe171f2e5fdb7b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i171eeb2ca4ff40c8aa59454fe0649995_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iae043b92111d49dea53104af438cae87_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i43dfaf6a69a9448dbeaad8511ca6599f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i727b4cea45e840c595ed4071c0efc30f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5bbcb194e016455ca224904b253aff7e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i627dc77dc581425492e6a2efc7a71b6a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1779215bab2443df9518c0d760bd4097_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibb619380c1df42aca737476da470cd1b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6f28be2e5f414109aa6edba56d928690_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i29fb3e347dc345cfba47e9db7ea6e116_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic28101a6be104f06a27d6e814b1c6d6c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i76d425a4039143e3bb5d1b13ef3c1d5f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib5905013aeeb4f2cb39823bb0b2d36dd_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3993179bb8cd412da2e86291f6b169ba_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6271e87a89724d4d97a244263fb2044b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i004fd5a8f7654961a111888fd81ed882_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i5590cd4c08ee46cc806334b73e196d71_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6e485d31ad9f497993d65a0f26c27664_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6992e3c7faab476d8c03869ab63ff121_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i148159c157ef42c8a13aff97edbcbef2_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8191d090ea2745db981907ddafd93a9d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ifa2f364539a64eaaa92b3b40cb82a18d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i979b5982652c43468a70262328a06272_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i23f0bb6109514d5090ecfde3255f9f3d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i15149e8fedda4395b8646b2382f7a984_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i5746fc0bcf194215abbb27e272d355fa_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="icfa550eed64f4c2ea0f18c17f0902c9f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="icb748777a421482d8700ebe22fb9d4ee_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib2c60fa1e6044f6e8667dcbf536b76df_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i575f18ab83bc40979444ed5ab8404853_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mygn:ClinicAssetGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i91ea1f91d8664913a4764506bfd207e4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id87ab67a6dd04168b8b70d5bdbae26ca_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0452133252384a1cbc2014d4918a6cae_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6930cef02e60442f932a3ba59be2846f_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0cbd1c604d9240fb9eab710d8047bbcb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf79e13bdaa84cbcb926eceecb0225f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib992d3be9ee24862b803ebce955a4939_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ibe1dff6ed82241299a6565c84a2b4ad3_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i7293118ad87849e1979a9a4529ece677_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i2bd030e591724771a7ef00c6278cee2c_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ife885bcb6b0042d8879fb750f6ac752c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mygn:MyriadAutoimmuneReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i45a2fa48f3c343368a8e72ee16163874_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mygn:ClinicReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i08cb205cf6ff477cbb17f7110077d7cd_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:DevelopedTechnologyAndDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibdf71da88168472ba6c7919001d183a6_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:DevelopedTechnologyAndDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i358e9cbf8de8453c97ef831209748f8b_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90d7ec9fb1de477e8189293731c018d6_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia52ebc6a5c564a3ba28fffe021227a85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib82e7ad1d54745bf9f3e53cb046e5adb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i83a65cbe1f3b4d65b6f51bc3d1b557ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i063c58e973c84e0c90eb3b292cd80d2f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ceb8d39a9034275a4786f69cadfae9d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i05db2823ea2e4f1983fc881d4d120ee6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0836938b4b5749e7b04cda79f7d778d7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib5eb1e7015b84a099b7eec0436d24272_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ide312d0b744845ed9d38a50c79ac314f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3927b5f25dab43d8bba22d95423cf7a5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i368a22ba17754f239a339d70f874d4e4_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i777e19d7ca9f43749f30b1d52f56cb12_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0f6ff2934a84433bafc32b6df84630bf_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="ic8168706f12149b6b5546e5eb8c2880d_I20161223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-23</instant>
        </period>
    </context>
    <context id="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i8db25c9c8c1a4f0d9143e0fa38d1b8c0_I20200501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-01</instant>
        </period>
    </context>
    <context id="ieb698caa638b42d1979314bc3a5847bd_D20200401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id495302512264408b7c35e7b17c70ddd_D20200401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia62ae255eb174dda98733a496df5ac02_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="id0a3ba1b79114c77afaf02ff36fa05be_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="if227e7110e014058a767b9bd13ef0d3e_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i82d2b9e5a08048bf9897aa33a87b7756_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f1482ec3ab648658454bf97344b72e8_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ac03d04962f4c50ba2419ea9529b2bd_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7fa5fc13241a4e07b520ff640cb97a2c_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ica5c0cd9bacd45798f5d92217ef8280f_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i0012a57e73a64c94a8b83d10ea8ca5ba_I20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2016-06-30</instant>
        </period>
    </context>
    <context id="ie6f9ba489d8849db94d404a44fac34d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifee3f7598bd244628200eb7c1522a119_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mygn:OptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib74ba2f47ec14d41bf4fd7f946d4e02f_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">mygn:NonEmployeeDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mygn:OptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idd2633e1f6014c3f8b71c92e1326ca6e_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">mygn:OptionsGrantedAfterDecemberFiveTwentyTwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56adf440338546748219fa30995a4533_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">mygn:OptionsGrantedPriorToDecemberFiveTwentyTwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib34f688522b74b03a5e5fc2174018149_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d7cae64d7814598b02a93c49e574096_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7db90b2bd66041aca744d0be2fd86e66_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifc558508c633449db6077544b82b507d_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29183a8749ff4b8b950a784fb91f41f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4d8a6bd4ff54f7fb304b7cde55db513_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if914d6dc8c544ca9bf117a7b245ae056_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b2ee9bf2f354a29b8a1b740bfdc485c_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea4af06edff047ee8cd215ccaf7dd5a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ba05d7b0e05418d9b5864d5649ff8a3_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8e685bf03924016a2c1ce3f87d79686_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mygn:RangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05899c67f3004572be84cd6af2e63fe0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if13ddbf93c05491fb76d747f160a6ad5_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i38be9b78e6e342588bbc14159dd49ce3_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0ab2a24695d64791be56bebc9b0cb5c2_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i43833f7c5d3b4c9c95d487f7e63e9156_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4bfbbfa5a61e4bc6aa5bdeaa03ce3091_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id248408952024238bf703d63749f4e7a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1127c488310e4180956064bbc8092648_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i02292b2ac40d46f0810c4f1a5b7d76a1_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c834bbd0ecb46ad9e21a66915c89bee_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia7909094154b445eb24949027733ca0d_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i69beccee306244899e7edc744b9830e8_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i684fee383d8541d38b5854aeea927eef_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iccae9b334463460489fb7e7e124291af_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5d841afaaabb47038d152a7cc4778e70_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i670c9600a2a343be93044b942108970a_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="ie295001ae44145ad9a4d6b31fb6ba297_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i31d63dfe2df342b8b82f3e732ee0282e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2d855b4fd3e14b829f9b52d5ab9a2dec_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ied19858901194f0fb47bb12a54ee79e3_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i2ad05ffee6ab407185af3f3ebf0e736f_I20121205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-05</instant>
        </period>
    </context>
    <context id="if5e8d6c3e7334a0db7f88d66dc52bdb9_D20121205-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-12-05</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="ieaf36f83f64d4f13b41bbd03dd9248e5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i8fac106fccce4731bad8f044406b0d14_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04912f8e67024702bb6f1c7d9d8715ea_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib296c9d50bcd48e081759995543ac418_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7682eeb892144ef397fcb8d2b3f3b075_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i339e09f971f1423ca61ec703598013f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifef84203e8cf4c45a050df8ee892e0ab_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0e4dd2b1c99b42c4830a26066e6f5d03_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff189668e46b4b2d99f01b54ece5899e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a77486cbfda4985a95b5409f5114d75_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8dee92637b14ad4b0ddc3ee7a893148_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28b353bd32614ef98f4d1b7b28197946_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i801b880fffca41b7981a7975da3eba9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:OtherStateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e435f848ff041c69b87c98ccab2b8f2_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:OtherStateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6f20a97b70f8439284f983b91fd4a5ce_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:OtherStateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7066ecd804994d66ab4a3853aa09f501_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:OtherStateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifc0e279dbee74c3b96393ff366a521d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i442e0a95c01243a3836a2900086d9a01_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3a8545dd5b34bafb56de3bd607512ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8308537e63d24a72a6fcf5c902e127e2_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i373106c9787844db8567a937ae2715a1_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7667d8c3c8a9406ab36ea5da42680f55_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2893df02bcc84b2e95bf0c21a4687f83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3484e0b911345c28f8748b196210eb4_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i65319c42541d4efc8d864e8dcfdd14e9_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if348e8b1625f477a94c7cf316377a0f5_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:UT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1d7ca3e4ae2740b884faeec8053514ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5b6e713bd16480f900779c66826595d_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i994ec55512434040bf3680a9030ee7ce_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i87c5f75363cf466e8c5c30864649562a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i394783302fb644de93bf6aa850b4dc82_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92918a0809ac433d8348fe4fa4338b6b_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5864baf1324e4e15b61aadc049035ef1_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3aa2c73215b4412381289f30cd0a1630_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2263ff4bbd034dac9cc9bc7dbeb427ea_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbfaa476fbe246298adb7720d942ac91_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i77fc28b9a23e4dfcaa3fbc650b50adbb_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30273d0d5378455ba4f0bb60b947d31e_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f0397e662d04de99568a428f4703477_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if0d38d53cfdc4cd0afb30d1604caabf9_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia9d4db6aa0484fc0a5e43e4cfb14bc3a_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90c324220132439d95ca49aab6989a29_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:FederalMinistryOfFinanceGermanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2e4548adbe5b4e3d9fb80fd7b51ed7cb_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:FederalMinistryOfFinanceGermanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i259c8637e98a44e8aec3d5243fde0562_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf91bb0e041742dfbd75694127229a2f_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i550af371f2b04deca040bcd59c119038_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied2066eada724e118523d0b6f7522a9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i91ef0e4a089942639d68319973aeaa47_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic71c74fc3d084045809129a196e2f974_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i664dad294d884038be88785f325b2bf5_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i476843d04c844d4e95a7e5e176903dcb_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia4659bde391c4d01852f685ef94ad2be_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i89e55ec2aeb84ba29ad2e15182881349_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i3ef3b53c398c432a93dbdbb67ae409c1_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i428a5fa0807f4da086f039c34215397a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0db858d5901a46708854a964d2b950ba_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ied74c9d465394d488f630f4d4876d14a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib4a637b79289401cacaeae110a5223e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i33b939605911461db48890438cae974c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iea3f9a2649e348faaacb48e8cc8e8902_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie2a0de5212d9437b9c547a36e207b87f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2e876378b87406f8adbbf8ce2e6cddd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i395a6bf2ed5a4516a97cb9dfd143feb1_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i950b875f77734623b789ea990425b829_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a1f560877784761aecb5fecd5cc3ec6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibb7f24f854d147699f0cbec384e49317_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i71f9622e189741ed9e209051bad9c565_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i095006ddbfd24e619e8e422986256785_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia9be740ad7044f4882e0d2a5c0a6dc86_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iaed4be03cd544752819f842c6fdf12ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d28bb175fb446de9c4a1a2ff2e5f146_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id8619e2e18714ee0808436fe3942e76f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8622695f21e2408d87455391982da0ec_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27e62f9190914161943bf5ea28f91cef_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifc2b51c7302d434a8cc407ad3c95cc0e_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie4d9c21becba4a2e82b923527a2ec975_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i2a0fa951cb5a4ec2b189987010cc8a1c_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib714b0e057fc4f5e8fb0c1045086c48f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icbe81c4efa2445fdb62fa8055200c3d2_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6b03b59516e541509ec6f0854b5b2266_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mygn:ClinicAssetGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-28</startDate>
            <endDate>2020-02-28</endDate>
        </period>
    </context>
    <context id="i93a834facdc34dff87795122a884aa47_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i4404c2e49c864be6b8c89615b7c19e72_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i01ca278c54bd4c979932880e1cf44d22_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib375fb1450054a4aad0facea3d6370ce_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i989c0ce93f6e4f0fad3b86a4df6adedf_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5274fcc1e4cf4cddb09da83ac2cbc368_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mygn:CounsylIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i4e14cc8f30fb41298c08929c2d88cda2_I20210222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-22</instant>
        </period>
    </context>
    <context id="if4d51abe6c704a11849ba0fee98381b0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7379beb581ae4463a448487c90805d3e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie8d38cab5c564bc9b20105859dec05a3_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i417fd6436fa34961ad7783ba3007e98d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie222e257470d49d4b5328c8b76c753c1_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i280a6b01f275425d87a80ea2b0b0a40e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iacfe0fce6e9744d5958f4fc65b2cceb5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7da9afb8114544a681d59d52fbda4b5f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia66a2e9352774e61bb66d72a0ec6ba0a_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaa76971edb2f495597ee3f81808bc71c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieea11b6adbeb41c5bcf4dadb78975fbb_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if5aa650d52994396ad41ee3b0e5b738c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i18f36b0ed57f4719bdab785d76fd50ae_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2c8bb11b2e0d4568a0ef8208b3edb143_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i69d1e7b850654e99931da975936ee358_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i30498117f20e422cbecf6623972988bf_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i41ddfab48a7c49588075c9ec7dc244bc_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:GoodwillAndIntangibleAssetImpairmentChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i66fa6edac2d94c43bca8e78ac4dac0ea_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4eec8d2bdc5c4301bfe722e319ae93cc_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i6c5f6f6847984744b8727e6b2748075b_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if6d258bc15d9449697c4b3d79d8b436b_D20180701-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="i4ad87c73a1144a68bba850b4fd323dcf_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib895d88eeb224f0886c00fd6c2b4b139_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i313a22005bec4e29ad90ba1925c6405a_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i25884080c80b406690ede2277d9da6dd_D20180701-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="id4c958e9dcae428b93a535d59a805155_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="iaea7896145214af8aee0379692eb0499_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="idf7a7e67e93c4b6c84e303b4742aafc0_D20190701-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i90c63d45d0a049b1b11b7c5d73024451_D20190701-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="security">
        <measure>mygn:security</measure>
    </unit>
    <unit id="plan">
        <measure>mygn:plan</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="segment">
        <measure>mygn:segment</measure>
    </unit>
    <dei:DocumentType
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl8zLTEtMS0xLTE1MDI2_1eaef4a7-f5b1-4623-b6c1-06b9d67e5791">10-KT</dei:DocumentType>
    <dei:AmendmentFlag
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl80LTEtMS0xLTA_87a6349a-9b8a-4954-94dd-fbd6d3c4607d">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl82LTEtMS0xLTA_fa5668cb-f72c-435c-95d4-efb06548bb2e">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl83LTEtMS0xLTA_19693f97-7014-415f-bbbb-48e3743bf4c5">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV80L2ZyYWc6OWQ3NmUyZDA4YzdiNGI5Zjg1MWI2MWVjOGU4Mzc3ZGYvdGFibGU6NDc3MDFkOTNiMmY3NDg1Zjk2MTdkY2JlYmFkMGY3NjYvdGFibGVyYW5nZTo0NzcwMWQ5M2IyZjc0ODVmOTYxN2RjYmViYWQwZjc2Nl8xOC0xLTEtMS0w_fa5f3cb7-ac37-4d29-b48b-2d01217cd98e">0000899923</dei:EntityCentralIndexKey>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3c7e7c0e30134c1f85ddb2bb2b412b35_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYxNA_1b34527f-c366-49c7-adfd-f87850ee8bcc">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2b6d0590314f493197793e32e6438ba4_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc2NA_20a77949-7d3f-4d64-b771-723fbeeb3bce">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i550af371f2b04deca040bcd59c119038_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE4MA_d8822eb6-7013-498c-93f5-ea1a56cc78c9">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <dei:DocumentAnnualReport
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6Nzg5MGZmMmNhMWFiNGY5MWIzNGZlNjE2NTJlYTM4ZmQvdGFibGVyYW5nZTo3ODkwZmYyY2ExYWI0ZjkxYjM0ZmU2MTY1MmVhMzhmZF8wLTAtMS0xLTA_13ff8dc0-4b0a-41fe-b155-57d6b4c64c15">false</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6ZWQ4Yzk5YWE0ZDliNGI0MTlkMDMyYzJlNjEwMDg0MDMvdGFibGVyYW5nZTplZDhjOTlhYTRkOWI0YjQxOWQwMzJjMmU2MTAwODQwM18wLTAtMS0xLTA_f93d2a5c-9cf1-4eb5-b2f7-d63c367fc5a9">true</dei:DocumentTransitionReport>
    <dei:DocumentPeriodStartDate
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDE4_3ab0e08d-0caf-4bdd-b5f4-e309a2511e72">2020-07-01</dei:DocumentPeriodStartDate>
    <dei:DocumentPeriodEndDate
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDIy_dfb0fcae-f257-448d-9aad-2e3c0b725faa">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDIy_43c1f6b1-c18f-4e8f-a75a-d9b9511274a0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityFileNumber
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDk2_88839caf-1155-4279-af24-d9140971e5b0">0-26642</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDI3_b5704273-28e1-4eda-9ba1-3bf6b48aa7e5">MYRIAD GENETICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDI4_b07776e6-9cec-4b90-8c59-e61086f159c6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDI5_eec19089-1b07-4841-964a-1a6dd18370a6">320 Wakara Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDMw_99beaa2e-58b0-431f-ba8a-1e3fcd60630a">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDMx_f945fffa-be5f-4c2a-9ec1-ce751a47c6ef">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityTaxIdentificationNumber
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDMy_9c3e12ed-2539-4aee-a6ab-431f37184c16">87-0494517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressPostalZipCode
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDM1_d42d7366-8153-4d13-8f18-ccbc25e08126">84108</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDYy_999580d7-f967-4579-ad00-f2f3309a4d90">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDcx_ee81c29e-b69c-4f4c-9469-3b91babb8ba3">584-3600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6MjcwMDAxM2FmNTlmNDdiYWIwMjI5MTU4ZmI1YjdkY2QvdGFibGVyYW5nZToyNzAwMDEzYWY1OWY0N2JhYjAyMjkxNThmYjViN2RjZF8xLTAtMS0xLTA_b8e90b49-72cb-4ac7-8e19-4b87c35140a6">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6MjcwMDAxM2FmNTlmNDdiYWIwMjI5MTU4ZmI1YjdkY2QvdGFibGVyYW5nZToyNzAwMDEzYWY1OWY0N2JhYjAyMjkxNThmYjViN2RjZF8xLTItMS0xLTA_e7f969d6-e62f-46eb-96ca-6bb388763aa0">MYGN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6MjcwMDAxM2FmNTlmNDdiYWIwMjI5MTU4ZmI1YjdkY2QvdGFibGVyYW5nZToyNzAwMDEzYWY1OWY0N2JhYjAyMjkxNThmYjViN2RjZF8xLTQtMS0xLTA_d1c475c9-f5e7-44c0-8a1f-e864ae1b0be4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDc5_2175b49b-22ec-4e2c-a484-caabc82262e9">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDc4_fbab5973-63f0-408b-8aac-689aa228b5b3">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDgw_84258246-020b-43bd-97a2-585413537ac1">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDgx_1f790045-2218-4bb4-9b77-02f536290341">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6YzI0ZTBhYWEzNTZhNGM3NmJiYjc5ODk5ZDkyOGMxNDgvdGFibGVyYW5nZTpjMjRlMGFhYTM1NmE0Yzc2YmJiNzk4OTlkOTI4YzE0OF8wLTAtMS0xLTA_cee6c2ac-689f-42bc-9eb4-cbd2a0509c10">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6YzI0ZTBhYWEzNTZhNGM3NmJiYjc5ODk5ZDkyOGMxNDgvdGFibGVyYW5nZTpjMjRlMGFhYTM1NmE0Yzc2YmJiNzk4OTlkOTI4YzE0OF8xLTQtMS0xLTA_a531895e-668d-441e-b6e3-4c0c41c138d3">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGFibGU6YzI0ZTBhYWEzNTZhNGM3NmJiYjc5ODk5ZDkyOGMxNDgvdGFibGVyYW5nZTpjMjRlMGFhYTM1NmE0Yzc2YmJiNzk4OTlkOTI4YzE0OF8yLTEtMS0xLTA_8a4c673d-a848-494c-8935-30e71cafec51">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDEx_c9047b46-ddb2-4aab-9f8f-d91ef0db8279">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF8zNjUx_2017a06d-f7d6-4212-8e66-ecf9d78b5a69">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF80OTQ3ODAyMzI5NDgz_77df50a7-5015-4f1d-b4b1-e8ce69e100e4"
      unitRef="usd">847193483</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i12f58929baf0442f9477c970c47bf549_I20210309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF8zMTky_39c1814c-6c94-469b-b9fe-53472cfa9e23"
      unitRef="shares">76297150</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xL2ZyYWc6YzMyZGI2ODc0YTE1NDMyYmFhNmUzN2E1MGQ5YjZkNTgvdGV4dHJlZ2lvbjpjMzJkYjY4NzRhMTU0MzJiYWE2ZTM3YTUwZDliNmQ1OF8zNjQx_0b6f3d72-57a6-4c1e-85c6-3bb2d7ce4b43">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following documents (or parts thereof) are incorporated by reference into the following parts of this Form 10-K:&#160;&#160;Certain information required in Part III of this Transition Report on Form 10-K is incorporated from the Registrant's Proxy Statement, to be filed no later than 120 days following &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, for the Annual Meeting of Stockholders to be held on June 3, 2021.&lt;/span&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNC0xLTEtMS00NTE_82806cc2-ec2f-4f5d-aadc-ed1f51150d37"
      unitRef="usd">117000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNC0xLTEtMS0w_d0accf03-e865-4827-b44b-b3733227a990"
      unitRef="usd">163700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNC0zLTEtMS0w_a0b569c4-b36c-4677-8f6a-58e7c0da9839"
      unitRef="usd">93200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNS0xLTEtMS00NTg_25d0b315-1b7b-4ac9-90d2-735d16f36a0c"
      unitRef="usd">33700000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNS0xLTEtMS0w_ce3d9fb7-6b92-401b-8bca-036fac940b59"
      unitRef="usd">54100000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNS0zLTEtMS0w_85ad8686-45b8-4685-9241-0c8b6e3634c2"
      unitRef="usd">43700000</us-gaap:MarketableSecuritiesCurrent>
    <mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNi0xLTEtMS00NTg_1fa9271c-9c94-4c2d-af4e-4c70adc9db93"
      unitRef="usd">11700000</mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent>
    <mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNi0xLTEtMS0w_7fa2d6b3-1c4f-452b-8149-6e84a62d2279"
      unitRef="usd">13800000</mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent>
    <mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNi0zLTEtMS0w_c6e071fe-1ac7-4a0e-8216-680478b08539"
      unitRef="usd">16600000</mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent>
    <us-gaap:InventoryNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNy0xLTEtMS00NTg_617dca9e-ea91-4234-91aa-e9998bba013c"
      unitRef="usd">27100000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNy0xLTEtMS0w_1f0a6c56-cf84-4ce5-9cb0-e854e97a46bc"
      unitRef="usd">29100000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNy0zLTEtMS0w_f888edca-e3b5-475f-8e71-176195816b18"
      unitRef="usd">31400000</us-gaap:InventoryNet>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOC0xLTEtMS00NTg_e5fe176b-193c-4909-bb3b-9d4ff8077222"
      unitRef="usd">89500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOC0xLTEtMS0w_08a991f3-605f-49ac-8d9b-6831b2fe7600"
      unitRef="usd">68100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOC0zLTEtMS0w_0fd95373-b759-44b4-9d8a-983f3f070f90"
      unitRef="usd">133900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidTaxes
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOS0xLTEtMS00NTg_a595272d-523c-44ec-a8d1-12dca66f3a12"
      unitRef="usd">108400000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOS0xLTEtMS0w_958fc6a5-7a1f-41a2-bdda-61aa098bc9c7"
      unitRef="usd">0</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfOS0zLTEtMS0w_96c9cf80-4c82-4c50-b27f-494ec9c60dfd"
      unitRef="usd">25100000</us-gaap:PrepaidTaxes>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTAtMS0xLTEtNDU4_70fe4634-ef5e-4290-811d-e980f4c9a0d8"
      unitRef="usd">2000000.0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTAtMS0xLTEtMA_764293be-2e0c-474a-a21f-09cc28c5d181"
      unitRef="usd">2900000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTAtMy0xLTEtMA_5f8de33f-9727-4f56-9415-24273b225c1f"
      unitRef="usd">4700000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTEtMS0xLTEtNDU4_0c271e88-b2a0-42bd-9718-a1c8ad58787b"
      unitRef="usd">389400000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTEtMS0xLTEtMA_cb1b24fe-00d8-4ed8-920a-2defc0c41aef"
      unitRef="usd">331700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTEtMy0xLTEtMA_0742d040-0671-4d56-8a61-6d2922086a37"
      unitRef="usd">348600000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTItMS0xLTEtNDU4_f2731463-d1e1-4e70-8c35-63165412dc6f"
      unitRef="usd">40700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTItMS0xLTEtMA_a860c509-321f-40f0-9525-218653b66e41"
      unitRef="usd">37000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTItMy0xLTEtMA_dbf9c03c-a5c9-4cd0-a6f2-fd7c80585723"
      unitRef="usd">57300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTMtMS0xLTEtNDU4_b7de98e6-c2f6-49fd-8e3c-8cad9a7eb8ff"
      unitRef="usd">59700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTMtMS0xLTEtMA_2ba7be32-9975-45bc-9c40-5e951e872a31"
      unitRef="usd">66000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTMtMy0xLTEtMA_1ad5d25f-78b9-4f25-bac4-ad1b1229d81c"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTQtMS0xLTEtNDU4_629aa629-3a39-4a16-8a1d-14d071d7d6f1"
      unitRef="usd">21000000.0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTQtMS0xLTEtMA_a81fab52-820d-4c6e-9e99-7002f0345bb4"
      unitRef="usd">37000000.0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTQtMy0xLTEtMA_fd8e538b-8a67-4c9d-aab4-244d9b35c892"
      unitRef="usd">54900000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTUtMS0xLTEtNDU4_3d779f76-996a-42ae-8984-e86c2f831640"
      unitRef="usd">576500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTUtMS0xLTEtMA_2e6053a1-0694-426e-b9ae-8ca84fa68772"
      unitRef="usd">605300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTUtMy0xLTEtMA_a7c8fa5b-5e71-49fb-af04-03cb7b88f7c3"
      unitRef="usd">684700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTYtMS0xLTEtNDU4_cdfcacc8-83c8-47e3-b6d8-db2d6f2fe495"
      unitRef="usd">329200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTYtMS0xLTEtMA_961fce50-955d-4450-a1b3-17945f516408"
      unitRef="usd">327600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTYtMy0xLTEtMA_5bb59b11-4576-45aa-9797-f2752aecef22"
      unitRef="usd">417200000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMS0xLTEtNjUyNQ_8c9d2309-3146-4ee6-925b-6a478af476dd"
      unitRef="usd">2300000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMy0xLTEtMTM3ODE_c29b03f6-e861-4619-89e5-917f72df6ff8"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctNS0xLTEtMTM3ODM_596dabd9-d621-4bcc-920c-af35df2dc1cb"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMS0xLTEtNDU4_45aaf753-0407-45ae-b36f-2182e618db18"
      unitRef="usd">1418800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMS0xLTEtMA_3d2185af-0428-469f-8d8b-3e8298886573"
      unitRef="usd">1404600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMTctMy0xLTEtMA_a622e912-cfd0-4031-ad1a-27061d920b5a"
      unitRef="usd">1562700000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjAtMS0xLTEtNDYx_d869e4f1-429d-4b4b-99f7-7ce90a9ee730"
      unitRef="usd">20500000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjAtMS0xLTEtMA_af9036c0-2dca-4f52-a083-31d633aad762"
      unitRef="usd">21700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjAtMy0xLTEtMA_3e8348a2-400a-4005-b9db-86667a7e9426"
      unitRef="usd">33300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjEtMS0xLTEtNDYx_06d863fd-5b8b-470a-9985-df342486af48"
      unitRef="usd">79100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjEtMS0xLTEtMA_f6e5bb7c-3844-48d8-8267-24d6e3ddeb31"
      unitRef="usd">79000000.0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjEtMy0xLTEtMA_bcb036d3-282c-4dc3-a29d-b5d24d3f45a5"
      unitRef="usd">82300000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjItMS0xLTEtNDYx_f3c63817-8903-4e50-a790-44c7ecad9632"
      unitRef="usd">13600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjItMS0xLTEtMA_ef9413e5-4934-4076-b2ba-3fcb6f73afe5"
      unitRef="usd">13500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjItMy0xLTEtMA_f109adca-adcf-424e-bb5b-b721a4fc84c1"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjQtMS0xLTEtNDYx_dbe86c00-a0a7-48ad-9b0e-ad6dfdfeabd7"
      unitRef="usd">32700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjQtMS0xLTEtMA_6b1e608b-652a-41a4-8734-6f4419fffa02"
      unitRef="usd">32800000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjQtMy0xLTEtMA_8c21bd67-45ec-49ad-86cd-9052bc398a3f"
      unitRef="usd">2200000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjUtMS0xLTEtNDYx_a4f21a8b-9f78-4857-9deb-695b8c985758"
      unitRef="usd">145900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjUtMS0xLTEtMA_b62a4688-07af-407d-a3a0-7b45ea17942f"
      unitRef="usd">147000000.0</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjUtMy0xLTEtMA_d9f9af01-3957-4038-8d3f-318dbfdb5e5a"
      unitRef="usd">117800000</us-gaap:LiabilitiesCurrent>
    <mygn:UnrecognizedTaxBenefitsNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjYtMS0xLTEtNDYx_6fc1cf00-7b0d-4b4f-8a37-2a9732a49beb"
      unitRef="usd">30500000</mygn:UnrecognizedTaxBenefitsNet>
    <mygn:UnrecognizedTaxBenefitsNet
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjYtMS0xLTEtMA_07d661f8-0487-4805-9325-ad398b94cabf"
      unitRef="usd">23500000</mygn:UnrecognizedTaxBenefitsNet>
    <mygn:UnrecognizedTaxBenefitsNet
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjYtMy0xLTEtMA_b2e740b2-8b74-4e95-a526-6dcaecf09399"
      unitRef="usd">21700000</mygn:UnrecognizedTaxBenefitsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMS0xLTEtNjUzMw_cbe9b0a8-9aa4-4b95-a9fd-32e0456be8a3"
      unitRef="usd">71300000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMy0xLTEtNjUzNQ_fc5b3ea0-2317-4d66-bff1-763b62d4a3f9"
      unitRef="usd">26600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtNS0xLTEtNjUzNQ_5b613a54-d81c-4e9e-a7a1-5ed6e5d9cf34"
      unitRef="usd">82600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LongTermDebt
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjktMS0xLTEtNjU0Ng_d7e1f17a-b45e-4805-acc5-fd26cfb6db2c"
      unitRef="usd">224800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjktMy0xLTEtNjU0Ng_2cbb3e69-d1d6-433f-8867-d33c08893a93"
      unitRef="usd">224400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjktNS0xLTEtNjU0Ng_bb7e952f-bfea-45f6-9e05-2fbc8fe5dd78"
      unitRef="usd">233500000</us-gaap:LongTermDebt>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjctMS0xLTEtNDYx_88a16120-0225-41c2-8a09-2262a0bf5221"
      unitRef="usd">50600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjctMS0xLTEtMA_9f4f3426-5210-4c3b-918a-6ed29e1d0f78"
      unitRef="usd">56900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjctMy0xLTEtMA_e5fc352a-3135-4cb6-8516-9d2bd23cbefd"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMS0xLTEtNDYx_918de255-87b6-4761-8dd6-a206a079204d"
      unitRef="usd">14700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMS0xLTEtMA_0cac4840-e9ba-4a24-ba07-9e0a02a5e9d9"
      unitRef="usd">8000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMjgtMy0xLTEtMA_e7e645d1-be85-4fa2-806d-362ca02e8c53"
      unitRef="usd">18200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzItMS0xLTEtNDYx_983f567d-088c-47c2-b5ce-4e85be1b6d5e"
      unitRef="usd">537800000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzItMS0xLTEtMA_5d84e696-0c26-42f0-b78b-1c44e60ac59a"
      unitRef="usd">486400000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzItMy0xLTEtMA_749aa494-5e7d-4648-b156-6f03d1bf5e03"
      unitRef="usd">473800000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzItMS0xLTEtMTM4MjI_b8ca94ce-2fe2-4eda-946a-73b92df2ed24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzMtMS0xLTEtMA_99d24724-27d5-49bb-bab2-587317e8b14f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzMtMy0xLTEtMA_70ebdc58-01dd-435d-a3c7-f7934374c00a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzQtMC0xLTEtMTM4NTgvdGV4dHJlZ2lvbjpiOWU4NTQyMDUxY2Q0Nzk4YTI0ZjNiNGRhMjE5MzViMF8xMTU0NDg3MjA5MTc3NQ_0610e208-c473-472b-835a-264e41603b12"
      unitRef="shares">75400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzQtMC0xLTEtMTM4NTgvdGV4dHJlZ2lvbjpiOWU4NTQyMDUxY2Q0Nzk4YTI0ZjNiNGRhMjE5MzViMF8xMTU0NDg3MjA5MTc4Mg_3862fcdc-a755-480c-82c0-364fd56cd4bf"
      unitRef="shares">74700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzQtMC0xLTEtMTM4NTgvdGV4dHJlZ2lvbjpiOWU4NTQyMDUxY2Q0Nzk4YTI0ZjNiNGRhMjE5MzViMF8xMTU0NDg3MjA5MTc4OQ_f2abb5c6-a4b0-402d-965d-14116cdd9f98"
      unitRef="shares">73500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzUtMS0xLTEtNDY0_4410fbd4-2485-4897-a626-6ac2b38dbf7b"
      unitRef="usd">800000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzUtMS0xLTEtMA_ee3c8c98-715a-4e8f-b509-a64a6f68d6e2"
      unitRef="usd">700000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzUtMy0xLTEtMA_3d36845f-f2d3-46ed-b46d-9593786e94a1"
      unitRef="usd">700000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzYtMS0xLTEtNDY0_c65c1e13-d08f-484a-88fe-ee08fa5f150d"
      unitRef="usd">1109500000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzYtMS0xLTEtMA_16b6f3f6-e314-4bf4-ac34-ff560b48eace"
      unitRef="usd">1096600000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzYtMy0xLTEtMA_81684969-2036-4dec-91a8-0cbb2902fb90"
      unitRef="usd">1068000000.0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzctMS0xLTEtNDY0_b8a47ef5-6e2d-46c8-bb6f-caaefeb0e286"
      unitRef="usd">-2300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzctMS0xLTEtMA_811b2ecb-0be1-488d-b7bc-94ba955b12e6"
      unitRef="usd">-5200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzctMy0xLTEtMA_5b9685f6-7ed4-41d6-b070-b31f523f5af7"
      unitRef="usd">-5400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzgtMS0xLTEtNDY0_f29b987a-5b29-4ebb-a379-509f73dc88a1"
      unitRef="usd">-227000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzgtMS0xLTEtMA_c93cece8-f751-4c33-aa33-b05fa50b1ecc"
      unitRef="usd">-173900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzgtMy0xLTEtMA_22b2c75d-3628-4195-b765-96d843b84714"
      unitRef="usd">25600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzktMS0xLTEtNDY0_49e9d6d0-1337-4500-82fc-e22614281dd9"
      unitRef="usd">881000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzktMS0xLTEtMA_e0d10d81-3ee9-48a5-a19a-258a03d10f78"
      unitRef="usd">918200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfMzktMy0xLTEtMA_5ac9ddfa-2c62-4512-bd3d-3a61ae90c744"
      unitRef="usd">1088900000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDAtMS0xLTEtNDY0_38ec5440-afea-4916-9c24-4463bc5aca3f"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDAtMS0xLTEtMA_2ff68495-9184-45b3-80fc-b1d52f482604"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDAtMy0xLTEtMA_1d741d7c-81b8-4076-82af-7e1a65ef6b84"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDEtMS0xLTEtNDY0_aaf9e735-66cd-4b01-a98e-5caee14b118c"
      unitRef="usd">881000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDEtMS0xLTEtMA_6bd5ec2f-49ba-4693-9451-1fbe03b480bf"
      unitRef="usd">918200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDEtMy0xLTEtMA_056f3560-71f5-42af-a66e-f59968b7c26b"
      unitRef="usd">1088900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDItMS0xLTEtNDY0_7e29eb48-963c-4da3-9367-7c8664a6d631"
      unitRef="usd">1418800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDItMS0xLTEtMA_d6187821-a7b4-459c-bd79-b8b8146ba360"
      unitRef="usd">1404600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV83Ni9mcmFnOmZhNmRhZWRiZDg5NTQzN2VhMjIwZWIyZjM0OGVlMGFkL3RhYmxlOmVkODRjNGY0MDQ2ZTRkZTdiMTlhOTAwN2QwZTA0NWVlL3RhYmxlcmFuZ2U6ZWQ4NGM0ZjQwNDZlNGRlN2IxOWE5MDA3ZDBlMDQ1ZWVfNDItMy0xLTEtMA_b22e0a7a-762b-496b-b873-b4d3ee59bdaa"
      unitRef="usd">1562700000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic729b712df4f4a8ead8475fab8f0790d_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMi0xLTEtMS00NzA_de7bf453-e2a9-48d9-a5ef-08f714a4eb09"
      unitRef="usd">279600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib871150772b344349cbdf35a395d8267_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMi0xLTEtMS0w_03bd5541-cf22-4f89-8032-04d513f06980"
      unitRef="usd">586900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7633cb8e372444994b1efa8de166955_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMi0zLTEtMS0w_ecf49399-3122-4a80-8dce-b2e1030d684b"
      unitRef="usd">789400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie935c63c1ef24d07993e26cd5a18d415_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMi01LTEtMS0w_ef13812a-1d5d-4f15-8d3f-2babcc607a8c"
      unitRef="usd">690400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c097ed969db458690ef357352106593_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMy0xLTEtMS00NzA_ec10df1b-03a4-4536-85d8-23438d6b6a90"
      unitRef="usd">20200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4fbf604a73ce4ed6bb5884b4cb199fac_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMy0xLTEtMS0w_45949589-8c25-4e69-bee1-bdcb4a937b1f"
      unitRef="usd">51700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib094ccbcf5d544e9803960dda6b5c3f0_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMy0zLTEtMS0w_9ffcd166-f75b-4d43-a0cb-a2ac303cead7"
      unitRef="usd">61700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97a926ad86c54867989a14b026bd3593_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMy01LTEtMS0w_4bf2191b-b890-4f62-89fb-4600e7c11007"
      unitRef="usd">53300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNC0xLTEtMS00NzA_91405895-8bd8-43d6-9e90-363107ef992f"
      unitRef="usd">299800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNC0xLTEtMS0w_eac71abe-9d3c-43e3-8bf2-5f523fa7eeab"
      unitRef="usd">638600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNC0zLTEtMS0w_c9e9cc3a-d8a1-41a9-ac2c-0bf76e75fd77"
      unitRef="usd">851100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNC01LTEtMS0w_5a30a794-6b92-4743-b702-1be8eeaee585"
      unitRef="usd">743700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic729b712df4f4a8ead8475fab8f0790d_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNi0xLTEtMS00NzA_6232e853-52fb-4ffe-9adb-7ea978050b2c"
      unitRef="usd">82600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib871150772b344349cbdf35a395d8267_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNi0xLTEtMS0w_3d495606-fb9a-4751-adaf-c698c46b594f"
      unitRef="usd">157500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic7633cb8e372444994b1efa8de166955_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNi0zLTEtMS0w_a29f3516-1950-4f5a-bfdb-c8fa5273f8c4"
      unitRef="usd">168200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie935c63c1ef24d07993e26cd5a18d415_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNi01LTEtMS0w_2eac113e-fa53-4fca-b58c-fc35507ff38a"
      unitRef="usd">148700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2c097ed969db458690ef357352106593_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNy0xLTEtMS00NzA_c0d1872b-8358-4f5f-a48d-38e48e02e23d"
      unitRef="usd">8800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4fbf604a73ce4ed6bb5884b4cb199fac_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNy0xLTEtMS0w_17061b9e-cffb-472b-b3c4-836b1c454a14"
      unitRef="usd">28600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib094ccbcf5d544e9803960dda6b5c3f0_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNy0zLTEtMS0w_5f5e5230-4315-42f9-bc0c-0e561c17c568"
      unitRef="usd">32800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i97a926ad86c54867989a14b026bd3593_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfNy01LTEtMS0w_411d7944-db8f-424f-bb6e-c03600f8b9d9"
      unitRef="usd">28500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOC0xLTEtMS00NzA_55b2d686-4f41-48b4-8bfd-0c943dcfc843"
      unitRef="usd">35800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOC0xLTEtMS0w_20a4fcbd-bce7-410b-8a29-7d1215a67c7e"
      unitRef="usd">77200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOC0zLTEtMS0w_36eb0dbd-88c5-47c2-bafe-f6c081db780e"
      unitRef="usd">85900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOC01LTEtMS0w_454306e0-c34b-45fe-9531-90af160d9e5c"
      unitRef="usd">70800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOS0xLTEtMS00NzA_6ec19f30-d1de-40fd-8b78-53cd3f07c76c"
      unitRef="usd">3500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOS0xLTEtMS0w_ddca314d-34c2-415f-a029-ab303d2bd367"
      unitRef="usd">-2800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOS0zLTEtMS0w_e6f31ee7-8aa9-4281-b2b1-c650a2fb67fc"
      unitRef="usd">1100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfOS01LTEtMS0w_a3afb4d7-9d39-44bc-8dbc-81693c8928e5"
      unitRef="usd">-61200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTAtMS0xLTEtNDcw_644a5a47-b82d-49b2-841b-07172a5b9d62"
      unitRef="usd">256900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTAtMS0xLTEtMA_edf0b0d6-abdd-4c7c-966d-1434bdee21b6"
      unitRef="usd">510100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTAtMy0xLTEtMA_7f6fe8b3-6028-4cba-a15d-c6367e4a1535"
      unitRef="usd">555500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTAtNS0xLTEtMA_51160e05-3356-497d-966c-0a9fb1633897"
      unitRef="usd">435000000.0</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTEtMS0xLTEtNDcw_a38380c7-1ad8-48bc-9fad-1ce4354935b0"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTEtMS0xLTEtMA_7e3f6c79-d90c-46ef-8692-378e2c4fb84f"
      unitRef="usd">99700000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTEtMy0xLTEtMA_19216d18-00a1-4c89-a087-7bed619c25e3"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTEtNS0xLTEtMA_5c1baf72-979e-463b-8554-3d524e404470"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:CostsAndExpenses
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTItMS0xLTEtNDcw_53a0c75d-8851-4f50-adb2-6b7415ee7729"
      unitRef="usd">387600000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTItMS0xLTEtMA_a10d27d2-d7ea-43a5-b27e-94835d48c269"
      unitRef="usd">870300000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTItMy0xLTEtMA_d2ad95f6-e618-4b37-853f-870ff254bd3c"
      unitRef="usd">843500000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTItNS0xLTEtMA_64f6be2d-fee4-465f-8d51-b9588141e28e"
      unitRef="usd">621800000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTMtMS0xLTEtNDcw_2c91112b-e3b7-4e6a-bb2a-97fdba02e640"
      unitRef="usd">-87800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTMtMS0xLTEtMA_3413e2b8-f48c-4bae-b63f-5b367438b543"
      unitRef="usd">-231700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTMtMy0xLTEtMA_e1d54998-8286-4fe8-ad4c-17261a782798"
      unitRef="usd">7600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTMtNS0xLTEtMA_210ae50d-263e-4af8-bf7c-b0fd586ddb43"
      unitRef="usd">121900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTUtMS0xLTEtNDcw_ab701e64-8229-4857-8dbc-432d3ece12c8"
      unitRef="usd">700000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTUtMS0xLTEtMA_2d096475-b45d-4ccb-bbfe-1bd53908c19d"
      unitRef="usd">3000000.0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTUtMy0xLTEtMA_d96a9546-b919-4247-b745-1b9e6f6d123f"
      unitRef="usd">3200000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTUtNS0xLTEtMA_9f1ed3fe-c091-4037-b8a2-085a7ea194e5"
      unitRef="usd">1800000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTYtMS0xLTEtNDcw_70c68a94-86e0-4d96-8e54-5671a0e2da95"
      unitRef="usd">5800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTYtMS0xLTEtMA_0c1ab714-8672-45de-af1c-6b4bf6da7d9b"
      unitRef="usd">10800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTYtMy0xLTEtMA_4092fa35-f6db-4f8b-8c11-75ccd97b402e"
      unitRef="usd">12000000.0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTYtNS0xLTEtMA_73fefd3d-274b-4b66-b006-439b5f650172"
      unitRef="usd">3200000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTctMS0xLTEtNDcw_c7bc5990-88e4-42ee-bcdc-d0a1a62a3f29"
      unitRef="usd">-1200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTctMS0xLTEtMA_da792416-9391-4ccf-b7c6-3e8cf9f6cf12"
      unitRef="usd">16200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTctMy0xLTEtMA_10ae1b9e-642c-40ef-ae63-ce0db7a47df8"
      unitRef="usd">1200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTctNS0xLTEtMA_b44d11cb-e64a-4fd1-8889-7d3d1dde6cd2"
      unitRef="usd">-400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTgtMS0xLTEtNDcw_127091df-0c8a-4c56-9500-eff0f3815567"
      unitRef="usd">-6300000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTgtMS0xLTEtMA_1e6d0741-04a2-47de-8a91-9eeb3bf4de63"
      unitRef="usd">8400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTgtMy0xLTEtMA_59de58d2-d929-4499-bfbd-4b07c8028232"
      unitRef="usd">-7600000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTgtNS0xLTEtMA_709ce939-98e8-4262-8d78-4783b7fefe6a"
      unitRef="usd">-1800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTktMS0xLTEtNDcw_4af422f5-115a-48e8-b1f4-f1a210785932"
      unitRef="usd">-94100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTktMS0xLTEtMA_4749fa4f-eee8-4883-8c5d-fa432f599e3c"
      unitRef="usd">-223300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTktMy0xLTEtMA_d8b2c152-6bd1-4bbc-8fd1-4a4dff31219a"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMTktNS0xLTEtMA_59117d2d-2842-47a1-8cc9-da4d007ee6d3"
      unitRef="usd">120100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjAtMS0xLTEtNDcw_cb9addcc-29b0-4383-97e0-592d5a968476"
      unitRef="usd">-41000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjAtMS0xLTEtMA_101259f5-e7d9-4a8b-b2b7-17ab5912247b"
      unitRef="usd">-23700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjAtMy0xLTEtMA_8b633266-859e-4eac-8da2-4cd3063670b8"
      unitRef="usd">-4400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjAtNS0xLTEtMA_5d0770f9-6aa3-41a1-9b27-0c3a1ac63bac"
      unitRef="usd">-13000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjEtMS0xLTEtNDcw_48b108f2-dbba-4400-8371-d49998219f25"
      unitRef="usd">-53100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjEtMS0xLTEtMA_2d2eba85-a9b6-45df-b0f5-622203394b1b"
      unitRef="usd">-199600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjEtMy0xLTEtMA_48f56ee9-360a-4a7a-9a5a-bc23c9669200"
      unitRef="usd">4400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjEtNS0xLTEtMA_92c434ee-6b1a-47de-996a-d8b69ee471fe"
      unitRef="usd">133100000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjItMS0xLTEtNDcw_7356454e-5d26-47db-a95e-1c0224c9b6cf"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjItMS0xLTEtMA_64dad20b-29d1-4c8e-8e01-cf7d5934e845"
      unitRef="usd">-100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjItMy0xLTEtMA_6eb091eb-2a28-4f4b-8d0c-b6b7b13c2bf4"
      unitRef="usd">-200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjItNS0xLTEtMA_194933f1-ef66-427d-8bcb-94d7a79439f9"
      unitRef="usd">-200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjMtMS0xLTEtNDcw_e7b7a1bb-2261-4a92-b0ef-7b1db5d0af6e"
      unitRef="usd">-53100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjMtMS0xLTEtMA_3c5cad38-a8aa-449b-a00f-03fafbf07745"
      unitRef="usd">-199500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjMtMy0xLTEtMA_2b24f951-e63e-427d-85dd-c9acea00e9fb"
      unitRef="usd">4600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjMtNS0xLTEtMA_bced6939-3cc5-4571-a017-dc6c41fa690f"
      unitRef="usd">133300000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjUtMS0xLTEtNDcw_00874f3f-1319-45c8-b8dc-17a061428b97"
      unitRef="usdPerShare">-0.71</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjUtMS0xLTEtMA_7eabf2ac-cb3d-4c7d-baf0-7c7590a8e8d9"
      unitRef="usdPerShare">-2.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjUtMy0xLTEtMA_2852a520-22a0-48c1-9be3-dd1bd87a9f98"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjUtNS0xLTEtMA_7a22d9dd-10e9-4792-87dc-2199b81e4fb7"
      unitRef="usdPerShare">1.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjYtMS0xLTEtNDcw_150bcdb9-8acb-42bf-abcb-491e860e7992"
      unitRef="usdPerShare">-0.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjYtMS0xLTEtMA_5a24affc-2134-42fd-bc91-d48d70b11df4"
      unitRef="usdPerShare">-2.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjYtMy0xLTEtMA_516f9f97-3248-497e-a984-2da1d338bfe2"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjYtNS0xLTEtMA_4df18f68-b15c-411a-a4f1-1b044fc9274d"
      unitRef="usdPerShare">1.85</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjgtMS0xLTEtNDcw_13de22d6-f65c-43bd-952e-b0feee3c769b"
      unitRef="shares">75000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjgtMS0xLTEtMA_3fb318e8-78fc-4ece-bf81-d5981f4295f0"
      unitRef="shares">74300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjgtMy0xLTEtMA_85664eda-33f3-4548-adf2-07881da1dec2"
      unitRef="shares">73500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjgtNS0xLTEtMA_32ee4e6a-2416-4c20-8d3b-e64daa065a2f"
      unitRef="shares">69400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjktMS0xLTEtNDcw_def52eaf-f742-4543-be5f-f894db362a27"
      unitRef="shares">75000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjktMS0xLTEtMA_601887ee-fa46-4d28-ba94-77033398cb62"
      unitRef="shares">74300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjktMy0xLTEtMA_078f96a7-e3ac-4a01-994c-922319f7c214"
      unitRef="shares">76000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84Mi9mcmFnOmE3N2Q0ZWIxOTFlNjQ0YjM5MWYxNzRmNjdiM2ZmZjIwL3RhYmxlOjEyZmE5ODg0NGI5ZTRmZWNiNmZiZTlkMjYzNGMwYjJiL3RhYmxlcmFuZ2U6MTJmYTk4ODQ0YjllNGZlY2I2ZmJlOWQyNjM0YzBiMmJfMjktNS0xLTEtMA_752c54d3-28e6-4c9d-9b99-3f4889460cb9"
      unitRef="shares">72000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMi0xLTEtMS04MjU_6bd2fd6b-428e-4e32-b742-0338670f808f"
      unitRef="usd">-53100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMi0xLTEtMS0w_5500a566-8ad7-4cf0-beb8-963a67d46640"
      unitRef="usd">-199500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMi0zLTEtMS0w_dab10188-4695-4707-ba8d-4065308612ea"
      unitRef="usd">4600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMi01LTEtMS0w_d8c78805-6721-4626-8e83-e36914653f56"
      unitRef="usd">133300000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMy0xLTEtMS04MjU_79e06ed1-0be6-42d1-87e3-cd891eac4019"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMy0xLTEtMS0w_026aefc5-3948-4953-8d75-392cc41ca606"
      unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMy0zLTEtMS0w_04d32e5f-0f37-4bd7-864f-fb9686179669"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfMy01LTEtMS0w_c7cb84fe-fd76-4a04-8d5b-b968e09f17b6"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNC0xLTEtMS04MjU_47fdcbe7-87cf-4f37-aacc-e0a782b4293d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNC0xLTEtMS0w_9b2004e0-92b1-4d6d-9558-efe0d77dc213"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNC0zLTEtMS0w_577a5976-2d12-4ad0-9d41-62131abb93af"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNC01LTEtMS0w_cebc3b21-3c44-4db5-b477-540a8049afd9"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNS0xLTEtMS04MjU_88d93e9c-a854-466c-ab95-ff579ac23c0a"
      unitRef="usd">3400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNS0xLTEtMS0w_4a548c0f-7562-4e54-80f0-8470e04b2cfc"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNS0zLTEtMS0w_d23f0f14-e1e2-4bd5-887d-1a0da1cee384"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNS01LTEtMS0w_21af94d5-b13c-4bdd-ae57-6be513d1d218"
      unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNi0xLTEtMS04MjU_f08138c9-240e-4fc5-a7a3-f7cfee67ceb5"
      unitRef="usd">-50200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNi0xLTEtMS0w_6aa30cf1-8361-4e26-98ad-630dfb7022d8"
      unitRef="usd">-199400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNi0zLTEtMS0w_2f1b299b-12e7-4edb-b93f-75fe7cefb061"
      unitRef="usd">3300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84NS9mcmFnOjdjYTg3NDdmNDg4ZTQ0ODk4Zjg2OTU3YjE5MDlhNjMxL3RhYmxlOjMyZjk0ODVlYTU0MTQxOTk4Y2JjMDFjOGE4MTZhN2RhL3RhYmxlcmFuZ2U6MzJmOTQ4NWVhNTQxNDE5OThjYmMwMWM4YTgxNmE3ZGFfNi01LTEtMS0w_f0819750-2050-4939-bffa-5e76d890f84e"
      unitRef="usd">134800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81b96726504343d28522421de58c84e0_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS0xLTEtMS0w_c263a17c-3eb2-4a00-8c2f-ff4d1b2eadc3"
      unitRef="usd">700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i043df983c75d4d9790fca62e5627f01e_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS0zLTEtMS0w_985e8b01-b04b-4249-932a-ad927861a6c8"
      unitRef="usd">851400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i605b2c9f9a9b44f3bbf09333a54305b7_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS01LTEtMS0w_9b17f9fd-8640-4461-951e-8c0cbe044b34"
      unitRef="usd">-5500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6b39f6952cb488a9feeaf585599ff97_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS03LTEtMS0w_28d3566f-7896-4760-a37c-5eeab8fda062"
      unitRef="usd">-79200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMS05LTEtMS0w_98538446-5538-43fa-a64d-8781d7aa9055"
      unitRef="usd">767400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i29c0e698144e42648f61bbf6031c1c5c_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMi0zLTEtMS0w_43fc76d2-3925-46e8-8722-fa2633d282f5"
      unitRef="usd">36900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMi05LTEtMS0w_ebb8ab2c-3723-4ef9-9778-d0ac5f2cae0a"
      unitRef="usd">36900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i29c0e698144e42648f61bbf6031c1c5c_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMy0zLTEtMS0w_6458aa3c-0bf4-4ad2-9439-c9870570e1b5"
      unitRef="usd">27100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMy05LTEtMS0w_45e13403-a90f-420b-b4bc-06ff7ec606c7"
      unitRef="usd">27100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ic7794eda7c67461e96370052bfb99427_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNC03LTEtMS0w_a5ada811-b2b5-4602-8d69-a484d4e2a827"
      unitRef="usd">133300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNC05LTEtMS0w_9eea3c7e-4f4b-4920-91f1-79578375f027"
      unitRef="usd">133300000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6a575b7c8ca744ed8ee5d39d3377da1f_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNS01LTEtMS0w_e3c737a6-e82a-4093-8e4c-8984abb92d2e"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNS05LTEtMS0w_79594662-185f-4fbf-b92a-fd39c9003b05"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec0b2aaccecb48f5b7031f656787f005_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi0xLTEtMS0w_0311ca07-6d03-4768-aa09-821ac58d4984"
      unitRef="usd">700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a96e8e1248b4ab6be94a21fba042643_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi0zLTEtMS0w_e2fd9ff0-a291-498f-a105-ca56664ed6b0"
      unitRef="usd">915400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia44d866f0781417d83a00587086cfc79_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi01LTEtMS0w_6a05ffbb-5225-4ea6-b70b-35ce20bfe2f9"
      unitRef="usd">-4100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i947239044e8241b8b52a22ece554dedc_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi03LTEtMS0w_5ae2a8d7-9938-4a09-993c-88bf891bf2f8"
      unitRef="usd">54100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNi05LTEtMS0w_7ffcb355-0c62-4af3-bd74-89c25af6e066"
      unitRef="usd">966100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i99f729f126dc44f9b8d4c81d5418ce8f_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNy0zLTEtMS0w_cb8dc2d9-8aba-49c7-81e8-61a41802ecf5"
      unitRef="usd">136000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfNy05LTEtMS0w_b84b7674-0128-4b64-a718-10ec8f2c947e"
      unitRef="usd">136000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i99f729f126dc44f9b8d4c81d5418ce8f_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOC0zLTEtMS0w_df68af7c-ee6c-4c56-b809-8c365cb569ae"
      unitRef="usd">33500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOC05LTEtMS0w_0e0488cf-491f-4345-9209-1840ae588cec"
      unitRef="usd">33500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i99f729f126dc44f9b8d4c81d5418ce8f_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOS0zLTEtMS0w_d9bc9cd9-cd69-44fa-93c3-424bb3d08f09"
      unitRef="usd">16900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0d35e18907a547819b6deae0efc98b7a_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOS03LTEtMS0w_4d3e1e69-8bd8-409c-b736-5ee86de25625"
      unitRef="usd">33100000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfOS05LTEtMS0w_c2e4eef2-d7e2-4813-85d7-a9e01763e8fc"
      unitRef="usd">50000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:NetIncomeLoss
      contextRef="i0d35e18907a547819b6deae0efc98b7a_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTAtNy0xLTEtMA_1a1ebe19-0447-48d8-81ac-cf9248701c2f"
      unitRef="usd">4600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTAtOS0xLTEtMA_f7a6d40d-d2a5-4fc0-8a30-658e339270fe"
      unitRef="usd">4600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i95fef7707d9841e09fdeefb682e39bfb_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTEtNS0xLTEtMA_46c9a553-ff50-44f1-af09-2ac1420ecf2a"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTEtOS0xLTEtMA_a500fa0c-8107-495d-adc5-97a306c3cb6f"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55d0ee12bc344eeeb30b549901738171_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItMS0xLTEtMA_f49e349a-e642-451c-b701-327cbb9f112f"
      unitRef="usd">700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c71239012bf47869827c00bc3e89106_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItMy0xLTEtMA_5df1fc88-a812-4935-a765-1269127e52ad"
      unitRef="usd">1068000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i312cecad66074aa4a77f2187852e77ab_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItNS0xLTEtMA_4243ba59-64f7-43f0-a16e-c461de3e1040"
      unitRef="usd">-5400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie27fadcacb1f46029eb6fd3895d61378_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItNy0xLTEtMA_dee6ea16-164e-489e-89eb-6c0276b21e55"
      unitRef="usd">25600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTItOS0xLTEtMA_6e910192-10c7-4fec-b00f-84d71483a671"
      unitRef="usd">1088900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibb6b952dfa944ca698bd7b95b7b9c665_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTMtMy0xLTEtMA_80f42d35-24af-417e-b051-caaf7f5bd770"
      unitRef="usd">3400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTMtOS0xLTEtMA_d10bc2f2-b325-4f16-9bd6-3db703031262"
      unitRef="usd">3400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibb6b952dfa944ca698bd7b95b7b9c665_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTQtMy0xLTEtMA_dba2fdee-94f6-4209-a5bd-b7b9a02f2e36"
      unitRef="usd">25200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTQtOS0xLTEtMA_d195355e-cf5f-4e64-9d49-903723f3a57a"
      unitRef="usd">25200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i52119e935ff9454ca95aa15f28434db7_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTUtNy0xLTEtMA_18803d18-7d4e-4275-ae9f-b94c25f5f57d"
      unitRef="usd">-199500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTUtOS0xLTEtMA_3ba10a65-c5cd-41ab-83b8-102fedfdc8c7"
      unitRef="usd">-199500000</us-gaap:NetIncomeLoss>
    <mygn:ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary
      contextRef="i3eefa8a416fd4ec6972a8e54adb82cbc_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTYtNS0xLTEtMA_599f3f7c-ff56-4872-935a-9b3407540169"
      unitRef="usd">100000</mygn:ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary>
    <mygn:ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTYtOS0xLTEtMA_c48345c2-7f43-474c-99c6-65fc6835e14f"
      unitRef="usd">100000</mygn:ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3eefa8a416fd4ec6972a8e54adb82cbc_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTctNS0xLTEtMA_d128ef9d-946c-4ee7-9631-00e4ed5ba168"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTctOS0xLTEtMA_5fc7f69e-69c6-4493-979d-4c4b36738c41"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie824f0b48e99445ebdbd34568b4a740c_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtMS0xLTEtMA_73ccd451-ca6b-44ee-ab96-31e04ef9d3db"
      unitRef="usd">700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b2496737dd9420db74ac84923507079_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtMy0xLTEtMA_c1c28a12-182a-4d66-b86b-fdf2c1fdd64e"
      unitRef="usd">1096600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic821396f205a43a1b2be38d8d4ea121d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtNS0xLTEtMA_04013163-42bd-4fbd-b0aa-77ea37231229"
      unitRef="usd">-5200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifdbb159f7b6a41a28bf0f80b2e7f99a6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtNy0xLTEtMA_b77411ec-7d84-4aed-808e-8d6bb0c9e324"
      unitRef="usd">-173900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTgtOS0xLTEtMA_ce70fb43-efe5-4f12-9821-f97d3c3452f6"
      unitRef="usd">918200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i941e632acb5a4786968dffa4c42b7c43_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTktMS0xLTEtODM4_6677f13c-a7b6-4ab8-bce5-ac2636753604"
      unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1cad8a5377bb4f6583cdde4abd9bf533_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTktMy0xLTEtODM4_b37ff3b9-0ad2-4f9e-bede-e99c24e2c8b1"
      unitRef="usd">-2000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMTktOS0xLTEtODM4_e6b18de8-ad27-41a2-9f5e-a2eff508fe8b"
      unitRef="usd">-1900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1cad8a5377bb4f6583cdde4abd9bf533_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjAtMy0xLTEtODM4_143da3da-422a-4f09-9ebc-b6684b6b13d8"
      unitRef="usd">14900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjAtOS0xLTEtODM4_804fa0bd-acd2-4f90-9575-ebaf4f6e35db"
      unitRef="usd">14900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="id5d5fb59c6a349e99c8e0851e720a933_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjEtNy0xLTEtODM4_9e959d55-c308-4930-b4a1-799739f0792e"
      unitRef="usd">-53100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjEtOS0xLTEtODM4_0aa9a56e-7385-494e-84f6-76ace610b68f"
      unitRef="usd">-53100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8d1a7c06a6ad43389dd94e306a8d5f31_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjMtNS0xLTEtODM4_4466a461-928d-45f2-88f7-e0ffe80fbf4a"
      unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjMtOS0xLTEtODM4_17f077ca-d8c9-46fe-b6d0-10b1e9df81ee"
      unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i778d038d06274b8a8f9c85edc661fbd2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtMS0xLTEtODM4_a47dccda-6546-4f02-a8e5-41491733da9d"
      unitRef="usd">800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a7c360decc543eb8824c43a173dc0d4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtMy0xLTEtODM4_e6118745-1df9-4236-8dbb-4e1d00eeab05"
      unitRef="usd">1109500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib78ee580b5334e728f7c6add95026777_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtNS0xLTEtODM4_a516c1a3-006d-4a0f-88f3-10a1782283b2"
      unitRef="usd">-2300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee94c647141649b6bb2fb3d6b3b18e85_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtNy0xLTEtODM4_49a40cc6-4486-46fb-a20d-ab2bb965b795"
      unitRef="usd">-227000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV84OC9mcmFnOjZkNDEzZTdkZmUxYTQxYjk5OWQxYjdlMDEzMWE0ODQwL3RhYmxlOjM0NzRlY2ZmNjU0ZjQ3MTJhNjQ5ZDRjZjVlOWI2NTYzL3RhYmxlcmFuZ2U6MzQ3NGVjZmY2NTRmNDcxMmE2NDlkNGNmNWU5YjY1NjNfMjQtOS0xLTEtODM4_f63b877f-2649-4ed0-8c35-d3b4485e3da8"
      unitRef="usd">881000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMy0xLTEtMS04NDg_91a17c7a-41d4-4ff4-b0f8-f27962dad61e"
      unitRef="usd">-53100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMy0xLTEtMS0w_738e5267-a7c6-4db6-b8ce-ad33d11a6e56"
      unitRef="usd">-199500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMy0zLTEtMS0w_4c33e582-c72b-48b6-a3a2-29edfda643aa"
      unitRef="usd">4600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMy01LTEtMS0w_a8c88a73-5370-4b6c-9c99-205abae9f724"
      unitRef="usd">133300000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNS0xLTEtMS04NDg_bde15296-e4ad-4d46-bcfb-18847115e167"
      unitRef="usd">35800000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNS0xLTEtMS0w_3e82f0b9-b61f-48d6-89bf-fd24c90e46a2"
      unitRef="usd">72000000.0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNS0zLTEtMS0w_86a3d91b-86ca-4ebc-a480-a382f440da13"
      unitRef="usd">73000000.0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNS01LTEtMS0w_efbfdadb-9cc2-4a16-86ef-555bb8ae8690"
      unitRef="usd">54400000</us-gaap:DepreciationAndAmortization>
    <mygn:NonCashInterestExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNi0xLTEtMS04NDg_54e97ac9-17e1-4ac6-84af-3f6550be3a0a"
      unitRef="usd">400000</mygn:NonCashInterestExpense>
    <mygn:NonCashInterestExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNi0xLTEtMS0w_80c6a065-3532-467f-baba-24b21a45e0c6"
      unitRef="usd">500000</mygn:NonCashInterestExpense>
    <mygn:NonCashInterestExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNi0zLTEtMS0w_2c047532-591b-4677-9020-d1e584cacb26"
      unitRef="usd">400000</mygn:NonCashInterestExpense>
    <mygn:NonCashInterestExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNi01LTEtMS0w_ef4b5077-7581-4936-ad85-01883b5256a5"
      unitRef="usd">200000</mygn:NonCashInterestExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0xLTEtMS0xMTAxNQ_21f90f58-af5f-4435-99a3-21de29375ece"
      unitRef="usd">6400000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0zLTEtMS0xMTAxOQ_09e802be-8b13-4b01-8063-17638804b760"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy01LTEtMS0xMTAxOQ_a371afff-7452-401d-a9b2-e1daba05e861"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy03LTEtMS0xMTAxOQ_7746eca6-42dd-4d58-9191-0b51b235f323"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0xLTEtMS04NDg_7f5e87b7-1844-4f28-953f-5342cddadcba"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0xLTEtMS0w_6de34450-4d5f-4596-85c9-d9346a8b7554"
      unitRef="usd">1000000.0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy0zLTEtMS0w_1af62ebc-0067-4f49-bf1f-ed7b2c5497de"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNy01LTEtMS0w_2c5215fc-37b0-4f65-b2a1-05890b5734c6"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0xLTEtMS0xNzEyMQ_2ae15e60-b280-49ae-bb9a-686643cc3167"
      unitRef="usd">1000000.0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0zLTEtMS0xNzEyNQ_9b9df7a6-b842-4d9c-bb18-c8cb2297bb1b"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS01LTEtMS0xNzEyNQ_b1a12800-d4c4-41a3-9c3c-df3909da6f19"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS03LTEtMS0xNzEyNQ_0eca048e-4c7a-43b8-8408-7eb32d14ae7c"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOC0xLTEtMS04NDg_52c577aa-4fe7-4721-99f4-3bafdb36b4a4"
      unitRef="usd">100000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOC0xLTEtMS0w_59733ed2-5fb4-44f3-bcc2-0bd39ea03a0b"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOC0zLTEtMS0w_a777df78-48c5-4f49-a42c-d5d6396588b5"
      unitRef="usd">900000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOC01LTEtMS0w_ec37ed03-641f-4951-9201-e4201ce2e0cd"
      unitRef="usd">200000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:ShareBasedCompensation
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0xLTEtMS04NDg_6b5fa639-4f3a-4e81-a1d9-706b6ccd25b2"
      unitRef="usd">14900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0xLTEtMS0w_0913eac9-bf83-4869-8f65-bc9b80ce9f25"
      unitRef="usd">25200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS0zLTEtMS0w_a93c6f94-038e-4265-8475-d6da24ae9527"
      unitRef="usd">33500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfOS01LTEtMS0w_ba97a418-84c2-4a98-bca4-c9e9f2e55a12"
      unitRef="usd">27100000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTAtMS0xLTEtODQ4_d46cb5c7-d270-4b56-9ec1-f7be6121813f"
      unitRef="usd">-44200000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTAtMS0xLTEtMA_419b0bc0-b59d-4c1e-823e-081249be4635"
      unitRef="usd">55800000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTAtMy0xLTEtMA_2ab25d2c-dff5-47cd-b5b6-33e7d3e429f0"
      unitRef="usd">-18600000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTAtNS0xLTEtMA_83f0ad49-5101-4de6-8570-d19185fc1482"
      unitRef="usd">23500000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <mygn:IncreaseDecreaseInUnrecognizedTaxBenefits
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTEtMS0xLTEtODQ4_4fe5137c-b025-429e-9e94-a12e59b0c066"
      unitRef="usd">-7100000</mygn:IncreaseDecreaseInUnrecognizedTaxBenefits>
    <mygn:IncreaseDecreaseInUnrecognizedTaxBenefits
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTEtMS0xLTEtMA_f28f98e7-9568-476d-a148-c1e0b44158dd"
      unitRef="usd">-1700000</mygn:IncreaseDecreaseInUnrecognizedTaxBenefits>
    <mygn:IncreaseDecreaseInUnrecognizedTaxBenefits
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTEtMy0xLTEtMA_05a36842-3efd-4111-b445-c3cc1ff24b12"
      unitRef="usd">5500000</mygn:IncreaseDecreaseInUnrecognizedTaxBenefits>
    <mygn:IncreaseDecreaseInUnrecognizedTaxBenefits
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTEtNS0xLTEtMA_14b1732b-8f37-46d1-aa8b-5687e93167a7"
      unitRef="usd">300000</mygn:IncreaseDecreaseInUnrecognizedTaxBenefits>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTItMS0xLTEtODQ4_6f4911be-17a7-4ca5-b025-3751a38e7cef"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTItMS0xLTEtMA_3759705b-c445-422f-92e6-d0e53d6d57fc"
      unitRef="usd">99700000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTItMy0xLTEtMA_e0c6e469-df50-4cd3-aa5b-73ed3f50df77"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTItNS0xLTEtMA_dde22ed0-c368-4331-b128-32204974fea7"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <mygn:ChangeInFairValueOfContingentConsideration
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTMtMS0xLTEtODQ4_25500577-ab02-4f64-9edb-7649389fba1e"
      unitRef="usd">3500000</mygn:ChangeInFairValueOfContingentConsideration>
    <mygn:ChangeInFairValueOfContingentConsideration
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTMtMS0xLTEtMA_ea90f90b-146e-4a07-9147-d3bbc36c40d9"
      unitRef="usd">2800000</mygn:ChangeInFairValueOfContingentConsideration>
    <mygn:ChangeInFairValueOfContingentConsideration
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTMtMy0xLTEtMA_a4ccc98c-dc32-42a8-bb91-b9e925a25f1a"
      unitRef="usd">-1400000</mygn:ChangeInFairValueOfContingentConsideration>
    <mygn:ChangeInFairValueOfContingentConsideration
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTMtNS0xLTEtMA_00379a76-7b4c-4c19-87ed-8ea8dec92715"
      unitRef="usd">-60900000</mygn:ChangeInFairValueOfContingentConsideration>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTQtMS0xLTEtODQ4_7165f43b-1613-4fa6-8c6a-fdd030a33883"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTQtMS0xLTEtMA_40e377e9-aa31-43c2-b898-19fed192ea81"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTQtMy0xLTEtMA_d36b53b3-c939-4eb0-a163-26a1d336924b"
      unitRef="usd">1500000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTQtNS0xLTEtMA_13c1dff0-9205-46ea-84b3-8ae28e730b82"
      unitRef="usd">22700000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTYtMS0xLTEtODQ4_2456e304-c2b4-4ce4-84ef-dd8a7918524f"
      unitRef="usd">-2100000</mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes>
    <mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTYtMS0xLTEtMA_5fc755df-4388-4a8b-badc-a6b12a454409"
      unitRef="usd">-2200000</mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes>
    <mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTYtMy0xLTEtMA_79582c26-d2af-42df-8c49-f8fd876d5a2d"
      unitRef="usd">3200000</mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes>
    <mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTYtNS0xLTEtMA_1fa177e3-d7e1-452f-b99e-866ec720fb11"
      unitRef="usd">-3300000</mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTctMS0xLTEtODQ4_ed05f354-f751-4a69-b8af-deccf913f522"
      unitRef="usd">21400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTctMS0xLTEtMA_dffe4152-b478-4fe9-a5fc-3e523e5db14c"
      unitRef="usd">-64000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTctMy0xLTEtMA_5da9bcff-bbf1-40ac-86a4-5d59c6a808c2"
      unitRef="usd">18200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTctNS0xLTEtMA_744ff44c-00fc-4cfd-8415-0000f77b507c"
      unitRef="usd">9100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTgtMS0xLTEtODQ4_c6bf4cd3-bb7f-4e8d-a618-67ed079e5d20"
      unitRef="usd">-1000000.0</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTgtMS0xLTEtMA_283dbb75-7fef-4d83-978b-eac933e21702"
      unitRef="usd">-600000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTgtMy0xLTEtMA_d0159121-d6d9-4994-8c2c-2c55d3162c64"
      unitRef="usd">700000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTgtNS0xLTEtMA_d2d45a5b-0576-43aa-ba1f-b1dcfc98b227"
      unitRef="usd">-1100000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTktMS0xLTEtODQ4_ccf67d85-c0f3-4feb-93fc-90e3e62680a1"
      unitRef="usd">-2200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTktMS0xLTEtMA_54e60e3e-e955-4033-979b-595439f8ebc3"
      unitRef="usd">-1600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTktMy0xLTEtMA_dedddd42-4d54-4f22-9aeb-31fbaa5c90b1"
      unitRef="usd">-8000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMTktNS0xLTEtMA_10bc1455-c230-4cb9-b89b-9ee7eaddf30b"
      unitRef="usd">-7900000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjAtMS0xLTEtODQ4_87e62dc0-2e4a-4ac1-9c2f-3b00da0d87b0"
      unitRef="usd">108400000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjAtMS0xLTEtMA_fafd9ddb-f2c3-479e-9749-285b7cb5faed"
      unitRef="usd">-25100000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjAtMy0xLTEtMA_fd928ac6-eb0e-4036-a138-a9365b1bf8cb"
      unitRef="usd">25100000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjAtNS0xLTEtMA_6407c798-e575-4b2e-8978-ccfd5fdb4a38"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMS0xLTEtMTc1OTc_bae00f7d-1e4e-4e70-99d0-ab26caa7f5a1"
      unitRef="usd">2300000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMy0xLTEtMTc2MTE_d9c69a99-926e-4ea0-a9e2-887a6fecf0b4"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtNS0xLTEtMTc2MTE_d25e148c-b24b-4644-8a61-721324fcfe63"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtNy0xLTEtMTc2MTE_fae1d275-080d-4d5b-bd04-254a43bf10fb"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjEtMS0xLTEtODQ4_1c30bf8b-1856-4b60-982f-15a7a26e4271"
      unitRef="usd">-1200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjEtMS0xLTEtMA_1e0b05b1-5bfc-4cbe-b8d6-dd444886bcbf"
      unitRef="usd">-10700000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjEtMy0xLTEtMA_6d3611fe-3333-4d4d-a565-137588e6dea7"
      unitRef="usd">1100000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjEtNS0xLTEtMA_f71804c3-3303-404d-8b6c-854142bff0d7"
      unitRef="usd">4000000.0</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjItMS0xLTEtODQ4_54c5e2e1-86b5-479e-a227-b114b1d60750"
      unitRef="usd">-3600000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjItMS0xLTEtMA_c2158a41-a48e-4e4f-95d1-c281987a9644"
      unitRef="usd">1600000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjItMy0xLTEtMA_d0fc0e22-da02-428a-9d77-ec00abd71fd1"
      unitRef="usd">1500000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjItNS0xLTEtMA_68a07de5-051a-41fa-adb5-b4b7b16b5dd6"
      unitRef="usd">1400000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMS0xLTEtODQ4_892860bb-2280-4abc-aa7d-16dc1c9a2b03"
      unitRef="usd">-200000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMS0xLTEtMA_b75be70b-5a32-4b3d-ab4d-a8a77e2711c2"
      unitRef="usd">30700000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtMy0xLTEtMA_fe9c4aab-c99a-4675-abde-61bc5c627274"
      unitRef="usd">-500000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjMtNS0xLTEtMA_7eedd170-6fde-4446-be23-815239e8bc20"
      unitRef="usd">-100000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjQtMS0xLTEtODQ4_3d2de5d0-2dc6-4aac-a485-10323470571f"
      unitRef="usd">-73700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjQtMS0xLTEtMA_a5b63b76-a8c3-48e1-bbf1-c2a16cfe4f19"
      unitRef="usd">60700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjQtMy0xLTEtMA_af42e10b-5df4-4077-b5b6-228f676e38c1"
      unitRef="usd">83700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjQtNS0xLTEtMA_a0ecc5b5-8c22-4595-9827-1c2a6c0b721b"
      unitRef="usd">115900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjYtMS0xLTEtODQ4_1c33b42d-21e7-4c23-9cc2-5bd59b273113"
      unitRef="usd">7900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjYtMS0xLTEtMA_c7a348fe-b94c-4d7b-a3ca-92ddf17d3b9f"
      unitRef="usd">10200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjYtMy0xLTEtMA_143ca60c-c2b2-44b6-b7a0-2d0d87e459af"
      unitRef="usd">8600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjYtNS0xLTEtMA_be4dbd58-2943-4989-93ae-63d3d8afc776"
      unitRef="usd">8400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjctMS0xLTEtODQ4_5870dc39-3994-4204-b777-6ed26ee403c3"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjctMS0xLTEtMA_e3ef4f0e-a3cf-4fed-b1e9-b0da520728c8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjctMy0xLTEtMA_832471aa-7727-45ef-9625-fc545e09c731"
      unitRef="usd">278500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjctNS0xLTEtMA_65070c5e-ce80-4bf1-a259-5ab39d31896b"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjgtMS0xLTEtODQ4_9807b5c4-bfae-4491-956c-8ec154004bc6"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjgtMS0xLTEtMA_05d10ed7-e7db-4c09-958b-a0dca29c948c"
      unitRef="usd">21300000</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjgtMy0xLTEtMA_245da604-4993-4893-a131-57bd01048a52"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjgtNS0xLTEtMA_ed940953-07d5-436a-b895-b16e92bdcd04"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjktMS0xLTEtODQ4_98ad3239-b662-4a7f-8e32-d8a6a3500fea"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjktMS0xLTEtMA_a295e421-b42a-4872-a225-420afead1f5f"
      unitRef="usd">60800000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjktMy0xLTEtMA_48dec1ea-03d2-446b-94ea-6c22f3f4cab6"
      unitRef="usd">78500000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMjktNS0xLTEtMA_ab3bad36-982a-45c1-9a73-83fb9f270e83"
      unitRef="usd">80900000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzAtMS0xLTEtODQ4_f522d4fe-02c2-49be-bc42-32ca9d81d8c3"
      unitRef="usd">35900000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzAtMS0xLTEtMA_951a9d75-de20-4b91-a84b-59e64c10e73c"
      unitRef="usd">69000000.0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzAtMy0xLTEtMA_d6fe74e8-d0fe-4e49-bdab-dddd2d48377f"
      unitRef="usd">79200000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzAtNS0xLTEtMA_ffc95ab7-1de5-479d-b468-70f87cef7c3b"
      unitRef="usd">77700000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzEtMS0xLTEtODQ4_73a39173-e5d8-489f-b16c-f50db467c3ab"
      unitRef="usd">28000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzEtMS0xLTEtMA_c295c482-b197-4a15-8285-61a5286e7599"
      unitRef="usd">19300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzEtMy0xLTEtMA_1790f4a8-7458-44eb-846a-385496bc3ac2"
      unitRef="usd">-286400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzEtNS0xLTEtMA_6067b0f7-4147-4fd7-b967-3a218bcb1b1b"
      unitRef="usd">-11600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzMtMS0xLTEtODQ4_3218e6e1-5964-4498-bd41-38bf2730452f"
      unitRef="usd">1800000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzMtMS0xLTEtMA_25c7f0cf-0386-48a5-a901-3fe4a5c1d731"
      unitRef="usd">13300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzMtMy0xLTEtMA_42da0da9-24e1-48e2-8fa0-5229747fd422"
      unitRef="usd">23200000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzMtNS0xLTEtMA_dc3d8cab-1d51-49df-9ee1-46e492521f2c"
      unitRef="usd">45300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMS0xLTEtMTgwMTk_94a7c0a2-7018-4c92-b08d-9e18bbf39cfb"
      unitRef="usd">3800000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMy0xLTEtMTgwMjM_54524939-a5b4-4906-8680-0a8d02c8a09a"
      unitRef="usd">9800000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctNS0xLTEtMTgwMjM_4f1cb3c8-9acc-48ae-afcc-a218f1d212ab"
      unitRef="usd">14500000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctNy0xLTEtMTgwMjM_f9424879-2a1f-455f-a495-0288df0f5683"
      unitRef="usd">8400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzQtMS0xLTEtODQ4_43a3c0f4-7183-4057-8371-ed5dfae796ab"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzQtMS0xLTEtMA_52dce659-34a6-471d-97b4-44f32f494bf2"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzQtMy0xLTEtMA_a6377507-81e5-4631-88ba-1f14dbe3ea3f"
      unitRef="usd">340000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzQtNS0xLTEtMA_99a60b58-f334-4b1e-9873-b37407bd9246"
      unitRef="usd">53000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzUtMS0xLTEtODQ4_24f3e3ac-af1d-4b30-bda2-404a840b4e0f"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzUtMS0xLTEtMA_61d776b6-40fa-4d12-a3d1-d82121ed6849"
      unitRef="usd">8600000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzUtMy0xLTEtMA_42c777c2-8e91-473a-b679-7ea43023684a"
      unitRef="usd">115000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzUtNS0xLTEtMA_78a269ec-849f-40db-ab64-e62b0d1c2b65"
      unitRef="usd">143000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzYtMS0xLTEtODQ4_7bb42fee-c13f-45f2-ba5c-f80d856ee3af"
      unitRef="usd">100000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzYtMS0xLTEtMA_0e278af4-da7b-403e-8b6d-4d12e11a575f"
      unitRef="usd">3900000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzYtMy0xLTEtMA_0b9347d8-e0f9-49dc-a8cc-3df1086a3db3"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzYtNS0xLTEtMA_45eb867e-b74e-491c-9922-3a3776753bdd"
      unitRef="usd">42400000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMS0xLTEtODQ4_4ec4b6f7-77fc-464c-b66f-b7990ad42805"
      unitRef="usd">0</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMS0xLTEtMA_a4741ba6-e436-4f7b-af03-762fc2e78dae"
      unitRef="usd">1000000.0</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctMy0xLTEtMA_52fc7a22-e8d9-41b7-978c-86ea0d33d3f5"
      unitRef="usd">1400000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzctNS0xLTEtMA_09af0616-87b1-4635-9879-08342c214a31"
      unitRef="usd">0</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzgtMS0xLTEtODQ4_c1de13af-55b6-4236-80dc-c75b936ed80b"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzgtMS0xLTEtMA_d859bab2-0a6e-4fb2-be9a-26b57af7e454"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzgtMy0xLTEtMA_ac04deab-ebf6-4231-b570-42b1def56df1"
      unitRef="usd">50000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzgtNS0xLTEtMA_2fe26f51-295d-4baf-88e9-42790c22c951"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzktMS0xLTEtODQ4_3746bd74-9e34-422b-a791-fa071d32fdfe"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzktMS0xLTEtMA_48a1fe85-d337-412e-8ecc-ca2d2728b4a3"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzktMy0xLTEtMA_5fe3749d-72e8-44f8-b144-0e6deadb67d9"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfMzktNS0xLTEtMA_21d473c3-2f0a-4cd0-9768-c0ca06ac3214"
      unitRef="usd">500000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDAtMS0xLTEtODQ4_0a0ae9aa-5f70-4370-906e-7fcc845b83a3"
      unitRef="usd">-2100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDAtMS0xLTEtMA_c6385ce4-bd2a-4d9d-be16-bb52fcf2f814"
      unitRef="usd">-10000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDAtMy0xLTEtMA_db9b7f98-64ac-4d69-9f95-19ef06f3a6c8"
      unitRef="usd">182300000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDAtNS0xLTEtMA_1fd050d6-2503-47c5-bf0a-a92a46684281"
      unitRef="usd">-95000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDEtMS0xLTEtODQ4_d7b8c39d-7319-477e-98bb-cedbe2b9cb5e"
      unitRef="usd">1100000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDEtMS0xLTEtMA_64435ad5-0bd2-4cbe-8a51-79c6c5196962"
      unitRef="usd">500000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDEtMy0xLTEtMA_b4f15911-c0ea-49c5-95bc-629d89d19e65"
      unitRef="usd">2700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDEtNS0xLTEtMA_bf741566-00eb-4977-9a48-58644baf15be"
      unitRef="usd">-800000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDItMS0xLTEtODQ4_085b4292-f722-4702-8c46-2d8ec8e6a9a3"
      unitRef="usd">-46700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDItMS0xLTEtMA_23a7cb3d-f2cb-437f-86db-2c2de08a9769"
      unitRef="usd">70500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDItMy0xLTEtMA_4087ad8b-6444-44ac-841c-aadaf480ded6"
      unitRef="usd">-17700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDItNS0xLTEtMA_d7abed7f-0c1b-48b9-901e-3487098cd9b6"
      unitRef="usd">8500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDMtMS0xLTEtODQ4_3352802e-24cd-4cb6-a312-babf1a457600"
      unitRef="usd">163700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDMtMS0xLTEtMA_8ef596e6-e701-403b-b332-8d3f7ddb4509"
      unitRef="usd">93200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDMtMy0xLTEtMA_4ea69b27-14f9-47a2-b4fa-479a642934fa"
      unitRef="usd">110900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDMtNS0xLTEtMA_b970cbfa-bc3f-4c68-b67f-7dc66f4a630e"
      unitRef="usd">102400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDQtMS0xLTEtODQ4_5ea34c4f-3b57-45ff-bdff-419553c38c46"
      unitRef="usd">117000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDQtMS0xLTEtMA_aed2a8d0-f1c3-4fbc-b0c5-65c5390bf190"
      unitRef="usd">163700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDQtMy0xLTEtMA_e3802c6a-bb6a-4334-8af3-b3c25f675a44"
      unitRef="usd">93200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85MS9mcmFnOmEzYWUzOGRlZjQ1NjQ0MGI5MzYyZWY2YmRlNWE2ZWZiL3RhYmxlOmFlZTUwZWFmNGVmZDQ2NmY5N2EwNDA1OWQ5NTg3MTQ4L3RhYmxlcmFuZ2U6YWVlNTBlYWY0ZWZkNDY2Zjk3YTA0MDU5ZDk1ODcxNDhfNDQtNS0xLTEtMA_4f90816e-7695-433c-a7d3-1c9c0a40525d"
      unitRef="usd">110900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODc_7b43ea17-6938-4c2b-8b00-15d5e654667a">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Financial Statement Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Myriad Genetics, Inc. and subsidiaries (collectively, the&#160;"Company" or "Myriad") is a leading personalized precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics. The Company employs a number of proprietary technologies, including DNA, RNA and protein analysis, that help it to understand the genetic basis of human disease and the role that genes and their related proteins may play in the onset and progression of disease. The Company uses this information to guide the development of molecular diagnostic and companion diagnostic tests that are designed to assess an individual&#x2019;s risk for developing disease later in life (predictive medicine), identify a patient&#x2019;s likelihood of responding to drug therapy and guide a patient&#x2019;s dosing to ensure optimal treatment (personalized medicine), or assess a patient&#x2019;s risk of disease progression and disease recurrence (prognostic medicine).&#160;&#160;The Company generates revenue by performing molecular diagnostic tests as well as by providing pharmaceutical and clinical services to the pharmaceutical and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.&#160;The Company&#x2019;s corporate headquarters are located in Salt Lake City, Utah.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared by the Company in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.&#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with U.S. GAAP.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the transition period ended December&#160;31, 2020, the Company identified errors related to its accounting for its international su&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;bsidiaries and its determination of fair value of contingent consideration related to an acquisition that occurred&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in May 2016. These errors were not material to any previously reported period. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management analyzed the potential impact of these errors in accordance with the SEC Staff Accounting Bulletin No. 108, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and concluded that the correction of the errors are not material to the transition period ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements in accordance with U.S. GAAP requires Company management to make estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include revenue recognition estimates for the average expected reimbursement per test, valuation allowances for deferred income tax assets, certain accrued liabilities, share-based compensation, and impairment analysis of goodwill and intangible assets. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The full impact of the COVID-19 outbreak continues to evolve and its future impacts remain uncertain and unpredictable. Management is actively monitoring the impact of the global situation on the Company&#x2019;s financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Substantially all of the Company&#x2019;s account receivable are with companies in the healthcare industry, U.S. and state governmental agencies, and individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments. The Company only has one payor, Medicare, that represents greater than 10% of its revenues. Revenues received from Medicare are included within the Diagnostics reporting segment and represented approximately 16%, 15%, 14% and 17% of total revenue for the six-month transition period ended December&#160;31, 2020 (the "Transition Period") and the fiscal years ended June&#160;30, 2020, 2019 and 2018, respectively. Concentrations of credit risk are mitigated due to the number of the Company&#x2019;s customers as well as their dispersion across many geographic regions. No customer accounted for&#160;more than 10%&#160;of accounts receivable at&#160;December&#160;31, 2020, June&#160;30, 2020 or June 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Investment Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified its marketable investment securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders&#x2019; equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The Company&#x2019;s cash equivalents consist of short-term, highly liquid investments that are readily convertible to known amounts of cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A decline in the market value of any available-for-sale security below cost that is deemed other than temporary results in a charge to earnings and establishes a new cost basis for the security. Losses are charged against Other income when a decline in fair value is determined to be other than temporary. The Company reviews several factors to determine whether a loss is other than temporary. These factors include but are not limited to: (i) the extent to which the fair value is less than cost and the cause for the fair value decline, (ii) the financial condition and near term prospects of the issuer, (iii) the length of time a security is in an unrealized loss position and (iv) the Company&#x2019;s ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. There were no other-than-temporary impairments recognized during the transition period ended December&#160;31, 2020 or during the fiscal years ended June&#160;30, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of supplies such as reagents, plates and testing kits, which are consumed when providing test results, and therefore the Company does not maintain finished goods inventory. Inventories are stated at the lower of cost or market and costs are determined on a first-in, first-out basis.&#160;&#160;In order to assess the ultimate realization of inventories, the Company is required to make judgments as to future demand requirements compared to current or committed inventory levels.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its inventories for excess quantities and obsolescence.&#160;&#160;Inventories that are considered excess or obsolete are expensed.&#160;&#160;The valuation of inventories requires the use of estimates as to the amounts of current inventories that will be sold. These estimates are dependent on management&#x2019;s assessment of current and expected orders from the Company&#x2019;s customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable represents amounts billed to customers for revenue recognized related to molecular diagnostic tests and pharmaceutical and clinical services. The Company does not have any off-balance-sheet credit exposure related to its customers and does not require collateral.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method based on the lesser of estimated useful lives of the related assets or lease terms. Equipment items have depreciable lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYxNA_1b34527f-c366-49c7-adfd-f87850ee8bcc"&gt;five&lt;/span&gt; to seven years. Leasehold improvements are depreciated over the shorter of the estimated useful lives or the associated lease terms, which range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc2NA_20a77949-7d3f-4d64-b771-723fbeeb3bce"&gt;one&lt;/span&gt; to seven years. Repairs and maintenance costs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible and other long-lived assets are comprised of acquired licenses, technology and intellectual property and purchased in-process research and development. Acquired intangible assets are recorded at fair value and amortized over the shorter of the contractual life or the estimated useful life. The estimated useful life of acquired in-process research and development was also evaluated in conjunction with the annual impairment analysis of intangible assets. The classification of the Company&#x2019;s acquired in-process research and development as an indefinite lived asset was deemed appropriate as the related research and development was not yet complete nor had it been abandoned. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain implementation costs incurred in a cloud computing arrangement to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. Implementation costs incurred in cloud computing arrangement are capitalized as part of Other assets in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually reviews and monitors long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment by reporting unit on an annual basis as of October 1 and in the interim if events and circumstances indicate that goodwill may be impaired. Prior to the change in the Company's fiscal year from the last day of June to a calendar fiscal year end, goodwill was tested for impairment on an annual basis as of April 1 and in the interim if events and circumstances indicated that goodwill may be impaired. The voluntary change is preferable under the circumstances as it provides the Company with additional time to complete its annual goodwill impairment testing in advance of its year-end reporting and results in better alignment with the Company&#x2019;s strategic planning and forecasting process given the Company's change in fiscal year end. The events and circumstances that are considered include business climate and market conditions, legal factors, operating performance indicators and competition.&#160;&#160;Impairment of goodwill is first assessed using a qualitative approach.&#160;&#160;If the qualitative assessment suggests that impairment is more likely than not, a quantitative analysis is performed.&#160;&#160;The quantitative analysis involves a comparison of the fair value of the reporting unit with its carrying amount.&#160;If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.&#160;&#160;If an event occurs that would cause a revision to the estimates and assumptions used in analyzing the value of the goodwill, the revision could result in a non-cash impairment charge that could have a material impact on the financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Myriad generates revenue by performing molecular diagnostic testing and pharmaceutical services. The Company previously provided clinical services until selling Privatklinik Dr. Robert Schindlbeck GmbH &amp;amp; Co. KG (the "Clinic") in February 2020. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated transaction price. The Company has determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company&#x2019;s revenue by type for the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, 2019, and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hereditary Cancer Testing&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GeneSight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prenatal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vectra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;myChoice CDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prolaris&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EndoPredict&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total molecular diagnostic revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC Topic 606, Revenue from Contracts with Customers (&#x201c;Topic 606&#x201d;), an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company performs its obligation under a contract with a customer by processing diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. The Company has the right to bill its customers upon the completion of performance obligations and thus does not record contract assets.&#160;Occasionally customers make payments prior to the Company's performance of its contractual obligations.&#160;When this occurs, the Company records a contract liability as deferred revenue. During the fiscal year ended June 30, 2020, the Company received approximately $29.7 million in advance Medicare payments as part of the CARES Act, which was enacted on March 27, 2020 to provide relief from the economic impacts of COVID-19. Repayment of the advanced Medicare payments begins April 2021. The advance Medicare payments are included in prepayments of deferred revenue for the fiscal year ended June 30, 2020 and in the beginning and ending balance of deferred revenue for the transition period ended December 31, 2020. A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue - beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue - ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Topic 606, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#x2019;s right to payment is in an amount that directly corresponds with the value of Company&#x2019;s performance to date. However, periodically, the Company enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations. As of December&#160;31, 2020, the aggregate amount of the transaction price of such contracts that is allocated to the remaining performance obligations is $11.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the transaction price, Myriad includes an estimate of the expected amount of consideration as revenue. The Company applies this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled. An estimate of transaction price does not include any estimated amount of variable consideration that are constrained. In addition, the Company considers all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. In determining the expected value, the Company considers the probability of the variable consideration for each possible scenario. The Company also has significant experience with historical discount patterns and uses this experience to estimate transaction prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimate of revenue is affected by assumptions in payor behavior such as changes in payor mix, payor collections, current customer contractual requirements, and experience with collections from third-party payors. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in Accrued liabilities in the Consolidated Balance Sheets in anticipation of request for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the Consolidated Statements of Operations and Comprehensive Income (Loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash collections for certain diagnostic tests delivered may differ from rates originally estimated, primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third party payors. As a result of this new information, the Company updates its estimate of the amounts to be recognized for previously delivered tests. During the transition period ended December 31, 2020, and fiscal year ended June 30, 2019 and 2018, the impact to revenue and earnings (loss) per share, for tests in which the performance obligation of delivering the test results was met in the prior period was immaterial. During the fiscal year ended June 30, 2020, the Company recognized a $9.9 million decrease in revenue, which resulted in a $(0.10) impact to earnings (loss) per share for tests in which the performance obligation of delivering the tests results was met in prior periods. The changes were primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third-party payors. In addition, during the fiscal year ended June 30, 2020, the Company identified an error related to prior periods for Medicare claims and has reduced revenue and recorded an accrued liability for a total of $4.7 million that will be refunded to Medicare. The impact of correcting the error during that period and the impact to all prior periods was concluded to be immaterial. The correction of the error in the fiscal year ended June 30, 2020 resulted in an impact to earnings (loss) per share for the fiscal year ended June 30, 2020 of $(0.05).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Topic 606, the Company has elected to exclude from the measurement of transaction price, all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer for e.g. sales tax, value added tax etc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to apply the practical expedient related to costs to obtain or fulfill a contract since the amortization period for such costs will be one year or less. Accordingly, no costs incurred to obtain or fulfill a contract have been capitalized. The Company has also elected to apply the practical expedient for not adjusting revenue recognized for the effects of the time value of money. This practical expedient has been elected because the Company collects very little cash from customers under payment terms and vast majority of payments terms have a payback period of less than one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based payment expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the fair value compensation cost relating to share-based payment transactions in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 718, Compensation &#x2013; Stock Compensation. Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#x2019;s requisite service period, which is generally the vesting period. The fair value of restricted stock units (RSUs) is based on the number of shares granted and the quoted price of the Company&#x2019;s common stock on the grant date. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. The fair value of shares issued under the Employee Stock Purchase Plan is calculated using the Black-Scholes option-pricing model, based on assumptions including the risk-free interest rate, expected life, expected dividend yield and expected volatility. The average risk-free interest rate is determined using the U.S. Treasury rate. We determine the expected life based on offering period of the Employee Stock Purchase Plan. The expected volatility is determined using the weighted average of daily historical volatility of our stock price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stimulus or grant payments that it receives that do not need to be paid back as other income. During the fiscal year ended June 30, 2020, the Company received approximately $14.6 million from the Provider Relief Fund under the CARES Act to reimburse the Company for health care related expenses or lost revenues that are attributable to COVID-19, which was recognized as a component of Other income in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes income taxes under the asset and liability method. This approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes, including the effective tax rate and analysis of potential tax exposure items, if any, requires significant judgment and expertise in federal and state income tax laws, regulations and strategies, including the determination of deferred tax assets and liabilities and any estimated valuation allowances deemed necessary to recognize deferred tax assets at an amount that is more likely than not to be realized. The Company&#x2019;s filings, including the positions taken therein, are subject to audit by various taxing authorities. While the Company believes it has provided adequately for its income tax liabilities in the consolidated financial statements, adverse determinations by these taxing authorities could have a material adverse effect on the consolidated financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding.&#160;&#160;Diluted earnings per share is computed based on the weighted-average number of shares of common stock, including the dilutive effect of common stock equivalents, outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 16.75pt;text-indent:31.5pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding used to compute &lt;br/&gt;    basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding and dilutive &lt;br/&gt;   securities used to compute diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain outstanding options and RSUs were excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive. These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Anti-dilutive options and RSUs excluded from EPS computation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The functional currency of the Company&#x2019;s international subsidiaries is the local currency. For those subsidiaries, expenses denominated in the functional currency are translated into U.S. dollars using average exchange rates in effect during the period and assets and liabilities are translated using period-end exchange rates. The foreign currency translation adjustments are included in Accumulated other comprehensive income (loss) as a separate component of Stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the cumulative translation adjustments included in Accumulated other comprehensive income (loss) (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders' equity, cash flows from operations, or net loss for the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standard Effective in Future Years and Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for public companies with fiscal years beginning after December 15, 2020, with early adoption permitted. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Recently Adopted Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses (Topic 326) (&#x201c;ASU 2016-13&#x201d;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, Intangibles &#x2013; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#x201c;ASU 2018-15&#x201d;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of Other assets in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODM_dc365155-bad3-4d7d-abf1-0e8a40c38ccf">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Financial Statement Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Myriad Genetics, Inc. and subsidiaries (collectively, the&#160;"Company" or "Myriad") is a leading personalized precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics. The Company employs a number of proprietary technologies, including DNA, RNA and protein analysis, that help it to understand the genetic basis of human disease and the role that genes and their related proteins may play in the onset and progression of disease. The Company uses this information to guide the development of molecular diagnostic and companion diagnostic tests that are designed to assess an individual&#x2019;s risk for developing disease later in life (predictive medicine), identify a patient&#x2019;s likelihood of responding to drug therapy and guide a patient&#x2019;s dosing to ensure optimal treatment (personalized medicine), or assess a patient&#x2019;s risk of disease progression and disease recurrence (prognostic medicine).&#160;&#160;The Company generates revenue by performing molecular diagnostic tests as well as by providing pharmaceutical and clinical services to the pharmaceutical and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.&#160;The Company&#x2019;s corporate headquarters are located in Salt Lake City, Utah.  &lt;/span&gt;&lt;/div&gt;The accompanying consolidated financial statements have been prepared by the Company in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.&#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with U.S. GAAP.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODA_29aa800b-f4b8-42a6-95c8-32fe3ab3c67c">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements in accordance with U.S. GAAP requires Company management to make estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include revenue recognition estimates for the average expected reimbursement per test, valuation allowances for deferred income tax assets, certain accrued liabilities, share-based compensation, and impairment analysis of goodwill and intangible assets. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODg_531b3276-6386-4653-917c-b9b476556df5">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Substantially all of the Company&#x2019;s account receivable are with companies in the healthcare industry, U.S. and state governmental agencies, and individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments. The Company only has one payor, Medicare, that represents greater than 10% of its revenues. Revenues received from Medicare are included within the Diagnostics reporting segment and represented approximately 16%, 15%, 14% and 17% of total revenue for the six-month transition period ended December&#160;31, 2020 (the "Transition Period") and the fiscal years ended June&#160;30, 2020, 2019 and 2018, respectively. Concentrations of credit risk are mitigated due to the number of the Company&#x2019;s customers as well as their dispersion across many geographic regions. No customer accounted for&#160;more than 10%&#160;of accounts receivable at&#160;December&#160;31, 2020, June&#160;30, 2020 or June 30, 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8f96d09d51df44fbad84bb579131bdab_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTM3NDM4OTU0MDgyODU_7af2f639-4b5a-4512-959a-94a0c352cbe9"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i10cba38383e5458b892db6d39c7d18c8_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNDM0NQ_63d1241d-f4d0-432e-be0b-c74109352ab0"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ide4c77d70ac54992b13f6f397ae45339_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNDM0OQ_603702be-8dd5-48fb-9104-9b4612d7c568"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0deff0d97a2e4113ac45f71cc4c1aee6_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNDM1Ng_3a840041-966c-461d-9961-fd2b7191791d"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTY_6724cfb4-bfd2-4453-9483-6dcd73c7bc69">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Investment Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified its marketable investment securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders&#x2019; equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The Company&#x2019;s cash equivalents consist of short-term, highly liquid investments that are readily convertible to known amounts of cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A decline in the market value of any available-for-sale security below cost that is deemed other than temporary results in a charge to earnings and establishes a new cost basis for the security. Losses are charged against Other income when a decline in fair value is determined to be other than temporary. The Company reviews several factors to determine whether a loss is other than temporary. These factors include but are not limited to: (i) the extent to which the fair value is less than cost and the cause for the fair value decline, (ii) the financial condition and near term prospects of the issuer, (iii) the length of time a security is in an unrealized loss position and (iv) the Company&#x2019;s ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. There were no other-than-temporary impairments recognized during the transition period ended December&#160;31, 2020 or during the fiscal years ended June&#160;30, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNjE3Ng_037e399f-7b4d-43f6-8a5e-63cf7d024a87"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNjE3Ng_d036d2d6-8e98-4fbc-a1b3-3e9396abad6c"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNjE3Ng_d7f29f20-ab68-4357-b5b6-f4170ccd5f8e"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNjE3Ng_e4886a1f-a857-472f-99c5-3a11f57803df"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTc_2cf50233-e6b6-42c8-86c2-5c6740f5255f">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of supplies such as reagents, plates and testing kits, which are consumed when providing test results, and therefore the Company does not maintain finished goods inventory. Inventories are stated at the lower of cost or market and costs are determined on a first-in, first-out basis.&#160;&#160;In order to assess the ultimate realization of inventories, the Company is required to make judgments as to future demand requirements compared to current or committed inventory levels.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its inventories for excess quantities and obsolescence.&#160;&#160;Inventories that are considered excess or obsolete are expensed.&#160;&#160;The valuation of inventories requires the use of estimates as to the amounts of current inventories that will be sold. These estimates are dependent on management&#x2019;s assessment of current and expected orders from the Company&#x2019;s customers.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTg_5ab07118-f44c-4d0f-86af-e3329be267cf">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable represents amounts billed to customers for revenue recognized related to molecular diagnostic tests and pharmaceutical and clinical services. The Company does not have any off-balance-sheet credit exposure related to its customers and does not require collateral.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODk_4e06202c-c392-49fb-a358-4a9015a5a94d">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method based on the lesser of estimated useful lives of the related assets or lease terms. Equipment items have depreciable lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYxNA_1b34527f-c366-49c7-adfd-f87850ee8bcc"&gt;five&lt;/span&gt; to seven years. Leasehold improvements are depreciated over the shorter of the estimated useful lives or the associated lease terms, which range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc2NA_20a77949-7d3f-4d64-b771-723fbeeb3bce"&gt;one&lt;/span&gt; to seven years. Repairs and maintenance costs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iff673b26c96b445a959922f9e0f6766d_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYyMA_9afd3128-3054-4d45-829a-c37fb1b87048">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i63bb7805ca1545da94822eeccb9d2208_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc3MA_03b7e6f4-e5b6-40ae-b5f6-fbfaa01ddbe0">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTk_721e47a8-e803-4410-8285-f96f51291313">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible and other long-lived assets are comprised of acquired licenses, technology and intellectual property and purchased in-process research and development. Acquired intangible assets are recorded at fair value and amortized over the shorter of the contractual life or the estimated useful life. The estimated useful life of acquired in-process research and development was also evaluated in conjunction with the annual impairment analysis of intangible assets. The classification of the Company&#x2019;s acquired in-process research and development as an indefinite lived asset was deemed appropriate as the related research and development was not yet complete nor had it been abandoned. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain implementation costs incurred in a cloud computing arrangement to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. Implementation costs incurred in cloud computing arrangement are capitalized as part of Other assets in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually reviews and monitors long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODQ_4732049b-f4b9-45cd-a5eb-610743ad27b6">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment by reporting unit on an annual basis as of October 1 and in the interim if events and circumstances indicate that goodwill may be impaired. Prior to the change in the Company's fiscal year from the last day of June to a calendar fiscal year end, goodwill was tested for impairment on an annual basis as of April 1 and in the interim if events and circumstances indicated that goodwill may be impaired. The voluntary change is preferable under the circumstances as it provides the Company with additional time to complete its annual goodwill impairment testing in advance of its year-end reporting and results in better alignment with the Company&#x2019;s strategic planning and forecasting process given the Company's change in fiscal year end. The events and circumstances that are considered include business climate and market conditions, legal factors, operating performance indicators and competition.&#160;&#160;Impairment of goodwill is first assessed using a qualitative approach.&#160;&#160;If the qualitative assessment suggests that impairment is more likely than not, a quantitative analysis is performed.&#160;&#160;The quantitative analysis involves a comparison of the fair value of the reporting unit with its carrying amount.&#160;If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.&#160;&#160;If an event occurs that would cause a revision to the estimates and assumptions used in analyzing the value of the goodwill, the revision could result in a non-cash impairment charge that could have a material impact on the financial results.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTA_6b4a1e4f-1539-47f3-9c10-ac77753e8e55">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Myriad generates revenue by performing molecular diagnostic testing and pharmaceutical services. The Company previously provided clinical services until selling Privatklinik Dr. Robert Schindlbeck GmbH &amp;amp; Co. KG (the "Clinic") in February 2020. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated transaction price. The Company has determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company&#x2019;s revenue by type for the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, 2019, and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hereditary Cancer Testing&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GeneSight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prenatal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vectra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;myChoice CDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prolaris&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EndoPredict&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total molecular diagnostic revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC Topic 606, Revenue from Contracts with Customers (&#x201c;Topic 606&#x201d;), an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company performs its obligation under a contract with a customer by processing diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. The Company has the right to bill its customers upon the completion of performance obligations and thus does not record contract assets.&#160;Occasionally customers make payments prior to the Company's performance of its contractual obligations.&#160;When this occurs, the Company records a contract liability as deferred revenue. During the fiscal year ended June 30, 2020, the Company received approximately $29.7 million in advance Medicare payments as part of the CARES Act, which was enacted on March 27, 2020 to provide relief from the economic impacts of COVID-19. Repayment of the advanced Medicare payments begins April 2021. The advance Medicare payments are included in prepayments of deferred revenue for the fiscal year ended June 30, 2020 and in the beginning and ending balance of deferred revenue for the transition period ended December 31, 2020. A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue - beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue - ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Topic 606, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#x2019;s right to payment is in an amount that directly corresponds with the value of Company&#x2019;s performance to date. However, periodically, the Company enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations. As of December&#160;31, 2020, the aggregate amount of the transaction price of such contracts that is allocated to the remaining performance obligations is $11.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the transaction price, Myriad includes an estimate of the expected amount of consideration as revenue. The Company applies this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled. An estimate of transaction price does not include any estimated amount of variable consideration that are constrained. In addition, the Company considers all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. In determining the expected value, the Company considers the probability of the variable consideration for each possible scenario. The Company also has significant experience with historical discount patterns and uses this experience to estimate transaction prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimate of revenue is affected by assumptions in payor behavior such as changes in payor mix, payor collections, current customer contractual requirements, and experience with collections from third-party payors. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in Accrued liabilities in the Consolidated Balance Sheets in anticipation of request for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the Consolidated Statements of Operations and Comprehensive Income (Loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash collections for certain diagnostic tests delivered may differ from rates originally estimated, primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third party payors. As a result of this new information, the Company updates its estimate of the amounts to be recognized for previously delivered tests. During the transition period ended December 31, 2020, and fiscal year ended June 30, 2019 and 2018, the impact to revenue and earnings (loss) per share, for tests in which the performance obligation of delivering the test results was met in the prior period was immaterial. During the fiscal year ended June 30, 2020, the Company recognized a $9.9 million decrease in revenue, which resulted in a $(0.10) impact to earnings (loss) per share for tests in which the performance obligation of delivering the tests results was met in prior periods. The changes were primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third-party payors. In addition, during the fiscal year ended June 30, 2020, the Company identified an error related to prior periods for Medicare claims and has reduced revenue and recorded an accrued liability for a total of $4.7 million that will be refunded to Medicare. The impact of correcting the error during that period and the impact to all prior periods was concluded to be immaterial. The correction of the error in the fiscal year ended June 30, 2020 resulted in an impact to earnings (loss) per share for the fiscal year ended June 30, 2020 of $(0.05).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Topic 606, the Company has elected to exclude from the measurement of transaction price, all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer for e.g. sales tax, value added tax etc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to apply the practical expedient related to costs to obtain or fulfill a contract since the amortization period for such costs will be one year or less. Accordingly, no costs incurred to obtain or fulfill a contract have been capitalized. The Company has also elected to apply the practical expedient for not adjusting revenue recognized for the effects of the time value of money. This practical expedient has been elected because the Company collects very little cash from customers under payment terms and vast majority of payments terms have a payback period of less than one year.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTE1NDQ4NzIxNTAwOTE_99da09e6-137e-4a96-8281-f7ac4ce3aca9">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company&#x2019;s revenue by type for the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, 2019, and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hereditary Cancer Testing&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GeneSight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prenatal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vectra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;myChoice CDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prolaris&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EndoPredict&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total molecular diagnostic revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea7c3564b9c44c23a5c4dfb365017793_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMy0xLTEtMS0xODAzNg_e7b1d5c9-93f2-42a8-acfd-f0d7787fea70"
      unitRef="usd">159300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875db6ff7af64f6c9b97fad10e61b5fd_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMy0zLTEtMS0xODAzNg_04fdd9ec-04a0-4c07-a92c-ba2fae8805a5"
      unitRef="usd">347400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbb4994d91de4c549d6dae2b213aebe6_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMy01LTEtMS0xODAzNg_706e7aad-d42f-454c-bc81-fa0231ae9229"
      unitRef="usd">479700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8669478b996c461297c9b935fda6b141_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMy03LTEtMS0xODAzNg_ae98f580-bf09-4540-b58f-e8a707abeebc"
      unitRef="usd">471400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida7c7b6ac227491f92c17991812e3869_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNC0xLTEtMS0xODAzNg_c19ea81e-7d3e-429b-a98f-71f78afce4be"
      unitRef="usd">29800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f622f3ae0ff49d8b617b9d61d2c97ad_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNC0zLTEtMS0xODAzNg_321e2452-4b89-4836-9cd1-9a5825f41a4f"
      unitRef="usd">74100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3b0cd7d81bb4bb89cd9aa952ab8bd0f_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNC01LTEtMS0xODAzNg_76169d26-caf0-4f96-93b7-969daac6ffbf"
      unitRef="usd">112600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id09b5abba4b34fb68e4eb34834cba9f1_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNC03LTEtMS0xODAzNg_978abc6a-71a7-450a-ac88-42941998a4a1"
      unitRef="usd">124900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52e307d2445b40d8aa07d3ec14ba2be0_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNS0xLTEtMS0xODAzNg_bf2b1441-914b-45f6-9e0a-7c5c5aec6724"
      unitRef="usd">37600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ec76ab3fed647e58dde13a62d7ab5cb_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNS0zLTEtMS0xODAzNg_c81565bb-af69-4f8e-aa69-8b25ab7bca1e"
      unitRef="usd">76700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1612014e0c7849f8bd70b02fabac071a_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNS01LTEtMS0xODAzNg_0527f079-49e0-43fd-afdb-0b734632bbdf"
      unitRef="usd">104900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63e77a5395ef4cd98c05a28cd36491b6_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNS03LTEtMS0xODAzNg_3df99c97-5fe1-4f3e-b874-f14b9a17890f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib82a8ffe32674a43a4391daf728784cd_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNi0xLTEtMS0xODAzNg_2c4d289a-8468-4b4b-8678-a047a695288a"
      unitRef="usd">18000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26f87eb2c79e4687904b9c3be92b905d_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNi0zLTEtMS0xODAzNg_83426908-e272-4e55-9b39-9e282c6a5c44"
      unitRef="usd">39100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbdba8e49ff540fe876fbb36882f6f5d_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNi01LTEtMS0xODAzNg_59ffeac9-efe9-49e3-bb57-eff1c5716234"
      unitRef="usd">48300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if506fdf6e01e48fabc4c32668075bd86_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNi03LTEtMS0xODAzNg_dd0412c3-0d04-4ad9-a4c7-5147ead3e18c"
      unitRef="usd">55200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2772ca9aefb2473c9f3ff73415e8016b_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNy0xLTEtMS0xODAzNg_0af00423-b086-4d2b-9656-757bb1f41ae9"
      unitRef="usd">13200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e90e77c40c74a8d9ce1811c7fec3667_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNy0zLTEtMS0xODAzNg_eb8c6c82-30a2-4003-a9c7-0837ded52c97"
      unitRef="usd">13100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8154ac2d56b4a3ebdb3fb57f831633a_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNy01LTEtMS0xODAzNg_db12d194-5338-432b-9dc5-41d2233e5d84"
      unitRef="usd">7100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69345f3695f9481ca79acaab212b8bc8_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfNy03LTEtMS0xODAzNg_e9839855-c327-4420-8259-3cefa8ecc063"
      unitRef="usd">5100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i333fb6ad9b6b43ac9e8439a13405ff71_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOC0xLTEtMS0xODAzNg_0ce48caf-95c8-40b5-a2b7-2b7254a9b51c"
      unitRef="usd">14800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i520c7e479d204ea1ab81cbebaa679338_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOC0zLTEtMS0xODAzNg_a26ef33b-8f10-4b80-91f2-d1af32223af0"
      unitRef="usd">24700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i139ff307433f4c42ba54d26e15f894d9_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOC01LTEtMS0xODAzNg_33b0e8bc-ed9b-494d-8085-7ea810f0a231"
      unitRef="usd">25500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4a2be4df4b147d6aad9dab664baae09_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOC03LTEtMS0xODAzNg_f238172d-3a89-441e-9488-e441675f396a"
      unitRef="usd">21500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b2dabb0c3074d16846d868ece0861f2_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOS0xLTEtMS0xODAzNg_92a76351-00cc-445e-8cc1-4d3cbb127b24"
      unitRef="usd">5900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49a6759c9c7f46b5bea7b177dbc8de41_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOS0zLTEtMS0xODAzNg_d6b4e548-3908-44cc-bfd7-1768f89d5882"
      unitRef="usd">10500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92ef11da463d4f049fdb71cb91e6e4ac_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOS01LTEtMS0xODAzNg_2847b898-8689-4f76-9672-388900fa65eb"
      unitRef="usd">10400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ed4976cdda34693bc7a2223ae7a47d8_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfOS03LTEtMS0xODAzNg_8cc66664-ea99-4c66-b1e5-6a875a6428b3"
      unitRef="usd">8800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdde0ae552b34e9394dd2670d0615284_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTAtMS0xLTEtMTgwMzY_1bbd1af4-9257-4b99-9df9-97f0c2b7f031"
      unitRef="usd">1000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bd823528cb5452e9aa3bd695577208b_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTAtMy0xLTEtMTgwMzY_a2bbdd28-f0fd-4ffa-9020-709a9560eb70"
      unitRef="usd">1300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6fd54ea912347b6bbee02a245eae55c_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTAtNS0xLTEtMTgwMzY_04113804-96e4-4090-9030-537968e14a9f"
      unitRef="usd">900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51af285dcaea45c8a830624ee2362d76_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTAtNy0xLTEtMTgwMzY_56dae5cb-b9e6-40c5-b4e8-212317e81100"
      unitRef="usd">3500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic729b712df4f4a8ead8475fab8f0790d_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTEtMS0xLTEtMTgwMzY_2039ced0-b62c-4f37-816c-86b5ff01f080"
      unitRef="usd">279600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib871150772b344349cbdf35a395d8267_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTEtMy0xLTEtMTgwMzY_1f33b426-ab8a-417b-9be6-09538389a0b3"
      unitRef="usd">586900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7633cb8e372444994b1efa8de166955_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTEtNS0xLTEtMTgwMzY_23aed0a6-1ebf-45dd-93e7-f45526cf7b18"
      unitRef="usd">789400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie935c63c1ef24d07993e26cd5a18d415_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTEtNy0xLTEtMTgwMzY_5ff768df-bd52-41c3-b802-d32dfd74052b"
      unitRef="usd">690400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c097ed969db458690ef357352106593_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTItMS0xLTEtMTgwMzY_534182ca-f5a3-4581-bd4a-534a6fbea9a5"
      unitRef="usd">20200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4fbf604a73ce4ed6bb5884b4cb199fac_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTItMy0xLTEtMTgwMzY_0d3b1a3d-ab84-46b3-9b0d-b5dd3e50de7d"
      unitRef="usd">51700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib094ccbcf5d544e9803960dda6b5c3f0_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTItNS0xLTEtMTgwMzY_90e4bf5c-2d06-4467-bc7d-8f55ef59a2c2"
      unitRef="usd">61700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97a926ad86c54867989a14b026bd3593_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTItNy0xLTEtMTgwMzY_d6a82e1a-9521-437a-9523-e4b860c3a2c4"
      unitRef="usd">53300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTMtMS0xLTEtMTgwMzY_d2714997-beef-43ba-bf22-b4addc0af5fd"
      unitRef="usd">299800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTMtMy0xLTEtMTgwMzY_37712a28-9b85-47f5-b03e-5f99bf2d4fa6"
      unitRef="usd">638600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTMtNS0xLTEtMTgwMzY_1cd4fdca-e8a3-4bd9-87a6-21e9be877a0a"
      unitRef="usd">851100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjg4YTM0MTFhNDI3NDQ0MzhhYWYwMTg3NjYwZGU0NjZmL3RhYmxlcmFuZ2U6ODhhMzQxMWE0Mjc0NDQzOGFhZjAxODc2NjBkZTQ2NmZfMTMtNy0xLTEtMTgwMzY_6ecbca7e-37dd-4e5d-8a92-f10f54f92b7f"
      unitRef="usd">743700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mygn:CARESActOf2020MedicarePaymentAmount
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTE1ODQ_685f1bfb-b736-4307-8fc2-005f9ab9e9a1"
      unitRef="usd">29700000</mygn:CARESActOf2020MedicarePaymentAmount>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc3MDA_4d4aa3bd-e702-413a-a633-616a56864a1b">A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue - beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue - ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMi0xLTEtMS04ODc_74ef5a5b-feca-449e-ae70-87f01f011730"
      unitRef="usd">32800000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMi0xLTEtMS0w_066a45f7-53c0-4d33-815a-b4c9572cc571"
      unitRef="usd">2200000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMi0zLTEtMS0w_6f81c4a9-6283-4f60-8c5d-77e7cedc51fc"
      unitRef="usd">2600000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMy0xLTEtMS04ODc_9b154929-8ba0-4dcc-b4ab-a5b04d2a0305"
      unitRef="usd">6100000</mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized>
    <mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMy0xLTEtMS0w_e858c6e2-d225-41ef-be2a-39a5a57ef90f"
      unitRef="usd">7200000</mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized>
    <mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfMy0zLTEtMS0w_a8d7ee83-2cf9-43cf-bbfc-bed382832c6a"
      unitRef="usd">7900000</mygn:ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized>
    <mygn:ContractWithCustomerLiabilityPrepayments
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNC0xLTEtMS04OTI_a64ad7a5-3cc9-483a-b09a-2d52b8a7186a"
      unitRef="usd">6000000.0</mygn:ContractWithCustomerLiabilityPrepayments>
    <mygn:ContractWithCustomerLiabilityPrepayments
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNC0xLTEtMS0w_3310b7e1-15ed-4cc8-a4e4-a6c50cfc4cd5"
      unitRef="usd">37800000</mygn:ContractWithCustomerLiabilityPrepayments>
    <mygn:ContractWithCustomerLiabilityPrepayments
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNC0zLTEtMS0w_6b498700-8bb5-44e4-b26c-3e154c362ae7"
      unitRef="usd">7500000</mygn:ContractWithCustomerLiabilityPrepayments>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNS0xLTEtMS04OTI_c36113d1-5392-4393-a764-d25cc9ad010b"
      unitRef="usd">32700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNS0xLTEtMS0w_fdb21b39-9d8a-4b5d-98e1-7c84920f49e7"
      unitRef="usd">32800000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOjZhNjk3YTdjMGU0MzRlMTI4NGFlYWRkMTg0MjU1ZjlkL3RhYmxlcmFuZ2U6NmE2OTdhN2MwZTQzNGUxMjg0YWVhZGQxODQyNTVmOWRfNS0zLTEtMS0w_9b2ffb90-c1c1-4f78-9134-143b72b6cdc7"
      unitRef="usd">2200000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTI0OTc_66b8905a-14ca-4dc1-b0b8-a120e466188c"
      unitRef="usd">11200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTQzNjk_00631f0d-d98b-4322-9c2e-c44702322e84"
      unitRef="usd">-9900000</us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <mygn:IncreaseDecreaseInEarningsLossPerShare
      contextRef="i04423ea583664800b488265dcd960706_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTQ1MDA_f45bc95b-594d-4d65-b4ec-17df145d17f8"
      unitRef="usdPerShare">-0.10</mygn:IncreaseDecreaseInEarningsLossPerShare>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i034631d7d5ef4b7c8d6d34aca4620ab5_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTUxMjE_33c95b39-fe28-495a-8cda-8877e9c21f32"
      unitRef="usd">-4700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iabcdc79361b245d5916d394962a748d5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTUxMjE_97351117-722d-45e1-ac4f-da6d1f8809f7"
      unitRef="usd">4700000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <mygn:IncreaseDecreaseInEarningsLossPerShare
      contextRef="i05d1b3e5218742268c6886435321836a_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTU0MDI_196a6289-3557-4a36-a8b4-7fbc32d0224c"
      unitRef="usdPerShare">-0.05</mygn:IncreaseDecreaseInEarningsLossPerShare>
    <us-gaap:CapitalizedContractCostGross
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTU2MTA_5b40ebb9-9386-42f5-b848-585a7a458d37"
      unitRef="usd">0</us-gaap:CapitalizedContractCostGross>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODE_68cd7372-7588-4f9f-b47f-98966eb03cd9">&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based payment expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the fair value compensation cost relating to share-based payment transactions in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 718, Compensation &#x2013; Stock Compensation. Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#x2019;s requisite service period, which is generally the vesting period. The fair value of restricted stock units (RSUs) is based on the number of shares granted and the quoted price of the Company&#x2019;s common stock on the grant date. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. The fair value of shares issued under the Employee Stock Purchase Plan is calculated using the Black-Scholes option-pricing model, based on assumptions including the risk-free interest rate, expected life, expected dividend yield and expected volatility. The average risk-free interest rate is determined using the U.S. Treasury rate. We determine the expected life based on offering period of the Employee Stock Purchase Plan. The expected volatility is determined using the weighted average of daily historical volatility of our stock price.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <mygn:OtherIncomePolicyPolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTE_53cc66e0-96f0-439b-a219-657256ed4050">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stimulus or grant payments that it receives that do not need to be paid back as other income. During the fiscal year ended June 30, 2020, the Company received approximately $14.6 million from the Provider Relief Fund under the CARES Act to reimburse the Company for health care related expenses or lost revenues that are attributable to COVID-19, which was recognized as a component of Other income in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</mygn:OtherIncomePolicyPolicyTextBlock>
    <mygn:CARESActOf2020ProviderReliefFundAmount
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTczODM_af61b1bf-e496-4286-a287-fa35ca32f34e"
      unitRef="usd">14600000</mygn:CARESActOf2020ProviderReliefFundAmount>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTQ_41ebea64-51e2-4a04-9837-86e83161f537">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes income taxes under the asset and liability method. This approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes, including the effective tax rate and analysis of potential tax exposure items, if any, requires significant judgment and expertise in federal and state income tax laws, regulations and strategies, including the determination of deferred tax assets and liabilities and any estimated valuation allowances deemed necessary to recognize deferred tax assets at an amount that is more likely than not to be realized. The Company&#x2019;s filings, including the positions taken therein, are subject to audit by various taxing authorities. While the Company believes it has provided adequately for its income tax liabilities in the consolidated financial statements, adverse determinations by these taxing authorities could have a material adverse effect on the consolidated financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODI_5806897d-2de2-4453-bd69-e0260e2f0ae7">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding.&#160;&#160;Diluted earnings per share is computed based on the weighted-average number of shares of common stock, including the dilutive effect of common stock equivalents, outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 16.75pt;text-indent:31.5pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding used to compute &lt;br/&gt;    basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding and dilutive &lt;br/&gt;   securities used to compute diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain outstanding options and RSUs were excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive. These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Anti-dilutive options and RSUs excluded from EPS computation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTI_a63d37ed-0d20-4e4e-b6a3-ca1e031bde99">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 16.75pt;text-indent:31.5pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding used to compute &lt;br/&gt;    basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding and dilutive &lt;br/&gt;   securities used to compute diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfMy0xLTEtMS05NjA_d4f59644-2faf-4b50-b16c-5fd30646cd7d"
      unitRef="shares">75000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfMy0xLTEtMS0w_8a75366e-59ae-4410-9c0c-150e1c971de3"
      unitRef="shares">74300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfMy0zLTEtMS0w_e6e82918-763b-4044-b3c7-2b55e12af540"
      unitRef="shares">73500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfMy01LTEtMS0w_122d69d1-e09b-4d73-9a03-ba8a7d07c8f1"
      unitRef="shares">69400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNC0xLTEtMS05NjA_3834eeb5-4e53-459d-91a4-82749ee87f95"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNC0xLTEtMS0w_edac5da7-e634-4ff8-9a3e-3060f3b3a7c1"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNC0zLTEtMS0w_10fc7802-ce60-4fc9-82ba-abf85647cc49"
      unitRef="shares">2500000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNC01LTEtMS0w_7337f2cf-cac1-469c-83f2-a606b92c3d2a"
      unitRef="shares">2600000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNS0xLTEtMS05NjA_e6710d15-239d-4ec7-8deb-2c8ce5752db9"
      unitRef="shares">75000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNS0xLTEtMS0w_e6986756-459a-4732-aed3-f12ec66e8ad5"
      unitRef="shares">74300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNS0zLTEtMS0w_08f23e2d-e64f-40bb-bac3-59698b4ec8e7"
      unitRef="shares">76000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmJlOGM2ZTRmZjg1ZDQ4Njc5NTViOWFlMzgxNTM1Njg2L3RhYmxlcmFuZ2U6YmU4YzZlNGZmODVkNDg2Nzk1NWI5YWUzODE1MzU2ODZfNS01LTEtMS0w_2e5d3b56-8bec-4fdd-9d42-5c34013a1d75"
      unitRef="shares">72000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODU_d364724a-7a7c-401a-93b1-7342bd340877">These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Anti-dilutive options and RSUs excluded from EPS computation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmQ3ZWYwNGU0YTk3ZjRhYTc4NWJkN2VkM2IwODZlYzZkL3RhYmxlcmFuZ2U6ZDdlZjA0ZTRhOTdmNGFhNzg1YmQ3ZWQzYjA4NmVjNmRfMi0xLTEtMS05NjU_6a4bbdad-c330-44da-b414-c7f991e7f5f9"
      unitRef="shares">6600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmQ3ZWYwNGU0YTk3ZjRhYTc4NWJkN2VkM2IwODZlYzZkL3RhYmxlcmFuZ2U6ZDdlZjA0ZTRhOTdmNGFhNzg1YmQ3ZWQzYjA4NmVjNmRfMi0xLTEtMS0w_6da6b7fb-1c4b-483e-b760-1a1474b13f1c"
      unitRef="shares">5500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmQ3ZWYwNGU0YTk3ZjRhYTc4NWJkN2VkM2IwODZlYzZkL3RhYmxlcmFuZ2U6ZDdlZjA0ZTRhOTdmNGFhNzg1YmQ3ZWQzYjA4NmVjNmRfMi0zLTEtMS0w_5b90d289-9d34-4877-a600-a25b402780a3"
      unitRef="shares">800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmQ3ZWYwNGU0YTk3ZjRhYTc4NWJkN2VkM2IwODZlYzZkL3RhYmxlcmFuZ2U6ZDdlZjA0ZTRhOTdmNGFhNzg1YmQ3ZWQzYjA4NmVjNmRfMi01LTEtMS0w_7dfa6520-7ce5-4729-9261-9b1521754673"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTU_ba2b31ba-b9b4-4bca-90dc-c645b7e7463b">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The functional currency of the Company&#x2019;s international subsidiaries is the local currency. For those subsidiaries, expenses denominated in the functional currency are translated into U.S. dollars using average exchange rates in effect during the period and assets and liabilities are translated using period-end exchange rates. The foreign currency translation adjustments are included in Accumulated other comprehensive income (loss) as a separate component of Stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the cumulative translation adjustments included in Accumulated other comprehensive income (loss) (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2ODY_f6255955-0eac-44a5-b48c-d0f2d4447afb">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the cumulative translation adjustments included in Accumulated other comprehensive income (loss) (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmY3MmZjM2Y4NWYxNzRlMWY5Y2I5MjBmNjJjMWNjNTY3L3RhYmxlcmFuZ2U6ZjcyZmMzZjg1ZjE3NGUxZjljYjkyMGY2MmMxY2M1NjdfMy0xLTEtMS0w_33732dea-12c7-4eb0-aa80-9290ad0c3324"
      unitRef="usd">-6500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmY3MmZjM2Y4NWYxNzRlMWY5Y2I5MjBmNjJjMWNjNTY3L3RhYmxlcmFuZ2U6ZjcyZmMzZjg1ZjE3NGUxZjljYjkyMGY2MmMxY2M1NjdfNC0xLTEtMS05ODA_a62496aa-0f87-4fa9-9d2e-7568d7c09dbe"
      unitRef="usd">2400000</us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease>
    <mygn:OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmY3MmZjM2Y4NWYxNzRlMWY5Y2I5MjBmNjJjMWNjNTY3L3RhYmxlcmFuZ2U6ZjcyZmMzZjg1ZjE3NGUxZjljYjkyMGY2MmMxY2M1NjdfMi0xLTEtMS0xNzk2OA_9608b4ee-485b-4373-a297-3bd3fe0e05ad"
      unitRef="usd">1000000.0</mygn:OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RhYmxlOmY3MmZjM2Y4NWYxNzRlMWY5Y2I5MjBmNjJjMWNjNTY3L3RhYmxlcmFuZ2U6ZjcyZmMzZjg1ZjE3NGUxZjljYjkyMGY2MmMxY2M1NjdfNi0xLTEtMS05ODA_eb70262f-1c39-4881-b9e4-2bb5fa6e1085"
      unitRef="usd">-3100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMTE1NDQ4NzIxNTAwOTM_08daa358-4ccf-4b58-9b0f-f35a8d1b4336">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders' equity, cash flows from operations, or net loss for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfMjc2OTM_0a9131c2-bbd7-4217-88bd-71e3762c18bf">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standard Effective in Future Years and Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for public companies with fiscal years beginning after December 15, 2020, with early adoption permitted. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Recently Adopted Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses (Topic 326) (&#x201c;ASU 2016-13&#x201d;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, Intangibles &#x2013; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#x201c;ASU 2018-15&#x201d;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of Other assets in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzYxNA_deaeb740-de07-4cd8-a5f3-a30e2fbf752c">MARKETABLE INVESTMENT SECURITIES&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value debt securities classified as available-for-sale securities by major security type and class of security at December&#160;31, 2020, June&#160;30, 2020 and June 30, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and maturities of debt securities classified as available-for-sale are as follows at December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no debt securities classified as available-for-sale in a gross unrealized loss position as of December&#160;31, 2020, June&#160;30, 2020 or June 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional information relating to fair value of marketable investment securities can be found in Note 3.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzYxNQ_0cc01332-db3a-4d8f-a11c-b2762b5858b4">&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value debt securities classified as available-for-sale securities by major security type and class of security at December&#160;31, 2020, June&#160;30, 2020 and June 30, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzMtMS0xLTEtNDU1MQ_24dfd956-e0d9-4dd6-a02b-f6c8012bfdb5"
      unitRef="usd">47900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzMtNy0xLTEtNDU1MQ_44f36d90-c886-4ede-9783-701559bd48a1"
      unitRef="usd">47900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2974f743032d446b86850b246d3a169c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzQtMS0xLTEtNDU1MQ_f6b9f40b-1fca-4817-818f-9e9cb5bc240f"
      unitRef="usd">69100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2974f743032d446b86850b246d3a169c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzQtNy0xLTEtNDU1MQ_74012bfd-97ab-4dec-95af-fa49f99fcac9"
      unitRef="usd">69100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzUtMS0xLTEtNDU1MQ_aed3dd4b-471d-4c7f-a500-9a72defb564e"
      unitRef="usd">117000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzUtNy0xLTEtNDU1MQ_d2eb19af-e332-4374-8caa-f651bfd7bf4a"
      unitRef="usd">117000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzctMS0xLTEtNDU1MQ_b3a09d0c-ae1a-4d1a-a1bb-1d921aa3abb4"
      unitRef="usd">28800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzctMy0xLTEtNDU1MQ_b0395eba-72de-47f2-8499-4f203d495a69"
      unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzctNS0xLTEtNDU1MQ_14757e5f-b889-498e-9a35-ecabf8d828d1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzctNy0xLTEtNDU1MQ_7736a7e6-5d41-407f-a322-b52b992f8093"
      unitRef="usd">29300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzgtMS0xLTEtNDU1MQ_4d95e932-284a-46d2-981f-e610858f14e3"
      unitRef="usd">9400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzgtMy0xLTEtNDU1MQ_a65484ed-3aba-4627-8292-64da24b46a77"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzgtNS0xLTEtNDU1MQ_3d1ad79a-d542-466d-a9e2-a2008a978ae1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzgtNy0xLTEtNDU1MQ_f62f9b61-8534-4a90-8beb-c85b5a3ae53a"
      unitRef="usd">9600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzktMS0xLTEtNDU1MQ_72a493ac-0303-48de-93ee-b8f84676ca78"
      unitRef="usd">4000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzktMy0xLTEtNDU1MQ_c47fe23a-a45a-45d7-a977-74beb7e6f6b2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzktNS0xLTEtNDU1MQ_97e4d733-a129-49f1-98c9-7d801228dbed"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzktNy0xLTEtNDU1MQ_df22a483-847c-4966-9db6-684ffb28f8b3"
      unitRef="usd">4000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzEwLTEtMS0xLTQ1NTE_90dfa2cd-b58c-45a5-9aca-44c0fa16af4d"
      unitRef="usd">11700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzEwLTMtMS0xLTQ1NTE_2c8a3247-afb0-4983-904b-d481ac454f36"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzEwLTUtMS0xLTQ1NTE_b1ecafc7-94c5-4355-9e7d-196680ab46d9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzEwLTctMS0xLTQ1NTE_f9d07daa-3999-4df5-8557-97ae425a1736"
      unitRef="usd">11800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <mygn:InvestmentsAndCashAmortizedCost
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzExLTEtMS0xLTQ1NTE_9a876f05-e01d-484d-a9b1-55b4cd37d122"
      unitRef="usd">170900000</mygn:InvestmentsAndCashAmortizedCost>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzExLTMtMS0xLTQ1NTE_7fd646ec-e090-4c22-b0cf-ead210e67909"
      unitRef="usd">800000</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzExLTUtMS0xLTQ1NTE_1e1014c3-7383-4d63-9f1c-9df088f78493"
      unitRef="usd">0</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsAndCash
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZToyOTlhMDllYTNhMDU0ZWY5YWYyOTljMDIzMWVhNjVlMy90YWJsZXJhbmdlOjI5OWEwOWVhM2EwNTRlZjlhZjI5OWMwMjMxZWE2NWUzXzExLTctMS0xLTQ1NTE_5b07ef0f-7757-45d0-93c1-54d7e6ceddcf"
      unitRef="usd">171700000</us-gaap:InvestmentsAndCash>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id1a64b6a9eaf445c8e78ea7644ec0770_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzMtMS0xLTEtMA_ff90288b-ce95-4a99-b75b-c6fe5a7d4a61"
      unitRef="usd">132800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id1a64b6a9eaf445c8e78ea7644ec0770_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzMtNy0xLTEtMA_d1ba2367-de92-49f9-88d8-6da2c3f09aae"
      unitRef="usd">132800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i013cb277d59546beb41c64814afb77eb_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzQtMS0xLTEtMA_da43f144-87a9-4888-9a78-2756486b00a7"
      unitRef="usd">30900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i013cb277d59546beb41c64814afb77eb_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzQtNy0xLTEtMA_8d2f892e-6b77-4152-8b05-ea1845b513cb"
      unitRef="usd">30900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzUtMS0xLTEtMA_e7b5de75-ee05-4bb9-b65a-33a5501820c2"
      unitRef="usd">163700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzUtNy0xLTEtMA_a56ac17e-28b0-40d8-b467-d5ef54c18f7d"
      unitRef="usd">163700000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzctMS0xLTEtMA_084e63d9-e8de-48d5-b608-8efae2f72807"
      unitRef="usd">50100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzctMy0xLTEtMA_12e1b722-0286-4ccc-9dbe-e7fa8da6f70e"
      unitRef="usd">800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzctNS0xLTEtMA_29479800-55ce-4327-a770-b120c157d45f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzctNy0xLTEtMA_1eeb24de-918f-4733-972c-22510ed9b4ee"
      unitRef="usd">50900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzgtMS0xLTEtMA_d492e263-71c7-43d8-9657-b918aeafdd78"
      unitRef="usd">17800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzgtMy0xLTEtMA_e6216e47-64a2-4f00-a3f8-585f004f1d3f"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzgtNS0xLTEtMA_a963cdcb-bae8-457e-a529-9b3f448b83e7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzgtNy0xLTEtMA_8347d8db-a8f3-428b-bc2f-368140f343a5"
      unitRef="usd">18000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzktMS0xLTEtMA_9268a977-7905-4e07-9312-2121fa17abe0"
      unitRef="usd">5500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzktMy0xLTEtMA_2bca4bb5-1a5a-4ede-9f02-e8b02f0f6b88"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzktNS0xLTEtMA_3047ca14-ab5c-40f9-aec0-7abf20ee3b6d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzktNy0xLTEtMA_9b681ec6-aa04-4420-ba4e-9f2ee35dea25"
      unitRef="usd">5600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzEwLTEtMS0xLTA_a9cf1b99-f770-4040-98dc-5f945eb5a0ca"
      unitRef="usd">16400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzEwLTMtMS0xLTA_691b04ff-9c3e-4c89-b893-abb2e8dcbf47"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzEwLTUtMS0xLTA_1fee252d-c137-4abb-b0ad-7ddbe0ffdde2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzEwLTctMS0xLTA_f45d8ea0-8cf1-4d9a-a7dc-477e806de992"
      unitRef="usd">16600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <mygn:InvestmentsAndCashAmortizedCost
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzExLTEtMS0xLTA_2518d249-4292-4ad1-aeb6-dc5e6a665024"
      unitRef="usd">253500000</mygn:InvestmentsAndCashAmortizedCost>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzExLTMtMS0xLTA_510f40f0-acf0-478c-9b2e-709adb93ff22"
      unitRef="usd">1300000</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzExLTUtMS0xLTA_9d85284f-930c-4fcb-b5f6-1cc378b743dc"
      unitRef="usd">0</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsAndCash
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTozMDA3YWFlOTNkOTY0NWE1YWE0ZGUzNzlhZTc3OWZmZi90YWJsZXJhbmdlOjMwMDdhYWU5M2Q5NjQ1YTVhYTRkZTM3OWFlNzc5ZmZmXzExLTctMS0xLTA_f6d1ebcd-7620-4a8c-9208-b6d03e536cfa"
      unitRef="usd">254800000</us-gaap:InvestmentsAndCash>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibdb4f19b39fa4edcb9b9756b242e799d_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzMtMS0xLTEtMA_a39d8c6b-fa23-4f94-849c-bfce4c0ff215"
      unitRef="usd">68700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibdb4f19b39fa4edcb9b9756b242e799d_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzMtNy0xLTEtMA_52fb6731-7d44-43d5-91f0-eb12e1f25fe1"
      unitRef="usd">68700000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3637c2bf3c6e4176a82ad149102c6280_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzQtMS0xLTEtMA_7a6c25ce-7291-48ec-b843-3c80ddce237a"
      unitRef="usd">24500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3637c2bf3c6e4176a82ad149102c6280_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzQtNy0xLTEtMA_babbf3d8-ef34-4420-80a3-1055adfb42c6"
      unitRef="usd">24500000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzUtMS0xLTEtMA_892d7218-651c-482e-baf6-e6b7d6d54319"
      unitRef="usd">93200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzUtNy0xLTEtMA_b34aea59-18a5-4008-b36b-96fc3f217b80"
      unitRef="usd">93200000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzctMS0xLTEtMA_755f2715-b23b-4ec6-8414-cd3871b39583"
      unitRef="usd">64000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzctMy0xLTEtMA_cacc8ebe-f420-46ac-beda-464dbb7fc64d"
      unitRef="usd">600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzctNS0xLTEtMA_a84cf949-ae1a-42ab-8d9e-56b5b1d0e8b1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzctNy0xLTEtMA_7d0b8929-1e08-4679-b496-67b6515fbc7b"
      unitRef="usd">64600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i828a886282af459f9e614c44191e6917_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzgtMS0xLTEtMA_04e80755-f57d-4c43-b980-c35bbf14288e"
      unitRef="usd">15300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i828a886282af459f9e614c44191e6917_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzgtMy0xLTEtMA_24fa6ecb-9f43-48a2-a632-868765c21cad"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i828a886282af459f9e614c44191e6917_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzgtNS0xLTEtMA_afaf223f-4cf8-4f22-a9df-94d65cfe5c19"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i828a886282af459f9e614c44191e6917_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzgtNy0xLTEtMA_6bde0c9b-4186-4a54-aabf-2ca7bb6535b1"
      unitRef="usd">15300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i91ebf87daee4405886567face5312f8a_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzktMS0xLTEtMA_b1cc9302-f2a2-4d38-9385-e1544f05359f"
      unitRef="usd">9000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i91ebf87daee4405886567face5312f8a_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzktMy0xLTEtMA_cd3cf339-f984-4767-8d96-635efad1f9cd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i91ebf87daee4405886567face5312f8a_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzktNS0xLTEtMA_54ac87ab-8cc2-4a57-8eb4-a2832c2b2d58"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i91ebf87daee4405886567face5312f8a_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzktNy0xLTEtMA_88c3ca4e-4817-4c77-99a2-638048b6e33e"
      unitRef="usd">9000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzEwLTEtMS0xLTA_96875349-9374-4817-b866-1766a15d07c6"
      unitRef="usd">9700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzEwLTMtMS0xLTA_59834c90-4f9b-4009-821c-5c5a2b2c4e3b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzEwLTUtMS0xLTA_f316dd28-c88b-453f-baf2-a9d878f63001"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzEwLTctMS0xLTA_077442ae-9b61-4b16-a6f1-f96a382863a8"
      unitRef="usd">9700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <mygn:InvestmentsAndCashAmortizedCost
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzExLTEtMS0xLTA_18c80420-0bf0-4b75-81fc-f85aac0123ae"
      unitRef="usd">191200000</mygn:InvestmentsAndCashAmortizedCost>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzExLTMtMS0xLTA_9b705beb-2625-4fbe-841e-aa4609f09109"
      unitRef="usd">600000</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzExLTUtMS0xLTA_05aee9e7-045d-42e1-815e-40840e4a4a78"
      unitRef="usd">0</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsAndCash
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTo2OTg2N2RhNzI3MGE0NzFkYWNiOGI1NGNkNWEyZDQwZi90YWJsZXJhbmdlOjY5ODY3ZGE3MjcwYTQ3MWRhY2I4YjU0Y2Q1YTJkNDBmXzExLTctMS0xLTA_2134a779-b755-41a3-8913-6d246c11e89a"
      unitRef="usd">191800000</us-gaap:InvestmentsAndCash>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzYxNg_230d6efc-8545-46be-9287-9592f419577e">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and maturities of debt securities classified as available-for-sale are as follows at December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzEtMS0xLTEtMA_a8079e53-6b6e-4284-bea3-2b8b679a5ce2"
      unitRef="usd">47900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4a1d798708ea4df2ba7ed5f6d806b40e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzEtMy0xLTEtMA_512a9564-c1a4-434f-94ed-856a9ec30502"
      unitRef="usd">47900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2974f743032d446b86850b246d3a169c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzItMS0xLTEtMA_c38f6a9a-7463-46ea-8884-a8936f0b0f7b"
      unitRef="usd">69100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2974f743032d446b86850b246d3a169c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzItMy0xLTEtMA_b4119d53-a587-49d2-89e5-380d757e6a36"
      unitRef="usd">69100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzQtMS0xLTEtMA_b4f3ee57-bfa1-49be-af45-3febc46558bb"
      unitRef="usd">33500000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzQtMy0xLTEtMA_50054e55-49c7-49b9-b13a-a4c475260df8"
      unitRef="usd">33700000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzUtMS0xLTEtMA_59f81e6e-82ff-435a-acc8-1630a3ffaee7"
      unitRef="usd">20400000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzUtMy0xLTEtMA_23ce707d-2c94-406c-8a53-936c9ce9c6bf"
      unitRef="usd">21000000.0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzYtMS0xLTEtMA_99f2fcaf-f806-4059-8f31-513235c042c1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzYtMy0xLTEtMA_d8a7e614-dfa3-45b6-851f-1c3564e5ff92"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <mygn:InvestmentsAndCashAmortizedCost
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzctMS0xLTEtMA_b4a6bc70-fd25-473f-8d5b-2084a3d55bed"
      unitRef="usd">170900000</mygn:InvestmentsAndCashAmortizedCost>
    <us-gaap:InvestmentsAndCash
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90YWJsZTphYjMzYzU5MDlhOTk0NzBkOWMxMTkyNjAxZmVmMGMxYS90YWJsZXJhbmdlOmFiMzNjNTkwOWE5OTQ3MGQ5YzExOTI2MDFmZWYwYzFhXzctMy0xLTEtMA_029092e6-ce0f-4350-948a-1902431a40e0"
      unitRef="usd">171700000</us-gaap:InvestmentsAndCash>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzQwNg_849b04eb-d7eb-4c49-b0d4-04a7749b0ac4"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzQwNg_d7910e78-e065-4b36-8ddb-a138f82ec8f7"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDMvZnJhZzo2OGY0OTE4MTYxZjY0OGQ1OGIwZjA3NTRkNjY4NTcwZi90ZXh0cmVnaW9uOjY4ZjQ5MTgxNjFmNjQ4ZDU4YjBmMDc1NGQ2Njg1NzBmXzQwNg_f3b08a04-9051-4b09-b090-8a06d1723224"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzQ0ODE_99baa2a6-352c-4e20-a386-19359659edec">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s financial instruments reflects the amounts that the Company estimates to receive in connection with the sale of an asset or paid in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1&#x2014;quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2&#x2014; observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&#160;&#160;Some of the Company&#x2019;s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3&#x2014;unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s financial instruments are valued using quoted prices in active markets or based on other observable inputs.&#160;&#160;For Level 2 securities, the Company uses a third-party pricing service which provides documentation on an ongoing basis that includes, among other things, pricing information with respect to reference data, methodology, inputs summarized by asset class, pricing application and corroborative information.&#160;&#160;For Level 3 contingent consideration, the Company reassesses the fair value of expected contingent consideration and the corresponding liability each reporting period using the Monte Carlo Method, which is consistent with the initial measurement of the expected earn out liability.&#160;&#160;This fair value measurement is considered a Level 3 measurement because the Company estimates projections during the earn out period of approximately 14.5 years utilizing various potential pay-out scenarios.&#160;&#160;Probabilities were applied to each potential scenario and the resulting values were discounted using a rate that considers weighted average cost of capital as well as a specific risk premium associated with the riskiness of the earn out itself, the related projections, and the overall business.&#160;&#160;The contingent consideration liabilities are classified as a component of long-term and short-term contingent consideration in the Company&#x2019;s Consolidated Balance Sheets.&#160;Changes to the contingent consideration liabilities are reflected in Change in the fair value of contingent consideration in our Consolidated Statements of Operations. Changes to the unobservable inputs could have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our long-term debt, which we consider a Level 3 measurement, is estimated using discounted cash flow analyses, based on the Company&#x2019;s current estimated incremental borrowing rates for similar borrowing arrangements.&#160;&#160;The fair value of long-term debt is estimated to be $225.8 million at December&#160;31, 2020, $225.5 million at June&#160;30, 2020 and $192.7 million at June&#160;30, 2019.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the fair value of the Company&#x2019;s financial assets and liabilities that are re-measured on a regular basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.03pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the change in the fair value of the contingent consideration during the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in the statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments recognized in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <mygn:BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm
      contextRef="ia8a8fb4d167d466eb4a4cce37a8e2b4e_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzEzNzQzODk1MzUzMTEz_6a11cdf6-f04c-4996-8b72-0bc0c5fc9da9">P14Y6M</mygn:BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm>
    <us-gaap:LongTermDebtFairValue
      contextRef="i931f10a967bd4961a4edc7f16b906bfd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzM4NDgyOTA3MDE5NzI_a0883e33-e0b6-4afb-b8c3-25e414676e9b"
      unitRef="usd">225800000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i896a61f417824c539c7a8aaecb838a3c_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzMxNjQ_a9474f12-fd9b-4e41-9b20-861a5d57344f"
      unitRef="usd">225500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i4a9f5109771b480db9fd53efad3cf0a0_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzMxNzc_e9eb4fa5-36b1-4642-b189-2c2f2c75633d"
      unitRef="usd">192700000</us-gaap:LongTermDebtFairValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzQ0ODI_810ae423-094f-4277-a238-24c19bbac540">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the fair value of the Company&#x2019;s financial assets and liabilities that are re-measured on a regular basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.03pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i83200f7a7cb74ffb8132d4a54cb8fe09_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzItMS0xLTEtMTEwNQ_799cc883-4f5e-452e-a343-3c5beaffcafd"
      unitRef="usd">69100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib1c8d3889def46bf8964906a008e20a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzItMy0xLTEtMTEwNQ_975ea36c-c6a1-4e90-8060-5535e17021c2"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib838376273ee40509009d40b54ad4e6c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzItNS0xLTEtMTEwNQ_040c69c8-9de7-40f7-8871-8b45660b9454"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2d419b15db0344df99a90536add6f225_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzItNy0xLTEtMTEwNQ_1c53f5fe-4e5e-46f8-b078-6683e9ddeef2"
      unitRef="usd">69100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0f6fd7e6971b43b1972bf113b61ed7ac_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzMtMS0xLTEtMTEwNQ_12a95124-ec24-44f9-818b-543b94392f04"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i488a249f7b4a42e39a29a4875e046abc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzMtMy0xLTEtMTEwNQ_f97e7f9b-4741-48c3-84b7-a2d5aa608ce7"
      unitRef="usd">29300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9a6d1096e6b24d2691f8c3c10e1db359_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzMtNS0xLTEtMTEwNQ_755ba968-58be-49e5-bb06-e0bc48b92567"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icd8402868f614fb2b5d8521dad255a8b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzMtNy0xLTEtMTEwNQ_04d3fc2c-7a55-4d96-bf73-c628baed61c7"
      unitRef="usd">29300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7f8f4f7fa0654056a7679cd94f503372_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzQtMS0xLTEtMTEwNQ_53049d26-5c84-48ad-b982-0033d266a5d1"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3bd6bdb2356e42e79e270f09478ee175_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzQtMy0xLTEtMTEwNQ_2cc0801d-e47a-417b-8fcb-b1f2ca933e87"
      unitRef="usd">9600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i239bdbcee2ee46d7816c4aa9f59360cf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzQtNS0xLTEtMTEwNQ_b0c519ef-ae5d-41f0-b47d-3d1076169e4a"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3d45abcf8d864b0ba7496ed2a77ff2a5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzQtNy0xLTEtMTEwNQ_0bf347e1-73c7-4789-b791-ddedf37bf58f"
      unitRef="usd">9600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i67e81c739fd94f7aa9cd55bdaa5d052f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzUtMS0xLTEtMTEwNQ_2874a37b-d9f2-418e-b8fa-6a2b0309b5cf"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i45f0be353e5f417cbe7b3331221c88de_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzUtMy0xLTEtMTEwNQ_913068f1-eb17-47cc-a2a1-f14b22e2607b"
      unitRef="usd">4000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie4dcb16a16b64061ab91c4bb405d02f4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzUtNS0xLTEtMTEwNQ_f5752a05-04a4-44c8-ab98-7be39577c294"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5f4cfa165c0348d6b59935e4c7b11d3a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzUtNy0xLTEtMTEwNQ_4250943c-ae54-4a41-8a25-f8c402eb54e4"
      unitRef="usd">4000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i85bf9bccc1f74000bc926d84844d459f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzYtMS0xLTEtMTEwNQ_a6023bfc-dcab-4eb6-a85e-664fd3f99c3b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic516541272e1460189dd7d9460be5e00_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzYtMy0xLTEtMTEwNQ_aaa3ada0-1749-404c-98e2-bb9c1ee99e23"
      unitRef="usd">11800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6a7c5d5ea4d24bd5bc15c709de8583c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzYtNS0xLTEtMTEwNQ_7d63c13e-6c93-48ae-8cc5-a5233991bee4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1e9b65aa7b1946db8be28ed50ba72b7a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzYtNy0xLTEtMTEwNQ_9f2762c4-323e-44a8-b656-18432ba5b78b"
      unitRef="usd">11800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i75d72cd70f074af99ccef915b106a5c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzctMS0xLTEtMTEwNQ_b5e0efab-575e-4f37-b8bf-8a046d383783"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i32a837ac64224a79a96732a4ab5ce550_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzctMy0xLTEtMTEwNQ_b544ceb6-d9c6-4c5a-9952-4e6dbde70a3b"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i84dba07dc1964a8eaaa12c3e6bf3ac13_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzctNS0xLTEtMTEwNQ_d441c17e-68cc-4332-9f41-5a8c8461c23c"
      unitRef="usd">10900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9a4dcb3d42434870ab26e0dc5985c286_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzctNy0xLTEtMTEwNQ_f904d792-ed5d-4d7e-88c3-bd37eb17cf14"
      unitRef="usd">10900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i386c2dd77d7b42f1b542c00daa2a0722_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzgtMS0xLTEtMTEwNQ_cdbef9b4-d0e1-4e36-a67f-6ca820ca7df4"
      unitRef="usd">69100000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ideb92da4147d4f0aa235d0cbea519f7e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzgtMy0xLTEtMTEwNQ_4c41e346-c007-42c5-b6a6-7d3e1e8f115a"
      unitRef="usd">54700000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i931f10a967bd4961a4edc7f16b906bfd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzgtNS0xLTEtMTEwNQ_d59e6db8-5a9e-4919-b8aa-fc149fdc3e53"
      unitRef="usd">-10900000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNjFmMWQxZTc3MmM0MGM3OWZiZGQyMWI3OTFjMGViYy90YWJsZXJhbmdlOmI2MWYxZDFlNzcyYzQwYzc5ZmJkZDIxYjc5MWMwZWJjXzgtNy0xLTEtMTEwNQ_0ba36485-b9e3-4404-a0bf-8384f6926695"
      unitRef="usd">112900000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3c3dd37fd2174277a0fe47e35a4fcb5a_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzItMS0xLTEtMA_478fd9f9-d7d5-47b1-b3f9-999cc5b69d2f"
      unitRef="usd">30900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1476418622484fd6b123b4bcc1a2cd75_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzItMy0xLTEtMA_31356195-dade-4855-89ed-7dfa24b370c0"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie82bd2619aee4c15a6f7979e3f556c90_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzItNS0xLTEtMA_e0c9568a-cf5a-4028-bde0-aa2a068dfede"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id29e6e511f214306bdfcc76ff6f3baac_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzItNy0xLTEtMA_a8d09fe2-6be4-49fd-b1b1-b0874c9dc32a"
      unitRef="usd">30900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibd61fd98056c4fe8828fa4f7907744d5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzMtMS0xLTEtMA_9286f4fd-02d1-4e63-beae-ab1ddefcd75d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i825805b3de504095bdb13927c6069785_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzMtMy0xLTEtMA_d9b27d1b-7626-4fce-8274-f2462417c4d9"
      unitRef="usd">50900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3089884931004023a798595ad2485260_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzMtNS0xLTEtMA_aaec0972-086d-44c7-9351-1ebd9ae2fea8"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8283a90bb7fd45f88844263b5bcf523d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzMtNy0xLTEtMA_fe8c030b-90be-44ce-b9b9-5b1563df6f6a"
      unitRef="usd">50900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2426bfb819934ac9a2b31c1f162f3528_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzQtMS0xLTEtMA_cc6234f2-7528-410b-897d-6eb0c0d561b6"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idf88e0e27ffa4a739ee3847915ee542a_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzQtMy0xLTEtMA_c9befd19-1e49-4195-b0bc-86c7ca3678e6"
      unitRef="usd">18000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4b0a8ffc8cf1459d84e87db58725f2de_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzQtNS0xLTEtMA_31f4c2fc-cf79-4335-89ec-c4a3ae4aea97"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0e5b571f465447868a30d8b17e73e370_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzQtNy0xLTEtMA_e58e54a9-8a77-4462-beb0-e71857d52609"
      unitRef="usd">18000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibc4eeb4c0edb43d59cd752375d0ffdc5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzUtMS0xLTEtMA_b6d319f2-0e59-4781-a4b3-4d92a002daec"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i35c10b20b0e9404abc88a8f6d54ce6bb_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzUtMy0xLTEtMA_76a97060-58d7-49c3-a488-00e04986f26d"
      unitRef="usd">5600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibff6a96abc6e47a3a7673fe45b09702d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzUtNS0xLTEtMA_1d5797b7-821a-4d1a-8556-056e4d67dff9"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i807cd346a0754d6dba10fa435ce3ad0b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzUtNy0xLTEtMA_94a0abfb-d7e7-41a4-b8ae-ef0c4aca4799"
      unitRef="usd">5600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iea094ed8a36e482dad6d4d4ce8912c5e_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzYtMS0xLTEtMA_42659877-a6e6-428d-b4d6-1fc84c23dca6"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i418f1c63d800430dbdfe171f2e5fdb7b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzYtMy0xLTEtMA_4faa3ce3-5478-4e8d-85f1-dc26b9509bae"
      unitRef="usd">16600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i171eeb2ca4ff40c8aa59454fe0649995_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzYtNS0xLTEtMA_5c0ae356-dfa7-4dd7-ba23-5dc67f99a7b4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic00c784d2aed485bbb379ba0192e5f8e_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzYtNy0xLTEtMA_4e9e9595-6219-4f34-9250-9fed0154b4f6"
      unitRef="usd">16600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iae043b92111d49dea53104af438cae87_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzctMS0xLTEtMA_fae57ba6-d6fc-4dc3-8cd2-2f8c8c7f2baf"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i43dfaf6a69a9448dbeaad8511ca6599f_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzctMy0xLTEtMA_86454153-b8b8-438c-a018-d6493f803c35"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i727b4cea45e840c595ed4071c0efc30f_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzctNS0xLTEtMA_5f8ed9db-bd62-4efb-8886-216bdac9c836"
      unitRef="usd">6800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5bbcb194e016455ca224904b253aff7e_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzctNy0xLTEtMA_462d8152-11bf-449a-8062-09b4c94378f1"
      unitRef="usd">6800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i627dc77dc581425492e6a2efc7a71b6a_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzgtMS0xLTEtMA_a13174eb-b9d6-46cf-b24b-453b99c61a53"
      unitRef="usd">30900000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i1779215bab2443df9518c0d760bd4097_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzgtMy0xLTEtMA_c6a36c2d-73af-4802-a63a-f3d541fd0650"
      unitRef="usd">91100000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i896a61f417824c539c7a8aaecb838a3c_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzgtNS0xLTEtMA_ed0946f2-7853-49a4-a187-4a3ef4d90436"
      unitRef="usd">-6800000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTpiNzBiM2RmZDJmMTU0ZDMxOTk4NmU2NzMwNTE1YmE5NC90YWJsZXJhbmdlOmI3MGIzZGZkMmYxNTRkMzE5OTg2ZTY3MzA1MTViYTk0XzgtNy0xLTEtMA_03548655-965b-4498-9ef6-aa8ac88fed75"
      unitRef="usd">115200000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibb619380c1df42aca737476da470cd1b_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzItMS0xLTEtMA_a0e076fe-6c9b-4873-a070-ece77e4e17af"
      unitRef="usd">17200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6f28be2e5f414109aa6edba56d928690_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzItMy0xLTEtMA_69331be7-c1c7-4a6c-a8b0-71d0f9aa53ed"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i29fb3e347dc345cfba47e9db7ea6e116_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzItNS0xLTEtMA_ade5efb9-e37c-48f7-8360-9f68f78879d5"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic28101a6be104f06a27d6e814b1c6d6c_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzItNy0xLTEtMA_73581cdd-b922-4324-915b-4459ca03f4db"
      unitRef="usd">17200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i76d425a4039143e3bb5d1b13ef3c1d5f_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzMtMS0xLTEtMA_01b32532-2e3a-41af-9f81-c0e5f4892dcc"
      unitRef="usd">2500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib5905013aeeb4f2cb39823bb0b2d36dd_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzMtMy0xLTEtMA_9f0b1142-927c-4a1b-b33b-58af56890016"
      unitRef="usd">64400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3993179bb8cd412da2e86291f6b169ba_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzMtNS0xLTEtMA_ca33b6ce-595b-4d1a-aada-21ac52cea6b7"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i39da1921c4dd451f84c2ba0c7a37d8ab_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzMtNy0xLTEtMA_26a653a2-6141-4f9a-80a2-fcd0b98e9724"
      unitRef="usd">66900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6271e87a89724d4d97a244263fb2044b_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzQtMS0xLTEtMA_8123f3ca-2bb4-44c9-980b-22f604d15fbd"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i004fd5a8f7654961a111888fd81ed882_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzQtMy0xLTEtMA_83896819-5bf4-4273-8f20-50ae3653f0d1"
      unitRef="usd">15400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5590cd4c08ee46cc806334b73e196d71_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzQtNS0xLTEtMA_ad7eb2d6-5cc5-4489-a2cd-d3ca27e33821"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i828a886282af459f9e614c44191e6917_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzQtNy0xLTEtMA_ec7dcc9b-4f32-4f3a-957b-eea3cec0ccd6"
      unitRef="usd">15400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6e485d31ad9f497993d65a0f26c27664_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzUtMS0xLTEtMA_067e4220-ddc6-4ecb-a64a-eeb0bcf9fde4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6992e3c7faab476d8c03869ab63ff121_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzUtMy0xLTEtMA_a20e2125-833b-4be6-9e0d-ab9f353a55ac"
      unitRef="usd">9000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i148159c157ef42c8a13aff97edbcbef2_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzUtNS0xLTEtMA_73fa02b4-3bbb-435c-80f7-18c1189aa733"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i91ebf87daee4405886567face5312f8a_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzUtNy0xLTEtMA_b1ae81d4-ae99-4e19-8804-ae1b317bde64"
      unitRef="usd">9000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8191d090ea2745db981907ddafd93a9d_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzYtMS0xLTEtMA_813ebf70-cd09-4335-b2d4-77bf95e41f43"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifa2f364539a64eaaa92b3b40cb82a18d_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzYtMy0xLTEtMA_fc24605e-d7d1-4283-ad91-114c3ddad50c"
      unitRef="usd">9800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i979b5982652c43468a70262328a06272_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzYtNS0xLTEtMA_9a2614ba-3933-49f6-b264-8a9bfc38107e"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i22ae088f58f74d08ab0ee5cc22457e63_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzYtNy0xLTEtMA_3fb96368-e4c2-4c10-aff8-36358d8def62"
      unitRef="usd">9800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i23f0bb6109514d5090ecfde3255f9f3d_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzctMS0xLTEtMA_6c33f77d-a252-450f-8990-2889815162a5"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i15149e8fedda4395b8646b2382f7a984_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzctMy0xLTEtMA_977d5b5b-2cac-47cc-a3e8-ed736660efd1"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5746fc0bcf194215abbb27e272d355fa_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzctNS0xLTEtMA_7756a708-9f2b-425b-8fbf-0c1cd9b564ad"
      unitRef="usd">13800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icfa550eed64f4c2ea0f18c17f0902c9f_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzctNy0xLTEtMA_f65eef00-080c-46d1-9ae4-b365655719dd"
      unitRef="usd">13800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueNetAssetLiability
      contextRef="icb748777a421482d8700ebe22fb9d4ee_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzgtMS0xLTEtMA_b9f1c09f-793d-4b09-960e-57b68f7cd0d2"
      unitRef="usd">19700000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ib2c60fa1e6044f6e8667dcbf536b76df_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzgtMy0xLTEtMA_cb6a911d-bb27-4998-bc18-40faf228425e"
      unitRef="usd">98600000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i4a9f5109771b480db9fd53efad3cf0a0_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzgtNS0xLTEtMA_3432ca5c-c247-434b-9116-0f847af6e5c2"
      unitRef="usd">-13800000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo3YzQ3NzMwZDQ3MDQ0OTliYTIwMjA0ZDM2NTNiYzFlYS90YWJsZXJhbmdlOjdjNDc3MzBkNDcwNDQ5OWJhMjAyMDRkMzY1M2JjMWVhXzgtNy0xLTEtMA_6f308ad0-8784-4201-b4c5-ea20e8ab5e21"
      unitRef="usd">104500000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90ZXh0cmVnaW9uOmQ5OTBhOTUyOTRhYjRhOGU5YjEzMjQyNjhlZmU2ZTgxXzQ0ODM_fd7d2f6a-432e-4334-bd6c-5e602af0e4ed">&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the change in the fair value of the contingent consideration during the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in the statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments recognized in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzEtMS0xLTEtMA_ee0fa568-6ec1-4bdb-948a-7393ea364664"
      unitRef="usd">6800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzEtMy0xLTEtMTY3OTU_d472062a-1757-4b04-b1d2-777a9cbdf713"
      unitRef="usd">13800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzEtNS0xLTEtMTY3OTU_331e8db1-9c95-424d-b084-dabf273c7f41"
      unitRef="usd">14500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzItMS0xLTEtMA_851af1b2-e148-423f-a2d2-eb89bc393070"
      unitRef="usd">100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzItMy0xLTEtMTY3OTU_a2024fe9-ebcf-415b-b891-b7e7abe1073c"
      unitRef="usd">3900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzItNS0xLTEtMTY3OTU_90386ec9-491b-4842-bd29-15a57b21192d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzMtMS0xLTEtMA_657510ba-2fd4-4487-9b75-dafbf4f03cb3"
      unitRef="usd">-3500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzMtMy0xLTEtMTY3OTU_37a8ad16-c74f-440a-a5a1-47d663df3852"
      unitRef="usd">2800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzMtNS0xLTEtMTY3OTU_34e9a32e-3a5b-4171-80b6-496c3d581e0c"
      unitRef="usd">1100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzQtMS0xLTEtMA_a89b0e6d-5575-469f-8ea5-3fc33042d36e"
      unitRef="usd">-700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzQtMy0xLTEtMTY3OTU_1ff33086-7cf2-4f73-9d9f-684f61be9b65"
      unitRef="usd">300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzQtNS0xLTEtMTY3OTU_8f812037-9416-46ba-b517-dd07c5dd421f"
      unitRef="usd">-400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzUtMS0xLTEtMA_e112c6e2-4733-4f10-8696-da65c7ee3609"
      unitRef="usd">10900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzUtMy0xLTEtMTY3OTU_d9ad7daa-c2d3-44c9-81ee-de8a3bce95fe"
      unitRef="usd">6800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMDkvZnJhZzpkOTkwYTk1Mjk0YWI0YThlOWIxMzI0MjY4ZWZlNmU4MS90YWJsZTo4ZDQ4MjkxOWNhNDc0ODMxOGE3MGY3NjM2MmJkNTE0ZS90YWJsZXJhbmdlOjhkNDgyOTE5Y2E0NzQ4MzE4YTcwZjc2MzYyYmQ1MTRlXzUtNS0xLTEtMTY3OTU_b788d7d1-d7e8-4584-9ddc-2e89f3dc0899"
      unitRef="usd">13800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90ZXh0cmVnaW9uOjNmZWJhMWYwNTMyYzRhZjQ4MWYzMDVkN2JlMjA4ZjI5XzI4MQ_c8c32384-0c81-47eb-8237-7e85b24a8490">PROPERTY, PLANT AND EQUIPMENT, NET&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal year ended June 30, 2020, the Company sold the Clinic resulting in the deconsolidation of $19.5 million of the balance of property, plant and equipment. See Note 16 for additional information regarding the sale of the Clinic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90ZXh0cmVnaW9uOjNmZWJhMWYwNTMyYzRhZjQ4MWYzMDVkN2JlMjA4ZjI5XzI4Mg_c78f5083-7de3-4961-8e16-1f5711cb1e1a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzItMS0xLTEtMTEyMg_10dd8c31-e1e8-4027-9296-029ccbe07954"
      unitRef="usd">0</us-gaap:Land>
    <us-gaap:Land
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzItMS0xLTEtMA_edcb2e1d-2d29-4189-8722-39bdf35080d1"
      unitRef="usd">0</us-gaap:Land>
    <us-gaap:Land
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzItMy0xLTEtMA_a9f5507a-fcf8-48eb-b657-76cfd889b5d3"
      unitRef="usd">2300000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzMtMS0xLTEtMTEyMg_780f1f2b-c38d-41f7-b045-3af9001e0f08"
      unitRef="usd">0</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzMtMS0xLTEtMA_897f4813-67d4-4c89-8a3d-714497795146"
      unitRef="usd">0</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzMtMy0xLTEtMA_d421e69f-f4b8-4bbc-b290-3438a03e8e44"
      unitRef="usd">18800000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzQtMS0xLTEtMTEyMg_40e852b3-e17e-43b6-8243-ce84774d19a2"
      unitRef="usd">35700000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzQtMS0xLTEtMA_2cc27a9e-1b6c-441f-a268-e995d869e6f7"
      unitRef="usd">31800000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzQtMy0xLTEtMA_a801aca3-0da6-4fc1-b394-44b70fb8e658"
      unitRef="usd">31000000.0</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzUtMS0xLTEtMTEyMg_2643a9df-992b-4416-94c5-05e45e32cd08"
      unitRef="usd">117900000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzUtMS0xLTEtMA_f325d55e-77da-4e19-a5b0-842cf6e0205b"
      unitRef="usd">112100000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzUtMy0xLTEtMA_4459063f-5ae9-456e-b198-cb9d5f8a9951"
      unitRef="usd">117100000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzYtMS0xLTEtMTEyMg_fd41999a-a00c-4392-a1b8-c8b7c67b0543"
      unitRef="usd">153600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzYtMS0xLTEtMA_b3465f09-d27b-4c17-b6d5-3efc429a2fc8"
      unitRef="usd">143900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzYtMy0xLTEtMA_bf112d83-efd5-42b9-ba45-2007b191f37c"
      unitRef="usd">169200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzctMS0xLTEtMTEyMg_8464b334-950f-48b2-9c1f-8906af006689"
      unitRef="usd">112900000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzctMS0xLTEtMA_2830199b-ced1-44df-b587-b23f8f869336"
      unitRef="usd">106900000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzctMy0xLTEtMA_c3e5fe60-c5c6-4fec-a68c-e298609dd312"
      unitRef="usd">111900000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzgtMS0xLTEtMTEyMg_d0cd9243-6f60-4f33-97bb-3cb4772a468d"
      unitRef="usd">40700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzgtMS0xLTEtMA_f4c0afff-e8cf-45e7-af98-41086c6d5a71"
      unitRef="usd">37000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTo1ZTM1MDNhODQwMzU0MGY2YjU0MDM4ODRlOWM4NDkwMi90YWJsZXJhbmdlOjVlMzUwM2E4NDAzNTQwZjZiNTQwMzg4NGU5Yzg0OTAyXzgtMy0xLTEtMA_aef7b52e-e8c2-4f9e-a11a-0c64a51eec08"
      unitRef="usd">57300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="i575f18ab83bc40979444ed5ab8404853_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90ZXh0cmVnaW9uOjNmZWJhMWYwNTMyYzRhZjQ4MWYzMDVkN2JlMjA4ZjI5XzE1NQ_2adffd66-d2f3-4b1b-8dfc-60174df99b9d"
      unitRef="usd">19500000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:Depreciation
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTpkNzQzYzY5ZDllZjc0NWZjOTQ4MGZlODFiMDJjOWNmNi90YWJsZXJhbmdlOmQ3NDNjNjlkOWVmNzQ1ZmM5NDgwZmU4MWIwMmM5Y2Y2XzItMS0xLTEtMTEyNw_f20c91d2-830f-46d3-b8d8-02bd2fc1ac17"
      unitRef="usd">5000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTpkNzQzYzY5ZDllZjc0NWZjOTQ4MGZlODFiMDJjOWNmNi90YWJsZXJhbmdlOmQ3NDNjNjlkOWVmNzQ1ZmM5NDgwZmU4MWIwMmM5Y2Y2XzItMS0xLTEtMA_16ac899b-f403-4fe8-a281-b4f0f37bda99"
      unitRef="usd">11000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTpkNzQzYzY5ZDllZjc0NWZjOTQ4MGZlODFiMDJjOWNmNi90YWJsZXJhbmdlOmQ3NDNjNjlkOWVmNzQ1ZmM5NDgwZmU4MWIwMmM5Y2Y2XzItMy0xLTEtMA_2c9fd57b-0dc2-4465-bcfb-8264e396eb14"
      unitRef="usd">13700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTUvZnJhZzozZmViYTFmMDUzMmM0YWY0ODFmMzA1ZDdiZTIwOGYyOS90YWJsZTpkNzQzYzY5ZDllZjc0NWZjOTQ4MGZlODFiMDJjOWNmNi90YWJsZXJhbmdlOmQ3NDNjNjlkOWVmNzQ1ZmM5NDgwZmU4MWIwMmM5Y2Y2XzItNS0xLTEtMA_120ab044-de3d-43a0-8a5f-f43b53d5dcff"
      unitRef="usd">17100000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5ODY_257b765a-3c4e-42f5-97fc-da7fdb6c5e54">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the transition period ended December&#160;31, 2020 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diagnostic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the fiscal years ended June 30, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.877%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diagnostic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions (see note 17)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments to acquisitions (see note 17)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill deconsolidated on sale of Clinic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company assessed goodwill for impairment in accordance with the appropriate guidance (see Note 1) and determined none of its reporting units were impaired during the transition period ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the fiscal year ended June 30, 2020, as a result of the effect of COVID-19 on expected future cash flows and a corresponding decline in market capitalization and enterprise value, the Company performed an interim quantitative impairment review of goodwill for the Myriad Mental Health, Myriad Autoimmune and Myriad International reporting units as of March 31, 2020. Based on this analysis, the Company recognized a goodwill impairment charge of $80.7 million related to the goodwill from the Myriad Autoimmune reporting unit. The Myriad Autoimmune reporting unit is part of the Company&#x2019;s diagnostic segment. The goodwill impairment charge is reflected in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the fiscal year ended June 30, 2020, the Company also recognized a $1.3 million impairment charge for goodwill allocated to the Clinic asset group that is included in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations. The Clinic asset group was part of the Company&#x2019;s other segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, developed technology, a laboratory database, trademarks, and customer relationships as well as a non-amortizable intangible asset of in-process research and development.&#160;&#160;The Company&#x2019;s developed technology and database acquired have estimated remaining useful lives between 1 and 16 years, trademarks acquired have an estimated remaining useful life of approximately eight years and customer relationships have an estimated remaining useful life of approximately one year.&#160;The estimated useful life of acquired in-process research and development was also evaluated in conjunction with the annual impairment analysis of intangible assets.&#160;&#160;The classification of the acquired in-process research and development as an indefinite lived asset was deemed appropriate as the related research and development was not yet complete nor had it been abandoned. During the fiscal year ended June 30, 2020, the Company decided to abandon the development of one of its in-process research and development intangible assets, and as a result the Company recognized a charge of $17.7 million, which is reflected in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations. The abandoned in-process research and development intangible asset was reported as part of the Company&#x2019;s diagnostic segment. The Company concluded there was no impairment of long-lived assets for the transition period ended December&#160;31, 2020 or for the fiscal years ended June&#160;30, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the amounts reported as intangible assets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At June 30, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 the weighted average remaining amortization period for purchased licenses and technologies, trademarks, and customer relationships is approximately 11 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded amortization during the respective periods for these intangible assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense of intangible assets as of December 31, 2020 is estimated to be as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.264%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5ODc_952abbbc-a1f6-492c-bcd0-274ed141912d">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the transition period ended December&#160;31, 2020 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diagnostic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the fiscal years ended June 30, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.877%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diagnostic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions (see note 17)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments to acquisitions (see note 17)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill deconsolidated on sale of Clinic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i91ea1f91d8664913a4764506bfd207e4_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzMtMS0xLTEtNDkyNw_0dbea68b-ae7c-4aa3-8957-9aedb555d01f"
      unitRef="usd">270700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id87ab67a6dd04168b8b70d5bdbae26ca_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzMtMy0xLTEtNDkyNA_4ee1d5e2-44e1-44d6-b83a-a661218475ea"
      unitRef="usd">56900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzMtNS0xLTEtNDkzMg_2a5fc10c-b25b-47a4-b314-464a38a0fa76"
      unitRef="usd">327600000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0452133252384a1cbc2014d4918a6cae_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzgtMS0xLTEtNDkyNw_693dde0a-43d0-46d2-8440-85c078d78f21"
      unitRef="usd">1600000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6930cef02e60442f932a3ba59be2846f_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzgtMy0xLTEtNDkyNA_0b0322f0-0055-4ed6-92ed-615d57238a3c"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzgtNS0xLTEtNDkzMg_a3a76eea-b751-49a1-9f16-ebcf4d7149f5"
      unitRef="usd">1600000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i0cbd1c604d9240fb9eab710d8047bbcb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzktMS0xLTEtNDkyNw_81cd041e-40cb-4a92-8210-b8cde5711066"
      unitRef="usd">272300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idf79e13bdaa84cbcb926eceecb0225f7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzktMy0xLTEtNDkyNA_70915183-ab43-4cf4-8c11-8d8404837592"
      unitRef="usd">56900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZToxMWEzMmU4OWFjOTE0NzBmYmM1ZGFjZTFjN2ZjZWE3ZC90YWJsZXJhbmdlOjExYTMyZTg5YWM5MTQ3MGZiYzVkYWNlMWM3ZmNlYTdkXzktNS0xLTEtNDkzMg_5c16ff9d-1649-4c7d-9ae8-41ef39ae58ca"
      unitRef="usd">329200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib992d3be9ee24862b803ebce955a4939_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtMS0xLTEtMA_3175743c-1e7a-4ec8-aef0-b82df43d10bb"
      unitRef="usd">351600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibe1dff6ed82241299a6565c84a2b4ad3_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtMy0xLTEtMA_5f25244f-7eac-492c-b3af-3fbb9dc0e942"
      unitRef="usd">252800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7293118ad87849e1979a9a4529ece677_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtNS0xLTEtMA_9998d421-b687-4f5d-ad99-2dafe0c5220b"
      unitRef="usd">65600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2bd030e591724771a7ef00c6278cee2c_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtNy0xLTEtMA_21518030-7817-4b35-9d36-9a28eb61b3bc"
      unitRef="usd">65800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtOS0xLTEtMA_a58c7aa5-7ab6-4b66-b3d3-ccf4e52f1cc8"
      unitRef="usd">417200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzMtMTEtMS0xLTA_e05b4647-0b5b-4564-a738-f50aef1368ea"
      unitRef="usd">318600000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtMS0xLTEtMA_22eecd1c-61e3-4275-bdfb-77cf862dff29"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtMy0xLTEtMA_69d2b4c6-bbb7-401d-bed3-f3176f55446e"
      unitRef="usd">94900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtNS0xLTEtMA_e9cc05dd-4cf8-4a69-b7b9-f1b1a1e33c7c"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtNy0xLTEtMA_3aac09d2-ef9a-4fd3-920d-40017e018097"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtOS0xLTEtMA_e7bd5c53-f7ad-4614-b27c-c801caed2403"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzQtMTEtMS0xLTA_2f059d4b-65aa-4d1a-b964-9e81561ce012"
      unitRef="usd">94900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtMS0xLTEtMA_ff6e3814-b04f-4541-b58e-fceae92dea7d"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtMy0xLTEtMA_8722466f-c38e-491d-967d-85a9eb052cb4"
      unitRef="usd">4400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtNS0xLTEtMA_e2c9cfc5-52b9-4d24-a7d6-2e833be34128"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtNy0xLTEtMA_3d177d83-fe3e-4d2a-859f-048806cce03b"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtOS0xLTEtMA_c924c411-9bbc-4577-b209-0beeb8426c31"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzUtMTEtMS0xLTA_832e7208-4cc8-4519-976a-c31a2d1c462a"
      unitRef="usd">4400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtMS0xLTEtMA_0eaac89b-1e79-470a-a750-3da949d697fe"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtMy0xLTEtMA_6c1d15db-b564-4d4b-afe6-e77cad8f5530"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtNS0xLTEtMA_fd3ec656-a62d-4d7f-8aa4-612edf905ea5"
      unitRef="usd">7300000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtNy0xLTEtMA_86d28d1a-49d4-479e-a64f-34df6b6f483b"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtOS0xLTEtMA_3169ca22-e81f-4a6c-8f31-59f84f707a41"
      unitRef="usd">7300000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzYtMTEtMS0xLTA_a85d583c-3789-498c-8684-bbebc3baeb85"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctMS0xLTEtMA_c5399f2b-e0b0-4fb7-994d-4ad718031404"
      unitRef="usd">80700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctMy0xLTEtMA_3cb553cc-ecc9-46fb-b1d1-b835b61cc427"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctNS0xLTEtMA_08896b71-d85a-4b5f-b791-bdaa69e63bc8"
      unitRef="usd">1300000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctNy0xLTEtMA_f4caf69f-661a-4535-8fc6-c530b3e8115c"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctOS0xLTEtMA_5555fe2b-856f-46e0-a886-b849f2721bb8"
      unitRef="usd">82000000.0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzctMTEtMS0xLTA_1ed56975-ebc5-4ffe-afd3-b5db0fab8dd9"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtMS0xLTEtMA_97dc1d1e-c0bf-4f70-bce3-7142b409b0e0"
      unitRef="usd">-200000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia8fc7b452d554c3b9187a5b2bd36d03e_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtMy0xLTEtMA_7bfd5f48-6d07-4f85-a495-4bbbfbcb254c"
      unitRef="usd">-500000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id228e11e1e444f3a8169bd6f2a61fb7f_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtNS0xLTEtMA_2c45ee0b-7939-421b-be51-4859da6da241"
      unitRef="usd">-100000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ideb6cc823dd1450f9e422b1450b92bcd_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtNy0xLTEtMA_49cf46d1-3612-4670-bdbe-eb61684fe53b"
      unitRef="usd">-200000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtOS0xLTEtMA_ad76ce31-3aa9-42c5-8d02-cbecd3a3348d"
      unitRef="usd">-300000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzgtMTEtMS0xLTA_c43c7fec-be9c-4992-803a-b09661726f5e"
      unitRef="usd">-700000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i91ea1f91d8664913a4764506bfd207e4_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktMS0xLTEtMA_f1e295f8-8219-4311-bf17-b15bfd883009"
      unitRef="usd">270700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib992d3be9ee24862b803ebce955a4939_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktMy0xLTEtMA_e6ca2597-f680-4b4e-b18f-5c634432c7bf"
      unitRef="usd">351600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id87ab67a6dd04168b8b70d5bdbae26ca_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktNS0xLTEtMA_6e865128-b523-4a6c-823b-7b68ee9e58ac"
      unitRef="usd">56900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7293118ad87849e1979a9a4529ece677_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktNy0xLTEtMA_feffc1bf-af98-4c8a-a5df-2278f52b1bbf"
      unitRef="usd">65600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktOS0xLTEtMA_4c8f6a3c-e0de-4b2b-bcf8-0e9992ddd6a7"
      unitRef="usd">327600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTozODEzNzU2MzZhYzU0ZWQ3YjBmMjNkMjFkNGYxODcwMC90YWJsZXJhbmdlOjM4MTM3NTYzNmFjNTRlZDdiMGYyM2QyMWQ0ZjE4NzAwXzktMTEtMS0xLTA_15376602-ca29-4f0c-979e-a454d7dabd8e"
      unitRef="usd">417200000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzk2NjI_94580da1-4764-4c2f-9fd3-9d62d2bc63b0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ife885bcb6b0042d8879fb750f6ac752c_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MTI_ea7cd84d-567e-4404-bc5f-a1203a161ec9"
      unitRef="usd">80700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i45a2fa48f3c343368a8e72ee16163874_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MjI_394f0271-65aa-4ed2-ba3a-81488db4dd79"
      unitRef="usd">1300000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i08cb205cf6ff477cbb17f7110077d7cd_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzM0MTA_cb769f15-d908-4908-b29d-67f392df8275">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibdf71da88168472ba6c7919001d183a6_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzM0MTc_5b5f8654-d466-477a-89c2-62063a5589f7">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i358e9cbf8de8453c97ef831209748f8b_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzM0OTg_7d902729-9ccf-4e55-ab37-5079a707cceb">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i90d7ec9fb1de477e8189293731c018d6_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzM1ODU_e2ba1dd6-ea45-4435-b96b-0825df212558">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i630e10b5aa094e7f89a22372825917b0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2NDA_aab163d7-6f8c-48bd-a836-4f74798de459"
      unitRef="usd">17700000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ0NDc_08dd0988-da9d-4891-b6fb-867adb03a894"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ0NDc_4b3960b4-b70a-4164-966d-9078a0f2ca83"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ0NDc_68e4e54d-a277-4687-a856-3e194980f4bd"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ0NDc_8c55e84e-ff30-4ada-8e92-41b89390f280"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MDk_74592303-6aea-45f4-8a29-77fe2e70cffe">&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the amounts reported as intangible assets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At June 30, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MDk_cb13d986-fe57-42d6-8dd1-b33a51ec6090">&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the amounts reported as intangible assets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At June 30, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia52ebc6a5c564a3ba28fffe021227a85_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzEtMi0xLTEtNDU4MQ_f24916ce-381f-4d23-a206-94ac732be820"
      unitRef="usd">818200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia52ebc6a5c564a3ba28fffe021227a85_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzEtNC0xLTEtNDU4MQ_db116998-7d69-462e-99a8-ca46d465b043"
      unitRef="usd">248200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia52ebc6a5c564a3ba28fffe021227a85_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzEtNi0xLTEtNDU4MQ_f9ea2f7f-661c-46f3-a6d8-c56d5f96d4a4"
      unitRef="usd">570000000.0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib82e7ad1d54745bf9f3e53cb046e5adb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzItMi0xLTEtNDU4MQ_eaefa53d-3f49-4d18-9a12-3af9ee604902"
      unitRef="usd">4700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib82e7ad1d54745bf9f3e53cb046e5adb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzItNC0xLTEtNDU4MQ_bc7bd050-4ab3-4aa6-b676-1170a716ee83"
      unitRef="usd">4500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib82e7ad1d54745bf9f3e53cb046e5adb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzItNi0xLTEtNDU4MQ_2197d4bc-2259-4635-9b00-9eac360668c0"
      unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i83a65cbe1f3b4d65b6f51bc3d1b557ab_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzMtMi0xLTEtNDU4MQ_63e4a099-9f63-414f-bf86-e1588279434a"
      unitRef="usd">3000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i83a65cbe1f3b4d65b6f51bc3d1b557ab_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzMtNC0xLTEtNDU4MQ_f88989c0-50a0-43f9-a6a4-2f199ebc37e2"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i83a65cbe1f3b4d65b6f51bc3d1b557ab_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzMtNi0xLTEtNDU4MQ_a05dd424-c5fe-40ef-a643-1fc950e93bb6"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzQtMi0xLTEtNDU4MQ_2a650ac7-5231-46ed-81fa-b45f6bbbc6b5"
      unitRef="usd">825900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzQtNC0xLTEtNDU4MQ_2584d2f1-debe-431e-8266-ae69661d42e3"
      unitRef="usd">254200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzQtNi0xLTEtNDU4MQ_459e7bf5-cda2-4911-b2cf-47f4c2fb8da1"
      unitRef="usd">571700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i063c58e973c84e0c90eb3b292cd80d2f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzUtMi0xLTEtNDU4MQ_17d1eca0-77ff-40a0-a022-d4e8df8a19e2"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i063c58e973c84e0c90eb3b292cd80d2f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzUtNi0xLTEtNDU4MQ_427fc00b-7e97-463a-9557-0e9b3392dee8"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzYtMi0xLTEtNDU4MQ_36915001-0113-40ac-8ba5-5a0f9206e541"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzYtNi0xLTEtNDU4MQ_893882d7-9ced-4049-b411-012ad7cc9497"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzctMi0xLTEtNDU4MQ_603772fe-7ff5-4060-851d-fd16306da912"
      unitRef="usd">830700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzctNC0xLTEtNDU4MQ_b2258a2d-ca89-408c-b54d-90a5320827ba"
      unitRef="usd">254200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmOGQyOWRkNzBhMzY0ZDA5YTMxZGU0MjA1Y2E5ZjA5Yi90YWJsZXJhbmdlOmY4ZDI5ZGQ3MGEzNjRkMDlhMzFkZTQyMDVjYTlmMDliXzctNi0xLTEtNDU4MQ_b006beb8-45fc-424c-ad7f-ec7ee7c47c40"
      unitRef="usd">576500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0ceb8d39a9034275a4786f69cadfae9d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzEtMS0xLTEtMA_e21af39a-2388-45c7-aa50-49287b5ac2c7"
      unitRef="usd">815600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0ceb8d39a9034275a4786f69cadfae9d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzEtMy0xLTEtMA_d073e869-79f0-44b3-b019-b1dff7746e71"
      unitRef="usd">217100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0ceb8d39a9034275a4786f69cadfae9d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzEtNS0xLTEtMA_803c0713-af2c-4c1d-acba-6f0b33bc4902"
      unitRef="usd">598500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i05db2823ea2e4f1983fc881d4d120ee6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzItMS0xLTEtMA_f0ae0807-f2f2-496c-8a76-a3631d05c4a0"
      unitRef="usd">4600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i05db2823ea2e4f1983fc881d4d120ee6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzItMy0xLTEtMA_23946dee-0ed7-455e-b5e5-8dfab8ba690f"
      unitRef="usd">4200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i05db2823ea2e4f1983fc881d4d120ee6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzItNS0xLTEtMA_fe3285a9-7ae0-4812-9516-335ba616aa52"
      unitRef="usd">400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0836938b4b5749e7b04cda79f7d778d7_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzMtMS0xLTEtMA_9b2320bb-7124-44bc-ab3a-3e6392d100ae"
      unitRef="usd">3000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0836938b4b5749e7b04cda79f7d778d7_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzMtMy0xLTEtMA_cadd7ad8-daa9-4e5b-a8ba-549d9785dc53"
      unitRef="usd">1400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0836938b4b5749e7b04cda79f7d778d7_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzMtNS0xLTEtMA_910b189b-da07-4f71-8df4-60b16f943531"
      unitRef="usd">1600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzQtMS0xLTEtMA_122c6388-eb89-4c23-83b2-e508943f49f2"
      unitRef="usd">823200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzQtMy0xLTEtMA_c483c5fb-57e7-4874-b78a-f580265e74b9"
      unitRef="usd">222700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzQtNS0xLTEtMA_50492a56-de23-463e-8b4a-2548c5a54858"
      unitRef="usd">600500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib5eb1e7015b84a099b7eec0436d24272_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzUtMS0xLTEtMA_9d2bae3a-fb03-4136-9c62-64ed310b107d"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib5eb1e7015b84a099b7eec0436d24272_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzUtNS0xLTEtMA_b9a29889-4cf7-4c05-bfda-7b0587af05fb"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzYtMS0xLTEtMA_340ae605-2897-4adc-ae4a-48749af2bde7"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzYtNS0xLTEtMA_813640a7-0829-4301-a4a5-b9e8081d7821"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzctMS0xLTEtMA_6458790b-e00f-4465-bafc-0506d5381eee"
      unitRef="usd">828000000.0</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzctMy0xLTEtMA_18179219-8f7f-4db9-9e94-9a0b9f7d75b1"
      unitRef="usd">222700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpiMjE2MzkzY2RmN2U0YzdhOTZkMzhiY2I3MjVlMzdjOC90YWJsZXJhbmdlOmIyMTYzOTNjZGY3ZTRjN2E5NmQzOGJjYjcyNWUzN2M4XzctNS0xLTEtMA_8276e5c4-ef16-4bf5-a384-e3e0d14173d5"
      unitRef="usd">605300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ide312d0b744845ed9d38a50c79ac314f_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzEtMS0xLTEtMA_1799906f-3f4d-4b9b-ae83-23a4547217e0"
      unitRef="usd">815700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ide312d0b744845ed9d38a50c79ac314f_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzEtMy0xLTEtMA_6a3d4d47-4256-4049-a18d-8b67512a553e"
      unitRef="usd">156600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ide312d0b744845ed9d38a50c79ac314f_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzEtNS0xLTEtMA_a9e08188-75ea-4d24-a1f1-1696cd838033"
      unitRef="usd">659100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3927b5f25dab43d8bba22d95423cf7a5_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzItMS0xLTEtMA_4a6ada40-6a0d-4056-bebd-679f577f2e39"
      unitRef="usd">4600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3927b5f25dab43d8bba22d95423cf7a5_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzItMy0xLTEtMA_6f7155f3-50ee-4d93-ba1f-898b0be796d3"
      unitRef="usd">3800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3927b5f25dab43d8bba22d95423cf7a5_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzItNS0xLTEtMA_46c0816e-367d-4981-b553-377ac0b29a23"
      unitRef="usd">800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i368a22ba17754f239a339d70f874d4e4_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzMtMS0xLTEtMA_a594b331-c2c7-42c9-a748-ac863d940086"
      unitRef="usd">3000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i368a22ba17754f239a339d70f874d4e4_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzMtMy0xLTEtMA_5aef62e4-75b2-43c9-ab0b-75b0055c3b55"
      unitRef="usd">1200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i368a22ba17754f239a339d70f874d4e4_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzMtNS0xLTEtMA_6ce361ec-1d18-462c-afd9-34c3af066d2e"
      unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzQtMS0xLTEtMA_54f74765-6938-4c5f-92ff-5ead5206e09e"
      unitRef="usd">823300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzQtMy0xLTEtMA_10a76a17-089d-4bfc-aec0-77c826417cb3"
      unitRef="usd">161600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzQtNS0xLTEtMA_a0e08672-ba6a-452a-b2d7-4418aaa5bb6c"
      unitRef="usd">661700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i777e19d7ca9f43749f30b1d52f56cb12_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzUtMS0xLTEtMA_4cfb12dd-60c4-4616-b934-56f56632cc68"
      unitRef="usd">23000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i777e19d7ca9f43749f30b1d52f56cb12_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzUtNS0xLTEtMA_5dd2462c-c3df-47f6-919e-417ab3afc5a6"
      unitRef="usd">23000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzYtMS0xLTEtMA_6511086e-ea39-4b5d-aa83-2218af8b8299"
      unitRef="usd">23000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzYtNS0xLTEtMA_e8c68eca-c310-4f49-a5e7-661d879c2e74"
      unitRef="usd">23000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzctMS0xLTEtMA_44044700-40bf-4983-91a5-959f7cb3bb7b"
      unitRef="usd">846300000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzctMy0xLTEtMA_285a7dae-84b5-4c9b-8565-0ed7ac4badc3"
      unitRef="usd">161600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTo1MDU5MjBkMzQ3ZDU0NDc3OWIxNWZiY2Q1NmQzZjllNS90YWJsZXJhbmdlOjUwNTkyMGQzNDdkNTQ0Nzc5YjE1ZmJjZDU2ZDNmOWU1XzctNS0xLTEtMA_e96a9d62-f677-4568-93fd-089200bf7d33"
      unitRef="usd">684700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ3NDY_3aebd2f7-864d-480f-935e-b5c34a467852">P11Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5ODk_d8b5030f-5e98-433b-bb91-a55c4038ca0f">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded amortization during the respective periods for these intangible assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmNDVmZjZkNDRmZDU0ZmUwODBhMTRmMzllZmMzOTUwYS90YWJsZXJhbmdlOmY0NWZmNmQ0NGZkNTRmZTA4MGExNGYzOWVmYzM5NTBhXzItMS0xLTEtMjcyNw_4030becb-8aec-4dc5-9d6c-eaf36a7f37ad"
      unitRef="usd">30800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmNDVmZjZkNDRmZDU0ZmUwODBhMTRmMzllZmMzOTUwYS90YWJsZXJhbmdlOmY0NWZmNmQ0NGZkNTRmZTA4MGExNGYzOWVmYzM5NTBhXzItMS0xLTEtMA_aebf9f1a-4c0d-4484-acd9-3239e28e85c2"
      unitRef="usd">61000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmNDVmZjZkNDRmZDU0ZmUwODBhMTRmMzllZmMzOTUwYS90YWJsZXJhbmdlOmY0NWZmNmQ0NGZkNTRmZTA4MGExNGYzOWVmYzM5NTBhXzItMy0xLTEtMA_74937ac2-c028-469e-8ed4-b019a8a0c262"
      unitRef="usd">59300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTpmNDVmZjZkNDRmZDU0ZmUwODBhMTRmMzllZmMzOTUwYS90YWJsZXJhbmdlOmY0NWZmNmQ0NGZkNTRmZTA4MGExNGYzOWVmYzM5NTBhXzItNy0xLTEtMTY5MDg_c8efc72e-93bc-4169-8a4e-83303b416278"
      unitRef="usd">37300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90ZXh0cmVnaW9uOjhlN2NhYWE2NmFiZDQ4NWU4MzMyN2VkMGM3ZWNlOThlXzQ5NDc4MDIzMzg2MTA_96e1e506-420e-4e81-8d65-3ffe4eea0972">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense of intangible assets as of December 31, 2020 is estimated to be as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.264%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzEtMS0xLTEtMTA4NDg_04336cd6-b845-45ef-9b87-0a094828ec7e"
      unitRef="usd">58300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzItMS0xLTEtMTA4NDg_b88f3170-e2b3-4bf9-9c58-018064591e8f"
      unitRef="usd">52800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzMtMS0xLTEtMTA4NDg_4289fcd1-d9ff-4770-bfc3-b4f8d59467c7"
      unitRef="usd">52600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzQtMS0xLTEtMTA4NDg_fb88e6d4-ce69-450d-a21b-d5d44e5d82ae"
      unitRef="usd">52600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzUtMS0xLTEtMTA4NDg_ac5aad5e-5a1c-4430-a8c6-7f39e03285dd"
      unitRef="usd">52600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzYtMS0xLTEtMTI2MDM_cc780516-9323-4310-9e4d-e82fd59dceed"
      unitRef="usd">302800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMTgvZnJhZzo4ZTdjYWFhNjZhYmQ0ODVlODMzMjdlZDBjN2VjZTk4ZS90YWJsZTplMjA3MjZmZTllMWU0MGY2YTdmNWM4ZjRlMjkyMDdkNy90YWJsZXJhbmdlOmUyMDcyNmZlOWUxZTQwZjZhN2Y1YzhmNGUyOTIwN2Q3XzctMS0xLTEtMTMyOTg_bf2d4371-3be8-406e-bfff-855b0e5db867"
      unitRef="usd">571700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90ZXh0cmVnaW9uOjM1ZDIxMmI2MjI0NzQ0ZGU5NDkzNDhkOTlkMWI2N2QyXzI5_634171d2-c08d-41aa-9003-db04acf4c6ab">ACCRUED LIABILITIES&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Qui tam settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoupments payable and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90ZXh0cmVnaW9uOjM1ZDIxMmI2MjI0NzQ0ZGU5NDkzNDhkOTlkMWI2N2QyXzMw_60ee53d7-4708-4306-b289-62a3086f8e9c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Qui tam settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoupments payable and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzItMS0xLTEtMTEzNg_d280d3cd-323c-441a-974e-28a85ef63994"
      unitRef="usd">43700000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzItMS0xLTEtMA_73146740-fc09-4897-a64f-49c21df8d100"
      unitRef="usd">47400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzItMy0xLTEtMA_b48dd134-80d9-4ac8-bd92-2a4bd5645b67"
      unitRef="usd">48800000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzMtMS0xLTEtMTEzNg_a0a8daa6-e9ce-447d-8650-7993bf5983c4"
      unitRef="usd">4300000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzMtMS0xLTEtMA_21efd1c0-c0b8-445c-892d-9812fb1b408c"
      unitRef="usd">6100000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzMtMy0xLTEtMA_dfb6d8b8-4b00-4ed8-a266-7fc97596594e"
      unitRef="usd">3000000.0</us-gaap:TaxesPayableCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzQtMS0xLTEtMTEzNg_70c6414c-b52e-42b4-9edb-77e71526ce49"
      unitRef="usd">0</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzQtMS0xLTEtMA_2e2c8d6d-8c22-426b-a49e-0975044b9ff2"
      unitRef="usd">0</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzQtMy0xLTEtMA_e23ceee1-a33b-477c-a81e-26dde53a3cf1"
      unitRef="usd">9100000</us-gaap:LitigationReserveCurrent>
    <mygn:RecoupmentsPayableAndReserveCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMS0xLTEtOTY4NA_2cc8f4b7-4f61-48d9-8644-cdeb2172f700"
      unitRef="usd">9300000</mygn:RecoupmentsPayableAndReserveCurrent>
    <mygn:RecoupmentsPayableAndReserveCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMy0xLTEtMTMzODU_7742bb81-40ea-4fda-ab00-79dc10e083be"
      unitRef="usd">8300000</mygn:RecoupmentsPayableAndReserveCurrent>
    <mygn:RecoupmentsPayableAndReserveCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtNS0xLTEtMTMzODc_6717f90e-1b36-43fb-af6a-168cc81acfe8"
      unitRef="usd">0</mygn:RecoupmentsPayableAndReserveCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMS0xLTEtMTIxODg_e36c53fd-51c8-486a-b129-8c9e35c2caf4"
      unitRef="usd">3400000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMy0xLTEtMTIxOTA_c1021357-4f2b-4318-88cb-039527a04dcc"
      unitRef="usd">3100000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtNS0xLTEtMTIxOTA_5f7c9cd5-da95-439a-8a00-566210db8f24"
      unitRef="usd">3400000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMS0xLTEtMTEzNg_72bbef5a-3c55-415b-942d-5eabcc331386"
      unitRef="usd">18400000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMS0xLTEtMA_c38412d9-75a5-4414-ae99-ab575e9ce89b"
      unitRef="usd">14100000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzUtMy0xLTEtMA_ccd264bb-ec74-40b2-a164-83459d64b505"
      unitRef="usd">18000000.0</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMS0xLTEtMTEzNg_709893bb-d9a6-4dca-ac27-28646753c54a"
      unitRef="usd">79100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMS0xLTEtMA_3a99bd92-ce1f-4ef4-97ad-ca9f719f1105"
      unitRef="usd">79000000.0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjQvZnJhZzozNWQyMTJiNjIyNDc0NGRlOTQ5MzQ4ZDk5ZDFiNjdkMi90YWJsZTpkZGI5ODQxYjM0MGU0MGY1YjIzNmQxMmY1ZWZiMzk5MS90YWJsZXJhbmdlOmRkYjk4NDFiMzQwZTQwZjViMjM2ZDEyZjVlZmIzOTkxXzYtMy0xLTEtMA_76e59050-b38f-4f2e-92e8-7cde6a7589f7"
      unitRef="usd">82300000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQxOTc_b341e602-fac0-42aa-b3e2-a5c08892b9da">LONG-TERM DEBT&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 23, 2016, the Company entered into a senior secured revolving credit facility (the &#x201c;Facility&#x201d;) as borrower, with the lenders from time to time party thereto. On July 31, 2018, the Company entered into Amendment No. 1 to the Facility (the &#x201c;Amended Facility&#x201d;), which effected an &#x201c;amend and extend&#x201d; transaction with respect to the Facility by which the maturity date thereof was extended to July 31, 2023 and the maximum aggregate principal commitment was increased from $300.0 million to $350.0 million.&#160;&#160;On May 1, 2020, the Company entered into Amendment No. 2 to the Amended Facility, which waived the Company&#x2019;s compliance with certain covenants and modified the interest rate and other terms during the Amendment Period from March 31, 2020 through June 30, 2021 (&#x201c;Amendment Period&#x201d;). Both amendments were accounted for as modifications pursuant to guidance in ASC 470-50. &#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Amended Facility, the Company borrowed revolving loans in an aggregate principal amount of $300.0 million with $1.8 million in upfront fees and $0.3 million debt issuance costs recorded as a debt discount to be amortized over the term of the Amended Facility. The Company incurred an additional $1.0 million in upfront fees as a result of Amendment No. 2, which was also recorded as a debt discount that will be amortized over the term of the Amended Facility. There are no scheduled principal payments of the Amended Facility prior to its maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The proceeds of the Amended Facility were used to: (i) refinance in full the obligations under the Facility, (ii) finance the acquisition of Counsyl (See Note 17), (iii) pay fees, commissions, transactions costs and expenses incurred in connection with the foregoing, and (iv) for working capital and other general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Facility contains customary loan terms, interest rates, representations and warranties, affirmative and negative covenants, in each case, subject to customary limitations, exceptions and exclusions. The Amended Facility also contains certain customary events of default. Amendment No. 2 modified the Amended Facility to increase the interest rate to be fixed at a spread of LIBOR plus 350 basis points on drawn balances and the undrawn fee was increased to 50 basis points during the Amendment Period, at which point they return to the existing pricing of 200 basis points on drawn balances and an undrawn fee ranging from 25 to 45 basis points based on the Company&#x2019;s leverage ratio. The LIBOR floor was also increased to 1.0% during the Amendment Period. The interest rate as of December&#160;31, 2020 was 4.5%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Covenants in the Amended Facility impose operating and financial restrictions on the Company. These restrictions may prohibit or place limitations on, among other things, the Company&#x2019;s ability to incur additional indebtedness, create certain types of liens or complete mergers or consolidations, and/or change in control transactions. The Amended Facility may also prohibit or place limitations on the Company&#x2019;s ability to sell assets, pay dividends or provide other distributions to stockholders. The Company must maintain specified leverage and interest ratios measured as of the end of each quarter as a financial covenant in the Amended Facility. Amendment No. 2 modified the Amended Facility&#x2019;s compliance with the leverage ratio covenant and the interest coverage ratio covenant, which were waived through March 31, 2021. A minimum liquidity covenant was added for the period beginning May 2020 until March 2021, and a minimum EBITDA covenant was added for the quarters ending December 31, 2020 and March 31, 2021. Amendment No. 2 also revised certain negative covenants of the Amended Facility during the Amendment Period. As of December&#160;31, 2020, the Company was not in compliance with the minimum EBITDA covenant related to the Amended Facility. The Company is in compliance with all debt covenants as of the date the consolidated financial statements are available for issuance. As discussed in Note 18, on February 22, 2021 the Company entered into Amendment No. 3 to the Amended Facility which removed the minimum EBITDA covenant and also amended other covenant terms. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the transition period ended December 31, 2020, the Company did not make any principal repayments. During the fiscal years ended June&#160;30, 2020, 2019 and 2018 the Company made $8.6 million, $115.0 million and $143.0 million in principal repayments, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Facility is secured by a first-lien security interest in substantially all of the assets of Myriad and certain of its domestic subsidiaries and each such domestic subsidiary of Myriad has guaranteed the repayment of the Amended Facility. Amounts outstanding under the Amended Facility were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i0f6ff2934a84433bafc32b6df84630bf_D20180731-20180731"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQyMg_48e84557-50ea-4e57-96df-5fd93e1bad2d">2023-07-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic8168706f12149b6b5546e5eb8c2880d_I20161223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQ5MQ_f67f38ff-753f-4735-a49b-e0f898d537db"
      unitRef="usd">300000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQ5Nw_28464775-251a-47ec-9273-d9a2f1f04fe9"
      unitRef="usd">350000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4Xzk4MQ_b5cae528-3dcd-44f7-b939-aedec0a8098d"
      unitRef="usd">300000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4Xzk4OQ_eef2d804-7456-4e86-9afb-a8f1222955c3"
      unitRef="usd">1800000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross
      contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzEwMTI_fc948d52-b8e7-4014-8c18-04c2d8a19948"
      unitRef="usd">300000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i8db25c9c8c1a4f0d9143e0fa38d1b8c0_I20200501"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzExNTM_1e40d8a2-0ba8-4593-848e-950395306373"
      unitRef="usd">1000000.0</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="i4154d8d1b34d4189b61c52d5e3db0e61_I20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzEzNzI_7ff3562b-4421-4da8-83bf-8c4820d5859d"
      unitRef="usd">0</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ieb698caa638b42d1979314bc3a5847bd_D20200401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzIxODc_eab1e86b-707b-40b4-ae99-fe66cad5bdf3"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="id495302512264408b7c35e7b17c70ddd_D20200401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzIyNTg_eb545321-f9bd-429c-8010-293f12f0ac6a"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia62ae255eb174dda98733a496df5ac02_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzIzNTc_611d5277-2d76-485c-a79a-0d5c673b9a8a"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="id0a3ba1b79114c77afaf02ff36fa05be_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzI0MjM_765f79ff-f242-4abd-abcf-6dd2be3319f1"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="if227e7110e014058a767b9bd13ef0d3e_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzI0Mjk_08db68af-9988-431f-981f-0b9747bff076"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <mygn:DebtInstrumentLIBORFloorPercentage
      contextRef="id495302512264408b7c35e7b17c70ddd_D20200401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzI1MjI_4fc6b5e6-6a6f-4860-867c-069f3addfe73"
      unitRef="number">0.010</mygn:DebtInstrumentLIBORFloorPercentage>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i82d2b9e5a08048bf9897aa33a87b7756_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzM4NDgyOTA3MDE2NTI_a12f5c77-e19b-47f4-bbf7-affc85693723"
      unitRef="number">0.045</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i6f1482ec3ab648658454bf97344b72e8_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQ5NDc4MDIzMzAyMDY_3738fd06-56ec-48fe-9117-fe62e3338bef"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i0ac03d04962f4c50ba2419ea9529b2bd_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzM4Mjk_ed87a911-6614-4d3a-bba4-6c1c45f26d2c"
      unitRef="usd">8600000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i7fa5fc13241a4e07b520ff640cb97a2c_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzM4MzM_1e0f4d97-b7ee-4768-8d35-2789a32b32f6"
      unitRef="usd">115000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ica5c0cd9bacd45798f5d92217ef8280f_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzM4NDA_5283fbb0-a5f0-4aa5-a129-449777b44550"
      unitRef="usd">143000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90ZXh0cmVnaW9uOjdkYmJjNmMxNDIyNzQ5YTdiZGM4MDRjYzNiNzVkYzk4XzQxOTk_faab02f7-5ab0-4b41-8b1b-05e32b2780df">Amounts outstanding under the Amended Facility were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzItMS0xLTEtMTE1Mw_bd44f87f-b60d-4ee2-b53b-f4d9332eb876"
      unitRef="usd">226700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzItMS0xLTEtMA_ad3bc0cb-0927-427a-aa4e-9160125b4ff3"
      unitRef="usd">226700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzItMy0xLTEtMA_3b909bdd-2f82-4cba-9cd8-f9aca74ecbab"
      unitRef="usd">235000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzMtMS0xLTEtMTE1Mw_bd007194-54c3-4fd9-9363-90aa4fd61157"
      unitRef="usd">1900000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzMtMS0xLTEtMA_68beac4d-b198-4c53-8c75-eba715994067"
      unitRef="usd">2300000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzMtMy0xLTEtMA_c23073da-260b-419d-86a5-dc5a0a1a6bf5"
      unitRef="usd">1500000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzQtMS0xLTEtMTE1Mw_1705e08b-7926-4ae7-b641-59d95434099a"
      unitRef="usd">224800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzQtMS0xLTEtMA_ac2b8872-5cb7-4c41-902e-24b8f72338ce"
      unitRef="usd">224400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMjcvZnJhZzo3ZGJiYzZjMTQyMjc0OWE3YmRjODA0Y2MzYjc1ZGM5OC90YWJsZTpiNTlkZmU3ODIxNGY0MDhhYjJjNjk3YjNhMDQ0NTkxZS90YWJsZXJhbmdlOmI1OWRmZTc4MjE0ZjQwOGFiMmM2OTdiM2EwNDQ1OTFlXzQtMy0xLTEtMA_65b08b7d-57b7-4bb8-9fbd-2a06a5f91716"
      unitRef="usd">233500000</us-gaap:LongTermDebt>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzc5MQ_c7c31256-12fd-4f7b-9d98-a639df28fbf2">OTHER LONG-TERM LIABILITIES&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s balance of other long-term liabilities for the transition period ended December&#160;31, 2020 consists of Company&#x2019;s portion of social security taxes that have been deferred under the CARES Act that do not have to be deposited until December 2022. The Company previously held two non-contributory defined benefit pension plans for its current and former Clinic employees. The Company has closed participation in the plans to exclude those employees hired after 2002. As of June&#160;30, 2019 the fair value of the plan assets were approximately $0.1 million&#160;resulting in a net pension liability of $6.8 million. The Company sold the Clinic in February 2020 and as a result the net pension liability was removed upon deconsolidation. See Note 16 for further discussion regarding the sale of the Clinic.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzc5Mg_53590a0e-789c-4c53-bd4f-db5a860ca235">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzItMS0xLTEtMTE1Nw_66549eb2-b4b9-43ea-918e-cad72fc1254a"
      unitRef="usd">0</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzItMS0xLTEtMA_ee1ce4cd-01e0-4b10-8fb6-ce8e3382d868"
      unitRef="usd">0</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzItMy0xLTEtMA_189369aa-8b1e-4aef-b486-272b81180978"
      unitRef="usd">6800000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMS0xLTEtNzA2OA_03066269-c2f3-4647-8a18-6e14d7deb984"
      unitRef="usd">7400000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMy0xLTEtNzA2OA_e5fb3762-70a2-49c0-9f71-907842f21b6d"
      unitRef="usd">3700000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtNS0xLTEtNzA2OA_47ac4142-c6c9-4c1d-a994-406447d42019"
      unitRef="usd">10400000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMS0xLTEtMTE1Nw_6b93b7f0-8bc6-4cdb-b93d-115c6da0899e"
      unitRef="usd">7300000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMS0xLTEtMA_e22a476d-4dde-41b7-8e56-992e4b398b64"
      unitRef="usd">4300000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzMtMy0xLTEtMA_b633544d-8b5a-4382-b233-2996b5f02c5c"
      unitRef="usd">1000000.0</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzQtMS0xLTEtMTE1Nw_9ce19e5c-e5d7-4252-a0d2-b3c59fa2eb64"
      unitRef="usd">14700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzQtMS0xLTEtMA_0d03ceb5-4a1d-43a6-a3c7-f367449cc706"
      unitRef="usd">8000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90YWJsZTpmMDg0N2Y1ZWJjYzc0OTNkOTI3NjhmNWI2Njg3ODI0Yy90YWJsZXJhbmdlOmYwODQ3ZjVlYmNjNzQ5M2Q5Mjc2OGY1YjY2ODc4MjRjXzQtMy0xLTEtMA_3395061c-df72-4f1d-a6eb-147eec3426d8"
      unitRef="usd">18200000</us-gaap:OtherLiabilitiesNoncurrent>
    <mygn:NumberOfDefinedBenefitPensionPlans
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzMwNA_c88d00c4-c92a-4687-abbe-f9f75ec3d824"
      unitRef="plan">2</mygn:NumberOfDefinedBenefitPensionPlans>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzU1Ng_6c0306be-4cdc-4d27-a7da-753a0787e102"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzMvZnJhZzozZGVkZjMyZGE0NzI0Mjc3YjNjYjZjNmE0YTY5Yjc0YS90ZXh0cmVnaW9uOjNkZWRmMzJkYTQ3MjQyNzdiM2NiNmM2YTRhNjliNzRhXzU5OQ_d48d3a52-9986-4a82-973f-b5fa9a4e6810"
      unitRef="usd">6800000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE2NDk_0d1358ca-2c65-488f-82e7-46373bc2ecb2">PREFERRED AND COMMON STOCKHOLDERS' EQUITY&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 5.0 shares of preferred stock, par value $0.01 per share.&#160;There were no preferred shares outstanding at December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 150.0 million shares of common stock, par value $0.01 per share. There were 75.4&#160;million, 74.7&#160;million, 73.5&#160;million, and 70.6&#160;million shares issued and outstanding at December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Common shares issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning common stock issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock issued upon exercise of options and employee stock plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchase and retirement of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending common stock issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Company&#x2019;s Board of Directors authorized a share repurchase program of $200.0 million of the Company&#x2019;s outstanding common stock. The Company may repurchase its common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company&#x2019;s management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.&#160;&#160;As of December&#160;31, 2020, the Company has $110.7 million remaining on its current share repurchase authorization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the par value method of accounting for its stock repurchases.&#160;&#160;As a result of the stock repurchases, the Company reduced common stock and additional paid-in capital and recorded charges to Retained earnings (accumulated deficit).&#160;&#160;During the fiscal year ended June 30, 2019 the Company used $50.0 million to repurchase shares of the Company&#x2019;s stock as part of an accelerated share repurchase. The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to Retained earnings (accumulated deficit) for the repurchases for periods ended December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased and retired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock and additional paid-in-capital reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges to retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2Xzkx_a90ebf18-2041-46f0-b648-bb0096087589"
      unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzEzMQ_3a29bcb5-0a52-493f-901d-9fa570725121"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE1Nw_2725a9b2-a287-4e15-8a03-545554590b87"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE1Nw_31ead9a0-56b9-4004-910d-a79b0000c1a1"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE1Nw_6fe3e2ac-820e-4fad-ae27-d262caac5af2"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE1Nw_e65d8b91-7b1d-4fd5-be6a-cc77ce0eb2c3"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzI0OA_d554d046-21d9-466a-9e83-6174535198e3"
      unitRef="shares">150000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzI4NQ_fde23bed-01c1-447b-a73d-879715850ddf"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzQ5NDc4MDIzMjczNzQ_32649eff-fb73-4540-bff7-c9f7398337e8"
      unitRef="shares">75400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzQ5NDc4MDIzMjczNzQ_946acc59-7a87-4bd9-8a92-5323e8cf0d94"
      unitRef="shares">75400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMxMA_10c9f50c-0c47-4d7e-9e74-cff8d2c7c780"
      unitRef="shares">74700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMxMA_31155553-f250-486f-81b2-d4f453336286"
      unitRef="shares">74700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMxNA_7c7ebc7f-c119-4748-8e20-218acf667a92"
      unitRef="shares">73500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMxNA_8c29bbe5-c9a2-4b17-9902-90e6d7466fe6"
      unitRef="shares">73500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMyMg_8c6beaa7-3465-4ba3-a809-4c241fedf76a"
      unitRef="shares">70600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzMyMg_dfa4e853-ceff-4369-8ecb-8bb2ee32869b"
      unitRef="shares">70600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE2NTA_748f5a34-009f-4537-ba62-3345c7ce0ad6">&lt;div style="margin-top:18pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Common shares issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning common stock issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock issued upon exercise of options and employee stock plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchase and retirement of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending common stock issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMS0xLTEtNzA4OA_08e638fe-a3ff-4a0d-a70c-f65d8172d75e"
      unitRef="shares">74700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMS0xLTEtNzA4OA_98ec168a-9d09-43a4-816d-ad5c171af3e0"
      unitRef="shares">74700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMS0xLTEtMA_1809de55-b444-45b9-8602-a15de260e8ad"
      unitRef="shares">73500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMS0xLTEtMA_a6230d77-1986-462c-94dd-c3a53ca92cb8"
      unitRef="shares">73500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMy0xLTEtMA_068a6fe6-1e28-4e77-a422-468a8316db68"
      unitRef="shares">70600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItMy0xLTEtMA_1b954b01-606f-400d-80a8-2e7e5ac515c3"
      unitRef="shares">70600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItNS0xLTEtMA_2008537a-08d3-48c0-93f3-f2ecb6cb4cb7"
      unitRef="shares">68400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzItNS0xLTEtMA_29ba6f84-9724-4c2f-a6f4-d46cbf9045d5"
      unitRef="shares">68400000</us-gaap:CommonStockSharesIssued>
    <mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzMtMS0xLTEtNzA4OA_9be17de2-3380-4414-8b12-1956a1e089ce"
      unitRef="shares">700000</mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans>
    <mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzMtMS0xLTEtMA_18a52988-fd93-4677-bc62-9ada5fb39ef3"
      unitRef="shares">1200000</mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans>
    <mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzMtMy0xLTEtMA_ccf76194-13a7-44fa-a37c-5d48b23d79c4"
      unitRef="shares">4500000</mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans>
    <mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzMtNS0xLTEtMA_84eccd77-6254-42fd-97cd-714dc756b9da"
      unitRef="shares">2200000</mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzQtMS0xLTEtNzA4OA_38238a0e-f0db-43fe-81ea-ed3741966083"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzQtMS0xLTEtMA_d4d64e86-52a0-42b2-b969-2ca366ef83bc"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzQtMy0xLTEtMA_2741b9a4-36ff-420f-90e7-efc84d0e5c2c"
      unitRef="shares">1600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzQtNS0xLTEtMA_24b12071-e1af-4cfb-8a32-61a9805f823d"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMS0xLTEtNzA4OA_26d6551f-c230-4895-9bc2-5ec96e6515d8"
      unitRef="shares">75400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMS0xLTEtNzA4OA_d3ace5f5-2336-41f5-98f4-148bda6b2fab"
      unitRef="shares">75400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMS0xLTEtMA_342cb66b-47a9-42ba-8d5f-0ce935f81f0e"
      unitRef="shares">74700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMS0xLTEtMA_9f1ba7cc-9964-44fb-9d96-7d41bcdc63d9"
      unitRef="shares">74700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMy0xLTEtMA_1fab5138-91f2-432c-a159-0aee3001d0f6"
      unitRef="shares">73500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtMy0xLTEtMA_5181a096-9e7b-4dba-8bce-b26d0e8092a5"
      unitRef="shares">73500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtNS0xLTEtMA_10cabd18-a2f5-4956-b916-d5aec80c8686"
      unitRef="shares">70600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTo2NTIzYmMyZGU0MGQ0Y2EyYjZmYTZjOTIzNWFlYzM0Ni90YWJsZXJhbmdlOjY1MjNiYzJkZTQwZDRjYTJiNmZhNmM5MjM1YWVjMzQ2XzUtNS0xLTEtMA_4204e516-c13f-42ba-ba33-0d6c5749a5fb"
      unitRef="shares">70600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i0012a57e73a64c94a8b83d10ea8ca5ba_I20160630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzUzOA_9b795993-8868-4e22-8056-af59acb80425"
      unitRef="usd">200000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzEwMDE_de660504-5d9d-42cc-8b47-0d4d47172f31"
      unitRef="usd">110700000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzEzNzQzODk1MzQ5NDg2_8711e21d-bbeb-4e40-9828-08c84adf9a08"
      unitRef="usd">50000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <mygn:ScheduleOfCommonStockRepurchasedTableTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90ZXh0cmVnaW9uOjg4NTgzZDA5M2Y3MDQyNmU5YjUxYjdiYWU4YWYyMjU2XzE2NTE_de92ab7c-207f-4e3b-a74e-548d497d2c8d">The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to Retained earnings (accumulated deficit) for the repurchases for periods ended December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased and retired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock and additional paid-in-capital reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges to retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mygn:ScheduleOfCommonStockRepurchasedTableTableTextBlock>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzItMS0xLTEtMTk5MA_ee87c2e9-c2a1-4238-bfc0-be67e89b11e0"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzItMS0xLTEtMA_42646509-a3bc-4d96-aadd-65171651caec"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzItMy0xLTEtMA_d2756e93-5462-4046-8ce9-1e5ac97abc9d"
      unitRef="shares">1600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzItNS0xLTEtMA_901eca94-4a20-4dc7-992e-b6e2592361cb"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzMtMS0xLTEtMTk5MA_cbb3e340-e9b0-47f4-9bd5-bdd397bfb599"
      unitRef="usd">0</mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases>
    <mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzMtMS0xLTEtMA_5f6ee7bb-b865-49e4-bc88-821527b09c7a"
      unitRef="usd">0</mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases>
    <mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzMtMy0xLTEtMA_2a3993e1-3216-41c8-a325-4ead834bba85"
      unitRef="usd">16900000</mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases>
    <mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzMtNS0xLTEtMA_7f7a1dd4-0a63-42a0-8322-d5c6fd7cf974"
      unitRef="usd">0</mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases>
    <mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzQtMS0xLTEtMTk5MA_69c530fe-b20a-4434-bc2a-9346b2e9ef2c"
      unitRef="usd">0</mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases>
    <mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzQtMS0xLTEtMA_c4924c30-d06b-4f06-a35c-f3136a67b566"
      unitRef="usd">0</mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases>
    <mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzQtMy0xLTEtMA_f50f5ac0-4e0a-4ca2-b69a-dea0aecb4f1c"
      unitRef="usd">33100000</mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases>
    <mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xMzYvZnJhZzo4ODU4M2QwOTNmNzA0MjZlOWI1MWI3YmFlOGFmMjI1Ni90YWJsZTphNTU0YjhlZjk0NWU0NDU3YWQ3YmRmMGI2MGQ2ZTVkNi90YWJsZXJhbmdlOmE1NTRiOGVmOTQ1ZTQ0NTdhZDdiZGYwYjYwZDZlNWQ2XzQtNS0xLTEtMA_14ddd86a-e453-4197-93b9-5fa898389d00"
      unitRef="usd">0</mygn:AmountChargedToRetainedEarningsAsResultOfStockRepurchases>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjY_3437a626-4fec-41ed-843b-302050898c49">SHARE-BASED COMPENSATIONOn November 30, 2017, the Company&#x2019;s stockholders approved the adoption of the 2017 Employee, Director and Consultant Equity Incentive Plan (the &#x201c;2017 Plan&#x201d;).&#160;&#160;The 2017 Plan allows the Company, under the direction of the Compensation Committee of the Board of Directors, to make grants of restricted and unrestricted stock awards to employees, consultants and directors.&#160;&#160;The 2017 Plan allows for issuance of up to 4.6 million shares of common stock.&#160;&#160;In addition, as of December&#160;31, 2020, the Company may grant additional shares of common stock under the 2017 Plan with up to 4.0 million options and restricted stock units outstanding under its 2010 Employee, Director and Consultant Equity Incentive Plan, as amended, that expire or are cancelled without delivery of shares of common stock. If an RSU awarded under the 2017 Plan is cancelled or forfeited without the issuance of shares of common stock, the unissued or reacquired shares, which were subject to the RSU, shall again be available for issuance pursuant to the 2017 Plan. &lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of shares, terms, and vesting periods are determined by the Company&#x2019;s Board of Directors or a committee thereof on an award-by-award basis. RSUs granted to employees generally vest ratably over four years from the month of the anniversary date in which the RSUs are granted. Options and RSUs granted to our non-employee directors vest in full upon completion of one year of service on the anniversary following the date of the grant. Options generally vest ratably over service periods of four years. Options granted after December 5, 2012 expire eight years from the date of grant, and options granted prior to that date generally expire ten years from the date of grant. In September 2014, the Company began generally issuing RSUs in lieu of stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of RSUs awarded to certain executive officers that ultimately vest may be increased or reduced based on certain additional performance and market conditions. The performance and market conditions associated with awards granted during the transition period ended December 31, 2020 include vesting that is based 50% on achieving certain levels of earnings per share targets, and 50% based on achieving certain performance targets compared to the performance of the Nasdaq Healthcare Provider Index. The Company estimates the likelihood of achievement of performance conditions at the end of each period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the transition period ended December 31, 2020, the Company granted stock-based awards to the Company's President and Chief Executive Officer as an inducement material to his commencement of employment and entry into an employment agreement with the Company. The awards that were granted consist of time-based RSUs as well as RSUs that have the same performance conditions as other executives discussed in the preceding paragraph. The awards also consist of time-based stock options as well as stock options with market-based vesting conditions based on achievement of certain levels of Myriad's stock price for a period of 20 consecutive days. The inducement awards were made in accordance with Nasdaq Stock Market rules and were not made under the Company's existing equity plans. The inducement awards are included in the tables presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the Company's equity plans, including the Company's inducement awards, is as follows for the transition period ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(number of shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of options granted is estimated on the grant date using the Black-Scholes option-pricing model except for options with a market condition, which are valued using a Monte Carlo Simulation. The fair value of the stock options is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. During the transition period ended December 31, 2020, the valuation assumptions used for stock options were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.826%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3% - 0.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derived service period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 - 2.6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73% - 77%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no options granted during the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about stock options outstanding at December&#160;31, 2020 (number of shares in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options outstanding and exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range of&lt;br/&gt;exercise&lt;br/&gt;prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number outstanding at December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&lt;br/&gt;life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.38 - 19.47&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.29 - 25.39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.49 - 26.49&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.07 - 36.55&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 there was $4.6 million of unrecognized share-based compensation expense related to the inducement stock options that will be recognized over a weighted-average period of 2.5 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the RSU activity under the Company's equity plans, including the Company's inducement awards and RSU awards with performance metrics, is as follows for the transition period ended December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(number of shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;grant date&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant-date fair value of restricted stock units grants during the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 was $13.69, $27.96, $46.62 and $32.67, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock units that vested during the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 was $29.1 million, $32.4 million, $27.6 million and $20.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, there was $54.3 million of total unrecognized share-based compensation expense related to RSUs that will be recognized over a weighted-average period of 2.7 years. We expect all unvested awards to vest and recognize forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense recognized and included in the Consolidated Statements of Operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has unrecognized share-based compensation cost related to share-based compensation granted under its current plans.&#160;&#160;The estimated unrecognized share-based compensation cost and related weighted average recognition period, aggregate intrinsic value of options outstanding, aggregate intrinsic value of options that are fully vested and aggregate intrinsic value of RSUs vested and expected to vest is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized share-based compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of options fully vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of RSUs outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of options exercised was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intrinsic value of options exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 5, 2012, following stockholder approval, the Company adopted the 2012 Employee Stock Purchase Plan (the &#x201c;2012 Purchase Plan&#x201d;), under which 2.0 million shares of common stock have been authorized. Shares are issued under the 2012 Purchase Plan twice yearly at the end of each offering period. At December&#160;31, 2020, a total of 1.8 million shares of common stock had been purchased under the 2012 Plan. Shares purchased under and compensation expense associated with the 2012 Plan for the years reported are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under the plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From June 1, 2017 through May 31, 2018 there was an amendment to the 2012 Purchase Plan implemented such that the plan was non-compensatory.&#160;&#160;As of December&#160;31, 2020, there is $0.5 million unrecognized share-based compensation expense related to the 2012 Purchase Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of shares issued under the Plan that was in effect for each period reported was calculated using the Black&#x2011;Scholes option-pricing model using the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ie6f9ba489d8849db94d404a44fac34d1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQ0MA_5af6d533-45b5-4ff2-a4ee-f8eca4838842"
      unitRef="shares">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ifee3f7598bd244628200eb7c1522a119_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzYyMw_02cd48c3-18f8-458b-ae7b-1f3d7c1e94e3"
      unitRef="shares">4000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQzOTgwNDY1MTc5NzM_d9c330ac-779a-4d40-a7ce-205ffdec5d2a">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib74ba2f47ec14d41bf4fd7f946d4e02f_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzExNTQ0ODcyMTAyNTM0_57fcc02e-7d0d-4ae0-9a89-ff4413fb2d46">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzExNTQ0ODcyMTAyNTU4_f92ed507-1f5a-4152-81aa-fb6b6b973817">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="idd2633e1f6014c3f8b71c92e1326ca6e_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQzOTgwNDY1MTgwMjc_3a1b9485-f6d6-40fb-ae86-52099e3927c6">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i56adf440338546748219fa30995a4533_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQzOTgwNDY1MTgwNDA_01fa1684-1fbe-4788-80c7-34ee64365fe0">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ib34f688522b74b03a5e5fc2174018149_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE0MjkzNjUxMTcyMjg5_01653195-af6d-44f4-b2ce-6a106e8fe9f6"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i7d7cae64d7814598b02a93c49e574096_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE0MjkzNjUxMTcyNDE5_65a5d1f3-70d6-4ae4-9054-6f1cf97c91d8"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice
      contextRef="i7db90b2bd66041aca744d0be2fd86e66_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQ5NDc4MDIzMzkxNDU_f90d3fe1-b2cc-4dc8-90a3-1022fa2664be"
      unitRef="d">20</mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjc_107f8b9b-242a-49f8-b561-98556261b976">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the Company's equity plans, including the Company's inducement awards, is as follows for the transition period ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(number of shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzEtMS0xLTEtMA_becc89e0-8f43-4fb8-9f1f-0de0281824a6"
      unitRef="shares">4800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzEtMy0xLTEtMA_4bb0f2f8-48c4-4434-a776-c8c2cff7c170"
      unitRef="usdPerShare">24.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzItMS0xLTEtMA_cc1b46f0-c265-47de-8ddd-40c726dede6a"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzItMy0xLTEtMA_b01dc8ad-fc65-451b-9e4d-ce9fa6cfb267"
      unitRef="usdPerShare">13.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzQtMS0xLTEtMA_9a215876-8ee7-4228-af58-69415c115100"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzQtMy0xLTEtMA_5ca9ddc5-44ae-449e-b915-075d11864531"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzUtMS0xLTEtMA_a70699a9-baa7-4e28-8c65-bedeb3dac1b6"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzUtMy0xLTEtMA_7631d4b1-cbee-4c41-9ecf-29d8db23e6ef"
      unitRef="usdPerShare">19.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzYtMS0xLTEtMA_127b6214-bf6b-44b8-8994-9b68c8816062"
      unitRef="shares">5200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzYtMy0xLTEtMA_eb838e12-f461-4e08-949d-55041549d251"
      unitRef="usdPerShare">23.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzctMS0xLTEtMA_a0fcedae-6025-4ede-a43f-09896899c0b5"
      unitRef="shares">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzctMy0xLTEtMA_889e8500-6521-4f52-b420-4ade9c37687b"
      unitRef="usdPerShare">24.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzgtMS0xLTEtMA_53202144-093b-4465-976a-469b675d4a57"
      unitRef="shares">5200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3YWIyM2IzOWQ5Y2M0OTE0OTU3OWM5MmZlNmQ5YzRhNi90YWJsZXJhbmdlOjdhYjIzYjM5ZDljYzQ5MTQ5NTc5YzkyZmU2ZDljNGE2XzgtMy0xLTEtMA_7849ba13-634f-4740-af7a-d2ea979e6375"
      unitRef="usdPerShare">23.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQ5NDc4MDIzMzU4NzY_7fe36ee2-684f-40b3-8177-cacb78115d5d">During the transition period ended December 31, 2020, the valuation assumptions used for stock options were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.826%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3% - 0.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derived service period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 - 2.6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73% - 77%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzItMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo0NzRiZTBhZTUzZDc0OTE5ODNiZTNjZGY2Njg5MjhlM180OTQ3ODAyMzI1MDEx_445436c8-4b16-44c2-ba00-76e4e7576881"
      unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzItMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo0NzRiZTBhZTUzZDc0OTE5ODNiZTNjZGY2Njg5MjhlM180OTQ3ODAyMzI1MDE4_7d6359b3-6798-4ed0-87f5-57da21e27908"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzMtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo3YzRkMTZmM2FmZGQ0M2E4OTUzNmM5YTZmZGE5ZDU4Nl80OTQ3ODAyMzI0OTk4_0b79a531-6943-43f1-8b7b-ccf1ed05c2eb"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzQtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjpkZjVhMjEwM2EzMWU0MTVlOGM0NDZlYmFkNGJkNGEyOF80OTQ3ODAyMzI1MDA0_47631752-8210-4a71-a9b5-9b2d0c9c7ea7">P4Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzUtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo5ZDBiYmFhMjk3OWE0OWEwYmQwNjE2ZTMzY2ZjMzUwZl80OTQ3ODAyMzI1MDA0_91917690-8ede-44de-b34d-7e4474f21762">P1Y</mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum>
    <mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzUtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjo5ZDBiYmFhMjk3OWE0OWEwYmQwNjE2ZTMzY2ZjMzUwZl80OTQ3ODAyMzI1MDEw_4d8d8180-1303-4fb3-8e65-7bf8fc2cb647">P2Y7M6D</mygn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzYtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjpjNWI4Yzg0NjllOGQ0MWI4YTlhMjVhYTQ4MmI5NDMwOV80OTQ3ODAyMzI1MDA4_a51ad6d2-4cd3-4df4-bb38-24b2a9c2e8e7"
      unitRef="number">0.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTozZDczMzM0Yjg4MDg0ZGI4YWUxMjJhNDFiNzlhODY5Yy90YWJsZXJhbmdlOjNkNzMzMzRiODgwODRkYjhhZTEyMmE0MWI3OWE4NjljXzYtMS0xLTEtMTQ5MTAvdGV4dHJlZ2lvbjpjNWI4Yzg0NjllOGQ0MWI4YTlhMjVhYTQ4MmI5NDMwOV80OTQ3ODAyMzI1MDE0_d6248ac5-57f6-4bb4-a4fe-b5dd8c7b7a25"
      unitRef="number">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE2MDQ_366516d9-74f0-4450-8f43-a4e281ae6bf2"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE2MDQ_7f803449-094f-4028-a0e8-cb90d3620f5a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE2MDQ_c928c1bb-b175-4020-bc76-fa2a43c69dda"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjI_ccb386a9-19e4-44bb-a3ec-8dce669fda89">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about stock options outstanding at December&#160;31, 2020 (number of shares in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options outstanding and exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range of&lt;br/&gt;exercise&lt;br/&gt;prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number outstanding at December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&lt;br/&gt;life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.38 - 19.47&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.29 - 25.39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.49 - 26.49&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.07 - 36.55&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ifc558508c633449db6077544b82b507d_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItMC0xLTEtNjE4NC90ZXh0cmVnaW9uOmNiNWYxZmVjZTBlYzQzY2RhZGExNzRiZDEzYjYzNDJmXzQ5NDc4MDIzMjUwMzQ_bea36062-25a1-49c2-8eff-08536b104181"
      unitRef="usdPerShare">13.38</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ifc558508c633449db6077544b82b507d_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItMC0xLTEtNjE4NC90ZXh0cmVnaW9uOmNiNWYxZmVjZTBlYzQzY2RhZGExNzRiZDEzYjYzNDJmXzQ5NDc4MDIzMjUwNDI_817eaa97-8c6d-41f3-a306-8f1795b664ab"
      unitRef="usdPerShare">19.47</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i29183a8749ff4b8b950a784fb91f41f1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItMi0xLTEtMA_ff9cdea1-0d75-44ea-9c21-b70a31e9b242"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ifc558508c633449db6077544b82b507d_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItNC0xLTEtMA_4704b00e-50db-48f0-a5fa-7ac5c62fdd55">P2Y11M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i29183a8749ff4b8b950a784fb91f41f1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzItNi0xLTEtMA_61d302ef-f95e-44dd-8249-d284fb5df73a"
      unitRef="usdPerShare">19.13</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ie4d8a6bd4ff54f7fb304b7cde55db513_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjU2NWY1YmEzMjY2MTQwMTliYTkzNzI0NTY4OWE4YTU5XzQ5NDc4MDIzMjUwMjQ_3739ba4f-34eb-4eea-9bf4-c2d40592c4a7"
      unitRef="usdPerShare">21.29</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ie4d8a6bd4ff54f7fb304b7cde55db513_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjU2NWY1YmEzMjY2MTQwMTliYTkzNzI0NTY4OWE4YTU5XzQ5NDc4MDIzMjUwMzI_ad378644-f102-4285-ad57-390c2c9dd163"
      unitRef="usdPerShare">25.39</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="if914d6dc8c544ca9bf117a7b245ae056_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtMi0xLTEtMA_635f27cb-4e49-4fd8-9126-a6660957e7e8"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ie4d8a6bd4ff54f7fb304b7cde55db513_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtNC0xLTEtMA_18a8beb8-691b-460a-9e16-60ff83146972">P0Y11M23D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="if914d6dc8c544ca9bf117a7b245ae056_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzMtNi0xLTEtMA_ccd588ea-228a-4ab3-938d-e51b33c07123"
      unitRef="usdPerShare">23.97</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i4b2ee9bf2f354a29b8a1b740bfdc485c_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjVmYmRlMmYzM2ZhZDQxN2U4ZmUzZmU1MjM1ZjUwNTljXzQ5NDc4MDIzMjUwMTQ_f419f019-875b-41fe-b099-126e3474f034"
      unitRef="usdPerShare">26.49</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i4b2ee9bf2f354a29b8a1b740bfdc485c_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjVmYmRlMmYzM2ZhZDQxN2U4ZmUzZmU1MjM1ZjUwNTljXzQ5NDc4MDIzMjUwMjI_d36b9d06-cc3e-4613-9c58-470b028e6c77"
      unitRef="usdPerShare">26.49</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="iea4af06edff047ee8cd215ccaf7dd5a2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtMi0xLTEtMA_8f3dac2b-05be-49e4-8cc6-91256d141ed4"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i4b2ee9bf2f354a29b8a1b740bfdc485c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtNC0xLTEtMA_7a8b11cc-96e9-4517-bc7f-af9c1b332a5a">P0Y8M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="iea4af06edff047ee8cd215ccaf7dd5a2_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzQtNi0xLTEtMA_4ddcdc0f-294a-449a-b821-40e7c1e4a83d"
      unitRef="usdPerShare">26.49</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i4ba05d7b0e05418d9b5864d5649ff8a3_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjNkZWJmNWNmMzcxOTQxZTZhN2JhMTdmMWQzMDY5NjA5XzQ5NDc4MDIzMjUwMTQ_c2236a6d-7253-4a58-92e3-356e31909890"
      unitRef="usdPerShare">27.07</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i4ba05d7b0e05418d9b5864d5649ff8a3_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtMC0xLTEtNjE4NC90ZXh0cmVnaW9uOjNkZWJmNWNmMzcxOTQxZTZhN2JhMTdmMWQzMDY5NjA5XzQ5NDc4MDIzMjUwMjI_87830394-070a-4298-826d-77d77892f863"
      unitRef="usdPerShare">36.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ib8e685bf03924016a2c1ce3f87d79686_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtMi0xLTEtMA_c9306071-0dfc-48f9-b61c-53c09f8338b5"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i4ba05d7b0e05418d9b5864d5649ff8a3_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtNC0xLTEtMA_21e41533-9a82-41b4-a9f7-0e4db50895d3">P1Y8M8D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ib8e685bf03924016a2c1ce3f87d79686_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzUtNi0xLTEtMA_f460e111-b71f-40b8-b58f-171b23deab7d"
      unitRef="usdPerShare">27.18</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzYtMi0xLTEtMA_00bd8d23-8f69-49b0-939b-db8b29790241"
      unitRef="shares">5200000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzYtNC0xLTEtMA_03df647f-f748-4caa-95ac-2d1e2dbb7f45">P1Y9M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpiZmIyYmY3YTk3YzM0NDk0YjBkYmVjNDIzZTJjN2QwNS90YWJsZXJhbmdlOmJmYjJiZjdhOTdjMzQ0OTRiMGRiZWM0MjNlMmM3ZDA1XzYtNi0xLTEtMA_246151a6-c6f3-4ab1-b663-1d7035af1c8e"
      unitRef="usdPerShare">24.71</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzE0MjkzNjUxMTcxODU4_9c20c990-45aa-43b2-a74b-7035180d5561"
      unitRef="usd">4600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie5de9e03237140d3891cfbfca360c035_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQ5NDc4MDIzMzU5NDk_44a62999-aa7c-4fb9-9eff-26aa42b013de">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjg_ac87e662-824d-407d-aef6-f6432d05a6de">&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the RSU activity under the Company's equity plans, including the Company's inducement awards and RSU awards with performance metrics, is as follows for the transition period ended December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(number of shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;grant date&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i05899c67f3004572be84cd6af2e63fe0_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzItMS0xLTEtMA_ca751f6e-3b08-472e-9fe0-49ec3cf985b6"
      unitRef="shares">2300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i05899c67f3004572be84cd6af2e63fe0_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzItMy0xLTEtMA_419c94c4-d74b-4b08-9049-e4ccff6efc05"
      unitRef="usdPerShare">32.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzMtMS0xLTEtMA_f0e8e3fd-ea26-4c90-912f-0010f5a89100"
      unitRef="shares">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzMtMy0xLTEtMA_6de6a903-e723-49d2-a9fe-78ba33f454ac"
      unitRef="usdPerShare">13.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzUtMS0xLTEtMA_47cb4561-b763-4f6c-9126-0b64b14d7493"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzUtMy0xLTEtMA_b0a536e0-f906-4552-829c-83913c2996bf"
      unitRef="usdPerShare">32.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzYtMS0xLTEtMA_393fbda3-8103-4d2b-88c4-b8b7b7bfa56d"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzYtMy0xLTEtMA_6f19c6e9-b499-4da6-9258-8b4bfc6ee224"
      unitRef="usdPerShare">31.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzctMS0xLTEtMA_040de222-70b4-4dbb-9f3e-8efb2062c469"
      unitRef="shares">3200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTowNmJhMGE5OGMyOWI0MTQyYWZhNTQ1ZTFhODI5ODljNi90YWJsZXJhbmdlOjA2YmEwYTk4YzI5YjQxNDJhZmE1NDVlMWE4Mjk4OWM2XzctMy0xLTEtMA_9f807336-22b0-4748-bb4c-1935d7a7753b"
      unitRef="usdPerShare">20.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQzOTgwNDY1MTk1NTg_6de6a903-e723-49d2-a9fe-78ba33f454ac"
      unitRef="usdPerShare">13.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if13ddbf93c05491fb76d747f160a6ad5_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIwMDM_b7e989dc-b0a6-4852-b522-dc3eed45d972"
      unitRef="usdPerShare">27.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i38be9b78e6e342588bbc14159dd49ce3_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIwMDc_74551937-3ec6-4d0f-b341-77789ff5db4b"
      unitRef="usdPerShare">46.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0ab2a24695d64791be56bebc9b0cb5c2_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIwMTQ_be7a5232-30b3-4351-9ef4-9a6bead4d42c"
      unitRef="usdPerShare">32.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzI3NDg3NzkwNzkzMzE_06b14256-023f-4f8d-a090-d0d3691950bb"
      unitRef="usd">29100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="if13ddbf93c05491fb76d747f160a6ad5_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIxMTc_b71483b4-bd0d-46ca-b3d5-5af6b95eea67"
      unitRef="usd">32400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i38be9b78e6e342588bbc14159dd49ce3_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIxMjE_448ce040-adb4-4dcf-8047-d75476ca7822"
      unitRef="usd">27600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i0ab2a24695d64791be56bebc9b0cb5c2_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIxMjg_5a930ce0-7fdc-428b-ae9d-67ce0c5848b6"
      unitRef="usd">20400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIxNjY_7002effa-b0aa-41fd-8182-22f2d488c79b"
      unitRef="usd">54300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzIyOTk_37dc0086-4fae-4999-9a34-10c662a81151">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjM_1aed0b69-1f31-4e98-b65f-e9bc86f60705">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense recognized and included in the Consolidated Statements of Operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i43833f7c5d3b4c9c95d487f7e63e9156_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzItMS0xLTEtMjA4Mw_0dddd856-4b5c-440f-8974-49c79ddcd695"
      unitRef="usd">600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4bfbbfa5a61e4bc6aa5bdeaa03ce3091_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzItMS0xLTEtMA_bcd5e041-e504-4610-9592-60c4f010c6cb"
      unitRef="usd">1200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id248408952024238bf703d63749f4e7a_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzItMy0xLTEtMA_271d9596-cd73-4015-b3d1-2462344d7459"
      unitRef="usd">800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1127c488310e4180956064bbc8092648_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzItNS0xLTEtMA_fb6e9667-6c53-477d-9d0b-26c0b0f8b94b"
      unitRef="usd">700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i02292b2ac40d46f0810c4f1a5b7d76a1_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzMtMS0xLTEtMjA4Mw_8732576a-9f51-4021-b06a-048c36201d0e"
      unitRef="usd">100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5c834bbd0ecb46ad9e21a66915c89bee_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzMtMS0xLTEtMA_41dfeaea-de4d-42a2-b741-17c7b9b98aaf"
      unitRef="usd">300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia7909094154b445eb24949027733ca0d_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzMtMy0xLTEtMA_4f622852-42e5-4493-b71e-32e42f68fc04"
      unitRef="usd">200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i69beccee306244899e7edc744b9830e8_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzMtNS0xLTEtMA_6f10ca92-9d28-4df6-a711-552c60e60b6e"
      unitRef="usd">200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i684fee383d8541d38b5854aeea927eef_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzQtMS0xLTEtMjA4Mw_c677ba38-cb2d-4cc9-961a-69b8766838e7"
      unitRef="usd">2400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iccae9b334463460489fb7e7e124291af_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzQtMS0xLTEtMA_2fc149ee-526e-466d-a3cc-bcb87d6eb8cf"
      unitRef="usd">5000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5d841afaaabb47038d152a7cc4778e70_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzQtMy0xLTEtMA_f9e8f806-7626-407d-a561-8a257b21ffa7"
      unitRef="usd">5400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i670c9600a2a343be93044b942108970a_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzQtNS0xLTEtMA_9a7b0182-e755-4a4d-adcb-4276673eaae1"
      unitRef="usd">4300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie295001ae44145ad9a4d6b31fb6ba297_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzUtMS0xLTEtMjA4Mw_30178049-034e-4f3b-bf7d-6eda91e9b209"
      unitRef="usd">11800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i31d63dfe2df342b8b82f3e732ee0282e_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzUtMS0xLTEtMA_f77db6ca-b0fd-4b9e-9346-f582a87282c4"
      unitRef="usd">18700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2d855b4fd3e14b829f9b52d5ab9a2dec_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzUtMy0xLTEtMA_a6baf21f-bb97-4160-9e7b-075e872777b2"
      unitRef="usd">27100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ied19858901194f0fb47bb12a54ee79e3_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzUtNS0xLTEtMA_dc08a109-33e5-4895-a059-161776c6a283"
      unitRef="usd">21900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzYtMS0xLTEtMjA4Mw_95c2b7da-c97e-4a23-9d46-bd97a601a425"
      unitRef="usd">14900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzYtMS0xLTEtMA_5792726e-88f5-4b68-9240-02f62a90099e"
      unitRef="usd">25200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzYtMy0xLTEtMA_eb53bc0c-49c7-4671-be18-cbe5557f7700"
      unitRef="usd">33500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTpkMGMzZWUwM2VmNWI0NDEyYmRhYzAwZTJiYzZhYTQ0Mi90YWJsZXJhbmdlOmQwYzNlZTAzZWY1YjQ0MTJiZGFjMDBlMmJjNmFhNDQyXzYtNS0xLTEtMA_1a0aee61-18f7-4309-a815-f0c9725d27f0"
      unitRef="usd">27100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjQ_79c2ecba-7eef-49f2-ad16-548087742a56">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has unrecognized share-based compensation cost related to share-based compensation granted under its current plans.&#160;&#160;The estimated unrecognized share-based compensation cost and related weighted average recognition period, aggregate intrinsic value of options outstanding, aggregate intrinsic value of options that are fully vested and aggregate intrinsic value of RSUs vested and expected to vest is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized share-based compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of options fully vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of RSUs outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZToyOTk3OWQ2ZDc2NWM0MGExYTc5MDZmYjE2NjBhMzFlMS90YWJsZXJhbmdlOjI5OTc5ZDZkNzY1YzQwYTFhNzkwNmZiMTY2MGEzMWUxXzEtMS0xLTEtMA_7b979a3c-d015-4a3d-a083-daa8dfaa553a"
      unitRef="usd">54300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZToyOTk3OWQ2ZDc2NWM0MGExYTc5MDZmYjE2NjBhMzFlMS90YWJsZXJhbmdlOjI5OTc5ZDZkNzY1YzQwYTFhNzkwNmZiMTY2MGEzMWUxXzItMS0xLTEtMA_47302fe9-3a38-4682-860f-d1b5455459f3"
      unitRef="usd">5000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZToyOTk3OWQ2ZDc2NWM0MGExYTc5MDZmYjE2NjBhMzFlMS90YWJsZXJhbmdlOjI5OTc5ZDZkNzY1YzQwYTFhNzkwNmZiMTY2MGEzMWUxXzMtMS0xLTEtMA_58a82f03-1467-4230-97cd-d673daf093f8"
      unitRef="usd">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i7ea50a40b94d4cd5981d1beaa64aaf80_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZToyOTk3OWQ2ZDc2NWM0MGExYTc5MDZmYjE2NjBhMzFlMS90YWJsZXJhbmdlOjI5OTc5ZDZkNzY1YzQwYTFhNzkwNmZiMTY2MGEzMWUxXzQtMS0xLTEtMA_193bdb0e-4854-402e-b1e8-a0f85f9153f0"
      unitRef="usd">63100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjk_97a09767-ec44-4a79-afb3-06f5f86cdae3">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of options exercised was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intrinsic value of options exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo0YzhmMmVlZWZlNWI0Y2FlYTQzZDFjNzk2OTM5MGJjNy90YWJsZXJhbmdlOjRjOGYyZWVlZmU1YjRjYWVhNDNkMWM3OTY5MzkwYmM3XzItMS0xLTEtMjA5Mw_e64d69f3-2167-4cbe-9441-97cee3744f53"
      unitRef="usd">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo0YzhmMmVlZWZlNWI0Y2FlYTQzZDFjNzk2OTM5MGJjNy90YWJsZXJhbmdlOjRjOGYyZWVlZmU1YjRjYWVhNDNkMWM3OTY5MzkwYmM3XzItMS0xLTEtMA_8928d54f-31d3-4d92-be75-c31fc1f5aab7"
      unitRef="usd">8800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo0YzhmMmVlZWZlNWI0Y2FlYTQzZDFjNzk2OTM5MGJjNy90YWJsZXJhbmdlOjRjOGYyZWVlZmU1YjRjYWVhNDNkMWM3OTY5MzkwYmM3XzItMy0xLTEtMA_6738f130-19fe-409f-a8d3-733568d01544"
      unitRef="usd">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo0YzhmMmVlZWZlNWI0Y2FlYTQzZDFjNzk2OTM5MGJjNy90YWJsZXJhbmdlOjRjOGYyZWVlZmU1YjRjYWVhNDNkMWM3OTY5MzkwYmM3XzItNS0xLTEtMA_a0bafe99-cf7a-438a-86b1-0724cf60efbe"
      unitRef="usd">17000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i2ad05ffee6ab407185af3f3ebf0e736f_I20121205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzMyMjg_055bdd6f-74b9-472e-9f90-76b7a75a04b7"
      unitRef="shares">2000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="if5e8d6c3e7334a0db7f88d66dc52bdb9_D20121205-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzMzOTA_2c5eb148-0e7c-4f8b-a68a-4a033de5a9a8"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMzA_110e4995-a8cd-4d91-9e10-71072e1ea1cd">Shares purchased under and compensation expense associated with the 2012 Plan for the years reported are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under the plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzItMS0xLTEtMjEwNA_188a0fac-5ba7-4441-9c60-3aea3939331a"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzItMS0xLTEtMA_a9fdcd83-d92d-474d-ac07-db8cca323178"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzItMy0xLTEtMA_e7929305-0913-42cc-9024-a0e8e7158c29"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzItNS0xLTEtMA_cccb10b8-0d5b-43a4-8854-dc1473c1e264"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzMtMS0xLTEtMjEwNA_9a73cbae-49ae-4b24-ba36-b40deef63a13"
      unitRef="usd">600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzMtMS0xLTEtMA_66b777ed-6c86-4290-a157-3b2922caa74c"
      unitRef="usd">1700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzMtMy0xLTEtMA_de2e80ae-e02e-4673-a8ad-a3a3675b7725"
      unitRef="usd">1000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo4MGNmZWM1MzZkYzM0NzdhYWFjMzlmOWY3NTE0MjljMC90YWJsZXJhbmdlOjgwY2ZlYzUzNmRjMzQ3N2FhYWMzOWY5Zjc1MTQyOWMwXzMtNS0xLTEtMA_74ef13cd-99b1-4103-af03-ef5eb9838ea5"
      unitRef="usd">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="ieaf36f83f64d4f13b41bbd03dd9248e5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzM3MzY_fc08c755-dde6-48f8-960d-dbd4d5ee35df"
      unitRef="usd">500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90ZXh0cmVnaW9uOjY3OGU0NzNkMTcxYTRlYzRhN2RlOGM5YWU2NDI1NWJiXzQwMjU_8c781ad0-f6db-42e3-a8fd-c0845cfb997d">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of shares issued under the Plan that was in effect for each period reported was calculated using the Black&#x2011;Scholes option-pricing model using the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzEtMS0xLTEtMjExNg_7d994fe1-6362-4d06-b844-06e9fc5f64b8"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzEtMS0xLTEtMA_9c6e87b7-e958-40ef-bae2-14eebf624eeb"
      unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzEtMy0xLTEtMA_90b261f0-5460-4179-a70c-6ac07630327c"
      unitRef="number">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzEtNS0xLTEtMA_cdeda71f-d994-437e-be8b-70271a5553af"
      unitRef="number">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzItMS0xLTEtMjExNg_42963fe8-b865-46a2-bd47-bf86e73ebc1a"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzItMS0xLTEtMA_56d6e810-b7c1-49ab-b863-690bff3ea7db"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzItMy0xLTEtMA_caa0d8c0-e10d-4bea-8f4b-ecac0b7d9fa7"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzItNS0xLTEtMA_abd88dab-9493-4404-bd75-c46e74e2d155"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzMtMS0xLTEtMjExNg_936bf362-9799-4915-b5f8-f5f39e4bec01">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzMtMS0xLTEtMA_d8cea9ff-b62f-4e74-a616-f6c27375e98c">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzMtMy0xLTEtMA_34fa5206-61e8-489f-b76c-ba7d270644b1">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzMtNS0xLTEtMA_14211879-1197-4260-82a2-cc822bc3c18a">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzQtMS0xLTEtMjExNg_c70a2b37-4601-4e9b-9b87-6d7cec6c2549"
      unitRef="number">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ifa0d1f2365994daaa5542d7df2604619_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzQtMS0xLTEtMA_330dd556-316d-4f3e-94b8-6cbb050a1a6a"
      unitRef="number">0.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i4498151f3b1342cf83d48ce60dba91cd_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzQtMy0xLTEtMA_e5823e07-6344-45fd-a087-b7768f415989"
      unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i8cb21e329bb347be928e7fb4ad5b607e_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDIvZnJhZzo2NzhlNDczZDE3MWE0ZWM0YTdkZThjOWFlNjQyNTViYi90YWJsZTo3NjYxYjQwZGEyYmM0M2I3YjE0NTdhYmM4NzQ5MDY0My90YWJsZXJhbmdlOjc2NjFiNDBkYTJiYzQzYjdiMTQ1N2FiYzg3NDkwNjQzXzQtNS0xLTEtMA_569cd378-4f7c-492f-9283-8b937d0681cb"
      unitRef="number">0.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxODg_7c00daee-73f7-4e47-8210-cc13613bdd0a">INCOME TAXES&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax benefit consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The differences between income taxes at the statutory federal income tax rate and income taxes reported in the consolidated statements of operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal income tax expense at the statutory rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;6,422.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development credits, net of the federal tax on state credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(11,880.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;9,312.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Uncertain tax benefits statute expired, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(22,798.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incentive stock option and employee stock purchase plan expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(9,954.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,568.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(642.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax Cut and Jobs Act impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CARES Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value adjustments related to acquisition contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,568.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible contingent purchase price and transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;4,174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible officer compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,926.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired tax attributes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible legal settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;6,101.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign disregarded election&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;20,550.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in revenue recognition/method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(23,440.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;963.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;-14,107.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;-10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of the Company&#x2019;s deferred tax assets and liabilities were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AR allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain state tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted in response to COVID-19 pandemic. The CARES Act made various tax law changes, including among other things (i) increased the limitation under IRC Section 163(j) for 2019 and 2020 to permit additional expensing of interest (ii), enacted technical corrections so that qualified improvement property can be immediately expensed under IRC Section 168(k) and net operating losses arising in fiscal tax years beginning before January 1, 2018 and ending after December 31, 2017 can be carried back two years and carried forward twenty years without a taxable income limitation as opposed to carried forward indefinitely, and (iii) made modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years. As a result of the provision provided under the CARES Act, the Company was able to carry-back federal net operating losses to previous periods, resulting in a $20.7 million tax benefit in the transition period ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2017, the Tax Cuts and Jobs Act (the &#x201c;Tax Act&#x201d;) was enacted. The Tax Act makes broad and complex changes to the U.S. tax code that are affecting our fiscal year ending June 30, 2018, and all following fiscal years. The Company&#x2019;s final analysis of the impact of the Tax Cuts and Jobs Act resulted in a net income tax benefit during the fiscal year ended June 30, 2018 of approximately $32.0 million ($0.44 earnings per share increase).&#160;&#160;This amount primarily consisted of a net benefit for the corporate rate reduction due to the revaluing of net deferred tax liabilities as a result of the reduction in the federal corporate tax rates.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the provisions of the Tax Act affecting foreign earnings had no material effect or were not applicable to the Company&#x2019;s fiscal years ended June 30, 2018, 2019, 2020, or to the transition period ended December 31, 2020. This was primarily due to the Company's election made during the fiscal year ended June 30, 2019 to treat its foreign subsidiaries as disregarded entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As a result of the economic impact of COVID-19, the Company has incurred a cumulative three-year loss. Pursuant to Accounting Standards Codification Topic 740, the negative evidence of a cumulative loss may be difficult to overcome. However, the Company will have significant future taxable income resulting from the reversal of taxable temporary differences. Primarily due to the availability of such expected future taxable income, the Company concluded that it is more likely than not that the benefits of the majority of its deferred income tax assets will be realized. However, for certain deferred tax assets a valuation allowance has been established, primarily due to limitations imposed by I.R.C. Section 382 and certain jurisdictional limitations. For the transition period ended December 31, 2020, the Company's valuation allowance increased by $0.3 million. For the fiscal years ended June 30, 2020, 2019 and 2018, the Company&#x2019;s valuation allowance increased by $3.5 million, $1.1 million, and $0.6 million,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;respectively. The Company will continue to evaluate the impact that the COVID-19 pandemic may have on its results of operations and its ability to realize its deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acquired Counsyl, Inc. on July 31, 2018 (see Note 17).&#160;&#160;As part of the purchase accounting for the acquisition, a net deferred tax liability of approximately $67.6 million was recorded, consisting primarily of intangible assets for which the book basis exceeds the tax basis. A corresponding deferred tax asset of $60.7 million was recorded, consisting primarily of net operating loss and research credit carryforwards.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the Company had the following net operating loss and research credit carryforwards (tax effected), with their respective expiration periods. Certain carryforwards are subject to the limitations of Section 382 and 383 of the Internal Revenue Code as indicated (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.735%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.959%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Subject to&lt;br/&gt;sections 382, 383&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expires&lt;br/&gt;beginning in year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Through&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2038&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utah net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other state net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign net operating losses (various jurisdictions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utah research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Texas research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Consistent with the indefinite reversal criteria of ASC 740-30-25-17, the Company intends to continue to invest undistributed earnings of its foreign subsidiaries indefinitely. However, due to the cumulative losses that have been incurred to date in such foreign operations, the changes of the Tax Act and the aforementioned election to treat its foreign subsidiaries as disregarded entities, no deferred taxes related to the Company&#x2019;s foreign operations have been recorded. For those foreign entities for which an election has been made to be treated as disregarded for U.S. tax purposes, the appropriate U.S. jurisdiction deferred tax assets and liabilities have been recorded.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement criteria as set forth in ASC 740. As of December&#160;31, 2020 and June 30, 2020, the Company had net unrecognized tax benefits of $30.5 million and $23.5&#160;million, respectively. The Company&#x2019;s gross unrecognized tax benefits as of the transition period ended December&#160;31, 2020 and the fiscal years ended June 30, 2020, 2019 and 2018, and the changes in those balances are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at the beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases - current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases - prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases - acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases - prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases - settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases - statute lapse&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and penalties in year-end balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and penalties related to uncertain tax positions are included as a component of income tax expense and all other interest and penalties are included as a component of other income (expense).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files U.S. federal, foreign and state income tax returns in jurisdictions with various statutes of limitations and is subject to examination for the open tax years in the U.S. federal and state jurisdictions of 2015 through 2020 and in the foreign jurisdictions of 2013 through 2020. The Company is currently under audit by the State of New Jersey for the fiscal years June 30, 2013 through 2017; the city of New York for the fiscal years June 30, 2016 through 2018; Germany for the fiscal years June 30, 2013 through 2015; and Switzerland for the fiscal years June 30, 2015 through 2016.&#160;&#160;Annual tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxODk_b725591a-f06b-4b95-aa6b-d95809dc7eb4">&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax benefit consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzMtMS0xLTEtMTMwMzI_4e8b956c-4591-4990-a2cd-be9950c31d7a"
      unitRef="usd">-75800000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzMtMS0xLTEtMA_5ec77349-9b26-4520-93c9-3727d99299c5"
      unitRef="usd">26600000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzMtMy0xLTEtMA_bff58095-5f42-427a-a5ae-2b19306f1693"
      unitRef="usd">-24200000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzMtNS0xLTEtMA_af259b8b-8207-47ad-b7d9-ef8b8c551537"
      unitRef="usd">7700000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzQtMS0xLTEtMTMwMzI_5fae198f-c33f-4693-89bd-319817d998e2"
      unitRef="usd">-600000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzQtMS0xLTEtMA_a707595c-ec71-4237-9b63-6fa8c925d08e"
      unitRef="usd">4900000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzQtMy0xLTEtMA_2bbdf08b-cfa2-4a31-8bbe-4ecd7ef973cd"
      unitRef="usd">-100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzQtNS0xLTEtMA_4eb39390-25f7-4fa4-b089-1232c6cbc695"
      unitRef="usd">2200000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzUtMS0xLTEtMTMwMzI_ef1a2a09-92ab-4edc-85bb-95a010bb8eac"
      unitRef="usd">200000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzUtMS0xLTEtMA_2e9ae9c3-f827-4691-8a71-6ec5e4554b44"
      unitRef="usd">500000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzUtMy0xLTEtMA_39b8bbe3-a60f-4df5-bb32-110b08f49437"
      unitRef="usd">200000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzUtNS0xLTEtMA_89a971ed-9498-45cc-b4d0-84785ea04f33"
      unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzYtMS0xLTEtMTMwMzI_a08516fd-baca-4800-b8a0-c17926e7f46b"
      unitRef="usd">-76200000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzYtMS0xLTEtMA_1858c20d-638d-41f4-8f01-6389d0c95526"
      unitRef="usd">32000000.0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzYtMy0xLTEtMA_9ee1f9cf-d4b6-4bd0-b43e-da30ae3212c6"
      unitRef="usd">-24100000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzYtNS0xLTEtMA_207c668c-3468-4a62-8230-e298ef13d541"
      unitRef="usd">9900000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzgtMS0xLTEtMTMwMzI_56b4adae-81b3-41e9-8f25-a1bd13888710"
      unitRef="usd">39100000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzgtMS0xLTEtMA_087f93d8-c029-4efc-81f0-58b9c9378d18"
      unitRef="usd">-51500000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzgtMy0xLTEtMA_83f4cd3c-e865-46a0-bf76-d58b7665107c"
      unitRef="usd">17800000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzgtNS0xLTEtMA_bdca5750-d601-4e3b-902e-4ef6e9b084c2"
      unitRef="usd">-22700000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzktMS0xLTEtMTMwMzI_170378c7-bcdb-4dbd-813d-c7a7e0e786ab"
      unitRef="usd">-3400000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzktMS0xLTEtMA_64078293-5086-4804-8726-3621512f73b5"
      unitRef="usd">-4100000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzktMy0xLTEtMA_271efd72-085d-47e4-beae-61aafc9af0dd"
      unitRef="usd">1700000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzktNS0xLTEtMA_c53340e4-7e49-4306-b57e-0436ba448691"
      unitRef="usd">700000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEwLTEtMS0xLTEzMDMy_4a89fdee-0474-4730-9d21-cb569319a0c7"
      unitRef="usd">-500000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEwLTEtMS0xLTA_f1f2102c-27e4-4ba2-aa87-3c80fe4567fa"
      unitRef="usd">-3600000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEwLTMtMS0xLTA_55f7aaeb-d0d1-4149-8606-1b67b65a29d6"
      unitRef="usd">400000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEwLTUtMS0xLTA_e275a326-5b8a-4238-9f8d-a20e37f85372"
      unitRef="usd">-1400000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzExLTEtMS0xLTEzMDMy_50b2a8fc-141c-4fb0-a966-994ceaf7b657"
      unitRef="usd">0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzExLTEtMS0xLTA_0dc68a3d-a073-424b-a049-3e57569d4faa"
      unitRef="usd">-3500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzExLTMtMS0xLTA_d8904f9c-1561-4856-b75a-a68f032d1430"
      unitRef="usd">200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzExLTUtMS0xLTA_efd3baca-24be-4857-a1f5-6c94fe7065d0"
      unitRef="usd">-500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEyLTEtMS0xLTEzMDMy_bc287499-7b43-43ef-943e-ea4925485334"
      unitRef="usd">35200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEyLTEtMS0xLTA_8ef9ecb2-ec29-4bf4-a815-dfc2b2333145"
      unitRef="usd">-55700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEyLTMtMS0xLTA_bc9e650b-5645-47a2-a57d-2ab18329b1ab"
      unitRef="usd">19700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEyLTUtMS0xLTA_c286d76a-ac92-4747-94d4-f1d16213c6c3"
      unitRef="usd">-22900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEzLTEtMS0xLTEzMDMy_2cce8398-3712-475d-9ce8-b790354c7ba5"
      unitRef="usd">-41000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEzLTEtMS0xLTA_2150359c-4b9b-4b51-bab6-a15b5fcce93f"
      unitRef="usd">-23700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEzLTMtMS0xLTA_b89ac5bc-ec00-4b7a-9538-954857e6a4a3"
      unitRef="usd">-4400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpkYTRlZDgwN2M0ZjA0ZThiOGQxZWE0OGRhMTgyYWRkYy90YWJsZXJhbmdlOmRhNGVkODA3YzRmMDRlOGI4ZDFlYTQ4ZGExODJhZGRjXzEzLTUtMS0xLTA_1e65d060-683d-4ae6-bf0d-dabaf4ae24b9"
      unitRef="usd">-13000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTA_711c732e-4df7-4d19-b55b-475493b288e7">&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzItMS0xLTEtMTMwNjc_a5955165-3dc8-4bfe-8428-a7495fa439a3"
      unitRef="usd">-101800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzItMS0xLTEtMA_24d28621-c06b-41f2-9483-9859f290a527"
      unitRef="usd">-240900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzItMy0xLTEtMA_c236de27-600d-4633-ad25-adb8d3a1a1ae"
      unitRef="usd">-600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzItNS0xLTEtMA_06b4a563-3444-4d48-b1b7-9789a6238531"
      unitRef="usd">122300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzMtMS0xLTEtMTMwNjc_4a13d3af-f142-4cd6-a9d8-0975584408e6"
      unitRef="usd">7700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzMtMS0xLTEtMA_151c2ee6-4d5b-44d8-8bc4-5c393291427c"
      unitRef="usd">17600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzMtMy0xLTEtMA_c390c60c-e64c-43f4-9e2d-4a9c4471ec16"
      unitRef="usd">600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzMtNS0xLTEtMA_2ab519f2-621f-42b9-978c-b736e0599a6c"
      unitRef="usd">-2200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzQtMS0xLTEtMTMwNjc_c4c715d7-7079-4609-a2c0-4d648d719c2f"
      unitRef="usd">-94100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzQtMS0xLTEtMA_3bb7f386-d61c-41d6-98b5-b1246fe08471"
      unitRef="usd">-223300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzQtMy0xLTEtMA_5f621e0b-391a-4339-9027-a73c97a67f12"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo4ODQ4ZjJiNjI2YTI0ZDBkYTA1YmY5OTBiMzlkYjhhNC90YWJsZXJhbmdlOjg4NDhmMmI2MjZhMjRkMGRhMDViZjk5MGIzOWRiOGE0XzQtNS0xLTEtMA_3c76eb99-ad4b-4342-9405-a708200ffe59"
      unitRef="usd">120100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTE_370d2ac3-6755-407e-b590-c38ba116982b">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The differences between income taxes at the statutory federal income tax rate and income taxes reported in the consolidated statements of operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal income tax expense at the statutory rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;6,422.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development credits, net of the federal tax on state credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(11,880.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;9,312.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Uncertain tax benefits statute expired, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(22,798.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incentive stock option and employee stock purchase plan expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(9,954.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,568.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(642.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax Cut and Jobs Act impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CARES Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value adjustments related to acquisition contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,568.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible contingent purchase price and transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;4,174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible officer compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,926.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired tax attributes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible legal settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;6,101.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign disregarded election&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;20,550.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in revenue recognition/method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(23,440.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;963.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;-14,107.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;-10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMS0xLTEtMTMwNzI_aabcb449-73c2-4db5-ac3d-09100739e38e"
      unitRef="usd">-19800000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMy0xLTEtMTMwNzI_8ffb307b-3032-4d82-8b62-9741fad28f2e"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMS0xLTEtMA_f0d936da-ee0d-4f82-95ca-f2b16cdaba25"
      unitRef="usd">-46900000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMy0xLTEtMA_875ef5f8-e9d7-45f9-b1c0-c853dae58eb8"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItNS0xLTEtMA_988bb2d7-5911-4d52-8fea-5f3978ff2ea4"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItNy0xLTEtMA_4aa690e1-b634-456d-ada6-e2ecfa862475"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItOS0xLTEtMA_df684c6e-7081-4d57-9ebf-1c657d61c942"
      unitRef="usd">33700000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzItMTEtMS0xLTA_ca04cee2-168a-48b8-97b3-e43a23a9218a"
      unitRef="number">0.281</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMS0xLTEtMTMwNzI_e44d2e9c-c4ed-40ea-94e8-38645844a84c"
      unitRef="usd">-1200000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMy0xLTEtMTMwNzI_31c24354-20ca-4405-b7eb-0ad3be826309"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMS0xLTEtMA_60884b48-7464-4b26-bff1-99ecade2def2"
      unitRef="usd">-200000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMy0xLTEtMA_555f9d1a-9266-4387-8fb3-c732cebff3d3"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtNS0xLTEtMA_3f613db5-e54d-44f7-9684-87d6eb6ca3d7"
      unitRef="usd">2000000.0</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtNy0xLTEtMA_dafc0a3a-29db-4b45-9488-91c8f3c76c40"
      unitRef="number">64.221</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtOS0xLTEtMA_b5412288-a6af-4ab5-ab31-740f0fb99378"
      unitRef="usd">2900000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzMtMTEtMS0xLTA_5977a1fa-ebdf-4736-8866-3a729a222559"
      unitRef="number">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMS0xLTEtMTMwNzI_4664fdbf-240b-4517-8e35-ccdcfb0791bf"
      unitRef="usd">1300000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMy0xLTEtMTMwNzI_ab9e913b-525b-468c-bf8c-59358ec0395f"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMS0xLTEtMA_3d5744e0-8775-4aa3-96b5-3cc04fc0bbfa"
      unitRef="usd">2800000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMy0xLTEtMA_325a1bf1-35cd-465e-80fd-609ff9d3bdbf"
      unitRef="number">-0.013</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtNS0xLTEtMA_dbab0cf9-4e2f-4a4e-b790-637568452041"
      unitRef="usd">3700000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtNy0xLTEtMA_138bfad3-d1bb-44b5-891d-d219d4793faf"
      unitRef="number">118.809</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtOS0xLTEtMA_7ce1590e-7538-45de-a76a-dd64d60f8fd4"
      unitRef="usd">2100000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzQtMTEtMS0xLTA_4e153b76-51c3-40d4-b892-9ace52731f0c"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMS0xLTEtMTMwNzI_a6a315f3-9399-4e55-9e47-7d3896e5e6a9"
      unitRef="usd">1300000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMy0xLTEtMTMwNzI_78405f0a-9d55-4275-a211-b5d9358c74ba"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMS0xLTEtMA_2cf0e126-3b7b-4f1e-b1f1-3655b5751ef7"
      unitRef="usd">1900000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMy0xLTEtMA_88d2df4e-9f8b-49f2-98e1-b7aa9e01aad7"
      unitRef="number">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtNS0xLTEtMA_781dd286-1daf-403c-adaf-6db4c65fc8fc"
      unitRef="usd">2900000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtNy0xLTEtMA_40ea69c1-ef7f-44eb-ad43-20e1e925daa8"
      unitRef="number">93.121</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtOS0xLTEtMA_7514793f-b217-4b53-b0e2-32f87270c509"
      unitRef="usd">2500000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzUtMTEtMS0xLTA_66c93a9a-8847-4522-af24-41ca1b8297de"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <mygn:IncomeTaxReconciliationStatuteExpiration
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMS0xLTEtMTMwNzI_5b20628e-a11c-48aa-afbb-034288cd12f9"
      unitRef="usd">-700000</mygn:IncomeTaxReconciliationStatuteExpiration>
    <mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMy0xLTEtMTMwNzI_784cdacc-69c0-4f12-865c-4a6016cb50a2"
      unitRef="number">0.007</mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations>
    <mygn:IncomeTaxReconciliationStatuteExpiration
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMS0xLTEtMA_18f746a9-3444-4d57-a4af-1604f97115c0"
      unitRef="usd">-400000</mygn:IncomeTaxReconciliationStatuteExpiration>
    <mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMy0xLTEtMA_8a928c2d-2410-45c3-ad6a-76306ac91e93"
      unitRef="number">0.002</mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations>
    <mygn:IncomeTaxReconciliationStatuteExpiration
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtNS0xLTEtMA_d4ee5c0c-f395-4818-ac3b-9d5c6d2f4437"
      unitRef="usd">-7100000</mygn:IncomeTaxReconciliationStatuteExpiration>
    <mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtNy0xLTEtMA_8691750d-37d7-425e-aa8b-bdcbb143d563"
      unitRef="number">-227.985</mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations>
    <mygn:IncomeTaxReconciliationStatuteExpiration
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtOS0xLTEtMA_9881070d-b6b3-4bc4-9a65-99602e91cedf"
      unitRef="usd">0</mygn:IncomeTaxReconciliationStatuteExpiration>
    <mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzYtMTEtMS0xLTA_1a3e7447-c31c-418c-b214-4fea36dc7d41"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationStatuteExpirations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMS0xLTEtMTMwNzI_e9a3a24f-16b2-4ef1-9d43-e241b6055150"
      unitRef="usd">2500000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMy0xLTEtMTMwNzI_ed9d82b1-a147-49b9-8a73-e3a9f32683ef"
      unitRef="number">-0.027</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMS0xLTEtMA_86b027d9-1f03-45d6-87ad-87775c0c2628"
      unitRef="usd">-200000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMy0xLTEtMA_6bde3868-2012-476f-8639-1ac2908fd033"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctNS0xLTEtMA_048f1722-e9c8-4029-9357-248a51a52b4b"
      unitRef="usd">-3100000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctNy0xLTEtMA_9c4d18ab-5130-4f13-97db-3374d75ba827"
      unitRef="number">-99.543</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctOS0xLTEtMA_70057864-0522-4ffb-a370-cbe54b3e1a68"
      unitRef="usd">-1700000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzctMTEtMS0xLTA_b8c0f04e-71ee-4538-84c1-86b68786d5ba"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMS0xLTEtMTMwNzI_3b0a59e2-9e01-4c47-b6ac-0f4826f865f6"
      unitRef="usd">-2100000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMy0xLTEtMTMwNzI_765a4a58-4b7f-4589-a440-fcee9b65bc11"
      unitRef="number">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMS0xLTEtMA_2a8dd46d-b0ed-4cd5-ae4b-f3c12c5b82a9"
      unitRef="usd">700000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMy0xLTEtMA_7deafc65-0ab6-46d7-9375-981035483981"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtNS0xLTEtMA_2e1eef22-b0ad-4bc1-b0f2-e85b2fb2266e"
      unitRef="usd">800000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtNy0xLTEtMA_33a911b2-6341-4d46-9ab7-f9914b485580"
      unitRef="number">25.688</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtOS0xLTEtMA_2086a009-b6ae-4fb5-a5fb-6f612ad71da9"
      unitRef="usd">-800000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzgtMTEtMS0xLTA_d1151461-6bd7-4b0f-bdf2-3e915a9457fa"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMS0xLTEtMTMwNzI_b9e32666-c149-40ca-af2f-57447b7e5a08"
      unitRef="usd">-300000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMy0xLTEtMTMwNzI_d5f532b6-9142-4717-9069-dbcb9b08269d"
      unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMS0xLTEtMA_d8c1d968-ad68-44b2-9475-e1c54f3c7124"
      unitRef="usd">3500000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMy0xLTEtMA_4772d642-bc4b-4585-a65e-24d45c23bade"
      unitRef="number">-0.017</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktNS0xLTEtMA_f9f1f6c3-d3b1-4a9b-ac86-64187b2d2d47"
      unitRef="usd">-200000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktNy0xLTEtMA_6917971f-53d0-4167-ac7b-29e88911e947"
      unitRef="number">-6.422</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktOS0xLTEtMA_5e0aa7ac-f6fc-427f-a05b-dd37d31f33fc"
      unitRef="usd">600000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzktMTEtMS0xLTA_4730a525-1862-48d9-a11b-336ac210190b"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTEtMS0xLTEzMDcy_50096c14-9821-4b1b-b0ca-9543c8fd0131"
      unitRef="usd">0</mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact>
    <mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTMtMS0xLTEzMDcy_cad28829-7e2a-4968-93dc-d43478e3052e"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact>
    <mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTEtMS0xLTA_7251e896-db71-4ce8-a870-57868bf44044"
      unitRef="usd">0</mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact>
    <mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTMtMS0xLTA_07b4675e-99f7-4033-96af-76dcdee4fe5f"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact>
    <mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTUtMS0xLTA_174343ee-0997-478e-b009-f69caea48877"
      unitRef="usd">0</mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact>
    <mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTctMS0xLTA_a6555dd4-fcee-4434-98c6-0360fe2185c7"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact>
    <mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTktMS0xLTA_71a956ca-3467-4852-b8d4-c26d87e4519c"
      unitRef="usd">-32000000.0</mygn:IncomeTaxReconciliationTaxCutAndJobsActImpact>
    <mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEwLTExLTEtMS0w_331bb5a6-6222-44b7-891b-11f4d6d0f3d5"
      unitRef="number">-0.266</mygn:EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact>
    <mygn:IncomeTaxReconciliationCARESAct
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTEtMS0xLTEzMDg0_9338ee76-ef33-4f10-aa63-b80e2095a6a2"
      unitRef="usd">-20700000</mygn:IncomeTaxReconciliationCARESAct>
    <mygn:EffectiveIncomeTaxRateReconciliationCARESAct
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTMtMS0xLTEzMDg0_c2752c10-d7ee-41ce-8581-29afd350c324"
      unitRef="number">0.220</mygn:EffectiveIncomeTaxRateReconciliationCARESAct>
    <mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTEtMS0xLTEzMDcy_bf7c61b1-9a56-49d4-b28a-d01cb19a1d8c"
      unitRef="usd">0</mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration>
    <mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTMtMS0xLTEzMDcy_3cafd5ec-1153-45c2-ab7c-6d6cf1a3825e"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration>
    <mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTEtMS0xLTA_ad507f03-7657-4cff-b704-371ff42eb8ca"
      unitRef="usd">0</mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration>
    <mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTMtMS0xLTA_ee17a399-d98d-4123-869e-ff8ee82d0b48"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration>
    <mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTUtMS0xLTA_f6b1adf8-4b23-476d-9595-30d854302fb9"
      unitRef="usd">-800000</mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration>
    <mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTctMS0xLTA_1ca7c303-eace-4112-8d30-241b7bcebd00"
      unitRef="number">-25.688</mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration>
    <mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTktMS0xLTA_b1b27251-f4d1-4fcf-9fca-c7a005d7df21"
      unitRef="usd">17000000.0</mygn:IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration>
    <mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzExLTExLTEtMS0w_66cb1155-67aa-47a1-879d-093c4b791412"
      unitRef="number">0.142</mygn:EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration>
    <mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTEtMS0xLTEzMDcy_e82e629e-0f08-4529-bcf8-13321167618d"
      unitRef="usd">700000</mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTMtMS0xLTEzMDcy_98ca87c5-d715-4af1-b995-c606a44e15b1"
      unitRef="number">-0.007</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts>
    <mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTEtMS0xLTA_750c5b1e-8da6-4a0f-a6ab-bfe9dae1b8ab"
      unitRef="usd">-300000</mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTMtMS0xLTA_4c6d2348-d50b-4fbe-a93d-a26fa552acaf"
      unitRef="number">0.001</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts>
    <mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTUtMS0xLTA_458d5dc8-7d8a-4617-8f22-fa90dda18bc9"
      unitRef="usd">0</mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTctMS0xLTA_63a2f15e-1ffb-4677-b869-c558fae54ee2"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts>
    <mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTktMS0xLTA_0b8ff0e0-b35a-4f83-a060-0ee586b59b95"
      unitRef="usd">0</mygn:IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEyLTExLTEtMS0w_35a44379-f0ad-486d-9cc0-db4e64fbf3b7"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTEtMS0xLTEzMDcy_7e073e0f-0ce8-4b1e-9b53-c532c7996ff7"
      unitRef="usd">500000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTMtMS0xLTEzMDcy_1cdbec03-ec8d-431d-bf95-95d15082eab8"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTEtMS0xLTA_f853a98e-f92e-40f7-97ab-de57f2186bad"
      unitRef="usd">1800000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTMtMS0xLTA_160419b8-8f7d-4f55-ab3e-08c66e6ed3ea"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTUtMS0xLTA_3e7f37b7-e145-45ea-ad3a-4cca69ade49a"
      unitRef="usd">1300000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTctMS0xLTA_8efd5acd-2192-430e-a919-d682ac05b5b7"
      unitRef="number">41.744</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTktMS0xLTA_e5d7687c-41d7-4638-a456-5651e509c7cf"
      unitRef="usd">400000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzEzLTExLTEtMS0w_15aa7b79-c980-46c9-aa02-6f5bb8ae1de9"
      unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTEtMS0xLTEzMDcy_0b8d9291-53ee-45d2-a319-6236a3178328"
      unitRef="usd">100000</mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTMtMS0xLTEzMDcy_b7883d75-3384-447c-9799-82919d464221"
      unitRef="number">-0.001</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation>
    <mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTEtMS0xLTA_886e7689-7c44-43d1-980e-f7a48b75392b"
      unitRef="usd">1600000</mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTMtMS0xLTA_7a6473d2-a701-4219-847f-6d5a3701ee65"
      unitRef="number">-0.007</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation>
    <mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTUtMS0xLTA_7984a768-1c59-401f-9d26-46b30e879adf"
      unitRef="usd">600000</mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTctMS0xLTA_6c1b4ff4-2ad4-4301-b91e-d55f98a49698"
      unitRef="number">19.266</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation>
    <mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTktMS0xLTA_5632e327-dc6a-416d-acdf-3e5ee9b95f9c"
      unitRef="usd">0</mygn:IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE0LTExLTEtMS0w_6c1db60f-70c5-4633-88eb-1e0b8cea52cf"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation>
    <mygn:IncomeTaxReconciliationAssetImpairment
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTEtMS0xLTEzMDcy_140ee4b3-9164-40ff-bb91-9c151d4ba352"
      unitRef="usd">0</mygn:IncomeTaxReconciliationAssetImpairment>
    <mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTMtMS0xLTEzMDcy_13802005-25ec-4bd6-881c-1e2610dcb5c9"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment>
    <mygn:IncomeTaxReconciliationAssetImpairment
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTEtMS0xLTA_a249f2b0-5dee-4b91-b474-3020700d98e2"
      unitRef="usd">12600000</mygn:IncomeTaxReconciliationAssetImpairment>
    <mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTMtMS0xLTA_7e93ca42-9e44-4d62-b2b6-c6e03328a0d7"
      unitRef="number">-0.056</mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment>
    <mygn:IncomeTaxReconciliationAssetImpairment
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTUtMS0xLTA_3be502e4-c9f0-4e05-a6de-ef78ba595e77"
      unitRef="usd">0</mygn:IncomeTaxReconciliationAssetImpairment>
    <mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTctMS0xLTA_37b44401-5dd8-4eab-96de-20fb3527d64f"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment>
    <mygn:IncomeTaxReconciliationAssetImpairment
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTktMS0xLTA_b73118fa-babd-4321-bf89-93302d9c9b82"
      unitRef="usd">0</mygn:IncomeTaxReconciliationAssetImpairment>
    <mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE1LTExLTEtMS0w_f04fc8e0-c5e8-4299-8d3e-7e87e75e2432"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationAssetImpairment>
    <mygn:IncomeTaxReconciliationExpiredTaxAttributes
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTEtMS0xLTEzMDcy_229fd187-8048-480e-80c7-9de0c08ad6b9"
      unitRef="usd">0</mygn:IncomeTaxReconciliationExpiredTaxAttributes>
    <mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTMtMS0xLTEzMDcy_8776db27-e129-453a-91e9-3fe758668dd8"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes>
    <mygn:IncomeTaxReconciliationExpiredTaxAttributes
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTEtMS0xLTA_7cc044d5-96f3-46b4-8376-345e74b39ae6"
      unitRef="usd">4200000</mygn:IncomeTaxReconciliationExpiredTaxAttributes>
    <mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTMtMS0xLTA_42e960de-f9bf-4e2b-8681-add970550221"
      unitRef="number">-0.019</mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes>
    <mygn:IncomeTaxReconciliationExpiredTaxAttributes
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTUtMS0xLTA_02430885-7be7-4324-8ac5-685626f5d5d6"
      unitRef="usd">0</mygn:IncomeTaxReconciliationExpiredTaxAttributes>
    <mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTctMS0xLTA_3f0dedad-0909-4e6c-84e9-38d6f1e5df42"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes>
    <mygn:IncomeTaxReconciliationExpiredTaxAttributes
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTktMS0xLTA_c964ad6a-1b9e-4873-b932-788ccb6afbd6"
      unitRef="usd">0</mygn:IncomeTaxReconciliationExpiredTaxAttributes>
    <mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE2LTExLTEtMS0w_a920058c-fa93-40a9-b366-777ed076c59b"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes>
    <mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTEtMS0xLTEzMDcy_d86af89e-f0c8-473d-8b24-a8b328934363"
      unitRef="usd">0</mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTMtMS0xLTEzMDcy_b9f219ea-e095-4307-9620-2b8785a3ee79"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements>
    <mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTEtMS0xLTA_b8f69cdd-e508-4474-ba34-537607ca2dab"
      unitRef="usd">0</mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTMtMS0xLTA_ae152a68-ca45-470a-bb41-6c3e77133c39"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements>
    <mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTUtMS0xLTA_866e54bf-7542-4f0b-9689-b52ec7d0a210"
      unitRef="usd">1900000</mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTctMS0xLTA_569395f0-ee02-4e88-9801-2bdea5445b46"
      unitRef="number">61.010</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements>
    <mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTktMS0xLTA_62c29674-2270-46b5-a884-138783ad0016"
      unitRef="usd">0</mygn:IncomeTaxReconciliationNonDeductibleLegalSettlement>
    <mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE3LTExLTEtMS0w_2e6ad592-0953-4195-9b4c-e1670402c16d"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements>
    <mygn:IncomeTaxReconciliationForeignDisregardedElection
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTEtMS0xLTEzMDcy_d1d6881f-e914-4e92-b5a9-17034ba68d12"
      unitRef="usd">0</mygn:IncomeTaxReconciliationForeignDisregardedElection>
    <mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTMtMS0xLTEzMDcy_5bdc5c3e-cdf2-47e6-bfff-ca565927766d"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection>
    <mygn:IncomeTaxReconciliationForeignDisregardedElection
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTEtMS0xLTA_08bf0988-c7d2-4162-8856-5bf9fe399474"
      unitRef="usd">0</mygn:IncomeTaxReconciliationForeignDisregardedElection>
    <mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTMtMS0xLTA_5429d412-c1f5-42de-85c8-6da2d1948078"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection>
    <mygn:IncomeTaxReconciliationForeignDisregardedElection
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTUtMS0xLTA_f6957824-ee1d-48e3-9a44-e2299cdaf038"
      unitRef="usd">6400000</mygn:IncomeTaxReconciliationForeignDisregardedElection>
    <mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTctMS0xLTA_cb319e86-c24b-4282-a69d-2751003fb2bb"
      unitRef="number">205.508</mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection>
    <mygn:IncomeTaxReconciliationForeignDisregardedElection
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTktMS0xLTA_eece378c-6d40-4d7a-96a8-7371eab80279"
      unitRef="usd">0</mygn:IncomeTaxReconciliationForeignDisregardedElection>
    <mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE4LTExLTEtMS0w_fcf2ee0e-262c-43fe-8b85-f30e6dbf0652"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationForeignDisregardedElection>
    <mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTEtMS0xLTEzMDcy_0d7447af-6c99-4cca-81b4-5df5c4669741"
      unitRef="usd">0</mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod>
    <mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTMtMS0xLTEzMDcy_98d68c36-f12f-4b68-913d-76255a4447bb"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod>
    <mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTEtMS0xLTA_c9f4d1c4-5e27-4497-b423-af67d4856760"
      unitRef="usd">0</mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod>
    <mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTMtMS0xLTA_781cd7f3-6695-427a-9b45-0588f85f3abf"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod>
    <mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTUtMS0xLTA_3c7e8f15-2f5a-4223-a840-5104189435bc"
      unitRef="usd">-7300000</mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod>
    <mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTctMS0xLTA_6e8b7ca4-104d-4e79-bc43-098600c234b7"
      unitRef="number">-234.408</mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod>
    <mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTktMS0xLTA_190e1af9-42ab-44ba-aff2-9a3dc49e94be"
      unitRef="usd">0</mygn:IncomeTaxReconciliationChangesInRevenueRecognitionMethod>
    <mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzE5LTExLTEtMS0w_c77bcf40-a63c-42ad-b1e2-e14cbbdf8a1c"
      unitRef="number">0</mygn:EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTEtMS0xLTEzMDcy_d0569b1b-8231-4a5b-81aa-0ca77427992f"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTMtMS0xLTEzMDcy_809563b4-b59f-4542-bbd5-ea78609c5b4a"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTEtMS0xLTA_e883e99b-d0f9-4944-8538-3df99f891ed7"
      unitRef="usd">800000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTMtMS0xLTA_7dc0af9d-fd3d-4e37-aa83-b0e7bc0f66d1"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTUtMS0xLTA_6f2d2317-5dcc-4cdf-92e5-6f57bf414874"
      unitRef="usd">300000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTctMS0xLTA_c5f9dca3-a625-4125-9f6d-6504b1ff6963"
      unitRef="number">9.634</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTktMS0xLTA_86720468-573e-4a0b-9beb-d2a597638f2e"
      unitRef="usd">500000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIwLTExLTEtMS0w_f05bd095-e569-41ef-927b-269f1462bbc2"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTEtMS0xLTEzMDcy_844dbcf5-7c64-4af6-87da-cbde68f8e242"
      unitRef="usd">-41000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTMtMS0xLTEzMDcy_c5fef8b3-3127-4ec2-bdbf-d5521a5a0721"
      unitRef="number">0.435</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTEtMS0xLTA_ed147d71-a829-4bb5-940f-eedf672798ec"
      unitRef="usd">-23700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTMtMS0xLTA_49265315-5dd8-4fbe-87d9-abb2c06e8b38"
      unitRef="number">0.106</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTUtMS0xLTA_a88da3a2-2ab9-4bea-839c-c54ecb1fe97b"
      unitRef="usd">-4400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTctMS0xLTA_93df5ebf-0b72-4abd-a105-5110c4d5ae28"
      unitRef="number">-141.077</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTktMS0xLTA_446989dc-ebb0-4b59-b0e4-10ce2c9d82b9"
      unitRef="usd">-13000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo1NGFiMmU4MDE4OTk0NGNhYjYwMzc3Y2I0OWY3MGExYy90YWJsZXJhbmdlOjU0YWIyZTgwMTg5OTQ0Y2FiNjAzNzdjYjQ5ZjcwYTFjXzIxLTExLTEtMS0w_de15826f-d2c5-4a5e-b68b-9965650f1ccc"
      unitRef="number">-0.107</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTI_09592f96-b6ec-439e-a5c8-4f0bdbed139f">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of the Company&#x2019;s deferred tax assets and liabilities were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AR allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain state tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzMtMS0xLTEtMTMxMDA_5b314890-3233-4f60-95cc-966f9941db39"
      unitRef="usd">72200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzMtMS0xLTEtMA_7ae51247-3597-4cc0-96bb-7468b42b2e70"
      unitRef="usd">73100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzMtMy0xLTEtMA_59afa89f-fed7-4b3e-9c46-78f623993554"
      unitRef="usd">85700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzQtMS0xLTEtMTMxMDA_970e5be8-3043-4f18-bfa1-001f63ae78a1"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzQtMS0xLTEtMA_b6bb5455-12ad-4f5a-86ef-6edf295bac20"
      unitRef="usd">37200000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzQtMy0xLTEtMA_637a7453-7ca2-4b57-b9bd-2355f9ff226b"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzUtMS0xLTEtMTMxMDA_db6e8a41-a8d2-4f8d-8adf-8616997559f0"
      unitRef="usd">1600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzUtMS0xLTEtMA_d89a41f9-445a-4d9e-b89e-0958da1a186a"
      unitRef="usd">1500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzUtMy0xLTEtMA_8e7b21e1-8fed-49b2-8316-ebcee34267e0"
      unitRef="usd">1200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzYtMS0xLTEtMTMxMDA_e5c4ef3d-c096-4e06-b877-1f5dce305a99"
      unitRef="usd">1600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzYtMS0xLTEtMA_6c2b49c0-1b00-4892-addd-6401fb1a860a"
      unitRef="usd">1200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzYtMy0xLTEtMA_a8b0db7f-753a-4d17-920e-eddb52f7113c"
      unitRef="usd">3300000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzctMS0xLTEtMTMxMDA_78bf221b-4b54-4039-a0d2-a36fa7e7583e"
      unitRef="usd">11500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzctMS0xLTEtMA_1dcdaf3a-6c68-4bd4-ae75-1d9bf9577534"
      unitRef="usd">13800000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzctMy0xLTEtMA_1b9b1e12-9eee-40a0-a5ed-7e7bb7124a60"
      unitRef="usd">16000000.0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzgtMS0xLTEtMTMxMDA_05f498c2-29c6-4e2e-a095-493ebe96e525"
      unitRef="usd">24900000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzgtMS0xLTEtMA_759b3817-41f1-4c56-a3ed-151237af1efe"
      unitRef="usd">27600000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzgtMy0xLTEtMA_16d4b816-f829-4045-b705-29e39ca86ceb"
      unitRef="usd">25400000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <mygn:DeferredTaxAssetsLeaseRightOfUseAsset
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzktMS0xLTEtMTMxMDA_87a7005f-9da6-47bb-ae62-3614583c9a52"
      unitRef="usd">15200000</mygn:DeferredTaxAssetsLeaseRightOfUseAsset>
    <mygn:DeferredTaxAssetsLeaseRightOfUseAsset
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzktMS0xLTEtMA_96243c1d-d1f9-4acc-9860-fe6cecafde12"
      unitRef="usd">16300000</mygn:DeferredTaxAssetsLeaseRightOfUseAsset>
    <mygn:DeferredTaxAssetsLeaseRightOfUseAsset
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzktMy0xLTEtMA_36c1d8a8-b676-4917-9a2d-b341cb500476"
      unitRef="usd">0</mygn:DeferredTaxAssetsLeaseRightOfUseAsset>
    <mygn:DeferredTaxAssetsUncertainStateTaxPositions
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEwLTEtMS0xLTEzMTAw_f164f65e-bd8a-41b2-9e44-8d3059daed9e"
      unitRef="usd">1100000</mygn:DeferredTaxAssetsUncertainStateTaxPositions>
    <mygn:DeferredTaxAssetsUncertainStateTaxPositions
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEwLTEtMS0xLTA_30ff9fbd-f09d-4284-8581-6a279ec6c9a6"
      unitRef="usd">1600000</mygn:DeferredTaxAssetsUncertainStateTaxPositions>
    <mygn:DeferredTaxAssetsUncertainStateTaxPositions
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEwLTMtMS0xLTA_0102e23c-e17c-4bac-9140-f88566d03214"
      unitRef="usd">1300000</mygn:DeferredTaxAssetsUncertainStateTaxPositions>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzExLTEtMS0xLTEzMTAw_263660d3-9f2d-40e3-8c10-9cd15614b203"
      unitRef="usd">16900000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzExLTEtMS0xLTA_833aca77-e5f1-4015-85d0-ed7713b6d20a"
      unitRef="usd">9600000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzExLTMtMS0xLTA_774325c8-db7b-4ed4-a36b-c1d8b9805fdf"
      unitRef="usd">9000000.0</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEyLTEtMS0xLTEzMTAw_378a4c14-8651-49ed-a114-c46174b77e15"
      unitRef="usd">145000000.0</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEyLTEtMS0xLTA_095fadae-4e40-46dc-8f1f-17684be13b6f"
      unitRef="usd">181900000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEyLTMtMS0xLTA_c223d058-bcc4-4030-8247-d8cea7919a1d"
      unitRef="usd">141900000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEzLTEtMS0xLTEzMTAw_d9e36876-04c1-44be-9944-adaf0fb47057"
      unitRef="usd">42000000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEzLTEtMS0xLTA_854386df-3e5e-45a3-ad2d-844c8d4f645d"
      unitRef="usd">42400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzEzLTMtMS0xLTA_988880d1-f651-4811-9f1a-5922f1c435dd"
      unitRef="usd">38900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE0LTEtMS0xLTEzMTAw_141f8432-b912-4533-8cac-0447759dfb4f"
      unitRef="usd">103000000.0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE0LTEtMS0xLTA_946e1280-4021-4ccb-92dd-a4538a5a460e"
      unitRef="usd">139500000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE0LTMtMS0xLTA_1a319969-f354-4892-9509-47bf8eda8ac4"
      unitRef="usd">103000000.0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE2LTEtMS0xLTEzMTAw_9bab2b18-7f85-4dbc-80c1-27f227951e00"
      unitRef="usd">144000000.0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE2LTEtMS0xLTA_27e2c502-27d9-4aa9-9c98-758e8da4e9db"
      unitRef="usd">150300000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE2LTMtMS0xLTA_607d85a2-81aa-472b-8d80-7781a741857a"
      unitRef="usd">175400000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <mygn:DeferredTaxLeaseLiability
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE3LTEtMS0xLTEzMTAw_1a2a10c4-6c4c-4f06-b1fc-7ca202dd25da"
      unitRef="usd">14600000</mygn:DeferredTaxLeaseLiability>
    <mygn:DeferredTaxLeaseLiability
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE3LTEtMS0xLTA_1be97e8e-1235-4bc0-ae16-c5c077814393"
      unitRef="usd">15800000</mygn:DeferredTaxLeaseLiability>
    <mygn:DeferredTaxLeaseLiability
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE3LTMtMS0xLTA_264457c5-3d27-4ced-94e1-a77c7d0a0d78"
      unitRef="usd">0</mygn:DeferredTaxLeaseLiability>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE4LTEtMS0xLTEzMTAw_25b2c965-d1a8-4618-9872-2d59d1c112c3"
      unitRef="usd">15700000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE4LTEtMS0xLTA_37dedaf5-8dd2-45aa-bd0f-97db71a9cf05"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE4LTMtMS0xLTA_9f0a30e2-2fde-46ab-8350-db44805f56e0"
      unitRef="usd">2500000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE5LTEtMS0xLTEzMTAw_62624d54-e1b3-407b-a3d4-5af0673db266"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome>
    <us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE5LTEtMS0xLTA_33605f2d-c326-4e64-b7c9-f4e1f195dfe1"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome>
    <us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzE5LTMtMS0xLTA_e34ff1a1-58d5-42c8-ad18-8c7e792f620e"
      unitRef="usd">7700000</us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIwLTEtMS0xLTEzMTAw_1a73f978-619e-4a05-9fee-eae95bea2a6e"
      unitRef="usd">174300000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIwLTEtMS0xLTA_6e6061d9-62f6-48b8-aba9-45d29d6a7b1c"
      unitRef="usd">166100000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIwLTMtMS0xLTA_c192d62b-3292-45f0-ae50-cba6a0673b1c"
      unitRef="usd">185600000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIxLTEtMS0xLTEzMTAw_f806ce1b-9bc5-4459-bb3e-cf0eafceef0c"
      unitRef="usd">71300000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIxLTEtMS0xLTA_87da0dfd-001d-4f0d-9ed1-2ed171c3afbe"
      unitRef="usd">26600000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTpmZGExYTM3MjFlNGI0OTQxYWI4MTk4NTdlMWYwZTM0NS90YWJsZXJhbmdlOmZkYTFhMzcyMWU0YjQ5NDFhYjgxOTg1N2UxZjBlMzQ1XzIxLTMtMS0xLTA_acdfdd60-3774-44a1-b6aa-2b96e2009248"
      unitRef="usd">82600000</us-gaap:DeferredTaxLiabilities>
    <mygn:IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzQ1OTM_5f58db1a-713b-4da7-81a0-3749a6709f05"
      unitRef="usd">-20700000</mygn:IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct>
    <us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzQ2MDM_07611589-5844-41ce-87d0-a43943765334"
      unitRef="usd">-32000000.0</us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit>
    <mygn:TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzEzNzQzODk1MzYwNDM1_a0852b90-3fff-480e-ba70-aaf060fd1053"
      unitRef="usdPerShare">0.44</mygn:TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare>
    <mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzgyMDE_3ecc8a2e-e3a6-4fe5-81d6-33cd5e41daa2"
      unitRef="usd">-300000</mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod>
    <mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzgxODQ_24859f09-7ffd-42db-9a2d-64771c1e5899"
      unitRef="usd">3500000</mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod>
    <mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzUyOTU_3f1a1a6c-7614-46cd-895a-6b3693fd10e4"
      unitRef="usd">1100000</mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod>
    <mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzgxOTU_0fd4c078-717f-429e-9d8e-8c7580b1bcd5"
      unitRef="usd">600000</mygn:ValuationAllowanceIncreaseDecreaseDuringPeriod>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzU2NDk_b534c300-e227-4418-a57b-da00190d522c"
      unitRef="usd">67600000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzU3OTQ_bb46d680-c05a-48c1-b234-d055ac12606f"
      unitRef="usd">60700000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTM_77ce3bb6-c2d1-40a1-9113-8f56f929e948">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the Company had the following net operating loss and research credit carryforwards (tax effected), with their respective expiration periods. Certain carryforwards are subject to the limitations of Section 382 and 383 of the Internal Revenue Code as indicated (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.735%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.959%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Subject to&lt;br/&gt;sections 382, 383&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expires&lt;br/&gt;beginning in year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Through&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2038&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utah net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other state net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign net operating losses (various jurisdictions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utah research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;California research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Texas research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;No&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8fac106fccce4731bad8f044406b0d14_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzEtMi0xLTEtMA_d231af2d-8846-41a2-826d-772a128d7a49"
      unitRef="usd">45000000.0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="i04912f8e67024702bb6f1c7d9d8715ea_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzEtNC0xLTEtMA_54c9cb27-6bf4-47ee-9fc4-b4d6c80bb44a">Yes</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <mygn:OperatingLossCarryforwardsExpirationYear
      contextRef="ib296c9d50bcd48e081759995543ac418_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzEtNi0xLTEtMA_6c95cfc2-626d-4dfd-af69-a51c933e073f">2031</mygn:OperatingLossCarryforwardsExpirationYear>
    <mygn:OperatingLossCarryforwardsExpirationYear
      contextRef="i7682eeb892144ef397fcb8d2b3f3b075_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzEtOC0xLTEtMA_ceaa30a7-a0a8-4ea2-9fa3-4d12315ab03f">2038</mygn:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i339e09f971f1423ca61ec703598013f6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzItMi0xLTEtMA_98d0a09a-7943-4e6e-bb77-c82014c1ed8e"
      unitRef="usd">2700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="ifef84203e8cf4c45a050df8ee892e0ab_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzItNC0xLTEtMA_923aed90-86b6-4434-8e53-60bad3caf32f">No</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <mygn:OperatingLossCarryforwardsExpirationYear
      contextRef="i0e4dd2b1c99b42c4830a26066e6f5d03_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzItNi0xLTEtMA_ede39314-8ebe-44eb-b0f5-8c58ab200692">2021</mygn:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="iff189668e46b4b2d99f01b54ece5899e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzMtMi0xLTEtMA_29c62e4b-4b31-4f5d-a82b-e086c641918b"
      unitRef="usd">3700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="i8a77486cbfda4985a95b5409f5114d75_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzMtNC0xLTEtMA_7a16f895-859a-4e1e-a088-daf5c3edfb1e">No</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <mygn:OperatingLossCarryforwardsExpirationYear
      contextRef="ia8dee92637b14ad4b0ddc3ee7a893148_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzMtNi0xLTEtMA_0747b1f2-4908-4fe5-940e-671424e15ce4">2027</mygn:OperatingLossCarryforwardsExpirationYear>
    <mygn:OperatingLossCarryforwardsExpirationYear
      contextRef="i28b353bd32614ef98f4d1b7b28197946_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzMtOC0xLTEtMA_569c0b1d-93fe-4529-a40d-6fbd7de061d2">2042</mygn:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i801b880fffca41b7981a7975da3eba9d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzQtMi0xLTEtMA_d923c40f-d36a-4a0b-ac3a-02783824861a"
      unitRef="usd">11500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="i8e435f848ff041c69b87c98ccab2b8f2_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzQtNC0xLTEtMA_5d02ef94-e2e3-497e-bc8f-620f5e8a2fad">Yes</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <mygn:OperatingLossCarryforwardsExpirationYear
      contextRef="i6f20a97b70f8439284f983b91fd4a5ce_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzQtNi0xLTEtMA_275e1ada-37a9-4d2f-989a-e1144dbeca52">2027</mygn:OperatingLossCarryforwardsExpirationYear>
    <mygn:OperatingLossCarryforwardsExpirationYear
      contextRef="i7066ecd804994d66ab4a3853aa09f501_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzQtOC0xLTEtMA_56557d0d-caa2-41e8-a396-a370d311a6ac">2040</mygn:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ifc0e279dbee74c3b96393ff366a521d0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzUtMi0xLTEtMA_1860d389-725a-45b6-9d34-cf98ef8b0ebf"
      unitRef="usd">9400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="i442e0a95c01243a3836a2900086d9a01_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzUtNC0xLTEtMA_5e0e70db-9bd4-4e4a-85d8-f120d07649a2">No</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ia3a8545dd5b34bafb56de3bd607512ca_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzYtMi0xLTEtMA_37bc6e7c-c89a-46b2-ab9d-eb90a968023d"
      unitRef="usd">9400000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardLimitationsOnUse
      contextRef="i8308537e63d24a72a6fcf5c902e127e2_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzYtNC0xLTEtMA_79053bea-119b-4813-850f-20eb085b38b3">Yes</us-gaap:TaxCreditCarryforwardLimitationsOnUse>
    <mygn:TaxCreditCarryforwardsExpirationDate
      contextRef="i373106c9787844db8567a937ae2715a1_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzYtNi0xLTEtMA_e95a8b61-cb60-42ef-864e-e05211ff2696">2027</mygn:TaxCreditCarryforwardsExpirationDate>
    <mygn:TaxCreditCarryforwardsExpirationDate
      contextRef="i7667d8c3c8a9406ab36ea5da42680f55_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzYtOC0xLTEtMA_e96ba247-33d1-4a5c-a2b4-664f85f6ef1b">2040</mygn:TaxCreditCarryforwardsExpirationDate>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i2893df02bcc84b2e95bf0c21a4687f83_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzctMi0xLTEtMA_d20548e1-9713-4a1b-9418-06babc1135b0"
      unitRef="usd">11700000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardLimitationsOnUse
      contextRef="ia3484e0b911345c28f8748b196210eb4_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzctNC0xLTEtMA_0ac34673-7b5f-4e69-8834-a1d998be34c0">No</us-gaap:TaxCreditCarryforwardLimitationsOnUse>
    <mygn:TaxCreditCarryforwardsExpirationDate
      contextRef="i65319c42541d4efc8d864e8dcfdd14e9_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzctNi0xLTEtMA_778be554-f40b-495e-9301-713bf63a6d61">2021</mygn:TaxCreditCarryforwardsExpirationDate>
    <mygn:TaxCreditCarryforwardsExpirationDate
      contextRef="if348e8b1625f477a94c7cf316377a0f5_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzctOC0xLTEtMA_d6de4dc6-c9d5-4fff-bedc-d3fd759f4e6a">2034</mygn:TaxCreditCarryforwardsExpirationDate>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i1d7ca3e4ae2740b884faeec8053514ab_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzgtMi0xLTEtMA_4b13f59f-17a7-456d-9660-b83a799a577f"
      unitRef="usd">3600000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardLimitationsOnUse
      contextRef="ib5b6e713bd16480f900779c66826595d_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzgtNC0xLTEtMA_f2cc0ff3-8b0b-43da-99b0-368335097f16">No</us-gaap:TaxCreditCarryforwardLimitationsOnUse>
    <mygn:TaxCreditCarryforwardsExpirationDate
      contextRef="i994ec55512434040bf3680a9030ee7ce_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzgtNi0xLTEtMA_62df6148-9f5b-498a-a253-9b101a74ae2c">2027</mygn:TaxCreditCarryforwardsExpirationDate>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i87c5f75363cf466e8c5c30864649562a_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzktMi0xLTEtMTczMjE_0842c7b1-2447-46b6-b122-6b956dfe4a83"
      unitRef="usd">100000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardLimitationsOnUse
      contextRef="i394783302fb644de93bf6aa850b4dc82_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzktNC0xLTEtMTc2NjU_96f8b21b-2671-4db3-b101-29c4b247847b">No</us-gaap:TaxCreditCarryforwardLimitationsOnUse>
    <mygn:TaxCreditCarryforwardsExpirationDate
      contextRef="i92918a0809ac433d8348fe4fa4338b6b_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzktNi0xLTEtMTc2NTk_566453da-b14c-4f0c-a629-26450909fc55">2039</mygn:TaxCreditCarryforwardsExpirationDate>
    <mygn:TaxCreditCarryforwardsExpirationDate
      contextRef="i5864baf1324e4e15b61aadc049035ef1_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTowNzM3YmQzY2FmMmY0ZWI2YWUzOTJjZGZjOGJlNjA5Ni90YWJsZXJhbmdlOjA3MzdiZDNjYWYyZjRlYjZhZTM5MmNkZmM4YmU2MDk2XzktOC0xLTEtMTc2NjE_ee4977e0-8aa1-4494-989d-5b7eafc67a81">2040</mygn:TaxCreditCarryforwardsExpirationDate>
    <mygn:UnrecognizedTaxBenefitsNet
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzEzNzQzODk1MzYwNDI3_4630607d-6569-4876-a19c-ad2ba3af3318"
      unitRef="usd">30500000</mygn:UnrecognizedTaxBenefitsNet>
    <mygn:UnrecognizedTaxBenefitsNet
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzQ5NDc4MDIzMzgyNDU_3e277a0d-e80d-47af-90c9-ad93c3dce76c"
      unitRef="usd">23500000</mygn:UnrecognizedTaxBenefitsNet>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4XzgxOTQ_3d3a4889-290d-4f12-a916-9d1fdf57b610">The Company&#x2019;s gross unrecognized tax benefits as of the transition period ended December&#160;31, 2020 and the fiscal years ended June 30, 2020, 2019 and 2018, and the changes in those balances are as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at the beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases - current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases - prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases - acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases - prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases - settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases - statute lapse&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and penalties in year-end balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzItMS0xLTEtMTMwOTI_17f140d1-7cf9-47a9-880f-5993cc34b6d5"
      unitRef="usd">23500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzItMS0xLTEtMA_14285091-00a2-40ee-8eed-7934cb1f595c"
      unitRef="usd">21700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzItMy0xLTEtMA_6b560538-f128-409c-b64a-9e773df324ba"
      unitRef="usd">24900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i28ea8f3abcd243cc8055858b4e824489_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzItNS0xLTEtMA_34514ab5-a003-4134-b022-d2aa1ec16242"
      unitRef="usd">25200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzMtMS0xLTEtMTMwOTI_0dabbe2f-d9cf-4fb7-9cbc-6ac58f187a2d"
      unitRef="usd">13900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzMtMS0xLTEtMA_d84020c9-c5ed-4a19-8fbb-2f1030417921"
      unitRef="usd">1600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzMtMy0xLTEtMA_e4aa4338-7ac5-4058-91fe-251afbd6ef31"
      unitRef="usd">2200000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzMtNS0xLTEtMA_e8252e7d-05a0-41ad-8d02-324c392d1cc6"
      unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzQtMS0xLTEtMTMwOTI_4f9e1fb6-9546-4c3d-b82d-e9a32391f363"
      unitRef="usd">1000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzQtMS0xLTEtMA_abb5e0ca-f5de-4d32-bc8f-c2a771fc4a33"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzQtMy0xLTEtMA_bcc87e42-d418-434a-82de-409c598c0727"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzQtNS0xLTEtMA_a4bfe6e6-9960-4b18-9aaf-9175ef274f9b"
      unitRef="usd">2400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzUtMS0xLTEtMTMwOTI_06d60476-067f-4f60-a5b8-a072b7a97e61"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzUtMS0xLTEtMA_12d6faf9-23c4-4e45-b316-cfb13eae36f3"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzUtMy0xLTEtMA_f5cbd36f-390c-482d-a905-f1d2dd7e999b"
      unitRef="usd">2300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzUtNS0xLTEtMA_c76ed6ed-acec-4fc1-8b62-55405af3d06d"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzYtMS0xLTEtMTMwOTI_669e0f2f-69f5-4148-9b05-7cb9f5089b29"
      unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzYtMS0xLTEtMA_b1f8feb4-2bc0-4831-842a-be9ed8ea9550"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzYtMy0xLTEtMA_d6ddb80d-522c-4a31-a9ea-a5cc41c3300e"
      unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzYtNS0xLTEtMA_00b01d9c-95ec-4c98-b66a-72846fb840be"
      unitRef="usd">3300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzctMS0xLTEtMTMwOTI_b8c23879-9a73-46c0-af6f-43b7b6d7b835"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzctMS0xLTEtMA_b92237a0-7489-4042-8603-814050ba6d08"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzctMy0xLTEtMA_f931fb85-d9e0-4c25-9825-59468ac29b9a"
      unitRef="usd">2700000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzctNS0xLTEtMA_949ee59a-0878-43eb-8111-54b71e5147a4"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzgtMS0xLTEtMTMwOTI_d870ed7a-900d-4989-8308-48d3b324acbc"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzgtMS0xLTEtMA_aeaa45af-08e0-440d-ba51-d0d8f5a29225"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzgtMy0xLTEtMA_af89acc2-0b2f-420f-9115-e4bd5695c8c1"
      unitRef="usd">5400000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzgtNS0xLTEtMA_25545818-c37e-469f-9b83-2a522e10f2bd"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzktMS0xLTEtMTMwOTI_ec9d7aee-1ffe-4d7b-b609-0a35106a5f31"
      unitRef="usd">37600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzktMS0xLTEtMA_87c754c4-3a56-4ee1-b047-22d41de52887"
      unitRef="usd">23500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzktMy0xLTEtMA_413bff5a-d1a4-447b-b400-4607280df46e"
      unitRef="usd">21700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzktNS0xLTEtMA_60d05e08-6c17-4f4d-ad6f-3f038c4da578"
      unitRef="usd">24900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzEwLTEtMS0xLTEzMDky_9d4b761f-46e7-44f0-b120-3ef4a3d462d1"
      unitRef="usd">2200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzEwLTEtMS0xLTA_e93a22f9-4cbe-4458-9918-99adf25d76f5"
      unitRef="usd">1400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzEwLTMtMS0xLTA_2d335413-87a9-4c37-a4d2-d00d8e3e3959"
      unitRef="usd">800000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i171870dd15d143e2bd07f52254307cce_I20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90YWJsZTo5YWM0ZWI4ZGQ5ZTM0YWMwYTM0MTQ2MWNiNWI1YmNmYS90YWJsZXJhbmdlOjlhYzRlYjhkZDllMzRhYzBhMzQxNDYxY2I1YjViY2ZhXzEwLTUtMS0xLTA_d0233542-9b1b-4cf6-ba53-7c5e047c13be"
      unitRef="usd">1500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i3aa2c73215b4412381289f30cd0a1630_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc1ODg_fc785791-2682-4648-841c-1682f11716b3">2015</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i2263ff4bbd034dac9cc9bc7dbeb427ea_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc1OTk_fc234502-5b95-4919-803c-0c0d1e3177c0">2020</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="idbfaa476fbe246298adb7720d942ac91_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc2Mzg_6ee7c2c4-a71d-4d7c-8520-485e49f77207">2013</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i77fc28b9a23e4dfcaa3fbc650b50adbb_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc2NDk_84e82490-1208-42c6-a251-6ce8eef09f69">2020</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i30273d0d5378455ba4f0bb60b947d31e_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc3NDc_4bd2f2f2-7b41-4a10-bad7-15e5e0941379">2013</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i0f0397e662d04de99568a428f4703477_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc3NTg_829a415a-4170-4a18-a996-b6af6c06f245">2017</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="if0d38d53cfdc4cd0afb30d1604caabf9_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc4MTM_039b5f97-d292-462a-906e-1c54b52fa957">2016</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="ia9d4db6aa0484fc0a5e43e4cfb14bc3a_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc4MjQ_b2389f6b-f735-4917-92c9-7b3b9e2f3ff6">2018</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i90c324220132439d95ca49aab6989a29_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc4NjY_3a334fb2-b053-40d4-bd3c-7fc6975df6e4">2013</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i2e4548adbe5b4e3d9fb80fd7b51ed7cb_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc4Nzc_f96c5dfe-7a55-4117-9aae-9f320e37a9a2">2015</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i259c8637e98a44e8aec3d5243fde0562_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc5Mjc_e11b1e96-f235-4caa-805e-60b5b080e1fb">2015</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="icf91bb0e041742dfbd75694127229a2f_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNDgvZnJhZzo1YmRlNGExYzBkNDY0YjRlODVjOWFjYTA2OTQ3YmEyOC90ZXh0cmVnaW9uOjViZGU0YTFjMGQ0NjRiNGU4NWM5YWNhMDY5NDdiYTI4Xzc5Mzg_cce15bdc-29b4-4b62-b1a7-62442bd7cf5b">2016</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTQvZnJhZzphY2NjMTczNzAwNGQ0YzUxYWM2MWFmYzA1MGI3OThmYS90ZXh0cmVnaW9uOmFjY2MxNzM3MDA0ZDRjNTFhYzYxYWZjMDUwYjc5OGZhXzQyNg_3ef143f3-5e83-4f9c-b073-c4c157cfe4c7">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. As of December&#160;31, 2020, management of the Company believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company&#x2019;s consolidated financial position, operating results, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company received recoupment requests from third-party payors for alleged overpayments. The Company disagrees with the contentions of the pending requests or has recorded an estimated reserve for the alleged overpayments.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzIwMzY_c3c7a4d0-3426-46c2-abc0-99f1f7fec75e">LEASESThe Company leases certain office spaces and research and development laboratory facilities, vehicles, and office equipment with remaining lease terms ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE4MA_d8822eb6-7013-498c-93f5-ea1a56cc78c9"&gt;one&lt;/span&gt; to seven years. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options which allows the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These optional periods have not been considered in the determination of the right-of-use-assets or lease liabilities associated with these leases as the Company did not consider it reasonably certain it would exercise the options.&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 1, 2019, the Company adopted ASU 2016-02 under the modified retrospective approach by initially applying ASU 2016-02 at the adoption date, rather than at the beginning of the earliest comparative period presented. Results for the fiscal year ended June 30, 2020 are presented under ASU 2016-02. Prior period amounts were not adjusted and continue to be reported under previous lease accounting guidance. As part of the adoption, the Company elected the package of practical expedients to avoid reassessing prior conclusions about lease identification, lease classification and initial direct costs. The Company also elected the practical expedient allowing the use of hindsight in determining the lease term and assessing impairment of right-of-use assets based on all facts and circumstances through the effective date of the new standard. The Company has elected the recognition exemption for short-term leases for all leases that qualify. Under this exemption, the Company will not recognize right-of-use assets or lease liabilities for those leases that qualify as a short-term lease (leases with lease terms of 12 months or less), which includes not recognizing right-of-use assets or lease liabilities for existing short-term leases in transition. The Company also has elected the practical expedient to avoid separating lease and non-lease components for any of its leases within its existing classes of assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company performed evaluations of its contracts and determined each of its identified leases are operating leases. For the transition period ended December&#160;31, 2020, the Company incurred $9.9 million in lease costs which are included in operating expenses in the consolidated statement of operations in relation to these operating leases. Of such lease costs, $1.8 million was variable lease expense and $0.1 million was short-term lease expense, neither of which were included in the measurement of the Company's operating right of use assets and lease liabilities. The variable rent expense is comprised primarily of the Company's proportionate share of operating expenses, property taxes, and insurance and is classified as lease expense due to the Company's election to not separate lease and non-lease components. For the fiscal year ended June 30, 2020, the Company incurred $18.4 million in lease costs, of which $2.6 million was variable lease expense and $0.2 million was short-term lease expense. Prior to the adoption of the lease guidance in ASU 2016-02, the Company's total rent expense for the fiscal years ended June&#160;30, 2019 and 2018 was $19.7 million and $15.5 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maturities of the Company&#x2019;s operating lease liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal year ending:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current maturities of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the weighted average remaining lease term is 4.9 years and the weighted average discount rate used to determine the operating lease liability was 3.87%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the implicit rate in the Company's leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of future lease payments. When calculating the Company&#x2019;s incremental borrowing rates, the Company gives consideration to its credit risk, term of the lease, total lease payments and adjust for the impacts of collateral, as necessary. The lease term used may reflect any option to extend or terminate the lease when it is reasonably certain the Company will exercise such options. Lease expenses for the Company's operating leases are recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ied2066eada724e118523d0b6f7522a9d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE4Ng_b8a16137-e1e8-48dd-b4f6-7daca1dd0481">P7Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LeaseCost
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQzOTgwNDY1MTMxNDU_fb3b6f0a-4f56-40ec-8cfe-2224ccdc7c4d"
      unitRef="usd">9900000</us-gaap:LeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQzOTgwNDY1MTMyMDU_507f3b23-0d68-4253-8bc1-aaac9cc5d8fe"
      unitRef="usd">1800000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQzOTgwNDY1MTMyMDE_2eadb85b-1283-4d17-9910-b361c5ff823d"
      unitRef="usd">100000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQ5NDc4MDIzMzM1MDU_6b674eaf-b3b5-40c3-8932-35d1a2d0f459"
      unitRef="usd">18400000</us-gaap:LeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQ5NDc4MDIzMzM1MTU_61e355d7-d9c7-4ffc-9f2f-8ceace6ccc28"
      unitRef="usd">2600000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzQ5NDc4MDIzMzM1MjQ_d274c289-9861-4350-92c4-bdeebe821a31"
      unitRef="usd">200000</us-gaap:ShortTermLeaseCost>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzI3NDg3NzkwNzI4MzY_4c6ed4c1-c264-444a-bb31-fa6338f85ffd"
      unitRef="usd">19700000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzI3NDg3NzkwNzI4NDQ_5a1ed69b-4a8d-425e-812f-f0a65d712d82"
      unitRef="usd">15500000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzIwMzc_51173480-4819-47b4-b9e0-38c016381289">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maturities of the Company&#x2019;s operating lease liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal year ending:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current maturities of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzEtMS0xLTEtMA_daa39921-52cb-47f6-9bb6-7c8185471fd4"
      unitRef="usd">15800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzItMS0xLTEtMA_7a1e3b4e-b327-43b0-9708-1b24ab1d6447"
      unitRef="usd">13900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzMtMS0xLTEtMA_4e73b865-3b97-493f-a0d3-c507881a22e0"
      unitRef="usd">13600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzQtMS0xLTEtMA_16df180b-1d7b-4b41-bdeb-577ce38dc1ab"
      unitRef="usd">13000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzUtMS0xLTEtMA_1543423c-150e-4955-a9f8-396c62933e77"
      unitRef="usd">7200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzYtMS0xLTEtMA_87fd9904-39cd-4872-9d21-cb16136b2d30"
      unitRef="usd">7100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzctMS0xLTEtMA_afb45b46-53bf-4dac-97d4-a6082531b893"
      unitRef="usd">70600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzgtMS0xLTEtMA_f75e1c6e-9c0c-404e-b28d-369df2d68a28"
      unitRef="usd">6400000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzktMS0xLTEtMA_0e726e92-15ac-4452-87ca-d8b8a81aefc8"
      unitRef="usd">64200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzEwLTEtMS0xLTA_706c88a4-1768-4323-a07a-4909654650e3"
      unitRef="usd">13600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90YWJsZTo5YTYzMTliMjc5MmI0YTQ0ODVjNmI5NTVlZTZiM2NmYi90YWJsZXJhbmdlOjlhNjMxOWIyNzkyYjRhNDQ4NWM2Yjk1NWVlNmIzY2ZiXzExLTEtMS0xLTA_36585d2d-53b4-4daf-a1ef-22a059035901"
      unitRef="usd">50600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE1OTc_eef38d79-7a51-4cb9-953b-2f79d3710bf6">P4Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE2OTE_e5822a4e-13f9-4afa-9e3b-95e0d2ce8df6"
      unitRef="number">0.0387</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90ZXh0cmVnaW9uOjRlNWM3NmY0NzZmZTQ5MjBiMGMyZDg0MzAxZWRiZWYwXzY0OA_f03172c2-93ac-465c-a20c-7d11cc817402">EMPLOYEE DEFERRED SAVINGS PLANThe Company has a deferred savings plan which qualifies under Section&#160;401(k) of the Internal Revenue Code. Substantially all of the Company&#x2019;s U.S. employees are covered by the plan. The Company makes matching contributions of 50% of each employee&#x2019;s contribution with the employer&#x2019;s contribution not to exceed 4% of the employee&#x2019;s compensation. &lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s recorded contributions to the plan are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred savings plan contributions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90ZXh0cmVnaW9uOjRlNWM3NmY0NzZmZTQ5MjBiMGMyZDg0MzAxZWRiZWYwXzI2Ng_0dbe92dc-cf5c-4c78-81b0-f699b7fe9080"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90ZXh0cmVnaW9uOjRlNWM3NmY0NzZmZTQ5MjBiMGMyZDg0MzAxZWRiZWYwXzM0OA_fdd35363-b757-4c96-88fb-c30956c14b61"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanDisclosuresTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90ZXh0cmVnaW9uOjRlNWM3NmY0NzZmZTQ5MjBiMGMyZDg0MzAxZWRiZWYwXzY0OQ_89255d5b-879e-44ad-b580-00417e291521">&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s recorded contributions to the plan are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred savings plan contributions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DefinedContributionPlanDisclosuresTableTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90YWJsZToyZjk3ZDgzMDhiZDI0ZWUzOGM3YTZhNTM4MThhYWM1Mi90YWJsZXJhbmdlOjJmOTdkODMwOGJkMjRlZTM4YzdhNmE1MzgxOGFhYzUyXzItMS0xLTEtNzM1Mw_93b2aa6f-d164-406f-95b4-1c4375c9b3be"
      unitRef="usd">4000000.0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90YWJsZToyZjk3ZDgzMDhiZDI0ZWUzOGM3YTZhNTM4MThhYWM1Mi90YWJsZXJhbmdlOjJmOTdkODMwOGJkMjRlZTM4YzdhNmE1MzgxOGFhYzUyXzItMS0xLTEtMA_05763a3f-9533-45c1-a1e9-cd2959f2c8ac"
      unitRef="usd">7100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90YWJsZToyZjk3ZDgzMDhiZDI0ZWUzOGM3YTZhNTM4MThhYWM1Mi90YWJsZXJhbmdlOjJmOTdkODMwOGJkMjRlZTM4YzdhNmE1MzgxOGFhYzUyXzItMy0xLTEtMA_40d8b0b7-c658-4998-ac24-eafefbb42b82"
      unitRef="usd">8300000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjAvZnJhZzo0ZTVjNzZmNDc2ZmU0OTIwYjBjMmQ4NDMwMWVkYmVmMC90YWJsZToyZjk3ZDgzMDhiZDI0ZWUzOGM3YTZhNTM4MThhYWM1Mi90YWJsZXJhbmdlOjJmOTdkODMwOGJkMjRlZTM4YzdhNmE1MzgxOGFhYzUyXzItNS0xLTEtMA_f524e896-ccbf-488b-bbdd-f4c1e5f97100"
      unitRef="usd">7200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzE1NTg_04e48a26-9427-445c-b0a8-01443e1221cb">SEGMENT AND RELATED INFORMATION&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s business is aligned with how the chief operating decision maker ("CODM") reviews performance and makes decisions in managing the Company. The Company&#x2019;s operating segments have been aggregated into two reportable segments: (i)&#160;diagnostics and (ii) other. The diagnostics segment primarily provides testing and collaborative development of testing that is designed to assess an individual&#x2019;s risk for developing disease later in life, identify a patient&#x2019;s likelihood of responding to drug therapy and guide a patient&#x2019;s dosing to ensure optimal treatment, or assess a patient&#x2019;s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. The CODM evaluates segment performance based on operating income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transition Period Ended December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal Year Ended June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal Year Ended June 30, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal Year Ended June 30, 2018:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income (loss) for reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to Myriad Genetics, Inc stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a comparison of balance sheet assets by operating segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net equipment, leasehold improvements and property:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total assets less cash, cash equivalents, and marketable investment securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,215.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,247.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles assets by geographical region to total assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net equipment, leasehold improvements and property:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,190.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets by segment and geographical region&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,247.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and marketable investment &lt;br/&gt;     securities (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles revenue by geographical region to total revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzk2_0e5c4e7e-b4b3-4eb4-8c2b-03d37d90ad31"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzE1NTk_29fc3a73-ce42-4d14-be46-48b4ace006b9">The CODM evaluates segment performance based on operating income (loss).&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transition Period Ended December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal Year Ended June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal Year Ended June 30, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal Year Ended June 30, 2018:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income (loss) for reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to Myriad Genetics, Inc stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItMS0xLTEtMjI2OA_e6ca919a-6c10-4a04-a040-f7332485b225"
      unitRef="usd">271700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91ef0e4a089942639d68319973aeaa47_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItMy0xLTEtMjI2OA_2107138f-7710-4ee3-aea3-c7da895134e2"
      unitRef="usd">28100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItNS0xLTEtMjI2OA_85064ab2-a001-458d-9767-d3bba5bebd01"
      unitRef="usd">299800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtMS0xLTEtMjI2OA_7c794ce1-37d1-43fd-bf9e-83f6a12d5c26"
      unitRef="usd">33500000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i91ef0e4a089942639d68319973aeaa47_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtMy0xLTEtMjI2OA_b72cd2f4-c065-4cda-bcb2-4f8894cd01a1"
      unitRef="usd">2300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtNS0xLTEtMjI2OA_5937ab9b-3ed2-41a5-91b9-ba9057306f25"
      unitRef="usd">35800000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtMS0xLTEtMjI2OA_8682b372-72bf-4fd7-9a09-1cc0c711a0ec"
      unitRef="usd">-1400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i91ef0e4a089942639d68319973aeaa47_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtMy0xLTEtMjI2OA_a044a926-1f22-4aed-bc19-87ae98b3e8c2"
      unitRef="usd">-86400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtNS0xLTEtMjI2OA_6a226f7e-94bd-4d71-bc46-9263b85e887e"
      unitRef="usd">-87800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic71c74fc3d084045809129a196e2f974_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItMS0xLTEtMA_046be84a-e774-4d94-aae7-8af8a1cae507"
      unitRef="usd">593500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i664dad294d884038be88785f325b2bf5_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItMy0xLTEtMA_48196bc3-26ea-4572-a909-84fb9b263dd8"
      unitRef="usd">45100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzItNS0xLTEtMA_e9f76914-ac17-44d6-aeec-cc8ab475c60a"
      unitRef="usd">638600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic71c74fc3d084045809129a196e2f974_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtMS0xLTEtMA_c3bec33c-b67c-4573-bab4-cf7ea63bb499"
      unitRef="usd">68200000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i664dad294d884038be88785f325b2bf5_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtMy0xLTEtMA_1d2eee26-ad51-4e3a-9753-8945e81f76f4"
      unitRef="usd">3800000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzMtNS0xLTEtMA_5749d009-a027-46b5-aff6-a77e123ac26a"
      unitRef="usd">72000000.0</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic71c74fc3d084045809129a196e2f974_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtMS0xLTEtMA_28d07fe4-eb8c-4694-83e7-a948b10e2e67"
      unitRef="usd">-82400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i664dad294d884038be88785f325b2bf5_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtMy0xLTEtMA_3a6a58c0-c886-4462-b626-31eca5ce3039"
      unitRef="usd">-149300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzQtNS0xLTEtMA_ec341062-3230-4f89-993f-74a5da94350e"
      unitRef="usd">-231700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i476843d04c844d4e95a7e5e176903dcb_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzYtMS0xLTEtMA_7dcddc97-a68d-4fa1-b1f3-8a14bcc6358f"
      unitRef="usd">789400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4659bde391c4d01852f685ef94ad2be_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzYtMy0xLTEtMA_2f05e46e-3c17-444d-b9ad-7b54730cbef7"
      unitRef="usd">61700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzYtNS0xLTEtMA_361ccedd-dc73-4b9d-95f0-1031aed48894"
      unitRef="usd">851100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DepreciationAndAmortization
      contextRef="i476843d04c844d4e95a7e5e176903dcb_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzctMS0xLTEtMA_76d04670-b9ee-473f-ba92-ececa32a13a5"
      unitRef="usd">67700000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia4659bde391c4d01852f685ef94ad2be_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzctMy0xLTEtMA_e6156eb9-e54f-4ea1-8d1a-bdd3b8f4a5d9"
      unitRef="usd">5300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzctNS0xLTEtMA_2a6b5b85-b94f-416b-9bf2-650e7669ec6f"
      unitRef="usd">73000000.0</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="i476843d04c844d4e95a7e5e176903dcb_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzgtMS0xLTEtMA_0f144ac9-025a-4860-aeeb-d003cfc4fc4e"
      unitRef="usd">133300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia4659bde391c4d01852f685ef94ad2be_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzgtMy0xLTEtMA_6cc155dc-72df-445a-a311-2b55b82374af"
      unitRef="usd">-125700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzgtNS0xLTEtMA_f5aa414c-c4c0-4322-8ff3-1e3a10b5ec3f"
      unitRef="usd">7600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89e55ec2aeb84ba29ad2e15182881349_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEwLTEtMS0xLTA_2238eb8f-75f8-4525-96d7-8d6dc445272f"
      unitRef="usd">690400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ef3b53c398c432a93dbdbb67ae409c1_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEwLTMtMS0xLTA_a04919e5-970c-43e8-96b9-48e1b8d74306"
      unitRef="usd">53300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEwLTUtMS0xLTA_563de34d-f93a-40a6-b4fe-9774c47f1682"
      unitRef="usd">743700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DepreciationAndAmortization
      contextRef="i89e55ec2aeb84ba29ad2e15182881349_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzExLTEtMS0xLTA_3b33c8ff-69f3-4b84-9873-85f8ecc99d96"
      unitRef="usd">49200000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3ef3b53c398c432a93dbdbb67ae409c1_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzExLTMtMS0xLTA_f5ed7e25-b404-4d1c-872a-fd703826ad31"
      unitRef="usd">5200000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzExLTUtMS0xLTA_0c102253-8d45-4669-9f05-d6f0671799aa"
      unitRef="usd">54400000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="i89e55ec2aeb84ba29ad2e15182881349_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEyLTEtMS0xLTA_86cdca65-7d2f-472e-8f2b-a30a00a3ce0d"
      unitRef="usd">142600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ef3b53c398c432a93dbdbb67ae409c1_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEyLTMtMS0xLTA_8a9f36dd-7c22-4e9c-956a-1ee116ed87ef"
      unitRef="usd">-20700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZToxZTdmZWMyODFmZDE0YzU5OTRhY2QzOGJjZTExZTczOS90YWJsZXJhbmdlOjFlN2ZlYzI4MWZkMTRjNTk5NGFjZDM4YmNlMTFlNzM5XzEyLTUtMS0xLTA_ac9a4b9f-5f0b-48f5-aead-6c61cba8e152"
      unitRef="usd">121900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzItMS0xLTEtMjI5Nw_2c91112b-e3b7-4e6a-bb2a-97fdba02e640"
      unitRef="usd">-87800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzItMS0xLTEtMA_f1566870-04bc-4230-b121-f826609aa6e5"
      unitRef="usd">-231700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzItMy0xLTEtMA_995b893d-7323-4272-8a49-03b05fe44a21"
      unitRef="usd">7600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzItNS0xLTEtMA_6d837289-53aa-457f-98b4-f187e070463e"
      unitRef="usd">121900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzQtMS0xLTEtMjI5Nw_ab701e64-8229-4857-8dbc-432d3ece12c8"
      unitRef="usd">700000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzQtMS0xLTEtMA_652a21e7-c1e4-44ed-9baa-ed35e9010638"
      unitRef="usd">3000000.0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzQtMy0xLTEtMA_89d6602d-be61-4b4c-89c4-efb199e8bcfd"
      unitRef="usd">3200000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzQtNS0xLTEtMA_4cb585cd-3896-44a1-bfa8-b562e6617167"
      unitRef="usd">1800000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzUtMS0xLTEtMjI5Nw_70c68a94-86e0-4d96-8e54-5671a0e2da95"
      unitRef="usd">5800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzUtMS0xLTEtMA_861008c7-4ecc-42f5-8f5e-7747ffc7be98"
      unitRef="usd">10800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzUtMy0xLTEtMA_32022b89-132e-4532-b78f-6a4ab0fbf8b6"
      unitRef="usd">12000000.0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzUtNS0xLTEtMA_2b858d36-3722-4b86-8acb-7547f7204ef8"
      unitRef="usd">3200000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzYtMS0xLTEtMjI5Nw_c7bc5990-88e4-42ee-bcdc-d0a1a62a3f29"
      unitRef="usd">-1200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzYtMS0xLTEtMA_49702c44-03e6-4049-ad4d-23907ee0a2bf"
      unitRef="usd">16200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzYtMy0xLTEtMA_2bc742e4-ab7f-4e24-aa29-487d3181ec92"
      unitRef="usd">1200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzYtNS0xLTEtMA_20d7dd77-e288-45b0-b7bb-8d554a835b48"
      unitRef="usd">-400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzctMS0xLTEtMjI5Nw_bdf5cdab-55ae-4142-8624-e43eb0fb7aa8"
      unitRef="usd">-94100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzctMS0xLTEtMA_b5987645-86a7-4be1-b9af-abb3757842ee"
      unitRef="usd">-223300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzctMy0xLTEtMA_740287a3-99c5-42b5-b4f1-1259248e1c49"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzctNS0xLTEtMA_c9845146-08dd-409d-945c-b932c539a847"
      unitRef="usd">120100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzgtMS0xLTEtMjI5Nw_12d2b8ef-eb11-4b48-86b5-22ed62c1035b"
      unitRef="usd">-41000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzgtMS0xLTEtMA_1ab17132-3d8d-4158-ae86-9640569cb491"
      unitRef="usd">-23700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzgtMy0xLTEtMA_3e254934-cae8-4ab6-abe4-f0adeb978dd0"
      unitRef="usd">-4400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzgtNS0xLTEtMA_e4f89d86-b27c-465d-a05d-8d1392228890"
      unitRef="usd">-13000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzktMS0xLTEtMjI5Nw_5c67998b-2e91-41aa-ae83-4975e49a4f3f"
      unitRef="usd">-53100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzktMS0xLTEtMA_a40815c8-0eae-4740-8707-5afa4cc88380"
      unitRef="usd">-199600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzktMy0xLTEtMA_81a4168d-8167-4441-9e74-fec9705eddf3"
      unitRef="usd">4400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzktNS0xLTEtMA_95ab07bd-e806-4de8-a940-202cc3f90893"
      unitRef="usd">133100000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzEwLTEtMS0xLTIyOTc_9bfa9219-d7e9-422d-93c2-e6aa48e798a2"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzEwLTEtMS0xLTA_9e920750-6feb-4e8a-92ad-65eb0ac7030a"
      unitRef="usd">-100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzEwLTMtMS0xLTA_b956fdc3-7833-4f11-9344-ce15d6caae46"
      unitRef="usd">-200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzEwLTUtMS0xLTA_39700de1-8fb6-4e0c-bb68-7693f1638d70"
      unitRef="usd">-200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzExLTEtMS0xLTIyOTc_5988b40f-ed51-43df-82ca-d6c5b9fb357b"
      unitRef="usd">-53100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzExLTEtMS0xLTA_a232686a-4849-4904-82e0-a967407f459a"
      unitRef="usd">-199500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzExLTMtMS0xLTA_cb43b66f-02dc-4879-89ff-3dbc1cbba6b6"
      unitRef="usd">4600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTowZWQ4NzU2ZmE4ZGE0M2EyYTZjOWRmNzU1YjZmNzZmYy90YWJsZXJhbmdlOjBlZDg3NTZmYThkYTQzYTJhNmM5ZGY3NTViNmY3NmZjXzExLTUtMS0xLTA_45489bd2-c458-4753-9c54-234ddfc2b39e"
      unitRef="usd">133300000</us-gaap:NetIncomeLoss>
    <mygn:ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzE1NTU_03d19bae-1493-457e-bc13-e8aa97afb3e2">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a comparison of balance sheet assets by operating segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net equipment, leasehold improvements and property:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total assets less cash, cash equivalents, and marketable investment securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,215.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,247.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mygn:ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i428a5fa0807f4da086f039c34215397a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzMtMS0xLTEtMjMxNg_c29b0c0c-292c-4bf2-b5ef-0ea58421f7c6"
      unitRef="usd">23000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0db858d5901a46708854a964d2b950ba_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzMtMS0xLTEtMA_91af6653-1ca7-40b3-be27-33f4e7038566"
      unitRef="usd">23900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ied74c9d465394d488f630f4d4876d14a_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzMtMy0xLTEtMA_8db0003d-7992-401e-b5d8-56364d53824e"
      unitRef="usd">25700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib4a637b79289401cacaeae110a5223e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzQtMS0xLTEtMjMxNg_89bae49c-238e-42cf-9712-5482b4b871ec"
      unitRef="usd">17700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i33b939605911461db48890438cae974c_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzQtMS0xLTEtMA_3f8ee62d-25a2-4cb7-a7d1-5907db1e90bd"
      unitRef="usd">13100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iea3f9a2649e348faaacb48e8cc8e8902_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzQtMy0xLTEtMA_205c4711-7ad2-43db-86c1-8a7fef2460de"
      unitRef="usd">31600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie2a0de5212d9437b9c547a36e207b87f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzUtMS0xLTEtMjMxNg_ec371e78-a2e6-4faa-ae92-7387d9cf75b1"
      unitRef="usd">40700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie2e876378b87406f8adbbf8ce2e6cddd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzUtMS0xLTEtMA_f6152ef5-5e7c-4aa3-b1a2-591b152c612c"
      unitRef="usd">37000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i395a6bf2ed5a4516a97cb9dfd143feb1_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzUtMy0xLTEtMA_0cdd64d1-e6d3-4481-88d6-8a315c8c4ac7"
      unitRef="usd">57300000</us-gaap:PropertyPlantAndEquipmentNet>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i428a5fa0807f4da086f039c34215397a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzctMS0xLTEtMjMxNg_3ff39786-6368-4700-bd6a-f325d46eaf5d"
      unitRef="usd">994000000.0</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i0db858d5901a46708854a964d2b950ba_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzctMS0xLTEtMA_d8d2d286-7d97-4d71-851c-74c6d0d76a4f"
      unitRef="usd">1002800000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="ied74c9d465394d488f630f4d4876d14a_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzctMy0xLTEtMA_d71b7b76-2125-4ae7-a863-7ae86eb8f852"
      unitRef="usd">1215600000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="ib4a637b79289401cacaeae110a5223e9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzgtMS0xLTEtMjMxNg_fb4f4cb4-3b5f-4c84-bab3-fd08d2db3f35"
      unitRef="usd">253100000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i33b939605911461db48890438cae974c_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzgtMS0xLTEtMA_c5c5d99d-84de-44f1-a12d-29acaa5cce03"
      unitRef="usd">147000000.0</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="iea3f9a2649e348faaacb48e8cc8e8902_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzgtMy0xLTEtMA_ba4806a2-7ecf-4591-80c6-1616d935b6b6"
      unitRef="usd">155300000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="ie2a0de5212d9437b9c547a36e207b87f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzktMS0xLTEtMjMxNg_662962e2-5e45-43ec-a20b-c8be7fd46bbd"
      unitRef="usd">1247100000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="ie2e876378b87406f8adbbf8ce2e6cddd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzktMS0xLTEtMA_48facf7f-7942-4e6f-a721-43c4230ca67c"
      unitRef="usd">1149800000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i395a6bf2ed5a4516a97cb9dfd143feb1_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTozYTFjMGY5YzRkZWM0ZTdlYWM5YTk1M2M2Y2VhNzAyZi90YWJsZXJhbmdlOjNhMWMwZjljNGRlYzRlN2VhYzlhOTUzYzZjZWE3MDJmXzktMy0xLTEtMA_881a7b24-522f-4d1b-8940-2870c8539544"
      unitRef="usd">1370900000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzE1NTY_10fe58cb-3708-449e-a7a1-dbd5b930c643">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles assets by geographical region to total assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net equipment, leasehold improvements and property:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,190.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets by segment and geographical region&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,247.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and marketable investment &lt;br/&gt;     securities (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i950b875f77734623b789ea990425b829_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzMtMS0xLTEtMjMzMg_a0df78e4-8744-4d7a-a280-e93c6ad8e42c"
      unitRef="usd">38400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6a1f560877784761aecb5fecd5cc3ec6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzMtMS0xLTEtMA_2f339d2e-3521-4bf5-84cd-bf402c14aec6"
      unitRef="usd">35400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibb7f24f854d147699f0cbec384e49317_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzMtMy0xLTEtMA_ddb95dea-7a32-400e-99b1-d81155661b76"
      unitRef="usd">36000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i71f9622e189741ed9e209051bad9c565_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzQtMS0xLTEtMjMzMg_48bdae4d-e4aa-44e6-872f-81ef42ad1a8a"
      unitRef="usd">2300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i095006ddbfd24e619e8e422986256785_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzQtMS0xLTEtMA_d43287f7-eb5a-4780-afec-ac33216ffd01"
      unitRef="usd">1600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia9be740ad7044f4882e0d2a5c0a6dc86_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzQtMy0xLTEtMA_78ed2a8a-d02b-4c26-9089-36da6642b191"
      unitRef="usd">21300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iaed4be03cd544752819f842c6fdf12ae_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzUtMS0xLTEtMjMzMg_e9afccff-9822-4d8b-8f0c-1d7b18179908"
      unitRef="usd">40700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0d28bb175fb446de9c4a1a2ff2e5f146_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzUtMS0xLTEtMA_15cd95c2-ace2-4a67-b0f9-d9c33eb0f8fb"
      unitRef="usd">37000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id8619e2e18714ee0808436fe3942e76f_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzUtMy0xLTEtMA_321939ee-bc39-40d3-9f2f-bd8c04c5b75e"
      unitRef="usd">57300000</us-gaap:PropertyPlantAndEquipmentNet>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i950b875f77734623b789ea990425b829_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzctMS0xLTEtMjMzMg_f3c801f4-e5bd-485f-9143-8228bc716bb8"
      unitRef="usd">1190300000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i6a1f560877784761aecb5fecd5cc3ec6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzctMS0xLTEtMA_3362fb1a-fa32-4506-98a5-62874de3361f"
      unitRef="usd">1097200000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="ibb7f24f854d147699f0cbec384e49317_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzctMy0xLTEtMA_6dd44542-cbe5-4627-bdf4-e21daaff5ec7"
      unitRef="usd">1265800000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i71f9622e189741ed9e209051bad9c565_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzgtMS0xLTEtMjMzMg_82d28950-b3a1-46ae-b054-fc6d6537c2da"
      unitRef="usd">56800000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i095006ddbfd24e619e8e422986256785_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzgtMS0xLTEtMA_ca78e965-bd14-4c78-a1f1-071fdd289f25"
      unitRef="usd">52600000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="ia9be740ad7044f4882e0d2a5c0a6dc86_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzgtMy0xLTEtMA_37cf708f-53a0-4ffe-a3cf-ba11fed06e1f"
      unitRef="usd">105100000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="iaed4be03cd544752819f842c6fdf12ae_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzktMS0xLTEtMjMzMg_6fdb6c64-def8-4e46-b38c-527ac0ea8c9a"
      unitRef="usd">1247100000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="i0d28bb175fb446de9c4a1a2ff2e5f146_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzktMS0xLTEtMA_28c8a78b-82af-4b95-9436-8db6a0a41682"
      unitRef="usd">1149800000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <mygn:AssetsLessCashCashEquivalentsAndInvestments
      contextRef="id8619e2e18714ee0808436fe3942e76f_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzktMy0xLTEtMA_5f08533e-fe94-47f1-adbc-6f8c6c6162b3"
      unitRef="usd">1370900000</mygn:AssetsLessCashCashEquivalentsAndInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzEwLTEtMS0xLTEzNDMx_e8827dcd-e8a3-4341-a7f6-4e0e15b77c6e"
      unitRef="usd">171700000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzEwLTMtMS0xLTEzNDMx_f28c7263-c34a-41b9-a836-ac0a43a7872e"
      unitRef="usd">254800000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzEwLTUtMS0xLTEzNDMx_8c28702c-505c-483e-9e1f-7b1acef497a3"
      unitRef="usd">191800000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:Assets
      contextRef="i3713c16ca67a4a2c92019768c7306642_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzExLTEtMS0xLTEzNDMx_987ba71c-9789-4d49-9ef4-c0824950cb4d"
      unitRef="usd">1418800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic1a86f3dc9014d3994d6dbfb20000c19_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzExLTMtMS0xLTEzNDMx_3e80aa4b-a7b9-4fab-94bb-771405dd2114"
      unitRef="usd">1404600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i69f08e4358544efba7545f11fac65d70_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTpjYTcxMmRhYTdlM2I0ZjIyOGUzOWU2YjJjYjgwZmMyYy90YWJsZXJhbmdlOmNhNzEyZGFhN2UzYjRmMjI4ZTM5ZTZiMmNiODBmYzJjXzExLTUtMS0xLTEzNDMx_f0836ed7-723e-4ad9-aa72-944a9e937e5f"
      unitRef="usd">1562700000</us-gaap:Assets>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90ZXh0cmVnaW9uOjk5Yjk3MDhmNDUxMjRmMTVhMDRkY2Y5YTU5NGE1YzAxXzQ5NDc4MDIzMjkzNzc_945ef728-1f2b-4d12-8297-33b2d142a428">&lt;div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles revenue by geographical region to total revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8622695f21e2408d87455391982da0ec_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzItMS0xLTEtMTY3MTg_268e6bac-ac08-4a0d-bf94-39d44fe92070"
      unitRef="usd">275400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27e62f9190914161943bf5ea28f91cef_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzItMy0xLTEtMTY3MTg_44e32efe-36d1-47d9-bc47-b8e6d7a0a4ce"
      unitRef="usd">596200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc2b51c7302d434a8cc407ad3c95cc0e_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzItNS0xLTEtMTY3MTg_e481a4a6-a27e-4348-9274-28042322991d"
      unitRef="usd">805400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4d9c21becba4a2e82b923527a2ec975_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzItNy0xLTEtMTY3MTg_315b5aee-18e6-4f64-a3e8-a233d23eab2c"
      unitRef="usd">700500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a0fa951cb5a4ec2b189987010cc8a1c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzMtMS0xLTEtMTY3MTg_82925dd9-782e-42ad-b55a-cd7d2ca94f5c"
      unitRef="usd">24400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib714b0e057fc4f5e8fb0c1045086c48f_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzMtMy0xLTEtMTY3MTg_bfb8740b-53cd-48bd-9fd4-658793d0f84f"
      unitRef="usd">42400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbe81c4efa2445fdb62fa8055200c3d2_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzMtNS0xLTEtMTY3MTg_d49129df-cf93-4e4f-91b5-b641af6094b5"
      unitRef="usd">45700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b03b59516e541509ec6f0854b5b2266_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzMtNy0xLTEtMTY3MTg_fec544b7-26b4-46c2-9d60-2572a95e18cb"
      unitRef="usd">43200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzQtMS0xLTEtMTY3MTg_f33c1ec9-734f-46bb-acba-aa39930320f5"
      unitRef="usd">299800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzQtMy0xLTEtMTY3MTg_f5db733e-a2eb-4997-bdc3-a1b868a16103"
      unitRef="usd">638600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzQtNS0xLTEtMTY3MTg_785365da-eb5c-4ba2-a2e6-3b4329aaa9dd"
      unitRef="usd">851100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjMvZnJhZzo5OWI5NzA4ZjQ1MTI0ZjE1YTA0ZGNmOWE1OTRhNWMwMS90YWJsZTo3NTRjN2QyOGU5N2Q0OTY3OTRjZWMzNjc3YTZjODc3Ni90YWJsZXJhbmdlOjc1NGM3ZDI4ZTk3ZDQ5Njc5NGNlYzM2NzdhNmM4Nzc2XzQtNy0xLTEtMTY3MTg_9527b7e8-a48b-4628-95e2-607e991116ab"
      unitRef="usd">743700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjYvZnJhZzo0MjEzNjNkOTNmMDY0MjBiYjcxZmUwOTAyZDc4MmE0OS90ZXh0cmVnaW9uOjQyMTM2M2Q5M2YwNjQyMGJiNzFmZTA5MDJkNzgyYTQ5XzcxMQ_25bddd92-0a95-4607-91ca-4902795de7af">SALE OF SUBSIDIARYOn February 28, 2020, the Company closed the sale of the Clinic with Landkreis Starnberg. As a result of the sale, the Clinic was deconsolidated from the Company&#x2019;s consolidated financial statements in accordance with ASC 810. The Company recorded a pre-tax net gain of $1.0 million on the sale, which was recorded in other income in the Company&#x2019;s Consolidated Statements of Operations during the fiscal year ended June 30, 2020. The gain recorded consists of a pre-tax gain of $1.2 million associated with the settlement of the Clinic pension, offset by a loss of $0.2 million due to the difference between the purchase price and net assets as well as the effects of foreign currency. The Clinic was previously reported as part of the Company&#x2019;s other segment.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjYvZnJhZzo0MjEzNjNkOTNmMDY0MjBiYjcxZmUwOTAyZDc4MmE0OS90ZXh0cmVnaW9uOjQyMTM2M2Q5M2YwNjQyMGJiNzFmZTA5MDJkNzgyYTQ5XzI5Nw_19ddc634-60d3-47a4-8302-e66c52c41020"
      unitRef="usd">1000000.0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <mygn:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension
      contextRef="idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjYvZnJhZzo0MjEzNjNkOTNmMDY0MjBiYjcxZmUwOTAyZDc4MmE0OS90ZXh0cmVnaW9uOjQyMTM2M2Q5M2YwNjQyMGJiNzFmZTA5MDJkNzgyYTQ5XzQ1MA_8654d8a7-9cfb-4884-bb5c-95f3240a9ff2"
      unitRef="usd">1200000</mygn:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension>
    <mygn:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect
      contextRef="idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjYvZnJhZzo0MjEzNjNkOTNmMDY0MjBiYjcxZmUwOTAyZDc4MmE0OS90ZXh0cmVnaW9uOjQyMTM2M2Q5M2YwNjQyMGJiNzFmZTA5MDJkNzgyYTQ5XzUyNw_8f60cabf-bbfa-4bf2-84cc-2aded0e4db81"
      unitRef="usd">-200000</mygn:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU1MjU_e98e594a-e295-4005-ba8b-616b6c69a476">BUSINESS ACQUISITIONS&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counsyl&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2018, the Company completed the acquisition of Counsyl, Inc. (&#x201c;Counsyl&#x201d;), a leading provider of genetic testing and DNA analysis services, pursuant to the Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;), dated May 25, 2018.&#160;&#160;Pursuant to the terms of the Merger Agreement, Myriad Merger Sub, Inc., a newly created wholly-owned subsidiary of the Company, was merged with and into Counsyl, with Counsyl continuing as the surviving corporation and a wholly-owned subsidiary of Myriad.&#160;&#160;The Company believes the acquisition allows for further entry into the high-growth reproductive testing market, with the ability to become a leader in women&#x2019;s health genetic testing.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acquired Counsyl for total consideration of $405.9 million, consisting of $278.5 million in cash, financed in part by the Amendment No. 1 to the Facility (see Note 7) and 3.0 million shares of common stock issued, valued at $127.4 million.&#160;&#160;The shares were issued and valued as of July&#160;31, 2018 at a per share market closing price of $42.53.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the cash consideration, $5.0 million was deposited into an escrow account to fund any post-closing adjustments payable to Myriad based upon differences between the estimated working capital and the actual working capital of Counsyl at closing.&#160;&#160;The working capital was finalized during the fiscal year ended June 30, 2019 as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration transferred was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the acquisition date. Management estimated the fair value of tangible and intangible assets and liabilities in accordance with the applicable accounting guidance for business combinations and utilized the services of third-party valuation consultants. The significant assumptions used in the model to estimate the value of the intangible assets included projected cash flows, discount rates, net working capital and long-term growth rate. The initial allocation of the consideration transferred is based on a preliminary valuation and is subject to adjustments. Balances subject to adjustment primarily include the valuations of acquired assets (tangible and intangible), liabilities assumed, as well as tax-related matters. During the measurement period, the Company may record adjustments to the provisional amounts recognized. During the fiscal year ended June 30, 2019, $1.1 million of this escrow was returned to Myriad as a result of a working capital adjustment which reduced the total consideration and goodwill.&#160;&#160;There was also a reduction in the intangible assets of $2.9 million due to updated assumptions related to contributory asset charges associated with the related acquired asset, a $1.9 million decrease in the deferred tax liability, and a $0.7 million reduction to equipment due to updated valuations. The offset for the intangible asset, deferred tax liability and equipment changes was a $4.4 million increase in goodwill. The allocation of the consideration transferred was finalized within the measurement period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the estimated fair value of total consideration transferred:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acquired intangible assets that consisted of developed screening processes, which had an estimated fair value of $290.0 million. The fair values of these developed screening processes and related useful lives were determined using a probability-weighted income approach that discounts expected future cash flows to present value. The estimated net cash flows were discounted using a discount rate of 12.5%, which is based on the estimated internal rate of return for the acquisition and represents the rate that market participants might use to value the intangible assets. The Company will amortize the intangible assets on a straight-line basis over their estimated useful lives of 12 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill represents the excess of consideration transferred over the fair value of assets acquired and liabilities assumed and is attributable to the benefits expected from combining the Company&#x2019;s expertise with Counsyl&#x2019;s technology, customer insights, and ability to effectively integrate genetic screening into clinical practice with OBGYNs.&#160;Changes in goodwill since the initial purchase are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance September 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment to equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Working capital adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This goodwill is not deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pro Forma Information (Unaudited)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro-forma results presented below include the effects of the Counsyl acquisition as if it had been consummated as of July 1, 2017, with adjustments to give effect to pro forma events that are directly attributable to the acquisition, which includes adjustments related to the amortization of acquired intangible assets, interest income and expense, and depreciation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results do not reflect any operating efficiency or potential cost savings that may result from the consolidation of Counsyl with the Company. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operation of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations and are not necessarily indicative of results that might have been achieved had the acquisition been consummated as of July 1, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To complete the purchase transaction, the Company incurred approximately $6.8 million of acquisition costs, which are recorded as selling, general and administrative expenses in the period incurred. For the fiscal year ended June 30, 2019, Counsyl contributed revenue of approximately $104.9 million.&#160;For the fiscal year ended June 30, 2019, operating expenses related to Counsyl were approximately $67.6 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzc2OQ_5a530daa-dd64-42f8-810e-255d4f8643a9"
      unitRef="usd">405900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzc4Nw_7aea4440-685d-46b0-8987-f44d0fcad92e"
      unitRef="usd">278500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i4404c2e49c864be6b8c89615b7c19e72_D20180731-20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzg3MQ_9d5f90ae-6121-4d0d-b69d-8285fd231055"
      unitRef="shares">3000000.0</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i01ca278c54bd4c979932880e1cf44d22_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzkxNQ_81d51c53-7dfd-4826-a311-987cac20f2fa"
      unitRef="usd">127400000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i01ca278c54bd4c979932880e1cf44d22_I20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzEwMTM_93bd62ae-ffa1-4de9-b19f-5aa118edae3e"
      unitRef="usdPerShare">42.53</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:EscrowDepositDisbursementsRelatedToPropertyAcquisition1
      contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzEwNDQ_67d6b5f1-6c31-4e65-97bb-51f367b63c12"
      unitRef="usd">5000000.0</us-gaap:EscrowDepositDisbursementsRelatedToPropertyAcquisition1>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzIzMjc_7c09c91d-e2c2-43c4-8c15-4baf70e57ae8"
      unitRef="usd">-1100000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzI1MjA_6155c475-1213-45a3-9c1e-b40fb7b08c80"
      unitRef="usd">-2900000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzI2MzQ_a46ab755-a629-43f7-962f-916e7deeaaa0"
      unitRef="usd">-1900000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzI2ODM_5ac7b4c2-5c81-4687-89e6-2ff68f28fddd"
      unitRef="usd">-700000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzI4MjQ_def697f5-bc49-43d7-b4f1-015235179b0d"
      unitRef="usd">-4400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzQ5NDc4MDIzMzEyNzA_dd78cddf-e122-4e23-818a-1af6fc75ecc1">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the estimated fair value of total consideration transferred:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzEtMS0xLTEtMA_fa41d59f-18fd-4727-80d2-f23960dd7192"
      unitRef="usd">42500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzItMS0xLTEtMA_9cb580bd-9280-4eaa-b0a5-f3ac1d66568c"
      unitRef="usd">290000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzMtMS0xLTEtMA_83cd02ee-ffbc-43e6-82f2-151e716c1fce"
      unitRef="usd">18200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzQtMS0xLTEtMA_7a257318-8555-4d34-843e-a675c254b4a0"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:Goodwill
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzUtMS0xLTEtMA_07541075-b649-4354-9bda-94272a14dc55"
      unitRef="usd">99300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzYtMS0xLTEtMA_ef01ee29-4b1d-489b-b403-ff4aaec66d94"
      unitRef="usd">19600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzctMS0xLTEtMA_44d5f521-2b4c-4b3f-bf04-b09d2e3cc717"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzgtMS0xLTEtMA_856c5299-8fa3-469b-8491-cb19ffa8f3f6"
      unitRef="usd">9200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzktMS0xLTEtMA_6f979417-722e-4ab2-8b2a-f46ccb05fddb"
      unitRef="usd">421200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzEwLTEtMS0xLTA_12efa770-c7ac-4840-8298-f62686f50c10"
      unitRef="usd">15300000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i93a834facdc34dff87795122a884aa47_D20180731-20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTpiMmRiYjU0NWU5YTY0YThkOGNkMGZjZDA1NTA0ZGQ4Zi90YWJsZXJhbmdlOmIyZGJiNTQ1ZTlhNjRhOGQ4Y2QwZmNkMDU1MDRkZDhmXzExLTEtMS0xLTA_8a43927d-1bdf-47f0-af5d-ce116d56f0d6"
      unitRef="usd">405900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ib375fb1450054a4aad0facea3d6370ce_D20180731-20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzMxMDA_d9d16dde-d95c-4055-9c88-379bbd1006f3"
      unitRef="usd">290000000.0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <mygn:AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent
      contextRef="ib375fb1450054a4aad0facea3d6370ce_D20180731-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzMzNzU_e676614b-8473-4c10-8128-e26f0af4b9da"
      unitRef="number">0.125</mygn:AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib375fb1450054a4aad0facea3d6370ce_D20180731-20180731"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzM2NTY_bf9adb4b-60bf-48b2-936b-cd5d24b1dde7">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationSegmentAllocationTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU1Mjc_600f771d-d3bc-4fa8-ba10-d0a87ef5d88b">Changes in goodwill since the initial purchase are shown below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance September 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment to equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Working capital adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessCombinationSegmentAllocationTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i989c0ce93f6e4f0fad3b86a4df6adedf_I20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzEtMS0xLTEtMA_81ea6891-bfd3-46ae-9d66-81fad894dd48"
      unitRef="usd">94900000</us-gaap:Goodwill>
    <mygn:GoodwillIncreaseDecreaseFairValueAdjustmentEquipment
      contextRef="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzItMS0xLTEtMA_5f380889-bbd9-43cb-9b98-e80f4247df05"
      unitRef="usd">700000</mygn:GoodwillIncreaseDecreaseFairValueAdjustmentEquipment>
    <mygn:GoodwillIncreaseDecreaseIntangibleAssetsAdjustment
      contextRef="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzMtMS0xLTEtMA_7d4dc888-fd98-412f-9c88-99df9e126697"
      unitRef="usd">2900000</mygn:GoodwillIncreaseDecreaseIntangibleAssetsAdjustment>
    <mygn:GoodwillIncreaseDecreaseWorkingCapitalAdjustment
      contextRef="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzQtMS0xLTEtMA_ccb4ed6a-32e1-4270-a7f0-d9ef549c64e4"
      unitRef="usd">-1100000</mygn:GoodwillIncreaseDecreaseWorkingCapitalAdjustment>
    <mygn:GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment
      contextRef="i503fe559aeef481c886d5f95a4b941da_D20181001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzUtMS0xLTEtMA_c4de2e44-b8f4-4998-b38f-fac43bbde752"
      unitRef="usd">1900000</mygn:GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment>
    <us-gaap:Goodwill
      contextRef="i5274fcc1e4cf4cddb09da83ac2cbc368_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NzhiYTM5ZjJjMDE0N2JkYTE3YmVhMWFiZDY4ODFiOS90YWJsZXJhbmdlOjQ3OGJhMzlmMmMwMTQ3YmRhMTdiZWExYWJkNjg4MWI5XzYtMS0xLTEtMA_20b6a907-f13d-492f-a7be-49a6c74b29f7"
      unitRef="usd">99300000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU1MjQ_1210f57a-fad2-4181-b103-63bc4a0d285b">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results do not reflect any operating efficiency or potential cost savings that may result from the consolidation of Counsyl with the Company. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operation of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations and are not necessarily indicative of results that might have been achieved had the acquisition been consummated as of July 1, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzItMS0xLTEtMA_6e63c123-770c-4c48-977f-b7cfbeb4c2d4"
      unitRef="usd">861300000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzItMy0xLTEtMA_094c6359-afec-4b63-83df-9920d82abbba"
      unitRef="usd">881800000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzMtMS0xLTEtMA_11ca367f-f6d3-4765-8e2e-9a3e2b990bfa"
      unitRef="usd">17900000</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzMtMy0xLTEtMA_e9ee4734-e611-4b11-898f-dbe59e631656"
      unitRef="usd">74300000</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzQtMS0xLTEtMA_d456b20c-01b0-4fb0-b3fc-1faed1721dd4"
      unitRef="usd">13800000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzQtMy0xLTEtMA_6e4361f3-5605-4250-995b-8bb7819b6577"
      unitRef="usd">73000000.0</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzUtMS0xLTEtMA_d4643e12-2c4e-4cf8-9dd7-ccebdc74f676"
      unitRef="usdPerShare">0.19</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzUtMy0xLTEtMA_430f1a32-1bea-413f-8728-8b7e28ac75d6"
      unitRef="usdPerShare">1.01</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzYtMS0xLTEtMA_7d1d861d-68ff-44c4-b9aa-e20fbc132c67"
      unitRef="usdPerShare">0.18</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i94247a4a629c4e259c9f3d1eaea2992c_D20170701-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90YWJsZTo0NTBjYzBjMDQ2NDU0NDIwOWY3ZDFlZjdhN2JiMTQ2Yi90YWJsZXJhbmdlOjQ1MGNjMGMwNDY0NTQ0MjA5ZjdkMWVmN2E3YmIxNDZiXzYtMy0xLTEtMA_630817a4-e1eb-46d6-8376-78b86abb0f20"
      unitRef="usdPerShare">0.98</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i5909e1e0ad1e4dee9cc11be4c51097af_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzUyNjk_7f09e9b8-6af4-4aae-b459-cba801108cea"
      unitRef="usd">6800000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU0NDU_a5f5f5b7-4fa4-49e3-b9b7-22c2da29c27a"
      unitRef="usd">104900000</us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod>
    <us-gaap:OperatingExpenses
      contextRef="ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNjkvZnJhZzpjOGZiMzYzNGNiNzQ0ZjAxODNlY2M3YjZhZGEzYTdmZS90ZXh0cmVnaW9uOmM4ZmIzNjM0Y2I3NDRmMDE4M2VjYzdiNmFkYTNhN2ZlXzU1MjI_58caa4cf-da61-4f4d-8914-b15eb0425af5"
      unitRef="usd">67600000</us-gaap:OperatingExpenses>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODk2L2ZyYWc6MTkwNTYxNmYzNGU4NDAyZWI2YTU5YjM0OTJkNTlmYzQvdGV4dHJlZ2lvbjoxOTA1NjE2ZjM0ZTg0MDJlYjZhNTliMzQ5MmQ1OWZjNF80OTQ3ODAyMzMxNzc2_6acda383-40bd-47c2-a5c2-370c870689af">SUBSEQUENT EVENT&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 22, 2021, the Company entered into Amendment No. 3 to the Amended Facility discussed in Note 7, which modified the Amended Facility as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Extends the Modification Period established pursuant to Amendment No. 2 for an additional year, through June 30, 2022, and revises certain negative covenants in connection therewith.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Restricts the Company from borrowing under the revolving credit facility if unrestricted cash and cash equivalents exceed $150.0 million, unless such borrowings are in connection with acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Reduces the revolving commitments to $300.0 million, with a further reduction to $250.0 million by September 30, 2021. Provides for further reductions to the revolving commitments, or mandatory prepayments of outstanding revolving loans, in the event of certain asset sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Waives compliance with the leverage ratio and the interest coverage ratio covenants through the quarter ended March 31, 2022 and also lowers the minimum liquidity covenant applicable through such quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Removes the minimum EBITDA covenant added pursuant to Amendment No. 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Permits the Company to change its fiscal year end to December 31.&lt;/span&gt;&lt;/div&gt;&#x25e6;Permits the Company to keep the net cash proceeds of material asset sales received above certain dollar thresholds without corresponding mandatory prepayments or commitment reductions.</us-gaap:SubsequentEventsTextBlock>
    <mygn:DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum
      contextRef="i4e14cc8f30fb41298c08929c2d88cda2_I20210222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODk2L2ZyYWc6MTkwNTYxNmYzNGU4NDAyZWI2YTU5YjM0OTJkNTlmYzQvdGV4dHJlZ2lvbjoxOTA1NjE2ZjM0ZTg0MDJlYjZhNTliMzQ5MmQ1OWZjNF80OTQ3ODAyMzMxNzQ0_0a8a8e3f-15eb-4705-a6bd-a5b7ba082956"
      unitRef="usd">150000000.0</mygn:DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4e14cc8f30fb41298c08929c2d88cda2_I20210222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODk2L2ZyYWc6MTkwNTYxNmYzNGU4NDAyZWI2YTU5YjM0OTJkNTlmYzQvdGV4dHJlZ2lvbjoxOTA1NjE2ZjM0ZTg0MDJlYjZhNTliMzQ5MmQ1OWZjNF80OTQ3ODAyMzMxNzU1_2d62e58e-b2cc-4831-82d1-5f02f462a406"
      unitRef="usd">300000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if4d51abe6c704a11849ba0fee98381b0_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODk2L2ZyYWc6MTkwNTYxNmYzNGU4NDAyZWI2YTU5YjM0OTJkNTlmYzQvdGV4dHJlZ2lvbjoxOTA1NjE2ZjM0ZTg0MDJlYjZhNTliMzQ5MmQ1OWZjNF80OTQ3ODAyMzMxNzY2_d647f394-6eda-43b2-918a-877ab9dc157c"
      unitRef="usd">250000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90ZXh0cmVnaW9uOmMyMDVmNGRlMzM1NTQ0ZWU4M2UzZmU2YzM5MjI3MjU3XzQ1_c79335b4-c6b3-4f5c-8af3-5c6aef108ce3">SUPPLEMENTAL CASH FLOW INFORMATION&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment on marketable investment securities recorded to stockholders' equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment of operation lease right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities and other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90ZXh0cmVnaW9uOmMyMDVmNGRlMzM1NTQ0ZWU4M2UzZmU2YzM5MjI3MjU3XzQ2_df0f27db-cf3e-4696-a388-a598a9e04209">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transition Period Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment on marketable investment securities recorded to stockholders' equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment of operation lease right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities and other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxesPaid
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzItMS0xLTEtMjM1Mg_2492ec00-c212-4efa-9085-3db609beb6cb"
      unitRef="usd">1800000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzItMS0xLTEtMA_57e953d7-3d2b-422e-9503-359ee565bc33"
      unitRef="usd">1000000.0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzItMy0xLTEtMA_1334bbde-2cc2-4c02-ac63-aaf027355512"
      unitRef="usd">6500000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzItNS0xLTEtMA_0076e5b9-6214-4b34-84e3-f690cfc0023c"
      unitRef="usd">11700000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzMtMS0xLTEtMjM1Mg_0fb5eb09-1f1b-4280-a7f8-31bbd5ed521e"
      unitRef="usd">5200000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzMtMS0xLTEtMA_cc88459f-0530-421c-ac1c-913684beeaed"
      unitRef="usd">9500000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzMtMy0xLTEtMA_ecfcb44f-1fc8-4d89-b4eb-800bf2ef0360"
      unitRef="usd">11600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzMtNS0xLTEtMA_6bdae661-cb06-4864-8ae6-f1707335226e"
      unitRef="usd">3000000.0</us-gaap:InterestPaidNet>
    <mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzUtMS0xLTEtMjM1Mg_70c4dd6f-44aa-453f-9fb9-40f42aafaa54"
      unitRef="usd">-500000</mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity>
    <mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzUtMS0xLTEtMA_b10d3ebf-5856-427e-b0e3-600f9a36e3bc"
      unitRef="usd">700000</mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity>
    <mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity
      contextRef="ib2586c0af4a5487f869bfb628c1bfd03_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzUtMy0xLTEtMA_cdcd9575-1464-4a44-9f87-32a27c3e9b9f"
      unitRef="usd">1200000</mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity>
    <mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity
      contextRef="if8551321c6c747299d61ae064b4f7a11_D20170701-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzUtNS0xLTEtMA_035621f0-9fd4-4a0a-bfa7-a124904ef69e"
      unitRef="usd">-400000</mygn:FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i7379beb581ae4463a448487c90805d3e_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzctMS0xLTEtMA_1706e283-733b-45ad-a0d3-99ddde90d11c"
      unitRef="usd">74500000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <mygn:OperatingLeaseLiabilityEstablished
      contextRef="i7379beb581ae4463a448487c90805d3e_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzgtMS0xLTEtMA_3e4199d2-0a9b-4fd1-b1b0-6989457d56bf"
      unitRef="usd">78800000</mygn:OperatingLeaseLiabilityEstablished>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="iebca8052884e4c15bfe4d21293d70468_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzUvZnJhZzpjMjA1ZjRkZTMzNTU0NGVlODNlM2ZlNmMzOTIyNzI1Ny90YWJsZTo0ODBiNzQxNTkwMzE0NWM3YmM5MmM4NTUzMzc4ZTNkMC90YWJsZXJhbmdlOjQ4MGI3NDE1OTAzMTQ1YzdiYzkyYzg1NTMzNzhlM2QwXzktMS0xLTEtMA_6374732f-e8d9-4a79-af77-e63204b4a566"
      unitRef="usd">4300000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90ZXh0cmVnaW9uOjYzNTBiYjc1ZjJkYzQ2MTY4NTIyZTViNThjMTE1NTQzXzQ1Ng_42936a25-963e-496a-ae64-c9b8de56dd92">SUPPLEMENTARY QUARTERLY FINANCIAL DATA (UNAUDITED)&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quarters Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Change in the fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net loss attributable to non-controlling interest  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Myriad Genetics Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quarters Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in the fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to Myriad Genetics Inc. stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) An immaterial prior period goodwill impairment charge of $1.3 million was previously classified as part of selling, general and administrative expense in the condensed consolidated statements of operations was reclassified to conform to the current period presentation and is included as part of the goodwill and intangible asset impairment charges financial statement line item in the current period.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quarters Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to Myriad Genetics, Inc. stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90ZXh0cmVnaW9uOjYzNTBiYjc1ZjJkYzQ2MTY4NTIyZTViNThjMTE1NTQzXzQ1Nw_0ed13c6a-367e-463a-ae30-d3dd6468006a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quarters Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Change in the fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net loss attributable to non-controlling interest  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Myriad Genetics Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quarters Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in the fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to Myriad Genetics Inc. stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) An immaterial prior period goodwill impairment charge of $1.3 million was previously classified as part of selling, general and administrative expense in the condensed consolidated statements of operations was reclassified to conform to the current period presentation and is included as part of the goodwill and intangible asset impairment charges financial statement line item in the current period.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quarters Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to Myriad Genetics, Inc. stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8d38cab5c564bc9b20105859dec05a3_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzItMS0xLTEtNzQyOQ_22a6294a-f844-4b96-a8a2-6a27ea76424d"
      unitRef="usd">143900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i417fd6436fa34961ad7783ba3007e98d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzItMy0xLTEtMTM3NTQ_bd18e51f-05f0-4e3b-8e59-4655d8f887e9"
      unitRef="usd">135700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie222e257470d49d4b5328c8b76c753c1_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzMtMS0xLTEtNzQzMg_404f1696-0f66-4038-8cd6-ea5f71c1718c"
      unitRef="usd">10700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i280a6b01f275425d87a80ea2b0b0a40e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzMtMy0xLTEtMTM3NTQ_b0e121e1-4d88-49d9-a16c-354d1f9562fb"
      unitRef="usd">9500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzQtMS0xLTEtNzQzMg_a1e504a2-1a81-46b6-8bec-b150f90875aa"
      unitRef="usd">154600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzQtMy0xLTEtMTM3NTQ_64690a3e-76e0-4621-a861-cb4039fdb381"
      unitRef="usd">145200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie8d38cab5c564bc9b20105859dec05a3_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzYtMS0xLTEtNzQzMg_f8287689-ac12-4716-8cab-ae3c6dd66cc1"
      unitRef="usd">42700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i417fd6436fa34961ad7783ba3007e98d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzYtMy0xLTEtMTM3NTQ_08f70c92-f9db-46b3-8e13-afb8684e4257"
      unitRef="usd">39900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie222e257470d49d4b5328c8b76c753c1_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzctMS0xLTEtNzQzMg_a6c79dd3-4207-4bf3-844e-a90940bb5f64"
      unitRef="usd">4500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i280a6b01f275425d87a80ea2b0b0a40e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzctMy0xLTEtMTM3NTQ_9f3f5229-6864-45d1-a2c6-7e0a287c8e98"
      unitRef="usd">4300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzgtMS0xLTEtNzQzMg_619e8324-ad8b-47ea-9206-19c012a6cb0b"
      unitRef="usd">18200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzgtMy0xLTEtMTM3NTQ_323a5c95-9c52-49c7-8b69-9570eb799da8"
      unitRef="usd">17600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzktMS0xLTEtNzQzMg_7a5856a1-361b-4f1d-a2ce-b3e864286c69"
      unitRef="usd">4600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzktMy0xLTEtMTM3NTQ_23571489-5e39-4ab5-bbd1-2a2b26c41d67"
      unitRef="usd">-1100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzEwLTEtMS0xLTc0MzI_9dc7c084-3b50-4c2d-8fe9-e3bfaeebd069"
      unitRef="usd">132800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzEwLTMtMS0xLTEzNzU0_cf01bcfc-d2b9-4f3b-b0d2-2adfaa63e229"
      unitRef="usd">124100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzExLTEtMS0xLTc0MzI_2ad2b8f1-69df-4acb-a1ba-c6bf59b6cd25"
      unitRef="usd">202800000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzExLTMtMS0xLTEzNzU0_e79e7d12-1760-4500-bee1-0559b04c0569"
      unitRef="usd">184800000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzEyLTEtMS0xLTc0MzI_09331529-6537-48c2-8082-95373ad2c146"
      unitRef="usd">-48200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzEyLTMtMS0xLTEzNzU2_432626c9-3725-4ee5-b124-dbb78f908a52"
      unitRef="usd">-39600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE0LTEtMS0xLTc0MzI_5251aec1-69c5-450e-9ce5-bf27d1db651c"
      unitRef="usd">300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE0LTMtMS0xLTEzNzU0_0e317772-2cee-4c01-ad07-0b1ebb679628"
      unitRef="usd">400000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE1LTEtMS0xLTc0MzI_664177d4-538c-4f28-92e5-7adaf83f3308"
      unitRef="usd">2900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE1LTMtMS0xLTEzNzU0_17c9eea1-5999-471b-8301-914b966a2008"
      unitRef="usd">2900000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE2LTEtMS0xLTc0MzI_1066acee-6923-4410-8bb9-3ba5b70ad873"
      unitRef="usd">400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE2LTMtMS0xLTEzNzU0_dde9c46c-f0bf-4d76-a19e-e0274feaf58a"
      unitRef="usd">-1600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE3LTEtMS0xLTc0MzI_3ff7ba9a-f494-4413-afbb-f25b447c6ea2"
      unitRef="usd">-2200000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE3LTMtMS0xLTEzNzU0_bc8d1536-76c0-45bf-9fe1-2782d7ab4d6d"
      unitRef="usd">-4100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE4LTEtMS0xLTc0MzI_2c80466d-1126-4c38-8fc3-9eabe1fabdce"
      unitRef="usd">-50400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE4LTMtMS0xLTEzNzU0_cdb490d9-29ea-47c9-846a-9388a209f99f"
      unitRef="usd">-43700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE5LTEtMS0xLTc0MzI_72df2099-b7df-4770-8e30-8155fdcc9cd1"
      unitRef="usd">-12500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzE5LTMtMS0xLTEzNzU0_e1655fad-93ee-4be8-9241-90e2007ce8e6"
      unitRef="usd">-28500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIwLTEtMS0xLTc0MzI_294cd040-1095-4cc0-96da-d5b9b8673f59"
      unitRef="usd">-37900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIwLTMtMS0xLTEzNzU0_8cc3f180-16b1-4b0c-b0f0-ae162a14a06d"
      unitRef="usd">-15200000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIxLTEtMS0xLTc0MzI_a273e35d-da06-45d9-9f2a-120a5d8cbd73"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIxLTMtMS0xLTEzNzU0_181b470d-3708-4e8e-b939-99852ad4488b"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIyLTEtMS0xLTc0MzI_ca4dba33-315b-4327-8830-30d424f3c19f"
      unitRef="usd">-37900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzIyLTMtMS0xLTEzNzU0_9a039426-4592-486b-94d8-8b7f981208b8"
      unitRef="usd">-15200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI0LTEtMS0xLTc0MzU_980cc111-2ad1-4704-acc0-1f64d6b86da4"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI0LTMtMS0xLTEzNzU0_b22ddd54-e189-4a4c-9fd9-c04f662393be"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI1LTEtMS0xLTc0MzU_0f7bab43-f3d0-497d-9bae-bc565cc86189"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI1LTMtMS0xLTEzNzU0_392df9dd-40b0-4ea1-8a03-939f04230020"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI3LTEtMS0xLTc0MzU_547e1bac-7925-4e6b-81bd-3e957dca0a7b"
      unitRef="shares">75300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI3LTMtMS0xLTEzNzU0_88be0a78-7348-4c68-8a07-24e4897639f4"
      unitRef="shares">74700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI4LTEtMS0xLTc0MzU_684a71fc-d805-4f60-9bf2-41db3f025174"
      unitRef="shares">75300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i704533aa05a5498bb4df6bfc06bbbf84_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTo5MWIxY2RkZGY1MDA0MzA1ODA1ZDc2YWRjMjJjMmY3MC90YWJsZXJhbmdlOjkxYjFjZGRkZjUwMDQzMDU4MDVkNzZhZGMyMmMyZjcwXzI4LTMtMS0xLTEzNzU0_6a5f08fe-bf19-4f2f-9a44-7838fcfb377a"
      unitRef="shares">74700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacfe0fce6e9744d5958f4fc65b2cceb5_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzItMS0xLTEtMA_e0b66769-eca7-4523-9134-bd9aafd9ff06"
      unitRef="usd">83300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7da9afb8114544a681d59d52fbda4b5f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzItMy0xLTEtMA_0db7d9a7-7c55-45ae-9dda-c6bb701ed7d5"
      unitRef="usd">150500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia66a2e9352774e61bb66d72a0ec6ba0a_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzItNS0xLTEtMA_b81cdf0c-aea8-4351-b367-5f3b1f624cd8"
      unitRef="usd">181100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa76971edb2f495597ee3f81808bc71c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzItNy0xLTEtMA_148b09e9-2441-4be6-84f5-e9e86c8659ec"
      unitRef="usd">172000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieea11b6adbeb41c5bcf4dadb78975fbb_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzMtMS0xLTEtMA_ae323c28-dd65-4e59-bf1d-20c05a65221c"
      unitRef="usd">9900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5aa650d52994396ad41ee3b0e5b738c_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzMtMy0xLTEtMA_eb7fb0ec-94f0-4e4e-b11a-d8e2532105bc"
      unitRef="usd">13500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18f36b0ed57f4719bdab785d76fd50ae_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzMtNS0xLTEtMA_5dc2a86f-353a-476f-a041-59a28a8275fe"
      unitRef="usd">14000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c8bb11b2e0d4568a0ef8208b3edb143_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzMtNy0xLTEtMA_7bc1380d-03cc-4390-bd21-512cdfea37e6"
      unitRef="usd">14300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzQtMS0xLTEtMA_cd8d4247-26bf-408f-a26b-22b9063ccb54"
      unitRef="usd">93200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzQtMy0xLTEtMA_2ffd6464-9197-481c-a13b-0147c4a4016a"
      unitRef="usd">164000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzQtNS0xLTEtMA_9e754361-eb3b-4c09-b700-23baa219584c"
      unitRef="usd">195100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzQtNy0xLTEtMA_54374154-fc63-4845-9737-5d14fc528696"
      unitRef="usd">186300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iacfe0fce6e9744d5958f4fc65b2cceb5_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzYtMS0xLTEtMA_03616ce2-1739-47bd-a733-5579f796e07e"
      unitRef="usd">32200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7da9afb8114544a681d59d52fbda4b5f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzYtMy0xLTEtMA_bd970787-4f69-4c62-be0a-baf110f9fb76"
      unitRef="usd">43100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia66a2e9352774e61bb66d72a0ec6ba0a_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzYtNS0xLTEtMA_a5461fb9-0136-4f88-b464-b673c55ef758"
      unitRef="usd">41000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iaa76971edb2f495597ee3f81808bc71c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzYtNy0xLTEtMA_25a862d1-4030-4a2c-a314-3fd8b48a9a71"
      unitRef="usd">41200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ieea11b6adbeb41c5bcf4dadb78975fbb_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzctMS0xLTEtMA_ebad950c-5326-4cb6-8a67-92dda98a6364"
      unitRef="usd">4500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if5aa650d52994396ad41ee3b0e5b738c_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzctMy0xLTEtMA_afea7f60-4564-4f0c-a6ff-68b5138244fe"
      unitRef="usd">7000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i18f36b0ed57f4719bdab785d76fd50ae_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzctNS0xLTEtMA_a51dc5d0-54fd-46aa-bd4f-264b9059ba23"
      unitRef="usd">8600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2c8bb11b2e0d4568a0ef8208b3edb143_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzctNy0xLTEtMA_39a05158-6db9-4a1c-963f-bb046c42f6b8"
      unitRef="usd">8500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzgtMS0xLTEtMA_6c9c9be0-c962-4115-af22-b4b113b9648c"
      unitRef="usd">17400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzgtMy0xLTEtMA_af8b8452-3370-46d4-bbea-15bcffcef7f8"
      unitRef="usd">19700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzgtNS0xLTEtMA_6d66cfae-5a36-43c5-8803-022d1f870d17"
      unitRef="usd">18800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzgtNy0xLTEtMA_b7c750e4-b0c4-487e-8b6b-c3073358666b"
      unitRef="usd">21300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzktMS0xLTEtMA_ad3aac24-00a0-48ba-a993-57dc911dba5a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzktMy0xLTEtMA_46eb4057-eb05-4129-b469-67f21aa41dc5"
      unitRef="usd">-3400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzktNS0xLTEtMA_f4446157-1002-40a6-aac4-23bf7b768d89"
      unitRef="usd">-100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzktNy0xLTEtMA_1f30c09e-e880-47f3-baa4-5abe252ba433"
      unitRef="usd">700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEwLTEtMS0xLTA_49f80181-2be9-4b7f-819a-1ee00bfcf305"
      unitRef="usd">107400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEwLTMtMS0xLTA_b33fc04c-2ea0-4b22-879d-4032ac18be3d"
      unitRef="usd">132900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEwLTUtMS0xLTA_d01d875a-5289-4953-abbe-d1fc3c4fa341"
      unitRef="usd">134300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEwLTctMS0xLTA_fc1faf7d-0001-47b1-a95d-1114af942b32"
      unitRef="usd">135500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzExLTEtMS0xLTA_85ca9f7e-c337-47d7-b660-d1accc039385"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzExLTMtMS0xLTA_3218d5ae-a29d-4d47-b4ae-61fa1f83024e"
      unitRef="usd">98400000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzExLTUtMS0xLTA_e511278e-1303-4e97-81a3-8b1325ccb585"
      unitRef="usd">1300000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzExLTctMS0xLTA_acd95aa7-a487-4e74-83c8-01aafc4a23c8"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:CostsAndExpenses
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEyLTEtMS0xLTA_2da88fc1-e44a-42a1-9471-39757198b586"
      unitRef="usd">161500000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEyLTMtMS0xLTA_e044d903-bad1-4b25-af75-f99e09a8f51a"
      unitRef="usd">297700000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEyLTUtMS0xLTA_e9b6d2fa-4682-445f-8b84-2d3e15f865a1"
      unitRef="usd">203900000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEyLTctMS0xLTA_0bd81eea-8bfb-4e11-9a29-7c537d6f91fd"
      unitRef="usd">207200000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEzLTEtMS0xLTA_77e2d9f1-68b7-4abc-9dd4-ee8c315598a7"
      unitRef="usd">-68300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEzLTMtMS0xLTA_21a772b0-0b08-4cb3-bd8e-22211b9a824e"
      unitRef="usd">-133700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEzLTUtMS0xLTA_b0a3e120-e43d-4be7-ad5e-92e87db32151"
      unitRef="usd">-8800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzEzLTctMS0xLTA_87035aa1-f52a-415a-8ce4-b6c5d87ee918"
      unitRef="usd">-20900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE1LTEtMS0xLTA_0fbf0f05-5693-4abb-90b6-e1e5b8c79537"
      unitRef="usd">500000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE1LTMtMS0xLTA_e5eb2aa6-373a-457a-9b25-b9be6a31e9e5"
      unitRef="usd">800000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE1LTUtMS0xLTA_b797417b-7be4-4104-b1f6-d319e9398313"
      unitRef="usd">800000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE1LTctMS0xLTA_e95b744e-5627-4c46-8df6-b93bc3059381"
      unitRef="usd">900000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE2LTEtMS0xLTA_a9d54f50-e39e-4912-a9a6-983f7af0cb10"
      unitRef="usd">3100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE2LTMtMS0xLTA_df6e634b-507b-4516-832e-0580d8e2ad24"
      unitRef="usd">2300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE2LTUtMS0xLTA_4389c99e-d10f-4a26-b2b9-a973d6e3eac6"
      unitRef="usd">2500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE2LTctMS0xLTA_ad3348d6-fc65-494c-b7e2-ed2f484cc9a4"
      unitRef="usd">2900000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE3LTEtMS0xLTA_e47913ac-d1a5-43b2-af2c-cd835d233d36"
      unitRef="usd">12400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE3LTMtMS0xLTA_7ac03e62-2d01-482e-a2d4-ca291a043211"
      unitRef="usd">4100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE3LTUtMS0xLTA_1756ca20-3da8-4b2c-affd-4d779fec704e"
      unitRef="usd">-900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE3LTctMS0xLTA_a913b78c-0638-4c2d-8f7c-2535a5f4e336"
      unitRef="usd">600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE4LTEtMS0xLTA_97707762-89c8-4344-a1d7-6150d9c69a7e"
      unitRef="usd">9800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE4LTMtMS0xLTA_31a7986b-b9b2-4167-b821-c89898fe5cb3"
      unitRef="usd">2600000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE4LTUtMS0xLTA_0b0c8c3d-169a-4a99-81a5-9fc67aa35035"
      unitRef="usd">-2600000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE4LTctMS0xLTA_2595d0b2-bb5d-422f-913a-1588c9587379"
      unitRef="usd">-1400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE5LTEtMS0xLTA_763a6ec4-a5e0-4f6d-b01e-b10fcaf774eb"
      unitRef="usd">-58500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE5LTMtMS0xLTA_19897e03-04f2-416f-af94-2cbf1472448e"
      unitRef="usd">-131100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE5LTUtMS0xLTA_bf9c1536-d909-47fa-a64a-4228ba526aa9"
      unitRef="usd">-11400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzE5LTctMS0xLTA_4c6c63e4-9489-4ab8-8e4c-36610b138546"
      unitRef="usd">-22300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIwLTEtMS0xLTA_efed0357-cdeb-40db-92cd-97b631dc8d15"
      unitRef="usd">-3000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIwLTMtMS0xLTA_537acc45-55f6-4dbb-aa15-3c73b0c7215b"
      unitRef="usd">-15900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIwLTUtMS0xLTA_3fdbf09a-47ec-4f06-ac0e-09ec70d82ebb"
      unitRef="usd">-3100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIwLTctMS0xLTA_f5d9ef0a-0f50-478d-980b-39ae2c51fe19"
      unitRef="usd">-1700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIxLTEtMS0xLTA_7dd2dded-4d76-4c5c-85d3-2d21ac73bd4d"
      unitRef="usd">-55500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIxLTMtMS0xLTA_89de2281-df5a-4e47-a4f5-e9a4af358f52"
      unitRef="usd">-115200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIxLTUtMS0xLTA_ee4776d3-5c1c-4dc9-a453-4a37a89011d6"
      unitRef="usd">-8300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIxLTctMS0xLTA_baa4647e-0388-4bbe-ba57-6f172a4db6b4"
      unitRef="usd">-20600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIyLTEtMS0xLTA_964a3558-e0b7-4008-9496-fb622837695a"
      unitRef="usd">-100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIyLTMtMS0xLTA_ff53b4c5-25d4-4698-b10b-a1cfab9a3e4e"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIyLTUtMS0xLTA_9ae5f2c9-2fed-4978-bc0b-2f583de81632"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIyLTctMS0xLTA_d670b17e-c380-44f0-88d6-13fa8a2f3eb3"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIzLTEtMS0xLTA_c6cd3e0d-85b9-47db-af47-9bb1bccbd107"
      unitRef="usd">-55400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIzLTMtMS0xLTA_4bf3f6b6-5fd3-4761-8042-dc00a442043e"
      unitRef="usd">-115200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIzLTUtMS0xLTA_2d238bc9-5216-4dbc-b66d-62fe23f87930"
      unitRef="usd">-8300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzIzLTctMS0xLTA_35878a0a-deba-4cbb-8892-819d795e5935"
      unitRef="usd">-20600000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI1LTEtMS0xLTA_5cead4d7-9d50-4425-8db8-130324b2494d"
      unitRef="usdPerShare">-0.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI1LTMtMS0xLTA_38027f76-0ba5-4915-8b8a-087970f1afa3"
      unitRef="usdPerShare">-1.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI1LTUtMS0xLTA_96e323ec-4d9d-447c-aa9d-296b0a768888"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI1LTctMS0xLTA_c630c3f6-7ea3-4ad5-a5b5-ee4e6c65838f"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI2LTEtMS0xLTA_ac2e2898-af0c-4784-bac1-9acfdfdea793"
      unitRef="usdPerShare">-0.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI2LTMtMS0xLTA_61c622ec-537e-40e7-a0d2-2083dc14b9d4"
      unitRef="usdPerShare">-1.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI2LTUtMS0xLTA_6f4b4ae1-4400-428b-9cad-3c742ae6fa37"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI2LTctMS0xLTA_5bf2da16-305c-4fb6-9e31-5cb1de79cda9"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI4LTEtMS0xLTA_97a317d7-aa18-4454-b74c-8da8778e8770"
      unitRef="shares">74600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI4LTMtMS0xLTA_ce6240ae-a3d5-4b27-82ae-343537d9a4ef"
      unitRef="shares">74500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI4LTUtMS0xLTA_423c665e-0012-4331-869f-c3775e96b134"
      unitRef="shares">74400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI4LTctMS0xLTA_186c8466-5288-4d28-b1c3-e124eb726152"
      unitRef="shares">73700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i23af7572e7024b3cb1afa86687b265f3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI5LTEtMS0xLTA_f570475e-7d54-4919-9c48-2f50073081ad"
      unitRef="shares">74600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifdf9a8a9885042b1857cedb967662536_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI5LTMtMS0xLTA_5270c7cd-324f-4841-9918-0b06d2323c17"
      unitRef="shares">74500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1efb332cd921482b88b6007ff0dc87b6_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI5LTUtMS0xLTA_86392c20-ecd0-4e8d-b9ec-488aaba7fcd7"
      unitRef="shares">74400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i69d1e7b850654e99931da975936ee358_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplOGNhZWE0ZDNiYWY0MGZlODNmNDExMjUxZjhkYmE4NC90YWJsZXJhbmdlOmU4Y2FlYTRkM2JhZjQwZmU4M2Y0MTEyNTFmOGRiYTg0XzI5LTctMS0xLTA_3a8052a9-183f-4a5a-97c1-775fa12472bc"
      unitRef="shares">73700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i30498117f20e422cbecf6623972988bf_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90ZXh0cmVnaW9uOjYzNTBiYjc1ZjJkYzQ2MTY4NTIyZTViNThjMTE1NTQzXzEyMA_33b0cf38-d576-4c6e-8bfa-c8f30f3d479f"
      unitRef="usd">-1300000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i41ddfab48a7c49588075c9ec7dc244bc_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90ZXh0cmVnaW9uOjYzNTBiYjc1ZjJkYzQ2MTY4NTIyZTViNThjMTE1NTQzXzEyMA_c5548548-683a-4baa-907c-3d985e75139d"
      unitRef="usd">1300000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66fa6edac2d94c43bca8e78ac4dac0ea_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzItMS0xLTEtMA_fda03b82-1eab-497f-b2b2-1efc92ecbe72"
      unitRef="usd">196900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4eec8d2bdc5c4301bfe722e319ae93cc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzItMy0xLTEtMA_1808642a-8750-49fe-8056-6aae9a4a9622"
      unitRef="usd">200500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c5f6f6847984744b8727e6b2748075b_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzItNS0xLTEtMA_99da8508-a1c2-4389-90ab-e5a4e4967b18"
      unitRef="usd">203000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6d258bc15d9449697c4b3d79d8b436b_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzItNy0xLTEtMA_8049dc75-ab3f-42b9-ac8b-0f34bd457478"
      unitRef="usd">189000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ad87c73a1144a68bba850b4fd323dcf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzMtMS0xLTEtMA_c31be0d9-1ed5-4c60-8582-7cdc725a2fff"
      unitRef="usd">18500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib895d88eeb224f0886c00fd6c2b4b139_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzMtMy0xLTEtMA_9f0a1a77-fa5d-4384-ac3b-ec58b5af05db"
      unitRef="usd">16100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i313a22005bec4e29ad90ba1925c6405a_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzMtNS0xLTEtMA_0924783b-bda9-4165-b47a-3c5230fa7b40"
      unitRef="usd">13800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25884080c80b406690ede2277d9da6dd_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzMtNy0xLTEtMA_8f81fe7e-ee8e-4d5e-976c-b1db6e778db5"
      unitRef="usd">13300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzQtMS0xLTEtMA_4a2e9c95-ae1f-4182-b532-7d440d7fa7d2"
      unitRef="usd">215400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzQtMy0xLTEtMA_7a2ebe33-ccab-4f7b-897c-97b284391300"
      unitRef="usd">216600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzQtNS0xLTEtMA_f653597e-25db-4a59-bf8f-9cd9ec2b4503"
      unitRef="usd">216800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzQtNy0xLTEtMA_e909ba34-4cd1-4376-a3f9-d923edc18fb3"
      unitRef="usd">202300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i66fa6edac2d94c43bca8e78ac4dac0ea_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzYtMS0xLTEtMA_fe9f3bbf-a4c1-4c44-9d05-0965def99c44"
      unitRef="usd">41600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4eec8d2bdc5c4301bfe722e319ae93cc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzYtMy0xLTEtMA_3ae76708-7c99-461e-aa73-6e0082dc4e1a"
      unitRef="usd">40300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6c5f6f6847984744b8727e6b2748075b_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzYtNS0xLTEtMA_09fe0a76-9810-4be0-b9f9-51217a26f7b8"
      unitRef="usd">44000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if6d258bc15d9449697c4b3d79d8b436b_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzYtNy0xLTEtMA_7e0ae924-82a1-49ce-9de7-3fa8c16d7f56"
      unitRef="usd">42300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4ad87c73a1144a68bba850b4fd323dcf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzctMS0xLTEtMA_d77124c7-77c5-48a9-9f8c-f1d2378dc780"
      unitRef="usd">9000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib895d88eeb224f0886c00fd6c2b4b139_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzctMy0xLTEtMA_d5429d49-30d3-4f95-a1df-ebc02dacceb8"
      unitRef="usd">8300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i313a22005bec4e29ad90ba1925c6405a_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzctNS0xLTEtMA_984fde47-8be4-47a9-a8c8-c4e3eda9d3c1"
      unitRef="usd">8100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i25884080c80b406690ede2277d9da6dd_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzctNy0xLTEtMA_e00bad34-0eb9-4ca5-985c-ea7268bd4a54"
      unitRef="usd">7400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzgtMS0xLTEtMA_b1bc7fd8-0a0b-406f-a191-6da598b7e9d3"
      unitRef="usd">20900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzgtMy0xLTEtMA_0a3aecbb-047b-4c87-9893-5b5fa01dc41a"
      unitRef="usd">21500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzgtNS0xLTEtMA_2657c9f0-3a30-4eac-9c51-864e3e0940af"
      unitRef="usd">22400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzgtNy0xLTEtMA_4f65332c-217f-43e3-af30-6c9d78d0e173"
      unitRef="usd">21100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzktMS0xLTEtMA_ff5ba8db-75c2-40fe-8594-486722705fd5"
      unitRef="usd">-300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzktMy0xLTEtMA_c20a5f04-1ab0-4472-b293-c35bb4cda640"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzktNS0xLTEtMA_9a1f7faa-e856-40ab-9311-0767b6cf17b3"
      unitRef="usd">1000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzktNy0xLTEtMA_b9eb6909-70e0-46fd-baa2-bfc80f144773"
      unitRef="usd">400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEwLTEtMS0xLTA_288292e9-5f1f-4593-a106-6d6a1430ada8"
      unitRef="usd">149800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEwLTMtMS0xLTA_da330202-4e6a-4b2e-87f5-8daa88c7bca1"
      unitRef="usd">140600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEwLTUtMS0xLTA_c1636cb8-490d-4def-9b42-c5373451f9a6"
      unitRef="usd">135200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEwLTctMS0xLTA_cca526f5-45f0-427d-b5b2-808426c4dc5e"
      unitRef="usd">129900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzExLTEtMS0xLTA_e224e3d7-c2dd-4a5a-968e-c1cfac763458"
      unitRef="usd">221000000.0</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzExLTMtMS0xLTA_3eefbff6-6a86-4f7c-9935-0d6f98793d5b"
      unitRef="usd">210700000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzExLTUtMS0xLTA_21efe404-d1c2-4e01-8e36-bee8a17709d1"
      unitRef="usd">210700000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzExLTctMS0xLTA_d21b07dd-e12f-43f3-b455-fd546fb2562a"
      unitRef="usd">201100000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEyLTEtMS0xLTA_03c09ef3-971d-46af-a63f-e126fab2c26e"
      unitRef="usd">-5600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEyLTMtMS0xLTA_262df015-282c-49e8-a779-ef223ace3436"
      unitRef="usd">5900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEyLTUtMS0xLTA_750b61f0-0fe0-4650-a8f3-1beffbb46c85"
      unitRef="usd">6100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzEyLTctMS0xLTA_7e0c150d-15f0-4265-84b8-b322f1d3ad84"
      unitRef="usd">1200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE0LTEtMS0xLTA_b7387a30-5e96-4877-b6f1-ac348363eda1"
      unitRef="usd">900000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE0LTMtMS0xLTA_ca3c038f-16e5-4ee3-b5dc-d90ad8a66183"
      unitRef="usd">700000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE0LTUtMS0xLTA_49c9370b-1db0-4c60-8c3f-09a3ff3233ed"
      unitRef="usd">900000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE0LTctMS0xLTA_e4093792-7791-4299-a6dd-849ac814d239"
      unitRef="usd">700000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE1LTEtMS0xLTA_daf0c261-b0c2-4203-9d3b-adaff5bff4c1"
      unitRef="usd">3200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE1LTMtMS0xLTA_65d064a7-ad3e-4132-8438-1bcbbe8e869c"
      unitRef="usd">3200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE1LTUtMS0xLTA_208a94cb-5e44-4789-a2d7-cd642a6b69d6"
      unitRef="usd">3400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE1LTctMS0xLTA_73585b50-dede-4779-b585-af44f57147e6"
      unitRef="usd">2200000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE2LTEtMS0xLTA_1dcff1ad-dfa3-42a6-ad83-e20c4a417608"
      unitRef="usd">200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE2LTMtMS0xLTA_db352b18-2c92-4125-a26d-d591a65289dd"
      unitRef="usd">-100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE2LTUtMS0xLTA_d3929487-5b6c-4a72-b2f7-86125a3d20bc"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE2LTctMS0xLTA_f55e3450-8774-4355-9450-88e5828fa181"
      unitRef="usd">1100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE3LTEtMS0xLTA_86c5955b-1560-4eee-86ed-36fc2526d0c0"
      unitRef="usd">-2100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE3LTMtMS0xLTA_dcfa4fb5-87a1-4306-a83a-06f67105b835"
      unitRef="usd">-2600000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE3LTUtMS0xLTA_57727710-7898-4a84-9bdb-5e224e950841"
      unitRef="usd">-2500000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE3LTctMS0xLTA_ccac5536-9ac1-47e9-95f8-87cdb1f7a544"
      unitRef="usd">-400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE4LTEtMS0xLTA_c29ac134-6dfb-44c4-b50e-a9c5738fce5f"
      unitRef="usd">-7700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE4LTMtMS0xLTA_49cbb4c5-5777-464a-b670-ba8f287061e7"
      unitRef="usd">3300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE4LTUtMS0xLTA_7061c058-3aef-47e8-97d8-97f6e49f008f"
      unitRef="usd">3600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE4LTctMS0xLTA_fb109422-5c00-43ff-9833-02f4ea441e7b"
      unitRef="usd">800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE5LTEtMS0xLTA_69a81761-0ff7-4f60-a60f-e223c0286e09"
      unitRef="usd">-3400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE5LTMtMS0xLTA_f2373e73-c495-47a1-a1e5-ac610a59ea92"
      unitRef="usd">-3600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE5LTUtMS0xLTA_127224c6-60da-4138-b073-29f03ea11508"
      unitRef="usd">1000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzE5LTctMS0xLTA_40c5c838-4d43-43fa-b4f6-050125425ac1"
      unitRef="usd">1600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIwLTEtMS0xLTA_583606d4-c036-42a8-ba42-f315db2383ef"
      unitRef="usd">-4300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIwLTMtMS0xLTA_e2056291-d1f3-41bf-937d-ec6edbf49823"
      unitRef="usd">6900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIwLTUtMS0xLTA_cb27cbaf-d71d-4ccf-ba7c-c8c7a8a04b8a"
      unitRef="usd">2600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIwLTctMS0xLTA_84c60044-d12c-4426-a8f5-623309ca8662"
      unitRef="usd">-800000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIxLTEtMS0xLTA_8019939f-7bfd-4fed-aa15-16737ee82b46"
      unitRef="usd">-100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIxLTMtMS0xLTA_5e02c4ee-ed34-42f6-a9ce-1ae5ff26dedf"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIxLTUtMS0xLTA_fa3fb76e-388b-4fa0-814c-d913e420790e"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIxLTctMS0xLTA_4398a648-ad4b-4c65-9c74-7221898d917f"
      unitRef="usd">-100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIyLTEtMS0xLTA_f8b524ee-2ced-42ca-aaa8-d02ada54832d"
      unitRef="usd">-4200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIyLTMtMS0xLTA_2a81693e-adcb-479f-b4e9-d7d6a215a28a"
      unitRef="usd">6900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIyLTUtMS0xLTA_f874b9c7-970b-4730-bc32-f113bc4e7744"
      unitRef="usd">2600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzIyLTctMS0xLTA_5be54446-22b0-4c6e-83bb-efb30e89cb98"
      unitRef="usd">-700000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI0LTEtMS0xLTA_7de46ad4-14e5-4d77-af22-976ae267b590"
      unitRef="usdPerShare">-0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI0LTMtMS0xLTA_b9b0d33d-c4c9-4e7b-97de-d849e0a02835"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI0LTUtMS0xLTA_ff261d11-45a7-442b-977e-e10e302fee2a"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI0LTctMS0xLTA_30a4590a-0ce8-4131-b30a-7000fd5d01d5"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI1LTEtMS0xLTA_4f594f9c-1fb3-4cc1-9a85-bec73cc7f5a5"
      unitRef="usdPerShare">-0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI1LTMtMS0xLTA_6000e246-da87-48e2-95be-c92e2d2358ca"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI1LTUtMS0xLTA_b8a7d699-cb6a-443b-9452-efbf36bfe732"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI1LTctMS0xLTA_942d351b-45e9-46e0-aa2b-c2f24729fb89"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI3LTEtMS0xLTA_bd25eb1e-01b4-43e6-890b-e98e01c5bda7"
      unitRef="shares">73400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI3LTMtMS0xLTA_9fc6f074-93f6-4764-926e-79d5ba2beaf5"
      unitRef="shares">73300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI3LTUtMS0xLTA_7c5ab684-430a-47f3-9248-4d47166ece0c"
      unitRef="shares">74200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI3LTctMS0xLTA_691ee690-e3e7-4c91-9df7-dfcd2bfb627f"
      unitRef="shares">73000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id4c958e9dcae428b93a535d59a805155_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI4LTEtMS0xLTA_ab79fc28-db89-4d1f-a95b-1b674fd2c2f6"
      unitRef="shares">74800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id7e73e97780f45298e99ec021cd25acc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI4LTMtMS0xLTA_c3841755-5300-4e0d-97b4-2988877552c6"
      unitRef="shares">74900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaea7896145214af8aee0379692eb0499_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI4LTUtMS0xLTA_148539d9-aa66-4b11-95ea-3089b0e3540e"
      unitRef="shares">76500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i50e83c46b66247dcbfa51e0479d63c3c_D20180701-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNzgvZnJhZzo2MzUwYmI3NWYyZGM0NjE2ODUyMmU1YjU4YzExNTU0My90YWJsZTplYjk0OTk5MjBiZDA0YzEzOWQ0YjM3ZTZjNzhkNTU5OC90YWJsZXJhbmdlOmViOTQ5OTkyMGJkMDRjMTM5ZDRiMzdlNmM3OGQ1NTk4XzI4LTctMS0xLTA_41dd3a68-3688-430c-a3ca-2dd549a33fb7"
      unitRef="shares">73000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <mygn:TransitionPeriodComparativeDataTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGV4dHJlZ2lvbjozMjY2Mzg1OWI3OGI0NzY1OGMyNDNjNGU3YzVjNzM1Ml80OTQ3ODAyMzI1MDU0_5faa3671-25ed-4797-a13a-c58c64f865da">TRANSITION PERIOD COMPARATIVE DATA (UNAUDITED)&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six-month Period Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in the fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Myriad Genetics Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mygn:TransitionPeriodComparativeDataTextBlock>
    <mygn:ScheduleOfTransitionPeriodComparativeDataTableTextBlock
      contextRef="i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGV4dHJlZ2lvbjozMjY2Mzg1OWI3OGI0NzY1OGMyNDNjNGU3YzVjNzM1Ml80OTQ3ODAyMzI1MDU1_5960b5ec-27f2-4632-a3eb-5a87140837f1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six-month Period Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in the fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Myriad Genetics Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mygn:ScheduleOfTransitionPeriodComparativeDataTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf7a7e67e93c4b6c84e303b4742aafc0_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yLTEtMS0xLTEyODY3_205ccda0-010e-47e6-9ae5-e06400d45059"
      unitRef="usd">353100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90c63d45d0a049b1b11b7c5d73024451_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8zLTEtMS0xLTEyODY3_75b9b154-3003-4da9-ab74-67fef21c2980"
      unitRef="usd">28300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF80LTEtMS0xLTEyODY3_a18f5fc0-6ee6-4e7e-a85a-2d892155a8c1"
      unitRef="usd">381400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idf7a7e67e93c4b6c84e303b4742aafc0_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF82LTEtMS0xLTEyODY3_942a05c0-7b1e-4af5-8b6a-41a721c38db7"
      unitRef="usd">82200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i90c63d45d0a049b1b11b7c5d73024451_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF83LTEtMS0xLTEyODY3_2747dc09-85b2-4c81-a265-eed955aa7b47"
      unitRef="usd">17100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF84LTEtMS0xLTEyODY3_c66567db-ad58-4a8a-9560-57897650c3de"
      unitRef="usd">40100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF85LTEtMS0xLTEyODY3_b50ea286-a0ee-4aaa-89bc-d39c396e5cc6"
      unitRef="usd">600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xMC0xLTEtMS0xMjg2Nw_ada9a03b-340d-4ffc-9e6f-4c609a9d3e28"
      unitRef="usd">269800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xMS0xLTEtMS0xNjQxOQ_8e0ea5a0-d785-47f3-b6a4-97534ce4aa0f"
      unitRef="usd">1300000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:CostsAndExpenses
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xMS0xLTEtMS0xMjg2Nw_76b667b3-33c8-4231-ac6a-4e7693db3de5"
      unitRef="usd">411100000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xMi0xLTEtMS0xMjg2Nw_f9024618-6f51-4fdc-a047-44107bd855c3"
      unitRef="usd">-29700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xNC0xLTEtMS0xMjg2Nw_93ccac21-8d48-4c89-9ecf-e2949baea562"
      unitRef="usd">1700000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xNS0xLTEtMS0xMjg2Nw_b1307736-68e2-45f6-a012-c77f055e77da"
      unitRef="usd">5400000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xNi0xLTEtMS0xMjg2Nw_0e2fd9ce-03b9-4954-93de-e987ec6c842e"
      unitRef="usd">-300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xNy0xLTEtMS0xMjg2Nw_e37a48a3-ac9b-4265-ab01-abf1054bcf07"
      unitRef="usd">-4000000.0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xOC0xLTEtMS0xMjg2Nw_11139e5a-1b70-4217-b66f-b1bac2809384"
      unitRef="usd">-33700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8xOS0xLTEtMS0xMjg2Nw_d877a273-505a-46b2-aced-7258f59c0ac1"
      unitRef="usd">-4800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yMC0xLTEtMS0xMjg2Nw_adc043ec-56b1-45b4-af2c-ea319cc563ec"
      unitRef="usd">-28900000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yMS0xLTEtMS0xMjg2Nw_d7d34e47-eb3e-40f5-8777-db1a01d9836f"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yMi0xLTEtMS0xMjg2Nw_3efb6c6d-7d20-4be7-8d87-689b84d64213"
      unitRef="usd">-28900000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yNC0xLTEtMS0xMjg2Nw_4419ca1e-1929-4154-8864-c134edb9bbeb"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yNS0xLTEtMS0xMjg2Nw_ebaa269f-2f39-4e8a-87da-37c0a0973c67"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yNy0xLTEtMS0xNTAzNg_6bf11add-765b-4ba8-8b4b-49602d2124e4"
      unitRef="shares">74100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0a9801cc99294844bba346dce7e48f88_D20190701-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xODg3L2ZyYWc6MzI2NjM4NTliNzhiNDc2NThjMjQzYzRlN2M1YzczNTIvdGFibGU6MTQ0OTQyMWUyYTgxNDJjNjg1Zjg0NGE5NmUzYjkwOGQvdGFibGVyYW5nZToxNDQ5NDIxZTJhODE0MmM2ODVmODQ0YTk2ZTNiOTA4ZF8yOC0xLTEtMS0xNTAzNg_3b938e2f-2a72-4d8f-9655-57def119e2aa"
      unitRef="shares">74100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979754317048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 09, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-KT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodStartDate', window );">Document Period Start Date</a></td>
<td class="text">Jul.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MYRIAD GENETICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000899923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0494517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">320 Wakara Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">584-3600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MYGN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 847,193,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,297,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following documents (or parts thereof) are incorporated by reference into the following parts of this Form 10-K:&#160;&#160;Certain information required in Part III of this Transition Report on Form 10-K is incorporated from the Registrant's Proxy Statement, to be filed no later than 120 days following </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, for the Annual Meeting of Stockholders to be held on June 3, 2021.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodStartDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The start date of the period covered in the document, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodStartDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979675747944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 117.0<span></span>
</td>
<td class="nump">$ 163.7<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable investment securities</a></td>
<td class="nump">33.7<span></span>
</td>
<td class="nump">54.1<span></span>
</td>
<td class="nump">43.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent', window );">Prepaid expenses</a></td>
<td class="nump">11.7<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">27.1<span></span>
</td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">31.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable</a></td>
<td class="nump">89.5<span></span>
</td>
<td class="nump">68.1<span></span>
</td>
<td class="nump">133.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">108.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">25.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">389.4<span></span>
</td>
<td class="nump">331.7<span></span>
</td>
<td class="nump">348.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">40.7<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="nump">57.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">59.7<span></span>
</td>
<td class="nump">66.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term marketable investment securities</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="nump">54.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangibles, net</a></td>
<td class="nump">576.5<span></span>
</td>
<td class="nump">605.3<span></span>
</td>
<td class="nump">684.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">329.2<span></span>
</td>
<td class="nump">327.6<span></span>
</td>
<td class="nump">417.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,418.8<span></span>
</td>
<td class="nump">1,404.6<span></span>
</td>
<td class="nump">1,562.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">20.5<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
<td class="nump">33.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">79.1<span></span>
</td>
<td class="nump">79.0<span></span>
</td>
<td class="nump">82.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating lease liabilities</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">32.7<span></span>
</td>
<td class="nump">32.8<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">145.9<span></span>
</td>
<td class="nump">147.0<span></span>
</td>
<td class="nump">117.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_UnrecognizedTaxBenefitsNet', window );">Unrecognized tax benefits</a></td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred taxes</a></td>
<td class="nump">71.3<span></span>
</td>
<td class="nump">26.6<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">224.8<span></span>
</td>
<td class="nump">224.4<span></span>
</td>
<td class="nump">233.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">50.6<span></span>
</td>
<td class="nump">56.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">18.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">537.8<span></span>
</td>
<td class="nump">486.4<span></span>
</td>
<td class="nump">473.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, 75.4, 74.7 and 73.5 shares outstanding at December 31, 2020, June 30, 2020 and 2019, respectively</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,109.5<span></span>
</td>
<td class="nump">1,096.6<span></span>
</td>
<td class="nump">1,068.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="num">(227.0)<span></span>
</td>
<td class="num">(173.9)<span></span>
</td>
<td class="nump">25.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Myriad Genetics, Inc. stockholders' equity</a></td>
<td class="nump">881.0<span></span>
</td>
<td class="nump">918.2<span></span>
</td>
<td class="nump">1,088.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">881.0<span></span>
</td>
<td class="nump">918.2<span></span>
</td>
<td class="nump">1,088.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,418.8<span></span>
</td>
<td class="nump">$ 1,404.6<span></span>
</td>
<td class="nump">$ 1,562.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expense excluding prepaid taxes current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_UnrecognizedTaxBenefitsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_UnrecognizedTaxBenefitsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671166792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">75.4<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">70.6<span></span>
</td>
<td class="nump">68.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979668892232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 154.6<span></span>
</td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="nump">$ 164.0<span></span>
</td>
<td class="nump">$ 195.1<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
<td class="nump">$ 215.4<span></span>
</td>
<td class="nump">$ 216.6<span></span>
</td>
<td class="nump">$ 216.8<span></span>
</td>
<td class="nump">$ 202.3<span></span>
</td>
<td class="nump">$ 299.8<span></span>
</td>
<td class="nump">$ 381.4<span></span>
</td>
<td class="nump">$ 638.6<span></span>
</td>
<td class="nump">$ 851.1<span></span>
</td>
<td class="nump">$ 743.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">18.2<span></span>
</td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
<td class="nump">35.8<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">77.2<span></span>
</td>
<td class="nump">85.9<span></span>
</td>
<td class="nump">70.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in the fair value of contingent consideration</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(61.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expense</a></td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">124.1<span></span>
</td>
<td class="nump">107.4<span></span>
</td>
<td class="nump">132.9<span></span>
</td>
<td class="nump">134.3<span></span>
</td>
<td class="nump">135.5<span></span>
</td>
<td class="nump">149.8<span></span>
</td>
<td class="nump">140.6<span></span>
</td>
<td class="nump">135.2<span></span>
</td>
<td class="nump">129.9<span></span>
</td>
<td class="nump">256.9<span></span>
</td>
<td class="nump">269.8<span></span>
</td>
<td class="nump">510.1<span></span>
</td>
<td class="nump">555.5<span></span>
</td>
<td class="nump">435.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">98.4<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">99.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">202.8<span></span>
</td>
<td class="nump">184.8<span></span>
</td>
<td class="nump">161.5<span></span>
</td>
<td class="nump">297.7<span></span>
</td>
<td class="nump">203.9<span></span>
</td>
<td class="nump">207.2<span></span>
</td>
<td class="nump">221.0<span></span>
</td>
<td class="nump">210.7<span></span>
</td>
<td class="nump">210.7<span></span>
</td>
<td class="nump">201.1<span></span>
</td>
<td class="nump">387.6<span></span>
</td>
<td class="nump">411.1<span></span>
</td>
<td class="nump">870.3<span></span>
</td>
<td class="nump">843.5<span></span>
</td>
<td class="nump">621.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(48.2)<span></span>
</td>
<td class="num">(39.6)<span></span>
</td>
<td class="num">(68.3)<span></span>
</td>
<td class="num">(133.7)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="num">(20.9)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(87.8)<span></span>
</td>
<td class="num">(29.7)<span></span>
</td>
<td class="num">(231.7)<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">121.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income tax</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="num">(43.7)<span></span>
</td>
<td class="num">(58.5)<span></span>
</td>
<td class="num">(131.1)<span></span>
</td>
<td class="num">(11.4)<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
<td class="num">(7.7)<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(94.1)<span></span>
</td>
<td class="num">(33.7)<span></span>
</td>
<td class="num">(223.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">120.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(28.5)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(15.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="num">(41.0)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="num">(23.7)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(37.9)<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
<td class="num">(55.5)<span></span>
</td>
<td class="num">(115.2)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(53.1)<span></span>
</td>
<td class="num">(28.9)<span></span>
</td>
<td class="num">(199.6)<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">133.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (37.9)<span></span>
</td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="num">$ (55.4)<span></span>
</td>
<td class="num">$ (115.2)<span></span>
</td>
<td class="num">$ (8.3)<span></span>
</td>
<td class="num">$ (20.6)<span></span>
</td>
<td class="num">$ (4.2)<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
<td class="num">$ (53.1)<span></span>
</td>
<td class="num">$ (28.9)<span></span>
</td>
<td class="num">$ (199.5)<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 133.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (2.69)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (2.69)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 1.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (weighted average shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">73.4<span></span>
</td>
<td class="nump">73.3<span></span>
</td>
<td class="nump">74.2<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">69.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (weighted average shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">74.8<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">76.5<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">76.0<span></span>
</td>
<td class="nump">72.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember', window );">Molecular diagnostic testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 143.9<span></span>
</td>
<td class="nump">$ 135.7<span></span>
</td>
<td class="nump">$ 83.3<span></span>
</td>
<td class="nump">$ 150.5<span></span>
</td>
<td class="nump">$ 181.1<span></span>
</td>
<td class="nump">$ 172.0<span></span>
</td>
<td class="nump">$ 196.9<span></span>
</td>
<td class="nump">$ 200.5<span></span>
</td>
<td class="nump">$ 203.0<span></span>
</td>
<td class="nump">$ 189.0<span></span>
</td>
<td class="nump">$ 279.6<span></span>
</td>
<td class="nump">$ 353.1<span></span>
</td>
<td class="nump">$ 586.9<span></span>
</td>
<td class="nump">$ 789.4<span></span>
</td>
<td class="nump">$ 690.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs and expenses</a></td>
<td class="nump">42.7<span></span>
</td>
<td class="nump">39.9<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
<td class="nump">43.1<span></span>
</td>
<td class="nump">41.0<span></span>
</td>
<td class="nump">41.2<span></span>
</td>
<td class="nump">41.6<span></span>
</td>
<td class="nump">40.3<span></span>
</td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">42.3<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
<td class="nump">157.5<span></span>
</td>
<td class="nump">168.2<span></span>
</td>
<td class="nump">148.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember', window );">Pharmaceutical and clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">20.2<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">61.7<span></span>
</td>
<td class="nump">53.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs and expenses</a></td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 17.1<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 28.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979754267304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (53.1)<span></span>
</td>
<td class="num">$ (199.5)<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 133.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Change in pension liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Change in foreign currency translation adjustment</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (50.2)<span></span>
</td>
<td class="num">$ (199.4)<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 134.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979754342872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Retained earnings (accumulated deficit)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2017</a></td>
<td class="nump">$ 767.4<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 851.4<span></span>
</td>
<td class="num">$ (5.5)<span></span>
</td>
<td class="num">$ (79.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</a></td>
<td class="nump">36.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based payment expense</a></td>
<td class="nump">27.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">133.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2018</a></td>
<td class="nump">966.1<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">915.4<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
<td class="nump">54.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</a></td>
<td class="nump">136.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based payment expense</a></td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(50.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2019</a></td>
<td class="nump">1,088.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1,068.0<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="nump">25.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based payment expense</a></td>
<td class="nump">25.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(199.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(199.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary', window );">Reclassification out of accumulated other comprehensive loss upon the deconsolidation of a subsidiary</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">918.2<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1,096.6<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="num">(173.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based payment expense</a></td>
<td class="nump">14.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(53.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 881.0<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 1,109.5<span></span>
</td>
<td class="num">$ (2.3)<span></span>
</td>
<td class="num">$ (227.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification From Accumulated Other Comprehensive Loss, Deconsolidation Of Subsidiary</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979668547864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (53.1)<span></span>
</td>
<td class="num">$ (199.5)<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 133.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">35.8<span></span>
</td>
<td class="nump">72.0<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">54.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_NonCashInterestExpense', window );">Non-cash interest expense</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Gain on deconsolidation of subsidiary</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Non-cash impact of foreign currency transactions</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gain on disposition of assets</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">14.9<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">27.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="nump">44.2<span></span>
</td>
<td class="num">(55.8)<span></span>
</td>
<td class="nump">18.6<span></span>
</td>
<td class="num">(23.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment of goodwill and intangible assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">99.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(60.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment of contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(22.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes', window );">Prepaid expenses</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="num">(21.4)<span></span>
</td>
<td class="nump">64.0<span></span>
</td>
<td class="num">(18.2)<span></span>
</td>
<td class="num">(9.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="num">(108.4)<span></span>
</td>
<td class="nump">25.1<span></span>
</td>
<td class="num">(25.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(10.7)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">30.7<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(73.7)<span></span>
</td>
<td class="nump">60.7<span></span>
</td>
<td class="nump">83.7<span></span>
</td>
<td class="nump">115.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="num">(7.9)<span></span>
</td>
<td class="num">(10.2)<span></span>
</td>
<td class="num">(8.6)<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(278.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable investment securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(60.8)<span></span>
</td>
<td class="num">(78.5)<span></span>
</td>
<td class="num">(80.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities and sales of marketable investment securities</a></td>
<td class="nump">35.9<span></span>
</td>
<td class="nump">69.0<span></span>
</td>
<td class="nump">79.2<span></span>
</td>
<td class="nump">77.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="nump">19.3<span></span>
</td>
<td class="num">(286.4)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from common stock issued under share-based compensation plans</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">23.2<span></span>
</td>
<td class="nump">45.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment of tax withheld for common stock issued under share-based compensation plans</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(9.8)<span></span>
</td>
<td class="num">(14.5)<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">340.0<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of revolving credit facility</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(8.6)<span></span>
</td>
<td class="num">(115.0)<span></span>
</td>
<td class="num">(143.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration recognized at acquisition</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(42.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtRestructuringCosts', window );">Fees associated with refinancing of revolving credit facility</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase and retirement of common stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(50.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Proceeds from non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
<td class="nump">182.3<span></span>
</td>
<td class="num">(95.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash and cash equivalents</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(46.7)<span></span>
</td>
<td class="nump">70.5<span></span>
</td>
<td class="num">(17.7)<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">163.7<span></span>
</td>
<td class="nump">93.2<span></span>
</td>
<td class="nump">110.9<span></span>
</td>
<td class="nump">102.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">$ 117.0<span></span>
</td>
<td class="nump">$ 163.7<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="nump">$ 110.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in prepaid expense excluding increase decrease in prepaid taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncreaseDecreaseInUnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_NonCashInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_NonCashInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664579512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization and Summary of Significant Accounting Policies</a></td>
<td class="text">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Financial Statement Presentation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad Genetics, Inc. and subsidiaries (collectively, the&#160;"Company" or "Myriad") is a leading personalized precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics. The Company employs a number of proprietary technologies, including DNA, RNA and protein analysis, that help it to understand the genetic basis of human disease and the role that genes and their related proteins may play in the onset and progression of disease. The Company uses this information to guide the development of molecular diagnostic and companion diagnostic tests that are designed to assess an individual&#8217;s risk for developing disease later in life (predictive medicine), identify a patient&#8217;s likelihood of responding to drug therapy and guide a patient&#8217;s dosing to ensure optimal treatment (personalized medicine), or assess a patient&#8217;s risk of disease progression and disease recurrence (prognostic medicine).&#160;&#160;The Company generates revenue by performing molecular diagnostic tests as well as by providing pharmaceutical and clinical services to the pharmaceutical and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.&#160;The Company&#8217;s corporate headquarters are located in Salt Lake City, Utah.  </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared by the Company in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.&#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with U.S. GAAP.&#160;&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the transition period ended December&#160;31, 2020, the Company identified errors related to its accounting for its international su</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bsidiaries and its determination of fair value of contingent consideration related to an acquisition that occurred</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in May 2016. These errors were not material to any previously reported period. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management analyzed the potential impact of these errors in accordance with the SEC Staff Accounting Bulletin No. 108, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and concluded that the correction of the errors are not material to the transition period ended December 31, 2020.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires Company management to make estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include revenue recognition estimates for the average expected reimbursement per test, valuation allowances for deferred income tax assets, certain accrued liabilities, share-based compensation, and impairment analysis of goodwill and intangible assets. Actual results could differ from those estimates.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full impact of the COVID-19 outbreak continues to evolve and its future impacts remain uncertain and unpredictable. Management is actively monitoring the impact of the global situation on the Company&#8217;s financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for future periods.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Substantially all of the Company&#8217;s account receivable are with companies in the healthcare industry, U.S. and state governmental agencies, and individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments. The Company only has one payor, Medicare, that represents greater than 10% of its revenues. Revenues received from Medicare are included within the Diagnostics reporting segment and represented approximately 16%, 15%, 14% and 17% of total revenue for the six-month transition period ended December&#160;31, 2020 (the "Transition Period") and the fiscal years ended June&#160;30, 2020, 2019 and 2018, respectively. Concentrations of credit risk are mitigated due to the number of the Company&#8217;s customers as well as their dispersion across many geographic regions. No customer accounted for&#160;more than 10%&#160;of accounts receivable at&#160;December&#160;31, 2020, June&#160;30, 2020 or June 30, 2019.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Investment Securities</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its marketable investment securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders&#8217; equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The Company&#8217;s cash equivalents consist of short-term, highly liquid investments that are readily convertible to known amounts of cash.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A decline in the market value of any available-for-sale security below cost that is deemed other than temporary results in a charge to earnings and establishes a new cost basis for the security. Losses are charged against Other income when a decline in fair value is determined to be other than temporary. The Company reviews several factors to determine whether a loss is other than temporary. These factors include but are not limited to: (i) the extent to which the fair value is less than cost and the cause for the fair value decline, (ii) the financial condition and near term prospects of the issuer, (iii) the length of time a security is in an unrealized loss position and (iv) the Company&#8217;s ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. There were no other-than-temporary impairments recognized during the transition period ended December&#160;31, 2020 or during the fiscal years ended June&#160;30, 2020, 2019 and 2018.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of supplies such as reagents, plates and testing kits, which are consumed when providing test results, and therefore the Company does not maintain finished goods inventory. Inventories are stated at the lower of cost or market and costs are determined on a first-in, first-out basis.&#160;&#160;In order to assess the ultimate realization of inventories, the Company is required to make judgments as to future demand requirements compared to current or committed inventory levels.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its inventories for excess quantities and obsolescence.&#160;&#160;Inventories that are considered excess or obsolete are expensed.&#160;&#160;The valuation of inventories requires the use of estimates as to the amounts of current inventories that will be sold. These estimates are dependent on management&#8217;s assessment of current and expected orders from the Company&#8217;s customers.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Accounts Receivable</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable represents amounts billed to customers for revenue recognized related to molecular diagnostic tests and pharmaceutical and clinical services. The Company does not have any off-balance-sheet credit exposure related to its customers and does not require collateral.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method based on the lesser of estimated useful lives of the related assets or lease terms. Equipment items have depreciable lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYxNA_1b34527f-c366-49c7-adfd-f87850ee8bcc">five</span> to seven years. Leasehold improvements are depreciated over the shorter of the estimated useful lives or the associated lease terms, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc2NA_20a77949-7d3f-4d64-b771-723fbeeb3bce">one</span> to seven years. Repairs and maintenance costs are charged to expense as incurred.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible and other long-lived assets are comprised of acquired licenses, technology and intellectual property and purchased in-process research and development. Acquired intangible assets are recorded at fair value and amortized over the shorter of the contractual life or the estimated useful life. The estimated useful life of acquired in-process research and development was also evaluated in conjunction with the annual impairment analysis of intangible assets. The classification of the Company&#8217;s acquired in-process research and development as an indefinite lived asset was deemed appropriate as the related research and development was not yet complete nor had it been abandoned. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain implementation costs incurred in a cloud computing arrangement to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. Implementation costs incurred in cloud computing arrangement are capitalized as part of Other assets in the Consolidated Balance Sheets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually reviews and monitors long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment by reporting unit on an annual basis as of October 1 and in the interim if events and circumstances indicate that goodwill may be impaired. Prior to the change in the Company's fiscal year from the last day of June to a calendar fiscal year end, goodwill was tested for impairment on an annual basis as of April 1 and in the interim if events and circumstances indicated that goodwill may be impaired. The voluntary change is preferable under the circumstances as it provides the Company with additional time to complete its annual goodwill impairment testing in advance of its year-end reporting and results in better alignment with the Company&#8217;s strategic planning and forecasting process given the Company's change in fiscal year end. The events and circumstances that are considered include business climate and market conditions, legal factors, operating performance indicators and competition.&#160;&#160;Impairment of goodwill is first assessed using a qualitative approach.&#160;&#160;If the qualitative assessment suggests that impairment is more likely than not, a quantitative analysis is performed.&#160;&#160;The quantitative analysis involves a comparison of the fair value of the reporting unit with its carrying amount.&#160;If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.&#160;&#160;If an event occurs that would cause a revision to the estimates and assumptions used in analyzing the value of the goodwill, the revision could result in a non-cash impairment charge that could have a material impact on the financial results.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad generates revenue by performing molecular diagnostic testing and pharmaceutical services. The Company previously provided clinical services until selling Privatklinik Dr. Robert Schindlbeck GmbH &amp; Co. KG (the "Clinic") in February 2020. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated transaction price. The Company has determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s revenue by type for the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, 2019, and 2018:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic revenues:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hereditary Cancer Testing</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GeneSight</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vectra</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myChoice CDx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prolaris</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EndoPredict</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total molecular diagnostic revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical service revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC Topic 606, Revenue from Contracts with Customers (&#8220;Topic 606&#8221;), an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company performs its obligation under a contract with a customer by processing diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. The Company has the right to bill its customers upon the completion of performance obligations and thus does not record contract assets.&#160;Occasionally customers make payments prior to the Company's performance of its contractual obligations.&#160;When this occurs, the Company records a contract liability as deferred revenue. During the fiscal year ended June 30, 2020, the Company received approximately $29.7 million in advance Medicare payments as part of the CARES Act, which was enacted on March 27, 2020 to provide relief from the economic impacts of COVID-19. Repayment of the advanced Medicare payments begins April 2021. The advance Medicare payments are included in prepayments of deferred revenue for the fiscal year ended June 30, 2020 and in the beginning and ending balance of deferred revenue for the transition period ended December 31, 2020. A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:60.768%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 606, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#8217;s right to payment is in an amount that directly corresponds with the value of Company&#8217;s performance to date. However, periodically, the Company enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations. As of December&#160;31, 2020, the aggregate amount of the transaction price of such contracts that is allocated to the remaining performance obligations is $11.2 million.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the transaction price, Myriad includes an estimate of the expected amount of consideration as revenue. The Company applies this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled. An estimate of transaction price does not include any estimated amount of variable consideration that are constrained. In addition, the Company considers all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. In determining the expected value, the Company considers the probability of the variable consideration for each possible scenario. The Company also has significant experience with historical discount patterns and uses this experience to estimate transaction prices. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimate of revenue is affected by assumptions in payor behavior such as changes in payor mix, payor collections, current customer contractual requirements, and experience with collections from third-party payors. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in Accrued liabilities in the Consolidated Balance Sheets in anticipation of request for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the Consolidated Statements of Operations and Comprehensive Income (Loss). </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash collections for certain diagnostic tests delivered may differ from rates originally estimated, primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third party payors. As a result of this new information, the Company updates its estimate of the amounts to be recognized for previously delivered tests. During the transition period ended December 31, 2020, and fiscal year ended June 30, 2019 and 2018, the impact to revenue and earnings (loss) per share, for tests in which the performance obligation of delivering the test results was met in the prior period was immaterial. During the fiscal year ended June 30, 2020, the Company recognized a $9.9 million decrease in revenue, which resulted in a $(0.10) impact to earnings (loss) per share for tests in which the performance obligation of delivering the tests results was met in prior periods. The changes were primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third-party payors. In addition, during the fiscal year ended June 30, 2020, the Company identified an error related to prior periods for Medicare claims and has reduced revenue and recorded an accrued liability for a total of $4.7 million that will be refunded to Medicare. The impact of correcting the error during that period and the impact to all prior periods was concluded to be immaterial. The correction of the error in the fiscal year ended June 30, 2020 resulted in an impact to earnings (loss) per share for the fiscal year ended June 30, 2020 of $(0.05).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 606, the Company has elected to exclude from the measurement of transaction price, all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer for e.g. sales tax, value added tax etc.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to apply the practical expedient related to costs to obtain or fulfill a contract since the amortization period for such costs will be one year or less. Accordingly, no costs incurred to obtain or fulfill a contract have been capitalized. The Company has also elected to apply the practical expedient for not adjusting revenue recognized for the effects of the time value of money. This practical expedient has been elected because the Company collects very little cash from customers under payment terms and vast majority of payments terms have a payback period of less than one year.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based payment expense</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the fair value compensation cost relating to share-based payment transactions in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718, Compensation &#8211; Stock Compensation. Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#8217;s requisite service period, which is generally the vesting period. The fair value of restricted stock units (RSUs) is based on the number of shares granted and the quoted price of the Company&#8217;s common stock on the grant date. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. The fair value of shares issued under the Employee Stock Purchase Plan is calculated using the Black-Scholes option-pricing model, based on assumptions including the risk-free interest rate, expected life, expected dividend yield and expected volatility. The average risk-free interest rate is determined using the U.S. Treasury rate. We determine the expected life based on offering period of the Employee Stock Purchase Plan. The expected volatility is determined using the weighted average of daily historical volatility of our stock price.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stimulus or grant payments that it receives that do not need to be paid back as other income. During the fiscal year ended June 30, 2020, the Company received approximately $14.6 million from the Provider Relief Fund under the CARES Act to reimburse the Company for health care related expenses or lost revenues that are attributable to COVID-19, which was recognized as a component of Other income in the Consolidated Statements of Operations.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes income taxes under the asset and liability method. This approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes, including the effective tax rate and analysis of potential tax exposure items, if any, requires significant judgment and expertise in federal and state income tax laws, regulations and strategies, including the determination of deferred tax assets and liabilities and any estimated valuation allowances deemed necessary to recognize deferred tax assets at an amount that is more likely than not to be realized. The Company&#8217;s filings, including the positions taken therein, are subject to audit by various taxing authorities. While the Company believes it has provided adequately for its income tax liabilities in the consolidated financial statements, adverse determinations by these taxing authorities could have a material adverse effect on the consolidated financial condition, results of operations or cash flows.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding.&#160;&#160;Diluted earnings per share is computed based on the weighted-average number of shares of common stock, including the dilutive effect of common stock equivalents, outstanding.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 16.75pt;text-indent:31.5pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding used to compute <br/>    basic EPS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive stock options</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding and dilutive <br/>   securities used to compute diluted EPS</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain outstanding options and RSUs were excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive. These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-dilutive options and RSUs excluded from EPS computation</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of the Company&#8217;s international subsidiaries is the local currency. For those subsidiaries, expenses denominated in the functional currency are translated into U.S. dollars using average exchange rates in effect during the period and assets and liabilities are translated using period-end exchange rates. The foreign currency translation adjustments are included in Accumulated other comprehensive income (loss) as a separate component of Stockholders&#8217; equity.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the cumulative translation adjustments included in Accumulated other comprehensive income (loss) (in millions):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance June 30, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders' equity, cash flows from operations, or net loss for the period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Effective in Future Years and Not Yet Adopted</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for public companies with fiscal years beginning after December 15, 2020, with early adoption permitted. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Recently Adopted Standards</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326) (&#8220;ASU 2016-13&#8221;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.  </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, Intangibles &#8211; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU 2018-15&#8221;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of Other assets in the Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664851944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Investment Securities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Marketable Investment Securities</a></td>
<td class="text">MARKETABLE INVESTMENT SECURITIES<div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value debt securities classified as available-for-sale securities by major security type and class of security at December&#160;31, 2020, June&#160;30, 2020 and June 30, 2019 were as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:48.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.676%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:47.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.118%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and maturities of debt securities classified as available-for-sale are as follows at December&#160;31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:73.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.9&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no debt securities classified as available-for-sale in a gross unrealized loss position as of December&#160;31, 2020, June&#160;30, 2020 or June 30, 2019.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information relating to fair value of marketable investment securities can be found in Note 3.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664802264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s financial instruments reflects the amounts that the Company estimates to receive in connection with the sale of an asset or paid in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1&#8212;quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2&#8212; observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&#160;&#160;Some of the Company&#8217;s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#8212;unobservable inputs.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s financial instruments are valued using quoted prices in active markets or based on other observable inputs.&#160;&#160;For Level 2 securities, the Company uses a third-party pricing service which provides documentation on an ongoing basis that includes, among other things, pricing information with respect to reference data, methodology, inputs summarized by asset class, pricing application and corroborative information.&#160;&#160;For Level 3 contingent consideration, the Company reassesses the fair value of expected contingent consideration and the corresponding liability each reporting period using the Monte Carlo Method, which is consistent with the initial measurement of the expected earn out liability.&#160;&#160;This fair value measurement is considered a Level 3 measurement because the Company estimates projections during the earn out period of approximately 14.5 years utilizing various potential pay-out scenarios.&#160;&#160;Probabilities were applied to each potential scenario and the resulting values were discounted using a rate that considers weighted average cost of capital as well as a specific risk premium associated with the riskiness of the earn out itself, the related projections, and the overall business.&#160;&#160;The contingent consideration liabilities are classified as a component of long-term and short-term contingent consideration in the Company&#8217;s Consolidated Balance Sheets.&#160;Changes to the contingent consideration liabilities are reflected in Change in the fair value of contingent consideration in our Consolidated Statements of Operations. Changes to the unobservable inputs could have a material impact on the Company&#8217;s financial statements.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term debt, which we consider a Level 3 measurement, is estimated using discounted cash flow analyses, based on the Company&#8217;s current estimated incremental borrowing rates for similar borrowing arrangements.&#160;&#160;The fair value of long-term debt is estimated to be $225.8 million at December&#160;31, 2020, $225.5 million at June&#160;30, 2020 and $192.7 million at June&#160;30, 2019.&#160;&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the fair value of the Company&#8217;s financial assets and liabilities that are re-measured on a regular basis:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"><tr><td style="width:1.0%"/><td style="width:48.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"><tr><td style="width:1.0%"/><td style="width:48.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.676%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.03pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the change in the fair value of the contingent consideration during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:61.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount at beginning of period</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in the statement of operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments recognized in other comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount at end of period</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664831240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT, NET<div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:60.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.135%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June 30, 2020, the Company sold the Clinic resulting in the deconsolidation of $19.5 million of the balance of property, plant and equipment. See Note 16 for additional information regarding the sale of the Clinic.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:47.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.118%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664913320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the transition period ended December&#160;31, 2020 are as follows: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:39.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the fiscal years ended June 30, 2020 and 2019 are as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.877%"><tr><td style="width:1.0%"/><td style="width:26.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (see note 17)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to acquisitions (see note 17)</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill deconsolidated on sale of Clinic</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.7)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.0)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company assessed goodwill for impairment in accordance with the appropriate guidance (see Note 1) and determined none of its reporting units were impaired during the transition period ended December 31, 2020. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fiscal year ended June 30, 2020, as a result of the effect of COVID-19 on expected future cash flows and a corresponding decline in market capitalization and enterprise value, the Company performed an interim quantitative impairment review of goodwill for the Myriad Mental Health, Myriad Autoimmune and Myriad International reporting units as of March 31, 2020. Based on this analysis, the Company recognized a goodwill impairment charge of $80.7 million related to the goodwill from the Myriad Autoimmune reporting unit. The Myriad Autoimmune reporting unit is part of the Company&#8217;s diagnostic segment. The goodwill impairment charge is reflected in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fiscal year ended June 30, 2020, the Company also recognized a $1.3 million impairment charge for goodwill allocated to the Clinic asset group that is included in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations. The Clinic asset group was part of the Company&#8217;s other segment.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, developed technology, a laboratory database, trademarks, and customer relationships as well as a non-amortizable intangible asset of in-process research and development.&#160;&#160;The Company&#8217;s developed technology and database acquired have estimated remaining useful lives between 1 and 16 years, trademarks acquired have an estimated remaining useful life of approximately eight years and customer relationships have an estimated remaining useful life of approximately one year.&#160;The estimated useful life of acquired in-process research and development was also evaluated in conjunction with the annual impairment analysis of intangible assets.&#160;&#160;The classification of the acquired in-process research and development as an indefinite lived asset was deemed appropriate as the related research and development was not yet complete nor had it been abandoned. During the fiscal year ended June 30, 2020, the Company decided to abandon the development of one of its in-process research and development intangible assets, and as a result the Company recognized a charge of $17.7 million, which is reflected in Goodwill and intangible asset impairment charges in the Consolidated Statements of Operations. The abandoned in-process research and development intangible asset was reported as part of the Company&#8217;s diagnostic segment. The Company concluded there was no impairment of long-lived assets for the transition period ended December&#160;31, 2020 or for the fiscal years ended June&#160;30, 2020, 2019 and 2018.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the amounts reported as intangible assets (in millions):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:61.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"/><td style="width:60.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.060%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At June 30, 2020:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222.7)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"/><td style="width:60.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.060%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At June 30, 2019:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 the weighted average remaining amortization period for purchased licenses and technologies, trademarks, and customer relationships is approximately 11 years.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization during the respective periods for these intangible assets as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"/><td style="width:33.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense of intangible assets as of December 31, 2020 is estimated to be as follows (in millions):</span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.264%"><tr><td style="width:1.0%"/><td style="width:66.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664846920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">ACCRUED LIABILITIES<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:60.768%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qui tam settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoupments payable and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663537064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">LONG-TERM DEBT<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2016, the Company entered into a senior secured revolving credit facility (the &#8220;Facility&#8221;) as borrower, with the lenders from time to time party thereto. On July 31, 2018, the Company entered into Amendment No. 1 to the Facility (the &#8220;Amended Facility&#8221;), which effected an &#8220;amend and extend&#8221; transaction with respect to the Facility by which the maturity date thereof was extended to July 31, 2023 and the maximum aggregate principal commitment was increased from $300.0 million to $350.0 million.&#160;&#160;On May 1, 2020, the Company entered into Amendment No. 2 to the Amended Facility, which waived the Company&#8217;s compliance with certain covenants and modified the interest rate and other terms during the Amendment Period from March 31, 2020 through June 30, 2021 (&#8220;Amendment Period&#8221;). Both amendments were accounted for as modifications pursuant to guidance in ASC 470-50. &#160;&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended Facility, the Company borrowed revolving loans in an aggregate principal amount of $300.0 million with $1.8 million in upfront fees and $0.3 million debt issuance costs recorded as a debt discount to be amortized over the term of the Amended Facility. The Company incurred an additional $1.0 million in upfront fees as a result of Amendment No. 2, which was also recorded as a debt discount that will be amortized over the term of the Amended Facility. There are no scheduled principal payments of the Amended Facility prior to its maturity date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proceeds of the Amended Facility were used to: (i) refinance in full the obligations under the Facility, (ii) finance the acquisition of Counsyl (See Note 17), (iii) pay fees, commissions, transactions costs and expenses incurred in connection with the foregoing, and (iv) for working capital and other general corporate purposes.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility contains customary loan terms, interest rates, representations and warranties, affirmative and negative covenants, in each case, subject to customary limitations, exceptions and exclusions. The Amended Facility also contains certain customary events of default. Amendment No. 2 modified the Amended Facility to increase the interest rate to be fixed at a spread of LIBOR plus 350 basis points on drawn balances and the undrawn fee was increased to 50 basis points during the Amendment Period, at which point they return to the existing pricing of 200 basis points on drawn balances and an undrawn fee ranging from 25 to 45 basis points based on the Company&#8217;s leverage ratio. The LIBOR floor was also increased to 1.0% during the Amendment Period. The interest rate as of December&#160;31, 2020 was 4.5%.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covenants in the Amended Facility impose operating and financial restrictions on the Company. These restrictions may prohibit or place limitations on, among other things, the Company&#8217;s ability to incur additional indebtedness, create certain types of liens or complete mergers or consolidations, and/or change in control transactions. The Amended Facility may also prohibit or place limitations on the Company&#8217;s ability to sell assets, pay dividends or provide other distributions to stockholders. The Company must maintain specified leverage and interest ratios measured as of the end of each quarter as a financial covenant in the Amended Facility. Amendment No. 2 modified the Amended Facility&#8217;s compliance with the leverage ratio covenant and the interest coverage ratio covenant, which were waived through March 31, 2021. A minimum liquidity covenant was added for the period beginning May 2020 until March 2021, and a minimum EBITDA covenant was added for the quarters ending December 31, 2020 and March 31, 2021. Amendment No. 2 also revised certain negative covenants of the Amended Facility during the Amendment Period. As of December&#160;31, 2020, the Company was not in compliance with the minimum EBITDA covenant related to the Amended Facility. The Company is in compliance with all debt covenants as of the date the consolidated financial statements are available for issuance. As discussed in Note 18, on February 22, 2021 the Company entered into Amendment No. 3 to the Amended Facility which removed the minimum EBITDA covenant and also amended other covenant terms. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the transition period ended December 31, 2020, the Company did not make any principal repayments. During the fiscal years ended June&#160;30, 2020, 2019 and 2018 the Company made $8.6 million, $115.0 million and $143.0 million in principal repayments, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility is secured by a first-lien security interest in substantially all of the assets of Myriad and certain of its domestic subsidiaries and each such domestic subsidiary of Myriad has guaranteed the repayment of the Amended Facility. Amounts outstanding under the Amended Facility were as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:60.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.135%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663589000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Long-Term Liabilities</a></td>
<td class="text">OTHER LONG-TERM LIABILITIES<div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:60.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.116%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s balance of other long-term liabilities for the transition period ended December&#160;31, 2020 consists of Company&#8217;s portion of social security taxes that have been deferred under the CARES Act that do not have to be deposited until December 2022. The Company previously held two non-contributory defined benefit pension plans for its current and former Clinic employees. The Company has closed participation in the plans to exclude those employees hired after 2002. As of June&#160;30, 2019 the fair value of the plan assets were approximately $0.1 million&#160;resulting in a net pension liability of $6.8 million. The Company sold the Clinic in February 2020 and as a result the net pension liability was removed upon deconsolidation. See Note 16 for further discussion regarding the sale of the Clinic.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663569864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Preferred and Common Stockholders' Equity</a></td>
<td class="text">PREFERRED AND COMMON STOCKHOLDERS' EQUITY<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 5.0 shares of preferred stock, par value $0.01 per share.&#160;There were no preferred shares outstanding at December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 150.0 million shares of common stock, par value $0.01 per share. There were 75.4&#160;million, 74.7&#160;million, 73.5&#160;million, and 70.6&#160;million shares issued and outstanding at December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 respectively.</span></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common shares issued and outstanding</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"/><td style="width:48.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning common stock issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued upon exercise of options and employee stock plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending common stock issued and outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Company&#8217;s Board of Directors authorized a share repurchase program of $200.0 million of the Company&#8217;s outstanding common stock. The Company may repurchase its common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company&#8217;s management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.&#160;&#160;As of December&#160;31, 2020, the Company has $110.7 million remaining on its current share repurchase authorization.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the par value method of accounting for its stock repurchases.&#160;&#160;As a result of the stock repurchases, the Company reduced common stock and additional paid-in capital and recorded charges to Retained earnings (accumulated deficit).&#160;&#160;During the fiscal year ended June 30, 2019 the Company used $50.0 million to repurchase shares of the Company&#8217;s stock as part of an accelerated share repurchase. The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to Retained earnings (accumulated deficit) for the repurchases for periods ended December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 were as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"/><td style="width:48.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased and retired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock and additional paid-in-capital reductions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to retained earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664935832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">SHARE-BASED COMPENSATIONOn November 30, 2017, the Company&#8217;s stockholders approved the adoption of the 2017 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2017 Plan&#8221;).&#160;&#160;The 2017 Plan allows the Company, under the direction of the Compensation Committee of the Board of Directors, to make grants of restricted and unrestricted stock awards to employees, consultants and directors.&#160;&#160;The 2017 Plan allows for issuance of up to 4.6 million shares of common stock.&#160;&#160;In addition, as of December&#160;31, 2020, the Company may grant additional shares of common stock under the 2017 Plan with up to 4.0 million options and restricted stock units outstanding under its 2010 Employee, Director and Consultant Equity Incentive Plan, as amended, that expire or are cancelled without delivery of shares of common stock. If an RSU awarded under the 2017 Plan is cancelled or forfeited without the issuance of shares of common stock, the unissued or reacquired shares, which were subject to the RSU, shall again be available for issuance pursuant to the 2017 Plan. <div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares, terms, and vesting periods are determined by the Company&#8217;s Board of Directors or a committee thereof on an award-by-award basis. RSUs granted to employees generally vest ratably over four years from the month of the anniversary date in which the RSUs are granted. Options and RSUs granted to our non-employee directors vest in full upon completion of one year of service on the anniversary following the date of the grant. Options generally vest ratably over service periods of four years. Options granted after December 5, 2012 expire eight years from the date of grant, and options granted prior to that date generally expire ten years from the date of grant. In September 2014, the Company began generally issuing RSUs in lieu of stock options.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of RSUs awarded to certain executive officers that ultimately vest may be increased or reduced based on certain additional performance and market conditions. The performance and market conditions associated with awards granted during the transition period ended December 31, 2020 include vesting that is based 50% on achieving certain levels of earnings per share targets, and 50% based on achieving certain performance targets compared to the performance of the Nasdaq Healthcare Provider Index. The Company estimates the likelihood of achievement of performance conditions at the end of each period. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the transition period ended December 31, 2020, the Company granted stock-based awards to the Company's President and Chief Executive Officer as an inducement material to his commencement of employment and entry into an employment agreement with the Company. The awards that were granted consist of time-based RSUs as well as RSUs that have the same performance conditions as other executives discussed in the preceding paragraph. The awards also consist of time-based stock options as well as stock options with market-based vesting conditions based on achievement of certain levels of Myriad's stock price for a period of 20 consecutive days. The inducement awards were made in accordance with Nasdaq Stock Market rules and were not made under the Company's existing equity plans. The inducement awards are included in the tables presented. </span></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the Company's equity plans, including the Company's inducement awards, is as follows for the transition period ended December&#160;31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:73.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(number of shares in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.47&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options canceled or expired</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.12&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at end of period</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at end of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.71&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options granted is estimated on the grant date using the Black-Scholes option-pricing model except for options with a market condition, which are valued using a Monte Carlo Simulation. The fair value of the stock options is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. During the transition period ended December 31, 2020, the valuation assumptions used for stock options were as follows:</span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.826%"><tr><td style="width:1.0%"/><td style="width:80.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.636%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3% - 0.5%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derived service period (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 - 2.6</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73% - 77%</span></div></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no options granted during the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at December&#160;31, 2020 (number of shares in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:59.909%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.135%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options outstanding and exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of<br/>exercise<br/>prices</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number outstanding at December 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual<br/>life (years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.38 - 19.47</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.13&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.29 - 25.39</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.49 - 26.49</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.49&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.07 - 36.55</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.71&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 there was $4.6 million of unrecognized share-based compensation expense related to the inducement stock options that will be recognized over a weighted-average period of 2.5 years. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the RSU activity under the Company's equity plans, including the Company's inducement awards and RSU awards with performance metrics, is as follows for the transition period ended December 31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:73.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(number of shares in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.50&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs canceled</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.51&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs outstanding at end of period</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant-date fair value of restricted stock units grants during the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 was $13.69, $27.96, $46.62 and $32.67, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units that vested during the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 was $29.1 million, $32.4 million, $27.6 million and $20.4 million, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, there was $54.3 million of total unrecognized share-based compensation expense related to RSUs that will be recognized over a weighted-average period of 2.7 years. We expect all unvested awards to vest and recognize forfeitures as they occur.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense recognized and included in the Consolidated Statements of Operations were as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has unrecognized share-based compensation cost related to share-based compensation granted under its current plans.&#160;&#160;The estimated unrecognized share-based compensation cost and related weighted average recognition period, aggregate intrinsic value of options outstanding, aggregate intrinsic value of options that are fully vested and aggregate intrinsic value of RSUs vested and expected to vest is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of<br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized share-based compensation cost</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of options outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of options fully vested</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of RSUs outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised was as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of options exercised</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2012, following stockholder approval, the Company adopted the 2012 Employee Stock Purchase Plan (the &#8220;2012 Purchase Plan&#8221;), under which 2.0 million shares of common stock have been authorized. Shares are issued under the 2012 Purchase Plan twice yearly at the end of each offering period. At December&#160;31, 2020, a total of 1.8 million shares of common stock had been purchased under the 2012 Plan. Shares purchased under and compensation expense associated with the 2012 Plan for the years reported are as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under the plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan compensation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From June 1, 2017 through May 31, 2018 there was an amendment to the 2012 Purchase Plan implemented such that the plan was non-compensatory.&#160;&#160;As of December&#160;31, 2020, there is $0.5 million unrecognized share-based compensation expense related to the 2012 Purchase Plan.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of shares issued under the Plan that was in effect for each period reported was calculated using the Black&#8209;Scholes option-pricing model using the following weighted-average assumptions:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.676%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979759438984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit consists of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes consists of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223.3)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between income taxes at the statutory federal income tax rate and income taxes reported in the consolidated statements of operations were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax expense at the statutory rate</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">6,422.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development credits, net of the federal tax on state credits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(11,880.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">9,312.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertain tax benefits statute expired, net of federal benefit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(22,798.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incentive stock option and employee stock purchase plan expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(9,954.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2,568.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(642.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Cut and Jobs Act impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CARES Act</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value adjustments related to acquisition contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2,568.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible contingent purchase price and transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">4,174.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1,926.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired tax attributes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">6,101.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign disregarded election</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">20,550.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in revenue recognition/method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(23,440.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">963.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-14,107.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of the Company&#8217;s deferred tax assets and liabilities were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:60.768%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AR allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain state tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;) was enacted in response to COVID-19 pandemic. The CARES Act made various tax law changes, including among other things (i) increased the limitation under IRC Section 163(j) for 2019 and 2020 to permit additional expensing of interest (ii), enacted technical corrections so that qualified improvement property can be immediately expensed under IRC Section 168(k) and net operating losses arising in fiscal tax years beginning before January 1, 2018 and ending after December 31, 2017 can be carried back two years and carried forward twenty years without a taxable income limitation as opposed to carried forward indefinitely, and (iii) made modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years. As a result of the provision provided under the CARES Act, the Company was able to carry-back federal net operating losses to previous periods, resulting in a $20.7 million tax benefit in the transition period ended December 31, 2020.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;) was enacted. The Tax Act makes broad and complex changes to the U.S. tax code that are affecting our fiscal year ending June 30, 2018, and all following fiscal years. The Company&#8217;s final analysis of the impact of the Tax Cuts and Jobs Act resulted in a net income tax benefit during the fiscal year ended June 30, 2018 of approximately $32.0 million ($0.44 earnings per share increase).&#160;&#160;This amount primarily consisted of a net benefit for the corporate rate reduction due to the revaluing of net deferred tax liabilities as a result of the reduction in the federal corporate tax rates.&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the provisions of the Tax Act affecting foreign earnings had no material effect or were not applicable to the Company&#8217;s fiscal years ended June 30, 2018, 2019, 2020, or to the transition period ended December 31, 2020. This was primarily due to the Company's election made during the fiscal year ended June 30, 2019 to treat its foreign subsidiaries as disregarded entities.</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of the economic impact of COVID-19, the Company has incurred a cumulative three-year loss. Pursuant to Accounting Standards Codification Topic 740, the negative evidence of a cumulative loss may be difficult to overcome. However, the Company will have significant future taxable income resulting from the reversal of taxable temporary differences. Primarily due to the availability of such expected future taxable income, the Company concluded that it is more likely than not that the benefits of the majority of its deferred income tax assets will be realized. However, for certain deferred tax assets a valuation allowance has been established, primarily due to limitations imposed by I.R.C. Section 382 and certain jurisdictional limitations. For the transition period ended December 31, 2020, the Company's valuation allowance increased by $0.3 million. For the fiscal years ended June 30, 2020, 2019 and 2018, the Company&#8217;s valuation allowance increased by $3.5 million, $1.1 million, and $0.6 million,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">respectively. The Company will continue to evaluate the impact that the COVID-19 pandemic may have on its results of operations and its ability to realize its deferred tax assets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired Counsyl, Inc. on July 31, 2018 (see Note 17).&#160;&#160;As part of the purchase accounting for the acquisition, a net deferred tax liability of approximately $67.6 million was recorded, consisting primarily of intangible assets for which the book basis exceeds the tax basis. A corresponding deferred tax asset of $60.7 million was recorded, consisting primarily of net operating loss and research credit carryforwards.&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company had the following net operating loss and research credit carryforwards (tax effected), with their respective expiration periods. Certain carryforwards are subject to the limitations of Section 382 and 383 of the Internal Revenue Code as indicated (in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.735%"><tr><td style="width:1.0%"/><td style="width:52.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.959%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforwards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subject to<br/>sections 382, 383</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expires<br/>beginning in year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Through</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal net operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2038</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah net operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California net operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2042</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other state net operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign net operating losses (various jurisdictions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah research credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2034</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas research credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consistent with the indefinite reversal criteria of ASC 740-30-25-17, the Company intends to continue to invest undistributed earnings of its foreign subsidiaries indefinitely. However, due to the cumulative losses that have been incurred to date in such foreign operations, the changes of the Tax Act and the aforementioned election to treat its foreign subsidiaries as disregarded entities, no deferred taxes related to the Company&#8217;s foreign operations have been recorded. For those foreign entities for which an election has been made to be treated as disregarded for U.S. tax purposes, the appropriate U.S. jurisdiction deferred tax assets and liabilities have been recorded.&#160;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement criteria as set forth in ASC 740. As of December&#160;31, 2020 and June 30, 2020, the Company had net unrecognized tax benefits of $30.5 million and $23.5&#160;million, respectively. The Company&#8217;s gross unrecognized tax benefits as of the transition period ended December&#160;31, 2020 and the fiscal years ended June 30, 2020, 2019 and 2018, and the changes in those balances are as follows:&#160;</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:50.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.385%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.155%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at the beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - statute lapse</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and penalties in year-end balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties related to uncertain tax positions are included as a component of income tax expense and all other interest and penalties are included as a component of other income (expense).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S. federal, foreign and state income tax returns in jurisdictions with various statutes of limitations and is subject to examination for the open tax years in the U.S. federal and state jurisdictions of 2015 through 2020 and in the foreign jurisdictions of 2013 through 2020. The Company is currently under audit by the State of New Jersey for the fiscal years June 30, 2013 through 2017; the city of New York for the fiscal years June 30, 2016 through 2018; Germany for the fiscal years June 30, 2013 through 2015; and Switzerland for the fiscal years June 30, 2015 through 2016.&#160;&#160;Annual tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663494904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. As of December&#160;31, 2020, management of the Company believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company&#8217;s consolidated financial position, operating results, or cash flows.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company received recoupment requests from third-party payors for alleged overpayments. The Company disagrees with the contentions of the pending requests or has recorded an estimated reserve for the alleged overpayments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664608072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LEASESThe Company leases certain office spaces and research and development laboratory facilities, vehicles, and office equipment with remaining lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV8xNTcvZnJhZzo5NjUxYWYwODM0NGE0OTE4YmQ4ZWRiNDFjNjQ2MTFiMC90ZXh0cmVnaW9uOjk2NTFhZjA4MzQ0YTQ5MThiZDhlZGI0MWM2NDYxMWIwXzE4MA_d8822eb6-7013-498c-93f5-ea1a56cc78c9">one</span> to seven years. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options which allows the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These optional periods have not been considered in the determination of the right-of-use-assets or lease liabilities associated with these leases as the Company did not consider it reasonably certain it would exercise the options.<div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 1, 2019, the Company adopted ASU 2016-02 under the modified retrospective approach by initially applying ASU 2016-02 at the adoption date, rather than at the beginning of the earliest comparative period presented. Results for the fiscal year ended June 30, 2020 are presented under ASU 2016-02. Prior period amounts were not adjusted and continue to be reported under previous lease accounting guidance. As part of the adoption, the Company elected the package of practical expedients to avoid reassessing prior conclusions about lease identification, lease classification and initial direct costs. The Company also elected the practical expedient allowing the use of hindsight in determining the lease term and assessing impairment of right-of-use assets based on all facts and circumstances through the effective date of the new standard. The Company has elected the recognition exemption for short-term leases for all leases that qualify. Under this exemption, the Company will not recognize right-of-use assets or lease liabilities for those leases that qualify as a short-term lease (leases with lease terms of 12 months or less), which includes not recognizing right-of-use assets or lease liabilities for existing short-term leases in transition. The Company also has elected the practical expedient to avoid separating lease and non-lease components for any of its leases within its existing classes of assets.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company performed evaluations of its contracts and determined each of its identified leases are operating leases. For the transition period ended December&#160;31, 2020, the Company incurred $9.9 million in lease costs which are included in operating expenses in the consolidated statement of operations in relation to these operating leases. Of such lease costs, $1.8 million was variable lease expense and $0.1 million was short-term lease expense, neither of which were included in the measurement of the Company's operating right of use assets and lease liabilities. The variable rent expense is comprised primarily of the Company's proportionate share of operating expenses, property taxes, and insurance and is classified as lease expense due to the Company's election to not separate lease and non-lease components. For the fiscal year ended June 30, 2020, the Company incurred $18.4 million in lease costs, of which $2.6 million was variable lease expense and $0.2 million was short-term lease expense. Prior to the adoption of the lease guidance in ASU 2016-02, the Company's total rent expense for the fiscal years ended June&#160;30, 2019 and 2018 was $19.7 million and $15.5 million, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of the Company&#8217;s operating lease liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year ending:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts representing interest</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current maturities of operating lease liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the weighted average remaining lease term is 4.9 years and the weighted average discount rate used to determine the operating lease liability was 3.87%. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the implicit rate in the Company's leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of future lease payments. When calculating the Company&#8217;s incremental borrowing rates, the Company gives consideration to its credit risk, term of the lease, total lease payments and adjust for the impacts of collateral, as necessary. The lease term used may reflect any option to extend or terminate the lease when it is reasonably certain the Company will exercise such options. Lease expenses for the Company's operating leases are recognized on a straight-line basis over the lease term.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664842872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Deferred Savings Plan<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Deferred Savings Plan</a></td>
<td class="text">EMPLOYEE DEFERRED SAVINGS PLANThe Company has a deferred savings plan which qualifies under Section&#160;401(k) of the Internal Revenue Code. Substantially all of the Company&#8217;s U.S. employees are covered by the plan. The Company makes matching contributions of 50% of each employee&#8217;s contribution with the employer&#8217;s contribution not to exceed 4% of the employee&#8217;s compensation. <div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s recorded contributions to the plan are as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred savings plan contributions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664729432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Related Information</a></td>
<td class="text">SEGMENT AND RELATED INFORMATION<div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business is aligned with how the chief operating decision maker ("CODM") reviews performance and makes decisions in managing the Company. The Company&#8217;s operating segments have been aggregated into two reportable segments: (i)&#160;diagnostics and (ii) other. The diagnostics segment primarily provides testing and collaborative development of testing that is designed to assess an individual&#8217;s risk for developing disease later in life, identify a patient&#8217;s likelihood of responding to drug therapy and guide a patient&#8217;s dosing to ensure optimal treatment, or assess a patient&#8217;s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. The CODM evaluates segment performance based on operating income (loss).</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:60.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.116%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition Period Ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2018:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:58.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income (loss) for reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc stockholders</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a comparison of balance sheet assets by operating segment:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"/><td style="width:61.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net equipment, leasehold improvements and property:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total assets less cash, cash equivalents, and marketable investment securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles assets by geographical region to total assets:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:60.942%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net equipment, leasehold improvements and property:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets by segment and geographical region</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and marketable investment <br/>     securities (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles revenue by geographical region to total revenue:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:48.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664811144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Subsidiary<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Sale of Subsidiary</a></td>
<td class="text">SALE OF SUBSIDIARYOn February 28, 2020, the Company closed the sale of the Clinic with Landkreis Starnberg. As a result of the sale, the Clinic was deconsolidated from the Company&#8217;s consolidated financial statements in accordance with ASC 810. The Company recorded a pre-tax net gain of $1.0 million on the sale, which was recorded in other income in the Company&#8217;s Consolidated Statements of Operations during the fiscal year ended June 30, 2020. The gain recorded consists of a pre-tax gain of $1.2 million associated with the settlement of the Clinic pension, offset by a loss of $0.2 million due to the difference between the purchase price and net assets as well as the effects of foreign currency. The Clinic was previously reported as part of the Company&#8217;s other segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664732712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Acquisitions</a></td>
<td class="text">BUSINESS ACQUISITIONS<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counsyl</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2018, the Company completed the acquisition of Counsyl, Inc. (&#8220;Counsyl&#8221;), a leading provider of genetic testing and DNA analysis services, pursuant to the Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), dated May 25, 2018.&#160;&#160;Pursuant to the terms of the Merger Agreement, Myriad Merger Sub, Inc., a newly created wholly-owned subsidiary of the Company, was merged with and into Counsyl, with Counsyl continuing as the surviving corporation and a wholly-owned subsidiary of Myriad.&#160;&#160;The Company believes the acquisition allows for further entry into the high-growth reproductive testing market, with the ability to become a leader in women&#8217;s health genetic testing.&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired Counsyl for total consideration of $405.9 million, consisting of $278.5 million in cash, financed in part by the Amendment No. 1 to the Facility (see Note 7) and 3.0 million shares of common stock issued, valued at $127.4 million.&#160;&#160;The shares were issued and valued as of July&#160;31, 2018 at a per share market closing price of $42.53.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the cash consideration, $5.0 million was deposited into an escrow account to fund any post-closing adjustments payable to Myriad based upon differences between the estimated working capital and the actual working capital of Counsyl at closing.&#160;&#160;The working capital was finalized during the fiscal year ended June 30, 2019 as described below.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration transferred was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the acquisition date. Management estimated the fair value of tangible and intangible assets and liabilities in accordance with the applicable accounting guidance for business combinations and utilized the services of third-party valuation consultants. The significant assumptions used in the model to estimate the value of the intangible assets included projected cash flows, discount rates, net working capital and long-term growth rate. The initial allocation of the consideration transferred is based on a preliminary valuation and is subject to adjustments. Balances subject to adjustment primarily include the valuations of acquired assets (tangible and intangible), liabilities assumed, as well as tax-related matters. During the measurement period, the Company may record adjustments to the provisional amounts recognized. During the fiscal year ended June 30, 2019, $1.1 million of this escrow was returned to Myriad as a result of a working capital adjustment which reduced the total consideration and goodwill.&#160;&#160;There was also a reduction in the intangible assets of $2.9 million due to updated assumptions related to contributory asset charges associated with the related acquired asset, a $1.9 million decrease in the deferred tax liability, and a $0.7 million reduction to equipment due to updated valuations. The offset for the intangible asset, deferred tax liability and equipment changes was a $4.4 million increase in goodwill. The allocation of the consideration transferred was finalized within the measurement period.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the estimated fair value of total consideration transferred:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value purchase price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Identifiable Intangible Assets</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired intangible assets that consisted of developed screening processes, which had an estimated fair value of $290.0 million. The fair values of these developed screening processes and related useful lives were determined using a probability-weighted income approach that discounts expected future cash flows to present value. The estimated net cash flows were discounted using a discount rate of 12.5%, which is based on the estimated internal rate of return for the acquisition and represents the rate that market participants might use to value the intangible assets. The Company will amortize the intangible assets on a straight-line basis over their estimated useful lives of 12 years. </span></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill represents the excess of consideration transferred over the fair value of assets acquired and liabilities assumed and is attributable to the benefits expected from combining the Company&#8217;s expertise with Counsyl&#8217;s technology, customer insights, and ability to effectively integrate genetic screening into clinical practice with OBGYNs.&#160;Changes in goodwill since the initial purchase are shown below:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance September 30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment to equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This goodwill is not deductible for income tax purposes.</span></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma Information (Unaudited)</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro-forma results presented below include the effects of the Counsyl acquisition as if it had been consummated as of July 1, 2017, with adjustments to give effect to pro forma events that are directly attributable to the acquisition, which includes adjustments related to the amortization of acquired intangible assets, interest income and expense, and depreciation.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results do not reflect any operating efficiency or potential cost savings that may result from the consolidation of Counsyl with the Company. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operation of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations and are not necessarily indicative of results that might have been achieved had the acquisition been consummated as of July 1, 2017.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:73.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To complete the purchase transaction, the Company incurred approximately $6.8 million of acquisition costs, which are recorded as selling, general and administrative expenses in the period incurred. For the fiscal year ended June 30, 2019, Counsyl contributed revenue of approximately $104.9 million.&#160;For the fiscal year ended June 30, 2019, operating expenses related to Counsyl were approximately $67.6 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663517928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">SUBSEQUENT EVENT<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, the Company entered into Amendment No. 3 to the Amended Facility discussed in Note 7, which modified the Amended Facility as follows:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Extends the Modification Period established pursuant to Amendment No. 2 for an additional year, through June 30, 2022, and revises certain negative covenants in connection therewith.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricts the Company from borrowing under the revolving credit facility if unrestricted cash and cash equivalents exceed $150.0 million, unless such borrowings are in connection with acquisitions.</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Reduces the revolving commitments to $300.0 million, with a further reduction to $250.0 million by September 30, 2021. Provides for further reductions to the revolving commitments, or mandatory prepayments of outstanding revolving loans, in the event of certain asset sales.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Waives compliance with the leverage ratio and the interest coverage ratio covenants through the quarter ended March 31, 2022 and also lowers the minimum liquidity covenant applicable through such quarter.</span></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Removes the minimum EBITDA covenant added pursuant to Amendment No. 2.</span></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Permits the Company to change its fiscal year end to December 31.</span></div>&#9702;Permits the Company to keep the net cash proceeds of material asset sales received above certain dollar thresholds without corresponding mandatory prepayments or commitment reductions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664798392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment on marketable investment securities recorded to stockholders' equity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment of operation lease right-of-use assets and lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664701496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Quarterly Financial Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Supplementary Quarterly Financial Data (Unaudited)</a></td>
<td class="text">SUPPLEMENTARY QUARTERLY FINANCIAL DATA (UNAUDITED)<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total other expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net loss attributable to non-controlling interest  </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Myriad Genetics Inc. stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:5pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019 (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics Inc. stockholders</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) An immaterial prior period goodwill impairment charge of $1.3 million was previously classified as part of selling, general and administrative expense in the condensed consolidated statements of operations was reclassified to conform to the current period presentation and is included as part of the goodwill and intangible asset impairment charges financial statement line item in the current period.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663556088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transition Period Comparative Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TransitionPeriodComparativeDataTextBlock', window );">Transition Period Comparative Data (Unaudited)</a></td>
<td class="text">TRANSITION PERIOD COMPARATIVE DATA (UNAUDITED)<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six-month Period Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Myriad Genetics Inc. stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_TransitionPeriodComparativeDataTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transition Period Comparative Data</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_TransitionPeriodComparativeDataTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979760410328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Financial Statement Presentation</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Financial Statement Presentation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad Genetics, Inc. and subsidiaries (collectively, the&#160;"Company" or "Myriad") is a leading personalized precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics. The Company employs a number of proprietary technologies, including DNA, RNA and protein analysis, that help it to understand the genetic basis of human disease and the role that genes and their related proteins may play in the onset and progression of disease. The Company uses this information to guide the development of molecular diagnostic and companion diagnostic tests that are designed to assess an individual&#8217;s risk for developing disease later in life (predictive medicine), identify a patient&#8217;s likelihood of responding to drug therapy and guide a patient&#8217;s dosing to ensure optimal treatment (personalized medicine), or assess a patient&#8217;s risk of disease progression and disease recurrence (prognostic medicine).&#160;&#160;The Company generates revenue by performing molecular diagnostic tests as well as by providing pharmaceutical and clinical services to the pharmaceutical and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.&#160;The Company&#8217;s corporate headquarters are located in Salt Lake City, Utah.  </span></div>The accompanying consolidated financial statements have been prepared by the Company in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.&#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with U.S. GAAP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires Company management to make estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include revenue recognition estimates for the average expected reimbursement per test, valuation allowances for deferred income tax assets, certain accrued liabilities, share-based compensation, and impairment analysis of goodwill and intangible assets. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Substantially all of the Company&#8217;s account receivable are with companies in the healthcare industry, U.S. and state governmental agencies, and individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments. The Company only has one payor, Medicare, that represents greater than 10% of its revenues. Revenues received from Medicare are included within the Diagnostics reporting segment and represented approximately 16%, 15%, 14% and 17% of total revenue for the six-month transition period ended December&#160;31, 2020 (the "Transition Period") and the fiscal years ended June&#160;30, 2020, 2019 and 2018, respectively. Concentrations of credit risk are mitigated due to the number of the Company&#8217;s customers as well as their dispersion across many geographic regions. No customer accounted for&#160;more than 10%&#160;of accounts receivable at&#160;December&#160;31, 2020, June&#160;30, 2020 or June 30, 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Investment Securities</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Investment Securities</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its marketable investment securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders&#8217; equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The Company&#8217;s cash equivalents consist of short-term, highly liquid investments that are readily convertible to known amounts of cash.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A decline in the market value of any available-for-sale security below cost that is deemed other than temporary results in a charge to earnings and establishes a new cost basis for the security. Losses are charged against Other income when a decline in fair value is determined to be other than temporary. The Company reviews several factors to determine whether a loss is other than temporary. These factors include but are not limited to: (i) the extent to which the fair value is less than cost and the cause for the fair value decline, (ii) the financial condition and near term prospects of the issuer, (iii) the length of time a security is in an unrealized loss position and (iv) the Company&#8217;s ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. There were no other-than-temporary impairments recognized during the transition period ended December&#160;31, 2020 or during the fiscal years ended June&#160;30, 2020, 2019 and 2018.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of supplies such as reagents, plates and testing kits, which are consumed when providing test results, and therefore the Company does not maintain finished goods inventory. Inventories are stated at the lower of cost or market and costs are determined on a first-in, first-out basis.&#160;&#160;In order to assess the ultimate realization of inventories, the Company is required to make judgments as to future demand requirements compared to current or committed inventory levels.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its inventories for excess quantities and obsolescence.&#160;&#160;Inventories that are considered excess or obsolete are expensed.&#160;&#160;The valuation of inventories requires the use of estimates as to the amounts of current inventories that will be sold. These estimates are dependent on management&#8217;s assessment of current and expected orders from the Company&#8217;s customers.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade Accounts Receivable</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Accounts Receivable</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable represents amounts billed to customers for revenue recognized related to molecular diagnostic tests and pharmaceutical and clinical services. The Company does not have any off-balance-sheet credit exposure related to its customers and does not require collateral.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method based on the lesser of estimated useful lives of the related assets or lease terms. Equipment items have depreciable lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzYxNA_1b34527f-c366-49c7-adfd-f87850ee8bcc">five</span> to seven years. Leasehold improvements are depreciated over the shorter of the estimated useful lives or the associated lease terms, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMwMWIyNTViY2UwMDQzOWJhOTM4MGZjMjE5ZWI3MGUxL3NlYzpjMDFiMjU1YmNlMDA0MzliYTkzODBmYzIxOWViNzBlMV85Ny9mcmFnOjI5ZmFlOGJmNWM3MDRkZmZiYzQwMjE3MWQzYmI1YzVlL3RleHRyZWdpb246MjlmYWU4YmY1YzcwNGRmZmJjNDAyMTcxZDNiYjVjNWVfNzc2NA_20a77949-7d3f-4d64-b771-723fbeeb3bce">one</span> to seven years. Repairs and maintenance costs are charged to expense as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets and Other Long-Lived Assets</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible and other long-lived assets are comprised of acquired licenses, technology and intellectual property and purchased in-process research and development. Acquired intangible assets are recorded at fair value and amortized over the shorter of the contractual life or the estimated useful life. The estimated useful life of acquired in-process research and development was also evaluated in conjunction with the annual impairment analysis of intangible assets. The classification of the Company&#8217;s acquired in-process research and development as an indefinite lived asset was deemed appropriate as the related research and development was not yet complete nor had it been abandoned. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain implementation costs incurred in a cloud computing arrangement to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. Implementation costs incurred in cloud computing arrangement are capitalized as part of Other assets in the Consolidated Balance Sheets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually reviews and monitors long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment by reporting unit on an annual basis as of October 1 and in the interim if events and circumstances indicate that goodwill may be impaired. Prior to the change in the Company's fiscal year from the last day of June to a calendar fiscal year end, goodwill was tested for impairment on an annual basis as of April 1 and in the interim if events and circumstances indicated that goodwill may be impaired. The voluntary change is preferable under the circumstances as it provides the Company with additional time to complete its annual goodwill impairment testing in advance of its year-end reporting and results in better alignment with the Company&#8217;s strategic planning and forecasting process given the Company's change in fiscal year end. The events and circumstances that are considered include business climate and market conditions, legal factors, operating performance indicators and competition.&#160;&#160;Impairment of goodwill is first assessed using a qualitative approach.&#160;&#160;If the qualitative assessment suggests that impairment is more likely than not, a quantitative analysis is performed.&#160;&#160;The quantitative analysis involves a comparison of the fair value of the reporting unit with its carrying amount.&#160;If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.&#160;&#160;If an event occurs that would cause a revision to the estimates and assumptions used in analyzing the value of the goodwill, the revision could result in a non-cash impairment charge that could have a material impact on the financial results.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad generates revenue by performing molecular diagnostic testing and pharmaceutical services. The Company previously provided clinical services until selling Privatklinik Dr. Robert Schindlbeck GmbH &amp; Co. KG (the "Clinic") in February 2020. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated transaction price. The Company has determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s revenue by type for the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, 2019, and 2018:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic revenues:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hereditary Cancer Testing</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GeneSight</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vectra</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myChoice CDx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prolaris</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EndoPredict</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total molecular diagnostic revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical service revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC Topic 606, Revenue from Contracts with Customers (&#8220;Topic 606&#8221;), an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company performs its obligation under a contract with a customer by processing diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. The Company has the right to bill its customers upon the completion of performance obligations and thus does not record contract assets.&#160;Occasionally customers make payments prior to the Company's performance of its contractual obligations.&#160;When this occurs, the Company records a contract liability as deferred revenue. During the fiscal year ended June 30, 2020, the Company received approximately $29.7 million in advance Medicare payments as part of the CARES Act, which was enacted on March 27, 2020 to provide relief from the economic impacts of COVID-19. Repayment of the advanced Medicare payments begins April 2021. The advance Medicare payments are included in prepayments of deferred revenue for the fiscal year ended June 30, 2020 and in the beginning and ending balance of deferred revenue for the transition period ended December 31, 2020. A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:60.768%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 606, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#8217;s right to payment is in an amount that directly corresponds with the value of Company&#8217;s performance to date. However, periodically, the Company enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations. As of December&#160;31, 2020, the aggregate amount of the transaction price of such contracts that is allocated to the remaining performance obligations is $11.2 million.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the transaction price, Myriad includes an estimate of the expected amount of consideration as revenue. The Company applies this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled. An estimate of transaction price does not include any estimated amount of variable consideration that are constrained. In addition, the Company considers all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. In determining the expected value, the Company considers the probability of the variable consideration for each possible scenario. The Company also has significant experience with historical discount patterns and uses this experience to estimate transaction prices. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimate of revenue is affected by assumptions in payor behavior such as changes in payor mix, payor collections, current customer contractual requirements, and experience with collections from third-party payors. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in Accrued liabilities in the Consolidated Balance Sheets in anticipation of request for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the Consolidated Statements of Operations and Comprehensive Income (Loss). </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash collections for certain diagnostic tests delivered may differ from rates originally estimated, primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third party payors. As a result of this new information, the Company updates its estimate of the amounts to be recognized for previously delivered tests. During the transition period ended December 31, 2020, and fiscal year ended June 30, 2019 and 2018, the impact to revenue and earnings (loss) per share, for tests in which the performance obligation of delivering the test results was met in the prior period was immaterial. During the fiscal year ended June 30, 2020, the Company recognized a $9.9 million decrease in revenue, which resulted in a $(0.10) impact to earnings (loss) per share for tests in which the performance obligation of delivering the tests results was met in prior periods. The changes were primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third-party payors. In addition, during the fiscal year ended June 30, 2020, the Company identified an error related to prior periods for Medicare claims and has reduced revenue and recorded an accrued liability for a total of $4.7 million that will be refunded to Medicare. The impact of correcting the error during that period and the impact to all prior periods was concluded to be immaterial. The correction of the error in the fiscal year ended June 30, 2020 resulted in an impact to earnings (loss) per share for the fiscal year ended June 30, 2020 of $(0.05).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Topic 606, the Company has elected to exclude from the measurement of transaction price, all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer for e.g. sales tax, value added tax etc.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to apply the practical expedient related to costs to obtain or fulfill a contract since the amortization period for such costs will be one year or less. Accordingly, no costs incurred to obtain or fulfill a contract have been capitalized. The Company has also elected to apply the practical expedient for not adjusting revenue recognized for the effects of the time value of money. This practical expedient has been elected because the Company collects very little cash from customers under payment terms and vast majority of payments terms have a payback period of less than one year.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based payment expense</a></td>
<td class="text"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based payment expense</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the fair value compensation cost relating to share-based payment transactions in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718, Compensation &#8211; Stock Compensation. Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#8217;s requisite service period, which is generally the vesting period. The fair value of restricted stock units (RSUs) is based on the number of shares granted and the quoted price of the Company&#8217;s common stock on the grant date. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. The fair value of shares issued under the Employee Stock Purchase Plan is calculated using the Black-Scholes option-pricing model, based on assumptions including the risk-free interest rate, expected life, expected dividend yield and expected volatility. The average risk-free interest rate is determined using the U.S. Treasury rate. We determine the expected life based on offering period of the Employee Stock Purchase Plan. The expected volatility is determined using the weighted average of daily historical volatility of our stock price.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OtherIncomePolicyPolicyTextBlock', window );">Other Income</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stimulus or grant payments that it receives that do not need to be paid back as other income. During the fiscal year ended June 30, 2020, the Company received approximately $14.6 million from the Provider Relief Fund under the CARES Act to reimburse the Company for health care related expenses or lost revenues that are attributable to COVID-19, which was recognized as a component of Other income in the Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes income taxes under the asset and liability method. This approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes, including the effective tax rate and analysis of potential tax exposure items, if any, requires significant judgment and expertise in federal and state income tax laws, regulations and strategies, including the determination of deferred tax assets and liabilities and any estimated valuation allowances deemed necessary to recognize deferred tax assets at an amount that is more likely than not to be realized. The Company&#8217;s filings, including the positions taken therein, are subject to audit by various taxing authorities. While the Company believes it has provided adequately for its income tax liabilities in the consolidated financial statements, adverse determinations by these taxing authorities could have a material adverse effect on the consolidated financial condition, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding.&#160;&#160;Diluted earnings per share is computed based on the weighted-average number of shares of common stock, including the dilutive effect of common stock equivalents, outstanding.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 16.75pt;text-indent:31.5pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding used to compute <br/>    basic EPS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive stock options</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding and dilutive <br/>   securities used to compute diluted EPS</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain outstanding options and RSUs were excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive. These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-dilutive options and RSUs excluded from EPS computation</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of the Company&#8217;s international subsidiaries is the local currency. For those subsidiaries, expenses denominated in the functional currency are translated into U.S. dollars using average exchange rates in effect during the period and assets and liabilities are translated using period-end exchange rates. The foreign currency translation adjustments are included in Accumulated other comprehensive income (loss) as a separate component of Stockholders&#8217; equity.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the cumulative translation adjustments included in Accumulated other comprehensive income (loss) (in millions):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance June 30, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders' equity, cash flows from operations, or net loss for the period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Effective in Future Years and Not Yet Adopted</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for public companies with fiscal years beginning after December 15, 2020, with early adoption permitted. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Recently Adopted Standards</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326) (&#8220;ASU 2016-13&#8221;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.  </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, Intangibles &#8211; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU 2018-15&#8221;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of Other assets in the Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_OtherIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other income policy text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_OtherIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663301816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Type</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s revenue by type for the transition period ended December&#160;31, 2020, and the fiscal years ended June&#160;30, 2020, 2019, and 2018:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic revenues:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hereditary Cancer Testing</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GeneSight</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vectra</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myChoice CDx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prolaris</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EndoPredict</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total molecular diagnostic revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical service revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Reconciliation of Deferred Revenue Balances</a></td>
<td class="text">A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:60.768%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 16.75pt;text-indent:31.5pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding used to compute <br/>    basic EPS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive stock options</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding and dilutive <br/>   securities used to compute diluted EPS</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potential Dilutive Common Shares</a></td>
<td class="text">These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-dilutive options and RSUs excluded from EPS computation</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cumulative Translation Adjustments Included in Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the cumulative translation adjustments included in Accumulated other comprehensive income (loss) (in millions):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance June 30, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979669895208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Investment Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value debt securities classified as available-for-sale securities by major security type and class of security at December&#160;31, 2020, June&#160;30, 2020 and June 30, 2019 were as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:48.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.676%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:47.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.118%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and maturities of debt securities classified as available-for-sale are as follows at December&#160;31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:73.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.9&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664650552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Fair Value of Financial Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the fair value of the Company&#8217;s financial assets and liabilities that are re-measured on a regular basis:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"><tr><td style="width:1.0%"/><td style="width:48.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.017%"><tr><td style="width:1.0%"/><td style="width:48.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.53pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.676%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.03pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Change in Fair Value of Contingent Consideration</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the change in the fair value of the contingent consideration during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:61.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount at beginning of period</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in the statement of operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments recognized in other comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount at end of period</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979669126248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment, Net</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:60.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.135%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:47.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.118%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671153688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the transition period ended December&#160;31, 2020 are as follows: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:39.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the fiscal years ended June 30, 2020 and 2019 are as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.877%"><tr><td style="width:1.0%"/><td style="width:26.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.403%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (see note 17)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to acquisitions (see note 17)</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill deconsolidated on sale of Clinic</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.7)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.0)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Amortizable Intangible Assets</a></td>
<td class="text"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the amounts reported as intangible assets (in millions):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:61.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"/><td style="width:60.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.060%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At June 30, 2020:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222.7)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"/><td style="width:60.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.060%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At June 30, 2019:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Non-amortizable Intangible Assets</a></td>
<td class="text"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the amounts reported as intangible assets (in millions):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:61.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"/><td style="width:60.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.060%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At June 30, 2020:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222.7)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"/><td style="width:60.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.060%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At June 30, 2019:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased licenses and technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Schedule of Recorded Amortization Expense for Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization during the respective periods for these intangible assets as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.732%"><tr><td style="width:1.0%"/><td style="width:33.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Amortization Expense of Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense of intangible assets as of December 31, 2020 is estimated to be as follows (in millions):</span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.264%"><tr><td style="width:1.0%"/><td style="width:66.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979665015992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Summary of Accrued Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:60.768%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qui tam settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoupments payable and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663254824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text">Amounts outstanding under the Amended Facility were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:60.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.135%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979669414088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Summary of Other Long-Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:60.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.116%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664795464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Summary of Common Shares Issued and Outstanding</a></td>
<td class="text"><div style="margin-top:18pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common shares issued and outstanding</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"/><td style="width:48.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning common stock issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued upon exercise of options and employee stock plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending common stock issued and outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock', window );">Schedule of Stock Repurchases</a></td>
<td class="text">The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to Retained earnings (accumulated deficit) for the repurchases for periods ended December&#160;31, 2020, June&#160;30, 2020, June&#160;30, 2019, and June&#160;30, 2018 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"/><td style="width:48.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased and retired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock and additional paid-in-capital reductions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to retained earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of common stock repurchased table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979667436216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the Company's equity plans, including the Company's inducement awards, is as follows for the transition period ended December&#160;31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:73.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(number of shares in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.47&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options canceled or expired</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.12&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at end of period</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at end of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.71&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions for Stock Options</a></td>
<td class="text">During the transition period ended December 31, 2020, the valuation assumptions used for stock options were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.826%"><tr><td style="width:1.0%"/><td style="width:80.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.636%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3% - 0.5%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derived service period (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 - 2.6</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73% - 77%</span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock', window );">Summary of Stock Options Outstanding</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at December&#160;31, 2020 (number of shares in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:59.909%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.135%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options outstanding and exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of<br/>exercise<br/>prices</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number outstanding at December 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual<br/>life (years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.38 - 19.47</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.13&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.29 - 25.39</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.49 - 26.49</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.49&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.07 - 36.55</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.71&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the RSU activity under the Company's equity plans, including the Company's inducement awards and RSU awards with performance metrics, is as follows for the transition period ended December 31, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:73.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(number of shares in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.50&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs canceled</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.51&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs outstanding at end of period</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense recognized and included in the Consolidated Statements of Operations were as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Schedule of Unrecognized Share-Based Compensation Cost</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has unrecognized share-based compensation cost related to share-based compensation granted under its current plans.&#160;&#160;The estimated unrecognized share-based compensation cost and related weighted average recognition period, aggregate intrinsic value of options outstanding, aggregate intrinsic value of options that are fully vested and aggregate intrinsic value of RSUs vested and expected to vest is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of<br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized share-based compensation cost</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of options outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of options fully vested</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value of RSUs outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock', window );">Schedule of Intrinsic Value of Options Exercised</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised was as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of options exercised</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock', window );">Schedule of Shares Purchased and Compensation Expenses for ESPP</a></td>
<td class="text">Shares purchased under and compensation expense associated with the 2012 Plan for the years reported are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under the plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan compensation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions for ESPP</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of shares issued under the Plan that was in effect for each period reported was calculated using the Black&#8209;Scholes option-pricing model using the following weighted-average assumptions:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.676%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of employee stock purchase plan activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670979832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Tax Benefit</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit consists of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) Before Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes consists of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.162%"><tr><td style="width:1.0%"/><td style="width:47.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223.3)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Differences Between Statutory Federal Income Tax Rate and Income Taxes Reported</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between income taxes at the statutory federal income tax rate and income taxes reported in the consolidated statements of operations were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax expense at the statutory rate</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">6,422.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development credits, net of the federal tax on state credits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(11,880.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">9,312.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertain tax benefits statute expired, net of federal benefit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(22,798.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incentive stock option and employee stock purchase plan expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(9,954.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2,568.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(642.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Cut and Jobs Act impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CARES Act</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value adjustments related to acquisition contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2,568.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible contingent purchase price and transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">4,174.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1,926.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired tax attributes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">6,101.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign disregarded election</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">20,550.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in revenue recognition/method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(23,440.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">963.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-14,107.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of the Company&#8217;s deferred tax assets and liabilities were comprised of the following:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:60.768%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AR allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain state tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of Net Operating Loss and Research Credit Carryforwards (Tax Effected)</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company had the following net operating loss and research credit carryforwards (tax effected), with their respective expiration periods. Certain carryforwards are subject to the limitations of Section 382 and 383 of the Internal Revenue Code as indicated (in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.735%"><tr><td style="width:1.0%"/><td style="width:52.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.959%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforwards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subject to<br/>sections 382, 383</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expires<br/>beginning in year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Through</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal net operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2038</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah net operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California net operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2042</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other state net operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign net operating losses (various jurisdictions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah research credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2034</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas research credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text">The Company&#8217;s gross unrecognized tax benefits as of the transition period ended December&#160;31, 2020 and the fiscal years ended June 30, 2020, 2019 and 2018, and the changes in those balances are as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:50.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.385%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.155%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at the beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - statute lapse</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and penalties in year-end balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979665275416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of the Company&#8217;s operating lease liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year ending:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts representing interest</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current maturities of operating lease liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670241784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Deferred Savings Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock', window );">Schedule of Contributions to the Plan</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s recorded contributions to the plan are as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred savings plan contributions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670413768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Revenue and Operating Income (Loss)</a></td>
<td class="text">The CODM evaluates segment performance based on operating income (loss).<div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:60.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.116%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition Period Ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2018:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:58.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income (loss) for reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc stockholders</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock', window );">Schedule of Comparison of Balance Sheet Assets by Operating Segment</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a comparison of balance sheet assets by operating segment:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.589%"><tr><td style="width:1.0%"/><td style="width:61.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net equipment, leasehold improvements and property:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total assets less cash, cash equivalents, and marketable investment securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Total Assets by Geographical Region</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles assets by geographical region to total assets:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:60.942%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net equipment, leasehold improvements and property:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets by segment and geographical region</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and marketable investment <br/>     securities (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Total Revenue by Geographic Region</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles revenue by geographical region to total revenue:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.304%"><tr><td style="width:1.0%"/><td style="width:48.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Comparison Of Balance Sheet Assets By Operating Segment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664659320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Estimated Total Consideration Transferred</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the estimated fair value of total consideration transferred:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value purchase price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock', window );">Schedule of Changes in Goodwill</a></td>
<td class="text">Changes in goodwill since the initial purchase are shown below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.019%"><tr><td style="width:1.0%"/><td style="width:86.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance September 30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment to equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Pro Forma Results</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results do not reflect any operating efficiency or potential cost savings that may result from the consolidation of Counsyl with the Company. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operation of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations and are not necessarily indicative of results that might have been achieved had the acquisition been consummated as of July 1, 2017.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.447%"><tr><td style="width:1.0%"/><td style="width:73.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSegmentAllocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663592088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transition Period Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment on marketable investment securities recorded to stockholders' equity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment of operation lease right-of-use assets and lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671250488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Quarterly Financial Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of Quarterly Financial Data</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total other expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net loss attributable to non-controlling interest  </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Myriad Genetics Inc. stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:5pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019 (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics Inc. stockholders</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) An immaterial prior period goodwill impairment charge of $1.3 million was previously classified as part of selling, general and administrative expense in the condensed consolidated statements of operations was reclassified to conform to the current period presentation and is included as part of the goodwill and intangible asset impairment charges financial statement line item in the current period.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarters Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664718136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transition Period Comparative Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock', window );">Schedule of Transition Period Comparative Data</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six-month Period Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Statement of Operations Data:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular diagnostic testing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Myriad Genetics Inc. stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Transition Period Comparative Data</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979674431688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale', window );">Other-than-temporary impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_CARESActOf2020MedicarePaymentAmount', window );">Advance Medicare payments to provide relief from economic impacts of COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Decrease in revenue due to changes in estimated transaction price due to contractual adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued liability for Medicare refund</a></td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,100,000<span></span>
</td>
<td class="nump">18,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">154,600,000<span></span>
</td>
<td class="nump">$ 145,200,000<span></span>
</td>
<td class="nump">93,200,000<span></span>
</td>
<td class="nump">$ 164,000,000.0<span></span>
</td>
<td class="nump">$ 195,100,000<span></span>
</td>
<td class="nump">$ 186,300,000<span></span>
</td>
<td class="nump">$ 215,400,000<span></span>
</td>
<td class="nump">$ 216,600,000<span></span>
</td>
<td class="nump">$ 216,800,000<span></span>
</td>
<td class="nump">$ 202,300,000<span></span>
</td>
<td class="nump">299,800,000<span></span>
</td>
<td class="nump">$ 381,400,000<span></span>
</td>
<td class="nump">638,600,000<span></span>
</td>
<td class="nump">$ 851,100,000<span></span>
</td>
<td class="nump">$ 743,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Capitalized costs incurred to obtain or fulfill contract</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_CARESActOf2020ProviderReliefFundAmount', window );">Provider fund relief under CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Immaterial prior period Medicare claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncreaseDecreaseInEarningsLossPerShare', window );">Change in earnings (loss) per share (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Immaterial prior period Medicare claims | Diagnostic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued liability for Medicare refund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=mygn_PerformanceObligationEstimatedTransactionPriceMember', window );">Performance obligation estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncreaseDecreaseInEarningsLossPerShare', window );">Change in earnings (loss) per share (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GovernmentContractsConcentrationRiskMember', window );">Medicare | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_CARESActOf2020MedicarePaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act of 2020 medicare payment amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_CARESActOf2020MedicarePaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_CARESActOf2020ProviderReliefFundAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act of 2020 Provider Relief Fund amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_CARESActOf2020ProviderReliefFundAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncreaseDecreaseInEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in earnings (loss) per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncreaseDecreaseInEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which increases (decreases) right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=mygn_PerformanceObligationEstimatedTransactionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=mygn_PerformanceObligationEstimatedTransactionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GovernmentContractsConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GovernmentContractsConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979666534840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Revenue by Type (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 154.6<span></span>
</td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="nump">$ 164.0<span></span>
</td>
<td class="nump">$ 195.1<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
<td class="nump">$ 215.4<span></span>
</td>
<td class="nump">$ 216.6<span></span>
</td>
<td class="nump">$ 216.8<span></span>
</td>
<td class="nump">$ 202.3<span></span>
</td>
<td class="nump">$ 299.8<span></span>
</td>
<td class="nump">$ 381.4<span></span>
</td>
<td class="nump">$ 638.6<span></span>
</td>
<td class="nump">$ 851.1<span></span>
</td>
<td class="nump">$ 743.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember', window );">Molecular diagnostic testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">143.9<span></span>
</td>
<td class="nump">135.7<span></span>
</td>
<td class="nump">83.3<span></span>
</td>
<td class="nump">150.5<span></span>
</td>
<td class="nump">181.1<span></span>
</td>
<td class="nump">172.0<span></span>
</td>
<td class="nump">196.9<span></span>
</td>
<td class="nump">200.5<span></span>
</td>
<td class="nump">203.0<span></span>
</td>
<td class="nump">189.0<span></span>
</td>
<td class="nump">279.6<span></span>
</td>
<td class="nump">353.1<span></span>
</td>
<td class="nump">586.9<span></span>
</td>
<td class="nump">789.4<span></span>
</td>
<td class="nump">690.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticHereditaryCancerTestingMember', window );">Molecular diagnostic - Hereditary Cancer Testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">347.4<span></span>
</td>
<td class="nump">479.7<span></span>
</td>
<td class="nump">471.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticGenesightTestingMember', window );">Molecular diagnostic - GeneSight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">112.6<span></span>
</td>
<td class="nump">124.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticPrenatalTestingMember', window );">Molecular diagnostic - Prenatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.7<span></span>
</td>
<td class="nump">104.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticVectraTestingMember', window );">Molecular diagnostic - Vectra</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
<td class="nump">48.3<span></span>
</td>
<td class="nump">55.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticMyChoiceCDxMember', window );">Molecular diagnostic - myChoice CDx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticProlarisTestingMember', window );">Molecular diagnostic - Prolaris</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
<td class="nump">25.5<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticEndoPredictTestingMember', window );">Molecular diagnostic - EndoPredict</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticOtherTestingMember', window );">Molecular diagnostic - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember', window );">Pharmaceutical and clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 10.7<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 13.5<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="nump">$ 18.5<span></span>
</td>
<td class="nump">$ 16.1<span></span>
</td>
<td class="nump">$ 13.8<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="nump">$ 20.2<span></span>
</td>
<td class="nump">$ 28.3<span></span>
</td>
<td class="nump">$ 51.7<span></span>
</td>
<td class="nump">$ 61.7<span></span>
</td>
<td class="nump">$ 53.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticHereditaryCancerTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticHereditaryCancerTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticGenesightTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticGenesightTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticPrenatalTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticPrenatalTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticVectraTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticVectraTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticMyChoiceCDxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticMyChoiceCDxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticProlarisTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticProlarisTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticEndoPredictTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticEndoPredictTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticOtherTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticOtherTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670408584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Reconciliation of Deferred Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Reconciliation of Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue - beginning balance</a></td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized', window );">Revenue recognized</a></td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(7.2)<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ContractWithCustomerLiabilityPrepayments', window );">Prepayments</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">37.8<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue - ending balance</a></td>
<td class="nump">$ 32.7<span></span>
</td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Including New Contract, Revenue Recognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ContractWithCustomerLiabilityPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer, liability, prepayments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ContractWithCustomerLiabilityPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979754353528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Earnings Per Share (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding used to compute basic EPS</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">73.4<span></span>
</td>
<td class="nump">73.3<span></span>
</td>
<td class="nump">74.2<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">69.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares outstanding and dilutive securities used to compute diluted EPS</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">74.8<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">76.5<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">76.0<span></span>
</td>
<td class="nump">72.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive options and RSUs excluded from EPS computation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664838136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Foreign Currency Cumulative Translation Adjustments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward', window );"><strong>Cumulative Translation Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Beginning balance</a></td>
<td class="num">$ (6.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease', window );">Period translation adjustments</a></td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax', window );">Other</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Ending balance</a></td>
<td class="num">$ (3.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency, Other Adjustment, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeTranslationAdjustmentSummaryRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979667688472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, Amortized cost</a></td>
<td class="nump">$ 117.0<span></span>
</td>
<td class="nump">$ 163.7<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Estimated fair value</a></td>
<td class="nump">117.0<span></span>
</td>
<td class="nump">163.7<span></span>
</td>
<td class="nump">93.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCashAbstract', window );"><strong>Total:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_InvestmentsAndCashAmortizedCost', window );">Total, Amortized cost</a></td>
<td class="nump">170.9<span></span>
</td>
<td class="nump">253.5<span></span>
</td>
<td class="nump">191.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax', window );">Total, Gross unrealized holding gains</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax', window );">Total, Gross unrealized holding gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Total, Estimated fair value</a></td>
<td class="nump">171.7<span></span>
</td>
<td class="nump">254.8<span></span>
</td>
<td class="nump">191.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, Amortized cost</a></td>
<td class="nump">47.9<span></span>
</td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">68.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Estimated fair value</a></td>
<td class="nump">47.9<span></span>
</td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">68.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, Amortized cost</a></td>
<td class="nump">69.1<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Estimated fair value</a></td>
<td class="nump">69.1<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized cost</a></td>
<td class="nump">28.8<span></span>
</td>
<td class="nump">50.1<span></span>
</td>
<td class="nump">64.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Gross unrealized holding gains</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Estimated fair value</a></td>
<td class="nump">29.3<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">64.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized cost</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Gross unrealized holding gains</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Estimated fair value</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized cost</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Gross unrealized holding gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Estimated fair value</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized cost</a></td>
<td class="nump">11.7<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Gross unrealized holding gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Estimated fair value</a></td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="nump">$ 16.6<span></span>
</td>
<td class="nump">$ 9.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments And Cash, Accumulated Gross Unrealized Gain, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments And Cash, Accumulated Gross Unrealized Loss, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_InvestmentsAndCashAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments And Cash, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_InvestmentsAndCashAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979668583576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 117.0<span></span>
</td>
<td class="nump">$ 163.7<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Available-for-sale, Due within one year</a></td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Available-for-sale, Due after one year through five years</a></td>
<td class="nump">20.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Available-for-sale, Due after five years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_InvestmentsAndCashAmortizedCost', window );">Total, Amortized cost</a></td>
<td class="nump">170.9<span></span>
</td>
<td class="nump">253.5<span></span>
</td>
<td class="nump">191.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Estimated fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">117.0<span></span>
</td>
<td class="nump">163.7<span></span>
</td>
<td class="nump">93.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Available-for-sale, Due within one year</a></td>
<td class="nump">33.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Available-for-sale, Due after one year through five years</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Available-for-sale, Due after five years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Total, Estimated fair value</a></td>
<td class="nump">171.7<span></span>
</td>
<td class="nump">254.8<span></span>
</td>
<td class="nump">191.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">47.9<span></span>
</td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">68.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Estimated fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">47.9<span></span>
</td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">68.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">69.1<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Estimated fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 69.1<span></span>
</td>
<td class="nump">$ 30.9<span></span>
</td>
<td class="nump">$ 24.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_InvestmentsAndCashAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments And Cash, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_InvestmentsAndCashAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664735240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Investment Securities - Narrative (Details) - security<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Debt securities, available-for-sale, in unrealized loss position</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670973304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - Level 3 - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Estimated fair value of long-term debt</a></td>
<td class="nump">$ 225.8<span></span>
</td>
<td class="nump">$ 225.5<span></span>
</td>
<td class="nump">$ 192.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Measurement input, expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm', window );">Measurement period for earn out liability</a></td>
<td class="text">14 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Measurement Input, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979667397528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">$ 112.9<span></span>
</td>
<td class="nump">$ 115.2<span></span>
</td>
<td class="nump">$ 104.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">69.1<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">29.3<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">66.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mygn_ContingentConsiderationMember', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="num">(10.9)<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">69.1<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">19.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">69.1<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">54.7<span></span>
</td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">98.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">29.3<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">64.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="num">(10.9)<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="num">$ (10.9)<span></span>
</td>
<td class="num">$ (6.8)<span></span>
</td>
<td class="num">$ (13.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mygn_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mygn_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979661808984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Reconciliation of change in fair value of contingent consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 13.8<span></span>
</td>
<td class="nump">$ 14.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payment of contingent consideration</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value recognized in the statement of operations</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Translation adjustments recognized in other comprehensive income</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 10.9<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 13.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671371528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">35.7<span></span>
</td>
<td class="nump">31.8<span></span>
</td>
<td class="nump">31.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Equipment</a></td>
<td class="nump">117.9<span></span>
</td>
<td class="nump">112.1<span></span>
</td>
<td class="nump">117.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">153.6<span></span>
</td>
<td class="nump">143.9<span></span>
</td>
<td class="nump">169.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(112.9)<span></span>
</td>
<td class="num">(106.9)<span></span>
</td>
<td class="num">(111.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 40.7<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="nump">$ 57.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664651864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mygn_ClinicAssetGroupMember', window );">Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisposals', window );">Property, plant and equipment sold and deconsolidated</a></td>
<td class="nump">$ 19.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mygn_ClinicAssetGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mygn_ClinicAssetGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671074104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Depreciation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
<td class="nump">$ 13.7<span></span>
</td>
<td class="nump">$ 17.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979672894056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Carrying Amount of Goodwill (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 327,600,000<span></span>
</td>
<td class="nump">$ 417,200,000<span></span>
</td>
<td class="nump">$ 318,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">94,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments to acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill deconsolidated on sale of Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,300,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(82,000,000.0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation adjustments</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">329,200,000<span></span>
</td>
<td class="nump">327,600,000<span></span>
</td>
<td class="nump">417,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember', window );">Diagnostic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">270,700,000<span></span>
</td>
<td class="nump">351,600,000<span></span>
</td>
<td class="nump">252,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">94,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments to acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill deconsolidated on sale of Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation adjustments</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">272,300,000<span></span>
</td>
<td class="nump">270,700,000<span></span>
</td>
<td class="nump">351,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">56,900,000<span></span>
</td>
<td class="nump">65,600,000<span></span>
</td>
<td class="nump">65,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments to acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill deconsolidated on sale of Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,300,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,300,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 56,900,000<span></span>
</td>
<td class="nump">$ 56,900,000<span></span>
</td>
<td class="nump">$ 65,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979667732392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 82,000,000.0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average remaining amortization period</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_DevelopedTechnologyAndDatabaseMember', window );">Developed technology and database | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_DevelopedTechnologyAndDatabaseMember', window );">Developed technology and database | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember', window );">Diagnostic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible assets impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember', window );">Diagnostic | Myriad Autoimmune reporting unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other | Clinic reporting unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill And Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_GoodwillAndIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_GoodwillAndIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_DevelopedTechnologyAndDatabaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_DevelopedTechnologyAndDatabaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mygn_MyriadAutoimmuneReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mygn_MyriadAutoimmuneReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mygn_ClinicReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mygn_ClinicReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979668169576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, amortizable</a></td>
<td class="nump">$ 825.9<span></span>
</td>
<td class="nump">$ 823.2<span></span>
</td>
<td class="nump">$ 823.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(254.2)<span></span>
</td>
<td class="num">(222.7)<span></span>
</td>
<td class="num">(161.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total, net, amortizable</a></td>
<td class="nump">571.7<span></span>
</td>
<td class="nump">600.5<span></span>
</td>
<td class="nump">661.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount, total</a></td>
<td class="nump">830.7<span></span>
</td>
<td class="nump">828.0<span></span>
</td>
<td class="nump">846.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net, total</a></td>
<td class="nump">576.5<span></span>
</td>
<td class="nump">605.3<span></span>
</td>
<td class="nump">684.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_PurchasedLicensesAndTechnologiesMember', window );">Purchased licenses and technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, amortizable</a></td>
<td class="nump">818.2<span></span>
</td>
<td class="nump">815.6<span></span>
</td>
<td class="nump">815.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(248.2)<span></span>
</td>
<td class="num">(217.1)<span></span>
</td>
<td class="num">(156.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total, net, amortizable</a></td>
<td class="nump">570.0<span></span>
</td>
<td class="nump">598.5<span></span>
</td>
<td class="nump">659.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, amortizable</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total, net, amortizable</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, amortizable</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total, net, amortizable</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 23.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_PurchasedLicensesAndTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_PurchasedLicensesAndTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671217608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Amortization on Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 30.8<span></span>
</td>
<td class="nump">$ 61.0<span></span>
</td>
<td class="nump">$ 59.3<span></span>
</td>
<td class="nump">$ 37.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979668877176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Future Amortization Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future Amortization Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 58.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">52.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">52.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">52.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">52.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">302.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total, net, amortizable</a></td>
<td class="nump">$ 571.7<span></span>
</td>
<td class="nump">$ 600.5<span></span>
</td>
<td class="nump">$ 661.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979665074920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">$ 43.7<span></span>
</td>
<td class="nump">$ 47.4<span></span>
</td>
<td class="nump">$ 48.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Accrued taxes payable</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Qui tam settlement</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_RecoupmentsPayableAndReserveCurrent', window );">Recoupments payable and reserves</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Short-term contingent consideration</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">18.4<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 79.1<span></span>
</td>
<td class="nump">$ 79.0<span></span>
</td>
<td class="nump">$ 82.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_RecoupmentsPayableAndReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recoupments Payable And Reserve, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_RecoupmentsPayableAndReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979860731544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Dec. 23, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Aggregate principal amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226,700,000<span></span>
</td>
<td class="nump">$ 226,700,000<span></span>
</td>
<td class="nump">$ 235,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Principal repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
<td class="nump">115,000,000.0<span></span>
</td>
<td class="nump">$ 143,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Principal repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="nump">$ 115,000,000.0<span></span>
</td>
<td class="nump">$ 143,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum aggregate principal commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Aggregate principal amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Upfront fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Scheduled principal payments prior to maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended facility | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum aggregate principal commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Undrawn fee (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_DebtInstrumentLIBORFloorPercentage', window );">LIBOR floor (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended facility | Forecast | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Undrawn fee (percent)</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended facility | Forecast | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Undrawn fee (percent)</a></td>
<td class="nump">0.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended facility | LIBOR | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on rate (percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_DebtInstrumentLIBORFloorPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, LIBOR Floor, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_DebtInstrumentLIBORFloorPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section S45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68176171&amp;loc=SL68176184-208336<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mygn_AmendmentToCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mygn_AmendmentToCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671001080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 226.7<span></span>
</td>
<td class="nump">$ 226.7<span></span>
</td>
<td class="nump">$ 235.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent', window );">Long-term debt discount</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net long-term debt</a></td>
<td class="nump">$ 224.8<span></span>
</td>
<td class="nump">$ 224.4<span></span>
</td>
<td class="nump">$ 233.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671122904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Long-Term Liabilities - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Pension obligation</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 14.7<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663268328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Long-Term Liabilities - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>plan</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_NumberOfDefinedBenefitPensionPlans', window );">Number of defined benefit pension plans | plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Net pension liability</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_NumberOfDefinedBenefitPensionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of defined benefit pension plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_NumberOfDefinedBenefitPensionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670022584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">75,400,000<span></span>
</td>
<td class="nump">74,700,000<span></span>
</td>
<td class="nump">73,500,000<span></span>
</td>
<td class="nump">70,600,000<span></span>
</td>
<td class="nump">68,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">75,400,000<span></span>
</td>
<td class="nump">74,700,000<span></span>
</td>
<td class="nump">73,500,000<span></span>
</td>
<td class="nump">70,600,000<span></span>
</td>
<td class="nump">68,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining repurchase authorization</a></td>
<td class="nump">$ 110.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of Company stock</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979665099368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Common shares issued and outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning common stock issued</a></td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">70.6<span></span>
</td>
<td class="nump">68.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning common stock outstanding</a></td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">70.6<span></span>
</td>
<td class="nump">68.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans', window );">Common stock issued upon exercise of options and employee stock plans</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending common stock issued</a></td>
<td class="nump">75.4<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">70.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending common stock outstanding</a></td>
<td class="nump">75.4<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">70.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671106712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity - Stock Repurchases (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares purchased and retired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases', window );">Common stock and additional paid-in-capital reductions</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases', window );">Charges to retained earnings</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 33.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to retained earnings as a result of stock repurchases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reduction in common stock as a result of stock repurchases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979668045800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">97 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 05, 2012 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (shares) | shares</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense related to stock options | $</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of restricted stock units vested during period | $</a></td>
<td class="nump">$ 29.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mygn_OptionsAndRestrictedStockUnitsMember', window );">Options and RSUs | Non-employee director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Service period for award vesting (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Service period for award vesting (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized share-based compensation expense, weighted-average period for recognition</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | President and Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice', window );">Stock price consecutive days threshold for award vesting condition | d</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Awards granted after December 5, 2012</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period (in years)</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Awards granted prior to December 5, 2012</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Service period for award vesting (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (dollars per share) | $ / shares</a></td>
<td class="nump">$ 13.69<span></span>
</td>
<td class="nump">$ 27.96<span></span>
</td>
<td class="nump">$ 46.62<span></span>
</td>
<td class="nump">$ 32.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of restricted stock units vested during period | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.4<span></span>
</td>
<td class="nump">$ 27.6<span></span>
</td>
<td class="nump">$ 20.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized share-based compensation expense | $</a></td>
<td class="nump">$ 54.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized share-based compensation expense, weighted-average period for recognition</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Achievement levels based on EPS targets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting weight (percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Performance based on Nasdaq Healthcare Provider Index</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting weight (percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember', window );">2017 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares available for future grant | shares</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember', window );">2010 Plan | Options and RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares available for future grant | shares</a></td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember', window );">2012 Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares available for future grant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued under the Plan | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Metric, Threshold Consecutive Days, Stock Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mygn_OptionsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mygn_OptionsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=mygn_NonEmployeeDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=mygn_NonEmployeeDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979676531064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Options Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning (shares)</a></td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (shares)</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options canceled or expired (shares)</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, ending (shares)</a></td>
<td class="nump">5,200,000<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (shares)</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest (shares)</a></td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Options, Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning (dollars per share)</a></td>
<td class="nump">$ 24.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (dollars per share)</a></td>
<td class="nump">13.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options canceled or expired (dollars per share)</a></td>
<td class="nump">19.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, ending (dollars per share)</a></td>
<td class="nump">23.24<span></span>
</td>
<td class="nump">$ 24.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable (dollars per share)</a></td>
<td class="nump">24.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest (dollars per share)</a></td>
<td class="nump">$ 23.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979754345528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Valuation Assumptions for Stock Options (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum', window );">Derived service period, minimum (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum', window );">Derived service period, maximum (in years)</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">73.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">77.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979667706264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Options Outstanding (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding | shares</a></td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (years</a></td>
<td class="text">1 year 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price</a></td>
<td class="nump">$ 24.71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeOneMember', window );">$ 13.38 - 19.47</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, minimum</a></td>
<td class="nump">13.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, maximum</a></td>
<td class="nump">$ 19.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding | shares</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (years</a></td>
<td class="text">2 years 11 months 1 day<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price</a></td>
<td class="nump">$ 19.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeTwoMember', window );">$ 21.29 - 25.39</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, minimum</a></td>
<td class="nump">21.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, maximum</a></td>
<td class="nump">$ 25.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding | shares</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (years</a></td>
<td class="text">11 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price</a></td>
<td class="nump">$ 23.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeThreeMember', window );">$ 26.49 - 26.49</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, minimum</a></td>
<td class="nump">26.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, maximum</a></td>
<td class="nump">$ 26.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding | shares</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (years</a></td>
<td class="text">8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price</a></td>
<td class="nump">$ 26.49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeFourMember', window );">$ 27.07 - 36.55</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, minimum</a></td>
<td class="nump">27.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, maximum</a></td>
<td class="nump">$ 36.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding | shares</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (years</a></td>
<td class="text">1 year 8 months 8 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price</a></td>
<td class="nump">$ 27.18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mygn_RangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979662152200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Restricted Stock Units Activity (Details) - RSUs - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>RSUs, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSUs outstanding, beginning (shares)</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (shares)</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (shares)</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">RSUs canceled (shares)</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSUs outstanding, ending (shares)</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>RSUs, Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">RSUs outstanding, beginning (dollars per share)</a></td>
<td class="nump">$ 32.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">RSUs granted (dollars per share)</a></td>
<td class="nump">13.69<span></span>
</td>
<td class="nump">$ 27.96<span></span>
</td>
<td class="nump">$ 46.62<span></span>
</td>
<td class="nump">$ 32.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (dollars per share)</a></td>
<td class="nump">32.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">RSUs canceled (dollars per share)</a></td>
<td class="nump">31.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">RSUs outstanding, ending (dollars per share)</a></td>
<td class="nump">$ 20.56<span></span>
</td>
<td class="nump">$ 32.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670275432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Share-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 14.9<span></span>
</td>
<td class="nump">$ 25.2<span></span>
</td>
<td class="nump">$ 33.5<span></span>
</td>
<td class="nump">$ 27.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mygn_CostOfMolecularDiagnosticTestingMember', window );">Cost of molecular diagnostic testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mygn_CostOfPharmaceuticalAndClinicalServicesMember', window );">Cost of pharmaceutical and clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general, and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="nump">$ 18.7<span></span>
</td>
<td class="nump">$ 27.1<span></span>
</td>
<td class="nump">$ 21.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mygn_CostOfMolecularDiagnosticTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mygn_CostOfMolecularDiagnosticTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mygn_CostOfPharmaceuticalAndClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mygn_CostOfPharmaceuticalAndClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671183672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-Based Compensation - Unrecognized Share-Based Compensation Cost (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized share-based compensation cost</a></td>
<td class="nump">$ 54.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value of options fully vested</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value of RSUs outstanding</a></td>
<td class="nump">$ 63.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664822680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Intrinsic Value of Options Exercised (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 17.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979671014680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Shares Purchased and Compensation Expenses for ESPP (Details) - 2012 Purchase Plan - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Shares purchased under the plans</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Plan compensation expense</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979667715336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Valuation Assumptions for ESPP (Details) - 2012 Purchase Plan<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">94.00%<span></span>
</td>
<td class="nump">99.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979751064920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Benefit (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (75.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.6<span></span>
</td>
<td class="num">$ (24.2)<span></span>
</td>
<td class="nump">$ 7.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.0<span></span>
</td>
<td class="num">(24.1)<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51.5)<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
<td class="num">(22.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55.7)<span></span>
</td>
<td class="nump">19.7<span></span>
</td>
<td class="num">(22.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax benefit</a></td>
<td class="num">$ (12.5)<span></span>
</td>
<td class="num">$ (28.5)<span></span>
</td>
<td class="num">$ (3.0)<span></span>
</td>
<td class="num">$ (15.9)<span></span>
</td>
<td class="num">$ (3.1)<span></span>
</td>
<td class="num">$ (1.7)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="num">$ (3.6)<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="num">$ (41.0)<span></span>
</td>
<td class="num">$ (4.8)<span></span>
</td>
<td class="num">$ (23.7)<span></span>
</td>
<td class="num">$ (4.4)<span></span>
</td>
<td class="num">$ (13.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979668176232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income (Loss) Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income (loss) before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (101.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (240.9)<span></span>
</td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="nump">$ 122.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income tax</a></td>
<td class="num">$ (50.4)<span></span>
</td>
<td class="num">$ (43.7)<span></span>
</td>
<td class="num">$ (58.5)<span></span>
</td>
<td class="num">$ (131.1)<span></span>
</td>
<td class="num">$ (11.4)<span></span>
</td>
<td class="num">$ (22.3)<span></span>
</td>
<td class="num">$ (7.7)<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="num">$ (94.1)<span></span>
</td>
<td class="num">$ (33.7)<span></span>
</td>
<td class="num">$ (223.3)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 120.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670178872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Statutory Federal Income Tax Rate and Income Taxes Reported (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal income tax expense at the statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46.9)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 33.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits, net of the federal tax on state credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax positions, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationStatuteExpiration', window );">Uncertain tax benefits statute expired, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Incentive stock option and employee stock purchase plan expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact', window );">Tax Cut and Jobs Act impact</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(32.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationCARESAct', window );">CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration', window );">Fair value adjustments related to acquisition contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(17.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts', window );">Non-deductible contingent purchase price and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Non-deductible meals and entertainment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation', window );">Non-deductible officer compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationAssetImpairment', window );">Asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationExpiredTaxAttributes', window );">Expired tax attributes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement', window );">Non-deductible legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationForeignDisregardedElection', window );">Foreign disregarded election</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod', window );">Changes in revenue recognition/method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(7.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax benefit</a></td>
<td class="num">$ (12.5)<span></span>
</td>
<td class="num">$ (28.5)<span></span>
</td>
<td class="num">$ (3.0)<span></span>
</td>
<td class="num">$ (15.9)<span></span>
</td>
<td class="num">$ (3.1)<span></span>
</td>
<td class="num">$ (1.7)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="num">$ (3.6)<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="num">$ (41.0)<span></span>
</td>
<td class="num">$ (4.8)<span></span>
</td>
<td class="num">$ (23.7)<span></span>
</td>
<td class="num">$ (4.4)<span></span>
</td>
<td class="num">$ (13.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal income tax expense at the statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">6422.10%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credits, net of the federal tax on state credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="num">(11880.90%)<span></span>
</td>
<td class="num">(1.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Uncertain tax positions, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
<td class="nump">9312.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations', window );">Uncertain tax benefits statute expired, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(22798.50%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Incentive stock option and employee stock purchase plan expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(9954.30%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">2568.80%<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.70%)<span></span>
</td>
<td class="num">(642.20%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact', window );">Tax Cut and Jobs Act impact</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(26.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationCARESAct', window );">CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration', window );">Fair value adjustments related to acquisition contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2568.80%<span></span>
</td>
<td class="num">(14.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts', window );">Non-deductible contingent purchase price and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Non-deductible meals and entertainment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
<td class="nump">4174.40%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation', window );">Non-deductible officer compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="nump">1926.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment', window );">Asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.60%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes', window );">Expired tax attributes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.90%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements', window );">Non-deductible legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">6101.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection', window );">Foreign disregarded election</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">20550.80%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod', window );">Changes in revenue recognition/method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(23440.80%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">963.40%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.60%<span></span>
</td>
<td class="num">(14107.70%)<span></span>
</td>
<td class="num">(10.70%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation asset impairment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation, changes in revenue recognition/method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation expired tax attributes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation fair value adjustments related to acquisition contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation foreign disregarded election.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation non deductible contingent purchase price and transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation non deductible legal settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation non-deductible officer compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Statute Expirations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation tax cut and jobs act impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation asset impairment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Reconciliation CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation changes in revenue recognition method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationExpiredTaxAttributes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation expired tax attributes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationExpiredTaxAttributes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation fair value adjustments related to acquisition contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationForeignDisregardedElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation foreign disregarded election.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationForeignDisregardedElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation non deductible contingent purchase price and transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation non-deductible legal settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense officers compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationStatuteExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation statute expiration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationStatuteExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation tax cut and jobs act impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979666878328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 72.2<span></span>
</td>
<td class="nump">$ 73.1<span></span>
</td>
<td class="nump">$ 85.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">37.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences', window );">Accrued vacation</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">AR allowance</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation expense</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development credits</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">27.6<span></span>
</td>
<td class="nump">25.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_DeferredTaxAssetsLeaseRightOfUseAsset', window );">Lease right-of-use asset</a></td>
<td class="nump">15.2<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_DeferredTaxAssetsUncertainStateTaxPositions', window );">Uncertain state tax positions</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other, net</a></td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">145.0<span></span>
</td>
<td class="nump">181.9<span></span>
</td>
<td class="nump">141.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(42.0)<span></span>
</td>
<td class="num">(42.4)<span></span>
</td>
<td class="num">(38.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">103.0<span></span>
</td>
<td class="nump">139.5<span></span>
</td>
<td class="nump">103.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">144.0<span></span>
</td>
<td class="nump">150.3<span></span>
</td>
<td class="nump">175.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_DeferredTaxLeaseLiability', window );">Lease liability</a></td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">15.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="nump">174.3<span></span>
</td>
<td class="nump">166.1<span></span>
</td>
<td class="nump">185.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">$ (71.3)<span></span>
</td>
<td class="num">$ (26.6)<span></span>
</td>
<td class="num">$ (82.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_DeferredTaxAssetsLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_DeferredTaxAssetsLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_DeferredTaxAssetsUncertainStateTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Uncertain State Tax Positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_DeferredTaxAssetsUncertainStateTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_DeferredTaxLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_DeferredTaxLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979669517192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct', window );">Tax benefit related to operating loss carryback, CARES Act</a></td>
<td class="nump">$ 20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit', window );">Final tax benefit of Tax Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare', window );">Earnings per share impact of Tax Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod', window );">Increase in valuation allowance</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="nump">174.3<span></span>
</td>
<td class="nump">166.1<span></span>
</td>
<td class="nump">185.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">145.0<span></span>
</td>
<td class="nump">181.9<span></span>
</td>
<td class="nump">141.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_UnrecognizedTaxBenefitsNet', window );">Net unrecognized tax benefits</a></td>
<td class="nump">$ 30.5<span></span>
</td>
<td class="nump">$ 23.5<span></span>
</td>
<td class="nump">$ 21.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">U.S. Federal and state jurisdictions | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">U.S. Federal and state jurisdictions | Latest tax years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Latest tax years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Germany | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Germany | Latest tax years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Switzerland | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Switzerland | Latest tax years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and local jurisdictions | New Jersey | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and local jurisdictions | New Jersey | Latest tax years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and local jurisdictions | New York | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and local jurisdictions | New York | Latest tax years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember', window );">Counsyl Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit), Operating Loss Carryback, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts And Jobs Act, Change In Tax Rate, Increase (Decrease) In Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_UnrecognizedTaxBenefitsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_UnrecognizedTaxBenefitsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Increase (Decrease) During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationYearUnderExamination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year being audited in the income tax examination, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationYearUnderExamination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_FederalMinistryOfFinanceGermanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_FederalMinistryOfFinanceGermanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979675488248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Net Operating Loss and Research Credit Carryforwards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Net operating loss subject to sections 382,383</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Federal | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss, expiration in year</a></td>
<td class="text">2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Federal | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss, expiration in year</a></td>
<td class="text">2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Federal | Research credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research credit</a></td>
<td class="nump">$ 9.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse', window );">Research credit subject to sections 382,383</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Federal | Research credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TaxCreditCarryforwardsExpirationDate', window );">Research credit, expiration in year</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Federal | Research credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TaxCreditCarryforwardsExpirationDate', window );">Research credit, expiration in year</a></td>
<td class="text">2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Utah</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Net operating loss subject to sections 382,383</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Utah | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss, expiration in year</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Utah | Research credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research credit</a></td>
<td class="nump">$ 11.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse', window );">Research credit subject to sections 382,383</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Utah | Research credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TaxCreditCarryforwardsExpirationDate', window );">Research credit, expiration in year</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Utah | Research credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TaxCreditCarryforwardsExpirationDate', window );">Research credit, expiration in year</a></td>
<td class="text">2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Net operating loss subject to sections 382,383</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss, expiration in year</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss, expiration in year</a></td>
<td class="text">2042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California | Research credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research credit</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse', window );">Research credit subject to sections 382,383</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California | Research credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TaxCreditCarryforwardsExpirationDate', window );">Research credit, expiration in year</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Texas | Research credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse', window );">Research credit subject to sections 382,383</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Texas | Research credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TaxCreditCarryforwardsExpirationDate', window );">Research credit, expiration in year</a></td>
<td class="text">2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Texas | Research credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TaxCreditCarryforwardsExpirationDate', window );">Research credit, expiration in year</a></td>
<td class="text">2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Net operating loss subject to sections 382,383</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Other | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss, expiration in year</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Other | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss, expiration in year</a></td>
<td class="text">2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">$ 9.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Net operating loss subject to sections 382,383</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_OperatingLossCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Expiration Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_OperatingLossCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_TaxCreditCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Credit Carryforwards Expiration Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_TaxCreditCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the limitation related to use of the tax credit carryforward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=stpr_UT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=stpr_UT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=mygn_OtherStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=mygn_OtherStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979759395672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at the beginning of period</a></td>
<td class="nump">$ 23.5<span></span>
</td>
<td class="nump">$ 21.7<span></span>
</td>
<td class="nump">$ 24.9<span></span>
</td>
<td class="nump">$ 25.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increases - current year tax positions</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases - prior year tax positions</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Gross increases - acquisitions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross decreases - prior year tax positions</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Gross decreases - settlements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Gross decreases - statute lapse</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at end of year</a></td>
<td class="nump">37.6<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Interest and penalties in year-end balance</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979665059656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease cost</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 18.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease expense</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense (prior to adoption of ASU 2016-02)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.7<span></span>
</td>
<td class="nump">$ 15.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease weighted average remaining lease term</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease weighted average discount rate</a></td>
<td class="nump">3.87%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979754352392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturities of operating lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 15.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">70.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: amounts representing interest</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future lease payments</a></td>
<td class="nump">64.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current maturities of operating lease liabilities</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">$ 13.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">$ 50.6<span></span>
</td>
<td class="nump">$ 56.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979665401432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Deferred Savings Plan - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Company matching contribution as percentage of employee contribution</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Company matching contribution, maximum as percentage of employee compensation</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664910344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Deferred Savings Plan - Contributions to Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Deferred savings plan contributions</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664781672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979776308104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information - Segment Operating Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 154.6<span></span>
</td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="nump">$ 164.0<span></span>
</td>
<td class="nump">$ 195.1<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
<td class="nump">$ 215.4<span></span>
</td>
<td class="nump">$ 216.6<span></span>
</td>
<td class="nump">$ 216.8<span></span>
</td>
<td class="nump">$ 202.3<span></span>
</td>
<td class="nump">$ 299.8<span></span>
</td>
<td class="nump">$ 381.4<span></span>
</td>
<td class="nump">$ 638.6<span></span>
</td>
<td class="nump">$ 851.1<span></span>
</td>
<td class="nump">$ 743.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.0<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">54.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income (loss)</a></td>
<td class="num">$ (48.2)<span></span>
</td>
<td class="num">$ (39.6)<span></span>
</td>
<td class="num">$ (68.3)<span></span>
</td>
<td class="num">$ (133.7)<span></span>
</td>
<td class="num">$ (8.8)<span></span>
</td>
<td class="num">$ (20.9)<span></span>
</td>
<td class="num">$ (5.6)<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="num">(87.8)<span></span>
</td>
<td class="num">$ (29.7)<span></span>
</td>
<td class="num">(231.7)<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">121.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable segments | Diagnostic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">593.5<span></span>
</td>
<td class="nump">789.4<span></span>
</td>
<td class="nump">690.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.2<span></span>
</td>
<td class="nump">67.7<span></span>
</td>
<td class="nump">49.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82.4)<span></span>
</td>
<td class="nump">133.3<span></span>
</td>
<td class="nump">142.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable segments | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.1<span></span>
</td>
<td class="nump">61.7<span></span>
</td>
<td class="nump">53.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (86.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (149.3)<span></span>
</td>
<td class="num">$ (125.7)<span></span>
</td>
<td class="num">$ (20.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979674546504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income (loss)</a></td>
<td class="num">$ (48.2)<span></span>
</td>
<td class="num">$ (39.6)<span></span>
</td>
<td class="num">$ (68.3)<span></span>
</td>
<td class="num">$ (133.7)<span></span>
</td>
<td class="num">$ (8.8)<span></span>
</td>
<td class="num">$ (20.9)<span></span>
</td>
<td class="num">$ (5.6)<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="num">$ (87.8)<span></span>
</td>
<td class="num">$ (29.7)<span></span>
</td>
<td class="num">$ (231.7)<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="nump">$ 121.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income tax</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="num">(43.7)<span></span>
</td>
<td class="num">(58.5)<span></span>
</td>
<td class="num">(131.1)<span></span>
</td>
<td class="num">(11.4)<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
<td class="num">(7.7)<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(94.1)<span></span>
</td>
<td class="num">(33.7)<span></span>
</td>
<td class="num">(223.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">120.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(28.5)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(15.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="num">(41.0)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="num">(23.7)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(37.9)<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
<td class="num">(55.5)<span></span>
</td>
<td class="num">(115.2)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(53.1)<span></span>
</td>
<td class="num">(28.9)<span></span>
</td>
<td class="num">(199.6)<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">133.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (37.9)<span></span>
</td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="num">$ (55.4)<span></span>
</td>
<td class="num">$ (115.2)<span></span>
</td>
<td class="num">$ (8.3)<span></span>
</td>
<td class="num">$ (20.6)<span></span>
</td>
<td class="num">$ (4.2)<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
<td class="num">$ (53.1)<span></span>
</td>
<td class="num">$ (28.9)<span></span>
</td>
<td class="num">$ (199.5)<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 133.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979667313336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment and Related Information - Balance Sheet Assets By Operating Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net equipment, leasehold improvements and property</a></td>
<td class="nump">$ 40.7<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="nump">$ 57.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net equipment, leasehold improvements and property</a></td>
<td class="nump">40.7<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="nump">57.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AssetsLessCashCashEquivalentsAndInvestments', window );">Total assets less cash, cash equivalents, and marketable investment securities</a></td>
<td class="nump">1,247.1<span></span>
</td>
<td class="nump">1,149.8<span></span>
</td>
<td class="nump">1,370.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable segments | Diagnostic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net equipment, leasehold improvements and property</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="nump">25.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AssetsLessCashCashEquivalentsAndInvestments', window );">Total assets less cash, cash equivalents, and marketable investment securities</a></td>
<td class="nump">994.0<span></span>
</td>
<td class="nump">1,002.8<span></span>
</td>
<td class="nump">1,215.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable segments | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net equipment, leasehold improvements and property</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">31.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AssetsLessCashCashEquivalentsAndInvestments', window );">Total assets less cash, cash equivalents, and marketable investment securities</a></td>
<td class="nump">$ 253.1<span></span>
</td>
<td class="nump">$ 147.0<span></span>
</td>
<td class="nump">$ 155.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_AssetsLessCashCashEquivalentsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets, Less Cash, Cash Equivalents, And Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_AssetsLessCashCashEquivalentsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979674509224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment and Related Information - Assets by Geographical Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net equipment, leasehold improvements and property</a></td>
<td class="nump">$ 40.7<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="nump">$ 57.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, and marketable investment securities</a></td>
<td class="nump">171.7<span></span>
</td>
<td class="nump">254.8<span></span>
</td>
<td class="nump">191.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,418.8<span></span>
</td>
<td class="nump">1,404.6<span></span>
</td>
<td class="nump">1,562.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember', window );">Reportable geographical components</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net equipment, leasehold improvements and property</a></td>
<td class="nump">40.7<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="nump">57.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AssetsLessCashCashEquivalentsAndInvestments', window );">Total assets by segment and geographical region</a></td>
<td class="nump">1,247.1<span></span>
</td>
<td class="nump">1,149.8<span></span>
</td>
<td class="nump">1,370.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember', window );">Reportable geographical components | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net equipment, leasehold improvements and property</a></td>
<td class="nump">38.4<span></span>
</td>
<td class="nump">35.4<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AssetsLessCashCashEquivalentsAndInvestments', window );">Total assets by segment and geographical region</a></td>
<td class="nump">1,190.3<span></span>
</td>
<td class="nump">1,097.2<span></span>
</td>
<td class="nump">1,265.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember', window );">Reportable geographical components | Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net equipment, leasehold improvements and property</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AssetsLessCashCashEquivalentsAndInvestments', window );">Total assets by segment and geographical region</a></td>
<td class="nump">$ 56.8<span></span>
</td>
<td class="nump">$ 52.6<span></span>
</td>
<td class="nump">$ 105.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_AssetsLessCashCashEquivalentsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets, Less Cash, Cash Equivalents, And Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_AssetsLessCashCashEquivalentsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979675179080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information - Revenue by Geographical Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 154.6<span></span>
</td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="nump">$ 164.0<span></span>
</td>
<td class="nump">$ 195.1<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
<td class="nump">$ 215.4<span></span>
</td>
<td class="nump">$ 216.6<span></span>
</td>
<td class="nump">$ 216.8<span></span>
</td>
<td class="nump">$ 202.3<span></span>
</td>
<td class="nump">$ 299.8<span></span>
</td>
<td class="nump">$ 381.4<span></span>
</td>
<td class="nump">$ 638.6<span></span>
</td>
<td class="nump">$ 851.1<span></span>
</td>
<td class="nump">$ 743.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596.2<span></span>
</td>
<td class="nump">805.4<span></span>
</td>
<td class="nump">700.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.4<span></span>
</td>
<td class="nump">$ 45.7<span></span>
</td>
<td class="nump">$ 43.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979664608072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Sale of Subsidiary (Details) - Clinic asset group<br> $ in Millions</strong></div></th>
<th class="th">
<div>Feb. 28, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Disposal of Subsidiary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale of subsidiary</a></td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension', window );">Gain related to pension settlement</a></td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect', window );">Loss to adjust net assets to purchase price and effects of foreign currency</a></td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Settlement Of Pension</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Writedown And Foreign Currency Effect</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mygn_ClinicAssetGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mygn_ClinicAssetGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979751079752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period increase to goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember', window );">Counsyl Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business acquisition consideration</a></td>
<td class="nump">$ 405.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment on business acquisition</a></td>
<td class="nump">278.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1', window );">Amount of cash consideration deposited in escrow account</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets', window );">Return of escrow as result of working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Reduction of intangible assets related to updated assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities', window );">Decrease in deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment', window );">Reduction of equipment related to updated assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period increase to goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Acquisition costs</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod', window );">Revenue contributed by acquired entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses related to acquired entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember', window );">Counsyl Inc | Developed screening processes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Acquired intangible assets</a></td>
<td class="nump">$ 290.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent', window );">Acquired intangible assets, valuation assumptions discount rate</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired intangible assets, estimated useful life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember', window );">Counsyl Inc | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, shares issued</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business acquisition, value of shares issued</a></td>
<td class="nump">$ 127.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business acquisition, per share market closing price</a></td>
<td class="nump">$ 42.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired Finite-Lived Intangible Assets, Valuation Assumptions, Net Cash Flow Discount Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue reported by the acquired entity for its previous full fiscal year before the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial assets acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial liabilities assumed in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of escrow deposit disbursements related to property acquisition in noncash investing or financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979751164152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Acquisitions - Total Consideration Transferred (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329.2<span></span>
</td>
<td class="nump">$ 327.6<span></span>
</td>
<td class="nump">$ 417.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 318.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember', window );">Counsyl Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="nump">$ 42.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">290.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment', window );">Equipment</a></td>
<td class="nump">18.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">99.3<span></span>
</td>
<td class="nump">$ 99.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(19.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Long term liabilities</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(9.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total fair value purchase price</a></td>
<td class="nump">421.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: Cash acquired</a></td>
<td class="num">(15.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration transferred</a></td>
<td class="nump">$ 405.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670408584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions - Changes to Goodwill Balance (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">27 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 329.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember', window );">Counsyl Inc</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">94.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment', window );">Fair value adjustment to equipment</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment', window );">Intangible adjustment</a></td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment', window );">Working capital adjustment</a></td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment', window );">Change in deferred tax liability</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 99.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill adjustment to deferred tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Increase (Decrease), Fair Value Adjustment, Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, intangible adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Increase (Decrease), Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979663404008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions - Pro Forma Results (Details) - Counsyl Inc - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationAbstract', window );"><strong>Pro Forma Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 861.3<span></span>
</td>
<td class="nump">$ 881.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax', window );">Income from operations</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 13.8<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Net income per share, basic</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Net income per share, diluted</a></td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="nump">$ 0.98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mygn_CounsylIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979676692904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Event (Details) - Revolving credit facility - Amended facility - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Dec. 23, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum aggregate principal commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum aggregate principal commitment</a></td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum', window );">Minimum unrestricted cash required for borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum aggregate principal commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Unrestricted Cash Required For Borrowing, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mygn_AmendmentToCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mygn_AmendmentToCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979676600360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="nump">$ 11.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity', window );">Fair value adjustment on marketable investment securities recorded to stockholders' equity</a></td>
<td class="num">$ (0.5)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Establishment of operation lease right-of-use assets and lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Accrued liabilities and other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Establishment of operation lease right-of-use assets and lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLeaseLiabilityEstablished', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (78.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment on marketable investment securities recorded to stockholders equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_OperatingLeaseLiabilityEstablished">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability Established</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_OperatingLeaseLiabilityEstablished</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979750700184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Quarterly Financial Data (Unaudited) - Quarterly Data (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 154.6<span></span>
</td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="nump">$ 164.0<span></span>
</td>
<td class="nump">$ 195.1<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
<td class="nump">$ 215.4<span></span>
</td>
<td class="nump">$ 216.6<span></span>
</td>
<td class="nump">$ 216.8<span></span>
</td>
<td class="nump">$ 202.3<span></span>
</td>
<td class="nump">$ 299.8<span></span>
</td>
<td class="nump">$ 381.4<span></span>
</td>
<td class="nump">$ 638.6<span></span>
</td>
<td class="nump">$ 851.1<span></span>
</td>
<td class="nump">$ 743.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">18.2<span></span>
</td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
<td class="nump">35.8<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">77.2<span></span>
</td>
<td class="nump">85.9<span></span>
</td>
<td class="nump">70.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in the fair value of contingent consideration</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(61.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expense</a></td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">124.1<span></span>
</td>
<td class="nump">107.4<span></span>
</td>
<td class="nump">132.9<span></span>
</td>
<td class="nump">134.3<span></span>
</td>
<td class="nump">135.5<span></span>
</td>
<td class="nump">149.8<span></span>
</td>
<td class="nump">140.6<span></span>
</td>
<td class="nump">135.2<span></span>
</td>
<td class="nump">129.9<span></span>
</td>
<td class="nump">256.9<span></span>
</td>
<td class="nump">269.8<span></span>
</td>
<td class="nump">510.1<span></span>
</td>
<td class="nump">555.5<span></span>
</td>
<td class="nump">435.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">98.4<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">99.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">202.8<span></span>
</td>
<td class="nump">184.8<span></span>
</td>
<td class="nump">161.5<span></span>
</td>
<td class="nump">297.7<span></span>
</td>
<td class="nump">203.9<span></span>
</td>
<td class="nump">207.2<span></span>
</td>
<td class="nump">221.0<span></span>
</td>
<td class="nump">210.7<span></span>
</td>
<td class="nump">210.7<span></span>
</td>
<td class="nump">201.1<span></span>
</td>
<td class="nump">387.6<span></span>
</td>
<td class="nump">411.1<span></span>
</td>
<td class="nump">870.3<span></span>
</td>
<td class="nump">843.5<span></span>
</td>
<td class="nump">621.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(48.2)<span></span>
</td>
<td class="num">(39.6)<span></span>
</td>
<td class="num">(68.3)<span></span>
</td>
<td class="num">(133.7)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="num">(20.9)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(87.8)<span></span>
</td>
<td class="num">(29.7)<span></span>
</td>
<td class="num">(231.7)<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">121.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income tax</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="num">(43.7)<span></span>
</td>
<td class="num">(58.5)<span></span>
</td>
<td class="num">(131.1)<span></span>
</td>
<td class="num">(11.4)<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
<td class="num">(7.7)<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(94.1)<span></span>
</td>
<td class="num">(33.7)<span></span>
</td>
<td class="num">(223.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">120.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(28.5)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(15.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="num">(41.0)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="num">(23.7)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(37.9)<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
<td class="num">(55.5)<span></span>
</td>
<td class="num">(115.2)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(53.1)<span></span>
</td>
<td class="num">(28.9)<span></span>
</td>
<td class="num">(199.6)<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">133.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (37.9)<span></span>
</td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="num">$ (55.4)<span></span>
</td>
<td class="num">$ (115.2)<span></span>
</td>
<td class="num">$ (8.3)<span></span>
</td>
<td class="num">$ (20.6)<span></span>
</td>
<td class="num">$ (4.2)<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
<td class="num">$ (53.1)<span></span>
</td>
<td class="num">$ (28.9)<span></span>
</td>
<td class="num">$ (199.5)<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 133.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (2.69)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (2.69)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 1.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (weighted average shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">73.4<span></span>
</td>
<td class="nump">73.3<span></span>
</td>
<td class="nump">74.2<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">69.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (weighted average shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">74.8<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">76.5<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">76.0<span></span>
</td>
<td class="nump">72.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember', window );">Molecular diagnostic testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 143.9<span></span>
</td>
<td class="nump">$ 135.7<span></span>
</td>
<td class="nump">$ 83.3<span></span>
</td>
<td class="nump">$ 150.5<span></span>
</td>
<td class="nump">$ 181.1<span></span>
</td>
<td class="nump">$ 172.0<span></span>
</td>
<td class="nump">$ 196.9<span></span>
</td>
<td class="nump">$ 200.5<span></span>
</td>
<td class="nump">$ 203.0<span></span>
</td>
<td class="nump">$ 189.0<span></span>
</td>
<td class="nump">$ 279.6<span></span>
</td>
<td class="nump">$ 353.1<span></span>
</td>
<td class="nump">$ 586.9<span></span>
</td>
<td class="nump">$ 789.4<span></span>
</td>
<td class="nump">$ 690.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs and expenses</a></td>
<td class="nump">42.7<span></span>
</td>
<td class="nump">39.9<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
<td class="nump">43.1<span></span>
</td>
<td class="nump">41.0<span></span>
</td>
<td class="nump">41.2<span></span>
</td>
<td class="nump">41.6<span></span>
</td>
<td class="nump">40.3<span></span>
</td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">42.3<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
<td class="nump">157.5<span></span>
</td>
<td class="nump">168.2<span></span>
</td>
<td class="nump">148.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember', window );">Pharmaceutical and clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">20.2<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">61.7<span></span>
</td>
<td class="nump">53.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs and expenses</a></td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 17.1<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 28.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979670967416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Quarterly Financial Data (Unaudited) - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationLineItems', window );"><strong>Reclassification [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 82,000,000.0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Reclassification | Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationLineItems', window );"><strong>Reclassification [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="num">$ (1,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Reclassification | Goodwill and intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationLineItems', window );"><strong>Reclassification [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mygn_GoodwillAndIntangibleAssetImpairmentChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mygn_GoodwillAndIntangibleAssetImpairmentChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139979665429624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transition Period Comparative Data (Unaudited) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TransitionPeriodFinancialInformationLineItems', window );"><strong>Transition Period Financial Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 154.6<span></span>
</td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="nump">$ 164.0<span></span>
</td>
<td class="nump">$ 195.1<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
<td class="nump">$ 215.4<span></span>
</td>
<td class="nump">$ 216.6<span></span>
</td>
<td class="nump">$ 216.8<span></span>
</td>
<td class="nump">$ 202.3<span></span>
</td>
<td class="nump">$ 299.8<span></span>
</td>
<td class="nump">$ 381.4<span></span>
</td>
<td class="nump">$ 638.6<span></span>
</td>
<td class="nump">$ 851.1<span></span>
</td>
<td class="nump">$ 743.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">18.2<span></span>
</td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
<td class="nump">35.8<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">77.2<span></span>
</td>
<td class="nump">85.9<span></span>
</td>
<td class="nump">70.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in the fair value of contingent consideration</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(61.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expense</a></td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">124.1<span></span>
</td>
<td class="nump">107.4<span></span>
</td>
<td class="nump">132.9<span></span>
</td>
<td class="nump">134.3<span></span>
</td>
<td class="nump">135.5<span></span>
</td>
<td class="nump">149.8<span></span>
</td>
<td class="nump">140.6<span></span>
</td>
<td class="nump">135.2<span></span>
</td>
<td class="nump">129.9<span></span>
</td>
<td class="nump">256.9<span></span>
</td>
<td class="nump">269.8<span></span>
</td>
<td class="nump">510.1<span></span>
</td>
<td class="nump">555.5<span></span>
</td>
<td class="nump">435.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">98.4<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">99.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">202.8<span></span>
</td>
<td class="nump">184.8<span></span>
</td>
<td class="nump">161.5<span></span>
</td>
<td class="nump">297.7<span></span>
</td>
<td class="nump">203.9<span></span>
</td>
<td class="nump">207.2<span></span>
</td>
<td class="nump">221.0<span></span>
</td>
<td class="nump">210.7<span></span>
</td>
<td class="nump">210.7<span></span>
</td>
<td class="nump">201.1<span></span>
</td>
<td class="nump">387.6<span></span>
</td>
<td class="nump">411.1<span></span>
</td>
<td class="nump">870.3<span></span>
</td>
<td class="nump">843.5<span></span>
</td>
<td class="nump">621.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(48.2)<span></span>
</td>
<td class="num">(39.6)<span></span>
</td>
<td class="num">(68.3)<span></span>
</td>
<td class="num">(133.7)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="num">(20.9)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(87.8)<span></span>
</td>
<td class="num">(29.7)<span></span>
</td>
<td class="num">(231.7)<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">121.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income tax</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="num">(43.7)<span></span>
</td>
<td class="num">(58.5)<span></span>
</td>
<td class="num">(131.1)<span></span>
</td>
<td class="num">(11.4)<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
<td class="num">(7.7)<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(94.1)<span></span>
</td>
<td class="num">(33.7)<span></span>
</td>
<td class="num">(223.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">120.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(28.5)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(15.9)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="num">(41.0)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="num">(23.7)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(37.9)<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
<td class="num">(55.5)<span></span>
</td>
<td class="num">(115.2)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(53.1)<span></span>
</td>
<td class="num">(28.9)<span></span>
</td>
<td class="num">(199.6)<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">133.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (37.9)<span></span>
</td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="num">$ (55.4)<span></span>
</td>
<td class="num">$ (115.2)<span></span>
</td>
<td class="num">$ (8.3)<span></span>
</td>
<td class="num">$ (20.6)<span></span>
</td>
<td class="num">$ (4.2)<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
<td class="num">$ (53.1)<span></span>
</td>
<td class="num">$ (28.9)<span></span>
</td>
<td class="num">$ (199.5)<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 133.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (2.69)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (2.69)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 1.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (weighted average shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">73.4<span></span>
</td>
<td class="nump">73.3<span></span>
</td>
<td class="nump">74.2<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">69.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (weighted average shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">74.8<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">76.5<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">76.0<span></span>
</td>
<td class="nump">72.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember', window );">Molecular diagnostic testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TransitionPeriodFinancialInformationLineItems', window );"><strong>Transition Period Financial Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 143.9<span></span>
</td>
<td class="nump">$ 135.7<span></span>
</td>
<td class="nump">$ 83.3<span></span>
</td>
<td class="nump">$ 150.5<span></span>
</td>
<td class="nump">$ 181.1<span></span>
</td>
<td class="nump">$ 172.0<span></span>
</td>
<td class="nump">$ 196.9<span></span>
</td>
<td class="nump">$ 200.5<span></span>
</td>
<td class="nump">$ 203.0<span></span>
</td>
<td class="nump">$ 189.0<span></span>
</td>
<td class="nump">$ 279.6<span></span>
</td>
<td class="nump">$ 353.1<span></span>
</td>
<td class="nump">$ 586.9<span></span>
</td>
<td class="nump">$ 789.4<span></span>
</td>
<td class="nump">$ 690.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs and expenses</a></td>
<td class="nump">42.7<span></span>
</td>
<td class="nump">39.9<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
<td class="nump">43.1<span></span>
</td>
<td class="nump">41.0<span></span>
</td>
<td class="nump">41.2<span></span>
</td>
<td class="nump">41.6<span></span>
</td>
<td class="nump">40.3<span></span>
</td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">42.3<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
<td class="nump">157.5<span></span>
</td>
<td class="nump">168.2<span></span>
</td>
<td class="nump">148.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember', window );">Pharmaceutical and clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_TransitionPeriodFinancialInformationLineItems', window );"><strong>Transition Period Financial Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">20.2<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">61.7<span></span>
</td>
<td class="nump">53.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs and expenses</a></td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 17.1<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 28.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_TransitionPeriodFinancialInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transition Period Financial Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_TransitionPeriodFinancialInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>126
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MN[(4TSTH_!LI2P]0%''-!C@[ RB>%H<TX_1HHEM^GIWPW#*CA(J$? 6FULD
MUHO,#DVR&RTVZ3'"4F@MHO32YPQ8FP_@_4H(O;\Q#11'5Q?_ 5!+ P04
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M ]C?[Y0R3P_NMO_TYR#7_P%02P,$%     @ #G-P4BB4_H5@ @  = 8  !@
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6R-E6UOFS 0Q[^*Q:M-ZH! GEH1
MI"9IM$VJ%#7:]F+:"P<NP8JQ,]MIVF^_LR&(:*2"%^"'^_W/]MV9Y"S501<
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ML8=OKYI%V7.<Y-9&/>DJZ,"M=9 =OA#J\*%(7_=?9/,]+8ITN__Q145KE96
M_OM3FA;'#V4!IZ_E>O@'4$L#!!0    (  YS<%)>/O%"AP,  ,H*   8
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M<6?\4%7 UD#B0$LV5NJ6U!, EY_6HGF$9HIWJ(#; T36,('84WR@Q1ZP<%>
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MCY>IA&D=QGBQ,*SU,*[/\FPSL-MGW+ XHT*D\#QSFA%>U<-!!YZO5$6H.D(
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M >#\/>?R^X%Z)]S^6V+U+U!+ P04    "  .<W!2#$#MWS$*  !9,0  &
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M(ZK)'-2Q )&Y*\ ,F#':CDS7YX:I7#M4?4\-*3RF\A_MMW:8/&AXVLB!'/?
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M;%>^W JNP<T(]/>;+"N.;\P%3K^FN/H/4$L#!!0    (  YS<%)^_#1Q'24
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M_*+OS+MJ;"9'ST9$!3F[(^*KV8SL,[XX-P18;?Y*LM2\I>L9..)A02S_[Y
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MG]\?#!M;[ !QJ DBHL<=?+[$Z4FW=]/-9LAR"=[8^Y('.7)'VCQ?)>*YI;!
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M*#H@%M80* 0DJY22B+%(X"A++C29TFO5IDM%=NTJ;]F*;'RT/,<22U]$),8
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M!\<]%:Q(8ZX72ON;0QXG>7C-9C$K1'B4-7?51_3MY7:[V5>DC47[:3VE6I-
M'MQ B5LQ&.R'.=-JB;*H* PY70^</JX_[!?WLU3,NM1S@L?,$+A1GRCR>;ZQ
MB;%[U2M%OY8BXGU4&Q^,S16"OSTR@X44<5ON<&:1#8>-"+T8-\])2)>N#9FI
M[$%Z(HVB=J6LYN3.=!US\!>"EJ[A(N;<J*-[I'4,'&]?95IR$L0=0R>LVN,U
MC<$GB )K3;G&0CB!MMBEP?F5I59CDN?<%K$=PO?#]._'9</A?0ZZLQA#'YM]
MB*'L2T$Y1C\/[GT]Y>4M6Q1TB]@M4(HI]WO[SEDM/.;:]9IJ6-5(;H#M4I%P
M+%A<7?P^LC$'W#W*79XC\>ZLU(-$0:(=V&<7C8\V&(QQQ%&VDG"%'A*?Y4N7
MQ/B[ @<.Z8EY\GS\W$<+,IO67.86[JN[X0*@*])YLG\TGAP=1,C:B:!_"'Z:
M(03%R''E57HKN23\_]NUW5!K/?-JN&[]R[P2S6J ;8S&_+B2M$<"IK2/R*1%
MDB_E[ NG#"+?7"=6:.9GNX_:=0R()B:N>'(:A;5Z-<:BO00@M[VP0V@Q=D,&
MG W'!_%(25IWQURV)# V3-#^,4&):(Y!)542X5XR(PX/-7!\]Z5H4^^VE5]_
MS;YB::"2;N_1V<'X=\8^ ,9G\0-\Q$_+M'Q4;]O58E,^^6R;4"_ )5W]'M>.
MW"1I"W,NP[1J.;M;:16OFR*AAJ'&PUV3F.,OE$T2PS%Y(UCDY:+PYFI\1CY,
M%%IG4VT\'W/"LP'P(U?$FC'ET4S7IMLA\ A1< +7*LH! T@#(S7CII?H)OE"
M*:UJY&[M8L89^A!*#OV\O7)H9=Z9L[!E,7<_-F-$8ZZ#KQ$90Y"B=)O[<L8O
M01'&X$15C=MHD#K:K\4%@.?N>):Q(-Q 4;UC\HUN>9:=/F*SI -S&Q?7)FWO
M!-ATB(_R@94BAKXG5T@NB/N.2""U<-JX; ]L$N4S.$/C(DT290&;W:/R:YG\
M*NP<6];RC-8DT&^G27H7=4:%-C%'N#&9\6&@A-M*NSK,7R(,;=:NQ,,GI.P^
M'C;2#*S::\<<&'H2S9:YQ;BZ!,F.JRH+-<TNHW=YZR<ZF8L)3YZ)@.%XVN1[
M6J2BT\<?C36=J!ZTE'Y(@=OME:S$;:@#\S7DB''5J"K7>0U'&5IZU.\'&*B*
M?* C:4=_K^;&UZK+2$!KHRR]C RR/K4JU'2V$ZT3IG-Q%$"C>6XHRL<M2-##
M2G(3W,F'Y5(<DOH?;C\U/"NQ=XK0Q\TD;>2\-JBSW[I*I@%JY&TH:HHT8:4M
MOF[A@+>Q>5W5,YNCEK79;*M-Q$-0=T_T;405QZEY&?27,W"%[6/+<"UYM2&L
MZ.FXIS&+B@U?*464FVZTD8'[58 LNO^I=IF$9I$7!=V[P]MT@08KGLM7H=H^
M3Z6*AZS0B%>VQ]"X9=!A?SBKK0V]QS7SF8\3H1$A^C%S_<KKW!4[AY!2A=M9
M<#LMY[ETALV.33:Z9</9>'[#QYIOP9H?'4-.A%[87B"+.R7\42LXQ8$[';L\
MAF.-#FV?8B> #SPW%ZRC)X3=SP-8HNA5M [&G72U,J?6 DG1A,8#^@$47RX
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MG.U)SX?[@>XP_^W#:=72Y>5O\=>;;(T'Z/-95;7N!VS@_QCF3_\-4$L#!!0
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MRX#[,XE^KA?60/4?-O@&4$L#!!0    (  YS<%)C&^CDQ0@  .T8   9
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M*X7X]D2 ^85#I:@'M$#["\?UOP%02P,$%     @ #G-P4M LZ@MH P  C@<
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M3:X.OQ+!SPC!Z=F1D($.9LK)#"-D>>[.\-)#4]]$4X1<=(^>_,/9"T"4)?6
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M:TY<ESTM C'LU@E"!]F/Z-M("#8!%_&>WSYLG-'Q@J/-2*SRC)'9 FQ,*ER
M/MJ9IH$1,/8U_CW=L^DQ72'"EP@Z:$!-A'0&[Q^5KF5,A7)U8.4%;Q[FD-UC
M#00M;)[;M7^Y'2+=61["L.8(_%&$K.8?3E<NXF2 DQ0]0)*<CL[ZOW,^U4?;
MNM'P<#KZ_4@=SD;S(WX^.5(?*6 Z>,+T&"-V_#T6IO/1B=IUCSCNW<A*_\#W
MSER0("U>SG:KW=7V=;S1?=@>[\6!R4ON[G-:@'0R.CL9*!?OFN-+L)7<[R8V
MH.V7QQ6Z<'*\ =\7%BC2O+" [L+_ZG]02P,$%     @ #W-P4M(&'\W[ P
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M!FR# 9ZO# CVFQ!@_V=C]@]02P,$%     @ #W-P4F8)ESUY!0  R0X  !D
M  !X;"]W;W)K<VAE971S+W-H965T,38N>&ULM5=M;]LV$/XK!R_86L"5+=MQ
MTC0QD-@NVFUI/"?=4 S[P$AGFX@DJB05U_OUNR,E64Z<K 7:+Y9(\^Z>>^Y-
M/%TK?6=6B!:^I$EFSEHK:_.33L=$*TR%"52.&?VS4#H5EI9ZV3&Y1A$[H33I
M]+K=82<5,FN-3MW>3(].56$3F>%,@RG25.C-!29J?=8*6]7&7"Y7EC<ZH]-<
M+/$:[<=\IFG5J;7$,L7,2)6!QL59ZSP\N1CP>7?@3XEKTW@']N16J3M>O(_/
M6ET&A E&EC4(>MSC&).$%1&,SZ7.5FV2!9OOE?:WSG?RY588'*OD+QG;U5GK
MN 4Q+D21V+E:O\/2GT/6%ZG$N%]8^[.#7@NBPEB5EL*$()69?XHO)0\-@>/N
M$P*]4J#G<'M##N5$6#$ZU6H-FD^3-GYQKCII B<S#LJUU?2O)#D[FA$)J#7&
M(+(8QBI-B:IKJZ*[E4IBU.87F'XNI-V<=BR98Z%.5*J^\*I[3Z@>PJ7*[,K
M-(LQWI7O$,P::Z_">M%[5N$$HP#Z81MZW5[W&7W]VO>^T]=_0I]W#/X^OS56
M4WK\\XS.0:USX'0.?@2?SZKF\CPQN8CPK$7U9U#?8VLTFT_?3N?SZ03./TQ@
M?'5Y>?4!KF^NQK^]N_I],IU?D[T_/KZ_^00W*V0\N<@V( V(PJZ4EO\24JMH
MPQ0(1<[OAT$7S$J0"5 +R&N'#'O1AEQHN!<)'3_H!MT0<M3^>, F-,*:?S+5
ME"RU%=98HD5F2Q 6*)R8WI)T%=(V_%ID"/WNGF7XNNT8;6X=!U_O5'A(8*F
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M]%E7)702)_G,4J:GH-S]7O]AD24B$>A!4LI*J&\+4!!$ )>(-)JF8(38!@-
MWQ2S]9)DW:G4*587MW=?C'55O%412>F1QWHPXE0EE;<6C??-NGT]8QZH"",-
M)63*".)JTA]/Z8C'>1+-Q:."3&4]^3=41 :@B6"S0\/25,@9,JJ8($8?9)+*
M2:I6/6M1:_K53&UD,6Z9U^PV#:-@3.D,%S+% VQ*AELHG11P>-)NK&@ L"<6
MD^56&-F,,K8,RV_"$;.TP@#*MKG1]_%D><P_*'<FB!F(6!J?)0SR(DW,5*XT
M1%\R?T(CG4UP [ B>]1:+)7$FE-=9,Q?1NG&08#,<W*%$H6%B&4%6^56SU:O
M1DJ[<""N/1=?9XG6RHO\V+'6AKSA#*2G-4Q4+R HI%^DRF%5D2MFDQ6O]$-"
MSI)O<#@M""O(!(QVQ*^5@]EHV=NG$T??61$46C5Y)*Q@<@H#MX RY(P1NACC
MZF5=PXXQ)F%<IUBCNL#:VO@@ I8GM#Q;VI7*]U)FY+M3B\IP!K8&JS W43/X
M4TN7@H"4QX:#-=)$U:QQ!BC+XGH<&!^P& "&(Z4K"C'U344UHU QG4*?NC2R
M *L25'W*Z9ZP=D)^%2&D2Q?<<1TI]FUZD#=$/3B&>;AVIJ E#:+VO4>QC;1B
MAEA&GQP&>"R+*)$.E%RV<I:(:^T<"E4,JF;V2>,<@E%U,YN0-&D=JP816'*
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M5149_YPK"2>B 7@_+8K*W= "S:>-;_\+4$L#!!0    (  ]S<%)Z8N%>C!$
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MQ< W $0[/62N),5NBF;N@D2GH5D,Z-1*5BV7F^_$4H=Q?=IVA4&TU'X345?
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MK-/Q^>E!G""ZCV ;?B!:V!!LS<M22:0$$>#WPMK0?9""_L7P]O]02P,$%
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MKQ^K%2Q7[U:;S6H)V_FWF\_OM[#^-/_\I4"X5F7%Y D*9H"Y>]IX,:V7BKS
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M< P2$L#SE<(;47M!"_2?^D[_ U!+ P04    "  /<W!2"O<,!&T#  !V!P
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M:P,0AK\I<I/+'YQ8*EEBV5;V#)5G?6O8F5Q%VGKK)3O-40;*E,.'Y^.+[!I
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M""C!6"Q1^R1_1J:WM8/WE43HQJ]@CTMZ?D(0U.S[.C1+Y[5;!G5H)>,94&#
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M$/I7L*6GC0XO@,Y)7D-A*3T:W#:GZYXV4GQUXX_@LY3IF:KH-#DUN3CR?8[
MM*9QP*GIN'( $\KQ:-/HF$S^Q1T,HXC@-Z4EEG*I-?3B&_^Z#RO*15&(1!8(
MO<:D/X:E,$@]:-JCR+_^+FO!]B[]8>NB%_J#?H-!.DFG-?3#/OQF@^Z1IA6V
M/@U[(72]P< "678RTA)XX,8:COKP2!DWB$?^S:L],T;Q?6689<9($%)\M'50
MTM%M>:OA_OS3*([B7]ZV?/BF.$OA,\6E7M$6BP_TPB?/F<RIE)KZNHGNTB F
M01/S.(9;IJG_/KCTZ7C!\\I>JD[PU4T?DK 3T4_MX^PTT!C65-:4@+9.KH=4
MI=:!V_S7FQ6\&BD%4O'MX-14]DJ8>KITTFXVS^N1]%V]'NP/U#N<;GJ.!S(-
M_>M+#U0]+.N-D:4;4'MI:-RY94;_+U!9!3H_2&G:C0W0_6.9_0U02P,$%
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M.OA\VNMNOW?3S6:(G0K>V &1!T'KQ.N976EQ7C)81>L^K?!-P<(T?"URFT=
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MP2A_PP5"HIO1;''TX8&U30HD,YSYF.%<OW7@NA!<J:9-14(K0Q"QC_:@Y)B
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MKK:N+FIA'']&6<&BX-^;-* 1W1K2-JW*-?,9AS?@!=.]%>0_X;GD'?K-*,(
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M6B1ER%Q"X_MHR35O[#; KF!HD(P"0;BPX3#D^"WQ\33)^(E8&400E[-INI\
M#PK8Z-EJ@Z:0HX<8;I*F/ !46Q/45\2/\KDW-.0BT=OX)*,CR^15U%%[(MBB
M@*9?;)#T#S+#,GFZ9&6O^T]:?HC:2 3!\/9EFDFV59Y8VH\C]ZUOP><PNJ]B
M"_Y.:I:GI8:C4.B6HB)9RUNGMLZ/8/6N93MOT$M0/(@*=G^W[\BB*YJECW0\
MN,"]:W=N1DE7);=,L2)-J5YN.G .>9SDX36;=>$\WB"6#_CR-?KV9KMY\0GY
M<]%^KC3969- 'MQ B5LQ&.R'>=-JB;JZ) PY70^</JVF[??NL%3,NRQ00L#,
M$+CWL6<5F<65J1/W[[;7U?%6ZO&?HW#_<*QN$8;N73-(R"%NRQW.#<H"8"-"
M+Z:MF!+2);8A,Y4]R'!)HZ0;,:\YS31=IQ3\B:"E[Z=**5?GOW:N]V+D"CHX
M\K_*7>U-%'<,G9!JC]9<-D C"NS:,UPLA%-YBUT:G%]9NMIB\IS;(K5#F#]4
MGS]N&DXT</B?Q1BQ//HJ$BC[4E".T2\("+Z>H^4M6Q3WEI!;O"F^N9Z;_)G1
MS[VN7:]GCE6-9"G8+A4)QX+%MY@\1U[HD'N1N6=X)-Z=D<*8)$BT _OLHO'1
M!H,Q_G(<64FXPAT2G]FE3Z?\J<"!1[I6SZ['UR%:D)NLYIK$R*^>PP5 7ZWT
M[/GQ>')\F"!K)X+^$OPT0PA*D>/KS!Q7<G?%_S>VW5!K/?-JN 7DT[3BV]=
M*V0EUG45A[6PIY)< =]TB,ADA;9+.?O"*X/$-Y>: )_YV>[*]\TWHHF)*IZ=
M)6&M7L6\:"\!R&\OY. SCC/Q\;)H4/-! E)TZWG,9TLB8<,$[1\3-X'8C,28
M1)"E?,F$Z/:+D1O9TI9/N8,^MY5/9[,G+ U4$O<>GQ^._V#L V!\%#\@1/Q<
MO5J(ZFV[6FS*ZX^FB94+7-O6;V'OR$V2#DOO,DRKEO/,E2NYEHAVZ0U#%P_W
M_9:>OE _2@3'UYO (B\713!7TS/R89+0.IMJX_F8$YX-@!_Y:MZ<;QY]J6VV
M'0)/$ 4G<.U$.6# U<!(S;E_+.&D4#'FRCM15-85,ZX5B*'DV*[?JUUWQ#OS
M%K8LYOEC,T8TYD:*&I$Q!"E*OWFHZ_P4%!Q/X!K8I+QS&PU24/Q47 !XN)@B
M8W%Q UT9GLC%(0ZE]2P[0\1F20?FCDBNDMK>"; Q]!ZVJ9%RBKXG5T@NB%OX
M2""U<-JX?A%DDN0S.$/C(TT290&9/: &;:E_%7).+6MYQE5'T&^G.ON0-!G&
MCDM_<7LK(^)LMLG^X6SWR8@3#Z[K<QJLD/C#JZE?DCO;K.M)AZM(UT8Z3*<9
M6+77:STPU">9:G>/B60:Z9?;*H_EYC['>'-_Z[.+ZA+VWFT*#$?X)E_0(A7=
M1_K1V"4XG4\O93%2_'=_*RMQC_G _!@Y8EK0Z]3]O(;K#KMAU&\G&2A8?:0C
MN1$BO7JDT$8@4]^,2>H&R#-N4!7OD[U"7]Z:HW6DCJ5P'/G@XHM^Z,_[+4C0
MH$Z2'/S"A^4R)=)#[^Y_;G@<7N\4<7 $7VDCYS51P?[653+PS<4"A^*X2%Q6
MKG_?+QSQ-E9OJGIF+,J,F\V>>2T^BW- Q0)(;L53JBVC1O4FMS!B:JNN)=,W
MA!5W.FY8SI-"S-?N1APUW;D>$VYW K)((F6N22GV&GU3D"0XNL\6:&#DT6L5
M&B%L)G5%9!<GM+(]9LDO@Y$>1[/:F#A8H&8Z"Y$K](@D/^9^&,':^CKT&.2J
MP)T%]\ISYLW-:-JQR48K?#P;#XQY7S,7K/G1,>1$;'3OA=:XB24<M8*;'JG3
MD\L^'+MXU?8I=@+XR,-.03KNA/!$-+R'))Z6K$,?5UWMB%.JD_:)Z3A!;;)_
M )J4@DB48U N/_WUC:A2J*& T],5'9<C"#]%W<2!4S]\R"<1\HI5<VF"O;O2
M%FUP='3M)Q+(H(2_/I\].1M?!,,_&)QWDB.IU3O)/;_IRI3_0BY;''DW1JQO
M[J&?AX<=J4PG'99A%AK,)5%0+G(5;%+=DBB<=JT/)_O<=IHXWQ1&D#^DT,ND
M_\6-EOB<@-A>&HLSPB;[QWIY\H Y/DAC3W]]%XW% 6RF2>Y%&C32X7;K,!.%
M#39?N=SOK4X+ZM(D=YSOUEO3=XCW9(IK2,$K",@B_.F3YG'R@H0$Y8.I:1^-
M*RK?J"N.H_6P' 35GIE_8S?#T!D.+I <T3/:D-]BW"+6B<5K7V2>MMF%^6KB
MA/@F8>X<':'O@&YC%%&89@M\]WZ,E[=6-.',Y#R')([U2J;H%?J1P]MS:*T0
MFO4%^MN'\#)6?\Z=R3'3U-+@I#_7V5<:E#WQ5-LJ,3@'-VHWL[\["MQ#7'+
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MVARS5A (E#Z\,,/8%5%+8AF!!B'EK0G+OE-KT"#J;RI;R&O<8]G?Q<M/07&
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M^R.8&PS:(66;JZ56,=)T_4!!#U\P!!3A-\!O8C0<4I:"/BS#6D3AH#V@,,"
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M!"DN2-1U^E0+LOQU*!=:K.QU?2XT7?[M9T)_6R@- ^TO!/7S;F$,5/]OX_\
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M7.-P>!J [A9'=["J\<.Z5)9&WZL5[5K4SH#>5TK9W<$%Z+?WY!]02P,$%
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M37HL$DM>).9:;GX3Y82&J"^4B:9OMK%C1X,>"PMM9%H*@P=IG-E?_KE<B(;
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MBF7$!(:?0?!$N@#K50!/V5%6T!-P5&,HT I@.TE 6+]@?]JW'RFA0(-=+\V
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M,/L>L_\.YCW-1MX(!%7 +;.-YI93#M)^U*B9Y7(-/B_<<+;BPA^_U=NC:=Q
M3DS-,IP%-'$&]1,&\X7/0UW":H6ZZ]0YV!+I9AR2<99+5=5,;C]^&*?)Z#.9
M.X+"$Q0O!&&#&H$9*)2@8:5;P27=.2%H?,S9!*ZYR9B +3(-*'/"F+C4"9Q
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MB=GAX#C8/\EHO]WP:RGN]=HU(TLF4M[2S?GT<. 3(%&)PI $CN5.G(JJ(D&
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MA;H3@Z.;A6"GG\XNF+CCU0IAU4RW(*#7QK<IA"7TE"'.LD=3MF@J0N.Q8=F
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M2$"U,2"^(4W3-MT15]]6URBSQY(,X74_M:9A(M*LX'JQ9[\M.O19PK%G@6#
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M0D\#T+_4V@U_:('Q0^O5?P%02P,$%     @ #W-P4JD+&-,'!   EP@  !D
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MI4'FER7]<T#M%.A\JY3M-R[ \%]D^0]02P,$%     @ #W-P4HF.?<_3!@
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M%'K<B-$E6@H>(QKPA,<LR.H1@!T<:</9E]O1L7E5Y]/[.Q&[@YZC_Y@#]\O
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M=P'?*.Y5;PVVDJT0SW;S)9\'D16$##-M$8AYO. =,F:!C(R?+6;04=K$_OJ
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M6U9F?*.T >9](80^;"Q!]T%(?P-02P,$%     @ #W-P4E23:XBZ!0  KA\
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M-WGI>4Z5IO)E;/?EIT>P8GN:)OGN!2^W(VPC69DC'EY2(90AX>Z&U$(A1KK
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MUFLG+3-F\%J);SRURT%P'D"*<U8(^ZC6G['2TW%\B1+&?V%=V48!)(6Q*JO
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M#F^*=%<]P_*8%D6ZK5X^B5 R6@+D]^M4[G+J-^5C,<US4XO_ 5!+ P04
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M-]W#.TQA9C15#FYTB>7? #$7T5>2;BN9I@<1O[5Z */D%-(D31X?KN'XZ.0
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M.*/RG?[ZY3X&;]^\ V] QL!'[4?/I5PZ2D=6^'>2*HH/IRC02!0Q26; @U<
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MDO;O9YN$$2"L/"0VG'/O.1=?[,F>\6>Q 9#H):.YF%H;*8L;QQ')!C(L;%9
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M?*JWYY&0/%';@03_W"D#,)<D%/\:Z)V"WDGI>T?H+Y9+3I98$A!S&GDTQ@'
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MGH'"A,H+O?:XS-#YV04Z0X2A.T*I?GURZBEMQDAZ>5/XIBX<'BF<0>ZB*/B
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M%/7Z>TJ[:)Q2O_7T%@14F)ZG4"HJKMUSTJPV;?7>=I.]]1FT6]<=_]&X7OT
MP:%<(4;60!GTKL$?Z?J?FVA1V@=^)32T"SO,X9.!2&, ^VLA]&YB#F@^0B9_
M 5!+ P04    "  /<W!2)UJQUI4&  "O'P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970W-2YX;6R]6=MNVS@0_17"Z ()T-@2)<MVX01H;FT7V]:HD?9AL0^,
M1,=")=$E*3M9].-W2,FF;$N4T\:;!T>7F<.YD&=&Y'C%^'<QIU2BQS3)Q'EG
M+N7B3:\GPCE-B>BR!<W@S8SQE$BXY0\]L>"41%HI37K8<8)>2N*L<S'6SR;\
M8LQRF<09G7 D\C0E_.F2)FQUWG$[ZP=?XH>Y5 ]Z%^,%>:!3*N\6$PYWO0U*
M%*<T$S'+$*>S\\Y;]\T[/U *6N)K3%>B<HV4*_>,?5<W'Z+SCJ,LH@D-I8(@
M\&])KVB2*"2PXT<)VMF,J12KUVOT6^T\.'-/!+UBR;<XDO/SSK"#(CHC>2*_
ML-5[6CK45W@A2X3^1:M2UNF@,!>2I:4R6)#&6?&?/):!J"AXPP8%7"K@785!
M@X)7*GB'*OBE@G^H0K]4Z.\HX":%H%0(=A6:HC0H%08Z645T=6JNB2078\Y6
MB"MI0%,7.K]:&S(29VHJ3B6'MS'HR8OIG'!Z=@G)C- 52V&&"Z+GR!GZ1#@G
M:J*@DVLJ29R(4_0*]9!0*@+%&;K+8BE>PT.X_A@G">B)<4^"60J\%Y8F7!8F
MX 83 O2197(NT$T6T:A&_\JN[^(V@%L[P&A@ >A!0#=1Q>NH7F(KXC4-N\AS
M7R/L8.=N>HU.7IU&)G;%;YVG=M@_\PQ@G2W8 U"O#T9U1X>CWAR..CP<]?;Y
M@6W$>G< EM/7%N(ZD*W4>YL%Y6E4S[J@[O<7U-]_@23Z(&DJ_K&,XV_&\?4X
M?L,XGQ<*5: '3C()8YT4'IRBGZ@Q()<%9* A59%:7@P<]3?N+:NS<%]L1^*Z
M5>+&)K'E<'_C<-_J\%W&:<@>LOA?\%94HAQ6HTP?U36%*ID0%1;)$'!H^!VQ
M,EX_T:NZR!1C#RKF^MU@VZ5;N\R64\'&J<#JU"V).5J2)*>(S<!H(7D<*KL+
MHW-%L&@)C^%1E/,X>T +RF,6-?D1[-F(1UVWWLC!QLC!05.-9!'Z,KU3,?S$
MLC.:+A+V1"F*8LB,9-PRJX>;H89'73VCS3@CJTM3RI=Q2-?!A)8.D17AD8ZU
MBO()E+0G2K@XK8NR'=S5FA8K7<=49\=N9W7NVA K]=X]:H1=;$;"QXQQ"[I?
MJ-HL-93M>B]'+:_12O>W-#HC2\JA7Z]Z6 (IA5JG[(;@PBD4H%0W)#;O3*%P
M[95BNL-_$Z"9.**9U OZ:A[3&;IYI&&N>[W/LQDDS3I[#6.[_>/.-4.CKIU'
M"Q\77,VW$-Q<>Q.1)X'D'#R>LZ1N#H)PI+,%@:EK'2_+@:N%##=4,M<0JFMG
MU-V4O%4VF5I.9I)R!/T)3>_AHFQ1;($R_.H>EV!=P["NG06U3VK1Q+P8H5PE
M+:O>#CIL7?78<"M^!K?N)P$F$\P6Z!^>D0=L:!@?EX:QH6%L)\I?RT,+J.NT
M)\+0+[:SGNHI;$"&Z;!_W* :9L/V9O0W:UL+>GMMPX89L9T9OY7%"JV+E9[?
M0(R2HIGI/D\BEB2J](!'10E47Q+F@ZW6BV+D484:7:\;C':^)FK$\* [VNFN
MKVO$_* ;X)WOBAHQ#W>#03TE8T/)V$[)+]V)7Y7C#;8-]7>]WI>"X 2[3M=(
M.16L;9]-,<##%_RD:OCB*,>HVM;WN][.MU.;U+8'ILA@>SWX_SJW%D/6G=NP
M[-R0BW7S8=M1,)7*LU>J">5ZTSD#QM$<5^R\J9H50ONVI*GJYA*X2 0J_ >O
M;R93) E_H-)JA2E9WG%+EF=*EF>O+E]+$BW2A4X@2R%X6$NE+5!]I^LX?]BL
MJFSLV,M4<Q:J;S;A_T1$1'Z@]Y0D<AXJ\0EG2VB\.?J01?319I.I>-YQ*YYG
M*IYGKTG/RHD=JCTGIKIY]NH&_=@ 31*2V=!,#? &QXVF85[/SKS38@^=+$F<
MD/N$:@::Y3+GZP)MV\8KP8.M4EFSD7=[@."V X9XO1:^<Z %5($'0W?WAVR[
MFX;S?.>X^ZB&UWS7WB!'Q1<@2=9'&[^8EG*<K6@[EFC[AA!].XNISPXTR7DX
MAWBTS7??,)I_Y+WJRF9URQ[$[P3VG;^_F8RM@36LYK_DIG)#I^?O;PP[W7Z#
M:8;:_)8MC?*838@<[,DS53CDG*X77?,)BK^_8^$.ZZ+5JQP;IA0:!74B+,#U
M/)/%6=?FZ>;4^:T^:]UY?N6^N2G.C@U,<93]$?J/&*@AH3. =+H#"!4O3H>+
M&\D6^G#RGDG)4GTYIP1\50+P?L:87-^H 39G]!?_ 5!+ P04    "  /<W!2
M6DUU;K #  "U#@  &0   'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6RE5VUO
MFSH8_2L6VH=-:@,& F1*(K5)K^XF[=YJU;;/#CB)5;"YMI-T_WZVH9"$E[JZ
M_5!L\YSCX\=/#O;\Q/BSV&,LP4N14[%P]E*6GUU7I'M<(#%A):;JS9;Q DG5
MY3M7E!RCS("*W/4]+W(+1*BSG)NQ1[Z<LX/,"<6/'(A#42#^^Q[G[+1PH/,Z
M\)WL]E(/N,MYB7;X"<L?Y2-7/;=AR4B!J2", HZW"^<.?GZ B0:8B)\$G\19
M&^BE;!A[UITOV<+QM"*<XU1J"J0>1[S">:Z9E([_:E*GF5,#S]NO['^9Q:O%
M;)# *Y;_(IG<+YS$ 1G>HD,NO[/3W[A>T%3SI2P7YC\X5;%QX(#T("0K:K!2
M4!!:/=%+G8@S@.+I!_@UP+\&1 . H 8$UX!P !#6@- 6,*T!9NENM7:3N#62
M:#GG[ 2XCE9LNF&R;] J7X3J0GF27+TE"B>73WO$\>V]2G4&5JQ0]2>0V<%;
M\"19^@S^+757@#N]HT3^!A_76"*2BT\JY -P@= ,8NY*I49SNFD]\WTULS\P
M<P2^,2KW CS0#&<]^-4X'OHC!*Y*0Y,+_S47]_XHXQJG$Q# &^![OM<G:!S^
M]4 5W!N$KZWA<-8#?["')R/)")K"" Q?,,!7[_L-^.=0;# ';-N[TQ?<8<,=
M&NYPG!LHXQ(2T8S0W0W8X!VA5#7!QVJB3WTU51%'AEB;X'$9)I[^F[O''D73
M1M'42M&.(RK53V%,PK0C(;Y44!5+-^PJ8OUFQ,-8Q,4ZHV:=D=4Z\0OF*1%O
MK#2RG3YNIH^MID\13=6W(@.,*RDEX6\(B3M";H.174\:.<G[ZQ";YZB<I"-G
MZO>50#=NM%AGC>S9>S81;7(\*G?6E1&-R(!>^^WPK(0<L= _&I5!O9OJ"* Z
MDIGA46$U_5@B+Y6=?=6@G7O],B<%+>Z(N3KY-)4/2DY2/&)FT&\G\_^7G64L
MSQ$7H%0V:K+1GXQJDME9,OQP$L8#J6A]' ;OLS9+.16KWJ)&#PPF03*@I_5^
M:&?^9Q9DJ:CK_4-UTMH^M//]7D.RE#7M2=1L OT!;:U50SNO[G4G2VU15YL?
M3/SPRJCJ.-O::^T>VOG]A5-92H][I(>3& YH:CT?VIG^J&E9:DRZ:;O(;B71
M/3N>%YCOS+U(U1P[4%F=3IO1YNYU9VX<5^,K?2<SQ_Z6IKK0?4-<V8T .=XJ
M2F\2JZ+DU1VIZDA6FDO ADEUI3#-O;I78JX#U/LM8_*UHR=H;JK+/U!+ P04
M    "  /<W!2J#*N=\<"  #O"   &0   'AL+W=O<FMS:&5E=',O<VAE970W
M-RYX;6R=EMMNXC 0AE_%BK12*[7D (6V J12NMJ]J+8JVNZU&P_$PHZSMCF]
M_8Z=D+(2F*HWB4_S^YOQ83S<*+TT!8 E6RE*,XH*:ZO[.#9Y 9*:CJJ@Q)ZY
MTI):K.I%;"H-E'DC*>(L2?JQI+R,QD/?]J+'0[6R@I?PHHE924GU;@)";491
M&NT;7OFBL*XA'@\KNH 9V-_5B\9:W*HP+J$T7)5$PWP4/:3WD]0;^!%O'#;F
MH$R<*^]*+5WE)QM%B2," ;EU$A1_:W@$(9P2<OQM1*-V3F=X6-ZK?_?.HS/O
MU,"C$G\XL\4HNHT(@SE="?NJ-C^@<>C&Z>5*&/\EFV9L$I%\9:R2C3$22%[6
M?[IM G%@D/5.&&2-0>:YZXD\Y91:.AYJM2':C48U5_"N>FN$XZ5;E9G5V,O1
MSHYG!=5P/4&_&'E4$A?;4!^N:_)&Q:HN/QA<M,H5#<&-0&96Y4ORJVFYF(*E
M7)A+M*E[5-TSC"T2NGGBO*&9U#39"9H^>5:E+0QY*AFP_^UC]*QU+]N[-\F"
M@E/(.Z2;7I$LR9* 7K<-5]?K=4_H'8U)0+?7ZO:\;N^$[BLWR^NY!B"\M*#!
M6**IA2NWY%RNY+%0AA633C?Y%B"[:<ENODA&MZ?(PHI)YR9(UF_)^D&=IVV%
M1QOW+>-KSJ!D9,=!L&- 8:&DDP2!!BW0X'- @L^!7/"2[(!J<WF,**S4JRW)
M'9'^/ 3@;ENXVZ#D%#1>?XP8T&N> ZFPKEB[P<[@AK53;QF O&LA[[X&6>^U
M,Y!A[:R)Z:")*>D31G>AT*;)QR6:?&[EUTK@]2"XW06/[AFY0??,CDP/KO?T
M"V2GC^X9N<'@%%E\D(,DZ(7/M(;D:E7:.AVUK6TV?ZASV,?P^BGP3/6"8V(1
M,$?3I#/ ^T37V;6N6%7YC/:N+.9'7RSP10+:#<#^N5)V7W$3M&^<\3]02P,$
M%     @ #W-P4G4V[NEG!   'Q4  !D   !X;"]W;W)K<VAE971S+W-H965T
M-S@N>&ULQ5A=;]LV%/TKA)&'#D@ED?1G81N(DPXKT*Q&@K4/Q1YHB[:%2*)'
MTG$"[,>/I&A13B2Z%H+EQ1(EWL-S[]4YDCG>,_X@-I1*\)2EN9AT-E)N/X6A
M6&YH1D3 MC17=U:,9T2J(5^'8LLIB4U0EH8HBOIA1I*\,QV;:W,^';.=3).<
MSCD0NRPC_'E&4[:?=&#G<.$N66^DOA!.QUNRIO=4_K6=<S4*2Y0XR6@N$I8#
M3E>3SA7\-,-='6!F?$_H7E3.@4YEP=B#'GR))YU(,Z(I74H-0=3AD5[3--5(
MBL<_%K13KJD#J^<']-]-\BJ9!1'TFJ4_DEAN)IUA!\1T17:IO&/[/ZA-J*?Q
MEBP5YA?L[=RH Y8[(5EF@Q6#+,F+(WFRA:@$X*8 9 .0X5TL9%C>$$FF8\[V
M@.O9"DV?F%1-M"*7Y+HK]Y*KNXF*D]/[#>'TXTSE%8-KEJEF"V+*]1'<2[9\
M -^V>BC MYT4DN1QDJ_!AQLJ29**WX#0X0(D.;A-TE1/'(=2T=+@X=)2F!44
M4 .%/KAEN=P(\#F/:7P<'ZITRIS0(:<9\@+>T&4 ,+P$*$+1!0@MR^+7@X_+
MFF&#C[TU6YB:S<FS>D8EN.*<Y&NJSR]MS2[!YR?*EXF@8,Z3)05W>@;X^57!
M@2^29N)O#YEN2:9KR'0;R/RYRQ:4 U9IS[^@+M6B<@78T(!IQ3Y.>P$:AX\U
M#'HE@YZ7P0_SY*M:D$?*E9*56+4=:"9+U5BNA+<C*4B3%04?GBGAM<3\:T"@
M \$(9.91\=2M7[+NG\>:'IJUU<VJHU@ CBJU0]U@ .NK-RAY#+P\+@#$ 1XJ
MO<%1T!UX,AN6B,/W?SQ')9F1-[T"E*U>E%=<:C-+LEU65^@"$D:52ILBU5<:
M1L[KHK9DR%,3&8M9;;OM5"V9BO'"MQ2N1:LJ%P9-)) C@?X'[9Y8!!GQ"@"A
ME2^ (";/GJ<+.BN&^*UE;!%?-!3BAEHZ(X9^)[X " 9HI)2,>@$>^=)SU@I[
M[Z]EZ#P3^DVSE9HMYI&<3:4:"NZ<$_JMLYV<!Z]=O&A7+1EGNG#XIG(>OI)S
M%/0:2#BSA7ZW?2,Y^Q=Q,D98Z]CW-D;.FY'?FUL(&;UV9H2#48,I(N?,R._,
M2LC]H&N$K(^^])S1(O3^0D;.-I'?-EL)V6(>"[FH4&W!G7,BOW.V$K+%'/TB
M&6>YR/^I>::0+=KQ>[E!R,@9+3KSZ[25D$\L,BQ?Q^BDCITI([\IM]%QC25[
M.NDL&?DM6>EX$$0#I6/<#WH]7WK.8='H_76,G6OBUE^TS3JVF,<ZUI6J+SAV
MQHG]QME*QQ:SVGW;KEHRSG&Q_ZOS3!U;M%_2,:[L%)SY>=I*QR<6L7^.2SD/
M3ZD9.V?&?F=NH69<X\N# +[\\Q96]JPRRM=F9TZHJNQR66Q?E5?+W;^K8L_+
M32^V#F\)7R>Y "E=J= H&"A+YL5N7#&0;&MVP!9,2I:9TPTE,>5Z@KJ_8DP>
M!GJ!<D]T^A]02P,$%     @ #W-P4D+,BKYY P  1PP  !D   !X;"]W;W)K
M<VAE971S+W-H965T-SDN>&ULG5==;^(X%/TK5K0/,U*;#R<$& %2"UWMKM15
M5=2=9Y,8L.K8K&U@YM_/M1,""TF:[@OYNN?<XV-?^S(Y2O6NMY0:]*/@0D^]
MK3&[;T&@LRTMB/;EC@KXLI:J( 8>U2;0.T5)[D %#W 8ID%!F/!F$_?N1<TF
M<F\X$_1%(;TO"J)^/E(NCU,O\DXO7MEF:^R+8#;9D0U=4O.V>U'P%-0L.2NH
MT$P*I.AZZCU$WYZBQ )<Q#^,'O7%/;)#64GY;A_^S*=>:!513C-C*0A<#G1.
M.;=,H./?BM2K<UK@Y?V)_7<W>!C,BF@ZE_P[R\UVZHT\E-,UV7/S*H]_T&I
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M?:)8>DJISJ?P0DL4^^GX:N:JN$O)>.B/T_^&+1K"DM1/K];!4T,8&) .6QS
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MY!\+].#W*BX@'I" WA'?\[VN"?73?]EQI'M7Z8N;Z?2^@[Z\G3[N*490KY;
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MXM& KLKR35)VM-C:2_>+T'B%M\T4WW$@#0"_KX70QXX)4+\,9_\"4$L#!!0
M   (  ]S<%(9'R7E;0(  (P&   9    >&PO=V]R:W-H965T<R]S:&5E=#@Q
M+GAM;+65;6O;,!#'OXHP?='"&CO.(\4Q- ECA15"0K878R\4^VR+RI(G*4F[
M3[^3[!IW33+8V!M;#W?W_]W).D='J9YT 6#(<\F%GGF%,=6=[^ND@)+JGJQ
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M<X,!J7)REALC=VXTK*7!0>.6&;YL0%D#O-](:>J-=="\OL9_ 5!+ P04
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M5N6A04"=;D)0$8(V87*&,*P(PS9A=(8PJ@BCCQ+&%<%:=TOO-G%+JFDXE>)
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MM<,$6RY( \#]G1#Z.#$!ZB8>_@-02P,$%     @ #W-P4E+&9.?B @  APH
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MX'%QN6%4OK!S@'R^XEP<;O(.ZK/9X7]02P,$%     @ #W-P4LD#F/6G P
M7 \  !D   !X;"]W;W)K<VAE971S+W-H965T.#8N>&ULI9=;<]HZ$,>_BL;3
MAW2FL27;F,L ,R4D;1)(F')RSK,# CRU)6J)D'[[2O+E^")<S80'L.3_;[6K
ME19I?*;I3W; F(/W)"9L8ATX/XX<AVT.. F938^8B#<[FB8A%\UT[[!CBL.M
M@I+8<2$,G"2,B#4=J[Y5.AW3$X\C@E<I8*<D"=/?,QS3\\1"5M'Q(]H?N.QP
MIN-CN,=KS%^.JU2TG-+*-DHP81$E(,6[B?45C5:!U"O!OQ$^L\HSD)&\4OI3
M-NZW$PM*AW",-UQ:",7/&[[!<2P-"3=^Y3:M<D@)5I\+ZW<J=A'+:\CP#8W_
MB[;\,+$&%MCB77B*^0]Z_H[S>'K2WH;&3'V#<ZZ%%MB<&*=)#@L/DHADO^%[
M/@\50-C1 VX.N$W OP!X.>"9 GX.^*9 +P=ZID"0 X$IT,^!OBDPR(&!*3#,
M@:$I@&"1.6B,E,DVSC8JTHV,\XV*A*-6QH-+2)%R9)QS5"0=&6<=%6E'*N].
MMDG4#IN'/)R.4WH&J=0+>_)!;5/%BXT5$5E0UCP5;R/!\>D]V= $@W_"=\S
M-<B;5PO*V&<PPZ)B85#37,TQ#Z-8O+T&+^LYN/KT&7P"$0'+*(Y%C6!CAPN_
MI'5GD_LPRWQP+_C@@24E_,# +=GBK89?=//!W_BG;AZY'08<,:'EK+K%K,[<
M3HMSO+&!A[X %[I0X]!--[[&1X'#B_B\&W\XD4[\MAM?AFFG\W?&L:.A!O]F
M'+L6_VX<NQ:_-XY=BS^8QS[0X(_FL>OPQ<=6W?)CB7OZV*I[_ECB5N;XH&,'
M>V5=])0]K[LN7L6J$+YFA3#*.KDLA*..0?QR$%\-XE\8Y(5$'&_!FH<<Z^KF
M(L/["I='P[?I-8+(%@&^51.CD;D^M(=UV;-&!NV@+EJU1<AU;:]4U0+ME8'V
M.@,5AS]QM".Z$#-P4!FO;_<;\;4UJ-]T_+DM:@?7UER[MJN/+2AC"SIC^\M*
MT?T=!NU$]*#MUYV]T:A\KSDW<YVM@=VKJVXU*N0A&]5E=SH9:CKV3:.J+9&L
M3FM4K<S>MT5>T]"#3M-([&-; YN[9*%Q:.C;<%C]U)&E!O%:*7C2SD<KCN=,
MUJOZV%B>;4/(A94D9>O3J9SV$ISNU7V,@0T]$9[5GK*WO/)]52??1O\,C1Z1
MIG^!1DM=_Y.X.F8WO?^'S>Z=XF]S'Q$&8KP3+D"[+Z),L[M<UN#TJ,Z@KY2+
M,ZUZ/(CK+TZE0+S?4<J+AAR@O%!/_P!02P,$%     @ #W-P4N\M+R[5"0
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MK"9-C],<!QB0,]=6*1IC7_4UK",J'T>OZO>XJ[PUN')LN5<-@WH@MA1*Q#,
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MI,^,KF4!Q;T%5#.9GUO<T._DTW<2>5)UP94 4B DDKAJ\GLFB!R5/M]2#7#
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MMV]B/$JW*N()^R:0W,8Q%4\?6)3NKCINY_G#=[[>*/VA-Q[=TS5;,'5S_TW
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M@:\WBREZ_>H->H5Z2&ZH@*$\03<)5_(M?(3G+SR*H%#DJ*< E%;="PL 'W(
M^ B  'U)$[61:)8LV;)&?F*7=[%%00^B488$/X?D [9JG+*PBSSW+<(.=NH
MV<4_;1,0=XZ*3T\6=X<UXK/3Q0<UXO,F\>C9]WWQ%['TRO+R,GU>8WFA"62)
M)VN6A$_HK\\P#GU4+)9_6ZR0T@K)K) C5K3Z6Y:P%5? =A%5;(E4BH!^=3$G
M:Q2E4J(0:OOIEH9W;]'D^OML@:Y#55>ON:U^9DL3\\,8.]W^J/=0@] O$?I6
MA'.>T BI"LYTE46E'L,LU^97,'BX'D%0(@BL"&94)! *B2 H^21&/+X'8F]
MDFL=5I X74+JL?1++'TK%J@*Z(*2:>9XH-&6YDTF@C9'DY#5)257.*C >.=T
MO1)&/C'[!YGSNO[+,=/#,6[7?3EF=CC&Z0;U+@]*EP=6E[_"(@$:'A-"UR:$
M.^+TED=<<59+FH,#?]T^.7"X9E00[+LSK1DU\(\Y-"P=&EH=FE:=H5(R5>M'
MKB2HVB9[*9D,:_"YW>&>%S6C2'74"R]<Q_0_IS$QVT2P,%TG_$?A3S%)Z]N9
M<UAESGZ936I&X<-BK!OE'N,:M]+37:M/-]U%%\W9$N@O0C19(JF $]$_6\'E
MDF=+.HE^(J"$",I/92X_,2HL5.QB8QRW2/FNZ2RNUTCZ&C0D2U,\W2ZYYGV@
M%)XCT%ZQ1PJ+IHQ?:G-I-P%-T+=A-?W)M3>H$Q/R&3Y6TB%MMDWG<?TV\V'Z
MBVMO,!?)A]W$X8KJ)5;3?UQ[ X)-"6PYDG/G@"%[=]!FS T'NW82ODC,[29@
M#GBV1;4A6FPG6A/S,\H<&\[#;HLAQX;>,&X]Y TF&LH<&XK$=OXR(?^%P2X\
M>3JSX+$A.$S:C+XA,VQ?1U\D^G83305O"!';V:HN^N>4OF$SW&\S^(;5L'T-
M>Y'@VTTT=%QLF!';:<L$?['CZ@<3D6Z[YY6_9[C-<UK,@&=(SK,O["Z1@083
M#1GP#%%Z=A8[EH$SIH!7.69H\YS!,SSG-9\T_.\$V$U  @(;5L.5GIW(%MD:
M4P<]2D-8=^ZO-K^R'?K$A&3GM@7/4* 7M)D6PX">?3UWD;38332T!<^PJ&>G
MN+/2<LYD,=SH#=L\E#.L2.PKODMDI<$$9*5OPVJ8E=AI[Y2L_)F*NS.G"C%T
M2=K<-A/#E*3];7.#B08&(Y5C73L5GI&4,R8*,0Q*VMPZ$T.3I/VM<X.)AO-\
M8JB6V'EPDFX3^10AB(U-GZ%#TN96F1C2(_8%X9D'L/-"7?5H+NAW_6'UWY$[
M 4.0OIV]3CM#G?N'IX3!X8U$KW()&#.QSJYK)0HA7RJ__"J_EE?"U]E%Z-[W
MB?M^EE_L&C7Y/?,7*M8<9E[$5J 2(,#T$?G5;?ZBTOOLJO$V52J-L\<-HTLF
M] #X?96FZOE%&R@OT,?_ 5!+ P04    "  /<W!23W9X)\H%  "]*0  &0
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MS.O#M>!+458WF,]OI-1W)Y6#9L?F[']02P,$%     @ #W-P4K^MSMW- P
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MX!J@WF\9D^>";J"Y:"[^!U!+ P04    "  /<W!2"7QV=7(#   I#   &0
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M41UEJHGB>;FY+[B"HT(YW,#QCP@= .L)YVH_T>>%YD Y_0M02P,$%     @
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MGH"R #POI33[C770?Z'2/U!+ P04    "  /<W!2-3);<1("  !F!   &0
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M +0+L/NU4G@V7(+Q:<E? 5!+ P04    "  /<W!2&"3ZJ"@%  "7&   &0
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MH?8K9T)V\/A/(4%ID:PI^@=- G\3TY0%JXYCQZFW</[[,\ZM-W/?>L9YKN1
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M$A$J/BCDXV8%WK_[ -X!4H(OA%(%$#-'JFGJ8$[23.ES/27ORI16.+&!#^^
MYWKN@/ERW/R7?:G,W:OFJYO-X?3<W%&Y;1/LM0GVC#__/Q*\QA7CDI3967K_
M^E7!P;W$A?A[))C?!O--L.!*L-_41H&_[DFE0]X!BM6*R!E- 2DJS@Y8OQ:F
MUFI882Z?A\I3QXA-#+UO'!:!:\<SY] M0@T*.R#_ K+J^PECVV]!9PR#EF$P
MRG")1'X'$G4U1 ^(:DIWAI/:N)Z4&K<4*P$>L) F\0(G>TXDP8-2K*--.G.$
M,>R1[:.\,+ G%WP'?$UA!W5&.&P)AZ.$?V=2K39D%N$0@; ?-("3R[DMAV!N
M8$<7% 9@8>1U\G'&(6HY1*,<:NV;PF3=/21A1<5*7< 1[<=MD/CU%]JD#39Y
M@X4VZ65[8*'5H&ALH?7]7%]HTY;A]&;=Z<U?=!K%61&Y:01#]*9],7E!;,,+
M@@,P&$Q[JVL YL>N/1VF"=U3 W3_ISC!/^"Q)+HS;J1JD&-BA9V^"U]?KO#4
MA:#W!H)M@G2+X$_LX**@0ZCP$K5J4&?"CJX4\]3_X'@#_ ZJ;2*<ZW'J=M93
MPW( YTYCV[OD.8#SHO!:7X"G3@C'6^%-PEVK-@C83O]]TW1,2:=^!,,W$.ZI
M=<#QWO&=A!OU.WB_HGT0['7((4_PVF8+3\T+QJ\NW+C_OQ7U?@2&4%Z?91\%
MW;"S==<TG<[!0Q\3OR">D5*H*NV4G>IE2DJ\/GG5 \DJ<Q;9,JE.-N8Q5Z=5
MS#5 ?=\Q)E\&^GC3GG\7_P)02P,$%     @ #W-P4ES<VZ#J P  XQ   !H
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M L((Z/<;SM7SQ'20W5?/_#]02P,$%     @ #W-P4FQOWZGI @  *0@  !H
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M6BN1Q@#VUT+HP\0<T#3KZ3]02P,$%     @ #W-P4K/* &>Y @  H@@  !H
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M&KY$,&7_HF-E&W@H*946>06&"'+*W2]^J1+1  !/.R"J -$Y8'0%,*@ @W-
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M'<^DX7W8C\YT7MI,SU6L+FU Q>A,JC,:-8P&[3I'M<Y19P/])G@O,5HI/X!
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M(BW2WVJAZI=9M%)I6&QID5P]WB\L.'/F,QN%[A[RSJ 6D2IP8],1[P.(C=.
M0RVJ^2%T1.0\NEGI,2=(91Y194BK)IRQZ828(C]D)&:@49)*?<XA'H2!(T^<
M2?U"D^VC)MM&37Y7>F<3OWRRM/2TY-:?RK@9KO1F+LKR0H-ORA0ZV[SB-FM>
M!U#287($5(M'3UPBB6=]1#E42P-$N724AX!RV%5YA"BFAC$ND<2K1]1? 6WC
MA%/2]2@U!93':C_CE"O8))X#RF7]M6BS^>?8+I:I?Y2I;Y3I($E6[WH37JHS
MBG,=2*.GM;+"+%.Y%6VV.IB65_FEWL*_*+11[_HWHYW/FA?X#<=PF>AS"W;]
M'=PL=W*3F-8H9P9JSY85\YM%+4S$Q=@%Q[$+:FPWEFRUA\)) -8J/)QP2O@.
MI;J \MB:I@=*#-IL-8;J9=.I-D 46XP, ];!4A)=C8 GP:Z7XUK4(ZH57Y%Q
MRO;9^G;**4<P7S-.^6UV(9\#RF&7V 6G/+V>O+(2$ZU36K%E%.5\6RZPXA<=
M39;)1ED?UDF6?80)OA:_\#I\?X P.V [!(1Y/NV<'L*$;3-A(D[O$UJ&H#5
M-GQ+,$282]LS I1+78T!Y%'5/ )(T%Z>P/:VV=8!-I%%PQG$;,&B)N#8W%B@
M^FNI!E>D>I8!%\9]\ESO%M*C3*OH^=&T5Q;RY%L:I\$HSE6JLKQR#^4OP2+7
MIN)'D$.ECR :CR'D4]77@ 808B*O 8T@1(-Q'4^/=3Q-ZD!3 #'=SBKH_%I#
MHS#PP_)S"UC8M1A\2D,*<Q[R*#[#_J)R0;9/ 95?':J+*)N&H1[V95,%0LJE
M$JQ3KR&NEZ0BK$.-,45S-+A>+-8"BF=I,$6SD8@2;,[.*\R[P)@:;_3$I1Q/
MZ4CAF)<$19R%&G1N![<.@#X+?O7GE& IM!Z@V&ZYCPID 6< Z^Y1 2*(Z0^6
M)ZC^G%L;C$?4!VPYBKM34NW!.M&-$2K08SE"6"TF/5B@<T5ZIYRU,">M]UND
M!%[HH2)Y>I+/WPZB>-8%4(%Y =D#)I**JH_KZ%%] HK=RQAB7W335*O$,:9<
M*E) \1PAHMC=IFE%700U%A]!BIH6-T?%@74H[-)K5^M3\EJ8L]>C\WV2]:2>
MDU0=Q)J'/Z%,0<K2!:$38 [;ZG2A-Y\O(%'JVV81I@\Y)KT!PB1;#PP1QM((
M(T#9U-480A[5)TH]^U2>H%*!TV@%YW]4K"CESP9CAKN%-68N;J;K%\"5D.=7
MEDO!GC+;PIS:'AVU:6W3Y"TJ#QE^>%*Q>HYR'%9Y?E.O/JC".@B33(A=P?.@
MG]DV'Y7(]L]]A+&5ZP Z8S=9L"]Z[QM3+);R)K)=/<AE4S\3U%6.H,H$56)9
MOQD<'*;?.7;F4&F">@G[BC!/N6QA3F;/5%XCZ\33N9_M-M_Y $SP4Q@(XYG[
M'O3&W?41YS=L<]8)V$BP%@48NW$S A2[\S$&$%L./*+R0"1%_<=FX!2VT:<5
MF\%N#EBN< XXH%$.%8G":^'SE+47YK1]H=)"G5:8YVGTM,O#XH9+GEAQ$G\N
M;E>G27GKL+@=4V[CH8IYLKM%%7P3Z0J>!.9;C]YM1_W;R. V,JQ5G=%M1^/;
MR&.MLB:W'4UO([-:9<TQQ39*-ZC+HZ>GM+TTI^U9Z&3JG/Z=1N'*&NC+?!XM
MLT^67@8TK"Q/EG^])NN52N%]IZK8]HUHBS 0;1'FLIQ(#WH#T19QMZ(ML@'1
M%F$.V_H#BD=; /%HB\KC"5#8?SS:PC;R: N[64=;<O&; XZ=JUD J(BV5]8$
M\I3DE^8D?R],8QU,LX.LMRK='T<WY?GE*<\OS7G^;V$6+:T/46RM=-0.T^Q4
M %Q]5.Z"RW&B"V%,L=D J3:;#0 3#=>EDP%Z$TS_N&H^U3_$6O0F%\ TQ68
MI&CN]4J1-*1?Z34V!R!FLSD ,#T[ SH%8 O8'."4: 378OOI=H TWP[H1NM=
MKE;_1*5V+95"BJD44ERE $,JA=ZX2G'5F$HAQE7*,:122-E4I;A(IE+<:TRE
M$.,J!1A2*6P!4RFG1,._<@Y)GNX22/.IY3_+9P"U3,,WE88OZO#04+++LSR,
M5SJ(&T/V*2<LS3GA*F2_X_+P? "G5EUVKQ91#LNV8<HUI(YZ5TSHU("4Z935
M )FP+?T04R;'(VQ"$W*XQO3,GN19WC8]WX\8>J84EV;*V<VP"4W%X<;2\S:
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M(#23@BB8]KWSQMEE([  %_&=P5ROW!.;RD3*!SNX3OI>8!4!A]A8"HJ71[@
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M&X#/IU*:Y<"^H#IX#?X"4$L#!!0    (  ]S<%)ONZ3__PP  $1-   :
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M'Y]5N%9I >B_/R9)?OBE*.#XQ6EW?P%02P,$%     @ #W-P4B=-%(I# @
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M.ZNWO]GE^?.F8/^:COX 4$L#!!0    (  ]S<%*7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ #W-P4D$<)1>!!P
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M@N8!*,P'C;B#H6>Y,QLU-(Y@/FC$+*+-.\]^NS, A=FAT4ZVR.V)2S/L1@M
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M;8JV =0V9=L ;IO";0"Y3>DV@-VF>!M ;Z]Z>X#>7O7V +U]]V,;H+=7O3U
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MU;L ]"[=84& WD7U+@"]B^I= 'I7U;L"]*ZJ=P7H757O"M"[JMX5H'=5O2M
M[ZIZ5X#>5?6N +VKZET!>M?NL#= [ZIZ5X#>3?5N +V;ZMT >C?5NP'T;JIW
M ^C=5.\&T+NIW@V@=U.]&T#OIGHW@-Y-]6X O5M7U@'H;:ZOZP#\-M<5=AQ
M<'-=9<<!##?7E78<0'%S76W' 1PWUQ5W'$!R<UUUQP$L-]>5=QQ <W-=?<<!
M/#?7%7@<0?2^@,EH8/85S.\4?9K?MN/TF>ACW07X3KWG\W?'S^>_+S]N]J_A
MG>OA:XSIYB]02P,$%     @ #W-P4E!^0+I\ @  L3X  !,   !;0V]N=&5N
M=%]4>7!E<UTN>&ULS=M/;YLP&,?QMQ)QK0*V 1NFII=VUZV'O0$&3H/"/V&W
M2]_]'-)6VM1%JS)IWPL(;#^_!UOZW+C^]CQ9MSKTW> VT<[[Z5.2N'IG^\K%
MXV2',+(=Y[[RX7%^2*:JWE</-E%"Z*0>!V\'O_;'&M'-]9W=5H^=7WT^A->N
M'8=---O.1:O;T\1CUB:JIJEKZ\J'\>1I:'Y+6;\DQ&'E,L?MVLE=A0E1\F["
M<>3/ 2_KOC[9>6X;N[JO9O^EZL.LY- ESC]WUL7G2[S3X[C=MK5MQOJQ#TMB
M-\VV:MS.6M]W\:GHU?ED'W;8GJ[RXORES+G ,/-^'B<73FRV'X][/9+CZO44
M"MG9M^<_\2TQE+[X^^SQM!O;_&5VV-X?X[Q?SL,ER^WR/?[UC-_J?[ /!>DC
MA?210?K((7UH2!\&TD<!Z:.$]"$%I1&*J))"JJ28*BFH2HJJDL*JI+@J*;!*
MBJR*(JNBR*HHLBJ*K(HBJZ+(JBBR*HJLBB*KHLB:4F1-*;*F%%E3BJPI1=:4
M(FM*D36ER)I29$TILF8463.*K!E%UHPB:T:1-:/(FE%DS2BR9A19,XJL.476
MG")K3I$UI\B:4V3-*;+F%%ESBJPY1=:<(JNFR*HILFJ*K)HBJZ;(JBFR:HJL
MFB*KILBJ*;(:BJR&(JNAR&HHLAJ*K(8BJZ'(:BBR&HJLAB)K09&UH,A:4&0M
M*+(6%%D+BJP%1=:"(FM!D;6@R%I29"TILI8464N*K"5%UI(B:TF1M:3(6E)D
M+2FR2D&A50J*K5)0<)6"HJL4%%ZEH/@J!058*2C"2D$A5@J,L:#?L?ZGL=_'
M<?^/XY=[W%?M\)J?+'^JW_P$4$L! A0#%     @ #G-P4@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M"  .<W!2,DLH7^\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    "  .<W!2F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  YS<%(6
MBW)>I08  ,8:   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    "  .<W!2;<C?UY\'   :(@  &
M    @('I#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
M#G-P4BB4_H5@ @  = 8  !@              ("!OA8  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    (  YS<%(?R"CHJ@P  *)+   8
M          " @509  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    "  .<W!27C[Q0H<#  #*"@  &               @($T)@  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ #G-P4LV5QF-?!0  HA@
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M965T,3 N>&UL4$L! A0#%     @ #G-P4M LZ@MH P  C@<  !D
M     ("!/6T  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  ]S<%)F"9<]>04  ,D.   9              "
M@6B*  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ #W-P
M4B-1.F))#0  YB@  !D              ("!&)   'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    "  /<W!2>F+A7HP1  #Z,0  &0
M        @(&8G0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   (  ]S<%+IE$H050,  !D'   9              " @5NO  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ #W-P4D8@'4GC!P  /10
M !D              ("!Y[(  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    "  /<W!27X<O12X#  #=!@  &0              @($!NP
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  ]S<%)*8!*<
MZP<  /83   9              " @6:^  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ #W-P4@KW# 1M P  =@<  !D
M ("!B,8  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  /
M<W!2>O![=*@+  !0'@  &0              @($LR@  >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (  ]S<%*BZ"(]%@0  /\(   9
M          " @0O6  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#
M%     @ #W-P4I>R@D5$ P  &@<  !D              ("!6-H  'AL+W=O
M<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    "  /<W!24W.C@8X'  "L
M%0  &0              @('3W0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM
M;%!+ 0(4 Q0    (  ]S<%(]UMEZ(00  +T(   9              " @9CE
M  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ #W-P4E],
MTQ;)(P  &70  !D              ("!\.D  'AL+W=O<FMS:&5E=',O<VAE
M970R.2YX;6Q02P$"% ,4    "  /<W!21^6P"? %  "X#P  &0
M    @('P#0$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M  ]S<%(I\4X/Q00  ,L-   9              " @1<4 0!X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ #W-P4KX2W$S!!   JPT  !D
M             ("!$QD! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    "  /<W!2(\<:5.8"  ",!@  &0              @($+'@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (  ]S<%)@K4+Z[P4
M " 7   9              " @2@A 0!X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ #W-P4J_1YI#! @  R04  !D              ("!
M3B<! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    "  /<W!2
M+)0F(H$"  !0!0  &0              @(%&*@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    (  ]S<%*&#M!.>P(  %4%   9
M      " @?XL 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ #W-P4GZ!@+"6 P  $0D  !D              ("!L"\! 'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    "  /<W!2E*0F$*4'   6&0
M&0              @(%],P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    (  ]S<%)+0[M[LPH  )0>   9              " @5D[ 0!X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ #W-P4F*<E*O+
M @  '08  !D              ("!0T8! 'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    "  /<W!2D%:U58P"  !?!0  &0
M@(%%20$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (  ]S
M<%)VBAO#:08  +@1   9              " @0A, 0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ #W-P4E.]Z@0.!0  YPL  !D
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M=#0X+GAM;%!+ 0(4 Q0    (  ]S<%)"-FJA> 8  #(B   9
M  " @4!N 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
M#W-P4O()]Z#E @  C @  !D              ("![W0! 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    "  /<W!2UY(KP%$$  #L$@  &0
M            @($+> $ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    (  ]S<%*\(*KV?@(  !P&   9              " @9-\ 0!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ #W-P4E23:XBZ!0
MKA\  !D              ("!2'\! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    "  /<W!2;87+D_P#  #X$   &0              @($Y
MA0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (  ]S<%)H
M4S%--@(  #P%   9              " @6R) 0!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @ #W-P4FL1;(:] @  20<  !D
M     ("!V8L! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  ]S<%+KT<07>0(  )X&   9              "
M@1>? 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ #W-P
M4C NQPF3!    18  !D              ("!QZ$! 'AL+W=O<FMS:&5E=',O
M<VAE970V,BYX;6Q02P$"% ,4    "  /<W!288KO:T8$  "W$P  &0
M        @(&1I@$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0
M   (  ]S<%(C+,#V: 0  #$4   9              " @0ZK 0!X;"]W;W)K
M<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ #W-P4DX"5CV  @  PP8
M !D              ("!K:\! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q0
M2P$"% ,4    "  /<W!2P)67.HP"  "T!P  &0              @(%DL@$
M>&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (  ]S<%)G]C6K
M(0,  ,X)   9              " @2>U 0!X;"]W;W)K<VAE971S+W-H965T
M-C<N>&UL4$L! A0#%     @ #W-P4EHTY[C!!   #!<  !D
M ("!?[@! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    "  /
M<W!2??>\(&("  "E!@  &0              @(%WO0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    (  ]S<%*)010WFP(  %4'   9
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M970W-"YX;6Q02P$"% ,4    "  /<W!2)UJQUI4&  "O'P  &0
M    @($^T $ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (
M  ]S<%):375NL ,  +4.   9              " @0K7 0!X;"]W;W)K<VAE
M971S+W-H965T-S8N>&UL4$L! A0#%     @ #W-P4J@RKG?' @  [P@  !D
M             ("!\=H! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"
M% ,4    "  /<W!2=3;NZ6<$   ?%0  &0              @('OW0$ >&PO
M=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    (  ]S<%)"S(J^>0,
M $<,   9              " @8WB 0!X;"]W;W)K<VAE971S+W-H965T-SDN
M>&UL4$L! A0#%     @ #W-P4E$$]:F: P  )0X  !D              ("!
M/>8! 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    "  /<W!2
M&1\EY6T"  ",!@  &0              @($.Z@$ >&PO=V]R:W-H965T<R]S
M:&5E=#@Q+GAM;%!+ 0(4 Q0    (  ]S<%("5A8PE@(  ,H&   9
M      " @;+L 0!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%
M  @ #W-P4K9;*PJU @  T <  !D              ("!?^\! 'AL+W=O<FMS
M:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    "  /<W!24L9DY^("  "'"@
M&0              @(%K\@$ >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+
M 0(4 Q0    (  ]S<%)^]1%AG 0  *<5   9              " @83U 0!X
M;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ #W-P4LD#F/6G
M P  7 \  !D              ("!5_H! 'AL+W=O<FMS:&5E=',O<VAE970X
M-BYX;6Q02P$"% ,4    "  /<W!2[RTO+M4)  !?/   &0
M@($U_@$ >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    (  ]S
M<%(=W>B%QP0  !,3   9              " @4$( @!X;"]W;W)K<VAE971S
M+W-H965T.#@N>&UL4$L! A0#%     @ #W-P4CGG*)K0!0  3!\  !D
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M=#DS+GAM;%!+ 0(4 Q0    (  ]S<%+JKZL#0 (  &0%   9
M  " @3DD @!X;"]W;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%     @
M#W-P4A)<S]B% @  K08  !D              ("!L"8" 'AL+W=O<FMS:&5E
M=',O<VAE970Y-2YX;6Q02P$"% ,4    "  /<W!2-3);<1("  !F!   &0
M            @(%L*0( >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4
M Q0    (  ]S<%(8)/JH* 4  )<8   9              " @;4K @!X;"]W
M;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @ #W-P4E 4<E9^!@
M/R(  !D              ("!%#$" 'AL+W=O<FMS:&5E=',O<VAE970Y."YX
M;6Q02P$"% ,4    "  /<W!2EZ.SPX,#  ""#0  &0              @(')
M-P( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    (  ]S<%((
M\OE*V ,   L/   :              " @8,[ @!X;"]W;W)K<VAE971S+W-H
M965T,3 P+GAM;%!+ 0(4 Q0    (  ]S<%)<W-N@Z@,  .,0   :
M      " @9,_ @!X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0
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M965T,3 U+GAM;%!+ 0(4 Q0    (  ]S<%*#(WOVS@(  +@'   :
M      " @2Q2 @!X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0
M   (  ]S<%*SR@!GN0(  *((   :              " @3)5 @!X;"]W;W)K
M<VAE971S+W-H965T,3 W+GAM;%!+ 0(4 Q0    (  ]S<%(G8:A9R0,  #$,
M   :              " @2-8 @!X;"]W;W)K<VAE971S+W-H965T,3 X+GAM
M;%!+ 0(4 Q0    (  ]S<%+.+4P5V P  .M+   :              " @21<
M @!X;"]W;W)K<VAE971S+W-H965T,3 Y+GAM;%!+ 0(4 Q0    (  ]S<%*E
MWPDR^ (  (0)   :              " @31I @!X;"]W;W)K<VAE971S+W-H
M965T,3$P+GAM;%!+ 0(4 Q0    (  ]S<%)ONZ3__PP  $1-   :
M      " @61L @!X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0
M   (  ]S<%(G312*0P(  %H+   -              "  9MY @!X;"]S='EL
M97,N>&UL4$L! A0#%     @ #W-P4I>*NQS     $P(   L
M ( !"7P" %]R96QS+RYR96QS4$L! A0#%     @ #W-P4D$<)1>!!P  +TD
M  \              ( !\GP" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M  ]S<%)^UC(F'@,  "Y!   :              "  :"$ @!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  ]S<%)0?D"Z? (  +$^   3
M              "  ?:' @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !W
- '< Q"   *.* @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>406</ContextCount>
  <ElementCount>598</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>95</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Organization and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210091002 - Disclosure - Marketable Investment Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecurities</Role>
      <ShortName>Marketable Investment Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210141003 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210191004 - Disclosure - Property, Plant and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNet</Role>
      <ShortName>Property, Plant and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210241005 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210311006 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210341007 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210381008 - Disclosure - Other Long-Term Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OtherLongTermLiabilities</Role>
      <ShortName>Other Long-Term Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210421009 - Disclosure - Preferred and Common Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquity</Role>
      <ShortName>Preferred and Common Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210471010 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210591011 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210681012 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210691013 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210731014 - Disclosure - Employee Deferred Savings Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/EmployeeDeferredSavingsPlan</Role>
      <ShortName>Employee Deferred Savings Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210771015 - Disclosure - Segment and Related Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformation</Role>
      <ShortName>Segment and Related Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210851016 - Disclosure - Sale of Subsidiary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SaleofSubsidiary</Role>
      <ShortName>Sale of Subsidiary</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210871017 - Disclosure - Business Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/BusinessAcquisitions</Role>
      <ShortName>Business Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210931018 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210951019 - Disclosure - Supplemental Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>Supplemental Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210981020 - Disclosure - Supplementary Quarterly Financial Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited</Role>
      <ShortName>Supplementary Quarterly Financial Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>211021021 - Disclosure - Transition Period Comparative Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited</Role>
      <ShortName>Transition Period Comparative Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230103002 - Disclosure - Marketable Investment Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecuritiesTables</Role>
      <ShortName>Marketable Investment Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/MarketableInvestmentSecurities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230153003 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/FairValueMeasurements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230203004 - Disclosure - Property, Plant and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNetTables</Role>
      <ShortName>Property, Plant and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/PropertyPlantandEquipmentNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230253005 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230323006 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/AccruedLiabilities</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230353007 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/LongTermDebt</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230393008 - Disclosure - Other Long-Term Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OtherLongTermLiabilitiesTables</Role>
      <ShortName>Other Long-Term Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/OtherLongTermLiabilities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230433009 - Disclosure - Preferred and Common Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables</Role>
      <ShortName>Preferred and Common Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/PreferredandCommonStockholdersEquity</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230483010 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/ShareBasedCompensation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230603011 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/IncomeTaxes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230703012 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/Leases</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230743013 - Disclosure - Employee Deferred Savings Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables</Role>
      <ShortName>Employee Deferred Savings Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/EmployeeDeferredSavingsPlan</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230783014 - Disclosure - Segment and Related Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationTables</Role>
      <ShortName>Segment and Related Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SegmentandRelatedInformation</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230883015 - Disclosure - Business Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/BusinessAcquisitionsTables</Role>
      <ShortName>Business Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/BusinessAcquisitions</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230963016 - Disclosure - Supplemental Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementalCashFlowInformationTables</Role>
      <ShortName>Supplemental Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230993017 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables</Role>
      <ShortName>Supplementary Quarterly Financial Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>231033018 - Disclosure - Transition Period Comparative Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables</Role>
      <ShortName>Transition Period Comparative Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Organization and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240054002 - Disclosure - Organization and Summary of Significant Accounting Policies - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Organization and Summary of Significant Accounting Policies - Reconciliation of Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Reconciliation of Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240074004 - Disclosure - Organization and Summary of Significant Accounting Policies - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240084005 - Disclosure - Organization and Summary of Significant Accounting Policies - Foreign Currency Cumulative Translation Adjustments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Foreign Currency Cumulative Translation Adjustments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240114006 - Disclosure - Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails</Role>
      <ShortName>Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240124007 - Disclosure - Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails</Role>
      <ShortName>Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240134008 - Disclosure - Marketable Investment Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails</Role>
      <ShortName>Marketable Investment Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240164009 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240174010 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240184011 - Disclosure - Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails</Role>
      <ShortName>Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240214012 - Disclosure - Property, Plant and Equipment, Net - Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240224013 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240234014 - Disclosure - Property, Plant and Equipment, Net - Depreciation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Depreciation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240264015 - Disclosure - Goodwill and Intangible Assets - Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240274016 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240284017 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240294018 - Disclosure - Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240304019 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240334020 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240364021 - Disclosure - Long Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240374022 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240404023 - Disclosure - Other Long-Term Liabilities - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails</Role>
      <ShortName>Other Long-Term Liabilities - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240414024 - Disclosure - Other Long-Term Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails</Role>
      <ShortName>Other Long-Term Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240444025 - Disclosure - Preferred and Common Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails</Role>
      <ShortName>Preferred and Common Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240454026 - Disclosure - Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails</Role>
      <ShortName>Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240464027 - Disclosure - Preferred and Common Stockholders' Equity - Stock Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails</Role>
      <ShortName>Preferred and Common Stockholders' Equity - Stock Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240494028 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240504029 - Disclosure - Share-Based Compensation - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails</Role>
      <ShortName>Share-Based Compensation - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240514030 - Disclosure - Share-Based Compensation - Valuation Assumptions for Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation - Valuation Assumptions for Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240524031 - Disclosure - Share-Based Compensation - Stock Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails</Role>
      <ShortName>Share-Based Compensation - Stock Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240534032 - Disclosure - Share-Based Compensation - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Share-Based Compensation - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240544033 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240554034 - Disclosure - Share-Based Compensation - Unrecognized Share-Based Compensation Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails</Role>
      <ShortName>Share-Based Compensation - Unrecognized Share-Based Compensation Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240564035 - Disclosure - Share-Based Compensation - Intrinsic Value of Options Exercised (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails</Role>
      <ShortName>Share-Based Compensation - Intrinsic Value of Options Exercised (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240574036 - Disclosure - Share-Based Compensation - Shares Purchased and Compensation Expenses for ESPP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails</Role>
      <ShortName>Share-Based Compensation - Shares Purchased and Compensation Expenses for ESPP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240584037 - Disclosure - Share-Based Compensation - Valuation Assumptions for ESPP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails</Role>
      <ShortName>Share-Based Compensation - Valuation Assumptions for ESPP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240614038 - Disclosure - Income Taxes - Income Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails</Role>
      <ShortName>Income Taxes - Income Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240624039 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income (Loss) Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240634040 - Disclosure - Income Taxes - Statutory Federal Income Tax Rate and Income Taxes Reported (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails</Role>
      <ShortName>Income Taxes - Statutory Federal Income Tax Rate and Income Taxes Reported (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240644041 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240654042 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240664043 - Disclosure - Income Taxes - Net Operating Loss and Research Credit Carryforwards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails</Role>
      <ShortName>Income Taxes - Net Operating Loss and Research Credit Carryforwards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240674044 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240714045 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240724046 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240754047 - Disclosure - Employee Deferred Savings Plan - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails</Role>
      <ShortName>Employee Deferred Savings Plan - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240764048 - Disclosure - Employee Deferred Savings Plan - Contributions to Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails</Role>
      <ShortName>Employee Deferred Savings Plan - Contributions to Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240794049 - Disclosure - Segment and Related Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails</Role>
      <ShortName>Segment and Related Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240804050 - Disclosure - Segment and Related Information - Segment Operating Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails</Role>
      <ShortName>Segment and Related Information - Segment Operating Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240814051 - Disclosure - Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails</Role>
      <ShortName>Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240824052 - Disclosure - Segment and Related Information - Balance Sheet Assets By Operating Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails</Role>
      <ShortName>Segment and Related Information - Balance Sheet Assets By Operating Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240834053 - Disclosure - Segment and Related Information - Assets by Geographical Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails</Role>
      <ShortName>Segment and Related Information - Assets by Geographical Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240844054 - Disclosure - Segment and Related Information - Revenue by Geographical Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails</Role>
      <ShortName>Segment and Related Information - Revenue by Geographical Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240864055 - Disclosure - Sale of Subsidiary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SaleofSubsidiaryDetails</Role>
      <ShortName>Sale of Subsidiary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SaleofSubsidiary</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240894056 - Disclosure - Business Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails</Role>
      <ShortName>Business Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240904057 - Disclosure - Business Acquisitions - Total Consideration Transferred (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails</Role>
      <ShortName>Business Acquisitions - Total Consideration Transferred (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240914058 - Disclosure - Business Acquisitions - Changes to Goodwill Balance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails</Role>
      <ShortName>Business Acquisitions - Changes to Goodwill Balance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240924059 - Disclosure - Business Acquisitions - Pro Forma Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails</Role>
      <ShortName>Business Acquisitions - Pro Forma Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240944060 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SubsequentEvent</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240974061 - Disclosure - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementalCashFlowInformationDetails</Role>
      <ShortName>Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SupplementalCashFlowInformationTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>241004062 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) - Quarterly Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails</Role>
      <ShortName>Supplementary Quarterly Financial Data (Unaudited) - Quarterly Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>241014063 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails</Role>
      <ShortName>Supplementary Quarterly Financial Data (Unaudited) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="mygn-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>241044064 - Disclosure - Transition Period Comparative Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails</Role>
      <ShortName>Transition Period Comparative Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-KT" original="mygn-20201231.htm">mygn-20201231.htm</File>
    <File>mygn-20201231.xsd</File>
    <File>mygn-20201231_cal.xml</File>
    <File>mygn-20201231_def.xml</File>
    <File>mygn-20201231_lab.xml</File>
    <File>mygn-20201231_pre.xml</File>
    <File>mygn-20201231xexx108.htm</File>
    <File>mygn-20201231xexx231.htm</File>
    <File>mygn-20201231xexx311.htm</File>
    <File>mygn-20201231xexx312.htm</File>
    <File>mygn-20201231xexx32.htm</File>
    <File>mygn-20201231xexx42.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mygn-20201231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/stpr/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>132
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mygn-20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 39,
   "contextCount": 406,
   "dts": {
    "calculationLink": {
     "local": [
      "mygn-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mygn-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mygn-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mygn-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mygn-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mygn-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 828,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 3,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 8
   },
   "keyCustom": 72,
   "keyStandard": 526,
   "memberCustom": 36,
   "memberStandard": 59,
   "nsprefix": "mygn",
   "nsuri": "http://www.myriad.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentAnnualReport",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover",
     "role": "http://www.myriad.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentAnnualReport",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210141003 - Disclosure - Fair Value Measurements",
     "role": "http://www.myriad.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834053 - Disclosure - Segment and Related Information - Assets by Geographical Region (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
     "shortName": "Segment and Related Information - Assets by Geographical Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844054 - Disclosure - Segment and Related Information - Revenue by Geographical Region (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails",
     "shortName": "Segment and Related Information - Revenue by Geographical Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i8622695f21e2408d87455391982da0ec_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864055 - Disclosure - Sale of Subsidiary (Details)",
     "role": "http://www.myriad.com/role/SaleofSubsidiaryDetails",
     "shortName": "Sale of Subsidiary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "idf5735f7cf7f4e7b873df22cc35b6279_D20200228-20200228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "iebca8052884e4c15bfe4d21293d70468_D20190701-20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894056 - Disclosure - Business Acquisitions - Narrative (Details)",
     "role": "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
     "shortName": "Business Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i93a834facdc34dff87795122a884aa47_D20180731-20180731",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904057 - Disclosure - Business Acquisitions - Total Consideration Transferred (Details)",
     "role": "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails",
     "shortName": "Business Acquisitions - Total Consideration Transferred (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i5909e1e0ad1e4dee9cc11be4c51097af_I20180731",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914058 - Disclosure - Business Acquisitions - Changes to Goodwill Balance (Details)",
     "role": "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails",
     "shortName": "Business Acquisitions - Changes to Goodwill Balance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i503fe559aeef481c886d5f95a4b941da_D20181001-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mygn:GoodwillIncreaseDecreaseFairValueAdjustmentEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924059 - Disclosure - Business Acquisitions - Pro Forma Results (Details)",
     "role": "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails",
     "shortName": "Business Acquisitions - Pro Forma Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic5799bad54844b258f6cc6e0b8296053_D20180701-20190630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i4154d8d1b34d4189b61c52d5e3db0e61_I20180731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944060 - Disclosure - Subsequent Event (Details)",
     "role": "http://www.myriad.com/role/SubsequentEventDetails",
     "shortName": "Subsequent Event (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i4e14cc8f30fb41298c08929c2d88cda2_I20210222",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mygn:DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974061 - Disclosure - Supplemental Cash Flow Information (Details)",
     "role": "http://www.myriad.com/role/SupplementalCashFlowInformationDetails",
     "shortName": "Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004062 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) - Quarterly Data (Details)",
     "role": "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
     "shortName": "Supplementary Quarterly Financial Data (Unaudited) - Quarterly Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210191004 - Disclosure - Property, Plant and Equipment, Net",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNet",
     "shortName": "Property, Plant and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014063 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) - Narrative (Details)",
     "role": "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails",
     "shortName": "Supplementary Quarterly Financial Data (Unaudited) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i30498117f20e422cbecf6623972988bf_D20191001-20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044064 - Disclosure - Transition Period Comparative Data (Unaudited) (Details)",
     "role": "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails",
     "shortName": "Transition Period Comparative Data (Unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210241005 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210311006 - Disclosure - Accrued Liabilities",
     "role": "http://www.myriad.com/role/AccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210341007 - Disclosure - Long-Term Debt",
     "role": "http://www.myriad.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210381008 - Disclosure - Other Long-Term Liabilities",
     "role": "http://www.myriad.com/role/OtherLongTermLiabilities",
     "shortName": "Other Long-Term Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210421009 - Disclosure - Preferred and Common Stockholders' Equity",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquity",
     "shortName": "Preferred and Common Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210471010 - Disclosure - Share-Based Compensation",
     "role": "http://www.myriad.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210591011 - Disclosure - Income Taxes",
     "role": "http://www.myriad.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210681012 - Disclosure - Commitments and Contingencies",
     "role": "http://www.myriad.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.myriad.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210691013 - Disclosure - Leases",
     "role": "http://www.myriad.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210731014 - Disclosure - Employee Deferred Savings Plan",
     "role": "http://www.myriad.com/role/EmployeeDeferredSavingsPlan",
     "shortName": "Employee Deferred Savings Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210771015 - Disclosure - Segment and Related Information",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformation",
     "shortName": "Segment and Related Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210851016 - Disclosure - Sale of Subsidiary",
     "role": "http://www.myriad.com/role/SaleofSubsidiary",
     "shortName": "Sale of Subsidiary",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210871017 - Disclosure - Business Acquisitions",
     "role": "http://www.myriad.com/role/BusinessAcquisitions",
     "shortName": "Business Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210931018 - Disclosure - Subsequent Event",
     "role": "http://www.myriad.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210951019 - Disclosure - Supplemental Cash Flow Information",
     "role": "http://www.myriad.com/role/SupplementalCashFlowInformation",
     "shortName": "Supplemental Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981020 - Disclosure - Supplementary Quarterly Financial Data (Unaudited)",
     "role": "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited",
     "shortName": "Supplementary Quarterly Financial Data (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mygn:TransitionPeriodComparativeDataTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211021021 - Disclosure - Transition Period Comparative Data (Unaudited)",
     "role": "http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited",
     "shortName": "Transition Period Comparative Data (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mygn:TransitionPeriodComparativeDataTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Organization and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230103002 - Disclosure - Marketable Investment Securities (Tables)",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecuritiesTables",
     "shortName": "Marketable Investment Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230153003 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.myriad.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230203004 - Disclosure - Property, Plant and Equipment, Net (Tables)",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNetTables",
     "shortName": "Property, Plant and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230253005 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230323006 - Disclosure - Accrued Liabilities (Tables)",
     "role": "http://www.myriad.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230353007 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.myriad.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230393008 - Disclosure - Other Long-Term Liabilities (Tables)",
     "role": "http://www.myriad.com/role/OtherLongTermLiabilitiesTables",
     "shortName": "Other Long-Term Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230433009 - Disclosure - Preferred and Common Stockholders' Equity (Tables)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables",
     "shortName": "Preferred and Common Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230483010 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Statements of Operations",
     "role": "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230603011 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.myriad.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230703012 - Disclosure - Leases (Tables)",
     "role": "http://www.myriad.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230743013 - Disclosure - Employee Deferred Savings Plan (Tables)",
     "role": "http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables",
     "shortName": "Employee Deferred Savings Plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230783014 - Disclosure - Segment and Related Information (Tables)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationTables",
     "shortName": "Segment and Related Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230883015 - Disclosure - Business Acquisitions (Tables)",
     "role": "http://www.myriad.com/role/BusinessAcquisitionsTables",
     "shortName": "Business Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230963016 - Disclosure - Supplemental Cash Flow Information (Tables)",
     "role": "http://www.myriad.com/role/SupplementalCashFlowInformationTables",
     "shortName": "Supplemental Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993017 - Disclosure - Supplementary Quarterly Financial Data (Unaudited) (Tables)",
     "role": "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables",
     "shortName": "Supplementary Quarterly Financial Data (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mygn:ScheduleOfTransitionPeriodComparativeDataTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231033018 - Disclosure - Transition Period Comparative Data (Unaudited) (Tables)",
     "role": "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables",
     "shortName": "Transition Period Comparative Data (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mygn:ScheduleOfTransitionPeriodComparativeDataTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:MarketableSecuritiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Organization and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:MarketableSecuritiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054002 - Disclosure - Organization and Summary of Significant Accounting Policies - Revenue by Type (Details)",
     "role": "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "iea7c3564b9c44c23a5c4dfb365017793_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic1a86f3dc9014d3994d6dbfb20000c19_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Organization and Summary of Significant Accounting Policies - Reconciliation of Deferred Revenue (Details)",
     "role": "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Reconciliation of Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i171870dd15d143e2bd07f52254307cce_I20180630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074004 - Disclosure - Organization and Summary of Significant Accounting Policies - Earnings Per Share (Details)",
     "role": "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic1a86f3dc9014d3994d6dbfb20000c19_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084005 - Disclosure - Organization and Summary of Significant Accounting Policies - Foreign Currency Cumulative Translation Adjustments (Details)",
     "role": "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Foreign Currency Cumulative Translation Adjustments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic1a86f3dc9014d3994d6dbfb20000c19_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114006 - Disclosure - Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails",
     "shortName": "Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124007 - Disclosure - Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
     "shortName": "Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134008 - Disclosure - Marketable Investment Securities - Narrative (Details)",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails",
     "shortName": "Marketable Investment Securities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i931f10a967bd4961a4edc7f16b906bfd_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164009 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i931f10a967bd4961a4edc7f16b906bfd_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174010 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)",
     "role": "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic1a86f3dc9014d3994d6dbfb20000c19_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184011 - Disclosure - Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)",
     "role": "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails",
     "shortName": "Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i171870dd15d143e2bd07f52254307cce_I20180630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214012 - Disclosure - Property, Plant and Equipment, Net - Balances (Details)",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails",
     "shortName": "Property, Plant and Equipment, Net - Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i28ea8f3abcd243cc8055858b4e824489_I20170630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i28ea8f3abcd243cc8055858b4e824489_I20170630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i575f18ab83bc40979444ed5ab8404853_D20190701-20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisposals",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224013 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details)",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails",
     "shortName": "Property, Plant and Equipment, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i575f18ab83bc40979444ed5ab8404853_D20190701-20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisposals",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234014 - Disclosure - Property, Plant and Equipment, Net - Depreciation Expense (Details)",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails",
     "shortName": "Property, Plant and Equipment, Net - Depreciation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic1a86f3dc9014d3994d6dbfb20000c19_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264015 - Disclosure - Goodwill and Intangible Assets - Carrying Amount of Goodwill (Details)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "iebca8052884e4c15bfe4d21293d70468_D20190701-20200630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274016 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284017 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294018 - Disclosure - Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304019 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334020 - Disclosure - Accrued Liabilities (Details)",
     "role": "http://www.myriad.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364021 - Disclosure - Long Term Debt - Narrative (Details)",
     "role": "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i6f1482ec3ab648658454bf97344b72e8_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLinesOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374022 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "role": "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mygn:NonCashInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404023 - Disclosure - Other Long-Term Liabilities - Summary (Details)",
     "role": "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails",
     "shortName": "Other Long-Term Liabilities - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i69f08e4358544efba7545f11fac65d70_I20190630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mygn:NumberOfDefinedBenefitPensionPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plan",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414024 - Disclosure - Other Long-Term Liabilities - Narrative (Details)",
     "role": "http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails",
     "shortName": "Other Long-Term Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i69f08e4358544efba7545f11fac65d70_I20190630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mygn:NumberOfDefinedBenefitPensionPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plan",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444025 - Disclosure - Preferred and Common Stockholders' Equity - Narrative (Details)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails",
     "shortName": "Preferred and Common Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic1a86f3dc9014d3994d6dbfb20000c19_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454026 - Disclosure - Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails",
     "shortName": "Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464027 - Disclosure - Preferred and Common Stockholders' Equity - Stock Repurchases (Details)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails",
     "shortName": "Preferred and Common Stockholders' Equity - Stock Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mygn:AmountOfReductionInCommonStockAsResultOfStockRepurchases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494028 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic1a86f3dc9014d3994d6dbfb20000c19_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504029 - Disclosure - Share-Based Compensation - Stock Options Activity (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails",
     "shortName": "Share-Based Compensation - Stock Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ie5de9e03237140d3891cfbfca360c035_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514030 - Disclosure - Share-Based Compensation - Valuation Assumptions for Stock Options (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails",
     "shortName": "Share-Based Compensation - Valuation Assumptions for Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ie5de9e03237140d3891cfbfca360c035_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524031 - Disclosure - Share-Based Compensation - Stock Options Outstanding (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails",
     "shortName": "Share-Based Compensation - Stock Options Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i05899c67f3004572be84cd6af2e63fe0_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534032 - Disclosure - Share-Based Compensation - Restricted Stock Units Activity (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
     "shortName": "Share-Based Compensation - Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ia7ed7fb544224687abcd95a843a924b2_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Organization and Summary of Significant Accounting Policies",
     "role": "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544033 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation - Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i43833f7c5d3b4c9c95d487f7e63e9156_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554034 - Disclosure - Share-Based Compensation - Unrecognized Share-Based Compensation Cost (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails",
     "shortName": "Share-Based Compensation - Unrecognized Share-Based Compensation Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564035 - Disclosure - Share-Based Compensation - Intrinsic Value of Options Exercised (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails",
     "shortName": "Share-Based Compensation - Intrinsic Value of Options Exercised (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574036 - Disclosure - Share-Based Compensation - Shares Purchased and Compensation Expenses for ESPP (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails",
     "shortName": "Share-Based Compensation - Shares Purchased and Compensation Expenses for ESPP (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584037 - Disclosure - Share-Based Compensation - Valuation Assumptions for ESPP (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails",
     "shortName": "Share-Based Compensation - Valuation Assumptions for ESPP (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "iee4e282cd76946aab6cd5763ab5f52ed_D20200701-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614038 - Disclosure - Income Taxes - Income Tax Benefit (Details)",
     "role": "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails",
     "shortName": "Income Taxes - Income Tax Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624039 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Details)",
     "role": "http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Income (Loss) Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634040 - Disclosure - Income Taxes - Statutory Federal Income Tax Rate and Income Taxes Reported (Details)",
     "role": "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails",
     "shortName": "Income Taxes - Statutory Federal Income Tax Rate and Income Taxes Reported (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644041 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Components of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mygn:IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654042 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.myriad.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mygn:IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210091002 - Disclosure - Marketable Investment Securities",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecurities",
     "shortName": "Marketable Investment Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i8fac106fccce4731bad8f044406b0d14_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664043 - Disclosure - Income Taxes - Net Operating Loss and Research Credit Carryforwards (Details)",
     "role": "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails",
     "shortName": "Income Taxes - Net Operating Loss and Research Credit Carryforwards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i8fac106fccce4731bad8f044406b0d14_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ic1a86f3dc9014d3994d6dbfb20000c19_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674044 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i28ea8f3abcd243cc8055858b4e824489_I20170630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714045 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.myriad.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724046 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)",
     "role": "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754047 - Disclosure - Employee Deferred Savings Plan - Narrative (Details)",
     "role": "http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails",
     "shortName": "Employee Deferred Savings Plan - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764048 - Disclosure - Employee Deferred Savings Plan - Contributions to Plan (Details)",
     "role": "http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails",
     "shortName": "Employee Deferred Savings Plan - Contributions to Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794049 - Disclosure - Segment and Related Information - Narrative (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails",
     "shortName": "Segment and Related Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3ca60105a548447eb9db3589c1e2356c_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804050 - Disclosure - Segment and Related Information - Segment Operating Income (Loss) (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails",
     "shortName": "Segment and Related Information - Segment Operating Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i6072bb4ef660450c9ee8f8cc85df19b6_D20200701-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ibf98085b61b34948a5fe61cb9f2c6421_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814051 - Disclosure - Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
     "shortName": "Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "i3713c16ca67a4a2c92019768c7306642_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824052 - Disclosure - Segment and Related Information - Balance Sheet Assets By Operating Segment (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
     "shortName": "Segment and Related Information - Balance Sheet Assets By Operating Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mygn:ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20201231.htm",
      "contextRef": "ie2a0de5212d9437b9c547a36e207b87f_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 95,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "verboseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r687",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "verboseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date",
        "terseLabel": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "verboseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "verboseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r687",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mygn_AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Finite-Lived Intangible Assets, Valuation Assumptions, Net Cash Flow Discount Rate, Percent",
        "label": "Acquired Finite-Lived Intangible Assets, Valuation Assumptions, Net Cash Flow Discount Rate, Percent",
        "terseLabel": "Acquired intangible assets, valuation assumptions discount rate"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsValuationAssumptionsNetCashFlowDiscountRatePercent",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_AmendmentToCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to Credit Agreement [Member].",
        "label": "Amendment To Credit Agreement [Member]",
        "terseLabel": "Amended facility"
       }
      }
     },
     "localname": "AmendmentToCreditAgreementMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to retained earnings as a result of stock repurchases.",
        "label": "Amount Charged To Retained Earnings As Result Of Stock Repurchases",
        "terseLabel": "Charges to retained earnings"
       }
      }
     },
     "localname": "AmountChargedToRetainedEarningsAsResultOfStockRepurchases",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reduction in common stock as a result of stock repurchases.",
        "label": "Amount Of Reduction In Common Stock As Result Of Stock Repurchases",
        "terseLabel": "Common stock and additional paid-in-capital reductions"
       }
      }
     },
     "localname": "AmountOfReductionInCommonStockAsResultOfStockRepurchases",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_AssetsLessCashCashEquivalentsAndInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, Less Cash, Cash Equivalents, And Investments",
        "label": "Assets, Less Cash, Cash Equivalents, And Investments",
        "terseLabel": "Total assets less cash, cash equivalents, and marketable investment securities",
        "verboseLabel": "Total assets by segment and geographical region"
       }
      }
     },
     "localname": "AssetsLessCashCashEquivalentsAndInvestments",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Measurement Input, Term",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input, Term",
        "terseLabel": "Measurement period for earn out liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mygn_CARESActOf2020MedicarePaymentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act of 2020 medicare payment amount.",
        "label": "CARES Act Of 2020 Medicare Payment Amount",
        "terseLabel": "Advance Medicare payments to provide relief from economic impacts of COVID-19"
       }
      }
     },
     "localname": "CARESActOf2020MedicarePaymentAmount",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_CARESActOf2020ProviderReliefFundAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act of 2020 Provider Relief Fund amount.",
        "label": "C A R E S Act Of2020 Provider Relief Fund Amount",
        "terseLabel": "Provider fund relief under CARES Act"
       }
      }
     },
     "localname": "CARESActOf2020ProviderReliefFundAmount",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_ChangeInFairValueOfContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of contingent consideration.",
        "label": "Change In Fair Value Of Contingent Consideration",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "ChangeInFairValueOfContingentConsideration",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_ClinicAssetGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinic asset group.",
        "label": "Clinic Asset Group [Member]",
        "terseLabel": "Clinic asset group",
        "verboseLabel": "Clinic"
       }
      }
     },
     "localname": "ClinicAssetGroupMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails",
      "http://www.myriad.com/role/SaleofSubsidiaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_ClinicReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinic Reporting Unit",
        "label": "Clinic Reporting Unit [Member]",
        "terseLabel": "Clinic reporting unit"
       }
      }
     },
     "localname": "ClinicReportingUnitMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration.",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Including New Contract, Revenue Recognized",
        "label": "Contract With Customer, Liability, Including New Contract, Revenue Recognized",
        "negatedLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_ContractWithCustomerLiabilityPrepayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer, liability, prepayments.",
        "label": "Contract With Customer Liability Prepayments",
        "terseLabel": "Prepayments"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityPrepayments",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_CostOfMolecularDiagnosticTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about the cost of molecular diagnostic testing expense have been included.",
        "label": "Cost Of Molecular Diagnostic Testing [Member]",
        "terseLabel": "Cost of molecular diagnostic testing"
       }
      }
     },
     "localname": "CostOfMolecularDiagnosticTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_CostOfPharmaceuticalAndClinicalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about the cost of pharmaceutical and clinical services expense have been included.",
        "label": "Cost Of Pharmaceutical And Clinical Services [Member]",
        "terseLabel": "Cost of pharmaceutical and clinical services"
       }
      }
     },
     "localname": "CostOfPharmaceuticalAndClinicalServicesMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_CounsylIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Counsyl Inc.",
        "label": "Counsyl Inc [Member]",
        "terseLabel": "Counsyl Inc"
       }
      }
     },
     "localname": "CounsylIncMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails",
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Unrestricted Cash Required For Borrowing, Minimum",
        "label": "Debt Covenant, Unrestricted Cash Required For Borrowing, Minimum",
        "terseLabel": "Minimum unrestricted cash required for borrowing"
       }
      }
     },
     "localname": "DebtCovenantUnrestrictedCashRequiredForBorrowingMinimum",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_DebtInstrumentLIBORFloorPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, LIBOR Floor, Percentage",
        "label": "Debt Instrument, LIBOR Floor, Percentage",
        "terseLabel": "LIBOR floor (percent)"
       }
      }
     },
     "localname": "DebtInstrumentLIBORFloorPercentage",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_DeferredTaxAssetsLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets lease right-of-use asset.",
        "label": "Deferred Tax Assets Lease Right Of Use Asset",
        "terseLabel": "Lease right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseRightOfUseAsset",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_DeferredTaxAssetsUncertainStateTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Uncertain State Tax Positions",
        "label": "Deferred Tax Assets Uncertain State Tax Positions",
        "terseLabel": "Uncertain state tax positions"
       }
      }
     },
     "localname": "DeferredTaxAssetsUncertainStateTaxPositions",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_DeferredTaxLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax lease liability.",
        "label": "Deferred Tax Lease Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxLeaseLiability",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_DevelopedTechnologyAndDatabaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology and database.",
        "label": "Developed Technology And Database [Member]",
        "terseLabel": "Developed technology and database"
       }
      }
     },
     "localname": "DevelopedTechnologyAndDatabaseMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_DiagnosticMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic.",
        "label": "Diagnostic [Member]",
        "terseLabel": "Diagnostic"
       }
      }
     },
     "localname": "DiagnosticMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Settlement Of Pension",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Settlement Of Pension",
        "terseLabel": "Gain related to pension settlement"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalSettlementOfPension",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/SaleofSubsidiaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Writedown And Foreign Currency Effect",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Writedown And Foreign Currency Effect",
        "negatedTerseLabel": "Loss to adjust net assets to purchase price and effects of foreign currency"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalWritedownAndForeignCurrencyEffect",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/SaleofSubsidiaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation asset impairment.",
        "label": "Effective Income Tax Rate Reconciliation Asset Impairment",
        "terseLabel": "Asset impairment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAssetImpairment",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation CARES Act",
        "label": "Effective Income Tax Rate Reconciliation CARES Act",
        "terseLabel": "CARES Act"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCARESAct",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 19.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation, changes in revenue recognition/method.",
        "label": "Effective Income Tax Rate Reconciliation Changes In Revenue Recognition Method",
        "terseLabel": "Changes in revenue recognition/method"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangesInRevenueRecognitionMethod",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation expired tax attributes.",
        "label": "Effective Income Tax Rate Reconciliation Expired Tax Attributes",
        "terseLabel": "Expired tax attributes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationExpiredTaxAttributes",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation fair value adjustments related to acquisition contingent consideration.",
        "label": "Effective Income Tax Rate Reconciliation Fair Value Adjustments Related To Acquisition Contingent Consideration",
        "negatedLabel": "Fair value adjustments related to acquisition contingent consideration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationForeignDisregardedElection": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 18.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation foreign disregarded election.",
        "label": "Effective Income Tax Rate Reconciliation Foreign Disregarded Election",
        "terseLabel": "Foreign disregarded election"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignDisregardedElection",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation non deductible contingent purchase price and transaction costs.",
        "label": "Effective Income Tax Rate Reconciliation Non Deductible Contingent Purchase Price And Transaction Costs",
        "terseLabel": "Non-deductible contingent purchase price and transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 17.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation non deductible legal settlements.",
        "label": "Effective Income Tax Rate Reconciliation Non Deductible Legal Settlements",
        "terseLabel": "Non-deductible legal settlement"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonDeductibleLegalSettlements",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation non-deductible officer compensation.",
        "label": "Effective Income Tax Rate Reconciliation Non Deductible Officer Compensation",
        "terseLabel": "Non-deductible officer compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonDeductibleOfficerCompensation",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationStatuteExpirations": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Statute Expirations",
        "label": "Effective Income Tax Rate Reconciliation Statute Expirations",
        "terseLabel": "Uncertain tax benefits statute expired, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStatuteExpirations",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation tax cut and jobs act impact.",
        "label": "Effective Income Tax Rate Reconciliation Tax Cut And Jobs Act Impact",
        "terseLabel": "Tax Cut and Jobs Act impact"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutAndJobsActImpact",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_EmployeeStockPurchasePlanTwentyTwelveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan Twenty Twelve [Member]",
        "label": "Employee Stock Purchase Plan Twenty Twelve [Member]",
        "terseLabel": "2012 Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanTwentyTwelveMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value adjustment on marketable investment securities recorded to stockholders equity.",
        "label": "Fair Value Adjustment On Marketable Investment Securities Recorded To Stockholders Equity",
        "terseLabel": "Fair value adjustment on marketable investment securities recorded to stockholders' equity"
       }
      }
     },
     "localname": "FairValueAdjustmentOnMarketableInvestmentSecuritiesRecordedToStockholdersEquity",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_GoodwillAndIntangibleAssetImpairmentChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill And Intangible Asset Impairment Charges",
        "label": "Goodwill And Intangible Asset Impairment Charges [Member]",
        "terseLabel": "Goodwill and intangible asset impairment charges"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairmentChargesMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_GoodwillAndIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and intangible assets.",
        "label": "Goodwill And Intangible Assets [Line Items]",
        "terseLabel": "Goodwill And Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsLineItems",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_GoodwillAndIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and intangible assets.",
        "label": "Goodwill And Intangible Assets [Table]",
        "terseLabel": "Goodwill And Intangible Assets [Table]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsTable",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill adjustment to deferred tax liabilities.",
        "label": "Goodwill, Increase (Decrease), Deferred Tax Liabilities Adjustment",
        "terseLabel": "Change in deferred tax liability"
       }
      }
     },
     "localname": "GoodwillIncreaseDecreaseDeferredTaxLiabilitiesAdjustment",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_GoodwillIncreaseDecreaseFairValueAdjustmentEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Increase (Decrease), Fair Value Adjustment, Equipment",
        "label": "Goodwill, Increase (Decrease), Fair Value Adjustment, Equipment",
        "terseLabel": "Fair value adjustment to equipment"
       }
      }
     },
     "localname": "GoodwillIncreaseDecreaseFairValueAdjustmentEquipment",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_GoodwillIncreaseDecreaseIntangibleAssetsAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, intangible adjustment.",
        "label": "Goodwill, Increase (Decrease), Intangible Assets Adjustment",
        "terseLabel": "Intangible adjustment"
       }
      }
     },
     "localname": "GoodwillIncreaseDecreaseIntangibleAssetsAdjustment",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_GoodwillIncreaseDecreaseWorkingCapitalAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Increase (Decrease), Working Capital Adjustment",
        "label": "Goodwill, Increase (Decrease), Working Capital Adjustment",
        "terseLabel": "Working capital adjustment"
       }
      }
     },
     "localname": "GoodwillIncreaseDecreaseWorkingCapitalAdjustment",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process research and development with indefinite lives.",
        "label": "In Process Research And Development With Indefinite Lives [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentWithIndefiniteLivesMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit), Operating Loss Carryback, CARES Act",
        "label": "Income Tax Expense (Benefit), Operating Loss Carryback, CARES Act",
        "negatedTerseLabel": "Tax benefit related to operating loss carryback, CARES Act"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitOperatingLossCarrybackCARESAct",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation asset impairment.",
        "label": "Income Tax Reconciliation Asset Impairment",
        "terseLabel": "Asset impairment"
       }
      }
     },
     "localname": "IncomeTaxReconciliationAssetImpairment",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Reconciliation CARES Act",
        "label": "Income Tax Reconciliation CARES Act",
        "terseLabel": "CARES Act"
       }
      }
     },
     "localname": "IncomeTaxReconciliationCARESAct",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationChangesInRevenueRecognitionMethod": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 19.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation changes in revenue recognition method.",
        "label": "Income Tax Reconciliation Changes In Revenue Recognition Method",
        "terseLabel": "Changes in revenue recognition/method"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangesInRevenueRecognitionMethod",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationExpiredTaxAttributes": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation expired tax attributes.",
        "label": "Income Tax Reconciliation Expired Tax Attributes",
        "terseLabel": "Expired tax attributes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationExpiredTaxAttributes",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation fair value adjustments related to acquisition contingent consideration.",
        "label": "Income Tax Reconciliation Fair Value Adjustments Related To Acquisition Contingent Consideration",
        "negatedLabel": "Fair value adjustments related to acquisition contingent consideration"
       }
      }
     },
     "localname": "IncomeTaxReconciliationFairValueAdjustmentsRelatedToAcquisitionContingentConsideration",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationForeignDisregardedElection": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 18.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation foreign disregarded election.",
        "label": "Income Tax Reconciliation Foreign Disregarded Election",
        "terseLabel": "Foreign disregarded election"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignDisregardedElection",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation non deductible contingent purchase price and transaction costs.",
        "label": "Income Tax Reconciliation Non Deductible Contingent Purchase Price And Transaction Costs",
        "terseLabel": "Non-deductible contingent purchase price and transaction costs"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNonDeductibleContingentPurchasePriceAndTransactionCosts",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationNonDeductibleLegalSettlement": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 17.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation non-deductible legal settlement.",
        "label": "Income Tax Reconciliation Non Deductible Legal Settlement",
        "terseLabel": "Non-deductible legal settlement"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNonDeductibleLegalSettlement",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation nondeductible expense officers compensation.",
        "label": "Income Tax Reconciliation Nondeductible Expense Officers Compensation",
        "terseLabel": "Non-deductible officer compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationStatuteExpiration": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation statute expiration.",
        "label": "Income Tax Reconciliation Statute Expiration",
        "terseLabel": "Uncertain tax benefits statute expired, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStatuteExpiration",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncomeTaxReconciliationTaxCutAndJobsActImpact": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation tax cut and jobs act impact.",
        "label": "Income Tax Reconciliation Tax Cut And Jobs Act Impact",
        "terseLabel": "Tax Cut and Jobs Act impact"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCutAndJobsActImpact",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncreaseDecreaseInEarningsLossPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in earnings (loss) per share.",
        "label": "Increase Decrease In Earnings Loss Per Share",
        "terseLabel": "Change in earnings (loss) per share (dollars per share)"
       }
      }
     },
     "localname": "IncreaseDecreaseInEarningsLossPerShare",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in prepaid expense excluding increase decrease in prepaid taxes.",
        "label": "Increase Decrease In Prepaid Expense Excluding Increase Decrease In Prepaid Taxes",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncreaseDecreaseInUnrecognizedTaxBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in unrecognized tax benefits.",
        "label": "Increase Decrease In Unrecognized Tax Benefits",
        "negatedLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInUnrecognizedTaxBenefits",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets.",
        "label": "Intangible Assets [Line Items]",
        "terseLabel": "Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsLineItems",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 1.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments And Cash, Accumulated Gross Unrealized Gain, before Tax",
        "label": "Investments And Cash, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Total, Gross unrealized holding gains"
       }
      }
     },
     "localname": "InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 2.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments And Cash, Accumulated Gross Unrealized Loss, before Tax",
        "label": "Investments And Cash, Accumulated Gross Unrealized Loss, before Tax",
        "terseLabel": "Total, Gross unrealized holding gains"
       }
      }
     },
     "localname": "InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_InvestmentsAndCashAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments And Cash, Amortized Cost",
        "label": "Investments And Cash, Amortized Cost",
        "totalLabel": "Total, Amortized cost"
       }
      }
     },
     "localname": "InvestmentsAndCashAmortizedCost",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_MolecularDiagnosticEndoPredictTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular diagnostic EndoPredict testing.",
        "label": "Molecular Diagnostic Endo Predict Testing [Member]",
        "terseLabel": "Molecular diagnostic - EndoPredict"
       }
      }
     },
     "localname": "MolecularDiagnosticEndoPredictTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticGenesightTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular diagnostic GeneSight testing.",
        "label": "Molecular Diagnostic Genesight Testing [Member]",
        "terseLabel": "Molecular diagnostic - GeneSight"
       }
      }
     },
     "localname": "MolecularDiagnosticGenesightTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticHereditaryCancerTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular diagnostic hereditary cancer testing.",
        "label": "Molecular Diagnostic Hereditary Cancer Testing [Member]",
        "terseLabel": "Molecular diagnostic - Hereditary Cancer Testing"
       }
      }
     },
     "localname": "MolecularDiagnosticHereditaryCancerTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticMyChoiceCDxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular Diagnostic MyChoice CDx",
        "label": "Molecular Diagnostic MyChoice CDx [Member]",
        "terseLabel": "Molecular diagnostic - myChoice CDx"
       }
      }
     },
     "localname": "MolecularDiagnosticMyChoiceCDxMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticOtherTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular diagnostic other testing.",
        "label": "Molecular Diagnostic Other Testing [Member]",
        "terseLabel": "Molecular diagnostic - Other"
       }
      }
     },
     "localname": "MolecularDiagnosticOtherTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticPrenatalTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular diagnostic Prenatal testing.",
        "label": "Molecular Diagnostic Prenatal Testing [Member]",
        "terseLabel": "Molecular diagnostic - Prenatal"
       }
      }
     },
     "localname": "MolecularDiagnosticPrenatalTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticProlarisTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular diagnostic Prolaris testing.",
        "label": "Molecular Diagnostic Prolaris Testing [Member]",
        "terseLabel": "Molecular diagnostic - Prolaris"
       }
      }
     },
     "localname": "MolecularDiagnosticProlarisTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular diagnostic testing.",
        "label": "Molecular Diagnostic Testing [Member]",
        "terseLabel": "Molecular diagnostic testing"
       }
      }
     },
     "localname": "MolecularDiagnosticTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticVectraTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular diagnostic Vectra testing.",
        "label": "Molecular Diagnostic Vectra Testing [Member]",
        "terseLabel": "Molecular diagnostic - Vectra"
       }
      }
     },
     "localname": "MolecularDiagnosticVectraTestingMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MyriadAutoimmuneReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Myriad Autoimmune Reporting Unit",
        "label": "Myriad Autoimmune Reporting Unit [Member]",
        "terseLabel": "Myriad Autoimmune reporting unit"
       }
      }
     },
     "localname": "MyriadAutoimmuneReportingUnitMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_NonCashInterestExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash interest expense.",
        "label": "Non Cash Interest Expense",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "NonCashInterestExpense",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_NonEmployeeDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non employee director.",
        "label": "Non Employee Director [Member]",
        "terseLabel": "Non-employee director"
       }
      }
     },
     "localname": "NonEmployeeDirectorMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_NumberOfDefinedBenefitPensionPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of defined benefit pension plans.",
        "label": "Number Of Defined Benefit Pension Plans",
        "terseLabel": "Number of defined benefit pension plans"
       }
      }
     },
     "localname": "NumberOfDefinedBenefitPensionPlans",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mygn_OperatingLeaseLiabilityEstablished": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability Established",
        "label": "Operating Lease Liability Established",
        "negatedLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityEstablished",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_OperatingLossCarryforwardsExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Expiration Year",
        "label": "Operating Loss Carryforwards Expiration Year",
        "terseLabel": "Net operating loss, expiration in year"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationYear",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "mygn_OptionsAndRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options and Restricted Stock Units.",
        "label": "Options And Restricted Stock Units [Member]",
        "terseLabel": "Options and RSUs"
       }
      }
     },
     "localname": "OptionsAndRestrictedStockUnitsMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options granted after December 5, 2012.",
        "label": "Options Granted After December Five Twenty Twelve [Member]",
        "terseLabel": "Awards granted after December 5, 2012"
       }
      }
     },
     "localname": "OptionsGrantedAfterDecemberFiveTwentyTwelveMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options granted prior to December 5, 2012.",
        "label": "Options Granted Prior To December Five Twenty Twelve [Member]",
        "terseLabel": "Awards granted prior to December 5, 2012"
       }
      }
     },
     "localname": "OptionsGrantedPriorToDecemberFiveTwentyTwelveMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Table]",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency, Other Adjustment, Net of Tax",
        "label": "Other Comprehensive Income (Loss), Foreign Currency, Other Adjustment, Net of Tax",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyOtherAdjustmentNetOfTax",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_OtherIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other income policy text block.",
        "label": "Other Income Policy [Policy Text Block]",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncomePolicyPolicyTextBlock",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mygn_OtherStateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other State.",
        "label": "Other State [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherStateMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_PerformanceObligationEstimatedTransactionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Obligation Estimated Transaction Price",
        "label": "Performance Obligation Estimated Transaction Price [Member]",
        "terseLabel": "Performance obligation estimate"
       }
      }
     },
     "localname": "PerformanceObligationEstimatedTransactionPriceMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_PharmaceuticalAndClinicalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical and clinical services.",
        "label": "Pharmaceutical And Clinical Services [Member]",
        "terseLabel": "Pharmaceutical and clinical services"
       }
      }
     },
     "localname": "PharmaceuticalAndClinicalServicesMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expense excluding prepaid taxes current.",
        "label": "Prepaid Expense Excluding Prepaid Taxes Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseExcludingPrepaidTaxesCurrent",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_PurchasedLicensesAndTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased licenses and technologies.",
        "label": "Purchased Licenses And Technologies [Member]",
        "terseLabel": "Purchased licenses and technologies"
       }
      }
     },
     "localname": "PurchasedLicensesAndTechnologiesMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_RangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Four [Member]",
        "label": "Range Four [Member]",
        "terseLabel": "$ 27.07 - 36.55"
       }
      }
     },
     "localname": "RangeFourMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_RangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range One [Member]",
        "label": "Range One [Member]",
        "terseLabel": "$ 13.38 - 19.47"
       }
      }
     },
     "localname": "RangeOneMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_RangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Three",
        "label": "Range Three [Member]",
        "terseLabel": "$ 26.49 - 26.49"
       }
      }
     },
     "localname": "RangeThreeMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_RangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Two [Member]",
        "label": "Range Two [Member]",
        "terseLabel": "$ 21.29 - 25.39"
       }
      }
     },
     "localname": "RangeTwoMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification From Accumulated Other Comprehensive Loss, Deconsolidation Of Subsidiary",
        "label": "Reclassification From Accumulated Other Comprehensive Loss, Deconsolidation Of Subsidiary",
        "terseLabel": "Reclassification out of accumulated other comprehensive loss upon the deconsolidation of a subsidiary"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_RecoupmentsPayableAndReserveCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recoupments Payable And Reserve, Current",
        "label": "Recoupments Payable And Reserve, Current",
        "terseLabel": "Recoupments payable and reserves"
       }
      }
     },
     "localname": "RecoupmentsPayableAndReserveCurrent",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_ScheduleOfCommonStockRepurchasedTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of common stock repurchased table.",
        "label": "Schedule Of Common Stock Repurchased Table [Table Text Block]",
        "terseLabel": "Schedule of Stock Repurchases"
       }
      }
     },
     "localname": "ScheduleOfCommonStockRepurchasedTableTableTextBlock",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Comparison Of Balance Sheet Assets By Operating Segment",
        "label": "Schedule Of Comparison Of Balance Sheet Assets By Operating Segment Table [Table Text Block]",
        "terseLabel": "Schedule of Comparison of Balance Sheet Assets by Operating Segment"
       }
      }
     },
     "localname": "ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTableTextBlock",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mygn_ScheduleOfIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Table]",
        "label": "Schedule Of Intangible Assets [Table]",
        "terseLabel": "Schedule Of Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsTable",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_ScheduleOfTransitionPeriodComparativeDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Transition Period Comparative Data",
        "label": "Schedule Of Transition Period Comparative Data [Table Text Block]",
        "terseLabel": "Schedule of Transition Period Comparative Data"
       }
      }
     },
     "localname": "ScheduleOfTransitionPeriodComparativeDataTableTextBlock",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Maximum",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Maximum",
        "terseLabel": "Derived service period, maximum (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMaximum",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Minimum",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Derived Service Period, Minimum",
        "terseLabel": "Derived service period, minimum (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDerivedServicePeriodMinimum",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mygn_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Metric, Threshold Consecutive Days, Stock Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Metric, Threshold Consecutive Days, Stock Price",
        "terseLabel": "Stock price consecutive days threshold for award vesting condition"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingMetricThresholdConsecutiveDaysStockPrice",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans",
        "label": "Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued upon exercise of options and employee stock plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mygn_TaxCreditCarryforwardsExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Credit Carryforwards Expiration Date",
        "label": "Tax Credit Carryforwards Expiration Date",
        "terseLabel": "Research credit, expiration in year"
       }
      }
     },
     "localname": "TaxCreditCarryforwardsExpirationDate",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "mygn_TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Cuts And Jobs Act, Change In Tax Rate, Increase (Decrease) In Earnings Per Share",
        "label": "Tax Cuts And Jobs Act, Change In Tax Rate, Increase (Decrease) In Earnings Per Share",
        "terseLabel": "Earnings per share impact of Tax Act"
       }
      }
     },
     "localname": "TaxCutsAndJobsActChangeInTaxRateIncreaseDecreaseInEarningsPerShare",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mygn_TransitionPeriodComparativeDataTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Period Comparative Data",
        "label": "Transition Period Comparative Data [Text Block]",
        "terseLabel": "Transition Period Comparative Data (Unaudited)"
       }
      }
     },
     "localname": "TransitionPeriodComparativeDataTextBlock",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mygn_TransitionPeriodFinancialInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Period Financial Information",
        "label": "Transition Period Financial Information [Line Items]",
        "terseLabel": "Transition Period Financial Information [Line Items]"
       }
      }
     },
     "localname": "TransitionPeriodFinancialInformationLineItems",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_TransitionPeriodFinancialInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Period Financial Information",
        "label": "Transition Period Financial Information [Table]",
        "terseLabel": "Transition Period Financial Information [Table]"
       }
      }
     },
     "localname": "TransitionPeriodFinancialInformationTable",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand seventeen employee director and consultant equity incentive plan.",
        "label": "Two Thousand Seventeen Employee Director And Consultant Equity Incentive Plan [Member]",
        "terseLabel": "2017 Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenEmployeeDirectorAndConsultantEquityIncentivePlanMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand ten employee director and consultant equity incentive plan.",
        "label": "Two Thousand Ten Employee Director And Consultant Equity Incentive Plan [Member]",
        "terseLabel": "2010 Plan"
       }
      }
     },
     "localname": "TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_UnrecognizedTaxBenefitsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Net",
        "label": "Unrecognized Tax Benefits, Net",
        "terseLabel": "Unrecognized tax benefits",
        "verboseLabel": "Net unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsNet",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_ValuationAllowanceIncreaseDecreaseDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Increase (Decrease) During Period",
        "label": "Valuation Allowance, Increase (Decrease) During Period",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceIncreaseDecreaseDuringPeriod",
     "nsuri": "http://www.myriad.com/20201231",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "President and Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r198",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r218",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r198",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r218",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r370",
      "r373",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r635",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails",
      "http://www.myriad.com/role/LeasesNarrativeDetails",
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r370",
      "r373",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r635",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails",
      "http://www.myriad.com/role/LeasesNarrativeDetails",
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r224",
      "r344",
      "r346",
      "r583",
      "r634",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r224",
      "r344",
      "r346",
      "r583",
      "r634",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r359",
      "r370",
      "r373",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r635",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails",
      "http://www.myriad.com/role/LeasesNarrativeDetails",
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r359",
      "r370",
      "r373",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r635",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails",
      "http://www.myriad.com/role/LeasesNarrativeDetails",
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ReportableGeographicalComponentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reportable Geographical Components [Member]",
        "terseLabel": "Reportable geographical components"
       }
      }
     },
     "localname": "ReportableGeographicalComponentsMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r145",
      "r149",
      "r150",
      "r151",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r171",
      "r266",
      "r267",
      "r420",
      "r464",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r145",
      "r149",
      "r150",
      "r151",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r171",
      "r266",
      "r267",
      "r420",
      "r464",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": {
     "auth_ref": [
      "r149",
      "r150",
      "r153",
      "r154",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Error Correction, Adjustment [Member]",
        "terseLabel": "Immaterial prior period Medicare claims"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodReclassificationAdjustmentMember": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Reclassification, Adjustment [Member]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodReclassificationAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r225",
      "r226",
      "r344",
      "r347",
      "r637",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r225",
      "r226",
      "r344",
      "r347",
      "r637",
      "r669",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r325",
      "r371",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r232",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "Texas"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_UT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UTAH",
        "terseLabel": "Utah"
       }
      }
     },
     "localname": "UT",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "ASU 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r16",
      "r40",
      "r233",
      "r234"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails",
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51",
      "r310"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r72",
      "r76",
      "r77",
      "r78",
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r76",
      "r77",
      "r78",
      "r622",
      "r646",
      "r650"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r75",
      "r78",
      "r79",
      "r139",
      "r140",
      "r142",
      "r507",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired intangible assets, estimated useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r142",
      "r417",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r147",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r461",
      "r462",
      "r463",
      "r464",
      "r585",
      "r586",
      "r587",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r375",
      "r377",
      "r423",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based payment expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r193",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r118",
      "r289",
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive options and RSUs excluded from EPS computation"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r132",
      "r206",
      "r213",
      "r220",
      "r261",
      "r501",
      "r509",
      "r532",
      "r592",
      "r619"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r19",
      "r21",
      "r71",
      "r132",
      "r261",
      "r501",
      "r509",
      "r532"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Financial assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Available-for-sale, Gross unrealized holding gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "terseLabel": "Available-for-sale, Gross unrealized holding losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r245",
      "r268"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Available-for-sale, Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]",
        "terseLabel": "Available-for-sale:"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r253"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 4.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Available-for-sale, Due after five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r249",
      "r253",
      "r612"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InvestmentsAndCash",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Available-for-sale, Due after five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r252"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Available-for-sale, Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r249",
      "r252",
      "r611"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InvestmentsAndCash",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Available-for-sale, Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r251"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Available-for-sale, Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r249",
      "r251",
      "r610"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentsAndCash",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Available-for-sale, Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r242",
      "r246",
      "r268",
      "r599"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale, Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r379",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r379",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Financial Statement Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r23",
      "r309"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r369",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails",
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r369",
      "r372",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails",
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Acquisition costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Business acquisition, value of shares issued"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business acquisition, shares issued"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Net income per share, basic"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Net income per share, diluted"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Information [Abstract]",
        "terseLabel": "Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of Pro Forma Results"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total revenue reported by the acquired entity for its previous full fiscal year before the business acquisition.",
        "label": "Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period",
        "terseLabel": "Revenue contributed by acquired entity"
       }
      }
     },
     "localname": "BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business acquisition, per share market closing price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax",
        "terseLabel": "Income from operations"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r488",
      "r489",
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business acquisition consideration",
        "verboseLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r117",
      "r495"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in the fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r487",
      "r490"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Short-term contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r487",
      "r490"
     ],
     "calculation": {
      "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial assets acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets",
        "negatedTerseLabel": "Return of escrow as result of working capital adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial liabilities assumed in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities",
        "negatedTerseLabel": "Decrease in deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "negatedTerseLabel": "Reduction of intangible assets related to updated assumptions"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment",
        "negatedTerseLabel": "Reduction of equipment related to updated assumptions"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedLabel": "Long term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total fair value purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSegmentAllocationTableTextBlock": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill in a business combination.",
        "label": "Business Combination, Segment Allocation [Table Text Block]",
        "terseLabel": "Schedule of Changes in Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationSegmentAllocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of California.",
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedContractCostGross": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Gross",
        "terseLabel": "Capitalized costs incurred to obtain or fulfill contract"
       }
      }
     },
     "localname": "CapitalizedContractCostGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "negatedLabel": "Less: Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r14",
      "r47",
      "r120"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents, Amortized cost"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]",
        "terseLabel": "Cash and cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentsAndCash",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents, Estimated fair value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "terseLabel": "Cash, cash equivalents, and marketable investment securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r113",
      "r120",
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r113",
      "r537"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Establishment of operation lease right-of-use assets and lease liabilities"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "auth_ref": [
      "r152",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting estimate.",
        "label": "Change in Accounting Estimate by Type [Axis]",
        "terseLabel": "Change in Accounting Estimate by Type [Axis]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "auth_ref": [
      "r152",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities.",
        "label": "Change in Accounting Estimate, Type [Domain]",
        "terseLabel": "Change in Accounting Estimate, Type [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Reconciliation of Deferred Revenue"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r130",
      "r132",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r178",
      "r179",
      "r180",
      "r261",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r66",
      "r324",
      "r600",
      "r627"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r321",
      "r322",
      "r323",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending common stock issued",
        "periodStartLabel": "Beginning common stock issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails",
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r39",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending common stock outstanding",
        "periodStartLabel": "Beginning common stock outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails",
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, 75.4, 74.7 and 73.5 shares outstanding at December 31, 2020, June 30, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r353",
      "r354",
      "r374",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Employee Deferred Savings Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/EmployeeDeferredSavingsPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r82",
      "r84",
      "r85",
      "r90",
      "r603",
      "r630"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r187",
      "r188",
      "r230",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r187",
      "r188",
      "r230",
      "r530",
      "r531",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r187",
      "r188",
      "r230",
      "r530",
      "r531",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r183",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r187",
      "r188",
      "r230",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r187",
      "r188",
      "r230",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Reconciliation of Deferred Revenue Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which increases (decreases) right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.",
        "label": "Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price",
        "negatedTerseLabel": "Decrease in revenue due to changes in estimated transaction price due to contractual adjustments"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r338",
      "r339",
      "r345"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Deferred revenue - ending balance",
        "periodStartLabel": "Deferred revenue - beginning balance",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesReconciliationofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r360",
      "r367",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds and notes"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r93",
      "r583"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Costs and expenses"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeTranslationAdjustmentSummaryRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Cumulative Translation Adjustment Summary [Roll Forward]",
        "terseLabel": "Cumulative Translation Adjustments"
       }
      }
     },
     "localname": "CumulativeTranslationAdjustmentSummaryRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r457",
      "r467"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r457"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r457",
      "r467",
      "r469"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r457",
      "r467"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the total principal payments made during the annual reporting period.",
        "label": "Debt Instrument, Annual Principal Payment",
        "terseLabel": "Scheduled principal payments prior to maturity date"
       }
      }
     },
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r593",
      "r596",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r33",
      "r328",
      "r596",
      "r618"
     ],
     "calculation": {
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Aggregate principal amount of loan"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Upfront fees"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r62",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r64",
      "r134",
      "r332",
      "r333",
      "r334",
      "r335",
      "r548",
      "r549",
      "r551",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": {
     "auth_ref": [
      "r548",
      "r551"
     ],
     "calculation": {
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Noncurrent",
        "negatedLabel": "Long-term debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Line of Credit Arrangements, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DebtIssuanceCostsLineOfCreditArrangementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r255",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Debt securities, available-for-sale, in unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeconsolidationGainOrLossAmount": {
     "auth_ref": [
      "r508"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.",
        "label": "Deconsolidation, Gain (Loss), Amount",
        "negatedLabel": "Gain on deconsolidation of subsidiary"
       }
      }
     },
     "localname": "DeconsolidationGainOrLossAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r458",
      "r467"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r458",
      "r467"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r133",
      "r458",
      "r467",
      "r468",
      "r469"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r35",
      "r36",
      "r447",
      "r594",
      "r617"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "terseLabel": "Net deferred tax liabilities",
        "totalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r431",
      "r432"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r458",
      "r467"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "terseLabel": "Deferred tax assets",
        "totalLabel": "Total gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Research and development credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days).",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences",
        "terseLabel": "Accrued vacation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts",
        "terseLabel": "AR allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r449"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r432",
      "r450"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.",
        "label": "Deferred Tax Liabilities, Tax Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesTaxDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r34",
      "r355",
      "r356",
      "r358"
     ],
     "calculation": {
      "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Pension obligation",
        "verboseLabel": "Net pension liability"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails",
      "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r357",
      "r360",
      "r361",
      "r362",
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Contributions to the Plan"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/EmployeeDeferredSavingsPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Deferred savings plan contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/EmployeeDeferredSavingsPlanContributionstoPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Company matching contribution as percentage of employee contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Company matching contribution, maximum as percentage of employee compensation"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/EmployeeDeferredSavingsPlanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r118",
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r118",
      "r308"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed screening processes"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Type"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r118",
      "r307",
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Gain on sale of subsidiary"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SaleofSubsidiaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r13",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Sale of Subsidiary"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SaleofSubsidiary"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r369",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails",
      "http://www.myriad.com/role/SaleofSubsidiaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal",
        "verboseLabel": "U.S. Federal and state jurisdictions"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarliestTaxYearMember": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earliest identified tax year.",
        "label": "Earliest Tax Year [Member]",
        "terseLabel": "Earliest tax year"
       }
      }
     },
     "localname": "EarliestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r91",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r159",
      "r161",
      "r165",
      "r166",
      "r167",
      "r171",
      "r172",
      "r604",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r91",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r161",
      "r165",
      "r166",
      "r167",
      "r171",
      "r172",
      "r604",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r127",
      "r168",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r537"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total income tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r434",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal income tax expense at the statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r434",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r434",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "auth_ref": [
      "r434",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent",
        "terseLabel": "Non-deductible meals and entertainment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r434",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 20.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r425",
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "terseLabel": "Incentive stock option and employee stock purchase plan expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r425",
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "Incentive stock option and employee stock purchase plan expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r434",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "auth_ref": [
      "r434",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "terseLabel": "Uncertain tax positions, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r434",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedLabel": "Research and development credits, net of the federal tax on state credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-Based Compensation Expense [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "verboseLabel": "Unrecognized share-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized share-based compensation expense, weighted-average period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation expense related to stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r139",
      "r140",
      "r142",
      "r145",
      "r154",
      "r157",
      "r177",
      "r265",
      "r331",
      "r336",
      "r417",
      "r418",
      "r419",
      "r463",
      "r464",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r544",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1": {
     "auth_ref": [
      "r122",
      "r123",
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of escrow deposit disbursements related to property acquisition in noncash investing or financing transactions.",
        "label": "Escrow Deposit Disbursements Related to Property Acquisition",
        "terseLabel": "Amount of cash consideration deposited in escrow account"
       }
      }
     },
     "localname": "EscrowDepositDisbursementsRelatedToPropertyAcquisition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r515",
      "r516",
      "r517",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r515",
      "r516",
      "r517",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Financial Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r515",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r516",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r360",
      "r361",
      "r366",
      "r367",
      "r516",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r360",
      "r361",
      "r366",
      "r367",
      "r516",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r516",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Reconciliation of change in fair value of contingent consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r520",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Change in Fair Value of Contingent Consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Change in fair value recognized in the statement of operations"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "negatedTerseLabel": "Translation adjustments recognized in other comprehensive income"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of asset after deduction of liability.",
        "label": "Fair Value, Net Asset (Liability)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FairValueNetAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalMinistryOfFinanceGermanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Germany.",
        "label": "Federal Ministry of Finance, Germany [Member]",
        "terseLabel": "Germany"
       }
      }
     },
     "localname": "FederalMinistryOfFinanceGermanyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r298"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r300"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Recorded Amortization Expense for Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r300"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r300"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r300"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r300"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r290",
      "r294",
      "r298",
      "r302",
      "r584",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Future Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r298",
      "r588"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount, amortizable"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r290",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r298",
      "r584"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total, net, amortizable"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted average remaining amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Acquired intangible assets"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r533",
      "r534",
      "r535",
      "r536"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Non-cash impact of foreign currency transactions"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r127",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r118",
      "r307",
      "r313"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Gain on disposition of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r276",
      "r278",
      "r591"
     ],
     "calculation": {
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails",
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "verboseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and intangible asset impairment charges",
        "verboseLabel": "Impairment of goodwill and intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r127",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r127",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets and Other Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r118",
      "r277",
      "r281",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Goodwill impairment charge",
        "verboseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r283",
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Measurement period increase to goodwill",
        "verboseLabel": "Adjustments to acquisitions"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedLabel": "Goodwill deconsolidated on sale of Clinic"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GovernmentContractsConcentrationRiskMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. Risk is the materially adverse effects of termination of a significant contract or group of contracts or from future loss of a significant portion of business with a specified political body or unit thereof, such as Department of Defense, US Navy, New York City.",
        "label": "Government Contracts Concentration Risk [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "GovernmentContractsConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r118",
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Intangible assets impairment charge"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r118",
      "r306",
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment of Long-Lived Assets Held-for-use",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r136",
      "r470"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r88",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r589",
      "r601",
      "r606",
      "r632"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r136",
      "r470"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income (loss) before income taxes:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r369",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails",
      "http://www.myriad.com/role/SaleofSubsidiaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Disposal of Subsidiary [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SaleofSubsidiaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SaleofSubsidiaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r438",
      "r444",
      "r446",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r435",
      "r445",
      "r452",
      "r465",
      "r472",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationYearUnderExamination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year being audited in the income tax examination, in CCYY format.",
        "label": "Income Tax Examination, Year under Examination",
        "terseLabel": "Tax year being audited in income tax examination"
       }
      }
     },
     "localname": "IncomeTaxExaminationYearUnderExamination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r156",
      "r157",
      "r204",
      "r433",
      "r466",
      "r473",
      "r633"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax benefit",
        "totalLabel": "Total income tax benefit",
        "verboseLabel": "Income tax provision (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails",
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r127",
      "r429",
      "r430",
      "r445",
      "r446",
      "r451",
      "r459",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Federal income tax expense at the statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount",
        "terseLabel": "Non-deductible meals and entertainment"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 20.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Uncertain tax positions, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedLabel": "Research and development credits, net of the federal tax on state credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesStatutoryFederalIncomeTaxRateandIncomeTaxesReportedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r115",
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Accrued liabilities and other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Common shares issued and outstanding"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r293",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Non-amortizable"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r293",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Gross Carrying Amount, total"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r288",
      "r296"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangibles, net",
        "totalLabel": "Net, total"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r87",
      "r200",
      "r547",
      "r550",
      "r605"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r110",
      "r114",
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r15",
      "r69"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r27",
      "r70",
      "r127",
      "r174",
      "r270",
      "r271",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r95",
      "r199"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAndCash": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 3.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of investments and unrestricted cash as of the balance sheet date.",
        "label": "Investments and Cash",
        "terseLabel": "Total, Estimated fair value",
        "totalLabel": "Total, Estimated fair value"
       }
      }
     },
     "localname": "InvestmentsAndCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAndCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments and Cash [Abstract]",
        "terseLabel": "Total:"
       }
      }
     },
     "localname": "InvestmentsAndCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r260",
      "r590",
      "r614",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Marketable Investment Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r22",
      "r50"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LatestTaxYearMember": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latest identified tax year.",
        "label": "Latest Tax Year [Member]",
        "terseLabel": "Latest tax years"
       }
      }
     },
     "localname": "LatestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r564",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r23",
      "r309"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: amounts representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r57",
      "r132",
      "r214",
      "r261",
      "r502",
      "r509",
      "r510",
      "r532"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r46",
      "r132",
      "r261",
      "r532",
      "r598",
      "r625"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r61",
      "r132",
      "r261",
      "r502",
      "r509",
      "r510",
      "r532"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "negatedTerseLabel": "Financial liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum aggregate principal commitment"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Undrawn fee (percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r66",
      "r324",
      "r326"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Qui tam settlement"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Total Assets by Geographical Region"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r33",
      "r329",
      "r596",
      "r621"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Net long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Unclassified [Abstract]",
        "terseLabel": "Long-term Debt, Unclassified [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Estimated fair value of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Interest rate (percent)"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r23",
      "r309"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r17",
      "r58"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable investment securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term marketable investment securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Investment Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Measurement input, expected term"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r68",
      "r132",
      "r261",
      "r532",
      "r597",
      "r624"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal bonds"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r113",
      "r116",
      "r119"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r12",
      "r80",
      "r83",
      "r89",
      "r119",
      "r132",
      "r144",
      "r149",
      "r150",
      "r151",
      "r152",
      "r156",
      "r157",
      "r164",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r261",
      "r532",
      "r602",
      "r629"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss) attributable to Myriad Genetics, Inc. stockholders",
        "totalLabel": "Net income (loss) attributable to Myriad Genetics, Inc. stockholders",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r83",
      "r156",
      "r157",
      "r504",
      "r512"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r151",
      "r171",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r461",
      "r462",
      "r463",
      "r464",
      "r585",
      "r586",
      "r587",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewJerseyDivisionOfTaxationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New Jersey.",
        "label": "New Jersey Division of Taxation [Member]",
        "terseLabel": "New Jersey"
       }
      }
     },
     "localname": "NewJerseyDivisionOfTaxationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New York.",
        "label": "New York State Division of Taxation and Finance [Member]",
        "terseLabel": "New York"
       }
      }
     },
     "localname": "NewYorkStateDivisionOfTaxationAndFinanceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating expenses related to acquired entity"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r206",
      "r212",
      "r216",
      "r219",
      "r222"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)",
        "verboseLabel": "Segment operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Maturities of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of future lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current maturities of operating lease liabilities",
        "verboseLabel": "Less: current maturities of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Noncurrent operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r555"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r563",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating lease weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r562",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rent expense (prior to adoption of ASU 2016-02)"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.",
        "label": "Operating Loss Carryforwards, Limitations on Use",
        "terseLabel": "Net operating loss subject to sections 382,383"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsOnUse",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Reportable segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r138",
      "r158",
      "r192",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Organization and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r59"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other",
        "verboseLabel": "Accrued liability for Medicare refund"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Change in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r81",
      "r84",
      "r499",
      "r500",
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r74",
      "r76"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Change in pension liability"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r76"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gain (loss) on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Summary of Other Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r34",
      "r595",
      "r620"
     ],
     "calculation": {
      "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale",
        "terseLabel": "Other-than-temporary impairments"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedLabel": "Payment of contingent consideration recognized at acquisition"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "negatedLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase and retirement of common stock",
        "terseLabel": "Repurchase of Company stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtRestructuringCosts": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.",
        "label": "Payments of Debt Restructuring Costs",
        "negatedLabel": "Fees associated with refinancing of revolving credit facility"
       }
      }
     },
     "localname": "PaymentsOfDebtRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payment of tax withheld for common stock issued under share-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r98",
      "r100",
      "r243"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedLabel": "Purchases of marketable investment securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r101",
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payment on business acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r379",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r18",
      "r20",
      "r273",
      "r274"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).",
        "label": "Proceeds from Divestiture of Interest in Consolidated Subsidiaries",
        "terseLabel": "Proceeds from sale of subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r103",
      "r412"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from common stock issued under share-based compensation plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r104",
      "r135"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Proceeds from non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from maturities and sales of marketable investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r12",
      "r80",
      "r83",
      "r112",
      "r132",
      "r144",
      "r156",
      "r157",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r261",
      "r499",
      "r503",
      "r505",
      "r512",
      "r513",
      "r532",
      "r606"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r51",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r318",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisposals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Disposals",
        "terseLabel": "Property, plant and equipment sold and deconsolidated"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisposals",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r50",
      "r309"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r29",
      "r30",
      "r311",
      "r626"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Net equipment, leasehold improvements and property"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r49",
      "r127",
      "r311",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r29",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r29",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives (in years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]",
        "terseLabel": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Supplementary Quarterly Financial Data (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification [Line Items]",
        "terseLabel": "Reclassification [Line Items]"
       }
      }
     },
     "localname": "ReclassificationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationTable": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification [Table]",
        "terseLabel": "Reclassification [Table]"
       }
      }
     },
     "localname": "ReclassificationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r107",
      "r135"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayment of revolving credit facility",
        "terseLabel": "Principal repayment"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r427",
      "r683"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research credit"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r42",
      "r336",
      "r420",
      "r623",
      "r645",
      "r650"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r142",
      "r145",
      "r154",
      "r157",
      "r265",
      "r417",
      "r418",
      "r419",
      "r463",
      "r464",
      "r641",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r197",
      "r198",
      "r211",
      "r217",
      "r218",
      "r224",
      "r225",
      "r230",
      "r343",
      "r344",
      "r583"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesRevenuebyTypeDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Total Revenue by Geographic Region"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r128",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r342"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r561",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r187",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Summary of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r78",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cumulative Translation Adjustments Included in Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Potential Dilutive Common Shares"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Schedule of Available-for-sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r250",
      "r254",
      "r256",
      "r257",
      "r258",
      "r259",
      "r608",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsProFormaResultsDetails",
      "http://www.myriad.com/role/BusinessAcquisitionsTotalConsiderationTransferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Estimated Total Consideration Transferred"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in common stock outstanding.",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "terseLabel": "Summary of Common Shares Issued and Outstanding"
       }
      }
     },
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Income Tax Benefit"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r64",
      "r134",
      "r332",
      "r333",
      "r334",
      "r335",
      "r548",
      "r549",
      "r551",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Components of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Differences Between Statutory Federal Income Tax Rate and Income Taxes Reported"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r377",
      "r409",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r377",
      "r409",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r290",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Amortizable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r284",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsChangestoGoodwillBalanceDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r284",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income (Loss) Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r301",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Non-amortizable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r51",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Quarterly Financial Data"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r206",
      "r209",
      "r215",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r206",
      "r209",
      "r215",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Revenue and Operating Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.",
        "label": "Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]",
        "terseLabel": "Schedule of Intrinsic Value of Options Exercised"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r379",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of employee stock purchase plan activity.",
        "label": "Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]",
        "terseLabel": "Schedule of Shares Purchased and Compensation Expenses for ESPP"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r386",
      "r397",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions for ESPP"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions for Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Share-Based Compensation Cost"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r444",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Future Amortization Expense of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r193",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r230",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r193",
      "r195",
      "r196",
      "r206",
      "r210",
      "r216",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r229",
      "r230",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Related Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationAssetsbyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationRevenuebyGeographicalRegionDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general, and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative expense",
        "verboseLabel": "Selling, general, and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense",
        "verboseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Service period for award vesting (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "RSUs canceled (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs canceled (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "RSUs granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "RSUs granted (dollars per share)",
        "verboseLabel": "Weighted average grant date fair value (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "RSUs outstanding, ending (shares)",
        "periodStartLabel": "RSUs outstanding, beginning (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "RSUs, Number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "RSUs outstanding, ending (dollars per share)",
        "periodStartLabel": "RSUs outstanding, beginning (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "RSUs, Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Valuation Assumptions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional shares available for future grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares available for future grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r399"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationIntrinsicValueofOptionsExercisedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Options canceled or expired (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options canceled or expired (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r411"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r388",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, ending (shares)",
        "periodStartLabel": "Options outstanding, beginning (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options, Number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, ending (dollars per share)",
        "periodStartLabel": "Options outstanding, beginning (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Options, Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options fully vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
        "terseLabel": "Summary of Stock Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options vested and expected to vest (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options vested and expected to vest (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued under the Plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "auth_ref": [
      "r376",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award",
        "terseLabel": "Shares purchased under the plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r376",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Achievement levels based on EPS targets"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Performance based on Nasdaq Healthcare Provider Index"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r127",
      "r379",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based payment expense"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Range of exercise prices, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Number outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Range of exercise prices, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting weight (percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Plan compensation expense"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationSharesPurchasedandCompensationExpensesforESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "terseLabel": "Aggregate intrinsic value of RSUs outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationUnrecognizedShareBasedCompensationCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r404",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforESPPDetails",
      "http://www.myriad.com/role/ShareBasedCompensationValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of restricted stock units vested during period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life (years"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsOutstandingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r559",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease expense"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State",
        "verboseLabel": "State and local jurisdictions"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails",
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r193",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r230",
      "r284",
      "r315",
      "r319",
      "r320",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationBalanceSheetAssetsByOperatingSegmentDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentOperatingIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r130",
      "r132",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r178",
      "r179",
      "r180",
      "r261",
      "r331",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BusinessAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r67",
      "r139",
      "r140",
      "r142",
      "r145",
      "r154",
      "r157",
      "r177",
      "r265",
      "r331",
      "r336",
      "r417",
      "r418",
      "r419",
      "r463",
      "r464",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r544",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r139",
      "r140",
      "r142",
      "r177",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r38",
      "r39",
      "r331",
      "r336",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r38",
      "r39",
      "r336",
      "r378",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining repurchase authorization"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r38",
      "r39",
      "r331",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedLabel": "Repurchase and retirement of common stock",
        "terseLabel": "Shares purchased and retired"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails",
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityStockRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r38",
      "r39",
      "r331",
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Repurchase and retirement of common stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r39",
      "r44",
      "r45",
      "r132",
      "r240",
      "r261",
      "r532"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Myriad Genetics, Inc. stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r132",
      "r139",
      "r140",
      "r142",
      "r145",
      "r154",
      "r261",
      "r265",
      "r336",
      "r417",
      "r418",
      "r419",
      "r463",
      "r464",
      "r497",
      "r498",
      "r511",
      "r532",
      "r538",
      "r539",
      "r544",
      "r642",
      "r643"
     ],
     "calculation": {
      "http://www.myriad.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedBalanceSheets",
      "http://www.myriad.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r131",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Preferred and Common Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r545",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r545",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r545",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r545",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r569",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "terseLabel": "Schedule of Net Operating Loss and Research Credit Carryforwards (Tax Effected)"
       }
      }
     },
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SwissFederalTaxAdministrationFTAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Switzerland.",
        "label": "Swiss Federal Tax Administration (FTA) [Member]",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "SwissFederalTaxAdministrationFTAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Research credit"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardLimitationsOnUse": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the limitation related to use of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Limitations on Use",
        "terseLabel": "Research credit subject to sections 382,383"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLimitationsOnUse",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNetOperatingLossandResearchCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Final tax benefit of Tax Act"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Accrued taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Trade Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease": {
     "auth_ref": [
      "r76",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.",
        "label": "Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)",
        "verboseLabel": "Period translation adjustments"
       }
      }
     },
     "localname": "TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesForeignCurrencyCumulativeTranslationAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r147",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r461",
      "r462",
      "r463",
      "r464",
      "r585",
      "r586",
      "r587",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r360",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "US government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r360",
      "r607",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "Federal agency issues"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r428",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits at end of year",
        "periodStartLabel": "Unrecognized tax benefits at the beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Gross decreases - prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Gross decreases - settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Interest and penalties in year-end balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Gross increases - acquisitions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Gross increases - current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Gross increases - prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Gross decreases - statute lapse"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r181",
      "r182",
      "r184",
      "r185",
      "r189",
      "r190",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r560",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease expense"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive stock options"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r160",
      "r167"
     ],
     "calculation": {
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (weighted average shares)",
        "totalLabel": "Weighted-average shares outstanding and dilutive securities used to compute diluted EPS"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r159",
      "r167"
     ],
     "calculation": {
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (weighted average shares)",
        "verboseLabel": "Weighted-average shares outstanding used to compute basic EPS"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails",
      "http://www.myriad.com/role/SupplementaryQuarterlyFinancialDataUnauditedQuarterlyDataDetails",
      "http://www.myriad.com/role/TransitionPeriodComparativeDataUnauditedDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e777-108305"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27340-111563"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=68176171&loc=SL68176184-208336"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1,2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r684": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r685": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r686": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r687": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r688": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r689": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r691": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r692": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>133
<FILENAME>0000899923-21-000021-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000899923-21-000021-xbrl.zip
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MO4[65QM5NQ,"NEI4=TO2Z"QY$R.X#XAAHT;@(PW]AA&(I9DL&H7F * A**8
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MC+FI @?A&J-MQ!=8UFG(''LN]::Z!OIH6&H-X(6R!NNUQQC)<S4,6P/->B+
M5<%$J:<@:_R@G@PHZ^66E O57@;C8DII>V!:>P2X*LA$"M0(R8*-4"@2N4:>
M(WFR67+8&L@N. +\!GS>[1&>'/9G^8/JC0?ZY^D%OKAVHU):9%,X6&X C7K5
M.J+>Z<%;8J0!^3*WII,JO3IY-Y>/1_/??CKJG4#.@GYO^EIFDW[EW@=EAG4Q
M_^1W?R((W_) /\FD[NWC[+>S3_4$QS)_+*]E<B@/9+&-OI0UE=!G_9\$")ER
M<4R1?:F);:[K*$%Q)6C;N&S# C4E3@9K3^]R9'V+S9>$ NJ%E $E]%T)VB8G
M%&KPT9IA%2PG8*W'"J$E6RM4BR)Q0)OMK@1MDS?[_97&'ALF:+THUV.<O#P1
MJ?YQ=S09[1_NKTIB_K 3QN=$^=W!;?2T6HO)DXNU1 ((6(*BZ%H1HP=B'$(A
MZG,%]2\)*[[] F$=I+C\E2XTVR NRZXK>],QW]\_F"FU]?/^; [@_.S<($4G
M>J*43:AH-:9C+- [N4BM5-@YDZ]$Y\KJ_-$L8Y^_#Q&H5(#J/(8*W,C'H$Y6
MVH9JSY^IWOU?,A,>Z?@>W>H]A6=;W#TAI\ 46TO8(C3U1:CTG0C62+04&@]@
MNF<@^*YIEH6HMU#@8OM\2X#"D5$<.8V#A4Z"W\V>91D*OFN9W,@Q%DB92HD5
MHG4E=17VJKD8R<(Z*KAN*[YKF5/HE;]ZCF=U+D&QK;AJ4RDV6R<^Q[*5_'M/
M)C(?O=Q;;#'QNA8UV%<C;)J&<YPIVM3;MUMVM23<3N*]6&#7Q+B>3.7$V2KU
M$N52N2"6X) RL1E";9&-!W8M5,NF4$ B!/+0*T\(B/Z5/53"TK:3:B\8V+5P
M;% J-8D=0" PG!'UDY=J@="1F*WDV$<SF> "Q]M,L5)31/)-.$*2D)E%PY[H
M."&%2EM)L1>*ZWH8UFJ<8RR(J2E#:7TKOB'C&A)6D^P0"CQM.JYK(=CH>WF2
MX$N0!NHUY6H"NES91PU]: @+]9N.ZUKXE;+#W)IX%Q/T#:;@BV5LR655X#J$
MA<ZOQ_47J8L9;C.[QI:3D*NI",2<BNF+!)ZD."HF;&< >X&HKH=;&S&A1C:E
MM0"F24ZQ$?F8LVNQG:"Z;=QZD:BNI\]7,+%QBV*L0%9'J4)5:QP5R$"<MY-9
M+Q+5]73B3<E5+"B-'"1?2_.M)0\V2#8V#F%/P->CNGMT:V^J9]VZ_78;6=5+
M,>H%5]#@!C!SJ6*SM34UJ3YN:3?["\-T3=TILPV U7&(!.A[@2+?**26O8W>
M;V>\>G&8KB=6+1Y"\[&$5B#;BJE@121G'64ZV2:S;8QZ<9BN)W_;JUI&Y+Z9
M4J/46B1KI(K6@PE*K$.H%_!7YA^F^GDTW^)(-3@E4X%4V)E>T0K5(%<20HRI
M>#^$+6T;CNN:YH&]1JG>)%"]7196P@#LHMC0<D]YVDI>O5A<U\*MZB0Y$N &
M9"%Q1#7)C!0CJ,J**5O)K1>+ZWK66<DIC&1JUUFV,4/D'+-4,3G:YK:27^],
M>/JHIZO5;<YF@J)<&DHM&JA"I$""B6Q*K*XPRTD:XK91[$5#NQZ6+4Z:M8P0
M/4,S4!I34O^I6(FB8>U6LNR%0[L6HK7"4%*LS.A!(UJJ"9US'B6A$N]V!K$7
M#NU:N+8QBT$)P9$'*5[]876-DV$3;7!Y"+L%OQ[:946G+6992YR=5_@J!0A.
M"J(GCB6$E)S)VYG0='&@KJE\?6P<0+"H#D+J=;Q$C$,'0;K^;B>_7B"HZVEB
M9K&Y'+BB((2:,7L3'8@XW],/MW/!]0)!70NG&@#G!4/V,4(VO>5$=E%!YA(5
MRC@ \_NN;LM>W\%\?W*SUNGAI -V1V';UX'Y<!_U$NA',FO3V7[?:/60QJ.7
MRU(OIV?STQE.YEC[=X]F*B';:*&-.L?><N*>ETA)(]K(7B,?#8F<01I"\Z?E
MIG753#PNN/A^Z_IC>3WJISQL"M]T]F@Y*G=FL^GLUG0VDR6P-_G5X7RQBHH=
MGU1^_.EP/IK(?/[D^$WF'\C=!\M.6RA32)5K*CY:4J;G4&ROL0<E.DR0.6QN
M_X8K43K_[A$FL"4OH7=M!.=BKC'G"#YX_<9'O+(X0]9]0"63DI/)ZAQR<X1)
M.+3(Z@<2&-G\RKVW<+YW<\+]/[T RVL<RZ>URO7@.:O;JDHINY*@)?#&.P:(
ME&,.1NVRFF2TL=3M >2#@P/!IG(&XQ21%BTT<A0XJUUD9!<"9MI\;.Y/7LNQ
M,?NT0I&:O(/I3.W(;:'%$PVH9J/%2(:"C6<(ZLBTS$I.9-2.J0,C['K#X>9P
M "7(_QTVNX<3_?$!CG^:3G@HD(0&M:G1"E6C%@U4*)3B0R^U2]:J.1LV),^>
M/)TM*Z8?J;%[7^=T(-A8*10#]I71HMQ"F<1E9?ZN.([2X+%Y#\C-ES*I:L<&
M:=78HEJSB$6P09^\DZ2.6HH 4DU*9G-#LPUSSU86#5E?R:6D47)0[TP(;(V0
M+6"CE(2V!Y"+<\]6A4UVV6,Q1*FI,]!RS@ N>@KJ%@3G!] Z=//<LY7IC00*
MR3:( 7H/RHS><":;)'GQ0S!D&^.>K4Q=3*KL(:)) 5A] +2F(?A0Q2.; 9BR
MS7//5M8%V2P+2FCX(@PY$)%/A=#8XD0MFPP=FS6[9ZN"B9B@V4*^J.((5^HE
M2T,D!TY2*4O&V<QE\DURSSY>Z_Z668#H4W74?(T"-D7,#ME"L<;5Z++9'D N
MR#U;)3:%4>V7K<#JGMF609%"M7/H$V>DS<=FP]RS%6*CKC/FK!KB-,X,I16)
M%BJ [9FUQ:9A8W-Q[MD*(=&1IY83HPB "8I.B*EAE>"M:QF'#<D:W+,58N/4
M+S,YMY!; C9JO(Q(J-4Y"$FB'SHVZW3/O@VF=VTOY\</>_1)X\OE*OSIT=.K
M?''O2^P=G:GO&$H,,0H!0M6 *6$61R #R&4^A?DNCF:_X/A0?CIZ]^=_Z15Q
M5O>.?I;7,CXK%N].NC\Y.%S,EV?X5:5.[!X#T%]A>?G/&/&/SKCS]D!JS_J2
MV59VNRC>-FNPQ$0,)=IE@)&:C:2&A1IO_@S]10C8IDS4YQ(QVJ8Q1V\J'GJ+
M4C45*)6RS^CKY@?L0T!K5?P-6%JPIJ1D";)A*HV#EX;L:S,X@#!QX]%:97#B
M57-:PE0I06N4;<^-P0"J7*WOP;X4EM"NBFK_;:0TG<C1+LY^D\7=P^%D&I"M
MF7W.A:5O^6UJC4'5%Q5+<2?ZO/T2XJXDY-_4O?+9I^B2UW#:!%.,*0R& B"#
MQ &DU6V4N[Z%$J*48@O9P&0\ +=2L)C@(S+'YMS0$\B&"8IIL7&26+JCYLF6
MY*A9ZRE:X8271&TOA/J'G?X).:.#TE*?D''B"[J"D%,0 Q%I (*R>FPVROG8
M%$$I&%DCORA]E99=++;EZJLU8IE\N"3!Q(4X L.V**GE!BTU-#&HQQ@QQ=3[
M9T$+QOOD+H>@7$S4.<3L]E[M@IB<#U&6Z1[BDFFF=\ 4L6D _N)P8LXARH?S
M1<6CBCB-.".G;&,%[!./Q4=3V^60CXN).(<H'S%)MC7YTCJG))6,RB$0(P8V
MP5T2^;@0?AGV5AT(S9#XX"7T]:5*DLA[;YVS-6<>P!;=U6.S41RW*8(BP)5L
M1!LI@HD6J=@*1.J]LG$--E]0!L,XP[8H.5 K5&NU+8$"2;6XR!DR /?LO\LA
M*!=$/5NR$[$&JW&P=<F)A6AL+LQ)/9>HW!3$#&")[5QANB*DS[FXF&K@T"N+
M." .5&VHR126'+*O^4IF-H<6-T5F4N#D*O>IE 382JE56K&!K(FHTK/Y,K-1
MW'1+QW8T4>E<Z%]S?;W9LF;>)Y7U_N"\@0B-=YA]PAK!.>CMCTI,^AWTUMH2
MP@#(Z7QQNF*GSWG!P(0F<;4E F9!1.NJETC-8[5^\X5FH\*ERV%I"O8@VS,X
M\)"307)1#-=0<J@NQ\T7FLN!D\^Q.HU0$B<"URP%<-481G2J\^YJ]6ZCT&*A
MXABAMUB"9A0D']A4$@RVM#2 *<[+1)R^>F:?&CN;P*6$I@DD\0&A50IX.?8Z
M;&,^]JHR]E6/(]@<U1O/T#B2JBX!U6JQQW8;7%%X>&OCPY00R8[815OZ]N9J
M \:62BKB6PBQE@'4 ]HHYWL+)81=D2C!VN8L>!.)6ZTIMA:;)\0![*C;0E"(
MHVU<LE$EA28YN]R4]5,Q*0%L<JGXP5'_L.N]91=42#10EF# E$!,UA>7:C2Q
MI#P 0;G*Q[X00?$*7<Y0O#4J*,YC*CF4@*RN8W#QRA&XLB@G^93@(O7-OZ7T
MAC<%'7E;;;/1M=Z'[G((RO;E8Z_,7VPYBQ&7FGHDF'P1\1E2L4$D@+LDLQ+;
MEX^]LIH/9#"W5G-M%D+A#)(34\C)A>9X "4U!T,T@Y0/JB!"4(TP@>=0^D25
M\RFP:8WK #S6P?#+L&OS^E"M(6?(2 $#2#7WHF"1 U2)="GK)F\4QVV*H%!K
M$4O??1P%$OJ^@] W@4"F).,&4(]^,(PS;(LB: H(9_0J*-DQ<F1@M2:Y6%?#
M)7%-+D<^]LK<69N;K=%S-@:\8>(F-MG6Z\,SI<&ST)!R:X="2"H?ZN*ZBM :
MF)H10X$ 34P$A7< +N[VR,Q02B6BJ'FAXJRU#(4%@[?J]#;PN:)&T)LO,QO%
M39N=?;<R<O+<4)W?6+  9"9!Y!RLK1A#.=U@MLE"<Y6/?>%"DUPB]7D1@F1E
MIU"",)ADJY%6O1F T&Q4N'0Y+$T@JKV%I1@;(82*SD$Q0"YX;.\R1S=9:"X'
M3M$EKDG_'[(%%Z XB>A4L1,F2_&2K,Z<=S[VZ@*%I!Y?("0'G<M+L+D:3M&0
MFN1R29R^H1 G4;3%9U,M-W!8,?D$*3)",I7M !HK;92+OBEI>RNLH!Z;ZPV>
MEP5DP)J"&(4)0^3B<BR7I-[]UN5CK[*C46GDQ8,RM(=0&ZGQD,*41$7%VG@Y
M)&3K\K%7*"'596LL1A)KH!GUWA)'46^.;(U\7$%]LR5D"T%1EE=O&L'X8D'U
MER@HX5LOS:LW$-KF@S(8ZA]V@T<*Q01C/?8<E^8J^9*=BHLAQS[R #K57N5C
M7U"7UN)M*D2Y,EC'&J3GZ(IMD6PL-("VDX-Q!(9M4:)+5G+"7)(#!BX)'8"+
MOI$S %=1YQ#S*5<H'T:]1 Z86XIAV;_06IMS;IRM<,[N<LC'EN5CKU ^@GHD
M2C'5Y%X?N]:LHN"!DA=;(B=[.>1CR_*Q5\DO CFPM\BE04GJEG ,:)J+U:48
MX7+(Q[;F8Z]24!0W\34U1.K3WKD:GV-!4E>D63< 0W*5CWTA@F(AVU"J#4D:
MN)K1]C7BDH2IDK1+XI%L:S[V*AO.VF+9%"/H$@2FHE^8Q(R-B\<R@,F2 5'/
M.O.Q5R@S#5WS$8(O&*'7DBR./(&IE!W:/ "9V9[<VJ$0DGJU%$IV,;@*'F+&
M9%QTWF4TT:4!$-+VR,Q0FJ$[WTQ/^# E6.#>R%AJ8_$NA%::'X"=V2ANVN#L
MNU5ZOBHK17(3]6' ET Y0B3GLVL)2QY +'V5CWWQ$W0)8JN&:K,%G U(1"Z)
M\A)[-397*T%7EN93H:D-0S B'*%!=8*FV5QM:DI4KI8!)"1<$IPH04XIH6IV
MWW*<DS%"XERCPB"R^3AM?#[V*K,W7(VFH95H %J4'&/B2BWX2"GR +3J<A%G
M4*.'E#W5GBU? $!8^3.#@1S\OVXOT4K&[FQZ&OW]29WNRY,%+J3_\B<<XZ3*
MDSV1Q<T)WV0>=9N'X]NC>1U/YX<SF?]TI!\.IG,<WYM-#P_F>HGQ(:NE[.<L
M;>:A\,.#$W,Y_]"BCD>34;TYG\MB^=/5PZV0SA:W]65. $\[YEU!]/?'WD'!
M)Z=^G*M_>N2OA/Q6T+9B6548BO78*V4'$ZFQ,TE@\W=6O!>&P_EH(O/YD^-+
M?(CD[1&^G$SGBU$=R!8*Y3^DF# R&[ Q4Z9DN%<M17&Q#F![TI_ <GK:S?'X
MX6)/9J='!X*/@>"L]RYHS IH*U558&#5H(P*CW23JOB<FM1-[A2Q;OWYT 9V
MA+[<!I[I'_$--C 6;ZHTXY;NC&O%._2$H:C_F37FW!XP+T[KUH^JJ<16W53@
MXL!H&"%(R1K.!E+?I+OY/5S6K9GGTUJGI2+6][[R&=1N4G%1JD@EXUQH ^BG
MN#$Z=B[XD X7>Y(BXB!'1]EXH2HE!(3BR^:'=INC-JN,N,5RTTB;LW-@72D8
M0PQ5G0]'@+QL#FCS%2Q?!$M>88V0XJWZ?.JO9U"[5GJO3U3GL*A-BRD-7EO6
M8<U6N3I);+R14&QRD)+%I'Z>J=&EK)SCZN#59BWXK$Y_=.#%&@JXK#B96B[H
MG$\NNPX9F0%-3:W;OJU_+@ESJXG4^'$(4#UI,)PPD.J@CZJ&RZ!8E>T8S$%;
MQ8L%,W\QF!];SF\ DYW+8JU8 8#F,??==AR;PV@;I;8]FKF>H'@]*LI"?6N+
M\\P6@FE%P#GJ?VH<1I6W1T77A.I:=+4W/@L:2D<R!ASGG(JJJ,(;L::@7LYP
M=/6Q'$QG?1W[V62T^,#8[A[-1L@W#Q?3T?[^X43.G+>JE(B-LOIKL0\0T#6$
MW'SUX'W,F"4Y$1MM]#G!%DC2\:K>.N3G,A&-R96<";7%UC3PJD0VM62M,;T%
M^C'1#&1._:[*RT)^'KT6OC_10.?EB,:R7!6>_W2TBZ^FLUMCG)^Q$3T[8'H@
M_%3JWF0ZGK[LVTYT*)%P+M\J;?/9XL9C?8R3Y)_^<5<?<?]P?QNG\8E5;!BS
M^I\9DB.,-14U0<:RS1[CE2"M5)#P[;8*D@]92J6663($7TN2EKUUIB3ENTS;
M*DBG/WHZ0Y9]G/VVE:M]Q7"2JFZO95&^D6QS<<4G;ZLZY;RU9N)=ENCA?#'=
ME]EC&1_G,>V-#K82: Q.J$8,-43HR_0NM];$..M<PM-&OEN#[Y(&'AW.ZIX:
M?/YY5/5J,E<2>,<(Y]\B9F5+B]E)0K8<($&@OCU(U!"3@2@!>0 K\INLFN<"
M6?>P0B6QS1-P#!1;L%0]6PHAX;9"=IY<>2XX:2!>NW^3?,T@IA8CY,D55SD;
M=FWS<;H_86E?;1GO3Q[-IE4C[<<REYZ[W=WC8Z>YW__7T6+O[(4' V@5RNP+
M%N/!I8"0<FRQ5.2&4H;0JV]H-+>RW-# Y++S@DZ@V9)]JQJ^,K &&R)QRZ!;
M)\VM#++L8_&9@$*"(DE=DLJ82DN<4N8A]!?8:)I;7=58(2L:Q 7*@*842B+5
M@(_LX*1 P6;CM"4TM[)]#N*M8T,)($,0+NPS!E-3P>HM#&$CV:!H;J6%>5VB
MT%Q@[/W),VDH[K@$<+ZVA&'+H%L;S:T2LI@5(T*;4H#FU+OTOG R+2=@D &4
M7=A@FEME%?V4Q"HP%4L#KQY)\X8L!]="K&0'48=G^#2WRMK#?1G4%0^8 ;PG
M;-4[BMPR*(C43M-N_#+M9OG'IB+;*R;=UY&8'?8??@#>3?W,_;NGTULSX='B
MYLN9+%?#5U:Q8GG9NUA'8QV1LSK^6%Y/QZ]'DY=G3[J(;!__1=D^'YWZ#3/@
MM2^%)A-[+5$H%"F$/H$JE*O+V1Q77(K6.7\E0YLI0Q_8F-AGC#X8W6]IP!Z
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M#4:N.5ZQPZ8+PPII H6!Q'CU#P%2<-F6EL'5V+A9AW)I:6)C3#>[3&0UJB.
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MF=.@T#R:32?Z9UV*S<=[P=^=I8(U89SQ_-D!JXCIBT?CMG$Q5C+W0@\4:HA
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M?U><-?]HW?QUDGKY2'NY/6P>.[J\89J,O>_)!7X-,"T9GC@*U'2J5:KC16R
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M7WIC!!0(>:^<C,4P\Y1WK:.H>1DGUS!,K3+8NP!^R KTMJK,"_0PC#FA\;0
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MZ+QLIL!J&NQ/,J&]!"F"VRB7F5VJ-;8?*^1%QH)\+6(C8667\% J8,+PR>'
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M2RXT>CPY=&%A.1\/X.#9;[OG1RM(1,"3,,^F/O-K?>9G S1 ZF\TMK_S7NN
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M'24W!KL[ L,?F^CE?&8KFE8< U%Q7%# ,"L($ -D*RH"&'C=\.!0H%:L,95
MW.\S SPBF0RC,\- \)6Y401<1D_^*7X?BO/< =QU7HNMV2WH!KZ9JK_H2>34
M,DVH,XNECAH"6:>PT@,N:L5^VN3[QW5OB!E764')C"GKU)R92>&UUVUM>/OE
MV,7/7-:NL;: :HJ!@P^'E;TFG8;#QCPL-29C%!4H1A$6C"*J^5[#<NI_$T[
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M8Q6^H-0)Q&DN4S;H"G3.2;<@\Y 9S16G:T9'78B7JHH,\XM$8<^R(@PS3-7
M6PD3S4PY,][A$#U'*B]HCW1(ZPWC'J,BG5"7!30&APY.F#VEU-]J6*1TCPMB
M7]WJTF!T"=.NK'1VL$S!D%T5S1V[#,%J4==S<L)9[/@J[1")BUE*#10N8I9<
M#AZ9-1OS$4J0;WB&P\JY048A/2%@WO\IJ ^Z8Z9^6*B4N0M6(O 1<__J62[7
M-!/-EEWW;(@:T836*:X8VVI.^RF7E$E67[/!7L1F<,+1I?FA.XARJ&(A.Y*
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MO2VD<]KHGF4%1ZP^]OM-U4 52I7$.WTK6J/3TCZ!+CQ*ZG@*(-10M^^79%?
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M&'JK*FE4ZM$P5Q+042,T:YR40T1L_UJ:T"IT6VZFOB?3^K&%&,G8>1("6IC
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M;C<[;]-#XTS*Y;[B!UBI3KA(%"H2G'.;ZB3W=!;)3(]XS+>?WR$V3\8H A\
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MHQO,PVGN>.EMU%G87L:Z73EXY633]'XL/B1PMO%P_1U *J>Y& ZMEE'C\-%
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MXEMX0/I.+\\GE+Q0@"#F!DF+*3AAS^$58RL<9J$LWY.>8R:8SZ-X''M <60
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M<>8$5 89Z2I!#"\E1M8R/C4&ZG>^:=.!/],G0Q?*@%0-=_0%K2OT8I,-P&X
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M)++R,TC;4X4&'7T."OA_D12(?8,??3I[Q\;CR8=SQ@6!?_%&OD'O%$LU!C.
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MY_BL+_I9%#D0YQ:_9W$0C$%JIL)QX%E$12,2@K3N<>,-LQA99PJER==]9G+
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M+NU/S5J2T<6]<X;6DA%IG6&2@ ^$WCMY-3,]IW:7WJQ"(PD#RNUW0$M.J6Q
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M!EO 6@'FD?P!AD+T4)A,T1!,1NQ,=*=?;+4B>!-_0L'C82PA5ZN=Q1LJ%1+
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MHGH'@,<&@PIWL.+&-Z5/!BF/)@(/JLYE;;G9YP[[57%=<C=9$^NU' AQJ)N
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MMW2X;FV*3O^OC+RO_AAK];!6=_-,GS/CL77W.9V,2#?Q= =;JT*J9H[@1L_
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M(LW2,H^GTNIA-:Y$N@FF[9V69G@Q[+K46\. "+9P9.([XA!!VJ74T.!I;\E
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M)^A<TIFSPF1#\:\ 1R'X;!%>T6B"G6M!=J=A,H+E"8XLQ*W-5 K8[(@Y!IC
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M^4K?D%(P[#9<WOVLF[)"A?=*BW^P:.Y95ZWK[NJ]!E99__+%@]4^K(->L'&
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M]J+W@'%:0F759<.H%)?V0WM:;'U5P'W6$NT<'4S&R2"IM*NRS (Q"XDH;6'
M@NVOE389C6H+I73]US$HD1Q3#L8]FE-_;'I6ZH1$F&[E7F&EC**JIU',Q%,9
MN)N#.5#+.$0]H9*@4\SW1R_OF%*F=\9)S'YE8!L"_<;X 13H]%+%*$C3M.R5
MKXZ!/NK8)$>;;,0+2J=XJ;6R1 OAJ-@QE^2#-C[_ H:^!'YERT;G0:H6U;/(
MR[0?+Q4V"&/:IBL&'V-?JWSO3;. !!EJZ>UDS[5"*96:*^!82M69(11CE(",
M"OJF_.5G6"30XMV;)&6[PA[Z60PO]&U4,*< BMG[^,="]W2LOF;:J'Z*/DGB
MQ4(S[3/-= ILF7]F:7U?\Q=^K/7UA9_=-ZSA]BW36VO8^S]S=7,KD[46?]P<
M]H%>5 \V")O]ZAPP<TY$3X/=[2\%W?VIY,Y#P9U')7=^ .Y<V*!S_S?F!^57
ME$I_,:D$XN>X$C_O2M'#/FMMT4YW?5UN7^8I((_IX[H;S8B7VQM=7[D9\4J[
ML ;2_7-PSA)28ZN-&/>*I-9L=+J_!+7332-7DK&UW;>6@)VS[AVA>7/=GNZ[
M3ML;ZM6SW^1AKMJQ=D^(X^4HERW_U&.4R]TC;MU8N8?K9AHR/SMYO_".W4N2
MA^.\3.IX.5I?VP7_PC2_U0WH/;G<I>:WQ)99:W:EW77BF-^IL OU'RLFUXG<
M^PLL5.Y,I?A[AF18EN9C]$YDAC6A^,071(XTK[1F&>@\GWB"+O0Z!%57)HHX
M)Z^\R/*(5"4F#<2:<U%W5RCOLH@%"7E5%\,QT'X^/'_'?M-__E%Q+4UA""SZ
MMN$-5LV;[,S9*D=E*2@>Y_R&)"PDV*C]K<Z9!ZQC 0@)YSV^87'@5DI?45:;
M\-I9> L/+6,ZYOS7"=* ;_(,9!&=YMD! 2^<YS6,91R:82O#GTM0ON:T^/2K
M(#8KP ?A5= 673?+21N)D_>4D[)BW8K\>;U2 [*B-3C^F2=6%G1J^ ;3P-BC
MG(Y%,0X&=V\37OF.>S$@-RP7.:>7-4RG6'^C"2:ONV;E5UC>)-*^<0!Z"Q24
MMFJ'^<^_L%AO4O 9I*(N&^0B_T>9D(VE'BP7*";76<YSTG)EDM;_I"6@L,B@
MYJ]><H\N6*5]^3)1"H(XE;Q,!(M$ZX3:=HJWV)Q><VMP#3_A;O'4=IZJ(FK2
MX_MV1@S-$1/7.)'&Q.J#9GU2JB8D A1*@<4,&?YJ 6L#FAP4/$V\ 7X:X9^S
M$:\-&=$4;^9>$TJ[_4:>C9Z/,I8M4(SS28B+Y)D6S>]A_'(P:+QUKLCF:5Z<
MJ?#XZ[Q?CG^<A%5F<%'5KR]WW+M7H'G$C^)AUF^6-+"*7\86F/]4BC31P%34
MVB!Q9)A@B-*R*L?FUVM6G7+"J+97UWDT<V2JFH^J/'.<<+SSF$8,/965N:,D
M;M[><[D&R0:^=YFT5\*;&'#Q5U6A1,M<'FRMS;+NNI %4]]O^"V/H].ADE*,
M'&/W%Z0G#@@_YRTM6CJ)&]BMF(Y6[I_H.L36.]T)%/=&""B.Y<V2'9'**_S\
M<:OHIIXK'C@>[*+5"_"%*MF];C59<4GC$/"XTJG;"+6LUIGB%^MSX; Z-2HQ
M@2-BN/G70I+#UUGAPP3TJ7RVJ=BGJV1 F\BX99HG(VJ&"A)A3<.8"F !G')-
MF4W]KR306OHTLC_G* %80ARQZW>*FGC_B8+.F?N"&H)RG!+/X-X)5'6#O>8]
MT* 'K(F>+@EBKE6LM.2 ,L"PO*M5:PN8%!?H>NS2BCAJ'VJZ62IJ"TN!.^?<
MU\;&M78*./X#Q;25%O1DGJ494M60)U<OAZW688/MO$K3K9J:-XGQUXH8&P78
M%<T _YS 'Q6OPF\62/2LOKN9ZLN5!+:;3;#&UFZN3U7N,E350FRSK24 [O!+
MLC)G866.+RMSNC$769FS8]-?IS+GT2+LJ2]/=C.XARTEKOGSSX^'9Q<G%X<7
M)W\=*X=G1PK\X??RWT<GY^]^?W_^\</QN7+XR_N/%\KIX8?_.[Y0/IR<_U\7
MK]V'P"\J%1^K=.N>HGA;QG#;9O,<B*@:WH ZB:#*K6?@:K_C]1-E#^&L1&8N
MR@+OF0<XOG3&V__D3'&&BSP988%(-3NXD4&]!%L(#+8(W9L(VDS!GJF+T%-6
M?,SA+6Z3(?9MN4OH #%JWL]];S&B(1A]J!.#X0%*/R_XN:O0R(I*7Z\?+FVR
M(:LZ;\-4\E% %\V*"5\3VFKH@$/3"3MB]?A_<N9K$KTIZK%W$#GN_=3F"!@U
M;L\&K=ZT GF,F52P]/*HFOUM8S3L>;D+;-" 57YS3,FT*N(03W DK9M,M*(5
M3= :KV-X* .P)/&(N1E1@HZI<*PJXG[UE<.9OTV/457K"1]M"Y\($1]9#8FH
M2.*E)!S(*07E8L#JVR]9OR-<48;H)*+$A$\* 9UP*:#+3X837KC&6T#=!QX$
M^FQK;$:3?/"LQ9-B,7=-8*]R76(28EV"&T)5P+&5L0 >1^@K1PE:L\S_$'%O
M'AIS99U47D%'EF"W"IP+@Y [1,0'I)RRWJBU5\*!.'LV]=3!L,YN@+**<04E
MA^X-*J T5,1O44&HHZ<NOZM,4E917U;/9VPZP(E%V0<)7I; &:)UF5(Q?%VG
MQ79$3& 'V?)P (<VN;Q:('$O08A2?*JTM<>\AR%N4\IE%Y/A3"!7#JJ67)X"
M$ )[/VVX-*]@+@V': ,7L5\[9<I(%=IW.6)V,?<O\US59')/L^LJ1G%3?J/I
M8RL=++4+-X#9LAY-2%*,;*L> OW2>5\YJ%@U7<+Z1E;!AL:[<;FLXE",5.'Y
M,:??O!Y7.TE&#]<S1\HKK>\U&U+/"#[AS9JG7;24L+(,]J&6O.UY5/ZV&DDO
M4N(!.NM)RYM6JS1<\M2-/[D[<^HFFR4=AAU223X>3LL3A,6>)]6FQV/-R[@@
M++'G9@% JIWC*"G,%\OP^+(\Y/Q9L&9O+1DOX@RHD!3A%8TF UI=K'<H?Z_N
M1B@I.2APLZ/IU&*".\6PA1 <90G.^J;V%O)Y5G MS7%F"XAQ]=@OM77HXE!1
MY&-=[2US8</^ P755>OD'IICW,7;OL)L1ERS'-RQ:F;ALN85P)0WXN*5TK7C
M,D$TPTGE/.:5O.*D&CN!I_J]HWU)']+GF5"JE?I&M3#3QTKMA5VDV,VSJ:V6
M+>9@]1Q8NPYRM2F%:]0+ADX* ;+(\+!!/<['C*39#<N*;J>8<XH*Q4&6J#;+
M^,'[RG^R&PQ$]Q:0(IL@@UH0'?"0Z\4TA+XVS*YK',?VE)K72A6O*[B.R_"W
ML:]I&9LL'UTL+8"G.5O!J'@-1OP.9?0IOB[\V=/M?^?O^&X2JD [9/3'5SA-
M%RC58*H"497W'4H8-@!V F2@\"7,Z&5.Q>%Q>%X.?%Z&8- ^.*(BXEOINV,8
M]!+!>MD?P:*EY+OX!X=M^I@F%<(GDN5@0/)>+:(9G&Y]UXE9WK67P45\T*K"
M7WQ>+]%=ZVB+W;7+N]I=[4#Z>#OO7Y0^WN>?_LOQ\7H+7;R_GIP=GKT[.?Q=
M.;\XO#@^/3Z[.&>NWO./?_SQ._OWX8?/RM'AQ>&2/MWGZB#^^</)X9'RV_'9
M\<7)N_.><G+V;BEU@+6%>F)$$=_O>[:Y#J*(Y_9US]DX2(>N]1W=VB1(QY+%
M'G "#UPLV[IRM34NEN>9RPI"3</\[HC>HDHX+S%@CK3;(%8(/\R-GJ.W5*K^
M'Z#>S"M5FM(F?<[JC\5065C7KS5*^UOC/#7/;.OR78=GGF<N*_",B5E$+"<&
MU#'D'C2/T$WS@5YB'QQ,Q?N#=8EOIAG]FN3#37'3W-*7+3#34IL*=HBQ2MF?
M)-[G)%Z':>$+D#&+*1>B4GNL_SM)J6)JY3]+;^*^4K0E*7I'*-HSIBAZ85N9
M,CAY40=)_I@7)%%:/O/RJ<\8+)\E]V?21+%?[GP#[:&V,<]^M+M+9L=/[[W8
MY/21QJ?$. \("6'N[:LPMZ4PWQ4RM>\5YO?D]:PNW7=&EDLIOE'ZXILZ<[4K
MQ^F+%9".%)"[0L#>O0+R''L_764##-S^4SG^WP23Q!9+QN/[]5XI(5\F@?%-
ME9(1)*,K)>..$*ZOWZ\Z8E'MKUA4*_T W3C:W26S%RP//2D/=X50K8.W6 7.
MTG4?+ #?5WKU9^EU&4PV4U:)WY-VJ&\D[="4:8?=3WF3:8?//_UUTPZ?7EXL
M@EQ9,UEBQTK"+WBEP?D5R:GPP7#0)/CC+QGFW6-H/<EI6'8R%.C!O]$4*XR*
M'KJT.UV2,/^ WX^25'3>Q+7.UR^ZNZB%=18<Z0E!K42G1ZSF'\)<6">I5FE-
MJ[1Y\=F6-8Y%$B4DQ[*,UQR?AXWZX[T57#P'0_Q-:UBF#4,$31".,<B+7UIS
M+%H&<8TYU6,8475<110FO\9"NA][2M'R*5+N4V1 ?A5.55WWF]PJ0]C:JZ7*
M#UDY,38.%%4C8Y"*91&[*(UK#3.[_E[%8.6*4Z;ROL8,W++&#3XK =*RLK.C
M0&E]L#RJQ'#MP_'QEJB<UODV/_@X+P1.>:7[X*['"@ '@QH\3-3B"6C(>HAF
MQ5^#0K L;$7JJ.W2*?!)+'IL (^QVG36I+$#I\HJ2%/LD(K$Q@J3/O;/^XT2
M-&!%.F)  $WL*59E/:"[7(#8%#J]>1 BO *KA-D0FRRNT)),&E?I>T2GP_>(
M.^AUJS;K1^7U'^\.W__R8Z])9O]L@+#".8SS;,"@XQH$6O?ZO%]F5;BR89XP
MFF\ "'"TL?)%[_B+5/S#9<XMU9P,Z4V6?^?8'Y% Y\-I#A%#A6FFYR/DPIRM
M-;\D:?)WC9/*W7R41&!%\*<*AI7Y&KC"5.)R^!\9T=:-@Q7.T:>(?\H7I#ML
M03H6W0$/%:R(K8+^$T(!7Y?3+%V.^CH%B_=+!=\@+O/=8R .8S)7"A,!RX#2
M%E%6!'I"6[;^LVCT)^9ENE/?3Y@O15  GG_65GS$0 )7MY@_EXHAD-P8GQ>L
M")OUNU5&G(\;0BT&51CK-DMEN9(!C&\YK&D3'KK$IJXU;5'YR2Z:&A&0"XH%
M\H4)VQ*SM8'=P*"&R[N$C$8P5V8@YI,!+4%':Q17L;_G#508^,;Q+2^.;O)C
M.21;TVX*;P3TF##PZ_I@EQ??;-T*!Y^N/Q6'RDO.;RCKE"U 0'.\'/DQ,-15
M!'0-6$4O0@MD*4?4 *F9LU>3()N,$5R&X>,L0$;GC!+G7*Y6.@H>4OF57C5&
M-.'8,'F>,4PF$*:3B+--M7B!*2EF*^ A0QI-<NZ61+#:@BMD##=@X6O+?9J/
MY'KOE'K-#9N> NXK9W)1*([[SR$,E/,)Z#"-+U?+X3#=# $;25<9TQ+_IJ=0
MAO034E%I7;6W9DA7G/ZQE?:  0=4^M#\POS&5C+-H)Z 0 ,N!Y^G ?$VY<S<
MF LI/T34&+A.:Y'7PYO\AF%D%-.O*'%CA3I+FJKI_,E_JE%]V2XWF$*4EG/,
MCI)4:_R@AI:]@Q?I.Y1T"!9RR-CRE(":DN^@^8M(=&&Y%BYBAGPM:"T.)RF"
M7*%&QA"F4&Z4'X-=RQHG,&@89B6Q\OYQJ?7SP>XAGE+<(0I9\U4,XZAUR[4^
M%C<;'SZL-$1^M9#Q&^6U_J,P$YGLX5S#P,6:+,E>+M;#!9$8>+[ A-%?&S\B
M6$LVN!;"GUVU"3-3X*H#0Y3A^/=*<".TL1$B!*[@ ;VM +8Y$EMC38+'%IQ"
ME,%D$>V##.#?'%D&3"70<QL,5&HF2\!ACQ'"@4-&WX"U+\#Z!8@.O*>'TJ(Q
M.2$9%LR.D45/L#I^MZ CP@!BQ,R*:FKS!T!!D#;%V^Q!976?C3MQL%TNX'4U
M=YT"7MWI6[Z]5@'O_9_9IKGQLF /AG6-]<N"_;DQ1L_J&[9H :7/%9)/&G%D
M(\Z#XYZY$5@XZ@0T;=#A40+2&L8?&/LRRR($UEFB$-7<3"'J8[^ZC7C_4Q_2
MHJX:+5QSE#O\ZEZBX=L:N[IJ1L2<$/ SP]LM]D/.LX1+4J_\Y#?S4I(6]H)[
MJE7![??*-/R^44*J]97#!W*GMCJ?@EUX$^9N@@N>@?K;]]M"U4ZCLP+4?<HS
MUY):"!'L\D,8H%@Z84H*?#[,N.7WOPE\!?Z4( !7A!>]"%4U!JBM4EK:5>Q,
M&1XI=QPFP]8;F9G'W2I,+4:%H#8\*BII/()3!VN$%)6:A-H(8F/"Y$J-"98N
M3#[NI9ZQ<Y";%_7-FD4[XQZBTJT):@X'Y46C&O]0[BQ8A@+O%3=O!C:MU6UI
MWI!,L2TH2SV\9K-OSAQ-]N&H!/)J=KUIK(EU@!*MMFI_?8]1"X-4%MAKW"%3
M)!&<LP*<=8..((Y"=['BK)E[BG4XX6[8 JWCLDT6P;E&()#RNR9%5&"G!2(J
MUNB@V0C'QG'OVAVT:'B5 FM=WHFOE?C4C8XH<Y*4MHK=L)$K<V'*T8M,'S(6
MIP_)3*#.9J'(3*#GG_X:F4#2V.VLL;OKAA,3L?_);M#7>QA%(BQ:FTYXI:,/
MFZE\3V9'/8='X*'8$(_,\)@Q8WT6XF$^0>$2$!L74=0%N<^2*^_,^UXI0E4/
MQQ3C)N@<Y$'S@H?G[S6]6AK\=0*+8\$-U,W["@*(8UQC-. HN^+ML\/_;P):
M:C+F\-!-'9^UD>3Z8_G*Z;Z-M?=CF$6(;\]Q8%$4WO%,@EKWG0AD6]%YE.N;
ME9;:YUG9^ .S[BCK;T ;O1UG-?OI?9E2<-FJA>Y*2R?U=*BHC,#T,*"#:+<8
M=BIZT]&2Z5<UULTZ0G 5%U<X\RB\L03G;H%O,Y6:#2%0NJ,R=E0-+O1][HDN
MFW[6KQ8^Z:08EZ&WA#6A8+O71/U?9(WPUF\!;DX Y-#C1T**^19&%>JJ[9%F
MAP$1?F9XV:.<#I/)4(3!F:TH"/\*IICEW#L<AF!"A'<\1#AC.C::&=?1/LQY
M$W86SUFK2731(C%\*#B2>Z<;ULE2!B./7331Z5D<9&J<QBO[2[C_NF3+O 27
M[2DE&&,H(\_#;$##R8!@_(%<IAG,/ZS8!KMXIY,G1!.43ESIQ-U0*^E)7MX[
M=8KG:BU$YKM[EV$8YMQ[9;A^WU$ZZ0RN7,#/Z0$^G.<"UDOJ7B*LN]11),5,
M"ZH9YVX !,LUB:1TRHYIPY_+&KFTY>:C2*/I]UW;X5O^N96&(^YH%H[ /629
MXL)/SA*7Q[P'1<HZC"5LMKV6?LE;WU9[U_2+-I6)1@N*$;E#1VFI,C74 ?:)
M,DQN>^+7,G6=9^:+W F@ +"O:<XU<H)=$@;E2LM^UF7/==;(1W12&X@)UX.6
M>1E)'JFXOCLQM]WTK.[E/29MZL?8U)P1MFU6E^POY":_+[D]#4*Q;DZ(1I@0
M;\S$9%T>(Y;)VW[)'*-&F.E"DBXR69@U)DR_T60L3&>LH""#D.7BM@-(N&5-
M.5BV65D@")N[-F>.U2*PIPSN$<:)N'@"N<*3I+!+>'(M!"$N*IL4 X9+1$-2
M\"(.;J-Q$Q"3':<=$&Q1K7S%YAN;:68\4%@9CG YDFI+AN3[]&[PI,/R0DMY
M9G=4V9L-3T.5C]GT"RPDD.4NW@4.!6X%XS?G^0[*3.J&%Z4<>#E"P6\U_"[U
M%M7U%65V.(O],<,Y$08Z-@R*VDTQ"]J@G'(JJ,!527F<(F9N,07CL7Q<<931
M&K0^2Q9M:WOZ:,JWPZ,B4#IS'38O3.QV%(D+EAT07NP@8%A9%PN +NVY8'2*
MP<S&)5\1YWUBIG'4K?>TZ!8#\!'*ZJI-6RNL&T_&V*ULYOTLYT\X*Z9<(]4Y
M$1@R$HI&8W=G=HD7!DYK-P&](L#U^1Q?QS)H#,^5X3O_[OFI^$DYSE.0C/^/
M#$<_*Y]!EEXJO__^Q^XE^98UKJQY=%361D[3()-Y<(H@CT"O-#3-V<$*C7,"
MU/T[^0[+8VD''R\6KJ$S<YY3?R:!2)J9!.9&@$@<"432_="W3#]X_NDOFW[0
M%>"1U5I\=676O)G:+^<G1R>''TZ.SSLTX?EB^)Y^(IV?^VLT"KFCM_AQ*:UF
M;F.K)T^Q@0NFK_%+9M4<&P=N*LW;1D<XVW"WD+IC>NL]^2R3M8VM]-JSS>4F
MM*1/]''>P/F]W(9)% WHIMEXNIW;_'AM$[%U$T[1^3'MI;:!<^GS;$,)!+0.
M1N>FVMCMQ$;Q]@^;=)Z_N+U9O:?A_F^</@=M=#'GS0:XPY!2, -6C%QM9\W^
M4FL^/#\_OCA?AEP6+79C=/30;CYFC#V=Y,H$*C(P.DF@\].3WY5!H:( <^3-
M6I0ZM>JUSNBEC+$AF<?S!@V60]AI\L)82H6%B.D8UV30PKML:^Q+K5^;ES79
MM96_>M0*'X0,?\ZE_2NY?9-FZ:\Y#V^RQ-X/Z"6;%-$!"XG!Y-D?$M/5S5!W
M0N*XQ")&Z*,2X#I>Z)J:XUC&UQ-4IW3#U ^4B(;)D R*?Q^H]H&2DB'%$=5+
M0D9OD(X.TPC_<UP3T>'X'<ES#-'^A2G'P$6P0?"4<\!=VY'YUUUPE%W_;GRX
M_FR>3J)OQ]=??O._O1^>WIQ^.KD[N_@K^6Q\O#D]^O/O]Y_^>_7^XM0Z_>W+
MM]-OQ_:73R?FZ6\?;W\WSP:?_QY].SWZ-3G]]E'_/#P;G!X=:J=_#Y+/%]__
M?G_TR_#SWR>W[S_]E9S]_<O@]"_//$O\83C\-7T__')U-OQP]>73A^3+T:5]
M=O'GWV?&7U>GWTYN8/P[>)/V_K>_!J>__?K]=_/#U>?A[>#]\*_O[X\^?#O[
M[;,&\S*^7'SX_N4B2DXO!C"_PYLSX\^;+Q>'VMFGOP;E,_"NR1?CH_/ETY_6
MV6^GVI=O?]Z<'7T9G/WV87!FX-R.;9BS^>4(YG?TI_[ETU_QV3OM]O>+X_'I
MN::=71Q_]0Q/<\+04&EHQ*H5VY%*2!2J--)C6]=M+3+=@[>Z[O9!^VT3P-MV
M$XUU"+X4:2L0_B;5""E]]E+ZA#KQG-B,0E_3K<CT?2MRHB .#)QAJ/M<^FB.
MJ4GI\VS2Y^9KI)$PC#53I9YCJY9GN&I@68$:F*YI&H9+?%\#T>.8?5>*'BEZ
M=D+T.'ZL>=0R;<^V+!H'Q+4M.];UF(2.';D:BA[=EZ+G643/WY7H(5I@.WYH
M@:QQ0M5R7%?U8H>HMD?=4(N([YG^P5O?[!L=DCP;<DOLB@UYRC!26/0P2:\I
MS]YK@.XN]%D8JVW)7.FZRS)H4\97?0 U4K'P&TG)LXKD.6^:7)=?#3O2 E.W
M53UP ]4BH:_Z6F2HKFE'.NBM#M'"@[?F!M2>>P3 MM2>91UI+YU)-V6C2";=
M.)/>? VI&?EQX*I.X!NJI>F!Z@4A4373 47.MT![ /7 MOJZY-"]Y=!-J?*2
M0S?&H;4"[]DD\AS/42T[\$"!]VS5-RQ=U4(O<*CIF%9H'+RUNG6'OK @T!\Y
M'9&$%]^FQ9H*^[+ND%V6-(]5V(=WL%:QV\=\LX]O!:2,^/,%N9529RVID[25
M=Q#_ON'JH>J#'J""E(E4$EL4?G,U MI<%/@FQDOVT6<I&79#RKMDV"=AV)NO
M;DR,R E,50^M&'0% Q1YW?)5AWH6<8S(,%Q0Y'6S[TENW5MN?:PB+[EUJ]Q:
M*_6A0S57CZFJD]!5+:)1U3-T1W4\S7*]0/-L],KK3M_I$+>^,*_\27H--)[E
M=]+]OF7W>[739U3*E)5DREU;97=T-PJ)3U5*?%VU#--2?9T0E?J^[P4!T>"\
M#MX:KO3F[3%7;LK?+KGR\5QY U:T1IS0=M0P]M"*IC;8TX&F4E#1J ]RTPF0
M)7W)DGO,DIMRL$N67)\E:^4[]CR/PCVI4C.P5<NU8]6CKJ[JKJ/[MJ<[@>X=
MO#7UOM4AEGQA'O6+'+O35HT?.7X<1I:D:WW+ROBAV/,/U9:#L)$&_^HRY_V[
MMG).[9B"B E4W3=#U?(U7PT",U#]R(IC3W-=PS .WGI^W^Z0S2\]=-U4SB67
M;IY+;[YJ'O%]/3951P.EP/))J'J1'ZB.9^J!$5/7T;2#MX[W>&5=LFAG6713
MRKIDT<VQ:*V\:W'DVZ9KJH%K^ZIE!19<H!Y1?<^,S5ASM9B5TIAFW^\0C[XP
MUWF9#S/&8)%TGV]98V]&YJ1@646P3*6K$]NW#=>(5-M #=VBH4J\2%=U(X)#
M K6-Z*"AZYK7*<^ =-9U147G+=I@B-OQF[]IGD6DN)+,NGEFO?GJVUX<.L16
M7:*#HJX30PVBB*B.3HCF>T'HA^[!6X9?;?PL>75O>753NKKDRO6YLM;-?0?X
M+O8TU0H] W[8FAH8+AK2<)7ZH:-%<73PUK [%>MZ88[U]Z)]16F3RESU;:OG
M;,=K)T AO0!K29K3BT.4,DP'.#OZ:'T%4Y]:CFFI-+:I:AF^IGJZ'JG4][38
M"GVB11Y(FWU$\Y$\NF%WNN31C?/HZ>%7%Z2D;P94-:@&]K1K$948H*]K?A@:
M7FA'NJ<CAW;)4R<YM)L:NN30S7'H7<6A=NQ%U#1CU7<-%S'Q'-6W=%LU+,,U
M \.P0ST^>&MUJL1KD[YTT^VVMGZ1C5G3O":$[6/\Z4MC;>^='-I8>@P[ REZ
MUA$]QVT%7@L-5Z>>IP8&T4"!#R(00[JG$CWT2&1[KN<&!V]-S]^8NWT5J/E=
M\>^]7);>6"Z-9.D-L#1H$V&@!X854U4#TUNU*/P ,4M4(Z)QJ(663FB,<$\;
M*!F7#+V'#+VQS!O)T(]AZ-H\T%S+B#1+4S7'U54K O/ (XZN.I'A&X;F.00A
MLTW+>WR=ZE,Q]%ZU9%F4?8-][;'%[6A 1#MT;$PP0EC)GI+2\6-\_B]7/&TN
M7X>?SQ]X.H=I=%R>C:SJ655:G;0MBMAP3=UR3#72*<@KZFJJ%YJVZIBZ8UN8
MQN.@.T/;F#^C,_K'!MV1+Y?!-V502 ;? H.#.@*GHX6VYJLF1A$L+=94WS9L
MU= ]QS8#QZ&6#NK(YAIX2/;>)_;>7+*09._-L7=M;8"H]4/-#%5BA[YJA9&F
M$B<VU#AR0T^#4W,-\^"M[?;-76'O%]!>[SVP AG#9)4!)055V*ZH6:Q.X!^/
M#UCLM4#:6(91>0:_XQ%\P,F\CS\6E/E!I$1:22*=MBV*P(VH[U%'#8W842T_
MCE2/@HCR0A+YQ*6!%X-%8?N=0M^56<;=M LDGVZ#3T%S,$"7"ZAIJ+[OV@B4
MC:"UEJ;:U+=UZKD& 1'ZUG$>;QA(+NTLEZZOWB]3MR-Y=Z.\6VO].HGLR+!C
MU?4"T/ICL.>!?BV51'J@&X8?>7K8Q5*>%Q!(^#U++]4QS8?*<!L=JEY"^N,V
M.U2=96DH8YQKR)\_VSJ^8_B$P _5)"9((*)CE%./5-#U-%>/W,B),4U9EY4$
M>\RHV^Q2)1GUT8S*O/^@R@6VH7J&%JE6Z%#5I[ZONIIFQ)H)6G]@;=3[+]FT
M>VRZS595DDW79]-:GX\CC]JF%V"FD MLZD<J(8&E&I85^8%IAYYOL(YR7:KZ
M>0&.^I-T3-++!&MGUL\!>@E^A,VAVI<;SO,1S^BX:J;Q6Y9%-\E@( 7-2H+F
M8UMQ-R/7]6/747W?(:IE$*IZOF>IU'-"(_9,W;$T#!@ZCX?4E'Z_SO+KYO#N
M);]NC5_124\=S3:)KFH.]I,S0'\/?&39D'A63!S/=4$Q@.\\/KXON;6SW+HY
M*'S)K9OGUEJ-)V[HQ<0.5!NA\2T_#E02:Y:JF6'@!IX7NZ&)4+@;J V63OE5
M>*TD;NERW[+^+J7(6E+D<UM'#Z,X)&'HJ9X)/RR7FFK@1)X:!4;DQ$9,+=\^
M>&L:?M_HD#] NNVZJ:-+GGPD3\+-[CMZ'%(;<^?M2+4L^(WHV#C6]4$3L]%H
MQO8WAMNIYI.2([NIATN.7)<C&R@\06#[@0YJMNTZ\(,0U7=]5XT-US8(#6F,
MG6$LW>W4'?D"?.8<+%-FL3\=3J8PYF4D;CVQ$M;*][>/=V=_?O5"/S),+)G3
M+1 ME#JJ;X!5[Q#+]4ALN4Z$D+S2Y;;'#+I=0'O)MAMAVU(;N#@UWQ\=?PT-
M/]#,V,%8%N@%CNZKGH^]8W4W=HTH=N+8ZV)6K.3=KJCIDG>?BG?/SIN\>_K5
M]IV(!)&O1HX!O!N$(<)@A2J)33N*C2C4PZ"+O+M))/S= -:<K]EOMX*^:SOQ
M:GO+WQ<AO+Z%TQ3"Z60896/Q^7S(,BEZU[5V,-2 CI/8M4U5LS07W2A4#4PG
M1G@0@SJZ%[&^WGK/TKV^MRL0 AOR>ZZ]CI<LT/93FFW&')32;'O2[/3PJQF!
MU+))#++,\,#^\V/5B[Q -:EG^)[G.;9K,EFF61L+TRS'!U*024'6#4&V&=M8
M"K(M>K,.OQ+',*BO&VH81YIJ:::.E=U$-5S-T2/0I .;H""S'6/[J(PR[C7-
MA.[\PN^3PU].?C^Y.#D^5P[/CI3SB_?O_N\_[W\_.OYP_D_E^,^/)Q>?%\;#
MEMB*Q@&9< I1-L'*\M8)+?0(;L*K^*@I[O@L7T"*I$#^5@8)"9(!J^U[LQ:Y
M+IM,(L=X<2WN#\,0%C,NE!&YPS+2QSAL]TP;G;?"?=$Y-]9&2)#/'YQZ9*^"
M-13-;\V&H)]OOT:>XU,KUK$7:*1:@16HOA^[JAM27R,^I7!&!V\-;1^K :6X
MV4MQL[$61U+<;%+<H%T;^YKIA)IJ1"'!SHF&2C3/5$T]<DR3D,AU# 8:U*7R
M*"ELI+!Y@O9+4MAL1-C43C23>J;E$4.%,R;XPU8#/PI4SW% #W6I;QD.-E;K
M5!KG)M-)=L,@S"<T:CH=9(GF]JTHW//?ZRV7PF8=87/<-J0T!TPI,XY4._ "
MU7)!YOB^9ZM1;%J&Y3DDMKR#MZ[?USM4CB(+Q#IK>D@>W2B/(LB:0^T@<$/5
M]"Q+M;S(4SW#<54##HF:440#!#P'#I58B/O+H1O4UR6';H9#:Y4]" /-=")3
M-3PC5*TH-%6";LG CH!)S=BRB7WPUMM Y57W2CIW164OXX1#,A80H$H6*]E4
M1Z/'*O0OH4QE.YV,2HET)^71.O+HI*W5QV;HF)[NJIZOF:J%"!#$]375LD*7
M8CLCQS0.WNKFQGHY=\AC*1EUJZV,)*-NB%%!<:"Q;^DFM57+-T&UUUQ'#8R
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M?_9[XW$5V'2)XH7L]D=[T_6#A^667[E:FOV)-\I:A+)>?E&TG2-W13)(/&5
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M$9I+\O^]!ANUAY+(<F1>2FME'P.5+?70QQA  WM?P5[;^UF6QF0'WDL.**.
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MW((VY,<;1R:_J.NR'F[OM[Q GP&\2H^] ;@C -=M=U8F0JX"4S+!-UD)SM@
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M[?T53F44' (*3XZ&$75;CZI%19X@G'A193KMP[94Y;;B=_F%!@V_W>)W%BA
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M9+IP0C$@=RV),+0@BJF"@.8)=UD&66B]]93J[Z]%Z G_'A'^9LPK[5G [;&
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M/8I//&[ROP%?0D_^=T7^H,*XDJO"!4&L9]@D$(P0&VA)K,6,Y,BB0A6&WD@
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ME#M:.E-*(PQS&HTM62HG>5Z"T&\\*5^OO^E9_8]C]7\L>U**8+AP(A)N"TG
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M#N '; ._"E(\3+K-'0&&)@##D]IG+$-A6B>HP5ZJ83,$$#\-^SZ:5CZD!7V
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MY3"#YPS0Y?OS%5"@%3))23B=9"FA)L-]_W*O+AR%\TT@_!4 \U!A<Z4#/S+
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MN&J_.TESN6(LHBLXCOW@G&H5/0NE \(%+IH#/PN ;*=P'Y/Q-&P]W4U"8N@
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M^."TA7D#783+., EU6 = %=Q@ C93[\#M?_\,$CKF:E74!7)H+W\"SWI?1@
M'# '"/T8OHK8N#\A-P -^]N.*SAXZN ^0[1M9$4 $=A[YL?P]2'>YP(53A:H
MVZ^38LW,@$7J,QZAUA+?R$Y:3\3TM+G21;&3=M>0VQ*]-+(&VV5/AQ^'V'_7
MM ,) +R-&%CKUTA? ;4@+5:'"8CB!;]1HO%LF<9WL9%\T[*_$2? MH9P>PN[
M7)9&S3&:@0*K:DU'CQ=\AWAO"R0SOZET<TL=ZJ_<T[H5SU]JLTUU^@RF3S:'
M:-J'-W[$ADLGYFC&>$-U]M, :0>?F]7'!CV:J=-VPB[ A?FDADN@GSHHIZ.M
MG8C074Z+5LVX@/:0^%YU@L $63[XKI[]'=#-C^[4C_H#_'8-G]>E;<.?34^F
MC=?CF9FXXS]/=V=$=3AJ/67/$I6^'+YHL? @'L[)\Q52YR/VEOWQ]_Z'C^_Q
MFFC,/?%:62(X8P0LND"<$#)G\&=08NNI7E-]-FOX#S>'"F]8$%6=<&OPNFF+
M#\CVQ0+'5V'\!DEJ!>MR(1@/IE"\+(7*<RN48F7AG=<EX%KY%:QC"TBWD ,-
MHC#M^7F[=\"1EL11.,ZWTF)'_OBP@V(K^B@*ZW1A2:&%)\*7!;$B.$*ECU04
MGLJHMI[F._1BT=#/"ZST4O9Y(]RS7L<^%UEGJR1V,OLLC,.C$^HKBON2$>R_
M49*TYFR%D@1L^?$XZ<.#+LRR= 7IIF>S,]S 5"?-V8\[=7<A,QM?;X;8-$N;
M%=6]<6*8UM8 K+B.&,NY );GI2]"%%8ZY4O/A7%&E"PWMK@5,?8(![U]!_/!
MQ(D7[SE'UL,UB8$I(G1AB'(>?B@I P@I&CF[5CJ,L9A*H7E)84N%+S2%F]="
ME\Q(H7QQ>0[AE>_Y *W6UM+\?6YH/I <F>^^4BUY02F51#(&\J0(E!@G(O&F
M]#0JE>LHMYZ*-3G5EZL?#<]LO8N-.=[PGX[;--R_E4;)CSK&4/W,L9;XUHP'
MPF*MPMT, %LT"= ON,S5D/'B')5F^$]CU2PJZ4GNM,^;3UEI'MF*F:^- 5K2
MH897EZI76!HYYS?I9"#Y+0\%HTH*QDKE2J5*P0L.K_#2]#K9[=!0OO?\Y7NJ
M2U,RI0DO"DF$X24QR@HBHW6<^9PQX5 GRR]6E_V\\Q!\/M^68H4$\[D)(\R&
MAIT FDT;+^C:",1V$PDPG]$KV4KFY*G-CD:@A [QBZCY32?'HS&J);.(@QW!
MKH!41W4SR*R9ACCL?++M+,7Z%&@BPLY;Q8><CD>@"25&M+"7YLN#P<Q3O'C&
M=)B%L8S)2[ISM)/50"4U;GZ[S3Z"&T4XF,]9F+@'@0FK$R 7[AK#8.>M$P7!
MB'P07=P>%>U%+=6-ZL8?U:CLF/D6IX.(\F1A?F)=I6!%X\$:3ZJ_S:+_*7;^
M^6:Q3ABM9M/MH \:\!:@B>E<MYY<]'+_UR75!<#L4'TYP^F087C!U6).T_B4
MOX/O=-1G<)[?QL!]'S/797N'N^\+*_)@K2::JY((%L$25D*10A4&[J10GH/F
M,AQ=U%,:G*@:VO=?Q;2476<#6*1N?A\7AYVFD-R5\1T1% .IC8V*_&5\H0OF
M3&MHPK[U+,T.;<]9_N()(/4Y;J>JUSX)]Y9VW^W-!F>F;4;G/%XY:,;= A,]
M!ZL.#58X;GW<<+.%D:UI"&V7=]GD'"(W_&1JS$7\T'#=Q=A+\YD$1(.O8A9T
M1Z;P.23#Y73%K^9Z+;#&=6/I+DO;NMUIBDD5^A<H21YA&D!4X&8/4O1P=^A!
ME4+3_%-X-0#V^FHTJ-SY8R/<#XX=/'_Q'IBDEUPR(@L%5F34D5@A(]%*EV6P
M.7=>KTY'O,J=WX*LNW2$U86Q-TGZ)1P@%I%@1B)(B,,Z/ 3A_M<"<VJL&5.-
M6T;D%I ^,=A&HB?%:=0802N 6="GFICNB@:YVX1@<84W$V Q!@<H/QOYE.W0
M)("T\\)WWSSK)H5G$L-&BQ28I<1N^@LL,@+&L_C63M8,*V]3-#Y5==H+,"4<
M7YY6JO%+[<8O'C'E\R2%U7=^P:,Q9F*@@W$[:[[6CKA>@%47>3N#(S41L92A
M,F/[J,DV?/_D=# Z#V&>^(Y) G4U"5T2>,M(.^\^K',4AF&< J8IS:1-*V\^
MU@BMY9V ,3L!?HB"(1TV*3U@P;Y^\R=8L+#@TBE 5['-:/5TI75SWC WS?]W
M.L(_9]G?Z]+W<0CY:-@^KEUX#K>=[-?1.(9J,AVWJ0>+\;$F]-G&XAO?P<*M
MM,26)I=WMG@7N6LDSJ)3^[R9U;T.*NWIJKI&+^=TAB8OVAMIL>G5=.R.,=""
M7!V!!:+731M-=CI+P/C7 $0>>>..1ZC_CY)(( @A_,#)R(?! JXLYYRT3LAV
MDGK]D<1QP..!4$U1RH1GLT2D0147_P0N@PYAGYU78>!G.25-SM((J1,]M^TP
M9< Y<W3I0_!L7?[3TMG^W'D#"XP3%9RGC^YDP"=FGUW.E,(-SH\ZPFC_'#L[
M=/D2C)O-KCG%I1ML.!JB3GM"#%D8##,LI$<MK -OCZ;C%CD3&J_11Y8FZ/:9
MYS\L\YSWF>>;L9<^\_R>;?_ZF>=?S21?R3P7\ X702O!G7 L:J$5["$$RK1T
MJMBZ+0LLN:I3F*=)IVN,J^;G(YY<SPX.7[PON'-@5.5$ES''GCF6&, +4A:2
M%67P(L>+O-S6VBSKY)KF6,*)-L?R(=A?RWFUK4Y<9Y@4,1U,,5FR5:/GOI>4
M_HZVF O5IZYDU(^2ZVD89@&R4U/Y+#EF0,$>);!5"6S?E=2&C_3H!QN//J>\
M#5"Z?G!ZVU?#Q$W_Q=W7+][LNLE!Q'5>-=6YX]=A4(7X*S#<W90C^8ACQ0[V
ML??>Q))::B,)0J/'597 3)0$9.>%,YQ%8/];3ZE8,UII%AN>17HZ*&<-F#.$
M\X*AE:XDV^T2/ZL3.QVO^"S1.WH<S !3XQLSL3&\6B,PT<.@\42TV=JS8)"9
M@,UKIY.N#.39P;]?/B=4=W;TF:DO6)UH:(Z&;6#J8(%&KI4$_A5CXG9]E TK
M/#2?>^%X</C'>T&##:84I  0$F%R0;3BDJ@R*$Y+&@LN'ZQP;$L/#C&4^H"%
M8TNB3<1XSEXP=MPDY\TSV)K2O#:2DJ2620FSJ2ZG:[J1%IZG/K8-3#&$FY:L
ME];$@I99#*?S6<0I>K;25["6!BM7AMC- ;T? 5C,V(R[2HCF#1LF9QB_P56P
M5N4\]8EHT_8[OQLNAXZ5M,[ZK3R8 //,5]N6,<UO>'O%9=8$SK#2!N&3'%D(
M%#,T@_.Z:FJ$1F@:56;0Q.$_GX[0GPM*4SC!Y5*EY?8<"Q;K[3Y,_5%R9<^J
MM295XWR, 2NMFKX=]23YSV:[S ;F+!57':5L^:XP"(NJ)N&HNGB(SJUEKH-V
MS3$7BS/1M]D6-0X&HS.3<,MCNQ4/JB#\42/B)6G;^?C7/FBRVF<%O> C -F@
M^AB2VQG>;[O'I/RO-0'3F2LXPGZ'1Q>.W+FF,%OB8X/ZV QF.PGO>FH_A#;]
M"[XRP?P++*<<35-R1:*.-O\#L3[[Z[@:+&L.%E6.3ZD@)H5'VWXL #$/]]PH
MJEU+FL6+NUBGYA9E?H0[&CI$I7HF_6'+_E- U67I&NLV::0.:[8,JTX'O@N9
M=JEKLX6Z(N O[@!>[I*)NUQL]&S.B]&P*BO%=P$7[E8KZ7+*NGRR7CDY>/[R
M?:'R4FGI"?.HG(B"$^M+34+.RCRPF&/'\H>JG'0HD0%.9 DI'H+L^I>I@7QF
M@:EY=FB58F*GTY2=L1ANZX(7I M>7(B_-1&PA7#:=%)CM!2>L-.T;FI^/J\&
M:?E;??H%R84/1>D[[UNPM%D4JB"6V@*-A9W_T,0-=QS\=! .XE_M>7>;X^ZG
MTQ[$A']U<F(_:J:4)A9QSR5@1.Y93D00@=C2<.(,#3FGU@?]Q=2->T2L*28\
M0DT)L;EJXLZ8, H:P$P3:]2SX2B)=:P=:E^SB=)1!_.7TUU#=(TX?O+M_ W@
MT_@Q9O&]U"L2,[K,:1V>=+_\XJOZ=&#.GU3#=-KTI5_:Y=N@($;!5L=#X(4T
M;[<!,LUW<JHQ1M8.IV@?W(;/=E+X;*7U9?.>D#NRH)>^G>]<_MZ7EJ5TAW[C
MLE]^3U!V?S9;E$6_V4)<:=FOC%99: E=-J'A1 75$,OKGG"Z4ZP?BW1QA36-
MG9L(^H]I8*Q66-T%;2O%N@_GY?NOFDR,%Q?*]R\=O+@6:NO!0XO["9^WP+SK
M%B9=Q&,)'E=$I[L;R*.^JH=?,O\6S-S6<U]?F&VZKLGZ97V*OS24:/,N'%7%
MFT#X*P#FH<+F2@=^9("CN@?<MP%.78?=KAG*%F,>W74'H_V@F0+K#_U\;E4\
MN0K67';FKW/DJ^#2UR#Z/6O<&,+WF[SV)F]6<;FK(1QM<<**LZIS4<W=2MCO
ML*TP3.ZN+&789O!?8Z^_>/7F"O/%'])@TP9&MS5)O/.P?=&O=C"_G^0?O>]9
M-LW4DI/_@<_OL7>'KT_>?3BB[Y[_(?8_N +W>O#7KX.]OX\^[Q_NT?T/1VQU
M:LG;DS_%V[_?#?9_>W=R\/S?'_>?'[']OS_2_;]>%F__^A/V^H+N_?TG.WC^
M+NZ=ST8]%?L?=M][$0M="D%8-!&G/>7$TM*1(GJ>EZ)T7OJMI[*X[DCQVQO+
M=(U1PP^>\&YL%'A/>#^0\,[>*R,+7I:!%-H$(@3-B7:Y([3( W5:4A\X4)W8
MX3W5;1[5W=@H[Y[J?@#5S8=TA3(HIJDBLN3_/WMONM16DK4+WXJ"]T2<Z@@G
ME?/@ZB#"9>,*U]>27Y=QN>&/(T<0%A)'$L9P]=_*O24T,!0" 1)D13?6L+5W
M3L^SAERYED,<@]1SS"N4#R=$0FT2'.<C0XO6]"ZH>PS4)2T$891XZ157U)@@
MB8V@HSB>E"6D0IT:HTX7U#TIZL@%Z@BE09I 4,0&4!<40\9BAIP%*1BP\CJ1
MC2UI-OGCH^YY^86N1MGV123%17#%*/"C/C-\"P/V5N/P+$EG"9;M](&2\]CO
M!3LXN!45C0)P+O'1)$ER(:4%2*GU=M;R99KQ&)U / J&N# !&6(YTE1Q$R/H
M=49L;%5QI_2W^Y;MO)HW'K18\6W=A 7F2S\W5F"^$C 'C3]8+X)5*$K&$4])
M@^[!(F)8XL0<L\J3@O&7@?''L=H+FI>-YHG]3F"=*HTI\E%B0+,W(*R=1=:!
M;2BY\IZ;7&1[0?.]('G-D/PXGH""Y&4C>>(34(RI1'U"WGJ"N#0>:98H F-+
M.D,]"]1F)%\^%OYT2'YA.]\7H>C983#>]AY$?S(Z<3:_,SX.6[_=EO@H\& 4
M1,Z.<XJ)DQR2/N[\K8.1GB7#/=:&^G4<5YAM$6;[/.M8B%(1'(A E)F >/0*
MZ1 =HE[[*)2@P9F[;*DO#S-/MDE18+\2V_D%]LN%?=Y:-%HJ(;,?T2*N&.@R
M,3"4"(TYG9:V0=QE0[]@_KEC_K&""0KFEX/YB3L"ZT19I %%R1/BV#D$!@A#
MP@ 9Y!)[.BK O"QROF#^:4(9"N:7@_F)XX)&$9@#.:]=](BG$) )G"+A&<>$
M61)4EO-T_3!?N3=^K8YX7Y?4Y5&R5*_P ?^WHYKDTVZ241!%Y2[)"?#KRJ2C
M*E5ADKQPZNC^12C&U8?\IXNMC+)@G$ZR^U1U67(Q>S1VSFPV'BW=Q1MX[OBQ
MGR]<0=NCSM:%,2^Z^3'-I^EYT;DPWGWY%I@$MN<6*:N /#"QR#!'D&*<N@ $
MHI6:SY'LI"%!*FJQ]MQIZKSFE'-XH:/AF,WGSMBI,D1-4I1=N/#&:50J63#.
M6GED<VJKR47#WCC9W/4+M$ZI90>C7!<Y$<5\?OO[0WLY)'%EENI_'-$GR(Y!
M)+UC=@Q-S8.D16!WRV/Q3]DQ'B:5QX,T5LC;989XWHV52\Z.4=)@O,0T&%E3
M>H0\& _<UZ=*A7&%BK_:\UZR891L&"4;Q@H-W--FP[A.<3=S:;*0><C*C#>:
M]F^F+>K+1OVL/;_]OY^G[?FY3+AWB-BZ71*D9^D*77JDPSU]%,^C<,?(0?J)
M[7W=/6W]\07#_=G>(7R^XWGKZY_?6_3O[TWZX?3CNSUHT][W>0?IWKO0V3M\
M@_=V_H*^A*/6'^\/6N?[T.9\3WC6X1O>.OK[L'7T5VJVI^,?OGR3ECL7+"QR
MQC#B/%CD..'(JV0,B2J)9#:VY-*"NVZ=0FQ= CA?]N;(TH,@"B,\(2.<?I/!
M2J>20\1SA[AF$3DE,2*6<,4=88GXC2VQM*CM)]H=+8RP/B$2A1&>@!$F@1/"
M&1RH-LB$?"I+*Y4#OS&R5#B.J=+8LHTMO*D+(Q1&>*@ BMN<URP\\00\,75*
M)"0K!<5(^2A0GF=DJ"3(."(H48)+Q99]>O.1XRPN50(O%<.?NF(X+Q7#5Z,M
MI6+XFC5_\8KA3U8!?"SAW_?Z, [=MR?]7#KQK-K0K>7'X$TW5&]')?=*C;&/
M.U^^.4L=(\XB9QRH[LY;!+J\1UYRX5147#*W/N5\KMW0O;K&V&BQ-,:KY3E4
M&*N*%IUTJR6?BP".NC8N2S1??;&=)7-=D# 7+3QQ U"0;;^J;U@7/ 5P3-UG
ML_&^JF;:&\29JU]-:BY?5$.*85PC\:H&Y:"SX0B/U97#7N/+YN?-1LCQ6/U\
M(+4ZMCHZT1I_^@/;A1>Y1F95?'$42QDFU<F/ZYB-JO#E-34Q9Q]:/Z+^&8I5
M"<_II]0%*]-HE5RT?#AAD8:].#Q>W[RN?E;W_(WW)T<G]9/JBNIYDZD?#V"<
M\J[4J*[D+YW>8/"ONL+T(![;JD;I3*GISSF]UT&O R0^&,U<53AM>/9$9=*F
M>E:5P7X[W:^ZK/!_H%.E8-J[W6])@I@U0B <K4><6X$<UQX%G&C@,!4VK1'#
M+E P;11T>= [K8EDM&2JL-1K$'1W],S$YKR,4FI:;DJN'Z:&UNU"&A>/._ 1
M6'N]LBW6P6[.=G*YY(N@M\9583^+]/M*-][*]?[_W*N+J^VA_.5:%^7)(,SY
M)SVQ6B86O,&$!V8,#S*XY&ANHR?FVX?KMBYSM7!X=<D3>3L)>I4Y4_/F)&M-
M*PX_IAW[\YGX):&E1] &NLM;7W=_ML[_ZC2_[HI=^D$T#W\_:AW^>=C\VCIL
M[>RR2W[)0W^V=]0\KPZ/P?U;T/Z]P\[A[N'WL^8?N[1YU/P)?TGK,,QF;V=,
M,1JB181ZA7AT&%FK,3+48!NP9XSR'.!P>4?S4ACH@M3W.$EN4_7?6M'N*/SZ
M&D7A3BENKQB%==]+N4Q42P^_NI)RWE_8<SN]O^)Q#X:JNS\FJ3$?U5,(7-:/
M=A#?Q?K?PE(+L-1TBMN/[]Y\LY)R(ZU%.&D@JF3SEBN-2 FI@_(8)COF-%L+
M9MZ^+6,\4DKN]5,2*Q%^M[S;M]0,"REE4CHZ@UXOH"]5EQ9-Z7Z:TB3V"Y[Q
MG7Y\\\U(G/-A1,2U<(B#]H0L-0HQ%UB*.,),AXTMLO"9^:(T+=56G3ZUMIB]
M.NK[C4D,[A/DOG(C=WL[=YE#L]H$OXA]S!1AGDC@>66YI=[DN#TEM5<,2\EI
M;1]?1>S%/EY)UF^U9S7/O"E,)4V(>&: ]S5!SD2.J',B61D)SIN[;)/<PT1>
M(K0>,&G*_/N'W7/Y7["A^K4E]5?T'3L8M!.T?G:%OXL#WV]79YS6<VG??9-E
M9YNT<IX@:$=KY\TI].,;UL%:&&;$O:\J8&ID'$XH,6%U((XS)M=GPV7!+>WY
M13)X#GO:XSP]QQD,%[N\53#F8"J+3O^B[^-,QMT<%-HX;0\/1CM064P,QW<
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M9Q%QKPURVC P#QR- &R7N"I;_ 7.Q>9?.Y!_N0 Y23%206%1$Z80!VPCAVU
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M[6W4ZG["^Z74#GT4FO'3IFBR42AG08++Y$&">X:T#Q31I+WV*E%G4W$\OP
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MJ2OZ-O?DKCPK_W7N%+QF=4B@\FSEV7K6=$EY]O9I*^>32=Z3R!.2K8R.6 9
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MMJ8(SEURK'M4WM%&VQ]T>T@E<;JY@ O5"5M(ZOTE?O^='F+AF=EG]Y81G.O
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MJ;QP@'> +XR_/40DO_7ZV+CNK^?]/G3CQ=A(O/?M;B67B<GE8#SZZTPJF7I
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MW3(&[]A$L8-?M',[CB)Q5V;R1*TMC2U!N01Y.,.&QE"Z,M7*JR2 8>1N;#,
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MGV.L]IMO;NW%F&C0F"/%A02%5TMD;,X@U:!04FJ$\.S=1S*C<OOE;@,"G)X
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MBZI$^FL+ ZM*8;PB8,AA1))+@0VRS'G$<\2]!1)&4A!%X"]OX]Q+852@\-I
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M/;%D+/B@EH^V ;'8#8@IIX=RA@:L>,@A$<2-U&"MUB ]#:L70JC:"D \P6Y
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ML(1<XS\'/@0164T[KXU..'NBFZ1KDJXSPJ5)NFZ6"FJ2;MY4/;&">6N3EUZ
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M\/M^W^F.<-(Y#^X=CJ"-[4-'2[1MW&[\A\@1%1826X,Q7/U9624A <(&(T!
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MP>9$<5IBE"(H!MZF$ FM?(,W#C]HL+JZ6+V=@\T-@F\/P3,%GTF K[8:.:E
MVIH</V1I0(YQXIW F"NYM /-C8/_ZOC[V//0%%OF%]M1K-(^3PMJ-=[].U;T
M3R?C0YX+^/COZ4PTW',M[GE]-*G_E_GGI+6]?K2;B.1)YNI_P$.($Y=W&CE'
M.C LP :(P>38H)LG>VQ\@ZL+V]M1]QO8W@)L06? *9GD DK8!,2I!K *39"T
M5)GH)9CHLCDI],@1>U-O?H/86T=LZQ2QF& :*?,H$N41AR6+#.%@IVLM<A%&
M1DF.T&M."=PEV+9&G3AX7O0:O_U]E)#(@]]PRO4XY=L%Y9U*)B4.#)E$017
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MC?UX]WB<LQ\-938&@Y&63B+.&4<Z"H8D=C8 >29&092W^TO1@1N +'*P1!Y
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M65JIO!4@U,HY_-LHAPB_K'J5%W39&U<1PO!)*+^^_ _\F/;EP [VRE[MK::
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MQQ:$.PCD7/R3.\\:)?EF$[C_;M>!Z0BBUJ&D6*4D*V2H-\"^S)E($]@HLII
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M7CPA5+WFN9JNUI1&)Q'0$<NIXSTR+ D4+;' 55YI;YZ][/>FIYZS;/P>^<5
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M^+B;'',R88MXROFP<?1(^Q01I91['[SR/(!QM2 !8P'+OUMIA+VI6,Q";^J
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M]]3.J4_0GT50J$V[LPV8.I;S-UFGG:B,\0<*XTP#^8&%N@258PDE8!N5XSH
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MW(H LI4)')=6*9M5?:F*17SR6$1BJEC$*A:QBD6L#MCOZVOC2FH.UB[WFO/
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MJRC ?FJ?PQM]#@E* NDD(E*@OJ7DE8L&[&N"*^Y\K=SY",9UQ9T/XLZQ3<T
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M@I*'Y)]IY&#0+._+?A0W%,!92QUY)LKG#_K-DK3*V([20UE.K-D-*-M/Y\6
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M*0N5/!"17J!".%F6\I+BGSY[MP*A21"Z%F=QN3,5!-T)@J[4<U.!!]@PC5(
MX.$D=P3*,1K&A&0BH5(:-;N9U5,6.7E[2M'W&QO>O3%EZ$YYN0\'HLN&.[=
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ME"Y!]'$&$)HP40T;W)L.:.[WWG P_#9(74GG3J3#+LH"2I!8BA^B+.,@!"6
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M-1?M7&HMQZP(D0@"E%@)(@0"5D4'47KKC=(\2[NQQ?52N7$U*+*6 %^=\J@
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M/$@PAG @C$6:C2:1ZI(,OFDJ7M<7KRLHZ:AX;1&O"WEH.FA)$JZJ) @01B=
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M!R)R$P;)4.9H PL^4Z&9$*;I1DF7*O.I=+&6=+&Z&$BEBR[1Q4*K@&P#Q84
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M1?2S$'_.3-%(*0CI=*F+*_2C$R1*$B<LI\1<0S^7^T-6^JGTTW$/;,F(<?7
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MC3XZ.G6CZK1:?:W18*V62]]]:A0<;5A?E%1N@Q>(C4<FUY1$<47*7X5!.*O
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MGM?JJLXV:U:[LR=]U;5:6]L7PNY?9]MK-5OG6U=L7V 0R&C^YYWY;HZ'2*X
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MF+A*F=ZW;:<XYJI'PDZQQ6IP9:/ ,8"3JE:@P&E&J=);F@&P9$V5*N,OR\K
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MD<BY#]/*#!99%Q-,MF##M*B1!5V!OL**GH 5-048]V!BIE;,%=>269V=(5W
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MUR?!^,9C;^;9 PHBBO&!88KBCF:.IH5$+:3:UAP"N8"-T@BT2,E7;N<GO;+
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MA/EU[X/2K;ZMSD'5&UC:*23K2!K?2(?%*[<!^+,3\OFG_P=02P,$%     @
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M+[W?Q/5 @;>),/\^6V":?YQ-_Q.KL_LSSFA)K>I./+%.>YXSL$@+B&E90HV
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MS >L?H_4#, #@Q2D,B[&T*O+]'Z$CNGBHCNRNFJQ(=:ND[6.^MRF+:=2#"_
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M;MTW\O)7W^'G^6(U*&VNS<1-#9%6 FAJH-RV?PF=A9.-RR2!D^FL XM>*^:
M.UZ$T,YUB21VBB!^DS+2\DS3D^EY N.=LSV[N*J_5-8U+4U4 B. %I-").?
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MS[/IYTU)'2O!(WG1',F-T5H&%HQ*S* )X -J=%T;RN](YZ@[R_?=7-KHKC/
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MHX&([B6K-=-#P+1EJ/8BZ*+^G\^6TUE->T__/)M>E(LY0 QWCC-<!@^3UT,
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M#M^1]YSA>(+LL1/O.O> =;_O%,<3Z(.K^SQ\4_\588G_]B__/U!+ P04
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MT&5GT1.6F!2*:ZEDJNHD_])7L9J'TD)=OJY_\K9I%TMTES@!$8 ZZ2+)R:!
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M0*A5S&7N7:Z3<E_C].+H )"8K+>*"A(9E*QGU"DGDB?X.1,RRF!=E330)Q,
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MFY]&9_8W>@94F7VHJ* J)<!PMCR(_PWFRRW5Y>BDU)8XZ60IY"6(,YZ2I(4
ML"!5K*(?&]$\ :/F*-+6BZP<+?$*1LS60,$[#H"QF@'H1!1S!B<=%R4C%-$@
MC<+/*:0JMVH=L'W;IDS?Y%4(WML*\8Z[T 5B38.F \;3V#2]\]M5?XXD9\A8
M]#M00V)&, &$>8:+L_5 '"MAJ\ZY&,"*$*JXZ2?3GT?LFZ>@/OMP4JE&U +2
M<K<%JFR0P1)/>>DYS0VQ&7=R+4TH]=-*,$$-%5G#,;QETSM7&TI#'2KH"F;-
M+R5,KM2V?'WYL6T^76^]2VA,AZ0]JGS4I59--(IXRR*)H;3;]!I$KG(LLP/3
M\].'O@BHX20O8V]OTVM74;AWUD5ON,5U,1!O7$F] DD"C>4PDX)"HQRXJM([
MNPNX;]OH[9V^&ND$6S'>>;VZ8*QZCM<!Y(G.\GJGN+,.'<G/H,O5W:7:*1E!
M6[3;;*D:S ()404"UD;AF:; Z\1-G$R''CO;>Q(JM \M/:K.=<_(37E6*XQI
M/=UDN35K[IDTFA(;&252J8AF&Y6$4@_*V!2HZQ8@=LCH)SCOZYW$9D@&>C2<
M2^/2=S!;[=B+U\.B9<8S[M*1!X?VGZ+$)S055*!9\>2-[N1/=^K'O#;VMVGB
M'$M"CVE@:U"6KT(7,'TW:7^ 8OCF[$=QLIG;(P3:XT:Q&11-5HK()-&L1%,(
MEDA@W))(HRRU 2-/74K:/"5V=_1?KT?N/G+LG=1/X]EBJ<*]I6FO.X#]V+9-
M^[)I6UCL.K=IJ:MJG$IG],@%\3D8W'IBZ2"@>8EK9I2:['GJDJ3<D??] 0[;
MQOM(/IL!R>C;#BA&T;6!3!U0;@41,N F%DP9/V62;1!,B"!=I\9(W31B->HW
MO/<?)/@>4WEO0*Q*O7> T?M^?SO^"7;ZPQA8Y_ (\?6]$=R!$Q7-$763T" D
M+BDY$$O1R4"5!)62]L+UM[[79G'7CMXKB?M(K6?R?D5)75Y=KFJEJVPH0"22
MES]42,2QTL-#&\.\MH[)WMRQ>R,/O.\>*ONF#\'UO)7^ZC_? :*!Q<P2(UY!
M)C([1AS7D8!BT7D:J.[4?* ;@W='_@H9/%AP-6+E5CO]BZO9> JSV?OK3+CK
MCCK4!^>2<<0D;4O'-B!V 3/QD#A08*I2_[X=J+Y-(ZI_PBH4MEAB63D5'<#4
MO 6ZA^;$_<N.9VM=#XX6=8W5Y!ZHH'.B%!=(H8J:!XE.I<^>9,-DBM[("'56
MC_J\=^U35IGV?23<]R7,J[$_GS:S^3@N=S(CI)69&P+.*R+!)^*E+YNB!Y,X
MRT:N>=1;+EC6GWR"9L"'2[GI2T1;S;4>F\(<5*E]&><=%I>-0Q?,WSCX:8KF
M/RZ'M<+YC DK/3A0P"77%NUSBWY:%DX[9[P_K'#^1AC'+>-HK_CS\Q;.ER;-
M<HA?;BI$<$:%YZ!("#&7,"=*/$A.<%[2,X7K6)U6QH\!.T5A+IIDRA9*EJ:"
MXH=YXHPUBP@PSWW"=[Z*+)YT8:XJFM1'K:U]V*H0O+E%'M=N0<A)R%*')P9:
M[L>+6X!>((' A-+,HKE0)3!O%ZBAVH57593>I'[J.C/E^.!MVZ2K.'_3OH?V
MTSA>GP:&D%1RS!.9HT&/,B?B OZ:@PXBE,Y+NK?;C$T 3M4HO#]FFQXEW/-9
MZ1+/[ Q-@FM$LY5EV@%4WY<86]$,?Z5Q/%$/6>])RL.I ',<1 HD<(GK8M%O
M!&<(8T%(4XZ24I=-XRE2O^,>9"CF]Q!NW_[UKRB->#7Q[:T7^0%FQ?)?Y1JP
MD*ECC#!NH833<>)QBR26*\&BES:8\)@/UFFD88_8>V*CJ27*'JW";>#^"UI(
MXSGZ?B]+A&6[!E9Q[\N5 Q-2$,D@$)^D),8+J=!^E8X]ZGL?-/+ Q33[9>T1
M?>A/Y .L S_#%&;C\XOY?90>&'4Z,.*H<T0F:8EU:#$#M2YQJW )[%:SOO.0
MSUDC>A!RCR5TMJ%\V\+4S_UD30[6^"2L)%8X7"D];N-.B?*KI=(4US?K0S5A
MXXC/61&.%W&/Q0>V@?PGQ'GKUR :%ACUFFC-<-6**1(?8T*+SFI'9<Q _:%:
ML&&\YZP#QXJWQT2\;1!__?+RHD%KZ>6KSTN V62=3.8D&Q5117'#<HPCWE+7
M109 LXD?RO^#T9XS^\>)ML?4A>U+5(._CV?W14 3Y3H[33CCN%4YZPCZ02B"
M9$M7 9EX[-:UMNN(SUD'CA=QC\&LVT#^.$W-VV+(QC6KA6FM@HKNNO.8]);B
M1B4I"51);XRF#P+LNJO"MD&?LS;T(N@> W"VX;SNTGH/84 G&O_3),FDT9=)
M"&[A1=-HHXHAV/7 ]^ZJ\'"XYZP$1PKW(?T'MW*YSLF\\.VECW"%T/SD;)I>
MXM?*CZMCE%7,J#;:![1<%:5HN9HB B8U,6!DIMRF&&DG!>@XX%=_?%1#L%M/
M"4X?W1&;:1Q/QHM_UN17D*'%E6YYLS)\O$<G.*>* -E?5FLQ(13 &AU89N@T
MNNB"*FW<$W="1>' '!H3LJ_4JNO5JJW?JJ7?T(JT;?S3:$XG::RI2O;>IU2B
MA4O5>B&=UA'=C22-R3Y3<9BJ=)!+==WXJ6D!__ZZ.U_\<MME=%%(8.+O9Q'.
MAE:= ^&=1K/ZD.6:XJ$1&Z3U*FC/T:.1EEJ3*/Y/:"]QWSQ,\8Z7ZCYZ^:MO
M_\ GA F\GGZ"ZV>^1X.N7?2%/$25'GGBT>SO@WB-,,L!/(YJK352*_"0&4?N
MC%'9)!='W;'W)^-%3$8%22^?6UG>F]"O23U9!@PMS)BIEIQ%%QF/2;$$S%GE
M["-2?SB/_F3_DQ^W__23*\A->_8)WZ/R1?RYU&V^_5;X\JO_;_SP^H-%/*DO
MQJZ?S?!=7GYZQ.([.,;*.E%;JFOZY8Q&-:)<A9"DH-')E++5P7BNE09X1+\J
MH#TR621>0+J:P)M\ ^>G=3B_W,3_9323G69 DA*E9[@KH?-4$0 CLI)>B?7+
MC)Z22?9!>7PKUME%\2_Q?Z5JY2<<I22-S%_ZMOV">^>"O[,P6\2ZCL!9H8T4
MQ'!#T=_T#!U: .*S4*#!>B:Z%#/9OS+:/BA/D+Q13:\>-F.M15>%T.-.8$=6
M&\&EC AR$>F@.0D:2K$8%@U3:$C0*@7Q.Z$[016U>@P?HDM[T5.C8.-&D#<[
MRVV>ZT@H'EG@CE"G4KD>1RE8B(1G*2 )'XVJTWVN*\)O3Y>.I:G':)85T.T+
M](T<N$HY)T 1",WPCR2)LYH29_!C&Z1PN4H2Z>/0GO/.UC,Q%9:B=82O(-PQ
M=L\NFW9^W21]-G_A9Z4=@(H,7ZE T"<NM2Z%)8%Y3Y2FGIED++@N%2J.5J3'
M@ ZO5GV3_8@N]<K4\)H5X_5)%:2?VV8V^WW:@I^4"?R,LGY1/"HHB68I4^%E
M<"0K6HJ<&8Y+MU?$.J<U8UIE(4^@;MW0?VLZ6('3 7;+KI/X!7^[G003SC+M
M 0V+C-M"Q+?+6P7$@0R!^^!I&&1#/0C]7XIY-*<]!J,^+J/[TQD)$#917,HI
MU^B^R&"(38JCRFBO$J@H>95#G*X G[UZ]<),A:X2MP>6LZ7C<C-]452X='!B
M&21: _B'+5V=N$=#5IJ4A*B27[\=TG,V_'LBHN_,APVP[MJ-(Z]3U,(IPDWI
MR21+Z(V+AK@<*<_!T>2ZI;X\,M#PU/=%2%-)FGVG.VW UM$ZXR@/QLRRHK 4
M:*>A=68(6%,NL%DI8GRH#CQ5LWD@[:C P  K1%?CR1E%L^!$Q Q$XJ))'%>:
M!,,A,9#>KO> [4%O3FS5GEIO#F>@@OGZ$/B(1A:Y=VAS28Y;J!:^G+-KHJQ2
MW$@J'*_23/$AE*]>-WJ2<@6CLXM5=5U)I 2'0_*69"-QW@(26M_.$BH\"P:M
MXTSK5#+LBG"H,CW#&:)UR#EU 9^'+\--QRY*O>8)US\:0RDG+"0)TB@2-<_2
M.*:5KG)@^!#*J8KY5*)\ZSITD.@K'#C?1_02M\OSIEV&4Z[RS#H@K%E*]W&(
MIZFO>RR9.W6C-R9.HS-<HP_G#%I55*(7QU4D3D9!L@_.B](-<#W/Y^O6E4=J
M\@ZO*OL04"-8HVD_-BT"NW_4MP+'0$LG(@%$0B3+$I=0EH@"HTT("9BITP5X
M%ZI3&KO]T+@>B=$;!Q4BPGZ]FH[C^*.?O&BFZ::#M3=HDU-/K"EQ)U0*XJT0
M)'@;N0N&:JCB^6P"\^S4X6B)5U@F?G__ ;WRV57[!=VRGYM/T$[O].K"V4KG
MDR+HCADB,\X[*!#HHF7@"A65KQ<9ZT<==J)Z=GK1'P<5KIU_?W^+Z.P<IO'!
M[=&J*$:R)BI49& AE.KFD?C !>'@K:>:YA!4'5WI!O 9JDT%9BH<L&V)?"PF
M&##.,KA$C$FE X+/Q$>*.V*.S#$GM-%UNGMOA?2\O=^>J*BPS)2FE.TXSB%M
MQKCYTZ6"=\%>TS\^!OQI/.>^%.%!3?:!6:Q@$1TU!\^%D]E2HNVBR7G"];ST
M>M$A.N6RU2ITJ<3]##3P$7_\*2K@/N152J]8(A$JQ. CD R .S83"LT":4BR
MW@0E#>/U<KM.92T-1]V&3?$ N5=*TGHX-V-%2#H[PGG"#3]D]!49;OV116<3
M59+6"9NKOEA\!7IQ'!M#E/G9G?9;YK V#S]-O_KY\N]+<9B['L,BU7><QVA@
MSG9%#U;* J\+MW)"^("R7J\-DY2AX).+Z!/XR!<-YHRDBV)"AIM'<L/K A\R
M31R\"I)S](TD%40:&4G@C)$@I"M]YY5/^50W];_TE2:^.ZKWEK;WX^GY!):_
M?WGEY_ PV^8FML.B5\FMBT0)7AKL*$I\XI)0'RS3F@6[7CU\B-CLPR;SU"-T
M]]'2_4*Z!R#_=+GIULID%"-&)(8@G2KU]00!M,F8@!B@3M>Y)YJ;?GI%."R%
M?0\6!\CNVR:UTDEN/'TSA?\#OKT?'JV\T88[1TK.#<X@:GQQ/1#-G+<,4A2Q
MBAX>#_TO)1V:_T&3YN_/X"S/H<4)?+AHFZOSBY_&GQ9SN9]QB]X,R@R$1673
MI9^%%L2)H-#U5?@^2J#&\E,J<Z=9_*77)]2*P1,*UR93IK"<S0>8;IA,I((&
MBN:5=,(0R77 '8=*8BGS.9N($QNXA,0!L_A+Q4^H%7VW[W@L 4LQ43(?,N%.
M2"*I0VS%/U"*ESKB''+'5NI/+IWMR2A5[SSTV.:C!V&M1./0%E&9L^N@ JFH
M)5Z4XVW/K(_*\N2KA/D=#_TO'[XW8D]:"8QEXZDQG*B(?TC-/7&04&P4' 6J
M<195\AJ><"6PH>D_N#S8/MP]%5_]9AZC( Q75 B20DECMC(@>OPUA@!*!Y^E
MJ%*#[CC8WYPZ#LCR$_3&;R<B@^;%Z"3.+RK^E;)7*2F2C<O4&R:L/.FQTJ,S
M^$MS!^'^"?K;MQ,Q-D291"!&2BBFN"X6LR'>>>&M<=S "2K\[#&#OY1X$.X'
MJ2$T<DXH"0&(A<7A54!$B7DBO& Y:D&#J7+R\Q32^$^L5D>R4<&;[AY@G0$M
M",8Y3K0D7*18BF%Q0PR3S-*L.4U_I?OWZQ'7(>>II/OOB'7-P$L?!T8XI^ZZ
MDZR75!/FC8XRY!1UE8"5KSD!8B\5Z)X L0\53RWLO OVOQ(@:BA"G_'GA[#X
MU#11141LT/8#FW&7!X=.3;$A4C!&9*\3[@7?A@8>G@!Q,@7<A[RZ"1#!02J!
MK,0ICTA2#L3FG GC+G AO<ZY6K#75QGHOA=UVQ,@]I'[8 D045%!044D2R"H
M[#+Q)@2B&-?"I&@#5+M#^-H3(([5B^/8.'T"Q&^^;1=]):OE+#P8H7*:P>X9
MK64&</!@8\XA2B>-B#[:A&Y:N=5.I>3S(YD!N^:V#T<WIT2_+NH<+-RK@ZC8
M_*"C)=X!WYI@ X %E@28;"25I2RN-?BA 0Z@+8P>17JT_ YOJ;GK<75DV:&!
MILA",PDZTE),4H2 9@ZU27LJM3$T;);H<7TS-SZRCR6CVX/KR'JO!4*Y$"Q0
MQ9GBT@=C%2X..!%!(R]U63=+_<$0QVW[-V.\\!,_C?#^ F#^<]M<?1Q/SW\:
M3_&SL9^\G_OY8OB7_F,1U)VS)P'6L 2>2%M2A@5PM)B#)<Y8[T0T$'25>X=C
M@1\51O;B:H;/F<U>-I<!ARI/?MDLFBR7H7"8,>ZX_EJE?!A/QO,O=SA\/?UX
M-?\ [>5(T6PU5XG@-L&(5%F2H'%K!RZ*%R*R%/XQ?>\3T/ 6UJ#Z=R\$[10<
M5K#;?VFFYP5'N5NXO1&*V0+X4A <5Q>T%&5$MR+D B]Y"%(Q4^5P<R.:;T2K
M^F.D@H-_*Y$OFV1R?;P;4T!P4A*KLT:,BA-'@:$+2I7F+"@OJO0@[0)NJ)N7
MDZI.[RP]E7N8.Q.[^?&_QKB^MO'BRR_P"2;7QV_!2.Z-(Q973Q0@-03=)TJL
MTPI*#71FJ]1PZ0;O5/<S_6O%=K7KBYV:2]A=<_@AWE>++:(3V)KW,GNA/<U%
M3 W:MVE6-<Y.KFB">^%=Y"3&B/9?2JRT);2$9D"7CH*/=?I-/@$%>^2>Y<GI
MUSY4U=2KA?,P6TA K,H?22H90R]"";%8OA6QRB9BJ$O<^@BNLNGU$-,)S?;^
MV=RF-T=24:,X]+J3N2J:GEP.PB5--#<E**RTH%>Q]/AP(".E+%<J$+T%T+,U
MAWIAH$+$^R9<RW>A"[*:ULYV:*<Q;?JAL(->'"'_"CO,#H0 R4I')<D,T"VU
MY9C*A40@!>II=J6:]7/0C$=LDJ$58Q^Q#Z 0/W[^".4ZNYQ/+;<[[;@+#HTN
M1.EQ&\4_7!"(U5/+?#+*UPD;>AS:\ 9(7T0^HA]'LK#5Z.CQ:G^W*=;DFY.P
ML]D,%D7K5J?DQQ4I[&7<.I=[1\U^[>XO91-HSCQ*1B7P$)3B.<3L4I <@GW$
M%.Z(H"=WY7J(LWM#+&&E-]-W)62A1<,+O_!;,VU7ORXJ!=P>BP:PR4F?"$W2
M$4D3&F0!7R?)0"7GG&:FRC+3ZRR.3O=:8-B4\!LI\YI%31(Z-27Z*Q(;J" L
M!J.%T3K+.N4"MB$ZH?<WN+X]R,SJA:8:EWVW MF8-<Z%]MH$Y%E$(H-1Q*$7
M3)!Z8077(0I=Y=9O)ZQO69-Z)*SF@=1O,%^(ZN:F>Y0S-=PE1Z)BG$C#,RE@
M"*5**A%%U'76H^V0OF4UZHFH"F<2?<AHF5ND&0#-Y<2&6;1[!=K"8#E)D6?)
M+4^\3JO?WF8P^ WUTU'+0<G_RNZT+0O&6^.)8>4X.<:(/I[RA/-B_W-.05;9
ME+^2.^UA5>>PB^]]*#SY?607L']=?/=.^U$7DX=P=G)%$UFE)*,BB4/ICNB!
M.&4M2<DFFDLA4U6ES?$34+!^+KZ'TZ]]J!KHXINM;EL#UY8'1QB5)5Q.)>*M
M,D0S'FG.I3Q/W?")AYB>_,7W/FQVN/@^A(H*AQN;H/$EM&04I\$!$<'@)J\7
M>;DB$6E!H;G* J2Z608/,7UK6G((%0,'T41FO,K&$,Y $!G0(0XZ!Q*CC8[%
M6(K'_A5$4U5+#J&BPK'$EDR.%U]N[GL!;&9.*D(CI45Y!?'&,))$T$F8'$2=
M4D./(ONV/;)^B1M.L^[=%#\.L*8#]BC"$Y5]Z9?9;GIS)"TU*FT\"E1SG;+6
M&JE-GD@#N'0F@333I#6E4!HK/B.]>:Q8RXG59A\V>E2718KB%G2K!O9E*P7'
M298 N'7S2()/G$1<8X5U-N;UOG%;DD=W#C.\ =,S)TT5@5;P?VZK0-RHMDJ2
M9AH"L1 Y[J0^$">#(D*R4O' .>&KN#T/H7S;5LF1U%0H''P?T4L_A_.F'?_/
M777N@K"F'?(XQ-,8(L>2N5,W>F.B@NG1 :D5BGDK-4D6-U3I,[J#I=DR#8II
MSABZ;>DYZ<HCQL?PJK(/ 37BA9LI?+DN3/33U33=]/)V3O)(%6$VV!+V)$AP
M5A%3.A]3L$R8*@<KF^$,;Y+T3=QZ?/#Q4J]1$:YI/S9H(,']%M1+<!"DU-84
M[;>NE*@&$DRF)$)6.0%PFJNHQ$Y4STXS^N.@QF)Q-1W'\4<_>='<4=H(+$AJ
MB# )O3$I _$RHZW%G0Y@O0,&59:*#6">G3H<+?$*!V*_O__0+NSP+VA[_]Q\
M@G9:YK^Z+:!"6,B,4 YENP1- H-2+"=Q&;)6B55).]J)ZMGI17\<5'!5?G]_
MB^@,?>^X[(3P8#FCS/ L<+]+J4A <O35E'3HCLLD.0,J;)6KX*X GZ':5&#F
MH0;)8;*37E[XZ3F,IW>R9+:<]_2=G[3_R'4RE(Z4P%J.DM,.M%<N6>.E%]%1
MU"@7+!CI!%-Y\TWC4;+81P?>MLU':.=?WD[\=.ZGJ93+_5@@_ ;S0YC=^;RC
M^>J.=HT%Z;*C'H2+64FN4I! M?<Y,89OO,BCKKC[DNWAM4\[/+6JG#M40J6)
M:N85M3;@^L90\""D\3PK+6+F>J>TCRN(NNO)RSH'QR16[O/XJBSLG,MZB525
M?0Y4QQ2]C,I9!Y()D. X\A'B3CIVS*HO7OJH5[O7\ZLRLU?UVNB-LQJYD!!E
MU-%YSZ+R3EF?I.%T)S4]%[&]-]39G:%^N4ESB-8;-(<2RMZAJYQT(K9D^ZM(
M$Q?@!.I3#=OR<6C'FM=;1W@UGGUL9GXR&VG*,RO-UAEE)7<=) F!XD\NR6B8
MQK^O4E;O<6C#F]0]Z\JZ2=TS&Q6.]6Z[/6W%>GUAIGU*7$E!(EA53I<RL8D:
MY%D!S4Q&SJMD;'<%.%2^566-J<+'4\F1>CW%G0=NJJ7>K=>$$SQ+:<&8G]SF
MQ,Y>?%F]*HN*3C-\Q.0JH?]0OK/P)*X@O?FX="*NV_8DQ7*DAI(@6$3Y<TT"
M98+(+%(4D U5E>[)AYC>Z?O"]:F9#^[$GIR&5#@JWPOP;_[RIJY4!]@U[_ /
MQ'VJB_VGITK-Z?3@":FQ@& 3N$2$+9D"4'J3>B@75=KBO!RZW54NA9Z4^CX:
M:_!LM7<?^GN/H<1/QW$1/;: O0K)<89;W)X(%]$226TF/J(8K*3EC"%:'OEC
MGON.YP_OUPS"3=.O8(<H9+;K&.(5?&PACA<R*379IK-:!SD[1JIZI--UANM'
M_RH;QY,.4'Q2:BT#EQ/'5XLJ9Z7;>;C3;:[[</ASTZ0_QQ,<*[TNPYV/T>J\
M#@@]A*A=CSN:C<Y8UT0.T3&)[V"VPDI#\1UBWE/!A7+,VB!''5'W)-?#3_D?
M?VA-&7<XX[=96C A99.\--)Z%&]&K>9194^]WB7IXX[X=SSXI6_;+R5^^;*Y
MFLZ;O/KJ$>O1$:/59&BOF:Y1QP*^"Y1Z?$VB]%&'%#,/.6BG3<K =U'WV+C'
M6<:KI]V>"?'2.#AG1Q@K?:$D[JE6"$Z2LDQDGP7NAS5LW@=(CC7Z5P]\UTPF
M/S7MG[Y-(R&,]+@K$!DS[O+."!)2*J&)DG.;N$NARHGR!BS#FUK'<;UN5!\K
MW@I'Q"M((PVX*&H=B [<H'&8%;$487$OA,-7D'M?)2)G!>!TW![,QA9V]Q)E
M!<]]A>,LHJ760GIU5=)CWD([;M)(>AJ,M9%0'VDI1(+8O/4$[7:A<C+:\"I!
M>KM /1_JCQ9YA:#-%;:W5VV\\#,XB['LBF5[3/]]=1UR-AN5T$!7(@5Q>U5$
MBJA)"$D2W'LIB^@D:%<E1[X3NN>C(/V14"%Z<P7R7^UXCK;8FYS?P<27XN7-
M>U_N!E9]-']'\8]4Y(F:4A^W%**4/' 2<HD63,9(P26 JJHQG5 ^'\WIGY2M
MT9O':]#KRX]^W"XN3IO9;)12C(ZZ0$0H0N L$ ]"D)RC!N&X$[Q*1,9F.,]'
M)XX0\T/R55_DXPQA?#Y]>=6V,(U?/K1^.ILLCHA^1F$MD&8/5%)A2!(<D7K.
MB<T^$6M44A3W1$&K6B&/0WP^2M(S'0\51_?F@Y0JV Z,(8%IG&[0DKA8\K9M
MB)X)IX*O4@YCLP]R3+S-ZHG7E^8JYX"V7R9&ZT1*K6824*0X.70(/ O2YBI;
MY18\0T73].L\]R'<IQ(K<WOUM]R\WU\_]_K>3D$*&;S#=5SBC*@H;[T!HB%S
M$2'I)*I4V]R)ZO21*4?0OJY*O8F_@ON^Q+*\L^L"IF94R#TTIXGUZ)&M=3TX
M6M35^7<RN]*BDB2M!)&EPZ'GU*/4K$X6S;WDJG2"'(#W1X(DAJ)]'PGW';'P
M:NS/I\UL/HZKND1<1U-<?C .-TC%&'%6<^)3 B/$XJ:^4ZS"^I.'MV>/D'+3
MEX@J')B?329OYA?0KK1QB8IIH1.G0+(5$DW77'ISH#%-N5 A9,F3KN+1;(;S
M-;+=HX"WOJ8]!IOLN'[L(U5HG\?7O,+=*U&(FA2=U(%1QR2 #M93S9P6,2;C
M8]YU9]M3GM!BS;@YCG\XS*TO8F.P3CE.M 1<1P0MJ?(\$D2:F08/0?M.2VV7
MT2H=K$&6V5-\*50.&?VI8$DP5N$N*%+T6NE0IY'.J0_6ZK#<\9AM'Z'7J)U>
MI J_X)NR/NW?9Y"OT-O.,#(@'+Y]CE"@I0Z$9:5&2"!<4<JDSR[J*A$)7< ]
M-S7IG9 :]>!N5/A-7I?"Z^F2 YB4.?SX>1E/>G,L9W#^PGM!,O.!2.8\<8)2
M L!$#@X ZAQ?'0/ZN2G98 16N(&^B_V79GJ^>%6NH?\73-)/38LORL@[GBR(
MTF^3+6K[&K09/?Z$;PYE5O$HJL09=4+WG-6I'THJW$=O7UAG[Z (\3K$KYTO
MR^1<QUNPD67 C!>)>&<0K%>!6.$9T31;R4I; EFG6]%A>)^;;@U!6X]WUX\)
MY?JXF8N4E8Z.^(12D8D[$ASZH$KI))1(#C@[UEL8Y'*FK@[T+\ROX\I&\$"E
M-XDXR1613D7<8;DE4D4!3D<0LDI6\I.ZLJE _EX7-_N04/W@O@N8;_KB9B^V
M=I[@'R+J^A<W&94:F"?,2X%JGA3QVD7"(915M)3XJK,B//&+F_YHWT?"U2]N
M0K2@LW1$&T'+B7= ,R8Y8CRW(DMM.;A.]L&3N[C91\H[+V[V$=%P%S?"@\LR
MR!*=7V)N=8D^2AQ-3[MH*J-RKO*>/M&+FP/8[E' %5;E=_"QN!K3\Q(?NUB!
M- LX&Z#EU#816931&V&(\!E5$1V0:*HP_@#)\[//CA-VA:.G>X!6+84Z0*II
MF6W =!K[[$BV=G%_A*AKKP&K:!^CA -=6CXE]&X-QV4I*T=BCJ"#A&A4E:8&
M@['_B)56G_Q])-RW??;KXH;[[&K>C"\OKZ9P#]]R8]*:)69+4Q>J2[A\R;81
MC!/-I:4I"DY%MZ9J'08;?E\_FI&FHCA[-._N%"C9A"IFXVQ*D020ADB&GH9'
M2Q-]#N&Y3&!"?#068_<07SFU_8BNPJ*]XQCYQ9=?_7\W[<N)GUT[E=0&+[67
M./&,L[=HNSK/+''1!1^Y J&K1$GN@?'Y&7NU"!KV)ND6Z)U*25W@UC01]\1[
M&O.Q&O_=]:PW\H9=OS;"=C+B(@Z<"*HBP0G@"LX-8C=*RRAL]+)* 88GH6N/
M&*M/5=7VX:SW(TCX!)/F(Z0/$"^FS:0Y+QV!7OFY#WX&JV!I+VF,'F>?# *4
M2J%Y9BQ15LCDF.1VO2?3MF/)#J,-;PE5Y:NI*>P*!YP?6I_@TK=_W)R\B03.
MA[*OQUAZ)WMB=<HD.LG0'!0ZARHKRCJ0YZD7O8B]PK[S\FHV;RZA790)*!4@
M+\8?5]"2,](DG@E+Q<6W)<=7I$ H#XEKSCU+N89&[,#TO)6C+S)Z/!I=K&>K
M.B3IEW$L51M+M^V;I>VV&9@**7.E/$%$"EU IA$BQ5]IE!GW5ZYRM^VCVWC/
M4Q=J";Q'/VG6SD?O2C.OA07%L_8I,U[2ZDK8GUQTK9"$.BUX"$8%T\6;QH?>
M62'PM_75X=ZHS\<_/ER8/4:UW8!8V28=8.SAT7;G]A3MWX]@8)W#(\37X]Z^
M#L=YSA(UFCB6')$Q :Y ,1/<3CB%K"&Z+OOXTV!QB^_7/XG[2*UG\GY%25U>
M7:Y6>1/1%P"-8BX91(NR!<I2]%.="HJJ;%*7NZ=.]-T;>;@-]BC9-WT(KD</
M:P'$?[X#)'&I'*66&$X%D2Z4XW:928;D''59**-[8_#NR%\A@P<+[L1IO.N_
MU\GFW39*S:3>3C-;;TX*TMG$@_>"2LU%B$IX8P#04C7HR>S*[=TVWA$.S/:P
M=0W!<.D5H8LJ:"DFXBT7:"V8:*(7D:Y;KUM\EFK)O#N<CI_;DF'J,F>66W0%
MLV)$9BW0Z@SH(P:AA8M(A6(=5I<^CX(7P ;.5.F'XSW.>/>7_J#YO;.S&*\N
MKQ;5'^\FT(QB9.B66D=@T1A<\4"L-IYD[XQE'D#**JES^T-][AK4!T/#WD7]
M!O-10NL)S:=2I,-%W)1I1N,:@"C4]2R" 2>KU-W;#>NYZ\J^DJ^1F7N3.;P1
MX<-,8NTM#5G@LD@!W3#C+0D*?P7+%7IG8(2MDEJY+]!GH3M5V:D09;%Q.WV(
M$CQ:DAK=![;(*XQ&$1L$D)PHE]D9QT*5:L#=X#T3S>F=B0K5HC<LB \Q4L<<
M:+3&HBA7:L7C#%1&PHT.0+-//E6QA;N >Y:Z<C0+/9:67DS[M@+HYC-ZEA5J
ML<D$0KDS$:C ME3FT3*!52FP;+L5<GIDH$$RL_OEN'?Y/95L[$>VQH=!02@J
MEM&)4U&@G55Z%]MH*9I=FC(;DDVL2CVD/7&>Y!*L5_W8SX0YBJ<:99)VP]T<
M;M@!<LU8T0,PGZIG<T5=V$_O>B/RB>@@<\I($TJI#NJ)M$X0)ZQ%:TXZ%YA5
MFE9QX)^,[CW:</EIJ]X^_/4=1_IZ^K9M(LQF[V &^-B+$MAX'>Y8=NI_C><7
M]Z>TBE5Q+&G-J"D)/RBD+#EQDI:*_C;[($34ZP6[MAZT'X9@^'"AZMPV0Q,S
M[ 'V@Q>-9:\4760LN4"D]XRX#)SDDK/$O0 G!ZY3^?QMLEK\5#B?W#<\KPO<
MO_)V:O%_9#+%(>0]@;R=H+G U560[.SB:"214.)"94[&N!2X#55BJI^$KO68
MMS.DJNW#6=_V5L=(X'+>EJ,-)&>SZ(452%#.E.APZW44@&+ZID*O]^+L@-#K
M?01>P6K:E2E@: #@1A.:2T-AF="TTSF52T.@W%KAZO1/_*K3-@[1E[[)J+ ]
M/4@WBBH(YS@:@!)-?NDENA:>*9(55R%YH46H<D'R]65Y':,11XE]JV4\3"#C
MW4B49CI,6&.W,6L&.1XPZ[601YXD4FF-"8E+*[3G2MH$8+DQ%!CL"GG<>_X]
M<?W3U?RJA;NC__CY8]GUZM#\Z' U&=YOKFOD1L,4U6AS,I8D>+#:*R&LLL$R
M'BG?1>X^L]Z'U[,8VZMBI_@PGJ"DX""Z-CSE:!8>0[8F7(@AI:"XTTY(PX(/
MRCI\B<#0Y*2/H]T8CY/9XH2D)\DMGU5!?IM0KDE1):]I,AY0<M*)9'E"=:4T
M E<0F-X@Q8=XCY/E$:O&]H=5D&:7-SXQD;4P/*!4)2L5+8VD-JL4#=?6APWB
M//)]+IT5/D![^0K"_! 1WOOW1TMM.YKU?<]YP3@%K2'*2*V5@EEMK)'",9/B
M:!NN0V5S^!N[X2F]RJG#6RH%1VWR.?N0)*/@J#6NQ&^F2#,*<+0;XZ$RZZ/)
MW,[G]2K'O=K(<:55Y RRE%IZZWU23+G,HY;1%;MKYY./<Z_*(U]/9_/V:M'O
MZR;Z!AT$""H"*28AD=8 <8ER$IBQ*@9A;*SB@F_!<ZP7>?^QOWJT9\;S+Z_\
M'$8ZVYRI4$0)XXAT#OU;3P/)Z.\"+_<.J4HGR^V0AO<L^]""=0^R)Y%7.'HJ
M\WN37[:0QO.??"Q[WY=EUMZ+IFV;/\?3\Y?^(_[-_,L(@@%N*"4^\EB.:4MQ
M @&$*NE8J><L696B,ON ?!X*4XV6"J=2]^?_$M?D+]==?JZF\Q&+$#*J-G%&
M>"*%UZC>T9",A@8*B)=VH?57E/N@GH>*]";V"G>W][']!+""Q='C=HP1I:DF
M,G@$Z" 2D&B$LZ"4X%62U;;@>8Z*<)BP*V2$+&#-9E=^&N%E,[L.9UZM:6=H
MN$W/%W'!R\Q+Q"AL*JWF<LF&DBP11Y%)CV+PDH;(;95&D_O!?$8:4X>:"JDB
M]R5P-IU>^<G;=CR-XX_X@_]2/ATQEH%ED0FS"F6"G@*Q3!LB=33>JB23KF*:
M= 'WC)2F3QIZS!79C/&%GXUG[S^VX-.;Z3\]>JCH@+]#HYN-:!":JZP)]1$%
MD:1"&=A(%-,Q@>$YNU1?7;8#?(XJTQ,=#]5&UW""?I]>S2"M;.R7S>7E>+[<
M7]]"&_$G?PZC(!/C*GD2M1=%1)9XZ9#Y&+F6(LM$J^C1P8B?AV(-0]A#33-'
M5NV])XG7+]Z\^VG2-.T=>%9QIJ3*),M2(D<:1ZQ5CG#+C)<:-V'6K=7HXV-]
MW9I00Z /^;9'KRS-]'R^/*W\%XS/+TIQB$_0(K374_P+F,W+"C@*BB:M;"8F
MZE#V35P A8X(4SN52O&S4,4QZHCOZ]:5FF0\U!G70\>B:VMJ]B:7B<]6*]W(
M&EUL\9+\&4*I<2YP\8J2)*=R:0#BE.I2>6QO+=F*Z'GH13\"WW"R=O3I[/W9
M+LN2:D%YF9J$B'\LDCN4<P2"R4E$:U.= E$;L-3.BA[.-MU?M$\E&_J^$70=
M3>U\1(O9XDYG5,D6I\0[SHG) :Q<W(17,4H?0ADZ?Z8W<M=C0H\3<HU*[_<0
MW:2;/8ZI9@K,)E"GR7,YEK"=_!\A[:$T 3B.7N);!<\4ET>:B]F+G$'*#@%Z
M*JKT.1U. Q[)/AE" ?81<I7.EI^:R:=R$7C_FG#9DL^%9 23Q"A9+@6E()8Y
M2;BF7HE(&=1I +(3U?#VXO'$/3 6^Y)ZA=O\M3/:HO4^,FEY*9GM2J=U'@T)
M06:B78HIVM)[N\I*\!#*<S$&CA1R]>O6.UD/77#5- BV 3N-47 L<3OUX$BI
M5X_+N(,O)<]]N0DN1^LEY5(2K]"KQ>5)"<I""GJ **\3IZ<.I0S["+OO=-,S
MQ)(6BUZSO-L];V'A?BZW*[!,6YHCR;;<NR@OT"0"1XS(H U-"OR:I[CEN/FQ
MD4Y]4'0H(4TM:5;8_.]>J2WT.>F8DC5HC&1K4)]9(%[@3SEH10,D*YBJ\9ZO
M WDN&_]1 JX087,7STJY.R"JN>$_A'2:K?XXJG;P?H2<*VSQ&Y Y , O2F*3
M+56E&2.6!T8H*CV7F9E89W,?BOE'MO7:Q.\CW@J$_]),TR*E%-K@IW^\R1EP
M*RKX%K>?RXTH0'8T22#:4T<DNI[$*5Z0)F6"D<KX*F5).J$;WA0XEL:'UX@]
M<]!SNZ+W<\12MKSW$:8X]V;Q(F2CK7;"D9+I2J2'1(*(D4!I.LB,<ZY3_\].
M;8LV(OC:S8!^1-MSG[\5CM^GLX\0QWD,::GB74#UW?5O*YKA>P#VP%132\P]
M-YC;#HY!%)P*3BR4(N_<2^(D(M2 #JU0-F3>6S?/@;G?T3EP*.KWD6XERG]J
M6HA^MO) %2CM=(BE>E9I4:L-(E*.4)%L"=16W4YV]N+[/H1A>]3UQ,T&MH\0
M;,^[^6T?3*N%X-&A%2MB1I-"EP(TFI5X66[0HA$I=ZGT^[1[\];8M0\388_Q
MZ>O]%+O >*8=>?=B8$LSUT/$5[$C+\U66LL$VO8L$6F"($$E1D#%I'E"=V+]
M%/4)L]BI(V\?).XCM:H=>1%N2"HXXECV)=P3@2S:M4$R3$:)ID*7]/ZOJ2/O
M7K+?VI%W'\%5[<C+&=<T,D^HYP%W9T1C%;?$&!VS-@&L[J^G\M/HR'LP@P<+
M;HB.O'>+>ZS*8#?Y[J<]53S9_?!>RY_L,8_U2EI*!F<IH',",NO@HXQ:9OPH
MR>@R'QTTHWWX>#._@';UO"-+DVU]UM'2[H9RO<"6XEDDGY2)1HH0K!/>H;BS
M\%D ^NQ=\/8AR\,+(#WRQ&IR[5 8B>(.H)/3TM$@DS!>!1L\+DO"@\LQ;97N
M<462MCWU_=7EI6^_'+%X='QR-9GOFL%Z42JO8S!.E=0F&;GRW&;K<"(J2HI;
MQE;9;Y]+'QST4;2J\[.K\;!7,2N#:PS+EJF *[:DZ*:F3)F7R4MAJ-Z^QNR:
MSSY<O$4Y0MM"\M-4,B*;Z?MY$_^X:":X@<]^_+]7I6#. 3QT>N[1'.R/?GT5
MLF!,S)3&H*25,G#)'4V@P5GOK!OM.X^^97_XVK_'TP?AH<.> ,E2? ^TI3JB
M%>.M4;@EX)_)<U'VA,/FU#<G?:Q3!XTS"$_[%>.+5I<B'[A^"9FR<1%-IAQ%
MJ=&'_$$GQH9<RY:?7_@69J7 R>++;Z[FLSG^?SP]KTQIU^$'8?H@6:PI@';2
MHB?HJ3=!6JZL4]IZ';+)6@C3;0$]0"I]Z\7BDW?P<=D-XIC2ML<,-PCOG>:Z
MQC.NPTE:82+U5#J+QGK)@#8Z28XFHZ>=>.XPZWUX72C,B]*[ P<L%;87Q;8/
MH6S+DXYFHPO"!R^4=LHK891#<T2!<\*A11*,4MXFYT:/8SU>AH=;'3N?5TF>
M'2P+D[G563,GHI7H=7JF;/2.T1!1UG2;5(^S)38_LP_KH>.3*\E[+PLAHV=/
MM7=1@)(B>\^"+^W"E;490>4MDN^Y<._F0>X4,GOQY?8KRU)59W_Z-OURDTI.
M8Z0*LB>E.'AIJF>(*ZT_'1C*;,S:\2KI<L=#/S:D\& $OUV5,^0W^7IG/[N:
M7S3M^'\@C4H&G:&"D@2LE+2UF3@!I00A-=)8&56=,K&]SV3X4,6!-7D]M/&T
MNE A)^+H"9VEM*#<3QY.+4AE&.4$6!&TDXR@H:R)\D88P2@H7:5_:<4Y_:7P
M)]*/"J'B!T]M\<<_839'W^PMM.,FL9'T(L9<*JU(5>*?1"8V)4>$I89%!2KF
M+H&$P^GZADG\I=Q#:4"%%.<%T/#X7,+Z7'[\_''<+KY\/9.1B")X&@+)QI:(
M%:6(CR:3;&D$5_I^09=@@<-4N8\9?)MZ/#CW%1+V#I[(W1?R72E<-[M7TM)8
M*K(F =TP(IGGQ">92!8F*(C,J52E*ER5V?REW(/K1(\9*=?]ZP\5Z'(RO\*\
M'<</J*JS<K[XLIG.(%XM3@O\E]GBE/$M?@%&6>+(I@0].9MPDDP2KYD@6D#R
M/H;H(#]VUC(HXF]&N9^N'E0H.G[P/-]\7/07_AF_.)^]7NY1UR7WF1"Q7%>3
M5 I0H!^A2OI")MQ3*[PS)0[L2=G;V^?RS2C]4]&'"@72?[S\.&F^ +R']A.^
M<5L.=9OI)WQSX7IGFGUHYGYR]^]+IXG?FOG_@?D[B,WYM#C)B[=X.>^1YH(F
M")R81$L5> K$JFA)5A2W/VU<J-/#89#9?7.OP=/3F1[KN1\MX^LKT]L$I]DB
M%.S#A9]N7 76RE4O_K*TC_O)C]M_^LD5C*RW5LJ,RJT=6GQ11N*,LX1)E4$E
MQ:FI4O?AR4C@FWO!GHSD]]*]"D7V#W:AEM/]YV(%6DWW9EIL)!6DX)Q$MPDL
MSHMY$J+A))HL*'A5XFR?E&?]R(2^S5?DU)I1H45 O;WUYDG7_VA]91BA$9I3
MM($$6FJ<:5.JY5%/K,V!F7*$IJL<-IULQM_<._-UZ%:-;@O59KY</IIV^5'Y
M'AL9+HP-4$Z?I2*2 \7I*B#,.O!@6?2\RD7$L-/\Z_UY.EJTX:4YW37SW8#@
MU0X[H@)T9$81W$!Q-L(Q$A('XKGSV;FLDZG2!;3767QS*G\Z'=B@T<=?-2\S
M:9?13+OF-=LVL>MZ)39;ST/D)/'2@9>R3*S@Z!RAL)G'5]5!G9NYOF8P5(.?
M4^OO21A_*AV$WD[\M-1'7E3V4,PY].89@9R 2 >,.(DFF8M*&&E3#+)+C:&]
M5?8NB%.5'#J1&C0]T5$AAFR%95E4JPN:FM6%[\,Y367AP^G9PO,1LJW/N/;)
M@E&,X.I:SCDT)];G1*A)T@"-PM$J)<2'8/J12L*UB-Y'I'TW!/CP9_/AHKF:
M^6EZ#Y]PS0*8KOR55^,6(O[;L^GBJAW5S$_GJZ/B$E<R_@1E*JOZMD%$FC4C
M6D5*I+>&!& )?^5,)!JH6D^8V!)\T1^FX>WN8ZAM3L]+CP'WZ]/X</ $P&FE
ME:$H1(:O6@Z46%NVTLAL8BRY$.*^BG4PFF>A4L-PT?=:=7..L@CT62:5%FP?
M_D2<7_#/R:=5-:PLM<:%.!$N'4I)AD1L]IQ0"J6K1Z92/IIUM^^@7Z]JU))L
MA;#O:YL:O[S8A77PCGKMB"X!C9([!,.L)$+I;#35#'05Y^0>BF_;.SF<D%I)
M 0<)XG8:T[3^6G684TTGI\:D3N,J':$K^QXP#D7T*?*T#ID;]UY[)H P)07.
M#=_NH(,FP).A1EO@\33QHT]&>1_Q_IZX[N[#;]^&V?*Z%D&]@UD)T9XO8_)^
M1UYFJT:H%)Q,49&8O42[@3ETF$,D6J+1$@)7P:E.%EF7T9[@A4MU4IN:C%3(
MQ+YG=%X#7@$31NE@(S$ZZM)VT1*G8R3HJP:1@HS)5FE7OQ71<.I4B;UM-])'
MB;Y*!^N'\WWW_O<E.,\<<*5IJ4N<B62RW.@X37241B0;G6!=ZG+OK1<[43TW
MW>B/@@KV_5MH<]->^NDRC&(U8>N<#MPS8IQ$;#0YXI56A!O(3C')1)UB+5OP
M?,/;3Y],55A@%K-]M6H%*"%Q+5PDX$UI7< B\3)*PJ/CZ/8Z;D.5(@;W4/QU
M?' 8(172L6_ +%^ +G!J>OYK>$[HM!_&T#:NCQ!OS35A"2LF$;WD"CTZA4M4
M*4X4M++$>,C 6)36U5T53NWE5B%['ZE6<E 7B2J0SO(<VE<0%QO23^-/L.&4
MVV3AC!.)*,[*-B4T<6@2$V^T<LY('?):\M1N;[7[T,/;#D<QM<'KK"3FON\F
M[Z-]VXZ;]D/S"-XH$G6< J$V%XLH&Q*D<T2)**/33%A'#U"+3H,_&\7H7]0]
M=X/Z,)X7L^CU-(T_C=.5GRP60T?!.A$XX3ATL7(,\=D) L8GECPXIGIKG;D1
MP;=I*/9#2,]-=A\ ^M=X?O$.)@MYS"[&'S\T/T[GX_F757?I#E#[;N^W)\;A
M6P#VP.HN':E 2>UUYA'()@6;O<8WQY1C'64<OCY1$U/B,)(R'%)O?>F>A/;L
M:#UX6N79AXF^C=G?F@?!.RMK2ELI70J$BL7R&G'+-)&1J+F1*5N53>ADG6P=
M8MCV=E59:7H7:<\=#5]>C"'_^'E9X>A-SN,(*U@,W3 A ?7<E)@^&Q-Q-BH"
MDNK(DU!!]-;?< >.YZ<.?0J^PE'%LA#68JT3(06TQ@6Q6I56C;K\A-3Q<C0O
M*?Y,JV3&W<'P;5JDQY)1H>+8$LI2\;N J7EL>0_-:0XM#^9F,\='"+;>*K $
M!8GQ9!0GGB>/:UVIM2)U0!5VGKD 8&*5.C\#L/S(864=DO>1YW#17XLE"U<U
M7/G>3%=G)."4#CEG8J@L4-$Z<<'B.L:R<4RS8$2]0J_=, Y_:G4$F]T"M8ZF
M8KBV!G>@?OBS6?5X5ME+M(&(HAGM(@:,!&\%B8%[3I7E^+:<1FMN,#YOK3F,
MBB':;6_&?K>^WEE$H[C8V'UW,]HU2*7&1IWGM=;C*%%0,K.4O:(R>^Z"!!4T
M\R[%%$W:H@(=9W@\7Z4DU;72S697E]<#YJ:].W[O].TQ9B4V#YWU.KDQ@=(E
MF->!%!HL0Y^129K0FW31;B-WC]%/WMI*L9"C#XPDZH%(KBCQSN,B%!++4*HJ
MV2HYO,=#/UEMFIM*;W?H/9NF7V%^T:1FTIQ_.0NS>>OC?)0%,]8")]2Q1:5U
M3>S"P\PR6IX=9>YI=0'J/K<G&-?6K[;W5L>FDKX\I898FZ;X;CS[XZ<6X/5T
M#BU:5._\''Y%);F\NAQED] 'LX9P-*Z0!UDZ$"1&*/IMI8P/1/:T*CGM.<&O
MZ.6HI9TUWYZ^5.LI-=;J/$__>3%/9P1+00HBE$"W1%I/?#"2B&"S%,D%5:E\
MU$ 3_.L5&OX5.D"U3I&XN\\\?_S\$4H"PZMR3X2V?9GG2#F=''.,2 LX0:LM
M<:4N/-4\B>Q9DJY*\LC_8^]=N]NXD77A7X1S<+]\=)QX5O;*Q'X=9^;L3UP%
MH&#SC$QZDY03GU__%DA=*4KJ)AM-BG;6C"V)<O>#J@*J"G5KOK(?FZ;IICE8
MF$YI;-A3"_R B\]B0GH3HW*%H:DKLS*RD"T)-O<R%QYC-.U\PR9+^K$_!FN"
M/JSXG,R8L5W+^AD7TZ^8KWKV;AJ17IN;&(U%A8D54T<8&^FJ1ZF9,,JAX]:&
M[8C;T&/&>B+^L06&F4/64E &S H8:9%7EB-1&YWRR$@+9J:#=<P+75B44**K
M!23"G\AN^.%E'&4W["$H#4:6-;$*_S6OZ6<7T]6WN_<1D(-7B3N&4*?*"BM8
M2+1P:;C6.J=LX;0NV'LO\<<>&L7I.%R\3FG$68^57A\9KL1@>6#9U4'C& ,#
M6Q23&04G5>HA-*GK'V^)/S;2,3;2'N+58DS98&FL0HMHZ31@AHO(= 3%?"#)
MCC)9S+D IC:QE>]PKL!!\<2C</Q4Y@K<;Z$6O5))TLD@H,YG(-BT^9Q@:*6R
M1IE,!&U69G\^O3M["<*3O3O[,.2EM#WLLJ8?O3O[]^[L)2MC]#_<A]$O1HB+
M<A&]9J((Q\C$IRW.?6(E>55HCVMMCS/)]V2$MU?OSM.3W1[\;2"SCW<#C-%F
M*<F]=*7.7Q10:K4;LB)2$34G4LHFJ6PGT(CQ=!C>N7=C'VX]FD@V:C+YV\O5
M<@6S7!/O6^:3[WC/""GESZUN*_'8R:*(]>0Z"] NYV"%=+R@S\YX!= AJWS'
M&UNHLTU#OU>7Y/<OZAS*/VD5=S.=J[23YTW6\'2)[Q;3A._K;KEUH30)I_#:
M,9,+N5 Q6P9.6!:$XR2D,7$SHD([=#EM;(9]4<W_PL45OL_3U23Y5%/A'"N^
MSD[TSC./M:$K. ]%8Y'X DA]?U&GH@5&W0?=+)$C2,UH.<E[KNW/+U_NK0UX
M"C&3Q!8M!-,J>Q93 %;#3UR4+'',_/QA%O5C1YR2U(SF5^ZYMM\O*V_?ECOF
MPO7$=2-LC$$"4[&F@5HR'P-B83(E#]QIM*7)"/*1UO=CGYRH++5**7Z0Y;;G
M,A\N[]\X_?BIMKG\B@OX2$Y1%0?Z^/5\MHZ!7<)%38F3DQP%!QLY"R626U9(
M_CUX2SO Q>RC5B8WN><^D?7_V'*GPXM>LCA:WO*>9+CZ20V"[";#O7\B)MZ;
M$$PJ-1FO#D4PD?DB(@M>9"\C1FG;34 ZTJ)_;+Z7)'4#)D1WC3-VHL)/WQ[2
M81-\S 6**S7DF+1E.@.=+%I[9C%)A\ 5E#9%-4V7==QDA./NE=.1EU/)6AB8
M$.L0%.3DK32:99<=Z6%16,RN,(]"R$C,0RM.S,UZ;"VGFD$QIJ0.YV -(C&G
M?O]P%07KLJ3Q<S,.6M-Q4C..+F\M+Q@.$)87L@]B,@$-)H:DF1DMI"841LF$
M]26B+%)NSRK_SN3_F>R.[T'\^\C(T W'-Y<.-YT.#>=D7,;"I,' M"6J1)6K
M;V.E"R8";E\1/U+O=?^Y+]Q5W8=/\V&(//1@G(T5=-.C,*,K2@;-!"V!Z9HS
MY85!)DO('JP&#;D[OX_8XO'T^+T?D9OL[P_$NFOAT]$%!"D8%H*@D\C,2ZT9
MQ)(X^9/9J#X<OWWR#Y[O3^@!(R2W8-[,+Z\[VZ=8I"N&/)SH%-.F> ;2*I9Y
M,-P'K32*[DR_?? /GN]-YD=OX)LGZ>T: MRL\VN7ES5*U^N]SJV</<^]$:A*
M*4[H(!!,)BV=7-$^6RG\([+8Y;5'[Q+J>$;(:,GF4)),$)U9D((.)R,<!!D#
MQM.JO?SMZ%U"?_F?2^+@KS/B[N4Z-_CMZA,N/GR"V56LX/?Y["OQ'O/[^<7%
MF_FB_J,)URFG6B(I71V"2-J> 03!N$2N=34 ]8B7@:V6>2IZH-D>&*R.M;T4
MG5(;T>ZKW:2:3+Q/'CP9360XU1BV"RQX69@HF1=;G!.CMJ\??H4O:*>,(*KC
M[ZH]Y.R4FHH^N]#U&-;EK[--=Y:)TD5:GQ0+1MDZY!E9<-HSF;D4$H0QWKVL
M_71_@3^VTU&VTP%2=DK]19]=Y[_6_+A9IR&_/6CP+,=4R*5/-=>*V&(C3\%D
M(*; R]I-]Q?X8S<=93<=(&6M\OB:K).X4'!Z=ZDBY>A=2LPH9^C@"(;Y '1Z
MJ% @E^A2.:UQ"OW7^&-/'65/'29K+9+U1K-MR7<%E!$9>A)^[6+U:X-DPI##
M:Q-W"*<UB^$P'^HD6;&5-[JVEWZ&%=ZTL;J[@YPKV@KA6,W09IJ,* ;9>6*8
M)*,J)D!U6MW+V]#A!9V4+^82J9D<OBBGN#LY)EP2"53TS.= -" NTE=),Q=+
M25QPR/$X[5A&6/P+VH"GL -.<#?W$M\7M87OWS@\3PBK>,R@R8GB,9*UQXF3
M(DH6/.KLBRRNS0#UDZ' C\U\FINYI2"_X+NUYPF!1G/BG*Y#C +3V1;FH1YR
MOA3 4M"V:2EY,A3XL:-/<T>W%.27>+]WN<#MNLD=5,C&^A2$9U'5/N<H(XM&
M"I:CX5R;'+U_84YOG^7_V,NGN9>;B?#+O%%\G@;.1A.<MDRDDICFGC-(-I+#
M$9V%Y*T[L8'(S?SEX>NWN_>)-EI&$6GW2.%];>DE602=&&8TH032*Y(?HU3[
M'%O$'W3C=Q2.GTJQ]?U.O<XDC4(H9BW2Z>FR9=YQ8$D@EARS]:&)S)Y9B_A>
M@O!DB_@^#'DIW;6[K.E'B_C^+>)[R<H8;;;W8?1+$6*(Q6$T)%P17)T"$1CM
M\,)2"K$8FYTL[9H;O0CA[=4B_N1DMP]_&\CLKH*5]W_\>5VL2G9]$"$0M53<
MC%&*V432+\&BE=Z3MFDA?$^B.D'WN3GCYZVX=L1V\3M_6L=ZS98X?-/X+F]K
MU3J^]TJW&\AK:X)*,AN=M8LV^$C?"JX,.&*U>ZHP\KGW#C1A8C,6])&-<K%^
M$'WUMKS'-/\XJV6:FQO3U_/E:GGK7QDE$M?",72NWBBX6C*;%',QY2)]44DW
MF:\Y\#K:6!(3E[F(MFB6?)UOPK$&>$-B"57@UG(K^8@IR..?P\>4MF[&0"\6
MM2C6NG$MAZ'5QLV4 95PUC.'03(-9"^!R([Q4)(KUCJ%;0I&6ZQFK-NFDQ+6
MHXO%J5Q#_3HC98U_K&"U?NYO5^M<^P;6HU>9)#'7$;PZ$YG!),^4Q8RVU#'6
M3:)23V Z_A75T01FWH9Q#7RH1Z!=V?E=P+6\A7H2W7&NDP;C93<9.8 1HTL+
M:F&3X8GE6*,,7'CF@T*&23@.V5EL<]US!"EYYM[F.$+2A_Y#MVNJ)^7;\D\B
M4[J\@,7/4_@XHQ]-TP=R]Z>SCU?N/1>"\SJA.&"AQ2<=F(\(9&(B"(4H8\<F
M3MW>-[Z9/R"'YFW).W2#M@W$=Z1C/T/"2\(&%Z]F^37]<OWR2@<OKY!ZDY,F
MHY EX9%I#YZ%4N^2%/"$":S/O(<@='SMF<E#"V*WN:=%>N G O@S?L6+^9=*
MBJN[G"N(4@5A>&TU9G6A4[$(%K15#,BR@BA-%&VFR7; =@Y"TXH5+1)W\8(^
M^O@/G.%B+=2O\F>B^'*U(")\Q2NLUZ*=932TWL1X]&26IZR8=UZQ%#$$L(H0
MM[E6ZH/RG"2H'7N.UUCNS]GBQO';_1OUO!W\7K_?:QM=\!^P]JV;?FO1:0#N
M;0X:G0((7MMHZ,Q 'C1_Y-JQ'X"C-Z"+T=-^R89YD2+3+@CF4RPL\%!TB40"
M=UIY@X-=['>Z3;E)0ER_>_EAOH*+;5[^/E_]-ZYN[UHF2DMP: Q+OFBF"S<L
M*$LD<)Q[$7B$W$3Y-UO1"89YAY7L1^=_'U4V3JF#W,/AU[_.5HOI;#E-FP1D
MDQ57,0EFPEH)>U+"O!#ULT[12//0 SKR0?+<BKX[H3\-V3BE:MA[A45D&U9K
ML&9Z?)C7']U9[ZN/'Q?XD:S3K85S(X+*R;,,DA9>HF;!IL"<UM)K159K"*>X
M*?9>\8]-<Y*R-=KDUX<+C[T+/QY9\!V23"*0J@R<5EPP,1U)@4(&8#%GGH7G
M8+"=LCG2HK_/K?42)*Q%<>AP=0D8..E?0A[75:X0F;=.L\(C*64O"ZHV2<O?
M84G20=)^%(Z?2B[(_<QP2%S+J"P+H)%II#^B*H*A5 B\1.MYDTN)<RM)ZB,(
M3Y8D]6'(BZGFZ+"F'R5)_4N2>LG**&4=>S#ZI0AQ*L981;O;.:>8ML756:J<
M%HBEY)RME\=IKW0RPMNK).GD9+</?T<O2<)8+-;H.WF@M7E_3 RT\#6RJJR3
M)84VPO<]E"3U8GRODJ0^7#M>2=)]SVQ>KCRWZ]EA>?#H9=<7-HI;[K7>K8BE
MM,+E*#'SXK3D"NI]D$G<HXA)*_V(I.ZQ\H%*SI;O+A?I4_V(O.X=A5'+,E_\
M\L>[=VU*T/J^O65)VD&4V!(#C)7W3E@7I48A0W;.H#?2%>U,,D_.[NN)X^CQ
MZX">E+)4S"6?2&,;TMW9!(8JEY1TYM:=5MAIL/CUW@BV&/UFOEC_>!) ZBP*
ML"05J9P8- O>!F84:N-"X@BG%:QX9"$G: $,*\>#Q2"&D(160>I]+GZWH^]B
MXK6NPP8D2[I48T<!"T+QZM.2J8])<=.N6>4@2_@^I7E\[K?P^ >[R>,V1F^<
M8=Y;VI">-F240K 8T*1H912ES3B^[_ 2_R#9/0K'3^42_]J%75^ED.69T"=@
MMH!D6@/4"2^<H8!00]>RM&D3?!?$R[_"[R4&\X'8T> HW+K=Z(*FY=W[*=R:
M[\^>1_A\ &W;<UQ #MGG&A UHK;' ^8+1\8#IF1#,#$U/0Z.>,7<BM%]2#IT
M?>1-@FR]8+QV("J^#W_1 ?:-_KSX>EV @\XF&2$Q'PBB5I$4JM6"V< !BBAD
MG&W5\C]2&]?CI>-;S8<P9SX"98]WE5NO%3=J;[F\_+RY7&QUL=?A78VN\?JN
M<NO23AD>H\A2^*(U2N>S,^2#<S0D0![3(Y9MA[<>_8K.&"NBBX5)4TA*P6@&
M+A=6K(I -K5.]K1&P!S_BNZFM?4=MKZ:Y7_BZM,\SR_F'[^]BK5$+:WHH!&6
M\Z2(IM$S+;*FTT"*>B1DI8H1)9Q6__[N:WN15Q]]I'VPB[Q&\G)*!2B[EOA^
MNOS/FP76-$Y<X'+U'E8X<1EDS8RN/I*J#2D4\]HZ9KA#X^BK$$YKU'K7E;V@
M[=!*'EONEX.%Z90J5W8M\+K"X.?IUVDFVV.]0#(AG3$>6%:FFI"TMB!0LISJ
M09:5</&TXF==5_9CMS3=+0<+TRF5I#RUP ^X^"PFVF@;0#B6>>URI+VA<R"Z
MVF(@%@1G,V]G9359TH_],5C@:5CQ.:518T^M[%_S"WK,Q73U;;WW$\= FE(R
M:6,M;!; O.6*6?"B6)Z"3B]'D=Q?VX^M,HHJ.4"@6DSU&BR&XVJ?3=2)!:QS
M#E!KTHJ6,T,_Y2K3J]LTTOX>@[<'>=]'X?A)!F^]LSJ$4J=R%%M[9B7F@7MF
M979)9&>":.)#GU?PMI<8/!6\[<..]J&\+FB^J^!M+_8\'=/;A[;M.2ZC 2\Q
M,52<3E6>@(&1@:5D$7E0X'P3V^[4@K<#,KH/28\9O$T\%Z'IY$K2<;+""F<@
MB%E:D-<23,P/TGC.('C;BSG[!F_[4':,X.VFQ^('^!OWBL?>_><'AU@?Q;(5
M-<TF(G<.3=%9D[L0$S?%!0UHC3%!3QY!M2==UFK]4.I</61(&NW"M46IX%42
M1G  Z[4J&(7V*?CDHLF^*I4G$>Y)KYLO?\(9K?&0EI,=GCHD13LAWR)QS-+$
M8+72%K2).BCAN-=16:([5_>$L<,:#J+Y;_/E\B<L\P7>^6A(\C_Y@N$YT7T]
MV_.Z).C: =@;2)H.;\^]#5(Z;55)*MJ'3.FZLCWY4YO87I)R_O8&<VTY>_-1
MO?2 6;[SJ^_QRWRQ.JC6<9@7#\G/H=:_Q6>=0 5#NI/VG;8V^EBX-*XDLGUD
M%GPR."7VY']U)>>SZCS.R\]8<+% <A?_?K5<XFI)+_]M"K%>@DV'VJ][O'!(
M?A^ZWFT]YHRQ$*0),NDH7;!H3-9%D+.=7+ZWGP];^9[\_1T6F];1PW#OP>.&
MY,W36+>KBYU*)?"4-10=BP)># CD2"HN6"DG3SUXB#DM].37\UD=#X&S].WV
MSH\T;L 4!)/%>J93RBPX+5CB%D,R= KD)CW3GT1UD(-V\^2KJMLK(^'M%ZQ4
MG7VL*NHUD?A;A/2?UZ_>__+'J[2:))$@"Z&94R[6E@&>!8B.OJ4?8O'DQ^A.
MKMI>KS]64_@AI.*>#]>>^ W2JBH5+E<UU/-?\[@D0&\+<=6]_E2O*G^=7>FV
M1Y8V<=ZC"2FPS%5B6B$R3]N:N90YN!B4U+[%#CH(]3D(W/CL&_HNZ0'RAY@7
M"'7&[>;O7V>_P&)&Q%N^P\7Z\GQ2A%(IVU)G*,I:<)>9!R>9%3;DB('ST.V*
MZ7 LYR!3QV#+@,D\:_BW:>T7%_._8)8> /[Y<D%H-V,-)\ 5&.$Y,SP5IB%+
M%M%X)@RH&$-)P<M.$M3OO6<C+0W)W2";Y=J4OR'&'3M^XH/4R7-@H03+=$B.
M:. ]RU)RCI"3#4TJI9\"=0YR,CCQ&Z1L//#Q_K$@6VTBDDNF8.WGQNF/9$E<
M-:^E4L&XH+(I7+04B?MPSE$8#B#X0S$P!VF.N^-W;J]7E[_C:N(%2K+1)7-9
M&Z8]&>L^@V,9%48O;2S;J<Z/:(G'WW$.S!V2C ^Y:X>9V;HV@N'S=+966_^-
ML/AS1L^_\[.)REYBS;F0T91-ZG[,PC*>>4I.2)=+$Z>F*\!SD)6F3'DH/&XP
MX;E#@:M>R<YZ4*(P[T6MR_:1@01@DBP=0&%5R4WLAD<1C95T-X)0'$3L4\F/
M^^ER2519DB_U/Y?3Y885-2<D62$,#XX!MV3SB%KH+6O!D$]9J)AE";J%X#R"
MYUA9<P,Q>SX\T1ND1^V"5;]<X$W[U@X 6^;(/8OP.&ES@_"S@XP<SHRC2$U!
M+X3UDBQE2Z:53H:^\L"24%9A+ERV:69Y)&EY)O7N.,+2AP?#3YV_G"V_U7CT
M]0!T[\ '71C72.82O9L%[RWS.BDOZVQTZ-8Z9?O)XQN? U-^/A39&@1C;G3A
MJ\O5I_EBNOJVEEL4,3A+SK# F)@.]4(U(#!1)/G%Z$V)3<:"[H9S7H;" "1O
M4)#Z$-7UQ.H.N%J:!X\!.XY5, 3SGI6' RC?P!9X%)\I/-7&40QM3O7H2BS:
M6L64 0MFF7*;3I_C2L0SFG],@>A#\ :"0"APN9JFJL-6BV]7"BRBT@&]8L55
M!>:38Y&'Q%Q2F+P*IK29;[@3S1$OJ@YBUO9E]<&4;F JO)DO</IQ=A\3";,O
M03AFR6IAVF7%P&C!O#5H0HP^RR8)3;O G GS#Z9SB^8N*UC5R2^_T6]>_-?E
M8KK,TU1I>P4OD_C%5"1SFI,]G!')Q=%K>QB4+%:F-E/PGL%U)A(Q)/5',1UO
MJ]"LRL(59#9&0B8$V<DAD'>3@U"HLU&ER8WCXY#.W9?8B_0-,A]V([LN'>V
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M 3UG,<=B'#B=VZ1"]4;ZXJ6D+6\:W*7> SR142MC'"<3#A2!,8Z%.O>*=%A
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ML4*S'*QXFQV]'SSB5=/V@W&?4'%_WN&X&"PI204?TMB*SVI\Y@A<J^U4QO;
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M&?+1<=37W "]^4#'(TT"HF7U2 #B,G*74N5W78"'[D=?G=R_!-NE,')/_"F
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MK!;98P.2_,"HNN$/]5*#"B>LLY;6=AY^*BVOJK:D:W@:X?@T2:'T[=GMQ.1
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M.0.CPA6><#96DH#1> 3_^W@BA\^80OM"F5XE?[+'+?I8B=;,O!>9N7O>ETA
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MTLM004)5/2?.IJ2H2B!+B RNXPIBK(G';VCAO4L5I$G \0.<9UIUW0)G1;F
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MV=K<;-D_/UT/U)LDL!;41P=(H]?*DH9G(1O^@I+)%#WRHC%9=A[#T7,QI%S
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MJ<3X37,"SW!V4L_;K;B6T^HO-%$SR(X',39OI%4 JPEU"+8B8!/ZNY'?Q5^
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M>.[NI\5?&$>^'SH<X@2E,. 4P902%T9Q&L=Q&O(H=F?W?TDY3Q%W8L@9]6'
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M9Z."W*1NE0"U%K/USL'+3.Y18P8^HXS.P#\8*L#-TB!?7@JBT?X!0V49M\O
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MH(]K<[Q!Z2;UK7\5,DCG6/;O?,=(?>3P(7MF=]^%#"]MN=+FG"R*/$;BE,'
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MY_@WA[WA'_/EO:R>)%>?.WGLUTOQ 2LK&;$G%H<\]=.0"O0HAT&,&,2>(]Q
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M1NH%29V,P^BAS(U>A/W@[!P=6RKN;=JVD&T_JY=CLQ?XV>A0!Y376HR4/3,
M23L),CJ"O%(.S "LCJ>Y#+F9N49JG\4JD[S,.6+8C2B') I2&!!.(484P1![
M& 6Q'X>!WJGMT:&F1I2]AF#7FS9JMP;;J+40*Q[;&@'.]K'MX29JC9S@6_NO
M%<(ZCX_MMFKM:*_>56U;:Y6F:CM7Z)$(9=G\_;+*JI?;1[18O%F5V9*5Y9QZ
MOL]C)ONNIQP&LE4-XC&'E+&4I 3Y+/!5F./(_:=&%XV(H)81=$*J<<0Q!$\3
M@P%<++.!'B3*;_P9Q3>O>=F]YR4C?[[/GW\15S:ON/AA]\T^=M=17N<S*G7O
M\+FO#9O]94+*9I=XXW(3%%'?#R/HI4D$ X>Z$(7<A1X-XI1[7A@PHC/U'QEG
M:B]RG8!UUR5@Z<WRQZ!4F^(- &3YC:ZK0O5/H*Q,Y6=P,#F/'QMJU$G\C+Z[
M,_BYKP]C@77<:&]_?U-0Z;\SL08IR,-+&VK(?9>YS$<PH$PL"US.((Z="!+$
M0B]D 79=K0IW6J-/C3%Z&0%K2>O]DT]7?QL8Y:EG#35ZL8:Q9=*Y#%YM]AD$
MDTE.TA-@5*8:A,TN?PV[R26=TDY'S&_ZV_?KC[[_081KM2E/WU:2GM,T#1%W
M$I@&U(>!\)$@#J,(^@YF:813S_>4EC76))P:.U[7);EEYDS3RSE_6@>\L,>G
M1?["ND^>Q) /\D3N2=Q@V+&<>7NK<>NK6M'V,DXQ,VY6?] >^("?6WW^-#M<
M"WI3WG==.-]TJS0+YC#?*,VDD*_0)LT"QH>;I-D82'^CZTH\L%0^M!\6Z'X>
MI5X8BOD AIPE,&"^!U'B,!A$R!,^L9.D5*DHZ-Z=I\;A:^& E$Y]5VL;KO/[
M68-!L$R!BOIK;6$=U/6"S:OM^XVV;750C?Z&U>$O7-"$8^\UWR\5_V:W5/PF
M*[(L5X]-N]ZK)?V-50\YS1?Y_<L5+JL"D6KNQ6[,8^I ZH4$!B%'$&/DPH@D
M#@K2V*>!UK;7"#)/C2ZDU&WP^D;T ;TZ+%M:,:9@6O:S'8%P>7^/?H&$C>:U
MP]_3'7SKM#<9M3">K8QW!K$L]O@]0\:QP\%N(B,-/7"G-5MF%?LH'%IZO:R$
M6!E>-(%SY6_HGWE1ES'\)-[1=G<O9-@-D$^@S^6.0X(<X66R%(9>E-(H]".,
MJ-9>J][X4YM<&O%A+3_8*-!$F):R$870 33%-Z460W=@-:VDN =K#WO;N[#&
M8=??F1T&GM&]64T1QMV='8;/WO[LP-N8[FK<K/4_LR5:U$T_EK2KDWA%2+%B
M=)YRC"E+7)BZF,GU=PI3C!+H>;[KX82)-7ALIK'Q65FFQI+K*J'2[7KJY 9M
MYSPHEF0 (W$%T=Q@O<1<:A0YDA$LT^7I;L?=+NI:E]I,:YNUZHS1\U@9TW':
M'I\79R*=CY5Q4V]^K'Y+<R?\?\^JAZ_+')>L>)8Q@75MEW)[;U7^NBJ*;'DO
M,P/*CQG"XJ/JI6F1YKM)G"2RKWR$A'?J>RY$E%(H'%,?\XCQ*';F3>/.VPH5
MU?!X@(MEU:&'78GM,<4;=I\M97K%,$*V8U6:>"&G"868R,+!@2P<S$@$XX1A
M$J8L)8BW5GV_/%,Y=&(V[>2U&?=()V;.X0$BHQIHM$"2V586\W>A(^@KV90<
M*_?.-]=ZUCE28BI?J]K<UFX0BC%3V Y6N5S05P]J,8:U2O"+N<&&.09=''&O
M.N1[\5/UTOD?UV4IW(^;0OXK!>RVR;+[I7#K$Q1[,?(IC%,LW #$$,0<$TBQ
M%Z<TC'#*E"I!F!%G:@NQ3IM^V==96R VYZ!L4OFR6B6]J>)"LZG-">,9PS+Y
MK^UPU;=#H\MFY=5H(]X>T.DSVQQEU"J9XW@ST)HD\PLE&I6US:"W2\^&[CH\
M$:.^KP#@;5Y6@N67[(:_+1C-JMX)1OEKD9?EG"$<1USV%B>I!X/4#2#R> !]
M%/D1C@3OZJ6WZPT_-9ZM4Q.R5GQ I/SZN1L:Z*O1ISU,+=-E#6<G.:A%E^[N
MLIZT&O'[1\+BPUH#LTD@^LB9S@W1D&#TE!%]= YED@RXRP6Q._C\P2S>/9CM
M?UU*Z<Z9[X2)*RQ&J.O"@*0)1'&80HQQ$B<L(3C52DHW)]K46/&SC*0F_3B.
M06'5!FVG$70SND5&C*TY& ?=QD[3^C3@+7K**K20^\1UW:25R0!I\_@:CX<Q
M(]WX82]&43T8W6)VA)$C,;?+F%RMJH>\D,_XW/?<U(EY A,OP# (7;F-X"00
MDX RZC#F1DK!U-8DG!JWMU6 T#/*%O6N)1?+5KZJ9&+NO=!2,W?9O$4UJ/ZU
M[#0BXP^,IMRK^K11= )QD^=L,(DHR:-"_C%B(L]A;"P"\NQ  ^N55@^L:(^P
MNWWKC)5O5T4A$^Q0[$0)82YD ?=@$ <.3 CAT&,$!U&( P<E\V=6X%RY/NG)
M 77HH3^L/99H106+]6F29/+?Q"*,R%)[XA5:+37WAL]@'D>8L<C!,':XF&O%
MF@FF+$IAZB).2.PD--:K"&L,\5$Z*$AIC>*I-M.90\GRM%4+VD4A@9ZH,] *
M:[!FJQ(H1BNTGAYQW'JL2MKO55]5N^K26JM'DBK;I.U;F;/]N4W9EOL,5S))
M4[#73N7.V$4)\02UAX[+8."F%(JGCD'&4Y)B'L6>YPRKPFI$OJF14[\$:.OQ
M=4JT^P)]/[+=,2CK&>/][>?/0VNQFK&UHL?_>A:T[>_O&N^ [S\#G7Z@5G!M
M7B!5G(%.R9'*NQHU@9W"KV9$?*62L$;Q/5XLUNPP YJ"R4VE&_Z;P(BL%JAX
MEZ'[92Y;1MRQ4A8*_XW)Q<4<1SQ*TU!,!#B(97:MF U<+#S/@+DN\YE+<:+<
MZDMMS*DQO)1:$L1C)S>@:\%!U4BNT;1)$?C3U&P)3LMT6R-YP\%:9+"1&;1"
M@V^-V#I]L!0AU>AN91[:D7I6?2ZR1U2(%>FZ%U6Y;M-(4%/*)UN"[P\9>0#"
M+16KU:>\D&7+.2)5"1#.5U7] 5%X[+O3*?" GAD0:U1Y<[)8449-=<36L\3)
MOE6*MQJO&Y6>;EL]IC0O';BT6.&2_6LEGIWWS_)8>>,X1IR(_PD]2)B'8< Q
MABEB8F[P'!*DCI,PPK06"<=&FMIDL!$4U))J^N]' 57TQ$W 9-NGWD&HM%1U
M]"P61IW;HX.-ZZ:>TWG/X3Q[P<C'B<T2N8G*NUY^KC,\YBA.TSB,(^@ZH:S+
MQ$*8.JEL)^UYD1<'V$?C'"4>DFYR#-2/0 :KI3!:/5_+9<)()X@'C6CY]/!2
MTTS_Y+ U;!O2+)RT1LD)G!J>PGX2)X8'!?QCG!:>PM;82>')0096:NVV*ECQ
MG!%V6+1/>=V)A=%:BO(NK]!B-[+E4U[]@U5?UDFV]=['35//9>ZD.,6NFT*7
ML4CZF3Y$44H@B1(:$C^FB&EM1H\B]=1FC*W<]K)'0(<"#<6"<('D>K#*MPK
M:D9GC_-XJ,TYDS/ZB'/1P;C%M:[=U-/H,*OCQL6G%7AA%=CH:3Z><523&"T"
M.XK@XQ:&'=,6>\5B1QU\V%1WL+%;VVNQF5EO5E59H3J-_(K^<]7T'IM[C)'$
MB3!$#N(P<$D,42#^XW+'2=PDCGRF5>YFH!Q3FXZ:^L!R:Y%*V7<KC6M.-$.-
MHS9UC "YY<G@6%O*KE=HN^KHJ0$V>I@C_ N!-$GA0T49E90OQ&N79B^]W3#B
M_%SD3ZRH7N361'6UI#(U\ZE9I]R).\K>ZO,@\E,2(P<RV><\H$X"$^9CF$1I
MZD:ISUVJU9E&8<RI$6+=P:HIU'>W5:8/?)/B:A9"5 %=C?P,0VF9Z :CJ,UE
M&KB8Y"V584?E* T<=OE(Y])AW-,4Z+KM#C\_2JL*[Z*M_LDP=Y'+'$BCE,&
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M5ZA^>437PT4OCWUYX+I1&%=V,J^#V%V&* E"N8GOB(4@D;7GPR2%+G(3QI.
M^K%2:;)#-Y_:VUWW!9'"#4L)Z,.FN#0;"(;MM98J#OHKIP,*&UT*]>\_[MKF
M@&9[BY5#WQGVCLI-[ZLEE?_(J/YGM)"3_KJ/YKNL)(M<MM*<$X8<&GL>#$.9
M^H/=""8!#B$/72[>8)>G6*LMD/+(4WN[Z^,AN5%*Y ]L(_L,O!?+QD?4U&?+
MBJ8/I=[+KVX/YCA!D)(8"GF%\X2Q^"E,&*21SSD*(B_$OEZLBQ6+C!/U<M0F
MMM!7XV4KB%HF[364]0_O^X_WIL4SV(ANCM2UT3+)^.J#CSH=:&.R.U?HWV!
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M,K_4DC7] \MZLTGN61,94(%:F?4H1LL8:IQC'.!Q2*@36YX1M.*!C>1-HKC
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M.$UX@*#/9&:;@S!,:.A!XB O3M* AFI-RL^,,S5.:D\[UG)>V"=L'U<U4C*
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M39L<_884N:AY<K7756HG3>-L($N% >4=?+"NDV9GV4:8BH&M7:4!J%4 !SJ
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MC<Z@4GH*<^ZPG9O"W(^TQ9O .^"V"1QZ;JYN# <;?+S-XM#X'6P@!Q]L,IT
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MM,0O^^R5.C;VM3_M0(_9M5Q[7VS.AEY#6]-U99T\F*_9A8FM2CS!(/UEAIF
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MOU,R<'J0)V%?.CW(+^86Z4&>!_0:XVUO)@X/@RA*],(2:V>>ABE$4O^-!E1
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M32E!):7/3.BK,/A->#X_U,AYS5?U/4U?OGYYAUXD>U*@DBYFG1>KY;UZ5<6
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M83S]^NN*E,1)FD4P9$&F5Z$(P4Q1 A,1QD$4992$5BSN]D-.;<G9"0W$3FH
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MV JS)WY+UR;'OYA3I;*(D02F*M-;4T)2F$49@01'(I+: A&^\QD?.G!C#ZU
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MW$1YH1JE3GA=KECJ]KB!N N^;.AFNY%O?S[EZ_('Q9QE2&C/+(!Z2Z<@(D1
MJB*FMW9"8,(IXY%]\D,W&:9F4O_4;\QZ0_-E657-JD8(!2@JP0T+?ZXG= :6
M%<VRDGJ&Z**YT',Q_)DINVY/1YJ(@6VI-3U!K05HJ3'\#'@F(.@W$Z-3#GB<
M$?\, Y>Q[,TI<.;1TV(1N*R[,V_ E4=U<_MM!Y5F?=2OP6)WG2SF.!09Q9A
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M]OGJ_<$;)?A22EGU4 9?C9S]8;18$ON#,W0\I<*EE+!FR^ZPN%UZS^R7L/Y
MC;10G;Y(OA:CZQ!<77(NW#K>PG)=]H/EX\:EW<)!'R0MI&$1>/_XM%Y]KXJ
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M(T_-")@T+"-YS;EK#I]-,H]JA ?4I >5G*J.K?;L)\/.=@P"\< FI989O#\
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M,$*&2P0D(0M@R$*,LS3E^GMEK2MU9;"IA2J[](@OZLPRP4E-Q0KK;G+QC>#
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MVPDXSIG(>")"#)&@"40!1A +9;K+R5"%J92A=#K*\F;9U-X=[0RSB[N*;>\
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M4CV-LE2'G1ID%&G.P22".-,+TQ )%.$ :]91UFO2LT-,D5^,=0YKT//062Q
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M.>=QEDF>0I08X>N0<H@1)C C,6%IA"-%R7QCENYV&Z?V0SN]R78&#/@FDQO
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MIC#CF$.D2* 7=/J?"J4JRA(2$>DJC7:C25/CD/WAS\_&5D ;8YUETFZ=+[M
M9]Q9&'KWW%)K>]<42D]5XV'5EZ5:#NZ<!#LO9V;%OEUZ$.?VC[QG(;9;K1I;
MF\T3BF?DVGS=N:^TT(-Y$]1UE%(0&H8!ABHC&*(X32%6*84I$TRO'-,DPE:9
M^V?O/C4FK8TK>E:E'B)GN=?5%X^A=[&LH>BA 7/&9;\:+^T!1M9P.>/;J4;+
MN0_U>UKO?M)\8;:4/JS6W^E"'O8CK[=[39O78O.&%GIIH%"2(4P5% %*(*+Z
MJ68!BV!*DB!1*"-A*ES2*ET-<'KF1TBNW-D/U6H-"^W!#.RL!ER;[48"SA-B
MQQ-#PCPPE1A3P=Y6#6\GY&^[('<FF[ZX^>0C9QM&I:R^"!VS6N_[#-3"ZO-*
M!TM-1OLG^4 7W^5F4VUK%7/.>,@C/5<8DUC'-4(O*U7$-!<&0@F<(AS9MT&Y
MV9RI!4)'M5,+8RXH=O9Z;L_4/5/=_#@^_A-93)I2*K#W")0N@99/HTZ2Y\9:
MWB9K]&Y;>:N:RDS::4D5Z'BP"E]U5-Y OKDU5_<HT^K7986(<Q,ON[L.$OY?
M+.[_7:\\]CH7-*-A(@G5;S_S,@R2!%(>$4@X"\-88!:%5B]#KU9-[9UX+FKU
M(1GC=RJ]K";\3] DEAA= B;&,[\")H-@/>*RQ-*P*:U5W+!T7, XWKSGYFMS
M$/=%-8?Q^Z[3@BL2QI+ ,*:F+%:D$#-%(=%DC8),L"1U4POO&&QJ[+NSU:35
M[7).^K?W[@3:<NO6$WQ#[^3V1\Y]:]<"$J\[O5WCC;OQ:^'YR3ZPS34]=D?^
MT'9S357K=SE]6*Z*3<Z_:E_H.B_N96$JS)I>L!Q3@5@*1:@X1")3D$H:0QE1
M@7G"91 PZTT0VU&GQBP[NX'8&0X@:&QW6$9;XVZQI3$$F@,3S1[(O<T[&$%M
M=9_N/=:X.NQ"#('O2)L-9[^P.YPWE?6^-A)<<>K<+["^V7C; J[^':S^G2_N
M%Q3JL++J(?26KM<OJE)T_Y0_Y=4WK?BR_%'(.8\9T62>P12%H4F4(E"OZS6M
M4Q5E:1#A($M<HD.K4:=&YM]D(36^CX!77:Z*+?NGY&7?J\)LU&B[08RC68QC
MMWC1;@[L D?OR Y,[&8'NNX:UK;8],;=V0Q62_"CHS&/<RCI!)+/F-)NX%&#
M2R<LCJ-,MXO[,=2;;9$O9:$7R?^]S8N\O*]FP@^FJ.*SW%2;HT90=!Y3D40H
M32!/D(1(5HJ%&!*<<H8$"J,L=&$IZY&GQE1&;:@Z+' C(GNH[<AH$  ')J3&
M9M R>F9"(%":#0RV]>G9;\;TO_FC)6>X?%*3_>"CTI,S)L<4Y7Z#6]+1=\ON
M3V:V3>:D*9F(!,UPC"5,L>F1*#F%E)$(HDB(B*@4$^DDS=0QUM2HJ'Y4]AM%
MC;&]!!"Z0+:C)$_0#4Q"O5'KF;+=B8?_7.SSP[U"DG6GW^>SI[LOZ;DS;YK1
M,UJ8#*:]'&;YV^)NNWE<K<U9P(^EOF/97_O+L_G[5_V5*=[_DFN>%_+K.N?R
MF\GC_K+O8U]]KOA/F3\\;J2X^RG7]$%^DR8W5/_9-!(Q^X%;NKB7ZZ=HSD46
M,D58O;B3&88,:<:*PSA-,D418LKI$& :?DV-$QN[ :T,!^O&<L#WIH-%KG2,
M\:+7G*[J"=. W?:H8QK63HC]2]]A"0GX2E_*%\#=>FW\,S_/0.7:##3^@Q(
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ML<\E]N$ HRZ9S_IVO 0^_Z&^S3'T8Z'O5TNGS%/.XCB,&!2!TI%H&,>0!IQ
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MYES*-(,&20P50S$)5$"(L%J+7QI@:F18VUBFE]1F.DMCG 6RF]U\P#,P9?5
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M=G7RC>E) RCO _1-6>5K/9I\)ZO_?ES><5YI*-"7\H&F@O&,<P83K*D995A
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M(.LR,\9&+J4BCBDBITTN<W0KF\&S[B>S-?"DC7=+AN[:/Z>Y:#C4>]\37OL
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M\>9S,^>8ZWZW</9:&7CCYIB7^]LU1Z_L&.!Q,!*E%8RU>/^VN:8.UBI#3>H
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MA$D81DY*VE:MCHU3UD:O]UAW#T,L#GDOZ 3;DR7/T/9^JN0!U>Z%4VQ0ZJ6
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M+*"U.$[S!EC/3'*L!D&7PZ[3H#F<7WD#;Z CJ6,OG*_3)2L\3AX8G7["<&=
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ME1L9C6=CFR5___';HGJ=].OU_Z,7R/*X8"SVCFBF[:%ZP5H4=[.96266+35
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M3G"60A91!!'1_Z&1)IB IF$B8JP2&4^6\R6=VA',N0:=.&;=;(^;0::-=;R
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M3*($!3Q+(JAB1B'*B-0+-CVOTNR# A3$&2?2+5BH!RO'%UM43H%-%ET97K$
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MWG?*3K4Y_'Z9!0('=\UL[O-<P_CS6@F)$APE01K"#!,!41PA2!(6089CD:&
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M6TPK1J5K1:]%J;E3*SGD,S O-P5YVZNZ-J3;<'J]U\EN?!WWVS',@+L9+?5
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M45N;59=ZOCYXN+OA8&X[HY^!JRW"*M_?Y1,%9[ZOZ^VB/OTZY6CLJ*>FIXM
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M#^G2ME/5R/&___R?X1/U0^^*_?-__A]02P,$%     @ #W-P4@K1[$C\^0
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MNE:];(RHA(OEA)F, 5(*Z!0Y@]A6C+C,%>$Q&*&!.6F'J/A^BH;=$-)\_G(
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M0RMAZ$B)-Y!K^'4Z7W17(X-@N9IXHYD(WI+LJ$+@&TI0)(DP3H$SFRSS58+
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M22)G-$5#'=-52GZ?I&I<&U476,.IHP%LO;Q8HAU?+L\6YV$Z[S5T?5=G50X
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MD9%7SXG@T,"V](@ ;EA)+B8O+!$F]CNL6=>T>Z:5==XK8)7N4VZEJ9&ZQA/
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M)TN"+9G\$ ,)F05"K6(N<^]RG;;-)TPXG;+A5@,)IWTT>F3"Z:?Y[;[0I[F
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MP4_0-/)HZSH(&DH'#<#IL9N!:TLZH8E+J1T0D0UR(K(B/OA$J'.2VI2TJ)-
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M']JODA@/AB>R($'6SJF2P$4F@:=HC;3&%-5FR]-C)^JDJN/X*+D[7GX0D76
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MS!>I[3:;/[:3_LUO'B>X&4SZ>S-Q;$_RB0OPUZM^:Y>B\YKN/Z.05S@;J.4
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M:)X[V(CIW(&$O[W7O;LD^D;6JY3.OYVOA_C??/&=I,23MLX#.D7JJ$4$TLX
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M;33FAOLXB5P7JX6B,!?K+<XS.0\E@2OD0\BB3#!-JLB>.=>XB=+&%FM?_G<
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MG,)ABED"!.$0///%B:(K,SK1DFUIZB$,?=%JU 1<W8?(]5GHG!3UY]W'R]K
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M4)PI^L.3IU.4ANQB*E)K;>_G1>\'N,=>NAOJ?M9+LZ8JZA1Z/_CA;RBZN_B
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M]5_ARW2V5DT][OMC1JJY\]E$9B<0E0(1->W%V4J(-26(99:2Y<+FTB2*W)7
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M"2V_7"ZG,UPNK]E9+ZT<;-&8'40E*!IA4M099PFTS+XD+V52;>[QGJ)JY*N
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MWPY,RUM<W1K:%ZNK9C_KZK7Y%ML91 Q)*P?&,[*=M==T],R *$%SH=!ST01
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MG"[[1.YZ(?Z^F":<6*L=4\X#5_4 HA9\><<0BG=*A>+0Z*;%/X]2M1/N],^
MNP,UT0&L7B])IG^^PJ]SXN35=!DOZ<EK)V8S^.CC_'JLXQU^^42GE+0J&HJC
MA:.<D+7BG(R_UQ91!59$DR2C ^G="8KF[*!X"NUU -)'8CABZ]MTN:[>O9.8
M_-N,& P7+])ZX,.Z:7::UVS=%;[(_W5Y-:WO5WK$+-5?NYK05K0+AOX'&0NM
MV"@Y!.$48+WY1,90V2;->YMRM1/@[=D!OA\D#%TQW<OJN#UO7DZLRBA=DJ!K
M>I%B:,%%D@=/.I<469!MCTL'YVBG5>'^YJOB4 3\K"OBQDJ\F88XO:"_08(I
M$67V.8 IBH$JEG9027%$2C)'HTM1HDF"2'O6=EHC_F^^1H[&Q,^Z6+;.@)]8
M"H.T0MI<O2&?,P0&7B<2EI.1],ILVFE6XL@K9BM_NUV?L+_YNAD&'OTLGG_,
MY_G/Z<7%[Y>+]#DL\9;[6YYK>@@FKW("4PN8%'>:PBWDD)620<N(NK 6T-^)
MNMV >WX7?\.KIH-(^"HQY.*QQ)#-E5/F$QF]0>XB(#I1!Y04XBE&\%A8\H[;
M')M,[=F%N-W0=GY7?X,K9NQ*G6NJGTA%JN?I5ZI;+B^_?+TJ/<;5R[#\_.O%
M_,]U(S-:<>_)Y/Z.BU2MO'=26Q$92%E;:A"0:AZ1A21DTDP(G>QN+:F;D+<;
M.,_GKJ\3179@-W<0PK^P9KUA?O$-%^$3_K'$<DGN?<%)8DSQ$!V0C#THX@]<
M;82,)::LT%F43?KM'D/T;E ^OTN_DRFR ] ^(L27\^7J7;D6PFMR9U;?UQE,
M(5W_>#D1PN;"I ?K6 :EE8.H:Y8)"SG9D@(1>Z++P%WHW0VJ/\4]X>#JZQ.E
MF\FB5Z-+,6^R2&\X_G6^>!.6%/[-+L,%;2C3>9Y$'ZV7/E*\1S)6L7 (M6):
MF(R1OHJQS6SK0:C?#<'G=[UX>M5V@.=-S]W9I]=_?<79$FE!*BZ%#AY"I+U#
MH340%+GMSLO:"<YR[9O4)3^@9#><G=^MWG$B/Y^^4A_GJW"Q+?MXX%Y3.[VK
M5<?1O?D\14\J*1&M\+2E%@I4E(X(SAE+=L@:$PW729[J-G.\GE1&<"5CL6"9
MK^./8AWE(C)$%5E"KR6W383P$_6DV@='1_>DVD=?'6R>VSK@%)N95-& "?6X
M0 <!,3@.-F?C,0LE0]/KTO/N2;47"';L2;6/1CH%UH\-=8SFV=*F")GB)%#2
MD0,B/4)1-@0?6+)M3KW/M"?57OK?NR?5/LH8^Z3[04,EJ5.,F9.W&84&):*"
MR#%"2LF@YUE&99]SR<ZR)]5>6GNR)]4^(NS3NMQ&-B()[YVM$R-%+7&AE>*#
M*B"-2":E6'0X5;.[&Z+.K#/5P!O88;KI"&=W_,KWF.:?9M/_P?Q;)M%/RS0\
MN#E\,<MW\HS6ES28KZ;]K#:IJP%)O,X$*-G5>^P4P4M50V?!)0IGF#E5/MHP
M''5G*P\$W?/I-",@X"=;"O=O@-ZM/N/BX^<PN\X!F42>4(G P3!GZB@'#2ZS
M5%ND,\YD-%B:.H<GX;+CJNI>ELRP2#EX&7W#19QWN)!NT_'(36.NV  \JSKR
M5];$;VM &QZS=XC^9".UCN>FXQ+N7A;&89K_R?:1M35X.Y^E'S96SQR68BT4
MIPLHIQV$I!'JK9:I4Q3)M^U]*3S*6<=UX;TLB^,1T<$2N=G;C+(VR*3 %\U
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MHUZSO+Y^O5A[G^&BKK9?+^9_WLF]/2S=Z^E'#I+WM0?5@R6 /7SGZZL/;I.
MG"*CX[T&@35G6-*VZC J8,EE#!E]D$VN$'<A;H@Q9O6Y=]_U:KI,%_/E)>GQ
M-O>19\DPD!OJ&0LU$TI %&25C?$%7;)9YB:6:U<"Q]X]!\;18W/.!M?365JO
MM9=[8,KJ+@]N;\D>X^"4]BQRKTI--6(\)E#,&7#"&K"<O"XC*!C4C:Z>VMNS
MVYX5SZV8JH3;91,D^CIG$HK3 A3%RA!"5I"L,EPY'QUO4T)P&+UG8.WV0=GV
M_FGMM'B6QN^HA/V=GMS>_+5-Z-\!F10V,,)#@AR#!84A@,]1 K?HH[!%B=QD
M"/<I[-]5T?#'\!<N?P_3/-'*)NF- <FD F5, :?JG9.RBJ%PRLDF+6GOT7$&
M]FH?5-RW5\=(O8,CC-]F]"Q<KBKM5Z.8"P]6*] B400LJBB,"I"*B%JQ3/YD
M$U__'AUC'T0T!\WA4N\ -&_GLT1B^6WVC7BX:J?QZW069HF^7I_8W @) T],
M%0\QLU0'W%-(PA@#8;A0-@<>1),!1CM3.';R4V.@M='4V,?\CTQ5>3?[9UC\
MF]P+<@JON%W?P&*Z7*Q;S-<Y]:3,_''^847NXN?Y!6EV66>QK+Y/#$==G&00
M2NWRJT@ SB4%1H80$H7/*>[6^7]@PL;=.AMA9]Z)(GNPH_CG;4^BWQ?S&7V9
MKE;_N\55VZ*[78M^7TQ)^&0PKF[[,+'D;-1@5*EYMF020BP,DB\AT8X2#&N2
MJGX4U6-G\+2VMR?3: ?PO5VTRU_GBR=87R? I)B#LXY!EM4QSM:"Y\F $5([
MDY0TA;6 ZUY4CFQQ3X>>^:E4V0%.:U+GN_(BS[]615Z7MPG+0U09'-957J(!
M[X2#P!GC7DKRN)N<!#Q&S+BH:ZC[^<"*Z !,M\+YL JS'!9Y^<?7'%9(OJ!A
M8L.4R9+S6*ND-!I006GRB'2I*5W:!6NM#TW"Z)VH&Q=NQX/@ONT:7",=P.S0
MK>#-3=*$3-*$Q!WH5$BD*BJ(.M4<"BM)TBZ(V*3X_FC*QSW[&6\//JW*.\#X
MM0>^:=A*$69:3;^MH[PWN%PBWKCDVL0H/$F4*U49TPQ<5 A.A,QX*,[[-HTD
M=J7P//W& Y&S)3]A6#5V@,_WTT^?5^_*'\NK$:OOXBJ0P/)OL]=_I;50R5VZ
M8?I-'6]X/=/P^T1'5U#97,ND&2A&'I+CLMJ%: 5*9TP;]_((FD?N;M$&1?=;
M7IQ(I6.?D&[AX?6RGJM-EY\Q3T1@MF1?YP') LH:4V>ZJCKFG+&8L[+W.R=N
M.?1\_EWC[NAMD=5"W/NCQU^A9X:?R._-@UB_AP.GWZT^XZ*>"E\N%NO\W)L!
MKA-CM1;&>G+8%:T-;C@$AA9,=-8()65&U\+<[4/DN%<]I[%OS936?<K,XOO_
M=QD6]+:+[YM;BG#Q*JS"'[-PF:>U-?)QB3///W_8])D]^1DHB>;A.^]F[]PD
M7]TV2;394F@CP08N"*N<P.1$@2*DM9&VR(A-[G?WI/-86_CDZVYST+(G1R"9
M5/O#UBS?E""R*" E;6UB4177)$S9C;QQ_;N6R+IO!1NHZ_SMWR#)T[N^Y<2V
ML&%:];ZX%9FSK)F%F KY>>3T0;0A@+480_U'VB;77">VB+=IND\OMA^3=+FA
ML(F7!*R02)2U#KP0&9ATW*NLA6Z4?GD(M>=E+_?!W?:<ZU;*/'_S>?/C^NDP
MN=B'O?/$IO5YOD<RM*ID@[((\(0V4%Y+B#(Z<A"B<071!]TDY#RUH;WN)G)U
MP5!,,*;>C&'2'I10$2(6![3$74"1O(AM"GA^(..\3.,^2'E@&@\7_\@]5WY?
MS/-E6KU;?,#%MVFZ:HH60G&%95X'B2&%_#:"8Z6.Z44=!$=CTB[>R4X=5QXC
M8.1B@".4.1]0LGT@8_EBEC<<+#>M9XP+*0JO01;I-D?<UDG DM&XR)DTNY0[
M[P./AU2,UY/G>,4^1,F14A[[(N&?]*QT>1$6KZ;ATVR^7$W3QZMTX.NF=DXS
MHTV&4AS)*%,X[730@$I$^B($G?QS/M%.;QH=%L=J<MY*K&-CY/?/@3;?A)?$
M1;@@*;VD7ZM?7DOKIJ-\UC(P1@;6UC1Q4R>J! DZB9 M=UKXL!-4=GSA.-=.
MC1#30L@=W+'?;,EO;G(1E"PY"Y))L);<-2LU!"$$"(Q:.\>E=6UZ;CP@9>0J
MM..]E8&DW %.-I/0KR<]5[_^7]/5YY>7R]7\"RY>_Y4N*%Z=?:K7^O1/KG.<
M-;G]*D<+*M2DPD VU&>!D(T0Q2M="I<M@'0 K9WXQ0?"X^%<D::ZZ@".-[>X
M+VGO7J['B7_%&;%S6Q/%-+>63+"4O.9)"PE.B@#!<>>943ZF)G=!SU+6B5$;
M!FK#ZJ$#8%4^WI5_S.?YKO/P87Z1)X&Y'+*NI<%7+B'M\2)'X$H:)TU)K$UI
M]G:2QK5: ^O^?E;C,(KH %+O22U$P&=BXQ59YHOYU[K^-L*:,&YUB,I#82R#
MBHG6H?8%$G?*L&0+^EUZ\!ZP23Y!U;@VJBVPAE-'!]BZ'L/]<OXE3F=K#=4M
MGV1'/-%7RVE>R[(J;E'S*]=)R3<IR5]J1O*[LN6OW.31\8F7UDO'+ 0F2KVJ
M#Q0.(T4UAK/"E$JY33'#B?@;-S6M+=Y[A$@'*^<#7M"//OT#9\1*C>=?Y"\4
MT%>!KZ;?\-H>8)1*.&4)F"F",A:A'A) EB+IDJPPODF1]V[DC5O-W1:W#134
M >RJ0_/G]*+R\QNI:O9I&B^N<N%_^_(U3!=U\4TB5T9R4YWQS$ 5S2&ZVL2-
MQ<BCBZJTZ=JR"W'CMEUO"[G!E=,!X.X+:I*D<$P;(MCH1/0S4[UGPH*1%.1S
MD7*;X4/W"=D)2.8\@724T \'S7P5+H8]7KGJKO9FOEQ.HG5."$]H#]'1_BXT
M&5HD%J2TC&#OM&_2SNX16G:"CCU/Z!PK^@[0\W8^F__(Q49"MPU*<Q"!D_G\
M?^U=68L<R1%^]W\)R/MX,5C+ODIBO>#'(?+2-HAIZ):$[5_OR)ZCYYZJZLRN
M;,D/$AH$4W%\&4<>\6G4I)"C-MZC+I!$]"P&85B?]Z3O2K;R.+*VFW-M_3!
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M<IV&2^OU1][AE_SQ>WU ^JD<5-Y_^OYM7\?IDQUN CFCVI-5)L.BC27EDH3
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MEI1#HFX).A;- UCBJK7G=TYY=O[;7[C[<J]=REXYZR@)L*CKM+8$Z)T!016
M#%&CS4^> [PRR7/VI]?-D.W1=08'#!#FGE86QV,Z+Y*QQD0(A1>RF7%4O=9G
M,ME)91EZ'_OP9+XFT;JOE=J78&U,/P"&[A;)<4G<7-VU,3M/O8C5,H*2.8*C
ME0'(G-;9:%Y\%P"]+,Y8FU +??W*5)(3#-_P)GW30YH_=WB]W]3?<=/^_K8E
M'6^/)D[E#IS\NQL<OBS3H]%!RZ?=%[S>_/=NLM=^^W63;B!_G3X_4.A3N=]1
MO\^@Q]-%RF%(UBN4T03!B=>;&S%+PA1R+;QA.O49[]%"^I/*KW><=R1<"IQ9
M'S)"3)3YE2C4-6%!,#Q*JBL%4V7:J/VI7UQYON?9<?6H*.OBEC'/JJ>&C^44
M@C._<,:0V)$ZL V C?'2%46(I7(/5$[UQ9K)8*)T-A=A59_K\>L'QB,MW7MK
M\3$QG>&)<<X3B*#J(!"9(61M( 7!1:"V+**9%"<7"O SA,TYJ'L4-L_AM,N.
MHB=<\IG[B3/&T9Y7>=I 6H3"C-(*D@FF3D4+=2J:A)28C,(:'467YR#K!]*G
M/GR5W/.*&\.#]0ZB48JJ)5KV3F@&J7"?T"(OY5V0SOODSQ LYR#KS1JSC6/&
MH)=[S*(F=/ L, T\.3*1YHHJ<&?!>"68"<*AF;)-<V'$@SV=_!XAX1R+CX&8
M%^BR=(Q,)&E!HY=U''X&M(Z1UT/1Q4CQ@ 7^5R$DG.78282$<ZR\]F'5N\QY
MM'086B[ FCH?F2D!3@<-WB=&@9AG9?6D%':)A(2S/#F+D'".6=?&R&2N/)84
MTA\@#6Q](U8@2(H+A96D31'9L3@)*A=,2+@8,3V,O#9PIJ3JXZ%*+L%)I"1M
M6.4L8\8#&HK&#!U*7:1!H9H5R_,.*)N#Z R53&</#'"$N8083Q7C7"4S":R2
M33&I *.K',3.I>B*Y7W.12Z&Q+ W;!J0&\[QX0 P?7_ ?-2N<"8(-+ZRV%+=
M"2X9 Z@T%LV<E4]W6!O/XA^+W/#,$&SKGP$ ]P;7GA<!F2X%>%TPBNQ"%:>-
MX(HV,07CU*1]@]E(NUS2PUF^GTYZ.,<1 T#J;9:](H*.ACNP2H3:0G.J26D=
M9FL==UG8C%W&&5\TZ>$IP&KGC@&P=2Y&NSJ44O#Z"+Y0TZ2X5^"#$! \E=)2
M:5$$ZX'2_Y,>GHSW$2$RP,J9R*D738E&4IIAJCX/*76;*5@)V@E61"4X<UU&
MS?P<I(>GX+:#@P: W21>/5DX]X64D*)>D65%0ZCS<4A%])%9[T77B\273'IX
M"N2:.V< P#WCWU,\,1:2 Q>\ 161FG^O G#CC+;4_67>):)=&NGAJ<W+8J,/
M,"_W)>:]P@RJ+!GPK.OT3.T T27(W%B.B@>AAR(];%ZNK;6ULM ' \#H?6Z:
MR&3T'A,HZ^O+#4.+S!@')B5>=*Q3*09F/VQ>69T98FW],T"R>Y603\42C&4.
MLJR'0"S58?8VTL)Q&'Q!TD?TP-FELB+.\OM45L0Y3A@"3(\I^HR5T0FC01W>
MU,J< "UZ\#K$+#//07:A(K\P5L33H+/<Y)? BB@)\TQ4)@TMJ%FE-@*\%09$
MHE"M+,IGSP$:U5 7S8IX"J(:.F2 D/2Z(@Z-EW76'\NI=BM,@J>N@AH,+>H@
M0*H1NLSCN%A6Q%- U<8- Q3H/9GQI+#,>C)K8JG.A9 1,*H(!FTJ#$/2LB.E
MW'JLB,WWOL[<%(R"B6&6QW/F/LQ2AV!IE0<E0.E,L2-$!5XZ:TLF(_=)XZ>P
M)3;?25L%EJ?Y8H ,_H#I3Z*5$EVF7%'I:(H00&8@OR>D.B1[$TJ7,]69'(K-
M&>[.#)R%%A\@_"S@[,N,Z1PY)%_CJ]"VWNZC&H078[RRC!9$ERJP"[=B<VJ\
M<V^O=?7? ,'L,2>@SUJBYQ%TJI'890F8= 3IB]:<(C/Z_L2>ZU#DK0FL678?
M(*I-9>P2TFI5$H>8%=99)F2@.IT3LS+"BF1<Z'((WI*+L3W-U)F1UL-9 P2N
ME_D!E611U>A+70BGYIW^%2PJ*)BM#A2:77%G0]S0]%'+_#Z)I'&.$P9$TATW
MH,PN4+')P(C*4,1=A."X!*D$%YSYD,U9L'11)(TMT;3$$0/B:3(C5J&E(2BJ
M:UG9NH/4$(H,P+6UT:7"N.BRV]:5I/'2'VB=PYD#8'8>[U](CM9CE!!\((-F
MZ2&D7""YZ(321NC4!:F_ GGC'-R<1-XXQXGC(O15SC_G@JX4E)2#^(&;TH!G
MW@#+)F<E M>FR[6D7X.\L3U*FSBR_RBWV_^H?P7<Y[__[7]02P,$%     @
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MA:&((C$V:&8*"""B?<D2PQH@AJ!QA-*$!T0&X(LXH5P1>Y%(I)<1-6A6D/*
M2AB'S _M%"YXB<9))":40L D^E!(901>($.0 #Y23C7S%68T]SW8-Y/>[C5K
MM4H[=]L_[Y"V#4Q ?2&MC2UKEAE5..F@[81/MJ=<X:1H'51M[[:C1"JWZ:3<
M1T+NMIO&= >\] Y13&>PQGU]B'Y#+#()*/F6^12(N@]@@]0,#$5@W(_2P) '
M#HMI/*"S0;=$,I$J(SYF6E-JKV!ZP&_"L E^.)L*WGT"L$KO0LR6]_\?WG,T
M&40T'S$0$HTMH3D1211MY?^T Z:2B$Q:C%NE[*1V3.0(RZV!T%K$K09:<$LE
M,CJ)LE7L@NYR5H@U#[U&O6EJ,8V*ZB!?."O3/%NFE76P?.VPXKVO'ZV]7/&J
M:Z\])+9^Z#4/ZX\26[8J.[71,0K3_T.A7L@G)"0P*&C5DCNHHB_FO!W1X9)O
MG%L*VRX*CE;FV2GG*=8XUU03O+95,H=]$D4YKRS46GG(-HM&YMJU =F&E6\.
M*T5<86K>--_*%FJ;%)"K.> 5Z/\$T+>;6JNQW D);N79AGQO!WM&\*G6+'[
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M36^DR=.K"/-RGV!2Q!AZ&A1AY]MIK*E&[UUHJ2FN:UB,R62.#(",L\8EZB+
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MJI;8@7O#[?VEGX<K.H(W;2@PQ[IP#UNP2W;@*VE)U7/\^?T.&R_K<K\"RYF
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M1EL4MF+Q2TCT# =!3NV]CYT*AREG4YQ3<68U_)K!:?D>\?WRH 3D[>T0_7>
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M"*+1/\S)5.:,_C5\-;A^.6*#X1Q?]Y\=';?88,8&5Z/KR]%E7: 549*49!R
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MD%;U3WHM8!W_VI! 3^OAPP6-(H@4X:-%AGG20" AJ\*P]G$:A;F<ULDL^4J
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M #9 >-C ;S"4V(\WSE$A0^ ><QYR:U:+RIC"F:' T,,:<,0Q&G6'O4F<SPW
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MR<$'J&[NDK!AH8$6(LR_6.G^?WGT)=C<9._[@++5FW*'W2R8"N$$!C J8\#
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MM!?-MBI'2(]^GU1'B%Z&34>TV>#^7UZ J\#27'K?]1=U8%/9:^M"W.:1E:8
M3,,A,D0)6:/RZ+HRO[FOWUKC046"VV0IO]9J8?9IZVL+_-;<.H 7Z!WVAS3[
MRX"B7?M;9OI5]?/_ %!+ 0(4 Q0    (  ]S<%),CVV9_^P$  [:.0 1
M          "  0    !M>6=N+3(P,C Q,C,Q+FAT;5!+ 0(4 Q0    (  ]S
M<%*Z1$Z!(1P  "I2 0 1              "  2[M! !M>6=N+3(P,C Q,C,Q
M+GAS9%!+ 0(4 Q0    (  ]S<%*I5&@LC4$  ([F @ 5              "
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M>#,Q,2YH=&U02P$"% ,4    "  /<W!2T)NL5]X'  "V)0  &
M    @ 'V PD ;7EG;BTR,#(P,3(S,7AE>'@S,3(N:'1M4$L! A0#%     @
M#W-P4A<UL/2F!   @A0  !<              ( !"@P) &UY9VXM,C R,#$R
M,S%X97AX,S(N:'1M4$L! A0#%     @ #W-P4N'**%+)#P  L#T  !<
M         ( !Y1 ) &UY9VXM,C R,#$R,S%X97AX-#(N:'1M4$L%!@     -
-  T ;@,  .,@"0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
